Citrus Sinensis ID: 004218
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 767 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.973 | 0.739 | 0.425 | 1e-154 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.984 | 0.736 | 0.415 | 1e-144 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.951 | 0.708 | 0.419 | 1e-142 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.963 | 0.754 | 0.357 | 1e-111 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.947 | 0.580 | 0.349 | 1e-111 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.946 | 0.581 | 0.342 | 1e-107 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.930 | 0.598 | 0.342 | 3e-99 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.921 | 0.709 | 0.334 | 6e-96 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.953 | 0.640 | 0.316 | 2e-95 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.934 | 0.722 | 0.326 | 1e-94 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 546 bits (1406), Expect = e-154, Method: Compositional matrix adjust.
Identities = 332/781 (42%), Positives = 455/781 (58%), Gaps = 34/781 (4%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++SL LG+ N G + D+G LPNLL FN N FTG IP +L N++ ++ + M
Sbjct: 233 LSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNE 292
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L G++P GN+P LK+ + N + L F+TSLTN T+L L N+ G+
Sbjct: 293 NNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGD 351
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+P SI NLS L L +GG G IP IG L +L L L N +SG + T +G+L L
Sbjct: 352 LPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNL 411
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
+ L L N++SG IP +GN+ L +DLS N +PTS GN +LL + + +NKLNG
Sbjct: 412 RYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNG 471
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
IP EI+ + L + ++S N L G+LP++IG L N+ T+ L N LSG LP + NC +
Sbjct: 472 TIPLEIMKIQQLLRL-DMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLT 530
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
+E L + N F G IP+ L L G++ +DLS+N LSGSIP + L LNL+FNNLE
Sbjct: 531 MESLFLEGNLFYGDIPD-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLE 589
Query: 361 GVVPREGIFRHTSMVHLEGNPKL-----------CLHLGCENSSSHGRR--RIIIYIIVA 407
G VP +GIF + + V + GN L CL H R +++I + V
Sbjct: 590 GKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVG 649
Query: 408 I---IAIIAGCFLIFWLIIVRKGKAKPIGVSTLFKHSPQMISYDELRRATGNFSHENLIG 464
I + + + WL +K K + + + ISY +LR AT FS N++G
Sbjct: 650 ITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVG 709
Query: 465 SGSFGSVYKG-YLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSL 523
SGSFG+VYK L E VAVKVL+++ G KSF AECE+L++ RHRNLVKL+T+CSS+
Sbjct: 710 SGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSI 769
Query: 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKNE---HGNGLNFLERLNIAIDIASALDYLHN 580
DF+ EF AL+YEF+ NGSL W+H E E L LERLNIAID+AS LDYLH
Sbjct: 770 DFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV 829
Query: 581 DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL----ERIGNQSSISSTHVLKGSIG 636
C PI HCDLKP N+LLD+D+TA V DFGLAR LL E NQ +SS V +G+IG
Sbjct: 830 HCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQ--LSSAGV-RGTIG 886
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQV 696
Y PEYG+G +PS GDVYSFG++LLE+FTG PT+E F G +L + +S P+ +
Sbjct: 887 YAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDI 946
Query: 697 LDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756
+D + + + ++ CL + E VGL C ESP R+ ++ L + ++
Sbjct: 947 VDESILHIGLRVGFPVVE---CLTMVFE-VGLRCCEESPMNRLATSIVVKELISIRERFF 1002
Query: 757 K 757
K
Sbjct: 1003 K 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1320), Expect = e-144, Method: Compositional matrix adjust.
Identities = 325/782 (41%), Positives = 463/782 (59%), Gaps = 27/782 (3%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++SL++L + N G + D G LPNL N FTG IP +L N+++++ + +
Sbjct: 248 LSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPS 307
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L G +P G L L + + N + L F+ +LTN ++L +L N+ G+
Sbjct: 308 NHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQ 367
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+P I NLS L++L +GGN G IP IG L SL L+L N ++G++ +G+L EL
Sbjct: 368 LPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSEL 427
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
+ + L N +SG IP++LGN+ L + L N IP+S G+ LL ++L NKLNG
Sbjct: 428 RKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNG 487
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+IP E++ L SL ++N+S N L G L ++IG L ++ +D+S N LSG +P + NC S
Sbjct: 488 SIPHELMELPSL-VVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLS 546
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
LE LL+ N F GPIP+I L GL LDLS N LSG+IP + N L++LNL+ NN +
Sbjct: 547 LEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFD 605
Query: 361 GVVPREGIFRHTSMVHLEGNPKLC-----LHL---GCENSSSHGRRRIIIYIIVA----- 407
G VP EG+FR+TS + + GN LC L L E H R II I V+
Sbjct: 606 GAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAA 665
Query: 408 IIAIIAGCFLIFWLII----VRKGKAKPIGVSTLFKHSPQMISYDELRRATGNFSHENLI 463
++ + + W + VR + + K + ISYDEL + TG FS NLI
Sbjct: 666 LLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLI 725
Query: 464 GSGSFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
GSG+FG+V+KG+L + +VA+KVL++ G KSF AECEAL RHRNLVKL+T CSS
Sbjct: 726 GSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSS 785
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGN---GLNFLERLNIAIDIASALDYLH 579
DF+ +F ALVYEF+ NG+L W+H + E GN L RLNIAID+ASAL YLH
Sbjct: 786 SDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLH 845
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSIS-STHVLKGSIGYI 638
C PI HCD+KP NILLD+D+TA V DFGLA+ LL+ + I S+ ++G+IGY
Sbjct: 846 TYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYA 905
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLD 698
PEYG+G PS GDVYSFG++LLEIFTG PT++ F ++L + +S K +Q LD
Sbjct: 906 APEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQK--RQALD 963
Query: 699 RELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKR 758
++ + +Q + +CL T++ VG+SC+ ESP RI + EA+ +L + ++ +
Sbjct: 964 ITDETILRGAYAQHFNMVECL-TLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022
Query: 759 RQ 760
+
Sbjct: 1023 EE 1024
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1299), Expect = e-142, Method: Compositional matrix adjust.
Identities = 324/772 (41%), Positives = 443/772 (57%), Gaps = 42/772 (5%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++SL L LA N G + D G LPNL N+FTG IP +L N+++++ ++
Sbjct: 240 ISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISS 299
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L G++P G L L I N + + GL FI ++ N T+L +L N+ GE
Sbjct: 300 NYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGE 359
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+P SI NLS L+ L++G N G IP IG L SL L+L N +SGE+ G+L L
Sbjct: 360 LPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNL 419
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q +DL N ISG IP+ GN+ +L ++ L+ N IP S G + LL + + N+LNG
Sbjct: 420 QVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNG 479
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
IP+EIL + SL I +LS NFL G PEE+G L +V + S N LSG +P + C S
Sbjct: 480 TIPQEILQIPSLAYI-DLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLS 538
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
+E L M N F G IP+I + L L+ +D S+N LSG IP L +L +LR+LNL+ N E
Sbjct: 539 MEFLFMQGNSFDGAIPDI-SRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFE 597
Query: 361 GVVPREGIFRHTSMVHLEGNPKLC-----LHLG-CENSSSHGRRR---IIIYIIVAIIAI 411
G VP G+FR+ + V + GN +C + L C +S +R+ + ++ I
Sbjct: 598 GRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIG 657
Query: 412 IAGCFLIF------WLIIVRKGKAKPIG---VSTLFKHSPQMISYDELRRATGNFSHENL 462
IA LI W + +K G ST + +SY+EL AT FS NL
Sbjct: 658 IASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNL 717
Query: 463 IGSGSFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
IGSG+FG+V+KG L E VAVKVL++ G KSF AECE + RHRNLVKLIT CS
Sbjct: 718 IGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCS 777
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIH---GERKNEHGNGLNFLERLNIAIDIASALDYL 578
SLD + +F ALVYEF+ GSL W+ ER N+H L E+LNIAID+ASAL+YL
Sbjct: 778 SLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYL 837
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSIS--STHVLKGSIG 636
H C P+ HCD+KP NILLD+D+TA V DFGLA+ LL + +S ++ S+ ++G+IG
Sbjct: 838 HVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQ-LLYKYDRESFLNQFSSAGVRGTIG 896
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQV 696
Y PEYG+G +PS GDVYSFG++LLE+F+G PT ESFAG+ +L + +S
Sbjct: 897 YAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKS--------- 947
Query: 697 LDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748
L S S I D + ++ VG+ C+ E P R+ EA+R L
Sbjct: 948 ---ILSGCTSSGGSNAI---DEGLRLVLQVGIKCSEEYPRDRMRTDEAVREL 993
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 404 bits (1039), Expect = e-111, Method: Compositional matrix adjust.
Identities = 286/801 (35%), Positives = 441/801 (55%), Gaps = 62/801 (7%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
+SL Y+ L++N L GEIP + L L NK TG +P SL N TN++ + + N
Sbjct: 166 SSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESN 225
Query: 62 LLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEG--LSFITSLTNSTRLNFLAFDGNQFE 118
+L G +P + +P L+ + +N V + F SL NS+ L L GN
Sbjct: 226 MLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLG 285
Query: 119 GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQ 178
GEI S+ +LS L ++++ NR +G IP I L +LTLLNLS N +SG I E+ +L
Sbjct: 286 GEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLS 345
Query: 179 ELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQ------------ 226
+L+ + L+ N ++G IP LG++ +L +D+S N L+ IP SFGN
Sbjct: 346 KLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHL 405
Query: 227 ------------NLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGM 273
NL +DLS+N L G IP E++S L +L +NLS N L G +P E+
Sbjct: 406 SGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSK 465
Query: 274 LGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSN 333
+ V+++DLS+N LSG +P +C +LE L ++ N FS +P+ L +L L+ LD+S N
Sbjct: 466 MDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFN 525
Query: 334 KLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCLHLGCENSS 393
+L+G+IP Q L+ LN +FN L G V +G F ++ G+ LC + +
Sbjct: 526 RLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQAC 585
Query: 394 SHGRRRIIIYIIVAIIAIIAGCFLIFWLIIVRKGK-AKPIGV---------STLFKHSPQ 443
+ + + V + I +F +V++ + K + V ++ P+
Sbjct: 586 KKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPK 645
Query: 444 M--ISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWK-SFFA 500
ISY +L ATG F+ +LIGSG FG VYKG LR VAVKVLD ++ + SF
Sbjct: 646 YPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKR 705
Query: 501 ECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIH-GERKNEHGNGL 559
EC+ L+ TRHRNL+++IT+CS F ALV + NGSL ++ GE +++ L
Sbjct: 706 ECQILKRTRHRNLIRIITTCSKPGFN-----ALVLPLMPNGSLERHLYPGEYSSKN---L 757
Query: 560 NFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR---SLL 616
+ ++ +NI D+A + YLH+ V +VHCDLKP NILLD++MTA V DFG++R +
Sbjct: 758 DLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVE 817
Query: 617 ERIGNQSSI---SSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
E + S+ S+ +L GS+GYI PEYG+G++ ST GDVYSFGV+LLEI +G PT
Sbjct: 818 ETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDV 877
Query: 674 SFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQ--LHDCLITIIESVGLSCT 731
SL ++++S++P + + ++++ L + + + + + ++ +IE +GL CT
Sbjct: 878 LVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIE-LGLVCT 936
Query: 732 TESPGGR---IDIREALRRLK 749
+P R +D+ + RLK
Sbjct: 937 QYNPSTRPDMLDVAHEMGRLK 957
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 403 bits (1036), Expect = e-111, Method: Compositional matrix adjust.
Identities = 280/802 (34%), Positives = 424/802 (52%), Gaps = 75/802 (9%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
T L + N+L GEIP +G +L +L + N+ G IP SL N + +I +A N
Sbjct: 457 TRLQEIDWYGNRLSGEIPSSIG-RLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADN 515
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNF------------ 109
L G++P G L L+++ I N + G+ + L +L N TR+NF
Sbjct: 516 QLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSL---INLKNLTRINFSSNKFNGSISPL 572
Query: 110 ------LAFD--GNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNL 161
L+FD N FEG+IP +G +N L +L +G N+F G+IP + G++ L+LL++
Sbjct: 573 CGSSSYLSFDVTENGFEGDIPLELGKSTN-LDRLRLGKNQFTGRIPRTFGKISELSLLDI 631
Query: 162 SYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTS 221
S NS+SG I E+G ++L +DL N +SG IP LG L L ++ LS N+ +PT
Sbjct: 632 SRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTE 691
Query: 222 FGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTID 281
+ N+L++ L N LNG+IP+EI +L +L + NL +N L G LP IG L + +
Sbjct: 692 IFSLTNILTLFLDGNSLNGSIPQEIGNLQALNAL-NLEENQLSGPLPSTIGKLSKLFELR 750
Query: 282 LSANGLSGNLPNSFKNCKSLEKLL-MANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIP 340
LS N L+G +P + L+ L ++ N F+G IP+ ++ L LE LDLS N+L G +P
Sbjct: 751 LSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVP 810
Query: 341 SDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC-------LHLGCENSS 393
+ ++++L LNL++NNLEG + ++ F GN LC G +N
Sbjct: 811 GQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGSPLSHCNRAGSKNQR 868
Query: 394 SHGRRRIIIYIIVAIIAIIAGCFLIFWLII---------VRKGKAKPIGV-----STLFK 439
S + ++I ++ +A IA L+ L VR G + + LF
Sbjct: 869 SLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFS 928
Query: 440 H--SPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVK-VLDIESTGTWK 496
+ + I +D++ AT + E +IGSG G VYK L+ G ++AVK +L + + K
Sbjct: 929 NGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNK 988
Query: 497 SFFAECEALRNTRHRNLVKLITSCSS-LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEH 555
SF E + L RHR+LVKL+ CSS D N+ L+YE++ NGS+ DW+H +
Sbjct: 989 SFNREVKTLGTIRHRHLVKLMGYCSSKADGLNL----LIYEYMANGSVWDWLHANENTKK 1044
Query: 556 GNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615
L + RL IA+ +A ++YLH DC PIVH D+K N+LLD ++ A +GDFGLA+ L
Sbjct: 1045 KEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKIL 1104
Query: 616 LERIGN-QSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674
GN ++ S + GS GYI PEY K + DVYS G++L+EI TG PT
Sbjct: 1105 ---TGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAM 1161
Query: 675 FAGEVSLVKWVES--NFPKNA---QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLS 729
F E +V+WVE+ + P + ++++D EL+ L+ E Q+ + + L
Sbjct: 1162 FDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLE--------IALQ 1213
Query: 730 CTTESPGGRIDIREALRRLKNA 751
CT P R R+A L N
Sbjct: 1214 CTKSYPQERPSSRQASEYLLNV 1235
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 391 bits (1004), Expect = e-107, Method: Compositional matrix adjust.
Identities = 274/801 (34%), Positives = 419/801 (52%), Gaps = 75/801 (9%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
TSL + + N GEIP +G +L L + N+ G +P SL N + I+ +A N
Sbjct: 456 TSLKMIDMFGNHFEGEIPPSIG-RLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADN 514
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLN------------- 108
L G++P G L L+ + N + G+ + L SL N TR+N
Sbjct: 515 QLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSL---ISLRNLTRINLSHNRLNGTIHPL 571
Query: 109 -----FLAFD--GNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNL 161
+L+FD N FE EIP +GN N L +L +G N+ GKIP ++G++R L+LL++
Sbjct: 572 CGSSSYLSFDVTNNGFEDEIPLELGNSQN-LDRLRLGKNQLTGKIPWTLGKIRELSLLDM 630
Query: 162 SYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTS 221
S N+++G I ++ ++L +DL N +SG IP LG L +L ++ LS N+ +PT
Sbjct: 631 SSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTE 690
Query: 222 FGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTID 281
N LL + L N LNG+IP+EI +L +L ++NL KN G+LP+ +G L + +
Sbjct: 691 LFNCTKLLVLSLDGNSLNGSIPQEIGNLGALN-VLNLDKNQFSGSLPQAMGKLSKLYELR 749
Query: 282 LSANGLSGNLPNSFKNCKSLEKLL-MANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIP 340
LS N L+G +P + L+ L ++ N F+G IP+ + L LE LDLS N+L+G +P
Sbjct: 750 LSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVP 809
Query: 341 SDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC------LHLGCENSSS 394
+ ++++L LN++FNNL G + ++ F GN LC + N+
Sbjct: 810 GSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQ 867
Query: 395 HGRRRIIIYIIVAIIAIIAGCFLIFWLIIVRKGKA---KPIGVST--------------- 436
G + II AI A+ A +I + + K + K +G +
Sbjct: 868 QGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHK 927
Query: 437 -LFKH--SPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVK-VLDIEST 492
LF++ S I ++++ AT N S E +IGSG G VYK L G +VAVK +L +
Sbjct: 928 PLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDL 987
Query: 493 GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK 552
+ KSF E + L RHR+LVKL+ CSS K+ L+YE++ NGS+ DW+H ++
Sbjct: 988 MSNKSFSREVKTLGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKP 1044
Query: 553 --NEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610
+ L++ RL IA+ +A ++YLH+DC PIVH D+K N+LLD +M A +GDFG
Sbjct: 1045 VLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFG 1104
Query: 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
LA+ L E ++ S S GYI PEY K + DVYS G++L+EI TG P
Sbjct: 1105 LAKVLTENC--DTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMP 1162
Query: 671 THESFAGEVSLVKWVESNFP---KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVG 727
T F E+ +V+WVE++ +++D +L+ L+ E Q+ + +
Sbjct: 1163 TDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLE--------IA 1214
Query: 728 LSCTTESPGGRIDIREALRRL 748
L CT SP R R+A L
Sbjct: 1215 LQCTKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 363 bits (931), Expect = 3e-99, Method: Compositional matrix adjust.
Identities = 282/824 (34%), Positives = 410/824 (49%), Gaps = 110/824 (13%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
+SL L L +NQ+ G IP D+ KLP L+ + N FTG+IP SL TN+ ++N
Sbjct: 401 SSLGELLLTNNQINGSIPEDLW-KLP-LMALDLDSNNFTGEIPKSLWKSTNLMEFTASYN 458
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
LEG +P +GN LK + N++ G + +TSL+ L + N F+G+I
Sbjct: 459 RLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLS------VLNLNANMFQGKI 512
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIP---TSIGRLRSLTL-------------------- 158
P +G+ ++ L+ L +G N G+IP T++ +L+ L L
Sbjct: 513 PVELGDCTS-LTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQI 571
Query: 159 -------------LNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN 205
+LSYN +SG I E+G+ L + L+ N +SG IP +L L L
Sbjct: 572 EMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLT 631
Query: 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDG 265
+DLSGN L IP GN L ++L+NN+LNG+IP+ L SL + NL+KN LDG
Sbjct: 632 ILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKL-NLTKNKLDG 690
Query: 266 TLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGL 325
+P +G L + +DLS N LSG L + + L L + NKF+G IP+ L L L
Sbjct: 691 PVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQL 750
Query: 326 EVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCL 385
E LD+S N LSG IP+ + L L LNL NNL G VP +G+ + S L GN +LC
Sbjct: 751 EYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCG 810
Query: 386 HLGCENSSSHGRRRIIIYIIVAII---AIIAGCFLIF---WLIIVR-------------- 425
+ + G + + I ++ II F+ W + R
Sbjct: 811 RVVGSDCKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESR 870
Query: 426 -KG-------------KAKPIGVS-TLFKHSPQMISYDELRRATGNFSHENLIGSGSFGS 470
KG +P+ ++ +F+ + ++ AT +FS +N+IG G FG+
Sbjct: 871 LKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGT 930
Query: 471 VYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530
VYK L +VAVK L T + F AE E L +H NLV L+ CS + K
Sbjct: 931 VYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEK---- 986
Query: 531 LALVYEFLGNGSLGDWIHGERKNEHG--NGLNFLERLNIAIDIASALDYLHNDCEVPIVH 588
LVYE++ NGSL W+ +N+ G L++ +RL IA+ A L +LH+ I+H
Sbjct: 987 -LLVYEYMVNGSLDHWL----RNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIH 1041
Query: 589 CDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP 648
D+K NILLD D KV DFGLAR + +S +S+ V+ G+ GYIPPEYG +
Sbjct: 1042 RDIKASNILLDGDFEPKVADFGLARLI---SACESHVST--VIAGTFGYIPPEYGQSARA 1096
Query: 649 STAGDVYSFGVMLLEIFTGMSPTHESFAGEV--SLVKWVESNFPK-NAQQVLDRELRQLM 705
+T GDVYSFGV+LLE+ TG PT F +LV W + A V+D L+
Sbjct: 1097 TTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVID----PLL 1152
Query: 706 MSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749
+S + QL + + + C E+P R ++ + L+ LK
Sbjct: 1153 VSVALKNSQLR------LLQIAMLCLAETPAKRPNMLDVLKALK 1190
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (903), Expect = 6e-96, Method: Compositional matrix adjust.
Identities = 267/799 (33%), Positives = 399/799 (49%), Gaps = 92/799 (11%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+T+L + L L G+IP +G +L L+ + N G IP SL LTN+ I + +
Sbjct: 204 LTNLEVMWLTECHLVGQIPDSLG-QLSKLVDLDLALNDLVGHIPPSLGGLTNVVQIELYN 262
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L G +PP LGNL L++ + N++ G + L + L L N EGE
Sbjct: 263 NSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-------LESLNLYENNLEGE 315
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+P SI LS L ++ + GNR G +P +G L L++S N SG++ ++ EL
Sbjct: 316 LPASIA-LSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGEL 374
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
+ L + N SG IP +L + + L +I L+ N + +PT F ++ ++L NN +G
Sbjct: 375 EELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSG 434
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSF----- 295
I K I S+L+ ++ LS N G+LPEEIG L N+ + S N SG+LP+S
Sbjct: 435 EISKSIGGASNLSLLI-LSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGE 493
Query: 296 -------------------KNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLS 336
K+ K L +L +A+N+F+G IP+ + L L LDLS N S
Sbjct: 494 LGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFS 553
Query: 337 GSIPSDLQNLRALRSLNLTFNNLEGVVP---REGIFRHTSMVHLEGNPKLCLHL-GCENS 392
G IP LQ+L+ L LNL++N L G +P + +++++ + GNP LC + G S
Sbjct: 554 GKIPVSLQSLK-LNQLNLSYNRLSGDLPPSLAKDMYKNSFI----GNPGLCGDIKGLCGS 608
Query: 393 SSHGRRRIIIYIIVAIIAIIAGCFL--IFWLII----VRKGKAKPIGVSTLFKHSPQMIS 446
+ ++R ++++ +I + A L + W +K +A TL S
Sbjct: 609 ENEAKKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFS 668
Query: 447 YDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVL---DIESTGTW-------- 495
E+ + +N+IG+G+ G VYK L G +VAVK L ++ TG
Sbjct: 669 EHEILES---LDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGYKP 725
Query: 496 ----KSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER 551
++F AE E L RH+N+VKL CS+ D K LVYE++ NGSLGD +H +
Sbjct: 726 GVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCK-----LLVYEYMPNGSLGDLLHSSK 780
Query: 552 KNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611
G L + R I +D A L YLH+D PIVH D+K NIL+D D A+V DFG+
Sbjct: 781 ----GGMLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGV 836
Query: 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPT 671
A++ ++ G S V+ GS GYI PEY + + D+YSFGV++LEI T P
Sbjct: 837 AKA-VDLTGKAP--KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPV 893
Query: 672 HESFAGEVSLVKWVESNFP-KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSC 730
GE LVKWV S K + V+D +L I+ I +VGL C
Sbjct: 894 DPEL-GEKDLVKWVCSTLDQKGIEHVIDPKLDSCFKEE-----------ISKILNVGLLC 941
Query: 731 TTESPGGRIDIREALRRLK 749
T+ P R +R ++ L+
Sbjct: 942 TSPLPINRPSMRRVVKMLQ 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 350 bits (898), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 269/851 (31%), Positives = 409/851 (48%), Gaps = 120/851 (14%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
+ LV L L N L G IP ++G +L L N G IP + N +N+++I ++ N
Sbjct: 274 SELVDLFLYENSLSGSIPREIG-QLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLN 332
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
LL G++P +G L FL+ + I NK GS T+++N + L L D NQ G I
Sbjct: 333 LLSGSIPSSIGRLSFLEEFMISDNKFSGS------IPTTISNCSSLVQLQLDKNQISGLI 386
Query: 122 PESIGNLSNV-----------------------LSKLYMGGNRFYGKIPTSIGRLRSLTL 158
P +G L+ + L L + N G IP+ + LR+LT
Sbjct: 387 PSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTK 446
Query: 159 LNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEI 218
L L NS+SG I EIG L L L N+I+G IP+ +G+LKK+N +D S N L ++
Sbjct: 447 LLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKV 506
Query: 219 PTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVV 278
P G+ L IDLSNN L G++P + SLS L ++++S N G +P +G L ++
Sbjct: 507 PDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQ-VLDVSANQFSGKIPASLGRLVSLN 565
Query: 279 TIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEV-LDLSSNKLSG 337
+ LS N SG++P S C L+ L + +N+ SG IP+ L +++ LE+ L+LSSN+L+G
Sbjct: 566 KLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTG 625
Query: 338 SIPSD-----------------------LQNLRALRSLNLTFNNLEGVVPREGIFRHTSM 374
IPS L N+ L SLN+++N+ G +P +FR S
Sbjct: 626 KIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSP 685
Query: 375 VHLEGNPKLCLH--------------LGCENSSSHGRRRIIIYIIVAIIAIIAGCFLIFW 420
LEGN KLC LG + +S R+ + ++ + ++
Sbjct: 686 QDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVA 745
Query: 421 LIIVRKG----KAKPIGVSTLFKHSPQM---ISYDELRRATGNFSHENLIGSGSFGSVYK 473
+I R+ + +G + ++ +P S D++ R N+IG G G VY+
Sbjct: 746 VIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRC---LVEPNVIGKGCSGVVYR 802
Query: 474 GYLREGISVAVKVL---------DIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLD 524
+ G +AVK L D ++ SF AE + L RH+N+V+ + C
Sbjct: 803 ADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCC---- 858
Query: 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEV 584
N L+Y+++ NGSLG +H R G+ L++ R I + A L YLH+DC
Sbjct: 859 -WNRNTRLLMYDYMPNGSLGSLLHERR----GSSLDWDLRYRILLGAAQGLAYLHHDCLP 913
Query: 585 PIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL 644
PIVH D+K NIL+ D + DFGLA+ + E G+ S+T + GS GYI PEYG
Sbjct: 914 PIVHRDIKANNILIGLDFEPYIADFGLAKLVDE--GDIGRCSNT--VAGSYGYIAPEYGY 969
Query: 645 GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQL 704
K + DVYS+GV++LE+ TG P + + LV WV N + + +VLD LR
Sbjct: 970 SMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQN--RGSLEVLDSTLRSR 1027
Query: 705 MMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK---------IL 755
+ + +Q + L C SP R +++ LK ++ +L
Sbjct: 1028 TEAEADEMMQ--------VLGTALLCVNSSPDERPTMKDVAAMLKEIKQEREEYAKVDLL 1079
Query: 756 LKRRQPNEKAM 766
LK+ P M
Sbjct: 1080 LKKSPPPTTTM 1090
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 347 bits (891), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 253/775 (32%), Positives = 400/775 (51%), Gaps = 58/775 (7%)
Query: 7 LGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGT 66
L LA N L GEIP +G +L ++ N+ +GK+P S+ NLT ++ ++ N L G
Sbjct: 249 LDLAMNSLTGEIPESIG-RLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGE 307
Query: 67 VPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIG 126
+P + L + +N+ N G GL + +L N + F F+ N F G +P ++G
Sbjct: 308 LPEKIAALQLIS-FNLNDNFFTG----GLPDVVAL-NPNLVEFKIFN-NSFTGTLPRNLG 360
Query: 127 NLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLA 186
S + S+ + NRF G++P + R L + N +SGEI G L + +A
Sbjct: 361 KFSEI-SEFDVSTNRFSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMA 419
Query: 187 GNQISGSIPNTLGNLKKLNQIDLSGN-ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKE 245
N++SG +P L L +++L+ N +L IP S ++L +++S N +G IP +
Sbjct: 420 DNKLSGEVPARFWELP-LTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVK 478
Query: 246 ILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLL 305
+ L L +++LS+N G++P I L N+ +++ N L G +P+S +C L +L
Sbjct: 479 LCDLRDLR-VIDLSRNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTELTELN 537
Query: 306 MANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVP- 364
++NN+ G IP L +L L LDLS+N+L+G IP++L L+ L N++ N L G +P
Sbjct: 538 LSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRLK-LNQFNVSDNKLYGKIPS 596
Query: 365 --REGIFRHTSMVHLEGNPKLCLHLGCENSSSHGRRRIIIYIIVAIIAIIAGCFLIFWLI 422
++ IFR + + GNP LC +R + ++I+ I+A + WL
Sbjct: 597 GFQQDIFRPSFL----GNPNLCAPNLDPIRPCRSKRETRYILPISILCIVALTGALVWLF 652
Query: 423 IVRKGKAKPIGVSTLFKHSPQMISYDELRRATG--------NFSHENLIGSGSFGSVYKG 474
I K KP LFK P+ + + + G + +N+IGSG G VY+
Sbjct: 653 I----KTKP-----LFKRKPKRTNKITIFQRVGFTEEDIYPQLTEDNIIGSGGSGLVYRV 703
Query: 475 YLREGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531
L+ G ++AVK L E+ T + F +E E L RH N+VKL+ C+ EF
Sbjct: 704 KLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGNIVKLLMCCNG-----EEFR 758
Query: 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDL 591
LVYEF+ NGSLGD +H E+++ + L++ R +IA+ A L YLH+D PIVH D+
Sbjct: 759 FLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDV 818
Query: 592 KPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTA 651
K NILLD +M +V DFGLA+ L + S S + GS GYI PEYG K +
Sbjct: 819 KSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEK 878
Query: 652 GDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW-VESNFPKNAQQVLD-----------R 699
DVYSFGV+LLE+ TG P SF +VK+ +E+ + D R
Sbjct: 879 SDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYPSPSAEDGAMNQDSLGNYR 938
Query: 700 ELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754
+L +L+ + + ++ + +++ V L CT+ P R +R+ + LK + +
Sbjct: 939 DLSKLVDPKMKLSTREYEEIEKVLD-VALLCTSSFPINRPTMRKVVELLKEKKSL 992
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 767 | ||||||
| 255573062 | 1015 | serine-threonine protein kinase, plant-t | 0.994 | 0.751 | 0.671 | 0.0 | |
| 255573058 | 983 | serine-threonine protein kinase, plant-t | 0.989 | 0.772 | 0.661 | 0.0 | |
| 356528416 | 1006 | PREDICTED: LRR receptor-like serine/thre | 0.980 | 0.747 | 0.626 | 0.0 | |
| 357519427 | 1023 | Kinase-like protein [Medicago truncatula | 0.989 | 0.741 | 0.623 | 0.0 | |
| 357519429 | 993 | Receptor protein kinase-like protein [Me | 0.981 | 0.758 | 0.622 | 0.0 | |
| 356511039 | 1019 | PREDICTED: probable LRR receptor-like se | 0.973 | 0.733 | 0.626 | 0.0 | |
| 449450542 | 988 | PREDICTED: probable LRR receptor-like se | 0.990 | 0.769 | 0.611 | 0.0 | |
| 449450538 | 1017 | PREDICTED: probable LRR receptor-like se | 0.990 | 0.747 | 0.596 | 0.0 | |
| 224076934 | 1005 | predicted protein [Populus trichocarpa] | 0.985 | 0.752 | 0.594 | 0.0 | |
| 449450540 | 1003 | PREDICTED: probable LRR receptor-like se | 0.984 | 0.752 | 0.572 | 0.0 |
| >gi|255573062|ref|XP_002527461.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533196|gb|EEF34953.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2542), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/771 (67%), Positives = 601/771 (77%), Gaps = 8/771 (1%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
M+SLV L LASNQLWG++P DVG LPNLL FN CFNKFTG +PGSLHNLTNI IIR+AH
Sbjct: 243 MSSLVNLALASNQLWGKLPSDVGVTLPNLLDFNLCFNKFTGLLPGSLHNLTNIHIIRVAH 302
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
NLLEG VPPGL NLPFL+MYNIGFN VG GD+GL FITSLTNS+RL FLAFDGN +G
Sbjct: 303 NLLEGKVPPGLENLPFLEMYNIGFNNFVGYGDKGLDFITSLTNSSRLKFLAFDGNLLQGV 362
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IPES+GNLS LSKLYMGGN+ YG IP SIG L SLTLLNLSYNSI+G I EIGQL+ L
Sbjct: 363 IPESVGNLSKNLSKLYMGGNQIYGGIPASIGHLSSLTLLNLSYNSITGSIPREIGQLEHL 422
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q L LAGNQ SGSIP++LGNL+KLNQIDLS N L IPT+FGNFQ+LL++DLSNNKLNG
Sbjct: 423 QFLGLAGNQFSGSIPDSLGNLRKLNQIDLSRNGLVGAIPTTFGNFQSLLAMDLSNNKLNG 482
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+I KEIL+L SL+ I+NLS NFL G L E+IG+L +VVTIDLS N LSG++P+ KNC+S
Sbjct: 483 SIAKEILNLPSLSKILNLSNNFLSGNLSEDIGLLESVVTIDLSNNHLSGDIPSLIKNCES 542
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
LE+L M+ N FSGP+P +L E+KGLE LDLS N LSG IP DLQ L AL+ LNL FN+LE
Sbjct: 543 LEELYMSRNSFSGPVPAVLGEMKGLETLDLSYNHLSGFIPPDLQKLEALQLLNLAFNDLE 602
Query: 361 GVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSSHGRRRIIIYIIVAIIAIIAGCFLIFW 420
G VP G+F + S VHLEGN KL L L C+N S + I I++A+ A +A C I +
Sbjct: 603 GAVPCGGVFTNISKVHLEGNTKLSLELSCKNPRSRRANVVKISIVIAVTATLAFCLSIGY 662
Query: 421 LIIVRKGKAKPIGVS-TLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREG 479
L+ +R+ K K S L K Q++SY ELR+AT NF+ NLIGSG FGSVYKG+L +G
Sbjct: 663 LLFIRRSKGKIEWASNNLIKEQHQIVSYRELRQATDNFAERNLIGSGGFGSVYKGFLVDG 722
Query: 480 ISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLG 539
+VAVKVLDI+ TG WKSF AECEALRN RHRNLVKLITSCSS+DFKN+EFLALVYEFLG
Sbjct: 723 SAVAVKVLDIKQTGCWKSFVAECEALRNVRHRNLVKLITSCSSIDFKNVEFLALVYEFLG 782
Query: 540 NGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD 599
NGSL DWI G+RK E+G+GLN +ERLN+ ID ASA+DYLH DCEVP+VHCDLKP N+LL
Sbjct: 783 NGSLDDWIKGKRKKENGDGLNLMERLNVVIDAASAMDYLHYDCEVPVVHCDLKPSNVLLK 842
Query: 600 EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGV 659
EDMTAKVGDFGLA L+E+IG Q+SISSTHVLKGSIGYIPPEYGLG KPSTAGDVYSFGV
Sbjct: 843 EDMTAKVGDFGLATLLVEKIGVQTSISSTHVLKGSIGYIPPEYGLGVKPSTAGDVYSFGV 902
Query: 660 MLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDREL----RQLMMSSESQTIQL 715
MLLE+FTG SPT +SF GE +LV WV+S F N QVLD L +S ++
Sbjct: 903 MLLELFTGKSPTCDSFKGEQNLVGWVQSAFSSNILQVLDPVLLLPVDNWYHDDQSIISEI 962
Query: 716 H-DCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQPNEKA 765
DCLIT+ E VGLSCT ESP RI +R+AL +LK A+ LL PN K
Sbjct: 963 QNDCLITVCE-VGLSCTAESPDRRISMRDALLKLKAARDNLLN-YVPNYKV 1011
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255573058|ref|XP_002527459.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533194|gb|EEF34951.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 978 bits (2528), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 510/771 (66%), Positives = 595/771 (77%), Gaps = 12/771 (1%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
M+SLV L LASNQLWGE+P DVG LPNLL FNFC NKFTG IPGSLHNLTNI++IRMAH
Sbjct: 215 MSSLVTLALASNQLWGELPSDVGVTLPNLLVFNFCINKFTGTIPGSLHNLTNIKVIRMAH 274
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
NLLEGTVPPGLGNLPFL+MYNIGFN IV SGD+GL FI SLTNSTRL FLAFDGN+ +G
Sbjct: 275 NLLEGTVPPGLGNLPFLEMYNIGFNNIVSSGDKGLDFIASLTNSTRLKFLAFDGNRLQGV 334
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IPESIGNLS L +LYMG N+ YG IP SIG L LTLLNLSYNSI+G I EIGQL+ L
Sbjct: 335 IPESIGNLSKDLLQLYMGENQIYGGIPASIGHLSGLTLLNLSYNSITGSIPREIGQLEHL 394
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q L LAGNQ SGSIP++LGNL+KLNQIDLS N L IPT+FGNFQ+LL++DLSNNKLNG
Sbjct: 395 QFLGLAGNQFSGSIPDSLGNLRKLNQIDLSRNGLVGAIPTTFGNFQSLLAMDLSNNKLNG 454
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+I KEIL+L SL+ I+NLS NFL G L E+IG+L +VVTIDLS N LSG++P+ KNC+S
Sbjct: 455 SIAKEILNLPSLSKILNLSNNFLSGNLSEDIGLLESVVTIDLSNNHLSGDIPSLIKNCES 514
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
LE+L M+ N FSGP+P +L E+KGLE LDLS N LSG IP DLQ L AL+ LNL FN+LE
Sbjct: 515 LEELYMSRNSFSGPVPAVLGEMKGLETLDLSYNHLSGFIPPDLQKLEALQLLNLAFNDLE 574
Query: 361 GVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSSHGRRRIIIYIIVAIIAIIAGCFLIFW 420
G VP G+F + S VHLEGN KL L L C+N S + I I++A+ A +A C I +
Sbjct: 575 GAVPCGGVFTNISKVHLEGNTKLSLELSCKNPRSRRTNVVKISIVIAVTATLAFCLSIGY 634
Query: 421 LIIVRKGKAK-PIGVSTLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREG 479
L+ +R+ K K + L K Q++SY ELR+AT NF +NLIGSG FGSVYKG+L +G
Sbjct: 635 LLFIRRSKGKIECASNNLIKEQRQIVSYHELRQATDNFDEQNLIGSGGFGSVYKGFLADG 694
Query: 480 ISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLG 539
+VAVKVLDI+ TG WKSF AECEALRN RHRNLVKLITSCSS+DFKN+EFLALVYEFLG
Sbjct: 695 SAVAVKVLDIKQTGCWKSFVAECEALRNVRHRNLVKLITSCSSIDFKNVEFLALVYEFLG 754
Query: 540 NGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD 599
NGSL DWI G+RK E+G+GLN +ERLN+ ID ASA+DYLH DCEVP+VHCDLKP N+LL
Sbjct: 755 NGSLEDWIKGKRKKENGDGLNLMERLNVVIDAASAMDYLHYDCEVPVVHCDLKPSNVLLK 814
Query: 600 EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGV 659
EDMTAKVGDFGLA L+E+IG Q+SISSTHV + EYGLG KPSTAGDVYSFGV
Sbjct: 815 EDMTAKVGDFGLATLLVEKIGIQTSISSTHVXX----HDDAEYGLGVKPSTAGDVYSFGV 870
Query: 660 MLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLM--MSSESQTI---Q 714
MLLE+FTG SPT +SF GE +LV WV+S F N QVLD L + + Q+I
Sbjct: 871 MLLELFTGKSPTCDSFKGEQNLVGWVQSAFSSNILQVLDPILLLPVDNWYDDDQSIISEI 930
Query: 715 LHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQPNEKA 765
+DCLIT+ E VGLSCT ESP RI +R+AL +LK A+ LL PN K
Sbjct: 931 QNDCLITVCE-VGLSCTAESPERRISMRDALLKLKAARDNLLN-YVPNHKV 979
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528416|ref|XP_003532799.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 929 bits (2401), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/763 (62%), Positives = 578/763 (75%), Gaps = 11/763 (1%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++SLV LASN WGEIP DVG KLP L+ F CFN FTG+IPGSLHNLTNIQ+IRMA
Sbjct: 247 LSSLVNFALASNSFWGEIPQDVGHKLPKLIVFCICFNYFTGRIPGSLHNLTNIQVIRMAS 306
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N LEG+VPPGLGNLPFL YNI +N IV SG GL FITSLTNST LNFLA DGN EG
Sbjct: 307 NHLEGSVPPGLGNLPFLCTYNIRYNWIVSSGVRGLDFITSLTNSTHLNFLAIDGNMLEGV 366
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IPE+IGNLS LS LYMG NRF G IP+SIGRL L LLNLSYNSISGEI E+GQL+EL
Sbjct: 367 IPETIGNLSKDLSTLYMGQNRFNGSIPSSIGRLSGLKLLNLSYNSISGEIPQELGQLEEL 426
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q L LAGN+ISG IP+ LGNL KLN +DLS N+L IPTSFGN QNLL +DLS+N+LNG
Sbjct: 427 QELSLAGNEISGGIPSILGNLLKLNLVDLSRNKLVGRIPTSFGNLQNLLYMDLSSNQLNG 486
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+IP EIL+L +L+ ++NLS NFL G +PE +G L +V +ID S N L G +P+SF NC S
Sbjct: 487 SIPMEILNLPTLSNVLNLSMNFLSGPIPE-VGRLSSVASIDFSNNQLYGGIPSSFSNCLS 545
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
LEKL + N+ SGPIP L +++GLE LDLSSN+LSG+IP +LQNL L+ LNL++N++E
Sbjct: 546 LEKLFLPRNQLSGPIPKALGDVRGLETLDLSSNQLSGTIPIELQNLHGLKLLNLSYNDIE 605
Query: 361 GVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSSHGRRRIIIYIIVAIIAIIAGCFLIFW 420
G +P G+F++ S VHLEGN KLCLH C GR+ I +YI++AI + C I
Sbjct: 606 GAIPGAGVFQNLSAVHLEGNRKLCLHFSCM-PHGQGRKNIRLYIMIAITVTLILCLTIGL 664
Query: 421 LIIV--RKGKAKPIGVSTLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLRE 478
L+ + +K K P+ K MISYDEL AT FS ENL+G GSFGSVYKG+L
Sbjct: 665 LLYIENKKVKVAPVAEFEQLKPHAPMISYDELLLATEEFSQENLLGVGSFGSVYKGHLSH 724
Query: 479 GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFL 538
G +VAVKVLD TG+ KSFFAECEA++N+RHRNLVKLITSCSS+DFKN +FLALVYE+L
Sbjct: 725 GATVAVKVLDTLRTGSLKSFFAECEAMKNSRHRNLVKLITSCSSIDFKNNDFLALVYEYL 784
Query: 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598
NGSL DWI G RK+E GNGLN +ERLNIA+D+A ALDYLHND E+P+VHCDLKP NILL
Sbjct: 785 CNGSLDDWIKGRRKHEKGNGLNLMERLNIALDVACALDYLHNDSEIPVVHCDLKPSNILL 844
Query: 599 DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFG 658
DEDMTAKVGDFGLAR L++R +Q SISST VL+GSIGYIPPEYG GEKPS AGDVYSFG
Sbjct: 845 DEDMTAKVGDFGLARLLIQRSTSQVSISSTRVLRGSIGYIPPEYGWGEKPSAAGDVYSFG 904
Query: 659 VMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSS-----ESQTI 713
++LLE+F+G SPT E F G++S+ +WV+S+ QV+D +L L+ + E +
Sbjct: 905 IVLLEMFSGKSPTDECFTGDLSIRRWVQSSCKDKIVQVIDPQLLSLIFNDDPSEGEGPIL 964
Query: 714 QLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756
QL+ C+ +I+ VG++CTT +P RI IREA+RRLK A+ LL
Sbjct: 965 QLY-CVDSIV-GVGIACTTNNPDERIGIREAVRRLKAARDSLL 1005
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357519427|ref|XP_003630002.1| Kinase-like protein [Medicago truncatula] gi|355524024|gb|AET04478.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 922 bits (2384), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/770 (62%), Positives = 571/770 (74%), Gaps = 11/770 (1%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++SLV L LA+N WGEIPYDVG LP LL FNFCFNKFTG+IPGSLHNLTNI++IRMA
Sbjct: 258 LSSLVNLALAANSFWGEIPYDVGHLLPKLLVFNFCFNKFTGRIPGSLHNLTNIRVIRMAS 317
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N LEG VPPGLGNLPFL MYNIG+N+IV +G GL FITSLTNST LNFLA DGN +G
Sbjct: 318 NHLEGIVPPGLGNLPFLHMYNIGYNRIVTTGVNGLDFITSLTNSTHLNFLAIDGNMLKGV 377
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IPE+IGNLS LS LYMG NRF G IP+SI RL L LLNLSYNSISG+I E+GQL EL
Sbjct: 378 IPETIGNLSKELSILYMGENRFNGSIPSSISRLSGLKLLNLSYNSISGDIPKELGQLDEL 437
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q L L GN+ISG IPN+LGNL KLN+IDLS NEL IP SFGNFQNLL +DLS+NKLNG
Sbjct: 438 QGLYLDGNKISGDIPNSLGNLIKLNKIDLSRNELVGRIPVSFGNFQNLLYMDLSSNKLNG 497
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+IP EIL++ +L+ ++NLSKN L G +P E+G L + TID S N L GN+P+SF NC S
Sbjct: 498 SIPVEILNIPTLSNVLNLSKNLLSGPIP-EVGQLTTISTIDFSNNQLYGNIPSSFSNCLS 556
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
LEK+ ++ N SG IP L ++KGLE LDLSSN LSG IP +LQNL L+ LN+++N+LE
Sbjct: 557 LEKMFLSQNMLSGYIPKALGDVKGLETLDLSSNLLSGPIPIELQNLHVLQLLNISYNDLE 616
Query: 361 GVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSSHGRRRIIIYIIVAIIAIIAGCFLIFW 420
G +P G+F++ S VHLEGN KLCLH C H R + YII+AI+ + C I
Sbjct: 617 GEIPSGGVFQNVSNVHLEGNKKLCLHFACV-PQVHKRSSVRFYIIIAIVVTLVLCLTIGL 675
Query: 421 LIIVRKGKAKPIGVSTLFKHSPQ--MISYDELRRATGNFSHENLIGSGSFGSVYKGYLRE 478
L+ ++ K K ST + PQ +SYDELR AT FS ENLIG GSFG VYKG+LR+
Sbjct: 676 LLYMKYTKVKVTETSTFGQLKPQAPTVSYDELRLATEEFSQENLIGIGSFGKVYKGHLRQ 735
Query: 479 GIS-VAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEF 537
G S VAVKVLD TG KSFFAECEA++N+RHRNLVKLITSCSS+DF+N +FLALVYE+
Sbjct: 736 GNSTVAVKVLDTSRTGFLKSFFAECEAMKNSRHRNLVKLITSCSSVDFRNNDFLALVYEY 795
Query: 538 LGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNIL 597
L GSL DWI G R + +GNGLN +ERLNI ID+A ALDYLHND E PIVHCDLKP NIL
Sbjct: 796 LSKGSLEDWIKGRRNHANGNGLNLMERLNIVIDVALALDYLHNDSETPIVHCDLKPSNIL 855
Query: 598 LDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSF 657
LDEDMTAKVGDFGLAR L+++ +Q SISSTHVL+GSIGYIPPEYG GEKPS AGDVYSF
Sbjct: 856 LDEDMTAKVGDFGLARLLIQKSTSQVSISSTHVLRGSIGYIPPEYGWGEKPSAAGDVYSF 915
Query: 658 GVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMM---SSESQTIQ 714
G++LLE+F G SP + F G + KWV+S F QV+D +L L+ S+ +Q
Sbjct: 916 GIVLLELFCGKSPQDDCFTGGQGITKWVQSAFKNKTAQVIDPQLLSLIFHDDSARDSDLQ 975
Query: 715 LHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQPNEK 764
L C + I VGLSCT ++P RI IR A+R+L A + L R +EK
Sbjct: 976 LR-C-VDAIMGVGLSCTADNPDERIGIRVAVRQLIAASQ-LKSSRDSSEK 1022
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357519429|ref|XP_003630003.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355524025|gb|AET04479.1| Receptor protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 915 bits (2366), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 476/765 (62%), Positives = 573/765 (74%), Gaps = 12/765 (1%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++SLV L LASN GEIPYDVG KLP LL FNFCFNKFTG+IPGSLHNLTNI++IRMA
Sbjct: 233 LSSLVNLPLASNSFSGEIPYDVGHKLPKLLVFNFCFNKFTGRIPGSLHNLTNIRVIRMAS 292
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N LEGTVPPGLGNLPFL MYNIG+N+IV +G GL FITSLTNST LNFLA DGN EG
Sbjct: 293 NHLEGTVPPGLGNLPFLHMYNIGYNRIVNAGVNGLDFITSLTNSTHLNFLAIDGNMVEGV 352
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
I E+IGNLS LS LYMG NRF G IP SIGRL L LLNL YNS SGEI E+GQL+EL
Sbjct: 353 ISETIGNLSKELSILYMGENRFNGSIPLSIGRLSGLKLLNLQYNSFSGEIPNELGQLEEL 412
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q L L GN+I+G+IPN+LGNL LN+IDLS N L IP SFGNFQNLL +DLS+NKLNG
Sbjct: 413 QELYLDGNKITGAIPNSLGNLINLNKIDLSRNLLVGRIPISFGNFQNLLYMDLSSNKLNG 472
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+IP EIL+L +L+ ++NLS N L G +P ++G L + +ID S N L G++P+SF +C S
Sbjct: 473 SIPAEILNLPTLSNVLNLSMNLLSGPIP-QVGKLTTIASIDFSNNQLYGSIPSSFSSCLS 531
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
LEKL +A N SG IP L E++ LE LDLSSN L+G IP +LQ+L+ LR LNL++N+LE
Sbjct: 532 LEKLFLARNMLSGSIPKALGEVRALETLDLSSNLLTGPIPIELQSLQVLRLLNLSYNDLE 591
Query: 361 GVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSSHGRRRIIIYIIVAIIAIIAGCFLIFW 420
G +P G+F++ S VHLEGN KLCL C H R + +YII+AI+ + C I
Sbjct: 592 GDIPSGGVFQNLSNVHLEGNKKLCLQFSCV-PQVHRRSHVRLYIIIAIVVTLVLCLAIGL 650
Query: 421 LIIVRKGKAKPIGVST---LFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLR 477
L+ ++ K K S + + P M+SYDELR AT FS ENLIG GSFGSVYKG+L
Sbjct: 651 LLYMKYSKVKVTATSASGQIHRQGP-MVSYDELRLATEEFSQENLIGIGSFGSVYKGHLS 709
Query: 478 EGIS-VAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536
+G S AVKVLD TG+ KSFFAECEA++N+RHRNLVKLITSCSS+DF+N +FLALVYE
Sbjct: 710 QGNSTTAVKVLDTLRTGSLKSFFAECEAMKNSRHRNLVKLITSCSSVDFRNNDFLALVYE 769
Query: 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNI 596
+L NGSL DWI G + + +GNGLN +ERLNIAID+A ALDYLHND E PI HCDLKP NI
Sbjct: 770 YLSNGSLEDWIKGRKNHANGNGLNLMERLNIAIDVALALDYLHNDSETPIAHCDLKPSNI 829
Query: 597 LLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYS 656
LLDEDMTAKVGDFGLAR L++R NQ SISSTHVL+GSIGYIPPEYG GEKPS AGDVYS
Sbjct: 830 LLDEDMTAKVGDFGLARLLIQRSTNQVSISSTHVLRGSIGYIPPEYGWGEKPSAAGDVYS 889
Query: 657 FGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQT---I 713
FG++LLE+F+G SP + F G + + KWV+S F QV+D +L L+ +S T +
Sbjct: 890 FGIVLLELFSGKSPQDDCFTGGLGITKWVQSAFKNKTVQVIDPQLLSLISHDDSATDSNL 949
Query: 714 QLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKR 758
QLH C + I VG+SCT ++P RI IR A+R+LK A+ LLK+
Sbjct: 950 QLH-C-VDAIMGVGMSCTADNPDERIGIRVAVRQLKAARDSLLKK 992
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511039|ref|XP_003524239.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2363), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/764 (62%), Positives = 575/764 (75%), Gaps = 17/764 (2%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++SLV L LA+N LWGEIP DVG KLP LL FNFCFNKFTG IPGSLHNLTNI++IRMA
Sbjct: 247 LSSLVNLALAANSLWGEIPQDVGQKLPKLLVFNFCFNKFTGGIPGSLHNLTNIRVIRMAS 306
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
NLLEGTVPPGLGNLPFL+MYNIG+N+IV SG GL FITSLTNST LNFLA DGN EG
Sbjct: 307 NLLEGTVPPGLGNLPFLRMYNIGYNRIVSSGVRGLDFITSLTNSTHLNFLAIDGNMLEGV 366
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IPESIGNLS L+KLYMG NRF G IP+SIGRL L LLNLSYNSI G+I E+GQL+ L
Sbjct: 367 IPESIGNLSKDLTKLYMGQNRFNGSIPSSIGRLSGLKLLNLSYNSIFGDIPNELGQLEGL 426
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q L LAGN+ISG IPN+LGNL KLNQIDLS N+L IPTSFGN QNLL +DLS+NKL+G
Sbjct: 427 QELSLAGNEISGGIPNSLGNLLKLNQIDLSKNKLVGRIPTSFGNLQNLLYMDLSSNKLDG 486
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+IP EIL+L +L+ ++NLS NFL G +P +IG L V +ID S+N L G +P+SF NC S
Sbjct: 487 SIPMEILNLPTLSNVLNLSMNFLSGPIP-QIGRLITVASIDFSSNQLFGGIPSSFSNCLS 545
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
LE L +A N+ SGPIP L ++KGLE LDLSSN+L G+IP +LQNL L+ LNL++N+LE
Sbjct: 546 LENLFLARNQLSGPIPKALGDVKGLETLDLSSNQLFGAIPIELQNLHVLKFLNLSYNDLE 605
Query: 361 GVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSSHGRRRIIIYIIVAIIAIIAGCFLIFW 420
GV+P G+F++ S +HLEGN KLCL+ C HGR +YII+AI+ + C I
Sbjct: 606 GVIPSGGVFQNLSAIHLEGNRKLCLYFPCM-PHGHGRNA-RLYIIIAIVLTLILCLTIGL 663
Query: 421 LIIVRKGKAKPIGVST----LFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYL 476
L+ ++ + K + L H P M+SYDELR AT FS ENL+G GSFGSVYKG+L
Sbjct: 664 LLYIKNKRVKVTATAATSEQLKPHVP-MVSYDELRLATEEFSQENLLGVGSFGSVYKGHL 722
Query: 477 REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536
G +VAVKVLD TG+ KSFFAECEA++N+RHRNLVKLITSCSS+DFKN +FLALVYE
Sbjct: 723 SHGATVAVKVLDTLRTGSLKSFFAECEAMKNSRHRNLVKLITSCSSVDFKNNDFLALVYE 782
Query: 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNI 596
+L NGSL DWI G R + +GNGLN +ERLNIAID+A ALDYLHND E+P+VHCDLKP NI
Sbjct: 783 YLCNGSLEDWIKGRRNHANGNGLNLMERLNIAIDVACALDYLHNDSEIPVVHCDLKPSNI 842
Query: 597 LLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYS 656
LLDEDMTAKVGDFGLARSL++ NQ SISSTH S EYG GEKPS AGDVYS
Sbjct: 843 LLDEDMTAKVGDFGLARSLIQNSTNQVSISSTHYCYLSNA----EYGWGEKPSAAGDVYS 898
Query: 657 FGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMM---SSESQTI 713
FG++LLE+F+G SPT E F G +S+ +WV+S QV+D +L L SE +
Sbjct: 899 FGIVLLELFSGKSPTDECFTGGLSIRRWVQSAMKNKTVQVIDPQLLSLTFHDDPSEGPNL 958
Query: 714 QLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757
QL+ T+ VG+SCT ++P RI IR+A+R+LK A+ LLK
Sbjct: 959 QLNYLDATV--GVGISCTADNPDERIGIRDAVRQLKAARDSLLK 1000
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450542|ref|XP_004143021.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] gi|449482805|ref|XP_004156409.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 909 bits (2348), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/768 (61%), Positives = 584/768 (76%), Gaps = 8/768 (1%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
M+SLV L LASN+LWG P D+GD LPNLL FNFCFN+FTG IP SLHN+TNIQIIR A+
Sbjct: 222 MSSLVTLALASNKLWGTFPMDIGDTLPNLLVFNFCFNEFTGTIPPSLHNITNIQIIRFAY 281
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N LEGTVPPGL NL L MYNIG+NK+ S +G+SFITSLT S+RL+FLA DGN FEG+
Sbjct: 282 NFLEGTVPPGLENLHNLIMYNIGYNKL-SSDKDGISFITSLTKSSRLSFLAIDGNNFEGQ 340
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IPESIGNLS LS L+MGGNR G IP +IG L L LLNLSYNS+SGEI +EIGQL+ L
Sbjct: 341 IPESIGNLSKSLSILFMGGNRLSGNIPHTIGNLNGLALLNLSYNSLSGEIPSEIGQLENL 400
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
QSL LA NQ SG IP+TLGNL+KL +DLS NEL +PTSF NFQ LLS+DLSNNKLNG
Sbjct: 401 QSLVLAKNQFSGWIPSTLGNLQKLTNLDLSRNELIGGVPTSFNNFQKLLSMDLSNNKLNG 460
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+IPKE L+L S + +N+S N L G LPEEIG L N+ IDLS N +SG +P+S K KS
Sbjct: 461 SIPKEALNLPS-SIRLNMSNNLLTGPLPEEIGYLANLFQIDLSTNLISGEIPSSIKGWKS 519
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
+EKL MA NK SG IPN + ELK ++++DLSSN LSG IP +LQ L AL+ LNL+FN+LE
Sbjct: 520 IEKLFMARNKLSGHIPNSIGELKAIQIIDLSSNLLSGPIPDNLQYLAALQYLNLSFNDLE 579
Query: 361 GVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSSHGRRRIIIYIIVAIIAIIAGCFLIFW 420
G VP+ GIF + V L+GN KLC + C+ S S + + + I+ A+ + +A CF+I
Sbjct: 580 GEVPKGGIFESRANVSLQGNSKLCWYSSCKKSDSKHNKAVKVIILSAVFSTLALCFIIGT 639
Query: 421 LIIVRKGKAKPIGVSTLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGI 480
LI + K+K + + L +M+SYDELR AT NFS +NLIG GSFGSVYKG L+E I
Sbjct: 640 LIHFLRKKSKTVPSTELLNSKHEMVSYDELRLATENFSEKNLIGKGSFGSVYKGMLKEDI 699
Query: 481 SVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGN 540
VA+KVLD+ TG+ +SF AECEALRN RHRNLV+LIT+CSS+DF NMEF AL+YE L N
Sbjct: 700 PVAIKVLDVNRTGSLRSFKAECEALRNVRHRNLVRLITTCSSIDFSNMEFRALIYELLSN 759
Query: 541 GSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE 600
GSL +W+HG+R +E+G GLN LER+NIAID+ASA++YLH+DCE+PIVHCDLKP N+LLDE
Sbjct: 760 GSLDEWVHGQRSHEYGIGLNILERVNIAIDVASAINYLHHDCELPIVHCDLKPSNVLLDE 819
Query: 601 DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVM 660
+MTAKVGDFGLAR L+E QSSI+STHVLKGSIGY+PPEYG G KP+TAGDVYSFGV
Sbjct: 820 NMTAKVGDFGLARLLMENKNAQSSITSTHVLKGSIGYLPPEYGFGVKPTTAGDVYSFGVT 879
Query: 661 LLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMS--SESQTI---QL 715
LLE+FTG SPT E F GE++L+KWVES++P++ +V+D +L +L + +TI
Sbjct: 880 LLELFTGKSPTDECFTGELNLIKWVESSYPEDIMEVIDHKLPELFVDLVYRGRTIGSDMQ 939
Query: 716 HDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQPNE 763
DCL +I V LSCT +P RID+ +A+ +L++A+ L++ N+
Sbjct: 940 KDCLTKVI-GVALSCTVNTPVNRIDMEDAVSKLRSAKDNLIRPSNKND 986
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450538|ref|XP_004143019.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] gi|449482798|ref|XP_004156407.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 894 bits (2310), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/773 (59%), Positives = 578/773 (74%), Gaps = 13/773 (1%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
M+SLV L LASNQLWG P D+G+KLPNLL FNFCFNKFTG IP SLHN+T IQ+IR AH
Sbjct: 248 MSSLVTLALASNQLWGTFPKDIGEKLPNLLVFNFCFNKFTGTIPESLHNITKIQVIRFAH 307
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSG-DEGLSFITSLTNSTRLNFLAFDGNQFEG 119
N LEGTVP GL L L MYNIG+NK VGS + GL FITSLTNS+RL FLA DGN FEG
Sbjct: 308 NFLEGTVPAGLEKLHNLSMYNIGYNKFVGSDTNGGLDFITSLTNSSRLAFLALDGNNFEG 367
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
IP+SIGNLS LSKLYMG NRFYG IP++I L+ L+LLNLS NS+SGEI ++IG+L++
Sbjct: 368 VIPDSIGNLSKDLSKLYMGENRFYGNIPSTISNLQGLSLLNLSDNSLSGEIPSQIGKLEK 427
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
LQ L LA NQ+SG IP +LG+L+ LNQIDLSGN+L IPTSFGN+ NLLS+DLS NKLN
Sbjct: 428 LQMLGLARNQLSGRIPTSLGDLRMLNQIDLSGNDLVGNIPTSFGNYMNLLSLDLSKNKLN 487
Query: 240 GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCK 299
G+IP+ L+L L+ I+NLS NF G LPEEIG L NVVTID+S N GN+P+S CK
Sbjct: 488 GSIPRATLALPGLSKILNLSNNFFSGPLPEEIGSLENVVTIDISNNHFFGNIPSSISGCK 547
Query: 300 SLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359
SLE L+MANN+FSGPIP +L+GL++LDLSSN+LSG IP + Q L+AL++LNL+FN+L
Sbjct: 548 SLEALIMANNEFSGPIPRTFEDLRGLQILDLSSNRLSGPIPREFQQLKALQTLNLSFNDL 607
Query: 360 EGVVPREGIFRHTSMVHLEGNPKLC--LHLGCE-NSSSHGRRRIIIYIIVAIIAIIAGCF 416
EG+VP E + + ++L+GNPKLC L+L C + +I++ +++ + I+ F
Sbjct: 608 EGIVPTE--LENITNLYLQGNPKLCDELNLSCAVTKTKEKVIKIVVVSVLSAVLAISIIF 665
Query: 417 LIFWLIIVRKGKAKPIGVSTLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYL 476
++ RK K K S L K P+MISY EL AT NFS ENLIG GSFG+VY+GYL
Sbjct: 666 GTVTYLMRRKSKDKSFQSSELVKGMPEMISYRELCLATQNFSSENLIGKGSFGTVYRGYL 725
Query: 477 REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536
+G ++AVKVL++E G+ +SF AECEALRN RHRNLVKLITSCSS+DFK EFLALVYE
Sbjct: 726 EQGTAIAVKVLNMERAGSVRSFLAECEALRNVRHRNLVKLITSCSSIDFKRKEFLALVYE 785
Query: 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNI 596
FL NGSL WIH + + G+GLN +ERLNIAID+AS LDYLHN +VPIVHCDLKP NI
Sbjct: 786 FLSNGSLDSWIHKHKLHADGSGLNLIERLNIAIDVASVLDYLHNGYDVPIVHCDLKPSNI 845
Query: 597 LLDEDMTAKVGDFGLARSLLERIGNQ-SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVY 655
+L E+MTAKVGDFGLAR L+E NQ SSI+S+HVLKGSIGY+PPEYG+G KP+TAGDVY
Sbjct: 846 ILSEEMTAKVGDFGLARLLMEGGNNQSSSITSSHVLKGSIGYVPPEYGVGRKPTTAGDVY 905
Query: 656 SFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDREL-----RQLMMSSES 710
SFGV L+E+FTG PTHESF+G+++L+KWV+ +PK+ +++D L + E
Sbjct: 906 SFGVTLMELFTGKCPTHESFSGDLNLIKWVQLAYPKDMDEIMDTTLLESGSKLYYEEQEI 965
Query: 711 QTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQPNE 763
+ + +DC T + SV L CT +SP R +++ L +L+ + L++ NE
Sbjct: 966 DSTKQYDCF-TDVMSVALCCTVDSPEKRSCMKDVLLKLQMIRATLIRSSNANE 1017
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076934|ref|XP_002305057.1| predicted protein [Populus trichocarpa] gi|222848021|gb|EEE85568.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 873 bits (2256), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/762 (59%), Positives = 573/762 (75%), Gaps = 6/762 (0%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++SLV+L +ASNQL G+IP DVGD+LPNLL FNFC NKF G IP SLHNLTN+Q IRMA
Sbjct: 244 ISSLVFLAVASNQLRGQIPIDVGDRLPNLLSFNFCINKFNGSIPWSLHNLTNMQSIRMAD 303
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
NL G+VPP L NLP L +YNIG N+I SGDEGL F++S TNS+ L FLA DGN EG
Sbjct: 304 NLFSGSVPPRLRNLPKLTLYNIGGNQIKSSGDEGLDFLSSFTNSSYLKFLAIDGNLLEGL 363
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IPESIGNLS L LY+G N+ YG IP SI L SL LLN++YN +SGEI EIG+L +L
Sbjct: 364 IPESIGNLSRSLRNLYLGRNQIYGSIPASIRHLSSLALLNINYNHVSGEIPPEIGELTDL 423
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q L LA N+ISG IP++LGNL+KL +I+LS NEL +PT+F NFQ L S+DLS+N+ NG
Sbjct: 424 QELHLAANKISGRIPDSLGNLQKLIKINLSANELVGRLPTTFVNFQQLQSMDLSSNRFNG 483
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+IPKE+ +LSSL+ +NLS N L G LP+EI L NV +D S N LSG++P++ +CKS
Sbjct: 484 SIPKEVFNLSSLSATLNLSSNQLTGPLPQEIRRLENVAAVDFSHNYLSGSIPDTIGSCKS 543
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
LE+L M NN FSG IP L ++KGLE+LDLSSN++SG+IP L+NL+AL LNL+FNNLE
Sbjct: 544 LEELFMGNNMFSGSIPATLGDVKGLEILDLSSNQISGTIPKTLENLQALLLLNLSFNNLE 603
Query: 361 GVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSSHGRRRIIIYIIVAIIAIIAGCFLIFW 420
G++P+EG FR+ S +H+EGN KLCL L C N+ R IYI++A IA + C +I
Sbjct: 604 GLLPKEGAFRNLSRIHVEGNSKLCLDLSCWNNQHRQRISTAIYIVIAGIAAVTVCSVIAV 663
Query: 421 LIIVRKGKAKPIGVSTLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGI 480
+ VRK K + + S K ISY ELR ATG+F ENLIG GSFGSVYKG LR+
Sbjct: 664 FLCVRKRKGEIMPRSDSIKLQHPTISYGELREATGSFDAENLIGKGSFGSVYKGELRDAT 723
Query: 481 SVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGN 540
VAVKVLD E G+WKSF AECEAL+N RHRNL+KLITSCSS+D + ++F+ALVYE++ N
Sbjct: 724 VVAVKVLDSEKYGSWKSFLAECEALKNVRHRNLIKLITSCSSMDNRGLQFVALVYEYMHN 783
Query: 541 GSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE 600
GSL +WI G R+ G LN LERLN+AID+A A+DYLH+DCEVP+VHCDLKP N+L+D+
Sbjct: 784 GSLEEWIKGSRRRLDGGLLNILERLNVAIDVACAVDYLHHDCEVPVVHCDLKPSNVLVDK 843
Query: 601 DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVM 660
DMTAKVGDFGLA+ L ER ++ SIS T L+GS+GYIPPEYGLG K +T+GDVYS+GV+
Sbjct: 844 DMTAKVGDFGLAKLLAERGADKQSISCTGGLRGSVGYIPPEYGLGLKATTSGDVYSYGVV 903
Query: 661 LLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDREL----RQLMMSSESQTIQ-L 715
LLE+FTG SPTHE F+ ++SL+KWV+S FP N ++V+D EL + ++ ++ +
Sbjct: 904 LLELFTGKSPTHEIFSRDLSLIKWVKSAFPANIEEVVDPELLLSIKDFHHGAQFESPEKQ 963
Query: 716 HDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757
H+CLI I+ VGLSCT ESPG RI +R++L +LK A+ LLK
Sbjct: 964 HECLIAIL-GVGLSCTVESPGQRITMRDSLHKLKKARDTLLK 1004
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450540|ref|XP_004143020.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] gi|449482801|ref|XP_004156408.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2209), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/761 (57%), Positives = 560/761 (73%), Gaps = 6/761 (0%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
M+SL+ L LASN+L G P ++GD L NL F+ CFN+FTG IP S+HNLT IQ++R AH
Sbjct: 244 MSSLLTLALASNRLRGAFPVNIGDNLSNLEVFHLCFNQFTGTIPHSIHNLTKIQVLRFAH 303
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L GT+PPGL NL L YNIG NK GD GLSFITSLTN++ L++LA D NQ EG
Sbjct: 304 NHLGGTLPPGLENLHELSYYNIGSNKFSSVGDNGLSFITSLTNNSHLSYLAIDDNQLEGM 363
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IP++IGNLS +S L MGGNR YG IP+SI LR L+LLNLS NS+SGEI+++IG+L+ L
Sbjct: 364 IPDTIGNLSKDISILNMGGNRMYGNIPSSISNLRGLSLLNLSDNSLSGEIISQIGKLENL 423
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
+ L LA N+ SG+IP+++GNL KL ++DLSGN L +IPTSFGNF LLS+D SNNKL G
Sbjct: 424 EILGLARNRFSGNIPSSMGNLHKLIEVDLSGNNLIGKIPTSFGNFVTLLSLDFSNNKLEG 483
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+IP+E LSL+ L+ ++NLS N G+LP+EIG+L NV+ ID+S N +SG++ S CKS
Sbjct: 484 SIPREALSLARLSKVLNLSNNHFSGSLPKEIGLLKNVIVIDISNNRISGDIVPSISGCKS 543
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
LEKL+MA N+F GPIP L +LKGL+ LDLSSN LSG IP +LQ++ L+ LNL+FN+LE
Sbjct: 544 LEKLIMARNEFFGPIPITLKDLKGLQHLDLSSNHLSGPIPYELQDIAGLQYLNLSFNDLE 603
Query: 361 GVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSSHGRRRIIIYIIVAIIAIIAGCFLIFW 420
G +P +F V+LEGN KLCL+ C S S + I + + + + +A CF+I
Sbjct: 604 GAIPVGEVFESIGSVYLEGNQKLCLYSSCPKSGSKHAKVIEVIVFTVVFSTLALCFIIGI 663
Query: 421 LIIVRKGKAKPIGVSTLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGI 480
LI ++ K+K K +M++Y LR T NFS ++LIG GSFG+VY+G L++GI
Sbjct: 664 LIYFKRNKSKIEPSIESEKRQYEMVTYGGLRLTTENFSEKHLIGKGSFGTVYRGSLKQGI 723
Query: 481 SVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGN 540
VA+KVLDI TG+ KSF AECEALRN RHRNLVKL+TSCS +DF NMEF AL+YE L N
Sbjct: 724 PVAIKVLDINKTGSIKSFLAECEALRNVRHRNLVKLVTSCSGIDFSNMEFRALIYELLSN 783
Query: 541 GSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE 600
GSL +WI G+R +++G+GL+ L R+NIAIDIASA++YLH+DCE PI+HCDLKP NILLD
Sbjct: 784 GSLEEWIKGQRSHQNGSGLDVLTRMNIAIDIASAINYLHHDCEYPIIHCDLKPSNILLDA 843
Query: 601 DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVM 660
DMTAKVGDFGLA L E Q+SI+STHVLKGSIGY+PPEYG G KP+ AGDVYSFG+
Sbjct: 844 DMTAKVGDFGLASLLSESARTQNSITSTHVLKGSIGYLPPEYGYGVKPTKAGDVYSFGIT 903
Query: 661 LLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDREL--RQLMMSSESQTIQL--- 715
LLE+FTG +PT E F GE++LVKWVES F K+ +V+D +L L + E Q + L
Sbjct: 904 LLELFTGKNPTDECFTGELNLVKWVESGFRKDVMEVIDIKLWKHSLDLKYEDQNMSLGKE 963
Query: 716 HDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756
DCL+ IE V LSCT P RIDI++ + +L+NA++ L+
Sbjct: 964 KDCLMETIE-VALSCTVNYPAERIDIKDVVSKLQNAKEKLI 1003
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 767 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.434 | 0.329 | 0.471 | 2.8e-150 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.409 | 0.310 | 0.475 | 2.7e-141 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.498 | 0.370 | 0.411 | 4.8e-139 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.967 | 0.723 | 0.405 | 1.1e-135 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.972 | 0.739 | 0.386 | 3.2e-120 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.949 | 0.710 | 0.375 | 3.7e-119 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.492 | 0.301 | 0.359 | 6.1e-107 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.955 | 0.747 | 0.346 | 1.2e-104 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.492 | 0.302 | 0.349 | 2.3e-104 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.941 | 0.615 | 0.357 | 8.6e-104 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 2.8e-150, Sum P(2) = 2.8e-150
Identities = 164/348 (47%), Positives = 217/348 (62%)
Query: 418 IFWLIIVRKGKAKPIGVSTLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYL- 476
+ WL +K K + + + ISY +LR AT FS N++GSGSFG+VYK L
Sbjct: 663 LIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLL 722
Query: 477 REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536
E VAVKVL+++ G KSF AECE+L++ RHRNLVKL+T+CSS+DF+ EF AL+YE
Sbjct: 723 TEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYE 782
Query: 537 FLGNGSLGDWIHGERKNE-H--GNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKP 593
F+ NGSL W+H E E H L LERLNIAID+AS LDYLH C PI HCDLKP
Sbjct: 783 FMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKP 842
Query: 594 GNILLDEDMTAKVGDFGLARSLL----ERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPS 649
N+LLD+D+TA V DFGLAR LL E NQ +SS V +G+IGY PEYG+G +PS
Sbjct: 843 SNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQ--LSSAGV-RGTIGYAAPEYGVGGQPS 899
Query: 650 TAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSE 709
GDVYSFG++LLE+FTG PT+E F G +L + +S P+ ++D + + +
Sbjct: 900 INGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVG 959
Query: 710 SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757
++ CL + E VGL C ESP R+ ++ L + ++ K
Sbjct: 960 FPVVE---CLTMVFE-VGLRCCEESPMNRLATSIVVKELISIRERFFK 1003
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 740 (265.6 bits), Expect = 2.7e-141, Sum P(2) = 2.7e-141
Identities = 155/326 (47%), Positives = 212/326 (65%)
Query: 443 QMISYDELRRATGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAE 501
+ ISY +LR AT FS N++GSGSFG+V+K L E VAVKVL+++ G KSF AE
Sbjct: 689 EKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAE 748
Query: 502 CEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNE---HGNG 558
CE+L++TRHRNLVKL+T+C+S DF+ EF AL+YE+L NGS+ W+H E E
Sbjct: 749 CESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRT 808
Query: 559 LNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618
L LERLNI ID+AS LDYLH C PI HCDLKP N+LL++D+TA V DFGLAR LL +
Sbjct: 809 LTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLL-K 867
Query: 619 IGNQSSIS--STHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676
+S ++ S+ ++G+IGY PEYG+G +PS GDVYSFGV+LLE+FTG PT E F
Sbjct: 868 FDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFG 927
Query: 677 GEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPG 736
G ++L + + P+ ++ D+ + + + +T + CL ++E VGL C E P
Sbjct: 928 GNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRTAE---CLTLVLE-VGLRCCEEYPT 983
Query: 737 GRIDIREALRRLKNAQKILLK-RRQP 761
R+ E + L + ++ K RR P
Sbjct: 984 NRLATSEVAKELISIRERFFKTRRTP 1009
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 707 (253.9 bits), Expect = 4.8e-139, Sum P(2) = 4.8e-139
Identities = 158/384 (41%), Positives = 221/384 (57%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++SL L LA N G + D G LPNL N+FTG IP +L N+++++ ++
Sbjct: 240 ISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISS 299
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L G++P G L L I N + + GL FI ++ N T+L +L N+ GE
Sbjct: 300 NYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGE 359
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+P SI NLS L+ L++G N G IP IG L SL L+L N +SGE+ G+L L
Sbjct: 360 LPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNL 419
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q +DL N ISG IP+ GN+ +L ++ L+ N IP S G + LL + + N+LNG
Sbjct: 420 QVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNG 479
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
IP+EIL + SL I +LS NFL G PEE+G L +V + S N LSG +P + C S
Sbjct: 480 TIPQEILQIPSLAYI-DLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLS 538
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
+E L M N F G IP+I + L L+ +D S+N LSG IP L +L +LR+LNL+ N E
Sbjct: 539 MEFLFMQGNSFDGAIPDI-SRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFE 597
Query: 361 GVVPREGIFRHTSMVHLEGNPKLC 384
G VP G+FR+ + V + GN +C
Sbjct: 598 GRVPTTGVFRNATAVSVFGNTNIC 621
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1329 (472.9 bits), Expect = 1.1e-135, P = 1.1e-135
Identities = 312/769 (40%), Positives = 434/769 (56%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++SL + N+L G IP + L L + N+F GKIP S+ N +++ +I++
Sbjct: 247 LSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYG 306
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
NL G + G G L L + N + FI+ LTN ++L L N G
Sbjct: 307 NLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGV 366
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+P S NLS LS L + N+ G IP IG L L L L N+ G + + +G+L+ L
Sbjct: 367 LPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNL 426
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
L N +SGSIP +GNL +LN + L N+ + IP + N NLLS+ LS N L+G
Sbjct: 427 GILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSG 486
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
IP E+ ++ +L+ ++N+SKN L+G++P+EIG L N+V +N LSG +PN+ +C+
Sbjct: 487 PIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQL 546
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
L L + NN SG IP+ L +LKGLE LDLSSN LSG IP+ L ++ L SLNL+FN+
Sbjct: 547 LRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFV 606
Query: 361 GVVPREGIFRHTSMVHLEGNPKLC-----LHLG--C---ENSSSHGXXXXXXXXXXXXXX 410
G VP G F S + ++GN KLC LHL C EN
Sbjct: 607 GEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAALAI 666
Query: 411 XXXGCFLIFWLIIVRKGKAKPIGVSTLFKHSPQMISYDELRRATGNFSHENLIGSGSFGS 470
LI W +KG T K P ++SY +L +AT F+ NL+GSGSFGS
Sbjct: 667 LSSLYLLITWHKRTKKGAPS----RTSMKGHP-LVSYSQLVKATDGFAPTNLLGSGSFGS 721
Query: 471 VYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530
VYKG L VAVKVL +E+ KSF AECEALRN RHRNLVK++T CSS+D + +F
Sbjct: 722 VYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDF 781
Query: 531 LALVYEFLGNGSLGDWIHGERKNEHGNG-LNFLERLNIAIDIASALDYLHNDCEVPIVHC 589
A+VY+F+ NGSL DWIH E ++ LN R+ I +D+A ALDYLH P+VHC
Sbjct: 782 KAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHC 841
Query: 590 DLKPGNILLDEDMTAKVGDFGLARSLLERIGN-QSSISSTHVLKGSIGYIPPEYGLGEKP 648
D+K N+LLD DM A VGDFGLAR L++ Q S SS + G+IGY PEYG+G
Sbjct: 842 DIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFI-GTIGYAAPEYGVGLIA 900
Query: 649 STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDREL-----RQ 703
ST GD+YS+G+++LEI TG PT +F ++ L ++VE V+D +L
Sbjct: 901 STHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENW 960
Query: 704 LMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI---DIREALRRLK 749
L ++ S ++ +C++ ++ +GLSC+ E P R DI + L +K
Sbjct: 961 LNSTNNSPCRRITECIVWLLR-LGLSCSQELPSSRTPTGDIIDELNAIK 1008
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1183 (421.5 bits), Expect = 3.2e-120, P = 3.2e-120
Identities = 304/787 (38%), Positives = 428/787 (54%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++SL L L N G + D G+ LPN+ + N TG IP +L N++ +++ +
Sbjct: 233 LSSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGK 292
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEG-LSFITSLTNSTRLNFLAFDGNQFEG 119
N + G++ P G L L + N + GS G L+F+ +LTN + L+ L+ N+ G
Sbjct: 293 NRMTGSISPNFGKLENLHYLELANNSL-GSYSFGDLAFLDALTNCSHLHGLSVSYNRLGG 351
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
+P SI N+S L+ L + GN YG IP IG L L L L+ N ++G + T +G L
Sbjct: 352 ALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVG 411
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
L L L N+ SG IP+ +GNL +L ++ LS N +P S G+ ++L + + NKLN
Sbjct: 412 LGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLN 471
Query: 240 GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCK 299
G IPKEI+ + +L + N+ N L G+LP +IG L N+V + L N LSG+LP + C
Sbjct: 472 GTIPKEIMQIPTLVHL-NMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCL 530
Query: 300 SLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359
S+E + + N F G IP+I L G++ +DLS+N LSGSI +N L LNL+ NN
Sbjct: 531 SMEVIYLQENHFDGTIPDIKG-LMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNF 589
Query: 360 EGVVPREGIFRHTSMVHLEGNPKLC-----LHLG-CENSSSHGXXXXXXXXXXXXXXXXX 413
EG VP EGIF++ ++V + GN LC L L C +
Sbjct: 590 EGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSV 649
Query: 414 GCFLIFWLIIV-------RKGKAKPIGVSTLFKHS--PQMISYDELRRATGNFSHENLIG 464
G L+ L IV RK K I S F + +SY +LR AT FS N++G
Sbjct: 650 GIALLLLLFIVSLSWFKKRKNNQK-INNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVG 708
Query: 465 SGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSL 523
SGSFG+V+K L+ E VAVKVL+++ G KSF AECE+L++ RHRNLVKL+T+C+S+
Sbjct: 709 SGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASI 768
Query: 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKNE-H--GNGLNFLERLNIAIDIASALDYLHN 580
DF+ EF AL+YEF+ NGSL W+H E E H L LERLNIAID+AS LDYLH
Sbjct: 769 DFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV 828
Query: 581 DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPP 640
C PI HCDLKP NILLD+D+TA V DFGLAR LL+ +Q S + G G I
Sbjct: 829 HCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKF--DQESFFNQLSSAGVRGTIG- 885
Query: 641 EYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA------- 693
Y E G G ++++ E F G+ + NF N+
Sbjct: 886 -YAAPEY-GMGGQPSIHG----DVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALP 939
Query: 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753
++VLD + ++ S + +CL I++ VGL C ESP R+ EA + L + ++
Sbjct: 940 ERVLDIADKSILHSGLRVGFPVLECLKGILD-VGLRCCEESPLNRLATSEAAKELISIRE 998
Query: 754 ILLKRRQ 760
K R+
Sbjct: 999 RFFKTRR 1005
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1173 (418.0 bits), Expect = 3.7e-119, P = 3.7e-119
Identities = 295/785 (37%), Positives = 430/785 (54%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++SL++L + N G + D G LPNL N FTG IP +L N+++++ + +
Sbjct: 248 LSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPS 307
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKI--VGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
N L G +P G L L + + N + SGD L F+ +LTN ++L +L N+
Sbjct: 308 NHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGD--LDFLGALTNCSQLQYLNVGFNKLG 365
Query: 119 GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQ 178
G++P I NLS L++L +GGN G IP IG L SL L+L N ++G++ +G+L
Sbjct: 366 GQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELS 425
Query: 179 ELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKL 238
EL+ + L N +SG IP++LGN+ L + L N IP+S G+ LL ++L NKL
Sbjct: 426 ELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKL 485
Query: 239 NGNIPKEILSLSSLTTI-----------------------VNLSKNFLDGTLPEEIGMLG 275
NG+IP E++ L SL + +++S N L G +P+ +
Sbjct: 486 NGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCL 545
Query: 276 NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKL 335
++ + L N G +P+ + L L ++ N SG IP +A L+ L+LS N
Sbjct: 546 SLEFLLLQGNSFVGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNF 604
Query: 336 SGSIPSDLQNLRALRSLNLTFN-NLEGVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSS 394
G++P++ R ++++ N NL G +P L+ P + L +SS
Sbjct: 605 DGAVPTE-GVFRNTSAMSVFGNINLCGGIPS-----------LQLQP-CSVELPRRHSSV 651
Query: 395 HGXXXXXXXXXXXXXXXXXGC--FLIFWLIIVRKGKAKPIGVSTLF---KHSPQMISYDE 449
C +L ++ + V+ +A F K + ISYDE
Sbjct: 652 RKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDE 711
Query: 450 LRRATGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAECEALRNT 508
L + TG FS NLIGSG+FG+V+KG+L + +VA+KVL++ G KSF AECEAL
Sbjct: 712 LYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGI 771
Query: 509 RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNG---LNFLERL 565
RHRNLVKL+T CSS DF+ +F ALVYEF+ NG+L W+H + E GN L RL
Sbjct: 772 RHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARL 831
Query: 566 NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL--ERIGNQS 623
NIAID+ASAL YLH C PI HCD+KP NILLD+D+TA V DFGLA+ LL +R
Sbjct: 832 NIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHI 891
Query: 624 SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK 683
SS V +G+IGY PEYG+G PS GDVYSFG++LLEIFTG PT++ F ++L
Sbjct: 892 QFSSAGV-RGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHS 950
Query: 684 WVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIRE 743
+ +S K +Q LD ++ + +Q + +CL T++ VG+SC+ ESP RI + E
Sbjct: 951 FTKSALQK--RQALDITDETILRGAYAQHFNMVECL-TLVFRVGVSCSEESPVNRISMAE 1007
Query: 744 ALRRL 748
A+ +L
Sbjct: 1008 AISKL 1012
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 6.1e-107, Sum P(2) = 6.1e-107
Identities = 144/401 (35%), Positives = 225/401 (56%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
T L + N+L GEIP +G +L +L + N+ G IP SL N + +I +A N
Sbjct: 457 TRLQEIDWYGNRLSGEIPSSIG-RLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADN 515
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLT----NSTRLN--------- 108
L G++P G L L+++ I N + G+ + L + +LT +S + N
Sbjct: 516 QLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGS 575
Query: 109 --FLAFD--GNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN 164
+L+FD N FEG+IP +G +N L +L +G N+F G+IP + G++ L+LL++S N
Sbjct: 576 SSYLSFDVTENGFEGDIPLELGKSTN-LDRLRLGKNQFTGRIPRTFGKISELSLLDISRN 634
Query: 165 SISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGN 224
S+SG I E+G ++L +DL N +SG IP LG L L ++ LS N+ +PT +
Sbjct: 635 SLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFS 694
Query: 225 FQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSA 284
N+L++ L N LNG+IP+EI +L +L + NL +N L G LP IG L + + LS
Sbjct: 695 LTNILTLFLDGNSLNGSIPQEIGNLQALNAL-NLEENQLSGPLPSTIGKLSKLFELRLSR 753
Query: 285 NGLSGNLPNSFKNCKSLEKLL-MANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDL 343
N L+G +P + L+ L ++ N F+G IP+ ++ L LE LDLS N+L G +P +
Sbjct: 754 NALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQI 813
Query: 344 QNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC 384
++++L LNL++NNLEG + ++ F GN LC
Sbjct: 814 GDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLC 852
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 1.2e-104, P = 1.2e-104
Identities = 272/784 (34%), Positives = 423/784 (53%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGS-LHNLTNIQIIRMA 59
+ L +L L SN+L G +P + + NL + N +G++P + + +Q + ++
Sbjct: 190 LKELRFLLLWSNKLTGTVPSSLSNST-NLKWMDLESNMLSGELPSQVISKMPQLQFLYLS 248
Query: 60 HNLLEG-----TVPP---GLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLA 111
+N + P L N L+ + N + G E S + L S L +
Sbjct: 249 YNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSL---GGEITSSVRHL--SVNLVQIH 303
Query: 112 FDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEIL 171
D N+ G IP I NL N L+ L + N G IP + +L L + LS N ++GEI
Sbjct: 304 LDQNRIHGSIPPEISNLLN-LTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIP 362
Query: 172 TEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSI 231
E+G + L LD++ N +SGSIP++ GNL +L ++ L GN L+ +P S G NL +
Sbjct: 363 MELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEIL 422
Query: 232 DLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGN 290
DLS+N L G IP E++S L +L +NLS N L G +P E+ + V+++DLS+N LSG
Sbjct: 423 DLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGK 482
Query: 291 LPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALR 350
+P +C +LE L ++ N FS +P+ L +L L+ LD+S N+L+G+IP Q L+
Sbjct: 483 IPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLK 542
Query: 351 SLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSSHGXXXXXXXXXXXXXX 410
LN +FN L G V +G F ++ G+ LC + +
Sbjct: 543 HLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSL 602
Query: 411 XXXGCFLIFWLIIVRKGK-AKPIGV---------STLFKHSPQM--ISYDELRRATGNFS 458
+F +V++ + K + V ++ P+ ISY +L ATG F+
Sbjct: 603 IATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFN 662
Query: 459 HENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWK-SFFAECEALRNTRHRNLVKLI 517
+LIGSG FG VYKG LR VAVKVLD ++ + SF EC+ L+ TRHRNL+++I
Sbjct: 663 ASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRII 722
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIH-GERKNEHGNGLNFLERLNIAIDIASALD 576
T+CS F ALV + NGSL ++ GE +++ L+ ++ +NI D+A +
Sbjct: 723 TTCSKPGFN-----ALVLPLMPNGSLERHLYPGEYSSKN---LDLIQLVNICSDVAEGIA 774
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR---SLLERIGNQSSIS--STH-V 630
YLH+ V +VHCDLKP NILLD++MTA V DFG++R + E + S+S ST +
Sbjct: 775 YLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGL 834
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690
L GS+GYI PEYG+G++ ST GDVYSFGV+LLEI +G PT SL ++++S++P
Sbjct: 835 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYP 894
Query: 691 KNAQQVLDRELRQLMMSSESQTIQL--HDCLITIIESVGLSCTTESPGGR---IDIREAL 745
+ + ++++ L + + + + + ++ +IE +GL CT +P R +D+ +
Sbjct: 895 DSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIE-LGLVCTQYNPSTRPDMLDVAHEM 953
Query: 746 RRLK 749
RLK
Sbjct: 954 GRLK 957
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 575 (207.5 bits), Expect = 2.3e-104, Sum P(2) = 2.3e-104
Identities = 140/401 (34%), Positives = 221/401 (55%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
TSL + + N GEIP +G +L L + N+ G +P SL N + I+ +A N
Sbjct: 456 TSLKMIDMFGNHFEGEIPPSIG-RLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADN 514
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLT----NSTRLN--------- 108
L G++P G L L+ + N + G+ + L + +LT + RLN
Sbjct: 515 QLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGS 574
Query: 109 --FLAFD--GNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN 164
+L+FD N FE EIP +GN N L +L +G N+ GKIP ++G++R L+LL++S N
Sbjct: 575 SSYLSFDVTNNGFEDEIPLELGNSQN-LDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSN 633
Query: 165 SISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGN 224
+++G I ++ ++L +DL N +SG IP LG L +L ++ LS N+ +PT N
Sbjct: 634 ALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFN 693
Query: 225 FQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSA 284
LL + L N LNG+IP+EI +L +L ++NL KN G+LP+ +G L + + LS
Sbjct: 694 CTKLLVLSLDGNSLNGSIPQEIGNLGALN-VLNLDKNQFSGSLPQAMGKLSKLYELRLSR 752
Query: 285 NGLSGNLPNSFKNCKSLEKLL-MANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDL 343
N L+G +P + L+ L ++ N F+G IP+ + L LE LDLS N+L+G +P +
Sbjct: 753 NSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSV 812
Query: 344 QNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC 384
++++L LN++FNNL G + ++ F GN LC
Sbjct: 813 GDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLC 851
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1028 (366.9 bits), Expect = 8.6e-104, P = 8.6e-104
Identities = 276/771 (35%), Positives = 407/771 (52%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
T L L L+ NQ+ GEIP G NL + N FTG+IP + N +N++ + +A N
Sbjct: 408 TGLKLLDLSHNQMTGEIPRGFGRM--NLTFISIGRNHFTGEIPDDIFNCSNLETLSVADN 465
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
L GT+ P +G L L++ + +N + G + N LN L N F G I
Sbjct: 466 NLTGTLKPLIGKLQKLRILQVSYNSLTGP------IPREIGNLKDLNILYLHSNGFTGRI 519
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQ 181
P + NL+ +L L M N G IP + ++ L++L+LS N SG+I +L+ L
Sbjct: 520 PREMSNLT-LLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLT 578
Query: 182 SLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSF-GNFQNL-LSIDLSNNKLN 239
L L GN+ +GSIP +L +L LN D+S N L IP + +N+ L ++ SNN L
Sbjct: 579 YLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLT 638
Query: 240 GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNS-FKNC 298
G IPKE+ L + I +LS N G++P + NV T+D S N LSG++P+ F+
Sbjct: 639 GTIPKELGKLEMVQEI-DLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGM 697
Query: 299 KSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNN 358
+ L ++ N FSG IP + L LDLSSN L+G IP L NL L+ L L NN
Sbjct: 698 DMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNN 757
Query: 359 LEGVVPREGIFRHTSMVHLEGNPKLCLHLG----C--ENSSSHGXXXXXXXXXXXXXXXX 412
L+G VP G+F++ + L GN LC C + SSH
Sbjct: 758 LKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAA 817
Query: 413 XGCFLIFWLIIVR-KGKAKPI---GVSTL--FKHSPQMISYD--ELRRATGNFSHENLIG 464
L+ LI+ K K K I S+L + ++ ++ EL +AT +F+ N+IG
Sbjct: 818 LLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIG 877
Query: 465 SGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
S S +VYKG L +G +AVKVL+++ S + K F+ E + L +HRNLVK++
Sbjct: 878 SSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----G 933
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC 582
+++ + ALV F+ NG+L D IHG G+ LE++++ + IAS +DYLH+
Sbjct: 934 FAWESGKTKALVLPFMENGNLEDTIHGSAA-PIGS---LLEKIDLCVHIASGIDYLHSGY 989
Query: 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEY 642
PIVHCDLKP NILLD D A V DFG AR L R + S+ +ST +G+IGY+ PE+
Sbjct: 990 GFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFR-EDGSTTASTSAFEGTIGYLAPEF 1048
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFTGMSPT--HESFAGEVSLVKWVES---NFPKNAQQVL 697
K +T DV+SFG++++E+ T PT ++ + +++L + VE N K +VL
Sbjct: 1049 AYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVL 1108
Query: 698 DRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748
D EL ++S + + + D L + L CT+ P R D+ E L L
Sbjct: 1109 DMELGDSIVSLKQEEA-IEDFL-----KLCLFCTSSRPEDRPDMNEILTHL 1153
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00014914001 | SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (1026 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 767 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-75 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-55 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-54 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-54 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-42 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-30 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 8e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 262 bits (670), Expect = 4e-75
Identities = 227/793 (28%), Positives = 365/793 (46%), Gaps = 90/793 (11%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
M SL ++ L N L GEIPY++G L +L + +N TG IP SL NL N+Q + +
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ 269
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L G +PP + +L L ++ N + G E + L N L L N F G+
Sbjct: 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE---LVIQLQN---LEILHLFSNNFTGK 323
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IP ++ +L L L + N+F G+IP ++G+ +LT+L+LS N+++GEI + L
Sbjct: 324 IPVALTSLPR-LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNL 382
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
L L N + G IP +LG + L ++ L N + E+P+ F + +D+SNN L G
Sbjct: 383 FKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442
Query: 241 NIPK---EILSLSSLTTIVN-------------------LSKNFLDGTLPEEIGMLGNVV 278
I ++ SL L+ N LS+N G +P ++G L ++
Sbjct: 443 RINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELM 502
Query: 279 TIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGS 338
+ LS N LSG +P+ +CK L L +++N+ SG IP +E+ L LDLS N+LSG
Sbjct: 503 QLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGE 562
Query: 339 IPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSSHGR- 397
IP +L N+ +L +N++ N+L G +P G F + + GN LC +++S
Sbjct: 563 IPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC----GGDTTSGLPP 618
Query: 398 -RRII------IYIIVAIIAIIAGCFLIFWLIIVRKGKAKPI-------GV-STLFKHSP 442
+R+ YI + A + + F + +R + G F S
Sbjct: 619 CKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSK 678
Query: 443 QMISYDELRRATGNFSHENLIGSGSFGSVYKG-YLREGISVAVK-VLDIESTGTWKSFFA 500
S + + EN+I G G+ YKG ++ G+ VK + D+ S + S A
Sbjct: 679 VSKSI-TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS--SEIA 735
Query: 501 ECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLN 560
+ + +H N+VKLI C S + L++E+ I G+ +E L+
Sbjct: 736 D---MGKLQHPNIVKLIGLCRS-----EKGAYLIHEY---------IEGKNLSEVLRNLS 778
Query: 561 FLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIG 620
+ R IAI IA AL +LH C +V +L P I++D L+ L
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLRLSLPGLLCTD 835
Query: 621 NQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS 680
+ ISS Y+ PE + + D+Y FG++L+E+ TG SP F S
Sbjct: 836 TKCFISS--------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS 887
Query: 681 LVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID 740
+V+W + D L + S + ++ I + ++ L CT P R
Sbjct: 888 IVEWARYCYS-------DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC 940
Query: 741 IREALRRLKNAQK 753
+ L+ L++A +
Sbjct: 941 ANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 7e-55
Identities = 130/364 (35%), Positives = 195/364 (53%), Gaps = 10/364 (2%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+TSL +L LASNQL G+IP ++G ++ +L +N +G+IP + LT++ + + +
Sbjct: 187 LTSLEFLTLASNQLVGQIPRELG-QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L G +P LGNL L+ + NK+ G S+ + +L L N GE
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSG------PIPPSIFSLQKLISLDLSDNSLSGE 299
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IPE + L N L L++ N F GKIP ++ L L +L L N SGEI +G+ L
Sbjct: 300 IPELVIQLQN-LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL 358
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
LDL+ N ++G IP L + L ++ L N L EIP S G ++L + L +N +G
Sbjct: 359 TVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG 418
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+P E L L +++S N L G + + ++ + L+ N G LP+SF + K
Sbjct: 419 ELPSEFTKL-PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KR 476
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
LE L ++ N+FSG +P L L L L LS NKLSG IP +L + + L SL+L+ N L
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536
Query: 361 GVVP 364
G +P
Sbjct: 537 GQIP 540
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 2e-54
Identities = 132/362 (36%), Positives = 193/362 (53%), Gaps = 10/362 (2%)
Query: 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLL 63
L L L++N L GEIP D+G +L + N GKIP SL NLT+++ + +A N L
Sbjct: 142 LETLDLSNNMLSGEIPNDIG-SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQL 200
Query: 64 EGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPE 123
G +P LG + LK +G+N + G + +TS LN L N G IP
Sbjct: 201 VGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTS------LNHLDLVYNNLTGPIPS 254
Query: 124 SIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSL 183
S+GNL N L L++ N+ G IP SI L+ L L+LS NS+SGEI + QLQ L+ L
Sbjct: 255 SLGNLKN-LQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL 313
Query: 184 DLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIP 243
L N +G IP L +L +L + L N+ + EIP + G NL +DLS N L G IP
Sbjct: 314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
Query: 244 KEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEK 303
+ + S +L ++ L N L+G +P+ +G ++ + L N SG LP+ F +
Sbjct: 374 EGLCSSGNLFKLI-LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432
Query: 304 LLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVV 363
L ++NN G I + ++ L++L L+ NK G +P D + L +L+L+ N G V
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFSGAV 491
Query: 364 PR 365
PR
Sbjct: 492 PR 493
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 5e-54
Identities = 118/360 (32%), Positives = 184/360 (51%), Gaps = 35/360 (9%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
+SL YL L++N G IP +PNL + N +G+IP + + ++++++ + N
Sbjct: 118 SSLRYLNLSNNNFTGSIP---RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
+L G +P L NL T L FL NQ G+I
Sbjct: 175 VLVGKIPNSLTNL------------------------------TSLEFLTLASNQLVGQI 204
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQ 181
P +G + + L +Y+G N G+IP IG L SL L+L YN+++G I + +G L+ LQ
Sbjct: 205 PRELGQMKS-LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQ 263
Query: 182 SLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN 241
L L N++SG IP ++ +L+KL +DLS N L+ EIP QNL + L +N G
Sbjct: 264 YLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK 323
Query: 242 IPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSL 301
IP + SL L ++ L N G +P+ +G N+ +DLS N L+G +P + +L
Sbjct: 324 IPVALTSLPRL-QVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNL 382
Query: 302 EKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEG 361
KL++ +N G IP L + L + L N SG +PS+ L + L+++ NNL+G
Sbjct: 383 FKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 2e-51
Identities = 131/343 (38%), Positives = 184/343 (53%), Gaps = 12/343 (3%)
Query: 40 TGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPF-LKMYNIGFNKIVGSGDEGLSFI 98
+GKI ++ L IQ I +++N L G +P + L+ N+ N GS G
Sbjct: 82 SGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG---- 137
Query: 99 TSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTL 158
S+ N L L N GEIP IG+ S+ L L +GGN GKIP S+ L SL
Sbjct: 138 -SIPN---LETLDLSNNMLSGEIPNDIGSFSS-LKVLDLGGNVLVGKIPNSLTNLTSLEF 192
Query: 159 LNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEI 218
L L+ N + G+I E+GQ++ L+ + L N +SG IP +G L LN +DL N L I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 219 PTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVV 278
P+S GN +NL + L NKL+G IP I SL L ++ +LS N L G +PE + L N+
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISL-DLSDNSLSGEIPELVIQLQNLE 311
Query: 279 TIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGS 338
+ L +N +G +P + + L+ L + +NKFSG IP L + L VLDLS+N L+G
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
Query: 339 IPSDLQNLRALRSLNLTFNNLEGVVPRE-GIFRHTSMVHLEGN 380
IP L + L L L N+LEG +P+ G R V L+ N
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 73/216 (33%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLV 514
+ +G GSFG VY ++ G VA+KV+ + + E + L+ +H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
+L F++ + L LV E+ G L D + + L+ E I SA
Sbjct: 61 RLYDV-----FEDEDKLYLVMEYCEGGDLFDLLKKRGR------LSEDEARFYLRQILSA 109
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
L+YLH+ IVH DLKP NILLDED K+ DFGLAR L G+
Sbjct: 110 LEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQL-------DPGEKLTTFVGT 159
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
Y+ PE LG+ A D++S GV+L E+ TG P
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 95/287 (33%), Positives = 135/287 (47%), Gaps = 42/287 (14%)
Query: 463 IGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWK--SFFAECEALRNTRHRNLVKLITS 519
+GSGSFG+VYK + G VAVK+L S + K + E LR H N+V+LI +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
F++ + L LV E+ G L D++ L+ E IA+ I L+YLH
Sbjct: 67 -----FEDKDHLYLVMEYCEGGDLFDYLSRGGP------LSEDEAKKIALQILRGLEYLH 115
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
++ I+H DLKP NILLDE+ K+ DFGLA+ LL+ S SS G+ Y+
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLK------SSSSLTTFVGTPWYMA 166
Query: 640 PEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLD 698
PE LG DV+S GV+L E+ TG P F+GE L + Q++
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENIL----------DQLQLIR 212
Query: 699 RELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREAL 745
R L + E + + +I+ C + P R E L
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIK----KCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 6e-43
Identities = 71/206 (34%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFA-ECEALRNTRHRNLVKLITSC 520
+G G FG+VY ++ G VA+K++ E + + E E L+ H N+VKL
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV- 59
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN 580
F++ L LV E+ GSL D + E+ L+ E L I + I L+YLH
Sbjct: 60 ----FEDENHLYLVMEYCEGGSLKDLLK-----ENEGKLSEDEILRILLQILEGLEYLH- 109
Query: 581 DCEVPIVHCDLKPGNILLDED-MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
I+H DLKP NILLD D K+ DFGL++ + + S+ T V G+ Y+
Sbjct: 110 --SNGIIHRDLKPENILLDSDNGKVKLADFGLSK----LLTSDKSLLKTIV--GTPAYMA 161
Query: 640 PEYGLGEKP-STAGDVYSFGVMLLEI 664
PE LG+ S D++S GV+L E+
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 4e-42
Identities = 78/265 (29%), Positives = 120/265 (45%), Gaps = 52/265 (19%)
Query: 463 IGSGSFGSVYKGYLRE-----GISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKL 516
+G G+FG VYKG L+ VAVK L ++ + F E ++ H N+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
+ C+ E L +V E++ G L D++ +HG L + L +A+ IA ++
Sbjct: 67 LGVCTQ-----GEPLYIVTEYMPGGDLLDFLR-----KHGEKLTLKDLLQMALQIAKGME 116
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
YL VH DL N L+ E++ K+ DFGL+R I K I
Sbjct: 117 YLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRD----IYEDDYYRKRGGGKLPIK 169
Query: 637 YIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-------GMSPTHESFAGEVSLVKWVE 686
++ PE G K ++ DV+SFGV+L EIFT GMS +++ +E
Sbjct: 170 WMAPESLKDG---KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE--------VLELLE 218
Query: 687 SNF----PKNAQQVLDRELRQLMMS 707
+ P+N EL +LM+
Sbjct: 219 DGYRLPRPENC----PDELYELMLQ 239
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-41
Identities = 103/289 (35%), Positives = 147/289 (50%), Gaps = 27/289 (9%)
Query: 102 TNSTRLNFLAFDG------------------------NQFEGEIPESIGNLSNVLSKLYM 137
NS+R+ + G NQ G IP+ I S+ L L +
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 138 GGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNT 197
N F G IP G + +L L+LS N +SGEI +IG L+ LDL GN + G IPN+
Sbjct: 126 SNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183
Query: 198 LGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVN 257
L NL L + L+ N+L +IP G ++L I L N L+G IP EI L+SL + +
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHL-D 242
Query: 258 LSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPN 317
L N L G +P +G L N+ + L N LSG +P S + + L L +++N SG IP
Sbjct: 243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
Query: 318 ILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE 366
++ +L+ LE+L L SN +G IP L +L L+ L L N G +P+
Sbjct: 303 LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 76/270 (28%), Positives = 117/270 (43%), Gaps = 51/270 (18%)
Query: 461 NLIGSGSFGSVYKGYLREGIS----VAVKVL-DIESTGTWKSFFAECEALRNTRHRNLVK 515
+G G+FG VYKG L+ VAVK L + S K F E ++ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL---ERLNIAIDIA 572
L+ + + LV E++ G L D++ R + L + L+ AI IA
Sbjct: 61 LL-GVCTEEEPLY----LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
++YL VH DL N L+ ED+ K+ DFGL+R + + K
Sbjct: 116 KGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY---------DDDYYRK 163
Query: 633 GSIGYIP-----PEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP-----THESFAGEVSL 681
+ G +P PE ++ DV+SFGV+L EIFT G +P E +
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------V 216
Query: 682 VKWVES----NFPKNAQQVLDRELRQLMMS 707
++++ P+ EL +LM+S
Sbjct: 217 LEYLRKGYRLPKPEYCPD----ELYELMLS 242
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 73/223 (32%), Positives = 107/223 (47%), Gaps = 40/223 (17%)
Query: 463 IGSGSFGSVYKGYLR-----EGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLVKL 516
+G G+FG VYKG L+ + + VAVK L + S + F E +R H N+VKL
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
+ C+ E L +V E++ G L D++ RKN L+ + L+ A+ IA ++
Sbjct: 67 LGVCTE-----EEPLMIVMEYMPGGDLLDYL---RKNRP-KELSLSDLLSFALQIARGME 117
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
YL +H DL N L+ E++ K+ DFGL+R + K G
Sbjct: 118 YLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----------DLYDDDYYKVKGG 164
Query: 637 YIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+P PE G K ++ DV+SFGV+L EIFT G P
Sbjct: 165 KLPIRWMAPESLKEG---KFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 463 IGSGSFGSVYKGYLR-----EGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLVKL 516
+G G+FG VYKG L+ + + VAVK L + S + F E +R H N+VKL
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
+ C+ E L +V E++ G L ++ ++ L+ + L+ A+ IA ++
Sbjct: 67 LGVCTE-----EEPLYIVMEYMEGGDLLSYLR-----KNRPKLSLSDLLSFALQIARGME 116
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
YL +H DL N L+ E++ K+ DFGL+R + + K I
Sbjct: 117 YLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRG-GKLPIR 168
Query: 637 YIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
++ PE G K ++ DV+SFGV+L EIFT G P
Sbjct: 169 WMAPESLKEG---KFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 23/223 (10%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE--STGTWKSFFAECEALRNTRHRN 512
++ L+G GSFGSVY ++ G +AVK +++ S ++ E L + +H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAID 570
+V+ S + L + E++ GSL + K E +
Sbjct: 61 IVRYYGSERD---EEKNTLNIFLEYVSGGSLSSLLKKFGK--------LPEPVIRKYTRQ 109
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
I L YLH++ IVH D+K NIL+D D K+ DFG A+ R+G+ + T
Sbjct: 110 ILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAK----RLGDIETGEGTGS 162
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
++G+ ++ PE GE+ A D++S G ++E+ TG P E
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 33/219 (15%)
Query: 463 IGSGSFGSVYKG-YLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
IG G FG VYK + R G VA+KV+ +ES + E + L+ +H N+VK S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS-- 65
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLN------IAIDIASAL 575
+ + L +V EF GSL D + + + L + ++ L
Sbjct: 66 ---YLKKDELWIVMEFCSGGSLKDLLK-----------STNQTLTESQIAYVCKELLKGL 111
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
+YLH++ I+H D+K NILL D K+ DFGL+ L + + + G+
Sbjct: 112 EYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-------GTP 161
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674
++ PE G+ D++S G+ +E+ G P E
Sbjct: 162 YWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 81/247 (32%), Positives = 117/247 (47%), Gaps = 26/247 (10%)
Query: 462 LIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
IG G FG V G R G VAVK L +ST ++F AE + RH NLV+L+
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV- 69
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHND 581
L L +V E++ GSL D++ R + ++L A+D+ ++YL
Sbjct: 70 -LQGNP---LYIVTEYMAKGSLVDYLR-SRGRAV---ITLAQQLGFALDVCEGMEYLE-- 119
Query: 582 CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE 641
E VH DL N+L+ ED+ AKV DFGLA+ G S K + + PE
Sbjct: 120 -EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE--ASQGQDSG-------KLPVKWTAPE 169
Query: 642 YGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRE 700
+K ST DV+SFG++L EI++ G P +V V VE + A + E
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPHVEKGYRMEAPEGCPPE 227
Query: 701 LRQLMMS 707
+ ++M
Sbjct: 228 VYKVMKD 234
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-30
Identities = 85/238 (35%), Positives = 131/238 (55%), Gaps = 8/238 (3%)
Query: 142 FYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNL 201
+ G + R+ S+ +LS +ISG+I + I +L +Q+++L+ NQ+SG IP+ +
Sbjct: 60 WQGITCNNSSRVVSI---DLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTT 116
Query: 202 -KKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSK 260
L ++LS N IP G+ NL ++DLSNN L+G IP +I S SSL +++L
Sbjct: 117 SSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSL-KVLDLGG 173
Query: 261 NFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILA 320
N L G +P + L ++ + L++N L G +P KSL+ + + N SG IP +
Sbjct: 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG 233
Query: 321 ELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLE 378
L L LDL N L+G IPS L NL+ L+ L L N L G +P IF ++ L+
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS-IFSLQKLISLD 290
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 70/226 (30%), Positives = 111/226 (49%), Gaps = 26/226 (11%)
Query: 457 FSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKL 516
F+ E +GSG FG V++G + + VA+K+L + + F E +AL+ RH++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
CS E + ++ E + GSL ++ ++ G L +++A +A +
Sbjct: 68 FAVCSV-----GEPVYIITELMEKGSLLAFL----RSPEGQVLPVASLIDMACQVAEGMA 118
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
YL E +H DL NIL+ ED+ KV DFGLAR + E + + K
Sbjct: 119 YLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE------DVYLSSDKKIPYK 169
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-------GMSPTHESF 675
+ PE ST DV+SFG++L E+FT GM+ HE +
Sbjct: 170 WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVY 214
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
+G+G FG V+ G VAVK L T + ++F E + ++ RH LV+L CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS- 71
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC 582
E + +V E++ GSL D++ K+ G L + +++A IA + YL
Sbjct: 72 ----EEEPIYIVTEYMSKGSLLDFL----KSGEGKKLRLPQLVDMAAQIAEGMAYLE--- 120
Query: 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEY 642
+H DL NIL+ E++ K+ DFGLAR + + + K I + PE
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA-----KFPIKWTAPEA 175
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ + DV+SFG++L EI T G P
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 73/238 (30%), Positives = 110/238 (46%), Gaps = 41/238 (17%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEAL-RNTRH 510
+F +IG GSF +V +E A+K+LD + K E E L R H
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
++KL + F++ E L V E+ NG L +I ++G+ L+ A +
Sbjct: 62 PGIIKLYYT-----FQDEENLYFVLEYAPNGELLQYIR-----KYGS-LDEKCTRFYAAE 110
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
I AL+YLH+ I+H DLKP NILLD+DM K+ DFG A+ L N S S+
Sbjct: 111 ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP---NSSPESNKGD 164
Query: 631 LK-----------------GSIGYIPPEYGLGEKPST-AGDVYSFGVMLLEIFTGMSP 670
G+ Y+ PE L EKP+ + D+++ G ++ ++ TG P
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPEL-LNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (277), Expect = 3e-26
Identities = 87/332 (26%), Positives = 133/332 (40%), Gaps = 35/332 (10%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGT---WKSFFAECEALRNTRH-R 511
++ +G GSFG VY R+ VA+KVL + + F E + L + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
N+VKL L LV E++ GSL D + +K L+ E L I I
Sbjct: 59 NIVKLYDFFQDEGS-----LYLVMEYVDGGSLEDLL---KKIGRKGPLSESEALFILAQI 110
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDED-MTAKVGDFGLARSLLERIGNQSSISSTHV 630
SAL+YLH I+H D+KP NILLD D K+ DFGLA+ L + S +
Sbjct: 111 LSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167
Query: 631 LKGSIGYIPPEYGLG---EKPSTAGDVYSFGVMLLEIFTGMSP------------THESF 675
G+ GY+ PE LG S++ D++S G+ L E+ TG+ P T +
Sbjct: 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227
Query: 676 AGEVS--LVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTE 733
+ L + + P+ + L++L+ + L + + ++
Sbjct: 228 LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESD 287
Query: 734 SPGGRIDIREALRRLKNAQKILLKRRQPNEKA 765
A RL + N A
Sbjct: 288 LSDLLKPDDSAPLRLSLPPSLEALISSLNSLA 319
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 91/326 (27%), Positives = 136/326 (41%), Gaps = 70/326 (21%)
Query: 449 ELRRATGNFSHENLIGSGSFGSVYKGYLREGIS------VAVKVL-DIESTGTWKSFFAE 501
++R T E +G G+FG V+ G VAVK L + S K F E
Sbjct: 1 HVQRDTIVLKRE--LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFERE 58
Query: 502 CEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HG-------ERK 552
E L N +H N+VK C+ D M V+E++ +G L ++ HG
Sbjct: 59 AELLTNFQHENIVKFYGVCTEGDPPIM-----VFEYMEHGDLNKFLRSHGPDAAFLKSPD 113
Query: 553 NEHGNGLNFLERLNIAIDIASALDYL---HNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609
+ G L + L IA+ IAS + YL H VH DL N L+ D+ K+GDF
Sbjct: 114 SPMGE-LTLSQLLQIAVQIASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDF 166
Query: 610 GLARSLLE----RIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIF 665
G++R + R+G + + I ++PPE + K +T DV+SFGV+L EIF
Sbjct: 167 GMSRDVYTTDYYRVGGHTMLP--------IRWMPPESIMYRKFTTESDVWSFGVVLWEIF 218
Query: 666 T-GMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIE 724
T G P + EV ++ + + E+ +M
Sbjct: 219 TYGKQPWYGLSNEEV--IECITQGRLLQRPRTCPSEVYDIM------------------- 257
Query: 725 SVGLSCTTESPGGRIDIREALRRLKN 750
L C P RI+I++ RL+
Sbjct: 258 ---LGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 69/218 (31%), Positives = 113/218 (51%), Gaps = 20/218 (9%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
+GSG FG V+ G R I VA+K++ E + F E + + H NLV+L C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT- 69
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC 582
K + +V E++ NG L +++ R+ + G +L L++ D+ A++YL ++
Sbjct: 70 ---KQRP-IFIVTEYMANGCLLNYL---RERKGKLGTEWL--LDMCSDVCEAMEYLESNG 120
Query: 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEY 642
+H DL N L+ ED KV DFGLAR +L+ +S+ K + + PPE
Sbjct: 121 ---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD-----DQYTSSQGTKFPVKWAPPEV 172
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA-GEV 679
+ S+ DV+SFGV++ E+F+ +E F+ EV
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 74/222 (33%), Positives = 98/222 (44%), Gaps = 44/222 (19%)
Query: 463 IGSGSFGSVY--------KGYLREGISVAVKVLD---IESTGTWKSFFAECEALRNTRHR 511
+G GSFG V K Y A+KVL I + E L H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY-------AMKVLKKKKIIKRKEVEHTLTERNILSRINHP 53
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIA 568
+VKL + F+ E L LV E+ G L + E + F E R A
Sbjct: 54 FIVKLHYA-----FQTEEKLYLVLEYAPGGELFSHLSKEGR--------FSEERARFYAA 100
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+I AL+YLH+ + I++ DLKP NILLD D K+ DFGLA+ L S T
Sbjct: 101 -EIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE------GSRT 150
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ G+ Y+ PE LG+ A D +S GV+L E+ TG P
Sbjct: 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 70/224 (31%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 456 NFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRN 512
N+ +LIG G+FG VYKG L G VA+K + +E KS E + L+N +H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+VK I S + + L ++ E+ NGSL I + G F E L +A+ +
Sbjct: 61 IVKYIGS-----IETSDSLYIILEYAENGSLRQIIK-----KFGP---FPESL-VAVYVY 106
Query: 573 ---SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
L YLH ++H D+K NIL +D K+ DFG+A L
Sbjct: 107 QVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKL------NDVSKDDA 157
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
+ G+ ++ PE STA D++S G ++E+ TG P ++
Sbjct: 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTW--KSFFAECEALRNTRHRNLVKLITSC 520
+G+G FG V++G VAVK L GT K F AE + ++ RH L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL-- 578
+ E + +V E + GSL +++ G G L + +++A +AS + YL
Sbjct: 71 T-----LEEPIYIVTELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEA 121
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
N +H DL N+L+ E+ KV DFGLAR + E I + K I +
Sbjct: 122 QN-----YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-----AREGAKFPIKWT 171
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
PE L + S DV+SFG++L EI T
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 74/255 (29%), Positives = 121/255 (47%), Gaps = 35/255 (13%)
Query: 462 LIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWK-SFFAECEALRNTRHRNLVKLITSC 520
IG G+FG VYKG L+ VAVK K F E E L+ H N+VKLI C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN 580
+ + +V E + GSL ++ RK + N L + L +++D A+ ++YL +
Sbjct: 62 V-----QKQPIYIVMELVPGGSLLTFL---RKKK--NRLTVKKLLQMSLDAAAGMEYLES 111
Query: 581 DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP- 639
+H DL N L+ E+ K+ DFG++R E G ++S + IP
Sbjct: 112 KN---CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSD------GLKQIPI 159
Query: 640 ----PE---YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692
PE YG + ++ DV+S+G++L E F+ + + + + + +ES +
Sbjct: 160 KWTAPEALNYG---RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-ERIESGYRMP 215
Query: 693 AQQVLDRELRQLMMS 707
A Q+ E+ +LM+
Sbjct: 216 APQLCPEEIYRLMLQ 230
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 463 IGSGSFGSVYKG-YLREGISVAVKVLDIESTGTW-KSFFAECEALRNTRHRNLVKLITSC 520
+G GS G VYK + G A+K + ++ + K E + LR+ +VK C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERK--NEHGNGLNFLERLNIAIDIASALDYL 578
+K E +++V E++ GSL D + + E L IA I LDYL
Sbjct: 65 YGAFYKEGE-ISIVLEYMDGGSLAD-LLKKVGKIPE-----PVLAY--IARQILKGLDYL 115
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H I+H D+KP N+L++ K+ DFG+++ L + +T V G++ Y+
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ----CNTFV--GTVTYM 167
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
PE GE S A D++S G+ LLE G P
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 72/242 (29%), Positives = 119/242 (49%), Gaps = 36/242 (14%)
Query: 449 ELRRATGNFSHENLIGSGSFGSVYKGYL------REGISVAVKVLDIESTG-TWKSFFAE 501
E+ + F E +G G+FG VYKG L SVA+K L + + F E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 502 CEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI----------HGER 551
E + + +H N+V L+ C+ + +++E+L +G L +++
Sbjct: 59 AELMSDLQHPNIVCLLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 552 KNEHGNGLNFLERLNIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609
+ L+ + L+IAI IA+ ++YL H+ VH DL N L+ E +T K+ DF
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDF 168
Query: 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GM 668
GL+R + + + S +L + ++PPE L K +T D++SFGV+L EIF+ G+
Sbjct: 169 GLSRDIYS--ADYYRVQSKSLL--PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGL 224
Query: 669 SP 670
P
Sbjct: 225 QP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 463 IGSGSFGSVYK-GYLREGISVAVKVLDIESTGTWKS--FFAECEALRNTRHRNLVKLITS 519
IG GSFG+V K +G + K +D + + +E LR +H N+V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
+D N + L +V E+ G L I +K F+ I + AL H
Sbjct: 68 --IIDRSN-QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI--WRILTQLLLALYECH 122
Query: 580 N--DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
N D ++H DLKP NI LD + K+GDFGLA+ L G+ SS + T+V G+ Y
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL----GHDSSFAKTYV--GTPYY 176
Query: 638 IPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ PE D++S G ++ E+ P
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 73/255 (28%), Positives = 113/255 (44%), Gaps = 31/255 (12%)
Query: 461 NLIGSGSFGSVYKG-YLREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLI 517
IG GSFG VY +G +K +D+ S + E + L+ H N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASAL 575
S F+ L +V E+ G L I ++K E F E L+ + + AL
Sbjct: 66 ES-----FEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKP---FPEEQILDWFVQLCLAL 116
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
YLH+ I+H D+KP NI L + K+GDFG+++ L S++ + G+
Sbjct: 117 KYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL------SSTVDLAKTVVGTP 167
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV--SLV-KWVESNFPKN 692
Y+ PE + + D++S G +L E+ T P F GE L K ++ +P
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGENLLELALKILKGQYPPI 223
Query: 693 AQQVLDRELRQLMMS 707
Q ELR L+ S
Sbjct: 224 PSQY-SSELRNLVSS 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 24/225 (10%)
Query: 449 ELRRATGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAECEALRN 507
E+ R + + ++ +G G +G VY+G + ++VAVK L E T + F E ++
Sbjct: 2 EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKE 58
Query: 508 TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI 567
+H NLV+L+ C+ + F ++ EF+ G+L D++ + E +N + L +
Sbjct: 59 IKHPNLVQLLGVCT----REPPFY-IITEFMTYGNLLDYLRECNRQE----VNAVVLLYM 109
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
A I+SA++YL +H DL N L+ E+ KV DFGL+R + +
Sbjct: 110 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYT 160
Query: 628 THV-LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
H K I + PE K S DV++FGV+L EI T GMSP
Sbjct: 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 67/217 (30%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 461 NLIGSGSFGSVYKGYL-----REGISVAVKVLDIESTGTWKS-FFAECEALRNTRHRNLV 514
+G G FG V G VAVK L+ +S F E E LR H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
K C ++ L L+ E+L +GSL D++ H + +N L + I
Sbjct: 70 KYKGVCEKPGGRS---LRLIMEYLPSGSLRDYLQ-----RHRDQINLKRLLLFSSQICKG 121
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
+DYL + +H DL NIL++ + K+ DFGLA+ L +
Sbjct: 122 MDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL--------PEDKDYYYVKE 170
Query: 635 IGYIP-----PEYGLGEKPSTAGDVYSFGVMLLEIFT 666
G P PE K S+A DV+SFGV L E+FT
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 70/239 (29%), Positives = 113/239 (47%), Gaps = 31/239 (12%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVKVLDIESTGT-WKSFFAECEALRNTRHRNLVKLITSC 520
IG G+ VY L VA+K +D+E T E +A+ H N+VK TS
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS- 67
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI---DIASALDY 577
F + L LV +L GSL D + + L+ IA ++ L+Y
Sbjct: 68 ----FVVGDELWLVMPYLSGGSLLDIM------KSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
LH++ ++ H D+K GNILL ED + K+ DFG++ SL + + T V G+ +
Sbjct: 118 LHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV--GTPCW 172
Query: 638 IPPE-----YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691
+ PE +G K D++SFG+ +E+ TG +P + +V L+ ++++ P
Sbjct: 173 MAPEVMEQVHGYDFK----ADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQNDPPS 226
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 462 LIGSGSFGSVYKG----YLREGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLVKL 516
+G GSFG V +G + I VAVK L + + F E + + H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL-NIAIDIASAL 575
L M +V E GSL D + + G + L + A+ IA+ +
Sbjct: 62 YGVV--LTHPLM----MVTELAPLGSLLDRLRKDAL-----GHFLISTLCDYAVQIANGM 110
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
YL + +H DL NILL D K+GDFGL R+L + + H LK
Sbjct: 111 RYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ--NEDHYVMEEH-LKVPF 164
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
+ PE S A DV+ FGV L E+FT
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 9e-23
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
IGSG FG V+ GY E VA+K + E + + F E + + H LV+L C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-- 68
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC 582
+ + LV+EF+ +G L D++ +R L L + +D+ + YL +
Sbjct: 69 --TERSP-ICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN 120
Query: 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEY 642
++H DL N L+ E+ KV DFG+ R +L+ +S+ K + + PE
Sbjct: 121 ---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-----DQYTSSTGTKFPVKWSSPEV 172
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEV 679
K S+ DV+SFGV++ E+F+ G +P EV
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 463 IGSGSFGSVYKGYLR------EGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLVK 515
+G GSFG VY+G + VA+K + + S F E ++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 516 LITSCSSLDFKNMEFLALV-YEFLGNGSLGDWIHGER-KNEHGNGLNFLER---LNIAID 570
L+ S LV E + G L ++ R + E+ GL + +A +
Sbjct: 74 LLGVVS------TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE----RIGNQSSIS 626
IA + YL VH DL N ++ ED+T K+GDFG+ R + E R G + +
Sbjct: 128 IADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL- 183
Query: 627 STHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
+ ++ PE +T DV+SFGV+L E+ T
Sbjct: 184 -------PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 72/236 (30%), Positives = 104/236 (44%), Gaps = 34/236 (14%)
Query: 463 IGSGSFGSVYKGYLREG----ISVAVKVL--DIESTGTWKSFFAECEALRNTRHRNLVKL 516
+G G+FGSV KG + VAVK L + + G K F E + H +V+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVRL 61
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
I C E L LV E G L ++ +K + E +A +A +
Sbjct: 62 IGVCKG------EPLMLVMELAPLGPLLKYL---KKRREIPVSDLKE---LAHQVAMGMA 109
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
YL VH DL N+LL AK+ DFG++R+L G+ ++T + +
Sbjct: 110 YLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAG-RWPLK 163
Query: 637 YIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688
+ PE YG K S+ DV+S+GV L E F+ G P E EV + +ES
Sbjct: 164 WYAPECINYG---KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV--IAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 73/231 (31%), Positives = 113/231 (48%), Gaps = 33/231 (14%)
Query: 456 NFSHENL---IGSGSFGSVYKG-YLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHR 511
N L IG G FG+V +G Y G VAVK + + T ++F E + H+
Sbjct: 4 NLQKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHK 59
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGL-NFLERLNIAID 570
NLV+L L L +V E + G+L +++ G L + ++ L ++D
Sbjct: 60 NLVRL------LGVILHNGLYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQFSLD 108
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
+A ++YL + +VH DL NIL+ ED AKV DFGLAR + +G +S
Sbjct: 109 VAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNS------ 157
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVS 680
K + + PE +K S+ DV+S+GV+L E+F+ G +P + EV
Sbjct: 158 -KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 71/205 (34%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
IG G FG V G R G VAVK I++ T ++F AE + RH NLV+L+
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLL----G 66
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGE-RKNEHGNGLNFLERLNIAIDIASALDYLHND 581
+ + L +V E++ GSL D++ R G+ L L ++D+ A++YL +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEAN 121
Query: 582 CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE 641
VH DL N+L+ ED AKV DFGL + SS T L + + PE
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-------SSTQDTGKL--PVKWTAPE 169
Query: 642 YGLGEKPSTAGDVYSFGVMLLEIFT 666
+K ST DV+SFG++L EI++
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 73/261 (27%), Positives = 120/261 (45%), Gaps = 39/261 (14%)
Query: 460 ENLIGSGSFGSVYKGYL----REGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLV 514
E +IG G FG V +G L ++ I VA+K L S F E + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 515 KL---ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
+L +T + M ++ E++ NGSL ++ R+N+ + + + I
Sbjct: 69 RLEGVVTKSRPV----M----IITEYMENGSLDKFL---REND--GKFTVGQLVGMLRGI 115
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
AS + YL VH DL NIL++ ++ KV DFGL+R R+ + + +T
Sbjct: 116 ASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR----RLEDSEATYTTKGG 168
Query: 632 KGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNF- 689
K I + PE K ++A DV+SFG+++ E+ + G P + +V +K VE +
Sbjct: 169 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV--IKAVEDGYR 226
Query: 690 ---PKNAQQVLDRELRQLMMS 707
P + L QLM+
Sbjct: 227 LPPPMDCPSA----LYQLMLD 243
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 8e-22
Identities = 74/253 (29%), Positives = 113/253 (44%), Gaps = 52/253 (20%)
Query: 455 GNFSHENLIGSGSFGSVYK----GYL--REGISVAVKVLDIE-STGTWKSFFAECEALRN 507
N + IG G+FG V++ G L VAVK+L E S F E +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 508 TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI-HGERKNEHGNG-------- 558
H N+VKL+ C+ + + L++E++ G L +++ H + +
Sbjct: 65 FDHPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 559 -------LNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611
L+ E+L IA +A+ + YL E VH DL N L+ E+M K+ DFGL
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 612 ARSLLERIGNQSSISSTHVLKGS------IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIF 665
+R +I S K S I ++PPE + +T DV+++GV+L EIF
Sbjct: 177 SR----------NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 226
Query: 666 T-GMSP----THE 673
+ GM P HE
Sbjct: 227 SYGMQPYYGMAHE 239
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-22
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
+G G FG V+ G VA+K L T + ++F E + ++ RH LV+L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC 582
E + +V E++ GSL D++ GE G L + +++A IAS + Y+
Sbjct: 73 ------EPIYIVTEYMSKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMAYVE--- 119
Query: 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEY 642
+ VH DL+ NIL+ E++ KV DFGLAR L+E + ++ K I + PE
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLAR-LIE----DNEYTARQGAKFPIKWTAPEA 174
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFT 666
L + + DV+SFG++L E+ T
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
+G+G FG V G R VA+K++ E + + F E + + H LV+L C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC 582
+ +V E++ NG L +++ EHG + L + D+ + YL +
Sbjct: 71 -----QRPIYIVTEYMSNGCLLNYLR-----EHGKRFQPSQLLEMCKDVCEGMAYLESK- 119
Query: 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEY 642
+H DL N L+D+ KV DFGL+R +L+ SS+ S ++ S PPE
Sbjct: 120 --QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWS----PPEV 172
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFT 666
L K S+ DV++FGV++ E+++
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 67/231 (29%), Positives = 111/231 (48%), Gaps = 36/231 (15%)
Query: 463 IGSGSFGSVYKGYL------REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKL 516
+G G+FG V+ ++ + VAVK L S + F E E L +H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HG-------ERKNEHGNGLNFLERLNI 567
C+ L +V+E++ +G L ++ HG ++ L + L I
Sbjct: 73 YGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE----RIGNQS 623
A IAS + YL + VH DL N L+ + + K+GDFG++R + R+G ++
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 624 SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHE 673
+ I ++PPE L K +T D++SFGV+L EIFT G P ++
Sbjct: 185 MLP--------IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
+G+G FG V+ GY VA+K L + + + ++F AE ++ +H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC 582
E + ++ E++ NGSL D++ K G L + +++A IA + ++
Sbjct: 73 ------EPIYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIE--- 119
Query: 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE- 641
+H DL+ NIL+ E + K+ DFGLA R+ + ++ K I + PE
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLA-----RLIEDNEYTAREGAKFPIKWTAPEA 174
Query: 642 --YGLGEKPSTAGDVYSFGVMLLEIFT 666
YG + DV+SFG++L EI T
Sbjct: 175 INYGTF---TIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 463 IGSGSFGSVYKGYLREGIS----VAVKVL---DIESTGTWKSFFAECEALRNTRHRNLVK 515
I G++G V+ L + S A+KV+ D+ E + L + +VK
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAIDIAS 573
L S F+ + L LV E+L G L + N + E + +I
Sbjct: 58 LYYS-----FQGKKNLYLVMEYLPGGDLASLLE--------NVGSLDEDVARIYIAEIVL 104
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK- 632
AL+YLH+ I+H DLKP NIL+D + K+ DFGL++ L R + +
Sbjct: 105 ALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 633 -GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
G+ YI PE LG+ S D +S G +L E G+ P H
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 463 IGSGSFGSVYK-GYLREGISVAVKVLD---IESTGTWKSFFAECEALRNTRHRNLVKLIT 518
+G G FG V + + A+K + I TG + F+E E L H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
+ FK+ +++ ++ E+ G L + + G + R IA + A +YL
Sbjct: 61 T-----FKDKKYIYMLMEYCLGGELWTILR-----DRGLFDEYTARFYIAC-VVLAFEYL 109
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
HN I++ DLKP N+LLD + K+ DFG A+ L S T G+ Y+
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL-------KSGQKTWTFCGTPEYV 159
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
PE L + + D +S G++L E+ TG P
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 463 IGSGSFGSVYKGYLR-EG----ISVAVKVLDIESTG--TWKSFFAECEALRNTRHRNLVK 515
+GSG+FG+VYKG EG I VA+KVL E T K E + + H ++V+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575
L+ C S + L+ + + G L D++ H + + LN + IA +
Sbjct: 74 LLGICLS------SQVQLITQLMPLGCLLDYVR-----NHKDNIGSQYLLNWCVQIAKGM 122
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
YL E +VH DL N+L+ K+ DFGLA+ LL+ + V I
Sbjct: 123 SYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAK-LLDVDEKEYHAEGGKV---PI 175
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
++ E L + DV+S+GV + E+ T
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 7e-20
Identities = 74/235 (31%), Positives = 112/235 (47%), Gaps = 34/235 (14%)
Query: 463 IGSGSFGSVYKGYL------REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKL 516
+G G+FG V+ ++ I VAVK L S K F E E L N +H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HGERKNEHGNG-----LNFLERLNIAI 569
C D L +V+E++ +G L ++ HG G L + L+IA
Sbjct: 73 YGVCVEGDP-----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE----RIGNQSSI 625
IA+ + YL + VH DL N L+ E++ K+GDFG++R + R+G + +
Sbjct: 128 QIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 626 SSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEV 679
I ++PPE + K +T DV+S GV+L EIFT G P ++ EV
Sbjct: 185 P--------IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 7e-20
Identities = 76/230 (33%), Positives = 103/230 (44%), Gaps = 37/230 (16%)
Query: 461 NLIGSGSFGSVYKGYLR-------EGISVAVKVLDIESTGTWKS-FFAECEALRNTRHRN 512
N +GSG+FG VY+G I VAVK L +T K F E + N H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGN-GLNFLERLNIAIDI 571
+VKL+ C N E ++ E + G L ++ R G L E L+I +D+
Sbjct: 61 IVKLLGVC----LLN-EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDE-----DMTAKVGDFGLARSLLERIGNQSSIS 626
A YL ++ +H DL N L+ E D K+GDFGLAR +
Sbjct: 116 AKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY---------K 163
Query: 627 STHVLKGSIGYIP-----PEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
S + K G +P PE L K +T DV+SFGV++ EI T G P
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 463 IGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
IG G+ G VYK R G VA+K + + + E +++ +H N+V S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDS-- 83
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWI--HGERKNEHGNGLNFLERLNIAI---DIASALD 576
+ + L +V E++ GSL D I + R NE IA ++ L+
Sbjct: 84 ---YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP----------QIAYVCREVLQGLE 130
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
YLH+ ++H D+K NILL +D + K+ DFG A L + ++S+ V G+
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV----V--GTPY 181
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
++ PE + D++S G+M +E+ G P
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-20
Identities = 71/229 (31%), Positives = 110/229 (48%), Gaps = 37/229 (16%)
Query: 463 IGSGSFGSVYKGY------LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKL 516
+G G+FG V+ ++ + VAVK L + K F E E L N +H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HG-------ERKNEHGNG-LNFLERLN 566
C D L +V+E++ +G L ++ HG + + G L + L+
Sbjct: 73 YGVCGDGDP-----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 567 IAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE----RIGNQ 622
IA IAS + YL + VH DL N L+ ++ K+GDFG++R + R+G
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ + I ++PPE + K +T DV+SFGV+L EIFT G P
Sbjct: 185 TMLP--------IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 51/231 (22%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---------IESTGTWKSFFAECEAL 505
+F +G+GSFG V + G A+K+L +E E L
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV------LNEKRIL 55
Query: 506 RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL 565
++ RH LV L S F++ L LV E++ G L + RK+ R
Sbjct: 56 QSIRHPFLVNLYGS-----FQDDSNLYLVMEYVPGGELFSHL---RKSG---------RF 98
Query: 566 NI------AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERI 619
A + AL+YLH+ + IV+ DLKP N+LLD D K+ DFG A+ + R
Sbjct: 99 PEPVARFYAAQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154
Query: 620 GNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
T+ L G+ Y+ PE L + A D ++ G+++ E+ G P
Sbjct: 155 --------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
+G+G FG V+ G VAVK L T + +SF E + ++ RH LV+L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC 582
E + +V E++ GSL D++ K+ G L +++A +A+ + Y+
Sbjct: 73 ------EPIYIVTEYMSKGSLLDFL----KDGEGRALKLPNLVDMAAQVAAGMAYIE--- 119
Query: 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEY 642
+ +H DL+ NIL+ + + K+ DFGLAR L+E + ++ K I + PE
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLAR-LIE----DNEYTARQGAKFPIKWTAPEA 174
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFT 666
L + + DV+SFG++L E+ T
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
+G G FG V+ G VA+K L T ++F E + ++ RH LV L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC 582
E + +V EF+G GSL D++ K G L + +++A IA + Y+
Sbjct: 73 ------EPIYIVTEFMGKGSLLDFL----KEGDGKYLKLPQLVDMAAQIADGMAYIE--- 119
Query: 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEY 642
+ +H DL+ NIL+ +++ K+ DFGLAR L+E + ++ K I + PE
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLAR-LIE----DNEYTARQGAKFPIKWTAPEA 174
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFT 666
L + + DV+SFG++L E+ T
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 30/226 (13%)
Query: 463 IGSGSFGSVYKGYL-----REGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLVKL 516
+G +FG +YKG+L VA+K L DI + W F E + H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWI-----H---GERKNEHG---NGLNFLERL 565
+ + + + +++E+L G L +++ H G +E G + L+ + L
Sbjct: 73 LGVVT-----QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 566 NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSI 625
+IAI IA+ ++YL + VH DL NIL+ E + K+ D GL+R + + +
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYS--ADYYRV 182
Query: 626 SSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+L I ++PPE + K S+ D++SFGV+L EIF+ G+ P
Sbjct: 183 QPKSLL--PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 81/286 (28%), Positives = 133/286 (46%), Gaps = 42/286 (14%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
+GSG FG V+ G R I VA+K ++ E + + F E + + H LV+L C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT- 69
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC 582
+ L +V EF+ NG L +++ R+ + + L L++ D+ ++YL +
Sbjct: 70 ----QQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDML--LSMCQDVCEGMEYLERN- 119
Query: 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEY 642
+H DL N L+ KV DFG+ R +L+ SS+ K + + PPE
Sbjct: 120 --SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD----DEYTSSSGA-KFPVKWSPPEV 172
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELR 702
K S+ DV+SFGV++ E+FT G++ K +SN+ +V++
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFT---------EGKMPFEK--KSNY-----EVVE---- 212
Query: 703 QLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748
M+S + + +T+ E V SC E P GR E LR +
Sbjct: 213 --MISRGFRLYRPKLASMTVYE-VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 27/222 (12%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISV-AVKVL---DIESTGTWKSFFAECEALRNTRHR 511
+F +IG G+FG V R+ + A+K + G+ ++ E L+ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI-HGERKNEHGNGLNFLERLNIAID 570
LV L S F++ E + LV + L G L + + +E +
Sbjct: 61 FLVNL---WYS--FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICE 108
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
I AL+YLH+ I+H D+KP NILLDE + DF +A + +S S
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT-KVTPDTLTTSTS---- 160
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTH 672
G+ GY+ PE + S A D +S GV E G P
Sbjct: 161 --GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 15/217 (6%)
Query: 462 LIGSGSFGSVYKGYLREG----ISVAVKV--LDIESTGTWKSFFAECEALRNTRHRNLVK 515
++G G FGSV +G L + + VAVK LDI + + F +E +++ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 516 LITSCSSLDFKNMEFLALV-YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
LI C +V F+ +G L ++ R L L +DIA
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
++YL N +H DL N +L EDMT V DFGL++ +I + + K
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK----KIYSGDYYRQGRIAKMP 178
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ +I E ++ DV++FGV + EI T G +P
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 71/221 (32%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 461 NLIGSGSFGSVYKGY-LREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLI 517
N IG G+FG VY L G +AVK + I+ T K E + L +H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
++ E + + E+ G+L E EHG L+ + + L Y
Sbjct: 64 --YYGVEVHR-EKVYIFMEYCSGGTL------EELLEHGRILDEHVIRVYTLQLLEGLAY 114
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV--LKGSI 635
LH IVH D+KP NI LD + K+GDFG A ++ N ++ V L G+
Sbjct: 115 LH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAV----KLKNNTTTMGEEVQSLAGTP 167
Query: 636 GYIPPEYGLGEKPS---TAGDVYSFGVMLLEIFTGMSPTHE 673
Y+ PE G K A D++S G ++LE+ TG P E
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVK 515
F +G GS+GSVYK +E G VA+KV + + E L+ +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575
S FKN + L +V E+ G GS+ D + K L E I L
Sbjct: 63 YYGSY----FKNTD-LWIVMEYCGAGSVSDIMKITNKT-----LTEEEIAAILYQTLKGL 112
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
+YLH+ +H D+K GNILL+E+ AK+ DFG++ L + + ++++ G+
Sbjct: 113 EYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI------GTP 163
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
++ PE + D++S G+ +E+ G P +
Sbjct: 164 FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 457 FSHENLIGSGSFGSVYKGY-LREGISVAVKV--LDIESTGTWKSFFAECEALRNTRHRNL 513
+ +G G++G VYK + G VA+K LD E G + E L+ +H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
VKL+ + L LV+E+ L ++ K N + +I +
Sbjct: 61 VKLLDVIHT-----ERKLYLVFEYCDM-DLKKYLD---KRPGPLSPNLI--KSIMYQLLR 109
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
L Y H+ I+H DLKP NIL++ D K+ DFGLAR+ + + TH +
Sbjct: 110 GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-----RTYTHEVV- 160
Query: 634 SIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
++ Y PE LG K STA D++S G + E+ TG
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 67/223 (30%), Positives = 95/223 (42%), Gaps = 39/223 (17%)
Query: 462 LIGSGSFGSVYKGYLREGISV-AVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
++G GSFG V L+ + AVKVL D+E T T K A +H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHP 56
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI--AI 569
L +L SC F+ + L V E++ G L I + F E A
Sbjct: 57 FLTQLH-SC----FQTKDRLFFVMEYVNGGDLMFHIQRSGR--------FDEPRARFYAA 103
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+I L +LH E I++ DLK N+LLD + K+ DFG+ + E I +T
Sbjct: 104 EIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGG---VTTS 154
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTH 672
G+ YI PE + A D ++ GV+L E+ G SP
Sbjct: 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
+G G+FG VYK +E G+ A K++ IES + F E + L +H N+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA-- 70
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHND 581
+ L ++ EF G+L + E GL + + + AL++LH+
Sbjct: 71 ---YFYENKLWILIEFCDGGALDSIM-----LELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 582 CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE 641
++H DLK GNILL D K+ DFG++ N+S++ G+ ++ PE
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAK------NKSTLQKRDTFIGTPYWMAPE 173
Query: 642 YGLGEKPSTA-----GDVYSFGVMLLEIFTGMSPTHE 673
E D++S G+ L+E+ P HE
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 462 LIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWK-SFFAECEALRNTRHRNLVKLITSC 520
L+G G+FG V+KG L++ VAVK + K F +E L+ H N+VKLI C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN 580
+ + + +V E + G ++ ++K+E L + + A+D A+ + YL +
Sbjct: 62 T-----QRQPIYIVMELVPGGDFLSFLR-KKKDE----LKTKQLVKFALDAAAGMAYLES 111
Query: 581 -DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
+C +H DL N L+ E+ K+ DFG++R + SS+ + + I +
Sbjct: 112 KNC----IHRDLAARNCLVGENNVLKISDFGMSRQ-----EDDGIYSSSGLKQIPIKWTA 162
Query: 640 PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
PE YG + S+ DV+S+G++L E F+ G+ P
Sbjct: 163 PEALNYG---RYSSESDVWSYGILLWETFSLGVCP 194
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
+G+G FG V+ GY VAVK L T + ++F E ++ +H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT- 71
Query: 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC 582
E + ++ E++ GSL D++ K++ G + + ++ + IA + Y+
Sbjct: 72 ----KEEPIYIITEYMAKGSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIERK- 122
Query: 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE- 641
+H DL+ N+L+ E + K+ DFGLAR + + ++ K I + PE
Sbjct: 123 --NYIHRDLRAANVLVSESLMCKIADFGLARVI-----EDNEYTAREGAKFPIKWTAPEA 175
Query: 642 --YGLGEKPSTAGDVYSFGVMLLEIFT 666
+G + DV+SFG++L EI T
Sbjct: 176 INFG---SFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 461 NLIGSGSFGSVYKGYLREG----ISVAVKVLD-IESTGTWKSFFAECEALRNTRHRNLVK 515
+IG G FG VY G L + I AVK L+ I + F E +++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575
L+ C L + + L Y + +G L ++I E N L + + +A +
Sbjct: 61 LLGIC--LPSEGSPLVVLPY--MKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGM 111
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
+YL + VH DL N +LDE T KV DFGLAR + ++ S+ + K +
Sbjct: 112 EYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDK--EYYSVHNHTGAKLPV 166
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
++ E +K +T DV+SFGV+L E+ T G P
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 202
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 68/258 (26%), Positives = 124/258 (48%), Gaps = 24/258 (9%)
Query: 455 GNFSHENLIGSGSFGSVYKGYL----REGISVAVKVLDIESTGTWKS-FFAECEALRNTR 509
+ + + +IG+G FG V++G L R+ ++VA+K L T + F +E +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
H N+++L + FK ++ E++ NG+L ++ +H + + + +
Sbjct: 65 HHNIIRLEGVVTK--FKPA---MIITEYMENGALDKYLR-----DHDGEFSSYQLVGMLR 114
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
IA+ + YL + + VH DL NIL++ ++ KV DFGL+R L + + +T
Sbjct: 115 GIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED---DPEGTYTTS 168
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688
K I + PE K ++A DV+SFG+++ E+ + G P + EV +K +
Sbjct: 169 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV--MKAINDG 226
Query: 689 FPKNAQQVLDRELRQLMM 706
F A + QLM+
Sbjct: 227 FRLPAPMDCPSAVYQLML 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 462 LIGSGSFGSVYKGYL-----REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKL 516
+G G+FGSV G VAVK L + + F E E L++ +H N+VK
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
C S +N+ LV E+L GSL D++ +K+ L+ + L A I ++
Sbjct: 71 KGVCYSAGRRNLR---LVMEYLPYGSLRDYL---QKHRER--LDHRKLLLYASQICKGME 122
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
YL VH DL NIL++ + K+GDFGL + L + ++ + I
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ---DKEYYKVREPGESPIF 176
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
+ PE K S A DV+SFGV+L E+FT
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 65/236 (27%), Positives = 114/236 (48%), Gaps = 41/236 (17%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREG---ISVAVKVL-DIESTGTWKSFFAECEAL-RNTRH 510
+ E++IG G+FG V + +++ ++ A+K+L + S + F E E L + H
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER--------KNEHGNGLNFL 562
N++ L+ +C +N +L + E+ G+L D++ R EHG
Sbjct: 63 PNIINLLGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 563 ER--LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIG 620
+ L A D+A+ + YL E +H DL N+L+ E++ +K+ DFGL+R E +
Sbjct: 118 SQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG--EEV- 171
Query: 621 NQSSISSTHVLKGSIGYIPPEYGLGEKP-----STAGDVYSFGVMLLEIFT-GMSP 670
+K ++G +P + E +T DV+SFGV+L EI + G +P
Sbjct: 172 ---------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 25/217 (11%)
Query: 462 LIGSGSFGSVYKG-YLR---EGISVAVKVLDIESTGTWKS-FFAECEALRNTRHRNLVKL 516
IG G FG VY+G Y+ E I+VAVK ++ + + F E +R H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
I + + +V E G L ++ + L+ + + +++AL
Sbjct: 73 IGVITE------NPVWIVMELAPLGELRSYLQVNK-----YSLDLASLILYSYQLSTALA 121
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
YL + VH D+ N+L+ K+GDFGL+R L + S K I
Sbjct: 122 YLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-----ESYYKASKGKLPIK 173
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTH 672
++ PE + ++A DV+ FGV + EI G+ P
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 77/239 (32%), Positives = 110/239 (46%), Gaps = 42/239 (17%)
Query: 441 SPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVL--DIESTGTWKS 497
S EL R N IGSG+ G+VYK R G A+KV+ + E T +
Sbjct: 67 PSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-VRRQ 118
Query: 498 FFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGN 557
E E LR+ H N+VK C + N E + ++ EF+ GSL + H
Sbjct: 119 ICREIEILRDVNHPNVVK----CHDMFDHNGE-IQVLLEFMDGGSL--------EGTHIA 165
Query: 558 GLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE 617
FL ++A I S + YLH IVH D+KP N+L++ K+ DFG++R L +
Sbjct: 166 DEQFLA--DVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220
Query: 618 RIGN-QSSISSTHVLKGSIGYIPPE-----YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ SS+ G+I Y+ PE G AGD++S GV +LE + G P
Sbjct: 221 TMDPCNSSV-------GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 25/227 (11%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE----GISVAVKVL--DIESTGTWKSFFAECEALRNTRH 510
F+ ++G G FGSV + L+ VAVK+L DI S+ + F E ++ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 511 RNLVKLI-TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
N++KLI S S + ++ F+ +G L ++ R E L + I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
DIAS ++YL + +H DL N +L+E+MT V DFGL++ + S +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIY---------SGDY 168
Query: 630 VLKGSIGYIPPEYGLGEKP-----STAGDVYSFGVMLLEIFT-GMSP 670
+G +P ++ E +T DV++FGV + EI T G +P
Sbjct: 169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 31/221 (14%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGIS---VAVKVLDIESTGTWKS---FFAECEALRNTR 509
+ +G+G+FG V+ +R+ IS A+KV+ I K E L+
Sbjct: 2 DLERIKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
H +++L + + FL ++ E++ G L ++ + + GL + A
Sbjct: 60 HPFIIRLFWT-----EHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY------AS 108
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+I AL+YLH+ IV+ DLKP NILLD++ K+ DFG A+ L +R T
Sbjct: 109 EIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---------TW 156
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
L G+ Y+ PE + + A D ++ G+++ E+ G P
Sbjct: 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 461 NLIGSGSFGSVYKGY-LREGISVAVKVLDIEST--GTWKSFFAECEALR---NTRHRNLV 514
IG G++G+VYK L G VA+K + + + G S E L+ + H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDW-IHGERKNEHGNGLNFLERLNIAIDIAS 573
+L+ C L LV+E + D + GL ++ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV------DQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
+D+LH+ IVH DLKP NIL+ D K+ DFGLAR + +++S V
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVVV--- 168
Query: 634 SIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIF 665
++ Y PE L +T D++S G + E+F
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 462 LIGSGSFGSVYKG-YLREGISVAVKVLDIESTGT---------WKSFFAECEALRNTRHR 511
LIGSGSFGSVY G G +AVK +++ S + E L+ +H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAI 569
N+V+ + S D N+ FL E++ GS+ + N +G F E L N
Sbjct: 67 NIVQYLGSSLDADHLNI-FL----EYVPGGSVAALL-----NNYGA---FEETLVRNFVR 113
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
I L+YLHN I+H D+K NIL+D K+ DFG+++ L + + +
Sbjct: 114 QILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
L+GS+ ++ PE + D++S G +++E+ TG P
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 33/219 (15%)
Query: 461 NLIGSGSFGSVYKGY-LREGISVAVK-VLDIESTGTW-KSFFAECEALRNTRHRNLVKL- 516
IGSG++G V R G VA+K + ++ K E + LR+ RH N++ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 517 --ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK--NEHGNGLNFLERLNIAIDIA 572
+ S DF + + +V E + L I + ++H + + I
Sbjct: 66 DILRPPSPEDFND---VYIVTELMET-DLHKVIKSPQPLTDDH---IQY-----FLYQIL 113
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L YLH ++H DLKP NIL++ + K+ DFGLAR G L
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR------GVDPDEDEKGFLT 164
Query: 633 GSIG---YIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTG 667
+ Y PE L + + A D++S G + E+ T
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 31/218 (14%)
Query: 460 ENLIGSGSFGSVYKGYL----REGISVAVKVLDIESTGTW-KSFFAECEALRNTRHRNLV 514
E +IG+G FG V +G L + I VA+K L T + F +E + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 515 KL---IT-SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
L +T S + ++ EF+ NG+L ++ R+N+ ++ + +
Sbjct: 69 HLEGVVTKSRPVM---------IITEFMENGALDSFL---RQND--GQFTVIQLVGMLRG 114
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
IA+ + YL E+ VH DL NIL++ ++ KV DFGL+R L + + S + T
Sbjct: 115 IAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED---DTSDPTYTSS 168
Query: 631 LKGSIG--YIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
L G I + PE K ++A DV+S+G+++ E+ +
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 68/215 (31%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 463 IGSGSFGSVY------KGYLREGISVAVKVLDIESTGT-----WKSFFAECEALRNTRHR 511
+G G FG V +G G VAVK L ES G K E E LRN H
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKK----EIEILRNLYHE 66
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
N+VK C+ ++ L+ EFL +GSL +++ +N+ N +N ++L A+ I
Sbjct: 67 NIVKYKGICTEDGGNGIK---LIMEFLPSGSLKEYL---PRNK--NKINLKQQLKYAVQI 118
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
+DYL + VH DL N+L++ + K+GDFGL +++ ++ + L
Sbjct: 119 CKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET---DKEYYTVKDDL 172
Query: 632 KGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
+ + PE + K A DV+SFGV L E+ T
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTR----- 509
+F N IG GSFG V+K + + A+K +D+ + EA+ R
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE----REEAIDEARVLAKL 56
Query: 510 -HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568
+++ S F + L +V E+ NG L + +R G L +
Sbjct: 57 DSSYIIRYYES-----FLDKGKLNIVMEYAENGDLHKLLKMQR----GRPLPEDQVWRFF 107
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
I I L +LH+ I+H D+K N+ LD K+GD G+A+ L + ++ ++T
Sbjct: 108 IQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL----SDNTNFANT 160
Query: 629 HVLKGSIGYIPPEYGLGEKPSTA-GDVYSFGVMLLEIFTGMSP 670
V G+ Y+ PE +KP DV++ GV+L E TG P
Sbjct: 161 IV--GTPYYLSPEL-CEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 66/233 (28%), Positives = 113/233 (48%), Gaps = 39/233 (16%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIEST----------GTWKSFFAECEALRNTRH 510
LIG G++G VY + G +AVK +++ +T K+ +E E L++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 511 RNLVKLITSCSSLDFKNME-FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
N+V+ L F+ E +L++ E++ GS+G + + E F E+
Sbjct: 68 LNIVQY------LGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ----- 116
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+ L YLH+ I+H DLK N+L+D D K+ DFG+++ + N ++S
Sbjct: 117 -VLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS--- 169
Query: 630 VLKGSIGYIPPE----YGLGEKPSTAGDVYSFGVMLLEIFTGMSP--THESFA 676
++GS+ ++ PE Y G S D++S G ++LE+F G P E+ A
Sbjct: 170 -MQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 463 IGSGSFGSVYKG-YLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
IGSG++G VYK + G VA+KV+ +E ++ E L+ RH N+V S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-- 68
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI---DIASALDYL 578
+ + L +V E+ G GSL D R L L IA + L YL
Sbjct: 69 ---YLRRDKLWIVMEYCGGGSLQDIYQVTRGP--------LSELQIAYVCRETLKGLAYL 117
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H E +H D+K NILL ED K+ DFG++ L ++I+ G+ ++
Sbjct: 118 H---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYWM 168
Query: 639 PPEYGLGEKPS---TAGDVYSFGVMLLEIFTGMSP 670
PE E+ D+++ G+ +E+ P
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITS 519
IG G+ G V+K RE G +VA+K + + G E +AL+ +H +VKL+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
F + LV E++ L + + E L + + + + Y+H
Sbjct: 68 -----FPHGSGFVLVMEYMP-SDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMH 116
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
I+H DLKP N+L+ D K+ DFGLAR + +H + + Y
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLF----SEEEPRLYSHQV-ATRWYRA 168
Query: 640 PEYGLGEKPSTAG-DVYSFGVMLLEIFTGMSPTHESFAGE 678
PE G + G D+++ G + E+ G SP F GE
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNG-SPL---FPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 461 NLIGSGSFGSVYKGYLR------EGISVAVKVLDIESTGTWKS-FFAECEALRNTRHRNL 513
+G G+FG VY+G R + VAVK L + +S F E + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN-EHGNGLNFLERLNIAIDIA 572
V+LI + + F+ L E + G L ++ R E + L + L A D+A
Sbjct: 72 VRLIGVS--FE-RLPRFILL--ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLD---EDMTAKVGDFGLARSLLE----RIGNQSSI 625
YL E +H D+ N LL AK+ DFG+AR + R G ++ +
Sbjct: 127 KGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 626 SSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
I ++PPE L ++ DV+SFGV+L EIF+ G P
Sbjct: 184 P--------IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 32/221 (14%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIESTG-TWKSFFAECEA----LRNTRHRNLVK 515
L+GSGSFGSVY+G L +G AVK + + G T + + E L +H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAIDIAS 573
+ + D + FL E + GSL + ++G+ F E + I
Sbjct: 67 YLGTEREEDNLYI-FL----ELVPGGSLAKLL-----KKYGS---FPEPVIRLYTRQILL 113
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
L+YLH+ VH D+K NIL+D + K+ DFG+A+ ++E S S KG
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE----FSFAKS---FKG 163
Query: 634 SIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHE 673
S ++ PE + A D++S G +LE+ TG P +
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 9e-16
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 43/220 (19%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFA--ECEALRNTRHRNLVKLITS 519
IG G++G VYK + G VA+K + +E+ A E + L+ RH N+V+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHG-NGLNFLERLNIAIDIA------ 572
+S K + +V+E++ +H GL L+ + +
Sbjct: 67 VTS---KGKGSIYMVFEYM---------------DHDLTGL--LDSPEVKFTESQIKCYM 106
Query: 573 ----SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
L YLH++ I+H D+K NIL++ D K+ DFGLAR S+ +
Sbjct: 107 KQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPY---TKRNSADYTN 160
Query: 629 HVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
V+ ++ Y PPE LG D++S G +L E+F G
Sbjct: 161 RVI--TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 43/226 (19%)
Query: 457 FSHENLIGSGSFGSVYKG-YLREGISVAVKVLDIESTGT-------WKSFFAECEALRNT 508
F+ IG GSFG VYK R VA+KV+D+E F ++C + T
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 509 R-HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI 567
+ + + +K K L ++ E+ G GS D + + +E I
Sbjct: 63 KYYGSFLK--------GSK----LWIIMEYCGGGSCLDLLKPGKLDET----------YI 100
Query: 568 AI---DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
A ++ L+YLH + ++ H D+K NILL E+ K+ DFG++ L + S
Sbjct: 101 AFILREVLLGLEYLHEEGKI---HRDIKAANILLSEEGDVKLADFGVSGQL----TSTMS 153
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+T V G+ ++ PE D++S G+ +E+ G P
Sbjct: 154 KRNTFV--GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 69/258 (26%), Positives = 109/258 (42%), Gaps = 25/258 (9%)
Query: 455 GNFSHENLIGSGSFGSVYKG-YLREGISVAVK---VLDIESTGTWKSFFAECEALRNTRH 510
NF E IG G F VY+ L +G+ VA+K + D+ E + L+ H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIA 568
N++K S F L +V E G L I +K + E+
Sbjct: 62 PNVIKYYAS-----FIEDNELNIVLELADAGDLSRMIKHFKKQKR----LIPEKTVWKYF 112
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+ + SAL+++H+ ++H D+KP N+ + K+GD GL R S ++
Sbjct: 113 VQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAA 163
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES- 687
H L G+ Y+ PE + D++S G +L E+ SP + SL K +E
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 223
Query: 688 NFPKNAQQVLDRELRQLM 705
++P ELRQL+
Sbjct: 224 DYPPLPSDHYSEELRQLV 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 73/256 (28%), Positives = 120/256 (46%), Gaps = 30/256 (11%)
Query: 460 ENLIGSGSFGSVYKGYLR----EGISVAVKVLDIESTGTWK-SFFAECEALRNTRHRNLV 514
E +IG+G FG V G L+ I VA+K L T + F +E + H N++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 515 KL---ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
L +T + +V E++ NGSL ++ RK H ++ + + I
Sbjct: 69 HLEGVVTKSKPV--------MIVTEYMENGSLDAFL---RK--HDGQFTVIQLVGMLRGI 115
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
AS + YL ++ VH DL NIL++ ++ KV DFGL+R L + + + +T
Sbjct: 116 ASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED---DPEAAYTTRGG 169
Query: 632 KGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFP 690
K I + PE K ++A DV+S+G+++ E+ + G P E +V +K +E +
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--IKAIEEGYR 227
Query: 691 KNAQQVLDRELRQLMM 706
A L QLM+
Sbjct: 228 LPAPMDCPAALHQLML 243
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 67/239 (28%), Positives = 101/239 (42%), Gaps = 48/239 (20%)
Query: 463 IGSGSFGSVYKGYL-----REGIS-VAVKVLDIESTGT-WKSFFAECEALRNTRHRNLVK 515
+G G FG V K R G + VAVK+L ++ + + +E L+ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHG------------------N 557
L +CS L L+ E+ GSL ++ RK
Sbjct: 68 LYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 558 GLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE 617
L + ++ A I+ + YL E+ +VH DL N+L+ E K+ DFGL+R + E
Sbjct: 123 ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 618 RIGNQSSISSTHVLKGSIGYIP-----PEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+K S G IP E +T DV+SFGV+L EI T G +P
Sbjct: 180 ---------EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 22/229 (9%)
Query: 450 LRRATGNFSHENLIGSGSFGSVYKG-YLREGISVAVKVLDIESTGTWKSFFAECEALRN- 507
LR G F L+G+G++G VYKG +++ G A+KV+D+ + E L+
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKY 59
Query: 508 TRHRNLVKLITSCSSLDFKNME-FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLN 566
+ HRN+ + + M+ L LV EF G GS+ D I KN GN L
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEWIAY 115
Query: 567 IAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSIS 626
I +I L +LH ++H D+K N+LL E+ K+ DFG++ L +G +++
Sbjct: 116 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 170
Query: 627 STHVLKGSIGYIPPEY-GLGEKPSTA----GDVYSFGVMLLEIFTGMSP 670
G+ ++ PE E P D++S G+ +E+ G P
Sbjct: 171 ----FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 463 IGSGSFGSVYKGYLR-EGISVAVKVLDIESTGT-WKSFFAECEALRNTRHRNLVKLITSC 520
+G+G+ G V K R G +AVK + +E K E + L +V +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERK--NEHGNGLNFLERLNIAIDIASALDYL 578
+ N + +++ E++ GSL + + E G IA+ + L YL
Sbjct: 69 ----YNNGD-ISICMEYMDGGSLDKILKEVQGRIPERILG-------KIAVAVLKGLTYL 116
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H + I+H D+KP NIL++ K+ DFG++ L+ S++ T V G+ Y+
Sbjct: 117 HEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN------SLAKTFV--GTSSYM 166
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
PE G S D++S G+ L+E+ TG P
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-15
Identities = 37/90 (41%), Positives = 53/90 (58%), Gaps = 1/90 (1%)
Query: 183 LDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNI 242
L L + G IPN + L+ L I+LSGN + IP S G+ +L +DLS N NG+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 243 PKEILSLSSLTTIVNLSKNFLDGTLPEEIG 272
P+ + L+SL I+NL+ N L G +P +G
Sbjct: 483 PESLGQLTSLR-ILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 65/251 (25%), Positives = 117/251 (46%), Gaps = 28/251 (11%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
E +G+G FG V+ + VAVK + + + ++F AE ++ +H LVKL
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
+ E + ++ EF+ GSL D++ K++ G+ + ++ + IA + ++
Sbjct: 70 VTK------EPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
+ +H DL+ NIL+ + K+ DFGLA R+ + ++ K I +
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLA-----RVIEDNEYTAREGAKFPIKWTA 171
Query: 640 PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQ 695
PE +G + DV+SFG++L+EI T G P EV ++ +E + +
Sbjct: 172 PEAINFG---SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--IRALERGYRMPRPE 226
Query: 696 VLDRELRQLMM 706
EL +MM
Sbjct: 227 NCPEELYNIMM 237
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 456 NFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIE--STGTWKSFFA-ECEA--LRNTR 509
N+ L+G G+FG VY Y + G +AVK + + S T K A ECE L+N +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
H +V+ C D E L++ E++ GS+ D + +G + R
Sbjct: 63 HERIVQYY-GCLRDD----ETLSIFMEYMPGGSVKDQL-----KAYGALTETVTR-KYTR 111
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
I ++YLH++ IVH D+K NIL D K+GDFG ++ L + + + S
Sbjct: 112 QILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ ++ PE GE DV+S G ++E+ T P
Sbjct: 169 ---GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 71/215 (33%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 463 IGSGSFGSVYKGYLR-EGISVAVKVLD---IESTGTWKSFFAECEAL-RNTRHRNLVKLI 517
IG GSFG V + +G AVKVL I K AE L +N +H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE-RLNI-AIDIASAL 575
S F+ + L V +++ G L + H +R+ +F E R A +IASAL
Sbjct: 63 YS-----FQTADKLYFVLDYVNGGEL--FFHLQRER------SFPEPRARFYAAEIASAL 109
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
YLH + I++ DLKP NILLD + DFGL + +E S +ST G+
Sbjct: 110 GYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH----SKTTSTFC--GTP 160
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
Y+ PE + D + G +L E+ G+ P
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 463 IGSGSFGSVYKGYLREGISVA-VKVLDIESTGTWK---SFFAECEALRNTRHRNLVKLIT 518
IG+G FG V G G+S A V V ++ ++ T F E + R H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
C +++ +L LV EF G L +++ R + +A ++AS L +L
Sbjct: 63 QCI----ESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL-QRMACEVASGLLWL 116
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H + +H DL N L D++ K+GD+GLA LE+ + + + ++
Sbjct: 117 H---QADFIHSDLALRNCQLTADLSVKIGDYGLA---LEQY-PEDYYITKDCHAVPLRWL 169
Query: 639 PPEYG-------LGEKPSTAGDVYSFGVMLLEIFT 666
PE L + + +++S GV + E+FT
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLI 517
L+G GS+G V K +E G VA+K +ES K E L+ RH NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
F+ + L LV+EF+ + L D NGL+ I +++
Sbjct: 67 EV-----FRRKKRLYLVFEFVDHTVLDDLEKYP------NGLDESRVRKYLFQILRGIEF 115
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
H+ I+H D+KP NIL+ + K+ DFG AR+L + + +V + Y
Sbjct: 116 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL----AAPGEVYTDYV--ATRWY 166
Query: 638 IPPEYGLGE-KPSTAGDVYSFGVMLLEIFTG 667
PE +G+ K A D+++ G ++ E+ TG
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 70/212 (33%), Positives = 111/212 (52%), Gaps = 26/212 (12%)
Query: 462 LIGSGSFGSVYKG-YLREG----ISVAVKVLDIESTGTWKS--FFAECEALRNTRHRNLV 514
++GSG+FG+VYKG ++ EG I VA+K+L+ E+TG + F E + + H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
+L+ C S + LV + + +G L D++H EH + + LN + IA
Sbjct: 73 RLLGVCLS------PTIQLVTQLMPHGCLLDYVH-----EHKDNIGSQLLLNWCVQIAKG 121
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
+ YL E +VH DL N+L+ K+ DFGLAR LLE G++ ++ K
Sbjct: 122 MMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR-LLE--GDEKEYNADGG-KMP 174
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
I ++ E K + DV+S+GV + E+ T
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 64/232 (27%), Positives = 113/232 (48%), Gaps = 41/232 (17%)
Query: 460 ENLIGSGSFGSVYKGYLREG---ISVAVKVL-DIESTGTWKSFFAECEAL-RNTRHRNLV 514
+++IG G+FG V K +++ + A+K + + S + F E E L + H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER----------KNEHGNGLNFLER 564
L+ +C ++ +L L E+ +G+L D++ R N + L+ +
Sbjct: 72 NLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
L+ A D+A +DYL + +H DL NIL+ E+ AK+ DFGL+R G +
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVY 177
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKP-----STAGDVYSFGVMLLEIFT-GMSP 670
+ K ++G +P + E +T DV+S+GV+L EI + G +P
Sbjct: 178 V------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 41/231 (17%)
Query: 461 NLIGSGSFGSVYKGYLREG---ISVAVKVL-DIESTGTWKSFFAECEAL-RNTRHRNLVK 515
++IG G+FG V K +++ + A+K + + S + F E E L + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER--------KNEHGNGLNFLER--L 565
L+ +C ++ +L L E+ +G+L D++ R + + L
Sbjct: 61 LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 566 NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSI 625
+ A D+A +DYL + +H DL NIL+ E+ AK+ DFGL+R + +
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEV------ 164
Query: 626 SSTHVLKGSIGYIPPEYGLGEKP-----STAGDVYSFGVMLLEIFT-GMSP 670
+K ++G +P + E +T DV+S+GV+L EI + G +P
Sbjct: 165 ----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-15
Identities = 35/80 (43%), Positives = 49/80 (61%)
Query: 144 GKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKK 203
G IP I +LR L +NLS NSI G I +G + L+ LDL+ N +GSIP +LG L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 204 LNQIDLSGNELASEIPTSFG 223
L ++L+GN L+ +P + G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 73/258 (28%), Positives = 107/258 (41%), Gaps = 25/258 (9%)
Query: 454 TGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKS---FFAECEALRNTR 509
GNF E IG G F VYK L +G VA+K + I K+ E + L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NI 567
H N++K + S F L +V E G L I K+ ER
Sbjct: 61 HPNVIKYLAS-----FIENNELNIVLELADAGDLSRMI----KHFKKQKRLIPERTIWKY 111
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
+ + SAL+++H I+H D+KP N+ + K+GD GL R S ++
Sbjct: 112 FVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTA 162
Query: 628 THVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687
H L G+ Y+ PE + D++S G +L E+ SP + SL K +E
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222
Query: 688 -NFPKNAQQVLDRELRQL 704
++P ELR L
Sbjct: 223 CDYPPLPADHYSEELRDL 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 69/226 (30%), Positives = 109/226 (48%), Gaps = 34/226 (15%)
Query: 463 IGSGSFGSVY-------KGYLREG--------ISVAVKVLDIESTGTWKS-FFAECEALR 506
+G G FG V+ +L EG + VAVK+L + T T ++ F E + +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 507 NTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHG---ERKNEHGNGLNFLE 563
++ N+++L+ C S D L ++ E++ NG L ++ E H N + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDP-----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 564 RLNI---AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIG 620
N+ A+ IAS + YL + VH DL N L+ T K+ DFG++R+L G
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS--G 182
Query: 621 NQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
+ I VL I ++ E L K +TA DV++FGV L E+FT
Sbjct: 183 DYYRIQGRAVL--PIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 80/317 (25%), Positives = 142/317 (44%), Gaps = 63/317 (19%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNL 513
NF +G G++ +VYKG R G VA+K + +++ GT + E ++ +H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 514 VKLITSCSSLDFKNMEF-LALVYEFLGNGSLGDW--IHGERKNEHGNGLNFLERLNIAID 570
V+L D + E L LV+E++ + L + HG R L+ +
Sbjct: 61 VRL------HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRG-----ALDPNTVKSFTYQ 108
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
+ + + H E ++H DLKP N+L+++ K+ DFGLAR+ G + S V
Sbjct: 109 LLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARA----FGIPVNTFSNEV 161
Query: 631 LKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM--------------------S 669
+ ++ Y P+ LG + ST+ D++S G ++ E+ TG +
Sbjct: 162 V--TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT 219
Query: 670 PTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLS 729
PT ++ G +S + + FP+ Q +L+QL ++ I L L+ +
Sbjct: 220 PTESTWPG-ISQLPEYKPTFPRYPPQ----DLQQLFPHADPLGIDLLHRLLQL------- 267
Query: 730 CTTESPGGRIDIREALR 746
+P RI +AL+
Sbjct: 268 ----NPELRISAHDALQ 280
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 26/235 (11%)
Query: 438 FKHSPQMI-SYDELRRATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTW 495
F+ + Q++ + R NF IG GS G V G VAVK +D+
Sbjct: 4 FRAALQLVVDPGDPRSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR 60
Query: 496 KSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEH 555
+ F E +R+ +H N+V++ +S + + L +V EFL G+L D + R NE
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSS-----YLVGDELWVVMEFLEGGALTDIVTHTRMNEE 115
Query: 556 GNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615
+ + + + AL +LH ++H D+K +ILL D K+ DFG +
Sbjct: 116 -------QIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165
Query: 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ + + S L G+ ++ PE T D++S G+M++E+ G P
Sbjct: 166 SKEVPRRKS------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 66/222 (29%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 462 LIGSGSFGSVYKGYLREGISV-AVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
++G GSFG V L+ A+K L D+E T + A H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLA-----LAWEHP 56
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI-AID 570
L L C+ F+ E L V E+L G L I + + R A +
Sbjct: 57 FLTHLF--CT---FQTKEHLFFVMEYLNGGDLMFHIQSSGRFD-------EARARFYAAE 104
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
I L +LH I++ DLK N+LLD+D K+ DFG+ + + G S+
Sbjct: 105 IICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC---- 157
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTH 672
G+ YI PE G+K + + D +SFGV+L E+ G SP H
Sbjct: 158 --GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 75/245 (30%), Positives = 110/245 (44%), Gaps = 40/245 (16%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
+G G+FG VYK +E G+ A KV+D +S + + E + L + H N+VKL+ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA-------SA 574
F L ++ EF G++ D + E LER I A
Sbjct: 71 ---FYYENNLWILIEFCAGGAV-DAVMLE-----------LERPLTEPQIRVVCKQTLEA 115
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
L+YLH E I+H DLK GNIL D K+ DFG++ N +I G+
Sbjct: 116 LNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK------NTRTIQRRDSFIGT 166
Query: 635 IGYIPPEYGLGE----KP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689
++ PE + E +P DV+S G+ L+E+ P HE V L+K +S
Sbjct: 167 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSEP 225
Query: 690 PKNAQ 694
P AQ
Sbjct: 226 PTLAQ 230
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 48/146 (32%), Positives = 67/146 (45%), Gaps = 5/146 (3%)
Query: 280 IDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSI 339
+ L GL G +PN + L+ + ++ N G IP L + LEVLDLS N +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 340 PSDLQNLRALRSLNLTFNNLEGVVPRE--GIFRHTSMVHLEGNPKLCLHLG---CENSSS 394
P L L +LR LNL N+L G VP G H + + N LC G C S
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLS 542
Query: 395 HGRRRIIIYIIVAIIAIIAGCFLIFW 420
G + I + + + C + +W
Sbjct: 543 VGAKIGIAFGVSVAFLFLVICAMCWW 568
|
Length = 623 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 71/222 (31%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 462 LIGSGSFGSVYKGYLR-EGISVAVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
++G GSFG V+ L+ A+K L D+E T K + H
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----WEHP 56
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI-AID 570
L L + F+ E L V E+L G L I K + L R A +
Sbjct: 57 FLTHLYCT-----FQTKENLFFVMEYLNGGDLMFHIQSCHKFD-------LPRATFYAAE 104
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
I L +LH+ IV+ DLK NILLD D K+ DFG+ + + +G+ + T
Sbjct: 105 IICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENM--LGD----AKTCT 155
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTH 672
G+ YI PE LG+K +T+ D +SFGV+L E+ G SP H
Sbjct: 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 18/218 (8%)
Query: 455 GNFSHENLIGSGSFGSVYKGYLREGISV-AVK-VLDIESTGTWKSFFAECEALRNTRHRN 512
+ +G G+ GSV K L+ + A+K + + K E E ++ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+VK + LD + + + E+ GSL D I+ + K + G + IA +
Sbjct: 61 IVKYYGAF--LDESSSS-IGIAMEYCEGGSL-DSIYKKVK-KRGGRIGEKVLGKIAESVL 115
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L YLH I+H D+KP NILL K+ DFG++ L+ S++ T
Sbjct: 116 KGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN------SLAGTFT-- 164
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ Y+ PE G+ S DV+S G+ LLE+ P
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 83/285 (29%), Positives = 124/285 (43%), Gaps = 57/285 (20%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKV--LDIESTGTWKSFFAECEALRNTRHRN 512
NF IG G++G VYK + G VA+K LD E+ G + E L+ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 513 LVKLITSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGL--NFLERLNIAI 569
+VKL LD L LV+EFL + L ++ + L ++L +L
Sbjct: 61 IVKL------LDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL---- 109
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
L + H+ ++H DLKP N+L++ + K+ DFGLAR+ + TH
Sbjct: 110 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTH 159
Query: 630 VLKGSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLE------IFTGMS------------- 669
+ ++ Y PE LG K STA D++S G + E +F G S
Sbjct: 160 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 218
Query: 670 -PTHESFAGEVSLVKWVESNFPKNAQQ-------VLDRELRQLMM 706
P + G SL + + +FPK A+Q LD + R L+
Sbjct: 219 TPDEVVWPGVTSLPDY-KPSFPKWARQDFSKVVPPLDEDGRDLLS 262
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 463 IGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKS-FFAECEALRNTRHRNLVKLITSC 520
IG G+FG V+ G LR + VAVK K+ F E L+ H N+V+LI C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN 580
+ + + +V E + G ++ E G L E + + + A+ ++YL +
Sbjct: 63 T-----QKQPIYIVMELVQGGDFLTFLRTE-----GPRLKVKELIQMVENAAAGMEYLES 112
Query: 581 DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPP 640
+H DL N L+ E K+ DFG++R E G +S + + + P
Sbjct: 113 KH---CIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQI--PVKWTAP 165
Query: 641 E---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
E YG + S+ DV+SFG++L E F+ G P
Sbjct: 166 EALNYG---RYSSESDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 56/297 (18%)
Query: 462 LIGSGSFGSVYKGYLREGIS--VAVKVLDI----------ESTGTWKSFFAECEALRNT- 508
+GSG+FG VYK + +A+K +++ E + +E ++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 509 RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE-RL-N 566
RH N+V+ + F + L +V + + LG+ + ++ + F E R+ N
Sbjct: 67 RHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQ----RFTEERIWN 117
Query: 567 IAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSIS 626
I + + AL YLH E IVH DL P NI+L ED + DFGLA+ + +S ++
Sbjct: 118 IFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK----QKQPESKLT 171
Query: 627 STHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686
S + G+I Y PE E DV++FG +L ++ T P +
Sbjct: 172 S---VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY-------------S 215
Query: 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIRE 743
+N A ++++ L S+ + +IT SC T R DI +
Sbjct: 216 TNMLSLATKIVEAVYEPLPEGMYSEDVTD---VIT-------SCLTPDAEARPDIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 62/226 (27%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 459 HENLIGSGSFGSVYKGY-LREGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKL 516
++ ++G G+ G+VYK Y L +AVKV+ ++ T K +E E L ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
+ F +++ EF+ GSL + + EH G IA+ + L
Sbjct: 65 YGA-----FFVENRISICTEFMDGGSLDVY---RKIPEHVLG-------RIAVAVVKGLT 109
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
YL + + I+H D+KP N+L++ K+ DFG++ L+ +SI+ T+V G+
Sbjct: 110 YLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV------NSIAKTYV--GTNA 158
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV 682
Y+ PE GE+ DV+S G+ +E+ G P + + SL+
Sbjct: 159 YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM 204
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 39/229 (17%)
Query: 463 IGSGSFGSVY-------KGYLREGIS----------VAVKVL-DIESTGTWKSFFAECEA 504
+G G FG V+ + + + + VAVKVL S + F E +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 505 LRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HGERKNEHGNGLNFL 562
L N+ +L+ C+ L ++ E++ NG L ++ H + L
Sbjct: 73 LSRLSDPNIARLLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 563 ER---LNIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE 617
L +A IAS + YL N VH DL N L+ ++ T K+ DFG++R+L
Sbjct: 128 SFSTLLYMATQIASGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 618 RIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
+ + L I ++ E L K +T DV++FGV L EI T
Sbjct: 183 --SDYYRVQGRAPL--PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 463 IGSGSFGSVYKGYLR-EGISVAVKVL---DIESTGTWKSFFAECEALRNTRHR-NLVKLI 517
I G+FGSVY R G A+KVL D+ + + AE + + KL
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
S F++ ++L LV E+L G I + GL ++ ++
Sbjct: 64 YS-----FQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAKQYIAEVVLGVED 112
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
LH I+H D+KP N+L+D+ K+ DFGL+R+ LE G+ Y
Sbjct: 113 LHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----------KKFVGTPDY 159
Query: 638 IPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTH 672
+ PE LG D +S G ++ E G P H
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 59/214 (27%), Positives = 85/214 (39%), Gaps = 27/214 (12%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALRNTRHRNLVKLIT 518
+G G FG V ++ G A K LD ++ + E + L R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-- 58
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWI--HGERKNEHGNGLNFLERLNIAIDIASALD 576
+ F+ + L LV + G L I GE G + A I L+
Sbjct: 59 ---AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP------GFPEARAIFYAAQIICGLE 109
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
+LH IV+ DLKP N+LLD+ ++ D GLA L G+ G
Sbjct: 110 HLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-------KKIKGRAGTPG 159
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
Y+ PE GE + D ++ G L E+ G SP
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 8e-14
Identities = 71/238 (29%), Positives = 114/238 (47%), Gaps = 14/238 (5%)
Query: 44 PGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTN 103
L LTN+ + + +N + P LK ++ NKI S + L N
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-------ESLPSPLRN 161
Query: 104 STRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163
L L N ++P+ + NLSN L+ L + GN+ +P I L +L L+LS
Sbjct: 162 LPNLKNLDLSFNDLS-DLPKLLSNLSN-LNNLDLSGNKI-SDLPPEIELLSALEELDLSN 218
Query: 164 NSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFG 223
NSI E+L+ + L+ L L+L+ N++ +P ++GNL L +DLS N+++S +S G
Sbjct: 219 NSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS--ISSLG 274
Query: 224 NFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTID 281
+ NL +DLS N L+ +P L L L ++NL L +L N + +
Sbjct: 275 SLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSN 332
|
Length = 394 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 73/230 (31%), Positives = 95/230 (41%), Gaps = 54/230 (23%)
Query: 463 IGSGSFGSVYKGYLRE------GISVAVKVLDIES----TGTWKSFFAECEALRNTRHRN 512
+G G FG V Y + G VAVK L E T WK E L+ H N
Sbjct: 12 LGEGHFGKVSL-YCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINILKTLYHEN 67
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+VK CS + + L L+ E++ GSL D++ + LN + L A I
Sbjct: 68 IVKYKGCCSE---QGGKGLQLIMEYVPLGSLRDYLPK-------HKLNLAQLLLFAQQIC 117
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
+ YLH+ +H DL N+LLD D K+GDFGLA+ V +
Sbjct: 118 EGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK---------------AVPE 159
Query: 633 GSIGYIPPEYG-----------LGE-KPSTAGDVYSFGVMLLEIFTGMSP 670
G Y E G L E K S A DV+SFGV L E+ T
Sbjct: 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVK-VLDIESTG-TWKSFFAECEALRNTRHRNLVKLIT 518
++G G++G V K + G VA+K + E K+ E + LR RH N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
+ F+ L LV+E++ L E GL + + A+ Y
Sbjct: 68 A-----FRRKGRLYLVFEYVERTLL------ELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 579 H-NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIG-NQSSISSTHVLKGSIG 636
H ++ I+H D+KP NIL+ E K+ DFG AR+L R + +T
Sbjct: 117 HSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR------W 166
Query: 637 YIPPEYGLGEKPSTAG-DVYSFGVMLLEIFTG 667
Y PE +G+ DV++ G ++ E+ G
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 25/217 (11%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
+G G+FG VYK +E G A KV++ +S + + E E L H +VKL+ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHND 581
F L ++ EF G++ D I E GL + I + AL YLH+
Sbjct: 78 ---FYWDGKLWIMIEFCPGGAV-DAIMLELDR----GLTEPQIQVICRQMLEALQYLHS- 128
Query: 582 CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE 641
+ I+H DLK GN+LL D K+ DFG++ ++ + + S G+ ++ PE
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS------FIGTPYWMAPE 180
Query: 642 YGLGEKPSTA-----GDVYSFGVMLLEIFTGMSPTHE 673
+ E D++S G+ L+E+ P HE
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
IG GS G V + G VAVK +D+ + F E +R+ H N+V + S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS-- 87
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHND 581
+ + L +V EFL G+L D + R NE + + + + AL YLHN
Sbjct: 88 ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQ 137
Query: 582 CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE 641
++H D+K +ILL D K+ DFG + + + + S L G+ ++ PE
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS------LVGTPYWMAPE 188
Query: 642 YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
T D++S G+M++E+ G P
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 22/234 (9%)
Query: 445 ISYDELRRATGNFSHENLIGSGSFGSVYKG-YLREGISVAVKVLDIESTGTWKSFFAECE 503
I LR G F ++G+G++G VYKG +++ G A+KV+D+ + + E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEIN 64
Query: 504 ALRN-TRHRNLVKLITS-CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNF 561
L+ + HRN+ + + + L LV EF G GS+ D + KN GN L
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV----KNTKGNALKE 120
Query: 562 LERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGN 621
I +I L +LH ++H D+K N+LL E+ K+ DFG++ L +G
Sbjct: 121 DWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 177
Query: 622 QSSISSTHVLKGSIGYIPPEY-GLGEKPSTA----GDVYSFGVMLLEIFTGMSP 670
+++ G+ ++ PE E P D++S G+ +E+ G P
Sbjct: 178 RNT------FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVK--VLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
IG G++G VYK G VA+K L ES G K+ E + L+ H N++KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL--- 63
Query: 520 CSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
LD F++ L LV+EF+ + L I ++ GL + + L +
Sbjct: 64 ---LDVFRHKGDLYLVFEFM-DTDLYKLIKDRQR-----GLPESLIKSYLYQLLQGLAFC 114
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H+ I+H DLKP N+L++ + K+ DFGLARS G+ + +V+ + Y
Sbjct: 115 HSH---GILHRDLKPENLLINTEGVLKLADFGLARSF----GSPVRPYTHYVV--TRWYR 165
Query: 639 PPEYGLGEKPSTAG-DVYSFGVMLLEIFTG 667
PE LG+K + D++S G + E+ +
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 67/249 (26%), Positives = 111/249 (44%), Gaps = 24/249 (9%)
Query: 463 IGSGSFGSVYKGYLR---EGISVAVKVLDIESTGTWK-SFFAECEALRNTRHRNLVKLIT 518
+GSG+FG V KG + + I VA+KVL E+ + + E E + + +V++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
C + E L LV E G L ++ G K + N +E ++ ++ + YL
Sbjct: 63 VCEA------EALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMH---QVSMGMKYL 111
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
VH DL N+LL AK+ DFGL+++L + S + K + +
Sbjct: 112 E---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL---GADDSYYKARSAGKWPLKWY 165
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQVL 697
PE K S+ DV+S+G+ + E F+ G P + EV + ++E +
Sbjct: 166 APECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--MSFIEQGKRLDCPAEC 223
Query: 698 DRELRQLMM 706
E+ LM
Sbjct: 224 PPEMYALMK 232
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 66/237 (27%), Positives = 98/237 (41%), Gaps = 43/237 (18%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVL---DIESTGTWKSFFAECEALRNTRHRNLVKLI 517
+IG G+FG V+ ++ G A+KVL D+ AE + L + +VKL
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDW-IHGERKNEHGNGLNFLERLNIAIDIASALD 576
S F++ E L LV E++ G L + I + E R IA ++ ALD
Sbjct: 68 YS-----FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE------TARFYIA-ELVLALD 115
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA-------RSLLERIGNQSSISSTH 629
+H + +H D+KP NIL+D D K+ DFGL + + + +
Sbjct: 116 SVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 630 VLK----------------GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
VL G+ YI PE G D +S GV+L E+ G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 50/162 (30%), Positives = 82/162 (50%), Gaps = 21/162 (12%)
Query: 461 NLIGSGSFGSVYKGYLRE-GISVAVKVLD--IESTGTWKSFFAECEALRNTRHRNLVKLI 517
+ +GSG++G V + + G VA+K L +S K + E L++ H N++ L+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 518 ---TSCSSL-DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
T SSL DF+++ LV +G L + + ++ ++ + + FL I
Sbjct: 81 DVFTPASSLEDFQDV---YLVTHLMG-ADLNNIVKCQKLSD--DHIQFL-----VYQILR 129
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615
L Y+H+ I+H DLKP NI ++ED K+ DFGLAR
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 72/258 (27%), Positives = 114/258 (44%), Gaps = 50/258 (19%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
IG GS G V ++ G VAVK +D+ + F E +R+ +H N+V++ S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHND 581
+ + L +V EFL G+L D + R NE + + + + AL LH
Sbjct: 86 ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLKALSVLHAQ 135
Query: 582 CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE 641
++H D+K +ILL D K+ DFG + + + + S L G+ ++ PE
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS------LVGTPYWMAPE 186
Query: 642 ------YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL--VKWVESNFP--- 690
YG P D++S G+M++E+ G P + E L +K + N P
Sbjct: 187 LISRLPYG----PEV--DIWSLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLPPKL 236
Query: 691 KNAQQV-------LDREL 701
KN +V LDR L
Sbjct: 237 KNLHKVSPSLKGFLDRLL 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 14/215 (6%)
Query: 463 IGSGSFGSVYKGYLREG---ISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLI 517
+G G FGSV +G L + + VAVK + I + + F +E ++ H N+++LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 518 TSC-SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
C +++ + ++ F+ +G L ++ R + L + DIAS ++
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
YL + +H DL N +L+E+M V DFGL++ +I N + K +
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSK----KIYNGDYYRQGRIAKMPVK 179
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+I E +T DV+SFGV + EI T G +P
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 66/274 (24%), Positives = 105/274 (38%), Gaps = 76/274 (27%)
Query: 460 ENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWK-----SFFAECEALRNTRHRNL 513
+G G++ VYK +E G VA+K + + K + E + L+ +H N+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL-------- 565
+ L+ + LV+EF+ D LE++
Sbjct: 65 IGLLDVFGHKSN-----INLVFEFM----ETD----------------LEKVIKDKSIVL 99
Query: 566 ------NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERI 619
+ + L+YLH++ I+H DLKP N+L+ D K+ DFGLARS
Sbjct: 100 TPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS----F 152
Query: 620 GNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLE------IFTGMS--- 669
G+ + + V+ + Y PE G D++S G + E G S
Sbjct: 153 GSPNRKMTHQVV--TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID 210
Query: 670 -----------PTHESFAGEVSLVKWVE-SNFPK 691
PT E++ G SL +VE FP
Sbjct: 211 QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPP 244
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-13
Identities = 38/90 (42%), Positives = 51/90 (56%), Gaps = 1/90 (1%)
Query: 110 LAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGE 169
L D G IP I L + L + + GN G IP S+G + SL +L+LSYNS +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 170 ILTEIGQLQELQSLDLAGNQISGSIPNTLG 199
I +GQL L+ L+L GN +SG +P LG
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 48/285 (16%)
Query: 463 IGSGSFGSVYKGYLRE---GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
IG GS G V RE G VAVK++D+ + F E +R+ +H+N+V++ S
Sbjct: 29 IGEGSTGIVCIA--REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
+ E L ++ EFL G+L D + R NE + + + AL YLH
Sbjct: 87 -----YLVGEELWVLMEFLQGGALTDIVSQTRLNEE-------QIATVCESVLQALCYLH 134
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
+ ++H D+K +ILL D K+ DFG + + + + S L G+ ++
Sbjct: 135 SQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS------LVGTPYWMA 185
Query: 640 PEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP---KNAQQV 696
PE T D++S G+M++E+ G P V +K + + P KNA ++
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD--SPVQAMKRLRDSPPPKLKNAHKI 243
Query: 697 -------LDREL-RQLMMSSESQTIQLH---------DCLITIIE 724
L+R L R+ + +Q + H +CL+ +I+
Sbjct: 244 SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVPLIQ 288
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 69/249 (27%), Positives = 111/249 (44%), Gaps = 26/249 (10%)
Query: 463 IGSGSFGSVYKGYLREGIS---VAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLI 517
+GSG+FG+V KG + S VAVK+L ++ E ++ + +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
C + E LV E G L ++ +KN+H N E ++ ++ + Y
Sbjct: 63 GICEA------ESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVH---QVSMGMKY 110
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
L E VH DL N+LL AK+ DFGL+++L +++ + K + +
Sbjct: 111 LE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA---DENYYKAKTHGKWPVKW 164
Query: 638 IPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQV 696
PE K S+ DV+SFGV++ E F+ G P EV + +ES Q
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV--TQMIESGERMECPQR 222
Query: 697 LDRELRQLM 705
E+ LM
Sbjct: 223 CPPEMYDLM 231
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 56/254 (22%)
Query: 442 PQMISYDELRRATGNFSHENL-----IGSGSFGSVYK----GYLREG--ISVAVKVLDIE 490
P + YD F NL +G+G+FG V + G + + VAVK+L
Sbjct: 21 PTQLPYDL----KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT 76
Query: 491 STGTWKSFFAECEALRNT--------RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGS 542
+ + E EAL + H N+V L+ +C+ L ++ E+ G
Sbjct: 77 AHSS------EREALMSELKIMSHLGNHENIVNLLGACT----IGGPIL-VITEYCCYGD 125
Query: 543 LGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDED 601
L +++ RK E + L + L+ + +A + +L + +C +H DL N+LL
Sbjct: 126 LLNFLR--RKRE--SFLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHG 177
Query: 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGS----IGYIPPEYGLGEKPSTAGDVYSF 657
K+ DFGLAR ++ S +V+KG+ + ++ PE + DV+S+
Sbjct: 178 KIVKICDFGLARDIMN--------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 229
Query: 658 GVMLLEIFT-GMSP 670
G++L EIF+ G +P
Sbjct: 230 GILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 33/232 (14%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALRNTRHRNLVKLIT 518
+G G +G V+ ++ G VA+K + + + E + L T+ LVKL+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIH--GERKNEHGNGLNFLERLNIAIDIASALD 576
+ F++ E+L L E++ G ++ G +H R +A ++ A+D
Sbjct: 69 A-----FQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA-------RFYMA-EMFEAVD 115
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
LH E+ +H DLKP N L+D K+ DFGL++ ++ + + GS
Sbjct: 116 ALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY---------ANSVVGSPD 163
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV--SLVKWVE 686
Y+ PE G+ D +S G ML E G P S E +L W E
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 71/225 (31%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 451 RRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKV--LDIESTGTWKSFFAECEALRN 507
+R F IG G++G VYK ++ G VA+K LD E G + E + LR
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 508 TRHRNLVKL----ITSCSSLDF-KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL 562
HRN+V L +LDF K+ LV+E++ + +G G + +F+
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 563 ERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
++L L+Y H +H D+K NILL+ K+ DFGLAR +
Sbjct: 123 KQL------LEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLY---NSEE 170
Query: 623 SSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFT 666
S + V+ ++ Y PPE LG E+ A DV+S G +L E+FT
Sbjct: 171 SRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 31/224 (13%)
Query: 462 LIGSGSFGSVYKG-YLREG----ISVAVKVLDIESTGTWKSFFAECE---ALRNTRHRNL 513
L+GSG FG+V+KG ++ EG I VA+K I+ ++F + A+ + H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
V+L+ C L LV + GSL D + +H + L+ LN + IA
Sbjct: 72 VRLLGICPGAS------LQLVTQLSPLGSLLDHVR-----QHRDSLDPQRLLNWCVQIAK 120
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
+ YL +VH +L NILL D ++ DFG+A L ++ S H K
Sbjct: 121 GMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP--DDKKYFYSEH--KT 173
Query: 634 SIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAG 677
I ++ E L + + DV+S+GV + E+ MS E +AG
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEM---MSYGAEPYAG 214
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 49/281 (17%)
Query: 460 ENLIGSGSFGSVYKGYL----REGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLV 514
E ++G+G FG + +G L + + VA+ L S + F AE L H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 515 KL---ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
+L IT +++ +V E++ NG+L ++ RK H L + + + +
Sbjct: 70 RLEGVITRGNTM--------MIVTEYMSNGALDSFL---RK--HEGQLVAGQLMGMLPGL 116
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG-LARSLLERIGNQSSISSTHV 630
AS + YL E+ VH L +L++ D+ K+ F L E +I +T
Sbjct: 117 ASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE------AIYTTMS 167
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNF 689
K + + PE S+A DV+SFG+++ E+ + G P + ++K VE F
Sbjct: 168 GKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD--MSGQDVIKAVEDGF 225
Query: 690 ----PKNAQQVLDRELRQLMM-------SSESQTIQLHDCL 719
P+N + L QLM+ + Q+H L
Sbjct: 226 RLPAPRNCPNL----LHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 33/229 (14%)
Query: 463 IGSGSFGSVY--------KGYLREGISVAVKVLDIEST-GTWKSFFAECEALRNT-RHRN 512
+G G FG V K +E ++VAVK+L ++T +E E ++ +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEH----------GNGLNFL 562
++ L+ +C+ L ++ E+ G+L +++ R + F
Sbjct: 83 IINLLGACTQDGP-----LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 563 ERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
+ ++ +A ++YL + +H DL N+L+ E+ K+ DFGLAR + N
Sbjct: 138 DLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD----VNNI 190
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
T + + ++ PE + DV+SFGV++ EIFT G SP
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 3/133 (2%)
Query: 256 VNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPI 315
+ L L G +P +I L ++ +I+LS N + GN+P S + SLE L ++ N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 316 PNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMV 375
P L +L L +L+L+ N LSG +P+ L R L + F + G+ G+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGG-RLLHRASFNFTDNAGLCGIPGL--RACGP 539
Query: 376 HLEGNPKLCLHLG 388
HL K+ + G
Sbjct: 540 HLSVGAKIGIAFG 552
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 35/103 (33%), Positives = 55/103 (53%)
Query: 159 LNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEI 218
L L + G I +I +L+ LQS++L+GN I G+IP +LG++ L +DLS N I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 219 PTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKN 261
P S G +L ++L+ N L+G +P + N + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 68/234 (29%), Positives = 113/234 (48%), Gaps = 43/234 (18%)
Query: 463 IGSGSFGSV---------------YKGYLREGIS--VAVKVLDIESTGTWKS-FFAECEA 504
+G G FG V + +R+G VAVK+L ++ ++ F E +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 505 LRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI---HGERKNEHGNG--- 558
L + N+++L+ C D L ++ E++ NG L ++ H + K E+GN
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDP-----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 559 -------LNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611
+++ L++A+ IAS + YL + + VH DL N L+ E++T K+ DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIF 665
+R+L G+ I VL I ++ E L K +TA DV++FGV L EI
Sbjct: 185 SRNLYA--GDYYRIQGRAVL--PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 55/183 (30%), Positives = 78/183 (42%), Gaps = 37/183 (20%)
Query: 438 FKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDI---ESTG 493
K P+ + + +LR IG GSFG+VY +R VA+K + +S
Sbjct: 9 SKDDPEKL-FTDLRE----------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE 57
Query: 494 TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN---MEFLA-LVYEFLGNGSLGDWIHG 549
W+ E L+ RH N ++++K E A LV E+ GS D +
Sbjct: 58 KWQDIIKEVRFLQQLRHPN---------TIEYKGCYLREHTAWLVMEYC-LGSASDILEV 107
Query: 550 ERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609
+K L +E I L YLH+ + H D+K GNILL E T K+ DF
Sbjct: 108 HKK-----PLQEVEIAAICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADF 159
Query: 610 GLA 612
G A
Sbjct: 160 GSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 69/221 (31%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 462 LIGSGSFGSVYKGYLR-EGISVAVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
++G GSFG V L+ +G AVK L D+E T K A A N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLAL--AWENPF-- 57
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
L L + F+ E L V EFL G L H + K + A +I
Sbjct: 58 -LTHLYCT-----FQTKEHLFFVMEFLNGGDL--MFHIQDKGR----FDLYRATFYAAEI 105
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
L +LH+ I++ DLK N++LD D K+ DFG+ + E + + S+
Sbjct: 106 VCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRAST---F 156
Query: 632 KGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTH 672
G+ YI PE G K + + D +SFGV+L E+ G SP H
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 31/228 (13%)
Query: 462 LIGSGSFGSVYKGYLR------EGISVAVKVLDIESTGT-WKSFFAECEALRNT-RHRNL 513
+G G+FG V K E +VAVK+L ++T +E E ++ +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNE----------HGNGLNFLE 563
+ L+ C+ L +V E+ +G+L D++ R L +
Sbjct: 79 INLLGVCT-----QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 564 RLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQS 623
++ A +A +++L + +H DL N+L+ ED K+ DFGLAR I +
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARD----IHHID 186
Query: 624 SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
T + + ++ PE + DV+SFGV+L EIFT G SP
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 39/232 (16%)
Query: 463 IGSGSFGSVY--------KGYLREGISVAVKVLDIESTGT-WKSFFAECEALRNT-RHRN 512
+G G FG V K + ++VAVK+L ++T +E E ++ +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK-------------NEHGNGL 559
++ L+ +C+ ++ LV E+ G+L +++ R E L
Sbjct: 80 IINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ---L 131
Query: 560 NFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERI 619
F + ++ A +A ++YL + +H DL N+L+ ED K+ DFGLAR +
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARD----V 184
Query: 620 GNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
N T + + ++ PE + DV+SFGV+L EIFT G SP
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 18/191 (9%)
Query: 482 VAVKVLDIESTGTWKS-FFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGN 540
VAVK+L ++ ++ F E + + + N+++L+ C + D L ++ E++ N
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDP-----LCMITEYMEN 103
Query: 541 GSLGDWIHGERKNEHGN-----GLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGN 595
G L ++ E +++ + +A IAS + YL + + VH DL N
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160
Query: 596 ILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVY 655
L+ ++ T K+ DFG++R+L G+ I VL I ++ E L K +TA DV+
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYS--GDYYRIQGRAVL--PIRWMSWESILLGKFTTASDVW 216
Query: 656 SFGVMLLEIFT 666
+FGV L EI T
Sbjct: 217 AFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 69/245 (28%), Positives = 103/245 (42%), Gaps = 36/245 (14%)
Query: 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVL---DIESTGTWKSFFAECEALRNTRHR 511
+F +G+GSFG V + G A+K L +I + E L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
+V ++ CS D + FL EF+ G L + H RK G N + + A ++
Sbjct: 79 FIVNMM--CSFQDENRVYFL---LEFVVGGEL--FTH-LRKA--GRFPNDVAKFYHA-EL 127
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
A +YLH+ I++ DLKP N+LLD KV DFG A+ + +R T L
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---------TFTL 175
Query: 632 KGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP--------THES-FAGEVSLV 682
G+ Y+ PE + A D ++ GV+L E G P +E AG +
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP 235
Query: 683 KWVES 687
W +
Sbjct: 236 NWFDG 240
|
Length = 329 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 461 NLIGSGSFGSVYKGYLREGIS-----VAVK-VLDIESTGTWKSFFAECEALRNTRHRNLV 514
+L+ G+FG ++ G L + V VK V D S E L H+N++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNG--LNFLERLNIAIDIA 572
++ C ++Y ++ G+L ++ R E N L+ + +++AI IA
Sbjct: 72 PILHVCIEDGEPPF----VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
+ YLH ++H D+ N ++DE++ K+ D L+R L H L
Sbjct: 128 CGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFP--------MDYHCLG 176
Query: 633 GS----IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ + ++ E + ++ S+A DV+SFGV+L E+ T G +P
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 60/232 (25%), Positives = 102/232 (43%), Gaps = 33/232 (14%)
Query: 463 IGSGSFGSVYKGYLREGIS------VAVKVLDIESTGTWK-SFFAECEALRNTRHRNLVK 515
+G GSFG VY+G + + VA+K ++ ++ + F E ++ ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLN----IAIDI 571
L+ S + ++ E + G L ++ R N + L +A +I
Sbjct: 74 LLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
A + YL+ + VH DL N ++ ED T K+GDFG+ R + E + +
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE---------TDYYR 176
Query: 632 KGSIGYIP-----PEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
KG G +P PE +T DV+SFGV+L EI T ++ + E
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 32/167 (19%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRN-------TRHRNLV 514
+G G+FGSVY +E G VA+K + + S+ EC LR H N+V
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSW-EECMNLREVKSLRKLNEHPNIV 61
Query: 515 KLITSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAIDI 571
KL + F+ + L V+E++ G+L + +RK + F E + +I I
Sbjct: 62 KL------KEVFRENDELYFVFEYM-EGNLYQLMK-DRKGKP-----FSESVIRSIIYQI 108
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618
L ++H H DLKP N+L+ K+ DFGLAR + R
Sbjct: 109 LQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 74/259 (28%), Positives = 111/259 (42%), Gaps = 39/259 (15%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKS-----FFAECEALRNTRH 510
+F+ +G+GSFG V + V + E + K F+E + L H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
V L S FK+ +L LV EF+ G ++ ++ + G + A
Sbjct: 91 PFCVNLYGS-----FKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY------AAQ 139
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
I +YL + + IV+ DLKP N+LLD+D K+ DFG A+ + R T+
Sbjct: 140 IVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---------TYT 187
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV--KWVES- 687
L G+ YI PE L A D ++ G+ + EI G P +A E L+ K +E
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF---YANEPLLIYQKILEGI 244
Query: 688 -NFPKNAQQVLDRELRQLM 705
FPK LD + LM
Sbjct: 245 IYFPK----FLDNNCKHLM 259
|
Length = 340 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 25/233 (10%)
Query: 457 FSHENLIGSGSFGSVYKG-YLREG----ISVAVKVL-DIESTGTWKSFFAECEALRNTRH 510
F ++GSG+FG+VYKG ++ EG I VA+K L + S K E + + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
++ +L+ C + + L+ + + G L D++ R+++ G +L LN +
Sbjct: 69 PHVCRLLGICLT------STVQLITQLMPFGCLLDYV---REHKDNIGSQYL--LNWCVQ 117
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
IA ++YL E +VH DL N+L+ K+ DFGLA+ L G
Sbjct: 118 IAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GADEKEYHAEG 170
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLV 682
K I ++ E L + DV+S+GV + E+ T G P A E+S +
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 223
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 71/227 (31%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 462 LIGSGSFGSVYKGYL-REGISVAVKVLD---IESTGTWKSFFAECEAL-RNTRHRNLVKL 516
+IG GSFG V +G AVKVL + + K AE L +N +H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIAIDIAS 573
S F+ E L V +F+ G L + ER +F E R A +IAS
Sbjct: 62 HYS-----FQTTEKLYFVLDFVNGGELFFHLQRER--------SFPEPRARFYAA-EIAS 107
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
AL YLH+ + IV+ DLKP NILLD + DFGL + + + +T G
Sbjct: 108 ALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGI------AQSDTTTTFCG 158
Query: 634 SIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP-----THESF 675
+ Y+ PE + D + G +L E+ G+ P E +
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 21/224 (9%)
Query: 456 NFSHENLIGSGSFGSVYKGY-LREGISVAVKVL--DIESTGTWKSFFA-ECEA--LRNTR 509
N+ L+G G+FG VY Y + G +A K + D ES T K A ECE L+N +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
H +V+ L + + L + E++ GS+ D + +G + R
Sbjct: 63 HERIVQYY---GCLRDRAEKTLTIFMEYMPGGSVKDQLKA-----YGALTESVTR-KYTR 113
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
I + YLH++ IVH D+K NIL D K+GDFG ++ L + + I S
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-- 168
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
+ G+ ++ PE GE DV+S G ++E+ T P E
Sbjct: 169 -VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 37/103 (35%), Positives = 60/103 (58%), Gaps = 9/103 (8%)
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
++A ALD+LH+ + I++ DLKP NILLDE+ K+ DFGL++ E I ++ +
Sbjct: 106 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHE---KKAY 156
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTH 672
G++ Y+ PE + + D +SFGV++ E+ TG P
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 33/218 (15%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIES-----TGTWK--SFFAECEALRNTRHRNL 513
LIG G++G+VY+G + G VA+K++++++ + + + ++ LR ++ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQ---LRQSQPPNI 64
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
K S + L ++ E+ GS+ + E + E L
Sbjct: 65 TKYYGS-----YLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL-------V 112
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
AL Y+H +V ++H D+K NIL+ K+ DFG+A L NQ+S S G
Sbjct: 113 ALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL-----NQNS-SKRSTFVG 163
Query: 634 SIGYIPPEYGL-GEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ ++ PE G+ T D++S G+ + E+ TG P
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-12
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 28/200 (14%)
Query: 479 GISVAVKVLDI---ESTGTWKSFFAE---CEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532
G VA+K+L E F E C L H N+V L+ S + L
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLY---HPNIVALLDSGEAPP----GLLF 55
Query: 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLK 592
V+E++ +L + + + L E + + + AL HN IVH DLK
Sbjct: 56 AVFEYVPGRTLREVLAAD------GALPAGETGRLMLQVLDALACAHNQ---GIVHRDLK 106
Query: 593 PGNILL---DEDMTAKVGDFGLARSLLERIGN--QSSISSTHVLKGSIGYIPPEYGLGEK 647
P NI++ AKV DFG+ +LL + + ++++ T + G+ Y PE GE
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIG-TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP 165
Query: 648 PSTAGDVYSFGVMLLEIFTG 667
+ D+Y++G++ LE TG
Sbjct: 166 VTPNSDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 54/222 (24%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 461 NLIGSGSFGSVYKGYLREGISVAVKVLDIESTGT------WKSFFAECEALRNTRHRNLV 514
++G G++G+VY G +G +AVK ++++++ ++ E + L++ +H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 515 KLITSCSSLDFKNME--FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+ + +C ++ +++ EF+ GS+ + N G + I
Sbjct: 66 QYLGTC-------LDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFC-KYTKQIL 112
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
+ YLHN+C +VH D+K N++L + K+ DFG AR L + + + +
Sbjct: 113 DGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 633 GSIGYIPPEY----GLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ ++ PE G G K D++S G + E+ TG P
Sbjct: 170 GTPYWMAPEVINESGYGRK----SDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 69/216 (31%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 462 LIGSGSFGSVYKGYLR-EGISVAVKVLD---IESTGTWKSFFAECEAL-RNTRHRNLVKL 516
+IG GSFG V + +G AVKVL I AE L +N +H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE-RLNI-AIDIASA 574
S F+ E L V +++ G L + H +R+ FLE R A ++ASA
Sbjct: 62 HYS-----FQTAEKLYFVLDYVNGGEL--FFHLQRER------CFLEPRARFYAAEVASA 108
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
+ YLH+ + I++ DLKP NILLD + DFGL + +E S+ G+
Sbjct: 109 IGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC------GT 159
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
Y+ PE E D + G +L E+ G+ P
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 59/269 (21%), Positives = 103/269 (38%), Gaps = 42/269 (15%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLREGIS------VAVKVLD-IESTGTWKSFFAECEA 504
F NL +G G FG V+ + V VK L + F E +
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 505 LRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNG---LNF 561
R H+N+V+L+ C + M + E+ G L ++ + + L+
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYM-----ILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 562 LERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGN 621
+++ + IA +D+L N VH DL N L+ KV L++ +
Sbjct: 117 KQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN---- 169
Query: 622 QSSISSTHVLKGS---IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
S + L+ + + ++ PE + ST DV+SFGV++ E+FT + E
Sbjct: 170 ----SEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE 225
Query: 679 VSL-------VKW-VESNFPKNAQQVLDR 699
L ++ V P +++ R
Sbjct: 226 EVLNRLQAGKLELPVPEGCPSRLYKLMTR 254
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 462 LIGSGSFGSVYKGYLREGISV-AVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
++G GSFG V L+E + AVKVL D+E T T K + H
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHP 56
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
L +L C F+ + L V EF+ G L I R+ + + A +I
Sbjct: 57 FLTQLYC-C----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY------AAEI 105
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
SAL +LH + I++ DLK N+LLD + K+ DFG+ + E I N + S+
Sbjct: 106 TSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTST---F 156
Query: 632 KGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ YI PE + D ++ GV+L E+ G +P
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 35/233 (15%)
Query: 463 IGSGSFGSVYKGYLREGIS------VAVKVLDIESTGTWK--SFFAECEALRNTRHRNLV 514
+G GSFG VY+G R+ I VAVK ++ ES + F E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER---KNEHGNGLNFL-ERLNIAID 570
+L+ S K L +V E + +G L ++ R +N G L E + +A +
Sbjct: 73 RLLGVVS----KGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
IA + YL+ VH DL N ++ D T K+GDFG+ R + E + +
Sbjct: 128 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE---------TDYY 175
Query: 631 LKGSIGYIP-----PEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
KG G +P PE +T+ D++SFGV+L EI + ++ + E
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 45/225 (20%)
Query: 463 IGSGSFGSVYKGYLREG-----------ISVAVKVLDIESTGTWKSFFAECEALRNTRHR 511
+G G+F ++YKG LR +SV +KVL +FF + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
+LVKL C + +V E++ G L ++H E N ++ +L++A +
Sbjct: 62 HLVKLYGVCVRDEN------IMVEEYVKFGPLDVFLHRE-----KNNVSLHWKLDVAKQL 110
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILL--DEDMT-----AKVGDFGLARSLLERIGNQSS 624
ASAL YL + +VH ++ NIL+ K+ D G+ ++L R
Sbjct: 111 ASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER 167
Query: 625 ISSTHVLKGSIGYIPPEY--GLGEKPSTAGDVYSFGVMLLEIFTG 667
I +I PE + A D +SFG LLEI +
Sbjct: 168 IP----------WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWK----SFFAECEALRNTRHR 511
+ ++G G+FG V+ R+ V + I K + EC+ L+ H
Sbjct: 1 KYEKIRVVGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
N+++ + F + L +V E+ G+L ++I +R N L+ L+ + I
Sbjct: 60 NIIEYYEN-----FLEDKALMIVMEYAPGGTLAEYIQ-KRCNSL---LDEDTILHFFVQI 110
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDE-DMTAKVGDFGLARSLLERIGNQSSISSTHV 630
AL ++H I+H DLK NILLD+ M K+GDFG+++ L SS S +
Sbjct: 111 LLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL-------SSKSKAYT 160
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEI 664
+ G+ YI PE G+ + D+++ G +L E+
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 463 IGSGSFGSV-YKGYLREGISVAVKVL--DIESTGTWKSFFAECEALRNTRHRNLVKLI-- 517
+GSG++G+V R G VA+K L +S K + E L++ +H N++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 518 -TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI-DIASAL 575
T SLD + +F LV F+G LG + E+ +E +R+ + + L
Sbjct: 83 FTPDLSLD-RFHDFY-LVMPFMGT-DLGKLMKHEKLSE--------DRIQFLVYQMLKGL 131
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
Y+H I+H DLKPGN+ ++ED K+ DFGLAR S ++ V +
Sbjct: 132 KYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ------TDSEMTGYVVTR--- 179
Query: 636 GYIPPEYGLGEKPSTAG-DVYSFGVMLLEIFTG 667
Y PE L T D++S G ++ E+ TG
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 38/221 (17%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVK--VLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
IG G+FG V+K ++ VA+K +++ E G + E + L+ +H N+V LI
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 520 CSSLDFKNMEFLA---LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA---- 572
C + + LV+EF + G L N+ ++
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAG----------------LLSNKNVKFTLSEIKK 123
Query: 573 ------SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSIS 626
+ L Y+H + I+H D+K NIL+ +D K+ DFGLAR+ ++ +
Sbjct: 124 VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 627 STHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFT 666
+ V+ ++ Y PPE LGE+ D++ G ++ E++T
Sbjct: 181 TNRVV--TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 463 IGSGSFGSV-YKGYLREGISVAVKVLDIESTGTWKSFFAECEA--LRNTRHRNLVKLITS 519
+G GS+G V + +G +K L++ + + AE EA L +H N+V S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
D L+Y +G GD H + K + G L + + + IA AL YLH
Sbjct: 68 WEGED-------GLLYIVMGFCEGGDLYH-KLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
E I+H DLK N+ L KVGD G+AR L NQ ++ST L G+ Y+
Sbjct: 120 ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL----ENQCDMAST--LIGTPYYMS 170
Query: 640 PEYGLGEKP-STAGDVYSFGVMLLEIFT 666
PE KP + DV++ G + E+ T
Sbjct: 171 PEL-FSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 462 LIGSGSFGSVYKG-YLREG----ISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLVK 515
++GSG+FG+VYKG ++ +G I VA+KVL + S K E + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575
L+ C + + LV + + G L D++ E+ + + + LN + IA +
Sbjct: 74 LLGICLT------STVQLVTQLMPYGCLLDYVR-----ENKDRIGSQDLLNWCVQIAKGM 122
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST--HVLKG 633
YL EV +VH DL N+L+ K+ DFGLAR L I T H G
Sbjct: 123 SYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL--------DIDETEYHADGG 171
Query: 634 S--IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
I ++ E L + + DV+S+GV + E+ T G P
Sbjct: 172 KVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 67/231 (29%), Positives = 96/231 (41%), Gaps = 48/231 (20%)
Query: 463 IGSGSFGSV----YKGYLREGISVAVKVL---------DIESTGTWKSFFAECEALRNTR 509
+G G FG V YK G A+K L ++ES K F E + R
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIF---ETANSER 60
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI-- 567
H LV L +C F+ + + V E+ G L IH + F E +
Sbjct: 61 HPFLVNLF-AC----FQTEDHVCFVMEYAAGGDLMMHIHTDV---------FSEPRAVFY 106
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
A + L YLH E IV+ DLK N+LLD + K+ DFGL + E +G S+
Sbjct: 107 AACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTST 160
Query: 628 THVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
G+ ++ PE + A D + GV++ E+ G SP F G+
Sbjct: 161 ---FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 463 IGSGSFGSVYKGYLREGIS---VAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLIT 518
IG+G FG V G + G + V VK L + S F E + R+ +H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEH-GNGLNFLERLNIAIDIASALDY 577
C+ + +L LV EF G L ++ RK E L+R+ A +IA L +
Sbjct: 63 QCTEV----TPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLH 115
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
LH + +H DL N LL D+T K+GD+GL+ + + + + L + +
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK----EDYYVTPDQLWVPLRW 168
Query: 638 IPPE-----YG--LGEKPSTAGDVYSFGVMLLEIF 665
I PE +G L + +V+S GV + E+F
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 40/241 (16%)
Query: 457 FSHENLI-----GSGSFGSVYK----GYLRE----GISVAVKVL-DIESTGTWKSFFAEC 502
F + L+ G G FG V + G + ++VAVK+L D + +E
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 503 EALRNT-RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER---------- 551
E ++ +H+N++ L+ C+ L ++ E+ G+L +++ R
Sbjct: 69 ELMKLIGKHKNIINLLGVCT-----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123
Query: 552 KNEHGNGLNFLERLNIAIDIASALDYLHND-CEVPIVHCDLKPGNILLDEDMTAKVGDFG 610
L+F + ++ A +A ++YL + C +H DL N+L+ ED K+ DFG
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFG 179
Query: 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMS 669
LAR + I S+ + + ++ PE + DV+SFG+++ EIFT G S
Sbjct: 180 LARG-VHDIDYYKKTSNGRL---PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS 235
Query: 670 P 670
P
Sbjct: 236 P 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 41/226 (18%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSC 520
++G G++G VY L + +A+K + + + E +HRN+V+ + S
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGE----RKNEHGNGLNFLERLNIAIDIASALD 576
S F + E + GSL + + + NE + F + I L
Sbjct: 75 SENGF-----FKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTK-----QILEGLK 122
Query: 577 YLHNDCEVPIVHCDLKPGNILLDE-DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
YLH + IVH D+K N+L++ K+ DFG ++ R+ + + T G++
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK----RLAGINPCTET--FTGTL 173
Query: 636 GYIPPE--------YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
Y+ PE YG D++S G ++E+ TG P E
Sbjct: 174 QYMAPEVIDKGPRGYG------APADIWSLGCTIVEMATGKPPFIE 213
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 462 LIGSGSFGSVYKGYLRE---GISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVK 515
L+G G+FG V +RE G A+K+L E + E L+NTRH L
Sbjct: 2 LLGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI-AIDIASA 574
L S F+ + L V E++ G L + H R+ +R +I SA
Sbjct: 60 LKYS-----FQTKDRLCFVMEYVNGGEL--FFHLSRERVFSE-----DRTRFYGAEIVSA 107
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
LDYLH+ IV+ DLK N++LD+D K+ DFGL + E I + +++ + G+
Sbjct: 108 LDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKT---FCGT 158
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
Y+ PE A D + GV++ E+ G P
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 27/237 (11%)
Query: 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRH 510
A ++ + +G GS+ +VYKG R G VA+KV+ +++ G + E L+ +H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
N+V L E L V+E++ + L ++ +H GL+
Sbjct: 63 ANIVLLHDI-----IHTKETLTFVFEYM-HTDLAQYM-----IQHPGGLHPYNVRLFMFQ 111
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
+ L Y+H I+H DLKP N+L+ K+ DFGLAR+ + I +Q+ S+ V
Sbjct: 112 LLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQT--YSSEV 164
Query: 631 LKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686
+ ++ Y PP+ LG S+A D++ G + +E+ G P F G + + +E
Sbjct: 165 V--TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG-QPA---FPGVSDVFEQLE 215
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 39/232 (16%)
Query: 463 IGSGSFGSVYKGYLREGI-----------SVAVKVLDIEST-GTWKSFFAECEALRNT-R 509
+G G FG V + E I VAVK+L ++T +E E ++ +
Sbjct: 26 LGEGCFGQVV---MAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK-------NEHGN---GL 559
H+N++ L+ +C+ D L ++ E+ G+L +++ R N L
Sbjct: 83 HKNIINLLGACTQ-DGP----LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 560 NFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERI 619
+F + ++ A +A ++YL + +H DL N+L+ ED K+ DFGLAR I
Sbjct: 138 SFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD----I 190
Query: 620 GNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ T + + ++ PE + DV+SFGV+L EIFT G SP
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 76/293 (25%), Positives = 128/293 (43%), Gaps = 68/293 (23%)
Query: 458 SHENL--IGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNL 513
+++ L +G GS+ +VYKG + G VA+K + +E G + E L++ +H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 514 VKL--ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLN------FLERL 565
V L I + L LV+E+L + L ++ ++ G GL+ FL +L
Sbjct: 66 VTLHDIIHTK-------KTLTLVFEYL-DTDLKQYM-----DDCGGGLSMHNVRLFLFQL 112
Query: 566 NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSI 625
L Y H ++H DLKP N+L+ E K+ DFGLAR+ +S
Sbjct: 113 ------LRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARA-------KSVP 156
Query: 626 SSTH---VLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM------------- 668
S T+ V+ ++ Y PP+ LG ST+ D++ G + E+ TG
Sbjct: 157 SKTYSNEVV--TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL 214
Query: 669 --------SPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTI 713
+PT E++ G S ++ +FP + L +L + +
Sbjct: 215 HKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEEL 267
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 51/161 (31%), Positives = 73/161 (45%), Gaps = 27/161 (16%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTG---TWKSFFAECEALRNTRHRNLVKLIT 518
IG GS+G V+K RE G VA+K +ES K E L+ +H NLV LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNE---HGNGLNFLERLNIAIDIASAL 575
F+ L LV+E+ + L NE + G+ I A+
Sbjct: 68 V-----FRRKRKLHLVFEYCDHTVL---------NELEKNPRGVPEHLIKKIIWQTLQAV 113
Query: 576 DYLH-NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615
++ H ++C +H D+KP NIL+ + K+ DFG AR L
Sbjct: 114 NFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 69/227 (30%), Positives = 102/227 (44%), Gaps = 54/227 (23%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVK-VLDIESTGTWKSFFAECEALRNTR----------H 510
+G G++G V+K R VA+K + D +F +A R R H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFD--------AFRNATDAQRTFREIMFLQELGDH 66
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLN---I 567
N+VKL+ + + +N + + LV+E++ L I R N LE ++ I
Sbjct: 67 PNIVKLL---NVIKAENDKDIYLVFEYM-ETDLHAVI---RAN-------ILEDVHKRYI 112
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
+ AL Y+H+ ++H DLKP NILL+ D K+ DFGLARSL E N +
Sbjct: 113 MYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 628 THVLKGSIGYI------PPEYGLGEKPSTAG-DVYSFGVMLLEIFTG 667
T Y+ PE LG T G D++S G +L E+ G
Sbjct: 170 TD-------YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-11
Identities = 31/88 (35%), Positives = 53/88 (60%), Gaps = 1/88 (1%)
Query: 207 IDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGT 266
+ L L IP ++L SI+LS N + GNIP + S++SL +++LS N +G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE-VLDLSYNSFNGS 481
Query: 267 LPEEIGMLGNVVTIDLSANGLSGNLPNS 294
+PE +G L ++ ++L+ N LSG +P +
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 29/219 (13%)
Query: 460 ENLIGSGSFGSVYKGYLRE--------GISVAVKVLDIESTGTWKSFFAECEALRNTRHR 511
E+L G G+F ++KG RE V +KVLD +SFF + H+
Sbjct: 1 ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
+LV C D M V E++ GSL ++ +KN N +N +L +A +
Sbjct: 60 HLVLNYGVCVCGDESIM-----VQEYVKFGSLDTYL---KKN--KNLINISWKLEVAKQL 109
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
A AL +L + + H ++ N+LL + K G+ + L G ++ +L
Sbjct: 110 AWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIK--LSDPGISITVLPKEIL 164
Query: 632 KGSIGYIPPEYGLGEKP---STAGDVYSFGVMLLEIFTG 667
I ++PPE E P S A D +SFG L EIF+G
Sbjct: 165 LERIPWVPPE--CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVKVLDIEST--GTWKSFFAECEALRNTR---HRNLVKL 516
IG G++G+VYK G VA+K + +++ G S E L+ H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
+ C++ + LV+E + + L ++ GL ++ LD
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYL----DKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV----LK 632
+LH +C IVH DLKP NIL+ K+ DFGLAR I S + +
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR-----------IYSCQMALTPVV 168
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIF 665
++ Y PE L +T D++S G + E+F
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 458 SHENL--IGSGSFGSVYKGYLR-EGISVAVKVLDI-ESTGTWKSFFAECEALRNTRHRNL 513
S+E L +G GS+ +VYKG + G VA+KV+ + E GT + E L+ +H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
V L + E L LV+E++ + L ++ ++H GL+ +
Sbjct: 66 VLLHDIIHT-----KETLTLVFEYV-HTDLCQYM-----DKHPGGLHPENVKLFLFQLLR 114
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
L Y+H + I+H DLKP N+L+ + K+ DFGLAR+ S S V+
Sbjct: 115 GLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAK----SVPSHTYSNEVV-- 165
Query: 634 SIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMS 669
++ Y PP+ LG ST D++ G + +E+ G++
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA 202
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 64/257 (24%), Positives = 110/257 (42%), Gaps = 25/257 (9%)
Query: 456 NFSHENLIGSGSFGSVYKGY-LREGISVAVK---VLDIESTGTWKSFFAECEALRNTRHR 511
NF E IG G F VY+ L + VA+K + ++ + E + L+ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAI 569
N++K + S F L +V E G L I +K + ER +
Sbjct: 63 NVIKYLDS-----FIEDNELNIVLELADAGDLSQMIKYFKKQKR----LIPERTVWKYFV 113
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+ SA++++H+ ++H D+KP N+ + K+GD GL R S ++ H
Sbjct: 114 QLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAH 164
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES-N 688
L G+ Y+ PE + D++S G +L E+ SP + SL + +E +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD 224
Query: 689 FPKNAQQVLDRELRQLM 705
+P + +LR+L+
Sbjct: 225 YPPLPTEHYSEKLRELV 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 66/229 (28%), Positives = 96/229 (41%), Gaps = 40/229 (17%)
Query: 452 RATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKV--LDIESTGTWKSFFAECEALRNT 508
R+ F N IG G++G VY+ G VA+K +D E G S E L N
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 509 RHRNLVKL--ITSCSSLD--FKNMEF----LALVYEFLGNGSLGDWIHGERKNEHGNGLN 560
RH N+V+L + LD F ME+ LA L N +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLA---SLLDNMP--------------TPFS 106
Query: 561 FLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIG 620
+ + + + L YLH + I+H DLK N+LL + K+ DFGLAR G
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR----TYG 159
Query: 621 N-QSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTG 667
++ V ++ Y PE LG +TA D+++ G +L E+
Sbjct: 160 LPAKPMTPKVV---TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 74/309 (23%), Positives = 122/309 (39%), Gaps = 54/309 (17%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVK--VLDIESTGTWKSFFAECEALRNTRHRN-LVKLIT 518
IG G++G VYK G VA+K L+++ G + E L+ +V+L+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
+ L LV+E+L + L ++ + G L + + + +
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGP-GRPLPAKTIKSFMYQLLKGVAHC 126
Query: 579 HNDCEVPIVHCDLKPGNILLDED-MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
H + ++H DLKP N+L+D+ K+ D GL R+ + S TH + ++ Y
Sbjct: 127 H---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-----SYTHEIV-TLWY 177
Query: 638 IPPEYGLGEKP-STAGDVYSFGVM-------------------LLEIFTGM-SPTHESFA 676
PE LG ST D++S G + LL IF + +PT + +
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 677 GEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPG 736
G L W E FP+ Q L R + L + + L ++ P
Sbjct: 238 GVSKLRDWHE--FPQWKPQDLSRAVPDL----SPEGLDLLQKMLRY-----------DPA 280
Query: 737 GRIDIREAL 745
RI + AL
Sbjct: 281 KRISAKAAL 289
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 67/236 (28%), Positives = 102/236 (43%), Gaps = 45/236 (19%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGIS--VAVKVL---------DIESTGTWKSFFAECEA 504
+F+ ++G GSFG V R+G A+K+L D+E T K A
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG- 58
Query: 505 LRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIH--GERKNEHGNGLNFL 562
+ L +L SC F+ M+ L V E++ G L I G+ K H
Sbjct: 59 ----KPPFLTQL-HSC----FQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHA------ 103
Query: 563 ERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
+ A +IA L +LH+ I++ DLK N++LD + K+ DFG+ + N
Sbjct: 104 --VFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKE------NI 152
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
+T G+ YI PE + + D ++FGV+L E+ G P F GE
Sbjct: 153 FGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP----FDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 21/224 (9%)
Query: 456 NFSHENLIGSGSFGSVYKGY-LREGISVAVKVL--DIESTGTWKSFFA-ECEA--LRNTR 509
N+ L+G G+FG VY Y G +AVK + D +S T K A ECE L+N R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
H +V+ + K L++ E++ GS+ D + +G + R
Sbjct: 63 HDRIVQYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKA-----YGALTENVTR-RYTR 113
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
I + YLH++ IVH D+K NIL D K+GDFG ++ + + + I S
Sbjct: 114 QILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-- 168
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
+ G+ ++ PE GE DV+S ++E+ T P E
Sbjct: 169 -VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 72/225 (32%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 462 LIGSGSFGSVYKGYLR-EGISVAVKVLD---IESTGTWKSFFAECEAL-RNTRHRNLVKL 516
+IG GSFG V + E AVKVL I K +E L +N +H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE-RLNI-AIDIASA 574
S F+ + L V +++ G L + ER FLE R A +IASA
Sbjct: 62 HFS-----FQTADKLYFVLDYINGGELFYHLQRER--------CFLEPRARFYAAEIASA 108
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
L YLH+ + IV+ DLKP NILLD + DFGL + +E G S+ G+
Sbjct: 109 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC------GT 159
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV 679
Y+ PE + D + G +L E+ G+ P + E+
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 69/242 (28%), Positives = 105/242 (43%), Gaps = 37/242 (15%)
Query: 462 LIGSGSFGSVYKGYLRE---GISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVK 515
L+G G+FG V +RE G A+K+L E + E L+NTRH L
Sbjct: 2 LLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI-AIDIASA 574
L F+ + L V E+ G L + H R+ ER +I SA
Sbjct: 60 L-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTE-----ERARFYGAEIVSA 107
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
L+YLH+ +V+ D+K N++LD+D K+ DFGL + E I + +++ + G+
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKT---FCGT 158
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP----THESFAGEVSLVKWVESNFP 690
Y+ PE A D + GV++ E+ G P HE L+ E FP
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILMEEIRFP 215
Query: 691 KN 692
+
Sbjct: 216 RT 217
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 37/228 (16%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVK----VLDIESTGTWKSFFAECEALRNTRHRNLVKL- 516
IGSG++G V R G VA+K D+ + K E + LR+ +H N++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA--KRTLRELKILRHFKHDNIIAIR 70
Query: 517 -ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER--KNEHGNGLNFLERLNIAIDIAS 573
I DFK+ + +V + + + L IH ++ EH FL +L
Sbjct: 71 DILRPPGADFKD---VYVVMDLMES-DLHHIIHSDQPLTEEHIR--YFLYQL------LR 118
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
L Y+H+ ++H DLKP N+L++ED ++GDFG+AR L + +V
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV--A 173
Query: 634 SIGYIPPE--YGLGEKPSTAGDVYS----FGVMLL--EIFTGMSPTHE 673
+ Y PE L E +TA D++S F ML ++F G + H+
Sbjct: 174 TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ 220
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 26/232 (11%)
Query: 450 LRRATGNFSHENLIGSGSFGSVYKG-YLREGISVAVKVLDIESTGTWKSFFAECEALRN- 507
L TG F +IG G++G VYK + + G VA+K++DI + E LR
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59
Query: 508 TRHRNLVKLITSCSSLDFKNMEF-LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLN 566
+ H N+ + + + L LV E G GS+ D + G RK L+
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-----KRLKEEW 114
Query: 567 IAI---DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQS 623
IA + L YLH + ++H D+K NILL ++ K+ DFG++ L S
Sbjct: 115 IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL------DS 165
Query: 624 SISSTHVLKGSIGYIPPEYGLGEKPSTA-----GDVYSFGVMLLEIFTGMSP 670
++ + G+ ++ PE ++ A DV+S G+ +E+ G P
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 66/225 (29%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 463 IGSGSFGSVYKG-YLREGISVAVKV--LDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
IG G++G VYK G VA+K L+ E G + E L+ H N+V+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRL--- 63
Query: 520 CSSLDFKNMEF-LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
LD + E L LV+EFL L + + G ++ + + Y
Sbjct: 64 ---LDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSY--LYQLLQGIAYC 115
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSI---SSTH-VLKGS 634
H+ ++H DLKP N+L+D + K+ DFGLAR+ + + TH V+ +
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF--------GVPVRTYTHEVV--T 162
Query: 635 IGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
+ Y PE LG + ST D++S G IF M F G+
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGC----IFAEMVNRRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 74/263 (28%), Positives = 117/263 (44%), Gaps = 53/263 (20%)
Query: 463 IGSGSFGSVYKGY--LREGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITS 519
+G G++ +V+KG L E + VA+K + +E G + E L+N +H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL--- 68
Query: 520 CSSLDFKNMEF-LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI---DIASAL 575
D + E L LV+E+L + + K N N + N+ I + L
Sbjct: 69 ---HDIIHTERCLTLVFEYLDS---------DLKQYLDNCGNLMSMHNVKIFMFQLLRGL 116
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
Y H + I+H DLKP N+L++E K+ DFGLAR+ + S V+ ++
Sbjct: 117 SYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAK----SVPTKTYSNEVV--TL 167
Query: 636 GYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM--------------------SPTHES 674
Y PP+ LG ST D++ G +L E+ TG +PT E+
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227
Query: 675 FAGEVSLVKWVESNFPKNAQQVL 697
+ G S ++ FP+ Q L
Sbjct: 228 WPGITSNEEFRSYLFPQYRAQPL 250
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 74/257 (28%), Positives = 116/257 (45%), Gaps = 42/257 (16%)
Query: 463 IGSGSFGSVYKGYLREGISV-AVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
IG G+FG VY+ ++ + A+KVL + K A+ E RN I +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERN----ILVRT 50
Query: 522 SLD-----------FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
LD F+ L LV +++ G L + E + + IA +
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA-----KFYIA-E 104
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
+ AL++LH + IV+ DLKP NILLD + DFGL+++ N + +T+
Sbjct: 105 LVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKA------NLTDNKTTNT 155
Query: 631 LKGSIGYIPPEYGLGEKPSTAG-DVYSFGVMLLEIFTGMSPTHESFAGEV-SLVKWVESN 688
G+ Y+ PE L EK T D +S GV++ E+ G SP + ++ + + +
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR 215
Query: 689 FPKNAQQVLDRELRQLM 705
FPKN VL E RQ +
Sbjct: 216 FPKN---VLSDEGRQFV 229
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 72/267 (26%), Positives = 113/267 (42%), Gaps = 33/267 (12%)
Query: 463 IGSGSFGSVYKGYLREGISV----AVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLIT 518
IG GSFG V + R+ + ++ I S AE L +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
S F++ E L LV F+ G L + H +R+ G R A ++ AL+ L
Sbjct: 61 S-----FQSPEKLYLVLAFINGGEL--FHHLQRE---GRFDLSRARFYTA-ELLCALENL 109
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H + +++ DLKP NILLD + DFGL + N T+ G+ Y+
Sbjct: 110 H---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL------NMKDDDKTNTFCGTPEYL 160
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES-NFPKNAQQ-- 695
PE LG + A D ++ GV+L E+ TG+ P ++ E+ E FP +
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDA 220
Query: 696 ------VLDRELRQLMMSSESQTIQLH 716
+L R+ + + + +Q I+ H
Sbjct: 221 KDLLIGLLSRDPTRRLGYNGAQEIKNH 247
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 456 NFSHENLIGSGSFGSVYK-GYLREGISVAVKVLDIESTGTWKSFFA--ECEALRNTRHRN 512
+F +G GS+GSVYK L + A+K +D+ S + A E L + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
++ + F + L +V E+ G L I ++ + + E I I +
Sbjct: 61 IISYKEA-----FLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIWRIFIQLL 113
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L LH E I+H DLK NILL + K+GD G+++ L + + + I + H
Sbjct: 114 RGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQIGTPH--- 166
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
Y+ PE G S D++S G +L E+ T P
Sbjct: 167 ----YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 74/267 (27%), Positives = 119/267 (44%), Gaps = 45/267 (16%)
Query: 463 IGSGSFGSVYKG-YLREGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITS 519
IG G++G VYKG + G VA+K + +ES G + E L+ +H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL--- 64
Query: 520 CSSLDFKNMEF-LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
D E L L++EFL + L ++ K ++ + L I + +
Sbjct: 65 ---QDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYL---YQILQGILFC 117
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H+ ++H DLKP N+L+D K+ DFGLAR+ G + + V+ ++ Y
Sbjct: 118 HSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARA----FGIPVRVYTHEVV--TLWYR 168
Query: 639 PPEYGLG-EKPSTAGDVYSFGVMLLEI------FTGMS--------------PTHESFAG 677
PE LG + ST D++S G + E+ F G S PT + + G
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228
Query: 678 EVSLVKWVESNFPKNAQQVLDRELRQL 704
SL + ++ FPK + L ++ L
Sbjct: 229 VTSLPDY-KNTFPKWKKGSLRSAVKNL 254
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 29/228 (12%)
Query: 462 LIGSGSFGSV-YKGYLREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLIT 518
++GSG+ G+V + +G AVKV+D+E S AE L N ++VK
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 519 SCSSLDFKNME---FLALVYEFLGNGSLGDWIHGERKN-----EHGNGLNFLERLNIAID 570
+ D +N E +ALV ++ G L I K EH GL F I
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF-------IQ 151
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
+ A+ ++H+ ++H D+K NILL + K+GDFG ++ S
Sbjct: 152 VLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMY----AATVSDDVGRT 204
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
G+ Y+ PE + S D++S GV+L E+ T P F GE
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP----FDGE 248
|
Length = 496 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 463 IGSGSFGSVYK-GYLREGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSC 520
+G+G+ GSV K ++ G +A KV+ I + + K E + + R +V +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA- 71
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL-NIAIDIASALDYLH 579
F N + + EF+ GSL D I+ + G +E L IA+ + L YL+
Sbjct: 72 ----FLNENNICMCMEFMDCGSL-DRIYKK------GGPIPVEILGKIAVAVVEGLTYLY 120
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
N I+H D+KP NIL++ K+ DFG++ L+ +SI+ T V G+ Y+
Sbjct: 121 N--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI------NSIADTFV--GTSTYMS 170
Query: 640 PEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674
PE G K + DV+S G+ ++E+ G P S
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 73/278 (26%), Positives = 108/278 (38%), Gaps = 54/278 (19%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSF---FAECEALRNTRHRNLVKLI 517
L+G G G V+ L+ G A+KVLD + E E L H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
S F+ +L LV ++ G L + + G L+ A ++ AL+Y
Sbjct: 68 AS-----FQTETYLCLVMDYCPGGEL----FRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL-------------LERIGNQSS 624
LH + IV+ DLKP NILL E + DF L++ R + +S
Sbjct: 119 LHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 625 ISSTHVLK----------GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674
I S + G+ YI PE G+ +A D ++ G++L E+ G +P
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP---- 231
Query: 675 FAGEVS-------LVKWVESNFPKNAQQVLDRELRQLM 705
F G L K E FP + + R L+
Sbjct: 232 FKGSNRDETFSNILKK--EVTFPGSPP--VSSSARDLI 265
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 37/226 (16%)
Query: 457 FSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVK 515
F+ IG GSFG V+KG R VA+K++D+E E E ++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED------EIEDIQQE-----IT 54
Query: 516 LITSCSSL-------DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568
+++ C S + L ++ E+LG GS D + +E + +
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE-------FQIATML 107
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE-RIGNQSSISS 627
+I LDYLH++ ++ H D+K N+LL E K+ DFG+A L + +I + +
Sbjct: 108 KEILKGLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-- 162
Query: 628 THVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
G+ ++ PE + D++S G+ +E+ G P +
Sbjct: 163 -----GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 73/255 (28%), Positives = 112/255 (43%), Gaps = 40/255 (15%)
Query: 462 LIGSGSFGSVYKGYLRE---GISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVK 515
L+G G+FG V ++E G A+K+L E + E L+N+RH L
Sbjct: 2 LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI-AIDIASA 574
L S F+ + L V E+ G L + H R+ +R +I SA
Sbjct: 60 LKYS-----FQTHDRLCFVMEYANGGEL--FFHLSRERVFSE-----DRARFYGAEIVSA 107
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
LDYLH++ V V+ DLK N++LD+D K+ DFGL + E I + +++ + G+
Sbjct: 108 LDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKT---FCGT 159
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP----THESFAGEVSLVKWVESNFP 690
Y+ PE A D + GV++ E+ G P HE L+ E FP
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILMEEIRFP 216
Query: 691 KNAQQVLDRELRQLM 705
+ L E + L+
Sbjct: 217 RT----LSPEAKSLL 227
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
IG G+ G+VY + G VA+K ++++ + E +R ++ N+V + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 84
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHND 581
+ + L +V E+L GSL D + +E + + + ALD+LH++
Sbjct: 85 ---YLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALDFLHSN 134
Query: 582 CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE 641
++H D+K NILL D + K+ DFG +I + S ST V G+ ++ PE
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMV--GTPYWMAPE 185
Query: 642 YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ D++S G+M +E+ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
IG G+ G+VY + G VA+K ++++ + E +R +H N+V + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS-- 84
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHND 581
+ + L +V E+L GSL D + E + G + + + AL++LH++
Sbjct: 85 ---YLVGDELWVVMEYLAGGSLTDVV-TETCMDEG------QIAAVCRECLQALEFLHSN 134
Query: 582 CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE 641
++H D+K NILL D + K+ DFG +I + S ST V G+ ++ PE
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMV--GTPYWMAPE 185
Query: 642 YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ D++S G+M +E+ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 68/221 (30%), Positives = 103/221 (46%), Gaps = 39/221 (17%)
Query: 462 LIGSGSFGSVYKGYLREGISV-AVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
+IG GS+ V L++ + A+KV+ DI+ T K F E N H
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVF---ETASN--HP 56
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK--NEHGNGLNFLERLNIAI 569
LV L SC F+ L V EF+ G L + +RK EH F +
Sbjct: 57 FLVGL-HSC----FQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHAR---FY-----SA 103
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+I+ AL++LH E I++ DLK N+LLD + K+ D+G+ + + R G+ +T
Sbjct: 104 EISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGD-----TTS 154
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ YI PE GE + D ++ GV++ E+ G SP
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 35/225 (15%)
Query: 457 FSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVK 515
F+ IG GSFG V+KG R VA+K++D+E E E ++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED------EIEDIQQE-----IT 54
Query: 516 LITSCSSL-------DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568
+++ C S + L ++ E+LG GS D + E G L+ + I
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGP-LDETQIATIL 107
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+I LDYLH++ ++ H D+K N+LL E K+ DFG+A L + + I
Sbjct: 108 REILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTD-----TQIKRN 159
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
+ G+ ++ PE + D++S G+ +E+ G P E
Sbjct: 160 TFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 35/114 (30%), Positives = 51/114 (44%), Gaps = 19/114 (16%)
Query: 567 IAIDIASALDYL---HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQS 623
+ + I AL YL H ++H D+KP NILLD K+ DFG++ L++
Sbjct: 119 MTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTR 173
Query: 624 SISSTHVLKGSIGYIPPEYGLGEKPSTA----GDVYSFGVMLLEIFTGMSPTHE 673
S G Y+ PE P+ DV+S G+ L+E+ TG P
Sbjct: 174 S-------AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 63/220 (28%), Positives = 93/220 (42%), Gaps = 37/220 (16%)
Query: 462 LIGSGSFGSVYKGYLREGISV-AVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
++G GSFG V L+ V A+KVL D++ T T K A +H
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILA-----LAAKHP 56
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
L L F+ + L V E++ G L I RK + + A ++
Sbjct: 57 FLTALHCC-----FQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFY------AAEV 105
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
AL +LH +++ DLK NILLD + K+ DFG+ + E I N +T
Sbjct: 106 TLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNG---VTTTTF 156
Query: 632 KGSIGYIPPEYGLGEKPSTAG-DVYSFGVMLLEIFTGMSP 670
G+ YI PE L E D ++ GV++ E+ G P
Sbjct: 157 CGTPDYIAPEI-LQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 40/229 (17%)
Query: 462 LIGSGSFGSVYKGYLREGIS----VAVKVLDIESTGTWKSFFAECEALRN----TRHRNL 513
++G G +G V++ G A+KVL + + A +A RN +H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI---- 569
V LI + F+ L L+ E+L G L ++H ER+ G+ F+E + A
Sbjct: 63 VDLIYA-----FQTGGKLYLILEYLSGGEL--FMHLERE-----GI-FME--DTACFYLS 107
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+I+ AL++LH + I++ DLKP NILLD K+ DFGL + + + TH
Sbjct: 108 EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH------EGTVTH 158
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
G+I Y+ PE + A D +S G ++ ++ TG P F E
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP----FTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 76/249 (30%), Positives = 122/249 (48%), Gaps = 27/249 (10%)
Query: 443 QMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAEC 502
+MI D R ++ N+IG+GSFG VY+ + S V + + +K+ E
Sbjct: 54 KMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICID-TSEKVAIKKVLQDPQYKN--REL 110
Query: 503 EALRNTRHRNLVKL----ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNG 558
++N H N++ L T C + KN+ FL +V EF+ ++ ++ +N H
Sbjct: 111 LIMKNLNHINIIFLKDYYYTECFKKNEKNI-FLNVVMEFIPQ-TVHKYMKHYARNNHALP 168
Query: 559 LNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-TAKVGDFGLARSLLE 617
L FL +L + + AL Y+H+ I H DLKP N+L+D + T K+ DFG A++LL
Sbjct: 169 L-FLVKL-YSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL- 222
Query: 618 RIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAG-DVYSFGVMLLEIFTGMSPTHESFA 676
Q S+S S Y PE LG T D++S G ++ E+ G + F+
Sbjct: 223 --AGQRSVSYI----CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG----YPIFS 272
Query: 677 GEVSLVKWV 685
G+ S+ + V
Sbjct: 273 GQSSVDQLV 281
|
Length = 440 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 39/221 (17%)
Query: 462 LIGSGSFGSVYKGYLREGISV-AVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
+IG GS+ V L++ + A+KV+ DI+ T K F + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-----NP 56
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK--NEHGNGLNFLERLNIAI 569
LV L SC F+ L LV E++ G L + +RK EH A
Sbjct: 57 FLVGL-HSC----FQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFY--------AA 103
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+I AL++LH E I++ DLK N+LLD D K+ D+G+ + L G+ +T
Sbjct: 104 EICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGD-----TTS 154
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ YI PE GE+ + D ++ GV++ E+ G SP
Sbjct: 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 21/224 (9%)
Query: 456 NFSHENLIGSGSFGSVYKGY-LREGISVAVKVL--DIESTGTWKSFFA-ECEA--LRNTR 509
N+ L+G G+FG VY Y G +AVK + D ES T K A ECE L+N
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
H +V+ L L++ E + GS+ D + +G + R
Sbjct: 63 HERIVQYY---GCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTR-KYTR 113
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
I + YLH++ IVH D+K NIL D K+GDFG ++ L + + + S
Sbjct: 114 QILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-- 168
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
+ G+ ++ PE GE D++S G ++E+ T P E
Sbjct: 169 -VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVK--VLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
IG G++G+V+K RE VA+K LD + G S E L+ +H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 520 CSSLDFKNMEFLALVYEFLGNG--SLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
S D K L LV+E+ D +G+ + +F+ +L L +
Sbjct: 68 LHS-DKK----LTLVFEYCDQDLKKYFDSCNGDI--DPEIVKSFMFQL------LKGLAF 114
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
H ++H DLKP N+L++++ K+ DFGLAR+ G S V+ ++ Y
Sbjct: 115 CH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAF----GIPVRCYSAEVV--TLWY 165
Query: 638 IPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSP 670
PP+ G K ST+ D++S G + E+ P
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 70/258 (27%), Positives = 109/258 (42%), Gaps = 53/258 (20%)
Query: 463 IGSGSFGSVYKG---YLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
IG G++G VYK E I++ L+ E G + E L+ +H N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA----IDIASAL 575
S + L LV+E+L + K + +F + + I +
Sbjct: 70 VHS-----EKRLYLVFEYLDL---------DLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTA-KVGDFGLARSLLERIGNQSSISSTHVLKGS 634
Y H+ ++H DLKP N+L+D A K+ DFGLAR+ G + V+ +
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF----GIPVRTFTHEVV--T 166
Query: 635 IGYIPPEYGLGEKP-STAGDVYSFGVMLLE------IFTGMS--------------PTHE 673
+ Y PE LG + ST D++S G + E +F G S P E
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226
Query: 674 SFAGEVSLVKWVESNFPK 691
++ G SL + +S FPK
Sbjct: 227 TWPGVTSLPDY-KSAFPK 243
|
Length = 294 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 67/248 (27%), Positives = 107/248 (43%), Gaps = 27/248 (10%)
Query: 437 LFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYK-GYLREGISVAVKVLDIESTGTW 495
LF ++ M+ + L T + IG G++G VYK ++G AVK+LD S
Sbjct: 4 LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD- 62
Query: 496 KSFFAECEALRN-TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNE 554
+ AE L++ H N+VK D L LV E GS+ + + G
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 555 HGNGLNFLERLNIAIDIASA---LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611
L+ I+ + A L +LHN+ I+H D+K NILL + K+ DFG+
Sbjct: 123 QR-----LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGV 174
Query: 612 ARSLLE-RIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAG-----DVYSFGVMLLEIF 665
+ L R+ +S+ G+ ++ PE E+ DV+S G+ +E+
Sbjct: 175 SAQLTSTRLRRNTSV-------GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227
Query: 666 TGMSPTHE 673
G P +
Sbjct: 228 DGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 70/254 (27%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 463 IGSGSFGSVYKGY--LREGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITS 519
+G G++ +VYKG L + + VA+K + +E G + E L++ +H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--- 69
Query: 520 CSSLDFKNME-FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
D + E L LV+E+L + L ++ ++ GN +N + L+Y
Sbjct: 70 ---HDIIHTEKSLTLVFEYL-DKDLKQYL-----DDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H ++H DLKP N+L++E K+ DFGLAR+ + I ++ S V+ ++ Y
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKT--YSNEVV--TLWYR 171
Query: 639 PPEYGLGEKP-STAGDVYSFGVMLLEIFTGM--------------------SPTHESFAG 677
PP+ LG ST D++ G + E+ TG +PT E++ G
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231
Query: 678 EVSLVKWVESNFPK 691
+S ++ N+PK
Sbjct: 232 ILSNEEFKSYNYPK 245
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 41/223 (18%)
Query: 459 HENL--IGSGSFGSVYKGY-LREGISVAVKVLD--IESTGTWKSFFAECEALRNTRHRNL 513
++NL +GSG++GSV + + G+ VAVK L +S K + E L++ +H N+
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 514 VKLITSCS-SLDFKNMEFLALVYEFLGNGSLGDWIHGER-KNEHGNGLNFLERLNIAIDI 571
+ L+ + + + + LV +G L + + ++ ++H + FL I
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDH---VQFL-----IYQI 129
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
L Y+H+ I+H DLKP N+ ++ED K+ DFGLAR H
Sbjct: 130 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---------------HTD 171
Query: 632 KGSIGYI------PPEYGLG-EKPSTAGDVYSFGVMLLEIFTG 667
GY+ PE L + D++S G ++ E+ TG
Sbjct: 172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKS---FFAECEALRNTRHRN 512
F ++G G FG V +R G A K L+ + K E + L R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIH--GERKNEHGNGLNFLERLNIAID 570
+V L + ++ + L LV + G L I+ GE E G + + A +
Sbjct: 62 VVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY------AAE 110
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
I L+ LH + IV+ DLKP NILLD+ ++ D GLA + E + +
Sbjct: 111 ICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV----- 162
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G++GY+ PE E+ + + D ++ G +L E+ G SP
Sbjct: 163 --GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 457 FSHENLIGSGSFGSVYKGYL-REGISVAVKVLD-------IESTGTWKSFFAECEALRNT 508
F+ IG GSFG VYKG R VA+K++D IE + ++C++ T
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 509 RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568
R+ + L ++ E+LG GS D + LE IA
Sbjct: 66 RYYG-----------SYLKGTKLWIIMEYLGGGSALDLLKP----------GPLEETYIA 104
Query: 569 I---DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSI 625
+I LDYLH++ ++ H D+K N+LL E K+ DFG+A L + +
Sbjct: 105 TILREILKGLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTD------TQ 155
Query: 626 SSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ G+ ++ PE D++S G+ +E+ G P
Sbjct: 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 68/221 (30%), Positives = 103/221 (46%), Gaps = 39/221 (17%)
Query: 462 LIGSGSFGSVYKGYLREGISV-AVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
+IG GS+ V L++ + A+KV+ DI+ T K F + + H
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-----SNHP 56
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK--NEHGNGLNFLERLNIAI 569
LV L SC F+ L V E++ G L + +RK EH R A
Sbjct: 57 FLVGL-HSC----FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSA- 103
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+I+ AL+YLH E I++ DLK N+LLD + K+ D+G+ + L R G+ +T
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-RPGD-----TTS 154
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ YI PE GE + D ++ GV++ E+ G SP
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 34/228 (14%)
Query: 456 NFSHENLIGSGSFGSVY----KGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTR-H 510
NF ++G+G++G V+ G G A+KVL ++T K+ AE +TR
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLK-KATIVQKAKTAE-----HTRTE 54
Query: 511 RNLVKLITSCSSL-----DFKNMEFLALVYEFLGNGSLGDWI-HGERKNEHGNGLNFLER 564
R +++ + C L F+ L L+ +++ G L + E E R
Sbjct: 55 RQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE------VR 108
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
+ IA +I ALD+LH ++ I++ D+K NILLD + + DFGL++ L
Sbjct: 109 VYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL-----AEE 159
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKP--STAGDVYSFGVMLLEIFTGMSP 670
+ G+I Y+ PE G A D +S GV+ E+ TG SP
Sbjct: 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS- 519
+IG G FG VY + G A+K LD + K E AL R ++ L+++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI---KMKQGETLALN---ERIMLSLVSTG 54
Query: 520 ------CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI--AIDI 571
C S F + L+ + + + G L + ++HG F E A +I
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGV---FSEAEMRFYAAEI 106
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
L+++HN +V+ DLKP NILLDE ++ D GLA S H
Sbjct: 107 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF--------SKKKPHAS 155
Query: 632 KGSIGYIPPE-YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ GY+ PE G ++ D +S G ML ++ G SP
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS- 519
+IG G FG VY + G A+K LD + K E AL R ++ L+++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI---KMKQGETLALN---ERIMLSLVSTG 54
Query: 520 ------CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
C + F + L + + + G L + ++HG + E A +I
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQHGV-FSEKEMRFYATEIIL 108
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
L+++HN +V+ DLKP NILLDE ++ D GLA S H G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF--------SKKKPHASVG 157
Query: 634 SIGYIPPE-YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ GY+ PE G ++ D +S G ML ++ G SP
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 463 IGSGSFGSVYKGY-LREGIS-VAVKVLDIEST--GTWKSFFAECEALRNTR---HRNLVK 515
IG G++G V+K L+ G VA+K + +++ G S E LR+ H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575
L C+ L LV+E + + L ++ ++ E G ++ ++ + L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIK--DMMFQLLRGL 123
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
D+LH+ +VH DLKP NIL+ K+ DFGLAR Q +++S V ++
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVV---TL 173
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIF 665
Y PE L +T D++S G + E+F
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 67/242 (27%), Positives = 97/242 (40%), Gaps = 61/242 (25%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGT-WKSFFAECEALRNTR 509
F+ E+L IG G+FG+V K + G +AVK + K + + + +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 510 H-RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGD-WIHGE-----------RKNEHG 556
+VK + AL E GD WI E E
Sbjct: 61 DCPYIVKF-------------YGALFRE-------GDCWICMELMDISLDKFYKYVYEVL 100
Query: 557 NGLNFLERL--NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614
E + IA+ AL+YL E+ I+H D+KP NILLD + K+ DFG++
Sbjct: 101 KS-VIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157
Query: 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTA------GDVYSFGVMLLEIFTGM 668
L++ SI+ T G Y+ PE PS DV+S G+ L E+ TG
Sbjct: 158 LVD------SIAKTRD-AGCRPYMAPERID---PSARDGYDVRSDVWSLGITLYEVATGK 207
Query: 669 SP 670
P
Sbjct: 208 FP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
+GSG++G VYK L G AVK++ +E + E ++ +H N+V S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS-- 74
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI---DIASALDYL 578
+ + E L + E+ G GSL D H L L IA + L YL
Sbjct: 75 ---YLSREKLWICMEYCGGGSLQDIYHVTGP---------LSELQIAYVCRETLQGLAYL 122
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H+ ++ H D+K NILL ++ K+ DFG+A + I + S G+ ++
Sbjct: 123 HSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS------FIGTPYWM 173
Query: 639 PPEYGLGEKPSTAG---DVYSFGVMLLEI 664
PE EK D+++ G+ +E+
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 73/216 (33%), Positives = 117/216 (54%), Gaps = 8/216 (3%)
Query: 145 KIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKL 204
+P+S+ RL SL LL+ S S S + + L L SLDL N++ +I + L L L
Sbjct: 61 LLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNL 118
Query: 205 NQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264
+DL N + P NL +DLS+NK+ ++P + +L +L ++LS N L
Sbjct: 119 TSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKN-LDLSFNDLS 176
Query: 265 GTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKG 324
LP+ + L N+ +DLS N +S +LP + +LE+L ++NN + + L+ LK
Sbjct: 177 -DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKN 233
Query: 325 LEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
L L+LS+NKL +P + NL L +L+L+ N +
Sbjct: 234 LSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 22/163 (13%)
Query: 463 IGSGSFGSVYKGYLREGIS---VAVKVLD---IESTGTWKSFFAECEALRNTRHRNLVKL 516
IG G++G VYK + G A+K + TG +S E LR +H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAIDIASA 574
+ L+ + + L++++ L I R ++ + ++ I +
Sbjct: 68 VEVF--LEHADKS-VYLLFDY-AEHDLWQIIKFHR---QAKRVSIPPSMVKSLLWQILNG 120
Query: 575 LDYLHNDCEVPIVHCDLKPGNILL----DEDMTAKVGDFGLAR 613
+ YLH++ ++H DLKP NIL+ E K+GD GLAR
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 66/248 (26%), Positives = 111/248 (44%), Gaps = 48/248 (19%)
Query: 449 ELRRATGNFSHENLIGSGSFGSVYKGYL------REGISVAVKVLDIESTGTWKSFFAEC 502
E+ +T F E +G FG VYKG+L + +VA+K L ++ G + F
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKH- 57
Query: 503 EALRNTR--HRNLVKLI-------------TSCSSLDFKNMEFLALVYEFLGNGSLGDWI 547
EA+ +R H N+V L+ + CS D EFL + GS D
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH--EFLVMRSPHSDVGSTDD-- 113
Query: 548 HGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607
+ L + ++I IA+ +++L + +VH DL N+L+ + + K+
Sbjct: 114 ----DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKIS 166
Query: 608 DFGLARSLLERIGNQSSISSTHVLKGS----IGYIPPEYGLGEKPSTAGDVYSFGVMLLE 663
D GL R + + + L G+ I ++ PE + K S D++S+GV+L E
Sbjct: 167 DLGLFREVYA--------ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218
Query: 664 IFT-GMSP 670
+F+ G+ P
Sbjct: 219 VFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 59/212 (27%), Positives = 85/212 (40%), Gaps = 20/212 (9%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSF---FAECEALRNTRHRNLVKLIT 518
+G G FG V +R G A K L+ + K + E L R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
+ F+ L LV + G L H +E G I S L++L
Sbjct: 61 A-----FQTKTDLCLVMTIMNGGDLR--YHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H I++ DLKP N+LLD D ++ D GLA L + S T G+ G++
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD------GQSKTKGYAGTPGFM 164
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
PE GE+ + D ++ GV L E+ P
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 463 IGSGSFGSVYKGYLREGISVAV-KVLDIESTGTWKSFFA--ECEALRNTRHRNLVKLITS 519
+G G+FG E S+ V K +++ + A E L +H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA--IDIASALDY 577
F + L + E+ G+L D I G F E + + I SA+ Y
Sbjct: 68 -----FMDDNTLLIEMEYANGGTLYDKI------VRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
+H + I+H D+K NI L + K+GDFG+++ L G++ S++ T V G+ Y
Sbjct: 117 IH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL----GSEYSMAETVV--GTPYY 167
Query: 638 IPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
+ PE G K + D+++ G +L E+ T
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVKVLD--IESTGTWKSFFAECEALRNTRHRNLVKLI-- 517
IGSG+ G V + GI+VAVK L ++ K + E L+ H+N++ L+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 518 -TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
T SL+ + + LV E + + +L IH E +E + L + + +
Sbjct: 89 FTPQKSLE--EFQDVYLVMELM-DANLCQVIHMELDHERMSYLLY--------QMLCGIK 137
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
+LH+ I+H DLKP NI++ D T K+ DFGLAR+ + + +
Sbjct: 138 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY------- 187
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG 667
Y PE LG D++S G ++ E+ G
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 89/327 (27%), Positives = 134/327 (40%), Gaps = 73/327 (22%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGIS--VAVKVL---------DIESTGTWKSFFAECEA 504
+F+ ++G GSFG V R+G A+K+L D+E T E
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECT------MVEKRV 53
Query: 505 LRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIH--GERKNEHGNGLNFL 562
L + + + SC F+ M+ L V E++ G L I G K H
Sbjct: 54 LALSGKPPFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHA------ 103
Query: 563 ERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
+ A +IA L +LH+ I++ DLK N++LD + K+ DFG+ + N
Sbjct: 104 --VFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE------NM 152
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS-- 680
+T G+ YI PE + + D ++FGV+L E+ G +P F GE
Sbjct: 153 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGEDEDE 208
Query: 681 -LVKWVESN--FPKNAQQVLDRELRQLMMSSESQTIQLHDC--LITIIESVGLSCTTESP 735
+E N +PK+ MS E+ I C L+T L C P
Sbjct: 209 LFQSIMEHNVAYPKS-------------MSKEAVAI----CKGLMTKHPGKRLGC---GP 248
Query: 736 GGRIDIRE-ALRRLKNAQKILLKRRQP 761
G DI+E A R + +K+ K QP
Sbjct: 249 EGERDIKEHAFFRYIDWEKLERKEVQP 275
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 451 RRATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTR 509
R +F IGSG++G VYK + G A+KV+ +E + E +++ +
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
H N+V S + + L + EF G GSL D H L+ + ++
Sbjct: 65 HSNIVAYFGS-----YLRRDKLWICMEFCGGGSLQDIYHVT------GPLSESQIAYVSR 113
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+ L YLH+ ++ H D+K NILL ++ K+ DFG++ + I + S
Sbjct: 114 ETLQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS----- 165
Query: 630 VLKGSIGYIPPEYGLGEKP---STAGDVYSFGVMLLEI 664
G+ ++ PE E+ + D+++ G+ +E+
Sbjct: 166 -FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 79/257 (30%), Positives = 114/257 (44%), Gaps = 45/257 (17%)
Query: 462 LIGSGSFGSVYKGYLRE---GISVAVKVLD---IESTGTWKSFFAECEALRNTRHRNLVK 515
L+G G+FG V +RE G A+K+L I + E L+NTRH L
Sbjct: 2 LLGKGTFGKVI--LVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIAIDIA 572
L S F+ + L V E+ G L + ER F E R A +I
Sbjct: 60 LKYS-----FQTHDRLCFVMEYANGGELFFHLSRERV--------FSEDRARFYGA-EIV 105
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
SAL YLH+ C+ +V+ DLK N++LD+D K+ DFGL + E I S ++
Sbjct: 106 SALGYLHS-CD--VVYRDLKLENLMLDKDGHIKITDFGLCK---EGI---SDGATMKTFC 156
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP----THESFAGEVSLVKWVESN 688
G+ Y+ PE A D + GV++ E+ G P HE E+ L++ E
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILME--EIR 213
Query: 689 FPKNAQQVLDRELRQLM 705
FP+ L E + L+
Sbjct: 214 FPRT----LSPEAKSLL 226
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 70/271 (25%), Positives = 113/271 (41%), Gaps = 56/271 (20%)
Query: 452 RATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFA-----ECEAL 505
R+ + N I G++G VY+ + G VA+K L +E K F E L
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE---KEGFPITSLREINIL 58
Query: 506 RNTRHRNLVKL--ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL- 562
+H N+V + + S N++ + +V E++ + L + E + FL
Sbjct: 59 LKLQHPNIVTVKEVVVGS-----NLDKIYMVMEYVEH-DLKSLM--ETMKQ-----PFLQ 105
Query: 563 -ERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGN 621
E + + + S + +LH++ I+H DLK N+LL+ K+ DFGLAR +
Sbjct: 106 SEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162
Query: 622 QSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYS----FGVMLLE--IFTGMS----- 669
+ + T Y PE LG K STA D++S F +L + +F G S
Sbjct: 163 YTQLVVTL------WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216
Query: 670 ---------PTHESFAGEVSLVKWVESNFPK 691
PT + + G L + F K
Sbjct: 217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTK 247
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITS 519
IG GSFG +E G +K ++I S + E L N +H N+V+ S
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDY 577
F+ L +V ++ G L I+ +R G+ F E L+ + I AL +
Sbjct: 68 -----FEENGNLYIVMDYCEGGDLYKKINAQR------GVLFPEDQILDWFVQICLALKH 116
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
+H+ I+H D+K NI L +D T K+GDFG+AR L S++ G+ Y
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL------NSTVELARTCIGTPYY 167
Query: 638 IPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
+ PE + D+++ G +L E+ T
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 13/108 (12%)
Query: 567 IAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSIS 626
IA+ I AL+YLH+ V +H D+KP N+L++ + K+ DFG++ L++ S++
Sbjct: 108 IAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVD------SVA 159
Query: 627 STHVLKGSIGYIPPEYGLGEKPSTA----GDVYSFGVMLLEIFTGMSP 670
T + G Y+ PE E DV+S G+ ++E+ TG P
Sbjct: 160 KT-IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 463 IGSGSFGSVYKGYLR-EGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSC 520
+G G++GSVYK R G+++A+K + +E + E + L H+ + I
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61
Query: 521 SSLDFKNMEFL-ALVY---EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
+DF F+ VY E++ GSL D ++ G + L R I + L
Sbjct: 62 --VDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLK 116
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
+L + I+H D+KP N+L++ + K+ DFG++ +L+ +S++ T++ G
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV------ASLAKTNI--GCQS 166
Query: 637 YIPPEYGLGEKPSTAG------DVYSFGVMLLEIFTGMSP 670
Y+ PE P+ DV+S G+ +LE+ G P
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
IG G+ G+VY + G VA++ ++++ + E +R ++ N+V + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHND 581
+ + L +V E+L GSL D + +E + + + AL++LH++
Sbjct: 86 ---YLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHSN 135
Query: 582 CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE 641
++H D+K NILL D + K+ DFG + +S+ + G+ ++ PE
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST------MVGTPYWMAPE 186
Query: 642 YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ D++S G+M +E+ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 23/159 (14%)
Query: 524 DFKNMEFLALVYEFLGNGSLGDWIHGERK-----NEHGNGLNFLERLNIAIDIASALDYL 578
DFK+ + L L+ E+ G L I K E+ GL F + I ALD +
Sbjct: 133 DFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQ-------IVLALDEV 185
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H+ ++H DLK NI L K+GDFG ++ + + S+ G+ Y+
Sbjct: 186 HSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV----SLDVASSFCGTPYYL 238
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAG 677
PE ++ S D++S GV+L E+ T H F G
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLT----LHRPFKG 273
|
Length = 478 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 22/160 (13%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLD--IESTGTWKSFFAECEALRNTRHRNLVKLI- 517
+GSG++GSV R G VA+K L +S K + E L++ +H N++ L+
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 518 --TSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
TS S D F++ +L + Y I G +E + + +L +
Sbjct: 82 VFTSAVSGDEFQDF-YLVMPYMQTDLQK----IMGHPLSE--DKVQYL-----VYQMLCG 129
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614
L Y+H I+H DLKPGN+ ++ED K+ DFGLAR
Sbjct: 130 LKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 27/234 (11%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKS---FFAECEALRNTRHRN 512
F H ++G G FG V +R G A K L+ + K E L R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+V L + ++ + L LV + G L I+ N G + + A ++
Sbjct: 62 VVSL-----AYAYETKDALCLVLTIMNGGDLKFHIY----NMGNPGFDEQRAIFYAAELC 112
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L+ L + IV+ DLKP NILLD+ ++ D GLA + E + +
Sbjct: 113 CGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV------- 162
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686
G++GY+ PE EK + + D + G ++ E+ G SP F VK E
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP----FRKRKERVKREE 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 463 IGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEA--LRNTRHRNLVKLITS 519
IG GSFG +Y + + +K +D+ + ++ E L +H N+V S
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDY 577
F+ L +V E+ G L I+ +R G+ F E L+ + I+ L +
Sbjct: 68 -----FQENGRLFIVMEYCDGGDLMKRINRQR------GVLFSEDQILSWFVQISLGLKH 116
Query: 578 LHNDCEVPIVHCDLKPGNILLDED-MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
+H+ I+H D+K NI L ++ M AK+GDFG+AR L S+ + G+
Sbjct: 117 IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL------NDSMELAYTCVGTPY 167
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
Y+ PE + D++S G +L E+ T P
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 23/218 (10%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKS---FFAECEALRNTRHRN 512
F ++G G FG V +R G A K L+ + K E + L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+V L + ++ + L LV + G L I+ N G L A +I
Sbjct: 62 VVNL-----AYAYETKDALCLVLTIMNGGDLKFHIY----NMGNPGFEEERALFYAAEIL 112
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L+ LH + V+ DLKP NILLD+ ++ D GLA + E + +
Sbjct: 113 CGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV------- 162
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G++GY+ PE ++ + + D + G ++ E+ G SP
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 70/262 (26%), Positives = 114/262 (43%), Gaps = 51/262 (19%)
Query: 463 IGSGSFGSVYKGY--LREGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITS 519
+G G++ +V+KG L E + VA+K + +E G + E L++ +H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI---DIASALD 576
+ + L LV+E+L + K + N + N+ I I L
Sbjct: 73 VHT-----DKSLTLVFEYLDK---------DLKQYMDDCGNIMSMHNVKIFLYQILRGLA 118
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
Y H ++H DLKP N+L++E K+ DFGLAR+ + S V+ ++
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAK----SVPTKTYSNEVV--TLW 169
Query: 637 YIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM--------------------SPTHESF 675
Y PP+ LG ST D++ G + E+ +G +PT E++
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
Query: 676 AGEVSLVKWVESNFPKNAQQVL 697
G S ++ NFPK Q L
Sbjct: 230 PGISSNDEFKNYNFPKYKPQPL 251
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 37/225 (16%)
Query: 463 IGSGSFGSVYKG-YLREGISVAVKVLDI--ESTGTWKSFFAECEALRNTRHRNLVKLIT- 518
+G G+FG VYK ++ G VA+K + + E G + E + L+ +H N+V LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 519 ----SCSSLDFKNMEFLALVYE------FLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568
S + ++ Y L N S+ K ++ +L
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--------KLTESQIKCYMLQL--- 124
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERI--GNQSSIS 626
++YLH E I+H D+K NIL+D K+ DFGLAR
Sbjct: 125 ---LEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 627 STHVLKGSI---GYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
T + Y PPE LGE+ +TA D++ G + E+FT
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
I L Y+H+ ++H DLKPGN+L++ D K+ DFGLAR E G + + +V
Sbjct: 114 ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 631 LKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
+ Y PE L + + A DV+S G +L E+
Sbjct: 171 --ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVK----LI 517
+G GS G V+ + VAVK + + + K E + +R H N+VK L
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 518 TSCSSL--DFKNMEFLALVY--EFLGNGSLGDWI-HGERKNEHGNGLNFLERLNIAIDIA 572
S S L D ++ L VY + L + + G EH RL +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-------RL-FMYQLL 124
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLD-EDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
L Y+H+ ++H DLKP N+ ++ ED+ K+GDFGLAR + ++ +S V
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 632 KGSIGYIPPEYGLGEKPST-AGDVYSFGVMLLEIFTG 667
K Y P L T A D+++ G + E+ TG
Sbjct: 182 K---WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 454 TGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVL--DIESTGTWKSFFAECEALRNTRH 510
T + +G G+FG V G +VA+K + + K + E + L++ RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
N++ L S + +E + V E LG L + + F++
Sbjct: 69 ENIISL----SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQ-----FIQYF--LYQ 116
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
I L Y+H+ +VH DLKP NIL++E+ K+ DFGLAR ++ + ST
Sbjct: 117 ILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM---TGYVSTRY 170
Query: 631 LKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTG 667
Y PE L +K D++S G + E+ G
Sbjct: 171 ------YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 53/222 (23%), Positives = 83/222 (37%), Gaps = 38/222 (17%)
Query: 464 GSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCS 521
+ K + VAVK ++++ S K E R +H N++ +TS
Sbjct: 11 EDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS-- 67
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH-N 580
F L +V + GS D + K GL L I D+ +ALDY+H
Sbjct: 68 ---FIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 581 DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS------ISSTHVLKGS 634
+H +K +ILL D + + S+++ G + SS L
Sbjct: 121 GF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKH-GKRQRVVHDFPKSSVKNLP-- 173
Query: 635 IGYIPPE------YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
++ PE G EK D+YS G+ E+ G P
Sbjct: 174 --WLSPEVLQQNLQGYNEK----SDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 49/160 (30%), Positives = 82/160 (51%), Gaps = 25/160 (15%)
Query: 463 IGSGSFGSVYKGY---LREGISVAVKVLD--IESTGTWKSFFAECEALRNTRHRNLVKLI 517
+GSG++GSV Y LR+ VAVK L +S + + E L++ +H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 518 ---TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER-KNEHGNGLNFLERLNIAIDIAS 573
T +S++ N + LV +G L + + ++ +EH + FL +
Sbjct: 81 DVFTPATSIE--NFNEVYLVTNLMG-ADLNNIVKCQKLSDEH---VQFL-----IYQLLR 129
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613
L Y+H+ I+H DLKP N+ ++ED ++ DFGLAR
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 52/214 (24%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 463 IGSGSFGSVYKGYLREGISVA-VKVLDIESTGTWK---SFFAECEALRNTRHRNLVKLIT 518
IG+G FG V + VA V V ++++ + K F + + R +H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
C + + +L LV+E+ G L ++ E+ + + L L+R+ A +IA+ + ++
Sbjct: 63 QC----VEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHM 115
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H + +H DL N L D+T KVGD+G+ S + + I + + ++
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK----EDYIETEDDKCVPLRWL 168
Query: 639 PPEYG-------LGEKPSTAGDVYSFGVMLLEIF 665
PE + + + +V++ GV L E+F
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 65/243 (26%), Positives = 100/243 (41%), Gaps = 19/243 (7%)
Query: 438 FKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWK 496
F S + I +D + + IG G++G V+K + G AVK+LD
Sbjct: 1 FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-----PIH 55
Query: 497 SFFAECEALRN-----TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER 551
E EA N + H N+VK D KN + L LV E GS+ D + G
Sbjct: 56 DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL 115
Query: 552 KNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611
K G + I + L +LH + +H D+K NILL + K+ DFG+
Sbjct: 116 K--RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV 170
Query: 612 ARSLLE-RIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ L R+ +S+ + + + I E L DV+S G+ +E+ G P
Sbjct: 171 SAQLTSTRLRRNTSVGTPFWMAPEV--IACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
Query: 671 THE 673
+
Sbjct: 229 LAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDI------ESTGTWKSFFAECEALRNTRHRNLV 514
+G+G+F S Y+ ++ G +AVK + E ++ E + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 515 KLI-TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
+++ +C F L E++ GS+ + + +N+ E+ +
Sbjct: 67 RMLGATCEDSHFN------LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ------LLR 114
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDED-MTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L YLH E I+H D+K N+L+D ++ DFG A L + L
Sbjct: 115 GLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ--LL 169
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+I ++ PE GE+ + DV+S G +++E+ T P
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 37/114 (32%), Positives = 60/114 (52%), Gaps = 17/114 (14%)
Query: 558 GLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL 616
GL L+ L+ +A +++L + +C VH DL N+LL + K+ DFGLAR ++
Sbjct: 233 GLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIM 288
Query: 617 ERIGNQSSISSTHVLKGS----IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
S +V KGS + ++ PE +T DV+S+G++L EIF+
Sbjct: 289 H--------DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 18/121 (14%)
Query: 559 LNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE 617
L++++ + + +A+ +++L + +C VH DL N+L+ E K+ DFGLAR ++
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMR 291
Query: 618 RIGNQSSISSTHVLKGS----IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTH 672
S ++ KGS + ++ PE +T DV+SFG++L EIFT G +P
Sbjct: 292 --------DSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343
Query: 673 E 673
E
Sbjct: 344 E 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 49/154 (31%), Positives = 71/154 (46%), Gaps = 34/154 (22%)
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
AL+YLHN IVH DLKP N+L+ K+ DFGL+ +IG S +T++ +G
Sbjct: 113 ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLS-----KIGLMS--LTTNLYEG 162
Query: 634 SIG----------------YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP-----TH 672
I YI PE L + D ++ G++L E G P
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222
Query: 673 ESFAGEVS-LVKWVESN--FPKNAQQVLDRELRQ 703
E F +S ++W E + P +AQ ++ R LRQ
Sbjct: 223 ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQ 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 35/89 (39%), Positives = 49/89 (55%), Gaps = 13/89 (14%)
Query: 587 VHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS----IGYIPPEY 642
+H DL NILL E+ K+ DFGLAR + + +V KGS + ++ PE
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYK--------DPDYVRKGSARLPLKWMAPES 247
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ +T DV+SFGV+L EIF+ G SP
Sbjct: 248 IFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 34/89 (38%), Positives = 48/89 (53%), Gaps = 13/89 (14%)
Query: 587 VHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS----IGYIPPEY 642
+H DL NILL E+ K+ DFGLAR + + +V KG + ++ PE
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYK--------DPDYVRKGDARLPLKWMAPES 246
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ +T DV+SFGV+L EIF+ G SP
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 71/253 (28%), Positives = 108/253 (42%), Gaps = 53/253 (20%)
Query: 425 RKGKAKPIGVSTLF-KHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGY-LREGISV 482
R G K ++ LF K P+ + + +LR IG GSFG+VY +R V
Sbjct: 5 RAGSLKDPEIAELFFKEDPEKL-FTDLRE----------IGHGSFGAVYFARDVRTNEVV 53
Query: 483 AVKVLDI---ESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN---MEFLA-LVY 535
A+K + +S W+ E + L+ +H N S+++K E A LV
Sbjct: 54 AIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN---------SIEYKGCYLREHTAWLVM 104
Query: 536 EF-LGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPG 594
E+ LG+ S + H L +E I L YLH+ ++H D+K G
Sbjct: 105 EYCLGSAS-------DLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAG 154
Query: 595 NILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAG- 652
NILL E K+ DFG A S S + G+ ++ PE L ++ G
Sbjct: 155 NILLTEPGQVKLADFGSA----------SIASPANSFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 653 -DVYSFGVMLLEI 664
DV+S G+ +E+
Sbjct: 205 VDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 456 NFSHENLIGSGSFGSVY-----KGYLREGISVAVKVLD----IESTGTWKSFFAECEALR 506
NF ++G+G++G V+ G+ G A+KVL ++ T + E + L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 507 NTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSL-GDWIHGERKNEHGNGLNFLERL 565
+ R + + D K L L+ +++ G L ER E +
Sbjct: 60 HIRQSPFLVTLHYAFQTDTK----LHLILDYINGGELFTHLSQRERFKEQ--------EV 107
Query: 566 NIAI-DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
I +I AL++LH ++ I++ D+K NILLD + + DFGL++ E
Sbjct: 108 QIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-----DE 159
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKP--STAGDVYSFGVMLLEIFTGMSP 670
+ + G+I Y+ P+ G A D +S GV++ E+ TG SP
Sbjct: 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVKVLDI---ESTGTWKSFFAECEALRNTRHRNLVKLIT 518
IG GSFG+VY +R VA+K + +S W+ E L+ RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY-R 81
Query: 519 SCSSLDFKNMEFLALVYEF-LGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
C + LV E+ LG+ S + H L +E + L Y
Sbjct: 82 GC----YLREHTAWLVMEYCLGSAS-------DLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
LH+ ++H D+K GNILL E K+GDFG A S ++ + G+ +
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----------SIMAPANXFVGTPYW 177
Query: 638 IPPEYGLG-EKPSTAG--DVYSFGVMLLEI 664
+ PE L ++ G DV+S G+ +E+
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 76/306 (24%), Positives = 126/306 (41%), Gaps = 68/306 (22%)
Query: 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVL---------DIESTGTWKSFFAECEAL 505
+F+ ++G GSFG V + A+K+L D+E T K A +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-- 58
Query: 506 RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL 565
+ + SC F+ ++ L V E++ G L I K + + +
Sbjct: 59 ----KPPFLTQLHSC----FQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY---- 106
Query: 566 NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR-SLLERIGNQSS 624
A +I+ L +LH I++ DLK N++LD + K+ DFG+ + +++ +
Sbjct: 107 --AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV----- 156
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS---L 681
+T G+ YI PE + + D +++GV+L E+ G P F GE
Sbjct: 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP----FDGEDEDELF 210
Query: 682 VKWVESN--FPKNAQQVLDRELRQLMMSSESQTIQLHDC--LITIIESVGLSCTTESPGG 737
+E N +PK+ +S E+ +I C L+T S L C P G
Sbjct: 211 QSIMEHNVSYPKS-------------LSKEAVSI----CKGLMTKHPSKRLGC---GPEG 250
Query: 738 RIDIRE 743
DIRE
Sbjct: 251 ERDIRE 256
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 462 LIGSGSFGSVYKGYLREGIS-VAVKVL-DIESTGTWK-SFFAECEALRNTRHRNLVKLIT 518
++G G++G V K +E VA+K D E K + E + LR + N+V+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
+ F+ L LV+E++ L E E NG+ + + + A+ +
Sbjct: 68 A-----FRRRGKLYLVFEYVEKNML------ELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H + IVH D+KP N+L+ + K+ DFG AR+L E G+ ++ + + Y
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE--GSNANYTEYVATR---WYR 168
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTG 667
PE LG A D++S G +L E+ G
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 71/253 (28%), Positives = 106/253 (41%), Gaps = 53/253 (20%)
Query: 425 RKGKAKPIGVSTLF-KHSPQMISYDELRRATGNFSHENLIGSGSFGSVY---KGYLREGI 480
RKG K ++ LF K P+ I HE IG GSFG+VY + E
Sbjct: 1 RKGVVKDPEIADLFYKDDPEEIFVG---------LHE--IGHGSFGAVYFATNSHTNE-- 47
Query: 481 SVAVKVLDIESTGT---WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEF 537
VAVK + T W+ E + L+ +H N ++ C + + +L + Y
Sbjct: 48 VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY-KGCYLKE--HTAWLVMEYCL 104
Query: 538 LGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD---YLHNDCEVPIVHCDLKPG 594
GS D + +K L+ + IA AL YLH+ ++H D+K G
Sbjct: 105 ---GSASDLLEVHKKP--------LQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAG 150
Query: 595 NILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAG- 652
NILL E K+ DFG A S S + G+ ++ PE L ++ G
Sbjct: 151 NILLTEPGQVKLADFGSA----------SKSSPANSFVGTPYWMAPEVILAMDEGQYDGK 200
Query: 653 -DVYSFGVMLLEI 664
DV+S G+ +E+
Sbjct: 201 VDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 38/119 (31%), Positives = 56/119 (47%), Gaps = 14/119 (11%)
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
A +I L+ LH + IV+ DLKP NILLD+ ++ D GLA I +I
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRG 160
Query: 628 THVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686
G++GY+ PE E+ + + D + G ++ E+ G SP F VK E
Sbjct: 161 R---VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP----FRQRKEKVKREE 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 35/220 (15%)
Query: 459 HENL--IGSGSFGSVYKGY-LREGISVAVKVLD--IESTGTWKSFFAECEALRNTRHRNL 513
++NL IGSG+ G V Y G +VA+K L ++ K + E ++ H+N+
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 514 VKLI---TSCSSLDFKNMEF--LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568
+ L+ T SL+ EF + LV E + + +L I + +H ER++
Sbjct: 78 IGLLNVFTPQKSLE----EFQDVYLVMELM-DANLCQVIQMDL--DH-------ERMSYL 123
Query: 569 I-DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
+ + + +LH+ I+H DLKP NI++ D T K+ DFGLA R S + +
Sbjct: 124 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA-----RTAGTSFMMT 175
Query: 628 THVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG 667
+V+ + Y PE LG D++S G ++ E+ G
Sbjct: 176 PYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 12/111 (10%)
Query: 560 NFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERI 619
N L +++IA+ L YL + I+H D+KP NIL++ K+ DFG++ L++
Sbjct: 99 NILGKISIAV--LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 152
Query: 620 GNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
S++++ V G+ Y+ PE G + D++S G+ L+E+ G P
Sbjct: 153 ----SMANSFV--GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 49/194 (25%), Positives = 73/194 (37%), Gaps = 50/194 (25%)
Query: 562 LERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA--------- 612
L R IA ++ A++ +H + +H D+KP NIL+D D K+ DFGL
Sbjct: 102 LARFYIA-ELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 613 ----------------------------RSLLERIGNQSSISSTHVLKGSIGYIPPEYGL 644
+ L R Q H L G+ YI PE L
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 645 GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL--VKWVES-NFPKNAQQVLDRE- 700
+ D +S GV+L E+ G P E L + W + + P A+ L RE
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK--LSREA 275
Query: 701 ---LRQLMMSSESQ 711
+ +L +E +
Sbjct: 276 SDLILRLCCGAEDR 289
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
IG G+ G+V+ + G VA+K ++++ + E ++ ++ N+V + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS-- 84
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHND 581
F + L +V E+L GSL D + +E + + + AL++LH +
Sbjct: 85 ---FLVGDELFVVMEYLAGGSLTDVVTETCMDE-------AQIAAVCRECLQALEFLHAN 134
Query: 582 CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE 641
++H D+K N+LL D + K+ DFG +I + S ST V G+ ++ PE
Sbjct: 135 ---QVIHRDIKSDNVLLGMDGSVKLTDFGFC----AQITPEQSKRSTMV--GTPYWMAPE 185
Query: 642 YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ D++S G+M +E+ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 36/118 (30%), Positives = 62/118 (52%), Gaps = 18/118 (15%)
Query: 559 LNFLERLNIAIDIASALDYL-HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE 617
L+ + L + +A +D+L +C +H D+ N+LL + AK+ DFGLAR ++
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 618 RIGNQSSISSTHVLKGS----IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
S +V+KG+ + ++ PE + DV+S+G++L EIF+ G SP
Sbjct: 265 --------DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 9/102 (8%)
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+I AL++LH ++ IV+ D+K NILLD + + DFGL++ L T+
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-----EKERTY 164
Query: 630 VLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSP 670
G+I Y+ PE G+ A D +S G+++ E+ TG SP
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 462 LIGSGSFGSVY--------KGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNL 513
++G GSFG + Y + I + +E + E L +H N+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK------EAVLLAKMKHPNI 60
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDI 571
V S F+ L +V E+ G L I +R G F E L + +
Sbjct: 61 VAFKES-----FEADGHLYIVMEYCDGGDLMQKIKLQR------GKLFPEDTILQWFVQM 109
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
+ ++H E ++H D+K NI L ++ K+GDFG AR L + + + T+V
Sbjct: 110 CLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL----TSPGAYACTYV- 161
Query: 632 KGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ Y+PPE + D++S G +L E+ T P
Sbjct: 162 -GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 58/234 (24%), Positives = 89/234 (38%), Gaps = 45/234 (19%)
Query: 461 NLIGSGSFGSVYKGY-LREGISVAVKVLDIE--STGTWKSF------------FAECEAL 505
+G G++G V K Y G VA+K + I S K E + +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 506 RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL 565
+H N++ L+ DF N LV + + + K + E
Sbjct: 75 NEIKHENIMGLVDVYVEGDFIN-----LVMDIM---------ASDLKKVVDRKIRLTESQ 120
Query: 566 N--IAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS--------- 614
I + I + L+ LH +H DL P NI ++ K+ DFGLAR
Sbjct: 121 VKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTG 667
L + Q T + ++ Y PE +G EK A D++S G + E+ TG
Sbjct: 178 LSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 33/89 (37%), Positives = 46/89 (51%), Gaps = 13/89 (14%)
Query: 587 VHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS----IGYIPPEY 642
+H DL NILL E+ K+ DFGLAR + + +V KG + ++ PE
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYK--------DPDYVRKGDARLPLKWMAPET 252
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ DV+SFGV+L EIF+ G SP
Sbjct: 253 IFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 58/249 (23%), Positives = 99/249 (39%), Gaps = 48/249 (19%)
Query: 153 LRSLTLLNLSYNSISGE----ILTEIGQLQELQSLDLAGNQISGSIPNT------LGNLK 202
L L +L L N++ E + + + L+ L L+ N+ L
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 203 KLNQIDLSGNELASEIPTSFGNFQNLLSI------DLSNNKLNGNIPKEI--------LS 248
L ++DLS N L P G ++LL L+NN L + + +
Sbjct: 82 GLQELDLSDNALG---PDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPA 138
Query: 249 LSSLTTIVNLSKNFLDGTLPEEIGML----GNVVTIDLSANGLSGN----LPNSFKNCKS 300
L L L +N L+G E + ++ ++L+ NG+ L K +
Sbjct: 139 LEKLV----LGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCN 194
Query: 301 LEKLLMANNKF----SGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQN-----LRALRS 351
LE L + NN + + LA LK LEVL+L N L+ + + L + +L +
Sbjct: 195 LEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLT 254
Query: 352 LNLTFNNLE 360
L+L+ N++
Sbjct: 255 LSLSCNDIT 263
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 43/228 (18%)
Query: 456 NFSHENLIGSGSFGSVYKGY-LREGISVAVK-VLDIESTGTWKSFFA-----ECEALRNT 508
+ + + IG G++G V G+ VA+K + E F E + LR
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-----HQTFCQRTLREIKILRRF 60
Query: 509 RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER-KNEHGNGLNFLERLNI 567
+H N++ ++ F++ + +V E + L I + N+H FL +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQ--YFLYQ--- 114
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
I L Y+H+ ++H DLKP N+LL+ + K+ DFGLAR
Sbjct: 115 ---ILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR----------IADP 158
Query: 628 THVLKGSIG-------YIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
H G + Y PE L K + A D++S G +L E+ +
Sbjct: 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 7e-07
Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 300 SLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359
+L+ L ++NN+ + L L+VLDLS N L+ P L +LRSL+L+ NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-07
Identities = 79/321 (24%), Positives = 127/321 (39%), Gaps = 71/321 (22%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKS-------------FFAECEALRNTR 509
IG+G FG V+ VK + WK+ E +R +
Sbjct: 21 IGNGRFGEVF----------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK-----NEHGNGLNFLER 564
H+N+V+ I + K + L ++ EF G L I K EH
Sbjct: 71 HKNIVRYIDRFLN---KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA-------I 120
Query: 565 LNIAIDIASALDYLHNDCEVP----IVHCDLKPGNILLDEDM-----------------T 603
++I + AL Y HN + P ++H DLKP NI L +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPS--TAGDVYSFGVML 661
AK+GDFGL+++ IG + S H G+ Y PE L E S D+++ G ++
Sbjct: 181 AKIGDFGLSKN----IGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 662 LEIFTGMSPTHES--FAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCL 719
E+ +G +P H++ F+ +S +K K + L+ ++ L+ S + CL
Sbjct: 234 YELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
Query: 720 -ITIIESVGLSCTTESPGGRI 739
II++VG G +
Sbjct: 294 GYQIIKNVGPPVGAAGGGAGV 314
|
Length = 1021 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 27/214 (12%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALRNTRHRNLVKLIT 518
+G G FG V ++ G A K LD ++ K E E L +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-- 58
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIH--GERKNEHGNGLNFLERLNIAIDIASALD 576
+ F++ L LV + G L I+ GER GL ++ + I +
Sbjct: 59 ---AYAFESKTHLCLVMSLMNGGDLKYHIYNVGER------GLEMERVIHYSAQITCGIL 109
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
+LH + IV+ D+KP N+LLD+ ++ D GLA L + + G+ G
Sbjct: 110 HLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-------KTITQRAGTNG 159
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
Y+ PE E S D ++ G + E+ G +P
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-07
Identities = 29/83 (34%), Positives = 48/83 (57%), Gaps = 1/83 (1%)
Query: 7 LGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGT 66
LGL + L G IP D+ KL +L N N G IP SL ++T+++++ +++N G+
Sbjct: 423 LGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 67 VPPGLGNLPFLKMYNIGFNKIVG 89
+P LG L L++ N+ N + G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSG 504
|
Length = 623 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 34/116 (29%), Positives = 57/116 (49%), Gaps = 10/116 (8%)
Query: 567 IAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSIS 626
++I + L YL + I+H D+KP NIL++ K+ DFG++ L++ + N
Sbjct: 108 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---- 161
Query: 627 STHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV 682
G+ Y+ PE G S D++S G+ L+E+ G P A E+ L+
Sbjct: 162 ----FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM 213
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 56/174 (32%), Positives = 98/174 (56%), Gaps = 8/174 (4%)
Query: 188 NQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL 247
+ +P++L L L+ + SG + + + N L S+DL+ N+L NI E+L
Sbjct: 56 SNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELL 113
Query: 248 SLSSLTTIVNLSKNFLDGTLPEEIGMLG-NVVTIDLSANGLSGNLPNSFKNCKSLEKLLM 306
L++LT++ + N D +P IG+L N+ +DLS N + +LP+ +N +L+ L +
Sbjct: 114 ELTNLTSLDLDNNNITD--IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170
Query: 307 ANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
+ N S +P +L+ L L LDLS NK+S +P +++ L AL L+L+ N++
Sbjct: 171 SFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII 222
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 1e-06
Identities = 24/59 (40%), Positives = 33/59 (55%)
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKL 238
L+SLDL+ N+++ L L +DLSGN L S P +F +L S+DLS N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 38/167 (22%)
Query: 463 IGSGSFGSVYKG-YLREGISVAVKVL-----DIESTGTWKSFFAECEALRN-TRHRNLVK 515
IG G+F V K + G A+K + +E E +ALR + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN----LREIQALRRLSPHPNILR 62
Query: 516 LI-------TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568
LI T LALV+E L + +L + I G ++ L +
Sbjct: 63 LIEVLFDRKTGR----------LALVFE-LMDMNLYELIKGRKRP-----LPEKRVKSYM 106
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615
+ +LD++H + I H D+KP NIL+ +D K+ DFG R +
Sbjct: 107 YQLLKSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGI 149
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 25/162 (15%)
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
+ N +KL S ++L + L+ +++ +G L D + E K L+ E I
Sbjct: 68 NPNFIKLYYSVTTLK----GHV-LIMDYIKDGDLFDLLKKEGK------LSEAEVKKIIR 116
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT-AKVGDFGLARSLLERIGNQSSISST 628
+ AL+ LH I+H D+K N+L D + D+GL + IG S
Sbjct: 117 QLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK----IIGTPS----- 164
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G++ Y PE G + D ++ GV+ E+ TG P
Sbjct: 165 -CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 33/116 (28%), Positives = 56/116 (48%), Gaps = 10/116 (8%)
Query: 567 IAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSIS 626
++I + L YL + I+H D+KP NIL++ K+ DFG++ L++ + N
Sbjct: 108 VSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---- 161
Query: 627 STHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV 682
G+ Y+ PE G S D++S G+ L+E+ G P A E+ +
Sbjct: 162 ----FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI 213
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 28/86 (32%), Positives = 47/86 (54%), Gaps = 6/86 (6%)
Query: 41 GKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITS 100
G IP + L ++Q I ++ N + G +PP LG++ L++ ++ +N GS E L +TS
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 101 LTNSTRLNFLAFDGNQFEGEIPESIG 126
L LN +GN G +P ++G
Sbjct: 492 L---RILN---LNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 54/172 (31%), Positives = 80/172 (46%), Gaps = 22/172 (12%)
Query: 463 IGSGSFGSVYKGYLR-EGISVAVKVL---DIESTGTWKSFFAECEALRNTRHRNLVKLIT 518
I G+FG VY G + AVKV+ D+ + AE +AL ++ +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIH--GERKNEHGNGLNFLERLNIAIDIASALD 576
S S + + LV E+L G + +H G E + I+ ++A ALD
Sbjct: 72 SLQSANN-----VYLVMEYLIGGDVKSLLHIYGYFDEE-------MAVKYIS-EVALALD 118
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
YLH I+H DLKP N+L+ + K+ DFGL++ L R N I +T
Sbjct: 119 YLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTT 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 37/112 (33%), Positives = 59/112 (52%), Gaps = 18/112 (16%)
Query: 565 LNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQS 623
L+ + +A + +L + +C +H DL NILL K+ DFGLAR I N S
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD----IRNDS 268
Query: 624 SISSTHVLKGS----IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ +V+KG+ + ++ PE + DV+S+G++L EIF+ G SP
Sbjct: 269 N----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 75/311 (24%), Positives = 130/311 (41%), Gaps = 74/311 (23%)
Query: 456 NFSHENLIGSGSFGSV-YKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRN-- 512
+F +IG G+FG V G A+K L ++S K A +A R+ +
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 513 --LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDW-IHGERKNEHGNGLNFLERLNIAI 569
+V L S F++ ++L L+ EFL G L I + +E + R +A
Sbjct: 61 PWVVSLYYS-----FQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED------VTRFYMA- 108
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA------------RSLLE 617
+ A++ +H ++ +H D+KP NIL+D K+ DFGL+ + LL+
Sbjct: 109 ECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 618 RIGNQS-----------SISSTHVLKGSIG------------------YIPPEYGLGEKP 648
N++ SI+ T K I YI PE L +
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225
Query: 649 STAGDVYSFGVMLLEIFTGMSP-----THESFAGEVSLVKWVES-NFPKNAQQVLDRE-- 700
D +S G ++ E G P +HE++ ++ W E+ FP + ++ E
Sbjct: 226 GQECDWWSLGAIMFECLIGWPPFCSENSHETYR---KIINWRETLYFPDDIHLSVEAEDL 282
Query: 701 LRQLMMSSESQ 711
+R+L+ ++E++
Sbjct: 283 IRRLITNAENR 293
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 64/226 (28%), Positives = 96/226 (42%), Gaps = 31/226 (13%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSF-FAECEALRNTRHRNLV 514
+F +IG G+FG V L+ A KV ++ W+ AE R R LV
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKN----ADKVFAMKILNKWEMLKRAETACFREERDV-LV 56
Query: 515 ----KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHG-ERKNEHGNGLNFLERLNIAI 569
+ IT+ F++ L LV ++ G L + E + +L + IAI
Sbjct: 57 NGDNQWITTLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI 115
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
D L Y VH D+KP NIL+D + ++ DFG L+E QSS++
Sbjct: 116 DSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-- 164
Query: 630 VLKGSIGYIPPEY--GLGEKPSTAG---DVYSFGVMLLEIFTGMSP 670
G+ YI PE + + G D +S GV + E+ G +P
Sbjct: 165 ---GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 61/255 (23%), Positives = 104/255 (40%), Gaps = 33/255 (12%)
Query: 463 IGSGSFGSVY-----KGYLREGISV--AVKVLDIESTGTWKSFFAECEALRNTRHRNLVK 515
+G GSFG+VY K E + V + V ++ T ++ E + L H +VK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575
S F + ++ E+ L + + N + I + +
Sbjct: 67 FHAS-----FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSEN--QVCEWFIQLLLGV 119
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
Y+H + I+H DLK NI L ++ K+GDFG++R L+ S G+
Sbjct: 120 HYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLM------GSCDLATTFTGTP 169
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL---VKWVESNFPKN 692
Y+ PE + + D++S G +L E M +F G+ L ++ VE P +
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYE----MCCLAHAFEGQNFLSVVLRIVEGPTP-S 224
Query: 693 AQQVLDRELRQLMMS 707
+ R+L +M S
Sbjct: 225 LPETYSRQLNSIMQS 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 45/230 (19%)
Query: 463 IGSGSFGSVYKGYLR-------------EGISVAVKVLDIESTGTWKSFFAECEALRNTR 509
+G G+ +Y G L + I V +KVLD +FF +R
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
H+++V L C D +N+ +V EF+ G L ++H RK++ L + +A
Sbjct: 63 HKHIVLLYGVCVR-DVENI----MVEEFVEFGPLDLFMH--RKSDV---LTTPWKFKVAK 112
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT-------AKVGDFGLARSLLERIGNQ 622
+ASAL YL + +VH ++ NILL + K+ D G+ ++L R Q
Sbjct: 113 QLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---Q 166
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEI-FTGMSP 670
+ I +I PE K S A D +SFG L EI + G P
Sbjct: 167 ECVER-------IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 24/69 (34%), Positives = 37/69 (53%), Gaps = 1/69 (1%)
Query: 7 LGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGT 66
+ L+ N + G IP +G + +L + +N F G IP SL LT+++I+ + N L G
Sbjct: 447 INLSGNSIRGNIPPSLGS-ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505
Query: 67 VPPGLGNLP 75
VP LG
Sbjct: 506 VPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 40/234 (17%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE---GISVAVKVLDIESTGTWK--SFFAECEALRNTRH 510
+F ++L+G G FG V +RE G A+KV+ + SFF E
Sbjct: 2 DFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEE--------E 51
Query: 511 RNLVKLITS--CSSLD--FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLN-FLERL 565
R+++ + S L F++ + L LV E+ G L + N + + + + +
Sbjct: 52 RDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-----NRYEDQFDEDMAQF 106
Query: 566 NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSI 625
+A ++ A+ +H ++ VH D+KP N+L+D K+ DFG A L N+
Sbjct: 107 YLA-ELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARL---TANKMVN 159
Query: 626 SSTHVLKGSIGYIPPEY--GL-GEKPSTAG---DVYSFGVMLLEIFTGMSPTHE 673
S V G+ YI PE + G+ T G D +S GV+ E+ G SP HE
Sbjct: 160 SKLPV--GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 459 HENL--IGSGSFGSV---YKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNL 513
++NL IGSG+ G V Y L +++ ++ K + E ++ H+N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 514 VKLITSCS-SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+ L+ + + + + LV E + + +L I E +E + L + +
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLY--------QML 129
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
+ +LH+ I+H DLKP NI++ D T K+ DFGLAR+ S + + +V+
Sbjct: 130 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTSFMMTPYVV- 180
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEI 664
+ Y PE LG D++S G ++ E+
Sbjct: 181 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLD--IESTGTWKSFFAECEALRNTRHRNLVKLITS 519
IG G++G V E VA+K + ++ K E + LR+ H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGER--KNEHGNGLNFLERLNIAIDIASALDY 577
+ + +VYE L + L I + ++H FL +L L Y
Sbjct: 73 MPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQ--YFLYQL------LRGLKY 123
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
+H+ ++H DLKP N+LL+ + K+ DFGLAR+ E+ + T Y
Sbjct: 124 IHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR------WY 174
Query: 638 IPPEYGLG-EKPSTAGDVYSFGVMLLEIFT 666
PE L + +TA DV+S G + E+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 459 HENL--IGSGSFGSV---YKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNL 513
++NL IGSG+ G V Y L +++ ++ K + E ++ H+N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 514 VKLI---TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
+ L+ T SL+ + + +V E + + +L I E +E + L +
Sbjct: 86 IGLLNVFTPQKSLE--EFQDVYIVMELM-DANLCQVIQMELDHERMSYLLY--------Q 134
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
+ + +LH+ I+H DLKP NI++ D T K+ DFGLAR+ S + + +V
Sbjct: 135 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTSFMMTPYV 186
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG 667
+ + Y PE LG D++S G ++ E+ G
Sbjct: 187 V--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 457 FSHENL-IGSGSFGSVYKGYLREGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLV 514
F +E +G G++G VYK ++G L IE TG S E LR +H N++
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 515 KLITS-CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL---NIAID 570
L S D K + L++++ L I R ++ L R ++
Sbjct: 62 ALQKVFLSHSDRK----VWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILL----DEDMTAKVGDFGLAR---SLLERIGNQS 623
I + YLH + ++H DLKP NIL+ E K+ D G AR S L+ + +
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 624 SISSTHVLKGSIGYIPPEYGLGEKPST-AGDVYSFGVMLLEIFT 666
+ T Y PE LG + T A D+++ G + E+ T
Sbjct: 174 PVVVT------FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 457 FSHENL-IGSGSFGSVYKGYLREGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLV 514
F +E +G G++G VYK ++G L IE TG S E LR +H N++
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 515 KLITS-CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER---LNIAID 570
L S D K + L++++ L I R ++ L R ++
Sbjct: 62 SLQKVFLSHADRK----VWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILL----DEDMTAKVGDFGLAR---SLLERIGNQS 623
I + YLH + ++H DLKP NIL+ E K+ D G AR S L+ + +
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 624 SISSTHVLKGSIGYIPPEYGLGEKPST-AGDVYSFGVMLLEIFT 666
+ T Y PE LG + T A D+++ G + E+ T
Sbjct: 174 PVVVT------FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
I L YLH+ I+H D+KPGN+L++ + K+ DFGLAR +E ++S + V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR--VEEP-DESKHMTQEV 165
Query: 631 LKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
+ Y PE +G + ++A D++S G + E+
Sbjct: 166 VTQY--YRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 45/189 (23%), Positives = 83/189 (43%), Gaps = 46/189 (24%)
Query: 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI--------AIDIASALD 576
F++ ++L +V E++ G L +N + ++ ++ ALD
Sbjct: 112 FQDDKYLYMVMEYMPGGDL---------------VNLMSNYDVPEKWAKFYTAEVVLALD 156
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
+H+ + ++H D+KP N+LLD+ K+ DFG + +++ + G+
Sbjct: 157 AIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-----DETGMVRCDTAVGTPD 208
Query: 637 YIPPEYGLGEKPSTAGDVY--------SFGVMLLEIFTGMSPTH-ESFAGEVSLVKWVES 687
YI PE S GD Y S GV L E+ G +P + +S G S + ++
Sbjct: 209 YISPEV----LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN 264
Query: 688 --NFPKNAQ 694
NFP++ +
Sbjct: 265 SLNFPEDVE 273
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 15/114 (13%)
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS-------LLE 617
L+I I + ++Y+H+ ++H DLKP NILL + D+G A LL+
Sbjct: 116 LSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 618 RIGNQSSISSTHVLK-----GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
++ +I + + G+ Y+ PE LG S + D+Y+ GV+L ++ T
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 70/291 (24%), Positives = 109/291 (37%), Gaps = 64/291 (21%)
Query: 463 IGSGSFGSV-YKGYLREGISVAVKVL---DIESTGTWKSFFAECEALRNTRHRNLVKLIT 518
+G G+FG V + A+K L D+ + AE + L + +VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDW-IHGERKNEHGNGLNFLERLNIAIDIASALDY 577
S F++ + L V +++ G + I E E L R IA ++ A++
Sbjct: 69 S-----FQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV------LARFYIA-ELTLAIES 116
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA------------------------- 612
+H ++ +H D+KP NIL+D D K+ DFGL
Sbjct: 117 VH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 613 ----------------RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYS 656
++L +R Q H L G+ YI PE L + + D +S
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 657 FGVMLLEIFTGMSPTHESFAGEVSL--VKWVESNFPKNAQQVLDRELRQLM 705
GV+L E+ G P E L + W E+ Q L E L+
Sbjct: 234 VGVILFEMLVGQPPFLAPTPTETQLKVINW-ENTLHIPPQVKLSPEAVDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 460 ENLIGSGSFGSVYKGY-LREGISVAVK-VLDI-ESTGTWKSFFAECEALRNTRHRNLVK- 515
+ +IG GS+G V G VA+K + D+ E E + LR RH ++V+
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64
Query: 516 --LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHG--ERKNEHGNGLNFLERLNIAIDI 571
++ S +FK+ + +V+E + + L I + EH FL +L
Sbjct: 65 KHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHHQ--FFLYQL------ 112
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
AL Y+H + H DLKP NIL + D K+ DFGLAR ++I T +
Sbjct: 113 LRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP--TAIFWTDYV 167
Query: 632 KGSIGYIPPEY--GLGEKPSTAGDVYSFGVMLLEIFTG 667
+ Y PE K + A D++S G + E+ TG
Sbjct: 168 -ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 37/229 (16%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISV-AVKVLDIESTGTWKSF-FAECEALRNTRHRNL 513
+F +IG G+FG V ++ + A+K+L+ W+ AE R R+
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-----KWEMLKRAETACFREERN--- 53
Query: 514 VKLITSCSSLD-----FKNMEFLALVYEFLGNGSLGDWIHG-ERKNEHGNGLNFLERLNI 567
V + C + F++ +L LV ++ G L + E + ++ + +
Sbjct: 54 VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL 113
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
AI L Y VH D+KP N+LLD + ++ DFG + + QSS++
Sbjct: 114 AIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV 164
Query: 628 THVLKGSIGYIPPEY------GLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ YI PE G+G K D +S GV + E+ G +P
Sbjct: 165 -----GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 45/154 (29%), Positives = 65/154 (42%), Gaps = 43/154 (27%)
Query: 543 LGDWI--HGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE 600
L DWI HG + H I ALDY H E+ ++H DLKP NIL++
Sbjct: 218 LLDWIMKHGPFSHRH--------LAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMET 267
Query: 601 DMTA----------------KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE--Y 642
T ++ D G ER + +S+ H Y PE
Sbjct: 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCD--ERHSRTAIVSTRH-------YRSPEVVL 318
Query: 643 GLGEKPSTAGDVYSFGVMLLEIFTG--MSPTHES 674
GLG ST D++S G ++ E++TG + TH++
Sbjct: 319 GLGWMYST--DMWSMGCIIYELYTGKLLYDTHDN 350
|
Length = 467 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 462 LIGSGSFGSVYKGYLREGISV-AVKVL---DIESTGTWKSFFAECEALRNTRHRNLVKLI 517
+IG G+FG V ++ V A+K+L ++ F E + L N R + L
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL- 66
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIH--GERKNEHGNGLNFLERLNIAIDIASAL 575
F++ L LV ++ G L + +R E + R +A ++ A+
Sbjct: 67 ----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED------MARFYLA-EMVLAI 115
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
D +H ++ VH D+KP N+LLD++ ++ DFG S L + + + S+ V G+
Sbjct: 116 DSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFG---SCLRLLADGTVQSNVAV--GTP 167
Query: 636 GYIPPEY------GLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
YI PE G G + D +S GV + E+ G +P
Sbjct: 168 DYISPEILQAMEDGKG-RYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 38/142 (26%), Positives = 63/142 (44%), Gaps = 19/142 (13%)
Query: 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCD 590
L+L+ E+ G L + + E+ L+F +L++AID L L+ P + +
Sbjct: 97 LSLILEYCTRGYLREVLDKEKD------LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148
Query: 591 LKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG--EKP 648
L + L+ E+ K+ GL + L SS +V + Y + +
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKIL-------SSPPFKNV--NFMVYFSYKMLNDIFSEY 199
Query: 649 STAGDVYSFGVMLLEIFTGMSP 670
+ D+YS GV+L EIFTG P
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 41/200 (20%)
Query: 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEV 584
F++ +L +V E++ G L + + E R A ++ ALD +H+ +
Sbjct: 112 FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK------WARFYTA-EVVLALDAIHS---M 161
Query: 585 PIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL 644
+H D+KP N+LLD+ K+ DFG + N+ + G+ YI PE
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-----NKEGMVRCDTAVGTPDYISPEV-- 214
Query: 645 GEKPSTAGDVY--------SFGVMLLEIFTGMSPTH-ESFAGEVS--------LVKWVES 687
S GD Y S GV L E+ G +P + +S G S L ++
Sbjct: 215 --LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272
Query: 688 NFPKNAQQVL-----DRELR 702
+ K A+ ++ DRE+R
Sbjct: 273 DISKEAKNLICAFLTDREVR 292
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 43/177 (24%), Positives = 66/177 (37%), Gaps = 48/177 (27%)
Query: 562 LERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA--------- 612
L R IA ++ A++ +H ++ +H D+KP NIL+D D K+ DFGL
Sbjct: 102 LARFYIA-ELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 613 --------------------------------RSLLERIGNQSSISSTHVLKGSIGYIPP 640
+ L R Q H L G+ YI P
Sbjct: 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAP 217
Query: 641 EYGLGEKPSTAGDVYSFGVMLLEIFTGMSP--THESFAGEVSLVKWVES-NFPKNAQ 694
E L + D +S GV+L E+ G P ++ ++ W S + P A+
Sbjct: 218 EVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAK 274
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 10/74 (13%)
Query: 543 LGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPI---VHCDLKPGNILLD 599
L +WI GE +E ++ E+ +IA +A L LH ++P+ H DL PGNIL+D
Sbjct: 71 LMEWIEGETLDE----VSEEEKEDIAEQLAELLAKLH---QLPLLVLCHGDLHPGNILVD 123
Query: 600 EDMTAKVGDFGLAR 613
+ + D+ A
Sbjct: 124 DGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 20/60 (33%), Positives = 31/60 (51%)
Query: 276 NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKL 335
N+ ++DLS N L+ +FK +L+ L ++ N + P + L L LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 2e-04
Identities = 22/61 (36%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 155 SLTLLNLSYNSISGEILTEI-GQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNE 213
+L L+LS N ++ I L L+ LDL+GN ++ P L L +DLSGN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 214 L 214
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 37/148 (25%), Positives = 62/148 (41%), Gaps = 20/148 (13%)
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
L I + A+ YLH + I+H D+K NI ++ +GDFG A ++ N+
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-- 239
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE--SFAGEVSLV 682
+ G+I PE + A D++S G++L E+ T E G+
Sbjct: 240 ---YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSD 296
Query: 683 KWVE----------SNFPKNAQQVLDRE 700
+ ++ + FP +AQ LD
Sbjct: 297 RQIKLIIRRSGTHPNEFPIDAQANLDEI 324
|
Length = 391 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 59/248 (23%), Positives = 93/248 (37%), Gaps = 56/248 (22%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVLDI------ESTGTWKSFFAECEALRNTRHRNLV 514
+IG G+FG V ++ G A+K L E + AE + L + +V
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVR---AERDILAEADNPWVV 64
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
KL S F++ +L L+ E+L G + + + ++ +AID
Sbjct: 65 KLYYS-----FQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK 119
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA-------RSLLERIGNQSSISS 627
L Y+H D +KP N+LLD K+ DFGL R+ RI + + S+
Sbjct: 120 LGYIHRD---------IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 628 THVLK-------------------------GSIGYIPPEYGLGEKPSTAGDVYSFGVMLL 662
G+ YI PE L + D +S GV++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 663 EIFTGMSP 670
E+ G P
Sbjct: 231 EMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 3e-04
Identities = 18/59 (30%), Positives = 29/59 (49%)
Query: 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQI 190
L L + NR + L +L +L+LS N+++ L L+SLDL+GN +
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 72/275 (26%), Positives = 110/275 (40%), Gaps = 56/275 (20%)
Query: 482 VAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNG 541
V +KVLD +FF + H +L + C + E + +V EF+ +G
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVC----VRGSENI-MVEEFVEHG 101
Query: 542 SLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD-- 599
L + E+ + ++ +A +ASAL YL + +VH ++ NILL
Sbjct: 102 PLDVCLRKEKGR-----VPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153
Query: 600 --EDMTA---KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE-YGLGEKPSTAGD 653
+ T+ K+ D G++ + L R V + I +I PE G STA D
Sbjct: 154 GLAEGTSPFIKLSDPGVSFTALSR--------EERVER--IPWIAPECVPGGNSLSTAAD 203
Query: 654 VYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTI 713
+SFG LLEI F GEV L + P ++ +++ R S +
Sbjct: 204 KWSFGTTLLEI---------CFDGEVPL----KERTPSEKERFYEKKHRLPEPSCKE--- 247
Query: 714 QLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748
L T+I C T P R R LR L
Sbjct: 248 -----LATLIS----QCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 29/102 (28%), Positives = 46/102 (45%), Gaps = 12/102 (11%)
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
A ++ ALD LH IV DL P NILLD+ ++ F + + ++ + +
Sbjct: 91 AAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEA-VEN 146
Query: 628 THVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMS 669
Y PE G + + A D +S G +L E+ TG +
Sbjct: 147 M--------YCAPEVGGISEETEACDWWSLGAILFELLTGKT 180
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 45/186 (24%), Positives = 79/186 (42%), Gaps = 3/186 (1%)
Query: 195 PNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTT 254
NTL + N + + P S + + L+ + + LS
Sbjct: 14 SNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLD 73
Query: 255 IVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGP 314
+++ S E + L + ++DL+ N L N+ + +L L + NN +
Sbjct: 74 LLSPSGI-SSLDGSENLLNLLPLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNITDI 131
Query: 315 IPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSM 374
P I L+ LDLS NK+ S+PS L+NL L++L+L+FN+L + + +
Sbjct: 132 PPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNN 190
Query: 375 VHLEGN 380
+ L GN
Sbjct: 191 LDLSGN 196
|
Length = 394 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 37/117 (31%), Positives = 55/117 (47%), Gaps = 21/117 (17%)
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
++ ALD +H+ + +H D+KP N+LLD+ K+ DFG + ++ N T
Sbjct: 150 EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMDANGMVRCDTA 203
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVY--------SFGVMLLEIFTGMSPTH-ESFAG 677
V G+ YI PE S GD Y S GV L E+ G +P + +S G
Sbjct: 204 V--GTPDYISPEVLK----SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 8e-04
Identities = 46/199 (23%), Positives = 66/199 (33%), Gaps = 56/199 (28%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVL--DIESTGTWKSFFAECEALR-----------NTR 509
I S S V++ L+ G VAVKV I A+ + LR R
Sbjct: 133 IASASIAQVHRAVLKSGEEVAVKVQRPGIRER-----IEADLKLLRRLARLIKRLPPGGR 187
Query: 510 HRNLVKLITSCSS-----LDF----KNMEFLAL------------VYEFLGNGSL--GDW 546
+LV+++ LD+ N E VY + +W
Sbjct: 188 RLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEW 247
Query: 547 IHG------ERKNEHGNGLNFLERLNIAIDIASA-LDYLHNDCEVPIVHCDLKPGNILLD 599
I G G ++R +A + A L L D H D PGNIL+
Sbjct: 248 IDGIKISDIAALKSAG-----IDRKELAELLVRAFLRQLLRD---GFFHADPHPGNILVR 299
Query: 600 EDMTAKVGDFGLARSLLER 618
D + DFG+ L +
Sbjct: 300 SDGRIVLLDFGIVGRLDPK 318
|
Length = 517 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 60/220 (27%), Positives = 82/220 (37%), Gaps = 64/220 (29%)
Query: 456 NFSHENLIGSGSFGSVYKGYL------REGISVAVKVLDIESTGTWKSFFAECEALRNTR 509
+F +G G+FG VYK L +EG V K + + E N R
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE----------YGAVEIWMNER 182
Query: 510 HRNLVKLITSCS--------SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNF 561
R SC+ + K + LV+ + G +L D + + K N +
Sbjct: 183 VRRACP--NSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLM--QSKEFPYNVEPY 238
Query: 562 L-----------ERLNIAI-----DIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-TA 604
L ER N I I ALD LH+ IVH D+KP NI+ E +
Sbjct: 239 LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSEGSGSF 295
Query: 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL 644
K+ D G A L R+G I YIP E+ L
Sbjct: 296 KIIDLGAAADL--RVG--------------INYIPKEFLL 319
|
Length = 566 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 18/76 (23%), Positives = 28/76 (36%), Gaps = 26/76 (34%)
Query: 463 IGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522
I + S V++ L++G VAVKV + K I S
Sbjct: 19 IAAASIAQVHRAVLKDGEEVAVKVQ----------------------RPGVKKRIRS--- 53
Query: 523 LDFKNMEFLALVYEFL 538
D K ++FLA + +
Sbjct: 54 -DLKLLKFLAKILKKF 68
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 58/248 (23%), Positives = 92/248 (37%), Gaps = 47/248 (18%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVL---DIESTGTWKSFFAECEALRNTRHR 511
+F +IG G+FG V ++ G A+K+L D+ AE + L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
+VK+ S F++ L L+ EFL G + + + ++ +AID
Sbjct: 62 WVVKMFYS-----FQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE-------------- 617
L ++H D +KP N+LLD K+ DFGL L +
Sbjct: 117 IHQLGFIHRD---------IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167
Query: 618 ----RIGNQSSISSTHVLK-----------GSIGYIPPEYGLGEKPSTAGDVYSFGVMLL 662
N +S K G+ YI PE + + D +S GV++
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 663 EIFTGMSP 670
E+ G P
Sbjct: 228 EMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 58/248 (23%), Positives = 92/248 (37%), Gaps = 47/248 (18%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVL---DIESTGTWKSFFAECEALRNTRHR 511
+F +IG G+FG V ++ G A+K+L D+ AE + L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
+VK+ S F++ L L+ EFL G + + + ++ +AID
Sbjct: 62 WVVKMFYS-----FQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE-------------- 617
L ++H D +KP N+LLD K+ DFGL L +
Sbjct: 117 IHQLGFIHRD---------IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 618 ----RIGNQSSISSTHVLK-----------GSIGYIPPEYGLGEKPSTAGDVYSFGVMLL 662
N +S K G+ YI PE + + D +S GV++
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 663 EIFTGMSP 670
E+ G P
Sbjct: 228 EMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 767 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.52 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.47 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.32 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.23 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.23 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.22 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.21 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.18 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.15 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.98 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.91 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.86 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.83 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.81 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.77 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.68 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.66 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.64 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-86 Score=794.71 Aligned_cols=709 Identities=29% Similarity=0.496 Sum_probs=490.0
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
|++|++|+|++|++++.+|..+. .+++|++|++++|.+.+.+|..++++++|++|+|++|.+.+.+|..+.++++|++|
T Consensus 211 l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 289 (968)
T PLN00113 211 MKSLKWIYLGYNNLSGEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISL 289 (968)
T ss_pred cCCccEEECcCCccCCcCChhHh-cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEE
Confidence 35566666666666666665554 36666666666666666666666666666666666666666666666666666666
Q ss_pred eecCccccCCCCCCc------------------cccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcc
Q 004218 81 NIGFNKIVGSGDEGL------------------SFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRF 142 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~------------------~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i 142 (767)
++++|.+.+..+..+ ..+..+.++++|+.|++++|++.+.+|..++.+.+ |+.|++++|++
T Consensus 290 ~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~-L~~L~Ls~n~l 368 (968)
T PLN00113 290 DLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN-LTVLDLSTNNL 368 (968)
T ss_pred ECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCC-CcEEECCCCee
Confidence 666665543110000 12233444444555555555554445554544444 55555555555
Q ss_pred cccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccc
Q 004218 143 YGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSF 222 (767)
Q Consensus 143 ~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 222 (767)
.+.+|..+..+++|+.|++++|.+.+..|..+..+++|++|++++|++++..|..|..+++|+.|++++|.+++..+..+
T Consensus 369 ~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 448 (968)
T PLN00113 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448 (968)
T ss_pred EeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhh
Confidence 54555555555555555555555555555556666666666666666666666666666777777777777766666666
Q ss_pred cCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccc
Q 004218 223 GNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLE 302 (767)
Q Consensus 223 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~ 302 (767)
..+++|+.|++++|++.+.+|..+ ..++| +.+++++|++++..|..+..+++|+.|+|++|.+.+.+|..+..+++|+
T Consensus 449 ~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L-~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 526 (968)
T PLN00113 449 WDMPSLQMLSLARNKFFGGLPDSF-GSKRL-ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526 (968)
T ss_pred ccCCCCcEEECcCceeeeecCccc-ccccc-eEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCC
Confidence 667777777777777766666544 34555 4458999999999999999999999999999999999999999999999
Q ss_pred eeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCccccccccccccCCcC
Q 004218 303 KLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPK 382 (767)
Q Consensus 303 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~ 382 (767)
.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|++++|++++.+|..+.+..+....+.|||.
T Consensus 527 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~ 606 (968)
T PLN00113 527 SLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNID 606 (968)
T ss_pred EEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999888888888888999999
Q ss_pred ccccC------CCCCCCCCCcceeeehhhHHHHHHHHHHHH-HHHHHHhHcCCC--CCCCc-ccccc------CCCCccC
Q 004218 383 LCLHL------GCENSSSHGRRRIIIYIIVAIIAIIAGCFL-IFWLIIVRKGKA--KPIGV-STLFK------HSPQMIS 446 (767)
Q Consensus 383 ~c~~~------~c~~~~~~~~~~~~~~i~~~~~~~i~~~~~-~~~~~~~r~~~~--~~~~~-~~~~~------~~~~~~~ 446 (767)
.|+.. +|..... .. ..+++++++++++++++++ +++++++++++. +.... ..... .....++
T Consensus 607 lc~~~~~~~~~~c~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (968)
T PLN00113 607 LCGGDTTSGLPPCKRVRK-TP-SWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSIT 684 (968)
T ss_pred ccCCccccCCCCCccccc-cc-eeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhh
Confidence 99743 3532211 11 1222222222222222222 222222322211 11100 00000 0011233
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc
Q 004218 447 YDELRRATGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF 525 (767)
Q Consensus 447 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 525 (767)
++++ ...|+..+.||+|+||.||+|+. .++..||||.+..... ...+|++++++++||||++++++|..
T Consensus 685 ~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~--- 754 (968)
T PLN00113 685 INDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS--- 754 (968)
T ss_pred HHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc---
Confidence 3333 35678888999999999999997 4689999998853322 22356889999999999999999754
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
....++||||+++|+|.++++. ++|.++.+++.|+++|++|||..+.++|+||||||+||+++.++.++
T Consensus 755 --~~~~~lv~Ey~~~g~L~~~l~~---------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~ 823 (968)
T PLN00113 755 --EKGAYLIHEYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH 823 (968)
T ss_pred --CCCCEEEEeCCCCCcHHHHHhc---------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceE
Confidence 3456999999999999999952 88999999999999999999966556999999999999999998888
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 685 (767)
+. ||.+..... .....||..|+|||++.+..++.++|||||||++|||+||+.||+..........+|.
T Consensus 824 ~~-~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~ 892 (968)
T PLN00113 824 LR-LSLPGLLCT----------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA 892 (968)
T ss_pred EE-ecccccccc----------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHH
Confidence 75 655433211 0123578999999999999999999999999999999999999976555555566666
Q ss_pred hhhcccc-hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 686 ESNFPKN-AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 686 ~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
...+... .....++.+...... ..++..++++ ++.+||+.||++||||+|+++.|+++.+..
T Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~-l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 893 RYCYSDCHLDMWIDPSIRGDVSV-------NQNEIVEVMN-LALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHhcCccchhheeCccccCCCCc-------cHHHHHHHHH-HHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 5433321 222223222111100 1122333444 888999999999999999999999886643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=407.08 Aligned_cols=290 Identities=41% Similarity=0.669 Sum_probs=237.7
Q ss_pred CCCccCHHHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeee
Q 004218 441 SPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSC 520 (767)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 520 (767)
....|++++++.+|++|...+.||+|+||.||+|...+|+.||||++........++|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56679999999999999999999999999999999998899999988654332146699999999999999999999999
Q ss_pred ecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC
Q 004218 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE 600 (767)
Q Consensus 521 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~ 600 (767)
.+.+. ..++|||||++|+|.++++..... +++|..+.+||.++|+||+|||+.++++||||||||+|||+|+
T Consensus 141 ~e~~~----~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~ 212 (361)
T KOG1187|consen 141 LEGGE----HRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE 212 (361)
T ss_pred ecCCc----eEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence 75331 469999999999999999876531 5999999999999999999999998889999999999999999
Q ss_pred CCceEEccccchhhhhhhcCCCccccccccc-cCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcc-cCC
Q 004218 601 DMTAKVGDFGLARSLLERIGNQSSISSTHVL-KGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF-AGE 678 (767)
Q Consensus 601 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~ 678 (767)
++++||+|||+|+..... .. ..... .||.+|+|||+...+..+.|+||||||+++.|++||+.|.+... ...
T Consensus 213 ~~~aKlsDFGLa~~~~~~----~~--~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~ 286 (361)
T KOG1187|consen 213 DFNAKLSDFGLAKLGPEG----DT--SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE 286 (361)
T ss_pred CCCEEccCccCcccCCcc----cc--ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc
Confidence 999999999999654321 00 00111 69999999999999999999999999999999999999887654 334
Q ss_pred cchhhHhhhhccc-chhhhccHHHHH-hhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 679 VSLVKWVESNFPK-NAQQVLDRELRQ-LMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 679 ~~~~~~~~~~~~~-~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
..+..|+...... ...+++|+.+.. ... ..+++.+++. ++.+|++.+|.+||+|.||+++|+.+..
T Consensus 287 ~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~--------~~~~~~~~~~-~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 287 LSLVEWAKPLLEEGKLREIVDPRLKEGEYP--------DEKEVKKLAE-LALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred ccHHHHHHHHHHCcchhheeCCCccCCCCC--------hHHHHHHHHH-HHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 4578887555444 356666665542 110 0144555555 8999999999999999999999966554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-48 Score=374.23 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=203.0
Q ss_pred CCCCCccccccceEEEEEEeC-CCcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce-eeEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME-FLAL 533 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~l 533 (767)
.+..+.||+|..|+||++.++ +++.+|+|++... .+...+++.+|+++++..+||+||++||+|.. .. .+.|
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-----~~~~isI 155 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-----NGEEISI 155 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-----CCceEEe
Confidence 345578999999999999987 4889999999544 33456789999999999999999999999653 33 5899
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||++|||++++...++ +++....+|+.++++||.|||+ + +||||||||+|||++..|++||||||.+
T Consensus 156 ~mEYMDgGSLd~~~k~~g~------i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGR------IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred ehhhcCCCCHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEecccccc
Confidence 9999999999999987543 9999999999999999999996 6 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCccc---CCcchhhHhhhhc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA---GEVSLVKWVESNF 689 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~ 689 (767)
+.+.+. .....+||..|||||.+.+..|+.++||||||++++|+++|+.||..... ....+..++-...
T Consensus 227 ~~lvnS--------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 227 GILVNS--------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP 298 (364)
T ss_pred HHhhhh--------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC
Confidence 987554 22456799999999999999999999999999999999999999976422 2223333333333
Q ss_pred ccchhh-hccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQ-VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
|+..+. .+.++++. ++..||++||.+|||++|++++
T Consensus 299 pP~lP~~~fS~ef~~----------------------FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRS----------------------FVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCcccCCHHHHH----------------------HHHHHhcCCcccCCCHHHHhcC
Confidence 333322 24444333 5557999999999999999876
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=381.12 Aligned_cols=263 Identities=32% Similarity=0.459 Sum_probs=207.5
Q ss_pred CCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcc--hhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 458 SHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGT--WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 458 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
.+.+.+|+|+||+||+|.++....||||++....... .+.|.+|+.+|.+++|||||+++|+|.... ...++||
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~iVt 119 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLCIVT 119 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceEEEE
Confidence 3445599999999999999844449999996543222 568999999999999999999999986532 1579999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeecCCCCCeeeCCCC-ceEEccccchh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVP-IVHCDLKPGNILLDEDM-TAKVGDFGLAR 613 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~ 613 (767)
||+++|+|.++++..+ ...+++..+..|+.|||+|+.|||++ + ||||||||+|||++.++ ++||+|||+++
T Consensus 120 Ey~~~GsL~~~l~~~~----~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKR----KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred EeCCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 9999999999998741 24499999999999999999999999 7 99999999999999997 99999999998
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccC--CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGL--GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
...... .......||+.|||||++. ...|+.|+||||||+++|||+||+.||..... .......+....+.
T Consensus 193 ~~~~~~------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp 265 (362)
T KOG0192|consen 193 EKVISK------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRP 265 (362)
T ss_pred eecccc------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCC
Confidence 654321 1123367999999999999 56899999999999999999999999987654 22222222222222
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhhcCC
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQ 760 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~ 760 (767)
..+....+.+.. ++.+||+.||+.||++.|++..|+.+........+
T Consensus 266 ~~p~~~~~~l~~----------------------l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~ 312 (362)
T KOG0192|consen 266 PIPKECPPHLSS----------------------LMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGP 312 (362)
T ss_pred CCCccCCHHHHH----------------------HHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCc
Confidence 222223322222 56679999999999999999999999887765433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=368.45 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=200.7
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-------cchhhHHHHHHHHhcCCCCCceeEEeeeecCC
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-------GTWKSFFAECEALRNTRHRNLVKLITSCSSLD 524 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 524 (767)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||++.+... .......+|+++|++++|||||++++++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---- 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---- 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence 4567888999999999999999965 599999999964311 1223457999999999999999999995
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC---
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED--- 601 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~--- 601 (767)
...+..|+||||++||+|.+.+-..+. +.+.....+++|++.|+.|||++ ||+||||||+|||+..+
T Consensus 246 -~~~ds~YmVlE~v~GGeLfd~vv~nk~------l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 246 -EVPDSSYMVLEYVEGGELFDKVVANKY------LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED 315 (475)
T ss_pred -ecCCceEEEEEEecCccHHHHHHhccc------cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence 455566999999999999999987654 78888899999999999999999 99999999999999866
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCC---CCcccchhhhHHHHHHHhCCCCCCCcccCC
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP---STAGDVYSFGVMLLEIFTGMSPTHESFAGE 678 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 678 (767)
..+||+|||+|+..++ ...+.+.+||+.|.|||++.+... ..++|+||+||++|-+++|.+||.+.....
T Consensus 316 ~llKItDFGlAK~~g~-------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGE-------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred eEEEecccchhhcccc-------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 6799999999997643 344577899999999999987654 347899999999999999999997754433
Q ss_pred cchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 679 VSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.-..+...+.++.. +.. +..+.+-..++|.+||..||++|||++|++++
T Consensus 389 sl~eQI~~G~y~f~----------------p~~----w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 SLKEQILKGRYAFG----------------PLQ----WDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cHHHHHhcCccccc----------------Chh----hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 22222222222221 111 22222223337779999999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=384.28 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=206.1
Q ss_pred cCCCCCCccccccceEEEEEEe-CCCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.+|...+.||+|||+.||.+++ .+|+.||+|++++. .....+...+|+++.++++|||||+++++ |++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 5799999999999999999997 67999999999653 45567789999999999999999999999 678889
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+|.|+|+.++|..+++..+ ++++.++..+++||+.||.|||++ +|+|||||..|++++++.++||+|||
T Consensus 93 VYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence 999999999999999998543 499999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCC-cchhhHhhhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE-VSLVKWVESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~ 689 (767)
+|..+..+.. ...+.+||+.|.|||++....++..+||||+||++|.|+.|++||+...-.+ ..-.+.....+
T Consensus 164 LAt~le~~~E------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~ 237 (592)
T KOG0575|consen 164 LATQLEYDGE------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM 237 (592)
T ss_pred eeeeecCccc------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc
Confidence 9998754322 2356789999999999999999999999999999999999999997642111 11111111111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
|. . +..-.+++|.++|+.||.+|||+++|+.+
T Consensus 238 P~----~----------------------ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 PS----H----------------------LSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cc----c----------------------cCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11 1 11222337778999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=355.38 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=207.3
Q ss_pred cCCCCCCccccccceEEEEEE-eCCCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
..|.+.++||+|.||+||++. ..+|..||.|.+... +....+....|+.+|++++|||||+++++-. .++...+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchhh
Confidence 357788999999999999999 457999999988644 3445677889999999999999999998532 2334448
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEeecCCCCCeeeCCCCceEEcccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEV-PIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+||||||++|+|.++++..+.. .+.+++.++|+++.|++.||.++|+..+. -|+||||||.||+++.+|.+||+|||
T Consensus 96 nivmE~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 9999999999999999876543 56699999999999999999999994322 28999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh-hhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV-ESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~ 689 (767)
+++.+... ....+..+||+.||+||.+.+.+|+.++||||+||++|||+.-++||... ....+.+.+ ...+
T Consensus 174 L~r~l~s~------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 174 LGRFLSSK------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDY 245 (375)
T ss_pred hHhHhcch------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCC
Confidence 99987543 33446688999999999999999999999999999999999999999764 222222222 2234
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
|+-+.+..+..+.. ||..|+..||+.||+...++..+..
T Consensus 246 ~~~p~~~YS~~l~~----------------------li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 PPLPDEHYSTDLRE----------------------LINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCcHHHhhhHHHH----------------------HHHHHccCCcccCCCcchHHHHHHH
Confidence 33333433333322 6667999999999997666655544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=363.22 Aligned_cols=203 Identities=33% Similarity=0.552 Sum_probs=180.2
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
..++|...+.||+|+||+||+|+++. +..||||.+... ..+..+.+..|+.+|+.++|||||.+++++ ..++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence 34688899999999999999999764 899999999665 445567788999999999999999999995 4566
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC------Cc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED------MT 603 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~------~~ 603 (767)
++|+|||||.||+|.+|++..+. +++..+..++.|+|.||++||++ +||||||||+|||++.. -.
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~------l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~ 153 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGR------LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPV 153 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCce
Confidence 88999999999999999998754 99999999999999999999999 99999999999999864 46
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
+||+|||+|+.+.+. ....+.+|++.|||||++...+|+.|+|+||+|+++|+|++|+.||+....
T Consensus 154 LKIADFGfAR~L~~~-------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 154 LKIADFGFARFLQPG-------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred EEecccchhhhCCch-------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 899999999987532 233567899999999999999999999999999999999999999976443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=428.42 Aligned_cols=375 Identities=34% Similarity=0.531 Sum_probs=303.2
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
|++|++|+|++|.+++.+|..+. .+++|++|+|++|.+.+.+|..++++++|++|+|++|.+++.+|..++++++|++|
T Consensus 187 l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 265 (968)
T PLN00113 187 LTSLEFLTLASNQLVGQIPRELG-QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL 265 (968)
T ss_pred CcCCCeeeccCCCCcCcCChHHc-CcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEE
Confidence 57899999999999988998876 59999999999999999999999999999999999999999999999999999999
Q ss_pred eecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEE
Q 004218 81 NIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLN 160 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~ 160 (767)
++++|++.+ ..+..+.++++|+.|++++|++.+.+|..+..+++ |++|++++|.+.+..|..+..+++|+.|+
T Consensus 266 ~L~~n~l~~------~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~-L~~L~l~~n~~~~~~~~~~~~l~~L~~L~ 338 (968)
T PLN00113 266 FLYQNKLSG------PIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQN-LEILHLFSNNFTGKIPVALTSLPRLQVLQ 338 (968)
T ss_pred ECcCCeeec------cCchhHhhccCcCEEECcCCeeccCCChhHcCCCC-CcEEECCCCccCCcCChhHhcCCCCCEEE
Confidence 999999864 45566778888888888888888888888888877 88888888888878888888888888888
Q ss_pred CcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCC
Q 004218 161 LSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 161 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
+++|.+.+..|..+..+++|+.|++++|++.+..|..+..+++|+.|++++|++.+..|..+..+++|+.|++++|++++
T Consensus 339 L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~ 418 (968)
T PLN00113 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG 418 (968)
T ss_pred CcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeee
Confidence 88888887777778888888888888888777667666666666666666666665555555555666666666655555
Q ss_pred CCChhhcccccccceeecccccCCCCCchhhcC-----------------------CCceeEEEccCCCCCCCCCccccc
Q 004218 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGM-----------------------LGNVVTIDLSANGLSGNLPNSFKN 297 (767)
Q Consensus 241 ~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~-----------------------l~~L~~L~ls~n~l~~~~~~~~~~ 297 (767)
.+|..+..++.+ ..+++++|.+++..+..+.. .++|+.|++++|++++..|..+..
T Consensus 419 ~~p~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~ 497 (968)
T PLN00113 419 ELPSEFTKLPLV-YFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGS 497 (968)
T ss_pred ECChhHhcCCCC-CEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhh
Confidence 555555555554 22345555444444333322 356777778888888888888889
Q ss_pred CcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCC-cccccccccc
Q 004218 298 CKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE-GIFRHTSMVH 376 (767)
Q Consensus 298 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~~~ 376 (767)
+++|+.|++++|.+.+.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|++++|++++..|.. ..+..+..+.
T Consensus 498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ 577 (968)
T PLN00113 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN 577 (968)
T ss_pred hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence 999999999999999999999999999999999999999999999999999999999999999877765 4567788899
Q ss_pred ccCCcCcc
Q 004218 377 LEGNPKLC 384 (767)
Q Consensus 377 l~~Np~~c 384 (767)
+.+|+..+
T Consensus 578 ls~N~l~~ 585 (968)
T PLN00113 578 ISHNHLHG 585 (968)
T ss_pred ccCCccee
Confidence 99998765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=340.42 Aligned_cols=272 Identities=21% Similarity=0.299 Sum_probs=199.7
Q ss_pred cCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
+.|+...++|+|+||.||++++++ |+.||||++... ++...+-.++|+++|++++|||+|.++++ |+....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence 457788899999999999999876 999999999432 22334567899999999999999999999 5677889
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++|+|||+. ++.+-++... .+++...+.++++|++.|+.|+|++ +++||||||+||+++.+|.+||||||+
T Consensus 77 hLVFE~~dh-TvL~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYP-----NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred EEEeeecch-HHHHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence 999999988 5555554443 3499999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhH--hhhh
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW--VESN 688 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~ 688 (767)
|+.+.... ...+..+.|.+|+|||.+.+ .+|+..+||||.||++.||++|.+-|.+...-+. +... .-+.
T Consensus 148 AR~L~~pg------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-Ly~I~ktLG~ 220 (396)
T KOG0593|consen 148 ARTLSAPG------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-LYLIRKTLGN 220 (396)
T ss_pred hHhhcCCc------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-HHHHHHHHcc
Confidence 99875321 12244568999999999887 6899999999999999999999998865433221 1111 1111
Q ss_pred cccchhhhccH--HHHHhhhcc---hhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDR--ELRQLMMSS---ESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~--~l~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+.+...+++.. .+....-.. .+....-...+...+-+++..|++.||++|++.+|++.+
T Consensus 221 L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 221 LIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 21111111110 000000000 011111111122334447779999999999999998864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=348.69 Aligned_cols=201 Identities=35% Similarity=0.482 Sum_probs=179.8
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
...|++.++||+|+||.||.++.++ ++.+|+|++++. .....+...+|..+|.+++||.||+++.. |++.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence 4578999999999999999999664 899999999654 33456778899999999999999999987 67888
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+|+|+||+.||.|..++++.+. +++..+.-++..|+.||.|||+. |||||||||+|||+|.+|+++|+||
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~------F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGR------FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCC------cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence 99999999999999999987654 99999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|+++..... ...+.+++||+.|||||++.+..|+.++|+||+|+++|||++|.+||...
T Consensus 170 gL~k~~~~~------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 170 GLCKEDLKD------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred ccchhcccC------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 999854322 22345689999999999999999999999999999999999999999663
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=363.29 Aligned_cols=257 Identities=31% Similarity=0.431 Sum_probs=210.1
Q ss_pred CCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
.++.++.||+|.||.||.|.++...+||+|.+... .-..+.|.+|+++|++++|++||+++++|... +.++|||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEEE
Confidence 34556889999999999999997779999998643 33457888999999999999999999998642 2579999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
|||+.|+|.++++... +..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+..
T Consensus 281 E~m~~GsLl~yLr~~~----~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTRE----GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EecccCcHHHHhhhcC----CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence 9999999999998732 34589999999999999999999999 9999999999999999999999999999955
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchh
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
.++...... ...-...|.|||.+..+.++.||||||||++||||+| |+.||.... .....+.+...++-..+
T Consensus 354 ~d~~Y~~~~-----~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--n~ev~~~le~GyRlp~P 426 (468)
T KOG0197|consen 354 GDDEYTASE-----GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--NEEVLELLERGYRLPRP 426 (468)
T ss_pred CCCceeecC-----CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--HHHHHHHHhccCcCCCC
Confidence 443322221 1123567999999999999999999999999999999 888875532 23345555666655556
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
+.+++.+.+ ++..||+.+|++|||++.+...++++...
T Consensus 427 ~~CP~~vY~----------------------lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 427 EGCPDEVYE----------------------LMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCHHHHH----------------------HHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 666666554 55579999999999999999888877543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=349.72 Aligned_cols=264 Identities=31% Similarity=0.424 Sum_probs=202.7
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
..+|...+.||+|+||+||++...+ |...|||.+........+.+.+|+++|++++|||||+++|.....+ . ..++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeE
Confidence 3467788999999999999999765 8999999987654333677899999999999999999999743211 1 4689
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEccccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE-DMTAKVGDFGL 611 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~ 611 (767)
+.|||+++|+|.+++...+. .+++..+..+++|+++||+|||++ |||||||||+|||++. ++.+||+|||.
T Consensus 93 i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence 99999999999999987652 499999999999999999999999 9999999999999999 79999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
++..... ...........||+.|||||++..+ ...+++||||+||++.||+||++||.........+.........
T Consensus 165 a~~~~~~---~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~ 241 (313)
T KOG0198|consen 165 AKKLESK---GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL 241 (313)
T ss_pred ccccccc---cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC
Confidence 9876531 1111223456799999999999853 34469999999999999999999997631111111111111111
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
+.++..++.. .++++..|+..||++||||++++++.-...+
T Consensus 242 P~ip~~ls~~----------------------a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 242 PEIPDSLSDE----------------------AKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred CCCCcccCHH----------------------HHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1222223322 2236668999999999999999998765543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=353.86 Aligned_cols=257 Identities=28% Similarity=0.403 Sum_probs=206.7
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCc
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDF 525 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 525 (767)
.+....|.+.+.||.|+|++|++|+.. +++.||||++.+. .....+-+..|-.+|.++ .||.|++++.. |
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence 344567889999999999999999965 4999999998643 233445567888899999 89999999988 6
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
.+...+|+|+||+++|+|.+++...+. +++..+..++.+|+.|++|||++ |||||||||+|||+|++|++|
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~Gs------fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYGS------FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhCc------chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence 677889999999999999999998765 99999999999999999999999 999999999999999999999
Q ss_pred EccccchhhhhhhcCCC-----c--cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCC
Q 004218 606 VGDFGLARSLLERIGNQ-----S--SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~-----~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 678 (767)
|+|||.|+.+.+..... . .......++||..|.+||++.....++.+|+|||||++|+|+.|++||....+-
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney- 293 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY- 293 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-
Confidence 99999999887654331 1 111124588999999999999999999999999999999999999999664221
Q ss_pred cchhhHh--hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 679 VSLVKWV--ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 679 ~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
..+.+.+ ...+|+..++ .+++|+.+.|..||.+|+|++|+.++-
T Consensus 294 liFqkI~~l~y~fp~~fp~--------------------------~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 294 LIFQKIQALDYEFPEGFPE--------------------------DARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHHHhcccCCCCCCH--------------------------HHHHHHHHHHccCccccccHHHHhhCc
Confidence 1122222 2223333221 222355677888999999999988763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=356.84 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=204.6
Q ss_pred cCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
..|+....||+|+.|.||.|.. .+++.||||++........+-+.+|+.+|+..+|+|||.+++.|. .++.+|+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----ccceeEE
Confidence 4678888999999999999994 458899999998777777788899999999999999999999854 3467899
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
|||||+||+|.|.+.... +++.++..|++++++||+|||.+ ||+|||||.+||+++.+|.+||+|||++.
T Consensus 348 VMEym~ggsLTDvVt~~~-------~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTR-------MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred EEeecCCCchhhhhhccc-------ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence 999999999999998765 99999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccch
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
.+..... .....+||+.|||||+.....|+++.||||||++++||+-|.+||-...+ ......+....
T Consensus 418 qi~~~~~------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--lrAlyLIa~ng---- 485 (550)
T KOG0578|consen 418 QISEEQS------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALYLIATNG---- 485 (550)
T ss_pred ccccccC------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--HHHHHHHhhcC----
Confidence 7755432 33567899999999999999999999999999999999999999854211 11111111111
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.......+.+...++++..+||..||.+||+|.|+|++
T Consensus 486 ----------------~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 486 ----------------TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ----------------CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11111122222333335558999999999999999975
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=342.33 Aligned_cols=265 Identities=25% Similarity=0.382 Sum_probs=208.3
Q ss_pred hcCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccCCcc-hhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIESTGT-WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.+.|+..++||.|..++||+|+. ..++.||||++..+.... .+.+.+|+..|+.++||||++++.. |..+..+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEeccee
Confidence 46799999999999999999994 458999999997765443 5889999999999999999999988 4566778
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
|+||+||.+||+.+++...-. .++++..+..|.+++++||.|||++ |.||||||+.||||+++|.+||+|||.
T Consensus 100 WvVmpfMa~GS~ldIik~~~~----~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYP----DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEeehhhcCCcHHHHHHHHcc----ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence 999999999999999987653 4599999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC--CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG--EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
+..+.+.. ...........||+.|||||++.. ..|+.|+||||||++..|+.+|..||....+-.+-+. ......
T Consensus 173 sa~l~~~G--~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~-tLqn~p 249 (516)
T KOG0582|consen 173 SASLFDSG--DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL-TLQNDP 249 (516)
T ss_pred eeeecccC--ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH-HhcCCC
Confidence 87766533 222222266789999999999543 4689999999999999999999999977554333222 222222
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
|.......+..-... +...++.++..||++||.+||||++++++
T Consensus 250 p~~~t~~~~~d~~k~--------------~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKK--------------FSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCcccccCChHHhhh--------------hcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 211111111111111 11123336778999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=343.90 Aligned_cols=264 Identities=28% Similarity=0.380 Sum_probs=202.3
Q ss_pred cCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
..|+..+.||+|.||.||+|++ .+|+.||+|.+..+. ++...-..+||.+|++++||||+++.+...+ .....+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~---~~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS---KLSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe---cCCceE
Confidence 4577778999999999999995 469999999987664 4556677899999999999999999998764 245688
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
|+|+|||+. +|..++.... ..+++.++..+++|++.||+|+|++ ||+|||||.+|||||.+|.+||+|||+
T Consensus 194 YlVFeYMdh-DL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred EEEEecccc-hhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccc
Confidence 999999988 9999887643 3499999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhh-------
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK------- 683 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------- 683 (767)
|+++....... .+..+-|.+|+|||.+.|. .|+.+.|+||.|||+.||++|++.|....+-+ ++..
T Consensus 265 Ar~y~~~~~~~-----~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGS 338 (560)
T KOG0600|consen 265 ARFYTPSGSAP-----YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGS 338 (560)
T ss_pred eeeccCCCCcc-----cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCC
Confidence 99775543222 3445679999999998875 68999999999999999999999987643221 1111
Q ss_pred -----Hhhhhcccc----hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 684 -----WVESNFPKN----AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 684 -----~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
|.....|.. ........++..+...+. ..+. |+..+|..||.+|.||.++++.
T Consensus 339 P~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~----------~~l~-Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 339 PTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPA----------SALD-LLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CChhccccccCCcccccCCCCcccchHHHHhccCCH----------HHHH-HHHHHhccCccccccHHHHhcC
Confidence 111111110 111112222222222111 1222 6668899999999999998863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=350.03 Aligned_cols=263 Identities=24% Similarity=0.321 Sum_probs=200.0
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhh--HHHHHHHHhcCC-CCCceeEEeeeecCCcccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKS--FFAECEALRNTR-HRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~ 528 (767)
..++|.+.++||.|.||.||+|+.. +|..||||.++..-.. +++ -++|++.|+++. ||||+++.+++.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d----~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRD----ND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhc----cC
Confidence 3468999999999999999999954 5899999999654333 333 358999999998 9999999999643 23
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..+++|||||+. +|+++++.++ +.+++.++..|++||++||+|+|++ |+.|||+||+|||+.....+||+|
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIAD 153 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecc
Confidence 389999999976 9999998764 4599999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccC-CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL-GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
||+|+..... ...+..+.|.+|+|||++. .+.|+.+.|+||+|||++|+.+-++-|.+..+-+ ++.+...-
T Consensus 154 FGLARev~Sk-------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~KIc~V 225 (538)
T KOG0661|consen 154 FGLAREVRSK-------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYKICEV 225 (538)
T ss_pred cccccccccC-------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHHHHHH
Confidence 9999976443 2335667899999999865 5668999999999999999999998886543221 12222111
Q ss_pred hc-cc--ch--------------hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 688 NF-PK--NA--------------QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 688 ~~-~~--~~--------------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
-. |. .+ ++.....+..++.. +..+.++ ++.+|+.+||.+||||+|++++-
T Consensus 226 LGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~----------~s~~~~~-li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN----------ASSEAAS-LIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc----------cCHHHHH-HHHHHhcCCCccCccHHHHhcCc
Confidence 00 00 00 11111112222211 2223333 77789999999999999999863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=316.78 Aligned_cols=270 Identities=23% Similarity=0.315 Sum_probs=200.0
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.+|...+++|+|.||.||+|++. +|+.||||.++... .+......+|++.|+.++|+||+.++++ |...+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 47888899999999999999954 59999999986542 2334568899999999999999999999 5667778
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
.+|+|||+. +|+..++... ..++..++..++.++++|++|||++ .|+||||||.|+|++++|.+||+|||+
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred EEEEEeccc-cHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence 999999987 9999998654 4599999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh---
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES--- 687 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--- 687 (767)
|+.+........ ..+-|.+|+|||.+.|. .|+...||||.|||+.||+.|.+-|..... -.++......
T Consensus 148 Ar~f~~p~~~~~------~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGT 220 (318)
T KOG0659|consen 148 ARFFGSPNRIQT------HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGT 220 (318)
T ss_pred hhccCCCCcccc------cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCC
Confidence 998866533221 22568999999988765 589999999999999999998776644321 1122221111
Q ss_pred hcccchhhhcc-HHHHH--hhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 NFPKNAQQVLD-RELRQ--LMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~~~~~~~~~~~-~~l~~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.-+..+++... +...+ .+...+.. .-+..+-.+.++ ++..|+.+||.+|+|++|++++
T Consensus 221 P~~~~WP~~~~lpdY~~~~~~P~~~~~-~lf~aas~d~ld-Ll~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 221 PTPDQWPEMTSLPDYVKIQQFPKPPLN-NLFPAASSDALD-LLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCcccCccccccccHHHHhcCCCCccc-cccccccHHHHH-HHHhhhccCchhcccHHHHhcc
Confidence 11111111111 00000 11110000 011122222333 7779999999999999999876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.29 Aligned_cols=199 Identities=31% Similarity=0.443 Sum_probs=179.1
Q ss_pred cCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.+|+..+.||.|+||.|.+++.+. |..+|+|++++..- ...+...+|..+|+.+.||+++++++. +.+...
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCCe
Confidence 467888999999999999999764 88999999975532 345567789999999999999999998 456778
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+++||||++||.|.+++++.++ +++..+..+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||
T Consensus 119 lymvmeyv~GGElFS~Lrk~~r------F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGR------FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCC------CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEecc
Confidence 8999999999999999998765 99999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
+|+.... .+.+.+||+.|+|||++...+++.++|+||||+++|||+.|.+||....+
T Consensus 190 FAK~v~~---------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 190 FAKRVSG---------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ceEEecC---------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 9987533 25678999999999999999999999999999999999999999977544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.23 Aligned_cols=247 Identities=30% Similarity=0.438 Sum_probs=201.6
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|.+.+.||+|+||.||+|+-+ +.+.||+|.+++. ..+..+.+.+|+++++.++||||+.++++ ++...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 57888999999999999999965 4889999999654 33456778999999999999999999999 6778889
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
|+|+||+.| +|..++..... ++++.+..++++++.||.|||+. +|.|||+||.||+++..|.+|+||||+
T Consensus 77 ~vVte~a~g-~L~~il~~d~~------lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDGK------LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred EEEehhhhh-hHHHHHHhccC------CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence 999999977 99999987654 99999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
|+..... ....+.+.||+-|||||...+.+|+..+|.||+||++||+++|++||... ....+.+.+..+.+.
T Consensus 147 Ar~m~~~------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--si~~Lv~~I~~d~v~ 218 (808)
T KOG0597|consen 147 ARAMSTN------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--SITQLVKSILKDPVK 218 (808)
T ss_pred hhhcccC------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--HHHHHHHHHhcCCCC
Confidence 9876442 12234567999999999999999999999999999999999999999542 111222222221111
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+ ...+..++.. ++...+.+||.+|.|..+++.+
T Consensus 219 ~-------------------p~~~S~~f~n----fl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 P-------------------PSTASSSFVN----FLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred C-------------------cccccHHHHH----HHHHHhhcChhhcccHHHHhcC
Confidence 1 1122233333 4447888999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=362.68 Aligned_cols=266 Identities=28% Similarity=0.429 Sum_probs=211.0
Q ss_pred hcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCCc-chhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
..+....+.||+|+||.||+|+.. +...||||.++..... ..++|.+|++.+..++|||||+++|+|..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~---- 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE---- 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc----
Confidence 345556788999999999999853 2467999999766555 78899999999999999999999999864
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCC----C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNE----H----GNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
++.+++|+|||..|||.+||+...... . ..+++..+.+.||.|||.|+.||-++ .+|||||..+|+||
T Consensus 561 -~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 561 -GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLV 636 (774)
T ss_pred -CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhcee
Confidence 455699999999999999998655431 1 23489999999999999999999999 99999999999999
Q ss_pred CCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccC
Q 004218 599 DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAG 677 (767)
Q Consensus 599 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~ 677 (767)
.++..|||+|||+++......+..... ...-..+|||||.+..++|+++||||||||++||+++ |+.||......
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~----~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRG----NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccC----CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 999999999999999776554433221 1123578999999999999999999999999999998 88998764333
Q ss_pred CcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 678 EVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
+ ..+.+...---..++....+++. |+..||+.+|++||+++||-..|+.....-
T Consensus 713 E--VIe~i~~g~lL~~Pe~CP~~vY~----------------------LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 713 E--VIECIRAGQLLSCPENCPTEVYS----------------------LMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred H--HHHHHHcCCcccCCCCCCHHHHH----------------------HHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 2 22222221112233444444433 666799999999999999999998776543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.50 Aligned_cols=250 Identities=30% Similarity=0.405 Sum_probs=198.6
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc----CC-cchhhHHHHHHHHhcCC-CCCceeEEeeeecCC
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE----ST-GTWKSFFAECEALRNTR-HRNLVKLITSCSSLD 524 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 524 (767)
...++|.+.+.||+|+||.|+.|.+. +++.||+|+++.. .. ...+.+.+|+.+++.++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~--- 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA--- 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence 45679999999999999999999854 5899999977543 11 23456678999999998 999999999954
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-Cc
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED-MT 603 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~ 603 (767)
....+++||||+.||+|.+++....+ +.+.++..+++|++.|++|+|++ ||+||||||+||+++.+ +.
T Consensus 91 --t~~~~~ivmEy~~gGdL~~~i~~~g~------l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 91 --TPTKIYIVMEYCSGGDLFDYIVNKGR------LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred --cCCeEEEEEEecCCccHHHHHHHcCC------CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence 44558999999999999999987433 89999999999999999999999 99999999999999999 99
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC-C-CCcccchhhhHHHHHHHhCCCCCCCcccCCcch
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-P-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL 681 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 681 (767)
+||+|||++.... .........+||+.|+|||++.+.. | +.++||||+|+++|.|++|+.||++...... .
T Consensus 160 ~Kl~DFG~s~~~~------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-~ 232 (370)
T KOG0583|consen 160 LKLSDFGLSAISP------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-Y 232 (370)
T ss_pred EEEeccccccccC------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-H
Confidence 9999999998753 1112335678999999999999877 7 5789999999999999999999987221110 1
Q ss_pred hhHhhhhcccchhhhc-cHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 682 VKWVESNFPKNAQQVL-DRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
.+.....+ ..+..+ .+.. .+++.+|+..||.+|+|+.|+++
T Consensus 233 ~ki~~~~~--~~p~~~~S~~~----------------------~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 233 RKIRKGEF--KIPSYLLSPEA----------------------RSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HHHhcCCc--cCCCCcCCHHH----------------------HHHHHHHcCCCcccCCCHHHHhh
Confidence 11111111 112222 2222 22667899999999999999993
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=311.06 Aligned_cols=273 Identities=24% Similarity=0.273 Sum_probs=214.2
Q ss_pred HHhcCCCCCCccccccceEEEEEE-eCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
...++|++.+.+|+|||+-||+++ ..+++.||+|++.....++.+..++|++..++++|||++++++++....-+....
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999999 5568899999998777778889999999999999999999999986654445667
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.|++++|+..|||.+.+...... +..+++.+++.|+.++++||++||+. .++++||||||.||++++.+.++|.|||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~k--g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIK--GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 89999999999999999876543 45699999999999999999999998 4469999999999999999999999999
Q ss_pred chhhhhhhcCCCc---cccccccccCCCCccCccccC---CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhH
Q 004218 611 LARSLLERIGNQS---SISSTHVLKGSIGYIPPEYGL---GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 611 ~a~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 684 (767)
.++...-...... ..........|..|+|||.+. +...++++|||||||++|+|+.|..||+........+.-.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 9875432211111 111112234789999999875 4456899999999999999999999998765543332221
Q ss_pred h---hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 685 V---ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 685 ~---~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
+ ...+|...+ .. +.+. +++.+|++.||.+||++.|++..++..
T Consensus 255 v~n~q~s~P~~~~--ys------------------e~l~----~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 VQNAQISIPNSSR--YS------------------EALH----QLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eeccccccCCCCC--cc------------------HHHH----HHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1 112222111 12 2222 266689999999999999999998764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.21 Aligned_cols=270 Identities=28% Similarity=0.449 Sum_probs=207.0
Q ss_pred CHHHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecC
Q 004218 446 SYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSL 523 (767)
Q Consensus 446 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 523 (767)
+.++.....+++.+...||+|.||+||+|.|. | .||||++..+ .++..+.|.+|+.++++-+|.||+-+.|+|...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 33555566667788899999999999999986 3 5999999765 334678899999999999999999999997543
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT 603 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~ 603 (767)
. . .||+.+|+|-+|+.+++..+. .++..+...||+|||+|+.|||.+ +|||||||..||++.+++.
T Consensus 461 ~-----~-AIiTqwCeGsSLY~hlHv~et-----kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 461 P-----L-AIITQWCEGSSLYTHLHVQET-----KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred c-----e-eeeehhccCchhhhhccchhh-----hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCc
Confidence 2 2 899999999999999987653 489999999999999999999999 9999999999999999999
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC---CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcc
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG---EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS 680 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 680 (767)
|||+|||++..-....+. .......|...|||||+++. .+|++.+||||||+|+|||+||..||..... +..
T Consensus 527 VkIgDFGLatvk~~w~g~----~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dqI 601 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGE----QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQI 601 (678)
T ss_pred EEEecccceeeeeeeccc----cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hhe
Confidence 999999999654332111 11233457889999999874 4689999999999999999999999973222 221
Q ss_pred hhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 681 LVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
+...-.+....+. .... .++- +.+++|+..||.++|++||++.+++..|+.+....
T Consensus 602 ifmVGrG~l~pd~--------s~~~----------s~~p-k~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 602 IFMVGRGYLMPDL--------SKIR----------SNCP-KAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred EEEecccccCccc--------hhhh----------ccCH-HHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 1111111111111 0000 1111 11223666899999999999999999998887754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=339.29 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=204.0
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
...|+..+.||+|.||.||+|.+. +++.||+|++..+.. ...+++++|+.++.+++++||.++|+.+ -.+..+
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy-----l~g~~L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY-----LKGTKL 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe-----eecccH
Confidence 346778899999999999999965 588999999976643 4567889999999999999999999984 456678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
+++||||.||++.+.++.... +++.++.-|+++++.|+.|||.+ +.+|||||+.||++..+|.+|++|||.
T Consensus 87 wiiMey~~gGsv~~lL~~~~~------~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgV 157 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNI------LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGV 157 (467)
T ss_pred HHHHHHhcCcchhhhhccCCC------CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecce
Confidence 999999999999999986552 58888889999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+..+.... .....++||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+ +...-.+....|+
T Consensus 158 a~ql~~~~------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--mrvlflIpk~~PP 229 (467)
T KOG0201|consen 158 AGQLTNTV------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--MRVLFLIPKSAPP 229 (467)
T ss_pred eeeeechh------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--ceEEEeccCCCCC
Confidence 97764432 223567899999999999998999999999999999999999999977654 2222222222333
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.......+.++ +++..||++||+.||+|.+++++
T Consensus 230 ~L~~~~S~~~k----------------------EFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFK----------------------EFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHH----------------------HHHHHHhhcCcccCcCHHHHhhh
Confidence 22222222222 25557999999999999998864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=347.60 Aligned_cols=249 Identities=26% Similarity=0.333 Sum_probs=203.6
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.+-|+..+.||+|+.|.|-+|++. +|+.+|||++.+. .......+.+|+-+|+-+.|||+++++++ +++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence 467889999999999999999965 5999999999654 23345678899999999999999999999 56778
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
++|+|.||+++|-|++++-..+. +++.++.++++||+.|+.|+|.. +|+|||+||+|+++|..+.+||+||
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~------l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGP------LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence 89999999999999999987654 99999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|+|..-.+ .....+.+|++.|+|||++.|.+| +.++||||.|||+|.|+||+.||++..-.. -+.+...+.
T Consensus 157 GMAsLe~~-------gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~-LLlKV~~G~ 228 (786)
T KOG0588|consen 157 GMASLEVP-------GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV-LLLKVQRGV 228 (786)
T ss_pred ceeecccC-------CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH-HHHHHHcCc
Confidence 99975322 233456789999999999999998 789999999999999999999997532110 011111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
|. ++.. +....++|+.+|+..||++|.|++||+++-
T Consensus 229 f~--MPs~----------------------Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 FE--MPSN----------------------ISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cc--CCCc----------------------CCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 11 1122 222233477789999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=318.83 Aligned_cols=202 Identities=28% Similarity=0.375 Sum_probs=173.9
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|+.++.|++|.||.||+|+++ +++.||+|+++.+.. +-.-.-++|+.+|.+++|||||.+-.+.... +.+.+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMDKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---cccee
Confidence 46778899999999999999976 589999999965532 3344568999999999999999999987643 34458
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
|+|||||+. +|..+++.-+ .++...++..+..|+++|++|||.+ .|+||||||+|+|++..|.+||+|||+
T Consensus 153 y~VMe~~Eh-DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGL 223 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGL 223 (419)
T ss_pred eeeHHHHHh-hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccch
Confidence 999999988 9999998765 3499999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|+.++... ...+..+-|.+|+|||.+.+. .|+++.|+||+|||+.||+++++-|...
T Consensus 224 AR~ygsp~------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 224 AREYGSPL------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred hhhhcCCc------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 99886542 223456679999999998775 5899999999999999999999888654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.59 Aligned_cols=267 Identities=25% Similarity=0.388 Sum_probs=200.6
Q ss_pred HhcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCC
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLD 524 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 524 (767)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.+ +||||++++++|..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-- 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC--
Confidence 3468999999999999999999742 25689999986432 23346788999999999 89999999998743
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCC--------------------------------------------------
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNE-------------------------------------------------- 554 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------- 554 (767)
....+++||||+++|+|.+++...+...
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 83 --PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred --CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 3345799999999999999997532100
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCcccccc
Q 004218 555 ------HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628 (767)
Q Consensus 555 ------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 628 (767)
...++++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........ ...
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~----~~~ 233 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRK 233 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch----hcc
Confidence 013488899999999999999999998 9999999999999999999999999999765322111 111
Q ss_pred ccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhc
Q 004218 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMS 707 (767)
Q Consensus 629 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 707 (767)
....++..|+|||++.+..++.++|||||||++|||++ |..||....... ..............+...+
T Consensus 234 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~--------- 303 (338)
T cd05102 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKDGTRMRAPENAT--------- 303 (338)
T ss_pred cCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhcCCCCCCCCCCC---------
Confidence 22345678999999999899999999999999999997 999986532211 1111111100000011111
Q ss_pred chhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 708 SESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 708 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 304 -------------~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 -------------PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred -------------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 112237778999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=326.70 Aligned_cols=284 Identities=24% Similarity=0.270 Sum_probs=212.2
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEee--ccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLD--IESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
......|...+.||+|+||.|+.|.++ +|+.||||.+. .......++..+|++.++.++|+||+.+.+.+.......
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344566777899999999999999965 59999999986 445556788999999999999999999999987645556
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
-..+|+|+|+|+. +|.+.++.... ++...+..+++|+++||.|+|+. +|+|||+||.|++++.+..+||+
T Consensus 98 f~DvYiV~elMet-DL~~iik~~~~------L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~ 167 (359)
T KOG0660|consen 98 FNDVYLVFELMET-DLHQIIKSQQD------LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKIC 167 (359)
T ss_pred cceeEEehhHHhh-HHHHHHHcCcc------ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEec
Confidence 6789999999954 99999987553 99999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccC-CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCC-cchhhHh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL-GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE-VSLVKWV 685 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~ 685 (767)
|||+|+..... ......+....|.+|+|||++. ...|+.+.||||.|||+.||++|++-|.+...-. ..+....
T Consensus 168 DFGLAR~~~~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 168 DFGLARYLDKF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred cccceeecccc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 99999987543 1223335567899999999765 4678999999999999999999999886532211 1111111
Q ss_pred hhhccc-chhhhccHHHHHhhhcch----hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 686 ESNFPK-NAQQVLDRELRQLMMSSE----SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 686 ~~~~~~-~~~~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
-+..+. ....+..+..+..+...+ ....+.........-+++.+||..||.+|+|++|++++-
T Consensus 244 lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 244 LGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred cCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 111111 122222233333322221 111122222222223377799999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=328.78 Aligned_cols=283 Identities=25% Similarity=0.296 Sum_probs=201.3
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhc--CCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRN--TRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
....+..+.+|+|+||.||+|++. ++.||||+++. ...+.|++|-+|.+. ++|+||++++++-...... ...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence 456667789999999999999987 68999999963 345677788777765 5899999999984332222 4478
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeecCCCCCeeeCCCCceE
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC------EVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
++|+||.+.|+|.+|+...- ++|.+..+|+..+++||+|||+.. .++|+|||||++||||.+|+.+.
T Consensus 284 wLVt~fh~kGsL~dyL~~nt-------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANT-------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred eEEeeeccCCcHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 99999999999999998765 999999999999999999999853 46899999999999999999999
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCC------CCcccchhhhHHHHHHHhCCCCCCCcccCCc
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP------STAGDVYSFGVMLLEIFTGMSPTHESFAGEV 679 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 679 (767)
|+|||+|..+....... .....+||.+|||||++.+..- -.+.||||+|.|+|||+++..-++.....+.
T Consensus 357 IaDFGLAl~~~p~~~~~----d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQG----DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred eeccceeEEecCCCCCc----chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 99999999887543332 3345789999999999876432 2368999999999999997755432111111
Q ss_pred chhhHhhhhcccchhhh----ccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 680 SLVKWVESNFPKNAQQV----LDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 680 ~~~~~~~~~~~~~~~~~----~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
++.-..+-...+...+. +.+..+..+.. ...... -.+.+.+.+..||+.||+.|.||.=|-+++.++....
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~-~W~~h~----~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPD-AWRKHA----GMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChh-hhhcCc----cHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 11111000011101110 00000000000 000011 1223333666899999999999999999998887655
Q ss_pred hh
Q 004218 756 LK 757 (767)
Q Consensus 756 ~~ 757 (767)
..
T Consensus 508 ~~ 509 (534)
T KOG3653|consen 508 ED 509 (534)
T ss_pred Cc
Confidence 43
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=340.72 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=200.3
Q ss_pred ccCHHHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecC
Q 004218 444 MISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSL 523 (767)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 523 (767)
.++|+++. ..+-||+|+.|.||+|+.+ ++.||||.++. .-..+|+-|++++||||+.|.|+|..
T Consensus 120 eiPFe~Is-------ELeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtq- 183 (904)
T KOG4721|consen 120 EIPFEEIS-------ELEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQ- 183 (904)
T ss_pred cCCHHHhh-------hhhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecC-
Confidence 34555543 3467999999999999998 78999998752 22357889999999999999999864
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT 603 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~ 603 (767)
...+|||||||+.|-|.++++..+. +...-...|.++||.|+.|||.+ .|||||||.-||||+.+..
T Consensus 184 ----sPcyCIiMEfCa~GqL~~VLka~~~------itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~ 250 (904)
T KOG4721|consen 184 ----SPCYCIIMEFCAQGQLYEVLKAGRP------ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDV 250 (904)
T ss_pred ----CceeEEeeeccccccHHHHHhccCc------cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccce
Confidence 3456999999999999999987554 88888999999999999999999 9999999999999999999
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhh
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK 683 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 683 (767)
+||+|||.++...+. .....++||..|||||++...+.++|+||||||||+|||+||..||.+...... -
T Consensus 251 VKIsDFGTS~e~~~~-------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---I 320 (904)
T KOG4721|consen 251 VKISDFGTSKELSDK-------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---I 320 (904)
T ss_pred EEeccccchHhhhhh-------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---E
Confidence 999999999876543 223457899999999999999999999999999999999999999966322211 1
Q ss_pred Hhhh--hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 684 WVES--NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 684 ~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
|--+ .....++..+.+.++ - |+..||+-.|..||++.+++.+|+-+...+.
T Consensus 321 wGVGsNsL~LpvPstcP~Gfk------------------l----L~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 321 WGVGSNSLHLPVPSTCPDGFK------------------L----LLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred EeccCCcccccCcccCchHHH------------------H----HHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 1100 111112222222221 1 5668999999999999999999976655443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=330.05 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=198.3
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---------Cc-----chhhHHHHHHHHhcCCCCCcee
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---------TG-----TWKSFFAECEALRNTRHRNLVK 515 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~-----~~~~~~~e~~~l~~l~h~niv~ 515 (767)
+...++|++.+.||+|.||.|-+|+.. +++.||||++++.. .. ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 455689999999999999999999965 58999999985431 11 1347889999999999999999
Q ss_pred EEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 004218 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGN 595 (767)
Q Consensus 516 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 595 (767)
++++..+ +..+.+|+|+|||..|.+...=.. ...+++.+++++++++..||+|||.+ |||||||||+|
T Consensus 173 LiEvLDD---P~s~~~YlVley~s~G~v~w~p~d------~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsN 240 (576)
T KOG0585|consen 173 LIEVLDD---PESDKLYLVLEYCSKGEVKWCPPD------KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSN 240 (576)
T ss_pred EEEeecC---cccCceEEEEEeccCCccccCCCC------cccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhh
Confidence 9998653 456789999999988877543211 11289999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC----CCCcccchhhhHHHHHHHhCCCCC
Q 004218 596 ILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK----PSTAGDVYSFGVMLLEIFTGMSPT 671 (767)
Q Consensus 596 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~el~tg~~p~ 671 (767)
+|++++|++||+|||.+......... ..........||+.|+|||...++. .+.+.||||+||++|.|+.|+.||
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~-~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDE-GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCcc-ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 99999999999999999866333111 1122223467999999999887633 367899999999999999999999
Q ss_pred CCcccCCcchhhHhhh--hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 672 HESFAGEVSLVKWVES--NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 672 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
.+...-+ ...+.+.. .+|.. ..+...+++||.++|.+||++|.+..+|..+.-
T Consensus 320 ~~~~~~~-l~~KIvn~pL~fP~~------------------------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 320 FDDFELE-LFDKIVNDPLEFPEN------------------------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ccchHHH-HHHHHhcCcccCCCc------------------------ccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 5532110 01111111 01110 012233445777999999999999999987764
Q ss_pred H
Q 004218 750 N 750 (767)
Q Consensus 750 ~ 750 (767)
-
T Consensus 375 v 375 (576)
T KOG0585|consen 375 V 375 (576)
T ss_pred e
Confidence 3
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=332.21 Aligned_cols=213 Identities=26% Similarity=0.378 Sum_probs=181.1
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
+...+.|+.++.||+|+||.||+|+-+ +|..+|+|++++. ..+..+.+..|-.+|...++|.||+++.. |.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQ 211 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQ 211 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ec
Confidence 335678999999999999999999965 4999999999754 34566778899999999999999999988 67
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
+..++|+||||++||++..+|..... +++..+..++.+++.|++.+|+. |||||||||+|+|||..|++||
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~~~------L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKL 282 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRKDT------LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKL 282 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhcCc------CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEee
Confidence 88899999999999999999987654 99999999999999999999999 9999999999999999999999
Q ss_pred ccccchhhhhhhcC-----------------CCcccc------------------------ccccccCCCCccCccccCC
Q 004218 607 GDFGLARSLLERIG-----------------NQSSIS------------------------STHVLKGSIGYIPPEYGLG 645 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~-----------------~~~~~~------------------------~~~~~~gt~~y~aPE~~~~ 645 (767)
+|||++.-+..... ...... .....+|||-|+|||++.+
T Consensus 283 SDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~ 362 (550)
T KOG0605|consen 283 SDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG 362 (550)
T ss_pred ccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc
Confidence 99999964432100 000000 0012569999999999999
Q ss_pred CCCCCcccchhhhHHHHHHHhCCCCCCCcccC
Q 004218 646 EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAG 677 (767)
Q Consensus 646 ~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 677 (767)
..|+..+|+||+|||+|||+.|-+||....+.
T Consensus 363 kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~ 394 (550)
T KOG0605|consen 363 KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ 394 (550)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999999999775443
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=325.25 Aligned_cols=264 Identities=27% Similarity=0.341 Sum_probs=194.2
Q ss_pred CCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
.|...+++|.|+||.||+|...+ ++.||||..-.+.. --.+|+++|+.++|||||++..++......+.-+..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 56677899999999999999654 78999998753322 22379999999999999999998876554444577899
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEccccchh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED-MTAKVGDFGLAR 613 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~ 613 (767)
||||+. +|.++++.... .+..++..++.-+.+||++||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+
T Consensus 101 leymP~-tL~~~~r~~~~--~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTR--ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHhchH-HHHHHHHHHhh--cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 999987 99999985321 133488889999999999999999998 99999999999999965 999999999999
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
.+...... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+... ..++...++---.+.
T Consensus 175 ~L~~~epn-------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 175 VLVKGEPN-------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTPT 246 (364)
T ss_pred eeccCCCc-------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCCC
Confidence 87554322 334578899999988775 589999999999999999999999876322 222332222111000
Q ss_pred ---h------------hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 ---A------------QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ---~------------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+ +++....+.+.+ ....-.+.++ ++.+++.++|.+|.++.|++.+
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~---------~~~~~~d~~d-ll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVF---------FKRLPPDALD-LLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeec---------ccCCCHHHHH-HHHHHhccChhhcCCHHHHhcc
Confidence 0 011111111100 0011112222 6778999999999999999864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=329.31 Aligned_cols=264 Identities=22% Similarity=0.262 Sum_probs=200.2
Q ss_pred CCccCHHHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcc---hhhHHHHHHHHhcCCCCCceeEEe
Q 004218 442 PQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGT---WKSFFAECEALRNTRHRNLVKLIT 518 (767)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~ 518 (767)
...++.+++ +......||+|++|.||+|.+. |+.||||.++...... .+.+.+|++++++++||||+++++
T Consensus 12 ~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDI-----DKYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHc-----CCCCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 344555555 2222357999999999999984 8899999986543332 467789999999999999999999
Q ss_pred eeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 519 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
++.+. .......++||||+++|+|.+++...+ .+++..+..++.|++.|++|||+.. +++||||||+||++
T Consensus 86 ~~~~~-~~~~~~~~lv~Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill 156 (283)
T PHA02988 86 FIIDI-VDDLPRLSLILEYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLV 156 (283)
T ss_pred eEEec-ccCCCceEEEEEeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEE
Confidence 87541 123456799999999999999997643 3899999999999999999999731 78899999999999
Q ss_pred CCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC--CCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 599 DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG--EKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 599 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
++++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 157 TENYKLKIICHGLEKILSSPP---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred CCCCcEEEcccchHhhhcccc---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999997653211 12347889999999876 6789999999999999999999999975322
Q ss_pred CCcchhhHh-hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 677 GEVSLVKWV-ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 677 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
. .....+ ....+...+...++ .+.+++.+||+.||++|||++|+++.|+..+.
T Consensus 228 ~--~~~~~i~~~~~~~~~~~~~~~----------------------~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 228 K--EIYDLIINKNNSLKLPLDCPL----------------------EIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred H--HHHHHHHhcCCCCCCCCcCcH----------------------HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1 111111 11111111101111 12337778999999999999999999988764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=319.36 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=204.2
Q ss_pred hcCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
..+|++.+.||+|.||.|-+|.. ..|+.||||.++++.- .+.-.+.+|++||..++||||+.++.+ |++.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence 35788889999999999999995 5699999999966533 344567899999999999999999999 67888
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+.|||||..+|.|+||+...+. +++.++..+++||..|+.|+|++ ++||||||.+|||+|.++++||+||
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~------LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGS------LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence 89999999999999999988765 99999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh-
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES- 687 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~- 687 (767)
|++-.+... ....+++|++-|.+||++.+.+| ++.+|-||+|+++|.++.|..||+... ...++.++..
T Consensus 198 GLSNly~~~-------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--hk~lvrQIs~G 268 (668)
T KOG0611|consen 198 GLSNLYADK-------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--HKRLVRQISRG 268 (668)
T ss_pred chhhhhccc-------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--HHHHHHHhhcc
Confidence 999776432 23456889999999999999988 789999999999999999999997632 2223332221
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
.|.+. ... .+. .-+|++||..+|+.|.|+.++..+.
T Consensus 269 aYrEP-~~P----------------SdA--------~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 AYREP-ETP----------------SDA--------SGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cccCC-CCC----------------chH--------HHHHHHHHhcCcccchhHHHHhhhh
Confidence 22111 000 000 0177789999999999999998765
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=352.33 Aligned_cols=271 Identities=22% Similarity=0.275 Sum_probs=208.4
Q ss_pred HhcCCCCCCccccccceEEEEEEeCCC-cEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCC-ccc-c
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLREG-ISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLITSCSSLD-FKN-M 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~-~ 528 (767)
...++++.+.|.+|||+.||.|.+..+ ..||+|++-..+....+.+.+|+++|+.+. |+|||.+++...... -.. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 445788899999999999999998765 999999987667777888999999999996 999999999432222 222 3
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
-.+++.||||+||.|-|++..+.. ..+++.++++|++|+++|+++||.. .++|||||||-+|||++.+|..||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 578899999999999999986542 3399999999999999999999997 67899999999999999999999999
Q ss_pred ccchhhhhhhcCCCcc---ccccccccCCCCccCcccc---CCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchh
Q 004218 609 FGLARSLLERIGNQSS---ISSTHVLKGSIGYIPPEYG---LGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV 682 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 682 (767)
||.|............ ....-....|+.|+|||++ .+.++++|+|||||||++|.|+....||+..-.-...-
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln- 268 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN- 268 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe-
Confidence 9999743322211000 0001123468999999975 57789999999999999999999999997642211111
Q ss_pred hHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 683 KWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
....+|.. . .+.+ .+++||+.||+.||.+||++-|++.++..+.+..
T Consensus 269 --g~Y~~P~~--p------------------~ys~----~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 269 --GNYSFPPF--P------------------NYSD----RLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --ccccCCCC--c------------------cHHH----HHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 11112221 1 1112 2233777899999999999999999998887543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=341.32 Aligned_cols=372 Identities=24% Similarity=0.257 Sum_probs=323.5
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
-+.||+|+|++. .+....|..+++|+++++..|.++ .+|...+...+|+.|+|.+|.|+..-.+.++.++.|+.||||
T Consensus 80 t~~LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 80 TQTLDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred eeeeeccccccc-cCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 357999999998 888888888999999999999999 899877777889999999999997777889999999999999
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcC
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~ 163 (767)
.|.|...+.. ++..-.++++|+|++|.|+..--..|..+.. |..|.|++|+++...+..|.++++|+.|+|..
T Consensus 158 rN~is~i~~~------sfp~~~ni~~L~La~N~It~l~~~~F~~lns-L~tlkLsrNrittLp~r~Fk~L~~L~~LdLnr 230 (873)
T KOG4194|consen 158 RNLISEIPKP------SFPAKVNIKKLNLASNRITTLETGHFDSLNS-LLTLKLSRNRITTLPQRSFKRLPKLESLDLNR 230 (873)
T ss_pred hchhhcccCC------CCCCCCCceEEeeccccccccccccccccch-heeeecccCcccccCHHHhhhcchhhhhhccc
Confidence 9999876443 3455567999999999999777778888875 99999999999988888888999999999999
Q ss_pred CcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCC
Q 004218 164 NSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIP 243 (767)
Q Consensus 164 n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 243 (767)
|+|.-...-.|.+|++|+.|.|..|.|+..-.++|..+.++++|+|+.|++.....+++-+++.|+.|+||+|.|....+
T Consensus 231 N~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~ 310 (873)
T KOG4194|consen 231 NRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHI 310 (873)
T ss_pred cceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeec
Confidence 99995556789999999999999999998888899999999999999999998888899999999999999999998889
Q ss_pred hhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCC---Cchhh
Q 004218 244 KEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPI---PNILA 320 (767)
Q Consensus 244 ~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~~~ 320 (767)
+.+.-.++| +.|+|++|+|+...+..|..|..|+.|.|++|.+..+....|..+.+|++|||++|.|+..+ ...|.
T Consensus 311 d~WsftqkL-~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~ 389 (873)
T KOG4194|consen 311 DSWSFTQKL-KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFN 389 (873)
T ss_pred chhhhcccc-eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhc
Confidence 999888888 45599999999999999999999999999999998888888999999999999999987644 34688
Q ss_pred ccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCccccccccccccCCcCccc
Q 004218 321 ELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 321 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c~ 385 (767)
++++|+.|+|.+|+|..+.-.+|..++.|+.|||.+|.+..+-+....-..+..+.+..-...|.
T Consensus 390 gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCD 454 (873)
T KOG4194|consen 390 GLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCD 454 (873)
T ss_pred cchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEe
Confidence 89999999999999996666789999999999999999998877664434666777777666774
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=297.68 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=203.4
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
+.+.|++.+.||+|-||.||.|+.+ ++-.||+|++.++ .....+++.+|++|-..++||||++++++ |.+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence 3467899999999999999999965 4788999998543 33456788999999999999999999999 6677
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..+|+++||.++|++...++..+ ...+++...+.+++|+|.|+.|+|.. +|+||||||+|+|++..+..||+|
T Consensus 95 ~riyLilEya~~gel~k~L~~~~----~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGR----MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcc----cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccC
Confidence 88899999999999999998554 34488888999999999999999998 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||.+.... .......+||..|.|||...+..++..+|+|++|+..||++.|.+||..... ...+.+..+..
T Consensus 168 fGwsV~~p--------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k~~ 238 (281)
T KOG0580|consen 168 FGWSVHAP--------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRKVD 238 (281)
T ss_pred CCceeecC--------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHHcc
Confidence 99996532 2234567899999999999999999999999999999999999999976441 11111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+. .+.. +..-.+++|.+|+..+|.+|.+..|++++
T Consensus 239 ~~--~p~~----------------------is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 LK--FPST----------------------ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cc--CCcc----------------------cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 10 0011 11222347778999999999999999876
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=306.67 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=198.0
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.+++|++.+.||+|+|+.||++... +|+.+|+|++... ...+.+.+.+|++|-+.++||||+++.+.+ ....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence 4567889999999999999999855 5999999988432 344678899999999999999999999984 4556
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEE
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE---DMTAKV 606 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl 606 (767)
+.|+|+|+|+|++|..-+-... .+++..+-..++||++||.|+|.+ +|||||+||+|+++.+ ..-+||
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R~------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL 154 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKL 154 (355)
T ss_pred eeEEEEecccchHHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceee
Confidence 6799999999999985443322 288889999999999999999999 9999999999999953 346999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh-
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV- 685 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~- 685 (767)
+|||+|..+... ......+||++|||||++...+|+..+|||+-|+++|-++.|.+||.+.... .+.+.+
T Consensus 155 ~~FGvAi~l~~g-------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--rlye~I~ 225 (355)
T KOG0033|consen 155 ADFGLAIEVNDG-------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYEQIK 225 (355)
T ss_pred cccceEEEeCCc-------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--HHHHHHh
Confidence 999999876521 2234567999999999999999999999999999999999999999653221 121111
Q ss_pred hh--hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 686 ES--NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 686 ~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
.+ .++...++.+.+. .++++++||..||++|.|+.|++++=
T Consensus 226 ~g~yd~~~~~w~~is~~----------------------Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPE----------------------AKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred ccccCCCCcccCcCCHH----------------------HHHHHHHHhccChhhhccHHHHhCCc
Confidence 11 2222222223322 22366789999999999999998753
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=333.02 Aligned_cols=276 Identities=25% Similarity=0.328 Sum_probs=197.9
Q ss_pred cCCCCCCccccccceEEEEEEeC--CCcEEEEEEeeccC--CcchhhHHHHHHHHhcC---CCCCceeEEeeeecCCccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR--EGISVAVKVLDIES--TGTWKSFFAECEALRNT---RHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~ 527 (767)
.+|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37899999999999999999863 36889999986442 22334566787777765 6999999999986544445
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
...+++||||++ ++|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 667899999996 59999987543 23489999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
|||.++..... .......||..|+|||++.+..++.++||||+||++|||++|++||......+ .+......
T Consensus 153 Dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~ 224 (290)
T cd07862 153 DFGLARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDV 224 (290)
T ss_pred cccceEeccCC-------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHH
Confidence 99999754322 11234568999999999988889999999999999999999999997543211 11111111
Q ss_pred h---cccchhhhccHHHHHhhh-cchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 N---FPKNAQQVLDRELRQLMM-SSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~---~~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. .+........- ....+. ............+...+.+++.+||+.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 225 IGLPGEEDWPRDVAL-PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hCCCChhhchhhhcc-cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 00000000000 000000 00000111111223344458889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=345.34 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=211.1
Q ss_pred CCCCCCccccccceEEEEEEeCC----CcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
..++.++||.|.||.|++|+++- ...||||.++.. ..+...+|+.|+.||.++.||||+++.|+. .....
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCce
Confidence 34567899999999999999763 457999999765 345677899999999999999999999994 45566
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+.||+|||++|+|+.|++....+ +++.+...++++||.|++||-+. ++|||||.++|||++.+..+|++|||
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGq-----ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQ-----FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCc-----eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccc
Confidence 79999999999999999876532 99999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
+++.+.++..... .+..-.=..+|.|||.+..++++.++||||||++|||.++ |..||-+.. .....+.++..+
T Consensus 777 LSRvledd~~~~y---tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--NQdVIkaIe~gy 851 (996)
T KOG0196|consen 777 LSRVLEDDPEAAY---TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVIKAIEQGY 851 (996)
T ss_pred ceeecccCCCccc---cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc--hHHHHHHHHhcc
Confidence 9998765542111 1111112478999999999999999999999999999887 889985543 234455566666
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
....+-.+...+.+ |++.||++|-.+||.+.|++..|.++-+
T Consensus 852 RLPpPmDCP~aL~q----------------------LMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 852 RLPPPMDCPAALYQ----------------------LMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred CCCCCCCCcHHHHH----------------------HHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 65555555555544 5567999999999999999999988654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=316.07 Aligned_cols=280 Identities=24% Similarity=0.326 Sum_probs=210.3
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhc--CCCCCceeEEeeeecCC
Q 004218 447 YDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRN--TRHRNLVKLITSCSSLD 524 (767)
Q Consensus 447 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~ 524 (767)
+-..+...++....+.||+|.||.||+|.|+ |+.||||+|... +.+.+.+|.++.+. ++|+||+.+++.-...
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~- 277 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKD- 277 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccC-
Confidence 3344556678889999999999999999998 999999999643 33556678888775 4999999999874322
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeecCCCCCeeeC
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHND-----CEVPIVHCDLKPGNILLD 599 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIl~~ 599 (767)
......+|+|++|.+.|||+||+.... ++....++++..+|.||+|||.. ..+.|.|||||+.||||.
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r~t-------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNRNT-------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhhcc-------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 244568999999999999999998744 99999999999999999999963 467899999999999999
Q ss_pred CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC----C--CCcccchhhhHHHHHHHhC------
Q 004218 600 EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK----P--STAGDVYSFGVMLLEIFTG------ 667 (767)
Q Consensus 600 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~slG~il~el~tg------ 667 (767)
+++.+.|+|+|+|......... -.-.....+||.+|||||++...- + -..+||||||.|+||++..
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~--idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDT--IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred cCCcEEEeeceeeEEecccCCc--ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence 9999999999999876554322 222335567999999999986532 1 2368999999999999863
Q ss_pred ----CCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHH
Q 004218 668 ----MSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIRE 743 (767)
Q Consensus 668 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~e 743 (767)
+.||.+..+.+.++.+..+......... ..+.+-+..+++..+.+ ++..||..+|+.|.||--
T Consensus 429 ~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP------------~ipnrW~s~~~l~~m~k-lMkeCW~~Np~aRltALr 495 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRP------------NIPNRWKSDPALRVMAK-LMKECWYANPAARLTALR 495 (513)
T ss_pred ehhhcCCcccCCCCCCCHHHHhcceeecccCC------------CCCcccccCHHHHHHHH-HHHHhhcCCchhhhHHHH
Confidence 2677665554444333322111111111 11112222344444555 888999999999999999
Q ss_pred HHHHHHHHHH
Q 004218 744 ALRRLKNAQK 753 (767)
Q Consensus 744 vl~~L~~~~~ 753 (767)
+-+.|.++.+
T Consensus 496 iKKtl~~l~~ 505 (513)
T KOG2052|consen 496 IKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHhc
Confidence 9999988875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=334.62 Aligned_cols=203 Identities=29% Similarity=0.418 Sum_probs=178.9
Q ss_pred HHhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 526 (767)
....+|...++||+|.||.|+++..+. ++.+|||++++. ..++.+..+.|.+|+... +||.++.++.. +.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQ 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQ 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----cc
Confidence 345689999999999999999999764 889999999765 456677888999998887 59999999998 67
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
..+++|+||||+.||++..+.+... +++..+..++..++.||.|||++ |||+||||.+|||+|.+|.+||
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~~~~-------F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIHTDV-------FSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEeccc-------ccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEe
Confidence 7889999999999999665554433 99999999999999999999999 9999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcc
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 675 (767)
+|||+++... .....+.+++||+.|+|||++.+..|+.++|+|||||++|||+.|+.||....
T Consensus 510 ADFGlcKe~m------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 510 ADFGLCKEGM------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred cccccccccC------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999998532 22345678999999999999999999999999999999999999999997643
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.10 Aligned_cols=263 Identities=22% Similarity=0.370 Sum_probs=197.9
Q ss_pred hcCCCCCCccccccceEEEEEEe------CCCcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL------REGISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDF 525 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 525 (767)
.++|++.+.||+|+||.||+|.+ .++..||||+++... ....+.+.+|+++++.+ +||||++++++|.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~---- 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT---- 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence 45789999999999999999974 235689999986432 23446788999999999 8999999999964
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCC----------------------------------------------------
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKN---------------------------------------------------- 553 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 553 (767)
.....++||||+++|+|.++++.....
T Consensus 110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 345569999999999999999753210
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhh
Q 004218 554 -----------------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL 616 (767)
Q Consensus 554 -----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 616 (767)
.....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 0123578999999999999999999998 99999999999999999999999999997653
Q ss_pred hhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchhh
Q 004218 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQ 695 (767)
Q Consensus 617 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (767)
..... .......++..|+|||++.+..++.++|||||||++|||++ |..||...... ....+.+........+.
T Consensus 266 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 340 (375)
T cd05104 266 NDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRMLSPE 340 (375)
T ss_pred Ccccc----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccCCCCC
Confidence 32111 11122335678999999999999999999999999999998 88888653221 11122222111111011
Q ss_pred hccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 696 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
..+ ..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 341 ~~~----------------------~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 CAP----------------------SEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCC----------------------HHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111 1122377789999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.16 Aligned_cols=265 Identities=23% Similarity=0.395 Sum_probs=199.1
Q ss_pred HhcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCC
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLD 524 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 524 (767)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+++++.+ +||||++++++|.
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~--- 112 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT--- 112 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec---
Confidence 3457999999999999999999852 24579999986442 23345688999999999 8999999999864
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCC---------------------------------------------------
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKN--------------------------------------------------- 553 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 553 (767)
....+++||||+++|+|.+++......
T Consensus 113 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 113 --HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred --CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 345679999999999999998643210
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcC
Q 004218 554 -------------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIG 620 (767)
Q Consensus 554 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 620 (767)
....++++.++.+++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 1123588999999999999999999998 999999999999999999999999999976533211
Q ss_pred CCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchhhhccH
Q 004218 621 NQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQVLDR 699 (767)
Q Consensus 621 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (767)
........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..........+...+...++
T Consensus 268 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 342 (374)
T cd05106 268 ----YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMSRPDFAPP 342 (374)
T ss_pred ----eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCccCCCCCCH
Confidence 011122335678999999998899999999999999999997 999986543221 11111111111111111111
Q ss_pred HHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 700 ELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 700 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
.+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 343 ----------------------~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 ----------------------EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ----------------------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1223677899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=311.93 Aligned_cols=210 Identities=28% Similarity=0.414 Sum_probs=174.9
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCC-ceeEEeeeecCC-cccce
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRN-LVKLITSCSSLD-FKNME 529 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~-~~~~~ 529 (767)
..|...++||+|+||+||+|+.+ +|+.||+|.+..+.. +......+|+.+++.++|+| |+.+++++.... +....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45666788999999999999954 589999999976533 35567789999999999999 999999976533 23345
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++|+||++. +|.+++....... ..++...+..+++||+.||+|||++ +|+||||||+||+|+++|.+||+||
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence 78999999976 9999998766421 3477789999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
|+|+...-.. ......++|.+|+|||++.+. .|+...||||+||+++||+++++-|.....
T Consensus 165 GlAra~~ip~------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 165 GLARAFSIPM------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred chHHHhcCCc------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 9998653221 113445689999999998887 689999999999999999999988866433
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=327.69 Aligned_cols=252 Identities=27% Similarity=0.351 Sum_probs=203.2
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|..++.+|+|+||.++.++.+ ++..||+|.+.... ....+...+|+.++++++|||||.+.+.+. .++..+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence 57889999999999999999966 47899999986543 333457889999999999999999999853 344559
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
+|||+||+||++.+.+.+.+ +.-++++.+..|+.|++.|+.|||+. .|+|||||+.||+++.++.+||+|||+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred EEEEeecCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhh
Confidence 99999999999999998766 34599999999999999999999988 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
|+.+.+.. .......||+.|+.||++.+.+|+.|+||||+||++|||++-+++|........ ..+..... -.
T Consensus 153 aK~l~~~~------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-i~ki~~~~-~~ 224 (426)
T KOG0589|consen 153 AKILNPED------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-ILKINRGL-YS 224 (426)
T ss_pred hhhcCCch------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-HHHHhhcc-CC
Confidence 99876543 123457899999999999999999999999999999999999999965322111 11111111 11
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+...... ++.++..|++.+|..||++.+++.+
T Consensus 225 Plp~~ys~e----------------------l~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSE----------------------LRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHH----------------------HHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111112222 2236668999999999999999988
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.90 Aligned_cols=267 Identities=29% Similarity=0.440 Sum_probs=209.0
Q ss_pred cCCCCCCccccccceEEEEEEeCC--Cc----EEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE--GI----SVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
.+.+..+.||+|.||.||.|...+ |. .||||.+... +.....+|.+|+.+|+.++|||||+++|+|.+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~----- 766 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD----- 766 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----
Confidence 455567789999999999999654 43 4899988544 44567889999999999999999999999865
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNE-HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
....+|++|||++|+|..|++..+... ....++..+.+.++.|||+|+.||+++ ++|||||.++|+|++....+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence 334599999999999999999875432 245599999999999999999999999 9999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHh
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~ 685 (767)
+|||+|+.+.+......... ..-...|||||.+..+.++.|+|||||||++||++| |..||......+. +..+.
T Consensus 844 aDFGlArDiy~~~yyr~~~~----a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~~ 918 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGE----AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDVL 918 (1025)
T ss_pred cccchhHhhhhchheeccCc----cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHHH
Confidence 99999996554433222111 112467999999999999999999999999999999 7788865332211 11122
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhh
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 757 (767)
.+. +-..+..+...+.+ ++..||+.+|++||++..+++++..+.+....
T Consensus 919 ~gg-RL~~P~~CP~~ly~----------------------lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 919 EGG-RLDPPSYCPEKLYQ----------------------LMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred hCC-ccCCCCCCChHHHH----------------------HHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 222 22333444443332 66679999999999999999999988776553
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.87 Aligned_cols=277 Identities=22% Similarity=0.258 Sum_probs=197.5
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|+||.||+|... +++.||||.+... .......+.+|+++++.++||||+++++++..........++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999965 5899999998643 223445688999999999999999999987654444445689
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||++ ++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 81 VVFELME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEecCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence 9999995 69999886543 389999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCC--CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG--EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+......... .......||..|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+.....
T Consensus 151 ~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~ 225 (338)
T cd07859 151 RVAFNDTPTA---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLG 225 (338)
T ss_pred cccccccCcc---ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhC
Confidence 7543221111 11123468999999999865 67899999999999999999999999653211 11111111000
Q ss_pred cc----hhhhccHHHHHhh----hcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KN----AQQVLDRELRQLM----MSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~----~~~~~~~~l~~~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. ............+ ...+....+........+.+++.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 0111111111110 000000000000011223347889999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.01 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=194.5
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++ .++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 36889999999999999999976 58999999986432 23345688999999999999999999874 45567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+++||||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence 899999999999999997643 389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+++..... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .....+.....
T Consensus 147 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~ 215 (291)
T cd05612 147 FAKKLRDR---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIYEKILAGKL 215 (291)
T ss_pred cchhccCC---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCc
Confidence 99765321 12345899999999999988999999999999999999999998653211 11111100000
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC-----HHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID-----IREALRR 747 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 747 (767)
..+... ...+++++.+||+.||.+||+ ++|++++
T Consensus 216 -~~~~~~----------------------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -EFPRHL----------------------DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CCCccC----------------------CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 000001 112233777899999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=334.03 Aligned_cols=259 Identities=29% Similarity=0.428 Sum_probs=202.3
Q ss_pred cCCCCCCccccccceEEEEEEeCC--C---cEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE--G---ISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.+....++||+|+||.||+|..+. + ..||||....+ .....+++++|+++|++++|||||+++|++..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~---- 232 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL---- 232 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC----
Confidence 344555899999999999999653 2 23899988742 34567889999999999999999999999653
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
...+++|||+|.||+|.++++.... .++..+...++.+.|.||+|||++ +++||||.++|+|++.++.+||
T Consensus 233 -~~Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 233 -EEPLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred -CCccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEe
Confidence 4456999999999999999988653 399999999999999999999999 9999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHh
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~ 685 (767)
+|||+++.-... .. ......-...|+|||.+....+++++|||||||++||+++ |..||...... ....++
T Consensus 304 SDFGLs~~~~~~-----~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI 375 (474)
T KOG0194|consen 304 SDFGLSRAGSQY-----VM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKI 375 (474)
T ss_pred CccccccCCcce-----ee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHH
Confidence 999998753210 00 0011124578999999999999999999999999999999 78898654322 222333
Q ss_pred -hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 686 -ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 686 -~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
...++...+...... +..++.+||..||++||||.++.+.++.+.....
T Consensus 376 ~~~~~r~~~~~~~p~~----------------------~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 VKNGYRMPIPSKTPKE----------------------LAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HhcCccCCCCCCCHHH----------------------HHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 323333322222211 1225558999999999999999999998876654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.25 Aligned_cols=242 Identities=27% Similarity=0.337 Sum_probs=188.7
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEe
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999965 58999999986532 23445678899999999999999999985 45567899999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhh
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL 616 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 616 (767)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 999999999987543 389999999999999999999999 99999999999999999999999999987432
Q ss_pred hhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhh
Q 004218 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQV 696 (767)
Q Consensus 617 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (767)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+..... ..+..
T Consensus 147 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~~~~~~-~~p~~ 217 (323)
T cd05571 147 SD------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMEEI-RFPRT 217 (323)
T ss_pred cC------CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHHHcCCC-CCCCC
Confidence 11 11123456899999999999999999999999999999999999999653211 11111100000 00011
Q ss_pred ccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 697 LDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 697 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
+ .+ .+.+++.+||+.||++|| ++.|++++
T Consensus 218 ~------------------~~----~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 L------------------SP----EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred C------------------CH----HHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1 11 122366689999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.27 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=192.7
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++|++|+++++++. .++..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence 3778899999999999999964 68999999986432 223346789999999999999999999853 45578
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMG----NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred EEEEEecCCCcHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999998886432 23489999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+....... ......||..|+|||++.+..++.++||||+||++|||++|+.||........ ...+......
T Consensus 149 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~ 219 (285)
T cd05631 149 AVQIPEGE-------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKE 219 (285)
T ss_pred cEEcCCCC-------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhc
Confidence 97542211 11234589999999999999999999999999999999999999975322111 0000000000
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC-----HHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID-----IREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 747 (767)
... .....+...+.+++.+||+.||++||+ ++|++++
T Consensus 220 ~~~-------------------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 DQE-------------------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccc-------------------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 000 000001112233777999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=298.17 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=199.5
Q ss_pred HHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc----c----hhhHHHHHHHHhcC-CCCCceeEEe
Q 004218 449 ELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG----T----WKSFFAECEALRNT-RHRNLVKLIT 518 (767)
Q Consensus 449 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~----~~~~~~e~~~l~~l-~h~niv~~~~ 518 (767)
+-...-..|...+.+|+|..++|-++..+ +|..+|+|++...... . .+.-.+|+.||+++ .||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 34455678888999999999999998865 5889999998643221 1 23345799999998 7999999999
Q ss_pred eeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 519 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
++ +.+.++++|+|.|+.|.|.|++...- .+++.+..+|++|+++|++|||.+ .|||||+||+||++
T Consensus 91 ~y-----es~sF~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILl 156 (411)
T KOG0599|consen 91 VY-----ESDAFVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILL 156 (411)
T ss_pred ec-----cCcchhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheee
Confidence 94 55667799999999999999998754 399999999999999999999999 99999999999999
Q ss_pred CCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccC------CCCCCCcccchhhhHHHHHHHhCCCCCC
Q 004218 599 DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL------GEKPSTAGDVYSFGVMLLEIFTGMSPTH 672 (767)
Q Consensus 599 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~el~tg~~p~~ 672 (767)
+++.++||+|||+|+.+.+. ......+||++|+|||.+. ...|+...|+||.|+++|.++.|.+||.
T Consensus 157 ddn~~i~isDFGFa~~l~~G-------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 157 DDNMNIKISDFGFACQLEPG-------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred ccccceEEeccceeeccCCc-------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 99999999999999976442 2345678999999999875 3467889999999999999999999984
Q ss_pred CcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 673 ESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
.... ..-+...+.+.+.- ..++..+ +..-.+++|.+||+.||.+|.|++|++++=
T Consensus 230 HRkQ-mlMLR~ImeGkyqF----------------~speWad----is~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 230 HRKQ-MLMLRMIMEGKYQF----------------RSPEWAD----ISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHHH-HHHHHHHHhccccc----------------CCcchhh----ccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 3110 00011111111111 1111122 222334477799999999999999999863
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=332.30 Aligned_cols=199 Identities=24% Similarity=0.388 Sum_probs=171.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||++++. ++..||+|.+..... ...+.+.+|++++++++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 468999999999999999999976 488999999875432 33467899999999999999999999854 44567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 99999999999999997643 3899999999999999999999851 699999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
+...... ......||..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 151 ~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 151 SGQLIDS--------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccccccc--------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 8755322 11234589999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=321.07 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=196.1
Q ss_pred hcCCCCCCccccccceEEEEEEeC----CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|++.+.||+|+||.||+|.++ .+..||+|.++.... .....+.+|+.++++++||||+++++++. .+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence 357889999999999999999853 367899999865432 33457889999999999999999999864 34
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++++|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d 150 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG 150 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence 56799999999999999997542 2389999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 687 (767)
||.+........ .......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ...+.+..
T Consensus 151 fg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~ 223 (266)
T cd05064 151 FRRLQEDKSEAI-----YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVED 223 (266)
T ss_pred Ccccccccccch-----hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHC
Confidence 998764321110 11112235678999999999999999999999999999775 99998653221 11111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
......+..++ ..+.+++.+||+.+|++|||++|+.+.|.++
T Consensus 224 ~~~~~~~~~~~----------------------~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 GFRLPAPRNCP----------------------NLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCC----------------------HHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11111111111 1122367789999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=333.05 Aligned_cols=245 Identities=23% Similarity=0.314 Sum_probs=194.3
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+.++++++||||+++++++. .++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCCE
Confidence 57889999999999999999976 4889999998643 2234567889999999999999999999853 4567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeecc
Confidence 899999999999999997643 388999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+....
T Consensus 164 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~~- 231 (329)
T PTZ00263 164 FAKKVPDR---------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIYEKILAGR- 231 (329)
T ss_pred CceEcCCC---------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHHHHHhcCC-
Confidence 99754321 12346899999999999999999999999999999999999999653211 1111111000
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC-----HHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID-----IREALRR 747 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 747 (767)
...+..++. .+++++.+||+.||.+||+ ++|++++
T Consensus 232 ~~~p~~~~~----------------------~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 LKFPNWFDG----------------------RARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred cCCCCCCCH----------------------HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 001111111 1223777899999999997 6888765
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=327.69 Aligned_cols=267 Identities=25% Similarity=0.367 Sum_probs=194.2
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-----------------CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCcee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-----------------GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVK 515 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~ 515 (767)
.++|++.+.||+|+||.||+|.+++ +..||+|++..... .....+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578999999999999999998532 34699999865432 23457889999999999999999
Q ss_pred EEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 004218 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN-------------EHGNGLNFLERLNIAIDIASALDYLHNDC 582 (767)
Q Consensus 516 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 582 (767)
+++++.. ....++||||+++|+|.+++...... .....+++.++..++.|++.||+|||+.
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~- 157 (304)
T cd05096 84 LLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL- 157 (304)
T ss_pred EEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence 9999643 34579999999999999998653211 1123478899999999999999999999
Q ss_pred CCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHH
Q 004218 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLL 662 (767)
Q Consensus 583 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ 662 (767)
+|+||||||+||+++.++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|
T Consensus 158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 231 (304)
T cd05096 158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231 (304)
T ss_pred --CccccCcchhheEEcCCccEEECCCccceecccCce----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHH
Confidence 999999999999999999999999999975432211 11112334578899999998888999999999999999
Q ss_pred HHHh--CCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC
Q 004218 663 EIFT--GMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID 740 (767)
Q Consensus 663 el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt 740 (767)
||++ +..||...... .....+...+.... .......+. . ....+.+++.+||+.||++|||
T Consensus 232 el~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~--------~~~~~~~~~------~-~~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 232 EILMLCKEQPYGELTDE--QVIENAGEFFRDQG--------RQVYLFRPP------P-CPQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred HHHHccCCCCCCcCCHH--HHHHHHHHHhhhcc--------ccccccCCC------C-CCHHHHHHHHHHccCCchhCcC
Confidence 9987 55676543211 11111110000000 000000000 0 0111233777999999999999
Q ss_pred HHHHHHHHH
Q 004218 741 IREALRRLK 749 (767)
Q Consensus 741 ~~evl~~L~ 749 (767)
+.|+.+.|+
T Consensus 295 ~~~i~~~l~ 303 (304)
T cd05096 295 FSDIHAFLT 303 (304)
T ss_pred HHHHHHHHh
Confidence 999998885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=332.09 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=195.1
Q ss_pred ccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeecCC
Q 004218 462 LIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGN 540 (767)
Q Consensus 462 ~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 540 (767)
+||+|.||+||.|++.+ ...+|||.+........+-+..|+...++++|.|||+++|.| ..++++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 69999999999999765 667999999766666778889999999999999999999994 456688999999999
Q ss_pred CChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEccccchhhhhhhc
Q 004218 541 GSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD-EDMTAKVGDFGLARSLLERI 619 (767)
Q Consensus 541 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~ 619 (767)
|+|.++++..-.. -.-.+.++-.+.+||++||.|||++ .|||||||-+||+|+ -.|.+||+|||.++.+..
T Consensus 657 GSLSsLLrskWGP---lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-- 728 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGP---LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-- 728 (1226)
T ss_pred CcHHHHHHhccCC---CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc--
Confidence 9999999875432 1126788889999999999999999 999999999999997 679999999999987632
Q ss_pred CCCccccccccccCCCCccCccccCCC--CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhhc
Q 004218 620 GNQSSISSTHVLKGSIGYIPPEYGLGE--KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVL 697 (767)
Q Consensus 620 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (767)
-...+.++.||..|||||++..+ .|+.++|||||||++.||.||++||.........+.+.--....++++
T Consensus 729 ----inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP--- 801 (1226)
T KOG4279|consen 729 ----INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP--- 801 (1226)
T ss_pred ----CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc---
Confidence 23345677899999999999765 489999999999999999999999976433322111110001111111
Q ss_pred cHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 698 DRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 698 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
+.+..-.+.+|.+|+.+||.+||+|+++++
T Consensus 802 -------------------eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 -------------------EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -------------------HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 112222333777899999999999999985
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=325.38 Aligned_cols=274 Identities=22% Similarity=0.281 Sum_probs=196.5
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++ ..++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 47899999999999999999976 48899999986432 23356788999999999999999999985 345678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||++++.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMP------NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred EEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 9999999987776554322 2389999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcc-hhhHhhhhcc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS-LVKWVESNFP 690 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~ 690 (767)
+........ .......|+..|+|||++.+..++.++||||+||++|||++|+.||......... .........+
T Consensus 147 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07848 147 ARNLSEGSN-----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP 221 (287)
T ss_pred ccccccccc-----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence 976532211 1112345899999999999888999999999999999999999999653221110 0000000111
Q ss_pred cchhhhc--cHHHHHhh----hcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KNAQQVL--DRELRQLM----MSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~~~~~~--~~~l~~~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
....... +....... .............+...+.+++.+||+.||++|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 222 AEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 00000000 000000011111233345558889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=333.86 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=195.9
Q ss_pred cCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|.+.. ++.||+|++.... ....+.+.+|+++++.++||||+++++++ ..+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 468999999999999999999764 8899999986442 23456688999999999999999999985 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence 899999999999999997543 389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc-
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF- 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~- 689 (767)
++..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...+....
T Consensus 147 ~a~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~ 215 (333)
T cd05600 147 LSKGIVT---------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENLKYWKE 215 (333)
T ss_pred CCccccc---------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHHHhccc
Confidence 9975432 12345689999999999999999999999999999999999999965322111 00000000
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
....+...+ ......+.+. +++.+||..+|.+||+++|++++
T Consensus 216 ~~~~~~~~~------------~~~~~s~~~~----~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 216 TLQRPVYDD------------PRFNLSDEAW----DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCCCCCc------------cccccCHHHH----HHHHHHhhChhhhcCCHHHHHhC
Confidence 000000000 0001112222 26668999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.94 Aligned_cols=200 Identities=29% Similarity=0.429 Sum_probs=167.6
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++. .....+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEE
Confidence 57999999999999999999965 58899999986443 233456789999999999999999999853 445679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 80 lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~ 150 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA 150 (288)
T ss_pred EEEeCCCc-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcce
Confidence 99999975 9999886543 2378999999999999999999999 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+...... .......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 151 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 151 RAKSVPT------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred eeccCCC------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 7542211 11123457899999998865 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.14 Aligned_cols=251 Identities=29% Similarity=0.452 Sum_probs=194.7
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
++|++.+.||+|+||.||+|.++++..+|+|.+... ....+.+.+|++++++++||||+++++++. .....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence 458888999999999999999988889999987533 233467889999999999999999999864 34567999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++.
T Consensus 78 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred EEcCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccc
Confidence 99999999999987543 1388999999999999999999999 999999999999999999999999999876
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccch
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+....+...
T Consensus 150 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~~~~ 222 (256)
T cd05114 150 VLDDEYT-----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFRLYR 222 (256)
T ss_pred cCCCcee-----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCCCCC
Confidence 4322111 1112235668999999988889999999999999999999 8999854321 111111111111100
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
+.... ..+.+++.+||+.+|++|||++|+++.|
T Consensus 223 ~~~~~----------------------~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PKLAS----------------------MTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCC----------------------HHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11111 1122377799999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=308.53 Aligned_cols=270 Identities=28% Similarity=0.364 Sum_probs=208.5
Q ss_pred cCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
+.|+..+.||+|.-|+||++..++ +..+|+|+++++. .....+...|-+||+.++||.++.+|+. ++.+.+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccce
Confidence 356677899999999999999875 6899999997653 3445677889999999999999999999 567778
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.|+|||||+||+|..+.+++. +..+++..+..++..++.||+|||-. |||.|||||+||||.++|++-|+||.
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp----~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQP----GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred eEEEEecCCCccHHHHHhhCC----CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecc
Confidence 899999999999999987765 56699999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcC--------------------------------C------------------CccccccccccCCCCccCc
Q 004218 611 LARSLLERIG--------------------------------N------------------QSSISSTHVLKGSIGYIPP 640 (767)
Q Consensus 611 ~a~~~~~~~~--------------------------------~------------------~~~~~~~~~~~gt~~y~aP 640 (767)
++........ . .........++||-.|.||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 9865421000 0 0011122346799999999
Q ss_pred cccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh--hcccchhhhccHHHHHhhhcchhhHHHHHHH
Q 004218 641 EYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES--NFPKNAQQVLDRELRQLMMSSESQTIQLHDC 718 (767)
Q Consensus 641 E~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 718 (767)
|++.+...+.++|+|+||+++|||+.|..||......+. +...+.+ .+|... .
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-l~NIv~~~l~Fp~~~------------------------~ 359 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-LRNIVGQPLKFPEEP------------------------E 359 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-HHHHhcCCCcCCCCC------------------------c
Confidence 999999999999999999999999999999977543322 2222211 122211 1
Q ss_pred HHHHHHHHhccccCCCCCCCCC----HHHHHHH--HHHHHHHHhhcCCC
Q 004218 719 LITIIESVGLSCTTESPGGRID----IREALRR--LKNAQKILLKRRQP 761 (767)
Q Consensus 719 ~~~~l~~l~~~cl~~dP~~Rpt----~~evl~~--L~~~~~~~~~~~~~ 761 (767)
+...+++||++.|.+||++|.- |.||-++ ++.+...+.+...|
T Consensus 360 vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~P 408 (459)
T KOG0610|consen 360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARP 408 (459)
T ss_pred chhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCC
Confidence 1222344777899999999998 8887654 45554444444333
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.50 Aligned_cols=260 Identities=29% Similarity=0.442 Sum_probs=199.2
Q ss_pred hcCCCCCCccccccceEEEEEEeCC------CcEEEEEEeeccCCc-chhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|.+.+.||+|+||.||+|...+ ++.||+|.+...... ..+.+.+|+++++.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT----- 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----
Confidence 3568889999999999999998643 478999998654433 4578999999999999999999999964
Q ss_pred cceeeEEEEeecCCCChhhhhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERK--------NEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
.....++||||+++++|.+++..... ......+++.++..++.|++.|++|||+. +++||||||+||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 34567999999999999999976532 11234588999999999999999999999 99999999999999
Q ss_pred CCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccC
Q 004218 599 DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAG 677 (767)
Q Consensus 599 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~ 677 (767)
+.++.+||+|||.++........ .......++..|+|||++.+..++.++||||+|+++|||++ |..||......
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~ 231 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231 (280)
T ss_pred cCCCeEEECCcccceecccCcce----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999754322110 01122335778999999999999999999999999999998 99998543221
Q ss_pred CcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 678 EVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
.....+............. ..+.+++.+||+.||++|||+.|+++.|+
T Consensus 232 --~~~~~~~~~~~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 --EVIECITQGRLLQRPRTCP----------------------SEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --HHHHHHHcCCcCCCCCCCC----------------------HHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111111111111111 11223777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=326.02 Aligned_cols=201 Identities=28% Similarity=0.452 Sum_probs=167.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence 468999999999999999999976 588999999864432 23346788999999999999999999854 45578
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred EEEEECCC-cCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence 99999996 58888876543 2388999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
++...... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 150 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 150 ARAKSVPS------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred ceeccCCC------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 86432211 11123457899999998765 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=318.85 Aligned_cols=257 Identities=29% Similarity=0.463 Sum_probs=203.0
Q ss_pred HHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
+...+|++.+.||.|+||.||+|.+.+++.||+|.+..........+.+|+++++.++||||+++++++. .....
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 77 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV 77 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence 3456799999999999999999998889999999997665555677889999999999999999999864 44567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++++|.+++.... +..+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||.
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPE----GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred EEEEeecccCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence 99999999999999997643 23489999999999999999999998 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+......... .....++..|+|||...+..++.++||||||+++|+|++ |+.||...... .........+.
T Consensus 151 ~~~~~~~~~~------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~ 222 (261)
T cd05148 151 ARLIKEDVYL------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITAGYR 222 (261)
T ss_pred hhhcCCcccc------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHhCCc
Confidence 9765332111 112335678999999988889999999999999999998 89998553211 11111111111
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
.......+ ..+.+++.+||+.||.+|||++++++.|+.
T Consensus 223 ~~~~~~~~----------------------~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCP----------------------QEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCC----------------------HHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11111111 112237778999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.33 Aligned_cols=200 Identities=24% Similarity=0.399 Sum_probs=171.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|++++++++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence 468999999999999999999976 588899998865422 33467889999999999999999999964 44578
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++|+|.+++.... .+++..+..++.|++.|++|||+. .+|+||||||+||++++++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 99999999999999997543 388999999999999999999974 1799999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+....... .....|+..|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 151 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 151 SGQLIDSM--------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred chhhhhhc--------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 97653321 12345889999999999888999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=331.47 Aligned_cols=352 Identities=24% Similarity=0.251 Sum_probs=317.7
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
|++|+++.|..|.++ .||..... ..+|+.|+|.+|.|..+-.+.++.++.|+.||||.|.|+...-..|..-.++++|
T Consensus 101 l~nLq~v~l~~N~Lt-~IP~f~~~-sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L 178 (873)
T KOG4194|consen 101 LPNLQEVNLNKNELT-RIPRFGHE-SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKL 178 (873)
T ss_pred CCcceeeeeccchhh-hccccccc-ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEE
Confidence 578999999999998 99987764 7889999999999998778899999999999999999995555678888899999
Q ss_pred eecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEE
Q 004218 81 NIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLN 160 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~ 160 (767)
+|++|.|+....+ .+.++.+|..|.|+.|+++...+..|.++++ |+.|+|..|+|.-.-.-+|.++++|+.|.
T Consensus 179 ~La~N~It~l~~~------~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~-L~~LdLnrN~irive~ltFqgL~Sl~nlk 251 (873)
T KOG4194|consen 179 NLASNRITTLETG------HFDSLNSLLTLKLSRNRITTLPQRSFKRLPK-LESLDLNRNRIRIVEGLTFQGLPSLQNLK 251 (873)
T ss_pred eeccccccccccc------cccccchheeeecccCcccccCHHHhhhcch-hhhhhccccceeeehhhhhcCchhhhhhh
Confidence 9999999986544 5677789999999999999555566666998 99999999999855577899999999999
Q ss_pred CcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCC
Q 004218 161 LSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 161 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
|..|+|.....++|-.+.++++|+|+.|++...-..++.+++.|+.|+||+|.|..+.++.+.-.++|+.|+|++|+|+.
T Consensus 252 lqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~ 331 (873)
T KOG4194|consen 252 LQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITR 331 (873)
T ss_pred hhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccccccc
Confidence 99999998888999999999999999999998888899999999999999999999999999999999999999999998
Q ss_pred CCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCC---cccccCcccceeeccCccccCCCCc
Q 004218 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLP---NSFKNCKSLEKLLMANNKFSGPIPN 317 (767)
Q Consensus 241 ~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~---~~~~~l~~L~~L~l~~n~l~~~~~~ 317 (767)
..+..|..+..|.++ +|+.|+++.+-...|..+++|+.|||++|.|+..+. ..|.+|++|+.|.+.+|+|..+...
T Consensus 332 l~~~sf~~L~~Le~L-nLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~kr 410 (873)
T KOG4194|consen 332 LDEGSFRVLSQLEEL-NLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKR 410 (873)
T ss_pred CChhHHHHHHHhhhh-cccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchh
Confidence 888899999999555 999999998888899999999999999999876543 4688899999999999999987788
Q ss_pred hhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcC
Q 004218 318 ILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVV 363 (767)
Q Consensus 318 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 363 (767)
+|.++++|++|||.+|.|..+.|.+|..| +|+.|-+..-.+-+..
T Consensus 411 Afsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDC 455 (873)
T KOG4194|consen 411 AFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDC 455 (873)
T ss_pred hhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEec
Confidence 99999999999999999999999999999 9999998766665543
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.69 Aligned_cols=264 Identities=29% Similarity=0.436 Sum_probs=201.6
Q ss_pred cCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.+|.+.+.||+|+||.||++... ++..||+|.+........+.+.+|++++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 46888999999999999999852 24568999887555555677899999999999999999999964 34
Q ss_pred eeeEEEEeecCCCChhhhhcccCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKN-------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED 601 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~ 601 (767)
...++||||+++++|.+++...... .....+++.+++.++.|++.||+|||+. +++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 5679999999999999999754321 1123489999999999999999999998 99999999999999999
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcc
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVS 680 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~ 680 (767)
+.+||+|||.++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 157 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-- 230 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-- 230 (288)
T ss_pred CcEEeccCCccccccCCce----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999975532211 011122335778999999998889999999999999999998 889985532211
Q ss_pred hhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 681 LVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
....+............+ ..+.+++.+||+.||.+|||+.|+.+.|+++.+.
T Consensus 231 ~~~~i~~~~~~~~~~~~~----------------------~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 VIECITQGRVLQRPRTCP----------------------KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHcCCcCCCCCCCC----------------------HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111111100000000011 1123377799999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.98 Aligned_cols=242 Identities=28% Similarity=0.370 Sum_probs=188.6
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEe
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
+.||+|+||.||++... +++.||+|++... .......+.+|+++++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46899999999999965 5899999998643 233456788999999999999999999884 45567899999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhh
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL 616 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 616 (767)
|+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 y~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 76 YVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999999999886543 389999999999999999999999 99999999999999999999999999987532
Q ss_pred hhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhh
Q 004218 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQV 696 (767)
Q Consensus 617 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (767)
... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .....+.... ...+..
T Consensus 147 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~~~~~~~~-~~~p~~ 217 (328)
T cd05593 147 TDA------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMED-IKFPRT 217 (328)
T ss_pred Ccc------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHHHHhccCC-ccCCCC
Confidence 111 1123356899999999999889999999999999999999999999653211 1111110000 000111
Q ss_pred ccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 697 LDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 697 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
++ . .+.+++.+||+.||++|| ++.|++++
T Consensus 218 ~~------------------~----~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LS------------------A----DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CC------------------H----HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11 1 122366689999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.63 Aligned_cols=242 Identities=26% Similarity=0.343 Sum_probs=187.7
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEe
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
+.||+|+||.||++... +|+.||+|++... .......+.+|+++++.++||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 46899999999999965 5899999998653 223445677899999999999999999985 34567899999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhh
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL 616 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 616 (767)
|+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 76 YANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 999999999886543 389999999999999999999999 99999999999999999999999999986432
Q ss_pred hhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhh
Q 004218 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQV 696 (767)
Q Consensus 617 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (767)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......... ...+..
T Consensus 147 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~~~~~~~-~~~p~~ 217 (323)
T cd05595 147 SDG------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILMEE-IRFPRT 217 (323)
T ss_pred CCC------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHhcCC-CCCCCC
Confidence 111 1112356899999999999989999999999999999999999998643211 1111100000 000111
Q ss_pred ccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 697 LDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 697 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
+++ .+.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~----------------------~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSP----------------------EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCH----------------------HHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 111 122366689999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.42 Aligned_cols=266 Identities=25% Similarity=0.400 Sum_probs=199.6
Q ss_pred hcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDF 525 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 525 (767)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++++ +|+||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~--- 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK--- 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec---
Confidence 357999999999999999999742 25789999986432 22345678899999999 89999999998753
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCC----------------------------------------------------
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKN---------------------------------------------------- 553 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 553 (767)
.+..++++|||+++++|.+++......
T Consensus 83 -~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 -PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred -CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 345678999999999999998643210
Q ss_pred ---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCcccccccc
Q 004218 554 ---EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630 (767)
Q Consensus 554 ---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 630 (767)
....++++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..+...... .....
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~----~~~~~ 234 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKGD 234 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch----hhccC
Confidence 0012589999999999999999999999 9999999999999999999999999999865332111 11123
Q ss_pred ccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcch
Q 004218 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSE 709 (767)
Q Consensus 631 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 709 (767)
..++..|+|||++.+..++.++||||+||++|||++ |..||......+ ..............+...
T Consensus 235 ~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~------------ 301 (337)
T cd05054 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTRMRAPEYA------------ 301 (337)
T ss_pred CCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCCCCCCccC------------
Confidence 345778999999999999999999999999999998 999986532211 111111100000000000
Q ss_pred hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 710 SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 710 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
...+.+++.+||+.+|++||++.|++++|+.+..
T Consensus 302 ----------~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 302 ----------TPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ----------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0112237778999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.79 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=198.3
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++. .....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEE
Confidence 35788999999999999999998888899999875432 23567889999999999999999999853 4455799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 79 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDE----GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred EEecCCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccce
Confidence 999999999999997543 23488999999999999999999998 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
....... .......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+...++..
T Consensus 152 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~ 224 (261)
T cd05072 152 VIEDNEY-----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYRMP 224 (261)
T ss_pred ecCCCce-----eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCCC
Confidence 6533211 11122335678999999988889999999999999999998 99998543211 1111111111111
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
....++ . .+.+++.+||+.+|++|||++++.+.|++
T Consensus 225 ~~~~~~------------------~----~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCP------------------D----ELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCC------------------H----HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000111 1 12237778999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=309.25 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=202.2
Q ss_pred CCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
-|.++.+||+|+||.||+|.+++ |+.||+|.+..+ .+.+++.+|+.+|++++.|++|++||.|+ ....+|+|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceEee
Confidence 36677899999999999999765 999999998744 46788999999999999999999999864 34457999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
||||..|+..+.++..+ .++++.++..+++..++||+|||.. .-+|||||+.||+++.+|.+||+|||.|..
T Consensus 107 MEYCGAGSiSDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARR-----KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred hhhcCCCcHHHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccch
Confidence 99999999999998765 4599999999999999999999998 889999999999999999999999999987
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchh
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
+.+.... ...+.||+.|||||++..-.|+.++||||+|++..||..|++||.+..+-..- -.+....|+
T Consensus 179 LTDTMAK------RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--FMIPT~PPP--- 247 (502)
T KOG0574|consen 179 LTDTMAK------RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--FMIPTKPPP--- 247 (502)
T ss_pred hhhhHHh------hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--EeccCCCCC---
Confidence 7654332 35678999999999999999999999999999999999999999765332110 011111111
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. ..-.+....-+.+++++||-++|++|-||-+++++
T Consensus 248 -T----------------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 -T----------------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -C----------------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1 11112222233347778999999999999998775
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.15 Aligned_cols=194 Identities=23% Similarity=0.299 Sum_probs=165.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|... .+.+.+|++++++++||||+++++++. .....+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeE
Confidence 357999999999999999999975 58899999753 245678999999999999999999854 455679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+|+|++. ++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 160 lv~e~~~-~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred EEEecCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 9999995 68988886543 389999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
+...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 230 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 230 CFPVDIN-----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccc-----ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 6532211 1112345699999999999998999999999999999999999988643
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=316.26 Aligned_cols=264 Identities=25% Similarity=0.364 Sum_probs=196.7
Q ss_pred CCCCCccccccceEEEEEEeCC-Cc--EEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-cccee
Q 004218 457 FSHENLIGSGSFGSVYKGYLRE-GI--SVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF-KNMEF 530 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 530 (767)
|.+.+.||+|+||.||+|++.+ +. .||+|.++.. .....+.+.+|+++++.++||||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999764 32 6999988643 23345678899999999999999999998754321 22235
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.+++|||+++|+|.+++...+.......+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885443222234589999999999999999999998 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
.++........ .......++..|+|||...+..++.++||||||+++|||++ |+.||..... ......+....
T Consensus 158 ~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYY----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQGN 231 (272)
T ss_pred cccccCcccce----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCC
Confidence 99865432110 01122345678999999999899999999999999999999 7888854221 11111111100
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
...... .. ...+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 232 ~~~~~~------------------~~----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLKQPP------------------DC----LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCC------------------CC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000000 00 11123377799999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.07 Aligned_cols=191 Identities=30% Similarity=0.403 Sum_probs=164.4
Q ss_pred cccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeec
Q 004218 463 IGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 463 lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++. .....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 699999999999976 4889999998643 2334566788999999999999999998853 456789999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhh
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 618 (767)
++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 76 NGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 9999999997543 389999999999999999999999 9999999999999999999999999998753221
Q ss_pred cCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 619 IGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 619 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 147 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 147 D------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred C------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 1 112345689999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=329.27 Aligned_cols=246 Identities=25% Similarity=0.316 Sum_probs=193.6
Q ss_pred hcCCCCCCccccccceEEEEEEeCC--CcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE--GISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|++.+.||+|+||.||+|.++. +..||+|++... .....+.+.+|+++++.++||||+++++++. ..
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----DE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----eC
Confidence 3579999999999999999998643 368999998643 2334567889999999999999999999954 45
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEec
Confidence 67899999999999999997643 389999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+...
T Consensus 175 FG~a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~i~~~ 243 (340)
T PTZ00426 175 FGFAKVVDTR---------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LIYQKILEG 243 (340)
T ss_pred CCCCeecCCC---------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HHHHHHhcC
Confidence 9999754221 12356899999999999888999999999999999999999999653211 111111000
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
.. ..+..+++ .+.+++.+|++.||++|+ +++|++++
T Consensus 244 ~~-~~p~~~~~----------------------~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 II-YFPKFLDN----------------------NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC-CCCCCCCH----------------------HHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00 00111111 122366789999999995 89998876
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=316.22 Aligned_cols=260 Identities=24% Similarity=0.351 Sum_probs=200.6
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++. ..+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 57999999999999999999965 5899999987542 2233456889999999999999999999854 3456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++|+|.+++...... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence 79999999999999988643221 23488999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh-hc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES-NF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~ 689 (767)
.+........ ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||.............+.. .+
T Consensus 152 ~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (267)
T cd08228 152 LGRFFSSKTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY 225 (267)
T ss_pred cceeccchhH------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC
Confidence 9876533211 1123457889999999988889999999999999999999999985532221111111111 11
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
+...... ....+.+++.+||+.+|++||++.|+++.+++++
T Consensus 226 ~~~~~~~----------------------~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PPLPTEH----------------------YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCChhh----------------------cCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111011 1112233777899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.25 Aligned_cols=264 Identities=28% Similarity=0.447 Sum_probs=202.2
Q ss_pred cCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
++|.+.+.||+|+||.||+|... ++..|++|.+........+.+.+|++++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence 45788899999999999999853 24568999886555555577899999999999999999999964 34
Q ss_pred eeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
...++||||+++++|.+++...... .....+++..++.++.|++.|++|||++ +|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 5679999999999999999754321 1123489999999999999999999999 99999999999999
Q ss_pred CCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccC
Q 004218 599 DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAG 677 (767)
Q Consensus 599 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~ 677 (767)
+.++.++|+|||+++....... ........++..|+|||++.+..++.++||||||+++|||+| |+.||......
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 232 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232 (291)
T ss_pred ccCCcEEECCCCcccccCCCce----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999975433211 011123346788999999998899999999999999999999 99998653221
Q ss_pred CcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 678 EVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
. ................. ...+.+++.+||+.||++|||++++++.|+++.+.
T Consensus 233 ~--~~~~~~~~~~~~~~~~~----------------------~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 E--VIECITQGRVLERPRVC----------------------PKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H--HHHHHhCCCCCCCCccC----------------------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 11111111110000000 11123377799999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=314.72 Aligned_cols=264 Identities=25% Similarity=0.395 Sum_probs=198.7
Q ss_pred CCCCCccccccceEEEEEEeCC----CcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-ccce
Q 004218 457 FSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDF-KNME 529 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 529 (767)
|++.+.||+|+||.||+|.... +..||+|.+..... .....+.+|++.++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5778999999999999998642 36799999864422 234578899999999999999999998754332 3334
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++|+|.+++...+.......+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 5799999999999999986654332334689999999999999999999998 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|.++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...+.....
T Consensus 158 g~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYR----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHG 231 (273)
T ss_pred cceeecccccccc----ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC
Confidence 9997653321111 1112234678999999988889999999999999999999 88888553221 111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
.......... + . +.+++.+||+.||++|||+.|+++.|+++
T Consensus 232 ~~~~~~~~~~------------------~---~-~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLKQPEDCL------------------D---E-LYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCcCCC------------------H---H-HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111111 1 1 22277789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.27 Aligned_cols=276 Identities=24% Similarity=0.311 Sum_probs=195.2
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcC---CCCCceeEEeeeecCCcccce
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNT---RHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 529 (767)
+|++.+.||+|+||.||+|.+. +++.||+|.++... ......+.+|+++++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999976 48899999986432 22234566777777665 799999999987654444556
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++ +|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 78999999975 8999886543 23489999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh-
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN- 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~- 688 (767)
|+++...... ......||..|+|||++.+..++.++||||+||++|+|++|++||....... .+.+.....
T Consensus 153 g~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~ 224 (288)
T cd07863 153 GLARIYSCQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIG 224 (288)
T ss_pred CccccccCcc-------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhC
Confidence 9997653221 1123457899999999998889999999999999999999999986532211 111111100
Q ss_pred ccc--chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPK--NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+. .........-.................+...+.+++.+|+++||++|||+.|++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00000000000000000000011111122333457789999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=330.33 Aligned_cols=265 Identities=23% Similarity=0.401 Sum_probs=199.1
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC------CcEEEEEEeeccCC-cchhhHHHHHHHHhcCC-CCCceeEEeeeecCC
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIEST-GTWKSFFAECEALRNTR-HRNLVKLITSCSSLD 524 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 524 (767)
..++|.+.+.||+|+||.||+|.+.. +..||||++..... ...+.+.+|+++++++. ||||++++++|.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--- 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--- 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc---
Confidence 35689999999999999999998632 34799999864432 33467889999999996 999999999964
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCC---------------------------------------------------
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKN--------------------------------------------------- 553 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 553 (767)
.....++||||+++|+|.+++...+..
T Consensus 112 --~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 112 --KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred --cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 345679999999999999998653210
Q ss_pred ---------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 004218 554 ---------------------------------------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPG 594 (767)
Q Consensus 554 ---------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~ 594 (767)
.....+++.++..++.|++.||+|||+. +|+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChH
Confidence 0123488899999999999999999998 9999999999
Q ss_pred CeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCC
Q 004218 595 NILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHE 673 (767)
Q Consensus 595 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~ 673 (767)
||+++.++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNY----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccc----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 999999999999999999765332111 11122346788999999998889999999999999999997 8899865
Q ss_pred cccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 674 SFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
...... ....+....+...... ....+.+++.+||+.||++|||+.++.+.|+++.
T Consensus 343 ~~~~~~-~~~~~~~~~~~~~~~~----------------------~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 343 MIVDST-FYNKIKSGYRMAKPDH----------------------ATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred cchhHH-HHHHHhcCCCCCCCcc----------------------CCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 322111 1111111111000000 1111223777899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.89 Aligned_cols=265 Identities=23% Similarity=0.319 Sum_probs=201.0
Q ss_pred HHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-
Q 004218 450 LRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF- 525 (767)
Q Consensus 450 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~- 525 (767)
.....++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+..+..++|+|++++++.+...+.
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445679999999999999999999864 58999999986542 2345567899999999999999999877643221
Q ss_pred --ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 004218 526 --KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT 603 (767)
Q Consensus 526 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~ 603 (767)
.....+++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence 112257899999999999999975432 134589999999999999999999999 9999999999999999999
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhh
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK 683 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 683 (767)
+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 182 vkL~DFGls~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~-~~~ 256 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSD----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV-MHK 256 (496)
T ss_pred EEEEecccCeeccccccc----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHH
Confidence 999999999765432111 112345689999999999999999999999999999999999999964321100 000
Q ss_pred HhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 684 WVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 684 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
......+ ..+..++ ..+.+++.+||+.||++||++.+++++
T Consensus 257 ~~~~~~~-~~~~~~~----------------------~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYD-PLPPSIS----------------------PEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCC-CCCCCCC----------------------HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0000000 0011111 112236778999999999999999875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=318.86 Aligned_cols=260 Identities=28% Similarity=0.458 Sum_probs=197.2
Q ss_pred cCCCCCCccccccceEEEEEEeCC------CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
..|++.+.||+|+||.||+|.... ...||+|.+..... .....+.+|+++++.++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence 468889999999999999998643 25799998864332 33456889999999999999999999864 3
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNE----------HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNIL 597 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl 597 (767)
....+++|||+++|+|.+++....... ....+++.++..++.|++.||+|||+. +++||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 455799999999999999997643211 014588999999999999999999999 9999999999999
Q ss_pred eCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCccc
Q 004218 598 LDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFA 676 (767)
Q Consensus 598 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~ 676 (767)
+++++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYY----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred EcCCCcEEECCCcceeeccccccc----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999754322111 11122346788999999988889999999999999999998 9999865322
Q ss_pred CCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 677 GEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
. .....+...........+. ..+.+++.+||+.||++||+++|++++|++
T Consensus 233 ~--~~~~~i~~~~~~~~~~~~~----------------------~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 Q--EVIEMIRSRQLLPCPEDCP----------------------ARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H--HHHHHHHcCCcCCCcccCC----------------------HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 1111111111111111111 112237778999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.26 Aligned_cols=247 Identities=29% Similarity=0.395 Sum_probs=185.6
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.+|+..+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+++++.++|+||+++++++ ...+.++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEE
Confidence 34567789999999999999975 589999999864432 2346788999999999999999999985 4556789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++|+|.+.. ..++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 149 lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~ 215 (353)
T PLN00034 149 VLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS 215 (353)
T ss_pred EEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccc
Confidence 999999999986532 156778889999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCC-----CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc-chhhHhh
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-----EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-SLVKWVE 686 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~ 686 (767)
+....... ......||..|+|||++.. ...+.++|||||||++|||++|+.||........ .......
T Consensus 216 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 289 (353)
T PLN00034 216 RILAQTMD------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC 289 (353)
T ss_pred eecccccc------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh
Confidence 76532211 1123468999999998743 2345689999999999999999999963221111 0000000
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+......+. . .+.+++.+||+.||++|||+.|++++
T Consensus 290 ~~~~~~~~~~~~------------------~----~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 290 MSQPPEAPATAS------------------R----EFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccCCCCCCCccC------------------H----HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000011111 1 12236778999999999999999986
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=313.56 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=197.9
Q ss_pred cCCCCCCccccccceEEEEEEeCC----CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
++|++.+.||+|+||.||+|.+.. ...||+|.++.... ...+.+.+|+.++++++||||+++++++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence 578999999999999999999752 45799998865432 33467889999999999999999999853 445
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+||
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~df 150 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECcc
Confidence 6799999999999999997643 2489999999999999999999998 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|+++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .....+...
T Consensus 151 g~~~~~~~~~~~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~ 224 (266)
T cd05033 151 GLSRRLEDSEATY----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDG 224 (266)
T ss_pred chhhcccccccce----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcC
Confidence 9998764211111 1112234678999999998899999999999999999998 99998543211 111221111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
.......... ..+.+++.+||+.+|++||++.|++++|+++
T Consensus 225 ~~~~~~~~~~----------------------~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 YRLPPPMDCP----------------------SALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCC----------------------HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111111011 1122377799999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.83 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=195.3
Q ss_pred CCCCCCccccccceEEEEEEeC-C-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-E-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++. .++.+++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence 4889999999999999999854 3 6789999875554455567788999999999999999999954 4567899
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++|+|.+++..... ...++++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 143 v~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 9999999999998864321 123488999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccch
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
....... ........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..........+. .
T Consensus 218 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~-~ 291 (478)
T PTZ00267 218 QYSDSVS----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-IMQQVLYGKYDP-F 291 (478)
T ss_pred ecCCccc----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC-C
Confidence 6543211 111234568999999999999999999999999999999999999986422110 000101111100 0
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+..++ . .+.+++.+||+.||++||+++|++.+
T Consensus 292 ~~~~s------------------~----~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 PCPVS------------------S----GMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CccCC------------------H----HHHHHHHHHhccChhhCcCHHHHHhC
Confidence 00111 1 12236678999999999999998754
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=313.73 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=196.8
Q ss_pred cCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.+|++.+.||+|+||.||+|.+++ ++.||+|.+... ....+.+.+|+++++.++||||+++++++. .+...++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEE
Confidence 457888999999999999999754 889999998643 334567889999999999999999999864 3456799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+.
T Consensus 80 v~e~~~~~~L~~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 80 ITEFMTYGNLLDYLRECN----RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred EEEeCCCCcHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 999999999999996543 23489999999999999999999998 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .........++..
T Consensus 153 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~ 225 (263)
T cd05052 153 LMTGDTYT-----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKGYRME 225 (263)
T ss_pred ccccceee-----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCCCC
Confidence 65432111 1112224567999999998899999999999999999998 88898542211 1111111111111
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
....++ ..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 226 ~~~~~~----------------------~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCP----------------------PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCC----------------------HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111111 1122377789999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.30 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=197.8
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCc----EEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGI----SVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.+|++.+.||+|+||.||+|.+. +++ .||+|.+.... ....+++.+|+.+++.++||||++++++|...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 46899999999999999999864 233 48999986432 33456788999999999999999999997532
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D 152 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD 152 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence 3479999999999999997643 2388999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 687 (767)
||+++......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .+......
T Consensus 153 fG~a~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~ 226 (316)
T cd05108 153 FGLAKLLGADEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK 226 (316)
T ss_pred ccccccccCCCcce----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhC
Confidence 99998654321111 1112224678999999999999999999999999999998 99998653221 11111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
............ . +.+++.+||..||++|||+.+++..+..+.+..
T Consensus 227 ~~~~~~~~~~~~---------------------~-~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 227 GERLPQPPICTI---------------------D-VYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCCCCCCCH---------------------H-HHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 110000111111 1 122777899999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=312.73 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=198.3
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.++|++.+.||+|++|.||+|.+.+++.||+|.++... ...+.+.+|++++++++||||+++++++. ..+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCeee
Confidence 45789999999999999999998778889999986433 33567889999999999999999999854 4456799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++++|.+++.... +..+++.++..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 79 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 79 VTELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred eeecccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 999999999999997543 23489999999999999999999998 99999999999999999999999999998
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
........ .......+..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+....+..
T Consensus 152 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~ 224 (261)
T cd05068 152 VIKEDIYE-----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGYRMP 224 (261)
T ss_pred EccCCccc-----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCC
Confidence 66422111 0111223457999999998899999999999999999999 99998653211 1111111111111
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
...... ..+.+++.+|++.+|++||++.++++.|++
T Consensus 225 ~~~~~~----------------------~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 CPPGCP----------------------KELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCcCC----------------------HHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 011011 112237778999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=332.38 Aligned_cols=205 Identities=25% Similarity=0.329 Sum_probs=170.8
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++. +...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 5888999999999999999965 48899999996532 234567889999999999999999999854 45678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 99999999999999987643 388999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCC-----------------------------------------ccccccccccCCCCccCccccCCCCCCC
Q 004218 612 ARSLLERIGNQ-----------------------------------------SSISSTHVLKGSIGYIPPEYGLGEKPST 650 (767)
Q Consensus 612 a~~~~~~~~~~-----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 650 (767)
++......... ..........||..|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 76432110000 0000112356999999999999888999
Q ss_pred cccchhhhHHHHHHHhCCCCCCCc
Q 004218 651 AGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 651 ~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
++||||+||++|||++|+.||...
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~ 251 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAP 251 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCC
Confidence 999999999999999999999654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=326.54 Aligned_cols=199 Identities=28% Similarity=0.371 Sum_probs=167.2
Q ss_pred CCCCCCccccccceEEEEEEeC----CCcEEEEEEeecc----CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcc
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIE----STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 526 (767)
+|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+++++.+ +||+|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4888999999999999999853 4789999998643 223345678899999999 599999999884 4
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
.+..+++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl 146 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL 146 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence 5567899999999999999986543 389999999999999999999999 9999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
+|||+++....... .......||..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 147 ~DfG~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 147 TDFGLSKEFLSEEK-----ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred eeCcCCccccccCC-----CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 99999975432211 112235689999999998765 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=317.05 Aligned_cols=275 Identities=28% Similarity=0.372 Sum_probs=199.3
Q ss_pred cCCCCCCccccccceEEEEEEeC-----CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-----EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++.. .+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence 57889999999999999999742 478999999876555556788999999999999999999998653 2344
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++|+|.+++...+ ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence 6799999999999999996543 2389999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|++.......... .......++..|+|||++.+..++.++||||||+++|||++|..|+...... .........
T Consensus 153 g~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~ 226 (284)
T cd05081 153 GLTKVLPQDKEYY---KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDK 226 (284)
T ss_pred cccccccCCCcce---eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhccccc
Confidence 9998654321110 0011122345699999998888999999999999999999998775432111 001000000
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
+ .......+...+..... ..........+.+++.+||+.+|++||||.|+++.|+.+
T Consensus 227 ~---~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 227 Q---GQMIVYHLIELLKNNGR--LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred c---cccchHHHHHHHhcCCc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 00011111111110000 000000111233477799999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=319.23 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=197.0
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++.+. .+...++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEEE
Confidence 58899999999999999999964 58899999997665556678889999999999999999999854 3456799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++++|.+++.... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 95 v~e~~~~~~L~~~~~~~~-------~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 95 VMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred eecccCCCCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence 999999999999986432 78999999999999999999999 99999999999999999999999999987
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc-c
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK-N 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~ 692 (767)
....... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||........ .........+. .
T Consensus 165 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~ 237 (296)
T cd06654 165 QITPEQS------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQ 237 (296)
T ss_pred hcccccc------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcCCCCCCC
Confidence 5432211 11234578899999999888889999999999999999999999965332111 11111000000 0
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
... .+...+.+++.+||..||++|||+.|++++
T Consensus 238 ~~~----------------------~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPE----------------------KLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred Ccc----------------------ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000 111223337778999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.61 Aligned_cols=206 Identities=28% Similarity=0.386 Sum_probs=174.6
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+++++.++||||+++++++ .++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 47899999999999999999976 5899999998643 224456788999999999999999999884 45567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence 899999999999999997653 389999999999999999999998 99999999999999999999999999
Q ss_pred chhhhhhhcCC-----------------------CccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhC
Q 004218 611 LARSLLERIGN-----------------------QSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG 667 (767)
Q Consensus 611 ~a~~~~~~~~~-----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg 667 (767)
++......... ...........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 99765433200 0000112345689999999999999999999999999999999999
Q ss_pred CCCCCCc
Q 004218 668 MSPTHES 674 (767)
Q Consensus 668 ~~p~~~~ 674 (767)
+.||...
T Consensus 227 ~~Pf~~~ 233 (350)
T cd05573 227 FPPFYSD 233 (350)
T ss_pred CCCCCCC
Confidence 9999654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.03 Aligned_cols=260 Identities=27% Similarity=0.390 Sum_probs=201.7
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|++++++++++. .++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 57999999999999999999976 6899999988532 2233567889999999999999999999864 3456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++|+|.+++..... ....+++.++..++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence 7999999999999999865332 134489999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh-hc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES-NF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~ 689 (767)
.+........ ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||................ .+
T Consensus 152 ~~~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (267)
T cd08224 152 LGRFFSSKTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY 225 (267)
T ss_pred eeeeccCCCc------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC
Confidence 9875432211 1123457889999999988889999999999999999999999985432211111111110 01
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
+..... .....+.+++.+||..+|++|||+.++++.+++++
T Consensus 226 ~~~~~~----------------------~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 PPLPAD----------------------HYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCChh----------------------hcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 100000 11112233777899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=315.81 Aligned_cols=273 Identities=26% Similarity=0.317 Sum_probs=198.3
Q ss_pred cCC-CCCCccccccceEEEEEEe-----CCCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 455 GNF-SHENLIGSGSFGSVYKGYL-----REGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 455 ~~~-~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
++| ++.+.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence 344 8889999999999988653 2477899999865432 345678899999999999999999998753 23
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
....++||||+++++|.+++.... +++.++..++.|++.|++|||++ +|+||||||+||++++++.+||+
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~-------l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~ 149 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIG 149 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEe
Confidence 456799999999999999996533 89999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
|||+++......... .......++..|+|||.+.+..++.++||||||+++|||++|+.||................
T Consensus 150 dfg~~~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 226 (283)
T cd05080 150 DFGLAKAVPEGHEYY---RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG 226 (283)
T ss_pred ecccccccCCcchhh---ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc
Confidence 999997654321110 00112235667999999988889999999999999999999999986543221111111000
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
. .....+.......... .........+.+++.+||+.||++|||++++++.|+++.
T Consensus 227 ---~----~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 227 ---Q----MTVVRLIELLERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ---c----cchhhhhhhhhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0 0000111110000000 000001112333777999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=330.00 Aligned_cols=206 Identities=26% Similarity=0.351 Sum_probs=172.4
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 36889999999999999999965 48899999986432 23345678899999999999999999985 45567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence 899999999999999997643 389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCC-----------------------------ccccccccccCCCCccCccccCCCCCCCcccchhhhHHH
Q 004218 611 LARSLLERIGNQ-----------------------------SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVML 661 (767)
Q Consensus 611 ~a~~~~~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il 661 (767)
+++......... ..........||+.|+|||++.+..++.++||||+||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 987543211000 000001235699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCc
Q 004218 662 LEIFTGMSPTHES 674 (767)
Q Consensus 662 ~el~tg~~p~~~~ 674 (767)
|||++|+.||...
T Consensus 227 ~ell~G~~Pf~~~ 239 (363)
T cd05628 227 YEMLIGYPPFCSE 239 (363)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=312.30 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=194.2
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
+.|++.+.||+|+||.||+|.+.++..||+|.+... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEEE
Confidence 457888999999999999999877777999988633 2334678999999999999999999999643 3456999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++|+|.+++..... .+++..++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.++.
T Consensus 78 ~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 78 TEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred EEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCcccee
Confidence 999999999999975432 389999999999999999999999 999999999999999999999999999875
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccch
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
...... .......++..|+|||...+..++.++||||||+++|+|++ |+.||...... .....+........
T Consensus 150 ~~~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 222 (256)
T cd05113 150 VLDDEY-----TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLRLYR 222 (256)
T ss_pred cCCCce-----eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCCCCC
Confidence 533211 01112235678999999988889999999999999999998 99998543221 11111111111100
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
..... ..+.+++.+||+.||.+|||+.++++.|+
T Consensus 223 ~~~~~----------------------~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLAS----------------------EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCC----------------------HHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11111 11223777899999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=323.89 Aligned_cols=242 Identities=26% Similarity=0.353 Sum_probs=186.9
Q ss_pred CccccccceEEEEEEeC----CCcEEEEEEeecc----CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 461 NLIGSGSFGSVYKGYLR----EGISVAVKVLDIE----STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+.||+|+||.||+++.. +++.||+|++... .......+.+|+++++.++||||+++++++. .++..+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence 67999999999999853 4789999998643 2233456778999999999999999999853 455789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (323)
T cd05584 77 LILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC 147 (323)
T ss_pred EEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999987543 378889999999999999999999 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .......... .
T Consensus 148 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-~~~~~~~~~~--~ 218 (323)
T cd05584 148 KESIHEG------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-TIDKILKGKL--N 218 (323)
T ss_pred eecccCC------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCC--C
Confidence 6432211 11233568999999999998889999999999999999999999996532110 0000000000 0
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
.+..++ ..+.+++.+||+.||++|| ++.+++++
T Consensus 219 ~~~~~~----------------------~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 LPPYLT----------------------PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCC----------------------HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 011111 1122377789999999999 78888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.25 Aligned_cols=206 Identities=26% Similarity=0.349 Sum_probs=172.3
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|++. +++.||||++... .......+.+|+++++.++||||+++++++ ..+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 46899999999999999999976 4899999999643 223445678899999999999999999985 45567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence 899999999999999987543 389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCcc--------------------------------ccccccccCCCCccCccccCCCCCCCcccchhhh
Q 004218 611 LARSLLERIGNQSS--------------------------------ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFG 658 (767)
Q Consensus 611 ~a~~~~~~~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG 658 (767)
+++.+......... ........||+.|+|||++.+..++.++||||+|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 98754321100000 0001124589999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCc
Q 004218 659 VMLLEIFTGMSPTHES 674 (767)
Q Consensus 659 ~il~el~tg~~p~~~~ 674 (767)
|++|||++|..||...
T Consensus 227 ~il~el~~G~~Pf~~~ 242 (364)
T cd05599 227 VIMYEMLVGYPPFCSD 242 (364)
T ss_pred hHHHHhhcCCCCCCCC
Confidence 9999999999999653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=318.02 Aligned_cols=250 Identities=34% Similarity=0.519 Sum_probs=186.4
Q ss_pred CCCccccccceEEEEEEeC-----CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 459 HENLIGSGSFGSVYKGYLR-----EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 459 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+.+.||.|.||.||+|.+. .+..|+||.+..... ...+.+.+|++.+++++||||++++|+|. ..+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence 4578999999999999977 267899999964333 34688999999999999999999999986 233379
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++|+|.+++.... ...+++.++..|+.|+++||+|||++ +++||||+++||++++++.+||+|||++
T Consensus 78 lv~e~~~~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~ 150 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS 150 (259)
T ss_dssp EEEE--TTEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred ccccccccccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 9999999999999998762 23489999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
....... .........+...|+|||.+....++.++||||||+++||+++ |+.||..... ..+...+......
T Consensus 151 ~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~~~~~~ 224 (259)
T PF07714_consen 151 RPISEKS----KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLKQGQRL 224 (259)
T ss_dssp EETTTSS----SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHHTTEET
T ss_pred ccccccc----cccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccc
Confidence 7652211 1111223346778999999988889999999999999999999 6788755421 1112222221111
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
..+..++..+. +++.+||+.||++|||+.|+++.|
T Consensus 225 ~~~~~~~~~~~----------------------~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIY----------------------SLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHH----------------------HHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHH----------------------HHHHHHcCCChhhCcCHHHHHhcC
Confidence 11222222222 266789999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=325.63 Aligned_cols=242 Identities=27% Similarity=0.354 Sum_probs=187.4
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEe
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
+.||+|+||.||++... +++.||+|++... .......+.+|+++++.++||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46899999999999965 5899999999653 223345678899999999999999999884 44567899999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 999999999886543 38999999999999999999997 6 9999999999999999999999999998643
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhh
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQ 695 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (767)
.... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .....+... ....+.
T Consensus 147 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~i~~~-~~~~p~ 217 (325)
T cd05594 147 IKDG------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILME-EIRFPR 217 (325)
T ss_pred CCCC------cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHHHhcC-CCCCCC
Confidence 2111 1112346899999999999989999999999999999999999999653211 111111000 000011
Q ss_pred hccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 696 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
.+++ .+.+++.+||+.||++|+ ++.|++++
T Consensus 218 ~~~~----------------------~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSP----------------------EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCH----------------------HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1111 122366689999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=323.55 Aligned_cols=197 Identities=27% Similarity=0.399 Sum_probs=165.3
Q ss_pred CCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHH---hcCCCCCceeEEeeeecCCcccce
Q 004218 457 FSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEAL---RNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++ +.++||||+++++++ ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 677899999999999999965 58999999996432 23345566776665 456899999999985 4556
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..|+||||+++|+|..++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 789999999999999888643 389999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|+++..... ........|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 146 g~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 146 GLCKEGMGF------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred cCCccCCCC------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 998643211 11123456899999999999989999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=310.32 Aligned_cols=251 Identities=29% Similarity=0.449 Sum_probs=193.5
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
.+|++.+.||+|+||.||+|.++++..+|+|.+... ......+.+|++++++++||||+++++++. .....++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEE
Confidence 357888999999999999999887778999988532 223457889999999999999999999854 34567999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++.
T Consensus 78 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 78 TEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred EecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCccccee
Confidence 999999999999975432 389999999999999999999999 999999999999999999999999999876
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccch
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
..+.... ......++..|+|||.+.+..++.++||||||+++|++++ |+.||...... .....+....+...
T Consensus 150 ~~~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 222 (256)
T cd05059 150 VLDDQYT-----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGYRLYR 222 (256)
T ss_pred ccccccc-----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcCCcCCC
Confidence 5322110 0111223467999999998899999999999999999999 88998653221 11111111111111
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
....+. .+.+++.+||..+|++|||+.|+++.|
T Consensus 223 ~~~~~~----------------------~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPT----------------------EVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCH----------------------HHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111111 122377799999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=324.58 Aligned_cols=247 Identities=28% Similarity=0.453 Sum_probs=199.3
Q ss_pred CCCccccccceEEEEEEeCC-CcEEEEEEeec----cCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 459 HENLIGSGSFGSVYKGYLRE-GISVAVKVLDI----ESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 459 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
...+||+|+|-+||+|.+.. |..||--.++. ..+...++|..|+++|+.++||||+++++++.+.. ...+-+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in~ 120 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTINF 120 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceeee
Confidence 34679999999999999754 77777544322 24445688999999999999999999999987532 366789
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEccccch
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD-EDMTAKVGDFGLA 612 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a 612 (767)
|+|.+..|+|..|..+.++ ++...+..|++||++||.|||++ .++|+|||||.+||||+ ..|.|||+|+|+|
T Consensus 121 iTEL~TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred eeecccCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHH
Confidence 9999999999999998775 88999999999999999999998 77999999999999998 4589999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
+...... ...+.|||.|||||++. ..|++.+||||||+++.||+|+.+||........-+.+-..+..|..
T Consensus 194 tl~r~s~--------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 194 TLLRKSH--------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred HHhhccc--------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 8764332 13367999999999876 78999999999999999999999999765443333333333444444
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+-++.++. +|.+|+.. .++|||+.|+++.
T Consensus 265 l~kV~dPevr~----------------------fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 265 LSKVKDPEVRE----------------------FIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hhccCCHHHHH----------------------HHHHHhcC-chhccCHHHHhhC
Confidence 44554554444 55679999 9999999999864
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=345.20 Aligned_cols=269 Identities=22% Similarity=0.309 Sum_probs=198.7
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.++||+|+||.||+|.+. +++.||+|++..... ...+++.+|++++++++||||+++++++. +++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 58999999999999999999976 489999999864322 23457889999999999999999999854 4456
Q ss_pred eEEEEeecCCCChhhhhcccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 004218 531 LALVYEFLGNGSLGDWIHGERKN-----EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
.++||||++||+|.+++...... ......++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 79999999999999998643211 1123467888899999999999999999 999999999999999999999
Q ss_pred EccccchhhhhhhcCCC------------ccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 606 VGDFGLARSLLERIGNQ------------SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
|+|||+++......... ..........||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 99999998652111000 001111235699999999999999999999999999999999999999965
Q ss_pred cccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-CHHHHHHHHHHHH
Q 004218 674 SFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-DIREALRRLKNAQ 752 (767)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~~ 752 (767)
............ ..+.... . ...+...+.+++.+|++.||++|| +++++.+.|+...
T Consensus 234 ~~~~ki~~~~~i--~~P~~~~----------------p----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 234 KKGRKISYRDVI--LSPIEVA----------------P----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred cchhhhhhhhhc--cChhhcc----------------c----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 322111100000 0000000 0 000111223377789999999997 5666777777654
Q ss_pred H
Q 004218 753 K 753 (767)
Q Consensus 753 ~ 753 (767)
.
T Consensus 292 q 292 (932)
T PRK13184 292 Q 292 (932)
T ss_pred h
Confidence 4
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=322.43 Aligned_cols=193 Identities=28% Similarity=0.377 Sum_probs=164.4
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|.+. +++.||+|+++.. .....+.+.+|..+++.+ +||||+++++++ .....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46899999999999975 4889999999753 223345678899999888 799999999985 3456789999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 9999999999886543 399999999999999999999999 9999999999999999999999999998642
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
... ........||..|+|||++.+..++.++||||+||++|+|++|+.||+.
T Consensus 147 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 147 IRP------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccC------CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 111 1112345689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=315.68 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=196.0
Q ss_pred HhcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF 525 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 525 (767)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... .....++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~---- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 4678999999999999999999854 25679999885332 223456889999999999999999999853
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNE----HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED 601 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~ 601 (767)
.+...++||||+++|+|.+++...+... ....+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 4456799999999999999997543211 123468889999999999999999998 99999999999999999
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcc
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVS 680 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~ 680 (767)
+.++|+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||...... .
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~ 229 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYR----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--Q 229 (277)
T ss_pred CCEEECCCCCccccCCcceee----cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 999999999987543321111 0112235678999999998889999999999999999999 68888543221 1
Q ss_pred hhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 681 LVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
..+.+............ ...+.+++.+||+.||++|||+.|+++.|+
T Consensus 230 ~~~~~~~~~~~~~~~~~----------------------~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 VLRFVMEGGLLDKPDNC----------------------PDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHcCCcCCCCCCC----------------------CHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111111000001101 112233777999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.05 Aligned_cols=254 Identities=21% Similarity=0.259 Sum_probs=192.9
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++ .++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 3568999999999999999999975 4889999998643 223345577899999999999999999884 455
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++|+|.+++.... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~-------l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNYD-------IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence 67899999999999999986532 78889999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCC----CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhH
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE----KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 684 (767)
||.+........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .....
T Consensus 186 fG~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i 259 (370)
T cd05596 186 FGTCMKMDANGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKI 259 (370)
T ss_pred ccceeeccCCCc-----ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHH
Confidence 999976432211 111235689999999988653 37889999999999999999999996532110 01111
Q ss_pred hhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCC--CCCHHHHHHH
Q 004218 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGG--RIDIREALRR 747 (767)
Q Consensus 685 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~ 747 (767)
.........+. ... +...+.+++.+|++.+|.+ |||++|++++
T Consensus 260 ~~~~~~~~~~~----------------~~~----~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 260 MDHKNSLTFPD----------------DIE----ISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HcCCCcCCCCC----------------cCC----CCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 10000000000 000 1112223667899999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.13 Aligned_cols=206 Identities=26% Similarity=0.313 Sum_probs=171.0
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
+.|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++.+ .+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 36899999999999999999965 4899999998543 123346678999999999999999999985 45567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 899999999999999997643 388899999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCC-------------------------------------CccccccccccCCCCccCccccCCCCCCCccc
Q 004218 611 LARSLLERIGN-------------------------------------QSSISSTHVLKGSIGYIPPEYGLGEKPSTAGD 653 (767)
Q Consensus 611 ~a~~~~~~~~~-------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 653 (767)
++..+...... ...........||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 97533110000 00000112356999999999999999999999
Q ss_pred chhhhHHHHHHHhCCCCCCCc
Q 004218 654 VYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 654 v~slG~il~el~tg~~p~~~~ 674 (767)
|||+||++|||++|+.||...
T Consensus 227 iwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred eeeccceeeehhhCCCCCCCC
Confidence 999999999999999999654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=326.71 Aligned_cols=204 Identities=27% Similarity=0.358 Sum_probs=169.8
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-ccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKN 527 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~ 527 (767)
...++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34578999999999999999999975 4899999998543 2334567889999999999999999999875432 223
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
....++||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~ 165 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 165 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence 3467999999975 67666632 278889999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|||+++..... .......||..|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 166 Dfg~a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 166 DFGLARTACTN-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cCCCccccccC-------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999754221 1112346899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.77 Aligned_cols=204 Identities=24% Similarity=0.329 Sum_probs=171.6
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
....++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~ 113 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----Q 113 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----E
Confidence 334578999999999999999999976 4889999998642 223345678899999999999999999984 4
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
++..+++||||+++|+|.+++.... +++..+..++.|++.||+|||++ +|+||||||+||++++++.+||
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~~-------~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL 183 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNYD-------VPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKL 183 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEE
Confidence 5667899999999999999996532 88899999999999999999999 9999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC----CCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK----PSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+|||++........ .......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...
T Consensus 184 ~DFG~a~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 184 ADFGTCMKMDETGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred EecccceecccCCc-----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 99999976532111 1113456999999999986543 788999999999999999999999653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.96 Aligned_cols=194 Identities=30% Similarity=0.407 Sum_probs=164.5
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|+.+ +++.||+|++... .....+.+..|..+++.. +||||+++++++ .....+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 46899999999999976 4889999998643 233456677888888876 699999999985 4556789999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 9999999999987643 389999999999999999999999 9999999999999999999999999998643
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 147 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 147 IFN------GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred CcC------CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 211 11123456899999999999889999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=321.81 Aligned_cols=193 Identities=28% Similarity=0.381 Sum_probs=163.6
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++.++ +||||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 46999999999999975 4889999999754 223345677898888776 899999999985 3456789999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9999999999886543 389999999999999999999999 9999999999999999999999999998743
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
.... .......||..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 147 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 147 LRPG------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cCCC------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 2111 112345689999999999999999999999999999999999999954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=321.75 Aligned_cols=199 Identities=26% Similarity=0.369 Sum_probs=167.1
Q ss_pred CCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCC-CceeEEeeeecCCccccee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNTRHR-NLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 530 (767)
+|++.+.||+|+||.||+|+... ++.||+|++... .....+.+..|.+++..+.|+ +|+++++++ ...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 47889999999999999999764 789999998643 233456778899999999765 577787774 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 899999999999999987543 388999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
++...... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 147 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 147 MCKENIFG------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred cceecCCC------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 98642111 11123456899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.04 Aligned_cols=249 Identities=30% Similarity=0.427 Sum_probs=194.8
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
.+|++.+.||+|+||.||++... |..||+|.+... ...+.+.+|+.++++++|+|++++++++. ..+...++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEEE
Confidence 47888999999999999999876 788999988533 33467889999999999999999999753 234567999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++++|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||.+..
T Consensus 79 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 79 TEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151 (256)
T ss_pred EECCCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCcccee
Confidence 99999999999987543 23488999999999999999999999 999999999999999999999999999875
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccch
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
..... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||..... ......+....+...
T Consensus 152 ~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 220 (256)
T cd05082 152 ASSTQ---------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKMDA 220 (256)
T ss_pred ccccC---------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCCCC
Confidence 42211 12234567999999988889999999999999999998 9999854211 111111111111111
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
.+..+ ..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 221 ~~~~~----------------------~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 PDGCP----------------------PVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCC----------------------HHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11111 122237778999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.09 Aligned_cols=269 Identities=25% Similarity=0.313 Sum_probs=203.7
Q ss_pred cCHHHHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeec
Q 004218 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSS 522 (767)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 522 (767)
+.++.+..+.++|++.+.||+|+||.||+|... +++.||+|+..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 556677788899999999999999999999975 48899999875422 2335678899999999 69999999998865
Q ss_pred CCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 004218 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM 602 (767)
Q Consensus 523 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~ 602 (767)
.....+...++||||+++++|.+++..... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLK--RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhc--cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 555566788999999999999998764321 123488999999999999999999999 999999999999999999
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC-----CCCCCcccchhhhHHHHHHHhCCCCCCCcccC
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-----EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAG 677 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 677 (767)
.+||+|||.++....... ......|+..|+|||++.. ..++.++||||+||++|||++|+.||......
T Consensus 162 ~~kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred CEEEccCCceeecccCCC------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 999999999876532211 1123458899999998753 44788999999999999999999998653221
Q ss_pred CcchhhHhhhhcccc-hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 678 EVSLVKWVESNFPKN-AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 678 ~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
. ..........+.. .....+ ..+.+++.+||+.||++|||+.|++++.
T Consensus 236 ~-~~~~~~~~~~~~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 236 R-ALFKIPRNPPPTLHQPELWS----------------------NEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred H-HHhhccccCCCcccCCCCcC----------------------HHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1 0100000000000 000000 1122377789999999999999999763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=318.44 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=203.5
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCc---chhhHHHHHHHHhcCC-CCCceeEEeeeecCCccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTG---TWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 527 (767)
....|++.+.||+|.||.||+++.+. |+.+|+|++.+.... ....+.+|+++|+++. ||||+.+++++ ++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----ED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ec
Confidence 45678999999999999999999775 999999999765332 3468899999999998 99999999995 45
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC----Cc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED----MT 603 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~----~~ 603 (767)
...+++|||++.||.|.+.+... .+++.++..++.|++.|++|||+. ||+|||+||+|+++... +.
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCc
Confidence 56789999999999999999765 189999999999999999999998 99999999999999633 57
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhh
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK 683 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 683 (767)
+|++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.......... .
T Consensus 178 ik~~DFGla~~~~~-------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~ 249 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKP-------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-A 249 (382)
T ss_pred EEEeeCCCceEccC-------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-H
Confidence 99999999987643 223467889999999999999999999999999999999999999997644322211 1
Q ss_pred Hhhh--hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 684 WVES--NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 684 ~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... .++...+..+. ..+++++..|+..||.+|+|+.+++++
T Consensus 250 i~~~~~~f~~~~w~~is----------------------~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 250 ILRGDFDFTSEPWDDIS----------------------ESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHcCCCCCCCCCccccC----------------------HHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111 12222222222 223346668999999999999999996
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.18 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=194.7
Q ss_pred CCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCC------cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIEST------GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
+|++.+.||+|+||.||+|...+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++. ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cCC
Confidence 4888999999999999999988899999998864321 12356889999999999999999999964 346
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccc
Confidence 7799999999999999996543 278999999999999999999998 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh-h
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES-N 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~ 688 (767)
|.+....................|+..|+|||++.+..++.++||||+|+++|+|++|+.||........ ....... .
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~~ 225 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYIGAHRG 225 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHhhhccC
Confidence 9998653321111111112334588999999999988899999999999999999999999964321110 0000000 0
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
.........+ ..+.+++.+||+.+|++||++.|+++
T Consensus 226 ~~~~~~~~~~----------------------~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPRLPDSFS----------------------AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCCC----------------------HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000111111 11223677899999999999999976
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.36 Aligned_cols=257 Identities=26% Similarity=0.347 Sum_probs=194.6
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCc----EEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGI----SVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
++|++.+.||+|+||.||+|.+. +++ +|++|.+..... ....++..|+..+++++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence 46888899999999999999974 344 477887753322 234567788889999999999999998632
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D 152 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD 152 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence 23578999999999999997543 2389999999999999999999998 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 687 (767)
||.++........ .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ...+.+..
T Consensus 153 fg~~~~~~~~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~ 226 (279)
T cd05111 153 FGVADLLYPDDKK----YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEK 226 (279)
T ss_pred CccceeccCCCcc----cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC
Confidence 9999765332111 11123446788999999988889999999999999999998 99998653221 11111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
............ . +.+++.+||..||++|||+.|+++.|..+.+
T Consensus 227 ~~~~~~~~~~~~---------------------~-~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 227 GERLAQPQICTI---------------------D-VYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCcCCCCCCCCH---------------------H-HHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111010111110 1 1126678999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.08 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=195.6
Q ss_pred cCCCCCCccccccceEEEEEEe-----CCCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYL-----REGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
..|++.+.||+|+||.||+|.+ .++..||+|.+.... ......+.+|+++++.++||||+++++++. .+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence 4678889999999999999984 236789999986433 233467889999999999999999999854 44
Q ss_pred eeeEEEEeecCCCChhhhhcccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKN-----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNIL 597 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl 597 (767)
...++||||+++++|.+++...... .....+++.++..++.|++.||+|||++ +++||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 5679999999999999998543210 0123488999999999999999999999 9999999999999
Q ss_pred eCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCccc
Q 004218 598 LDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFA 676 (767)
Q Consensus 598 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~ 676 (767)
+++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYY----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred EcCCCcEEeccccccccccCCcce----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999765332111 11122335678999999988889999999999999999998 8889854321
Q ss_pred CCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 677 GEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
......+...........+++. +.+++.+||+.||++||++.++.++|+.
T Consensus 233 --~~~~~~~~~~~~~~~~~~~~~~----------------------~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 --QEVIEMVRKRQLLPCSEDCPPR----------------------MYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHHHHHcCCcCCCCCCCCHH----------------------HHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111221111111111111111 2226678999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.68 Aligned_cols=266 Identities=24% Similarity=0.378 Sum_probs=198.2
Q ss_pred hcCCCCCCccccccceEEEEEEe------CCCcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL------REGISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDF 525 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 525 (767)
.++|++.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence 35799999999999999999974 247889999986433 23345688999999999 68999999998743
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCC---------------------------------------------------
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNE--------------------------------------------------- 554 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 554 (767)
.+..+++||||+++|+|.+++.......
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 3346789999999999999986532100
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCcc
Q 004218 555 ----------HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624 (767)
Q Consensus 555 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 624 (767)
....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--- 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch---
Confidence 012478889999999999999999999 9999999999999999999999999999765322111
Q ss_pred ccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHH
Q 004218 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQ 703 (767)
Q Consensus 625 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 703 (767)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..............+...++
T Consensus 236 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---- 309 (343)
T cd05103 236 -VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMRAPDYTTP---- 309 (343)
T ss_pred -hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCCCCCCCCCCH----
Confidence 01112335678999999988889999999999999999997 888985532211 11111111100000111111
Q ss_pred hhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 704 LMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
.+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus 310 ------------------~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 310 ------------------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ------------------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11226778999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=314.02 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=204.8
Q ss_pred CCCCCccccccceEEEEEEeCC---C--cEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 457 FSHENLIGSGSFGSVYKGYLRE---G--ISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.+..+.||.|-||.||+|...+ | -.||||.-+.+ ..+..+.|+.|+.+|++++||||++++|+|... .
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence 4455689999999999999543 3 35888887653 445678899999999999999999999998643 3
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.|||||.++.|.|.+|++..+. .++......+++||+.||+|||+. .+|||||..+||++.+...+||+|||
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred eeEEEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence 5999999999999999987654 389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
+++.+.+......+ ...-...|||||.+.-.+++.++|||.||+++||++. |..||......+.-. .++..-
T Consensus 537 LSR~~ed~~yYkaS-----~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--~iEnGe 609 (974)
T KOG4257|consen 537 LSRYLEDDAYYKAS-----RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--HIENGE 609 (974)
T ss_pred hhhhccccchhhcc-----ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--EecCCC
Confidence 99988766544332 1223567999999999999999999999999999986 899997754433211 111112
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
+...++.+.+.+.. ++.+||.+||.+||.+.|+...|.++..
T Consensus 610 RlP~P~nCPp~LYs----------------------lmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 610 RLPCPPNCPPALYS----------------------LMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCChHHHH----------------------HHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 22234445555543 5557999999999999999999988765
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.28 Aligned_cols=266 Identities=22% Similarity=0.347 Sum_probs=203.7
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC-----CcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE-----GISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
..++|++.+.||+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---- 79 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE---- 79 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 34688999999999999999999765 688999988533 23345668899999999999999999998753
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKN--EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA 604 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~ 604 (767)
.+...++++||+++|+|.+++...... ..+..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcE
Confidence 245568999999999999999764321 1124589999999999999999999998 99999999999999999999
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhh
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVK 683 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~ 683 (767)
||+|||+++.+....... ......++..|+|||++.+..++.++||||+|+++||+++ |+.||..... ..+..
T Consensus 157 kl~d~g~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~ 230 (280)
T cd05043 157 KITDNALSRDLFPMDYHC----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAA 230 (280)
T ss_pred EECCCCCcccccCCceEE----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHH
Confidence 999999997653321110 1112335678999999988889999999999999999999 9999865321 12222
Q ss_pred HhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 684 WVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 684 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
+....++......+++ .+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 231 ~~~~~~~~~~~~~~~~----------------------~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 231 YLKDGYRLAQPINCPD----------------------ELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHcCCCCCCCCcCCH----------------------HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2222111110111111 12237778999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=314.99 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=192.8
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
+|++.+.||+|+||.||++.+. +++.||+|++.... ......+.+|+++++.++||||+++++++. .+...
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence 4788899999999999999965 58999999986432 222345778999999999999999999853 44578
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++|+|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMG----NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEEeccCCCcHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999998886432 23489999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+....... ......|+..|+|||++.+..++.++||||+|+++|||++|+.||....... ..+.+...
T Consensus 149 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~--- 216 (285)
T cd05605 149 AVEIPEGE-------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERR--- 216 (285)
T ss_pred ceecCCCC-------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHH---
Confidence 87543211 1123358899999999998889999999999999999999999996532111 00000000
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
+.... ......+...+.+++.+||+.||++|| ++++++++
T Consensus 217 ---------~~~~~-------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 217 ---------VKEDQ-------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---------hhhcc-------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00000 000011122233477799999999999 88898775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=331.09 Aligned_cols=206 Identities=25% Similarity=0.335 Sum_probs=170.8
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++ .++.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 36889999999999999999965 5899999998543 223346678899999999999999999985 45567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence 899999999999999997543 388999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCC---------ccc--------------------------------cccccccCCCCccCccccCCCCCC
Q 004218 611 LARSLLERIGNQ---------SSI--------------------------------SSTHVLKGSIGYIPPEYGLGEKPS 649 (767)
Q Consensus 611 ~a~~~~~~~~~~---------~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~ 649 (767)
+++.+....... ... .......||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 996432110000 000 000124699999999999998999
Q ss_pred CcccchhhhHHHHHHHhCCCCCCCc
Q 004218 650 TAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 650 ~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
.++||||+||++|||++|+.||...
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~ 251 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSE 251 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCC
Confidence 9999999999999999999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=322.05 Aligned_cols=194 Identities=27% Similarity=0.376 Sum_probs=164.2
Q ss_pred CccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|+... ++.||+|++... .....+.+..|.++++.+ +||||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 469999999999999764 789999998653 233445677899988866 799999999985 3456789999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999887543 389999999999999999999999 9999999999999999999999999998753
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
.... .......||..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 147 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 147 ILNG------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred ccCC------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 2211 1123356899999999999889999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.44 Aligned_cols=194 Identities=30% Similarity=0.450 Sum_probs=162.5
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++... +||||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999975 48899999986432 23345566677777654 899999999985 3456789999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 9999999999987543 389999999999999999999999 9999999999999999999999999999753
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 147 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 147 MNGE------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred CCCC------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 2211 1123456899999999999989999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=319.11 Aligned_cols=241 Identities=29% Similarity=0.403 Sum_probs=184.6
Q ss_pred CccccccceEEEEEEeCC-CcEEEEEEeeccC---CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLRE-GISVAVKVLDIES---TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|.+.+ ++.||+|+++... ....+.+..|..++... +||||+++++++. ..+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 468999999999999764 7899999986531 23445667788888764 8999999999853 455789999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999999999997543 388999999999999999999999 9999999999999999999999999998643
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhh
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQ 695 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (767)
... ........||..|+|||++.+..++.++||||+||++|||++|+.||...... .....+....+. .+.
T Consensus 147 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~~~-~~~ 217 (316)
T cd05619 147 MLG------DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMDNPC-YPR 217 (316)
T ss_pred CCC------CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC-CCc
Confidence 211 11123456899999999999989999999999999999999999999653211 111111111000 001
Q ss_pred hccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHH-HHHH
Q 004218 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIR-EALR 746 (767)
Q Consensus 696 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~ 746 (767)
.++ ..+.+++.+||+.||++||++. ++.+
T Consensus 218 ~~~----------------------~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLT----------------------REAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCC----------------------HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111 1122367789999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.45 Aligned_cols=254 Identities=27% Similarity=0.426 Sum_probs=196.4
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|++++++++++. ....++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEE
Confidence 357889999999999999999988888899999864332 3467899999999999999999998752 234689
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
+|||+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+.
T Consensus 78 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred EEEecCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeee
Confidence 999999999999997543 23489999999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
........ ......++..|+|||...+..++.++||||||+++|+|++ |..||...... ..........+..
T Consensus 151 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~ 223 (260)
T cd05070 151 LIEDNEYT-----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGYRMP 223 (260)
T ss_pred eccCcccc-----cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCC
Confidence 65322110 1112235668999999988889999999999999999999 88898553211 1111111111111
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
..... ...+.+++.+|+..+|++|||++++.+.|++
T Consensus 224 ~~~~~----------------------~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDC----------------------PISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcC----------------------CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01001 1123337779999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.10 Aligned_cols=195 Identities=28% Similarity=0.405 Sum_probs=164.1
Q ss_pred cccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeec
Q 004218 463 IGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 463 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
||+|+||.||++.+. +++.||+|.+.... ....+.+..|+++++.++||||+++.+++ ......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999965 58899999986432 22345677899999999999999999884 3455689999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhh
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 618 (767)
++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 76 ~~g~L~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 76 NGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 99999988754321 134589999999999999999999999 9999999999999999999999999999755332
Q ss_pred cCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 619 IGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 619 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
.. ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..
T Consensus 151 ~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 151 QS------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred Cc------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 11 12234689999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=333.19 Aligned_cols=205 Identities=28% Similarity=0.397 Sum_probs=165.1
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc---ccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF---KNM 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~ 528 (767)
...+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++....+ ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999975 48899999885322 234579999999999999999987644322 223
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-TAKVG 607 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~ 607 (767)
.++++||||+++ ++.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 467899999975 78777754321 134589999999999999999999999 999999999999999664 79999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|||+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|.+||...
T Consensus 214 DFGla~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 214 DFGSAKNLLAGQ-------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred ccccchhccCCC-------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998653321 11234579999999987654 6899999999999999999999999653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.50 Aligned_cols=255 Identities=29% Similarity=0.430 Sum_probs=196.5
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.++|++.+.||+|+||.||+|.+.+...||+|.++... ...+.+.+|+++++.++||||+++++++. ....++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcEE
Confidence 35799999999999999999998777789999986432 23467889999999999999999998742 234689
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++|+|.+++.... ...+++..+..++.|++.||+|+|+. +++||||||+||++++++.++|+|||.++
T Consensus 78 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEM----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred EEEcCCCCcHHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCcee
Confidence 999999999999997532 23478999999999999999999998 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
........ ......++..|+|||+..+..++.++||||||+++|+|++ |+.||....... .........+..
T Consensus 151 ~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~ 223 (262)
T cd05071 151 LIEDNEYT-----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYRMP 223 (262)
T ss_pred eccccccc-----cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHHHHhcCCCCC
Confidence 65332111 1122345678999999988889999999999999999999 788885432211 111111000000
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
... . ....+.+++.+|++.||++||+++++++.|+..
T Consensus 224 ~~~------------------~----~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPP------------------E----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred Ccc------------------c----cCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 000 0 111122377899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.45 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=188.4
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeec
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
+.||+|+||.||+|.+. +++.||+|.+.... .+....+.+|++++++++||||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence 46899999999999975 58899999875432 233567899999999999999999999964 345679999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhh
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 618 (767)
++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 76 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 76 QGGDFLTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred cCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence 9999999986532 2388999999999999999999999 9999999999999999999999999998754321
Q ss_pred cCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchhhhc
Q 004218 619 IGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQVL 697 (767)
Q Consensus 619 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (767)
... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||...... ..........+.......
T Consensus 148 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 221 (252)
T cd05084 148 VYA----STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGVRLPCPELC 221 (252)
T ss_pred ccc----ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCCCCcccC
Confidence 100 00011123457999999988889999999999999999998 88888543211 111111111111111111
Q ss_pred cHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 698 DRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 698 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
+ ..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 222 ~----------------------~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 P----------------------DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred C----------------------HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1 11223777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.99 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=197.2
Q ss_pred CCCCCCccccccceEEEEEEeCC------CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
+|++.+.||+|+||.||+|.... ...+|+|.+..... ...+.+.+|+.+++.++||||+++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 47788999999999999998632 35689998864432 23467889999999999999999999864 33
Q ss_pred eeeEEEEeecCCCChhhhhcccCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKN------------------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCD 590 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 590 (767)
...++||||+++|+|.+++...+.. .....+++.+++.++.|++.||+|||+. +++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 4569999999999999998753221 1123588999999999999999999998 999999
Q ss_pred CCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCC
Q 004218 591 LKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMS 669 (767)
Q Consensus 591 lkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~ 669 (767)
|||+||++++++.+||+|||.++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 228 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYV----KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchh----cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCC
Confidence 99999999999999999999997653321111 1122335678999999988889999999999999999998 999
Q ss_pred CCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 670 PTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 670 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
||...... .+.......+......... . .+.+++.+||+.+|++||+++|+++.|+
T Consensus 229 p~~~~~~~--~~~~~~~~~~~~~~~~~~~------------------~----~~~~~i~~cl~~~P~~Rp~~~~i~~~l~ 284 (290)
T cd05045 229 PYPGIAPE--RLFNLLKTGYRMERPENCS------------------E----EMYNLMLTCWKQEPDKRPTFADISKELE 284 (290)
T ss_pred CCCCCCHH--HHHHHHhCCCCCCCCCCCC------------------H----HHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 98543211 1112211111111111111 1 1222777899999999999999999998
Q ss_pred HHHH
Q 004218 750 NAQK 753 (767)
Q Consensus 750 ~~~~ 753 (767)
++..
T Consensus 285 ~~~~ 288 (290)
T cd05045 285 KMMV 288 (290)
T ss_pred HHHh
Confidence 8754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=319.10 Aligned_cols=240 Identities=27% Similarity=0.381 Sum_probs=184.2
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|.++ +|+.||+|+++... ....+.+..|..++... +||||+++++++ ...+.+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46999999999999976 48899999986532 23445667788888754 899999999985 4556789999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999999999986543 389999999999999999999999 9999999999999999999999999998642
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhh
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQ 695 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (767)
... ........||..|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+....+. .+.
T Consensus 147 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~~~~-~~~ 217 (316)
T cd05620 147 VFG------DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVDTPH-YPR 217 (316)
T ss_pred ccC------CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC-CCC
Confidence 111 11123456899999999999999999999999999999999999999653211 111111111100 011
Q ss_pred hccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHH-HHH
Q 004218 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIR-EAL 745 (767)
Q Consensus 696 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl 745 (767)
.+.. -+.+++.+||+.||++||++. +++
T Consensus 218 ~~~~----------------------~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITK----------------------ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCH----------------------HHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111 122366789999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.80 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=200.7
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|... +++.||||.+.... ....+++.+|+++++.++||||+++++++. .++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 47888999999999999999964 68999999875432 223457889999999999999999999854 4456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.+++|||+++++|.+++..... ....+++..++.++.|++.|++|||++ +++|+||||+||+++.++.++|+|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence 7999999999999999864321 123589999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh-hc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES-NF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~ 689 (767)
.+........ ......|+..|+|||.+.+..++.++||||+|+++|+|++|..||...........+.+.. .+
T Consensus 152 ~~~~~~~~~~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (267)
T cd08229 152 LGRFFSSKTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY 225 (267)
T ss_pred hhhccccCCc------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCC
Confidence 9876533211 1123458889999999988889999999999999999999999986432221111111110 11
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
+...... ....+.+++.+||+.||++|||+.+|++.++++.
T Consensus 226 ~~~~~~~----------------------~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPLPSDH----------------------YSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCccc----------------------ccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1111111 1112333677899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.09 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=195.1
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEE
Confidence 357999999999999999999964 58899999987555555567889999999999999999999864 345679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++.... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999999986533 389999999999999999999998 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccC---CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGL---GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
........ ......|+..|+|||.+. ...++.++||||+||++|||++|+.||........ ........+
T Consensus 154 ~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~ 226 (267)
T cd06646 154 AKITATIA------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNF 226 (267)
T ss_pred eeeccccc------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCC
Confidence 76532211 112345788999999874 34578899999999999999999999854322111 001111111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
...... . ... +...+.+++.+||+.+|++|||++++++++
T Consensus 227 ~~~~~~--~-------------~~~----~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKLK--D-------------KTK----WSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCc--c-------------ccc----cCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 100000 0 000 111223377799999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=331.03 Aligned_cols=205 Identities=25% Similarity=0.316 Sum_probs=170.3
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++.+. ++..+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 5889999999999999999965 48899999986432 234467889999999999999999999854 45678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 99999999999999987543 388999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCC-----------------------------------------CccccccccccCCCCccCccccCCCCCCC
Q 004218 612 ARSLLERIGN-----------------------------------------QSSISSTHVLKGSIGYIPPEYGLGEKPST 650 (767)
Q Consensus 612 a~~~~~~~~~-----------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 650 (767)
+..+...... ...........||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 7533110000 00000112346899999999999999999
Q ss_pred cccchhhhHHHHHHHhCCCCCCCc
Q 004218 651 AGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 651 ~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
++||||+||++|||++|+.||...
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCC
Confidence 999999999999999999999653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.79 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=195.9
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|++|.||+|... +++.|++|.+... .....+.+.+|+++++.++|||++++++++. .....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 4778899999999999999975 5899999998643 2345667889999999999999999999854 445779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++.... ...+++..++.++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQR----GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred EEEEeCCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 9999999999999997642 23489999999999999999999998 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
+....... ......|+..|+|||+..+..++.++||||||+++|+|++|+.||...... .............
T Consensus 149 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~ 220 (256)
T cd08529 149 KLLSDNTN------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILKIIRGVFPP 220 (256)
T ss_pred eeccCccc------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCCC
Confidence 76543211 112345788999999999988999999999999999999999998653311 1111111100000
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
....++ ..+.+++.+||+.+|++||++.|++++
T Consensus 221 ~~~~~~----------------------~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYS----------------------QQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccC----------------------HHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111111 112237778999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.26 Aligned_cols=262 Identities=26% Similarity=0.417 Sum_probs=196.6
Q ss_pred cCCCCCCccccccceEEEEEEeCC-C--cEEEEEEeecc-CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccce
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-G--ISVAVKVLDIE-STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 529 (767)
++|++.+.||+|+||.||+|..++ + ..+++|.++.. .....+.+.+|+++++++ +||||+++++++. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence 578999999999999999998754 3 34788887632 233456788999999999 7999999999854 345
Q ss_pred eeEEEEeecCCCChhhhhcccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNE----------HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD 599 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~ 599 (767)
..++||||+++|+|.+++....... ....+++..+..++.|++.|++|||++ +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 6799999999999999997543211 123588999999999999999999998 999999999999999
Q ss_pred CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCC
Q 004218 600 EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGE 678 (767)
Q Consensus 600 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~ 678 (767)
+++.+||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |+.||.......
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~ 226 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYV-------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226 (297)
T ss_pred CCCeEEECCcCCCcccccee-------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999986422110 0111123557999999988889999999999999999997 999986532211
Q ss_pred cchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 679 VSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
................++ ..+.+++.+||+.+|.+|||++++++.|+.+.+..
T Consensus 227 --~~~~~~~~~~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 227 --LYEKLPQGYRMEKPRNCD----------------------DEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred --HHHHHhcCCCCCCCCCCC----------------------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111111110000011111 11223777999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.25 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=194.5
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-----cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-----GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
++|++.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++. .+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence 47899999999999999999965 589999999864322 12356788999999999999999999954 44
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 57899999999999999987543 288999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||.++........ ........|+..|+|||++.+..++.++||||+|+++|+|++|+.||...... ..........
T Consensus 148 fg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~ 223 (263)
T cd06625 148 FGASKRLQTICSS---GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-AAIFKIATQP 223 (263)
T ss_pred cccceeccccccc---cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-HHHHHHhccC
Confidence 9998755322111 01112345788999999999988999999999999999999999998643111 0011111110
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.....+..++. .+.+++.+||..+|.+|||+.|++++
T Consensus 224 ~~~~~~~~~~~----------------------~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TNPQLPSHVSP----------------------DARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCccCCH----------------------HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11111111111 12236678999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.07 Aligned_cols=265 Identities=25% Similarity=0.396 Sum_probs=198.9
Q ss_pred HHhcCCCCCCccccccceEEEEEEeCC------CcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecC
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSL 523 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 523 (767)
...++|++.+.||+|+||.||++.... ...||+|.+.... ......+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-- 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT-- 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--
Confidence 345678899999999999999998642 3679999886432 23345688999999999 8999999999864
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKP 593 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 593 (767)
.+...+++|||+++|+|.+++...... .....+++..++.++.|++.|++|||+. +|+||||||
T Consensus 87 ---~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp 160 (293)
T cd05053 87 ---QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA 160 (293)
T ss_pred ---CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence 345679999999999999999753210 1234589999999999999999999998 999999999
Q ss_pred CCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 004218 594 GNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTH 672 (767)
Q Consensus 594 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 672 (767)
+||++++++.+||+|||.++......... ......++..|+|||.+.+..++.++|||||||++||+++ |..||.
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYR----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred eeEEEcCCCeEEeCcccccccccccccee----ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 99999999999999999998654321111 1111234677999999988889999999999999999997 888885
Q ss_pred CcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 673 ESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
..... ................... ..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 237 ~~~~~--~~~~~~~~~~~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 237 GIPVE--ELFKLLKEGYRMEKPQNCT----------------------QELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCHH--HHHHHHHcCCcCCCCCCCC----------------------HHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 43211 1111111110000000000 11223777899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.38 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=185.6
Q ss_pred cccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeec
Q 004218 463 IGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 463 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
||+|+||.||++..+ +|+.||+|.+.... ....+.+..|++++++++||||+++++++ ..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999965 48999999985421 12234556799999999999999999885 3456789999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhh
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 618 (767)
++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 76 ~g~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 76 NGGDLKYHIYNVG----ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9999998886443 23488999999999999999999998 9999999999999999999999999998765321
Q ss_pred cCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhhcc
Q 004218 619 IGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLD 698 (767)
Q Consensus 619 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (767)
. ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... .............
T Consensus 149 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~------ 214 (277)
T cd05607 149 K-------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDE------ 214 (277)
T ss_pred c-------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccc------
Confidence 1 1123458899999999998889999999999999999999999986432111 0001100000000
Q ss_pred HHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 699 RELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 699 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
... .. ..+...+.+++.+||+.||++||+++|+++.+
T Consensus 215 ------~~~---~~----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 215 ------VKF---EH----QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ------ccc---cc----ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 000 00 00111223477789999999999997766444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=327.12 Aligned_cols=275 Identities=21% Similarity=0.256 Sum_probs=194.8
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|+||.||+|.+. +++.||+|.+... .....+++.+|+++++.++||||+++++++...........+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999964 5899999988543 223456788999999999999999999997654322234689
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||++ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEeeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence 9999996 58888875433 389999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+....... .......++..|+|||++.+. .++.++||||+||++|||++|+.||....... .+ ..+......
T Consensus 151 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~-~~i~~~~g~ 223 (372)
T cd07853 151 RVEEPDES-----KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QL-DLITDLLGT 223 (372)
T ss_pred eecccCcc-----ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HH-HHHHHHcCC
Confidence 75432211 111233578899999998774 47899999999999999999999996543211 11 111110000
Q ss_pred chhhhc---cHHHHHhhhcchhhHHH------HHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVL---DRELRQLMMSSESQTIQ------LHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~---~~~l~~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...... .......+......... ........+.+++.+||+.||++|||+.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 00011111000000000 000111223347889999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=314.71 Aligned_cols=266 Identities=26% Similarity=0.377 Sum_probs=201.8
Q ss_pred HhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcc-hhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGT-WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
......++++||+|-||.|.++....+.+||||.++...... ..+|.+|+++|.+++||||++++|+|.. ++.+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DePi 610 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDPL 610 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCch
Confidence 345677889999999999999998878999999998765544 4889999999999999999999999964 3456
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++|+|||++|+|.+|+..+... .+......+|+.||+.|++||.+. ++||||+.++|+|++.++++||+|||+
T Consensus 611 cmI~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccc
Confidence 9999999999999999877532 134455678999999999999998 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh--CCCCCCCcccCCcchhhHhhhhc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT--GMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t--g~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
++.+......... ....-..+|||||.+.-+++++++|||+||+++||+++ ...||.+...+. .++....-+
T Consensus 684 sR~lysg~yy~vq----gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~ 757 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQ----GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFF 757 (807)
T ss_pred ccccccCCceeee----cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhc
Confidence 9865443322221 22334688999999999999999999999999999876 678886543321 111111111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
+....+.+- ... .-|...+.+ ++.+||..|.++|||++++...|++.
T Consensus 758 ~~~~~~~~l-------~~P-------~~cp~~lye-lml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 758 RDQGRQVVL-------SRP-------PACPQGLYE-LMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCCcceec-------cCC-------CcCcHHHHH-HHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111110000 000 001112222 77789999999999999999998753
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.51 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=197.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++. .+...+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence 368999999999999999999964 58999999997655555677889999999999999999999854 455779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++.... +++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 93 lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 93 VVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred EeecccCCCCHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999999986432 88999999999999999999998 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
........ ......+++.|+|||.+.+..++.++||||+|+++|++++|+.||..................+..
T Consensus 163 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (297)
T cd06656 163 AQITPEQS------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ 236 (297)
T ss_pred eEccCCcc------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCC
Confidence 75432211 112345788999999999888999999999999999999999999653321111110000000000
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... +...+.+++.+||+.||++||++++++++
T Consensus 237 ~~~~----------------------~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 NPER----------------------LSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred Cccc----------------------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 11122336778999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=306.24 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=189.5
Q ss_pred ccccccceEEEEEEeC---CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEe
Q 004218 462 LIGSGSFGSVYKGYLR---EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 462 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
.||+|+||.||+|.++ ++..||+|+++.... ...+.+.+|+.+++.++||||+++++++. ....++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 5899999999999753 478899999864432 23567889999999999999999999863 234589999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhh
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL 616 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 616 (767)
|+++|+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.+....
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 76 LAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence 999999999996543 389999999999999999999998 99999999999999999999999999997654
Q ss_pred hhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchhh
Q 004218 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQ 695 (767)
Q Consensus 617 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (767)
...... .......++..|+|||.+....++.++||||||+++|||++ |+.||...... .....+........+.
T Consensus 147 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~~~~~~~ 221 (257)
T cd05116 147 ADENYY---KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGERMECPQ 221 (257)
T ss_pred CCCCee---eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCCCCCCCC
Confidence 321110 01112234578999999988888999999999999999998 99998653221 1112221111111111
Q ss_pred hccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 696 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
..++ .+.+++.+||+.||++||++++|.+.|++.
T Consensus 222 ~~~~----------------------~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPP----------------------EMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCH----------------------HHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1111 122377789999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.84 Aligned_cols=266 Identities=24% Similarity=0.383 Sum_probs=199.8
Q ss_pred hcCCCCCCccccccceEEEEEEeCC--------CcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecC
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE--------GISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSL 523 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 523 (767)
.++|.+.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+++++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-- 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence 3579999999999999999998532 3569999987542 23456788899999999 7999999999964
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKP 593 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 593 (767)
.....++||||+++|+|.+++...+.. .....+++.++..++.|++.||+|||+. +++||||||
T Consensus 95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 334679999999999999999764321 1123589999999999999999999998 999999999
Q ss_pred CCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 004218 594 GNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTH 672 (767)
Q Consensus 594 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 672 (767)
+||+++.++.+||+|||.++......... ......++..|+|||++.+..++.++||||+||++|||++ |+.||.
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhh----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999987553211100 0111224568999999988889999999999999999998 888875
Q ss_pred CcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 673 ESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
..... ..........+....... ...+.+++.+||..+|++|||+.|+++.|+++.
T Consensus 245 ~~~~~--~~~~~~~~~~~~~~~~~~----------------------~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 245 GVPVE--ELFKLLKEGHRMDKPSNC----------------------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred cCCHH--HHHHHHHcCCCCCCCCcC----------------------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 42211 111111111110000101 112223777899999999999999999999987
Q ss_pred HHH
Q 004218 753 KIL 755 (767)
Q Consensus 753 ~~~ 755 (767)
...
T Consensus 301 ~~~ 303 (307)
T cd05098 301 ALT 303 (307)
T ss_pred HHh
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=306.18 Aligned_cols=250 Identities=31% Similarity=0.465 Sum_probs=197.1
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.+.|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++. .....++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeEE
Confidence 357889999999999999999986 88999999865433 4678899999999999999999999864 3456799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~ 150 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK 150 (256)
T ss_pred EEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccc
Confidence 9999999999999975431 2489999999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
...... ....++..|+|||++.+..++.++||||+|+++|++++ |+.||...... .........++..
T Consensus 151 ~~~~~~---------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~ 219 (256)
T cd05039 151 EASQGQ---------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEKGYRME 219 (256)
T ss_pred cccccc---------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhcCCCCC
Confidence 653211 11224567999999988889999999999999999997 99998543211 1111111111111
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
.....+ ..+.+++.+||..+|++|||++|++++|+.
T Consensus 220 ~~~~~~----------------------~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCP----------------------PEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCC----------------------HHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111111 112237778999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=306.87 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=197.8
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.+.|++.++||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++|||++++++++. ....++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcEE
Confidence 45788999999999999999998889999999986433 33567889999999999999999998742 234699
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
+|||+++++|.+++.... +..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+.
T Consensus 78 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 78 ITEYMENGSLVDFLKTPE----GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCccee
Confidence 999999999999986543 23489999999999999999999998 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
....... .......++..|+|||++.+..++.++||||||+++||+++ |+.||...... ..........+..
T Consensus 151 ~~~~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~ 223 (260)
T cd05067 151 LIEDNEY-----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYRMP 223 (260)
T ss_pred ecCCCCc-----ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCCCC
Confidence 6532111 11122335678999999988889999999999999999999 99998643211 1111111111111
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
..... ...+.+++.+||+.+|++|||++++.+.|+.
T Consensus 224 ~~~~~----------------------~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNC----------------------PEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCC----------------------CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11111 1112337778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.01 Aligned_cols=242 Identities=26% Similarity=0.319 Sum_probs=187.2
Q ss_pred CccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|.+.. ++.||+|+++.. .......+.+|.++++.+ +||||+++++++. ..+.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 469999999999999764 789999998753 233456677899999887 7999999999853 455789999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9999999999887543 389999999999999999999999 9999999999999999999999999998642
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhh
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQ 695 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (767)
... ........|+..|+|||++.+..++.++||||+||++|+|++|+.||...... .....+....+ ..+.
T Consensus 147 ~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~~i~~~~~-~~~~ 217 (318)
T cd05570 147 ILG------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQSILEDEV-RYPR 217 (318)
T ss_pred CcC------CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHHHHHcCCC-CCCC
Confidence 111 11123346899999999999999999999999999999999999999643211 11111100000 0000
Q ss_pred hccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCH-----HHHHHH
Q 004218 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDI-----REALRR 747 (767)
Q Consensus 696 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~ 747 (767)
.+ ...+.+++.+||+.||++|||+ .+++++
T Consensus 218 ~~----------------------~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WL----------------------SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cC----------------------CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 01 1112237778999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.90 Aligned_cols=204 Identities=25% Similarity=0.309 Sum_probs=170.3
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-ccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKN 527 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~ 527 (767)
...++|++.+.||+|+||.||+|.+. .++.||+|.+... .....+.+.+|+.+++.++||||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35679999999999999999999965 4889999998643 2233467788999999999999999999875432 223
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
....++||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 3467999999975 77776642 278899999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|||+++...... ......||..|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 162 Dfg~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 162 DFGLARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred eCcccccCCCcc-------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999997543221 112346899999999999989999999999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.26 Aligned_cols=193 Identities=33% Similarity=0.448 Sum_probs=161.0
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHH-HHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECE-ALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|.+. +|+.||+|++.... ....+.+..|.. +++.++||||+++++++ ......++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 46899999999999975 58999999986432 222344555555 45778999999999885 3456779999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999999999987543 389999999999999999999999 9999999999999999999999999998643
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 147 IEH------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred ccC------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence 211 1112345689999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=313.94 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=196.4
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.+|++.+.||.|++|.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++. .....++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence 46899999999999999999964 58999999997665556678889999999999999999999854 4557799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
|+||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 94 v~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred EEEecCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence 99999999999998643 289999999999999999999999 99999999999999999999999999987
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc-c
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK-N 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~ 692 (767)
....... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........ .........+. .
T Consensus 164 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~ 236 (296)
T cd06655 164 QITPEQS------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGTPELQ 236 (296)
T ss_pred hcccccc------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCcccC
Confidence 6533211 11234578899999999988899999999999999999999999865322111 00000000000 0
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... +...+.+++.+||..||++|||+.+++++
T Consensus 237 ~~~~----------------------~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEK----------------------LSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred Cccc----------------------CCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000 11122236778999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=322.07 Aligned_cols=196 Identities=33% Similarity=0.450 Sum_probs=169.0
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-C-----CCceeEEeeeecCCcccc
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTR-H-----RNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~~ 528 (767)
+|.+.+.||+|+||.|-+|.+. +++.||||+++.. ..-..+...|+.+|..++ | -|+|+++++ |...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence 8999999999999999999965 4999999999743 334466778999999986 3 489999999 5567
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC--CceEE
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED--MTAKV 606 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~--~~~kl 606 (767)
++.|||+|.++. +|+++++..+. .+++...+..++.||+.||.+||+. +|||+||||+|||+.+. ..+||
T Consensus 261 ~HlciVfELL~~-NLYellK~n~f----~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNKF----RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence 788999999965 99999988763 4599999999999999999999999 99999999999999754 37999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+|||.|+....... ....+..|+|||++.+.+|+.+.||||||||++||++|.+.|...
T Consensus 333 IDFGSSc~~~q~vy---------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY---------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred EecccccccCCcce---------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 99999987644322 345678899999999999999999999999999999998777554
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.44 Aligned_cols=193 Identities=29% Similarity=0.377 Sum_probs=164.2
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +||+|+++++++ .....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 46999999999999975 47899999997542 23445678899999888 699999999985 3456789999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9999999999886543 399999999999999999999999 9999999999999999999999999998642
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 147 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 147 LGP------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred cCC------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 211 1112345689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=327.15 Aligned_cols=207 Identities=24% Similarity=0.326 Sum_probs=173.7
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeec
Q 004218 447 YDELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSS 522 (767)
Q Consensus 447 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 522 (767)
..++....++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-- 112 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-- 112 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence 3445556789999999999999999999976 4889999998642 223345677899999999999999999985
Q ss_pred CCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 004218 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM 602 (767)
Q Consensus 523 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~ 602 (767)
..+...++||||+++|+|.+++.... +++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 113 ---~~~~~~~lv~Ey~~gg~L~~~~~~~~-------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 113 ---QDDRYLYMVMEYMPGGDLVNLMSNYD-------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred ---EcCCEEEEEEcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCC
Confidence 45567899999999999999986533 88889999999999999999999 999999999999999999
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC----CCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK----PSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
.+||+|||+++....... .......||+.|+|||++.+.. ++.++||||+||++|||++|+.||..
T Consensus 180 ~ikL~DfG~a~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 180 HLKLADFGTCMKMNKEGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CEEEEeCCceeEcCcCCc-----ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 999999999976532111 1113456899999999987543 78899999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=313.90 Aligned_cols=259 Identities=22% Similarity=0.380 Sum_probs=197.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDF 525 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 525 (767)
.++|.+.+.||+|+||.||+|... .+..||+|.++... ....+.+.+|+++++++ +||||+++++++.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---- 109 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT---- 109 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe----
Confidence 357899999999999999999742 25579999886443 23346788999999999 7999999999864
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
..+..++||||+++|+|.+++.... ...+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.++
T Consensus 110 -~~~~~~lv~e~~~~~~L~~~i~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 110 -IGGPILVITEYCCYGDLLNFLRRKR----ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred -cCCceEEEEEcCCCCcHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEE
Confidence 3445799999999999999997543 22389999999999999999999998 999999999999999999999
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhH
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~ 684 (767)
++|||.++........ .......++..|+|||.+.+..++.++||||+|+++|||++ |..||....... .....
T Consensus 182 l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~ 256 (302)
T cd05055 182 ICDFGLARDIMNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKL 256 (302)
T ss_pred ECCCcccccccCCCce----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHH
Confidence 9999999765332110 11122345778999999998889999999999999999998 999986532211 11111
Q ss_pred hhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 685 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
.....+.......+ ..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 257 ~~~~~~~~~~~~~~----------------------~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGYRMAQPEHAP----------------------AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCCcCCCCCCCC----------------------HHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111110000111 1122377789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=307.46 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=193.6
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc---------chhhHHHHHHHHhcCCCCCceeEEeeeecCCc
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG---------TWKSFFAECEALRNTRHRNLVKLITSCSSLDF 525 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 525 (767)
+|.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 4788899999999999999965 4889999988644322 1246788999999999999999999854
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
.....++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 77 -DADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred -eCCccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence 3456799999999999999997643 288999999999999999999998 999999999999999999999
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 685 (767)
|+|||.++...................|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ..... .
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~-~ 224 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-QAIFK-I 224 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-HHHHH-H
Confidence 999999987653221111111122345788999999999888999999999999999999999999653211 00100 0
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
............+ ..+.+++.+||+.||.+||++.|++++
T Consensus 225 ~~~~~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 GENASPEIPSNIS----------------------SEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred hccCCCcCCcccC----------------------HHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0000000011111 112236678999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=324.59 Aligned_cols=203 Identities=25% Similarity=0.321 Sum_probs=170.3
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-cccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKNM 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~ 528 (767)
..++|++.+.||+|+||.||+|.+. .++.||||++... .....+.+.+|+.+++.++||||+++++++.... ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999965 4889999998643 2334567889999999999999999999865432 2334
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..+++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 568999999975 78777742 278899999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
||+++...... ......||..|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 170 fG~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 170 FGLARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCCccccCCCC-------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 99997543211 112346899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=310.11 Aligned_cols=274 Identities=27% Similarity=0.371 Sum_probs=198.0
Q ss_pred cCCCCCCccccccceEEEEEEe-----CCCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYL-----REGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
..|++.+.||+|+||.||++.. .++..||+|.++... ....+.+.+|+++++.++|||++++++++.. .+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 4578899999999999999984 247889999986443 3345678899999999999999999998753 223
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++++|.+++.... ..+++.++..++.|++.||+|||++ |++||||||+||+++.++.++|+|
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECC
Confidence 56799999999999999986542 2389999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||.++.+...... ........++..|+|||++.+..++.++||||||+++|||++++.|+........ ...
T Consensus 153 fg~~~~~~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~---~~~--- 223 (284)
T cd05079 153 FGLTKAIETDKEY---YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL---KMI--- 223 (284)
T ss_pred CccccccccCccc---eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh---hhc---
Confidence 9999865432211 1111234567789999999888899999999999999999998877533211100 000
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
.+.................... .........+.+++.+||+.||++|||++++++.++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 224 GPTHGQMTVTRLVRVLEEGKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccccccHHHHHHHHHcCccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000000000000000000 00000111233377799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=313.43 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=195.2
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-Cc--EEEEEEeecc-CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GI--SVAVKVLDIE-STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|++.+.||+|+||.||+|.++. +. .+|+|.+... .....+.+.+|++++.++ +||||+++++++. .+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CC
Confidence 3578889999999999999999753 54 4577776532 223446788999999999 8999999999954 44
Q ss_pred eeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
+..++||||+++|+|.+++...... .....+++.+++.++.|++.|++|||+. +++||||||+||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence 5679999999999999999754321 1123589999999999999999999998 99999999999999
Q ss_pred CCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccC
Q 004218 599 DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAG 677 (767)
Q Consensus 599 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~ 677 (767)
++++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 230 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230 (303)
T ss_pred cCCCcEEeCccccCcccchhh-------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence 999999999999986321110 0111224567999999988889999999999999999998 99998543221
Q ss_pred CcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 678 EVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
.................. . ..+.+++.+||+.+|++||+++++++.++.+...
T Consensus 231 --~~~~~~~~~~~~~~~~~~------------------~----~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 231 --ELYEKLPQGYRLEKPLNC------------------D----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred --HHHHHHhcCCcCCCCCCC------------------C----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111111111000000000 1 1122377799999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=310.17 Aligned_cols=261 Identities=26% Similarity=0.392 Sum_probs=195.2
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC------CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDF 525 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 525 (767)
..++|++.+.||+|++|.||+|.+.+ +..||+|.+..... .....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--- 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc---
Confidence 34679999999999999999999753 56799998864332 234568899999999999999999998643
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC--
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKN-EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-- 602 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-- 602 (767)
....++||||+++++|.+++...+.. .....+++..+..++.||+.|++|||+. +++||||||+||+++.++
T Consensus 81 --~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 81 --RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred --CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCC
Confidence 34458999999999999999765421 1223589999999999999999999999 999999999999998654
Q ss_pred -ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcc
Q 004218 603 -TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVS 680 (767)
Q Consensus 603 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~ 680 (767)
.+||+|||+++......... .......+..|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~ 229 (277)
T cd05036 156 RVAKIADFGMARDIYRASYYR----KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--E 229 (277)
T ss_pred cceEeccCccccccCCcccee----cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 69999999998653221100 0112223567999999988889999999999999999997 99998653221 1
Q ss_pred hhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 681 LVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
....+....+...+..++ ..+.+++.+||+.+|++|||+.|++++|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~----------------------~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 VMEFVTGGGRLDPPKGCP----------------------GPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHcCCcCCCCCCCC----------------------HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111111000000001 11223777899999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=304.38 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=188.2
Q ss_pred ccccccceEEEEEEeC---CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEee
Q 004218 462 LIGSGSFGSVYKGYLR---EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEF 537 (767)
Q Consensus 462 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 537 (767)
.||+|+||.||+|.++ .+..||+|+...... ...+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence 3899999999999864 355799999865432 234568899999999999999999998632 346899999
Q ss_pred cCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhh
Q 004218 538 LGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE 617 (767)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 617 (767)
+++++|.+++.... ..+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 76 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 76 ASGGPLNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred CCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 99999999987533 2389999999999999999999998 999999999999999999999999999975433
Q ss_pred hcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchhhh
Q 004218 618 RIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQV 696 (767)
Q Consensus 618 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (767)
...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+....+...+..
T Consensus 148 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 222 (257)
T cd05115 148 DDSYYK---ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGKRLDCPAE 222 (257)
T ss_pred Ccccee---ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCCCCCCCCC
Confidence 211110 1111223578999999988889999999999999999996 99998654221 11111111111111111
Q ss_pred ccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 697 LDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 697 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
..+. +.+++.+||..||++||++.++.+.|+.+
T Consensus 223 ~~~~----------------------l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPE----------------------MYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHH----------------------HHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1111 12266789999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=305.76 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=195.7
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
++|.+.+.||+|++|.||+|.+..+..||+|.+.... ...+.+.+|++++++++|||++++++++. ....++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEEE
Confidence 5688999999999999999998777789999875432 33467889999999999999999998753 2346899
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+..
T Consensus 79 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 79 TEFMGKGSLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred EEcCCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceE
Confidence 99999999999997543 23488999999999999999999998 999999999999999999999999999976
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccch
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
....... ......++..|+|||...+..++.++||||||+++|+|++ |+.||...... .........++...
T Consensus 152 ~~~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~ 224 (260)
T cd05069 152 IEDNEYT-----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYRMPC 224 (260)
T ss_pred ccCCccc-----ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCC
Confidence 5322110 1112235678999999988889999999999999999999 88998653221 11111111111110
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
... ....+.+++.+||+.||++||+++++++.|++
T Consensus 225 ~~~----------------------~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQG----------------------CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred Ccc----------------------cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 11123337778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=317.18 Aligned_cols=245 Identities=28% Similarity=0.363 Sum_probs=192.7
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.|.-.+.||.|+||.||-|++. +.+.||||.+... +.+.|+++.+|+++|++++|||++.+-|+|. .....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccchH
Confidence 3555678999999999999954 5889999999644 4456889999999999999999999999854 34556
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
|+|||||- |+-.|++.-.+ .++-+.++..|+.+.+.||+|||+. +.||||||+.|||+++.|.|||+|||.
T Consensus 102 WLVMEYCl-GSAsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 102 WLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred HHHHHHHh-ccHHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccc
Confidence 99999995 49899887665 3489999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccC---CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL---GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|....+. ..++||+.|||||++. .+.|+-++||||+|++..|+...++|+.....-. .+...+...
T Consensus 173 Asi~~PA----------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-ALYHIAQNe 241 (948)
T KOG0577|consen 173 ASIMAPA----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNE 241 (948)
T ss_pred hhhcCch----------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-HHHHHHhcC
Confidence 9765432 4578999999999875 5789999999999999999999999975432110 011111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.|.- -... ..+.+. +++..||++-|.+|||+++++++
T Consensus 242 sPtL----qs~e--------------WS~~F~----~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTL----QSNE--------------WSDYFR----NFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC----CCch--------------hHHHHH----HHHHHHHhhCcccCCcHHHHhhc
Confidence 1110 0111 122222 25568999999999999998875
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.94 Aligned_cols=199 Identities=26% Similarity=0.371 Sum_probs=167.0
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCccccee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 530 (767)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++... +|++|+++++++ ...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 4788899999999999999976 47899999986532 22344567788888777 588999998885 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 899999999999999986543 389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 147 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 147 MCKENMWD------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred CceecCCC------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 98643211 11123456899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.24 Aligned_cols=260 Identities=24% Similarity=0.350 Sum_probs=196.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCc----EEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGI----SVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
..+|++.+.||+|+||.||+|.+. +++ +||+|++.... ....+.+.+|+.+++.+.||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 357888999999999999999854 344 58999986432 2345678899999999999999999998753
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
...+++|||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~ 151 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKIT 151 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence 23579999999999999997543 2389999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 686 (767)
|||+++......... ......++..|+|||...+..++.++|||||||++|||++ |..||...... ....++.
T Consensus 152 dfG~~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~ 225 (279)
T cd05109 152 DFGLARLLDIDETEY----HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLE 225 (279)
T ss_pred CCCceeeccccccee----ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH
Confidence 999997653221110 0111234678999999988889999999999999999998 88998653221 1112221
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
............. .+.+++.+||+.||++||++.|+++.++.+..+.
T Consensus 226 ~~~~~~~~~~~~~----------------------~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 226 KGERLPQPPICTI----------------------DVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CCCcCCCCccCCH----------------------HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1111110111111 1223777899999999999999999998775543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.52 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=196.3
Q ss_pred cCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.+|...++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence 46788899999999999999742 35679999887555555678999999999999999999999854 34
Q ss_pred eeeEEEEeecCCCChhhhhcccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKN---------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD 599 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~ 599 (767)
...++||||+++++|.+++...... .....+++..+..++.|++.|++|||+. +++||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 5579999999999999999764321 1113489999999999999999999998 999999999999999
Q ss_pred CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCC
Q 004218 600 EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGE 678 (767)
Q Consensus 600 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~ 678 (767)
+++.+||+|||++........ ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 232 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDY----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232 (280)
T ss_pred CCCCEEECCCCceeEcCCCce----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH
Confidence 999999999999875432110 011122335678999999998899999999999999999998 899985432211
Q ss_pred cchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 679 VSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
.........+......+++ .+.+++.+||+.||.+||+++|+.+.|+
T Consensus 233 --~~~~~~~~~~~~~~~~~~~----------------------~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 --AIECITQGRELERPRTCPP----------------------EVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --HHHHHHcCccCCCCCCCCH----------------------HHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111111001000111111 1223777899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.44 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=196.3
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcc-cc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFK-NM 528 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~~ 528 (767)
.+++.|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|||++++++++...... ..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678999999999999999999965 48899999986543 3446788999999998 799999999997653322 23
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++++|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+|
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 56899999999999999987643 23489999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK 683 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 683 (767)
||++........ ......|+..|+|||++. +..++.++||||+||++|||++|+.||......... .
T Consensus 155 fg~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~--~ 226 (272)
T cd06637 155 FGVSAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--F 226 (272)
T ss_pred CCCceecccccc------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH--H
Confidence 999875432211 123356889999999876 335788999999999999999999998543211100 0
Q ss_pred HhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 684 WVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 684 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
....... ..... .... ..+.+++.+||..||.+|||+.|++++
T Consensus 227 ~~~~~~~---~~~~~--------------~~~~----~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 227 LIPRNPA---PRLKS--------------KKWS----KKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHhcCCC---CCCCC--------------CCcC----HHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0000000 00000 0001 112337779999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.13 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=194.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++. .....+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEE
Confidence 357888899999999999999965 58899999987655555567889999999999999999999853 456679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++.... .+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.+
T Consensus 83 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred EEEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceee
Confidence 9999999999999986543 389999999999999999999999 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccC---CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGL---GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
....... .......|+..|+|||++. ...++.++||||+||++|+|++|+.||........ ........+
T Consensus 154 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~ 226 (267)
T cd06645 154 AQITATI------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNF 226 (267)
T ss_pred eEccCcc------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCC
Confidence 7543221 1122346889999999874 45578899999999999999999999855332111 111111111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... .. . .....+ .+.+++.+||+.+|++|||+++++++
T Consensus 227 ~~~~---~~----~--------~~~~~~----~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 227 QPPK---LK----D--------KMKWSN----SFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCc---cc----c--------cCCCCH----HHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000 00 0 000011 12237778999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=314.58 Aligned_cols=203 Identities=25% Similarity=0.352 Sum_probs=162.6
Q ss_pred CCccccccceEEEEEEeC---CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEe
Q 004218 460 ENLIGSGSFGSVYKGYLR---EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
.++||+|+||.||+|... +++.||+|.+... .....+.+|++++++++||||+++++++.. ..+..+++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 468999999999999965 4678999988633 233567899999999999999999998653 23456899999
Q ss_pred ecCCCChhhhhcccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEccc
Q 004218 537 FLGNGSLGDWIHGERKN---EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL----DEDMTAKVGDF 609 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~Df 609 (767)
|+++ +|.+++...... .....+++..+..++.|++.||+|||++ +|+||||||+||++ +..+.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9864 898887643221 1123589999999999999999999999 99999999999999 45678999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|+++....... .........||+.|+|||++.+. .++.++||||+||++|+|++|++||...
T Consensus 157 G~a~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCc---cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99976543211 11122345689999999998764 5799999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=308.09 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=195.5
Q ss_pred cCCCCCCccccccceEEEEEEeCC-C---cEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-G---ISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
+.|++.+.||+|+||.||+|.+.. + ..||+|.+... .....+.+..|+.+++.++||||+++++++. .+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCC
Confidence 457889999999999999999653 3 36999998654 2334567899999999999999999999853 455
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++|+|.+++.... ..+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+||+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df 150 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence 6799999999999999987543 2389999999999999999999998 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|.+............ ........+..|+|||.+.+..++.++||||+|+++||+++ |..||...... .....+...
T Consensus 151 g~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~ 227 (269)
T cd05065 151 GLSRFLEDDTSDPTY-TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQD 227 (269)
T ss_pred ccccccccCcccccc-ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcC
Confidence 998765432211111 00011112457999999998899999999999999999886 99998553211 122222111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
.+.......+ ..+.+++.+||+.+|++||++.+++..|+++
T Consensus 228 ~~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLPPPMDCP----------------------TALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCCCcccCC----------------------HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111011 1122377789999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=321.05 Aligned_cols=266 Identities=24% Similarity=0.386 Sum_probs=198.6
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCC-CCCceeEEeeeecC
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIES-TGTWKSFFAECEALRNTR-HRNLVKLITSCSSL 523 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 523 (767)
...++|.+.+.||+|+||.||+|.++ .++.||+|++.... ....+.+.+|++++.++. ||||++++++|..
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~- 112 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK- 112 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-
Confidence 34457888999999999999999864 24689999996442 223457889999999997 9999999999643
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCC--------------------------------------------------
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKN-------------------------------------------------- 553 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------- 553 (767)
....++||||+++|+|.++++..+..
T Consensus 113 ----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 113 ----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred ----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 34679999999999999999754310
Q ss_pred ------------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC
Q 004218 554 ------------------------------------------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDL 591 (767)
Q Consensus 554 ------------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 591 (767)
.....+++..+..++.|++.||+|||+. +++||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdl 265 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDL 265 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccC
Confidence 0113478888999999999999999998 9999999
Q ss_pred CCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCC
Q 004218 592 KPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670 (767)
Q Consensus 592 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p 670 (767)
||+||++++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P 341 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSNY----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceeccccccc----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999765332111 01122346788999999988889999999999999999998 8889
Q ss_pred CCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 671 THESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
|........ ....+....+...+..+. ..+.+++.+||..+|.+||+++|+++.|+.
T Consensus 342 ~~~~~~~~~-~~~~~~~~~~~~~p~~~~----------------------~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 342 YPELPMNEQ-FYNAIKRGYRMAKPAHAS----------------------DEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred CCCCCchHH-HHHHHHcCCCCCCCCCCC----------------------HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 854321111 111111111100010111 112236778999999999999999999987
Q ss_pred HH
Q 004218 751 AQ 752 (767)
Q Consensus 751 ~~ 752 (767)
+.
T Consensus 399 ~~ 400 (401)
T cd05107 399 LL 400 (401)
T ss_pred Hh
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=320.07 Aligned_cols=193 Identities=31% Similarity=0.410 Sum_probs=164.6
Q ss_pred CccccccceEEEEEEe----CCCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 461 NLIGSGSFGSVYKGYL----REGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|++++++++||||+++++++. .+...|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence 5799999999999985 247899999996532 223456778999999999999999999853 45678999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 77 ~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 99999999999986543 389999999999999999999999 999999999999999999999999999875
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 148 ~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 148 SIDHE------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred cCCCC------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 43221 112335689999999999988899999999999999999999999965
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=303.73 Aligned_cols=249 Identities=30% Similarity=0.390 Sum_probs=191.2
Q ss_pred CccccccceEEEEEEeCC----CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLRE----GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|.+.. +..||+|.+..... ...+++.+|+++++.+.|||++++++++. ....++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 469999999999998542 36899999864433 34567889999999999999999999853 23468999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++..
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 75 ELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred EeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence 9999999999997644 389999999999999999999998 9999999999999999999999999999865
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchh
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
....... .......++..|+|||...+..++.++||||||+++|+|++ |+.||..... ......+....+....
T Consensus 146 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~ 220 (257)
T cd05060 146 GAGSDYY---RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERLPRP 220 (257)
T ss_pred ecCCccc---ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcCCCC
Confidence 4322111 01111223567999999998899999999999999999998 9999865322 1222222211111111
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
..++ ..+.+++.+||..+|++|||+.++++.|+++
T Consensus 221 ~~~~----------------------~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 221 EECP----------------------QEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCC----------------------HHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1111 1222377799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=306.96 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=195.9
Q ss_pred cCCCCCCccccccceEEEEEEeC----CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.+|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.+.+|+.++++++||||+++++++. .++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence 57889999999999999999864 23479999886432 233467889999999999999999999854 445
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+||
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~df 150 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDF 150 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCC
Confidence 6799999999999999997543 2389999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|.+.......... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+...
T Consensus 151 g~~~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~ 225 (267)
T cd05066 151 GLSRVLEDDPEAA---YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEG 225 (267)
T ss_pred Cccccccccccee---eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCC
Confidence 9998654321111 01111223567999999998889999999999999999886 99998653221 111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
.+.......+ ..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 226 ~~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRLPAPMDCP----------------------AALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcCCCCCCCC----------------------HHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1110000001 1122377789999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=307.36 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=193.3
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
+.+++++.....||+|+||.||+|.+. ++..||+|.+........+.+.+|+++++.++|+||+++++++. .++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 78 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENG 78 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCC
Confidence 445666767788999999999999965 47889999987655556678899999999999999999999854 446
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEcc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE-DMTAKVGD 608 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~D 608 (767)
..++|+||+++++|.+++...... ...++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~d 152 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISD 152 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEec
Confidence 679999999999999999754211 1127888899999999999999998 9999999999999986 67999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCC--CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK--PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
||.+........ ......|+..|+|||++.+.. ++.++||||+|+++|+|++|+.||...............
T Consensus 153 fg~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~ 226 (268)
T cd06624 153 FGTSKRLAGINP------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM 226 (268)
T ss_pred chhheecccCCC------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh
Confidence 999875532111 112234788999999986543 788999999999999999999998643221111100000
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.......+..++ ..+.+++.+||+.+|++|||+.|++++
T Consensus 227 ~~~~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 227 FKIHPEIPESLS----------------------AEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hccCCCCCcccC----------------------HHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000000111111 112236778999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=312.90 Aligned_cols=267 Identities=23% Similarity=0.386 Sum_probs=199.9
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC--------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeee
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR--------EGISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCS 521 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 521 (767)
....+|++.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33567889999999999999999742 24579999886432 33456788999999999 8999999999864
Q ss_pred cCCcccceeeEEEEeecCCCChhhhhcccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC
Q 004218 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNE----------HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDL 591 (767)
Q Consensus 522 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 591 (767)
.....++||||+++|+|.+++...+... ....+++.++..++.|++.||+|||++ +++||||
T Consensus 92 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dl 163 (304)
T cd05101 92 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDL 163 (304)
T ss_pred -----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccc
Confidence 3456799999999999999997643211 123588999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCC
Q 004218 592 KPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670 (767)
Q Consensus 592 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p 670 (767)
||+||++++++.+||+|||.++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 239 (304)
T cd05101 164 AARNVLVTENNVMKIADFGLARDVNNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239 (304)
T ss_pred ccceEEEcCCCcEEECCCccceeccccccc----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999765332111 11122335678999999988889999999999999999998 7788
Q ss_pred CCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 671 THESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
|...... .....+....+...... ....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 ~~~~~~~--~~~~~~~~~~~~~~~~~----------------------~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 240 YPGIPVE--ELFKLLKEGHRMDKPAN----------------------CTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred cccCCHH--HHHHHHHcCCcCCCCCC----------------------CCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 7542111 11111111110000000 01112237778999999999999999999988
Q ss_pred HHHH
Q 004218 751 AQKI 754 (767)
Q Consensus 751 ~~~~ 754 (767)
+...
T Consensus 296 ~~~~ 299 (304)
T cd05101 296 ILTL 299 (304)
T ss_pred HHHh
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=323.50 Aligned_cols=202 Identities=26% Similarity=0.327 Sum_probs=170.5
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.+++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 46889999999999999999975 58899999986532 23456688899999999999999999885 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence 899999999999999997652 2389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccC------CCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL------GEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
++......... ......||+.|+|||++. +..++.++||||+||++|||++|+.||...
T Consensus 148 ~a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 148 SAARLTANKMV-----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred CCeECCCCCce-----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 99765332111 112346899999999986 456788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.96 Aligned_cols=271 Identities=23% Similarity=0.285 Sum_probs=193.3
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|.+.+.||+|+||.||+|..+ +++.||+|.++.... .....+.+|++++++++||||+++++++. .++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 57899999999999999999976 478899999865432 23456778999999999999999999854 445679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 81 lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred EEEeCCCC-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence 99999975 8888876543 2388999999999999999999999 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+....... ......++..|+|||++.+ ..++.++||||+||++|+|++|+.||......+. ...+......
T Consensus 152 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~ 223 (309)
T cd07872 152 RAKSVPTK------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE--LHLIFRLLGT 223 (309)
T ss_pred eecCCCcc------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCC
Confidence 75422111 1122357889999998765 4578999999999999999999999965432211 1111100000
Q ss_pred ---c-hhhhccHHHHHhhhcc---hhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 ---N-AQQVLDRELRQLMMSS---ESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ---~-~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. ........-....... +.........+...+.+++.+|++.||.+|||++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 224 PTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred CCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0 0000000000000000 000000111122223347789999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=308.68 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=189.8
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
+|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++. .+...++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEEE
Confidence 5788899999999999999964 58899999986542 233467889999999999999999999964 3456789
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++.
T Consensus 77 v~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 77 CTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred EEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 99999999997652 178888999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcch--hhHhhhhccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL--VKWVESNFPK 691 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~ 691 (767)
..... ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||.......... ..........
T Consensus 144 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 215 (279)
T cd06619 144 QLVNS--------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE 215 (279)
T ss_pred ecccc--------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc
Confidence 54321 1123468899999999998889999999999999999999999986533221110 0000000000
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... . ...... ..+.+++.+||+.||++||+++|++++
T Consensus 216 ~~~~---------~-----~~~~~~----~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 216 DPPV---------L-----PVGQFS----EKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCC---------C-----CCCcCC----HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000 0 000001 112237778999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=309.62 Aligned_cols=260 Identities=24% Similarity=0.341 Sum_probs=197.6
Q ss_pred hcCCCCCCccccccceEEEEEEeCC------CcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~----- 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----- 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence 4578899999999999999998652 4689999985432 233457889999999999999999999954
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNE----HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM 602 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~ 602 (767)
.+...++||||+++|+|.+++....... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 3456799999999999999997543211 123478999999999999999999998 999999999999999999
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcch
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSL 681 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~ 681 (767)
.+||+|||.++......... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ...
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~ 230 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYR----KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEV 230 (277)
T ss_pred CEEECCcccchhhccCcccc----cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHH
Confidence 99999999997654322111 1123346788999999988889999999999999999998 8899854321 111
Q ss_pred hhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 682 VKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
.+..........+...+ ..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 231 ~~~~~~~~~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 231 LKFVIDGGHLDLPENCP----------------------DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHhcCCCCCCCCCCC----------------------HHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 12221111111111111 11223777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=305.63 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=200.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.+=|...+.||+|-|+.|-+|++- +|++||||++++..- -....+.+|++.|+-++|||||++|++ ......
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTK 91 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTK 91 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccce
Confidence 456888899999999999999843 699999999976533 345678899999999999999999998 566778
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD-EDMTAKVGDF 609 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~Df 609 (767)
+|+|.|.-++|+|++|+-+.. .++.+.-+.+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||+||
T Consensus 92 lyLiLELGD~GDl~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDF 163 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDF 163 (864)
T ss_pred EEEEEEecCCchHHHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeec
Confidence 899999999999999998764 3499999999999999999999999 999999999999775 6789999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCC-CcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPS-TAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|++-.+.+. ......+|+..|.|||++.+..|+ +++||||+|||+|.+++|++||+.....+. +-..+.-.
T Consensus 164 GFSNkf~PG-------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-LTmImDCK 235 (864)
T KOG4717|consen 164 GFSNKFQPG-------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-LTMIMDCK 235 (864)
T ss_pred cccccCCCc-------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-hhhhhccc
Confidence 999765432 233567899999999999999884 689999999999999999999987544332 11111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
| ..+..+. .-.+++|.+||..||++|.+.+||...
T Consensus 236 Y--tvPshvS----------------------~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 236 Y--TVPSHVS----------------------KECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred c--cCchhhh----------------------HHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1 1122222 223346778999999999999998753
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.65 Aligned_cols=275 Identities=21% Similarity=0.273 Sum_probs=196.2
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-ccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKN 527 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~ 527 (767)
...++|++.+.||+|+||.||+|.+. +++.||||.+.... ....+.+.+|++++++++||||+++++++.... ...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 44678999999999999999999965 58899999986432 223456778999999999999999999864322 122
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
....++++|++ +++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 34578999988 67999888643 289999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
|||+++..... .....||..|+|||++.+ ..++.++||||+||++|+|++|+.||...... ..+.....
T Consensus 161 Dfg~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~ 230 (343)
T cd07878 161 DFGLARQADDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIME 230 (343)
T ss_pred CCccceecCCC---------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence 99999754321 123458999999999876 56889999999999999999999999653211 11111111
Q ss_pred hh--cccc-hhhhccHHHHHhhhcc---hh-hHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SN--FPKN-AQQVLDRELRQLMMSS---ES-QTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~--~~~~-~~~~~~~~l~~~~~~~---~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. .+.. ................ +. ............+.+++.+|++.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 231 VVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000 0111111111111000 00 0000001111223448889999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=305.42 Aligned_cols=250 Identities=23% Similarity=0.275 Sum_probs=194.7
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
+|++.+.||+|+||.||++.+. +++.||+|.++.. .....+.+.+|+.+++.++|||++++++.+ ..+...++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 4788899999999999999975 5889999998643 234456788999999999999999999985 45567899
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++|+|.+++.... ...+++..+..++.|++.|+.|||++ +|+|+||||+||++++++.++++|||.+.
T Consensus 76 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQR----GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEeeCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 999999999999886533 23478999999999999999999999 99999999999999999999999999987
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccch
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
....... ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||....... .............
T Consensus 149 ~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~ 220 (255)
T cd08219 149 LLTSPGA------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--LILKVCQGSYKPL 220 (255)
T ss_pred eeccccc------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--HHHHHhcCCCCCC
Confidence 5532211 1123458889999999998889999999999999999999999996532111 1111100000000
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+..++ ..+.+++.+||+.||++|||+.|++..
T Consensus 221 ~~~~~----------------------~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYS----------------------YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccC----------------------HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01111 112337778999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=311.82 Aligned_cols=270 Identities=26% Similarity=0.299 Sum_probs=203.2
Q ss_pred ccCHHHHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeee
Q 004218 444 MISYDELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCS 521 (767)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 521 (767)
.+..+++..++++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4555667778899999999999999999999975 58899999985432 2345677899999998 8999999999987
Q ss_pred cCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 004218 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED 601 (767)
Q Consensus 522 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~ 601 (767)
..+.......++||||+++|+|.++++.... ....+++..++.++.|++.||+|||+. +++||||||+||+++.+
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~ 164 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE 164 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence 5443445678999999999999998864321 123489999999999999999999998 99999999999999999
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC-----CCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-----PSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
+.+||+|||.+......... .....|+..|+|||.+.... ++.++||||+||++|||++|+.||.....
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRLR------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred CCEEEeecccchhccccccc------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 99999999998765332111 12245788999999876433 68899999999999999999999865321
Q ss_pred CCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 677 GEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. ...........+ .. .. .+.....+.+++.+||+.+|++||++.|++++
T Consensus 239 ~-~~~~~~~~~~~~-~~---~~-----------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 239 V-KTLFKIPRNPPP-TL---LH-----------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H-HHHHHHhcCCCC-CC---Cc-----------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 111111100000 00 00 00011123347789999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=309.94 Aligned_cols=249 Identities=26% Similarity=0.383 Sum_probs=191.1
Q ss_pred CCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
|++.+.||+|+||.||+|.+.. +..+|+|.+........+.+.+|+++++.++|||++++++++. .+...++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence 6778899999999999999764 7788999986555555677889999999999999999999864 345679999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++++|.+++.... .++++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 82 e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 82 EFCAGGAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence 9999999999876432 2489999999999999999999999 9999999999999999999999999998754
Q ss_pred hhhcCCCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
..... ......++..|+|||++. +..++.++||||+||++|+|++|+.||....... ..........+
T Consensus 154 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~ 226 (282)
T cd06643 154 TRTIQ------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPP 226 (282)
T ss_pred ccccc------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcCCC
Confidence 32211 112345889999999874 3456789999999999999999999986532111 11111111000
Q ss_pred cc-hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KN-AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. .+..++ ..+.+++.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 TLAQPSRWS----------------------SEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCCCccccC----------------------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000011 112237778999999999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=304.67 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=198.8
Q ss_pred HhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
..++|++.+.||+|+||.||+|..++++.||||.+.... ...+++.+|+.++++++|||++++++++. .....+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceE
Confidence 346899999999999999999998888899999986432 34567899999999999999999999853 345679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++.... +..+++.++..++.|++.|++|||+. +++|+||||+||++++++.+||+|||.+
T Consensus 78 ~v~e~~~~~~L~~~i~~~~----~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred EEEeccCCCCHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccc
Confidence 9999999999999997643 23489999999999999999999999 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
......... ......++..|+|||.+.+..++.++||||+|+++|++++ |+.||...... .........+..
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~ 223 (261)
T cd05034 151 RLIEDDEYT-----AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERGYRM 223 (261)
T ss_pred eeccchhhh-----hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC
Confidence 765432110 1112224568999999998889999999999999999998 99998543211 111111111111
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
..+...+ . .+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 ~~~~~~~------------------~----~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCP------------------E----ELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCC------------------H----HHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111111 1 12237778999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.20 Aligned_cols=193 Identities=33% Similarity=0.430 Sum_probs=160.0
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHH-HHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECE-ALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|++. +++.||+|++.... ......+..|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 46999999999999976 47889999986432 122334444544 56778999999999985 3456779999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 76 DYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 9999999999997643 378889999999999999999999 9999999999999999999999999998753
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
.... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus 147 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 147 IEHN------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred ccCC------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 2211 112345689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=305.23 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=196.7
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|.+.+ ++.||+|.+..... .+.+.+|++++++++||||+++++++. .+...+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEE
Confidence 3689999999999999999999875 78999999864432 678999999999999999999999854 346679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+++||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 75 l~~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccc
Confidence 9999999999999986533 3489999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
........ ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......... .......+..
T Consensus 147 ~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~ 218 (256)
T cd06612 147 GQLTDTMA------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--FMIPNKPPPT 218 (256)
T ss_pred hhcccCcc------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--hhhccCCCCC
Confidence 86543211 112344788999999998888999999999999999999999998653221110 0000000000
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. ....+...+.+++.+||+.||++|||+.|++++
T Consensus 219 ~~--------------------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LS--------------------DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CC--------------------chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00 000011112236778999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=310.62 Aligned_cols=263 Identities=24% Similarity=0.351 Sum_probs=196.1
Q ss_pred HhcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF 525 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 525 (767)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS---- 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 4578999999999999999999754 24579999875332 223446788999999999999999999854
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKN----EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED 601 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~ 601 (767)
.....++||||+++|+|.+++...... ......++..+..++.|++.||+|||++ +|+||||||+||+++++
T Consensus 80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~ 155 (288)
T cd05061 80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155 (288)
T ss_pred -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence 334569999999999999999754321 1123467788899999999999999999 99999999999999999
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcc
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVS 680 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~ 680 (767)
+.++|+|||+++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~ 229 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRK----GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--Q 229 (288)
T ss_pred CcEEECcCCccccccccccccc----cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence 9999999999875433211110 112235678999999988889999999999999999998 78888542211 1
Q ss_pred hhhHhh-hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 681 LVKWVE-SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 681 ~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
..+... ...+. .... ....+.+++.+||+.||++|||+.|+++.+++..
T Consensus 230 ~~~~~~~~~~~~-~~~~----------------------~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 230 VLKFVMDGGYLD-QPDN----------------------CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHcCCCCC-CCCC----------------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111110 00000 0000 0112333777999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.47 Aligned_cols=193 Identities=34% Similarity=0.449 Sum_probs=161.1
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHH-HHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECE-ALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|... +|+.||+|++... .......+..|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 46899999999999965 5899999998643 2223345556655 46778999999999885 3456779999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 76 DFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999999999886543 389999999999999999999999 9999999999999999999999999998643
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
... ........||..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 147 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 147 IAQ------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred CCC------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence 211 1112345689999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=313.67 Aligned_cols=197 Identities=24% Similarity=0.391 Sum_probs=169.1
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||+|+||.||++.+. ++..||+|.+..... ....++.+|++++++++||||+++++++. .++.++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence 36889999999999999999965 488899998864422 23456889999999999999999999854 456789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+ . +++||||||+||+++.++.+||+|||.
T Consensus 76 lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred EEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCC
Confidence 9999999999999997643 38999999999999999999997 5 899999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
+...... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 147 SGQLIDS--------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ccccccc--------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 8654221 11234688999999999888899999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=306.19 Aligned_cols=258 Identities=24% Similarity=0.422 Sum_probs=195.3
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-C---cEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-G---ISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|+..+.||+|+||.||+|.... + ..||+|.++... ....+.+.+|++++++++|||++++.+++. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cC
Confidence 3578888999999999999999753 3 379999886442 334567889999999999999999999964 34
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
+..++||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 150 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSD 150 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECC
Confidence 55799999999999999986532 2389999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 687 (767)
||++........... .......+..|+|||++.+..++.++||||||+++||+++ |+.||...... .....+..
T Consensus 151 fg~~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~ 225 (268)
T cd05063 151 FGLSRVLEDDPEGTY---TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAIND 225 (268)
T ss_pred Cccceecccccccce---eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhc
Confidence 999976543211111 0111223457999999988889999999999999999997 99998543211 11111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
..+....... . .. +.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ~~~~~~~~~~------------------~---~~-~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRLPAPMDC------------------P---SA-VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCC------------------C---HH-HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1110000000 0 11 22377789999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.72 Aligned_cols=266 Identities=23% Similarity=0.390 Sum_probs=198.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC--------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecC
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR--------EGISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSL 523 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 523 (767)
.++|.+.+.||+|+||.||+|... ....||+|.+.... ......+.+|+++++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 357889999999999999999752 24579999886432 23456788999999999 6999999999864
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKP 593 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 593 (767)
.....++||||+++|+|.+++...... .....+++.++..++.|++.||+|||++ |++||||||
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 162 (314)
T cd05099 89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA 162 (314)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 345679999999999999999764321 1124589999999999999999999998 999999999
Q ss_pred CCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 004218 594 GNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTH 672 (767)
Q Consensus 594 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 672 (767)
+||++++++.+||+|||.++.......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKK----TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccc----cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999976533211110 111224467999999988889999999999999999999 888885
Q ss_pred CcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 673 ESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
..... .................+. . .+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 239 ~~~~~--~~~~~~~~~~~~~~~~~~~------------------~----~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 239 GIPVE--ELFKLLREGHRMDKPSNCT------------------H----ELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred CCCHH--HHHHHHHcCCCCCCCCCCC------------------H----HHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 43211 1111111110000000000 1 1223777999999999999999999999887
Q ss_pred HHH
Q 004218 753 KIL 755 (767)
Q Consensus 753 ~~~ 755 (767)
...
T Consensus 295 ~~~ 297 (314)
T cd05099 295 AAV 297 (314)
T ss_pred HHh
Confidence 644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=309.03 Aligned_cols=252 Identities=26% Similarity=0.345 Sum_probs=191.5
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.|+..+.||+|+||.||++.+. +++.||+|.+..... ...+.+.+|+.++++++|++++++++.+. .+...
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence 3677889999999999999976 588999998864322 22345778999999999999999999854 44567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++++|.+++.... ...+++.++..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMG----EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred EEEEEecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999886433 23489999999999999999999998 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+....... ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||........ . .....
T Consensus 149 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~-~~~~~---- 215 (285)
T cd05630 149 AVHVPEGQ-------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-R-EEVER---- 215 (285)
T ss_pred eeecCCCc-------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-H-HHHHh----
Confidence 86542211 11224589999999999998999999999999999999999999965322110 0 00000
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC-----HHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID-----IREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 747 (767)
... ...... .......+.+++.+||+.||++||| ++|++++
T Consensus 216 ----~~~-~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 216 ----LVK-EVQEEY----------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ----hhh-hhhhhc----------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 000 000000 0001111233777899999999999 8898874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=309.77 Aligned_cols=259 Identities=22% Similarity=0.351 Sum_probs=193.5
Q ss_pred CCCCCCccccccceEEEEEEeCC------CcEEEEEEeeccCCc-chhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.|++.+.||+|+||.||+|.+.+ ++.||+|++...... ..+.+.+|+.+++.++||||+++++++. ..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~ 80 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----KE 80 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC
Confidence 46778899999999999998632 578999998644322 2456889999999999999999999964 33
Q ss_pred eeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
...++++||+++++|.+++...... .....+++..+..++.|++.||+|+|++ +|+||||||+||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~ 157 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEe
Confidence 4569999999999999998532210 1123488999999999999999999999 99999999999999
Q ss_pred CCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccC
Q 004218 599 DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAG 677 (767)
Q Consensus 599 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~ 677 (767)
++++.+||+|||+++........ .......+++.|+|||.+.+..++.++||||+||++|||++ |..||......
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 233 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYY----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233 (283)
T ss_pred cCCCceEecccccccccccchhe----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999998765332111 11123345778999999988889999999999999999998 88887543211
Q ss_pred CcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 678 EVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
.....+............. ..+.+++.+||+.+|++||+++|+++.|+.
T Consensus 234 --~~~~~i~~~~~~~~~~~~~----------------------~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 --DVIEMIRNRQVLPCPDDCP----------------------AWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHHHHHcCCcCCCCCCCC----------------------HHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111111000011111 112237778999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.26 Aligned_cols=247 Identities=27% Similarity=0.425 Sum_probs=189.4
Q ss_pred CccccccceEEEEEEeCCCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeecC
Q 004218 461 NLIGSGSFGSVYKGYLREGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLG 539 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 539 (767)
+.||+|+||.||+|...+++.||+|.+..... .....+.+|+++++.++||||+++++++.. ....++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECCC
Confidence 36899999999999988889999999865433 233468899999999999999999999653 345699999999
Q ss_pred CCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhc
Q 004218 540 NGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERI 619 (767)
Q Consensus 540 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 619 (767)
+++|.+++.... ..+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+||+|||++.......
T Consensus 76 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 76 GGDFLSFLRKKK-----DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 999999986543 2378999999999999999999998 99999999999999999999999999986533221
Q ss_pred CCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchhhhcc
Q 004218 620 GNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQVLD 698 (767)
Q Consensus 620 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (767)
.. ......++..|+|||++.+..++.++||||||+++|++++ |..||...... .....+...........+.
T Consensus 148 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 220 (250)
T cd05085 148 YS-----SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKGYRMSCPQKCP 220 (250)
T ss_pred cc-----cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCC
Confidence 10 1112234577999999988889999999999999999998 99998643211 1111111111111000011
Q ss_pred HHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 699 RELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 699 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 221 ----------------------~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 ----------------------DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ----------------------HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11233777899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.85 Aligned_cols=253 Identities=31% Similarity=0.494 Sum_probs=194.6
Q ss_pred CccccccceEEEEEEeCC----CcEEEEEEeeccCCc-chhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLRE----GISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|++.++.++|+|++++++++. .+...++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 468999999999999754 788999998755433 3678899999999999999999999864 356779999
Q ss_pred eecCCCChhhhhcccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 536 EFLGNGSLGDWIHGERKN---EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
||+++++|.+++...... .....+++.+++.++.|++.|++|||++ +++||||||+||++++++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence 999999999999875210 0023489999999999999999999998 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
........ ........++..|+|||.+.+..++.++||||+|+++|+|++ |..||..... .............
T Consensus 153 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~ 226 (262)
T cd00192 153 RDVYDDDY----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRKGYRL 226 (262)
T ss_pred cccccccc----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCC
Confidence 87644321 111233457889999999988889999999999999999999 6899866421 1111111111110
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
.....++ ..+.+++.+||+.+|++|||+.|++++|+
T Consensus 227 ~~~~~~~----------------------~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PKPEYCP----------------------DELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCccCC----------------------hHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111111 11223677899999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=304.20 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=188.2
Q ss_pred CccccccceEEEEEEeCC----CcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLRE----GISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.+++.++|||++++++++.. .+...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 468999999999998532 457999987532 22345678899999999999999999997642 234568999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+.+|+|.+++..... ..++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 77 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 77 PYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred ecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999999975432 267888899999999999999998 9999999999999999999999999999754
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCC-CCCCCcccCCcchhhHhhhhcccchh
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGM-SPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
....... ........++..|+|||.+.+..++.++||||||+++|||++|+ +||..... ...........+....
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 224 (262)
T cd05058 149 YDKEYYS--VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQGRRLLQP 224 (262)
T ss_pred cCCccee--ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCCCCCCC
Confidence 3221100 01112234577899999998888999999999999999999954 55543211 1111111111000000
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
.... ..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 225 ~~~~----------------------~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 225 EYCP----------------------DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CcCC----------------------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0001 112237778999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=310.24 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=193.3
Q ss_pred cCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
+.|++.+.||+|+||.||+|.... ++.||+|.+........+.+.+|+++++.++|||++++++++. .+...++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence 578899999999999999999764 8899999997666566678889999999999999999999854 3456799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++++|..++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 87 MIEFCPGGAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred EEecCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence 999999999998876433 2389999999999999999999998 99999999999999999999999999986
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
...... .......++..|+|||++. ...++.++|||||||++|+|++|+.||...... ....+.....
T Consensus 159 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~ 231 (292)
T cd06644 159 KNVKTL------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSE 231 (292)
T ss_pred eccccc------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcCC
Confidence 532211 1112345788999999875 344678999999999999999999998653211 1111111100
Q ss_pred cccc-hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKN-AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+.. ....+ .. -+.+++.+||+.||++||+++|++++
T Consensus 232 ~~~~~~~~~~------------------~~----~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 PPTLSQPSKW------------------SM----EFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CccCCCCccc------------------CH----HHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 00000 01 12236778999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.34 Aligned_cols=203 Identities=24% Similarity=0.352 Sum_probs=163.9
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCC------CCceeEEeee
Q 004218 448 DELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRH------RNLVKLITSC 520 (767)
Q Consensus 448 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~ 520 (767)
+++....++|++.+.||+|+||.||+|.+. .++.||||+++... .....+..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344456789999999999999999999975 47889999986322 223445667777776654 4588888886
Q ss_pred ecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeC
Q 004218 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLD 599 (767)
Q Consensus 521 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~ 599 (767)
.. ...++++|||++ +++|.+++.... .+++..+..|+.||+.||+|||+ . +||||||||+||+++
T Consensus 201 ~~----~~~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~ 266 (467)
T PTZ00284 201 QN----ETGHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILME 266 (467)
T ss_pred Ec----CCceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEe
Confidence 42 345689999998 678999886543 38999999999999999999997 5 999999999999998
Q ss_pred CCC----------------ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHH
Q 004218 600 EDM----------------TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLE 663 (767)
Q Consensus 600 ~~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~e 663 (767)
.++ .+||+|||.+..... ......||..|+|||++.+..++.++|||||||++||
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~---------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~e 337 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH---------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYE 337 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccCcc---------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHH
Confidence 765 499999998753211 1234568999999999999999999999999999999
Q ss_pred HHhCCCCCCCc
Q 004218 664 IFTGMSPTHES 674 (767)
Q Consensus 664 l~tg~~p~~~~ 674 (767)
|++|+.||+..
T Consensus 338 lltG~~pf~~~ 348 (467)
T PTZ00284 338 LYTGKLLYDTH 348 (467)
T ss_pred HHhCCCCCCCC
Confidence 99999999653
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=315.31 Aligned_cols=199 Identities=25% Similarity=0.364 Sum_probs=166.8
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCccccee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 530 (767)
.|+..+.||+|+||.||+|... +++.||+|++... .....+.+..|..+++.+. |++|+++++++ ...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 3677899999999999999975 5889999998643 2234456778899988885 57777888874 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence 899999999999999986543 389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 147 ~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 147 MCKEHMVDG------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred cccccCCCC------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 987532211 1123356899999999999889999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=312.79 Aligned_cols=267 Identities=24% Similarity=0.340 Sum_probs=193.0
Q ss_pred hcCCCCCCccccccceEEEEEEeCC---------------CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE---------------GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLI 517 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~ 517 (767)
.++|++.+.||+|+||.||++...+ ...||+|.++.... .....+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3589999999999999999987642 23589999864422 2345688999999999999999999
Q ss_pred eeeecCCcccceeeEEEEeecCCCChhhhhcccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC
Q 004218 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDL 591 (767)
Q Consensus 518 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 591 (767)
+++. .....++||||+++++|.+++...... .....+++..++.++.|++.|++|||+. +++||||
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl 155 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL 155 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 9964 345679999999999999998653211 1112378899999999999999999999 9999999
Q ss_pred CCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh--CCC
Q 004218 592 KPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT--GMS 669 (767)
Q Consensus 592 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t--g~~ 669 (767)
||+||++++++.+||+|||++........ ........++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~ 231 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ 231 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcc----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999975432211 011122335678999999988889999999999999999998 556
Q ss_pred CCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 670 PTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 670 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
||....... ........+... ........+. ....-+.+++.+||+.||++|||++++++.|+
T Consensus 232 p~~~~~~~~--~~~~~~~~~~~~--------~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 232 PYSLLSDEQ--VIENTGEFFRNQ--------GRQIYLSQTP-------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCcccChHH--HHHHHHHhhhhc--------cccccCCCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 765422111 111110000000 0000000000 00112333788999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=312.21 Aligned_cols=266 Identities=23% Similarity=0.342 Sum_probs=193.9
Q ss_pred cCCCCCCccccccceEEEEEEeC-----------------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-----------------EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKL 516 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~ 516 (767)
++|++.+.||+|+||.||++... ++..||+|++.... ......+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998643 23468999986442 2334678899999999999999999
Q ss_pred EeeeecCCcccceeeEEEEeecCCCChhhhhcccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC
Q 004218 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN-----EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDL 591 (767)
Q Consensus 517 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 591 (767)
++++. .+...++||||+++|+|.+++...... .....+++.++..++.|++.|++|||+. +++||||
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl 156 (296)
T cd05095 85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL 156 (296)
T ss_pred EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence 99864 344579999999999999999764422 1123588899999999999999999999 9999999
Q ss_pred CCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh--CCC
Q 004218 592 KPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT--GMS 669 (767)
Q Consensus 592 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t--g~~ 669 (767)
||+||+++.++.++|+|||.++.+...... .......++..|+|||...++.++.++|||||||++|||++ |..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~ 232 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYY----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcce----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCC
Confidence 999999999999999999999765332111 11122234678999999888889999999999999999998 677
Q ss_pred CCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 670 PTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 670 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
||....... ........+..... ........ . ....+.+++.+||+.||++|||+.|+++.|+
T Consensus 233 p~~~~~~~~--~~~~~~~~~~~~~~-------~~~~~~~~----~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 233 PYSQLSDEQ--VIENTGEFFRDQGR-------QVYLPKPA----L----CPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CccccChHH--HHHHHHHHHhhccc-------cccCCCCC----C----CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 875432211 11000000000000 00000000 0 0112233777999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=310.11 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=195.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||.|+||.||+|.+. ++..||+|++........+.+.+|++++++++||||+++++++. .+...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence 357899999999999999999975 58899999997665556678889999999999999999999854 455679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++.... ..+++.++..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||.+
T Consensus 79 lv~e~~~~~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence 9999999999999987543 2489999999999999999999999 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
........ ......|+..|+|||.+. ...++.++||||+|+++|+|++|+.||....... ........
T Consensus 151 ~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~ 223 (280)
T cd06611 151 AKNKSTLQ------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILKS 223 (280)
T ss_pred hhhccccc------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhcC
Confidence 75432211 112345889999999874 3446789999999999999999999986532111 11111110
Q ss_pred hcccc-hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 NFPKN-AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+.. .+..++ ..+.+++.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 EPPTLDQPSKWS----------------------SSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCCcCCcccCC----------------------HHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00000 000011 112236778999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.69 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=197.6
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
++|++.+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++ .....+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence 57899999999999999999975 4788999999766555678899999999999999999999985 34567899
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
+|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+.
T Consensus 78 ~~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEeCCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence 999999999999987642 2389999999999999999999998 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCC---CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE---KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
....... ......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||........ ........++
T Consensus 150 ~~~~~~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~~~ 222 (262)
T cd06613 150 QLTATIA------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSNFP 222 (262)
T ss_pred hhhhhhh------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCC
Confidence 6543211 11234578899999998776 788999999999999999999999865322111 1001011000
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
... . ..... ....+.+++.+||..+|.+|||+++++.+
T Consensus 223 ~~~--~-------------~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 223 PPK--L-------------KDKEK----WSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred Ccc--c-------------cchhh----hhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0 00001 11122337779999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.47 Aligned_cols=206 Identities=26% Similarity=0.348 Sum_probs=172.4
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
+.|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++..++||+|+++++.+ .+...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 36888999999999999999976 4899999998643 233456778899999999999999999984 45567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence 899999999999999997543 389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCC-----------------------------ccccccccccCCCCccCccccCCCCCCCcccchhhhHHH
Q 004218 611 LARSLLERIGNQ-----------------------------SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVML 661 (767)
Q Consensus 611 ~a~~~~~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il 661 (767)
++.......... ..........||+.|+|||++.+..++.++||||+||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 987543211000 000011234699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCc
Q 004218 662 LEIFTGMSPTHES 674 (767)
Q Consensus 662 ~el~tg~~p~~~~ 674 (767)
|||++|+.||...
T Consensus 227 yel~tG~~Pf~~~ 239 (360)
T cd05627 227 YEMLIGYPPFCSE 239 (360)
T ss_pred eecccCCCCCCCC
Confidence 9999999999654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=306.57 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=196.1
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||.|++|.||+|.+. +++.||+|.+.... ......+.+|+++++.++|+|++++++++. ++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence 36888999999999999999976 48899999986543 344567889999999999999999999854 446789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+|+||+++++|.+++... ++++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 999999999999999754 389999999999999999999998 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+....+..
T Consensus 146 ~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~ 217 (274)
T cd06609 146 GQLTSTMS------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNNPPS 217 (274)
T ss_pred eeeccccc------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcCCCC
Confidence 77643211 1123457889999999998889999999999999999999999986532111 111111111111
Q ss_pred hhhh-ccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQV-LDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... ++. .+.+++.+||..||++|||+++++++
T Consensus 218 ~~~~~~~~----------------------~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGNKFSK----------------------PFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CcccccCH----------------------HHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0000 111 12236678999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=316.76 Aligned_cols=193 Identities=33% Similarity=0.430 Sum_probs=160.4
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHH-HHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECE-ALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|++. +++.||+|++.... ......+.+|.. +++.++||||+++++++ .+.+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999975 48899999986432 222344555554 57889999999999885 3456789999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 76 DYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999999998886533 388899999999999999999998 9999999999999999999999999998643
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 147 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 147 VEPE------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred CCCC------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 2111 112345689999999999988999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=307.67 Aligned_cols=266 Identities=25% Similarity=0.366 Sum_probs=200.7
Q ss_pred cCHHHHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeec
Q 004218 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSS 522 (767)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 522 (767)
.+..++..+.+.|++.+.||+|+||.||+|.+. +++.||+|++.... .....+..|+.+++++ +|||++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 455666777899999999999999999999975 48899999986443 2345678899999998 69999999998754
Q ss_pred CCc-ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 004218 523 LDF-KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED 601 (767)
Q Consensus 523 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~ 601 (767)
... ......+++|||+++|+|.+++...+ ...+++..+..++.|++.|++|||+. +|+||||+|+||+++++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK----GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 321 23567899999999999999997543 23478888999999999999999999 99999999999999999
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
+.++|+|||.+........ ......|+..|+|||.+. ...++.++||||+||++|||++|+.||.....
T Consensus 158 ~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred CCEEEeeCcchhhhhcccc------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 9999999999876532211 112345889999999876 34578899999999999999999999865322
Q ss_pred CCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 677 GEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
... .........+......+ . ..+.+++.+||+.||.+|||+.|++++
T Consensus 232 ~~~-~~~~~~~~~~~~~~~~~------------------~----~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 232 MRA-LFLIPRNPPPKLKSKKW------------------S----KKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred Hhh-hhhHhhCCCCCCccccc------------------C----HHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 111 00000000000000000 1 112237779999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.67 Aligned_cols=204 Identities=27% Similarity=0.418 Sum_probs=169.9
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-----cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-----GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.+|+..+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 46889999999999999999975 488999998854321 233568889999999999999999998642 234
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...+++|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 56789999999999999997543 288999999999999999999998 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
||++.......... .......++..|+|||.+.+..++.++||||+||++||+++|+.||..
T Consensus 150 fg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 150 FGASKRLQTICMSG---TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred CCCccccccccccC---CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 99987553211111 111234578899999999988899999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=324.94 Aligned_cols=195 Identities=22% Similarity=0.284 Sum_probs=164.4
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
..+|.+.+.||+|+||.||+|.+.. ++.||||... ...+.+|++++++++|+||+++++++. .++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEE
Confidence 4579999999999999999999764 7899999642 234678999999999999999999854 345679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+|||++. ++|.+++.... ..+++.++..|+.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 237 lv~e~~~-~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla 307 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARL-----RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA 307 (461)
T ss_pred EEEEccC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence 9999995 69998886532 2499999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCC
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTH 672 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 672 (767)
+........ .......||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 308 ~~~~~~~~~----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 308 CFARGSWST----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred eeccccccc----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 765322111 11123568999999999999999999999999999999999887653
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.34 Aligned_cols=274 Identities=27% Similarity=0.333 Sum_probs=200.7
Q ss_pred cCCCCCCccccccceEEEEEEeC-----CCcEEEEEEeeccCCc-chhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-----EGISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
+.|++.+.||+|+||.||+|.+. ++..||+|++...... ..+.+.+|+++++.+.||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 46778899999999999999853 3678999998755443 46789999999999999999999998653 234
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence 567999999999999999976442 389999999999999999999998 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||.+.......... .......++..|+|||...+..++.++||||||+++|||++|+.|+............ ..
T Consensus 153 fg~~~~~~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~---~~ 226 (284)
T cd05038 153 FGLAKVLPEDKDYY---YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG---IA 226 (284)
T ss_pred cccccccccCCcce---eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccc---cc
Confidence 99998764221110 1111223456799999998888999999999999999999999997553322111000 00
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
............+......... ......+.+++.+||+.+|++||||.|++++|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 227 QGQMIVTRLLELLKEGERLPRP------PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccccHHHHHHHHHcCCcCCCC------ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000000000111100000000 00111223378899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.03 Aligned_cols=253 Identities=32% Similarity=0.492 Sum_probs=191.5
Q ss_pred CCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchh--hHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWK--SFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
|++.+.||+|+||+||++.... ++.||+|++......... ...+|+.++++++||||+++++++. .....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence 5678899999999999999765 678999999765433322 3456999999999999999999954 4667789
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++++|.+++.... .+++.++..++.|+++||++||+. +|+|+||||+||++++++.++|+|||.+.
T Consensus 76 v~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEETTEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred cccccccccccccccccc------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 999999999999998332 389999999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccC-CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGL-GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
.... .........++..|+|||++. +..++.++||||+|+++|+|++|..||...... ..
T Consensus 147 ~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~----------- 207 (260)
T PF00069_consen 147 KLSE------NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQ----------- 207 (260)
T ss_dssp ESTS------TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HH-----------
T ss_pred cccc------cccccccccccccccccccccccccccccccccccccccccccccccccccccch--hh-----------
Confidence 5311 111223456889999999988 788999999999999999999999998764100 00
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
....................... ..+.+++.+||+.||++|||+.|++++
T Consensus 208 -~~~~~~~~~~~~~~~~~~~~~~~----~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 208 -LEIIEKILKRPLPSSSQQSREKS----EELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -HHHHHHHHHTHHHHHTTSHTTSH----HHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -hhhhhhcccccccccccccchhH----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001111000000000000000 223337779999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.64 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=193.8
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
.+|++.+.||+|+||.||+|.+.+++.+|+|.+.... .....+.+|++++++++|||++++++++. .....++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEE
Confidence 4678889999999999999998778899999886332 23467889999999999999999999853 44567999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+..
T Consensus 78 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred EEcCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceee
Confidence 99999999999987543 2378999999999999999999998 999999999999999999999999999875
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccch
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
....... ......++..|+|||.+.+..++.++||||+|+++|||++ |+.||...... ..............
T Consensus 150 ~~~~~~~-----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 222 (256)
T cd05112 150 VLDDQYT-----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAGFRLYK 222 (256)
T ss_pred cccCccc-----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCCCCCCC
Confidence 5332111 0112234678999999988889999999999999999998 89998643211 11111111000000
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
..... ..+.+++.+||+.+|++|||+.|++++|
T Consensus 223 ~~~~~----------------------~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 PRLAS----------------------QSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCC----------------------HHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00011 1122377799999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.01 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=196.9
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.++|++.+.||+|+||.||+|.+.++..||+|.+... ....+.+.+|+++++.++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence 4678999999999999999999877888999987643 2234678899999999999999999998542 45699
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
+|||+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 78 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred EEEeCCCCcHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCccee
Confidence 999999999999997643 23488999999999999999999998 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
....... .......++..|+|||++....++.++||||||+++|++++ |+.||...... .........++..
T Consensus 151 ~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~ 223 (260)
T cd05073 151 VIEDNEY-----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRMP 223 (260)
T ss_pred eccCCCc-----ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCCCC
Confidence 6532211 11112235677999999988889999999999999999999 89998643211 1112221111111
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
..... ...+.+++.+||+.+|++||++.++.+.|+.
T Consensus 224 ~~~~~----------------------~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENC----------------------PEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccC----------------------CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11001 1112237778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=288.74 Aligned_cols=209 Identities=27% Similarity=0.351 Sum_probs=175.5
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-----CcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-----GISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
...|+....||+|.||.||+|.-.+ ...+|+|.++.+ .++......+|+..++.++|||++.+..++. .
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl----~ 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL----S 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh----c
Confidence 3578999999999999999996432 237999999654 3344567889999999999999999999864 2
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC----C
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED----M 602 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~----~ 602 (767)
.+..+++++||.+. +|.++++-.+.... +.++...+..|+.||+.|+.|||++ -|+||||||.||++..+ |
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccC
Confidence 36789999999988 99999987765443 5699999999999999999999999 89999999999999877 8
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
.+||+|||+++.+.+..... .....++-|.+|+|||.+.+. .|+++.||||.|||+.||+|-++-|...
T Consensus 174 ~VKIaDlGlaR~~~~plkpl---~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNPLKPL---ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eeEeecccHHHHhhcccccc---ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999999999886654322 223456779999999998875 5899999999999999999998887654
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=310.18 Aligned_cols=267 Identities=25% Similarity=0.345 Sum_probs=195.7
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-----------------CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCcee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-----------------GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVK 515 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~ 515 (767)
..+|++.+.||+|+||.||+|.+.. +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4579999999999999999998642 24689999865432 34567889999999999999999
Q ss_pred EEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 004218 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN-----EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCD 590 (767)
Q Consensus 516 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 590 (767)
+++++. .+...++||||+++++|.+++...... .....+++..++.++.|++.||+|||+. +|+|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 999864 335679999999999999999765421 1123589999999999999999999998 999999
Q ss_pred CCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh--CC
Q 004218 591 LKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT--GM 668 (767)
Q Consensus 591 lkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t--g~ 668 (767)
|||+||+++.++.++|+|||.++........ .......++..|+|||++.+..++.++||||||+++|||++ |.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 231 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcce----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence 9999999999999999999998754322111 11123346778999999988889999999999999999998 66
Q ss_pred CCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 669 SPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 669 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
.||..... ..........+........ .... .. ....+.+++.+||+.||++|||+.|+++.|
T Consensus 232 ~p~~~~~~--~~~~~~~~~~~~~~~~~~~-------~~~~----~~----~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 232 QPYEHLTD--QQVIENAGHFFRDDGRQIY-------LPRP----PN----CPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred CCCCCcCh--HHHHHHHHhcccccccccc-------CCCc----cC----CCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 77744221 1111111100000000000 0000 00 001123377899999999999999999988
Q ss_pred H
Q 004218 749 K 749 (767)
Q Consensus 749 ~ 749 (767)
+
T Consensus 295 ~ 295 (296)
T cd05051 295 Q 295 (296)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.60 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=197.9
Q ss_pred cCCCCCCccccccceEEEEEEeCC-Cc----EEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GI----SVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.+|++.+.||+|+||.||+|.+.. |+ .||+|....... .....+.+|+.++++++|||++++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 578889999999999999999643 32 589998764432 345678899999999999999999998753
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++|+|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d 152 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD 152 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence 456899999999999999976432 389999999999999999999998 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 687 (767)
||.++......... ......++..|+|||.+....++.++||||||+++||+++ |+.||...... .....+..
T Consensus 153 fg~~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~ 226 (279)
T cd05057 153 FGLAKLLDVDEKEY----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEK 226 (279)
T ss_pred CcccccccCcccce----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhC
Confidence 99998654321111 0111224567999999988889999999999999999998 99998653221 11111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
..+...+...+.. +.+++.+||..||++|||+.++++.|+++.++
T Consensus 227 ~~~~~~~~~~~~~----------------------~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 227 GERLPQPPICTID----------------------VYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCCCCCCCCHH----------------------HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 1111111111111 11266789999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=303.06 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=196.7
Q ss_pred hcCCCCCCccccccceEEEEEEeCC----CcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
..+|++.+.||+|+||.||+|.+.+ ...||+|...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------ 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------
Confidence 3468888999999999999998643 3468999886544 3345678999999999999999999998642
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d 150 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGD 150 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEcc
Confidence 33589999999999999997543 2389999999999999999999998 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 687 (767)
||.++........ ......++..|+|||.+....++.++||||||+++||+++ |..||....... .......
T Consensus 151 ~g~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~ 223 (270)
T cd05056 151 FGLSRYLEDESYY-----KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIEN 223 (270)
T ss_pred Cceeeecccccce-----ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHc
Confidence 9998765332110 1112234567999999988889999999999999999986 999986543211 1111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
..+......++ ..+.+++.+|+..+|++|||+.++++.|+++.+
T Consensus 224 ~~~~~~~~~~~----------------------~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 224 GERLPMPPNCP----------------------PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCcCCCCCCCC----------------------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11000001111 112236778999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=339.30 Aligned_cols=261 Identities=23% Similarity=0.297 Sum_probs=194.2
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
....++|++.+.||+|+||.||+|.+.. +..||+|++.... ......+..|+.++++++||||+++++++.. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~ 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KA 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cC
Confidence 3455789999999999999999999764 7789999986432 2345678899999999999999999998653 23
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeecCCCCCeeeCC---
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCE----VPIVHCDLKPGNILLDE--- 600 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~Dlkp~NIl~~~--- 600 (767)
...+|+||||+++|+|.+++...... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 45789999999999999999753211 2349999999999999999999998521 25999999999999964
Q ss_pred --------------CCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC--CCCCCcccchhhhHHHHHH
Q 004218 601 --------------DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG--EKPSTAGDVYSFGVMLLEI 664 (767)
Q Consensus 601 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el 664 (767)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccc-------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence 3458999999997653221 1233468999999999854 4578999999999999999
Q ss_pred HhCCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 004218 665 FTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREA 744 (767)
Q Consensus 665 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ev 744 (767)
++|+.||....... .+...+.. .+....... . ..+.+++..||+.+|.+||++.|+
T Consensus 237 LTGk~PF~~~~~~~-qli~~lk~-~p~lpi~~~------------------S----~eL~dLI~~~L~~dPeeRPSa~Ql 292 (1021)
T PTZ00266 237 CSGKTPFHKANNFS-QLISELKR-GPDLPIKGK------------------S----KELNILIKNLLNLSAKERPSALQC 292 (1021)
T ss_pred HHCCCCCCcCCcHH-HHHHHHhc-CCCCCcCCC------------------C----HHHHHHHHHHhcCChhHCcCHHHH
Confidence 99999996432111 11111100 000000000 1 112237778999999999999999
Q ss_pred HHH
Q 004218 745 LRR 747 (767)
Q Consensus 745 l~~ 747 (767)
+.+
T Consensus 293 L~h 295 (1021)
T PTZ00266 293 LGY 295 (1021)
T ss_pred hcc
Confidence 853
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=303.25 Aligned_cols=239 Identities=27% Similarity=0.394 Sum_probs=181.0
Q ss_pred CccccccceEEEEEEeCC-------------CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 461 NLIGSGSFGSVYKGYLRE-------------GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
+.||+|+||.||+|.... ...||+|.+..........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~----- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR----- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 468999999999998532 23589998865555556678899999999999999999999653
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc----
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT---- 603 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---- 603 (767)
....++||||+++|+|..++.... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~ 147 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC 147 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCC
Confidence 344589999999999999886532 2389999999999999999999998 9999999999999986654
Q ss_pred ---eEEccccchhhhhhhcCCCccccccccccCCCCccCccccC-CCCCCCcccchhhhHHHHHHH-hCCCCCCCcccCC
Q 004218 604 ---AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL-GEKPSTAGDVYSFGVMLLEIF-TGMSPTHESFAGE 678 (767)
Q Consensus 604 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~-tg~~p~~~~~~~~ 678 (767)
++++|||.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||.......
T Consensus 148 ~~~~~l~d~g~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 148 GPFIKLSDPGIPITVLSR----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred CceeEeCCCCCCccccCc----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 899999998654211 2234788899999886 466899999999999999998 5888875422111
Q ss_pred cchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 679 VSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
. ........+. .. ...+ .+.+++.+||+.||.+||++.|+++.+
T Consensus 218 ~--~~~~~~~~~~-----~~---------------~~~~----~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 218 K--ERFYEGQCML-----VT---------------PSCK----ELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred H--HHHHhcCccC-----CC---------------CChH----HHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 0000000000 00 0001 123377799999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.25 Aligned_cols=265 Identities=24% Similarity=0.391 Sum_probs=198.3
Q ss_pred cCCCCCCccccccceEEEEEEeCC--------CcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCC
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE--------GISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLD 524 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 524 (767)
.+|++.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+++++++ +||||++++++|.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--- 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence 478999999999999999997521 2368999886432 23456788999999999 7999999999964
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPG 594 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~ 594 (767)
.+...+++|||+++|+|.+++...... .....+++.++..++.|++.||+|||+. +++||||||+
T Consensus 89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 345679999999999999999754321 1234588999999999999999999998 9999999999
Q ss_pred CeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCC
Q 004218 595 NILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHE 673 (767)
Q Consensus 595 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~ 673 (767)
||+++.++.+||+|||.++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYK----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccc----cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999997653321110 1112234567999999999899999999999999999998 8888854
Q ss_pred cccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 674 SFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
.... .....+............ .. .+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 240 ~~~~--~~~~~~~~~~~~~~~~~~------------------~~----~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 240 IPVE--ELFKLLKEGHRMDKPANC------------------TH----ELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CCHH--HHHHHHHcCCCCCCCCCC------------------CH----HHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 3211 111111111110000000 01 12237778999999999999999999998875
Q ss_pred HH
Q 004218 754 IL 755 (767)
Q Consensus 754 ~~ 755 (767)
..
T Consensus 296 ~~ 297 (334)
T cd05100 296 VT 297 (334)
T ss_pred hc
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=302.48 Aligned_cols=264 Identities=25% Similarity=0.364 Sum_probs=195.6
Q ss_pred CCCCCccccccceEEEEEEeC----CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc-cce
Q 004218 457 FSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK-NME 529 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 529 (767)
|++.+.||+|+||.||+|.+. +++.||||++... .....+++.+|+++++.++||||+++++++...... ...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999854 3688999998644 233456788999999999999999999987543211 122
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++++||+++|+|.+++...........+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 4578999999999998876443222223488999999999999999999998 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|.++......... ......++..|++||.+.+..++.++||||||+++|+|++ |+.||..... .....+....
T Consensus 158 g~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYR----QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKG 231 (273)
T ss_pred cccccccCCccee----cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcC
Confidence 9997653221110 1112235678999999988889999999999999999999 8888854322 1111111110
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
......... ...+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 232 ~~~~~~~~~----------------------~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLKQPPDC----------------------LEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCCCCCCC----------------------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000000000 01122377789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.19 Aligned_cols=249 Identities=29% Similarity=0.404 Sum_probs=192.4
Q ss_pred CccccccceEEEEEEeCC--C--cEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLRE--G--ISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 468999999999999653 3 3699999876554 556788999999999999999999998642 5679999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++..
T Consensus 75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence 99999999999976431 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhccc-ch
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPK-NA 693 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 693 (767)
....... .......++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ........... ..
T Consensus 148 ~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~~~ 222 (257)
T cd05040 148 PQNEDHY---VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKEGERLER 222 (257)
T ss_pred cccccce---ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcCCcCCC
Confidence 4422111 11123446788999999988889999999999999999998 999985432211 11111100000 00
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
.. .....+.+++.+||+.+|++|||+.|+++.|.
T Consensus 223 ~~----------------------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PE----------------------ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred Cc----------------------cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00 01112233777999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=322.97 Aligned_cols=198 Identities=24% Similarity=0.285 Sum_probs=166.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC---CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR---EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
..+|.+.+.||+|+||.||++... .++.||+|.+... +...+|++++++++||||+++++++ .....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence 457999999999999999999754 3678999987532 3456899999999999999999985 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++|||++. ++|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred EEEEehhcC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence 799999996 5899888443 2389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 675 (767)
+++........ .......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 231 ~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 231 AACKLDAHPDT----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccCccccc----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 99765432111 11234568999999999999999999999999999999999999986543
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.74 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=194.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|++.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~----- 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA----- 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence 467999999999999999999863 467899999864432 33467889999999999999999999864
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKN----------------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCD 590 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 590 (767)
.+...++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||+. +++|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 344569999999999999999743211 1123478999999999999999999998 999999
Q ss_pred CCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCC
Q 004218 591 LKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMS 669 (767)
Q Consensus 591 lkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~ 669 (767)
|||+||++++++.++|+|||.+.......... ......++..|+|||.+.+..++.++|||||||++|||++ |..
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~ 231 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYK----ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCcccc----ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999987543221100 0112234567999999988899999999999999999998 888
Q ss_pred CCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 670 PTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 670 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
||...... .....+............+ ..+.+++.+||+.||++|||+.|+++.|+
T Consensus 232 p~~~~~~~--~~~~~~~~~~~~~~~~~~~----------------------~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 232 PYYGMAHE--EVIYYVRDGNVLSCPDNCP----------------------LELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCCHH--HHHHHHhcCCCCCCCCCCC----------------------HHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 87543211 1111111000000000000 11223777899999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=305.64 Aligned_cols=238 Identities=29% Similarity=0.392 Sum_probs=179.3
Q ss_pred ccccccceEEEEEEeCC-------------------------CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeE
Q 004218 462 LIGSGSFGSVYKGYLRE-------------------------GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKL 516 (767)
Q Consensus 462 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 516 (767)
+||+|+||.||+|.... ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 23589998865544445678899999999999999999
Q ss_pred EeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 004218 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNI 596 (767)
Q Consensus 517 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 596 (767)
+++|.. ....++||||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni 148 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI 148 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence 999753 345699999999999999986532 2388999999999999999999998 999999999999
Q ss_pred eeCCCC-------ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHH-hC
Q 004218 597 LLDEDM-------TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIF-TG 667 (767)
Q Consensus 597 l~~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~-tg 667 (767)
+++..+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALSR----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred EEeccCcccCccceeeecCCccccccccc----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 997543 4899999988643211 12246788999998865 56799999999999999995 68
Q ss_pred CCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 668 MSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 668 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+.||........ ........+ .+.... . .+.+++.+||+.+|++|||+.++++.
T Consensus 219 ~~p~~~~~~~~~--~~~~~~~~~--~~~~~~------------------~----~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 219 EVPLKERTPSEK--ERFYEKKHR--LPEPSC------------------K----ELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred CCCccccChHHH--HHHHHhccC--CCCCCC------------------h----HHHHHHHHHcccChhhCcCHHHHHHh
Confidence 899865322111 111100000 000000 1 12237778999999999999999998
Q ss_pred H
Q 004218 748 L 748 (767)
Q Consensus 748 L 748 (767)
|
T Consensus 273 L 273 (274)
T cd05076 273 L 273 (274)
T ss_pred h
Confidence 7
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.12 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=194.0
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 4889999999999999999965 47899999986442 234567889999999999999999998743 2344679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++.... ...+++.++..++.|++.|+++||+. +++||||||+||+++.++.++|+|||.+
T Consensus 77 lv~e~~~~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQK----GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred EEecccCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence 9999999999999997533 23489999999999999999999999 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
........ ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ .........+ .
T Consensus 150 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~-~ 221 (257)
T cd08223 150 RVLENQCD------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRIIEGKLP-P 221 (257)
T ss_pred EEecccCC------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCCC-C
Confidence 76532211 11234578899999999998899999999999999999999999864221100 0011111010 0
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... ....+.+++.+|++.||++|||+.|++++
T Consensus 222 ~~~~----------------------~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 MPKD----------------------YSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred Cccc----------------------cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0011 11122337778999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.73 Aligned_cols=263 Identities=27% Similarity=0.416 Sum_probs=206.6
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 448 DELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 448 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
++++-.....+..++||.|.||.||.|.|+. .-.||||.++ ++.-..++|++|+.+|+.++|||+|+++|+|..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~---- 334 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH---- 334 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc----
Confidence 3344444567778899999999999999986 6679999986 344457899999999999999999999999864
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
...+|||+|||.+|+|.+|++...+. .++.--.+.++.||+.|++||..+ ++|||||.++|+|+.++..+|+
T Consensus 335 -EpPFYIiTEfM~yGNLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 335 -EPPFYIITEFMCYGNLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred -CCCeEEEEecccCccHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEe
Confidence 33469999999999999999987643 366677889999999999999998 9999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHh
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~ 685 (767)
+|||+++.+..+..... ....-.+.|.|||.+....++.|+|||+|||++||+.| |-.||..... .+.....
T Consensus 407 ADFGLsRlMtgDTYTAH-----AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--SqVY~LL 479 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYTAH-----AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYGLL 479 (1157)
T ss_pred eccchhhhhcCCceecc-----cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--HHHHHHH
Confidence 99999998754322111 11122467999999999999999999999999999998 6678754211 1222233
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
+..|.-..++-+.+..+. +++.||+.+|++||+++|+-+.++.+-
T Consensus 480 EkgyRM~~PeGCPpkVYe----------------------LMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 480 EKGYRMDGPEGCPPKVYE----------------------LMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred hccccccCCCCCCHHHHH----------------------HHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 333433334444443332 667899999999999999999998653
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=298.31 Aligned_cols=248 Identities=29% Similarity=0.440 Sum_probs=190.6
Q ss_pred CccccccceEEEEEEeCCCcEEEEEEeeccCCc-chhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeecC
Q 004218 461 NLIGSGSFGSVYKGYLREGISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLG 539 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 539 (767)
++||+|+||.||+|.+.+++.||+|.+...... ..+.+.+|++++++++||||+++++++. .....++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcCC
Confidence 468999999999999877999999988654333 4567899999999999999999999854 4456799999999
Q ss_pred CCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhc
Q 004218 540 NGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERI 619 (767)
Q Consensus 540 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 619 (767)
+++|.+++.... ..+++..+..++.+++.|++|||++ +++||||||+||+++.++.+||+|||.+.......
T Consensus 76 ~~~l~~~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 76 GGSLLTFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 999999986543 2378999999999999999999999 99999999999999999999999999997543211
Q ss_pred CCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchhhhcc
Q 004218 620 GNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQVLD 698 (767)
Q Consensus 620 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (767)
... ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||...... ..............+..
T Consensus 148 ~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~-- 219 (251)
T cd05041 148 YTV----SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGYRMPAPQL-- 219 (251)
T ss_pred cee----ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCCCCCCCcc--
Confidence 100 0011223567999999988889999999999999999999 78888553221 11111111111000111
Q ss_pred HHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 699 RELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 699 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
....+.+++.+||..+|++|||+.|+++.|+
T Consensus 220 --------------------~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 --------------------CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred --------------------CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1112333777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=301.01 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=188.4
Q ss_pred CccccccceEEEEEEeCC-Cc--EEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLRE-GI--SVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|.+.+ +. .+|+|.+.... ....+.+.+|+++++++ +||||+++++++.. ....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence 368999999999999754 43 46888876332 33456788999999999 79999999999643 44569999
Q ss_pred eecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 004218 536 EFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
||+++|+|.+++...+.. .....+++.++..++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 999999999999754321 1123488999999999999999999998 999999999999999999999
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhH
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~ 684 (767)
|+|||++....... .......+..|+|||++....++.++||||||+++|||++ |+.||...... .....
T Consensus 153 l~dfgl~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~ 223 (270)
T cd05047 153 IADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEK 223 (270)
T ss_pred ECCCCCccccchhh-------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHHHH
Confidence 99999985322110 0011223567999999988889999999999999999997 99998543211 11111
Q ss_pred hhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 685 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
.............+ ..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 224 ~~~~~~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 LPQGYRLEKPLNCD----------------------DEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HhCCCCCCCCCcCC----------------------HHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111000000000 11223777999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.09 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=192.6
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.|+..+.||+|+||.||+|.+. +++.||+|.++... ....+.+.+|++++++++||||+++++++. .+...++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence 4666788999999999999865 47899999986443 334567889999999999999999999853 4556799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++++|.+++... .+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++|+|||++.
T Consensus 80 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 80 IMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred EEEccCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccc
Confidence 99999999999998643 288999999999999999999998 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccch
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||........ ........+...
T Consensus 150 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~ 221 (277)
T cd06642 150 QLTDTQI------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLIPKNSPPTL 221 (277)
T ss_pred cccCcch------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--HhhhhcCCCCCC
Confidence 6533211 11224578899999999988899999999999999999999999865322111 111111111000
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. .....+.+++.+||+.+|++|||+.|++++
T Consensus 222 ~~----------------------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EG----------------------QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred Cc----------------------ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00 011112237779999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.94 Aligned_cols=202 Identities=25% Similarity=0.356 Sum_probs=161.7
Q ss_pred CccccccceEEEEEEeCC---CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEee
Q 004218 461 NLIGSGSFGSVYKGYLRE---GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEF 537 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 537 (767)
.+||+|+||.||+|+..+ +..||+|.+... .....+.+|+++++.++||||+++++++.. ..+...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEee
Confidence 579999999999999653 578999988643 233567899999999999999999998753 344567999999
Q ss_pred cCCCChhhhhcccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEcccc
Q 004218 538 LGNGSLGDWIHGERKN---EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL----DEDMTAKVGDFG 610 (767)
Q Consensus 538 ~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~Dfg 610 (767)
+++ +|.+++...... .....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 865 888887543211 1123588999999999999999999999 99999999999999 466799999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+++........ ........||..|+|||++.+. .++.++||||+||++|||+||++||...
T Consensus 158 ~a~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 158 FARLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCccc---ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 99865432211 1112345689999999998764 5789999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.88 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=196.4
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
++|.+.+.||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++|||++++++++. .....++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence 68999999999999999999864 57899999987555555677899999999999999999999854 3456799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
|+||+++++|.+++.... +++.++..++.|++.|++|||++ +++||||+|+||+++.++.++|+|||.+.
T Consensus 94 v~e~~~~~~L~~~~~~~~-------l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 94 VMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred EEecCCCCcHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 999999999999986533 78999999999999999999999 99999999999999999999999999886
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccch
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
....... ......|+..|+|||.+.+..++.++||||||+++|++++|+.||......... ........+..
T Consensus 164 ~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~- 235 (293)
T cd06647 164 QITPEQS------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTPEL- 235 (293)
T ss_pred ccccccc------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-eehhcCCCCCC-
Confidence 5433211 112345788999999998888999999999999999999999999653221110 00000000000
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+.+...+++++.+||..+|++||++.|++.+
T Consensus 236 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 --------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111123337778999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.86 Aligned_cols=199 Identities=28% Similarity=0.390 Sum_probs=168.2
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+++++.++|++++++.+++. .++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEE
Confidence 3677889999999999999965 58899999986432 223345778999999999999999998853 45678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~ 148 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMG----NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEEEeccCccHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCc
Confidence 99999999999998886433 23499999999999999999999998 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
+....... ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||..
T Consensus 149 ~~~~~~~~-------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 149 AVKIPEGE-------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred ceecCCCC-------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 86542211 11234589999999999888899999999999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.79 Aligned_cols=191 Identities=30% Similarity=0.370 Sum_probs=157.6
Q ss_pred cccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcC---CCCCceeEEeeeecCCcccceeeEEEE
Q 004218 463 IGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNT---RHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 463 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
||+|+||.||+|+.. +++.||+|++.... ......+..|..++... +||+|+++++++ ......++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 699999999999976 48999999986432 12233455677777655 699999999984 4456789999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 76 DYMSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred cCCCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999999999887543 389999999999999999999999 9999999999999999999999999998653
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
.... .......||..|+|||++.+. .++.++||||+||++|+|++|+.||..
T Consensus 147 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 147 LTDN------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred CCCC------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 2211 112345689999999998754 479999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.48 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=194.8
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
..|+..+.||.|+||.||+|.+. ++..||+|.+.... ....+.+.+|+++++++.||||+++++++. ++...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEE
Confidence 45778899999999999999975 48899999986443 344567889999999999999999999854 456789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++|+|.+++.... +++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 79 lv~e~~~~~~L~~~i~~~~-------l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 79 IIMEYLGGGSALDLLRAGP-------FDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEecCCCCcHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence 9999999999999986532 88899999999999999999998 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
........ ......++..|+|||++.+..++.++||||||+++|||++|+.||........ ........+..
T Consensus 149 ~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~ 220 (277)
T cd06640 149 GQLTDTQI------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--LFLIPKNNPPT 220 (277)
T ss_pred eeccCCcc------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--hhhhhcCCCCC
Confidence 76533211 11234578889999999888899999999999999999999999865322111 00110000100
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. .....-+.+++.+||+.+|++||++.|++++
T Consensus 221 ~~----------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LT----------------------GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred Cc----------------------hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00 0011122237779999999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=301.35 Aligned_cols=256 Identities=27% Similarity=0.361 Sum_probs=182.9
Q ss_pred CccccccceEEEEEEeCC---CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEe
Q 004218 461 NLIGSGSFGSVYKGYLRE---GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.. ....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence 368999999999998643 46799998864432 233578899999999999999999998643 345699999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhh
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL 616 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 616 (767)
|+++|+|.+++...+.. .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++...
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999999754321 123467788889999999999999999 99999999999999999999999999986532
Q ss_pred hhcCCCccccccccccCCCCccCccccCCC-------CCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhh
Q 004218 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLGE-------KPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 617 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 688 (767)
..... .......++..|+|||++.+. .++.++||||||+++|||++ |+.||........ ....+...
T Consensus 152 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~ 226 (269)
T cd05087 152 KEDYY----VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVREQ 226 (269)
T ss_pred Cccee----ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhhcc
Confidence 21110 111234467889999987642 35789999999999999996 9999965322211 00000000
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
... ...+.+. ....+. +.+++.+|| .+|++|||++|+++.|+
T Consensus 227 ~~~----~~~~~~~----------~~~~~~----~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLK----LPKPRLK----------LPLSDR----WYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCC----CCCCccC----------CCCChH----HHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000 0000000 000111 222666898 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.60 Aligned_cols=271 Identities=23% Similarity=0.301 Sum_probs=193.4
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||+|+||.||+|.++ +++.||+|.+.... ......+.+|+++++.++||||+++++++. .....+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeEE
Confidence 57899999999999999999975 48899999986443 233456778999999999999999999954 455679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+
T Consensus 81 lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCG-----NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred EEEeccc-cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcch
Confidence 9999997 59999886543 2388999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
........ ......++..|+|||++.+. .++.++||||+|+++|+|++|+.||....... ....+......
T Consensus 152 ~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~ 223 (301)
T cd07873 152 RAKSIPTK------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGT 223 (301)
T ss_pred hccCCCCC------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCC
Confidence 75432111 11223468899999987654 47889999999999999999999996542211 11111111110
Q ss_pred chhhhccHHHHH----h--hhcc-hhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQ----L--MMSS-ESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~----~--~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.........+.. . .... ..........+...+++++.+|++.||.+|||++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 224 PTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000000 0 0000 000000111122234457889999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.50 Aligned_cols=204 Identities=21% Similarity=0.249 Sum_probs=163.4
Q ss_pred CCCccccc--cceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 459 HENLIGSG--SFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 459 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
+.++||+| +|++||++..+ +|+.||+|+++... ....+.+.+|+++++.++||||+++++++. .++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 45789999 78899999965 58999999986543 223456778999999999999999999964 4456799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+.
T Consensus 77 v~e~~~~~~l~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 77 VTSFMAYGSAKDLICTHF----MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEeccCCCcHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 999999999999996543 12389999999999999999999998 99999999999999999999999998765
Q ss_pred hhhhhcCCC-ccccccccccCCCCccCccccCC--CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 614 SLLERIGNQ-SSISSTHVLKGSIGYIPPEYGLG--EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 614 ~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
......... ..........++..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 432211100 00011122346778999999876 45889999999999999999999999653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=306.18 Aligned_cols=240 Identities=26% Similarity=0.407 Sum_probs=181.2
Q ss_pred CccccccceEEEEEEeCC--------CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 461 NLIGSGSFGSVYKGYLRE--------GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+.||+|+||.||+|.... ..+||+|.+........+.+.+|+.+++.++|||++++++++.. +...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence 468999999999998642 23488888865544555678899999999999999999999653 34568
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--------e
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT--------A 604 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~--------~ 604 (767)
+||||+++|+|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +
T Consensus 76 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~ 147 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI 147 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceE
Confidence 99999999999999976432 389999999999999999999998 9999999999999987664 6
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCC-CCCCCcccCCcchh
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGM-SPTHESFAGEVSLV 682 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~-~p~~~~~~~~~~~~ 682 (767)
+++|||.+..... .....++..|+|||++.+. .++.++||||||+++|+|++|. .|+....... ..
T Consensus 148 ~l~d~g~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~ 215 (258)
T cd05078 148 KLSDPGISITVLP----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KL 215 (258)
T ss_pred EecccccccccCC----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HH
Confidence 9999998864322 1234578899999998764 5789999999999999999995 5543321110 00
Q ss_pred hHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 683 KWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
...... ...+.. ... .+.+++.+||+.||++|||++|+++.|+
T Consensus 216 ~~~~~~--~~~~~~------------------~~~----~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 QFYEDR--HQLPAP------------------KWT----ELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHcc--ccCCCC------------------CcH----HHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000000 000000 001 1223777899999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=317.11 Aligned_cols=192 Identities=22% Similarity=0.303 Sum_probs=161.4
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
...+|++.+.||+|+||.||+|.... ++.||+|+... .....|+.++++++||||+++++++. .....
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLV-----SGAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEE-----eCCee
Confidence 34579999999999999999999764 78899997532 23357999999999999999999864 34567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+. ++|.+++.... ..+++.++..|+.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 133 ~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred EEEEEccC-CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcc
Confidence 99999995 58998886533 3489999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCC
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPT 671 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 671 (767)
++..... .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 204 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 204 AQFPVVA-------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccC-------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9743211 1112356899999999999999999999999999999999866554
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.83 Aligned_cols=201 Identities=29% Similarity=0.422 Sum_probs=166.7
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|+.+++.++|||++++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 4788899999999999999975 58999999986432 223467889999999999999999999954 456779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||++ ++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred EEEecCC-CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence 9999997 589988865432 24589999999999999999999999 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
....... .......++..|+|||++.+. .++.++||||+|+++|+|+||+.||...
T Consensus 149 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 149 RAFGIPV------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred eecCCCc------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 7543211 111223468889999987654 4688999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=341.92 Aligned_cols=259 Identities=28% Similarity=0.371 Sum_probs=203.1
Q ss_pred HHHHhcCCCCCCccccccceEEEEEEe-CCCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 450 LRRATGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 450 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
++..+-+|.....||.|.||.||.|.. .+|...|+|-+... .....+.+.+|..++..++|||+|+++|+ .-
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----Ev 1304 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EV 1304 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----ee
Confidence 344566788889999999999999995 45999999987544 23456678899999999999999999998 55
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
+.+.++|.||||++|+|.+.++..+. .++.-...+..|++.|++|||++ |||||||||.||+++.+|.+|+
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll~~gri------~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~ 1375 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHGRI------EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKY 1375 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHHHhcch------hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEe
Confidence 66778999999999999999976543 66666678899999999999999 9999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC---CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhh
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK---PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK 683 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 683 (767)
+|||.|..+..... ..........||+.|||||++.+.. ...++||||+|||+.||+||+.||........-+.+
T Consensus 1376 ~DFGsa~ki~~~~~--~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~ 1453 (1509)
T KOG4645|consen 1376 GDFGSAVKIKNNAQ--TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH 1453 (1509)
T ss_pred ecccceeEecCchh--cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH
Confidence 99999988765521 2223344567999999999987643 567899999999999999999999775444333333
Q ss_pred HhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 684 WVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 684 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
-..+..|.- ++-+.++ -++++..|+..||++|.++.|++++
T Consensus 1454 V~~gh~Pq~-P~~ls~~----------------------g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 VAAGHKPQI-PERLSSE----------------------GRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HhccCCCCC-chhhhHh----------------------HHHHHHHHHhcCchhhhHHHHHHHh
Confidence 222222221 1112222 2235558999999999999988765
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.40 Aligned_cols=260 Identities=24% Similarity=0.327 Sum_probs=196.4
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++. .....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence 56888899999999999999965 48899999886543 334567889999999999999999999964 346779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
+||||+++++|.+++.... .+++..+..++.+++.|+.|||+ . +++||||+|+||++++++.++|+|||+
T Consensus 80 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred EEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCc
Confidence 9999999999999986543 38999999999999999999997 4 899999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+....... .....|+..|+|||++.+..++.++|||||||++|++++|+.||.......... ..+.
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~~~~ 216 (284)
T cd06620 151 SGELINSI--------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------DDPM 216 (284)
T ss_pred ccchhhhc--------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------hhhh
Confidence 86542211 123458899999999988889999999999999999999999997543321100 0000
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
... ..+......... .....+ ....+.+++.+|++.||++|||++|++++.
T Consensus 217 ~~~----~~~~~~~~~~~~-~~~~~~-~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 217 GIL----DLLQQIVQEPPP-RLPSSD-FPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHH----HHHHHHhhccCC-CCCchh-cCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000 011111100000 000000 111233477799999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.32 Aligned_cols=248 Identities=27% Similarity=0.358 Sum_probs=193.1
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-----CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-----TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
+|+..+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|+++++.++|+||+++++++. .+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 5788899999999999999976 68999999986543 224567889999999999999999999853 445
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 6799999999999999997543 388999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCC-CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|.+....... ......|+..|+|||.+.... ++.++|+||+|+++|+|++|+.||...... ..........
T Consensus 147 ~~~~~~~~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~ 218 (258)
T cd06632 147 GMAKQVVEFS-------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-AAVFKIGRSK 218 (258)
T ss_pred ccceeccccc-------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-HHHHHHHhcc
Confidence 9987653321 123345788999999987766 899999999999999999999998654311 1111111100
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
........++ ..+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~----------------------~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 219 ELPPIPDHLS----------------------DEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCCCcCCCcC----------------------HHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0000111111 112236678999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.50 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=196.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCc----EEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGI----SVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
..+|+..+.||+|+||.||+|.+. ++. .||+|.+..... .....+.+|+.+++.++||||++++++|...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence 356788899999999999999864 343 578888754322 2234688999999999999999999987532
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
..++++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~ 151 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT 151 (303)
T ss_pred --CceeeehhcCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEc
Confidence 2478999999999999987543 2388999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 686 (767)
|||.++........ .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ....+..
T Consensus 152 Dfg~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~~ 225 (303)
T cd05110 152 DFGLARLLEGDEKE----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLLE 225 (303)
T ss_pred cccccccccCcccc----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 99999865432111 11122335678999999988889999999999999999997 88998553211 1112211
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
............. . +.+++.+||..+|++||+++|+++.++.+.....
T Consensus 226 ~~~~~~~~~~~~~---------------------~-~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 226 KGERLPQPPICTI---------------------D-VYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred CCCCCCCCCCCCH---------------------H-HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 1110000000111 1 1227778999999999999999999998865544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.74 Aligned_cols=253 Identities=21% Similarity=0.344 Sum_probs=191.9
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|++++++++||||+++++++. ..+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEE
Confidence 36888999999999999999976 5899999988654 2334567889999999999999999999854 456789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++..... ...+++..+..++.|++.|+.|||+. .+|+||||||+||+++.++.+||+|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred EEEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999999999999875421 23489999999999999999999963 18999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCC------CCCcccchhhhHHHHHHHhCCCCCCCcccCCc-chhhHh
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK------PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-SLVKWV 685 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~ 685 (767)
....... .....++..|+|||.+.+.. ++.++||||+||++|+|++|+.||........ ......
T Consensus 151 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 222 (286)
T cd06622 151 GNLVASL--------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI 222 (286)
T ss_pred ccccCCc--------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH
Confidence 7553221 12234788999999886543 47899999999999999999999964321110 000000
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
....+......+ ...+.+++.+||+.+|++||++++++++
T Consensus 223 ~~~~~~~~~~~~----------------------~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 223 VDGDPPTLPSGY----------------------SDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hhcCCCCCCccc----------------------CHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 000000011101 1112236778999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.05 Aligned_cols=201 Identities=26% Similarity=0.346 Sum_probs=168.9
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++|+||+++++++ ..+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 46899999999999999999965 4889999998642 223445688899999999999999999985 45567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence 899999999999999996532 2389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCC-----CCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-----EKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
++........ .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||..
T Consensus 148 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 148 SCLRLLADGT-----VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeecCCCCC-----ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 9865432211 11123458999999999863 4578899999999999999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=300.15 Aligned_cols=204 Identities=27% Similarity=0.391 Sum_probs=169.3
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-----cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-----GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.+|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence 47889999999999999999975 489999998753321 224567889999999999999999998542 123
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..+++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence 46789999999999999987543 278889999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
||.+........ .........|+..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 150 fg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 150 FGASKRLQTICL---SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred Cccccccccccc---cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 999975432111 01112234588899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.14 Aligned_cols=262 Identities=27% Similarity=0.376 Sum_probs=198.4
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCc-ccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDF-KNM 528 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~ 528 (767)
..+++|++.+.||+|++|.||+|..+ +++.|++|++..... ..+.+.+|+.+++++ +|+||+++++++..... ..+
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999975 478999999865433 346788999999999 79999999999865433 345
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRK--KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 678999999999999999875431 123489999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCC-----CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-----EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK 683 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 683 (767)
||.+........ ......|+..|+|||++.. ..++.++||||+|+++|+|++|+.||...... .....
T Consensus 157 ~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~ 229 (275)
T cd06608 157 FGVSAQLDSTLG------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFK 229 (275)
T ss_pred Cccceecccchh------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHH
Confidence 999875432211 1123458889999998753 34678899999999999999999999643211 11111
Q ss_pred HhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 684 WVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 684 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... .+.. .. ......+.+.+++.+||..||++|||+.|++++
T Consensus 230 ~~~~-~~~~---~~-----------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 230 IPRN-PPPT---LK-----------------SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hhcc-CCCC---CC-----------------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1100 0000 00 000011223347779999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=300.45 Aligned_cols=254 Identities=24% Similarity=0.317 Sum_probs=196.2
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 4788899999999999999965 58899999986432 2335668889999999999999999997642 3445679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH-----NDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
++|||+++++|.+++..... ....+++..++.++.|++.||+||| +. +++||||+|+||++++++.+||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred EEehhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence 99999999999999976432 1345899999999999999999999 66 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+.+..
T Consensus 153 d~g~~~~~~~~~~------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~ 224 (265)
T cd08217 153 DFGLAKILGHDSS------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKE 224 (265)
T ss_pred cccccccccCCcc------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhc
Confidence 9999986543211 01234578999999999988899999999999999999999999865321 111111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
......... ....+.+++.+|++.+|++|||+.|++++
T Consensus 225 ~~~~~~~~~----------------------~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GKFRRIPYR----------------------YSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCCCCccc----------------------cCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 110000000 11122237778999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=297.40 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=196.0
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|+..+.||.|+||.||.++.. +++.|++|.+... .....+++.+|++++++++|+||+++++++. +....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 5889999999999999999954 4889999988644 2344567889999999999999999999964 456789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
++|||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+
T Consensus 76 ~~~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred EEEEecCCCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 9999999999999997643 23489999999999999999999998 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
........ ......|+..|+|||...+..++.++||||+|+++|+|++|..||....... .........++..
T Consensus 149 ~~~~~~~~------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~ 221 (256)
T cd08221 149 KILGSEYS------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-LVVKIVQGNYTPV 221 (256)
T ss_pred EEcccccc------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCCC
Confidence 76533221 1123458899999999988888999999999999999999999985432111 0111111111100
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
...+ .. .+.+++.+||+.+|++||+++|++++.
T Consensus 222 -~~~~------------------~~----~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -VSVY------------------SS----ELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -cccc------------------CH----HHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0001 11 122366789999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=307.87 Aligned_cols=270 Identities=22% Similarity=0.304 Sum_probs=191.5
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|+||.||+|.+. +|+.||+|.++... ......+.+|++++++++||||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 5888899999999999999976 58999999986432 22345678899999999999999999984 4556789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+|+||+++ +|.+++.... ..+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 76 lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 76 LVFEYCDQ-DLKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred EEEecCCC-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence 99999974 8888876432 2389999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCC-CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+....... ......++..|+|||++.+.. ++.++||||+||++|+|++|+.|+.........+..........
T Consensus 147 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07839 147 RAFGIPVR------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 220 (284)
T ss_pred hccCCCCC------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 75432211 112234688999999887644 68999999999999999999998644322211111111000000
Q ss_pred chhhhccHHHHH-----hhhcch--hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQ-----LMMSSE--SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~-----~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. .... +.+.. ...... ....+....+...+.+++.+||+.||.+|||++|++++
T Consensus 221 ~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 221 T-EESW-PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred C-hHHh-HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 0000 00000 000000 00011111122334457779999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.57 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=191.9
Q ss_pred CCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|||++++++.+. .++..++||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEEE
Confidence 344467999999999999965 58899999987655555677889999999999999999999854 456779999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++++|.+++.... +++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++...
T Consensus 99 e~~~~~~L~~~~~~~~-------l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 99 EFLEGGALTDIVTHTR-------MNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred eCCCCCcHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 9999999999885432 88999999999999999999999 9999999999999999999999999998754
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhh
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQ 695 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (767)
..... ......|+..|+|||...+..++.++||||+|+++|||++|+.||...... .....+....+....
T Consensus 169 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~- 239 (292)
T cd06658 169 SKEVP------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDNLPPRVK- 239 (292)
T ss_pred ccccc------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCccc-
Confidence 32211 112345889999999998888999999999999999999999998643211 111111111111000
Q ss_pred hccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 696 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... ....+.+++.+||..||++|||++|++++
T Consensus 240 ---------------~~~~----~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 ---------------DSHK----VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ---------------cccc----cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000 11122336668999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=297.57 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=193.5
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+++++.++|||++++++.+ ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 5888999999999999999965 58899999986542 33456788999999999999999999984 3456789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEccccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED-MTAKVGDFGL 611 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~ 611 (767)
+||||+++++|.+++.... ...+++..+..++.|++.|++|||++ +++||||+|+||+++++ +.+||+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred EEEecCCCCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 9999999999999997643 23489999999999999999999999 99999999999999854 4689999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+....... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||....... ...........
T Consensus 149 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~ 219 (256)
T cd08220 149 SKILSSKS-------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLKIMSGTFA 219 (256)
T ss_pred ceecCCCc-------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHHHHhcCCC
Confidence 97654321 1123457889999999998888999999999999999999999986532211 11111110001
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.....+.. .+.+++.+||+.||++|||+.|++++
T Consensus 220 ~~~~~~~~----------------------~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 PISDRYSP----------------------DLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCcCH----------------------HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11111111 12237778999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.66 Aligned_cols=253 Identities=28% Similarity=0.382 Sum_probs=197.3
Q ss_pred CCCCCCccccccceEEEEEEeCC--C--cEEEEEEeeccCCc-chhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE--G--ISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
..+..++||+|.||.|++|.|.. | ..||||.+...... ...+|++|+.+|.+++|||++++||+..+ ..
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QP 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------ch
Confidence 34456789999999999999864 4 36899999766544 67899999999999999999999999643 34
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+.+|||.++.|+|.+.++... ...+.......++.|||.|+.||.++ ++||||+..+|+++-....+||+|||
T Consensus 185 ~mMV~ELaplGSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred hhHHhhhcccchHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccc
Confidence 579999999999999998732 34588889999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
+.+-++........ .....-.+.|+|||.+....++.++|||+|||++|||+| |..||-.... ..+.+.++..-
T Consensus 258 LmRaLg~ned~Yvm---~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~qIL~~iD~~e 332 (1039)
T KOG0199|consen 258 LMRALGENEDMYVM---APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--IQILKNIDAGE 332 (1039)
T ss_pred ceeccCCCCcceEe---cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--HHHHHhccccc
Confidence 99988665433322 122224577999999999999999999999999999998 7788855321 12222222111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
....++.+.+.+++ ++..||..+|++|||+..+.+.+
T Consensus 333 rLpRPk~csedIY~----------------------imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQ----------------------IMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cCCCCCCChHHHHH----------------------HHHHhccCCccccccHHHHHHhH
Confidence 11122223333222 66689999999999999997544
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=305.48 Aligned_cols=256 Identities=23% Similarity=0.275 Sum_probs=192.1
Q ss_pred HHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeec--cCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDI--ESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 528 (767)
.-...|++.+.||+||.+.||++...+.+.||+|.+.. .+......|.+|+..|.++ .|.+|+++++| .-.+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-----Ev~d 432 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-----EVTD 432 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-----eccC
Confidence 44568999999999999999999988888888887632 2344567899999999999 59999999999 5568
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
+++|+||||= ..+|..++...... ++...+..+.+||+.|+.++|++ ||||.||||.|+++- .|.+||+|
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~~~-----~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLID 502 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKKSI-----DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLID 502 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhccCC-----CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeee
Confidence 8999999976 45999999876532 33237889999999999999999 999999999999985 46899999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCC-----------CCCCcccchhhhHHHHHHHhCCCCCCCcccC
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-----------KPSTAGDVYSFGVMLLEIFTGMSPTHESFAG 677 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 677 (767)
||.|..+..+... -.....+||+.|||||.+... +.++++||||+|||+|+|+.|+.||......
T Consensus 503 FGIA~aI~~DTTs----I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~ 578 (677)
T KOG0596|consen 503 FGIANAIQPDTTS----IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ 578 (677)
T ss_pred echhcccCccccc----eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH
Confidence 9999876554222 223456799999999987532 2567999999999999999999999653221
Q ss_pred CcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 678 EVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+.........-..++.-. ..+ ++. ++..||..||++|||..|++++
T Consensus 579 ~aKl~aI~~P~~~Iefp~~~~-----------------~~~---li~-~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 IAKLHAITDPNHEIEFPDIPE-----------------NDE---LID-VMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHhhcCCCccccccCCCC-----------------chH---HHH-HHHHHHhcCcccCCCcHHHhcC
Confidence 111111111100000000000 011 222 6778999999999999999874
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=282.50 Aligned_cols=257 Identities=23% Similarity=0.295 Sum_probs=199.6
Q ss_pred HhcCCCCC-CccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccce
Q 004218 453 ATGNFSHE-NLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 453 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++.|++. ++||-|-.|.|-.+..+ +|+++|+|++. +.....+|++..-.. .|||||.++++|... +....
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENS-YQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence 34556653 57999999999999865 59999999985 224556788876555 699999999997543 56677
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEE
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE---DMTAKV 606 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl 606 (767)
.+.+|||.|+||.|.+.++..+ ...+++.++..|++||+.|+.|||+. +|.||||||+|+|.+. +..+||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g----~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRG----DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eeEeeeecccchHHHHHHHHcc----cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence 8899999999999999998766 34599999999999999999999999 9999999999999974 457999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
+|||+|+...+. ......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||........
T Consensus 206 tDfGFAK~t~~~-------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai------- 271 (400)
T KOG0604|consen 206 TDFGFAKETQEP-------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------- 271 (400)
T ss_pred cccccccccCCC-------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-------
Confidence 999999865332 223445679999999999999999999999999999999999999976432111
Q ss_pred hhcccchhhhccHHHHHhhhcc-hhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSS-ESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
++..+..+... ..-...-++++.+..+++|+.+|..+|.+|.|+.|++++
T Consensus 272 -----------spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 272 -----------SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -----------ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11111111100 001112345566666678889999999999999998865
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=312.96 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=198.2
Q ss_pred CCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
-|.++..||.|+||.||+|+.++ +-..|.|++...+.+..++++-|++||..++||+||++++.|+ ..+.+||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceEEE
Confidence 45667789999999999999875 5556789988778888899999999999999999999999853 45678999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
.|||+||-.+.++-... .++++.++..+++|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+..
T Consensus 108 iEFC~GGAVDaimlEL~-----r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELG-----RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred EeecCCchHhHHHHHhc-----cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence 99999999999886654 4599999999999999999999999 999999999999999999999999999865
Q ss_pred hhhhcCCCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
... .......+.||+.|||||+.. ..+|+.++||||||+++.||..+.+|.....+- ..+.+..+...
T Consensus 180 n~~------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-RVllKiaKSeP 252 (1187)
T KOG0579|consen 180 NKS------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEP 252 (1187)
T ss_pred chh------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-HHHHHHhhcCC
Confidence 432 223345678999999999854 567999999999999999999999997553221 11222222222
Q ss_pred ccch-hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNA-QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
|.-. +.. +..-+.++..+||..||..||++++++++
T Consensus 253 PTLlqPS~----------------------Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 253 PTLLQPSH----------------------WSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CcccCcch----------------------hhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2210 111 11112235558999999999999998865
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=301.49 Aligned_cols=253 Identities=29% Similarity=0.411 Sum_probs=190.0
Q ss_pred CccccccceEEEEEEeCC-------CcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 461 NLIGSGSFGSVYKGYLRE-------GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+.||+|+||.||+|+..+ ++.||+|.+.... ......+.+|+++++.++||||+++++++. .....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 368999999999998653 2579999875432 244667889999999999999999999864 344579
Q ss_pred EEEeecCCCChhhhhcccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-----ceEE
Q 004218 533 LVYEFLGNGSLGDWIHGERKNE-HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-----TAKV 606 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-----~~kl 606 (767)
+||||+++++|.+++....... ....+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .++|
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence 9999999999999997543221 234488999999999999999999998 999999999999999877 8999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHh
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~ 685 (767)
+|||++.......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+
T Consensus 153 ~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~ 226 (269)
T cd05044 153 GDFGLARDIYKSDYYR----KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHV 226 (269)
T ss_pred CCcccccccccccccc----cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHH
Confidence 9999997653321111 1122235678999999998899999999999999999998 99998543211 111111
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
.......... .....+.+++.+||..+|++||+++++++.|+
T Consensus 227 ~~~~~~~~~~----------------------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 TAGGRLQKPE----------------------NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred hcCCccCCcc----------------------cchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1100000000 01112233777999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.62 Aligned_cols=259 Identities=28% Similarity=0.384 Sum_probs=202.5
Q ss_pred CCCCCCccccccceEEEEEEe-CC----CcEEEEEEeec-cCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 456 NFSHENLIGSGSFGSVYKGYL-RE----GISVAVKVLDI-ESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~-~~----~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
..+.+++||+|+||+||+|.| .+ ..+||+|++.. ...+..++++.|+-+|.+++|||+++++++|....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~----- 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST----- 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence 345568999999999999995 33 45799998853 35556789999999999999999999999986533
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
+.||++|++.|+|.++++..+. .+.....+.|..|||+|+.|||++ ++|||||.++||||.+-..+||.||
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~-----~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdf 842 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRD-----NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDF 842 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhc-----cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEec
Confidence 5799999999999999998764 388899999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|+++.+......... ....-.+.|||-|.+....++.++|||||||++||++| |..|++....++. .+..+..
T Consensus 843 gla~ll~~d~~ey~~----~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--~dlle~g 916 (1177)
T KOG1025|consen 843 GLAKLLAPDEKEYSA----PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--PDLLEKG 916 (1177)
T ss_pred chhhccCcccccccc----cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--hHHHhcc
Confidence 999987654332221 22223567999999999999999999999999999998 8899876443321 1111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
-+ +...+.-..+++. ++.+||..|++.||+++++...+.+..+...
T Consensus 917 eR--------------LsqPpiCtiDVy~--------~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 917 ER--------------LSQPPICTIDVYM--------VMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred cc--------------CCCCCCccHHHHH--------HHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 11 1111111222222 5667999999999999999999988765443
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.35 Aligned_cols=200 Identities=28% Similarity=0.362 Sum_probs=168.1
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|++|.||+|.++ +++.||+|++.... ....+.+.+|++++++++|||++++++++. .+...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 47889999999999999999976 48999999886432 223456789999999999999999999854 45567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++++|..+..... .+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred EEEEeccCccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 99999999988888765432 389999999999999999999998 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+........ ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...
T Consensus 147 ~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 147 ARILTGPGD------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred ceecCCCcc------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 976543211 1123447888999998876 45789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=297.49 Aligned_cols=247 Identities=28% Similarity=0.441 Sum_probs=191.4
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
..|++.+.||+|+||.||++.. +++.||+|..+.. ...+.+.+|+.++++++|||++++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEEE
Confidence 4688999999999999999975 4788999998643 234678899999999999999999998642 235899
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 77 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 77 MELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred EECCCCCCHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCcccee
Confidence 99999999999997543 23488999999999999999999998 999999999999999999999999999865
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccch
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
..... .....+..|+|||.+.+..++.++||||+|+++|+|++ |+.||...... .........+....
T Consensus 150 ~~~~~---------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 218 (254)
T cd05083 150 GSMGV---------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVEKGYRMEP 218 (254)
T ss_pred ccccC---------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhCCCCCCC
Confidence 32210 11224567999999988889999999999999999998 99998653221 11111111111100
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
...+ ...+.+++.+||+.+|++||+++++++.|++
T Consensus 219 ~~~~----------------------~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGC----------------------PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcC----------------------CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0001 1112237779999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=300.35 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=193.6
Q ss_pred CCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccCC------cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 456 NFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIEST------GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
+|+..+.||+|++|.||+|.. .+++.||+|++..... ...+.+.+|++++++++|+||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 478889999999999999996 4589999999864321 1346788999999999999999999995 345
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-TAKVG 607 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~ 607 (767)
+..++||||+++++|.+++.... ++++..+..++.|++.||+|||++ +++|+||+|+||+++.++ .+||+
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 67799999999999999997543 388999999999999999999999 999999999999998776 59999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc-chh-hHh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-SLV-KWV 685 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~-~~~ 685 (767)
|||.+.......... ........|+..|+|||.+.+..++.++||||+|+++|+|++|..||........ ... ...
T Consensus 147 dfg~~~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 224 (268)
T cd06630 147 DFGAAARLAAKGTGA--GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA 224 (268)
T ss_pred ccccccccccccccC--CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh
Confidence 999997764431111 1112334578999999999888899999999999999999999999864322111 000 000
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
........+. .+...+.+++.+|+..+|++|||+.|++++
T Consensus 225 ~~~~~~~~~~----------------------~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 225 SATTAPSIPE----------------------HLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ccCCCCCCch----------------------hhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0000111111 111222236778999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.38 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=191.8
Q ss_pred CCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++. .+...++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEE
Confidence 334457999999999999965 58999999987555555667889999999999999999999854 456679999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++++|.+++.... +++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 98 e~~~~~~L~~~~~~~~-------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 98 EFLQGGALTDIVSQTR-------LNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred ecCCCCCHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 9999999999875432 89999999999999999999999 9999999999999999999999999998754
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhh
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQ 695 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (767)
..... ......|+..|+|||++.+..++.++||||+|+++|||++|+.||...... ..........+.....
T Consensus 168 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 239 (297)
T cd06659 168 SKDVP------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSPPPKLKN 239 (297)
T ss_pred ccccc------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCCCccc
Confidence 33211 112345889999999999888999999999999999999999998643211 1111111100000000
Q ss_pred hccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 696 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...... .+.+++.+||+.+|++||+++|++++
T Consensus 240 ----------------~~~~~~----~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 ----------------AHKISP----VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ----------------cCCCCH----HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000011 12236668999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=330.75 Aligned_cols=264 Identities=27% Similarity=0.362 Sum_probs=195.2
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecC------
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSL------ 523 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 523 (767)
+....|+..+.||+||||.||+++.+ ||+.||||++... +......+.+|+..+.+++|||||+++..+...
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45667888899999999999999976 7999999999654 334566788999999999999999998654210
Q ss_pred ------------------------------------------------C-cc----------------------------
Q 004218 524 ------------------------------------------------D-FK---------------------------- 526 (767)
Q Consensus 524 ------------------------------------------------~-~~---------------------------- 526 (767)
. ..
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0 00
Q ss_pred -------------------------------cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 527 -------------------------------NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575 (767)
Q Consensus 527 -------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l 575 (767)
....+||-||||+..++.++++..... -.....++++++|++||
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGL 710 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHH
Confidence 003578999999998888888765421 14667899999999999
Q ss_pred HHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhh------hhcC------CCccccccccccCCCCccCcccc
Q 004218 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL------ERIG------NQSSISSTHVLKGSIGYIPPEYG 643 (767)
Q Consensus 576 ~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~------~~~~------~~~~~~~~~~~~gt~~y~aPE~~ 643 (767)
+|+|++ |||||||||.||+++++..|||+|||+|+... +... ........+..+||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 99999999999999999999999999998732 1110 11112233557799999999998
Q ss_pred CCCC---CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHH
Q 004218 644 LGEK---PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLI 720 (767)
Q Consensus 644 ~~~~---~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 720 (767)
.+.. |+.|+|+||+|+|++||+ +||.........+.....+.+|.. ....++.. .
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~-~~f~~~~~------------------~ 845 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEP-ADFFDPEH------------------P 845 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCC-cccccccc------------------h
Confidence 7654 999999999999999998 457554333333333333334433 11111110 0
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 721 TIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 721 ~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
. -.++|.+|++.||++||||.|++.
T Consensus 846 ~-e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 846 E-EASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred H-HHHHHHHHhcCCCccCCCHHHHhh
Confidence 1 112778999999999999999885
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.08 Aligned_cols=205 Identities=26% Similarity=0.380 Sum_probs=169.2
Q ss_pred cCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||++.... ++.||+|.+.... ....+.+.+|+++++.++||||+++++.+ ..+.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 368899999999999999999764 7899999986442 23345778999999999999999999985 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence 899999999999999996543 389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCC---------CccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 611 LARSLLERIGN---------QSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 611 ~a~~~~~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
.++........ ...........|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 98642111000 0000111224578899999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=300.87 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=196.3
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|+..+.||+|++|.||+|.++ +++.||+|.+..... ...+++.+|+++++.++||||+++++++. .....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEE
Confidence 36788899999999999999976 588999999865532 34567889999999999999999999854 346789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
+|+||+++++|.+++.... ..+++..+..++.|++.|++|||+ . +++||||||+||++++++.++|+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred EEEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999997643 238999999999999999999999 7 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+........ ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||....................
T Consensus 148 ~~~~~~~~~--------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (265)
T cd06605 148 SGQLVNSLA--------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE 219 (265)
T ss_pred chhhHHHHh--------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC
Confidence 876543211 114578899999999988999999999999999999999999865432111111111110000
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..... + ... ....+.+++.+||..||++|||+.|++++
T Consensus 220 ~~~~~------------~--~~~----~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 PPPRL------------P--SGK----FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCC------------C--hhh----cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00000 0 000 11112337778999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=296.83 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=194.4
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|+||.||++... +++.||+|.+... .....+++.+|++++++++||||+++++++ ......+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 5888999999999999999965 5889999998643 223446788999999999999999999984 4556789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQR----GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred EEEecCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 9999999999999987543 23478999999999999999999998 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
........ ......|+..|+|||+..+..++.++||||||+++|+|++|+.||....... ..........+.
T Consensus 149 ~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~- 220 (256)
T cd08218 149 RVLNSTVE------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-LVLKIIRGSYPP- 220 (256)
T ss_pred eecCcchh------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-HHHHHhcCCCCC-
Confidence 76533211 1123457889999999998889999999999999999999999985421110 000111111110
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
... .....+.+++.+||+.+|++||++.|++++
T Consensus 221 ~~~----------------------~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSS----------------------HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred Ccc----------------------cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000 011122337778999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=307.26 Aligned_cols=258 Identities=26% Similarity=0.330 Sum_probs=195.9
Q ss_pred cCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCc---chhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTG---TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|++|.||+|...+ ++.||+|.+...... ..+.+.+|+++++.++||||+++++.+ ..+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 368889999999999999999764 899999998654322 456788999999999999999999985 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence 899999999999999987543 24489999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCc-----------------------cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhC
Q 004218 611 LARSLLERIGNQS-----------------------SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG 667 (767)
Q Consensus 611 ~a~~~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg 667 (767)
++........... .........|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 9876533211100 00011234588999999999988899999999999999999999
Q ss_pred CCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC----HHH
Q 004218 668 MSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID----IRE 743 (767)
Q Consensus 668 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt----~~e 743 (767)
+.||....... ................ . +...+.+++.+||..||++||| ++|
T Consensus 229 ~~pf~~~~~~~-~~~~~~~~~~~~~~~~------------------~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~ 285 (316)
T cd05574 229 TTPFKGSNRDE-TFSNILKKEVTFPGSP------------------P----VSSSARDLIRKLLVKDPSKRLGSKRGAAE 285 (316)
T ss_pred CCCCCCCchHH-HHHHHhcCCccCCCcc------------------c----cCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence 99986532211 1111110000000000 0 1122233677899999999999 777
Q ss_pred HHHH
Q 004218 744 ALRR 747 (767)
Q Consensus 744 vl~~ 747 (767)
++++
T Consensus 286 ll~~ 289 (316)
T cd05574 286 IKQH 289 (316)
T ss_pred HHcC
Confidence 7774
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=301.01 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=195.2
Q ss_pred cCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCCc-chhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
.+|++.+.||+|+||.||+|+.+ +.+.||+|.+...... ..+.+.+|++++++++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-----E 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----C
Confidence 57888999999999999999964 2467999988644333 4567899999999999999999999864 3
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNE---HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA 604 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~ 604 (767)
....++||||+++|+|.+++....... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence 455699999999999999997654211 112489999999999999999999999 99999999999999999999
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhh
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVK 683 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~ 683 (767)
+++|||++....... ........++..|+|||.+.+..++.++||||+|+++|++++ |..||...... ....
T Consensus 157 ~l~~~~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~ 229 (275)
T cd05046 157 KVSLLSLSKDVYNSE-----YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLN 229 (275)
T ss_pred EEcccccccccCccc-----ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHH
Confidence 999999986442211 111122345678999999888888999999999999999999 77888543211 1111
Q ss_pred Hhhh-hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 684 WVES-NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 684 ~~~~-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
.... ..+......++ ..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 230 ~~~~~~~~~~~~~~~~----------------------~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 RLQAGKLELPVPEGCP----------------------SRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHcCCcCCCCCCCCC----------------------HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110 00000001111 12233777899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.31 Aligned_cols=282 Identities=21% Similarity=0.261 Sum_probs=201.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+.++++++||||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999965 58999999986432 2344668889999999999999999998776555556678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++|+||+++ ++.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 84 ~lv~e~~~~-~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEehhccc-CHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 999999975 888887643 289999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+.......... .......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...... .....+.....
T Consensus 153 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~~ 227 (336)
T cd07849 153 ARIADPEHDHT---GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLG 227 (336)
T ss_pred eeecccccccc---CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcC
Confidence 97653321111 11123468899999998654 46789999999999999999999999543211 11111111111
Q ss_pred ----cchhhhccHHHHHhhhcchh----hHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH--HHHH
Q 004218 691 ----KNAQQVLDRELRQLMMSSES----QTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR--LKNA 751 (767)
Q Consensus 691 ----~~~~~~~~~~l~~~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~ 751 (767)
.......+...+......+. ...+........+.+++.+||+.||++|||+.|++++ ++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 11111111111111100000 0000111112233448889999999999999999987 5443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.32 Aligned_cols=201 Identities=24% Similarity=0.312 Sum_probs=169.1
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|..++..++|++|+++++++ ...+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47899999999999999999976 4888999998642 222345577899999999999999999985 45567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence 899999999999999997632 2389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCC-----CCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-----EKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
++........ .......||+.|+|||++.+ +.++.++||||+|+++|+|++|+.||..
T Consensus 148 ~a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 148 SCLKMNQDGT-----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeeccCCCc-----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 9976532211 11123468999999998875 4678899999999999999999999965
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=300.84 Aligned_cols=255 Identities=25% Similarity=0.295 Sum_probs=180.1
Q ss_pred CccccccceEEEEEEeCC---CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEe
Q 004218 461 NLIGSGSFGSVYKGYLRE---GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
+.||+|+||.||+|.... ...+|+|.+..... .....+.+|+++++.++||||+++++++. .....++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence 368999999999997543 45788887754332 23456789999999999999999999864 3455799999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhh
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL 616 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 616 (767)
|+++|+|.+++...+... ....++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||.+....
T Consensus 76 ~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred eCCCCcHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence 999999999997654211 12356788899999999999999999 99999999999999999999999999986532
Q ss_pred hhcCCCccccccccccCCCCccCccccCC-------CCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhh
Q 004218 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLG-------EKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 617 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 688 (767)
..... .......++..|+|||++.. ..++.++||||+||++|||++ |..||....... .........
T Consensus 152 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~ 226 (269)
T cd05042 152 PEDYY----ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQ 226 (269)
T ss_pred cchhe----eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhcc
Confidence 21110 01122345678999998642 356889999999999999999 778875432211 111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
.........+ ......+..++..|| .||++|||++||++.|
T Consensus 227 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 227 DIKLPKPQLD------------------LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CccCCCCccc------------------ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 0000000000 001111122555687 5999999999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=301.87 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=197.0
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|+..+.||.|++|.||+|.+. +++.||+|.+..... ....++.+|+++++.++||||+++++++.. .....++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 36788899999999999999975 488999999864432 345678999999999999999999998753 2345679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 78 lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EEEEecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccc
Confidence 99999999999998764322 134488999999999999999999999 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCC---cchhhHhhhhc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE---VSLVKWVESNF 689 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~ 689 (767)
....... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... .....+.....
T Consensus 153 ~~~~~~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 153 GELVNSL--------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred ccccccc--------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 6543221 123347888999999998889999999999999999999999997542211 11111111100
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... .......... ...+.+++.+||+.+|++|||+.|++++
T Consensus 225 ~~~~------------~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 225 NPEL------------KDEPGNGIKW----SEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred chhh------------ccCCCCCCch----HHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0000 0000000011 1223347779999999999999999884
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.26 Aligned_cols=201 Identities=26% Similarity=0.330 Sum_probs=168.0
Q ss_pred cCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+++.+. ++.||+|++... .......+.+|+.++..++|++|+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 368899999999999999999764 788999998532 222334577899999999999999999985 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence 899999999999999997532 2389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
++........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 148 ~a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 148 SCLKLMEDGT-----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred hheecccCCc-----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 9875432211 1112346899999999886 34578899999999999999999999965
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.68 Aligned_cols=251 Identities=31% Similarity=0.513 Sum_probs=192.5
Q ss_pred CCCCCccccccceEEEEEEeCC-----CcEEEEEEeeccCCc-chhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 457 FSHENLIGSGSFGSVYKGYLRE-----GISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
+++.+.||.|+||.||++.+.+ +..||+|.+...... ..+.+.+|+++++.++|+||+++++++. ..+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCe
Confidence 4567899999999999999764 388999998654433 5678899999999999999999999864 3356
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.+++|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence 7999999999999999976432 1289999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
.+........... ....++..|+|||.+.+..++.++||||+|+++|+|++ |+.||..... ...........
T Consensus 149 ~~~~~~~~~~~~~-----~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~ 221 (258)
T smart00219 149 LSRDLYDDDYYKK-----KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGY 221 (258)
T ss_pred Cceeccccccccc-----ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC
Confidence 9976644311111 11226789999999988889999999999999999998 7788754211 11111111111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
........+ . .+.+++.+|+..||++|||+.|+++.|
T Consensus 222 ~~~~~~~~~------------------~----~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RLPKPENCP------------------P----EIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCcCC------------------H----HHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111111111 1 122266789999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=300.61 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=187.3
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHH-HhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEA-LRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|+||.||+|.+. +|+.||+|+++.... ....++..|+.. ++..+|||++++++++. .+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence 36889999999999999999976 589999999865432 233456666665 56678999999999964 34567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||++ |+|.+++...... ...+++..++.++.|++.|++|||++. +++||||||+||+++.++.+||+|||.
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~ 150 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI 150 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999997 5898888653321 245899999999999999999999742 899999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC----CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG----EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
+....... ......|+..|+|||.+.+ ..++.++|+||+||++|+|++|+.||................
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 223 (283)
T cd06617 151 SGYLVDSV-------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223 (283)
T ss_pred cccccccc-------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc
Confidence 97653221 1122357889999998765 446889999999999999999999985422211111111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+...... +...+.+++.+||..+|++||+++|++++
T Consensus 224 ~~~~~~~~~----------------------~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 PSPQLPAEK----------------------FSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCCCccc----------------------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011000000 11112236778999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=295.58 Aligned_cols=254 Identities=30% Similarity=0.393 Sum_probs=194.6
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc--chhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG--TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|+++++.++|+||+++++++ ......+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 5888999999999999999965 5889999998755443 567889999999999999999999984 3456679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred EEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999997543 378899999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCC---CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK---PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
........... .......++..|+|||++.+.. ++.++||||||+++|++++|+.||........ .........
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~ 223 (264)
T cd06626 147 VKLKNNTTTMG--EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFHVGAGH 223 (264)
T ss_pred cccCCCCCccc--ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHHHhcCC
Confidence 87644322111 0012345788999999988766 78999999999999999999999965321111 111111100
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
+...+... .. ...+.+++.+||+.+|.+|||+.|++.
T Consensus 224 ~~~~~~~~----------------~~----~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDSL----------------QL----SPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCccc----------------cc----CHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00 111123677899999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=300.99 Aligned_cols=272 Identities=25% Similarity=0.332 Sum_probs=192.9
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|+..+.||.|++|.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++ .++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 4788999999999999999975 58899999886442 22345788999999999999999999985 3456679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+. ++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+
T Consensus 76 ~v~e~~~-~~l~~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASP----LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred EEeeccc-cCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 9999996 58999886543 23489999999999999999999998 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCC-CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh-cc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN-FP 690 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~ 690 (767)
........ ......++..|+|||++.+.. ++.++||||||+++|+|+||+.||....... ...+..... .+
T Consensus 148 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~ 220 (284)
T cd07860 148 RAFGVPVR------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTP 220 (284)
T ss_pred hhcccCcc------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 75532211 112234678899999876644 5889999999999999999999986532211 111111100 00
Q ss_pred cc-hhhhcc--HHHHHhhhcch-hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KN-AQQVLD--RELRQLMMSSE-SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~-~~~~~~--~~l~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. ...... +.....+.... .........+...+.+++.+||+.||++|||++|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 221 DEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred ChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00 000000 00000000000 00001111122233447889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.70 Aligned_cols=252 Identities=26% Similarity=0.391 Sum_probs=197.8
Q ss_pred cCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||+|++|.||+|.... ++.||+|++..... ...+.+.+|++++++++|+|++++++++. .+...+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 368889999999999999999775 89999999865543 44678899999999999999999999854 446779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
+||||+++++|.+++.... .+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.
T Consensus 76 lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence 9999999999999997643 38999999999999999999999 8 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCccc-CCcchhhHhhhhcc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA-GEVSLVKWVESNFP 690 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~ 690 (767)
+......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ........+.....
T Consensus 147 ~~~~~~~~~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (264)
T cd06623 147 SKVLENTLDQ------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP 220 (264)
T ss_pred ceecccCCCc------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC
Confidence 9765332211 1234578899999999988899999999999999999999999866432 11111111111110
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...... . ....+.+++.+||+.+|++|||+.|++++
T Consensus 221 ~~~~~~-----------------~----~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAE-----------------E----FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcc-----------------c----CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000 0 11122236678999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=296.58 Aligned_cols=237 Identities=29% Similarity=0.436 Sum_probs=182.3
Q ss_pred CccccccceEEEEEEeCC-C----------cEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 461 NLIGSGSFGSVYKGYLRE-G----------ISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
+.||+|+||.||+|.+.+ + ..|++|.+...... ...+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 468999999999999764 3 25788877544333 6788899999999999999999998753 3
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-------
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM------- 602 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~------- 602 (767)
..++||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~ 145 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP 145 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence 34899999999999999976542 489999999999999999999998 999999999999999887
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC--CCCCcccchhhhHHHHHHHh-CCCCCCCcccCCc
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE--KPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEV 679 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~ 679 (767)
.+||+|||.+..... .....++..|+|||++.+. .++.++||||+|+++|++++ |..||.......
T Consensus 146 ~~kl~Dfg~a~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~- 214 (259)
T cd05037 146 FIKLSDPGIPITVLS----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE- 214 (259)
T ss_pred eEEeCCCCccccccc----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-
Confidence 799999999976432 1223467789999998876 78999999999999999999 567775532111
Q ss_pred chhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 680 SLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
...+...... .... .. ..+.+++.+||..+|.+|||+.|+++.|
T Consensus 215 -~~~~~~~~~~--~~~~--------------~~--------~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 215 -KERFYQDQHR--LPMP--------------DC--------AELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -HHHHHhcCCC--CCCC--------------Cc--------hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1111100000 0000 00 1122377799999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=295.53 Aligned_cols=261 Identities=26% Similarity=0.363 Sum_probs=198.5
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||.|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++|+|++++++.+. .+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEE
Confidence 46899999999999999999965 58899999986432 235677899999999999999999999853 456679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.++++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 76 iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred EEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 99999999999999976432 13489999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
..+........ .......|+..|+|||++... .++.++||||||+++|+|++|+.||....... ...+......+.
T Consensus 150 ~~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~ 226 (267)
T cd06610 150 ASLADGGDRTR--KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPPS 226 (267)
T ss_pred HHhccCccccc--cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCCC
Confidence 87654322210 112334588999999998776 78999999999999999999999996543221 111111111110
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...... ...+...+.+++.+||..||++|||+.|++++
T Consensus 227 -~~~~~~-----------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 -LETGAD-----------------YKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -cCCccc-----------------cccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 00111122237778999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.91 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=192.5
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
.|...+.||+|++|.||++... +++.||+|++........+.+.+|+.+++.++|||++++++++. .....++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence 3555679999999999999964 58899999986555455567889999999999999999999854 44567999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
+||+++++|.+++...+ +++.++..++.|++.|++|||++ +++||||+|+||+++.++.++|+|||.+..
T Consensus 95 ~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 95 MEFLEGGALTDIVTHTR-------MNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred EeccCCCCHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 99999999999987632 89999999999999999999999 999999999999999999999999998875
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchh
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
...... ......|+..|+|||...+..++.++||||+|+++|+|++|+.||...... ..........+....
T Consensus 165 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~ 236 (285)
T cd06648 165 VSKEVP------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKRIRDNLPPKLK 236 (285)
T ss_pred hccCCc------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHhcCCCCCc
Confidence 432211 112345889999999998888999999999999999999999998542211 111111111000000
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. ..... ..+.+++.+||+.+|++|||+.|++++
T Consensus 237 ~----------------~~~~~----~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 N----------------LHKVS----PRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred c----------------cccCC----HHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0 00001 112337778999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.39 Aligned_cols=197 Identities=31% Similarity=0.432 Sum_probs=171.2
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++ ..+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 46889999999999999999976 48999999986432 23456788999999999999999999985 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence 799999999999999987643 389999999999999999999998 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
++...... .....|++.|+|||.+.+...+.++||||+|+++|+|++|+.||...
T Consensus 147 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 147 FAKRVKGR---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred CccccCCC---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 99765332 12345889999999998888899999999999999999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.06 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=192.6
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
-|++.+.||+|+||.||+|.+. +++.||+|...... ....+.+.+|+.++++++||||+++++++. .+...++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence 4778889999999999999865 58899999885432 234467889999999999999999999854 4566799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 80 v~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 80 IMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred EEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence 99999999999998643 289999999999999999999998 99999999999999999999999999987
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccch
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
....... ......++..|+|||.+.+..++.++||||+||++|+|++|..||...... .....+....+...
T Consensus 150 ~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 221 (277)
T cd06641 150 QLTDTQI------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPKNNPPTL 221 (277)
T ss_pred ecccchh------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhcCCCCCC
Confidence 5432211 112345788999999998888899999999999999999999998643211 11111111111111
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...++ ..+.+++.+||+.+|.+||++.+++++
T Consensus 222 ~~~~~----------------------~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYS----------------------KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccC----------------------HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11111 112237778999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=301.79 Aligned_cols=199 Identities=27% Similarity=0.379 Sum_probs=168.3
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|++|.||+|.+. +|+.||+|++.... ....+.+.+|+.++++++|||++++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence 5888999999999999999975 58999999986543 334567889999999999999999999854 456779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+ +++|.+++.... ..+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+
T Consensus 76 ~v~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred EEeccc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 999999 999999987543 3489999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
........ .......|+..|+|||.+.+. .++.++||||+|+++|+|++|++||..
T Consensus 147 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 147 RLFSEEEP-----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred ccccCCCC-----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 76543211 111234588999999988654 468999999999999999999887754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=301.37 Aligned_cols=202 Identities=28% Similarity=0.441 Sum_probs=165.8
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++++++. .+..
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCe
Confidence 4578999999999999999999865 588999999865432 23346788999999999999999999854 4456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||++ +++.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence 799999996 68877765432 2378888999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
.++....... ......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||+..
T Consensus 149 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 149 LARAKSIPSQ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred cccccCCCCC------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9875422111 11223468899999998754 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.13 Aligned_cols=242 Identities=23% Similarity=0.308 Sum_probs=178.7
Q ss_pred ccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHHh---cCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 462 LIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEALR---NTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 462 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
.||+|+||.||++... +++.||+|.+..... .....+.+|..+++ ..+||+++.+++++. ..+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 4899999999999975 488999998864321 11233445544433 347999999998854 34567999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++..
T Consensus 76 ~e~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999999999987543 389999999999999999999999 999999999999999999999999999865
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccch
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
..... .....|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||..................+...
T Consensus 147 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 218 (279)
T cd05633 147 FSKKK--------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL 218 (279)
T ss_pred ccccC--------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCC
Confidence 43211 122358999999998864 567899999999999999999999996543221111111110011111
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
+..++ ..+.+++.+||+.||++|| |++|++++
T Consensus 219 ~~~~~----------------------~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFS----------------------PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccC----------------------HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11111 1122366689999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.50 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=192.5
Q ss_pred CCCCCCccccccceEEEEEEeCC--CcEEEEEEeeccC----------CcchhhHHHHHHHHhc-CCCCCceeEEeeeec
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE--GISVAVKVLDIES----------TGTWKSFFAECEALRN-TRHRNLVKLITSCSS 522 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 522 (767)
.|++.+.||+|+||.||+|.+.. ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 47888999999999999999765 6889999875321 1223457788888865 79999999999854
Q ss_pred CCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCC
Q 004218 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDED 601 (767)
Q Consensus 523 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~ 601 (767)
.++..++||||+++++|.+++...... ...+++..++.++.|++.|+.|||+ . +++||||+|+||+++++
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~ 150 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGED 150 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCC
Confidence 456779999999999999988543211 2348999999999999999999996 5 89999999999999999
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcch
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL 681 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 681 (767)
+.+||+|||.+....... ......|+..|+|||...+..++.++||||||+++|+|++|+.||...... ..
T Consensus 151 ~~~~l~dfg~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~ 221 (269)
T cd08528 151 DKVTITDFGLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SL 221 (269)
T ss_pred CcEEEecccceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HH
Confidence 999999999997643321 123345888999999999888999999999999999999999998543211 11
Q ss_pred hhHh-hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 682 VKWV-ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 682 ~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
.... ...++........ ..+.+++.+||+.||++||++.|+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~----------------------~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 222 ATKIVEAVYEPLPEGMYS----------------------EDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHhhccCCcCCcccCC----------------------HHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111 1111100000111 11223777899999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=301.93 Aligned_cols=200 Identities=29% Similarity=0.446 Sum_probs=166.1
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++. .+...+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeEE
Confidence 67899999999999999999976 588999999864432 22345678999999999999999999854 456779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++ +|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||.+
T Consensus 80 lv~e~~~~-~L~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 150 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA 150 (291)
T ss_pred EEEecCCC-CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccc
Confidence 99999975 9999887543 2489999999999999999999999 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+....... ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...
T Consensus 151 ~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 151 RAKSVPSK------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cccCCCCc------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 64321110 0112236788999998865 45789999999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.21 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=197.8
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
...+.|++.+.+|+|++|.||+|.+. ++..||+|++..... ..+.+.+|+++++.++|+|++++++++. ....
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL-----VGDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE-----ECCE
Confidence 34567888999999999999999976 588999999975444 5677889999999999999999999864 3466
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccc
Confidence 799999999999999998753 2499999999999999999999998 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
.+........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||....... ..........+
T Consensus 162 ~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~~~~~ 234 (286)
T cd06614 162 FAAQLTKEKS------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITTKGIP 234 (286)
T ss_pred hhhhhccchh------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCC
Confidence 9875533211 1123347889999999988889999999999999999999999985432111 01111110010
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. ... ...+...+.+++.+||+.+|.+|||+.|++++
T Consensus 235 ~-~~~--------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 235 P-LKN--------------------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred C-Ccc--------------------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 000 00011122337778999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=298.35 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=190.1
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc----------chhhHHHHHHHHhcCCCCCceeEEeeeecCC
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG----------TWKSFFAECEALRNTRHRNLVKLITSCSSLD 524 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 524 (767)
+|.+.+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|+.+++.++|||++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 5778899999999999999865 5889999987532111 1245778999999999999999999854
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA 604 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~ 604 (767)
.....++||||+++++|.+++.... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC 147 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence 3456799999999999999997643 389999999999999999999998 99999999999999999999
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC--CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchh
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK--PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV 682 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 682 (767)
+|+|||.++........ .......|+..|+|||.+.... ++.++||||+|+++|++++|..||....... ...
T Consensus 148 ~l~d~~~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~ 222 (272)
T cd06629 148 KISDFGISKKSDDIYDN----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-AMF 222 (272)
T ss_pred EEeeccccccccccccc----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-HHH
Confidence 99999999754322111 1122345788999999987654 7899999999999999999999985421110 000
Q ss_pred hHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 683 KWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
........... ... ....+...+.+++.+||..+|++|||++|++++
T Consensus 223 ~~~~~~~~~~~----~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 223 KLGNKRSAPPI----PPD--------------VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HhhccccCCcC----Ccc--------------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000000000 000 000111223336778999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.48 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=178.3
Q ss_pred CccccccceEEEEEEeCCC---cEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEe
Q 004218 461 NLIGSGSFGSVYKGYLREG---ISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.|.. ....++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEe
Confidence 3699999999999985433 346677665432 2345688999999999999999999998653 345699999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhh
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL 616 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 616 (767)
|+++|+|.+++...... ....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccC
Confidence 99999999999764321 22367778889999999999999998 99999999999999999999999999985422
Q ss_pred hhcCCCccccccccccCCCCccCccccCC-------CCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhh
Q 004218 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLG-------EKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 617 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 688 (767)
.... ........++..|+|||++.. ..++.++||||||+++|||++ |..||...... ..+.......
T Consensus 151 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~ 225 (268)
T cd05086 151 KEDY----IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKDQ 225 (268)
T ss_pred cchh----hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhhc
Confidence 1110 011123457889999998753 235789999999999999997 46677542211 1111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
... ..++.+ .....+.+ .+++..|| .+|++||+++|+++.|.
T Consensus 226 ~~~----~~~~~~----------~~~~~~~~----~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 226 QVK----LFKPQL----------ELPYSERW----YEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccc----cCCCcc----------CCCCcHHH----HHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 000 000000 00011111 22555788 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.97 Aligned_cols=210 Identities=35% Similarity=0.435 Sum_probs=173.6
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-cccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~ 531 (767)
..|...+.||+|+||.||+|+++ +|+.||||.+... .....+...+|++++++++|||||+++++-.... .......
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 45666788999999999999965 5999999999654 3345567889999999999999999998732211 0012345
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CCC--ceEEc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD--EDM--TAKVG 607 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~--~~kl~ 607 (767)
.+|||||.||||...++.... ..++++.+.+.++.+++.||.|||++ |||||||||.||++- .+| ..||+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN---~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPEN---AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred eEEEeecCCCcHHHHhcCccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeee
Confidence 799999999999999976443 45699999999999999999999999 999999999999984 333 58999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccC-CCCCCCcccchhhhHHHHHHHhCCCCCCCcccC
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL-GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAG 677 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 677 (767)
|||.|+.++++. .....+||..|.+||.+. .+.|+..+|.|||||++|+++||..||......
T Consensus 167 DfG~Arel~d~s-------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 167 DFGAARELDDNS-------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccccccCCCCC-------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999999875542 345678999999999988 478899999999999999999999999665443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=302.53 Aligned_cols=270 Identities=23% Similarity=0.284 Sum_probs=192.3
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc-----chhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG-----TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
+|++.+.||+|++|.||+|.+. +++.||+|.+...... ....+.+|++++++++|+||+++++++. +..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence 4788899999999999999975 5899999998654322 3445678999999999999999999964 356
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+ +|+|.+++.... ..+++.++..++.|+++||+|||++ +|+||||+|+||+++.++.++|+||
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 779999999 889999997543 2489999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|.++....... ......++..|+|||.+.+ ..++.++||||+||++|||++|.+||...... ....+... .
T Consensus 147 g~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~-~ 218 (298)
T cd07841 147 GLARSFGSPNR------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFE-A 218 (298)
T ss_pred eeeeeccCCCc------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHH-H
Confidence 99976543211 1122346788999998754 45788999999999999999998777543221 11111110 0
Q ss_pred cccchhhhccH-----HHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDR-----ELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~-----~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+.......... .......................+.+++.+||+.||++|||++|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 219 LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 000000000000001111112233347889999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=296.36 Aligned_cols=199 Identities=30% Similarity=0.391 Sum_probs=172.1
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
+|++.+.||.|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++.+ ..+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 5888999999999999999976 48999999986442 23457888999999999999999999884 456678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++|+||+++++|.+++.... .+++.++..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 99999999999999997642 389999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 675 (767)
+....... ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus 147 ~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 147 ATKVTPDT-------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred ccccCCCc-------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 97653321 1123457889999999988889999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.98 Aligned_cols=204 Identities=25% Similarity=0.347 Sum_probs=170.5
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-ccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKN 527 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~ 527 (767)
...++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 34578999999999999999999965 5899999998543 2334456778999999999999999999875432 233
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
....++||||+++ +|.+.+... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 4567999999965 888887531 78889999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|||.++...... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||...
T Consensus 161 Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 161 DFGLARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred cCccceeCCCCC-------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 999997653321 112345788999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=279.43 Aligned_cols=201 Identities=30% Similarity=0.406 Sum_probs=174.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.+.|...++||+|.||.|-+++-+ +++.+|+|+++++. .+....-+.|-++|+..+||.+..+-.. +...+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence 457888899999999999999955 59999999997653 2334455678999999999999887665 66778
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
++|+||||+.||.|.-++...+. +++.....+-..|..||.|||++ +||.||+|.+|.++|.+|++||+||
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~------FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERV------FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhc------ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeec
Confidence 89999999999999998877553 89999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|+++.-- .....+..++||+.|+|||++....|+.++|+|.+|+++|||++|+.||...
T Consensus 313 GLCKE~I------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 313 GLCKEEI------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred ccchhcc------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 9997532 2233456789999999999999999999999999999999999999999653
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=296.19 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=191.2
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc-CCcchhhHHHHHHHHhcCC---CCCceeEEeeeecCCccccee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE-STGTWKSFFAECEALRNTR---HRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 530 (767)
.|+..+.||+|+||.||+|.+. +++.||+|.+... .....+++.+|+.+++.++ |||++++++++. .+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 4778899999999999999964 5899999998654 3344567889999999986 999999999854 4456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++++|.+++... .+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 79999999999999998653 389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
.+........ ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||........ ........
T Consensus 147 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~ 218 (277)
T cd06917 147 VAALLNQNSS------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA--MMLIPKSK 218 (277)
T ss_pred ceeecCCCcc------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh--hhccccCC
Confidence 9976543221 11234588899999987654 468899999999999999999999965322110 00110000
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+..... . . ....+.+++.+||+.||++||++.|++++
T Consensus 219 ~~~~~~---~--------------~----~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLED---N--------------G----YSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCc---c--------------c----CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 100000 0 0 01112237778999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=310.72 Aligned_cols=368 Identities=29% Similarity=0.464 Sum_probs=249.2
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
..|++|++++|+++ ++|..+++ +..++.|+.++|++. ++|..+.++.+|..|+.++|.+. .+|+.++.+..|+.|+
T Consensus 68 ~~l~vl~~~~n~l~-~lp~aig~-l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~ 143 (565)
T KOG0472|consen 68 ACLTVLNVHDNKLS-QLPAAIGE-LEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLD 143 (565)
T ss_pred cceeEEEeccchhh-hCCHHHHH-HHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhh
Confidence 45677777777777 77777774 677777777777777 67777777777777777777776 6666677777777777
Q ss_pred ecCccccCCCCCCc----------------cccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCccccc
Q 004218 82 IGFNKIVGSGDEGL----------------SFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGK 145 (767)
Q Consensus 82 l~~n~l~~~~~~~~----------------~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~ 145 (767)
..+|++.+.|.+.. ..+...-++++|+.||+..|-++ .+|..++.+.+ |+-|||..|+|. .
T Consensus 144 ~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~-L~~LyL~~Nki~-~ 220 (565)
T KOG0472|consen 144 ATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLES-LELLYLRRNKIR-F 220 (565)
T ss_pred ccccccccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhh-hHHHHhhhcccc-c
Confidence 77776664432211 12222333455555555555555 55555555555 555555555555 3
Q ss_pred CCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCc
Q 004218 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNF 225 (767)
Q Consensus 146 ~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 225 (767)
+| .|.++..|++|+++.|.|.........++++|.+|||.+|++. ..|..+.-+.+|..||+|+|.|++ .|..++++
T Consensus 221 lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl 297 (565)
T KOG0472|consen 221 LP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL 297 (565)
T ss_pred CC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc
Confidence 34 3444444444444444444222222335566666666666666 556666666666666666666653 45555665
Q ss_pred cccccccccCcccCC-----------------------------------------------------------------
Q 004218 226 QNLLSIDLSNNKLNG----------------------------------------------------------------- 240 (767)
Q Consensus 226 ~~L~~L~l~~n~l~~----------------------------------------------------------------- 240 (767)
+|+.|-+.+|.+..
T Consensus 298 -hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~ 376 (565)
T KOG0472|consen 298 -HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTL 376 (565)
T ss_pred -eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccccc
Confidence 56666665555430
Q ss_pred -------------------------CCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCccc
Q 004218 241 -------------------------NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSF 295 (767)
Q Consensus 241 -------------------------~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~ 295 (767)
++|..+..+..+.+.+.+++|.++ .+|..++.+++|+.|+|++|.+. .+|..+
T Consensus 377 VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~ 454 (565)
T KOG0472|consen 377 VPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEM 454 (565)
T ss_pred CCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhh
Confidence 222222222233333344444444 66778889999999999999998 688889
Q ss_pred ccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCccccccccc
Q 004218 296 KNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMV 375 (767)
Q Consensus 296 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 375 (767)
+.+..|+.|++++|++. ..|..+..+..|+.+-.++|++....|..+..|.+|.+|||.+|.++.+||..+.+.+++.+
T Consensus 455 ~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hL 533 (565)
T KOG0472|consen 455 GSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHL 533 (565)
T ss_pred hhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEE
Confidence 99999999999999998 88988888888899989999999777777999999999999999999999999999999999
Q ss_pred cccCCcCc
Q 004218 376 HLEGNPKL 383 (767)
Q Consensus 376 ~l~~Np~~ 383 (767)
.+.|||..
T Consensus 534 eL~gNpfr 541 (565)
T KOG0472|consen 534 ELDGNPFR 541 (565)
T ss_pred EecCCccC
Confidence 99999964
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.87 Aligned_cols=280 Identities=21% Similarity=0.265 Sum_probs=200.5
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 378999999999999999999965 58999999986432 234567788999999999999999998765432 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||++ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence 899999996 59999886543 289999999999999999999998 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh--
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES-- 687 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-- 687 (767)
.+.......... ........|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||....... ....+..
T Consensus 153 ~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~~~~~~~~ 228 (334)
T cd07855 153 MARGLSSSPTEH--KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QLKLILSVL 228 (334)
T ss_pred cceeecccCcCC--CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HHHHHHHHh
Confidence 997654322111 111123468899999998765 457899999999999999999999996532211 1111111
Q ss_pred -hcccc-hhhhccHHHHHhhhcc----hhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 688 -NFPKN-AQQVLDRELRQLMMSS----ESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 688 -~~~~~-~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
..+.. ........+....... ..............+.+++.+||+.+|.+|||+++++.+-
T Consensus 229 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 229 GSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred CCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 11111 1111111111111110 0000111111223344578899999999999999998854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=307.26 Aligned_cols=284 Identities=21% Similarity=0.256 Sum_probs=201.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|.+.+.||+|+||.||+|... +++.||||.+... .......+.+|+.+++.++||||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999965 5899999988643 2334456778999999999999999999876543333456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence 899999996 68998886543 389999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc-c-hhhHhhh
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-S-LVKWVES 687 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~-~~~~~~~ 687 (767)
+++...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||........ . .......
T Consensus 154 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 154 LARTTSEKG------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred cccccCCCc------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 997653221 11123457889999998765 4688999999999999999999999965321100 0 0000000
Q ss_pred hcccchhhhccHHHHHhhhc---ch-hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH--HHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMS---SE-SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR--LKNAQK 753 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~---~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~~ 753 (767)
..+.......+......... .. .......+.+...+.+++.+||+.||++|||++|++++ ++.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00111111111111111100 00 00001111122333448889999999999999999988 665543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=300.72 Aligned_cols=283 Identities=24% Similarity=0.321 Sum_probs=196.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc---cc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF---KN 527 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 527 (767)
.++|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||++++++|..... ..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999975 58999999886432 2223456789999999999999999998865432 23
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
....++||||+++ ++.+++.... ..+++.+++.++.|++.||+|||++ +++|+||||+||+++.++.+||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEEC
Confidence 3567999999965 8888876532 2389999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCC-CCCcccchhhhHHHHHHHhCCCCCCCcccCCc-chhhHh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-SLVKWV 685 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~ 685 (767)
|||.+.......... ........++..|+|||.+.+.. ++.++||||+|+++|||++|+.||........ .....+
T Consensus 162 dfg~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 162 DFGLARAFSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred cCCCcccccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999997654332111 11112345788899999876643 68899999999999999999999865432110 111111
Q ss_pred hhhcccch-hhhccHHHHHhhhcchhhHHHHHHHH-----HHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 ESNFPKNA-QQVLDRELRQLMMSSESQTIQLHDCL-----ITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 ~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~-----~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+..+... +..........+.............+ ...+.+++.+||..||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 11111111 00000000000000000000000000 1122348889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=301.87 Aligned_cols=250 Identities=26% Similarity=0.347 Sum_probs=199.9
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
...+.|.+...||+|.|+.|.+|++. ++..||+|.+++..- ...+.+.+|+++|+.++|||||+++.+. ...
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~ 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETE 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eec
Confidence 34578999999999999999999965 599999999976533 3345688999999999999999999994 455
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..+|+||||+.+|.+++++..... ..+.++..++.|+.+|++|||++ .|||||||++||+++.+..+||+|
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeec
Confidence 678999999999999999988764 66688999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
||++..+... ......+|++.|+|||++.+..+ ++.+|+||+|+++|.|+.|..||+...-...+-. .+..
T Consensus 199 fgfS~~~~~~-------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r-vl~g 270 (596)
T KOG0586|consen 199 FGFSTFFDYG-------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR-VLRG 270 (596)
T ss_pred cccceeeccc-------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch-heee
Confidence 9999877532 22345789999999999998877 7899999999999999999999976422211100 0000
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+. ++..+. .-.++++++++..+|.+|++++++.+.
T Consensus 271 k~r--Ip~~ms----------------------~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KYR--IPFYMS----------------------CDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eec--ccceee----------------------chhHHHHHHhhccCccccCCHHHhhhh
Confidence 010 011111 112236667888999999999998765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=277.13 Aligned_cols=282 Identities=23% Similarity=0.349 Sum_probs=204.8
Q ss_pred cCCCCCCccccccceEEEEEEeCC-CcEEEEEEeec--cCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc---ccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDI--ESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF---KNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~ 528 (767)
+.|....+||+|.||.||+|+.++ |++||+|++-. +..+-.....+|++++..++|+|++.+++.|..... .+.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 466777899999999999999654 88899987633 344455678899999999999999999999866442 334
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..+|+|+++|+. +|..++.... .+++..++.++++++..||.|+|+. .|+|||+||.|++|+.+|.+||+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence 468999999987 9998887643 3489999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCC-cchhhHhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE-VSLVKWVE 686 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~ 686 (767)
||+++.+...... .....+..+-|.+|++||.+.+. .++++.|||+.|||+.||+||.+-++...... ..+....-
T Consensus 168 FGlar~fs~~~n~--~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 168 FGLARAFSTSKNV--VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred cccccceeccccc--CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 9999766543222 22223455569999999988764 58999999999999999999998876543221 11222222
Q ss_pred hhcccc-hhhhccHHHHHhhhcch---hhHHHHHHHHH------HHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 687 SNFPKN-AQQVLDRELRQLMMSSE---SQTIQLHDCLI------TIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 687 ~~~~~~-~~~~~~~~l~~~~~~~~---~~~~~~~~~~~------~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
+.+.++ ++....-.+.+.+...+ .+...+.+.++ ..+. ++..++..||.+|+++++++.+-
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~d-Lle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALD-LLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHH-HHHHHhccCcccCcchHhhhchh
Confidence 222222 22222222333221111 11111222222 2233 67789999999999999988764
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=300.91 Aligned_cols=199 Identities=29% Similarity=0.402 Sum_probs=166.8
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++||||+++++++ ..+...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 46889999999999999999976 489999998754322 2345688999999999999999999985 455678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||++++++.++..... .+++.++..++.|++.|++|||+. +++||||+|+||++++++.++|+|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred EEEEecCCccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence 99999999999988765432 389999999999999999999998 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
+........ ......++..|+|||++.+ ..++.++||||||+++|||++|++||..
T Consensus 147 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 147 ARTLAAPGE------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred eeeccCCcc------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 876433211 1123457889999998865 3468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=316.64 Aligned_cols=366 Identities=27% Similarity=0.375 Sum_probs=251.5
Q ss_pred CccEEeCCCCeee-ecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 3 SLVYLGLASNQLW-GEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 3 ~L~~L~l~~n~l~-~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
-.+-.|+|+|.++ +..|.++- .+..++.|.|...++. .+|+.++.+.+|++|.+++|++. .+...++.|+.|+.+.
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~-qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVE-QMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred eeecccccCCcCCCCcCchhHH-HhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 3456777888877 46776664 4777788888877777 67777888888888888888777 6666777777777777
Q ss_pred ecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEEC
Q 004218 82 IGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNL 161 (767)
Q Consensus 82 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l 161 (767)
+..|+++.. -+|+.+-.+..|+.||||+|++. +.|..+...++ +-.|+|++|+|..+....|-+++.|-.|||
T Consensus 85 ~R~N~LKns-----GiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn-~iVLNLS~N~IetIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 85 VRDNNLKNS-----GIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKN-SIVLNLSYNNIETIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred hhccccccC-----CCCchhcccccceeeecchhhhh-hcchhhhhhcC-cEEEEcccCccccCCchHHHhhHhHhhhcc
Confidence 777777654 56667777777778888888777 67777777766 777788888777444445667777777788
Q ss_pred cCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCC-CCCcccccCccccccccccCcccCC
Q 004218 162 SYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELA-SEIPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 162 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
|+|++. .+|+.+..+.+|++|+|++|.+...--..+..+++|+.|.+++.+=+ ..+|..+..+.+|..+|+|.|.+.
T Consensus 158 S~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp- 235 (1255)
T KOG0444|consen 158 SNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP- 235 (1255)
T ss_pred ccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-
Confidence 877777 56667777777777777777766333344455666666666665432 235666667777777777777776
Q ss_pred CCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccC-CCCchh
Q 004218 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSG-PIPNIL 319 (767)
Q Consensus 241 ~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~ 319 (767)
.+|..+..+++|.++ +|++|+|+ .+....+.-.+|+.|+||.|+++ .+|+.++.++.|+.|++.+|+++- -+|..+
T Consensus 236 ~vPecly~l~~LrrL-NLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGI 312 (1255)
T KOG0444|consen 236 IVPECLYKLRNLRRL-NLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGI 312 (1255)
T ss_pred cchHHHhhhhhhhee-ccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccch
Confidence 667777777776444 77777776 34444455556677777777776 666677777777777777776652 356666
Q ss_pred hccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCccccccccccccCCcCcc
Q 004218 320 AELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC 384 (767)
Q Consensus 320 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c 384 (767)
+++.+|+.+..++|.+. ..|+.+..|++|+.|.|+.|++-..|...-.++.+..+.+..||.+-
T Consensus 313 GKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLV 376 (1255)
T KOG0444|consen 313 GKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLV 376 (1255)
T ss_pred hhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCcc
Confidence 66667777777776665 66666777777777777777766665555556666666666666443
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=297.78 Aligned_cols=208 Identities=25% Similarity=0.336 Sum_probs=168.1
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|.+. +++.||+|..+... ......+.+|+.+++.+. ||||+++++++...+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999975 58999999886442 223467888999999995 699999999876544333445
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE-DMTAKVGDF 609 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~Df 609 (767)
.++||||+++ +|.+++...... ....+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999986 899988654321 124589999999999999999999999 9999999999999998 899999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
|.+..+..... ......+++.|+|||++.+ ..++.++||||+|+++|+|++|..||..
T Consensus 156 g~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 156 GLGRAFSIPVK------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred ccceecCCCcc------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 99875432211 1112246788999998765 4578999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=274.90 Aligned_cols=274 Identities=24% Similarity=0.372 Sum_probs=201.1
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEEE-eCCCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCC
Q 004218 447 YDELRRATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLD 524 (767)
Q Consensus 447 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 524 (767)
++++-..++ +.||+|+++.|-.++ ..+|..||||++++.......++.+|++++.+. .|+||++++++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief----- 144 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF----- 144 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----
Confidence 566665554 679999999999998 667999999999888777788999999999999 59999999999
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC--
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-- 602 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-- 602 (767)
|+++..+|+|||-|.||+|.+++++.+. +++.++.++.++|+.||.|||.+ ||.|||+||+|||..+..
T Consensus 145 FEdd~~FYLVfEKm~GGplLshI~~~~~------F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 145 FEDDTRFYLVFEKMRGGPLLSHIQKRKH------FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKV 215 (463)
T ss_pred hcccceEEEEEecccCchHHHHHHHhhh------ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCc
Confidence 6788899999999999999999987664 99999999999999999999999 999999999999997554
Q ss_pred -ceEEccccchhhhhhhcC-CCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhCCCCCCCcc
Q 004218 603 -TAKVGDFGLARSLLERIG-NQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675 (767)
Q Consensus 603 -~~kl~Dfg~a~~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 675 (767)
-+|||||.+..-...... ...........+|+..|||||+.. ...|+.++|.||+|+|+|-|++|.+||...-
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 489999988754322211 122233345577999999999753 2357889999999999999999999996542
Q ss_pred cCCcchhhHhhhhcccchhhhccHHHHH-hhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 676 AGEVSLVKWVESNFPKNAQQVLDRELRQ-LMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
..+- -|-++..-..-++.+-+.+.. .+...+..... +....++++...+..||.+|.+|.+++.
T Consensus 296 g~dC---GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWah----IS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 296 GADC---GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAH----ISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCcC---CccCCCccHHHHHHHHHHHhccCCcCChhhhHH----hhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 2211 111111100001111111111 01111112222 3333444666777789999999998887
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=290.13 Aligned_cols=249 Identities=21% Similarity=0.258 Sum_probs=186.8
Q ss_pred HHHHHHHhcCCCCCCcc--ccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeec
Q 004218 447 YDELRRATGNFSHENLI--GSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSS 522 (767)
Q Consensus 447 ~~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 522 (767)
..+.....++|++.+.+ |+|+||.||++..+ +++.+|+|.+........ |+.....+ +|||++++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~- 79 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT- 79 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe-
Confidence 34455556788888877 99999999999965 588899999864322211 22222222 7999999999864
Q ss_pred CCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 004218 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM 602 (767)
Q Consensus 523 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~ 602 (767)
..+..++||||+++++|.+++.... .+++.++..++.|+++|++|||+. +++||||||+||+++.++
T Consensus 80 ----~~~~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~ 146 (267)
T PHA03390 80 ----TLKGHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK 146 (267)
T ss_pred ----cCCeeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence 3457799999999999999997643 389999999999999999999999 999999999999999988
Q ss_pred -ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcch
Q 004218 603 -TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL 681 (767)
Q Consensus 603 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 681 (767)
.++|+|||.+...... ....|+..|+|||++.+..++.++||||+|+++|+|++|+.||..........
T Consensus 147 ~~~~l~dfg~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T PHA03390 147 DRIYLCDYGLCKIIGTP----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216 (267)
T ss_pred CeEEEecCccceecCCC----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH
Confidence 9999999998754321 22357899999999998889999999999999999999999997543332222
Q ss_pred hhHhhhhc-ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC-HHHHHH
Q 004218 682 VKWVESNF-PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID-IREALR 746 (767)
Q Consensus 682 ~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~evl~ 746 (767)
..+..... +...... ....+.+++.+||+.+|.+||+ ++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~----------------------~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 217 ESLLKRQQKKLPFIKN----------------------VSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHhhcccCCcccc----------------------cCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 22211110 0000111 1112233667899999999996 588875
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=290.31 Aligned_cols=254 Identities=24% Similarity=0.302 Sum_probs=191.9
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc-----CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE-----STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.+|++.+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence 46889999999999999999965 4899999987532 12234578899999999999999999998643 223
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..+++|+||+++++|.+++.... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence 46789999999999999987543 278999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||.++........ ........|+..|+|||.+.+..++.++||||||+++|++++|+.||....... ...+.....
T Consensus 150 fg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~ 225 (264)
T cd06653 150 FGASKRIQTICMS---GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFKIATQP 225 (264)
T ss_pred ccccccccccccc---CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHHHHcCC
Confidence 9999765321111 111123458899999999988889999999999999999999999986531111 111111110
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+...+..+. +.+.+++.+||. +|..|||+.+++.+
T Consensus 226 ~~~~~p~~~~----------------------~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 TKPMLPDGVS----------------------DACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCCCCcccC----------------------HHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1111111111 122236667888 57999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=298.71 Aligned_cols=247 Identities=26% Similarity=0.338 Sum_probs=188.2
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
...|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++|||++++++++.. +.
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CC
Confidence 356889999999999999999975 589999998864322 234568899999999999999999999653 44
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||++ |++.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+||
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~df 159 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADF 159 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeec
Confidence 5699999997 58877775432 2389999999999999999999998 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccC---CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL---GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
|++...... ....++..|+|||++. ...++.++||||||+++|||++|+.||........ ......
T Consensus 160 g~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~~~~~~ 228 (307)
T cd06607 160 GSASLVSPA----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ 228 (307)
T ss_pred CcceecCCC----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-HHHHhc
Confidence 998654221 2245788999999874 45678899999999999999999999854321110 000000
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+..... .....+.+++.+||+.||++||++.+++.+
T Consensus 229 ~~~~~~~~~----------------------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 229 NDSPTLSSN----------------------DWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCCCch----------------------hhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 011123337779999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=290.24 Aligned_cols=254 Identities=28% Similarity=0.379 Sum_probs=197.6
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4778899999999999999976 589999999865442 44678889999999999999999999865321 26779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+|+||+++++|.+++.... .+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 78 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence 9999999999999997653 389999999999999999999998 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
......... .......++..|+|||...+...+.++||||+|+++|+|++|+.||.....................
T Consensus 149 ~~~~~~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd06606 149 KRLGDIETG----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE 224 (260)
T ss_pred Eeccccccc----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcC
Confidence 766443211 0113345788999999998888999999999999999999999998664311111100000000001
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+... ...+.+++.+|++.||++||++.|++++
T Consensus 225 ~~~~~----------------------~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 IPEHL----------------------SEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCccc----------------------CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11111 1223336778999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=297.71 Aligned_cols=247 Identities=25% Similarity=0.327 Sum_probs=188.8
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.|+..+.||+|+||.||+|++. ++..||+|.+.... ....+.+.+|+++++.++|||++++++++. .+...
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeE
Confidence 3677889999999999999965 58899999986432 233457889999999999999999999964 34456
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++ ++.+++.... ..+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.
T Consensus 101 ~lv~e~~~g-~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred EEEEeCCCC-CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence 999999975 8888775433 2389999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccC---CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL---GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
+..... .....|+..|+|||++. .+.++.++||||+||++|+|++|+.||...... ..........
T Consensus 172 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~ 240 (317)
T cd06635 172 ASIASP----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNE 240 (317)
T ss_pred ccccCC----------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhcc
Confidence 864322 12345788999999874 456889999999999999999999998553111 0111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
.+..... .....+.+++.+||+.+|.+||++.|++++..
T Consensus 241 ~~~~~~~----------------------~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 241 SPTLQSN----------------------EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCCCCCc----------------------cccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 1110000 11112334777899999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=288.56 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=196.1
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
.|+..+.||+|++|.||++... +++.|++|++........+.+.+|+++++.++|++++++++++. .+...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 3778899999999999999976 58899999997655456678999999999999999999999854 34567999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
+||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred EecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 99999999999987652 2389999999999999999999998 999999999999999999999999999976
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchh
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
...... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||........ .........+....
T Consensus 148 ~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~ 219 (253)
T cd05122 148 LSDTKA-------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-LFKIATNGPPGLRN 219 (253)
T ss_pred cccccc-------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcCCCCcCc
Confidence 543211 2334578899999999888899999999999999999999999865321100 00000000000000
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. .. ....+.+++.+||+.||++|||+.|++++
T Consensus 220 ~-----------------~~----~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 P-----------------EK----WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred c-----------------cc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00 01122337778999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=271.51 Aligned_cols=249 Identities=22% Similarity=0.311 Sum_probs=190.1
Q ss_pred CCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc-CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE-STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+.+.+..||.|.-|.||++..+. |...|||.+... +.+..++++..++++... ..|+||+.+|++. .+..++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCchHH
Confidence 34455679999999999999765 889999999654 445567888888877665 4899999999953 445568
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+.||.|.. .++.++.... .++++.-+-++...+.+||.||.++. +|+|||+||+|||+|+.|++|+||||.+
T Consensus 168 IcMelMs~-C~ekLlkrik-----~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 168 ICMELMST-CAEKLLKRIK-----GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHHHHH-HHHHHHHHhc-----CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccc
Confidence 89998843 6666666544 34888888899999999999998863 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCC---CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG---EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
-.+.+.... ...+|.+.|||||.+.- ..|+-++||||||++++|++||+.||.....+...+.+... ..
T Consensus 240 GrlvdSkAh-------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~e 311 (391)
T KOG0983|consen 240 GRLVDSKAH-------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EE 311 (391)
T ss_pred ceeeccccc-------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cC
Confidence 776554322 33468899999998864 36788999999999999999999999875554444433333 22
Q ss_pred ccchhh-h-ccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQ-V-LDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~-~-~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
|+..+. . +.+. + .+++..||.+|+.+||...+++++
T Consensus 312 PP~L~~~~gFSp~------------------F----~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 PPLLPGHMGFSPD------------------F----QSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCcccCcCHH------------------H----HHHHHHHhhcCcccCcchHHHhcC
Confidence 221111 0 1211 2 225557999999999999998875
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.91 Aligned_cols=202 Identities=28% Similarity=0.373 Sum_probs=167.7
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|+||.||+|.++ +++.||+|.++.... .....+.+|+.++++++||||+++++++... +....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence 57899999999999999999976 488999999864432 2234567899999999999999999986532 23678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++ +|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred EEEehhcCc-CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence 999999975 9999887543 2489999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCC-CCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+........ ......++..|+|||.+.+.. ++.++||||+|+++|+|++|+.||...
T Consensus 153 ~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 153 AREYGSPLK------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred eeeccCCcc------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 976543211 112234688899999887644 688999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=290.40 Aligned_cols=250 Identities=25% Similarity=0.327 Sum_probs=192.2
Q ss_pred CCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|+||.||+|..+. |..||+|.+.... ....+.+.+|+++++.++|+|++++++.+. .+...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence 57888999999999999999764 8899999986542 234567789999999999999999999853 455779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEccccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-TAKVGDFGL 611 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~ 611 (767)
+|+||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++ .+||+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQR----GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred EEEecCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 9999999999999987543 23479999999999999999999998 999999999999999875 469999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+........ ......|+..|+|||+..+..++.++||||+|+++|+|++|+.||...... +........
T Consensus 149 ~~~~~~~~~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~ 217 (257)
T cd08225 149 ARQLNDSME------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVLKICQG 217 (257)
T ss_pred chhccCCcc------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhcc
Confidence 976543211 112245788999999998888999999999999999999999998543211 111111000
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..... . . .....+.+++.+||..+|++|||+.|++++
T Consensus 218 ~~~~~-~--------------~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 218 YFAPI-S--------------P----NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred cCCCC-C--------------C----CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00000 0 0 001112236778999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=293.76 Aligned_cols=273 Identities=23% Similarity=0.340 Sum_probs=194.3
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
+|++.+.||.|++|.||+|++. +|+.||+|.+..... ...+.+.+|++++++++||||+++++++. ..+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 5888999999999999999976 488999999865432 33466788999999999999999999964 3456799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++ +|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+.
T Consensus 76 v~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred EEecCCc-cHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 9999985 89988865432 23489999999999999999999998 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh-ccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN-FPK 691 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~ 691 (767)
....... ......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+. ........ .+.
T Consensus 149 ~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~ 221 (284)
T cd07836 149 AFGIPVN------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPT 221 (284)
T ss_pred hhcCCcc------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCC
Confidence 5432211 11223468889999987654 468899999999999999999999865432211 11111000 000
Q ss_pred --chhhhc-cHHHHHhhhc-chhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 --NAQQVL-DRELRQLMMS-SESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 --~~~~~~-~~~l~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...... .+.+...... .........+.....+.+++.+|++.||.+||+++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 222 ESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 0000000000 0001111111223334457789999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=299.39 Aligned_cols=202 Identities=22% Similarity=0.306 Sum_probs=160.7
Q ss_pred Cccccc--cceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSG--SFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
..||+| +||+||+|.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. .+...++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 456666 89999999975 59999999986442 223467889999999999999999999964 455679999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||++++++.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+...
T Consensus 79 e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 79 PFMAYGSANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred ecccCCCHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 99999999999876432 3489999999999999999999998 9999999999999999999999999876543
Q ss_pred hhhcCCCcc-ccccccccCCCCccCccccCCC--CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 616 LERIGNQSS-ISSTHVLKGSIGYIPPEYGLGE--KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 616 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
......... ........++..|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 222111100 0001112356679999998764 4789999999999999999999999654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=294.99 Aligned_cols=267 Identities=20% Similarity=0.239 Sum_probs=182.7
Q ss_pred hcCCCCCCccccccceEEEEEEeCC----CcEEEEEEeeccCCcch-----------hhHHHHHHHHhcCCCCCceeEEe
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIESTGTW-----------KSFFAECEALRNTRHRNLVKLIT 518 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~ 518 (767)
.++|++.+.||+|+||.||+|.+.+ +..+|+|+......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999999754 34667776433322111 11223334456678999999998
Q ss_pred eeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 519 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
++.... ....+.++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKLVE-NTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred eeeEec-CCceEEEEEEehhcc-CHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 754321 122345788888744 7777665432 257788899999999999999998 99999999999999
Q ss_pred CCCCceEEccccchhhhhhhcCCCc-cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccC
Q 004218 599 DEDMTAKVGDFGLARSLLERIGNQS-SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAG 677 (767)
Q Consensus 599 ~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 677 (767)
+.++.++|+|||+|+.+........ .........||+.|+|||+..+..++.++||||+||++|||++|+.||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 9999999999999986643211111 111123346999999999999999999999999999999999999999764222
Q ss_pred CcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 678 EVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
.. ........+. .... .. ......+ .+.+.+++..|++.+|++||+++++.+.+
T Consensus 240 ~~-~~~~~~~~~~-----------~~~~-~~---~~~~~~~-~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 240 GN-LIHAAKCDFI-----------KRLH-EG---KIKIKNA-NKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hH-HHHHhHHHHH-----------HHhh-hh---hhccCCC-CHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11 1111110000 0000 00 0000001 12222366789999999999999999876
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=289.26 Aligned_cols=202 Identities=29% Similarity=0.405 Sum_probs=175.2
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
..+.|+.-++||+|+||.||-++.+ +|+.||.|.+.+. ......-.++|-.++.++..+.||.+-.+ ++..
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTk 257 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETK 257 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCC
Confidence 3456788899999999999999965 4999999988543 33445567899999999999999998766 5667
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
+.+|+|+..|.||+|.-++-... ...+++..+..++.+|+.||++||+. +||.||+||+|||+|+.|+++|+|
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g----~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHG----NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred CceEEEEEeecCCceeEEeeccC----CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeec
Confidence 78899999999999998887665 35599999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
.|+|..+..... ....+||.+|||||++.++.|+...|+||+||++|||+.|+.||..
T Consensus 331 LGLAvei~~g~~-------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 331 LGLAVEIPEGKP-------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred cceEEecCCCCc-------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 999987754321 2334799999999999999999999999999999999999999954
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.65 Aligned_cols=209 Identities=26% Similarity=0.375 Sum_probs=169.4
Q ss_pred CCCCCCccccccceEEEEEEeCC---CcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE---GISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
+|++.+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 47888999999999999999754 7899999987532 34456778899999999999999999997532 235
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC----CCceE
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE----DMTAK 605 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~----~~~~k 605 (767)
..++||||+++ ++.+++...... ....+++..++.++.|++.|++|||+. +|+||||||+||+++. ++.+|
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccC-CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence 78999999975 777777543321 123589999999999999999999999 9999999999999999 99999
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcc
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESF 675 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~ 675 (767)
|+|||++......... ........++..|+|||++.+. .++.++||||+|+++|+|++|++||....
T Consensus 153 l~Dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 153 IGDLGLARLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ECCCccccccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9999999865433211 1112334578899999987664 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=296.16 Aligned_cols=201 Identities=27% Similarity=0.387 Sum_probs=168.8
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|+||.||+|.+. +++.||+|.++.. .....+.+.+|++++++++|+||+++++++. .++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence 46889999999999999999976 4889999988643 2334567889999999999999999999964 35567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||++++.+..+.... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.
T Consensus 76 ~iv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 76 YLVFEYVERTLLELLEASP------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred EEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence 9999999987776655432 2389999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+........ .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||...
T Consensus 147 ~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 147 ARALRARPA-----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccccCCCcc-----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 876543321 011234578889999999887 7899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=302.43 Aligned_cols=279 Identities=25% Similarity=0.292 Sum_probs=196.7
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 528 (767)
..++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.+++++ +||||+++++++.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 4578999999999999999999976 4889999988532 223345677899999999 99999999998643 234
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence 56799999997 4999988653 288999999999999999999998 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
||.+.......... .........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .......
T Consensus 151 ~g~~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~ 228 (337)
T cd07852 151 FGLARSLSELEENP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEV 228 (337)
T ss_pred ccchhccccccccc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH
Confidence 99998664332111 0112233468899999998755 4578899999999999999999999865322111 1111110
Q ss_pred h--cccc-hhhhccHHHHHhhhc----chhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 N--FPKN-AQQVLDRELRQLMMS----SESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~--~~~~-~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. .+.. ............+.. ......+........+.+++.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 0000 000000000001100 0000011111112233448889999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=298.76 Aligned_cols=203 Identities=28% Similarity=0.390 Sum_probs=167.1
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|.+. +|+.||+|.++.... .....+.+|+.++++++|+|++++++++.. ...+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence 468999999999999999999975 489999999864432 223456789999999999999999998653 22345
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++ +|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred EEEEEecCCC-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 7999999975 8988887543 3489999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
.+........ ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 154 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 154 LARTYGLPAK------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred eeeecCCccC------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9976543211 1122235788999998865 45789999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=295.12 Aligned_cols=271 Identities=24% Similarity=0.310 Sum_probs=191.8
Q ss_pred CCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
|++.+.||.|++|.||+|.+. +|+.||+|++.... ....+.+.+|+++++.++|||++++++++. ++...++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 677899999999999999975 59999999986543 233456889999999999999999999954 4467799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||++ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+.
T Consensus 76 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EEeccC-cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 999995 699999876441 3489999999999999999999998 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc-cc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF-PK 691 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~ 691 (767)
........ .....++..|+|||++.+. .++.++||||+|+++|+|++|+.||....... .......... +.
T Consensus 148 ~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~ 220 (283)
T cd07835 148 AFGVPVRT------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPD 220 (283)
T ss_pred ccCCCccc------cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 54322111 1122467889999987664 46889999999999999999999986532211 1111111100 00
Q ss_pred c-hhhh--ccHHHHHhhhcch-hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 N-AQQV--LDRELRQLMMSSE-SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~-~~~~--~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. .... ..+.......... .........+...+.+++.+||+.||++|||++|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 221 EDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000 0000000000000 00000011111223347889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=289.13 Aligned_cols=192 Identities=29% Similarity=0.423 Sum_probs=164.9
Q ss_pred cccccceEEEEEEeCC-CcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeec
Q 004218 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 463 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
||.|++|.||+|.... ++.||+|++.... ....+.+.+|+++++.++||||+++++++. ++...++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 6899999999999764 8899999986432 234567889999999999999999999853 456679999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhh
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 618 (767)
++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 76 LGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 9999999997643 289999999999999999999998 9999999999999999999999999999765432
Q ss_pred cCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcc
Q 004218 619 IGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675 (767)
Q Consensus 619 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 675 (767)
. ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus 147 ~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 147 Q-------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred c-------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 1 1123457889999999888889999999999999999999999996643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.67 Aligned_cols=242 Identities=23% Similarity=0.305 Sum_probs=178.4
Q ss_pred ccccccceEEEEEEeC-CCcEEEEEEeeccCCc---chhhHHHHHH---HHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 462 LIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG---TWKSFFAECE---ALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 462 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
.||+|+||.||+|... +++.||+|.+...... ....+..|.. .++...||+|+++++++ ......++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 4899999999999965 4889999998643221 1122334433 44445799999999884 345577999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 76 ~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 76 LDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999999999886533 389999999999999999999998 999999999999999999999999999875
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccch
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
..... .....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||..................+...
T Consensus 147 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 218 (278)
T cd05606 147 FSKKK--------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 218 (278)
T ss_pred cCccC--------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC
Confidence 43211 1234589999999998754 58899999999999999999999996542211111000000000111
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
+...+. .+.+++.+|+..+|++|| ++.|++++
T Consensus 219 ~~~~s~----------------------~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 PDSFSP----------------------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCcCCH----------------------HHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111111 122366689999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=287.30 Aligned_cols=247 Identities=29% Similarity=0.438 Sum_probs=194.4
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++|||++++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 5788999999999999999876 478999999865543 35567899999999999999999999854 346779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++.... .+++..+..++.|++.|+.|||+. ||+||||+|+||+++.++.++|+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 9999999999999987643 389999999999999999999998 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
......... .....++..|+|||...+..++.++||||+|+++|+|++|+.||...... ...........+ .
T Consensus 147 ~~~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~ 218 (254)
T cd06627 147 TKLNDVSKD------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-AALFRIVQDDHP-P 218 (254)
T ss_pred eecCCCccc------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHhccCCC-C
Confidence 866433211 12345788999999988888899999999999999999999998643211 000010000000 0
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
....++ ..+.+++.+||..+|++|||+.|++.
T Consensus 219 ~~~~~~----------------------~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGIS----------------------PELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCC----------------------HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111111 12223667899999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=287.10 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=197.1
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|+||.||++.+. ++..||+|++..... ...+.+.+|+++++.++|||++++++.+. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 5888899999999999999976 588999999875433 45567889999999999999999999854 346779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+|+||+++++|.+++..... ....+++.++..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence 99999999999999976531 124599999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
....... .......|+..|+|||...+..++.++||||+|+++|+|++|+.||...... .............
T Consensus 151 ~~~~~~~------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~ 222 (258)
T cd08215 151 KVLSSTV------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--ELALKILKGQYPP 222 (258)
T ss_pred eecccCc------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--HHHHHHhcCCCCC
Confidence 7654321 1123345788999999998888999999999999999999999998553211 1111111100111
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...... ..+.+++.+||..+|++|||+.|++++
T Consensus 223 ~~~~~~----------------------~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 IPSQYS----------------------SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCC----------------------HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111 112236778999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=302.70 Aligned_cols=278 Identities=21% Similarity=0.255 Sum_probs=194.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-------
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF------- 525 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------- 525 (767)
.++|++.+.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999975 488999999876666666788899999999999999999987654221
Q ss_pred --ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCC
Q 004218 526 --KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD-EDM 602 (767)
Q Consensus 526 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~ 602 (767)
......++||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++ +++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 11246799999997 5998888543 288999999999999999999999 999999999999997 456
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcch
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL 681 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 681 (767)
.+||+|||.++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~ 228 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHK---GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-M 228 (342)
T ss_pred eEEECCcccceecCCccccc---cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence 78999999997543221111 11122347888999997654 5578899999999999999999999965322111 1
Q ss_pred hhHhhhhcccchhhhccH---HHHHhhh----cchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 682 VKWVESNFPKNAQQVLDR---ELRQLMM----SSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~---~l~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. .....+......... .+..... ............+...+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 229 QL-ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HH-HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 11 111111110000000 0000000 00000000111122223347789999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.77 Aligned_cols=193 Identities=29% Similarity=0.394 Sum_probs=163.2
Q ss_pred cccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeec
Q 004218 463 IGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 463 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
||+|+||.||+|... +|+.||+|.+.... ....+.+.+|+++++.++||||+++++++ ...+..++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 689999999999865 58899999986432 22345667899999999999999999885 3456779999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhh
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 618 (767)
++++|.+++..... ..+++.++..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+......
T Consensus 76 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 76 NGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99999999875442 3489999999999999999999999 9999999999999999999999999998765321
Q ss_pred cCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 619 IGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 619 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
. ......++..|+|||++.+..++.++||||+|+++|+|++|+.||...
T Consensus 149 ~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 149 K-------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred C-------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 1 112335788999999998888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=294.03 Aligned_cols=245 Identities=25% Similarity=0.385 Sum_probs=189.4
Q ss_pred CCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeec
Q 004218 460 ENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
...||+|+||.||++... +++.||+|.+..........+.+|+.+++.++|+|++++++++. .++..++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEecC
Confidence 367999999999999875 58999999986544455667889999999999999999999854 456779999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhh
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 618 (767)
++++|.+++.... +++..+..++.|++.|++|||+. |++||||+|+||+++.++.++|+|||.+......
T Consensus 100 ~~~~L~~~~~~~~-------~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 100 EGGALTDIVTHTR-------MNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred CCCcHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 9999999875432 88999999999999999999999 9999999999999999999999999998654322
Q ss_pred cCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhhcc
Q 004218 619 IGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLD 698 (767)
Q Consensus 619 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (767)
.. ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ...........+......
T Consensus 170 ~~------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~-- 239 (292)
T cd06657 170 VP------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKLKNL-- 239 (292)
T ss_pred cc------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcccCCc--
Confidence 11 11234578899999999888889999999999999999999999854211 111111111111110000
Q ss_pred HHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 699 RELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 699 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..... .+.+++.+||+.||.+||++.|++++
T Consensus 240 --------------~~~~~----~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 --------------HKVSP----SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred --------------ccCCH----HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 00001 12236668999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.87 Aligned_cols=274 Identities=26% Similarity=0.318 Sum_probs=193.6
Q ss_pred CCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCC--cchhhHHHHHHHHhcC---CCCCceeEEeeeecCCccccee
Q 004218 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIEST--GTWKSFFAECEALRNT---RHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 530 (767)
|++.+.||+|+||.||+|+++. ++.||+|.+..... .....+.+|+.+++++ +|||++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778899999999999999875 89999999864322 2234566788777665 6999999999987654434445
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.+++|||+++ +|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence 8999999975 89998865432 2489999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh-c
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN-F 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~ 689 (767)
.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|++||...... ....+..... .
T Consensus 153 ~~~~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~ 224 (287)
T cd07838 153 LARIYSFEMA-------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGL 224 (287)
T ss_pred cceeccCCcc-------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCC
Confidence 9876533211 12234688899999999888999999999999999999999998653221 1111111100 0
Q ss_pred ccc--hhhhccHHHHHhhhc-chhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKN--AQQVLDRELRQLMMS-SESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~--~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+.. ...... ........ ...........+...+.+++.+||+.||++||+++|++++
T Consensus 225 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 225 PSEEEWPRNVS-LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CChHhcCCCcc-cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000 000000 00000000 0000011111222333447789999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=301.48 Aligned_cols=283 Identities=22% Similarity=0.249 Sum_probs=202.8
Q ss_pred CCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|++|.||+|+... ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..........++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58889999999999999999764 8999999986543 34456788999999999999999999987654333345789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++ +|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+
T Consensus 81 lv~e~~~~-~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred EEecchhh-hHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 99999974 8999886543 499999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
......... ........++..|+|||.+.+. .++.++||||+|+++|+|++|+.||....... ....+......
T Consensus 151 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~ 225 (330)
T cd07834 151 RGVDPDEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLGT 225 (330)
T ss_pred Eeecccccc---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcCC
Confidence 865433210 0112234578899999999887 78999999999999999999999996543211 11111110000
Q ss_pred c----hhhhccHHHHHhhh----cchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH--HHHHHH
Q 004218 692 N----AQQVLDRELRQLMM----SSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR--LKNAQK 753 (767)
Q Consensus 692 ~----~~~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~~ 753 (767)
. ............+. .......+....+...+.+++.+||+.+|++|||+.+++++ ++....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0 00000000111100 00001111111122333447889999999999999999986 554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=315.66 Aligned_cols=204 Identities=20% Similarity=0.243 Sum_probs=157.4
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC--CcEEEEEEee-----------------ccCCcchhhHHHHHHHHhcCCCCCc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE--GISVAVKVLD-----------------IESTGTWKSFFAECEALRNTRHRNL 513 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~-----------------~~~~~~~~~~~~e~~~l~~l~h~ni 513 (767)
..++|++.+.||+|+||.||++..+. +..++.|.+. .........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987542 2222222110 0111234567899999999999999
Q ss_pred eeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 004218 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKP 593 (767)
Q Consensus 514 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 593 (767)
+++++++. .....++|+|++. +++.+++....... .......++..++.|++.||+|||++ +||||||||
T Consensus 226 v~l~~~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP 295 (501)
T PHA03210 226 LKIEEILR-----SEANTYMITQKYD-FDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL 295 (501)
T ss_pred CcEeEEEE-----ECCeeEEEEeccc-cCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 99999954 4456699999985 47887775433211 12244667889999999999999999 999999999
Q ss_pred CCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCC
Q 004218 594 GNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPT 671 (767)
Q Consensus 594 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 671 (767)
+||+++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKERE-----AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCcccc-----cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999976543211 1112356899999999999999999999999999999999988643
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=295.37 Aligned_cols=257 Identities=23% Similarity=0.278 Sum_probs=184.8
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.|...+.||+|+||.||++.+. +++.||+|.+.... ......+.+|+.++.++. ||||+++++++. .+...+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcEE
Confidence 4556678999999999999975 48999999986443 234567889999999996 999999999854 344568
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
++|||++. ++.++...... .....+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred EEEecccC-CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchh
Confidence 99999864 66554322100 0123489999999999999999999963 28999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCC---CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE---KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
........ .....|+..|+|||++.+. .++.++||||+|+++|+|++|+.||...........+......
T Consensus 156 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd06616 156 GQLVDSIA-------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP 228 (288)
T ss_pred HHhccCCc-------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCC
Confidence 76533211 1223478899999998776 6889999999999999999999998653210000111100000
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+..... ....... .+.+++.+||+.||++|||++|++++
T Consensus 229 ~~~~~~---------------~~~~~~~----~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILSNS---------------EEREFSP----SFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCc---------------CCCccCH----HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 0000111 12237779999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=297.67 Aligned_cols=212 Identities=26% Similarity=0.366 Sum_probs=169.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc--chhhHHHHHHHHhcCCCCCceeEEeeeecCCc---cc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG--TWKSFFAECEALRNTRHRNLVKLITSCSSLDF---KN 527 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 527 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|.+...... ....+.+|+++++.++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999976 4889999988644322 23467789999999999999999987654321 23
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
...+++||||+++ ++.+.+.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence 4568999999975 7777775432 2499999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCc-----cccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 608 DFGLARSLLERIGNQS-----SISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|||++........... .........++..|+|||.+.+. .++.++||||+|+++|||++|++||...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 9999986543322111 11112234578889999987654 5789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=287.14 Aligned_cols=250 Identities=25% Similarity=0.301 Sum_probs=195.2
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|++.+.||+|++|.||++... +++.+|+|.+.... ......+.+|+++++.++|+||+++++++. .+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 4788899999999999999865 58899999986542 234557789999999999999999998853 446789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++..... ....+++..++.++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKK--KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred EEehhcCCCCHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence 99999999999999876321 134589999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
....... .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... .....+.......
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~ 220 (256)
T cd08530 151 KVLKKNM--------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQRGKYPP 220 (256)
T ss_pred hhhccCC--------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcCCCCC
Confidence 8764431 12234788999999999888999999999999999999999998653211 1111111100000
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
... .....+.+++.+|++.+|++|||+.|++++
T Consensus 221 ~~~----------------------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 IPP----------------------IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred Cch----------------------hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 111123337779999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.72 Aligned_cols=275 Identities=20% Similarity=0.211 Sum_probs=186.9
Q ss_pred CCccccccceEEEEEEeCCCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEee
Q 004218 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEF 537 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 537 (767)
.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|+++++.++||||+++++++. .....+++|||
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~ 80 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPL 80 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEec
Confidence 34445555555555544 5899999998654 3345678999999999999999999999853 45567999999
Q ss_pred cCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhh
Q 004218 538 LGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE 617 (767)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 617 (767)
+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~~~~l~~~l~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~ 153 (314)
T cd08216 81 MAYGSCEDLLKTHF----PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK 153 (314)
T ss_pred cCCCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecc
Confidence 99999999997543 23488999999999999999999999 999999999999999999999999999875533
Q ss_pred hcCCC-ccccccccccCCCCccCccccCCC--CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchh
Q 004218 618 RIGNQ-SSISSTHVLKGSIGYIPPEYGLGE--KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 618 ~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
..... ..........++..|+|||++.+. .++.++||||+||++|||++|+.||........ .........+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 232 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLD 232 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccc
Confidence 21110 011111334577889999998763 578899999999999999999999975432211 11111111110000
Q ss_pred hhccHHHHHhh--------hc--chhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 695 QVLDRELRQLM--------MS--SESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 695 ~~~~~~l~~~~--------~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
....+...... .. ...........+...+.+++.+||..||++|||++|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 00000000000 00 00000111111223344477799999999999999998853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.63 Aligned_cols=347 Identities=27% Similarity=0.422 Sum_probs=309.9
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCccc-CCccCCCCCCCcE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGT-VPPGLGNLPFLKM 79 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~-~~~~~~~l~~L~~ 79 (767)
|++++.|.|...++. .+|.++. ++.+|++|.+++|++. .+-+.++.|+.|+.+++..|.+... +|..+..+..|+.
T Consensus 31 Mt~~~WLkLnrt~L~-~vPeEL~-~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~ 107 (1255)
T KOG0444|consen 31 MTQMTWLKLNRTKLE-QVPEELS-RLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTI 107 (1255)
T ss_pred hhheeEEEechhhhh-hChHHHH-HHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhccccccee
Confidence 688999999999998 9999997 5999999999999999 6778899999999999999999753 6888999999999
Q ss_pred EeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchh-hhhccccCeEEccCCcccccCCccccCCCCCCE
Q 004218 80 YNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESI-GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTL 158 (767)
Q Consensus 80 L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~ 158 (767)
|+||+|+++ ..|..+...+++-.|+||+|+|. .+|..+ .+++. |-.|||++|++. .+|..+..+..|++
T Consensus 108 lDLShNqL~-------EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtD-LLfLDLS~NrLe-~LPPQ~RRL~~Lqt 177 (1255)
T KOG0444|consen 108 LDLSHNQLR-------EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTD-LLFLDLSNNRLE-MLPPQIRRLSMLQT 177 (1255)
T ss_pred eecchhhhh-------hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHh-Hhhhccccchhh-hcCHHHHHHhhhhh
Confidence 999999998 56777888999999999999999 666655 47777 999999999998 67878999999999
Q ss_pred EECcCCcCcccCccccCCCCCCCEEEccCCccc-cccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcc
Q 004218 159 LNLSYNSISGEILTEIGQLQELQSLDLAGNQIS-GSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNK 237 (767)
Q Consensus 159 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~ 237 (767)
|+|++|.+.......+..+++|++|.+++.+-+ .-+|..+..+.+|..+++|.|.+. ..|+.+-.+++|+.|+||+|+
T Consensus 178 L~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ 256 (1255)
T KOG0444|consen 178 LKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNK 256 (1255)
T ss_pred hhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCc
Confidence 999999988655566667788999999998754 467889999999999999999997 789999999999999999999
Q ss_pred cCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCC-CCCcccccCcccceeeccCccccCCCC
Q 004218 238 LNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSG-NLPNSFKNCKSLEKLLMANNKFSGPIP 316 (767)
Q Consensus 238 l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~ 316 (767)
|+ ++.........+.+ |+++.|+++ .+|+.++.+++|+.|.+.+|++.- -+|+.++.+.+|+.+..++|.+. ..|
T Consensus 257 it-eL~~~~~~W~~lEt-LNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVP 332 (1255)
T KOG0444|consen 257 IT-ELNMTEGEWENLET-LNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVP 332 (1255)
T ss_pred ee-eeeccHHHHhhhhh-hccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCc
Confidence 99 55555555556634 499999999 899999999999999999999862 47899999999999999999998 999
Q ss_pred chhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCC
Q 004218 317 NILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE 366 (767)
Q Consensus 317 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 366 (767)
+.++.|..|+.|.|+.|++. ++|+.+.-++.|+.|++..|+=.-.||..
T Consensus 333 EglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP 381 (1255)
T KOG0444|consen 333 EGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKP 381 (1255)
T ss_pred hhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCc
Confidence 99999999999999999998 89999999999999999999877777765
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.76 Aligned_cols=201 Identities=29% Similarity=0.439 Sum_probs=167.2
Q ss_pred CCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
|++.+.||+|++|.||+|...+ ++.||+|.+.... ....+.+.+|+++++.++|||++++++++... .....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 6778899999999999999764 8899999997653 33456788999999999999999999997532 1367899
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++ +|.+++.... ..+++..++.++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+.
T Consensus 78 v~e~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 78 VFEYMDH-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred Eeccccc-cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence 9999975 8998886542 2489999999999999999999998 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 149 ~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 149 PYTKRNS-----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred eccCCCc-----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 6543321 01122346788999997765 45789999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=289.86 Aligned_cols=268 Identities=23% Similarity=0.269 Sum_probs=187.8
Q ss_pred CCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccceeeEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
|++.+.||+|+||.||+|... +++.||+|.++... ........+|+.+++++. |+|++++++++.+. ..+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 677889999999999999965 58899999986432 222334567899998885 99999999997532 2256799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||++ |++.+++.... ..+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.++
T Consensus 78 v~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 78 VFELMD-MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred EEecCC-ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence 999997 48888876532 2389999999999999999999999 9999999999999999 999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
....... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... .............
T Consensus 148 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~ 218 (282)
T cd07831 148 GIYSKPP-------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTP 218 (282)
T ss_pred ccccCCC-------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCC
Confidence 6533211 122347889999997644 55788999999999999999999999653221 1111111111111
Q ss_pred hhhhccHHHHHh------hhc-chhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQL------MMS-SESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~------~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... ....... ... ....-..........+.+++.+||+++|++|||++|++++
T Consensus 219 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 219 DAEV-LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CHHH-HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 0000000 000 0000000011122333447889999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.84 Aligned_cols=208 Identities=29% Similarity=0.389 Sum_probs=169.3
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCC----
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLD---- 524 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 524 (767)
+..++|++.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+++++.++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999976 48899999986543 223456778999999999999999999875432
Q ss_pred -cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 004218 525 -FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT 603 (767)
Q Consensus 525 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~ 603 (767)
..+...+++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence 1223478999999976 7777776432 2389999999999999999999999 9999999999999999999
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
+||+|||.+......... ......++..|+|||.+.+ ..++.++||||+||++|+|++|++||..
T Consensus 155 ~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 155 IKLADFGLARLYNSEESR-----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred EEeCcccccccccCCccc-----ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999765432211 1112235778999998765 3568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=293.68 Aligned_cols=248 Identities=26% Similarity=0.336 Sum_probs=188.1
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
..|+..+.||+|+||.||+|+.. +++.||+|.+... .....+++.+|+++++.++|+|++++++++.. ...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence 34777889999999999999975 4788999988643 22334578899999999999999999998643 456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+. |++.+++.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 160 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence 799999996 58888775432 2388999999999999999999998 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccC---CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL---GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
.+...... ....|+..|+|||.+. ...++.++||||+||++|+|++|+.||....... ........
T Consensus 161 ~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~ 229 (308)
T cd06634 161 SASIMAPA----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN 229 (308)
T ss_pred cceeecCc----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhc
Confidence 98654221 2345788999999874 3567889999999999999999999985432111 01111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
..+...... ....+.+++.+||+.+|++||++.+++++-.
T Consensus 230 ~~~~~~~~~----------------------~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 230 ESPALQSGH----------------------WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CCCCcCccc----------------------ccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 111100001 1112233777999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=289.72 Aligned_cols=269 Identities=24% Similarity=0.299 Sum_probs=195.4
Q ss_pred CCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
|++.+.||+|++|.||+|... +++.+|+|.+..... .....+.+|++++++++|+||+++++++. .+...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence 677889999999999999975 588999999864432 24567889999999999999999999854 4467799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++ ++.+++.... ..+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||.+.
T Consensus 76 v~e~~~~-~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred EEeccCC-CHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 9999975 8888886642 2389999999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc-
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK- 691 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~- 691 (767)
...... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+ .... .......
T Consensus 147 ~~~~~~------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~-~~~~~~~~ 218 (283)
T cd05118 147 SFGSPV------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFK-IFRTLGTP 218 (283)
T ss_pred ecCCCc------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHcCCC
Confidence 654332 011223477889999998776 68999999999999999999999986532211 1111 1111000
Q ss_pred ---chhhhc---cHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 ---NAQQVL---DRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ---~~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...... ...................+.+...+.+++.+||+.||.+||++.|++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 219 DPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred chHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 00000000000111112222334445558889999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=285.89 Aligned_cols=189 Identities=31% Similarity=0.448 Sum_probs=157.1
Q ss_pred CccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHH-hcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEAL-RNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|... +++.||+|++..... .....+..|..++ ...+|+|++++++++. .++..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 56899999999999975 488999999864321 1223344555444 4458999999999854 455779999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+...
T Consensus 77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 9999999999997543 389999999999999999999998 9999999999999999999999999998653
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
.. .....|+..|+|||.+.+..++.++||||+|+++|+|++|..||..
T Consensus 148 ~~----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 195 (260)
T cd05611 148 LE----------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195 (260)
T ss_pred cc----------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence 22 1234578899999999888889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=290.70 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=187.3
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|.+.+ ++.||||.+.... ......+.+|+.++.+. .||||+++++++. .+..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCe
Confidence 3678899999999999999999875 8999999986442 23345667788777666 5999999999964 4456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.++||||+++ ++.++..... ..+++..+..++.|++.|++|||+ . +|+||||+|+||++++++.+||+||
T Consensus 89 ~~~v~e~~~~-~l~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 89 VFICMELMST-CLDKLLKRIQ-----GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred EEEEeeccCc-CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECcc
Confidence 7999999854 7877765532 248999999999999999999997 5 8999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCC----CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK----PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 685 (767)
|.+........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.........+....
T Consensus 160 g~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 232 (296)
T cd06618 160 GISGRLVDSKA-------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232 (296)
T ss_pred ccchhccCCCc-------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh
Confidence 99876533211 11234678899999987554 78899999999999999999999864322111111111
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
....+.. ... ....+ .+.+++.+||+.||++||++.+++++-
T Consensus 233 ~~~~~~~-~~~----------------~~~~~----~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 233 QEEPPSL-PPN----------------EGFSP----DFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred cCCCCCC-CCC----------------CCCCH----HHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1111100 000 00011 122367789999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=245.66 Aligned_cols=198 Identities=27% Similarity=0.427 Sum_probs=167.5
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+|...++||+|.||+||+|+.+ +++.||+|.++.+ .++......+|+-+++.++|.|||+++++ ...+..+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCceeE
Confidence 5667789999999999999965 4889999998654 33456778999999999999999999998 56677889
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+|+|||.. +|..+...... .++.+.+..++.|+++|+.++|++ ++.|||+||.|.+|+.+|+.|++|||++
T Consensus 78 lvfe~cdq-dlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred EeHHHhhH-HHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence 99999965 99999877653 389999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCC-CCCcccchhhhHHHHHHHhCCCC-CCC
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLEIFTGMSP-THE 673 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p-~~~ 673 (767)
+.++-.. .......-|.+|++|.++.+.+ |++..|+||.||++.|+.....| |..
T Consensus 149 rafgipv------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 149 RAFGIPV------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred hhcCCce------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 8764322 2223345689999999998866 68899999999999999874444 543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=290.82 Aligned_cols=201 Identities=27% Similarity=0.385 Sum_probs=164.0
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|++|.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++. .+...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 57899999999999999999976 58899999885432 233456889999999999999999999954 45577
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEcccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE-DMTAKVGDFG 610 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg 610 (767)
++||||++ +++.+++.... ....++..+..++.|++.||+|||++ +++||||+|+||+++. ++.+||+|||
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSP----DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred EEEEeccc-ccHHHHHHhCC----CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 99999996 58888875433 22367888899999999999999998 9999999999999985 5679999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
.+........ ......++..|+|||++.+. .++.++||||+|+++|+|+||+.||...
T Consensus 149 ~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 149 LARAFGIPVR------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cccccCCCcc------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9975432211 11223467899999987664 5788999999999999999999999653
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=296.60 Aligned_cols=277 Identities=22% Similarity=0.265 Sum_probs=194.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-ccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF-KNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 529 (767)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+++++.++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999965 5899999988543 22234567899999999999999999998754321 2234
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++|+||+.. ++.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred eEEEEeccccc-CHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence 56899999964 7776652 1288999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+.... ..
T Consensus 162 g~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~-~~ 230 (342)
T cd07879 162 GLARHADAE---------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQIL-KV 230 (342)
T ss_pred CCCcCCCCC---------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-Hh
Confidence 998753221 123356888999998876 457899999999999999999999996532111 111111 10
Q ss_pred cccchhh---hcc-HHHHHhh---hcchh-hHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH--HHHHHH
Q 004218 689 FPKNAQQ---VLD-RELRQLM---MSSES-QTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR--LKNAQK 753 (767)
Q Consensus 689 ~~~~~~~---~~~-~~l~~~~---~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~~ 753 (767)
.+...+. ... ....... ..... ............+.+++.+||+.||++||+++|++.+ ++..++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000000 000 0000000 00000 0000000011122347789999999999999999966 766654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=289.79 Aligned_cols=244 Identities=26% Similarity=0.345 Sum_probs=185.6
Q ss_pred CCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 457 FSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
|...+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+++++.++|||++++++++. ++...+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence 566678999999999999965 488999999864322 23456889999999999999999999964 345679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+. |++.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+
T Consensus 98 lv~e~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred EEEecCC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence 9999996 58888876433 2389999999999999999999999 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccC---CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGL---GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
..... .....|+..|+|||++. ...++.++||||||+++|+|++|..||....... ..........
T Consensus 169 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~ 237 (313)
T cd06633 169 SKSSP----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNDS 237 (313)
T ss_pred cccCC----------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCC
Confidence 53211 12345788999999974 4567889999999999999999999985532111 0101111111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+...... ....+++++.+||+.+|.+||++.+++++
T Consensus 238 ~~~~~~~----------------------~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 PTLQSNE----------------------WTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCccc----------------------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100000 01112337778999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=293.89 Aligned_cols=201 Identities=27% Similarity=0.353 Sum_probs=167.7
Q ss_pred HHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 450 LRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 450 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
+...+++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+++++.++||||+++++++..
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---- 80 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS---- 80 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----
Confidence 3456789999999999999999999965 5899999987532 22345678899999999999999999998642
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
.....++||||+ +++|.+++.... +++..+..++.|+++||+|||+. +|+||||+|+||++++++.++|
T Consensus 81 ~~~~~~lv~e~~-~~~L~~~~~~~~-------~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l 149 (328)
T cd07856 81 PLEDIYFVTELL-GTDLHRLLTSRP-------LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKI 149 (328)
T ss_pred CCCcEEEEeehh-ccCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEe
Confidence 234678999998 568998886432 78888999999999999999999 9999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+|||.+...... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...
T Consensus 150 ~dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 150 CDFGLARIQDPQ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred CccccccccCCC---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998743221 122346788999998765 56899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.99 Aligned_cols=203 Identities=27% Similarity=0.374 Sum_probs=167.9
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-ccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKN 527 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~ 527 (767)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.... ...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678999999999999999999855 58999999985432 223456789999999999999999999875322 112
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
...+++||||+ +++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 23568999999 67999888643 289999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|||.+...... .....++..|+|||.+.+ ..++.++||||+|+++|++++|+.||...
T Consensus 161 dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 161 DFGLARQTDSE---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ecccccccccC---------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999754321 122356889999998876 45788999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=279.09 Aligned_cols=270 Identities=23% Similarity=0.309 Sum_probs=198.1
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCC-C-C----CceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTR-H-R----NLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~~~~~~~~~~~~ 526 (767)
+++|.++..+|+|.||.|-.+.++. +..||||+++.- ..-.+..+-|+++++++. + | -++.+.+| ++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence 7899999999999999999999765 789999998632 223355677999999993 2 2 25666666 56
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC------
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE------ 600 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~------ 600 (767)
..++.|||+|.+ |.|+++++.... -.+++...+..|++|+++++++||+. +++|-||||+||++.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~----y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENN----YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCC----ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 778899999988 569999998755 35589999999999999999999999 9999999999999831
Q ss_pred --------------CCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh
Q 004218 601 --------------DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666 (767)
Q Consensus 601 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 666 (767)
+..++++|||.|+...+.. ..++.|..|+|||++.+-+++.++||||+|||++|++|
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc---------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 3368999999998643321 44668999999999999999999999999999999999
Q ss_pred CCCCCCCcccC-CcchhhHhhhhcccchhhhc-cHH-----------------HHHhhhcc---hhhHHHHHHHHHHHHH
Q 004218 667 GMSPTHESFAG-EVSLVKWVESNFPKNAQQVL-DRE-----------------LRQLMMSS---ESQTIQLHDCLITIIE 724 (767)
Q Consensus 667 g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~-----------------l~~~~~~~---~~~~~~~~~~~~~~l~ 724 (767)
|...|+..... ...+.+.+-+.+|..+.... .+. .+...... ......-..+-.++++
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 99988764322 12334444444444322211 000 00000000 0001111122233444
Q ss_pred HHhccccCCCCCCCCCHHHHHHH
Q 004218 725 SVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 725 ~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
|+.+||.+||.+|+|+.|++.+
T Consensus 385 -Ll~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 385 -LLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred -HHHHHHccCccccccHHHHhcC
Confidence 8889999999999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=294.25 Aligned_cols=280 Identities=21% Similarity=0.268 Sum_probs=198.0
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCC
Q 004218 448 DELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLD 524 (767)
Q Consensus 448 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 524 (767)
.++....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 455667899999999999999999999864 58899999986432 223456788999999999999999999875332
Q ss_pred -cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 004218 525 -FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT 603 (767)
Q Consensus 525 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~ 603 (767)
+......+++++++ +++|.+++.... +++..+..++.|+++|++|||+. +|+||||||+||++++++.
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~-------l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQK-------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 22334568888887 779998886432 89999999999999999999999 9999999999999999999
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchh
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV 682 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 682 (767)
+||+|||+++..... .....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... ....
T Consensus 159 ~kl~dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~ 228 (345)
T cd07877 159 LKILDFGLARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLK 228 (345)
T ss_pred EEEeccccccccccc---------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 999999998754221 123457889999998766 46788999999999999999999998543211 1111
Q ss_pred hHhhh--hcccchh-hhccHHHHHhh---hcchhhH-HHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 683 KWVES--NFPKNAQ-QVLDRELRQLM---MSSESQT-IQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 683 ~~~~~--~~~~~~~-~~~~~~l~~~~---~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
..... ..+.... ...+....... ...+... ..........+.+++.+|++.||.+|||+.+++++=
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 229 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 11110 0111111 11111111110 0000000 000000112233478899999999999999998773
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=288.18 Aligned_cols=254 Identities=27% Similarity=0.375 Sum_probs=195.4
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccce
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 529 (767)
++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++++. ||||+++++++ ..+.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 46889999999999999999975 5899999998643 2233467889999999998 99999999984 4556
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence 7899999999999999997653 399999999999999999999998 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCc--------------cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcc
Q 004218 610 GLARSLLERIGNQS--------------SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675 (767)
Q Consensus 610 g~a~~~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 675 (767)
|.+........... .........++..|+|||......++.++||||+|++++++++|+.||....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99986644321100 0112234457889999999888889999999999999999999999986532
Q ss_pred cCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCH----HHHHHH
Q 004218 676 AGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDI----REALRR 747 (767)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~----~evl~~ 747 (767)
. ............ .....+ ...+.+++.+||+.+|++|||+ +|++++
T Consensus 227 ~-~~~~~~~~~~~~--~~~~~~----------------------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 227 E-YLTFQKILKLEY--SFPPNF----------------------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred H-HHHHHHHHhcCC--CCCCcc----------------------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1 000000000000 000001 1112237778999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=294.30 Aligned_cols=206 Identities=26% Similarity=0.330 Sum_probs=165.8
Q ss_pred CCCCCCccccccceEEEEEEeC-C--CcEEEEEEeecc--CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccce
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-E--GISVAVKVLDIE--STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 529 (767)
+|++.+.||+|+||.||++... + +..||+|.+... .....+.+.+|+++++++ +||||+++++.+... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 4788899999999999999965 3 678999988643 222346778899999999 599999999875432 12334
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++++||++ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence 5788999986 59999886533 389999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|.++........ .........|+..|+|||.+.+ ..++.++||||+|+++|+|++|++||...
T Consensus 150 g~a~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 150 GLARGFSENPGE--NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred CCceeccccccc--ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 999865432211 1111233468999999998765 46789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=294.40 Aligned_cols=206 Identities=24% Similarity=0.354 Sum_probs=164.3
Q ss_pred hcCCCC-CCccccccceEEEEEEeC-CCcEEEEEEeeccCCcc--------------hhhHHHHHHHHhcCCCCCceeEE
Q 004218 454 TGNFSH-ENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGT--------------WKSFFAECEALRNTRHRNLVKLI 517 (767)
Q Consensus 454 ~~~~~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~ 517 (767)
.++|.. .+.||+|+||.||+|.+. +++.||+|.+....... ...+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356654 577999999999999965 58999999985432211 12477899999999999999999
Q ss_pred eeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 004218 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNIL 597 (767)
Q Consensus 518 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl 597 (767)
+++. .+...++||||++ |+|.+++.... .+++..+..++.|++.||+|||+. +|+||||+|+||+
T Consensus 87 ~~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nil 151 (335)
T PTZ00024 87 DVYV-----EGDFINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIF 151 (335)
T ss_pred EEEe-----cCCcEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeE
Confidence 9854 4457799999997 59999986533 389999999999999999999998 9999999999999
Q ss_pred eCCCCceEEccccchhhhhhhcCCC--------ccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCC
Q 004218 598 LDEDMTAKVGDFGLARSLLERIGNQ--------SSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGM 668 (767)
Q Consensus 598 ~~~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~ 668 (767)
++.++.++|+|||.+.......... ..........++..|+|||.+.+. .++.++||||+|+++|+|++|+
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999997654211000 001111223467889999998764 4688999999999999999999
Q ss_pred CCCCCc
Q 004218 669 SPTHES 674 (767)
Q Consensus 669 ~p~~~~ 674 (767)
.||...
T Consensus 232 ~p~~~~ 237 (335)
T PTZ00024 232 PLFPGE 237 (335)
T ss_pred CCCCCC
Confidence 998654
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=285.60 Aligned_cols=198 Identities=31% Similarity=0.456 Sum_probs=165.3
Q ss_pred cccccceEEEEEEeCC-CcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeec
Q 004218 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 463 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
||+|+||.||++.+.. |+.||+|++..... ...+.+.+|++++++++||||+++++.+ ..+...++||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999875 89999999865432 3456788999999999999999999874 4556779999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhh
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 618 (767)
++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 76 PGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 9999999997643 389999999999999999999998 9999999999999999999999999998754322
Q ss_pred cCCC--ccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 619 IGNQ--SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 619 ~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
.... ..........++..|+|||...+...+.++||||+|+++|++++|+.||...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 1100 0011223345788999999998888899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=286.34 Aligned_cols=199 Identities=28% Similarity=0.365 Sum_probs=165.5
Q ss_pred CCCCCCccccccceEEEEEEeC----CCcEEEEEEeeccC----CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcc
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIES----TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 526 (767)
+|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++++++ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4788899999999999999863 58899999986432 22345678899999999 599999999884 3
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
.+...++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 146 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 146 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence 4567799999999999999987543 388999999999999999999998 9999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCC--CCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE--KPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
+|||++........ .......|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||..
T Consensus 147 ~dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 147 TDFGLSKEFHEDEV-----ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred eeCccceecccccc-----cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 99999976533211 111234588899999998753 467899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.73 Aligned_cols=269 Identities=25% Similarity=0.346 Sum_probs=213.4
Q ss_pred CCccCHHHHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEee
Q 004218 442 PQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITS 519 (767)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 519 (767)
...+.++.+...++.|.+.+.||+|.+|.||+++.. +++.+|+|+.....+. .+++..|.++++.. .|||++.++|+
T Consensus 6 ~~~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~ 84 (953)
T KOG0587|consen 6 LMDIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGA 84 (953)
T ss_pred ccccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEE
Confidence 345566677777889999999999999999999954 5899999998755433 35677888899887 69999999999
Q ss_pred eecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 004218 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD 599 (767)
Q Consensus 520 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~ 599 (767)
+...+-..++.+|+|||||.+||.-|++.... +..+.|..+..|++.++.|+.|||.+ .++|||||-.||+++
T Consensus 85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT 157 (953)
T KOG0587|consen 85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLT 157 (953)
T ss_pred EEEecCCCCCeEEEEeeccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEe
Confidence 98777777889999999999999999998766 45699999999999999999999999 999999999999999
Q ss_pred CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-----CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 600 EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-----KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 600 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
.++.+||+|||.+..+... .....+..||+.|||||++... .|+..+|+||+|++..||.-|.+|+.+.
T Consensus 158 ~e~~VKLvDFGvSaQldsT------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 158 ENAEVKLVDFGVSAQLDST------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred ccCcEEEeeeeeeeeeecc------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 9999999999999876543 2334567899999999998643 4677899999999999999999998664
Q ss_pred ccCCcchhhHhhhhcccch-hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 675 FAGEVSLVKWVESNFPKNA-QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+... .- ..|..+ +....+ +...+-+.++|..|+.+|-.+||++.+++++
T Consensus 232 HPmra-----LF-~IpRNPPPkLkrp-----------------~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 232 HPMRA-----LF-LIPRNPPPKLKRP-----------------KKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred chhhh-----hc-cCCCCCCccccch-----------------hhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 33211 00 111111 111111 1111222337778999999999999998764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=296.87 Aligned_cols=273 Identities=23% Similarity=0.301 Sum_probs=195.1
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-ccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF-KNM 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~ 528 (767)
..++|++.+.||+|++|.||+|.+. +++.||+|++... .....+.+.+|+.++++++|||++++.+++...+. ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999976 4889999988543 22334667889999999999999999987543222 223
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++|+||+ +++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence 3579999998 56999998753 389999999999999999999998 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
||.+...... .....++..|+|||.+.+ ..++.++||||+|+++|++++|+.||....... ...... .
T Consensus 162 fg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~-~ 230 (343)
T cd07851 162 FGLARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIM-N 230 (343)
T ss_pred cccccccccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH-H
Confidence 9999764321 123357888999998765 367889999999999999999999996532211 111111 0
Q ss_pred hcccc----hhhhccHHHHHhhhcchh----hHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 NFPKN----AQQVLDRELRQLMMSSES----QTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~~~~~----~~~~~~~~l~~~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+.. ............+...+. ............+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 01000 011111111111110000 0001111112334458889999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=286.70 Aligned_cols=255 Identities=25% Similarity=0.285 Sum_probs=189.8
Q ss_pred CCCCCCccccccceEEEEEEeC----CCcEEEEEEeeccC----CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcc
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIES----TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 526 (767)
+|++.+.||+|++|.||+++.. +++.||||++.... ....+.+.+|+++++++ +||||+++++.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4788899999999999999853 47889999986432 22345678999999999 599999999884 4
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
.+...++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l 146 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL 146 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 5567799999999999999986533 388999999999999999999998 9999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC--CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhH
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK--PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 684 (767)
+|||++......... ......|+..|+|||...+.. .+.++||||+|+++|+|++|..||....... .....
T Consensus 147 ~dfg~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~ 220 (288)
T cd05583 147 TDFGLSKEFLAEEEE-----RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEI 220 (288)
T ss_pred EECcccccccccccc-----ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHH
Confidence 999998765332111 112345788999999987655 6889999999999999999999985321110 00000
Q ss_pred hhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 685 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
... .......... .+...+.+++.+||+.||++|||+.++.+.|+.
T Consensus 221 ~~~----------------~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 221 SRR----------------ILKSKPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHH----------------HHccCCCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 000 0000000000 011122336778999999999998877666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=271.23 Aligned_cols=274 Identities=23% Similarity=0.324 Sum_probs=211.8
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEEEeCC------CcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEee
Q 004218 447 YDELRRATGNFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITS 519 (767)
Q Consensus 447 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 519 (767)
.+++.....+++....+.+|.||.||.|.|++ .+.|-+|.++.. ++-....++.|.-.+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 35666667788888899999999999997763 345667766432 33345668889989999999999999999
Q ss_pred eecCCcccceeeEEEEeecCCCChhhhhcccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 004218 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNE--HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNIL 597 (767)
Q Consensus 520 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl 597 (767)
+.. +....++++.++.-|+|..|+...+..+ ..+.++..+...++.|++.|++|||++ +|||.||.++|.+
T Consensus 356 ~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCv 428 (563)
T KOG1024|consen 356 SIE----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCV 428 (563)
T ss_pred Eee----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcce
Confidence 853 4556689999999999999998555332 234577888899999999999999999 9999999999999
Q ss_pred eCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCccc
Q 004218 598 LDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFA 676 (767)
Q Consensus 598 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~ 676 (767)
||+..++||+|=.+++.+.+......... ......|||||.+....|+.++||||||+++|||+| |+.|+.+..+
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDn----EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP 504 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDN----ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP 504 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCC----CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence 99999999999999998876554433322 224577999999999999999999999999999998 8999866433
Q ss_pred CCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 677 GEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
.+ +..+.+..++- .+...|..+++. ++..||..+|++||+.+|++.-|.+.....
T Consensus 505 fE--m~~ylkdGyRl---------------------aQP~NCPDeLf~-vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 505 FE--MEHYLKDGYRL---------------------AQPFNCPDELFT-VMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred HH--HHHHHhcccee---------------------cCCCCCcHHHHH-HHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 22 22222222221 122233344444 777899999999999999999998876544
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=285.25 Aligned_cols=195 Identities=33% Similarity=0.464 Sum_probs=167.8
Q ss_pred CCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEe
Q 004218 460 ENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
.++||+|.||+||-|+++ +|+.||||++++. .++...++.+|+.||+++.||.||.+.-. ++..+.+++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence 578999999999999976 5999999999754 34456788999999999999999999887 456678899999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC---CceEEccccchh
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED---MTAKVGDFGLAR 613 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~a~ 613 (767)
-+.| +..+++-... ..++++.....++.||+.||.|||.+ +|||+||||+|||+.+. -++||||||+|+
T Consensus 644 Kl~G-DMLEMILSsE----kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 644 KLHG-DMLEMILSSE----KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred hhcc-hHHHHHHHhh----cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 9955 6666554433 23499999999999999999999999 99999999999999754 479999999999
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
++++.. ....++||+.|+|||++..+.|...-|+||.|+|+|.-++|..||.+.
T Consensus 716 iIgEks-------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 716 IIGEKS-------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred ecchhh-------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 987642 235678999999999999999999999999999999999999999654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=310.56 Aligned_cols=209 Identities=27% Similarity=0.343 Sum_probs=181.2
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeec---cCCcchhhHHHHHHHHhcCCCCCceeEEeeeec
Q 004218 447 YDELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDI---ESTGTWKSFFAECEALRNTRHRNLVKLITSCSS 522 (767)
Q Consensus 447 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 522 (767)
..+++-....|.++++||+|+||.|..++.+. ++.||+|++.+ -.......|..|-.+|...+.+-|+.++.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA--- 143 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA--- 143 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH---
Confidence 34566667789999999999999999999764 88999999865 234556778899999999999999999877
Q ss_pred CCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 004218 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM 602 (767)
Q Consensus 523 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~ 602 (767)
|.+..++|+|||||+||+|-.++.... ++++.-+..++..|..||.-+|+. |+|||||||+|||+|..|
T Consensus 144 --FQD~~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 144 --FQDERYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred --hcCccceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccC
Confidence 778899999999999999999998765 399999999999999999999999 999999999999999999
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccC----C-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL----G-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
++||+|||.+-.+..+.. ......+|||-|.|||++. + +.|++.+|+||+||++|||+.|..||+..
T Consensus 213 HikLADFGsClkm~~dG~-----V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDADGT-----VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred cEeeccchhHHhcCCCCc-----EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 999999999987754322 1224567999999999875 2 56899999999999999999999999653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=308.58 Aligned_cols=263 Identities=27% Similarity=0.444 Sum_probs=204.8
Q ss_pred hcCCCCCCccccccceEEEEEEeCC--------CcEEEEEEeecc-CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecC
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE--------GISVAVKVLDIE-STGTWKSFFAECEALRNT-RHRNLVKLITSCSSL 523 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 523 (767)
..+..+.+.+|+|.||.||+|.... ...||||..+.. .....+.+..|+++|+.+ +|+||+.++|+|..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 3444566799999999999998431 456999998644 334567899999999999 59999999999864
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccC---------CCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGER---------KNEHG-NGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKP 593 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 593 (767)
.+..++|+||++.|+|.++++..+ ..... ..++..+.+.++.|||.|++||++. ++||||+.+
T Consensus 374 ----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 374 ----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred ----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 566799999999999999999877 11111 2499999999999999999999999 999999999
Q ss_pred CCeeeCCCCceEEccccchhhhhhhcCCCccccccccccC--CCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCC
Q 004218 594 GNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG--SIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670 (767)
Q Consensus 594 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p 670 (767)
+||+++++..+||+|||+|+...+....... ...| ...|||||.+....|+.++||||||+++||++| |..|
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-----~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTK-----SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP 521 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEec-----CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence 9999999999999999999865443222111 1111 345999999999999999999999999999999 7788
Q ss_pred CCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 671 THESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
|... .....+.++.+.......+..+.+.+.. ++..||+.+|++||++.|+.+.++.
T Consensus 522 Yp~~-~~~~~l~~~l~~G~r~~~P~~c~~eiY~----------------------iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 522 YPGI-PPTEELLEFLKEGNRMEQPEHCSDEIYD----------------------LMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred CCCC-CcHHHHHHHHhcCCCCCCCCCCCHHHHH----------------------HHHHHhCCCcccCCCHHHHHHHHHH
Confidence 8652 2122234445444444444444444433 5667999999999999999999998
Q ss_pred HH
Q 004218 751 AQ 752 (767)
Q Consensus 751 ~~ 752 (767)
..
T Consensus 579 ~l 580 (609)
T KOG0200|consen 579 HL 580 (609)
T ss_pred HH
Confidence 53
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=283.36 Aligned_cols=198 Identities=28% Similarity=0.379 Sum_probs=163.8
Q ss_pred CCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCC-cchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccceeeEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIEST-GTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
|++.+.||+|++|.||+|...+ ++.||+|.+..... .......+|+..+++++ |||++++++++. .+...++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence 6778999999999999999764 78999999864322 22334567999999998 999999999854 3567799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+ +|+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.+.
T Consensus 76 v~e~~-~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred EEecC-CCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 99999 779999887643 23489999999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
....... .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus 148 ~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 148 EIRSRPP-------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred eccCCCC-------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 5533211 122357889999998754 45789999999999999999999998554
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=280.33 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=186.3
Q ss_pred CCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc-----CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE-----STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
+|.+.+.||+|+||.||++.+.. +..+++|+.+.. ......++..|+.+++.++||||+++++++. +..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 58889999999999999999754 455666665321 1223345678999999999999999999853 345
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++...... ...+++.+++.++.|++.|++|||+. +++|+||+|+||++++ +.++|+||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence 679999999999999988653221 34589999999999999999999998 9999999999999975 56999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|.+........ ......|+..|+|||...+..++.++|+||+|+++|+|++|..||..... ...........
T Consensus 150 g~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~ 221 (260)
T cd08222 150 GVSRLLMGSCD------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSVVLRIVEGP 221 (260)
T ss_pred CceeecCCCcc------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHcCC
Confidence 99876533211 11234578899999998888889999999999999999999999854211 00101100000
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..... +.....+.+++.+||+.||++||++.|++++
T Consensus 222 ~~~~~----------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 TPSLP----------------------ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCc----------------------chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00000 0111122337778999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=278.77 Aligned_cols=212 Identities=29% Similarity=0.413 Sum_probs=175.5
Q ss_pred HhcCCCCCCccccccceEEEEEEe-CCCcEEEEEEeecc-C------CcchhhHHHHHHHHhcCCCCCceeEEeeeecCC
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIE-S------TGTWKSFFAECEALRNTRHRNLVKLITSCSSLD 524 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 524 (767)
..++|-..++||+|||+.||+|.+ ...+.||||+-... + ..-.+...+|.+|.+.+.||.||++|+++.-
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl-- 538 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL-- 538 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee--
Confidence 345788888999999999999995 45889999986422 1 1123456789999999999999999999752
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CC
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD---ED 601 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~ 601 (767)
+...+|-|+|||+|.+|+-|+...+. +++.++..|+.||+.||.||.+. .++|||-||||.|||+- .-
T Consensus 539 --DtdsFCTVLEYceGNDLDFYLKQhkl------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gtac 609 (775)
T KOG1151|consen 539 --DTDSFCTVLEYCEGNDLDFYLKQHKL------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTAC 609 (775)
T ss_pred --ccccceeeeeecCCCchhHHHHhhhh------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccc
Confidence 34567999999999999999987664 99999999999999999999997 67999999999999995 34
Q ss_pred CceEEccccchhhhhhhcCC-CccccccccccCCCCccCccccCC----CCCCCcccchhhhHHHHHHHhCCCCCCCcc
Q 004218 602 MTAKVGDFGLARSLLERIGN-QSSISSTHVLKGSIGYIPPEYGLG----EKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 675 (767)
|.+||+|||+++.+.+.... ......+...+||.+|++||.+.- .+++.++||||.|||+|.++.|+.||....
T Consensus 610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 78999999999998766544 333344566789999999997653 346889999999999999999999997643
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=280.73 Aligned_cols=198 Identities=30% Similarity=0.436 Sum_probs=166.5
Q ss_pred CCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
|+..+.||+|++|.||+|+... ++.||+|++.... ....+.+.+|+++++.++|+|++++++++. .....++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 5677889999999999999764 8999999987543 334567788999999999999999999854 3467799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.+.
T Consensus 76 v~e~~~-~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred EecCcC-cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 999997 59999997652 2389999999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
....... ......++..|+|||.+.+. .++.++||||+|+++||+++|+.||...
T Consensus 147 ~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 147 AFGIPLR------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred ccCCCcc------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 6533211 11223357789999998766 7899999999999999999999998553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=275.42 Aligned_cols=192 Identities=35% Similarity=0.440 Sum_probs=164.6
Q ss_pred cccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeec
Q 004218 463 IGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 463 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
||+|+||.||++... +++.||+|++..... .....+..|++++++++|||++++++.+ ..+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 689999999999976 488999999865432 2455788999999999999999999884 4566789999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhh
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 618 (767)
++++|.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 76 PGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 9999999997653 389999999999999999999998 9999999999999999999999999999765332
Q ss_pred cCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 619 IGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 619 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
. .......++..|+|||...+...+.++|+||||+++|++++|+.||...
T Consensus 147 ~------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 147 G------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred C------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 1 1123445788999999998888899999999999999999999999553
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.70 Aligned_cols=242 Identities=25% Similarity=0.309 Sum_probs=190.1
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCccccee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.+..|.....+|.|+|+.|-.+... +++..++|++.... .+..+|+.++... .||||+++.+. +.++.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDV-----YEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecce-----ecCCce
Confidence 3567888888999999999999865 58889999996542 2334677666655 79999999999 456778
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee-CCCCceEEccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL-DEDMTAKVGDF 609 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~-~~~~~~kl~Df 609 (767)
.|+|||.+.|+-+.+.+...+ ....++..|+.+|+.|+.|||++ ||||||+||+|||+ ++.++++|+||
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred eeeeehhccccHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEe
Confidence 899999999998888887654 33377888999999999999999 99999999999999 68999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|.++..... ....+-|..|.|||++....+++++||||||+++|+|++|+.||.....+ ..
T Consensus 461 G~a~~~~~~---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~e--------- 521 (612)
T KOG0603|consen 461 GFWSELERS---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IE--------- 521 (612)
T ss_pred chhhhCchh---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HH---------
Confidence 999876543 12234578899999999999999999999999999999999999765433 11
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
+...+.. ....+.+....++++..||+.||.+||+|.|+..+=
T Consensus 522 -----------i~~~i~~-----~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 522 -----------IHTRIQM-----PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred -----------HHHhhcC-----CccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 1111111 001133344445577789999999999999997653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-34 Score=267.97 Aligned_cols=254 Identities=24% Similarity=0.288 Sum_probs=187.3
Q ss_pred CCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhc-CCCCCceeEEeeeecCCcccceeeEEEEe
Q 004218 460 ENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRN-TRHRNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
...||.|+||+|++..++ .|+..|||+++.... ...++++.|.+...+ -+.||||+++|+++. .+..|+.||
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcWiCME 143 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCWICME 143 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCceeeeHH
Confidence 357999999999999976 499999999976544 556788888886544 479999999999743 344689999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhh
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL 616 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 616 (767)
.|.- |++.+...-. ......+++.-.-.|+.....||.||.+. ..|+|||+||+|||++..|.+||||||.+..+.
T Consensus 144 LMd~-SlDklYk~vy-~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVY-SVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHhh-hHHHHHHHHH-HHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 9954 7766543211 11134488888889999999999999875 489999999999999999999999999998775
Q ss_pred hhcCCCccccccccccCCCCccCccccCC--CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchh
Q 004218 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLG--EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 617 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
+.... +..+|...|||||.+.. ..|+-++||||+|+++||+.||+.||.....-..++...+.+..|.-..
T Consensus 220 ~SiAk-------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 220 DSIAK-------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred HHHHh-------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 54322 34468889999998864 3478899999999999999999999866433333333333333332111
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. ........+.. ++--|+.+|-+.||...++.++
T Consensus 293 ~~--------------~~~~~s~~~~~----fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DK--------------ECVHYSFSMVR----FINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cc--------------cccccCHHHHH----HHHHHhhcccccCcchhhhhcC
Confidence 10 00111111222 5557999999999999998764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=309.95 Aligned_cols=145 Identities=31% Similarity=0.424 Sum_probs=127.9
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.++||||+++++++ ....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence 67999999999999999999976 58999999986432 22346788899999999999999999884 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFG 149 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFG 149 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCC
Confidence 899999999999999997543 288899999999999999999998 99999999999999999999999999
Q ss_pred chh
Q 004218 611 LAR 613 (767)
Q Consensus 611 ~a~ 613 (767)
+++
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=302.08 Aligned_cols=274 Identities=21% Similarity=0.213 Sum_probs=168.3
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC-----CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecC-Ccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE-----GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSL-DFK 526 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~ 526 (767)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.+..... .+....| .++...+.++..++..+... ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999753 68999998753221 1111111 12222233333322221111 113
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKN--------------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLK 592 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 592 (767)
.+...++||||+++++|.+++...... ..........+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 456789999999999999998754210 0001122345678999999999999999 99999999
Q ss_pred CCCeeeCC-CCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC----------------------CCC
Q 004218 593 PGNILLDE-DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE----------------------KPS 649 (767)
Q Consensus 593 p~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 649 (767)
|+|||++. ++.+||+|||+|+....... .......+++.|+|||.+... .++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-----~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-----cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 99999985 58999999999976532211 112345689999999965322 234
Q ss_pred CcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcch----hhHHHHHHHHHHHHHH
Q 004218 650 TAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSE----SQTIQLHDCLITIIES 725 (767)
Q Consensus 650 ~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~ 725 (767)
.++||||+||++|||+++..|++.... .+....... .... ..+........ ....+..+.......+
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~---~~~~~l~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~d 428 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLI---QFNRQLKRN-DYDL-----VAWRKLVEPRASPDLRRGFEVLDLDGGAGWE 428 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHH---HHHHHHHhc-CCcH-----HHHHHhhccccchhhhhhhhhccccchHHHH
Confidence 467999999999999998776543211 111111000 0000 00000000000 0000111111111223
Q ss_pred HhccccCCCCCCCCCHHHHHHH
Q 004218 726 VGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 726 l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
++.+|++.||++|||++|++++
T Consensus 429 Li~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 429 LLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHccCCcccCCCHHHHhCC
Confidence 7779999999999999999986
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-33 Score=269.65 Aligned_cols=203 Identities=27% Similarity=0.373 Sum_probs=173.1
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 528 (767)
...|..+.+||+|+||.|.+|.-+. .+.+|||+++++ ..++.+.-+.|-++|... +-|.++++..+ +...
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhh
Confidence 4578889999999999999998664 678999998755 233445556777777766 57788888877 5677
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
+.+|+||||+.||+|--.+++.++ +.+..+..+|..||-||-+||++ ||+.||||.+||+++.+|++||+|
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~Gk------FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGK------FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcc------cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeee
Confidence 788999999999999998887664 77888999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
||+++.- ......+.+++||+.|+|||++...+|+.++|+||||+++|||+.|++||+....
T Consensus 494 FGmcKEn------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 494 FGMCKEN------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred ccccccc------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9999742 2223345678999999999999999999999999999999999999999987543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=269.60 Aligned_cols=180 Identities=24% Similarity=0.201 Sum_probs=150.1
Q ss_pred ccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeecCCCChh
Q 004218 466 GSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLG 544 (767)
Q Consensus 466 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 544 (767)
|.+|.||++.+. +++.||+|.+.... .+.+|...+....|||++++++++. .....++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHH
Confidence 899999999975 58899999986432 2234555555667999999999853 456779999999999999
Q ss_pred hhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCcc
Q 004218 545 DWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624 (767)
Q Consensus 545 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 624 (767)
+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+.......
T Consensus 74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----- 139 (237)
T cd05576 74 SHISKFL------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----- 139 (237)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----
Confidence 9986543 289999999999999999999998 99999999999999999999999999886543211
Q ss_pred ccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 625 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
....++..|+|||...+..++.++||||+|+++|||++|+.|+..
T Consensus 140 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 140 ----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 122356779999999888899999999999999999999988743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-33 Score=280.13 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=176.8
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCc-EEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGI-SVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
..+++++..||-|+||.|-++..+... .+|+|++++. .+...+.+..|-++|...+.|.||++|-. +.+..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccch
Confidence 345666778999999999999976433 4888887543 45566778899999999999999999987 67888
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
++|+.||-|-||.++..++..+. ++..++..++..+++|++|||++ +||.|||||+|.+++.+|-+||.||
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~------Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGS------FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCC------cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeeh
Confidence 99999999999999999987654 88889999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|+|+.+... ..+.+++||+.|.|||++.....+.++|.||+|+++||+++|.+||...
T Consensus 565 GFAKki~~g-------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 565 GFAKKIGSG-------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred hhHHHhccC-------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 999987543 4467889999999999999999999999999999999999999999663
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=244.68 Aligned_cols=222 Identities=23% Similarity=0.303 Sum_probs=175.7
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 528 (767)
...+.......||+|++|.|-+.++. +|+..|+|.+...- ....++.++|+.+..+. .+|.+|.++|.. .+.
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~re 117 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FRE 117 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hcc
Confidence 33344555678999999999988864 59999999997553 34456778888876554 799999999974 455
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..+++.||.|.. ||+.+-..--. .+..+++.-.-+|+..+.+||.|||++ ..++|||+||+|||++.+|++|+||
T Consensus 118 gdvwIcME~M~t-Sldkfy~~v~~--~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 118 GDVWICMELMDT-SLDKFYRKVLK--KGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccEEEeHHHhhh-hHHHHHHHHHh--cCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcc
Confidence 678999999965 88877654322 245699999999999999999999997 4899999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCC----CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhH
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG----EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 684 (767)
||.+-.+.+.... +...|...|||||.+.. ..|+-++||||+|+++.||.+++.||+.......++.+.
T Consensus 193 FGIsG~L~dSiAk-------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 193 FGISGYLVDSIAK-------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred cccceeehhhhHH-------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 9999877554322 22457889999998753 368899999999999999999999998876666666555
Q ss_pred hhhhcc
Q 004218 685 VESNFP 690 (767)
Q Consensus 685 ~~~~~~ 690 (767)
++...|
T Consensus 266 Veep~P 271 (282)
T KOG0984|consen 266 VEEPSP 271 (282)
T ss_pred hcCCCC
Confidence 554433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=292.44 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=186.6
Q ss_pred CCccccccce-EEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeEEEEee
Q 004218 460 ENLIGSGSFG-SVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLALVYEF 537 (767)
Q Consensus 460 ~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 537 (767)
.+.+|.|+.| .||+|... |+.||||++- .+....+.+|+..++.- +|||||++++. ..+..+.||+.|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalEL 584 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALEL 584 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEehH
Confidence 4568899987 57999997 8899999884 23345677999999988 69999999987 6677888999999
Q ss_pred cCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---C--CceEEccccch
Q 004218 538 LGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE---D--MTAKVGDFGLA 612 (767)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~--~~~kl~Dfg~a 612 (767)
|.. +|.+++...... .........+.+..|+++||+|||+. +||||||||.||||+. + .+++|+|||++
T Consensus 585 C~~-sL~dlie~~~~d--~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLD--VEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred hhh-hHHHHHhccccc--hhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 966 999999875211 11112145678899999999999998 9999999999999975 2 57999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhC-CCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG-MSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+.+.... .+........||-+|+|||++....-+.++||||+||++|+.++| ..||.+....+.++..-......
T Consensus 659 Kkl~~~~---sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~- 734 (903)
T KOG1027|consen 659 KKLAGGK---SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVH- 734 (903)
T ss_pred cccCCCc---chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceee-
Confidence 9876543 223335667899999999999998889999999999999999986 89998765544333221110000
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+ ...++ ..+++|.+|++++|..||+|.+|+.+
T Consensus 735 --L~------------------~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 --LE------------------PLPDC---EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred --ec------------------cCchH---HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 00 00011 23348889999999999999998753
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-35 Score=283.56 Aligned_cols=354 Identities=32% Similarity=0.481 Sum_probs=246.9
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
|..|++++|.+. ++|.+++. +-.|..|+..+|++. .+|+.+.++.+|..|++.+|+++ ..|+..-+++.|++|+..
T Consensus 116 l~~l~~s~n~~~-el~~~i~~-~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~ 191 (565)
T KOG0472|consen 116 LVKLDCSSNELK-ELPDSIGR-LLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCN 191 (565)
T ss_pred hhhhhcccccee-ecCchHHH-Hhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccc
Confidence 444455555554 45544443 444455555555554 34444455555555555555554 222222225555555555
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCcc-ccCCCCCCEEECc
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTS-IGRLRSLTLLNLS 162 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~-l~~l~~L~~L~l~ 162 (767)
.|-+. .+|..++.+.+|.-|+|..|++. .+| .|..+.. |.+|+++.|+|+ .+|.. ..++++|.+|||+
T Consensus 192 ~N~L~-------tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~-L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLR 260 (565)
T KOG0472|consen 192 SNLLE-------TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSL-LKELHVGENQIE-MLPAEHLKHLNSLLVLDLR 260 (565)
T ss_pred hhhhh-------cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHH-HHHHHhcccHHH-hhHHHHhcccccceeeecc
Confidence 55554 45566777788888888888887 666 6667766 888888888887 44444 4478888888888
Q ss_pred CCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCC--------------------------
Q 004218 163 YNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELAS-------------------------- 216 (767)
Q Consensus 163 ~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-------------------------- 216 (767)
+|+++ +.|+.+..+.+|+.||+++|.|+ .+|..++++ .|+.|.+.+|++..
T Consensus 261 dNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dgl 337 (565)
T KOG0472|consen 261 DNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGL 337 (565)
T ss_pred ccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCC
Confidence 88888 67788888888888888888888 567777887 78888888887520
Q ss_pred ----------------------------------------------------------------CCcccccCcccc-ccc
Q 004218 217 ----------------------------------------------------------------EIPTSFGNFQNL-LSI 231 (767)
Q Consensus 217 ----------------------------------------------------------------~~~~~~~~l~~L-~~L 231 (767)
..|..+..+..+ +.+
T Consensus 338 S~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l 417 (565)
T KOG0472|consen 338 SQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDL 417 (565)
T ss_pred CCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHH
Confidence 011111111222 234
Q ss_pred cccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccc
Q 004218 232 DLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKF 311 (767)
Q Consensus 232 ~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l 311 (767)
.+++|.++ .+|..+..++++ ..++|++|.+. .+|..++.+..|+.|++|.|++. ..|..+-.+..|+.+-.++|++
T Consensus 418 ~lsnn~is-fv~~~l~~l~kL-t~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi 493 (565)
T KOG0472|consen 418 VLSNNKIS-FVPLELSQLQKL-TFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQI 493 (565)
T ss_pred HhhcCccc-cchHHHHhhhcc-eeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccc
Confidence 55666666 899999999999 55599999998 78899999999999999999998 7888888888888888888999
Q ss_pred cCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCccc-cccccccccCCc
Q 004218 312 SGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIF-RHTSMVHLEGNP 381 (767)
Q Consensus 312 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~~~~~~~l~~Np 381 (767)
....+..+..+.+|..|||.+|.+. .+|..+++|.+|++|.++||++. .|+....+ ++...+.+.+++
T Consensus 494 ~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylrdr 562 (565)
T KOG0472|consen 494 GSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAILSYLRDR 562 (565)
T ss_pred cccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHHHHhccChHHHHHHhccc
Confidence 9777888999999999999999998 88999999999999999999999 44443222 223334444443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=251.21 Aligned_cols=200 Identities=28% Similarity=0.384 Sum_probs=174.6
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 528 (767)
...|...++||+|+|+.|-.+++. +.+.||+|+++++ ..++....+.|-.+..+. +||.+|.+..+ +...
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence 457889999999999999999965 5888999999765 344556677788888776 79999999887 5667
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..+++|.||++||+|--++++.++ ++++.+..+...|..||.|||++ ||+.||+|.+||++|..|++||+|
T Consensus 324 srlffvieyv~ggdlmfhmqrqrk------lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRK------LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhc------CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecc
Confidence 788999999999999877776554 99999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
+|+++.-. .....+.+++||+.|.|||++.+..|+..+|+|++|++++||+.|+.||+.
T Consensus 395 ygmcke~l------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 395 YGMCKEGL------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred cchhhcCC------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 99997532 223345678999999999999999999999999999999999999999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=279.16 Aligned_cols=212 Identities=22% Similarity=0.296 Sum_probs=154.8
Q ss_pred HhcCCCCCCccccccceEEEEEEe-----------------CCCcEEEEEEeeccCCcchhh--------------HHHH
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYL-----------------REGISVAVKVLDIESTGTWKS--------------FFAE 501 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e 501 (767)
..++|++.++||+|+||.||+|.. ..++.||||.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235689999986543322223 3346
Q ss_pred HHHHhcCCCCC-----ceeEEeeeecCC---cccceeeEEEEeecCCCChhhhhcccCCC------------------CC
Q 004218 502 CEALRNTRHRN-----LVKLITSCSSLD---FKNMEFLALVYEFLGNGSLGDWIHGERKN------------------EH 555 (767)
Q Consensus 502 ~~~l~~l~h~n-----iv~~~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~ 555 (767)
+.++.+++|.+ +++++++|.... ....+..++||||+++++|.++++..... ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 66777776554 467777765321 11234579999999999999998753210 01
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCC
Q 004218 556 GNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635 (767)
Q Consensus 556 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~ 635 (767)
...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......... ......+|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-----~~~~g~~tp 374 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-----NPLYGMLDP 374 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-----CccccCCCc
Confidence 12357788999999999999999998 9999999999999999999999999999754322110 111223478
Q ss_pred CccCccccCCCCC----------------------CCcccchhhhHHHHHHHhCCC-CCC
Q 004218 636 GYIPPEYGLGEKP----------------------STAGDVYSFGVMLLEIFTGMS-PTH 672 (767)
Q Consensus 636 ~y~aPE~~~~~~~----------------------~~~~Dv~slG~il~el~tg~~-p~~ 672 (767)
.|+|||.+..... ..+.||||+||++|+|++|.. |+.
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 9999998754321 124799999999999999885 654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=258.94 Aligned_cols=136 Identities=28% Similarity=0.442 Sum_probs=115.5
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCC-----C---CCceeEEeeeecCC
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTR-----H---RNLVKLITSCSSLD 524 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~~~ 524 (767)
.++|.+.++||-|-|++||+|.+.. .+.||+|+.+.. ..-.+..+.||++|++++ | ..||++++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs- 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS- 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-
Confidence 3789999999999999999999764 788999998632 233456788999999883 2 4699999987654
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
-+++.++|+|+|+. |-+|..+|..... ++++...+.+|++|++.||.|||..| ||||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~Y----rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNY----RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCC----CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 36788999999999 5699999987653 45999999999999999999999986 99999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=259.19 Aligned_cols=238 Identities=34% Similarity=0.425 Sum_probs=184.8
Q ss_pred cceEEEEEEeCC-CcEEEEEEeeccCCcc-hhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeecCCCChh
Q 004218 467 SFGSVYKGYLRE-GISVAVKVLDIESTGT-WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLG 544 (767)
Q Consensus 467 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 544 (767)
+||.||+|...+ ++.||+|++....... .+.+.+|++.+++++|+|++++++++.. +...++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 589999999874 8999999997654444 6789999999999999999999998643 35679999999999999
Q ss_pred hhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCcc
Q 004218 545 DWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624 (767)
Q Consensus 545 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 624 (767)
+++..... +++..++.++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 76 ~~~~~~~~------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----- 141 (244)
T smart00220 76 DLLKKRGR------LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----- 141 (244)
T ss_pred HHHHhccC------CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence 99876432 88999999999999999999999 99999999999999999999999999998654321
Q ss_pred ccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHh
Q 004218 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQL 704 (767)
Q Consensus 625 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 704 (767)
......++..|+|||...+..++.++||||+|+++|++++|..||...... ....+.............
T Consensus 142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-------- 210 (244)
T smart00220 142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPKPPFPPPE-------- 210 (244)
T ss_pred --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCCcccc--------
Confidence 123345788999999998888899999999999999999999998653111 111111111111000000
Q ss_pred hhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 705 MMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
..+...+.+++.+|+..+|++||++.++++
T Consensus 211 ------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 211 ------------WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ------------ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 000111222777899999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=268.41 Aligned_cols=212 Identities=25% Similarity=0.324 Sum_probs=175.4
Q ss_pred cCCCCCCccccccceEEEEEEe-CCCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.-|..++.||-|+||.|.++.- .+...||+|.+++. ..........|-+||...+.+-||++|.. |.+.+.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence 4567778899999999999984 34778999988644 23445567789999999999999999987 667788
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+||||++||++-.++.+.+- +.+.-+..++..+..|+++.|+. |+|||||||+|||||.+|++||+|||
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgI------FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGI------FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhcc------CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence 9999999999999999877653 88888899999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCC-------C-----------------------------ccccccccccCCCCccCccccCCCCCCCcccc
Q 004218 611 LARSLLERIGN-------Q-----------------------------SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDV 654 (767)
Q Consensus 611 ~a~~~~~~~~~-------~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 654 (767)
++.-+...... + ......+..+||..|+|||++....++..+|+
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 98643211100 0 00011134679999999999999999999999
Q ss_pred hhhhHHHHHHHhCCCCCCCcccCCcc
Q 004218 655 YSFGVMLLEIFTGMSPTHESFAGEVS 680 (767)
Q Consensus 655 ~slG~il~el~tg~~p~~~~~~~~~~ 680 (767)
||.|||+|||+.|++||....+.+.+
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCCcce
Confidence 99999999999999999887666543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=239.79 Aligned_cols=265 Identities=20% Similarity=0.262 Sum_probs=196.0
Q ss_pred hcCCCCCCccccccceEEEEEE-eCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.+.|++.+++|+|.++.||.|. ..+.++++||+++. ...+.+.+|+.+++.+. ||||+++++...++ .....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccCc
Confidence 4678999999999999999999 45688999999863 34577889999999996 99999999987643 34456
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEcccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED-MTAKVGDFG 610 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg 610 (767)
.+|+||+.+.+...+... ++..++..++.+++.||.|+|+. ||+|||+||.|++||.. -..+|+|+|
T Consensus 111 aLiFE~v~n~Dfk~ly~t---------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPT---------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred hhHhhhhccccHHHHhhh---------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecc
Confidence 899999999888877643 77888999999999999999999 99999999999999954 579999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
+|.++.+.... .....+..|.-||.+..- .|+..-|+|||||++..|+..+.||........++++.++.--
T Consensus 179 LAEFYHp~~eY-------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG 251 (338)
T KOG0668|consen 179 LAEFYHPGKEY-------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG 251 (338)
T ss_pred hHhhcCCCcee-------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence 99887554322 334467778999987754 4788999999999999999999998665544445544433211
Q ss_pred ccc-------hhhhccHHHHHhhhcch----------hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKN-------AQQVLDRELRQLMMSSE----------SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~-------~~~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+ ..-.+++.+..++.... ....-..++..+ ++.+.|.+|..+||||+|++++
T Consensus 252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiD----lldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAID----LLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHH----HHHHHHhhccccccchHHHhcC
Confidence 110 01112222222211110 001111122333 4557888999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=264.45 Aligned_cols=199 Identities=25% Similarity=0.370 Sum_probs=170.7
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC--------CcchhhHHHHHHHHhcCC---CCCceeEEeee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES--------TGTWKSFFAECEALRNTR---HRNLVKLITSC 520 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~ 520 (767)
....|+..+.+|.|+||.|++|.++. ...|+||.+.++. ....-.+-.|++||..++ |+||++++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf- 637 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF- 637 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe-
Confidence 34568999999999999999999875 5679999885431 111223557999999997 9999999999
Q ss_pred ecCCcccceeeEEEEeec-CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 004218 521 SSLDFKNMEFLALVYEFL-GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD 599 (767)
Q Consensus 521 ~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~ 599 (767)
|++++++|++||-. +|.+|.+++..... +++.++..|++|++.|+++||++ ||||||||-+||.++
T Consensus 638 ----FEddd~yyl~te~hg~gIDLFd~IE~kp~------m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd 704 (772)
T KOG1152|consen 638 ----FEDDDYYYLETEVHGEGIDLFDFIEFKPR------MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVD 704 (772)
T ss_pred ----eecCCeeEEEecCCCCCcchhhhhhccCc------cchHHHHHHHHHHHhcccccccc---CceecccccccEEEe
Confidence 67888899999975 56799999987654 99999999999999999999999 999999999999999
Q ss_pred CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCC
Q 004218 600 EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 600 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
.+|.+||+|||.|..... .+...++||..|.|||++.+.+| +..-||||+|+++|.++...-||..
T Consensus 705 ~~g~~klidfgsaa~~ks--------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYTKS--------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cCCeEEEeeccchhhhcC--------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999976432 33467889999999999999988 7789999999999999999988753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-31 Score=246.96 Aligned_cols=203 Identities=27% Similarity=0.363 Sum_probs=165.2
Q ss_pred CCCCCccccccceEEEEEEe-CCCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 457 FSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.+..+.||-|+||.||.+.+ ++|+.||+|.+... +-...+++.+|++++..++|.|++..++.........-..+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 44568899999999999996 46999999988533 3345678999999999999999999988754333333345688
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
++|.|.. +|..++-.-. .++...+.-+.+||++||.|||+. +|.||||||.|.+++++-..||||||+++
T Consensus 135 ~TELmQS-DLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHh-hhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence 9999854 8888876533 388899999999999999999999 99999999999999999999999999998
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
....+.... ++...-|..|+|||++.+. .|+.+.||||.||++.|++..+..|+..
T Consensus 205 vee~d~~~h-----MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 205 TWDQRDRLN-----MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred ccchhhhhh-----hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 765432221 1223457889999998875 5899999999999999999988887653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=241.08 Aligned_cols=270 Identities=24% Similarity=0.307 Sum_probs=196.0
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-cccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 529 (767)
..+|.-.+.+|.|.- .|-.|.+. .+++||+|..... ....+++..+|...+..+.|+||++++.++.-.. .....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457778888999988 56666543 4889999987432 4455778899999999999999999999875433 22334
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+|+|||+|.. +|.+.+... ++-.++..|..|++.|++|||+. ||+||||||+||++..+..+||.||
T Consensus 95 e~y~v~e~m~~-nl~~vi~~e--------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILME--------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHHh--------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccc
Confidence 67999999965 999988732 67788999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|+|+..+.. -..+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|. +...+.+|.+..-
T Consensus 163 g~ar~e~~~-------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~ 231 (369)
T KOG0665|consen 163 GLARTEDTD-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIE 231 (369)
T ss_pred hhhcccCcc-------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHH
Confidence 999864332 12345668899999999999889999999999999999999998874 3333333332110
Q ss_pred ----c-cchhhhccHHHHHhhhcchhh-HH---------------HHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 ----P-KNAQQVLDRELRQLMMSSESQ-TI---------------QLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ----~-~~~~~~~~~~l~~~~~~~~~~-~~---------------~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
| ....+.+.+..+......+.. .. +-...-...+++++.+||..||++|.++++++++
T Consensus 232 ~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 232 QLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 001111111111111000000 00 0001123455668889999999999999999986
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=255.19 Aligned_cols=210 Identities=26% Similarity=0.296 Sum_probs=173.3
Q ss_pred ccCHHHHHHHhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCC------CCCceeE
Q 004218 444 MISYDELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTR------HRNLVKL 516 (767)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~ 516 (767)
.+++.--+...++|.+....|+|-|++|..|.+.. |..||||++.. +....+.=++|+++|+++. --|++++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 34444445567899999999999999999999765 88999999963 3334556678999999994 3467777
Q ss_pred EeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 004218 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNI 596 (767)
Q Consensus 517 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 596 (767)
+.. |...+++|+|+|-+. .+|.+++...+. ..++....+..++.|++.||..|... +|+|.||||+||
T Consensus 500 ~r~-----F~hknHLClVFE~Ls-lNLRevLKKyG~---nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNi 567 (752)
T KOG0670|consen 500 FRH-----FKHKNHLCLVFEPLS-LNLREVLKKYGR---NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNI 567 (752)
T ss_pred HHH-----hhhcceeEEEehhhh-chHHHHHHHhCc---ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccce
Confidence 776 667789999999884 499999988765 45688999999999999999999998 999999999999
Q ss_pred eeCCC-CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 597 LLDED-MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 597 l~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
||++. ..+||||||.|....+.. .+.+..+..|.|||++.|-+|+...|+||.||++||+.||+..|...
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~ene--------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENE--------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred EeccCcceeeeccCcccccccccc--------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 99865 568999999997654431 12233466799999999999999999999999999999999888654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=249.02 Aligned_cols=279 Identities=26% Similarity=0.308 Sum_probs=201.5
Q ss_pred HHHHhcCCCCCCccccccceEEEEEEeC----CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCC
Q 004218 450 LRRATGNFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLD 524 (767)
Q Consensus 450 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 524 (767)
+....+.|..+++||.|.|++||++.+. .++.||+|.+...+ ...++.+|+++|..+ .+.||+++.++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~----- 103 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGC----- 103 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhh-----
Confidence 4445678999999999999999999854 36789999986443 346788999999999 59999999998
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCc
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD-EDMT 603 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~ 603 (767)
+..++.+.+|+||++..+..++... ++..++..+++.++.||+++|+. |||||||||.|++.+ ..++
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCC
Confidence 6777888999999999999998865 77889999999999999999999 999999999999998 4578
Q ss_pred eEEccccchhhhhhhcC-----C---------------------------------CccccccccccCCCCccCccccCC
Q 004218 604 AKVGDFGLARSLLERIG-----N---------------------------------QSSISSTHVLKGSIGYIPPEYGLG 645 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~-----~---------------------------------~~~~~~~~~~~gt~~y~aPE~~~~ 645 (767)
-.|+|||+|...+.... . ..........+||++|+|||++..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 89999999983322110 0 000011123569999999999876
Q ss_pred CC-CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh----------cccc--hhh--h--ccHHHHHhh---
Q 004218 646 EK-PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN----------FPKN--AQQ--V--LDRELRQLM--- 705 (767)
Q Consensus 646 ~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~----------~~~~--~~~--~--~~~~l~~~~--- 705 (767)
.+ .++++||||.|+|+..+++++.||.....+...+.+.+.-. .+.. ..+ - ...+++..+
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~ 331 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL 331 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence 54 58899999999999999999999976554443333322110 0000 000 0 001111100
Q ss_pred -----hcchh---hHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 706 -----MSSES---QTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 706 -----~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+. ......+....++-++..+|++.||.+|.||+|++++
T Consensus 332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 01011 1222333344344458889999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=264.69 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=199.2
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
...|....++|+|.+|.||+|++. +++..|+|+++.+...+.+-++.|+-+++..+||||+.+++.+ ......|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcCcE
Confidence 357888999999999999999965 5999999999988888889999999999999999999999985 3455679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+.||||.+|+|++.-+.... +++.++..+++..++|++|||+. |-+|||||-.||++++.|.+|+.|||.+
T Consensus 89 icMEycgggslQdiy~~Tgp------lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGP------LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred EEEEecCCCcccceeeeccc------chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence 99999999999998876553 99999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCcccc---CCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh-hh
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYG---LGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE-SN 688 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~~ 688 (767)
..+..... ....+.||+.|||||+. ..+.|...+|||+.|++..|+-.-++|..+..+. +....+. ..
T Consensus 160 aqitati~------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l~LmTkS~ 231 (829)
T KOG0576|consen 160 AQITATIA------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RALFLMTKSG 231 (829)
T ss_pred hhhhhhhh------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHHHHhhccC
Confidence 87755432 33457799999999975 3567899999999999999998888885332111 1111111 11
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
+.... +++ .......+..++..|+..+|++|||+..++.
T Consensus 232 ~qpp~-------lkD------------k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 FQPPT-------LKD------------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCc-------ccC------------CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11100 000 0011222333666899999999999987765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=232.39 Aligned_cols=208 Identities=21% Similarity=0.349 Sum_probs=167.5
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.+.|++.+.+|+|.||.+-++.++. .+.+|+|.++..- ...++|.+|...--.+ .|.||+.-|++. |...+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence 4679999999999999999999875 7789999886432 3457888888765555 589999988874 5666788
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CCCceEEccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD--EDMTAKVGDF 609 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~~~kl~Df 609 (767)
.+++||++.|+|.+-+...+ +.+....+++.|+++|+.|||+. .+||||||.+||||- +..++|+|||
T Consensus 98 vF~qE~aP~gdL~snv~~~G-------igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG-------IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred EEeeccCccchhhhhcCccc-------ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence 99999999999998886543 88889999999999999999999 999999999999994 4458999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCC-----CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhH
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-----KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 684 (767)
|.++..+... ....-+..|.|||..... ...+.+|||.||+++|.++||+.||+..+..+.....|
T Consensus 168 G~t~k~g~tV---------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~ 238 (378)
T KOG1345|consen 168 GLTRKVGTTV---------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW 238 (378)
T ss_pred ccccccCcee---------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH
Confidence 9997654322 122245679999975432 24778999999999999999999998766665555544
Q ss_pred h
Q 004218 685 V 685 (767)
Q Consensus 685 ~ 685 (767)
.
T Consensus 239 ~ 239 (378)
T KOG1345|consen 239 E 239 (378)
T ss_pred H
Confidence 3
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-30 Score=280.11 Aligned_cols=366 Identities=26% Similarity=0.348 Sum_probs=276.7
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
|+.||||+|++. ..|..+.. +.+|+.|+++.|.|. .+|.+.+++.+|++|.|.+|.+. ..|..+..+.+|++|+++
T Consensus 47 L~~l~lsnn~~~-~fp~~it~-l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITL-LSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eEEeeccccccc-cCCchhhh-HHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 889999999998 89999874 899999999999999 78889999999999999999998 889999999999999999
Q ss_pred CccccCCCCCCcc-------------ccccccCCCCCCEEECcCCcceeecCchhhhhcc------------------cc
Q 004218 84 FNKIVGSGDEGLS-------------FITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSN------------------VL 132 (767)
Q Consensus 84 ~n~l~~~~~~~~~-------------~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~------------------~L 132 (767)
+|++...|.-... ....++. ...+.+++..|.+.+.++..+..+.. .|
T Consensus 123 ~N~f~~~Pl~i~~lt~~~~~~~s~N~~~~~lg~-~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dls~~~~l 201 (1081)
T KOG0618|consen 123 FNHFGPIPLVIEVLTAEEELAASNNEKIQRLGQ-TSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDLSNLANL 201 (1081)
T ss_pred hhccCCCchhHHhhhHHHHHhhhcchhhhhhcc-ccchhhhhhhhhcccchhcchhhhheeeecccchhhhhhhhhccch
Confidence 9988655421100 0000111 11333444444433333333332221 03
Q ss_pred CeEEccCCcc--------------------cccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCcccc
Q 004218 133 SKLYMGGNRF--------------------YGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISG 192 (767)
Q Consensus 133 ~~L~l~~n~i--------------------~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~ 192 (767)
+.|.+..|++ ....+. ..-.+|++++++.|+++ .+|+++..+.+|+.|++.+|++.
T Consensus 202 ~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~- 277 (1081)
T KOG0618|consen 202 EVLHCERNQLSELEISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV- 277 (1081)
T ss_pred hhhhhhhcccceEEecCcchheeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-
Confidence 3333333332 211111 12357888888888888 56688999999999999999997
Q ss_pred ccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccc--------------------
Q 004218 193 SIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSL-------------------- 252 (767)
Q Consensus 193 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l-------------------- 252 (767)
.+|..+..+++|+.|.+..|.++ -+|.....++.|++|+|..|+|. ..|..+......
T Consensus 278 ~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e 355 (1081)
T KOG0618|consen 278 ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEE 355 (1081)
T ss_pred hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccc
Confidence 77888888899999999999997 46667778899999999999988 455433222111
Q ss_pred -----cceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceE
Q 004218 253 -----TTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEV 327 (767)
Q Consensus 253 -----~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 327 (767)
...+.+.+|.++...-..+-++++|+.|+|++|+|.......+.+++.|++|+||+|+++ .+|..+..+..|++
T Consensus 356 ~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~t 434 (1081)
T KOG0618|consen 356 NNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHT 434 (1081)
T ss_pred hhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHH
Confidence 133578888888777778889999999999999999777788899999999999999999 77899999999999
Q ss_pred EEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCC-ccccccccccccCCcCc
Q 004218 328 LDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE-GIFRHTSMVHLEGNPKL 383 (767)
Q Consensus 328 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~~~l~~Np~~ 383 (767)
|...+|++. ..| .+..++.|+.+|++.|+|+...-.. ...+++..+.+.||+|.
T Consensus 435 L~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 435 LRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred HhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 999999998 777 7889999999999999999764333 33478899999999974
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=230.37 Aligned_cols=210 Identities=33% Similarity=0.531 Sum_probs=175.5
Q ss_pred cccccceEEEEEEeCC-CcEEEEEEeeccCCc-chhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeecCC
Q 004218 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGN 540 (767)
Q Consensus 463 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 540 (767)
||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++.. ....++++||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence 6899999999999765 899999998754332 35678999999999999999999999543 3567999999999
Q ss_pred CChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEccccchhhhhhhc
Q 004218 541 GSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE-DMTAKVGDFGLARSLLERI 619 (767)
Q Consensus 541 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~a~~~~~~~ 619 (767)
++|.+++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 76 ~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 76 GSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 99999997642 2389999999999999999999999 9999999999999999 8999999999997653321
Q ss_pred CCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhhcc
Q 004218 620 GNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLD 698 (767)
Q Consensus 620 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (767)
. ......+...|++||..... ..+.++|+|++|++++++
T Consensus 148 ~------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------- 187 (215)
T cd00180 148 S------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------- 187 (215)
T ss_pred c------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence 1 12234477889999998877 788999999999999999
Q ss_pred HHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 699 RELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 699 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. .+.+++..|++.+|++||++.++++.
T Consensus 188 ~----------------------~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 P----------------------ELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred H----------------------HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 0 01126668999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=228.97 Aligned_cols=199 Identities=37% Similarity=0.498 Sum_probs=169.5
Q ss_pred CCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCc-chhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
|++.+.||.|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.++.++|+|++++++++. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 5677899999999999999875 889999999765544 5678899999999999999999999854 33567999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
+||+++++|.+++...... +++..+..++.+++.++.+||+. +++|+|++|.||+++.++.++|+|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred EeccCCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 9999999999999764321 78899999999999999999999 999999999999999999999999999976
Q ss_pred hhhhcCCCccccccccccCCCCccCcccc-CCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYG-LGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
...... .......++..|++||.. ....++.++|||++|+++++|++|+.||..
T Consensus 148 ~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDLA-----ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCccc-----ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 643320 012334577889999998 666778899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-29 Score=266.22 Aligned_cols=354 Identities=26% Similarity=0.361 Sum_probs=219.0
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
+..|++++|-+. ..|-++.++-.+|+.|++++|.+. ..|..+..+.+|+.|+++.|.|. ..|....++.+|++|+|.
T Consensus 23 ~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 23 LQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 567888888887 777776666667999999999999 78989999999999999999998 788899999999999999
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCC-------------------cccc
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGN-------------------RFYG 144 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n-------------------~i~~ 144 (767)
.|.+. ..|.++..+.+|++|+++.|++. .+|..+..++. ++++..++| .+.+
T Consensus 100 ~n~l~-------~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~-~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~ 170 (1081)
T KOG0618|consen 100 NNRLQ-------SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTA-EEELAASNNEKIQRLGQTSIKKLDLRLNVLGG 170 (1081)
T ss_pred cchhh-------cCchhHHhhhcccccccchhccC-CCchhHHhhhH-HHHHhhhcchhhhhhccccchhhhhhhhhccc
Confidence 99987 55777899999999999999998 78887777765 555555555 3333
Q ss_pred cCCccccCCCCCCEEECcCCcCcccCccccCCCC--------------------CCCEEEccCCccccccCcCcccCCCC
Q 004218 145 KIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQ--------------------ELQSLDLAGNQISGSIPNTLGNLKKL 204 (767)
Q Consensus 145 ~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~--------------------~L~~L~L~~n~i~~~~~~~~~~l~~L 204 (767)
.++..+..++. .|+|++|.+... .+..+. +|+.|+.++|.+....+ .+ .-.+|
T Consensus 171 ~~~~~i~~l~~--~ldLr~N~~~~~---dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~-~p-~p~nl 243 (1081)
T KOG0618|consen 171 SFLIDIYNLTH--QLDLRYNEMEVL---DLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDV-HP-VPLNL 243 (1081)
T ss_pred chhcchhhhhe--eeecccchhhhh---hhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeecc-cc-ccccc
Confidence 33333433333 477777766621 122222 23333334443331111 11 11456
Q ss_pred ceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccC
Q 004218 205 NQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSA 284 (767)
Q Consensus 205 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~ 284 (767)
+++++++|+++. .|++++.+.+|+.|+..+|++. .+|..+...++|..+ ....|.+. .+|....+++.|+.|+|..
T Consensus 244 ~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l-~~~~nel~-yip~~le~~~sL~tLdL~~ 319 (1081)
T KOG0618|consen 244 QYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSL-SAAYNELE-YIPPFLEGLKSLRTLDLQS 319 (1081)
T ss_pred eeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHH-Hhhhhhhh-hCCCcccccceeeeeeehh
Confidence 777777777763 4567777777777777777775 566666666666333 56666665 4455555566666666666
Q ss_pred CCCCCCCCccc-------------------------ccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCC
Q 004218 285 NGLSGNLPNSF-------------------------KNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSI 339 (767)
Q Consensus 285 n~l~~~~~~~~-------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 339 (767)
|+|....+..+ ..++.|+.|++.+|.+++.....+.++++|+.|+|++|++....
T Consensus 320 N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fp 399 (1081)
T KOG0618|consen 320 NNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFP 399 (1081)
T ss_pred ccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCC
Confidence 65542221111 11223445555555555444444555555555555555554333
Q ss_pred CccccccccCceEeccCCcCcCcCCCCccccccccccccCC
Q 004218 340 PSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGN 380 (767)
Q Consensus 340 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N 380 (767)
...+.++..|+.|+||||+|+..+.....++.+.++...+|
T Consensus 400 as~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN 440 (1081)
T KOG0618|consen 400 ASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSN 440 (1081)
T ss_pred HHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCC
Confidence 33344555555555555555544433333333333433333
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-24 Score=258.74 Aligned_cols=322 Identities=23% Similarity=0.279 Sum_probs=134.5
Q ss_pred CCccccCCCCCcEEEccCCc------ccccCCccccCCC-CCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCC
Q 004218 19 PYDVGDKLPNLLGFNFCFNK------FTGKIPGSLHNLT-NIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSG 91 (767)
Q Consensus 19 p~~~~~~l~~L~~L~l~~n~------l~~~~~~~l~~l~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 91 (767)
....|.++++|+.|.+..+. +...+|+.|..++ +|+.|++.++.+. .+|..+ ...+|+.|+|++|++.
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~--- 624 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE--- 624 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc---
Confidence 33344445555555443332 1122344344332 3555555555444 444433 2344555555555443
Q ss_pred CCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCc
Q 004218 92 DEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEIL 171 (767)
Q Consensus 92 ~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~ 171 (767)
.++..+..+++|+.|+|++|.....+|. ++.+++ |++|+|++|.....+|..+.++++|+.|++++|..-+.+|
T Consensus 625 ----~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~-Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp 698 (1153)
T PLN03210 625 ----KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATN-LETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILP 698 (1153)
T ss_pred ----ccccccccCCCCCEEECCCCCCcCcCCc-cccCCc-ccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccC
Confidence 2223334444555555554433223332 344444 5555555444333444445555555555555443222333
Q ss_pred cccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccC-------CCCCh
Q 004218 172 TEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN-------GNIPK 244 (767)
Q Consensus 172 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~-------~~~~~ 244 (767)
..+ ++++|+.|++++|.....+|.. .++|+.|+|++|.+. ..|..+ .+++|+.|++.++... ...+.
T Consensus 699 ~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~ 772 (1153)
T PLN03210 699 TGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPL 772 (1153)
T ss_pred CcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchh
Confidence 322 4445555555554333233321 234445555555543 233322 3444444444432211 00011
Q ss_pred hhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCC
Q 004218 245 EILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKG 324 (767)
Q Consensus 245 ~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 324 (767)
.+...++| +.|++++|.....+|..++++++|+.|+|++|...+.+|..+ .+++|+.|++++|.....+|.. ..+
T Consensus 773 ~~~~~~sL-~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~n 847 (1153)
T PLN03210 773 MTMLSPSL-TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STN 847 (1153)
T ss_pred hhhccccc-hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccc
Confidence 11111222 222444444444444445555555555555443222333333 3445555555554332233321 134
Q ss_pred ceEEEcCCcccCCCCCccccccccCceEeccC-CcCcCcC
Q 004218 325 LEVLDLSSNKLSGSIPSDLQNLRALRSLNLTF-NNLEGVV 363 (767)
Q Consensus 325 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~ 363 (767)
|+.|+|++|.+. .+|..+..+++|+.|++++ |++++++
T Consensus 848 L~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~ 886 (1153)
T PLN03210 848 ISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVS 886 (1153)
T ss_pred cCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccC
Confidence 455555555554 3444444555555555544 3344333
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-24 Score=256.10 Aligned_cols=335 Identities=21% Similarity=0.260 Sum_probs=269.2
Q ss_pred CCCccEEeCCCCe------eeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCC
Q 004218 1 MTSLVYLGLASNQ------LWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNL 74 (767)
Q Consensus 1 l~~L~~L~l~~n~------l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l 74 (767)
|++|+.|.+..+. +...+|..+..-..+|+.|++.++.+. .+|..| ...+|+.|+|++|.+. .++..+..+
T Consensus 557 m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l 633 (1153)
T PLN03210 557 MRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSL 633 (1153)
T ss_pred CccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccC
Confidence 5778888886653 333577765542346999999999998 788877 5799999999999998 788889999
Q ss_pred CCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCC
Q 004218 75 PFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLR 154 (767)
Q Consensus 75 ~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~ 154 (767)
++|+.|+|++|... ...+.+..+++|++|+|++|.....+|..+..+.+ |+.|++++|.....+|..+ +++
T Consensus 634 ~~Lk~L~Ls~~~~l-------~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~-L~~L~L~~c~~L~~Lp~~i-~l~ 704 (1153)
T PLN03210 634 TGLRNIDLRGSKNL-------KEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNK-LEDLDMSRCENLEILPTGI-NLK 704 (1153)
T ss_pred CCCCEEECCCCCCc-------CcCCccccCCcccEEEecCCCCccccchhhhccCC-CCEEeCCCCCCcCccCCcC-CCC
Confidence 99999999987532 22235788999999999999877799999999998 9999999986555777765 789
Q ss_pred CCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCC-------CCCcccccCccc
Q 004218 155 SLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELA-------SEIPTSFGNFQN 227 (767)
Q Consensus 155 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-------~~~~~~~~~l~~ 227 (767)
+|+.|++++|......|.. ..+|++|+|++|.+. .+|..+ .+++|++|++.++... ...+..+...++
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~s 779 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPS 779 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhcccc
Confidence 9999999999765455532 468999999999998 667655 5789999999875432 112223334579
Q ss_pred cccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeecc
Q 004218 228 LLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMA 307 (767)
Q Consensus 228 L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~ 307 (767)
|+.|+|++|...+.+|..+.++++|.. |++++|...+.+|..+ .+++|+.|++++|......|.. .++|+.|+|+
T Consensus 780 L~~L~Ls~n~~l~~lP~si~~L~~L~~-L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls 854 (1153)
T PLN03210 780 LTRLFLSDIPSLVELPSSIQNLHKLEH-LEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLS 854 (1153)
T ss_pred chheeCCCCCCccccChhhhCCCCCCE-EECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECC
Confidence 999999999888889999999999954 4999986655777766 7899999999998655455543 3689999999
Q ss_pred CccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCc
Q 004218 308 NNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNN 358 (767)
Q Consensus 308 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 358 (767)
+|.++ .+|..+..+++|+.|+|++|.-...+|..+..+++|+.+++++|.
T Consensus 855 ~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 855 RTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 99998 688899999999999999965444688888999999999999885
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=207.98 Aligned_cols=172 Identities=21% Similarity=0.182 Sum_probs=124.1
Q ss_pred CChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcC
Q 004218 541 GSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIG 620 (767)
Q Consensus 541 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 620 (767)
|||.+++.... ..+++.+++.|+.|++.||+|||++ + ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~-- 62 (176)
T smart00750 1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE-- 62 (176)
T ss_pred CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc--
Confidence 68999997532 3499999999999999999999998 5 999999999999999 9998754321
Q ss_pred CCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhhccHH
Q 004218 621 NQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRE 700 (767)
Q Consensus 621 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (767)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..................+.....
T Consensus 63 ---------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 128 (176)
T smart00750 63 ---------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD----- 128 (176)
T ss_pred ---------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc-----
Confidence 124789999999999999999999999999999999999998653221111111111111000000
Q ss_pred HHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 701 LRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 701 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
........+ . ..+.+++.+||+.||++|||+.|+++++......
T Consensus 129 --------~~~~~~~~~-~-~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 129 --------RSNLESVSA-A-RSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred --------cccHHHHHh-h-hhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 000000111 0 0233477799999999999999999999776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=260.19 Aligned_cols=206 Identities=19% Similarity=0.228 Sum_probs=136.9
Q ss_pred cCCC-CCceeEEeeeecCC--cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 004218 507 NTRH-RNLVKLITSCSSLD--FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCE 583 (767)
Q Consensus 507 ~l~h-~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 583 (767)
.++| +||+++++++.... ...+..++.++||+ +++|.+++.... ..+++.+++.+++||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~-- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQ-- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 3455 57888888753221 12234567888987 559999996432 3489999999999999999999999
Q ss_pred CCeEeecCCCCCeeeCCC-------------------CceEEccccchhhhhhhcC----------CCccccccccccCC
Q 004218 584 VPIVHCDLKPGNILLDED-------------------MTAKVGDFGLARSLLERIG----------NQSSISSTHVLKGS 634 (767)
Q Consensus 584 ~~ivH~Dlkp~NIl~~~~-------------------~~~kl~Dfg~a~~~~~~~~----------~~~~~~~~~~~~gt 634 (767)
||+||||||+|||++.. +.+|++|||+++....... ............||
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 99999999999999653 4556666666653211000 00000011124588
Q ss_pred CCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHH
Q 004218 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQ 714 (767)
Q Consensus 635 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 714 (767)
+.|+|||++.+..++.++|||||||++|||++|.+|+..... ..........+.. .
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~~~~--------~------------- 234 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVLPPQ--------I------------- 234 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhcChh--------h-------------
Confidence 999999999999999999999999999999999888643110 0000000000000 0
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 715 LHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 715 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
........ +++.+||+++|.+|||+.|++++
T Consensus 235 -~~~~~~~~-~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 235 -LLNWPKEA-SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred -hhcCHHHH-HHHHHhCCCChhhCcChHHHhhc
Confidence 00011111 25668999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=217.32 Aligned_cols=174 Identities=22% Similarity=0.174 Sum_probs=131.8
Q ss_pred HHHHHhcCCCCCCccccccceEEEEEEeC--CCcEEEEEEeecc-----CCcchhhHHHHHHHHhcCCCCCceeEEeeee
Q 004218 449 ELRRATGNFSHENLIGSGSFGSVYKGYLR--EGISVAVKVLDIE-----STGTWKSFFAECEALRNTRHRNLVKLITSCS 521 (767)
Q Consensus 449 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 521 (767)
..+...++|++.+.||+|+||.||+|.+. +++.||||+.... .....+.+.+|++++++++|+|+++.+..+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34556788999999999999999999865 4777899986432 112345688999999999999998533221
Q ss_pred cCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC-CCCCeeeCC
Q 004218 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDL-KPGNILLDE 600 (767)
Q Consensus 522 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIl~~~ 600 (767)
+..++||||++|++|... . . .. ...++.|+++||+|||++ ||+|||| ||+||+++.
T Consensus 91 -------~~~~LVmE~~~G~~L~~~-~--~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~ 147 (365)
T PRK09188 91 -------GKDGLVRGWTEGVPLHLA-R--P-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGP 147 (365)
T ss_pred -------CCcEEEEEccCCCCHHHh-C--c-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcC
Confidence 235999999999999732 1 1 11 146789999999999999 9999999 999999999
Q ss_pred CCceEEccccchhhhhhhcCCCc--cccccccccCCCCccCccccCCC
Q 004218 601 DMTAKVGDFGLARSLLERIGNQS--SISSTHVLKGSIGYIPPEYGLGE 646 (767)
Q Consensus 601 ~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~ 646 (767)
++.+||+|||+|+.+........ .........+++.|+|||.+...
T Consensus 148 ~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 148 DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999999987654321111 11122356688999999987643
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=231.29 Aligned_cols=61 Identities=25% Similarity=0.321 Sum_probs=29.2
Q ss_pred ceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCc
Q 004218 276 NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPS 341 (767)
Q Consensus 276 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 341 (767)
+|+.|++++|.+++ +|.. ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|++++..+.
T Consensus 403 ~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 403 ELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred CCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 44555555555553 3322 123444555555554 3444455555555555555555544443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=232.39 Aligned_cols=265 Identities=23% Similarity=0.262 Sum_probs=211.6
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
-..|||+.|+++ ++|..+. ++|+.|++.+|+++ .+|.. .++|++|+|++|+|+ .+|.. .++|+.|+++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 468999999998 9999875 37999999999999 57753 589999999999999 56653 3689999999
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcC
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~ 163 (767)
+|.+...+ . ..++|+.|++++|+++ .+|.. .++ |+.|++++|++++ +|... .+|+.|++++
T Consensus 271 ~N~L~~Lp-------~---lp~~L~~L~Ls~N~Lt-~LP~~---p~~-L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~ 331 (788)
T PRK15387 271 SNPLTHLP-------A---LPSGLCKLWIFGNQLT-SLPVL---PPG-LQELSVSDNQLAS-LPALP---SELCKLWAYN 331 (788)
T ss_pred CCchhhhh-------h---chhhcCEEECcCCccc-ccccc---ccc-cceeECCCCcccc-CCCCc---cccccccccc
Confidence 99987442 2 1257889999999999 56653 344 9999999999985 45433 4688999999
Q ss_pred CcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCC
Q 004218 164 NSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIP 243 (767)
Q Consensus 164 n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 243 (767)
|.+++ +|. ...+|++|+|++|+|+ .+|.. ..+|+.|++++|+|+. +|.. .++|+.|++++|+++ .+|
T Consensus 332 N~L~~-LP~---lp~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP 398 (788)
T PRK15387 332 NQLTS-LPT---LPSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SLP 398 (788)
T ss_pred Ccccc-ccc---cccccceEecCCCccC-CCCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCccc-CCC
Confidence 99984 443 1258999999999999 45653 2578899999999985 5543 367999999999999 466
Q ss_pred hhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhc
Q 004218 244 KEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAE 321 (767)
Q Consensus 244 ~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 321 (767)
... +++ ..|++++|+++. +|.. +.+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..
T Consensus 399 ~l~---s~L-~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 399 VLP---SEL-KELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred Ccc---cCC-CEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 543 334 445999999995 5543 357889999999999 67889999999999999999999877776644
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-25 Score=218.08 Aligned_cols=270 Identities=19% Similarity=0.224 Sum_probs=210.2
Q ss_pred EEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecC-
Q 004218 6 YLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGF- 84 (767)
Q Consensus 6 ~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~- 84 (767)
..|-++-+++ +||.++-. .-++++|..|+|+.+.|++|+++.+|++||||+|.|+...|.+|..+++|..|-+-+
T Consensus 50 ~VdCr~~GL~-eVP~~LP~---~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~ 125 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLPP---ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGN 125 (498)
T ss_pred eEEccCCCcc-cCcccCCC---cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcC
Confidence 3566677787 89988754 678899999999977788999999999999999999988899999999988877666
Q ss_pred ccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCC
Q 004218 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN 164 (767)
Q Consensus 85 n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n 164 (767)
|+|+..+.+ .+.++.+|+.|.+.-|++.-...+.+.+++. |..|.+.+|.+..+--.+|..+..++.+.+..|
T Consensus 126 NkI~~l~k~------~F~gL~slqrLllNan~i~Cir~~al~dL~~-l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~n 198 (498)
T KOG4237|consen 126 NKITDLPKG------AFGGLSSLQRLLLNANHINCIRQDALRDLPS-LSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQN 198 (498)
T ss_pred Cchhhhhhh------HhhhHHHHHHHhcChhhhcchhHHHHHHhhh-cchhcccchhhhhhccccccchhccchHhhhcC
Confidence 889876654 4677888889999999998777888899988 999999999998555558999999999999988
Q ss_pred cCc------------ccCccccCCCCCCCEEEccCCc-------------------------cccccC-cCcccCCCCce
Q 004218 165 SIS------------GEILTEIGQLQELQSLDLAGNQ-------------------------ISGSIP-NTLGNLKKLNQ 206 (767)
Q Consensus 165 ~i~------------~~~~~~~~~l~~L~~L~L~~n~-------------------------i~~~~~-~~~~~l~~L~~ 206 (767)
.+- ...+..++...-..-..+.+++ .....| ..|..+++|+.
T Consensus 199 p~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~ 278 (498)
T KOG4237|consen 199 PFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRK 278 (498)
T ss_pred ccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceE
Confidence 722 1122233332222222222221 222223 34778889999
Q ss_pred eeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCC
Q 004218 207 IDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANG 286 (767)
Q Consensus 207 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~ 286 (767)
|+|++|+|+.+.+.+|.++..++.|.|..|++...-...|.++..|.. |+|.+|+|+-..|..|..+..|..|++-.|.
T Consensus 279 lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~t-L~L~~N~it~~~~~aF~~~~~l~~l~l~~Np 357 (498)
T KOG4237|consen 279 LNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKT-LSLYDNQITTVAPGAFQTLFSLSTLNLLSNP 357 (498)
T ss_pred eccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhcccccee-eeecCCeeEEEecccccccceeeeeehccCc
Confidence 999999999888889999999999999999988666677888888855 4899999988888888888888888887775
Q ss_pred C
Q 004218 287 L 287 (767)
Q Consensus 287 l 287 (767)
+
T Consensus 358 ~ 358 (498)
T KOG4237|consen 358 F 358 (498)
T ss_pred c
Confidence 4
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=208.42 Aligned_cols=207 Identities=26% Similarity=0.338 Sum_probs=166.4
Q ss_pred CCCCCCccccccceEEEEEEeCCC--cEEEEEEeeccCCcchhhHHHHHHHHhcCC----CCCceeEEeeeecCCcccce
Q 004218 456 NFSHENLIGSGSFGSVYKGYLREG--ISVAVKVLDIESTGTWKSFFAECEALRNTR----HRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~~~~~~~~~~~~~~~ 529 (767)
+|++.+.||+|+||.||.|...+. ..+|+|............+..|+.++..+. .+++..+++... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 899999999999999999997653 479999876553333337788999998886 368888888742 3455
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-----Cce
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED-----MTA 604 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-----~~~ 604 (767)
+-++||+.+ |.+|.++..... ...++..++.+|+.|++.+|+++|+. |++||||||.|+.+... ..+
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence 669999988 779999886554 34599999999999999999999999 99999999999999854 469
Q ss_pred EEccccchh--hhhhhcCCC--ccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 605 KVGDFGLAR--SLLERIGNQ--SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 605 kl~Dfg~a~--~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
.|.|||+++ .+....... ..........||..|+++....+...+.+.|+||++.++.++..|..||...
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 999999998 433222211 1111124566999999999999999999999999999999999999999553
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-24 Score=211.43 Aligned_cols=283 Identities=22% Similarity=0.245 Sum_probs=210.3
Q ss_pred CCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCC
Q 004218 76 FLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRS 155 (767)
Q Consensus 76 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~ 155 (767)
.-.+++|..|+|+.+|++ +++.+++|+.|||++|+|+.+-|++|..+...++-+..++|+|+....+.|.++.+
T Consensus 68 ~tveirLdqN~I~~iP~~------aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~s 141 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPG------AFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSS 141 (498)
T ss_pred cceEEEeccCCcccCChh------hccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHH
Confidence 345667777777765554 45667777777777777777777888887773344444457888766677888888
Q ss_pred CCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCc-CcccCCCCceeeCCCCcC------------CCCCcccc
Q 004218 156 LTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPN-TLGNLKKLNQIDLSGNEL------------ASEIPTSF 222 (767)
Q Consensus 156 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~L~~N~l------------~~~~~~~~ 222 (767)
|+.|.+.-|++..+..++|..+++|..|.+.+|.+. .++. .|..+.+++.+.+..|.+ ....|..+
T Consensus 142 lqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~iet 220 (498)
T KOG4237|consen 142 LQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIET 220 (498)
T ss_pred HHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhc
Confidence 888888888888777778888888888888888887 4444 777788888888887773 22344455
Q ss_pred cCccccccccccCcccCCCCChhhccc-ccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCccc
Q 004218 223 GNFQNLLSIDLSNNKLNGNIPKEILSL-SSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSL 301 (767)
Q Consensus 223 ~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L 301 (767)
+.+.-.....+.++++..+.+..|... .++...+....+.........|..+++|+.|+|++|+|+++-+.+|.++..|
T Consensus 221 sgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l 300 (498)
T KOG4237|consen 221 SGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAEL 300 (498)
T ss_pred ccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhh
Confidence 666666666777777765544444322 2332332233333333344579999999999999999999999999999999
Q ss_pred ceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCC
Q 004218 302 EKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPR 365 (767)
Q Consensus 302 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 365 (767)
++|+|..|+|.......|.++..|+.|+|.+|+|+..-|..|..+.+|.+|+|-.|++.+..--
T Consensus 301 ~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 301 QELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRL 364 (498)
T ss_pred hhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccch
Confidence 9999999999987788899999999999999999999999999999999999999998765433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.2e-23 Score=187.18 Aligned_cols=208 Identities=25% Similarity=0.346 Sum_probs=167.9
Q ss_pred HhcCCCCCCccccccceEEEEEE-eCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCC-CCceeEEeeeecCCccccee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRH-RNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~ 530 (767)
..+.|.++++||+|+||.+|.|. ..+|..||||+-+. .....++.-|.++.+.+++ ..|..+..+. .+..+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhc-----ccccc
Confidence 35789999999999999999999 56699999998653 2334567789999998864 5566666553 34445
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD---EDMTAKVG 607 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~ 607 (767)
-.+|||.. |.||.+++.-+.+ .++..+++-++-|++.-++|+|.+ +++||||||+|+++. ....+.++
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R-----~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSR-----RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhh-----hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEE
Confidence 58999998 7799999876643 399999999999999999999999 999999999999996 34579999
Q ss_pred cccchhhhhhhcCCC-ccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 608 DFGLARSLLERIGNQ-SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
|||+|+.+-+..... ..........||.+|++--...+...+.+.|+=|+|.++..+--|..||+...+
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 999999875543322 222233456799999998888877888999999999999999999999987644
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=186.28 Aligned_cols=207 Identities=21% Similarity=0.305 Sum_probs=171.2
Q ss_pred cCCCCCCccccccceEEEEEE-eCCCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
-.|++.++||+|+||.++.|+ .-++++||||.-+..+ ...++..|.+..+.+ ..++|..++.+ -..+.+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence 479999999999999999999 4569999999765332 335677888888888 57888888766 34455568
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-----CceEEc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED-----MTAKVG 607 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-----~~~kl~ 607 (767)
+|+|.. |.||+|++.-+. +.++..++..+|.|++.-++|+|++ .+|.|||||+|+||... ..+.|+
T Consensus 101 LVidLL-GPSLEDLFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCG-----RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred hhhhhh-CcCHHHHHHHhc-----CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEE
Confidence 999998 779999998765 3499999999999999999999999 99999999999999743 468999
Q ss_pred cccchhhhhhhcCCC-ccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccC
Q 004218 608 DFGLARSLLERIGNQ-SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAG 677 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 677 (767)
|||+|+.+.+..... ..........||.+||+--...+...+.+.|+=|+|-++++.+-|..||+.....
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 999999886654332 2222334567999999999999999999999999999999999999999875443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-23 Score=192.59 Aligned_cols=248 Identities=22% Similarity=0.338 Sum_probs=182.6
Q ss_pred CCCCCccccccceEEEEEEeCCCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
.....+|.+...|..|+|+|. |..+++|++... .....++|..|.-.++-+.||||+++++.|.++ ....++
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~i 265 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVII 265 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEe
Confidence 334557888999999999998 667888887543 233456788999999999999999999998653 445899
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc--cccch
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG--DFGLA 612 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~--Dfg~a 612 (767)
..||+.|+|+..++... +...+..++.+++.++|+|++|||+. ++-|-.--+.+..|++|++..++|+ |--++
T Consensus 266 sq~mp~gslynvlhe~t----~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQT----SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred eeeccchHHHHHHhcCc----cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee
Confidence 99999999999998754 34577889999999999999999997 4344445689999999999887763 33222
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCC---CCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP---STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
... ....-.+.||+||.+...+. -.++|+|||++++||+.|...||.+..+-+..+.-..++ .
T Consensus 341 fqe-------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg-l 406 (448)
T KOG0195|consen 341 FQE-------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG-L 406 (448)
T ss_pred eec-------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc-c
Confidence 110 11224678999999887654 357999999999999999999998765544333222221 1
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
...++.-+.+. +.+++.-|++.||.+||.++.++-.|++.
T Consensus 407 rv~ippgis~h----------------------m~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHIPPGISRH----------------------MNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCCCccHH----------------------HHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 11111111111 11255579999999999999999988875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.7e-23 Score=225.07 Aligned_cols=256 Identities=23% Similarity=0.254 Sum_probs=180.2
Q ss_pred CCCCccccccceEEEEEEeCC-CcEEEEEEeec-----cCCcc-hhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 458 SHENLIGSGSFGSVYKGYLRE-GISVAVKVLDI-----ESTGT-WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 458 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~-----~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
...+.+|.|++|.|+.+.... ....+.|.+.. ..... ...+..|.-+-..+.|||++..+..+.... ..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~----~~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID----GI 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc----cc
Confidence 345789999999888877442 33344443321 11111 122556777777889999988777653321 22
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.-+||||++ +|..++.... .+...++..+++|++.|++|+|+. ||.|||+|++|++++.+|.+||+|||
T Consensus 397 -~~~mE~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 397 -LQSMEYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred -hhhhhcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence 333999999 9999997652 288899999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCC-cccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPST-AGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
.+......... ........+|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+...... .+
T Consensus 466 ~~~vf~~~~e~--~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~---~~ 540 (601)
T KOG0590|consen 466 AASVFRYPWEK--NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN---NY 540 (601)
T ss_pred cceeeccCcch--hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh---cc
Confidence 99765443222 123345678999999999999999865 5899999999999999999997654443332100 00
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
..+.. . ......+...+....+.++.+|++.||.+|.|+++|++
T Consensus 541 ~~~~~--~-----------~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 541 SDQRN--I-----------FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccc--c-----------ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000 0 00111122223333334788999999999999999986
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=222.53 Aligned_cols=252 Identities=22% Similarity=0.251 Sum_probs=176.6
Q ss_pred CCCCCCccccccceEEEEEEeCCCcEEEEEEeeccC-Ccc---hhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIES-TGT---WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
+|...+.||++.|=.|.+|++++|. |+||++-+.. .-. .++-..|++ ...++|||++++.-+ ...+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-----~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-----LVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-----HHhhHHH
Confidence 6778899999999999999999886 9999985443 223 333444555 556699999998776 4455666
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
|+|-+|+.. +|+|.+..+.- +...+.+.|+.|++.|+..+|+. ||+|||||.+||||++-.-+.|+||..
T Consensus 97 ylvRqyvkh-nLyDRlSTRPF------L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLSTRPF------LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred HHHHHHHhh-hhhhhhccchH------HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccc
Confidence 889999966 99999987553 88889999999999999999999 999999999999999999999999977
Q ss_pred hhhh--hhhcCCCccccccccccCCCCccCccccCCC----------C-CCCcccchhhhHHHHHHHh-CCCCCCCcccC
Q 004218 612 ARSL--LERIGNQSSISSTHVLKGSIGYIPPEYGLGE----------K-PSTAGDVYSFGVMLLEIFT-GMSPTHESFAG 677 (767)
Q Consensus 612 a~~~--~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~slG~il~el~t-g~~p~~~~~~~ 677 (767)
-+.. .++.+.... ....+...-..|.|||.+... . .+++.||||+||+++|+++ |++||.-.
T Consensus 167 FKPtYLPeDNPadf~-fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--- 242 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFT-FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--- 242 (1431)
T ss_pred cCCccCCCCCcccce-EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---
Confidence 6432 222111111 111222233469999976431 2 5778999999999999998 57777431
Q ss_pred CcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 678 EVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
++..+.... .... +.+-+.+. ..-++.++..|++.||++|.+|++.++.-.
T Consensus 243 --QL~aYr~~~-~~~~-----e~~Le~Ie-------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 243 --QLLAYRSGN-ADDP-----EQLLEKIE-------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred --HHHhHhccC-ccCH-----HHHHHhCc-------------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 122221111 0000 00001110 011233777899999999999999998743
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=220.56 Aligned_cols=246 Identities=23% Similarity=0.373 Sum_probs=126.0
Q ss_pred CccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEee
Q 004218 3 SLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNI 82 (767)
Q Consensus 3 ~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 82 (767)
+..+|+|++++++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|++++|.++ .+|..+. .+|+.|+|
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip---~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP---EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc---cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 3456667766666 6666543 35666677776666 4554443 46666666666666 4454432 35666666
Q ss_pred cCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECc
Q 004218 83 GFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLS 162 (767)
Q Consensus 83 ~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~ 162 (767)
++|++...| ..+. ++|+.|++++|+++ .+|..+. .. |+.|++++|+++ .+|..+. ++|+.|+++
T Consensus 249 s~N~L~~LP-------~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~s-L~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls 312 (754)
T PRK15370 249 SINRITELP-------ERLP--SALQSLDLFHNKIS-CLPENLP--EE-LRYLSVYDNSIR-TLPAHLP--SGITHLNVQ 312 (754)
T ss_pred cCCccCcCC-------hhHh--CCCCEEECcCCccC-ccccccC--CC-CcEEECCCCccc-cCcccch--hhHHHHHhc
Confidence 666655332 1121 34556666666655 3444332 12 555666655555 2333322 345555555
Q ss_pred CCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCC
Q 004218 163 YNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNI 242 (767)
Q Consensus 163 ~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 242 (767)
+|.++. +|..+ .++|+.|++++|.++ .+|..+. ++|+.|+|++|+++. +|..+ .++|+.|++++|+++ .+
T Consensus 313 ~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~~-LP~~l--p~~L~~LdLs~N~Lt-~L 382 (754)
T PRK15370 313 SNSLTA-LPETL--PPGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQITV-LPETL--PPTITTLDVSRNALT-NL 382 (754)
T ss_pred CCcccc-CCccc--cccceeccccCCccc-cCChhhc--CcccEEECCCCCCCc-CChhh--cCCcCEEECCCCcCC-CC
Confidence 555552 23222 134555555555555 2343332 455555555555542 33332 134555555555554 23
Q ss_pred ChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcc----cccCcccceeeccCcccc
Q 004218 243 PKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNS----FKNCKSLEKLLMANNKFS 312 (767)
Q Consensus 243 ~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~----~~~l~~L~~L~l~~n~l~ 312 (767)
|. .+. ..|+.|++++|+++ .+|.. +..++++..|++.+|++.
T Consensus 383 P~-------------------------~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 383 PE-------------------------NLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CH-------------------------hHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 32 221 24566666666665 33332 233466667777777765
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-22 Score=188.94 Aligned_cols=177 Identities=14% Similarity=0.116 Sum_probs=135.8
Q ss_pred HHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhh---------HHHHHHHHhcCCCCCceeEEeeeec
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKS---------FFAECEALRNTRHRNLVKLITSCSS 522 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~~~ 522 (767)
...++|++.+++|.|+||.||++.. ++..+|+|++........+. +.+|++.+.++.||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3478999999999999999999766 57789999996543333222 5789999999999999999888543
Q ss_pred CC---cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 004218 523 LD---FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD 599 (767)
Q Consensus 523 ~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~ 599 (767)
.. +...+..++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||+||+||+++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 22 122356799999999999988732 332 2456999999999999 999999999999999
Q ss_pred CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHH
Q 004218 600 EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIF 665 (767)
Q Consensus 600 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 665 (767)
.+| ++|+|||.+........ ...+.....+..++|+||||+++....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKA------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhh------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 988 99999998865422110 011334455677899999999877654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-20 Score=198.23 Aligned_cols=264 Identities=30% Similarity=0.407 Sum_probs=190.7
Q ss_pred CCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCc---chhhHHHHHHHHhcCCCC-CceeEEeeeecCCcccceeeE
Q 004218 457 FSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTG---TWKSFFAECEALRNTRHR-NLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~~ 532 (767)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+. .....+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEEE
Confidence 677889999999999999987 78999998654332 367889999999999988 7999999862 333479
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEccccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-TAKVGDFGL 611 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~ 611 (767)
++++++.++++.+++...... ..++......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~ 148 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGL 148 (384)
T ss_pred EEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCc
Confidence 999999999999777654311 2488999999999999999999999 999999999999999988 799999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC---CCCCCcccchhhhHHHHHHHhCCCCCCCcccC--CcchhhHhh
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG---EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAG--EVSLVKWVE 686 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~ 686 (767)
++...................|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... .......+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 228 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence 9754332211110012355679999999999887 57889999999999999999999996554321 111111111
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
................ ......+.+++..|+..+|..|.++.+....
T Consensus 229 ~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 229 ELPTPSLASPLSPSNP--------------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred hcCCcccccccCcccc--------------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111000000000000 0011122236667888899999999988775
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-21 Score=217.02 Aligned_cols=222 Identities=23% Similarity=0.434 Sum_probs=128.4
Q ss_pred CCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEc
Q 004218 106 RLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDL 185 (767)
Q Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 185 (767)
+|++|++++|+++ .+|..+.. +|+.|+|++|++. .+|..+. .+|+.|++++|+++ .+|..+. ++|+.|++
T Consensus 221 nL~~L~Ls~N~Lt-sLP~~l~~---~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~L 290 (754)
T PRK15370 221 NIKTLYANSNQLT-SIPATLPD---TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSV 290 (754)
T ss_pred CCCEEECCCCccc-cCChhhhc---cccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEEC
Confidence 4445555555544 33433321 2555555555555 3344332 34555555555555 2343332 35666666
Q ss_pred cCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCC
Q 004218 186 AGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDG 265 (767)
Q Consensus 186 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~ 265 (767)
++|+++ .+|..+. ++|+.|++++|+++. +|..+ .++|+.|++++|.++ .+|..+. ++| +.|++++|+++
T Consensus 291 s~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt-~LP~~l~--~sL-~~L~Ls~N~L~- 359 (754)
T PRK15370 291 YDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALT-SLPASLP--PEL-QVLDVSKNQIT- 359 (754)
T ss_pred CCCccc-cCcccch--hhHHHHHhcCCcccc-CCccc--cccceeccccCCccc-cCChhhc--Ccc-cEEECCCCCCC-
Confidence 666655 3343332 356666666666653 33322 245666666666666 3444332 333 34467777666
Q ss_pred CCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhh----ccCCceEEEcCCcccCCCCCc
Q 004218 266 TLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILA----ELKGLEVLDLSSNKLSGSIPS 341 (767)
Q Consensus 266 ~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~l~~L~~L~Ls~N~l~~~~~~ 341 (767)
.+|..+ .++|+.|+|++|.|+. +|..+. ..|+.|++++|+++ .+|..+. .++++..|++.+|+++.
T Consensus 360 ~LP~~l--p~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~---- 429 (754)
T PRK15370 360 VLPETL--PPTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE---- 429 (754)
T ss_pred cCChhh--cCCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH----
Confidence 345444 3589999999999995 555554 47999999999998 5555443 45889999999999972
Q ss_pred cccccccCceEeccCCcCcC
Q 004218 342 DLQNLRALRSLNLTFNNLEG 361 (767)
Q Consensus 342 ~~~~l~~L~~L~l~~N~l~~ 361 (767)
..+++|+.| ++.+.+.|
T Consensus 430 --~tl~~L~~L-l~s~~~~g 446 (754)
T PRK15370 430 --RTIQNMQRL-MSSVGYQG 446 (754)
T ss_pred --HHHHHHHHh-hhcccccC
Confidence 345555555 44555554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-21 Score=181.79 Aligned_cols=139 Identities=18% Similarity=0.145 Sum_probs=106.7
Q ss_pred CCccccccceEEEEEEeCCCcEEEEEEeeccCCc--c-------hhh-----------------HHHHHHHHhcCCCCCc
Q 004218 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTG--T-------WKS-----------------FFAECEALRNTRHRNL 513 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~e~~~l~~l~h~ni 513 (767)
...||+|+||.||+|...+|+.||||+++..... . ... ..+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999654221 1 112 2349999999987776
Q ss_pred eeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeecCC
Q 004218 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL-HNDCEVPIVHCDLK 592 (767)
Q Consensus 514 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlk 592 (767)
.....+.. . ..++||||++++++....... .+++..++..++.|++.+|.|+ |+. ||+|||||
T Consensus 82 ~~p~~~~~----~---~~~iVmE~i~g~~l~~~~~~~------~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlk 145 (190)
T cd05147 82 PCPEPILL----K---SHVLVMEFIGDDGWAAPRLKD------APLSESKARELYLQVIQIMRILYQDC---RLVHADLS 145 (190)
T ss_pred CCCcEEEe----c---CCEEEEEEeCCCCCcchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 43332211 1 127999999988776543222 2388999999999999999999 688 99999999
Q ss_pred CCCeeeCCCCceEEccccchhhh
Q 004218 593 PGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 593 p~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
|+||+++ ++.++|+|||+|...
T Consensus 146 P~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 146 EYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHEEEE-CCcEEEEEccccccC
Confidence 9999998 478999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=185.01 Aligned_cols=207 Identities=21% Similarity=0.240 Sum_probs=142.5
Q ss_pred CCCCceeEEeeeecC----------------------CcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHH
Q 004218 509 RHRNLVKLITSCSSL----------------------DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLN 566 (767)
Q Consensus 509 ~h~niv~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 566 (767)
+|||||++.+++.+. ....+..+|+||..++. +|.+++.... .+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-------~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-------RSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-------CchHHHHH
Confidence 599999999876431 12234578999999976 9999998654 67778888
Q ss_pred HHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CCC--ceEEccccchhhhhhhcCCCccccccccccCCCCccCccc
Q 004218 567 IAIDIASALDYLHNDCEVPIVHCDLKPGNILLD--EDM--TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEY 642 (767)
Q Consensus 567 i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 642 (767)
++.|+++|+.|||++ ||.|||+|++||++. +++ ...++|||.+--.....-.-...+..-...|.-..||||+
T Consensus 346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 999999999999999 999999999999994 444 4688999998432211001111111123447778999998
Q ss_pred cCCCC------CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHH
Q 004218 643 GLGEK------PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLH 716 (767)
Q Consensus 643 ~~~~~------~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 716 (767)
....+ .-.++|.|+.|.+.||+++..-||...-+.......+-+.+.|. .++.+.+.
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa-lp~~vpp~---------------- 485 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA-LPSRVPPV---------------- 485 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC-CcccCChH----------------
Confidence 76432 13589999999999999999999976322222222222222222 22222322
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 004218 717 DCLITIIESVGLSCTTESPGGRIDIREALRRLK 749 (767)
Q Consensus 717 ~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 749 (767)
+++++...++.||++|+++.-+...+.
T Consensus 486 ------~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 486 ------ARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred ------HHHHHHHHhcCCccccCCccHHHhHHH
Confidence 333666688899999999877766654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=173.05 Aligned_cols=192 Identities=18% Similarity=0.053 Sum_probs=139.3
Q ss_pred CCCCCccccccceEEEEEEeCCCcEEEEEEeeccCC----cchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccceee
Q 004218 457 FSHENLIGSGSFGSVYKGYLREGISVAVKVLDIEST----GTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 531 (767)
+.+...|++|+||+||.+.. .+.+++.+.+..... -....+.+|+++|+++. |+++++++++. ..
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 34678899999999997766 588888877753322 11235789999999995 58899998861 23
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC-CCCCeeeCCCCceEEcccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDL-KPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIl~~~~~~~kl~Dfg 610 (767)
+++|||++|.+|.+.... ....++.|++.+++++|++ ||+|||| ||+||+++.++.++|+|||
T Consensus 74 ~lvmeyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG 137 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ 137 (218)
T ss_pred EEEEeeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence 899999999998754321 1134778999999999999 9999999 7999999999999999999
Q ss_pred chhhhhhhcCC-------CccccccccccCCCCccCccccCC--CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGN-------QSSISSTHVLKGSIGYIPPEYGLG--EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+|......... +...-.......++.|++|+...- ..--.+.+.++-|+-+|.++|++.|+...
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 99854332110 000000112235777888875322 22235679999999999999999986544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=7e-20 Score=175.50 Aligned_cols=138 Identities=21% Similarity=0.185 Sum_probs=108.6
Q ss_pred CCccccccceEEEEEEeCCCcEEEEEEeeccCCcc--------------------------hhhHHHHHHHHhcCCCCCc
Q 004218 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGT--------------------------WKSFFAECEALRNTRHRNL 513 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ni 513 (767)
...||+|++|.||+|...+|+.||||+++...... ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998789999999987542110 1123578899999999887
Q ss_pred eeEEeeeecCCcccceeeEEEEeecCCCChhhh-hcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecC
Q 004218 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDW-IHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDL 591 (767)
Q Consensus 514 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dl 591 (767)
.....+... ..++||||++|+++... +.. ..++..++..++.|++.++.++|+ . ||+||||
T Consensus 82 ~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDl 144 (190)
T cd05145 82 PVPEPILLK-------KNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDL 144 (190)
T ss_pred CCceEEEec-------CCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCC
Confidence 544433211 12899999998865433 322 127788999999999999999999 8 9999999
Q ss_pred CCCCeeeCCCCceEEccccchhhh
Q 004218 592 KPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 592 kp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+||+++ ++.++|+|||++...
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceec
Confidence 99999998 789999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-20 Score=183.83 Aligned_cols=207 Identities=24% Similarity=0.310 Sum_probs=131.4
Q ss_pred CCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCC---cchhhHHHHHHHHhcCC----------CCCceeEEeeee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIEST---GTWKSFFAECEALRNTR----------HRNLVKLITSCS 521 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~----------h~niv~~~~~~~ 521 (767)
.+...+.||.|+++.||.+++.+ ++++|||++..... ..++++.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 44566789999999999999875 89999999854332 24556666654444432 112222222221
Q ss_pred cCC----c---ccce-----eeEEEEeecCCCChhhhhcccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 004218 522 SLD----F---KNME-----FLALVYEFLGNGSLGDWIHGERKNE-HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVH 588 (767)
Q Consensus 522 ~~~----~---~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 588 (767)
... + .+.. ..+++|+-+. +||.+++..-.... ....+....+..+..|+++.+++||+. |+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 100 0 0011 2367888884 59988865321110 012244555677889999999999999 9999
Q ss_pred ecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC--------CCCCCcccchhhhHH
Q 004218 589 CDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG--------EKPSTAGDVYSFGVM 660 (767)
Q Consensus 589 ~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~i 660 (767)
+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec---------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999999999999999999888765432111 224577999997543 246889999999999
Q ss_pred HHHHHhCCCCCCCcc
Q 004218 661 LLEIFTGMSPTHESF 675 (767)
Q Consensus 661 l~el~tg~~p~~~~~ 675 (767)
+|.+++|..||+...
T Consensus 240 ly~lWC~~lPf~~~~ 254 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSS 254 (288)
T ss_dssp HHHHHHSS-STCCCG
T ss_pred HHHHHHccCCCCCCC
Confidence 999999999997653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-21 Score=166.38 Aligned_cols=180 Identities=30% Similarity=0.531 Sum_probs=133.9
Q ss_pred cCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeE
Q 004218 200 NLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVT 279 (767)
Q Consensus 200 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~ 279 (767)
++.+++.|.||+|+++ ..|..++.+.+|+.|++++|++. .+|..+++++++ ++++++-|++. ..|..|+.++.|+.
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~kl-r~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKL-RILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhh-hheecchhhhh-cCccccCCCchhhh
Confidence 3444555555555554 23334555555555555555555 455555555555 33355555555 77788888888888
Q ss_pred EEccCCCCCC-CCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCc
Q 004218 280 IDLSANGLSG-NLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNN 358 (767)
Q Consensus 280 L~ls~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 358 (767)
|||++|++.. .+|..|-.+..|+-|+|++|.+. .+|..++++.+|+.|.+..|.+. .+|..++.+..|++|.+.+|+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 9999988864 57888888999999999999998 88889999999999999999998 889999999999999999999
Q ss_pred CcCcCCCCccc---cccccccccCCcCccc
Q 004218 359 LEGVVPREGIF---RHTSMVHLEGNPKLCL 385 (767)
Q Consensus 359 l~~~~~~~~~~---~~~~~~~l~~Np~~c~ 385 (767)
++-.+|+.+.+ .+.....++.|||.-.
T Consensus 185 l~vlppel~~l~l~~~k~v~r~E~NPwv~p 214 (264)
T KOG0617|consen 185 LTVLPPELANLDLVGNKQVMRMEENPWVNP 214 (264)
T ss_pred eeecChhhhhhhhhhhHHHHhhhhCCCCCh
Confidence 99998887554 3345677889998653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=167.16 Aligned_cols=140 Identities=18% Similarity=0.220 Sum_probs=107.0
Q ss_pred CCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcC-----CCCCceeEEeeeecCCccccee-
Q 004218 457 FSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNT-----RHRNLVKLITSCSSLDFKNMEF- 530 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~- 530 (767)
++-.+.||+|+||.||. +.+....+||++........+.+.+|+++++.+ .||||++++|++.... ..+.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 34457899999999996 443333479998765455567899999999999 5799999999975421 1234
Q ss_pred eEEEEee--cCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeecCCCCCeeeCC----CCc
Q 004218 531 LALVYEF--LGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL-DYLHNDCEVPIVHCDLKPGNILLDE----DMT 603 (767)
Q Consensus 531 ~~lv~e~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlkp~NIl~~~----~~~ 603 (767)
+.+|+|| +++|+|.+++.... +++. ..++.|++.++ +|||++ +|+||||||+||+++. ++.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred EEEEecCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence 4478999 55799999996532 5554 35678888777 999999 9999999999999973 348
Q ss_pred eEEccccch
Q 004218 604 AKVGDFGLA 612 (767)
Q Consensus 604 ~kl~Dfg~a 612 (767)
++|+||+.+
T Consensus 148 ~~LiDg~G~ 156 (210)
T PRK10345 148 PVVCDNIGE 156 (210)
T ss_pred EEEEECCCC
Confidence 999995444
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-21 Score=166.30 Aligned_cols=161 Identities=27% Similarity=0.579 Sum_probs=103.5
Q ss_pred CCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCC
Q 004218 26 LPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNST 105 (767)
Q Consensus 26 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~ 105 (767)
+.+++.|.|++|+++ .+|..+..+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|.+. ..+..++.++
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-------~lprgfgs~p 102 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-------ILPRGFGSFP 102 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-------cCccccCCCc
Confidence 555666666666666 45555666666666666666666 56666666666666666666554 2333445555
Q ss_pred CCCEEECcCCcce-eecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEE
Q 004218 106 RLNFLAFDGNQFE-GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLD 184 (767)
Q Consensus 106 ~L~~L~l~~n~l~-~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 184 (767)
.|..|||..|++. ..+|..|+.+.. |+.|+|++|.+. .+|..++++++|+.|.+++|.+- .+|..++.+.+|++|.
T Consensus 103 ~levldltynnl~e~~lpgnff~m~t-lralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelh 179 (264)
T KOG0617|consen 103 ALEVLDLTYNNLNENSLPGNFFYMTT-LRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELH 179 (264)
T ss_pred hhhhhhccccccccccCCcchhHHHH-HHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHh
Confidence 5555555555543 246777777766 777777777776 66777777777777777777776 5667777777777777
Q ss_pred ccCCccccccCcCcc
Q 004218 185 LAGNQISGSIPNTLG 199 (767)
Q Consensus 185 L~~n~i~~~~~~~~~ 199 (767)
+.+|++. .+|..++
T Consensus 180 iqgnrl~-vlppel~ 193 (264)
T KOG0617|consen 180 IQGNRLT-VLPPELA 193 (264)
T ss_pred cccceee-ecChhhh
Confidence 7777776 4554444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-21 Score=202.59 Aligned_cols=286 Identities=22% Similarity=0.289 Sum_probs=136.7
Q ss_pred EEEccCCccc-ccCCccccCCCCCCEEEcccccCcc----cCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCC
Q 004218 31 GFNFCFNKFT-GKIPGSLHNLTNIQIIRMAHNLLEG----TVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNST 105 (767)
Q Consensus 31 ~L~l~~n~l~-~~~~~~l~~l~~L~~L~l~~n~i~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~ 105 (767)
.|+|..+.+. ...+..+..+.+|++|++++|.+++ .++..+...++|++|+++.+.+...+.....++..+.+++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3566666666 3344556666777777777777743 2344455556677777766655321111112233344455
Q ss_pred CCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcc----cCccccCCC-CCC
Q 004218 106 RLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISG----EILTEIGQL-QEL 180 (767)
Q Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~----~~~~~~~~l-~~L 180 (767)
+|+.|++++|.+....+..+..+... ++|++|++++|++.+ .....+..+ ++|
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~----------------------~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L 139 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRS----------------------SSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL 139 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhcc----------------------CcccEEEeeCCccchHHHHHHHHHHHhCCCCc
Confidence 55555555555543333333332221 124444444444441 111223333 455
Q ss_pred CEEEccCCcccc----ccCcCcccCCCCceeeCCCCcCCCC----CcccccCccccccccccCcccCCCCChhhcccccc
Q 004218 181 QSLDLAGNQISG----SIPNTLGNLKKLNQIDLSGNELASE----IPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSL 252 (767)
Q Consensus 181 ~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l 252 (767)
++|++++|.+++ .++..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+.+....
T Consensus 140 ~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~-------- 211 (319)
T cd00116 140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS-------- 211 (319)
T ss_pred eEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH--------
Confidence 555555555442 1122334444555555555555421 112223334555555555554421111
Q ss_pred cceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccc-----cCcccceeeccCccccC----CCCchhhccC
Q 004218 253 TTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFK-----NCKSLEKLLMANNKFSG----PIPNILAELK 323 (767)
Q Consensus 253 ~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~-----~l~~L~~L~l~~n~l~~----~~~~~~~~l~ 323 (767)
.++..+..+++|+.|++++|.+++.....+. ..+.|++|++++|.++. .+...+..++
T Consensus 212 -------------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~ 278 (319)
T cd00116 212 -------------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKE 278 (319)
T ss_pred -------------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCC
Confidence 1112234445666666666665532222221 12566666666666542 1223444556
Q ss_pred CceEEEcCCcccCCC----CCcccccc-ccCceEeccCCcC
Q 004218 324 GLEVLDLSSNKLSGS----IPSDLQNL-RALRSLNLTFNNL 359 (767)
Q Consensus 324 ~L~~L~Ls~N~l~~~----~~~~~~~l-~~L~~L~l~~N~l 359 (767)
+|+.+++++|.++.. ....+... +.|+++++.+|++
T Consensus 279 ~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 279 SLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred CccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 677777777777633 22233333 5666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.1e-19 Score=184.29 Aligned_cols=216 Identities=28% Similarity=0.410 Sum_probs=156.1
Q ss_pred HhcCCCCCceeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 004218 505 LRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEV 584 (767)
Q Consensus 505 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 584 (767)
|+.+.|.|+.+++|.+... ...++|.+||..|+|.|.+.... ..+++.....++++++.|++|+|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~s--- 67 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHNS--- 67 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhcC---
Confidence 3567899999999997643 66799999999999999998743 3489999999999999999999997
Q ss_pred Ce-EeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC-------CCCcccchh
Q 004218 585 PI-VHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-------PSTAGDVYS 656 (767)
Q Consensus 585 ~i-vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~s 656 (767)
+| .|+.+++.|.+++....+||+|||+.....+..... ......-..-|.|||.+.... .+.+.||||
T Consensus 68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~----~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs 143 (484)
T KOG1023|consen 68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPE----AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYS 143 (484)
T ss_pred cceeeeeeccccceeeeeEEEEechhhhccccccccccc----ccchhHHHHhccCHHHhcccccccccccccccCCeeh
Confidence 44 999999999999999999999999987664311100 011122345699999887631 467899999
Q ss_pred hhHHHHHHHhCCCCCCCcccCCc--chhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCC
Q 004218 657 FGVMLLEIFTGMSPTHESFAGEV--SLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTES 734 (767)
Q Consensus 657 lG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 734 (767)
||++++|+++.+.||+....... .+...+.... .....+.+.... +..+ .++. ++..||..+
T Consensus 144 ~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~----~~~~rP~i~~~~--------e~~~---~l~~-l~~~cw~e~ 207 (484)
T KOG1023|consen 144 FGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGG----SNPFRPSIELLN--------ELPP---ELLL-LVARCWEEI 207 (484)
T ss_pred HHHHHHHHHhccCccccccccCChHHHHHHHHhcC----CCCcCcchhhhh--------hcch---HHHH-HHHHhcccC
Confidence 99999999999999987544332 2222222201 111111111100 1111 2222 677899999
Q ss_pred CCCCCCHHHHHHHHHHHHH
Q 004218 735 PGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 735 P~~Rpt~~evl~~L~~~~~ 753 (767)
|.+||+++++-..++.+..
T Consensus 208 P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 208 PEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred hhhCccHHHHHhhhhhhcc
Confidence 9999999999888876654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-19 Score=189.75 Aligned_cols=186 Identities=30% Similarity=0.348 Sum_probs=153.8
Q ss_pred ccccccceEEEEEEe----CCCcEEEEEEeeccCCc--chhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccceeeEEE
Q 004218 462 LIGSGSFGSVYKGYL----REGISVAVKVLDIESTG--TWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 462 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
.+|+|.||.|+++.- ..|..+|+|+..+.... .......|-.++...+ ||.++++... +..+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 378999999998762 23778999987543221 1124446777788886 9999999887 5566778999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
++|..+|.+...+..... +++.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||.++.
T Consensus 76 ld~~rgg~lft~l~~~~~------f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVM------FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred hhhcccchhhhccccCCc------hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence 999999999998876554 77888888999999999999999 999999999999999999999999999987
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
.-+.. ..+||..|||||++. ....++|.||||++++||+||..||..
T Consensus 147 ~v~~~----------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 147 AVKEK----------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hHhhh----------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 64421 127899999999987 568899999999999999999999965
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-20 Score=195.96 Aligned_cols=203 Identities=23% Similarity=0.266 Sum_probs=130.4
Q ss_pred EEeCCCCeeeecCCCccccCCCCCcEEEccCCcccc----cCCccccCCCCCCEEEcccccCcc------cCCccCCCCC
Q 004218 6 YLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTG----KIPGSLHNLTNIQIIRMAHNLLEG------TVPPGLGNLP 75 (767)
Q Consensus 6 ~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~----~~~~~l~~l~~L~~L~l~~n~i~~------~~~~~~~~l~ 75 (767)
.|+|+++.+++.--...+..+.+|++|+++++.+.. .++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 588999998743333445568889999999999853 366778889999999999998872 3445677889
Q ss_pred CCcEEeecCccccCCCCCCccccccccCC---CCCCEEECcCCcceee----cCchhhhh-ccccCeEEccCCcccc---
Q 004218 76 FLKMYNIGFNKIVGSGDEGLSFITSLTNS---TRLNFLAFDGNQFEGE----IPESIGNL-SNVLSKLYMGGNRFYG--- 144 (767)
Q Consensus 76 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~l---~~L~~L~l~~n~l~~~----~~~~~~~l-~~~L~~L~l~~n~i~~--- 144 (767)
+|+.|++++|.+... .+..+..+ ++|++|++++|++++. +...+..+ .+ |++|++++|.+++
T Consensus 82 ~L~~L~l~~~~~~~~------~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~-L~~L~L~~n~l~~~~~ 154 (319)
T cd00116 82 GLQELDLSDNALGPD------GCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPA-LEKLVLGRNRLEGASC 154 (319)
T ss_pred ceeEEEccCCCCChh------HHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCC-ceEEEcCCCcCCchHH
Confidence 999999999988642 22222223 5699999999998732 22333444 34 7777777777762
Q ss_pred -cCCccccCCCCCCEEECcCCcCccc----CccccCCCCCCCEEEccCCcccccc----CcCcccCCCCceeeCCCCcCC
Q 004218 145 -KIPTSIGRLRSLTLLNLSYNSISGE----ILTEIGQLQELQSLDLAGNQISGSI----PNTLGNLKKLNQIDLSGNELA 215 (767)
Q Consensus 145 -~~~~~l~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~N~l~ 215 (767)
.++..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+.+.. +..+..+++|++|++++|+++
T Consensus 155 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 155 EALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred HHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCc
Confidence 2333455556666666666666632 1222334456666666666654221 222334445555555555544
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9e-20 Score=187.06 Aligned_cols=202 Identities=26% Similarity=0.363 Sum_probs=139.2
Q ss_pred CCCCCCccccccceEEEEEEeCC----CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEe-------eeecCC
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLIT-------SCSSLD 524 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~-------~~~~~~ 524 (767)
.+.+.+..+..+++.++..+... .+.++.+..+...........+++..+....|-+..-+.+ ......
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~ 324 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNK 324 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccc
Confidence 34445556666666666554322 2334444443333222333344444444443333333322 111111
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA 604 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~ 604 (767)
.....+++|.|++|+..+|.+++...+. ....++.....++.|++.|++| + +.+|+|+||.||++..+..+
T Consensus 325 v~~~~~lyI~Mn~c~~~tledWl~rr~~---~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~ 395 (516)
T KOG1033|consen 325 VGKKVYLYIQMNLCEKETLEDWLRRRRT---GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQL 395 (516)
T ss_pred cccccchhhhhhhhhhhhHHHHhhCCCc---ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhh
Confidence 2223468999999999999999976554 3457888999999999999999 5 99999999999999999999
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 666 (767)
||+|||+.....................||..||+||.+.+..|+.++||||+|++++|++.
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99999999765444322222333455679999999999999999999999999999999997
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=193.84 Aligned_cols=202 Identities=20% Similarity=0.220 Sum_probs=155.4
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCC---CCCceeEEeeeecCC
Q 004218 448 DELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTR---HRNLVKLITSCSSLD 524 (767)
Q Consensus 448 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~ 524 (767)
.+.......|.+.+.+|+|+||.||+|...+|+.||+|+-+..+. -+|.--.+++.+++ -+.|..+..++.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~--- 764 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHV--- 764 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHc---
Confidence 344556678889999999999999999988899999998653322 22222233444444 233444444322
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC----
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE---- 600 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---- 600 (767)
..+.-++|+||.+.|||.+++...+ .++|.-++.++.|++..+++||.. +||||||||+|.++..
T Consensus 765 --~~~~S~lv~ey~~~Gtlld~~N~~~------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 765 --FQNASVLVSEYSPYGTLLDLINTNK------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred --cCCcceeeeeccccccHHHhhccCC------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCC
Confidence 1222389999999999999998443 499999999999999999999999 9999999999999952
Q ss_pred ---CCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCC
Q 004218 601 ---DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670 (767)
Q Consensus 601 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 670 (767)
..-++|+|||.+-.+.- ..........++|-.+--+|+..++++++.+|.|.++.+++.|+.|++-
T Consensus 834 ~~~~~~l~lIDfG~siDm~l----fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKL----FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred CCcccceEEEecccceeeeE----cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 34589999999965422 1222344567789999999999999999999999999999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.4e-18 Score=166.56 Aligned_cols=141 Identities=23% Similarity=0.160 Sum_probs=109.7
Q ss_pred CCCCCCccccccceEEEEEE--eCCCcEEEEEEeeccCCc------------------------chhhHHHHHHHHhcCC
Q 004218 456 NFSHENLIGSGSFGSVYKGY--LREGISVAVKVLDIESTG------------------------TWKSFFAECEALRNTR 509 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 509 (767)
-|++.+.||+|++|.||+|. ..+|+.||+|+++..... ....+.+|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 457999999998643211 0123568999999996
Q ss_pred CC--CceeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-e
Q 004218 510 HR--NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVP-I 586 (767)
Q Consensus 510 h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i 586 (767)
+. .+.+++++. ..++||||++++++........ .....++..++.|++.++++||+. + |
T Consensus 109 ~~~i~~p~~~~~~---------~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---g~i 170 (237)
T smart00090 109 EAGVPVPKPIAWR---------RNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYKE---GEL 170 (237)
T ss_pred hcCCCCCeeeEec---------CceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHhc---CCE
Confidence 53 344444431 1389999999988876643221 255667789999999999999999 9 9
Q ss_pred EeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 587 VHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 587 vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
+||||||+||+++ ++.++|+|||.+...
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999999 889999999998643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.2e-17 Score=156.15 Aligned_cols=144 Identities=24% Similarity=0.167 Sum_probs=111.7
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCc----------------------chhhHHHHHHHH
Q 004218 448 DELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTG----------------------TWKSFFAECEAL 505 (767)
Q Consensus 448 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l 505 (767)
.++.+....|.+.+.||+|+||.||++...+|+.||||+++..... ....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444458889999999999999999888999999987543210 011356788888
Q ss_pred hcCCCCC--ceeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 004218 506 RNTRHRN--LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCE 583 (767)
Q Consensus 506 ~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 583 (767)
..+.|++ +...++. ...++||||++|++|.+.... .....++.+++.++.++|+.
T Consensus 88 ~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~-- 144 (198)
T cd05144 88 KALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH-- 144 (198)
T ss_pred HHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC--
Confidence 8887763 4444432 223899999999999765421 23567889999999999998
Q ss_pred CCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 584 VPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 584 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
+|+||||||+||++++++.++|+|||.+...
T Consensus 145 -gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 145 -GIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred -CCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=176.92 Aligned_cols=146 Identities=21% Similarity=0.248 Sum_probs=113.2
Q ss_pred cCHHHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeecc--CC------cchhhHHHHHHHHhcCCCCCceeE
Q 004218 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIE--ST------GTWKSFFAECEALRNTRHRNLVKL 516 (767)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~e~~~l~~l~h~niv~~ 516 (767)
.++.........|...+.||+|+||.||+|.+.. ..+++|+.... .. ...+++.+|+++++.++|++++..
T Consensus 323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred eeeccccccccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 3444444555666778999999999999998764 34555543211 11 123467899999999999998887
Q ss_pred EeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 004218 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNI 596 (767)
Q Consensus 517 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 596 (767)
..++.. ....++||||+++++|.+++. ....++.|+++++.|||+. +++|||+||+||
T Consensus 402 ~~~~~~-----~~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NI 459 (535)
T PRK09605 402 VIYDVD-----PEEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNF 459 (535)
T ss_pred EEEEEe-----CCCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHE
Confidence 666432 223489999999999999874 3467899999999999999 999999999999
Q ss_pred eeCCCCceEEccccchhh
Q 004218 597 LLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 597 l~~~~~~~kl~Dfg~a~~ 614 (767)
++ +++.++|+|||+++.
T Consensus 460 Ll-~~~~~~liDFGla~~ 476 (535)
T PRK09605 460 IV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EE-ECCcEEEEeCccccc
Confidence 99 678999999999964
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=155.64 Aligned_cols=133 Identities=24% Similarity=0.331 Sum_probs=108.4
Q ss_pred CccccccceEEEEEEeCCCcEEEEEEeeccCCc--------chhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 461 NLIGSGSFGSVYKGYLREGISVAVKVLDIESTG--------TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+.||+|++|.||+|.+ .|..|++|+....... ....+.+|++++..+.|+++.....++.. ....+
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PENFI 75 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCCCE
Confidence 5799999999999988 5778999986533211 12357789999999999888766655432 23458
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||++|++|.+++... .. ++..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+
T Consensus 76 lv~e~~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred EEEEEeCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcc
Confidence 999999999999998542 12 7889999999999999999 999999999999999 788999999988
Q ss_pred h
Q 004218 613 R 613 (767)
Q Consensus 613 ~ 613 (767)
.
T Consensus 142 ~ 142 (211)
T PRK14879 142 E 142 (211)
T ss_pred c
Confidence 5
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.8e-17 Score=177.71 Aligned_cols=172 Identities=28% Similarity=0.440 Sum_probs=123.2
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
...|..++.|..|++|.||.++++. .+.+|+|+=+ .+ -|++ ||..+.+. .+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----------lilR-----nilt~a~n-----------pf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----------LILR-----NILTFAGN-----------PF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----------hhhh-----ccccccCC-----------cc
Confidence 3578889999999999999999875 6778885422 11 1111 12222221 12
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
.| |+-.+.+...+. ++. +++.+++|+|+. ||+|||+||+|.+|+.-|++|++|||++
T Consensus 134 vv------gDc~tllk~~g~------lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 134 VV------GDCATLLKNIGP------LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLS 190 (1205)
T ss_pred ee------chhhhhcccCCC------Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhh
Confidence 22 344444443222 332 237899999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCC---------ccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 613 RSLLERIGNQ---------SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 613 ~~~~~~~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
+......... ...-.....+||+.|.|||++....|+..+|+|++|+|+||.+-|+.||....+
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 8654322110 000111346799999999999999999999999999999999999999977543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.9e-16 Score=150.92 Aligned_cols=130 Identities=24% Similarity=0.301 Sum_probs=101.7
Q ss_pred ccccccceEEEEEEeCCCcEEEEEEeeccCCc--------chhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 462 LIGSGSFGSVYKGYLREGISVAVKVLDIESTG--------TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 462 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.||+|+||.||+|.+. +..|++|........ ...++.+|+++++.+.|+++.....++. .....++
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCEE
Confidence 4899999999999964 788999986432111 1245678999999998876544333322 2233489
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||++|++|.+++.... . .++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+.
T Consensus 75 v~e~~~g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN-------D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred EEEEECCccHHHHHhhcH-------H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 999999999999875421 1 7899999999999999 999999999999999 7899999999885
Q ss_pred h
Q 004218 614 S 614 (767)
Q Consensus 614 ~ 614 (767)
.
T Consensus 138 ~ 138 (199)
T TIGR03724 138 Y 138 (199)
T ss_pred C
Confidence 3
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.7e-15 Score=143.19 Aligned_cols=135 Identities=27% Similarity=0.279 Sum_probs=96.5
Q ss_pred CCccccccceEEEEEEeCCCcEEEEEEeeccCCc--chhhH----------------------HHHHHHHhcCCCC--Cc
Q 004218 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTG--TWKSF----------------------FAECEALRNTRHR--NL 513 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~e~~~l~~l~h~--ni 513 (767)
.+.||+|+||.||+|...+++.||||++...... ..... ..|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5689999999999999888999999998643221 11111 2455555555333 23
Q ss_pred eeEEeeeecCCcccceeeEEEEeecCCCChhhh-hcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecC
Q 004218 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDW-IHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDL 591 (767)
Q Consensus 514 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dl 591 (767)
.+.++. ...++||||++++++... +.... .. .++..++.+++.++.++|. . +|+||||
T Consensus 82 ~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl 141 (187)
T cd05119 82 PKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-------LL-EDPEELYDQILELMRKLYREA---GLVHGDL 141 (187)
T ss_pred CceEec---------CCCEEEEEEeCCCCccChhhhhhh-------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCC
Confidence 444433 123899999999654321 11110 11 5678899999999999999 7 9999999
Q ss_pred CCCCeeeCCCCceEEccccchhhh
Q 004218 592 KPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 592 kp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+||+++ ++.++++|||.+...
T Consensus 142 ~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 142 SEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred ChhhEEEE-CCcEEEEECcccccc
Confidence 99999999 899999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.7e-16 Score=175.75 Aligned_cols=255 Identities=25% Similarity=0.310 Sum_probs=186.4
Q ss_pred hcCCCCCCccccccceEEEEEEeCC--CcEEEEEEeeccC--CcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE--GISVAVKVLDIES--TGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~ 528 (767)
...|.+.+.||+|+|+.|-.+.... ...+|+|.+.... .........|..+-+.+. |+|++.+++. ..+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence 4578888889999999998887643 4456777664432 223344556777777776 9999999998 4455
Q ss_pred eeeEEEEeecCCCChhhhh-cccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeecCCCCCeeeCCCC-ceE
Q 004218 529 EFLALVYEFLGNGSLGDWI-HGERKNEHGNGLNFLERLNIAIDIASALDYLH-NDCEVPIVHCDLKPGNILLDEDM-TAK 605 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlkp~NIl~~~~~-~~k 605 (767)
...++++||..++++.+.+ .... ...+...+..++.|+..++.|+| .. ++.|||+||+|.+++..+ ..+
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~ 165 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALK 165 (601)
T ss_pred cccccccCcccccccccccccCCc-----cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCccc
Confidence 6669999999999999888 3322 13667778889999999999999 77 999999999999999999 999
Q ss_pred EccccchhhhhhhcCCCccccccccccC-CCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhh
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKG-SIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK 683 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 683 (767)
+.|||+|..+....+ .........| ++.|+|||...+. ...+..|+||.|+++..+++|..||+...........
T Consensus 166 ~~df~~At~~~~~~g---~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~ 242 (601)
T KOG0590|consen 166 IADFGLATAYRNKNG---AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS 242 (601)
T ss_pred CCCchhhccccccCC---cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee
Confidence 999999987655211 1122234457 9999999998885 4478899999999999999999999876655554444
Q ss_pred Hhhhhcc--cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 684 WVESNFP--KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 684 ~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
|...... .....-...... ++..+++..+|..|.+.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~----------------------~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 243 WKSNKGRFTQLPWNSISDQAH----------------------DLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ecccccccccCccccCChhhh----------------------hcccccccCCchhccccccccc
Confidence 4433211 111111111111 1455688889999999887643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.9e-15 Score=135.91 Aligned_cols=135 Identities=22% Similarity=0.224 Sum_probs=110.3
Q ss_pred CCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCC--CCceeEEeeeecCCcccceeeEEEEe
Q 004218 459 HENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRH--RNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 459 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
+.+.+|+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| ..+++++++.. ..+..+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEE
Confidence 45789999999999999864 7899999864432 4678899999999976 58888888743 3356799999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|++++++..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 74 ~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9998777644 3456677899999999999986444799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-14 Score=142.07 Aligned_cols=139 Identities=18% Similarity=0.153 Sum_probs=104.8
Q ss_pred CCccc-cccceEEEEEEeCCCcEEEEEEeeccC-------------CcchhhHHHHHHHHhcCCCCCc--eeEEeeeecC
Q 004218 460 ENLIG-SGSFGSVYKGYLREGISVAVKVLDIES-------------TGTWKSFFAECEALRNTRHRNL--VKLITSCSSL 523 (767)
Q Consensus 460 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~ 523 (767)
...|| .|+.|+||.+... +..++||.+.... ......+.+|++++..+.|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35677 8889999999876 7789999874311 1223567889999999988775 6666654321
Q ss_pred CcccceeeEEEEeecCC-CChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 004218 524 DFKNMEFLALVYEFLGN-GSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM 602 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~ 602 (767)
. ......++|||+++| .+|.+++.... ++.. .+.+++.++.+||+. ||+||||||.||+++.++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~~~-------l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQEAP-------LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhcCC-------CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 1 111123699999997 69999886422 4543 357899999999999 999999999999999989
Q ss_pred ceEEccccchhh
Q 004218 603 TAKVGDFGLARS 614 (767)
Q Consensus 603 ~~kl~Dfg~a~~ 614 (767)
.++|+|||.+..
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 999999998864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.7e-14 Score=138.75 Aligned_cols=213 Identities=23% Similarity=0.333 Sum_probs=148.1
Q ss_pred HHhcCCCCCceeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 004218 504 ALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCE 583 (767)
Q Consensus 504 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 583 (767)
-+-++.|.|+++++.|+.+....+.....+++|||..|++.+++++.+.. ...+......+|+.||..||.|||+. .
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~--~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN--QKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh--hhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34455799999999999887777778889999999999999999876543 34588888899999999999999995 7
Q ss_pred CCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHH
Q 004218 584 VPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLE 663 (767)
Q Consensus 584 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~e 663 (767)
++|+|+++..+-|++..+|-+|++---........ .......+....+-++|.|||.-.....+.++|||+||+...|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~--~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSV--NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhh--hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 89999999999999999998988432211110000 0000111223346789999998777777889999999999999
Q ss_pred HHhCCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHH
Q 004218 664 IFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIRE 743 (767)
Q Consensus 664 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~e 743 (767)
|..+..-.......... ...+...+...... +-+..+..|++..|..||+|.+
T Consensus 275 mailEiq~tnseS~~~~-----------------ee~ia~~i~~len~----------lqr~~i~kcl~~eP~~rp~ar~ 327 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEV-----------------EENIANVIIGLENG----------LQRGSITKCLEGEPNGRPDARL 327 (458)
T ss_pred HHHheeccCCCcceeeh-----------------hhhhhhheeeccCc----------cccCcCcccccCCCCCCcchhh
Confidence 99887542111110000 00000000000000 0012667899999999999999
Q ss_pred HHHHH
Q 004218 744 ALRRL 748 (767)
Q Consensus 744 vl~~L 748 (767)
++.+.
T Consensus 328 llfHp 332 (458)
T KOG1266|consen 328 LLFHP 332 (458)
T ss_pred hhcCc
Confidence 88764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.3e-13 Score=155.38 Aligned_cols=115 Identities=36% Similarity=0.561 Sum_probs=101.9
Q ss_pred ceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEecc
Q 004218 276 NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLT 355 (767)
Q Consensus 276 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 355 (767)
.++.|+|++|.+++.+|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 48899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCcCcCCCCc--cccccccccccCCcCccccC---CCC
Q 004218 356 FNNLEGVVPREG--IFRHTSMVHLEGNPKLCLHL---GCE 390 (767)
Q Consensus 356 ~N~l~~~~~~~~--~~~~~~~~~l~~Np~~c~~~---~c~ 390 (767)
+|+++|..|... ...+...+.+.+|+..|+.. .|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 999999888752 22345577899999999732 564
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-13 Score=149.60 Aligned_cols=201 Identities=33% Similarity=0.549 Sum_probs=149.5
Q ss_pred EEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCC-CCcEEeecCccccCCCCCCccccccccCCCCCCE
Q 004218 31 GFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLP-FLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNF 109 (767)
Q Consensus 31 ~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~ 109 (767)
.|+++.|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++.. ++..+.+++.|+.
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~-------l~~~~~~l~~L~~ 167 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES-------LPSPLRNLPNLKN 167 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhh-------hhhhhhccccccc
Confidence 5777777775 23444666688888888888888 6676677774 88888888888763 3356778888888
Q ss_pred EECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCc
Q 004218 110 LAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQ 189 (767)
Q Consensus 110 L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 189 (767)
|++++|+++ .+|...+..+. |+.|++++|++. .+|........|++|++++|.+. ..+..+.++.++..|.+.+|+
T Consensus 168 L~l~~N~l~-~l~~~~~~~~~-L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~ 243 (394)
T COG4886 168 LDLSFNDLS-DLPKLLSNLSN-LNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243 (394)
T ss_pred cccCCchhh-hhhhhhhhhhh-hhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCce
Confidence 888888888 66666666666 888888888887 56666556667888888888544 446677788888888888888
Q ss_pred cccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhc
Q 004218 190 ISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL 247 (767)
Q Consensus 190 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 247 (767)
+. ..+..+..+++++.|++++|+++...+ ++.+.+|+.|++++|.+....+....
T Consensus 244 ~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 244 LE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred ee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence 87 446777888888888888888875433 77888888888888888755554433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.8e-13 Score=145.87 Aligned_cols=143 Identities=27% Similarity=0.300 Sum_probs=99.9
Q ss_pred CCccccccceEEEEEEeCCCcEEEEEEeeccCCcch----------------------------------------hhHH
Q 004218 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTW----------------------------------------KSFF 499 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 499 (767)
.+.||.|++|.||+|+.++|+.||||+.+....... -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999854311100 0244
Q ss_pred HHHHHHhcC----CCCCceeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHH-H
Q 004218 500 AECEALRNT----RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS-A 574 (767)
Q Consensus 500 ~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~-~ 574 (767)
+|++.+.++ ++.+-+.+-.++.. .....++||||++|++|.++...... .. ....++.+++. .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~~~-----~~---~~~~ia~~~~~~~ 269 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALDEA-----GL---DRKALAENLARSF 269 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHHhc-----CC---CHHHHHHHHHHHH
Confidence 555555554 23333333333321 12234899999999999987653221 12 23456666666 4
Q ss_pred HHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhh
Q 004218 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE 617 (767)
Q Consensus 575 l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 617 (767)
+..+|.. |++|+|+||.||+++.++.++++|||++..+.+
T Consensus 270 l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 270 LNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7888988 999999999999999999999999999976643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-14 Score=149.44 Aligned_cols=193 Identities=29% Similarity=0.513 Sum_probs=126.4
Q ss_pred CCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEE
Q 004218 105 TRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLD 184 (767)
Q Consensus 105 ~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 184 (767)
+--...||+.|++. ++|..++.+.. |+.|.|..|.+. .+|..+.++..|+.|+|+.|+++ .+|..++.|+ |+.|-
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~-Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVS-LESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHH-HHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 33455677777777 77777777776 777777777776 66777777777777777777777 5666666665 77777
Q ss_pred ccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCC
Q 004218 185 LAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264 (767)
Q Consensus 185 L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~ 264 (767)
+++|+++ .+|..++.+..|..|+.+.|++. .+|..++++.+|+.|.+..|++. .+|.++.
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~----------------- 209 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC----------------- 209 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-----------------
Confidence 7777777 66666777777777777777776 35666677777777777777766 4444433
Q ss_pred CCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCC---ceEEEcCCc
Q 004218 265 GTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKG---LEVLDLSSN 333 (767)
Q Consensus 265 ~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~---L~~L~Ls~N 333 (767)
.| .|..||+|.|+++ .+|-.|..|..|++|-|.+|.++ ..|..++..-. -++|+..-+
T Consensus 210 --------~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 210 --------SL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred --------CC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 22 3566666666666 55666666666666666666665 44444433322 244555444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=7e-15 Score=151.33 Aligned_cols=193 Identities=34% Similarity=0.511 Sum_probs=108.7
Q ss_pred eEEccCCcccccCCc--cccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 134 KLYMGGNRFYGKIPT--SIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 134 ~L~l~~n~i~~~~~~--~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
.|.|++-++.. .|. +=..+..-...||+.|++. ++|..+..+..|+.|.|..|.|. .+|..++++..|+.|+|+.
T Consensus 54 ~l~Ls~rrlk~-fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLKE-FPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhhc-CCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 35555555542 221 1133455566677777776 56666666667777777777776 6666677777777777777
Q ss_pred CcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCC
Q 004218 212 NELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNL 291 (767)
Q Consensus 212 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~ 291 (767)
|+++ ..|..+..++ |+.|.+++|+++ .+|..++ .+..|..||.+.|.+. .+
T Consensus 131 NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig-------------------------~~~tl~~ld~s~nei~-sl 181 (722)
T KOG0532|consen 131 NQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIG-------------------------LLPTLAHLDVSKNEIQ-SL 181 (722)
T ss_pred chhh-cCChhhhcCc-ceeEEEecCccc-cCCcccc-------------------------cchhHHHhhhhhhhhh-hc
Confidence 7775 4555555444 666666666666 4444444 4444555555555554 34
Q ss_pred CcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcC
Q 004218 292 PNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEG 361 (767)
Q Consensus 292 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 361 (767)
|..++++.+|+.|++..|++. .+|..+..++ |..||+|.|+++ .+|-.|.+|..|++|-|.+|+|+.
T Consensus 182 psql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 182 PSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 444555555555555555554 3344444333 555555555555 455555555555555555555554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-13 Score=147.63 Aligned_cols=201 Identities=33% Similarity=0.513 Sum_probs=167.3
Q ss_pred EEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCC-CCCEEEcccccCcccCCccCCCCCCCcEEeecC
Q 004218 6 YLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLT-NIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGF 84 (767)
Q Consensus 6 ~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (767)
.|+++.|.+. .-+..+. .+..++.|++.+|.+. .+|.....++ +|+.|++++|.+. .+|..+..+++|+.|++++
T Consensus 97 ~l~~~~~~~~-~~~~~~~-~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLR-SNISELL-ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccc-cCchhhh-cccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 5778888874 3333443 3678999999999999 6777778885 9999999999998 7777889999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCC
Q 004218 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN 164 (767)
Q Consensus 85 n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n 164 (767)
|++.. ++.....++.|+.|++++|++. .+|........ |++|.+++|++. ..+..+.++.++..|.+.+|
T Consensus 173 N~l~~-------l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~-L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n 242 (394)
T COG4886 173 NDLSD-------LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA-LEELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242 (394)
T ss_pred chhhh-------hhhhhhhhhhhhheeccCCccc-cCchhhhhhhh-hhhhhhcCCcce-ecchhhhhcccccccccCCc
Confidence 99984 3444448899999999999999 78887666666 999999999654 56778999999999999999
Q ss_pred cCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCccccc
Q 004218 165 SISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFG 223 (767)
Q Consensus 165 ~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 223 (767)
++. ..+..+..++++++|++++|+++.. +. ++.+.+++.|++++|.+....+....
T Consensus 243 ~~~-~~~~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 243 KLE-DLPESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred eee-eccchhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchhhhc
Confidence 998 4467888999999999999999944 44 89999999999999999876665543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.3e-13 Score=139.62 Aligned_cols=200 Identities=30% Similarity=0.296 Sum_probs=153.5
Q ss_pred CCCCCCcccc--ccceEEEEEEe--C-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCccc
Q 004218 456 NFSHENLIGS--GSFGSVYKGYL--R-EGISVAVKVLDIE--STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 456 ~~~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 527 (767)
.+.+.+.+|. |.+|.||.+.. + ++..+|+|.-+.. .......-.+|+...+.+ .|++.++.+.. +..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence 4566788999 99999999986 3 4888999984332 223334445677766666 48999986655 566
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeecCCCCCeeeCCC-C
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS----ALDYLHNDCEVPIVHCDLKPGNILLDED-M 602 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~ 602 (767)
++..++-+|++. .++.++.+... ..++....+.+..+..+ |+.++|+. +++|-|+||.||+...+ .
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~-----~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPC-----NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWT 260 (524)
T ss_pred CCcceeeecccc-chhHHhhhccc-----ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccc
Confidence 777899999985 68888877643 23777888888899988 99999999 99999999999999998 8
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCC
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPT 671 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 671 (767)
..+++|||+...+.+..-....... ....|...|++||... +.++.++|+|++|.++.+..++..+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVS-KRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred eeecCCcceeEEccCCccccceeee-ecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccc
Confidence 8999999999877654322221111 2224778899999854 46788999999999999999987664
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.4e-12 Score=138.57 Aligned_cols=150 Identities=20% Similarity=0.169 Sum_probs=95.2
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCc----------------------------------chh--
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTG----------------------------------TWK-- 496 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~-- 496 (767)
...|+. +.+|+|++|.||+|+.++ |+.||||+.++.... ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999987 999999998643110 001
Q ss_pred ----hHHHHHHHHhcC----CCCCceeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHH
Q 004218 497 ----SFFAECEALRNT----RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568 (767)
Q Consensus 497 ----~~~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~ 568 (767)
++.+|+..+.++ .+...+.+-.++.+ .....++||||++|+++.++-.-.........+....+..++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence 234455444444 23333333333221 122348999999999998753211110000113333334444
Q ss_pred HHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----ceEEccccchhhhhhh
Q 004218 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM----TAKVGDFGLARSLLER 618 (767)
Q Consensus 569 ~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~Dfg~a~~~~~~ 618 (767)
.|++ .. |++|+|+||.||+++.++ +++++|||++..+.+.
T Consensus 274 ~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 4443 45 999999999999999888 9999999999866543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.2e-12 Score=141.99 Aligned_cols=111 Identities=35% Similarity=0.527 Sum_probs=101.9
Q ss_pred ceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCc
Q 004218 254 TIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSN 333 (767)
Q Consensus 254 ~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N 333 (767)
..++|++|.+.+.+|..++.+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|+.+..+++|+.|+|++|
T Consensus 421 ~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N 500 (623)
T PLN03150 421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500 (623)
T ss_pred EEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence 44699999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccccc-ccCceEeccCCcCcCcCC
Q 004218 334 KLSGSIPSDLQNL-RALRSLNLTFNNLEGVVP 364 (767)
Q Consensus 334 ~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~ 364 (767)
.+++.+|..+..+ .++..+++.+|+..+..|
T Consensus 501 ~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 501 SLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred cccccCChHHhhccccCceEEecCCccccCCC
Confidence 9999999988764 467889999998665443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.8e-14 Score=137.29 Aligned_cols=236 Identities=17% Similarity=0.247 Sum_probs=140.4
Q ss_pred CCCccEEeCCCCeeeecCCC---ccccCCCCCcEEEccCC---cccccCCc-------cccCCCCCCEEEcccccCcccC
Q 004218 1 MTSLVYLGLASNQLWGEIPY---DVGDKLPNLLGFNFCFN---KFTGKIPG-------SLHNLTNIQIIRMAHNLLEGTV 67 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~---~~~~~l~~L~~L~l~~n---~l~~~~~~-------~l~~l~~L~~L~l~~n~i~~~~ 67 (767)
+.+++.|+||+|.+..+-.. ....+.++|++.++++- ++...+|. .+...++|++||||.|.+.-..
T Consensus 29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g 108 (382)
T KOG1909|consen 29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG 108 (382)
T ss_pred cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence 45678888888887532211 12224567777777653 22334443 3456678888888888877544
Q ss_pred Ccc----CCCCCCCcEEeecCccccCCCCCCcc---------ccccccCCCCCCEEECcCCcceeecCchh----hhhcc
Q 004218 68 PPG----LGNLPFLKMYNIGFNKIVGSGDEGLS---------FITSLTNSTRLNFLAFDGNQFEGEIPESI----GNLSN 130 (767)
Q Consensus 68 ~~~----~~~l~~L~~L~l~~n~l~~~~~~~~~---------~~~~l~~l~~L~~L~l~~n~l~~~~~~~~----~~l~~ 130 (767)
++. +..+..|++|+|.+|.+. |.++-. ...-...-++|+.+...+|++.......+ ...+.
T Consensus 109 ~~~l~~ll~s~~~L~eL~L~N~Glg--~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~ 186 (382)
T KOG1909|consen 109 IRGLEELLSSCTDLEELYLNNCGLG--PEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPT 186 (382)
T ss_pred hHHHHHHHHhccCHHHHhhhcCCCC--hhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccc
Confidence 443 345677888888888764 222222 11223344667777777777764433222 23333
Q ss_pred ccCeEEccCCcccc----cCCccccCCCCCCEEECcCCcCccc----CccccCCCCCCCEEEccCCccccccCcCc----
Q 004218 131 VLSKLYMGGNRFYG----KIPTSIGRLRSLTLLNLSYNSISGE----ILTEIGQLQELQSLDLAGNQISGSIPNTL---- 198 (767)
Q Consensus 131 ~L~~L~l~~n~i~~----~~~~~l~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~---- 198 (767)
|+.+.+..|.|.. .+..+|.++++|++|||++|-++.. +...+..+++|++|++++|.++.....+|
T Consensus 187 -leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al 265 (382)
T KOG1909|consen 187 -LEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDAL 265 (382)
T ss_pred -cceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHH
Confidence 7777777777652 2234466777777777777777632 23445566777777777777764333332
Q ss_pred -ccCCCCceeeCCCCcCCCC----CcccccCccccccccccCcccC
Q 004218 199 -GNLKKLNQIDLSGNELASE----IPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 199 -~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
...++|+.|.|.+|.|+.. +...+...+.|+.|+|++|.+.
T Consensus 266 ~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 266 KESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred hccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 2356777777777777632 1223345677777777777773
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-11 Score=130.66 Aligned_cols=167 Identities=21% Similarity=0.231 Sum_probs=127.7
Q ss_pred eCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCC
Q 004218 476 LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEH 555 (767)
Q Consensus 476 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~ 555 (767)
-.++.+|.|...+..+........+.++.++.++||||+++++. ....+..|+|+|.+. .|..++..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~------ 100 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKE------ 100 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHH------
Confidence 34588899998876655445667788999999999999999998 455568899999984 68888765
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCC
Q 004218 556 GNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635 (767)
Q Consensus 556 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~ 635 (767)
++...+...+.||+.||.|||+.+ +++|++|.-..|+|+..|+.||++|.++........ ......--.
T Consensus 101 ---l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------~~~~~~~~~ 169 (690)
T KOG1243|consen 101 ---LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------PAKSLYLIE 169 (690)
T ss_pred ---hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------ccccchhhh
Confidence 446678889999999999999764 999999999999999999999999998864322211 011111223
Q ss_pred CccCccccCCCCCCCcccchhhhHHHHHHHhCC
Q 004218 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGM 668 (767)
Q Consensus 636 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~ 668 (767)
.|..|+.+.... -..|.|.|||++||++.|.
T Consensus 170 s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 170 SFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 466676543322 3469999999999999993
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.6e-12 Score=123.67 Aligned_cols=133 Identities=29% Similarity=0.374 Sum_probs=94.2
Q ss_pred ccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCC
Q 004218 101 LTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180 (767)
Q Consensus 101 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L 180 (767)
+...+-|+++||++|.|+ .+.++..-+++ ++.|+++.|+|..+ +.+..+++|+.|||++|.++ ...+.-.++.|+
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pk-ir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPK-LRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccc-eeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 334456778888888887 66666666676 88888888888632 33777788888888888777 444555567788
Q ss_pred CEEEccCCccccccCcCcccCCCCceeeCCCCcCCCC-CcccccCccccccccccCcccCC
Q 004218 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASE-IPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 181 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
++|.|++|.|... ..+..+.+|..||+++|+|... ....++++|-|++|.|.+|.+.+
T Consensus 355 KtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 355 KTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 8888888887632 3466777788888888887643 23466777888888888887773
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.2e-11 Score=110.97 Aligned_cols=136 Identities=20% Similarity=0.161 Sum_probs=97.6
Q ss_pred CCccccccceEEEEEEeCC-------CcEEEEEEeeccC------------C----------cchhhH----HHHHHHHh
Q 004218 460 ENLIGSGSFGSVYKGYLRE-------GISVAVKVLDIES------------T----------GTWKSF----FAECEALR 506 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~e~~~l~ 506 (767)
...||.|--+.||.|...+ +..+|||+.+... + ...+.+ .+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998553 4799999875321 0 001122 37999998
Q ss_pred cCC--CCCceeEEeeeecCCcccceeeEEEEeecCCCChhh-hhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCC
Q 004218 507 NTR--HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGD-WIHGERKNEHGNGLNFLERLNIAIDIASALDYL-HNDC 582 (767)
Q Consensus 507 ~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~ 582 (767)
++. .-++.+.+++. .-++||||+++..+.. .+.. ..++..+...+..+++.++..+ |+.
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H~~- 144 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYKEC- 144 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 884 34566666541 1289999997654322 2221 1255566778889999999999 888
Q ss_pred CCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 583 EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 583 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
++||||+++.||+++ ++.++|+|||.+...
T Consensus 145 --glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 145 --NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred --CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999999999997 468999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-13 Score=134.75 Aligned_cols=257 Identities=19% Similarity=0.253 Sum_probs=127.1
Q ss_pred cccCCCCCCEEEcccccCcc----cCCccCCCCCCCcEEeecCccccCCCC-----CCccccccccCCCCCCEEECcCCc
Q 004218 46 SLHNLTNIQIIRMAHNLLEG----TVPPGLGNLPFLKMYNIGFNKIVGSGD-----EGLSFITSLTNSTRLNFLAFDGNQ 116 (767)
Q Consensus 46 ~l~~l~~L~~L~l~~n~i~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~-----~~~~~~~~l~~l~~L~~L~l~~n~ 116 (767)
.+..+.+++.|+||+|.+.. .+...+.+.++|+.-+++.-- ++-+. ....+...|..+++|++|+||+|-
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~f-tGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMF-TGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhh-cCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 34556667777777777664 233445555666666666421 11111 011223344555678888888888
Q ss_pred ceeecCchhhhh----ccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCcccc
Q 004218 117 FEGEIPESIGNL----SNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISG 192 (767)
Q Consensus 117 l~~~~~~~~~~l----~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~ 192 (767)
|....+..+..+ .. |++|+|.+|++.-.-...++. -|..|. .| .....-+.|+++..+.|.+..
T Consensus 104 ~G~~g~~~l~~ll~s~~~-L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~-------kk~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTD-LEELYLNNCGLGPEAGGRLGR--ALFELA--VN-------KKAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred cCccchHHHHHHHHhccC-HHHHhhhcCCCChhHHHHHHH--HHHHHH--HH-------hccCCCcceEEEEeecccccc
Confidence 776666655544 33 777777777775222222111 111111 00 111223445555555555542
Q ss_pred cc----CcCcccCCCCceeeCCCCcCCCC----CcccccCccccccccccCcccCCCCChhhcccccccceeecccccCC
Q 004218 193 SI----PNTLGNLKKLNQIDLSGNELASE----IPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264 (767)
Q Consensus 193 ~~----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~ 264 (767)
.. ...|...+.|+.+.++.|.|... ....|..+++|+.|||.+|-++.....
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~-------------------- 231 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV-------------------- 231 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH--------------------
Confidence 11 12334445555555555555421 112344556666666666655521111
Q ss_pred CCCchhhcCCCceeEEEccCCCCCCCCCccc-----ccCcccceeeccCccccCC----CCchhhccCCceEEEcCCccc
Q 004218 265 GTLPEEIGMLGNVVTIDLSANGLSGNLPNSF-----KNCKSLEKLLMANNKFSGP----IPNILAELKGLEVLDLSSNKL 335 (767)
Q Consensus 265 ~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l 335 (767)
.+...++.+++|+.|++++|.++..-...| ...|+|+.|.|.+|.|+.. +.......+.|..|+|++|++
T Consensus 232 -~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 232 -ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred -HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 112233444555555555555543322222 2245666666666666531 222344466777777777777
Q ss_pred C
Q 004218 336 S 336 (767)
Q Consensus 336 ~ 336 (767)
.
T Consensus 311 ~ 311 (382)
T KOG1909|consen 311 G 311 (382)
T ss_pred c
Confidence 4
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.6e-11 Score=113.46 Aligned_cols=130 Identities=22% Similarity=0.168 Sum_probs=95.0
Q ss_pred CCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCc-eeEEeeeecCCcccceeeEEEEeec
Q 004218 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNL-VKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
.+.++.|.++.||++... ++.|++|+...... ....+.+|+++++.+.+.++ .+++.+.. ...++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEEEec
Confidence 357899999999999876 77899998754321 23456789999998865444 34444321 1237999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC--EVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
+|.++.+.- . ....++.+++++++.||+.. +.+++|||++|.||+++ ++.++++|||.+.
T Consensus 74 ~G~~l~~~~-----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTED-----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCcccccc-----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 998876430 1 11235689999999999982 12359999999999999 6689999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-12 Score=123.65 Aligned_cols=131 Identities=32% Similarity=0.401 Sum_probs=83.5
Q ss_pred CCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccc
Q 004218 152 RLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSI 231 (767)
Q Consensus 152 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 231 (767)
..+.|++|||++|.|+ .+.++..-+|.++.|++++|.|.. +. .+..+++|+.||||+|.++ ...++-..+-+.++|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 3456677777777776 444555666777777777777762 22 2666777777777777775 234444456667777
Q ss_pred cccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCC-CcccccCcccceeeccCcc
Q 004218 232 DLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNL-PNSFKNCKSLEKLLMANNK 310 (767)
Q Consensus 232 ~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~-~~~~~~l~~L~~L~l~~n~ 310 (767)
.|++|.|. +| ..++.+-+|..||+++|+|.... ...++++|-|+.|.|.+|+
T Consensus 358 ~La~N~iE-----------------~L----------SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 358 KLAQNKIE-----------------TL----------SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred ehhhhhHh-----------------hh----------hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 77777665 11 12334456677777777765322 3567888888888888888
Q ss_pred ccC
Q 004218 311 FSG 313 (767)
Q Consensus 311 l~~ 313 (767)
+.+
T Consensus 411 l~~ 413 (490)
T KOG1259|consen 411 LAG 413 (490)
T ss_pred ccc
Confidence 874
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.1e-12 Score=144.66 Aligned_cols=290 Identities=19% Similarity=0.276 Sum_probs=129.7
Q ss_pred CCcEEEccCCcccccCCccccCCCCCCEEEccccc--CcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCC
Q 004218 28 NLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNL--LEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNST 105 (767)
Q Consensus 28 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~--i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~ 105 (767)
..+...+.+|.+. .++.. ...++|++|=+.+|. +....+..|..++.|+.|||++|.-. ..+|..++++-
T Consensus 524 ~~rr~s~~~~~~~-~~~~~-~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l------~~LP~~I~~Li 595 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGS-SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSL------SKLPSSIGELV 595 (889)
T ss_pred heeEEEEeccchh-hccCC-CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCcc------CcCChHHhhhh
Confidence 3444444444444 23322 122244444444443 22122223444555555555543211 03444445555
Q ss_pred CCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCc--ccCccccCCCCCCCEE
Q 004218 106 RLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSIS--GEILTEIGQLQELQSL 183 (767)
Q Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~--~~~~~~~~~l~~L~~L 183 (767)
+|++|++++..+. .+|..+.++.. |.+|++..+.-...+|.....|++|++|.+...... ......+..+.+|+.|
T Consensus 596 ~LryL~L~~t~I~-~LP~~l~~Lk~-L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~l 673 (889)
T KOG4658|consen 596 HLRYLDLSDTGIS-HLPSGLGNLKK-LIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENL 673 (889)
T ss_pred hhhcccccCCCcc-ccchHHHHHHh-hheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhh
Confidence 5555555555555 55555555555 555555555443344444455555555555544311 1112223333333333
Q ss_pred EccCCccccccCcCcccCCCCc----eeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcc------ccccc
Q 004218 184 DLAGNQISGSIPNTLGNLKKLN----QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS------LSSLT 253 (767)
Q Consensus 184 ~L~~n~i~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------l~~l~ 253 (767)
........ +-..+..++.|. .+.+..+... ..+..+..+.+|+.|.+.++.+.......... ++++.
T Consensus 674 s~~~~s~~--~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~ 750 (889)
T KOG4658|consen 674 SITISSVL--LLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLS 750 (889)
T ss_pred eeecchhH--hHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHH
Confidence 33222210 001112222222 2222222222 23344555666666666666654221111111 11111
Q ss_pred ceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCC-CCchhhccCCceEEEcCC
Q 004218 254 TIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGP-IPNILAELKGLEVLDLSS 332 (767)
Q Consensus 254 ~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~ 332 (767)
+. ...++... ..+.+.-..++|+.|.+..+.....+.+....+..++.+-+..+.+.+. .-.....++++..+.+++
T Consensus 751 ~~-~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~ 828 (889)
T KOG4658|consen 751 KV-SILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSF 828 (889)
T ss_pred HH-Hhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCc
Confidence 11 11111111 2333444567888888888887766666777777777766666666654 334444555555444443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-12 Score=131.41 Aligned_cols=143 Identities=19% Similarity=0.206 Sum_probs=82.5
Q ss_pred CCCCCCEEECcCCcCcccCc-cccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCC-cccccCccccc
Q 004218 152 RLRSLTLLNLSYNSISGEIL-TEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEI-PTSFGNFQNLL 229 (767)
Q Consensus 152 ~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~ 229 (767)
.+++|+.|.|++|+++.... .....+|+|+.|+|..|............+..|++|+|++|++-... -...+.++.|+
T Consensus 195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLN 274 (505)
T ss_pred hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchh
Confidence 34566677777776663211 22345677777777777433233334455667777777777765322 13445677777
Q ss_pred cccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCC-CCCcccccCcccceeeccC
Q 004218 230 SIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSG-NLPNSFKNCKSLEKLLMAN 308 (767)
Q Consensus 230 ~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~-~~~~~~~~l~~L~~L~l~~ 308 (767)
.|+++.|.+........ ..-+-...+++|++|+++.|++.+ .....+..+++|+.|.+..
T Consensus 275 ~Lnls~tgi~si~~~d~-------------------~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~ 335 (505)
T KOG3207|consen 275 QLNLSSTGIASIAEPDV-------------------ESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITL 335 (505)
T ss_pred hhhccccCcchhcCCCc-------------------cchhhhcccccceeeecccCccccccccchhhccchhhhhhccc
Confidence 77777777662110000 000112346678888888888753 1224556667788888888
Q ss_pred ccccC
Q 004218 309 NKFSG 313 (767)
Q Consensus 309 n~l~~ 313 (767)
|.++.
T Consensus 336 n~ln~ 340 (505)
T KOG3207|consen 336 NYLNK 340 (505)
T ss_pred ccccc
Confidence 88764
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.4e-12 Score=129.00 Aligned_cols=209 Identities=20% Similarity=0.205 Sum_probs=148.4
Q ss_pred CCCCCcEEEccCCcccccCC--ccccCCCCCCEEEcccccCccc--CCccCCCCCCCcEEeecCccccCCCCCCcccccc
Q 004218 25 KLPNLLGFNFCFNKFTGKIP--GSLHNLTNIQIIRMAHNLLEGT--VPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITS 100 (767)
Q Consensus 25 ~l~~L~~L~l~~n~l~~~~~--~~l~~l~~L~~L~l~~n~i~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~ 100 (767)
.+.+|++..|+++.+. ..+ +....+++++.||||+|-+... +..-...|++|+.|+|+.|.+........
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~----- 192 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNT----- 192 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccc-----
Confidence 5778888899988887 344 4678899999999999988752 23445668899999999998764321110
Q ss_pred ccCCCCCCEEECcCCcceeec-CchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccC-ccccCCCC
Q 004218 101 LTNSTRLNFLAFDGNQFEGEI-PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEI-LTEIGQLQ 178 (767)
Q Consensus 101 l~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~-~~~~~~l~ 178 (767)
-..++.|+.|.|+.|.++..- ...+..++. |+.|+|..|...........-+..|+.|||++|++-... ....+.++
T Consensus 193 ~~~l~~lK~L~l~~CGls~k~V~~~~~~fPs-l~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~ 271 (505)
T KOG3207|consen 193 TLLLSHLKQLVLNSCGLSWKDVQWILLTFPS-LEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLP 271 (505)
T ss_pred hhhhhhhheEEeccCCCCHHHHHHHHHhCCc-HHHhhhhcccccceecchhhhhhHHhhccccCCccccccccccccccc
Confidence 114678899999999987332 222334565 999999999533344444555788999999999887432 14567789
Q ss_pred CCCEEEccCCccccc-cCcC-----cccCCCCceeeCCCCcCCCC-CcccccCccccccccccCcccCC
Q 004218 179 ELQSLDLAGNQISGS-IPNT-----LGNLKKLNQIDLSGNELASE-IPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 179 ~L~~L~L~~n~i~~~-~~~~-----~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
.|+.|+++.|.|..+ .|+. ...+++|++|+++.|++... .-..+..+++|+.|....|.++.
T Consensus 272 ~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 272 GLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred chhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 999999999998842 2322 35678999999999999521 12345567888999999998874
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.5e-11 Score=113.24 Aligned_cols=123 Identities=26% Similarity=0.345 Sum_probs=34.5
Q ss_pred CCcEEEccCCcccccCCcccc-CCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccc-cCCC
Q 004218 28 NLLGFNFCFNKFTGKIPGSLH-NLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSL-TNST 105 (767)
Q Consensus 28 ~L~~L~l~~n~l~~~~~~~l~-~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l-~~l~ 105 (767)
.+++|+|++|.|. .+. .++ .+.+|+.|+|++|.|+ .+. .+..++.|++|++++|.|++. ...+ ..++
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i-------~~~l~~~lp 88 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSI-------SEGLDKNLP 88 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--------CHHHHHH-T
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCcc-------ccchHHhCC
Confidence 4555666666655 232 233 3555666666666655 222 355555566666666655432 1122 2345
Q ss_pred CCCEEECcCCcceeec-CchhhhhccccCeEEccCCcccccC---CccccCCCCCCEEECc
Q 004218 106 RLNFLAFDGNQFEGEI-PESIGNLSNVLSKLYMGGNRFYGKI---PTSIGRLRSLTLLNLS 162 (767)
Q Consensus 106 ~L~~L~l~~n~l~~~~-~~~~~~l~~~L~~L~l~~n~i~~~~---~~~l~~l~~L~~L~l~ 162 (767)
+|+.|++++|+|...- -..+..+++ |+.|+|.+|.+.... .-.+..+++|+.||-.
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~-L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPK-LRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT---EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCC-cceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 5666666666554221 133444555 666666666655210 1124567777777743
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.5e-11 Score=113.14 Aligned_cols=119 Identities=25% Similarity=0.399 Sum_probs=31.5
Q ss_pred cCCcccccCCccccCCCCCCEEEcccccCcccCCccCC-CCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECc
Q 004218 35 CFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLG-NLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFD 113 (767)
Q Consensus 35 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~ 113 (767)
..+.|. .+|. +.+..++++|+|++|.|+ .+. .++ .+.+|+.|+|++|.|+.. ..+..+++|++|+++
T Consensus 5 t~~~i~-~~~~-~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--------~~l~~L~~L~~L~L~ 72 (175)
T PF14580_consen 5 TANMIE-QIAQ-YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--------EGLPGLPRLKTLDLS 72 (175)
T ss_dssp -----------------------------------S--TT-TT--EEE-TTS--S----------TT----TT--EEE--
T ss_pred cccccc-cccc-cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--------cCccChhhhhhcccC
Confidence 344444 3443 455567788888888887 332 454 467788888888887532 345666777777777
Q ss_pred CCcceeecCchhh-hhccccCeEEccCCccccc-CCccccCCCCCCEEECcCCcCc
Q 004218 114 GNQFEGEIPESIG-NLSNVLSKLYMGGNRFYGK-IPTSIGRLRSLTLLNLSYNSIS 167 (767)
Q Consensus 114 ~n~l~~~~~~~~~-~l~~~L~~L~l~~n~i~~~-~~~~l~~l~~L~~L~l~~n~i~ 167 (767)
+|+++ .+++.+. .+++ |++|++++|+|... .-..+..+++|++|+|.+|.+.
T Consensus 73 ~N~I~-~i~~~l~~~lp~-L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 73 NNRIS-SISEGLDKNLPN-LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp SS----S-CHHHHHH-TT---EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCCCC-ccccchHHhCCc-CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 77777 3444443 4555 77777777776531 1133445556666666666555
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.7e-12 Score=135.71 Aligned_cols=235 Identities=30% Similarity=0.356 Sum_probs=122.4
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
++.+++..|.+.. .-..+..+++|+.|++.+|.|..+ ...+..+++|++|++++|+|+.+. .+..++.|+.|++++
T Consensus 74 l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 74 LKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSG 149 (414)
T ss_pred HHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhheecc
Confidence 4445555555542 223345555555555555555531 222455555666666666655332 244455556666666
Q ss_pred CcCCCCCcccccCccccccccccCcccCCCCChh-hcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCC
Q 004218 212 NELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKE-ILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGN 290 (767)
Q Consensus 212 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~ 290 (767)
|.|+. ...+..++.|+.+++++|.+...-+ . ...+..+..+ .+.+|.+... ..+..+..+..+++..|.++..
T Consensus 150 N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l-~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~ 223 (414)
T KOG0531|consen 150 NLISD--ISGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEEL-DLGGNSIREI--EGLDLLKKLVLLSLLDNKISKL 223 (414)
T ss_pred Ccchh--ccCCccchhhhcccCCcchhhhhhh-hhhhhccchHHH-hccCCchhcc--cchHHHHHHHHhhcccccceec
Confidence 66542 2334445556666666665552222 1 2333333222 5555555422 2233334445556777776633
Q ss_pred CCcccccCc--ccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcC---CC
Q 004218 291 LPNSFKNCK--SLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVV---PR 365 (767)
Q Consensus 291 ~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~---~~ 365 (767)
.+ +..+. .|+.+++++|++.. .+..+..+..+..|++++|++... ..+...+.+..+....|.+.... ..
T Consensus 224 ~~--l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (414)
T KOG0531|consen 224 EG--LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQE 298 (414)
T ss_pred cC--cccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcc
Confidence 22 22222 37778888887773 335566677788888888887632 23445566667777777765321 11
Q ss_pred --CccccccccccccCCc
Q 004218 366 --EGIFRHTSMVHLEGNP 381 (767)
Q Consensus 366 --~~~~~~~~~~~l~~Np 381 (767)
....+.+..+.+.+||
T Consensus 299 ~~~~~~~~~~~~~~~~~~ 316 (414)
T KOG0531|consen 299 YITSAAPTLVTLTLELNP 316 (414)
T ss_pred ccccccccccccccccCc
Confidence 1234455556666665
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.4e-12 Score=135.39 Aligned_cols=86 Identities=28% Similarity=0.311 Sum_probs=56.4
Q ss_pred ceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCC---CCcc-ccccccCce
Q 004218 276 NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGS---IPSD-LQNLRALRS 351 (767)
Q Consensus 276 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~-~~~l~~L~~ 351 (767)
+|+.+++++|.+. ..+..+..+..+..|++.+|++... ..+...+.+..+.++.|.+... .... ....+.+..
T Consensus 233 ~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (414)
T KOG0531|consen 233 HLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVT 309 (414)
T ss_pred HHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccc
Confidence 3677777777776 3335666777788888888877632 2244555677777777776521 1111 456678888
Q ss_pred EeccCCcCcCcCC
Q 004218 352 LNLTFNNLEGVVP 364 (767)
Q Consensus 352 L~l~~N~l~~~~~ 364 (767)
+.+.+|+.....+
T Consensus 310 ~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 310 LTLELNPIRKISS 322 (414)
T ss_pred cccccCccccccc
Confidence 8888888877554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.3e-10 Score=109.70 Aligned_cols=145 Identities=21% Similarity=0.186 Sum_probs=110.0
Q ss_pred CccccccceEEEEEEeCCCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCC--CCceeEEeeeecCCcccceeeEEEEee
Q 004218 461 NLIGSGSFGSVYKGYLREGISVAVKVLDIEST-GTWKSFFAECEALRNTRH--RNLVKLITSCSSLDFKNMEFLALVYEF 537 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~ 537 (767)
+.++.|.++.||++...+|+.+++|....... .....+.+|+++++.+.+ ..+.+++.+..... ..+..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEEE
Confidence 56899999999999987678999998754322 235678899999999965 34567777643321 12345899999
Q ss_pred cCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 004218 538 LGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC----------------------------------- 582 (767)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 582 (767)
++|.++.+.+.. ..++..+...++.++++++++||+..
T Consensus 82 i~G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 82 VDGRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred eCCEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 999888876532 12677788888899999999998531
Q ss_pred ------------------CCCeEeecCCCCCeeeCC--CCceEEccccchhh
Q 004218 583 ------------------EVPIVHCDLKPGNILLDE--DMTAKVGDFGLARS 614 (767)
Q Consensus 583 ------------------~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg~a~~ 614 (767)
+..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998853
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-09 Score=98.65 Aligned_cols=128 Identities=23% Similarity=0.277 Sum_probs=94.5
Q ss_pred CccccccceEEEEEEeCCCcEEEEEEeeccC---Cc-----chhhHHHHHHHHhcCCC--CCceeEEeeeecCCccccee
Q 004218 461 NLIGSGSFGSVYKGYLREGISVAVKVLDIES---TG-----TWKSFFAECEALRNTRH--RNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~ 530 (767)
..+++|+-+.+|.+.+. |.++++|.-.+.. +. ...+-.+|++++.+++- -+...++++ +...
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~~ 73 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPDN 73 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCCC
Confidence 46789999999999875 5567777642221 11 12345689999988753 333444544 2223
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
..|+|||++|..|.+++... ...++..+-.-+.-||.. ||||+|+.++||++..+. +.++|||
T Consensus 74 ~~I~me~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfG 136 (204)
T COG3642 74 GLIVMEYIEGELLKDALEEA-------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFG 136 (204)
T ss_pred CEEEEEEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECC
Confidence 37999999999999888653 134677777888899999 999999999999998765 9999999
Q ss_pred chh
Q 004218 611 LAR 613 (767)
Q Consensus 611 ~a~ 613 (767)
++.
T Consensus 137 Lg~ 139 (204)
T COG3642 137 LGE 139 (204)
T ss_pred ccc
Confidence 996
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.8e-11 Score=131.24 Aligned_cols=211 Identities=26% Similarity=0.337 Sum_probs=146.3
Q ss_pred HHhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
...+.+.+.+.+.+|.++.++.+.-.. |...+.|+.... ...+.+....+-.+.-...+|-++..... +..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCC
Confidence 345567777788999999999887442 433444433211 12223333333333333345655554433 344
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
....+++++|..+++|...++.... .+..-+......+..+.+|||.. .+.|+|++|.|.+...++..+++
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~~------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~ 946 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSGC------LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLT 946 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCCC------cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccC
Confidence 5566999999999999999887653 44444555667788899999997 79999999999999999999999
Q ss_pred cccchhhhhhhcC-----------------------CCcc--ccccccccCCCCccCccccCCCCCCCcccchhhhHHHH
Q 004218 608 DFGLARSLLERIG-----------------------NQSS--ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLL 662 (767)
Q Consensus 608 Dfg~a~~~~~~~~-----------------------~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ 662 (767)
|||.....+-... .... ........||+.|.|||...+.....++|+|+.|++++
T Consensus 947 ~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen 947 DFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLF 1026 (1205)
T ss_pred ccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhh
Confidence 9984332211100 0000 01124466899999999999999999999999999999
Q ss_pred HHHhCCCCCCCccc
Q 004218 663 EIFTGMSPTHESFA 676 (767)
Q Consensus 663 el~tg~~p~~~~~~ 676 (767)
|.++|.+||.....
T Consensus 1027 e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAETP 1040 (1205)
T ss_pred hhhcCCCCCCCcch
Confidence 99999999976544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.2e-09 Score=96.05 Aligned_cols=142 Identities=24% Similarity=0.230 Sum_probs=99.5
Q ss_pred CCCccccccceEEEEEEeCCCcEEEEEEeeccC--------CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 459 HENLIGSGSFGSVYKGYLREGISVAVKVLDIES--------TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 459 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
....+-+|+-+.|+++.+. |+.+.||.-.... .-..++..+|++.+.++.--.|.-..-++.+ ...
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-----~~~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-----TYG 84 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-----cCC
Confidence 5678999999999999987 8888888542211 1123566789999988753333222112111 111
Q ss_pred eEEEEeecCC-CChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEE
Q 004218 531 LALVYEFLGN-GSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM---TAKV 606 (767)
Q Consensus 531 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl 606 (767)
-.++|||++| .++.+++...-.. .....-...++.+|-+.+.-||.. +|+||||..+||++..++ .+.+
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMED----ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccC----cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEE
Confidence 2799999977 5788888765432 122223367899999999999999 999999999999997554 4689
Q ss_pred ccccchh
Q 004218 607 GDFGLAR 613 (767)
Q Consensus 607 ~Dfg~a~ 613 (767)
+|||++.
T Consensus 158 Idfgls~ 164 (229)
T KOG3087|consen 158 IDFGLSS 164 (229)
T ss_pred Eeecchh
Confidence 9999985
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.8e-09 Score=101.23 Aligned_cols=124 Identities=27% Similarity=0.276 Sum_probs=82.4
Q ss_pred EEEEEEeCCCcEEEEEEeeccCC-------------c--------c-----hhhHHHHHHHHhcCCCC--CceeEEeeee
Q 004218 470 SVYKGYLREGISVAVKVLDIEST-------------G--------T-----WKSFFAECEALRNTRHR--NLVKLITSCS 521 (767)
Q Consensus 470 ~V~~~~~~~~~~vavK~~~~~~~-------------~--------~-----~~~~~~e~~~l~~l~h~--niv~~~~~~~ 521 (767)
.||.|...+|..+|||+.+.... . . .....+|.+.|.++... ++.+.+++..
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 48999998899999998743200 0 0 12356899999999655 5667766521
Q ss_pred cCCcccceeeEEEEeecC--CCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEeecCCCCCeee
Q 004218 522 SLDFKNMEFLALVYEFLG--NGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY-LHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 522 ~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
-.+||||++ |..+..+.... ++..+...++.+++..+.. +|+. ||+|||+.+.||++
T Consensus 81 ---------~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv 140 (188)
T PF01163_consen 81 ---------NVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILV 140 (188)
T ss_dssp ---------TEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEE
T ss_pred ---------CEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEe
Confidence 289999998 65555443322 1133456678888886666 4677 99999999999999
Q ss_pred CCCCceEEccccchhh
Q 004218 599 DEDMTAKVGDFGLARS 614 (767)
Q Consensus 599 ~~~~~~kl~Dfg~a~~ 614 (767)
+++ .+.|+|||.+..
T Consensus 141 ~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 141 DDG-KVYIIDFGQAVD 155 (188)
T ss_dssp ETT-CEEE--GTTEEE
T ss_pred ecc-eEEEEecCccee
Confidence 987 899999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.4e-10 Score=120.83 Aligned_cols=197 Identities=25% Similarity=0.209 Sum_probs=141.9
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC--CCcEEEEEEeeccCCcch--hhHHHHHHHHhcC-CCCCceeEEeeeecCCc
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR--EGISVAVKVLDIESTGTW--KSFFAECEALRNT-RHRNLVKLITSCSSLDF 525 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 525 (767)
..-..+|..+..||.|.|+.|+....+ ++..|++|.......... ..-..|+.+...+ .|.+++..+..+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~---- 336 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS---- 336 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc----
Confidence 345668888999999999999998744 477899997743322222 2223455555555 4777777665532
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-Cce
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED-MTA 604 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~ 604 (767)
.....++--|||++++......... .+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..
T Consensus 337 -~~r~~~ip~e~~~~~s~~l~~~~~~------~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 337 -QLRQGYIPLEFCEGGSSSLRSVTSQ------MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred -ccccccCchhhhcCcchhhhhHHHH------hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhh
Confidence 2333468889999998887663322 277788899999999999999998 99999999999999886 788
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCcc--CccccCCCCCCCcccchhhhHHHHHHHhCCCC
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI--PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 670 (767)
+++|||.+..+.-. . ....+.-++. +|+......+..+.|+||||..+.+..+|..-
T Consensus 407 ~~~~~~~~t~~~~~--------~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 407 KLGDFGCWTRLAFS--------S-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred hcccccccccccee--------c-ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 99999998642111 0 1111223333 55555666788999999999999999998754
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4e-10 Score=129.90 Aligned_cols=157 Identities=23% Similarity=0.347 Sum_probs=119.3
Q ss_pred CCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCcc--ccCCCCCCccccccccCCCCCCEEECcCCcceee
Q 004218 43 IPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNK--IVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120 (767)
Q Consensus 43 ~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~ 120 (767)
.|. ..+....+...+-+|.+. .++.... .++|++|-+..|. +..+ ....+..++.|+.|||++|.=.+.
T Consensus 516 ~~~-~~~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~i------s~~ff~~m~~LrVLDLs~~~~l~~ 586 (889)
T KOG4658|consen 516 IPQ-VKSWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEI------SGEFFRSLPLLRVLDLSGNSSLSK 586 (889)
T ss_pred ccc-ccchhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhc------CHHHHhhCcceEEEECCCCCccCc
Confidence 443 344477889999999987 5555443 3589999999886 4321 122377899999999999977779
Q ss_pred cCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccc--cccCcCc
Q 004218 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQIS--GSIPNTL 198 (767)
Q Consensus 121 ~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~--~~~~~~~ 198 (767)
+|+.++++.+ |++|++++..+. .+|..+.+++.|.+|++..+.-....+.....+++|++|.+..-... ...-..+
T Consensus 587 LP~~I~~Li~-LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el 664 (889)
T KOG4658|consen 587 LPSSIGELVH-LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKEL 664 (889)
T ss_pred CChHHhhhhh-hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhh
Confidence 9999999998 999999999998 78999999999999999998876566778888999999999776532 1222233
Q ss_pred ccCCCCceeeCC
Q 004218 199 GNLKKLNQIDLS 210 (767)
Q Consensus 199 ~~l~~L~~L~L~ 210 (767)
.++.+|+.|...
T Consensus 665 ~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 665 ENLEHLENLSIT 676 (889)
T ss_pred hcccchhhheee
Confidence 445555555543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3e-08 Score=99.82 Aligned_cols=202 Identities=14% Similarity=0.124 Sum_probs=132.4
Q ss_pred CCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeec--CCcccceeeEEE
Q 004218 458 SHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSS--LDFKNMEFLALV 534 (767)
Q Consensus 458 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~--~~~~~~~~~~lv 534 (767)
...+.||+|+-+.+|..-. -...+.|++.........+ .+..|... .||-+-.-+.|=.. ..-..+..+.+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3457799999999996532 1224567775443332222 22333333 56644331222100 001223347888
Q ss_pred EeecCCC-ChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 535 YEFLGNG-SLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 535 ~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
|+.+.+. ...++.....+.+.-....|...+++++.++.+.+.||+. |.+-||+.++|+|+++++.+.|.|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 9888764 2333333222222233478999999999999999999999 99999999999999999999998875544
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhC-CCCCCCc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTG-MSPTHES 674 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg-~~p~~~~ 674 (767)
... ......+.+|...|.+||.-. +-.-+...|-|.+|+++++++.| +.||...
T Consensus 166 i~~-------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 INA-------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ecc-------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 321 112234567899999999644 33346789999999999999887 8898654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1e-08 Score=105.89 Aligned_cols=176 Identities=19% Similarity=0.184 Sum_probs=133.0
Q ss_pred cceEEEEEEe-CCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeecCC-CChh
Q 004218 467 SFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGN-GSLG 544 (767)
Q Consensus 467 ~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 544 (767)
...+.|++.. .+|..|++|++.............-+++++++.|+|+|++.+++....+ .+..+++||+|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHH
Confidence 3467899984 5799999999954433333334466889999999999999998764444 35567899999987 6787
Q ss_pred hhhcccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 545 DWIHGERKN---------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 545 ~~l~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
+........ ..+...++...|.++.|+..||.++|+. |..-+-+.|.+|+++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 765433221 2345688999999999999999999999 9999999999999999999999988887554
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCC
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMS 669 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~ 669 (767)
..+. . |-+. --.+-|.=.+|.+++.+.||..
T Consensus 444 ~~d~------------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDP------------------T--EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCC------------------C--cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 3321 0 1111 1235789999999999999954
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=8e-10 Score=83.53 Aligned_cols=61 Identities=34% Similarity=0.497 Sum_probs=43.8
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccC
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLL 63 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i 63 (767)
++|++|+|++|+++ .+|...|..+++|++|++++|.+....|++|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 45677777777776 77777777777777777777777766666777777777777777764
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.9e-09 Score=99.83 Aligned_cols=147 Identities=26% Similarity=0.183 Sum_probs=105.2
Q ss_pred ccCHHHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccC-----------------Cc-----chhhHHHH
Q 004218 444 MISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIES-----------------TG-----TWKSFFAE 501 (767)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------~~-----~~~~~~~e 501 (767)
.+....+..-..=+.+...||-|--+.||.|...+|.++|||.-+... .. ......+|
T Consensus 80 ~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rE 159 (304)
T COG0478 80 ALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAERE 159 (304)
T ss_pred HHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHH
Confidence 333444444444456778999999999999999999999999753210 00 12346789
Q ss_pred HHHHhcCCCC--CceeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 004218 502 CEALRNTRHR--NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579 (767)
Q Consensus 502 ~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 579 (767)
.++|.++... .+.+.+++ +...+||||++|-.|...- ++......++..|++-+..+-
T Consensus 160 f~~L~~L~~~G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~ 219 (304)
T COG0478 160 FEALQRLYPEGVKVPKPIAW---------NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAY 219 (304)
T ss_pred HHHHHHhhhcCCCCCCcccc---------ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHH
Confidence 9999998654 67776665 3348999999986655432 223344455666666666665
Q ss_pred hCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 580 ~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
.. ||||||+.+-||+++++|.+.++||-.+.
T Consensus 220 ~~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 220 RR---GIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred Hc---CccccCCchheEEEecCCCEEEEeCcccc
Confidence 66 99999999999999999999999996664
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.1e-08 Score=100.25 Aligned_cols=145 Identities=17% Similarity=0.023 Sum_probs=98.1
Q ss_pred CccccccceEEEEEEeCCCcEEEEEEeeccCCc-----------chhhHHHHHHHHhcCCCC--CceeEEeeeecCCccc
Q 004218 461 NLIGSGSFGSVYKGYLREGISVAVKVLDIESTG-----------TWKSFFAECEALRNTRHR--NLVKLITSCSSLDFKN 527 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~ 527 (767)
+.+-......|+++... |+.|.||........ ....+.+|.+.+.++... ..++.+++........
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 34444444557777664 788999977432210 111377888888777322 2334444432211111
Q ss_pred ceeeEEEEeecCCC-ChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC------
Q 004218 528 MEFLALVYEFLGNG-SLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE------ 600 (767)
Q Consensus 528 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~------ 600 (767)
....++|||++++. +|.+++..... ...+...+..++.+++..+.-||.. ||+|+|+++.||+++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCC
Confidence 23458999999885 89999853211 1255677789999999999999999 9999999999999975
Q ss_pred -CCceEEccccchh
Q 004218 601 -DMTAKVGDFGLAR 613 (767)
Q Consensus 601 -~~~~kl~Dfg~a~ 613 (767)
++.+.++||+.+.
T Consensus 180 ~~~~~~LIDl~r~~ 193 (268)
T PRK15123 180 EDLKLSVIDLHRAQ 193 (268)
T ss_pred CCceEEEEECCccc
Confidence 4689999999885
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.6e-09 Score=81.94 Aligned_cols=61 Identities=39% Similarity=0.570 Sum_probs=36.4
Q ss_pred CceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCccc
Q 004218 275 GNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKL 335 (767)
Q Consensus 275 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 335 (767)
++|+.|++++|+++.+.+..|.++++|++|++++|.++...+..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3556666666666655555666666666666666666555555566666666666666553
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.3e-10 Score=123.43 Aligned_cols=89 Identities=34% Similarity=0.273 Sum_probs=39.1
Q ss_pred hhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCC-Ccccccccc
Q 004218 270 EIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSI-PSDLQNLRA 348 (767)
Q Consensus 270 ~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~ 348 (767)
.+..+++|++|||++|.+..+.--...++. |+.|.+++|.++.. ..+.++.+|+.||+++|-|.+.- -..+..+..
T Consensus 204 ~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~ 280 (1096)
T KOG1859|consen 204 NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSS 280 (1096)
T ss_pred HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHH
Confidence 344455555555555555422222222332 55555555555421 12344445555555555544211 111334444
Q ss_pred CceEeccCCcCcC
Q 004218 349 LRSLNLTFNNLEG 361 (767)
Q Consensus 349 L~~L~l~~N~l~~ 361 (767)
|+.|+|.||++.+
T Consensus 281 L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 281 LIVLWLEGNPLCC 293 (1096)
T ss_pred HHHHhhcCCcccc
Confidence 5555555555543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.9e-09 Score=102.94 Aligned_cols=189 Identities=25% Similarity=0.283 Sum_probs=107.6
Q ss_pred hhhhccccCeEEccCCcccc--cCCccccCCCCCCEEECcCCcCcccCcccc-CCCCCCCEEEccCCccc-cccCcCccc
Q 004218 125 IGNLSNVLSKLYMGGNRFYG--KIPTSIGRLRSLTLLNLSYNSISGEILTEI-GQLQELQSLDLAGNQIS-GSIPNTLGN 200 (767)
Q Consensus 125 ~~~l~~~L~~L~l~~n~i~~--~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~-~~l~~L~~L~L~~n~i~-~~~~~~~~~ 200 (767)
++.....+++|||.+|.|+. .+...+.+|+.|++|+|+.|.+...+ +.+ ..+.+|++|-|.+..+. ......+..
T Consensus 66 ~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I-~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~ 144 (418)
T KOG2982|consen 66 FGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDI-KSLPLPLKNLRVLVLNGTGLSWTQSTSSLDD 144 (418)
T ss_pred HHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCcc-ccCcccccceEEEEEcCCCCChhhhhhhhhc
Confidence 34443447778888887762 34445677888888888888887432 233 46678888888887776 233345567
Q ss_pred CCCCceeeCCCCcCCCC--CcccccC-ccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCce
Q 004218 201 LKKLNQIDLSGNELASE--IPTSFGN-FQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNV 277 (767)
Q Consensus 201 l~~L~~L~L~~N~l~~~--~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L 277 (767)
++.+++|++|.|.+... ..+.... -+.+++|.+..|... +++..|++. .-++++
T Consensus 145 lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~----------------~w~~~~~l~-------r~Fpnv 201 (418)
T KOG2982|consen 145 LPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQ----------------LWLNKNKLS-------RIFPNV 201 (418)
T ss_pred chhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHH----------------HHHHHHhHH-------hhcccc
Confidence 77778888887744321 1111111 124444444444322 123333333 235667
Q ss_pred eEEEccCCCCCCCC-CcccccCcccceeeccCccccCC-CCchhhccCCceEEEcCCcccCC
Q 004218 278 VTIDLSANGLSGNL-PNSFKNCKSLEKLLMANNKFSGP-IPNILAELKGLEVLDLSSNKLSG 337 (767)
Q Consensus 278 ~~L~ls~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~ 337 (767)
..+.+..|.+.+.. ...+..++.+.-|+|+.|+|..- ..+.+.+++.|..|.+++|++.+
T Consensus 202 ~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 202 NSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred hheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 77777777665322 23344555666666666666531 22455566666666666666653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.4e-07 Score=88.77 Aligned_cols=143 Identities=15% Similarity=0.071 Sum_probs=104.9
Q ss_pred cccccceEEEEEEeCCCcEEEEEEeeccC------CcchhhHHHHHHHHhcCCC--CCceeEEeeeecCCcccceeeEEE
Q 004218 463 IGSGSFGSVYKGYLREGISVAVKVLDIES------TGTWKSFFAECEALRNTRH--RNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 463 lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
-|+||.+.|+..... |..+-+|.-.... +-....|.+|...++++.. -.+.+.+ ++........-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467899999998776 5578888764211 3355789999999988842 2244444 3322212233456899
Q ss_pred EeecCC-CChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--eEEccccc
Q 004218 535 YEFLGN-GSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT--AKVGDFGL 611 (767)
Q Consensus 535 ~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~ 611 (767)
+|-+++ .||.+++..... .+.+......+..+++..++-||+. |+.|+|+.+.||+++.++. ++++||.-
T Consensus 104 Te~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 998764 589888865331 2367778889999999999999999 9999999999999986666 99999987
Q ss_pred hhh
Q 004218 612 ARS 614 (767)
Q Consensus 612 a~~ 614 (767)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 754
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.8e-10 Score=104.18 Aligned_cols=235 Identities=17% Similarity=0.168 Sum_probs=137.0
Q ss_pred CCCccEEeCCCCeeeec----CCCccccCCCCCcEEEccCCcc---cccC-------CccccCCCCCCEEEcccccCccc
Q 004218 1 MTSLVYLGLASNQLWGE----IPYDVGDKLPNLLGFNFCFNKF---TGKI-------PGSLHNLTNIQIIRMAHNLLEGT 66 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~----ip~~~~~~l~~L~~L~l~~n~l---~~~~-------~~~l~~l~~L~~L~l~~n~i~~~ 66 (767)
|..++++|||+|.|.++ +...+. .-.+|+..+++.--. .+.+ ...+-++++|+..+||.|.++..
T Consensus 29 ~d~~~evdLSGNtigtEA~e~l~~~ia-~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~ 107 (388)
T COG5238 29 MDELVEVDLSGNTIGTEAMEELCNVIA-NVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSE 107 (388)
T ss_pred hcceeEEeccCCcccHHHHHHHHHHHh-hhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCcc
Confidence 45688899999988743 222333 255677777765422 2222 24567888999999999988765
Q ss_pred CCc----cCCCCCCCcEEeecCccccCCCCCCcccccccc---------CCCCCCEEECcCCcceeecCchhhhh----c
Q 004218 67 VPP----GLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLT---------NSTRLNFLAFDGNQFEGEIPESIGNL----S 129 (767)
Q Consensus 67 ~~~----~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~---------~l~~L~~L~l~~n~l~~~~~~~~~~l----~ 129 (767)
.|+ .++.-..|.+|.|++|.+. |..+-.+..++. +-+.|+...+..|++. ..|...+.. -
T Consensus 108 ~~e~L~d~is~~t~l~HL~l~NnGlG--p~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRle-ngs~~~~a~~l~sh 184 (388)
T COG5238 108 FPEELGDLISSSTDLVHLKLNNNGLG--PIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLE-NGSKELSAALLESH 184 (388)
T ss_pred cchHHHHHHhcCCCceeEEeecCCCC--ccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhc-cCcHHHHHHHHHhh
Confidence 554 4555688889999888763 333333433222 3367777778887776 334333321 1
Q ss_pred cccCeEEccCCcccccC-----CccccCCCCCCEEECcCCcCccc----CccccCCCCCCCEEEccCCccccccCcCc--
Q 004218 130 NVLSKLYMGGNRFYGKI-----PTSIGRLRSLTLLNLSYNSISGE----ILTEIGQLQELQSLDLAGNQISGSIPNTL-- 198 (767)
Q Consensus 130 ~~L~~L~l~~n~i~~~~-----~~~l~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-- 198 (767)
..|+++.+..|.|.... .-.+..+.+|++|||++|-++.. +..++...+.|+.|.+..|-++......+
T Consensus 185 ~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~ 264 (388)
T COG5238 185 ENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLR 264 (388)
T ss_pred cCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHH
Confidence 12677777777765221 11234566777777777776632 22344556667777777776663332221
Q ss_pred --c--cCCCCceeeCCCCcCCCCCccc-----c--cCccccccccccCcccC
Q 004218 199 --G--NLKKLNQIDLSGNELASEIPTS-----F--GNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 199 --~--~l~~L~~L~L~~N~l~~~~~~~-----~--~~l~~L~~L~l~~n~l~ 239 (767)
. ..++|..|-..+|.+.+..-.. | ..++-|..|.+.+|++.
T Consensus 265 ~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~ 316 (388)
T COG5238 265 RFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIK 316 (388)
T ss_pred HhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcch
Confidence 1 2356666666666655321111 1 24555666666666655
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.9e-07 Score=88.04 Aligned_cols=142 Identities=17% Similarity=0.160 Sum_probs=97.1
Q ss_pred HhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHH---------HHHHHHhcC---CCCCceeEEeee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFF---------AECEALRNT---RHRNLVKLITSC 520 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~e~~~l~~l---~h~niv~~~~~~ 520 (767)
..++|...+++-......|.+.... |+.+++|.........++.|. +++..+.++ .-.....++.++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4678888888888887778777765 789999988654433333222 233333333 333444444444
Q ss_pred ecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC
Q 004218 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE 600 (767)
Q Consensus 521 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~ 600 (767)
....+.-....+++|||++|..|.++.. +++ .++..+.+++.-+|+. |++|+|.+|.|+++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 3333333455679999999988876642 222 2456778889999999 9999999999999986
Q ss_pred CCceEEccccchh
Q 004218 601 DMTAKVGDFGLAR 613 (767)
Q Consensus 601 ~~~~kl~Dfg~a~ 613 (767)
++ ++++||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 55 9999997764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=2e-07 Score=90.26 Aligned_cols=110 Identities=23% Similarity=0.168 Sum_probs=82.7
Q ss_pred hhhHHHHHHHHhcCC--CCCceeEEeeeecCCcccceeeEEEEeecCC-CChhhhhcccCCCCCCCCCCHHHHHHHHHHH
Q 004218 495 WKSFFAECEALRNTR--HRNLVKLITSCSSLDFKNMEFLALVYEFLGN-GSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571 (767)
Q Consensus 495 ~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i 571 (767)
.....+|.+.+..+. .-.+.+.+++........ ...++|+|++++ .+|.+++..... .+......++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~~------~~~~~~~~ll~~l 127 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWEQ------LDPSQRRELLRAL 127 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhcc------cchhhHHHHHHHH
Confidence 345777888777663 223455555543322122 456899999988 479999876332 5566778899999
Q ss_pred HHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEEccccchhh
Q 004218 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDM---TAKVGDFGLARS 614 (767)
Q Consensus 572 ~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~Dfg~a~~ 614 (767)
+..++-||.. ||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 128 ~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 128 ARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999 999999999999999887 899999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.8e-10 Score=120.97 Aligned_cols=101 Identities=30% Similarity=0.429 Sum_probs=56.0
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCc-CcccCCCCceeeCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPN-TLGNLKKLNQIDLS 210 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~L~ 210 (767)
|...+++.|++. .+..++.-++.|+.|+|++|+++. ...+..++.|++|||++|++. .+|. ....+. |..|.|+
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~--v~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTK--VDNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhh--hHHHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 445556666665 455555556666666666666654 225556666666666666665 3332 122222 6666666
Q ss_pred CCcCCCCCcccccCccccccccccCcccC
Q 004218 211 GNELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 211 ~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
+|.++.. ..+.++.+|+.||+++|-|.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~ 267 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLS 267 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhh
Confidence 6666522 33455666666666666555
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.2e-08 Score=109.51 Aligned_cols=100 Identities=25% Similarity=0.467 Sum_probs=75.8
Q ss_pred HHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCcccc---ccccccCCCCccCccccCC
Q 004218 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSIS---STHVLKGSIGYIPPEYGLG 645 (767)
Q Consensus 569 ~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~ 645 (767)
.+++.|+.|+|.. .++||++|.|++|.++..+..||+.|+++.............+ ......-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3445899999987 4999999999999999999999999999876544221111111 1111224567999999999
Q ss_pred CCCCCcccchhhhHHHHHHHhCCCC
Q 004218 646 EKPSTAGDVYSFGVMLLEIFTGMSP 670 (767)
Q Consensus 646 ~~~~~~~Dv~slG~il~el~tg~~p 670 (767)
...+.++|+||+|+.+|.+..|..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcc
Confidence 8889999999999999999954443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 767 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-35 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-35 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-35 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-32 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-11 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-11 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-11 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 7e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-11 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 7e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-10 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 3t6q_A | 606 | Crystal Structure Of Mouse Rp105MD-1 Complex Length | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 4e-07 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 4e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-07 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 5e-07 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-07 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 9e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-07 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-06 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 6e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 2e-05 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 5e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-05 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 3e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-05 | ||
| 3o6n_A | 390 | Crystal Structure Of Apl1 Leucine-Rich Repeat Domai | 5e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-05 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 7e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-04 | ||
| 3oja_B | 597 | Crystal Structure Of Lrim1APL1C COMPLEX Length = 59 | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3O6N|A Chain A, Crystal Structure Of Apl1 Leucine-Rich Repeat Domain Length = 390 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3OJA|B Chain B, Crystal Structure Of Lrim1APL1C COMPLEX Length = 597 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 348 bits (896), Expect = e-109
Identities = 124/407 (30%), Positives = 187/407 (45%), Gaps = 21/407 (5%)
Query: 2 TSLVYLGLASNQLWGEIPYDVG-DKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
SL+ L L+SN G I ++ + L N FTGKIP +L N + + + ++
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L GT+P LG+L L+ + N + G L L L D N GE
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGE------IPQELMYVKTLETLILDFNDLTGE 481
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IP + N +N L+ + + NR G+IP IGRL +L +L LS NS SG I E+G + L
Sbjct: 482 IPSGLSNCTN-LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL 540
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN--KL 238
LDL N +G+IP + ++ N +A + N + N +
Sbjct: 541 IWLDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEF 596
Query: 239 NGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNC 298
G +++ LS+ N++ G G+++ +D+S N LSG +P +
Sbjct: 597 QGIRSEQLNRLSTRNPC-NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSM 655
Query: 299 KSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNN 358
L L + +N SG IP+ + +L+GL +LDLSSNKL G IP + L L ++L+ NN
Sbjct: 656 PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 715
Query: 359 LEGVVPREGIFRHTSMVHLEGNPKLC-LHL-----GCENSSSHGRRR 399
L G +P G F NP LC L + +H +R
Sbjct: 716 LSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRS 762
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 1e-88
Identities = 121/376 (32%), Positives = 173/376 (46%), Gaps = 23/376 (6%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVG-DKLPNLLGFNFCFNKFTGKIPGS-LHNLTNIQIIRM 58
SL L L+ N L G + L N N S L +++++ +
Sbjct: 99 SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 59 AHNLLEGTVPPGL---GNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGN 115
+ N + G G LK I NKI G ++ L FL N
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGD--------VDVSRCVNLEFLDVSSN 210
Query: 116 QFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIG 175
F IP +G+ S L L + GN+ G +I L LLN+S N G I
Sbjct: 211 NFSTGIP-FLGDCSA-LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP- 267
Query: 176 QLQELQSLDLAGNQISGSIPNTL-GNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLS 234
L+ LQ L LA N+ +G IP+ L G L +DLSGN +P FG+ L S+ LS
Sbjct: 268 -LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 326
Query: 235 NNKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIG-MLGNVVTIDLSANGLSGNLP 292
+N +G +P + L + L + +LS N G LPE + + +++T+DLS+N SG +
Sbjct: 327 SNNFSGELPMDTLLKMRGLKVL-DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 385
Query: 293 NSFKNC--KSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALR 350
+ +L++L + NN F+G IP L+ L L LS N LSG+IPS L +L LR
Sbjct: 386 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445
Query: 351 SLNLTFNNLEGVVPRE 366
L L N LEG +P+E
Sbjct: 446 DLKLWLNMLEGEIPQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 4e-83
Identities = 97/389 (24%), Positives = 162/389 (41%), Gaps = 28/389 (7%)
Query: 2 TSLVYLGLASNQL---WGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRM 58
+ + L+S L + + + L L + G + ++ + +
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLL-SLTGLESLFLSNSHINGSVS-GFKCSASLTSLDL 107
Query: 59 AHNLLEGTVPPG--LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQ 116
+ N L G V LG+ LK N+ N + G ++ L L N
Sbjct: 108 SRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK-----VSGGLKLNSLEVLDLSANS 162
Query: 117 FEGEIPESI---GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTE 173
G L L + GN+ G + + R +L L++S N+ S I
Sbjct: 163 ISGANVVGWVLSDGCGE-LKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PF 218
Query: 174 IGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDL 233
+G LQ LD++GN++SG + +L +++S N+ IP ++L + L
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL 276
Query: 234 SNNKLNGNIPKEIL-SLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLP 292
+ NK G IP + + +LT + +LS N G +P G + ++ LS+N SG LP
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGL-DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335
Query: 293 -NSFKNCKSLEKLLMANNKFSGPIPNILAELKG-LEVLDLSSNKLSGSIPSDLQN--LRA 348
++ + L+ L ++ N+FSG +P L L L LDLSSN SG I +L
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 349 LRSLNLTFNNLEGVVPREGIFRHTSMVHL 377
L+ L L N G +P + + +V L
Sbjct: 396 LQELYLQNNGFTGKIPPT-LSNCSELVSL 423
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 1e-73
Identities = 95/329 (28%), Positives = 151/329 (45%), Gaps = 22/329 (6%)
Query: 46 SLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNST 105
+T+I + N+ V L +L L+ + + I GS ++ S
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGS-------VSGFKCSA 100
Query: 106 RLNFLAFDGNQFEGEIPE--SIGNLSNVLSKLYMGGNRFYGKIPTSIG-RLRSLTLLNLS 162
L L N G + S+G+ S L L + N S G +L SL +L+LS
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCSG-LKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 163 YNSISGEILTEI---GQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIP 219
NSISG + EL+ L ++GN+ISG + + L +D+S N ++ IP
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP 217
Query: 220 TSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVT 279
G+ L +D+S NKL+G+ + I + + L + N+S N G +P L ++
Sbjct: 218 -FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLL-NISSNQFVGPIPPLP--LKSLQY 273
Query: 280 IDLSANGLSGNLPNSFK-NCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGS 338
+ L+ N +G +P+ C +L L ++ N F G +P LE L LSSN SG
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333
Query: 339 IPSD-LQNLRALRSLNLTFNNLEGVVPRE 366
+P D L +R L+ L+L+FN G +P
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPES 362
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 6e-59
Identities = 77/243 (31%), Positives = 118/243 (48%), Gaps = 10/243 (4%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
T+L ++ L++N+L GEIP +G +L NL N F+G IP L + ++ + +
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIG-RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
NL GT+P + N K +I + + A + +F+G
Sbjct: 548 NLFNGTIPAAMFKQSGKIAANFIAGKR-------YVYIKNDGMKKECH-GAGNLLEFQGI 599
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
E + LS + + + G + S+ L++SYN +SG I EIG + L
Sbjct: 600 RSEQLNRLST-RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYL 658
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
L+L N ISGSIP+ +G+L+ LN +DLS N+L IP + L IDLSNN L+G
Sbjct: 659 FILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718
Query: 241 NIP 243
IP
Sbjct: 719 PIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 16/59 (27%), Positives = 28/59 (47%), Gaps = 3/59 (5%)
Query: 325 LEVLDLSSNKLS---GSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGN 380
+ +DLSS L+ ++ S L +L L SL L+ +++ G V + + L N
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = 5e-96
Identities = 88/297 (29%), Positives = 141/297 (47%), Gaps = 10/297 (3%)
Query: 95 LSFITSLTNSTRL----NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYG--KIPT 148
L L N T L + G + ++ V + L + G IP+
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRV-NNLDLSGLNLPKPYPIPS 70
Query: 149 SIGRLRSLTLLNLS-YNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQI 207
S+ L L L + N++ G I I +L +L L + +SG+IP+ L +K L +
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 208 DLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTL 267
D S N L+ +P S + NL+ I N+++G IP S S L T + +S+N L G +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 268 PEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEV 327
P L N+ +DLS N L G+ F + K+ +K+ +A N + + + K L
Sbjct: 191 PPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNG 248
Query: 328 LDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC 384
LDL +N++ G++P L L+ L SLN++FNNL G +P+ G + + N LC
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 1e-60
Identities = 66/256 (25%), Positives = 108/256 (42%), Gaps = 35/256 (13%)
Query: 1 MTSLVYLGLAS-NQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMA 59
+ L +L + N L G IP + KL L +G IP L + + + +
Sbjct: 75 LPYLNFLYIGGINNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 60 HNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG 119
+N L GT+PP + +L L + FDGN+ G
Sbjct: 134 YNALSGTLPPSISSL------------------------------PNLVGITFDGNRISG 163
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
IP+S G+ S + + + + NR GKIP + L +L ++LS N + G+ G +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKN 222
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
Q + LA N ++ + +G K LN +DL N + +P + L S+++S N L
Sbjct: 223 TQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 240 GNIPKEILSLSSLTTI 255
G IP+ +L
Sbjct: 282 GEIPQG-GNLQRFDVS 296
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 6e-84
Identities = 112/317 (35%), Positives = 164/317 (51%), Gaps = 33/317 (10%)
Query: 441 SPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIEST-GTWKSFF 499
+ S EL+ A+ NFS++N++G G FG VYKG L +G VAVK L E T G F
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 500 AECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGL 559
E E + HRNL++L C + E L LVY ++ NGS+ + +++ L
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPT----ERL-LVYPYMANGSVASCLRERPESQ--PPL 128
Query: 560 NFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERI 619
++ +R IA+ A L YLH+ C+ I+H D+K NILLDE+ A VGDFGLA+ + +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK- 187
Query: 620 GNQSSISSTHV---LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676
THV ++G+IG+I PEY K S DV+ +GVMLLE+ TG +
Sbjct: 188 -------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 677 GE---VSLVKWVESNFP-KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTT 732
V L+ WV+ K + ++D +L+ E + +I+ V L CT
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE---------VEQLIQ-VALLCTQ 290
Query: 733 ESPGGRIDIREALRRLK 749
SP R + E +R L+
Sbjct: 291 SSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 8e-83
Identities = 104/322 (32%), Positives = 159/322 (49%), Gaps = 26/322 (8%)
Query: 435 STLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGT 494
S L + +L AT NF H+ LIG G FG VYKG LR+G VA+K ES+
Sbjct: 19 SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG 78
Query: 495 WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNE 554
+ F E E L RH +LV LI C + M L+Y+++ NG+L ++G +
Sbjct: 79 IEEFETEIETLSFCRHPHLVSLIGFCDERN--EM---ILIYKYMENGNLKRHLYG--SDL 131
Query: 555 HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614
+++ +RL I I A L YLH I+H D+K NILLDE+ K+ DFG+++
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674
E +Q+ + ST V KG++GYI PEY + + + DVYSFGV+L E+ S +S
Sbjct: 189 GTE--LDQTHL-STVV-KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244
Query: 675 F-AGEVSLVKWVESNFPK-NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTT 732
V+L +W + +Q++D L + + L + + C
Sbjct: 245 LPREMVNLAEWAVESHNNGQLEQIVDPNL-------ADKIRP--ESLRKFGD-TAVKCLA 294
Query: 733 ESPGGRIDIREALRRLKNAQKI 754
S R + + L +L+ A ++
Sbjct: 295 LSSEDRPSMGDVLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 4e-73
Identities = 96/321 (29%), Positives = 148/321 (46%), Gaps = 41/321 (12%)
Query: 441 SPQMISYDELRRATGNFSHE------NLIGSGSFGSVYKGYLREGISVAVKVL----DIE 490
S+ EL+ T NF N +G G FG VYKGY+ +VAVK L DI
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 491 STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGE 550
+ + F E + + +H NLV+L+ S D + LVY ++ NGSL D +
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD----DLC-LVYVYMPNGSLLDRLSCL 124
Query: 551 RKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610
L++ R IA A+ +++LH + +H D+K NILLDE TAK+ DFG
Sbjct: 125 DGTPP---LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178
Query: 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
LAR+ + Q+ + ++ ++ G+ Y+ PE G + + D+YSFGV+LLEI TG+
Sbjct: 179 LARASEK--FAQTVM-TSRIV-GTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233
Query: 671 THESFAGEVSLVKWVESNF--PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGL 728
E L+ E K + +D+++ +S V
Sbjct: 234 VDEH-REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYS-----------VAS 281
Query: 729 SCTTESPGGRIDIREALRRLK 749
C E R DI++ + L+
Sbjct: 282 QCLHEKKNKRPDIKKVQQLLQ 302
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 4e-70
Identities = 79/411 (19%), Positives = 154/411 (37%), Gaps = 39/411 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+T L + ++ E N + + NL ++ + + +
Sbjct: 205 LTKLRQFYMGNSPFVAENI------CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYN 258
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVG--SGDEGLSFITSLTNSTRLNFLAFDGNQF- 117
+P L LP +++ N+ N+ + + + ++ + N
Sbjct: 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 118 EGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQL 177
+ S+ + L L N+ GK+P + G L LNL+YN I+ G
Sbjct: 319 TFPVETSLQKMKK-LGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFT 376
Query: 178 QELQSLDLAGNQISGSIPNTL--GNLKKLNQIDLSGNELAS-------EIPTSFGNFQNL 228
+++++L A N++ IPN ++ ++ ID S NE+ S + + N+
Sbjct: 377 EQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 229 LSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDG-------TLPEEIGMLGNVVTID 281
SI+LSNN+++ + + S L++I NL N L E + +ID
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSI-NLMGNMLTEIPKNSLKDENENFKNTYLLTSID 494
Query: 282 LSANGLSGNLPN-SFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVL------DLSSNK 334
L N L+ + L + ++ N FS P L+ D N+
Sbjct: 495 LRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNR 553
Query: 335 LSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCL 385
P + +L L + N++ V E I + S++ ++ NP + +
Sbjct: 554 TLREWPEGITLCPSLTQLQIGSNDIRKVN--EKITPNISVLDIKDNPNISI 602
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 6e-63
Identities = 66/403 (16%), Positives = 130/403 (32%), Gaps = 51/403 (12%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTG----KIPGSLHNLTNIQII 56
+ L L G +P +G +L L + P + + +
Sbjct: 80 NGRVTGLSLEGFGASGRVPDAIG-QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 57 RMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQ 116
+ + T F + N S S + + + N
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQK----SIKKSSRITLKDTQIGQLSNN 194
Query: 117 FEGEIPESIGNLSNVLSKLYMGGNRF-------------------YGKIPTSIGRLRSLT 157
+ +++ L+ L + YMG + F Y L+ LT
Sbjct: 195 ITF-VSKAVMRLTK-LRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLT 252
Query: 158 LLNLSYNSISGEILTEIGQLQELQSLDLAGNQI--------SGSIPNTLGNLKKLNQIDL 209
+ + ++ T + L E+Q +++A N+ +K+ I +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 210 SGNELAS-EIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLP 268
N L + + TS + L ++ N+L G +P S L ++ NL+ N +
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASL-NLAYNQITEIPA 370
Query: 269 EEIGMLGNVVTIDLSANGLSGNLPNSF--KNCKSLEKLLMANNKFSG-------PIPNIL 319
G V + + N L +PN F K+ + + + N+ P+
Sbjct: 371 NFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429
Query: 320 AELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGV 362
+ + ++LS+N++S L S+NL N L +
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-61
Identities = 68/404 (16%), Positives = 124/404 (30%), Gaps = 62/404 (15%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFT--------GKIPGSLHNLTN 52
+ L + + + ++P + LP + N N+ +
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
Query: 53 IQIIRMAHN-LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLA 111
IQII + +N L V L + L M +N++ G + + + +L L
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-------KLPAFGSEIKLASLN 359
Query: 112 FDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIP--TSIGRLRSLTLLNLSYNSISG- 168
NQ G + L N+ IP + ++ ++ SYN I
Sbjct: 360 LAYNQITEIPANFCGFTEQ-VENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSV 417
Query: 169 ------EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELAS------ 216
+ + + S++L+ NQIS L+ I+L GN L
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477
Query: 217 -EIPTSFGNFQNLLSIDLSNNKLNGNIPKEI--LSLSSLTTIVNLSKNFLDGTLPEEIGM 273
+ +F N L SIDL NKL + + +L L I +LS N P +
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGI-DLSYNSFSK-FPTQPLN 534
Query: 274 LGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSN 333
+ + N+ P + L L + SN
Sbjct: 535 SSTLKGFGIRNQ------------------RDAQGNRTLREWPEGITLCPSLTQLQIGSN 576
Query: 334 KLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHL 377
+ + + + L++ N + + +
Sbjct: 577 DIR-KVNEKI--TPNISVLDIKDNPNIS-IDLSYVCPYIEAGMY 616
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 6e-59
Identities = 49/385 (12%), Positives = 132/385 (34%), Gaps = 35/385 (9%)
Query: 14 LWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEG----TVPP 69
+WG P + + G + +G++P ++ LT ++++ + + + P
Sbjct: 68 MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPK 127
Query: 70 GLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLS 129
G+ + + + + + L + + + I +S
Sbjct: 128 GISANMSDEQKQKMRMHYQKTFVDYD----PREDFSDLIKDCINSDPQQKSIKKSSRITL 183
Query: 130 NVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQ 189
+++ N + ++ RL L + + E + E + + + Q
Sbjct: 184 K-DTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQ 236
Query: 190 ISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKL--------NGN 241
+ NLK L +++ +++PT + I+++ N+ +
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296
Query: 242 IPKEILSLSSLTTIVNLSKN-FLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+ + I + N + + + + ++ N L G +F +
Sbjct: 297 ALADAPVGEKIQII-YIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIK 354
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQ--NLRALRSLNLTFNN 358
L L +A N+ + N + +E L + NKL IP+ ++ + +++ ++N
Sbjct: 355 LASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNE 413
Query: 359 LEGVVPR------EGIFRHTSMVHL 377
+ V + F+ ++ +
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSI 438
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-57
Identities = 49/356 (13%), Positives = 116/356 (32%), Gaps = 20/356 (5%)
Query: 32 FNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSG 91
FN + + + SL++ + + + G VP +G L L++ +G +
Sbjct: 62 FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE--KV 119
Query: 92 DEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNV-LSKLYMGGNRFYGKIPTSI 150
+E L ++ + ++ + L K + + I S
Sbjct: 120 NERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179
Query: 151 GRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLS 210
T + N+I+ + + +L +L+ + + +
Sbjct: 180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY 238
Query: 211 GNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFL------- 263
+ N ++L +++ N +P + +L + I N++ N
Sbjct: 239 KT-----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI-NVACNRGISGEQLK 292
Query: 264 -DGTLPEEIGMLGNVVTIDLSANGL-SGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAE 321
D + + + I + N L + + S + K L L N+ G +P
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GS 351
Query: 322 LKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHL 377
L L+L+ N+++ + + +L+ N L+ + + M +
Sbjct: 352 EIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAI 407
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 29/231 (12%), Positives = 65/231 (28%), Gaps = 39/231 (16%)
Query: 165 SISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGN 224
S G + LD+ G Q +L + ++ + L G + +P + G
Sbjct: 48 SQQGFGTQPGANWNFNKELDMWGAQP----GVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 225 FQNLLSIDLSNNKLNGN----IPKEILSLSSLTTIVN----------------------- 257
L + L ++ N PK I + S
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163
Query: 258 --LSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPI 315
++ + ++ + + I +N ++ + + L + M N+ F
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 316 PNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE 366
+ E + + + NL+ L + + +P
Sbjct: 223 I-----CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF 268
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-64
Identities = 70/324 (21%), Positives = 126/324 (38%), Gaps = 34/324 (10%)
Query: 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEA 504
+ + L + + G FG V+K L VAVK+ I+ +W+ E +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ-NEYEVYS 71
Query: 505 LRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER 564
L +H N+++ I + +++ L+ F GSL D++ N +++ E
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLW-LITAFHEKGSLSDFLKA-------NVVSWNEL 123
Query: 565 LNIAIDIASALDYLHND-------CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE 617
+IA +A L YLH D + I H D+K N+LL ++TA + DFGLA
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL---- 179
Query: 618 RIGNQSSISSTHVLKGSIGYIPPEY-----GLGEKPSTAGDVYSFGVMLLEIFTGMSP-T 671
+ S TH G+ Y+ PE D+Y+ G++L E+ + +
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 672 HESFAGEVSLVKWVESNFPKNAQQ--VLDRELRQLMMSSESQTIQLHDCLITIIESVGLS 729
+ + + + Q V+ ++ R ++ + + L IE
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMA-MLCETIE----E 294
Query: 730 CTTESPGGRIDIREALRRLKNAQK 753
C R+ R+ Q+
Sbjct: 295 CWDHDAEARLSAGCVGERITQMQR 318
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-63
Identities = 76/384 (19%), Positives = 142/384 (36%), Gaps = 24/384 (6%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLH--NLTNIQIIRM 58
+L+ L L+ N L +L NL NK L ++++ + +
Sbjct: 120 QKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178
Query: 59 AHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
+ N ++ P + L + ++ S E L + T+ + L+ +Q
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS---IRNLSLSNSQLS 235
Query: 119 GEIPESIGNLSNV-LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQL 177
+ L L+ L + N S L L L YN+I + L
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295
Query: 178 QELQSLDLAGN---------QISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNL 228
++ L+L + + + LK L +++ N++ F NL
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355
Query: 229 LSIDLSNNKLNGNIPKEI----LSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSA 284
+ LSN+ + L+ S L + NL+KN + + LG++ +DL
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHIL-NLTKNKISKIESDAFSWLGHLEVLDLGL 414
Query: 285 NGLSGNLP-NSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSG--SIPS 341
N + L ++ +++ ++ ++ NK+ N A + L+ L L L S PS
Sbjct: 415 NEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPS 474
Query: 342 DLQNLRALRSLNLTFNNLEGVVPR 365
Q LR L L+L+ NN+ +
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDD 498
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 9e-63
Identities = 73/393 (18%), Positives = 132/393 (33%), Gaps = 28/393 (7%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
S + +L ++P D+ N+ N N+ + + + + + N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
+ P LP LK+ N+ N++ D+ + T L L N +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDK------TFAFCTNLTELHLMSNSIQKIK 113
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIG--QLQE 179
N L L + N + +L +L L LS N I E+
Sbjct: 114 NNPFVKQKN-LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSI---DLSNN 236
L+ L+L+ NQI P + +L + L+ +L + SI LSN+
Sbjct: 173 LKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS 232
Query: 237 KLNGNIPKEI--LSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNS 294
+L+ L ++LT + +LS N L+ + L + L N + +S
Sbjct: 233 QLSTTSNTTFLGLKWTNLTML-DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 291
Query: 295 FKNCKSLEKLLMANN---------KFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQN 345
++ L + + LK LE L++ N + G +
Sbjct: 292 LHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG 351
Query: 346 LRALRSLNLTFNNLEGVVPREGIFRHTSMVHLE 378
L L+ L+L+ + F + L
Sbjct: 352 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 5e-60
Identities = 73/383 (19%), Positives = 126/383 (32%), Gaps = 26/383 (6%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L L L N+L NL + N N+ + ++H
Sbjct: 72 LPMLKVLNLQHNELSQLSDKTFAF-CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSH 130
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L T L L+ + NKI E L ++ L L NQ +
Sbjct: 131 NGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF----ANSSLKKLELSSNQIKEF 186
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIG---RLRSLTLLNLSYNSISGEILTEIGQL 177
P + L L++ + + + S+ L+LS + +S T L
Sbjct: 187 SPGCFHAIGR-LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 178 Q--ELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGN---------FQ 226
+ L LDL+ N ++ ++ L +L L N + S +
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 227 NLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANG 286
+ +S L L L + N+ N + G L N+ + LS +
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHL-NMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
Query: 287 LSGN--LPNSFKNC--KSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD 342
S +F + L L + NK S + + L LEVLDL N++ +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 343 -LQNLRALRSLNLTFNNLEGVVP 364
+ L + + L++N +
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTR 447
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-59
Identities = 74/383 (19%), Positives = 126/383 (32%), Gaps = 24/383 (6%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVG--------DKLPNLLGFNFCFNKFTGKIPGSLHNLTN 52
+ L Y L N + + + + + + S L
Sbjct: 271 LPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKC 330
Query: 53 IQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAF 112
++ + M N + G L LK ++ + +F SL +S L+ L
Sbjct: 331 LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF-VSLAHS-PLHILNL 388
Query: 113 DGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIP-TSIGRLRSLTLLNLSYNSISGEIL 171
N+ ++ L + L L +G N ++ L ++ + LSYN
Sbjct: 389 TKNKISKIESDAFSWLGH-LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447
Query: 172 TEIGQLQELQSLDLAGNQISG--SIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLL 229
+ LQ L L + S P+ L+ L +DLS N +A+ + L
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE 507
Query: 230 SIDLSNNKLN--------GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTID 281
+DL +N L G + LS L + NL N D E L + ID
Sbjct: 508 ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL-NLESNGFDEIPVEVFKDLFELKIID 566
Query: 282 LSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAE-LKGLEVLDLSSNKLSGSIP 340
L N L+ + F N SL+ L + N + + + L LD+ N +
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
Query: 341 SDLQNLRALRSLNLTFNNLEGVV 363
S + + + L
Sbjct: 627 SIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-48
Identities = 59/270 (21%), Positives = 112/270 (41%), Gaps = 12/270 (4%)
Query: 104 STRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163
+ + ++P+ + +N ++ L + N+ + R LT L++ +
Sbjct: 3 TVSHEVADCSHLKLT-QVPDDL--PTN-ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 164 NSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFG 223
N+IS +L L+ L+L N++S T L ++ L N + F
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
Query: 224 NFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNV--VTID 281
+NL+++DLS+N L+ + L +L + LS N + EE+ + N ++
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQEL-LLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 282 LSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAE---LKGLEVLDLSSNKLSGS 338
LS+N + P F L L + N + + L + L LS+++LS +
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237
Query: 339 IPSDLQNLR--ALRSLNLTFNNLEGVVPRE 366
+ L+ L L+L++NNL V
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 3e-58
Identities = 75/393 (19%), Positives = 138/393 (35%), Gaps = 51/393 (12%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTG---------KIPGSLHNLT 51
+ L + L + ++P + LP L N N+ ++
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548
Query: 52 NIQIIRMAHNLLEG-TVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFL 110
IQI M +N LE L + L + + NK + + + + +L L
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNK--------VRHLEAFGTNVKLTDL 600
Query: 111 AFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIP--TSIGRLRSLTLLNLSYNSISG 168
D NQ E EIPE ++ + L N+ IP + + + ++ SYN I
Sbjct: 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS 658
Query: 169 ---EILTEIGQLQE--LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELAS------- 216
I + + ++ L+ N+I ++ I LS N + S
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLK 718
Query: 217 EIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL--SLSSLTTIVNLSKNFLDGTLPEEIGML 274
++ N L +IDL NKL + + +L L+ + ++S N + P +
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNM-DVSYNCFS-SFPTQPLNS 775
Query: 275 GNVVTIDL------SANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVL 328
+ + N + P C SL +L + +N + L L +L
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYIL 832
Query: 329 DLSSNKL-SGSIPSDLQNLRALRSLNLTFNNLE 360
D++ N S + S + A L ++ +
Sbjct: 833 DIADNPNISIDVTSVCPYIEAGM-YVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-55
Identities = 75/398 (18%), Positives = 135/398 (33%), Gaps = 54/398 (13%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+T L + A++ + + N + K S NL ++ + + +
Sbjct: 447 LTKLQIIYFANSPFTYDNI------AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
+P L +LP L+ NI N+ + + +
Sbjct: 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW---------------------TR 539
Query: 121 IPESIGNLSNVLSKLYMGGNRFYG-KIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
+ + + YMG N S+ ++ L LL+ +N + L G +
Sbjct: 540 LADDEDTGPK-IQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVK 596
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIP--TSFGNFQNLLSIDLSNNK 237
L L L NQI + ++ + S N+L IP + + + S+D S NK
Sbjct: 597 LTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNK 655
Query: 238 LNGNIPKEILSLSSLT----TIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS----- 288
+ S+ + V LS N + E + TI LS N ++
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 289 --GNLPNSFKNCKSLEKLLMANNKFSGPIPNI-LAELKGLEVLDLSSNKLSGSIPSDLQN 345
++KN L + + NK + + L L +D+S N S S P+ N
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLN 774
Query: 346 LRALRSLNLTF------NNLEGVVPREGIFRHTSMVHL 377
L++ + N + P GI S++ L
Sbjct: 775 SSQLKAFGIRHQRDAEGNRILRQWP-TGITTCPSLIQL 811
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 197 bits (501), Expect = 5e-53
Identities = 52/429 (12%), Positives = 126/429 (29%), Gaps = 68/429 (15%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+T L L ++ ++L + L + + +
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ 405
Query: 61 NLLEG----------------------------TVPPGLGNLPFLKMYNIGFNKIVGSGD 92
+ + + + L L++ +
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPF----- 460
Query: 93 EGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGR 152
T + D + S NL + L+ + + ++P +
Sbjct: 461 ------TYDNIAVDWEDANSDYAKQYENEELSWSNLKD-LTDVELYNCPNMTQLPDFLYD 513
Query: 153 LRSLTLLNLSYNSISG---------EILTEIGQLQELQSLDLAGNQISG-SIPNTLGNLK 202
L L LN++ N + + ++Q + N + +L +
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573
Query: 203 KLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNF 262
KL +D N++ + +FG L + L N++ IP++ + + + S N
Sbjct: 574 KLGLLDCVHNKV-RHLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNK 630
Query: 263 LDGTLPEEIGM--LGNVVTIDLSANGLSGNLPNSFK-----NCKSLEKLLMANNKFSGPI 315
L +P + + ++D S N + N + + ++ N+
Sbjct: 631 LK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFP 689
Query: 316 PNILAELKGLEVLDLSSNKLS-------GSIPSDLQNLRALRSLNLTFNNLEGVVPREGI 368
+ A + + LS+N ++ + +N L +++L FN L +
Sbjct: 690 TELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRA 749
Query: 369 FRHTSMVHL 377
+ ++
Sbjct: 750 TTLPYLSNM 758
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 192 bits (488), Expect = 3e-51
Identities = 68/402 (16%), Positives = 132/402 (32%), Gaps = 51/402 (12%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L LA G +P +G +L L +F + T +
Sbjct: 322 NGRVTGLSLAGFGAKGRVPDAIG-QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 61 NLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTN-STRLNFLAFDGNQFE 118
+ + L L + ++ + I + + + I + S + + N+
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAI--NRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 119 GEIPESIGNLSNVLSKLYMGGNRF-------------------YGKIPTSIGRLRSLTLL 159
I ++I L+ L +Y + F Y S L+ LT +
Sbjct: 439 F-ISKAIQRLTK-LQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496
Query: 160 NLSYNSISGEILTEIGQLQELQSLDLAGNQISG---------SIPNTLGNLKKLNQIDLS 210
L ++ + L ELQSL++A N+ + + K+ +
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556
Query: 211 GNELASEIPTS--FGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLP 268
N L E P S L +D +NK+ + + LT + L N ++ +P
Sbjct: 557 YNNL-EEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDL-KLDYNQIE-EIP 611
Query: 269 EEIG-MLGNVVTIDLSANGLSGNLPN--SFKNCKSLEKLLMANNKFSGPIPNILAELKG- 324
E+ V + S N L +PN + K+ + + + NK NI +
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDY 670
Query: 325 ----LEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGV 362
+ LS N++ + ++ L+ N + +
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI 712
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 6e-49
Identities = 49/381 (12%), Positives = 126/381 (33%), Gaps = 29/381 (7%)
Query: 14 LWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGN 73
+WG+ P D + G + G++P ++ LT ++++ + +
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 74 LPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLS 133
M ++I F+ + L N+ P + ++
Sbjct: 370 ELTPDMSEERKHRI--RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKD 427
Query: 134 KLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGS 193
I +I RL L ++ + + + + + + + + + +
Sbjct: 428 TQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYEN 482
Query: 194 IPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG---------NIPK 244
+ NLK L ++L +++P + L S++++ N+ +
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 245 EILSLSSLTTIVNLSKNFLDGTLPEE--IGMLGNVVTIDLSANGLSGNLPNSFKNCKSLE 302
+ + + + N L+ P + + + +D N + +F L
Sbjct: 543 DEDTGPKIQIF-YMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLT 598
Query: 303 KLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD--LQNLRALRSLNLTFNNLE 360
L + N+ + A +E L S NKL IP+ +++ + S++ ++N +
Sbjct: 599 DLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIG 657
Query: 361 GVVPR----EGIFRHTSMVHL 377
++ + +
Sbjct: 658 SEGRNISCSMDDYKGINASTV 678
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 9e-45
Identities = 64/359 (17%), Positives = 120/359 (33%), Gaps = 26/359 (7%)
Query: 32 FNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSG 91
FN + + + L N + + +A +G VP +G L LK+ + G + SG
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 92 DE-GLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSI 150
G +T + R + + + + + + NLS++L S
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL-NLSDLLQDAINRNPEMKPIKKDSR 422
Query: 151 GRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLS 210
L+ + NL+ N I+ I I +L +LQ + A + + +
Sbjct: 423 ISLKDTQIGNLT-NRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSD 475
Query: 211 GNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDG----- 265
+ S+ N ++L ++L N +P + L L ++ N++ N
Sbjct: 476 YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSL-NIACNRGISAAQLK 534
Query: 266 ----TLPEEIGMLGNVVTIDLSANGLSGNLPNS--FKNCKSLEKLLMANNKFSGPIPNIL 319
L ++ + + N L P S + L L +NK
Sbjct: 535 ADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR--HLEAF 591
Query: 320 AELKGLEVLDLSSNKLSGSIPSDL-QNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHL 377
L L L N++ IP D + L + N L+ + M +
Sbjct: 592 GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSV 649
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-31
Identities = 35/261 (13%), Positives = 82/261 (31%), Gaps = 26/261 (9%)
Query: 128 LSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAG 187
L + L R+Y + + N + + ++ + L LAG
Sbjct: 274 LKAIWEALDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAG 332
Query: 188 NQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL 247
G +P+ +G L +L + + + +++ + K L
Sbjct: 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFL 392
Query: 248 SLSSLTTIVNLSKNFL-----DGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLE 302
+ +L ++ + + ++ + I N ++ + + + L+
Sbjct: 393 DYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQ 451
Query: 303 KLLMANNKFSGPIPNI-------------------LAELKGLEVLDLSSNKLSGSIPSDL 343
+ AN+ F+ + + LK L ++L + +P L
Sbjct: 452 IIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL 511
Query: 344 QNLRALRSLNLTFNNLEGVVP 364
+L L+SLN+ N
Sbjct: 512 YDLPELQSLNIACNRGISAAQ 532
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-17
Identities = 31/212 (14%), Positives = 69/212 (32%), Gaps = 16/212 (7%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFT-------GKIPGSLHNLTNI 53
+ + L+ N++ P ++ + N T G+ N +
Sbjct: 672 GINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
Query: 54 QIIRMAHNLLEGTVPPGL--GNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLA 111
I + N L ++ LP+L ++ +N S + L +
Sbjct: 731 TTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRD 788
Query: 112 FDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEIL 171
+GN+ + P I + L +L +G N K+ + L +L+++ N +
Sbjct: 789 AEGNRILRQWPTGITTCPS-LIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDV 844
Query: 172 TEIGQLQELQSLDLAGNQISGSIPNTLGNLKK 203
T + E L ++ +++
Sbjct: 845 TSVCPYIEAGMYVLLYDKTQDIRGCDALGIER 876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-57
Identities = 79/326 (24%), Positives = 129/326 (39%), Gaps = 60/326 (18%)
Query: 441 SPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFA 500
S MI Y E+ E ++G G+FG V K R VA+K ++ ES K+F
Sbjct: 1 SLHMIDYKEI-------EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIV 50
Query: 501 ECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLN 560
E L H N+VKL +C + + LV E+ GSL + +HG +
Sbjct: 51 ELRQLSRVNHPNIVKLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEPLPY---YT 100
Query: 561 FLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT-AKVGDFGLARSLLERI 619
++ + + + YLH+ ++H DLKP N+LL T K+ DFG A +
Sbjct: 101 AAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---- 156
Query: 620 GNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV 679
++ GS ++ PE G S DV+S+G++L E+ T P E
Sbjct: 157 -QTHMTNNK----GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211
Query: 680 SLVKWVESN----FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESP 735
++ V + KN L + + LM C ++ P
Sbjct: 212 RIMWAVHNGTRPPLIKN----LPKPIESLMT----------------------RCWSKDP 245
Query: 736 GGRIDIREALRRLKNAQKILLKRRQP 761
R + E ++ + + + +P
Sbjct: 246 SQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-57
Identities = 71/390 (18%), Positives = 129/390 (33%), Gaps = 30/390 (7%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNL------LGFNFCFNKFTGKIPGSLHNLTNIQI 55
L L L +N + L L LG +L L N+ I
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 56 IRMAHNLLE---GTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSF-----------ITSL 101
L+ + L + +++ I D +F
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF 319
Query: 102 TNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNR--FYGKIPTSIGRLRSLTLL 159
+ +G S +L + L L + N F G S SL L
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPS-LEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 160 NLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIP-NTLGNLKKLNQIDLSGNELASEI 218
+LS+N + + + L++L+ LD + + + +L+ L +D+S
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 219 PTSFGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGMLGNV 277
F +L + ++ N N +I + L +LT + +LS+ L+ P L ++
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL-DLSQCQLEQLSPTAFNSLSSL 496
Query: 278 VTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAEL-KGLEVLDLSSNKLS 336
+++S N +K SL+ L + N L L L+L+ N +
Sbjct: 497 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
Query: 337 GSIPSD--LQNLRALRSLNLTFNNLEGVVP 364
+ LQ ++ R L + +E P
Sbjct: 557 CTCEHQSFLQWIKDQRQLLVEVERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-47
Identities = 75/415 (18%), Positives = 129/415 (31%), Gaps = 70/415 (16%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
S L L+ N L Y P L + + G+ +L+++ + +
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFS-FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N ++ L + L L
Sbjct: 86 NPIQSLALGAFSGL------------------------------SSLQKLVAVETNLASL 115
Query: 121 IPESIGNLSNVLSKLYMGGNRF-YGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
IG+L L +L + N K+P L +L L+LS N I T++ L +
Sbjct: 116 ENFPIGHLKT-LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 180 LQ----SLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIP-TSFGNFQNLLSIDLS 234
+ SLDL+ N ++ P + +L+++ L N + + T L L
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 235 NNKLNGNIPKEILSLSSLTTIVNLSKNFLD--------GTLPEEIGMLGNVVTIDLSANG 286
+ E S+L + NL+ + + L NV + L +
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 287 LSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGL-------------------EV 327
+ S+ + L + N KF L LK L E
Sbjct: 294 IERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351
Query: 328 LDLSSNKLS--GSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGN 380
LDLS N LS G +L+ L+L+FN + + + + +
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-44
Identities = 58/249 (23%), Positives = 97/249 (38%), Gaps = 14/249 (5%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
+IP+ NL L + N S L +L+LS I L
Sbjct: 21 KIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
L +L L GN I L L ++ LAS G+ + L +++++N +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 240 G-NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGN----VVTIDLSANGLSGNLPNS 294
+P+ +L++L + +LS N + ++ +L +++DLS N ++ P +
Sbjct: 138 SFKLPEYFSNLTNLEHL-DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 295 FKNCKSLEKLLMANNKFSGPIP-NILAELKGLEVLDLSSNKLSGSI---PSDLQNLRALR 350
FK L KL + NN S + + L GLEV L + D L L
Sbjct: 197 FKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 351 SLNLTFNNL 359
+L + L
Sbjct: 256 NLTIEEFRL 264
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-22
Identities = 26/149 (17%), Positives = 52/149 (34%), Gaps = 4/149 (2%)
Query: 229 LSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS 288
++ IP + S + +LS N L + +DLS +
Sbjct: 10 ITYQCMELNFY-KIPDNLPF--STKNL-DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 289 GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRA 348
++++ L L++ N + L L+ L L+ + +L+
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 349 LRSLNLTFNNLEGVVPREGIFRHTSMVHL 377
L+ LN+ N ++ E T++ HL
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 6e-57
Identities = 73/343 (21%), Positives = 116/343 (33%), Gaps = 45/343 (13%)
Query: 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECE- 503
+ E N LIG G +G+VYKG L VAVKV + ++F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANR---QNFINEKNI 58
Query: 504 -ALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL 562
+ H N+ + I + LV E+ NGSL ++ +++
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-------SDWV 111
Query: 563 ERLNIAIDIASALDYLHND------CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL 616
+A + L YLH + + I H DL N+L+ D T + DFGL+ L
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 617 --ERIGNQSSISSTHVLKGSIGYIPPEY-------GLGEKPSTAGDVYSFGVMLLEIFTG 667
+ ++ G+I Y+ PE E D+Y+ G++ EIF
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 668 MSPTHES---------FAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDC 718
+ F EV F V + R + +
Sbjct: 232 CTDLFPGESVPEYQMAFQTEV----GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 719 LITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQP 761
L IE C + R+ + A R+ I + +
Sbjct: 288 LKETIE----DCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-56
Identities = 76/228 (33%), Positives = 116/228 (50%), Gaps = 25/228 (10%)
Query: 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAEC 502
I + +L + + IG+GSFG+V++ G VAVK+L + F E
Sbjct: 34 IPWCDL-------NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREV 85
Query: 503 EALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL 562
++ RH N+V + + + L++V E+L GSL +H K+ L+
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLH---KSGAREQLDER 137
Query: 563 ERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
RL++A D+A ++YLHN PIVH +LK N+L+D+ T KV DFGL+R L+
Sbjct: 138 RRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFL 194
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
SS S+ G+ ++ PE E + DVYSFGV+L E+ T P
Sbjct: 195 SSKSAA----GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-54
Identities = 66/385 (17%), Positives = 121/385 (31%), Gaps = 18/385 (4%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ +L +L L Q++ I D L N +L ++ +
Sbjct: 56 LINLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQ 114
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
+ L N L+ +G N I + +L L F N
Sbjct: 115 TGISSIDFIPLHNQKTLESLYLGSNHISSIKLP------KGFPTEKLKVLDFQNNAIHYL 168
Query: 121 IPESIGNLSN-VLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIG--QL 177
E + +L L + GN I LN I + +
Sbjct: 169 SKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI 227
Query: 178 QELQSLDLAGNQISGSIPNTLGNLKKLN--QIDLSGNELASEIPTSFGNFQNLLSIDLSN 235
Q L P L +++ I+L + + +F F L +DL+
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287
Query: 236 NKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNL-PNS 294
L+ +P ++ LS+L + LS N + ++ + + N L
Sbjct: 288 THLS-ELPSGLVGLSTLKKL-VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 295 FKNCKSLEKLLMANNK--FSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSL 352
+N ++L +L ++++ S L L L+ L+LS N+ + L L
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405
Query: 353 NLTFNNLEGVVPREGIFRHTSMVHL 377
+L F L+ + + L
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVL 430
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-54
Identities = 90/394 (22%), Positives = 149/394 (37%), Gaps = 24/394 (6%)
Query: 3 SLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHN--LTNIQIIRMAH 60
+ + L L N + I D NF + I L N + ++ +
Sbjct: 180 TNLSLNLNGNDIA-GIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFED 237
Query: 61 NLLEGTVPPGLGNLPFLKMY--NIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
E P L + + N+ + + + L L
Sbjct: 238 MDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN------TFHCFSGLQELDLTATHLS 291
Query: 119 GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTE-IGQL 177
E+P + LS L KL + N+F S SLT L++ N+ E+ T + L
Sbjct: 292 -ELPSGLVGLST-LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL 349
Query: 178 QELQSLDLAGNQI--SGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSN 235
+ L+ LDL+ + I S L NL L ++LS NE S +F L +DL+
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 236 NKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGN---L 291
+L + L L + NLS + LD + + L + ++L N
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVL-NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK 468
Query: 292 PNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRS 351
NS + LE L+++ S + LK + +DLS N+L+ S L +L+ +
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY- 527
Query: 352 LNLTFNNLEGVVPRE-GIFRHTSMVHLEGNPKLC 384
LNL N++ ++P I ++L NP C
Sbjct: 528 LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-53
Identities = 81/382 (21%), Positives = 139/382 (36%), Gaps = 21/382 (5%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
L L L +N L + L F + LHN ++ + +
Sbjct: 80 QHRLDTLVLTANPL-IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGS 138
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N + P LK+ + N I E +S + TN + L +GN
Sbjct: 139 NHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS----LNLNGNDIA-G 193
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIP-----TSIGRLRSLTLLNLSYNSISGEILTEIG 175
I + + L GG + I ++I L T ++ IS + +
Sbjct: 194 IEPGAFDSAV-FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 176 QLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSN 235
++ ++S++L + NT L ++DL+ L SE+P+ L + LS
Sbjct: 253 EMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSA 310
Query: 236 NKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEE-IGMLGNVVTIDLSANGL--SGNLP 292
NK + SLT + ++ N L + L N+ +DLS + + S
Sbjct: 311 NKFENLCQISASNFPSLTHL-SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 293 NSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIP-SDLQNLRALRS 351
+N L+ L ++ N+ E LE+LDL+ +L S QNL L+
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 352 LNLTFNNLEGVVPREGIFRHTS 373
LNL+ + L+ +F
Sbjct: 430 LNLSHSLLDISSE--QLFDGLP 449
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-50
Identities = 68/364 (18%), Positives = 124/364 (34%), Gaps = 18/364 (4%)
Query: 26 LPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFN 85
+ F FN + L N+ + + + + L + N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 86 KIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGK 145
++ + LS +L + L F + N L LY+G N
Sbjct: 92 PLIFMAETALSGPKALKH------LFFIQTGISSIDFIPLHNQKT-LESLYLGSNHISSI 144
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQ--SLDLAGNQISGSIPNTLGNLKK 203
L +L+ N+I ++ LQ+ SL+L GN I+ I +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAV 203
Query: 204 LNQIDLSGNELASEIPT--SFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLT-TIVNLSK 260
++ G + I Q+L + P L ++ +NL K
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 261 NFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILA 320
++ + +DL+A LS LP+ +L+KL+++ NKF +
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
Query: 321 ELKGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLTFNNLEGVVPREGIFRHTSM---VH 376
L L + N + + L+NL LR L+L+ +++E R+ S ++
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382
Query: 377 LEGN 380
L N
Sbjct: 383 LSYN 386
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-37
Identities = 46/272 (16%), Positives = 81/272 (29%), Gaps = 33/272 (12%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
EIP G L N L N T+ RL +LT L+L+ I
Sbjct: 26 EIP---GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR 82
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
L +L L N + L K L + ++S N + L S+ L +N ++
Sbjct: 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142
Query: 240 GNIPKEILSLSSLTTI-------------------------VNLSKNFLDGTLPEEIGML 274
+ L + +NL+ N + +
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDS 201
Query: 275 GNVVTIDLSANGLSGNLPNSFKNCK--SLEKLLMANNKFSGPIPNILAELKG--LEVLDL 330
+++ + KN SL + P + L +E ++L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 331 SSNKLSGSIPSDLQNLRALRSLNLTFNNLEGV 362
+ + L+ L+LT +L +
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLSEL 293
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-17
Identities = 38/239 (15%), Positives = 71/239 (29%), Gaps = 33/239 (13%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
L L LA +L + L L N + L +Q + +
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N SL RL L
Sbjct: 459 NHFPKGNIQKTN---------------------------SLQTLGRLEILVLSFCDLSSI 491
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+ +L ++ + + NR ++ L+ + LNL+ N IS + + + L +
Sbjct: 492 DQHAFTSLKM-MNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQ 549
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
++++L N + + N+ L + +L T N L + LS+ L+
Sbjct: 550 RTINLRQNPLDCTC----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-53
Identities = 74/297 (24%), Positives = 122/297 (41%), Gaps = 53/297 (17%)
Query: 431 PIGVSTLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKG-YLREGISVAVKVL-- 487
+G S K ++ +E+ +E IG G FG V+KG +++ VA+K L
Sbjct: 2 AMGGSEFPKSRLPTLADNEI-------EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL 54
Query: 488 -----DIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGS 542
+ E ++ F E + N H N+VKL +V EF+ G
Sbjct: 55 GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM-------HNPPRMVMEFVPCGD 107
Query: 543 LGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE-- 600
L + + + + +L + +DIA ++Y+ N PIVH DL+ NI L
Sbjct: 108 LYHRLLDKAHP-----IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLD 161
Query: 601 ---DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE--YGLGEKPSTAGDVY 655
+ AKV DFGL++ QS S + + G+ ++ PE E + D Y
Sbjct: 162 ENAPVCAKVADFGLSQ--------QSVHSVSGL-LGNFQWMAPETIGAEEESYTEKADTY 212
Query: 656 SFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN-----FPKNAQQVLDRELRQLMMS 707
SF ++L I TG P E G++ + + P++ LR ++
Sbjct: 213 SFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED----CPPRLRNVIEL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-52
Identities = 71/238 (29%), Positives = 108/238 (45%), Gaps = 40/238 (16%)
Query: 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVL----DIESTGTWKSFFA 500
I + EL E +IG G FG VY+ + G VAVK D + + T ++
Sbjct: 4 IDFAELTL-------EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 501 ECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLN 560
E + +H N++ L C L LV EF G L + G+R +
Sbjct: 56 EAKLFAMLKHPNIIALRGVCL-----KEPNLCLVMEFARGGPLNRVLSGKR-------IP 103
Query: 561 FLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE--------DMTAKVGDFGLA 612
+N A+ IA ++YLH++ VPI+H DLK NIL+ + + K+ DFGLA
Sbjct: 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
Query: 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
R ++++ S G+ ++ PE S DV+S+GV+L E+ TG P
Sbjct: 164 -----REWHRTTKMSA---AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-51
Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAEC 502
I + +L + + G ++KG + G + VKVL + ST + F EC
Sbjct: 7 IDFKQL-------NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 503 EALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL 562
LR H N++ ++ +C S + L+ ++ GSL + +H ++
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPH---PTLITHWMPYGSLYNVLH----EGTNFVVDQS 111
Query: 563 ERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
+ + A+D+A + +LH E I L ++++DEDMTA++ + S
Sbjct: 112 QAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF------- 163
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKPST----AGDVYSFGVMLLEIFTGMSP 670
S + ++ PE L +KP + D++SF V+L E+ T P
Sbjct: 164 ---QSPGR-MYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 8e-51
Identities = 73/231 (31%), Positives = 105/231 (45%), Gaps = 32/231 (13%)
Query: 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAEC 502
I ++ IGSGSFG+VYKG VAVK+L++ + ++F E
Sbjct: 21 IPDGQITV-------GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEV 71
Query: 503 EALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL 562
LR TRH N++ + ++ LA+V ++ SL +H
Sbjct: 72 GVLRKTRHVNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHASETK-----FEMK 120
Query: 563 ERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
+ ++IA A +DYLH I+H DLK NI L ED T K+GDFGLA G+
Sbjct: 121 KLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 623 SSISSTHVLKGSIGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ GSI ++ PE S DVY+FG++L E+ TG P
Sbjct: 178 QFEQLS----GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-50
Identities = 70/307 (22%), Positives = 124/307 (40%), Gaps = 36/307 (11%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECE--ALRNTRHRNLVKLI 517
+G G +G V++G + G +VAVK+ KS+F E E RH N++ I
Sbjct: 13 LECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
S + + + L L+ + GSL D++ L+ + L I + IAS L +
Sbjct: 69 ASDMTSRHSSTQ-LWLITHYHEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAH 120
Query: 578 LHND-----CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
LH + + I H DLK NIL+ ++ + D GLA + + NQ + +
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV-MHSQSTNQLDVGNNPR-V 178
Query: 633 GSIGYIPPEYGLGEKPSTAG-------DVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685
G+ Y+ PE L E D+++FG++L E+ M + V
Sbjct: 179 GTKRYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 686 ESN--FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIRE 743
++ F + V + R + + + L +++ C ++P R+
Sbjct: 238 PNDPSFEDMRKVVCVDQQR-PNIPNRWFSDPTLTSLAKLMK----ECWYQNPSARLTALR 292
Query: 744 ALRRLKN 750
+ L
Sbjct: 293 IKKTLTK 299
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 4e-50
Identities = 62/275 (22%), Positives = 107/275 (38%), Gaps = 38/275 (13%)
Query: 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAEC 502
I +++L LIG G FG VY G VA++++DIE + K+F E
Sbjct: 30 IPFEQLEI-------GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREV 80
Query: 503 EALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL 562
A R TRH N+V + +C + LA++ +L + + L+
Sbjct: 81 MAYRQTRHENVVLFMGACM-----SPPHLAIITSLCKGRTLYSVVRDAKIV-----LDVN 130
Query: 563 ERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
+ IA +I + YLH I+H DLK N+ D + + DFGL +
Sbjct: 131 KTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186
Query: 623 SSISSTHVLKGSIGYIPPE--------YGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHE 673
G + ++ PE + P S DV++ G + E+ P
Sbjct: 187 REDKLRIQ-NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
Query: 674 SFAGEVSLVKWVESNF-PKNAQQVLDRELRQLMMS 707
A + + + P +Q + +E+ +++
Sbjct: 246 QPAEAIIWQ--MGTGMKPNLSQIGMGKEISDILLF 278
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-49
Identities = 70/306 (22%), Positives = 116/306 (37%), Gaps = 34/306 (11%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECE--ALRNTRHRNLVKLI 517
IG G +G V+ G R G VAVKV S+F E E RH N++ I
Sbjct: 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
+ + L L+ ++ NGSL D++ L+ L +A S L +
Sbjct: 98 AADIKGTGSWTQ-LYLITDYHENGSLYDYLKS-------TTLDAKSMLKLAYSSVSGLCH 149
Query: 578 LHND-----CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
LH + + I H DLK NIL+ ++ T + D GLA N+ I
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-KFISDTNEVDIPPNTR-V 207
Query: 633 GSIGYIPPE-----YGLGEKPST-AGDVYSFGVMLLEIFTGMSPTHESFAGEV--SLVKW 684
G+ Y+PPE S D+YSFG++L E+ ++ +
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREA 744
+ ++ + V ++LR + + + + ++ C +P R+
Sbjct: 268 SDPSYEDMREIVCIKKLR-PSFPNRWSSDECLRQMGKLMT----ECWAHNPASRLTALRV 322
Query: 745 LRRLKN 750
+ L
Sbjct: 323 KKTLAK 328
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-49
Identities = 62/272 (22%), Positives = 107/272 (39%), Gaps = 29/272 (10%)
Query: 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECE 503
+L H ++G G FG K RE G + +K L T ++F E +
Sbjct: 7 FRPSDLI-------HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVK 59
Query: 504 ALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE 563
+R H N++K I + L + E++ G+L I + + +
Sbjct: 60 VMRCLEHPNVLKFIGVLY-----KDKRLNFITEYIKGGTLRGIIK-----SMDSQYPWSQ 109
Query: 564 RLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE------ 617
R++ A DIAS + YLH + I+H DL N L+ E+ V DFGLAR +++
Sbjct: 110 RVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166
Query: 618 --RIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675
R + + + G+ ++ PE G DV+SFG++L EI ++ +
Sbjct: 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226
Query: 676 AGEVSLVKWVESNFPKNAQQVLDRELRQLMMS 707
+ V + + +
Sbjct: 227 PRTMDFGLNVRGFLDRYCPPNCPPSFFPITVR 258
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 70/306 (22%), Positives = 127/306 (41%), Gaps = 34/306 (11%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECE--ALRNTRHRNLVKLI 517
+ IG G FG V++G R G VAVK+ +S+F E E RH N++ I
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
+ + + + L LV ++ +GSL D+++ + + +A+ AS L +
Sbjct: 103 AADNKDNGTWTQ-LWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAH 154
Query: 578 LHND-----CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
LH + + I H DLK NIL+ ++ T + D GLA + + I+ H
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-RHDSATDTIDIAPNHR-V 212
Query: 633 GSIGYIPPE-----YGLGEKPST-AGDVYSFGVMLLEIFTGMSP--THESFAGEVSLVKW 684
G+ Y+ PE + S D+Y+ G++ EI S HE + +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREA 744
+ + + + V +++LR + + Q+ + + I+ C + R+
Sbjct: 273 SDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMR----ECWYANGAARLTALRI 327
Query: 745 LRRLKN 750
+ L
Sbjct: 328 KKTLSQ 333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-48
Identities = 78/360 (21%), Positives = 142/360 (39%), Gaps = 34/360 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ + L + + + +L ++ K I G + LTN++ + +
Sbjct: 21 LAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNG 75
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N + T L NL L IG NKI + I++L N T L L + +
Sbjct: 76 NQI--TDISPLSNLVKLTNLYIGTNKI--------TDISALQNLTNLRELYLNEDNISD- 124
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+ NL+ + L +G N + + + L L ++ + + +T I L +L
Sbjct: 125 -ISPLANLTK-MYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDL 179
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
SL L NQI P L +L L+ N++ P N L S+ + NNK+
Sbjct: 180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
P + +LS LT + + N + + + L + +++ +N +S + N
Sbjct: 236 LSP--LANLSQLTWL-EIGTNQI--SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQ 288
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
L L + NN+ ++ L L L LS N ++ P L +L + S + ++
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 66/341 (19%), Positives = 136/341 (39%), Gaps = 31/341 (9%)
Query: 24 DKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83
L + T + L +I + +A + G+ L L+ N+
Sbjct: 19 ADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLN 74
Query: 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFY 143
N+I + I+ L+N +L L N+ ++ NL+N L +LY+ +
Sbjct: 75 GNQI--------TDISPLSNLVKLTNLYIGTNKIT--DISALQNLTN-LRELYLNEDNIS 123
Query: 144 GKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKK 203
P + L + LNL N ++ + + + L L + +++ P + NL
Sbjct: 124 DISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTD 178
Query: 204 LNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFL 263
L + L+ N++ P + +L N++ P + +++ L ++ + N +
Sbjct: 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSL-KIGNNKI 233
Query: 264 DGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELK 323
T + L + +++ N +S N+ K+ L+ L + +N+ S L L
Sbjct: 234 --TDLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISV--LNNLS 287
Query: 324 GLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVP 364
L L L++N+L + L L +L L+ N++ + P
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 74/337 (21%), Positives = 138/337 (40%), Gaps = 32/337 (9%)
Query: 46 SLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNST 105
+L + + T L + + K+ + I LTN
Sbjct: 17 PDADLAEGIRAVLQKASV--TDVVTQEELESITKLVVAGEKV-----ASIQGIEYLTN-- 67
Query: 106 RLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNS 165
L +L +GNQ P + NL L+ LY+G N+ +++ L +L L L+ ++
Sbjct: 68 -LEYLNLNGNQITDISP--LSNLVK-LTNLYIGTNKI--TDISALQNLTNLRELYLNEDN 121
Query: 166 ISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNF 225
IS ++ + L ++ SL+L N + L N+ LN + ++ +++ P N
Sbjct: 122 ISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANL 176
Query: 226 QNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSAN 285
+L S+ L+ N++ P + SL+SL N + T + + + ++ + N
Sbjct: 177 TDLYSLSLNYNQIEDISP--LASLTSLHYF-TAYVNQI--TDITPVANMTRLNSLKIGNN 231
Query: 286 GLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQN 345
++ + N L L + N+ S + +L L++L++ SN++S S L N
Sbjct: 232 KITD--LSPLANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNN 285
Query: 346 LRALRSLNLTFNNLEGVVPRE-GIFRHTSMVHLEGNP 381
L L SL L N L G + + + L N
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-22
Identities = 34/185 (18%), Positives = 75/185 (40%), Gaps = 14/185 (7%)
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
+L I+ P +L + + L + + +++ + ++ K+
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 240 GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCK 299
+ I L++L + NL+ N + + L + + + N ++ ++ +N
Sbjct: 58 S--IQGIEYLTNLEYL-NLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--ISALQNLT 110
Query: 300 SLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359
+L +L + + S P LA L + L+L +N S S L N+ L L +T + +
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167
Query: 360 EGVVP 364
+ V P
Sbjct: 168 KDVTP 172
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-48
Identities = 52/325 (16%), Positives = 109/325 (33%), Gaps = 27/325 (8%)
Query: 46 SLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNST 105
H+ + + + + L + NS
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADR----------NRWHSAWRQANSN 56
Query: 106 RLNFLAFDGNQFEGEIPESIGNLSNV-LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN 164
G + + + + + L + + P RL L + +
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAA 114
Query: 165 SISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGN 224
+ E+ + Q L++L LA N + ++P ++ +L +L ++ + +E+P +
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 225 F---------QNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLG 275
NL S+ L + ++P I +L +L ++ + + L L I L
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSL-KIRNSPLS-ALGPAIHHLP 229
Query: 276 NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKL 335
+ +DL N P F L++L++ + +P + L LE LDL
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289
Query: 336 SGSIPSDLQNLRALRSLNLTFNNLE 360
+PS + L A + + +
Sbjct: 290 LSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 50/318 (15%), Positives = 96/318 (30%), Gaps = 27/318 (8%)
Query: 42 KIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSL 101
L N ++ + + D +
Sbjct: 27 PYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALKATADL----LEDA 78
Query: 102 TNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNL 161
T L + P+ LS+ L + + ++P ++ + L L L
Sbjct: 79 T-QPGRVALELRSVPLP-QFPDQAFRLSH-LQHMTIDAAGL-MELPDTMQQFAGLETLTL 134
Query: 162 SYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGN---------LKKLNQIDLSGN 212
+ N + + I L L+ L + +P L + L L + L
Sbjct: 135 ARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193
Query: 213 ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIG 272
+ +P S N QNL S+ + N+ L+ + I L L + +L P G
Sbjct: 194 GI-RSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL-DLRGCTALRNYPPIFG 250
Query: 273 MLGNVVTIDLS-ANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLS 331
+ + L + L LP LEKL + +P+++A+L ++ +
Sbjct: 251 GRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309
Query: 332 SNKLSGSIPSDLQNLRAL 349
+ + A
Sbjct: 310 PHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 54/333 (16%), Positives = 101/333 (30%), Gaps = 30/333 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L + + + + N N QI
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLS-QWQRHYNADRNRWHS----AWRQANSNNPQIETRTG 65
Query: 61 NLLEGTVPPGLGNL--PFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
L+ L + P + + F + L + D
Sbjct: 66 RALK-ATADLLEDATQPGRVALELRSVPLP-------QFPDQAFRLSHLQHMTIDAAGLM 117
Query: 119 GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQ-- 176
E+P+++ + L L + N +P SI L L L++ E+ +
Sbjct: 118 -ELPDTMQQFAG-LETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTD 174
Query: 177 -------LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLL 229
L LQSL L I S+P ++ NL+ L + + + L S + + + L
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLE 232
Query: 230 SIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSG 289
+DL N P + L ++ + L TLP +I L + +DL
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL-LTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 290 NLPNSFKNCKSLEKLLMANNKFSGPIPNILAEL 322
LP+ + +L+ + + +
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 44/256 (17%), Positives = 87/256 (33%), Gaps = 12/256 (4%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
V L L S L + P +L +L ++P ++ ++ + +A
Sbjct: 80 QPGRVALELRSVPL-PQFPDQAF-RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136
Query: 61 NLLEGTVPPGLGNLPFLKMYNI-GFNKIVGSGDE--GLSFITSLTNSTRLNFLAFDGNQF 117
N L +P + +L L+ +I ++ + L L +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 118 EGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQL 177
+P SI NL N L L + + + +I L L L+L + G
Sbjct: 196 R-SLPASIANLQN-LKSLKIRNSPL-SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 178 QELQSLDLAG-NQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236
L+ L L + + ++P + L +L ++DL G S +P+ I + +
Sbjct: 253 APLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
Query: 237 KLNGNIPKEILSLSSL 252
++ +
Sbjct: 312 LQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 40/269 (14%), Positives = 89/269 (33%), Gaps = 29/269 (10%)
Query: 100 SLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLL 159
+S+ L F G+ + + + + +R + +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQW-----QRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 160 NLSYNSISGEILTEIGQLQE--LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASE 217
+ ++ + + +L+L + P+ L L + + L E
Sbjct: 62 TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-ME 118
Query: 218 IPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNV 277
+P + F L ++ L+ N L +P I SL+ L + ++ LPE +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL-SIRACPELTELPEPLAST--- 173
Query: 278 VTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSG 337
+ + +L+ L + +P +A L+ L+ L + ++ LS
Sbjct: 174 ------------DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS- 219
Query: 338 SIPSDLQNLRALRSLNLTFNNLEGVVPRE 366
++ + +L L L+L P
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPI 248
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 27/177 (15%), Positives = 58/177 (32%), Gaps = 11/177 (6%)
Query: 192 GSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSS 251
GS + + + G+ +Q + D + S+
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-----SN 56
Query: 252 LTTIVNLSKNFLDGTLPEEIGML--GNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANN 309
I + L + + V ++L + L P+ L+ + +
Sbjct: 57 NPQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 310 KFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE 366
+P+ + + GLE L L+ N L ++P+ + +L LR L++ +P
Sbjct: 115 GLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEP 169
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-46
Identities = 68/392 (17%), Positives = 128/392 (32%), Gaps = 43/392 (10%)
Query: 3 SLVYLGLASNQLWGEIPYDVGDKLPNL------LGFNFCFNKFTGKIPGSLHNLTNIQI- 55
L L L N I L L LG P + L ++ I
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264
Query: 56 -IRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDG 114
R+ + L + ++ I ++ + + L+
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--------KYLEDVPKHFKWQSLSIIR 316
Query: 115 NQFE-------------------GEIPESIGNLSNVLSKLYMGGNRFYGKIPTS--IGRL 153
Q + G I L + LS L + N S
Sbjct: 317 CQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPS-LSYLDLSRNALSFSGCCSYSDLGT 375
Query: 154 RSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIP-NTLGNLKKLNQIDLSGN 212
SL L+LS+N + L+ELQ LD + + + +L+KL +D+S
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 213 ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEI 271
+ F +L ++ ++ N N + + ++LT + +LSK L+
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFL-DLSKCQLEQISWGVF 493
Query: 272 GMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLS 331
L + +++S N L + + SL L + N+ + K L +L+
Sbjct: 494 DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLT 553
Query: 332 SNKLSGSIPSDLQNLRALRSLNLTFNNLEGVV 363
+N ++ I + L+ ++ N+E +
Sbjct: 554 NNSVA-CICEHQKFLQWVKEQKQFLVNVEQMT 584
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-44
Identities = 69/391 (17%), Positives = 128/391 (32%), Gaps = 30/391 (7%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L +L L+ ++ L +L N PGS LT+++ +
Sbjct: 55 FSELQWLDLSRCEIETIEDKAWHG-LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVE 113
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
L +G L LK N+ N I +N T L + N +
Sbjct: 114 TKLASLESFPIGQLITLKKLNVAHNFI-----HSCKLPAYFSNLTNLVHVDLSYNYIQTI 168
Query: 121 IPESIGNLSN---VLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQ- 176
+ L V L M N I + L L L N S I+ Q
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQN 227
Query: 177 LQELQSLDLAGNQISGSI------PNTLGNLKKL--NQIDLSGNELASEIPTSFGNFQNL 228
L L L + P+ + L + ++ L+ S+ F N+
Sbjct: 228 LAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANV 287
Query: 229 LSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS 288
++ L+ + +++ ++ ++ + L + L + ++ L+ N S
Sbjct: 288 SAMSLAGVSIKY--LEDVPKHFKWQSL-SIIRCQLKQFPTLD---LPFLKSLTLTMNKGS 341
Query: 289 GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKG--LEVLDLSSNKLSGSIPSDLQNL 346
+ SL L ++ N S ++L L LDLS N + ++ L
Sbjct: 342 --ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGL 398
Query: 347 RALRSLNLTFNNLEGVVPREGIFRHTSMVHL 377
L+ L+ + L+ V +++L
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-41
Identities = 76/365 (20%), Positives = 125/365 (34%), Gaps = 30/365 (8%)
Query: 27 PNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNK 86
+ + FN S N + +Q + ++ +E L L + N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 87 IVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYG-K 145
I S +TSL N L + IG L L KL + N + K
Sbjct: 92 IQSFSPGSFSGLTSLEN------LVAVETKLASLESFPIGQLIT-LKKLNVAHNFIHSCK 144
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL----QSLDLAGNQISGSIPNTLGNL 201
+P L +L ++LSYN I + ++ L+E SLD++ N I I +
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQG 203
Query: 202 KKLNQIDLSGNELASEIP-TSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSK 260
KL+++ L GN +S I T N L L + EI S + + +++
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 261 NFLDGT-------LPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSG 313
+ T + L NV + L+ + + L + +
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ 321
Query: 314 PIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTS 373
P +L L+ L L+ NK SI L +L L+L+ N L +
Sbjct: 322 -FPT--LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFS--GCCSYSDLG 374
Query: 374 MVHLE 378
L
Sbjct: 375 TNSLR 379
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-36
Identities = 50/264 (18%), Positives = 93/264 (35%), Gaps = 17/264 (6%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
++P+ ++ + + + N S L L+LS I L
Sbjct: 25 KVPD---DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHH 81
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
L +L L GN I P + L L + +LAS G L +++++N ++
Sbjct: 82 LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141
Query: 240 G-NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGN----VVTIDLSANGLSGNLPNS 294
+P +L++L + +LS N++ ++ L +++D+S N + +
Sbjct: 142 SCKLPAYFSNLTNLVHV-DLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA 200
Query: 295 FKNCKSLEKLLMANNKFSGPIP-NILAELKGLEVLDLSSNKLSGSI------PSDLQNLR 347
F+ L +L + N S I L L GL V L + PS ++ L
Sbjct: 201 FQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 348 ALRSLNLTFNNLEGVVPREGIFRH 371
+ F
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHC 283
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-42
Identities = 94/364 (25%), Positives = 153/364 (42%), Gaps = 38/364 (10%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ + L + + V L NL NF N+ T P L NLT + I M +
Sbjct: 45 LDQVTTLQADRLGI--KSIDGVE-YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 99
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N + L NL L + N+I + I L N T LN L N
Sbjct: 100 NQI--ADITPLANLTNLTGLTLFNNQI--------TDIDPLKNLTNLNRLELSSNTISD- 148
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
++ L++ L +L G + L +L L++S N +S ++ + +L L
Sbjct: 149 -ISALSGLTS-LQQLSFGNQV---TDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNL 201
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
+SL NQIS P LG L L+++ L+GN+L + + NL +DL+NN+++
Sbjct: 202 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
P + L+ LT + L N + + L + ++L+ N L + N K+
Sbjct: 258 LAP--LSGLTKLTEL-KLGANQISNI--SPLAGLTALTNLELNENQLED--ISPISNLKN 310
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
L L + N S P ++ L L+ L +NK+S S L NL + L+ N +
Sbjct: 311 LTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQIS 366
Query: 361 GVVP 364
+ P
Sbjct: 367 DLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-42
Identities = 86/359 (23%), Positives = 147/359 (40%), Gaps = 36/359 (10%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+T LV + + +NQ+ P L NL G N+ T P L NLTN+ + ++
Sbjct: 89 LTKLVDILMNNNQIADITPLA---NLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSS 143
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N + + L L L+ + G ++ + L N T L L N+
Sbjct: 144 NTI--SDISALSGLTSLQQLSFGNQ---------VTDLKPLANLTTLERLDISSNKVSD- 191
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+ L+N L L N+ P +G L +L L+L+ N + + + L L
Sbjct: 192 -ISVLAKLTN-LESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNL 245
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
LDLA NQIS P L L KL ++ L N++++ P L +++L+ N+L
Sbjct: 246 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED 301
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
P I +L +LT + L N + + + L + + N +S +S N +
Sbjct: 302 ISP--ISNLKNLTYL-TLYFNNI--SDISPVSSLTKLQRLFFYNNKVSD--VSSLANLTN 354
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359
+ L +N+ S P LA L + L L+ + + + N+ ++ L
Sbjct: 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-40
Identities = 87/362 (24%), Positives = 148/362 (40%), Gaps = 36/362 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+T+L L L +NQ+ P L NL N + +L LT++Q + +
Sbjct: 111 LTNLTGLTLFNNQITDIDPLK---NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGN 165
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
+ + L NL L+ +I NK+ S I+ L T L L NQ
Sbjct: 166 QVTD---LKPLANLTTLERLDISSNKV--------SDISVLAKLTNLESLIATNNQISDI 214
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
P +G L+N L +L + GN+ K ++ L +LT L+L+ N IS L + L +L
Sbjct: 215 TP--LGILTN-LDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISN--LAPLSGLTKL 267
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
L L NQIS P L L L ++L+ N+L P N +NL + L N ++
Sbjct: 268 TELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
P + SL+ L + N + + + L N+ + N +S P N
Sbjct: 324 ISP--VSSLTKLQRL-FFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTR 376
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
+ +L + + ++ N A + + + L P+ + + + ++T+N
Sbjct: 377 ITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS 434
Query: 361 GV 362
Sbjct: 435 YT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-40
Identities = 84/341 (24%), Positives = 146/341 (42%), Gaps = 35/341 (10%)
Query: 24 DKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83
L + T + +L + ++ + G+ L L N
Sbjct: 21 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFS 76
Query: 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFY 143
N++ ++ + +LT L + + NQ P + NL+N L+ L + N+
Sbjct: 77 NNQL-----TDITPLKNLTK---LVDILMNNNQIADITP--LANLTN-LTGLTLFNNQI- 124
Query: 144 GKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKK 203
+ L +L L LS N+IS ++ + L LQ L GNQ++ P L NL
Sbjct: 125 -TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTT 178
Query: 204 LNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFL 263
L ++D+S N+++ + NL S+ +NN+++ P + L++L + +L+ N L
Sbjct: 179 LERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL-SLNGNQL 233
Query: 264 DGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELK 323
+ L N+ +DL+ N +S P L +L + N+ S P LA L
Sbjct: 234 --KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLT 287
Query: 324 GLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVP 364
L L+L+ N+L P + NL+ L L L FNN+ + P
Sbjct: 288 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-35
Identities = 71/316 (22%), Positives = 127/316 (40%), Gaps = 30/316 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+T+L L ++SN++ KL NL N+ + P L LTN+ + +
Sbjct: 176 LTTLERLDISSNKVSDISVLA---KLTNLESLIATNNQISDITP--LGILTNLDELSLNG 230
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L+ L +L L ++ N+I L+ ++ LT L L NQ
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQI-----SNLAPLSGLTK---LTELKLGANQISNI 280
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
P + L+ L+ L + N+ P I L++LT L L +N+IS ++ + L +L
Sbjct: 281 SP--LAGLTA-LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD--ISPVSSLTKL 333
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q L N++S ++L NL +N + N+++ P N + + L++
Sbjct: 334 QRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
++S T+ N++ P I G+ D++ N S S+
Sbjct: 390 APVNYKANVSIPNTVKNVTGAL---IAPATISDGGSYTEPDITWNLPSYTNEVSYTF-SQ 445
Query: 301 LEKLLMANNKFSGPIP 316
+ FSG +
Sbjct: 446 PVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 62/275 (22%), Positives = 111/275 (40%), Gaps = 23/275 (8%)
Query: 90 SGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTS 149
+ D ++ I + T + +L ++ L K
Sbjct: 9 TQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQ-VTTLQADRLGI--KSIDG 63
Query: 150 IGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDL 209
+ L +LT +N S N ++ +T + L +L + + NQI+ P L NL L + L
Sbjct: 64 VEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119
Query: 210 SGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPE 269
N++ P N NL ++LS+N ++ + L+SL + + D +
Sbjct: 120 FNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQL-SFGNQVTD---LK 171
Query: 270 EIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLD 329
+ L + +D+S+N +S + +LE L+ NN+ S P L L L+ L
Sbjct: 172 PLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELS 227
Query: 330 LSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVP 364
L+ N+L L +L L L+L N + + P
Sbjct: 228 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 63/296 (21%), Positives = 120/296 (40%), Gaps = 31/296 (10%)
Query: 69 PGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNL 128
L +G + S T+ ++ L D + + + L
Sbjct: 18 FTDTALAEKMKTVLGKTNVTD--------TVSQTDLDQVTTLQADRLGIK--SIDGVEYL 67
Query: 129 SNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGN 188
+N L+++ N+ P + L L + ++ N I+ +T + L L L L N
Sbjct: 68 NN-LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNN 122
Query: 189 QISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS 248
QI+ P L NL LN+++LS N ++ ++ +L + N + K + +
Sbjct: 123 QITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLAN 175
Query: 249 LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMAN 308
L++L + ++S N + + + L N+ ++ + N +S +L++L +
Sbjct: 176 LTTLERL-DISSNKV--SDISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNG 230
Query: 309 NKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVP 364
N+ LA L L LDL++N++S P L L L L L N + + P
Sbjct: 231 NQLKDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 36/233 (15%)
Query: 151 GRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLS 210
G L S T+ I+ + L E L ++ ++ +L ++ +
Sbjct: 1 GPLGSATITQD--TPINQ--IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQAD 54
Query: 211 GNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEE 270
+ S NL I+ SNN+L P + +L+ L I ++ N +
Sbjct: 55 RLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI-LMNNNQI--ADITP 107
Query: 271 IGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIP-------------- 316
+ L N+ + L N ++ + KN +L +L +++N S
Sbjct: 108 LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGN 165
Query: 317 NI-----LAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVP 364
+ LA L LE LD+SSNK+S S L L L SL T N + + P
Sbjct: 166 QVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP 216
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 56/369 (15%), Positives = 110/369 (29%), Gaps = 29/369 (7%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ + L + + N+ + N + L T ++++ ++
Sbjct: 9 GNRYKIEKVTDSSL-KQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N+L L +L L+ ++ N + L + L N
Sbjct: 68 NVL--YETLDLESLSTLRTLDLNNNY-----------VQELLVGPSIETLHAANNNIS-R 113
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISG-EILTEIGQLQE 179
+ S G +Y+ N+ G + L+L N I
Sbjct: 114 VSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
L+ L+L N I + + KL +DLS N+L + + F + + I L NNKL
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 240 GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCK 299
I K + +L +L N + V ++ + + + C
Sbjct: 228 -LIEKALRFSQNLEHF-DLRGNGFHCGTLRDFFSKNQRVQ-TVAKQTVKKLTGQNEEECT 284
Query: 300 SLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGS----IPSDLQNLRALRSLNLT 355
L L+ + + GS + + +N R ++
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 356 FNNLEGVVP 364
V+
Sbjct: 345 KEQYRTVID 353
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-38
Identities = 50/279 (17%), Positives = 100/279 (35%), Gaps = 17/279 (6%)
Query: 103 NSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLS 162
N R + + + + N + +L + GN + L LLNLS
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWN-VKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 163 YNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSF 222
N + ++ L L++LDL N + L + + + N + S +
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVS--C 116
Query: 223 GNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDG-TLPEEIGMLGNVVTID 281
Q +I L+NNK+ + S + + +L N +D E + ++
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL-DLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 282 LSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPS 341
L N + ++ L+ L +++NK + + G+ + L +NKL I
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 342 DLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGN 380
L+ + L +L N R+ ++ + +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 53/259 (20%), Positives = 98/259 (37%), Gaps = 23/259 (8%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN 205
I + ++ +S+ + + ++ LDL+GN +S L KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPK----EILSLSS--LTTI---- 255
++LS N L E + L ++DL+NN + + E L ++ ++ +
Sbjct: 62 LLNLSSNVL-YETL-DLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAANNNISRVSCSR 118
Query: 256 ------VNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSG-NLPNSFKNCKSLEKLLMAN 308
+ L+ N + + G V +DL N + N + +LE L +
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 309 NKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGI 368
N + L+ LDLSSNKL+ + + Q+ + ++L N L +
Sbjct: 179 NFIYD-VKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRF 235
Query: 369 FRHTSMVHLEGNPKLCLHL 387
++ L GN C L
Sbjct: 236 SQNLEHFDLRGNGFHCGTL 254
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 5e-21
Identities = 39/185 (21%), Positives = 76/185 (41%), Gaps = 11/185 (5%)
Query: 193 SIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSL 252
+I N + ++ + L + + + N+ +DLS N L+ ++ + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 253 TTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFS 312
+ NLS N L ++ L + T+DL+ N + S+E L ANN S
Sbjct: 61 ELL-NLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 313 GPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHT 372
+ +G + + L++NK++ D ++ L+L N ++ V E
Sbjct: 113 RVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 373 SMVHL 377
++ HL
Sbjct: 170 TLEHL 174
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 9e-20
Identities = 34/329 (10%), Positives = 88/329 (26%), Gaps = 18/329 (5%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+L +L L N ++ ++ V L + NK + + + I + +
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L + L L+ +++ N F + + +
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGF--HCGTLRDFFSKNQRVQTVAKQTVK------K 274
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIG----Q 176
+ V + + G RL +L + S G +
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN 334
Query: 177 LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236
+ +D Q I + ++ L ++ L
Sbjct: 335 QARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV 394
Query: 237 KLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFK 296
+ S L + + K + + + ++ + D+ + + + +
Sbjct: 395 GQI-ELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENAR 453
Query: 297 NCKSLEKLLMANNKFSGPIPNILAELKGL 325
K + +A + + ++ + L
Sbjct: 454 LKKLNGEADLALASANATLQELVVREQNL 482
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 50/279 (17%), Positives = 100/279 (35%), Gaps = 17/279 (6%)
Query: 103 NSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLS 162
N R + + + + N + +L + GN + L LLNLS
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWN-VKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 163 YNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSF 222
N + ++ L L++LDL N + L + + + N + S +
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVS--C 116
Query: 223 GNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDG-TLPEEIGMLGNVVTID 281
Q +I L+NNK+ + S + + +L N +D E + ++
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL-DLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 282 LSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPS 341
L N + ++ L+ L +++NK + + G+ + L +NKL I
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 342 DLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGN 380
L+ + L +L N R+ ++ + +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-38
Identities = 50/337 (14%), Positives = 97/337 (28%), Gaps = 30/337 (8%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ + L + + N+ + N + L T ++++ ++
Sbjct: 9 GNRYKIEKVTDSSL-KQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N+L L +L L+ ++ N + L + L N
Sbjct: 68 NVL--YETLDLESLSTLRTLDLNNNY-----------VQELLVGPSIETLHAANNNIS-R 113
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISG-EILTEIGQLQE 179
+ S G +Y+ N+ G + L+L N I
Sbjct: 114 VSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
L+ L+L N I + + KL +DLS N+L + + F + + I L NNKL
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 240 GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCK 299
I K + +L +L N N ++ + + + C
Sbjct: 228 -LIEKALRFSQNLEHF-DLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 300 SLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLS 336
++ L +
Sbjct: 285 VPTLGHYGAYCCEDL-----PAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 56/320 (17%), Positives = 119/320 (37%), Gaps = 25/320 (7%)
Query: 43 IPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLT 102
I N +I ++ + L+ + + +K ++ N + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA------DLA 55
Query: 103 NSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLS 162
T+L L N E + + +LS L L + N + S+ L+ +
Sbjct: 56 PFTKLELLNLSSNVLY-ETLD-LESLST-LRTLDLNNNYV-----QELLVGPSIETLHAA 107
Query: 163 YNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELAS-EIPTS 221
N+IS + + Q +++ LA N+I+ G ++ +DL NE+ +
Sbjct: 108 NNNIS-RV--SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 222 FGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTID 281
+ L ++L N + ++ ++ + L T+ +LS N L + E V I
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTL-DLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 282 LSANGLSGNLPNSFKNCKSLEKLLMANNKFS-GPIPNILAELKGLEVLDLSSNK-LSGSI 339
L N L + + + ++LE + N F G + + ++ + ++ + + K L+G
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 340 PSDLQNLRALRSLNLTFNNL 359
+ +L
Sbjct: 280 EEECTVPTLGHYGAYCCEDL 299
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 53/259 (20%), Positives = 98/259 (37%), Gaps = 23/259 (8%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN 205
I + ++ +S+ + + ++ LDL+GN +S L KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPK----EILSLSS--LTTI---- 255
++LS N L E + L ++DL+NN + + E L ++ ++ +
Sbjct: 62 LLNLSSNVL-YETL-DLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAANNNISRVSCSR 118
Query: 256 ------VNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSG-NLPNSFKNCKSLEKLLMAN 308
+ L+ N + + G V +DL N + N + +LE L +
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 309 NKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGI 368
N + L+ LDLSSNKL+ + + Q+ + ++L N L +
Sbjct: 179 NFIYD-VKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRF 235
Query: 369 FRHTSMVHLEGNPKLCLHL 387
++ L GN C L
Sbjct: 236 SQNLEHFDLRGNGFHCGTL 254
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 39/185 (21%), Positives = 76/185 (41%), Gaps = 11/185 (5%)
Query: 193 SIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSL 252
+I N + ++ + L + + + N+ +DLS N L+ ++ + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 253 TTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFS 312
+ NLS N L ++ L + T+DL+ N + S+E L ANN S
Sbjct: 61 ELL-NLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 313 GPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHT 372
+ +G + + L++NK++ D ++ L+L N ++ V E
Sbjct: 113 RVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 373 SMVHL 377
++ HL
Sbjct: 170 TLEHL 174
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 8e-40
Identities = 86/397 (21%), Positives = 151/397 (38%), Gaps = 31/397 (7%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNL----LGFNFCFNKFTGKIPGSLHNLTNIQII 56
+T+L +L L+SN++ I L + L + N PG+ + + +
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKL 205
Query: 57 RMAHNLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGN 115
+ +N V + L L+++ + + G+ ++L L F
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 116 Q---FEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNSISGEIL 171
+ +I + L+N +S + S + L L+N +
Sbjct: 266 YLDYYLDDIIDLFNCLTN-VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT--- 321
Query: 172 TEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELA--SEIPTSFGNFQNLL 229
+L+ L+ L N+ + + +L L +DLS N L+ S +L
Sbjct: 322 ---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 230 SIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEI-GMLGNVVTIDLSANGLS 288
+DLS N + + L L L + + + L + L N++ +D+S
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHL-DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 289 GNLPNSFKNCKSLEKLLMANNKFSGPI-PNILAELKGLEVLDLSSNKLSGSIPSDLQNLR 347
F SLE L MA N F P+I EL+ L LDLS +L P+ +L
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 348 ALRSLNLTFNNLEGVVPREGIFRHTS---MVHLEGNP 381
+L+ LN+ N L+ V +GIF + + L NP
Sbjct: 495 SLQVLNMASNQLKSV--PDGIFDRLTSLQKIWLHTNP 529
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-37
Identities = 72/393 (18%), Positives = 125/393 (31%), Gaps = 33/393 (8%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
L L L+ ++ I L +L N G+ L+++Q +
Sbjct: 51 FPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
L +G+L LK N+ N I + +N T L L N+ +
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLI-----QSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 121 IPESIGNLSN---VLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEIL-TEIGQ 176
+ L + L + N I + L L L N S ++ T I
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223
Query: 177 LQELQSLDLAG------NQISGSIPNTLGNLKKLNQIDLSGNEL---ASEIPTSFGNFQN 227
L L+ L + + L L L + L +I F N
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 228 LLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGL 287
+ S L + + +VN L ++ + ++N
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKG 337
Query: 288 SGNLPNSFKNCKSLEKLLMANNK--FSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQN 345
S + SLE L ++ N F G L+ LDLS N + ++ S+
Sbjct: 338 GN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394
Query: 346 LRALRSLNLTFNNLEGVVPREGIFRH-TSMVHL 377
L L L+ +NL+ + +F ++++L
Sbjct: 395 LEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYL 426
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-37
Identities = 69/410 (16%), Positives = 137/410 (33%), Gaps = 42/410 (10%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++ L L L N + + L +L + +L ++ + +AH
Sbjct: 75 LSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 61 NLL-EGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG 119
NL+ +P NL L+ ++ NKI L + + L N
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL--NLSLDLSLNPMNF 191
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIP-TSIGRLRSLTLLNLSYNSISGE---ILTEIG 175
P + + L KL + N + T I L L + L E +
Sbjct: 192 IQPGAFKEIR--LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 176 QLQELQSLDLAGNQISG------SIPNTLGNLKKLNQIDLSGNELASEIPTSF------- 222
L+ L +L + +++ I + L ++ L + S+
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309
Query: 223 ------------GNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD--GTLP 268
++L + ++NK + + L SL + +LS+N L G
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFL-DLSRNGLSFKGCCS 366
Query: 269 EEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSG-PIPNILAELKGLEV 327
+ ++ +DLS NG+ + ++F + LE L ++ ++ L+ L
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 328 LDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHL 377
LD+S + L +L L + N+ + + ++ L
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-36
Identities = 72/354 (20%), Positives = 127/354 (35%), Gaps = 31/354 (8%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNL------LGFNFCFNKFTGKIPGSLHNLTNIQI 55
L L L +N + L L LG +L L N+ I
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 56 IRMAHNLLEGTVPPGLG---NLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAF 112
L+ + + L + +++ I + + + L
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--------ERVKDFSYNFGWQHLEL 311
Query: 113 DGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILT 172
+F + +L +L N+ G + + L SL L+LS N +S +
Sbjct: 312 VNCKFGQFPTLKLKSLK----RLTFTSNKG-GNAFSEVD-LPSLEFLDLSRNGLSFKGCC 365
Query: 173 --EIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTS-FGNFQNLL 229
L+ LDL+ N + ++ + L++L +D + L S F + +NL+
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424
Query: 230 SIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEI-GMLGNVVTIDLSANGL 287
+D+S+ I + LSSL + ++ N +I L N+ +DLS L
Sbjct: 425 YLDISHTHTR-VAFNGIFNGLSSLEVL-KMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 288 SGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPS 341
P +F + SL+ L MA+N+ I L L+ + L +N S P
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 59/253 (23%), Positives = 98/253 (38%), Gaps = 17/253 (6%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
+IP+ NL L + N S L +L+LS I L
Sbjct: 21 KIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
L +L L GN I L L ++ LAS G+ + L +++++N +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 240 -GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGN----VVTIDLSANGLSGNLPNS 294
+P+ +L++L + +LS N + ++ +L +++DLS N ++ P +
Sbjct: 138 SFKLPEYFSNLTNLEHL-DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 295 FKNCKSLEKLLMANNKFSGPIP-NILAELKGLEVLDL------SSNKLSGSIPSDLQNLR 347
FK L KL + NN S + + L GLEV L + L S L+ L
Sbjct: 197 FKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 348 ALRSLNLTFNNLE 360
L L+
Sbjct: 256 NLTIEEFRLAYLD 268
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 73/396 (18%), Positives = 132/396 (33%), Gaps = 57/396 (14%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
S L L+ N L + P L + + G+ +L+++ + + N
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
++ ++ G + + L L
Sbjct: 87 PIQ-SLALGA-----------------------------FSGLSSLQKLVAVETNLASLE 116
Query: 122 PESIGNLSNVLSKLYMGGNRF-YGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IG+L L +L + N K+P L +L L+LS N I T++ L ++
Sbjct: 117 NFPIGHLKT-LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Query: 181 Q----SLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIP-TSFGNFQNLLSIDLSN 235
SLDL+ N ++ I +L+++ L N + + T L L
Sbjct: 176 PLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 236 NKLNGNIPKEILSLSSLTTIVNLSKNFLDGT--------LPEEIGMLGNVVTIDLSANGL 287
+ E S+L + NL+ + + L NV + L + +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294
Query: 288 SGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLR 347
S+ + L + N KF P + +LK L+ L +SNK + +L
Sbjct: 295 ERVKDFSY--NFGWQHLELVNCKFGQ-FPTL--KLKSLKRLTFTSNKGGNAFS--EVDLP 347
Query: 348 ALRSLNLTFNNLEGVVPREGIFRHTS---MVHLEGN 380
+L L+L+ N L T+ + L N
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 50/247 (20%), Positives = 89/247 (36%), Gaps = 21/247 (8%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
L + Q KL +L F NK +L +++ + ++
Sbjct: 306 WQHLELVNCKFGQF-------PTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSR 356
Query: 61 NLLE--GTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
N L G LK ++ FN ++ + ++ +L L F + +
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-------TMSSNFLGLEQLEHLDFQHSNLK 409
Query: 119 GEIPESI-GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI-GQ 176
S+ +L N L L + L SL +L ++ NS L +I +
Sbjct: 410 QMSEFSVFLSLRN-LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
Query: 177 LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236
L+ L LDL+ Q+ P +L L ++++ N+L S F +L I L N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
Query: 237 KLNGNIP 243
+ + P
Sbjct: 529 PWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 40/201 (19%), Positives = 70/201 (34%), Gaps = 11/201 (5%)
Query: 1 MTSLVYLGLASNQL-WGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMA 59
+ SL +L L+ N L + +L + FN + + L ++ +
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ 404
Query: 60 HNLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
H+ L+ +L L +I + + + L L GN F+
Sbjct: 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG------IFNGLSSLEVLKMAGNSFQ 458
Query: 119 GEI-PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQL 177
P+ L N L+ L + + PT+ L SL +LN++ N + +L
Sbjct: 459 ENFLPDIFTELRN-LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRL 517
Query: 178 QELQSLDLAGNQISGSIPNTL 198
LQ + L N S P
Sbjct: 518 TSLQKIWLHTNPWDCSCPRID 538
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 20/109 (18%), Positives = 36/109 (33%), Gaps = 3/109 (2%)
Query: 254 TIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSG 313
+ +P+ + + +DLS N L SF + L+ L ++ +
Sbjct: 10 ITYQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 314 PIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGV 362
L L L L+ N + L +L+ L NL +
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-38
Identities = 89/417 (21%), Positives = 158/417 (37%), Gaps = 37/417 (8%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLT--NIQIIRM 58
+ +L L L+ NQ+ + KL +L +F N+ L L + +
Sbjct: 122 LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181
Query: 59 AHNLLEGTVPPGLGNLP------FLKMYNIGFNKI----VGSGDEGLSF--ITSLTNSTR 106
A N L V G L++ ++ N G+ +S SL +
Sbjct: 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241
Query: 107 LNFLAFDGNQFEGEIPESIGNLSNV-LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNS 165
+ F + + + L+ + L + + L+ L +LNL+YN
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK 301
Query: 166 ISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNF 225
I+ L LQ L+L+ N + + L K+ IDL N +A +F
Sbjct: 302 INKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL 361
Query: 226 QNLLSIDLSNNKLN-----GNIPKEILSLSSLTTI---------VNLSKNFLDGTLPEEI 271
+ L ++DL +N L +IP LS + L T+ ++LS+N L+
Sbjct: 362 EKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYF 421
Query: 272 GM-LGNVVTIDLSANGLSGNLPNS-FKNCKSLEKLLMANNKFSGPI-----PNILAELKG 324
+ + ++ + L+ N S + SLE+L + N ++ L
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 325 LEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNP 381
L+VL L+ N L+ P +L ALR L+L N L V+ + + ++ + N
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQ 537
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-37
Identities = 71/371 (19%), Positives = 128/371 (34%), Gaps = 36/371 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L L L S I + LPNL + +K P + L ++ +R+
Sbjct: 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYF 106
Query: 61 NLLEGTVPPG--LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
L V NL L ++ N+I L S L + F NQ
Sbjct: 107 CGLSDAVLKDGYFRNLKALTRLDLSKNQI-----RSLYLHPSFGKLNSLKSIDFSSNQIF 161
Query: 119 GEIPESIGNLSNV-LSKLYMGGNRFYGKIPTSIG------RLRSLTLLNLSYNSISGEIL 171
+ L LS + N Y ++ G R L +L++S N + +I
Sbjct: 162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI- 220
Query: 172 TEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQ--NLL 229
N IS S +L + + + +F ++
Sbjct: 221 -----------TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVR 269
Query: 230 SIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS 288
+DLS+ + ++ + L L + NL+ N ++ E L N+ ++LS N L
Sbjct: 270 HLDLSHGFVF-SLNSRVFETLKDLKVL-NLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327
Query: 289 GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRA 348
++F + + + N + L+ L+ LDL N L + + + +
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPS 382
Query: 349 LRSLNLTFNNL 359
+ + L+ N L
Sbjct: 383 IPDIFLSGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-36
Identities = 68/362 (18%), Positives = 129/362 (35%), Gaps = 36/362 (9%)
Query: 26 LPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPG-LGNLPFLKMYNIGF 84
L FN S L +Q++ + T+ NLP L++ ++G
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI--PESIGNLSNVLSKLYMGGNRF 142
+KI + + L L + NL L++L + N+
Sbjct: 83 SKIYFLHPDAFQGLFHLFE------LRLYFCGLSDAVLKDGYFRNLKA-LTRLDLSKNQI 135
Query: 143 YG-KIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQ--ELQSLDLAGNQISGSIPNTLG 199
+ S G+L SL ++ S N I E+ LQ L LA N + + G
Sbjct: 136 RSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG 195
Query: 200 NLKK------LNQIDLSGNELASEIPTSFGNF------------QNLLSIDLSNNKLNGN 241
L +D+SGN +I +F N +++ + + +
Sbjct: 196 KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-D 254
Query: 242 IPKEI---LSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNC 298
+ L+ SS+ + +LS F+ L ++ ++L+ N ++ +F
Sbjct: 255 PDQNTFAGLARSSVRHL-DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGL 313
Query: 299 KSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNN 358
+L+ L ++ N + L + +DL N ++ + L L++L+L N
Sbjct: 314 DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373
Query: 359 LE 360
L
Sbjct: 374 LT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-32
Identities = 69/366 (18%), Positives = 138/366 (37%), Gaps = 32/366 (8%)
Query: 3 SLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNL--TNIQIIRMAH 60
++ G SN + + +++G F F+ + L ++++ + ++H
Sbjct: 217 TVDITGNFSNAI-SKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSH 275
Query: 61 NLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG 119
+ ++ L LK+ N+ +NKI ++ + L L N
Sbjct: 276 GFVF-SLNSRVFETLKDLKVLNLAYNKI-----NKIA-DEAFYGLDNLQVLNLSYNLLGE 328
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
+ L ++ + + N + L L L+L N++ T I +
Sbjct: 329 LYSSNFYGLPK-VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPS 382
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELAS-EIPTSFGNFQNLLSIDLSNNKL 238
+ + L+GN++ L N I LS N L + +I +L + L+ N+
Sbjct: 383 IPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF 438
Query: 239 NGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEI-----GMLGNVVTIDLSANGLSGNLPN 293
+ + S + + L +N L E+ L ++ + L+ N L+ P
Sbjct: 439 SSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG 498
Query: 294 SFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLN 353
F + +L L + +N+ + N L LE+LD+S N+L P + L L+
Sbjct: 499 VFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVS---LSVLD 553
Query: 354 LTFNNL 359
+T N
Sbjct: 554 ITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-25
Identities = 60/344 (17%), Positives = 126/344 (36%), Gaps = 32/344 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L L LA N++ +I + L NL N +N + + L + I +
Sbjct: 289 LKDLKVLNLAYNKI-NKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N + L L+ ++ N + T++ + + GN+
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNAL-----------TTIHFIPSIPDIFLSGNKLV-- 394
Query: 121 IPESIGNLSNVLSKLYMGGNRFYG-KIPTSIGRLRSLTLLNLSYNSISGEILTEI-GQLQ 178
++ ++ + +++ NR I + R+ L +L L+ N S + +
Sbjct: 395 ---TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENP 451
Query: 179 ELQSLDLAGNQISGSI-----PNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDL 233
L+ L L N + + + L L + L+ N L S P F + L + L
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSL 511
Query: 234 SNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPN 293
++N+L + L ++L I+++S+N L ++ ++ +D++ N
Sbjct: 512 NSNRLT-VLSHNDL-PANL-EILDISRNQLL-APNPDV--FVSLSVLDITHNKFICECEL 565
Query: 294 S-FKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLS 336
S F N + + +A + G+ + LS+
Sbjct: 566 STFINWLNHTNVTIAGP-PADIYCVYPDSFSGVSLFSLSTEGCD 608
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 4e-19
Identities = 37/202 (18%), Positives = 71/202 (35%), Gaps = 35/202 (17%)
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
+ ++ +P L ++L LS N + + +SF + L ++L +
Sbjct: 7 RIAFYRFCNLT-QVPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 241 NIPKEIL-SLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCK 299
I KE +L +L + DL ++ + P++F+
Sbjct: 63 TIDKEAFRNLPNLRIL-------------------------DLGSSKIYFLHPDAFQGLF 97
Query: 300 SLEKLLMANNKFSGPI--PNILAELKGLEVLDLSSNKLSG-SIPSDLQNLRALRSLNLTF 356
L +L + S + LK L LDLS N++ + L +L+S++ +
Sbjct: 98 HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157
Query: 357 NNLEGVVPREGIFRHTSMVHLE 378
N + V E L
Sbjct: 158 NQIFLV--CEHELEPLQGKTLS 177
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 33/127 (25%), Positives = 48/127 (37%), Gaps = 5/127 (3%)
Query: 248 SLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMA 307
S S I L +P+ L + LS N + +SF + L+ L +
Sbjct: 1 SCSFDGRIAFYRFCNLT-QVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELG 56
Query: 308 NNKFSGPI-PNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE 366
+ I L L +LDL S+K+ P Q L L L L F L V ++
Sbjct: 57 SQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKD 116
Query: 367 GIFRHTS 373
G FR+
Sbjct: 117 GYFRNLK 123
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLR----EGISVAVKVL--DIESTGTWKSFFAECEAL 505
L +G G FGSV +G L+ + VAVK + D S + F +E +
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 506 RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL 565
++ H N+++L+ C + + + ++ F+ G L ++ R + L
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 566 NIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQS 623
+DIA ++YL N +H DL N +L +DMT V DFGL++ +
Sbjct: 151 KFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYS------ 199
Query: 624 SISSTHVLKGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ +G I +P E ++ DV++FGV + EI T GM+P
Sbjct: 200 ---GDYYRQGRIAKMPVKWIAIESLADR---VYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-38
Identities = 71/404 (17%), Positives = 147/404 (36%), Gaps = 40/404 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+T+L L + + + + EI L +L SL ++ +I + +
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181
Query: 61 NLLEGTVP---PGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQF 117
+ + L ++ +L++ + + S + S+ + LAF G+
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARF------QFSPLPVDEVSSPMKKLAFRGSVL 235
Query: 118 EGEIPESIGNLSNV---LSKLYMGGNRFYG------KIPTSIGRLRSLTLLNLSYNSISG 168
E + L LS++ G + L + + + I
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295
Query: 169 EILTEI-----GQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEI---PT 220
L L++++ + + +++ + +LK L +DLS N + E
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 221 SFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLT--TIVNLSKNFLDGTLPEEIGMLGNVV 278
G + +L ++ LS N L ++ K L +L T +++S+N +P+ +
Sbjct: 356 CKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMR 413
Query: 279 TIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGS 338
++LS+ G+ + LE L ++NN + L L+ L +S NKL +
Sbjct: 414 FLNLSSTGIRVVKTCIPQT---LEVLDVSNNNLD----SFSLFLPRLQELYISRNKLK-T 465
Query: 339 IPSDLQNLRALRSLNLTFNNLEGVVPRE-GIFRHTSMVHLEGNP 381
+P L + ++ N L+ V + L NP
Sbjct: 466 LPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNP 508
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-34
Identities = 61/375 (16%), Positives = 132/375 (35%), Gaps = 20/375 (5%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
++ L L+ N++ I + NL ++ + ++L +++ + ++ N
Sbjct: 26 AAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 62 LLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
L ++ G L LK N+ N G L N T L L + E
Sbjct: 85 HLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL-----FPNLTNLQTLRIGNVETFSE 138
Query: 121 IPE-SIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
I L++ L++L + S+ +R + L L + + + L
Sbjct: 139 IRRIDFAGLTS-LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
++ L+L ++ + L + + + + SF LL L +++
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
Query: 240 GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCK 299
+ +L+ L + + E + + + L +L + +
Sbjct: 258 ----FDDCTLNGLGDFNPSESDVVSELGKVE---TVTIRRLHIPQFYLFYDLSTVYSLLE 310
Query: 300 SLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSI---PSDLQNLRALRSLNLTF 356
++++ + N+K + LK LE LDLS N + + +L++L L+
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 357 NNLEGVVPREGIFRH 371
N+L + I
Sbjct: 371 NHLRSMQKTGEILLT 385
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-32
Identities = 66/388 (17%), Positives = 140/388 (36%), Gaps = 40/388 (10%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTG-KIPGSLHNLTNIQIIRMA 59
+ SL +L L+ N L + L +L N N + + NLTN+Q +R+
Sbjct: 73 LGSLEHLDLSDNHL-SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131
Query: 60 HNLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
+ + L L I + + L I + + L ++
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH------LTLHLSESA 185
Query: 119 GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISG---------- 168
+ E ++ + + L + + + + + S
Sbjct: 186 -FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL 244
Query: 169 EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKK--------LNQIDLSGNELASEIPT 220
++L I +L E++ D N + P+ + + + ++ + L ++ T
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
Query: 221 SFGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFL---DGTLPEEIGMLGN 276
+ + + I + N+K+ +P L SL + +LS+N + G +
Sbjct: 305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFL-DLSENLMVEEYLKNSACKGAWPS 362
Query: 277 VVTIDLSANGLS--GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNK 334
+ T+ LS N L K+L L ++ N F P+P+ + + L+LSS
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421
Query: 335 LSGSIPSDLQNLRALRSLNLTFNNLEGV 362
+ + + + + L L+++ NNL+
Sbjct: 422 IR-VVKTCI--PQTLEVLDVSNNNLDSF 446
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 45/245 (18%), Positives = 91/245 (37%), Gaps = 12/245 (4%)
Query: 145 KIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKL 204
IP+ + ++ L+LS+N I+ ++ LQ L L ++I+ + +L L
Sbjct: 19 SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 205 NQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG-NIPKEILSLSSLTTIVNLSKNFL 263
+DLS N L+S + FG +L ++L N + +L++L T+ +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL-RIGNVET 135
Query: 264 DGTLPEE-IGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAEL 322
+ L ++ +++ A L S K+ + + L + ++ + + L
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADIL 195
Query: 323 KGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPK 382
+ L+L L+ S L + R + S L +
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF-------RGSVLTDESFNELLKLLR 248
Query: 383 LCLHL 387
L L
Sbjct: 249 YILEL 253
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 40/236 (16%), Positives = 86/236 (36%), Gaps = 3/236 (1%)
Query: 127 NLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLA 186
L+ + L + N+ + +L +L L + I+ L L+ LDL+
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82
Query: 187 GNQISGSIPNTLGNLKKLNQIDLSGNELAS-EIPTSFGNFQNLLSIDLSNNKLNGNIPKE 245
N +S + G L L ++L GN + + + F N NL ++ + N + I +
Sbjct: 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
Query: 246 ILS-LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKL 304
+ L+SL + + L + + + ++ + L + + L S+ L
Sbjct: 143 DFAGLTSLNEL-EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYL 201
Query: 305 LMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
+ + + + L + + + + S L L L + +E
Sbjct: 202 ELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-21
Identities = 43/243 (17%), Positives = 83/243 (34%), Gaps = 21/243 (8%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++ L + L+ V L + +K +L +++ + ++
Sbjct: 285 TVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 61 NLLEGTVPPG---LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQF 117
NL+ G P L+ + N + G L L N F
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL----LTLKNLTSLDISRNTF 399
Query: 118 EGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQ- 176
+P+S + L + + T I ++L +L++S N+ L
Sbjct: 400 H-PMPDSCQWPEK-MRFLNLSSTGI-RVVKTCI--PQTLEVLDVSNNN-----LDSFSLF 449
Query: 177 LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236
L LQ L ++ N++ ++P+ L + +S N+L S F +L I L N
Sbjct: 450 LPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 237 KLN 239
+
Sbjct: 508 PWD 510
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-37
Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 36/219 (16%)
Query: 463 IGSGSFGSVYKGYLR-EGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLVKLITSC 520
IG G+FG V+ G LR + VAVK + F E L+ H N+V+LI C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN 580
+ + + +V E + G ++ G L L + D A+ ++YL
Sbjct: 182 T-----QKQPIYIVMELVQGGDFLTFLR-----TEGARLRVKTLLQMVGDAAAGMEYLE- 230
Query: 581 DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP- 639
+H DL N L+ E K+ DFG++R + + G + +P
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD---------GVYAASGGLRQVPV 279
Query: 640 ----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
PE YG + S+ DV+SFG++L E F+ G SP
Sbjct: 280 KWTAPEALNYG---RYSSESDVWSFGILLWETFSLGASP 315
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-37
Identities = 73/253 (28%), Positives = 116/253 (45%), Gaps = 30/253 (11%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
E +G G FG V+ G VA+K L T + ++F E + ++ RH LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
S E + +V E++ GSL D++ + G L + +++A IAS + Y+
Sbjct: 248 VSE------EPIYIVTEYMSKGSLLDFL---KGET-GKYLRLPQLVDMAAQIASGMAYVE 297
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
+ VH DL+ NIL+ E++ KV DFGLAR + + + ++ K I +
Sbjct: 298 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-----NEYTARQGAKFPIKWTA 349
Query: 640 PEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNF----PKNAQ 694
PE L + + DV+SFG++L E+ T G P EV + VE + P
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQVERGYRMPCPPECP 407
Query: 695 QVLDRELRQLMMS 707
+ L LM
Sbjct: 408 E----SLHDLMCQ 416
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 36/235 (15%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLR----EGISVAVKVL--DIESTGTWKSFFAECEAL 505
+ +G G FGSV + L+ + VAVK+L DI ++ + F E +
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 506 RNTRHRNLVKLITSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER 564
+ H ++ KL+ + ++ F+ +G L ++ R E+ L
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
+ +DIA ++YL +H DL N +L EDMT V DFGL+R +
Sbjct: 140 VRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS------- 189
Query: 625 ISSTHVLKGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ +G +P E + DV++FGV + EI T G +P
Sbjct: 190 --GDYYRQGCASKLPVKWLALESLADN---LYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-37
Identities = 69/337 (20%), Positives = 134/337 (39%), Gaps = 33/337 (9%)
Query: 49 NLTNIQIIRMAHNLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRL 107
L N +I+ ++ + +P L + +++ N+ +I + + +
Sbjct: 43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTY------AFAYAHTI 95
Query: 108 NFLAFDGNQFEGEIPESI-GNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNS 165
L N +P + N+ L+ L + N +P I LT L++S N+
Sbjct: 96 QKLYMGFNAIR-YLPPHVFQNVPL-LTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNN 152
Query: 166 ISGEILTEIGQ-LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGN 224
+ I + Q LQ+L L+ N+++ + L + L ++S N L ++
Sbjct: 153 LE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAI 203
Query: 225 FQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSA 284
+ +D S+N +N + + LT + L N L T + +V +DLS
Sbjct: 204 PIAVEELDASHNSIN-VVRGPVNV--ELTIL-KLQHNNL--TDTAWLLNYPGLVEVDLSY 257
Query: 285 NGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQ 344
N L + + F + LE+L ++NN+ + + L+VLDLS N L + +
Sbjct: 258 NELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQP 315
Query: 345 NLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNP 381
L +L L N++ + + + L N
Sbjct: 316 QFDRLENLYLDHNSIVTL--KLSTHHTLKNLTLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 64/363 (17%), Positives = 133/363 (36%), Gaps = 35/363 (9%)
Query: 26 LPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPG-LGNLPFLKMYNIGF 84
L N F + L + ++++ + +E + ++ +GF
Sbjct: 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 102
Query: 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESI-GNLSNVLSKLYMGGNRFY 143
N I + N L L + N +P I N L+ L M N
Sbjct: 103 NAIR-YLPPHV-----FQNVPLLTVLVLERNDLS-SLPRGIFHNTPK-LTTLSMSNNNL- 153
Query: 144 GKIPTSIGR-LRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLK 202
+I + SL L LS N ++ + ++ + L +++ N +S TL
Sbjct: 154 ERIEDDTFQATTSLQNLQLSSNRLT-HV--DLSLIPSLFHANVSYNLLS-----TLAIPI 205
Query: 203 KLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNF 262
+ ++D S N + + + L + L +N L + +L+ L + +LS N
Sbjct: 206 AVEELDASHNSI-NVVR--GPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEV-DLSYNE 259
Query: 263 LDGTLPEEI-GMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAE 321
L+ + + + + +S N L L + +L+ L +++N + +
Sbjct: 260 LE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQ 316
Query: 322 LKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNP 381
LE L L N + ++ L++L L+ N+ + +FR+ + ++
Sbjct: 317 FDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDC-NSLRALFRNVARPAVDDAD 372
Query: 382 KLC 384
+ C
Sbjct: 373 QHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-34
Identities = 67/362 (18%), Positives = 131/362 (36%), Gaps = 35/362 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ + + ++ + ++P + D + N + + IQ + M
Sbjct: 44 LNNQKIVTFKNSTM-RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102
Query: 61 NLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG 119
N + +PP N+P L + + N + N+ +L L+ N E
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRG------IFHNTPKLTTLSMSNNNLE- 154
Query: 120 EIPESI-GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQ 178
I + ++ L L + NR + + + SL N+SYN + + +
Sbjct: 155 RIEDDTFQATTS-LQNLQLSSNRL-THVD--LSLIPSLFHANVSYNLL-----STLAIPI 205
Query: 179 ELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKL 238
++ LD + N I+ + +L + L N L ++ N+ L+ +DLS N+L
Sbjct: 206 AVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL-TDTAW-LLNYPGLVEVDLSYNEL 260
Query: 239 NGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKN 297
I + L + +S N L L + + +DLS N L ++ +
Sbjct: 261 E-KIMYHPFVKMQRLERL-YISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316
Query: 298 CKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFN 357
LE L + +N + L+ L+ L LS N + L R + +
Sbjct: 317 FDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA 371
Query: 358 NL 359
+
Sbjct: 372 DQ 373
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-33
Identities = 57/346 (16%), Positives = 122/346 (35%), Gaps = 28/346 (8%)
Query: 34 FCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDE 93
I +L + + + L K+ + +
Sbjct: 4 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 63
Query: 94 GLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGR- 152
L + L + Q E + + KLYMG N +P + +
Sbjct: 64 LLDSFRQVE------LLNLNDLQIEEIDTYAFAYAHT-IQKLYMGFNAIR-YLPPHVFQN 115
Query: 153 LRSLTLLNLSYNSISGEILTEI-GQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211
+ LT+L L N +S + I +L +L ++ N + +T L + LS
Sbjct: 116 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS 174
Query: 212 NELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEI 271
N L + + +L ++S N L + ++ + + S N ++ +
Sbjct: 175 NRL-THVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEEL-DASHNSIN-VVRG-- 222
Query: 272 GMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLS 331
+ + + L N L+ N L ++ ++ N+ + + +++ LE L +S
Sbjct: 223 PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280
Query: 332 SNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHL 377
+N+L ++ Q + L+ L+L+ N+L V + + +L
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLLHV--ERNQPQFDRLENL 323
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 38/229 (16%), Positives = 95/229 (41%), Gaps = 17/229 (7%)
Query: 156 LTLLNLSYNSISGEILT--EIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNE 213
++ + + ++ E L + + + + L + +++ ++L+ +
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80
Query: 214 LASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEI- 271
+ +F + + + N + +P + + LT + L +N L +LP I
Sbjct: 81 IEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL-VLERNDLS-SLPRGIF 137
Query: 272 GMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLS 331
+ T+ +S N L ++F+ SL+ L +++N+ + + L+ + L ++S
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVS 194
Query: 332 SNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGN 380
N L S L A+ L+ + N++ V R + +++ L+ N
Sbjct: 195 YNLL-----STLAIPIAVEELDASHNSINVV--RGPVNVELTILKLQHN 236
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 23/140 (16%), Positives = 47/140 (33%), Gaps = 9/140 (6%)
Query: 247 LSLSSLTTIVNLSKNFL--DGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKL 304
+L ++ + D E L N + + + + + +E L
Sbjct: 15 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74
Query: 305 LMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLTFNNLEGVV 363
+ + + A ++ L + N + +P QN+ L L L N+L +
Sbjct: 75 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSL- 132
Query: 364 PREGIFRHTSM---VHLEGN 380
GIF +T + + N
Sbjct: 133 -PRGIFHNTPKLTTLSMSNN 151
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-36
Identities = 69/254 (27%), Positives = 123/254 (48%), Gaps = 30/254 (11%)
Query: 460 ENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLIT 518
++ +G G +G VY+G + ++VAVK L E T + F E ++ +H NLV+L+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
C+ ++ EF+ G+L D++ + + ++ + L +A I+SA++YL
Sbjct: 284 VCT-----REPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
+ +H +L N L+ E+ KV DFGL+R + + ++ K I +
Sbjct: 335 E---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHAGAKFPIKWT 386
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNF----PKNA 693
PE K S DV++FGV+L EI T GMSP +V + +E ++ P+
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELLEKDYRMERPEGC 444
Query: 694 QQVLDRELRQLMMS 707
++ +LM +
Sbjct: 445 P----EKVYELMRA 454
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-36
Identities = 73/253 (28%), Positives = 116/253 (45%), Gaps = 30/253 (11%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
E +G G FG V+ G VA+K L T + ++F E + ++ RH LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
S E + +V E++ GSL D++ + G L + +++A IAS + Y+
Sbjct: 331 VSE------EPIYIVTEYMSKGSLLDFL---KGET-GKYLRLPQLVDMAAQIASGMAYVE 380
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
+ VH DL+ NIL+ E++ KV DFGLAR + + + ++ K I +
Sbjct: 381 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-----NEYTARQGAKFPIKWTA 432
Query: 640 PEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNF----PKNAQ 694
PE L + + DV+SFG++L E+ T G P EV + VE + P
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQVERGYRMPCPPECP 490
Query: 695 QVLDRELRQLMMS 707
+ L LM
Sbjct: 491 E----SLHDLMCQ 499
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-36
Identities = 68/353 (19%), Positives = 119/353 (33%), Gaps = 53/353 (15%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
L + + L +P + + L N T +P L +++ + N
Sbjct: 40 NGNAVLNVGESGL-TTLPDCLPAHITTL---VIPDNNLT-SLPALPPELRTLEV---SGN 91
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
L ++P L L +++ + + + L L GNQ +
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCK------LWIFGNQLT-SL 136
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQ 181
P L L + N+ +P L L N N ++ + LQEL
Sbjct: 137 PVLPPGLQE----LSVSDNQL-ASLPALPSELCKLWAYN---NQLT-SLPMLPSGLQEL- 186
Query: 182 SLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN 241
++ NQ++ S+P L KL N L + +P + L +S N+L +
Sbjct: 187 --SVSDNQLA-SLPTLPSELYKL---WAYNNRL-TSLPALPSGLKEL---IVSGNRLT-S 235
Query: 242 IPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSL 301
+P L L +S N L +LP L +++ + N L+ LP S + S
Sbjct: 236 LPVLPSELKEL----MVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSE 286
Query: 302 EKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNL 354
+ + N S L E+ + + S + RAL
Sbjct: 287 TTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 44/208 (21%), Positives = 82/208 (39%), Gaps = 29/208 (13%)
Query: 152 RLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211
+LN+ + ++ + + + +L + N ++ S+P L+ L ++SG
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSG 90
Query: 212 NELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEI 271
N+L + +P L L P L L + N L +LP
Sbjct: 91 NQL-TSLPVLPPGLLELSIFSNPLTHL----PALPSGLCKL----WIFGNQL-TSLPVLP 140
Query: 272 GMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLS 331
+ + +S N L+ +LP L KL NN+ + ++ GL+ L +S
Sbjct: 141 ---PGLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT----SLPMLPSGLQELSVS 189
Query: 332 SNKLSGSIPSDLQNLRALRSLNLTFNNL 359
N+L+ S+P+ L L + N +L
Sbjct: 190 DNQLA-SLPTLPSELYKLWAYNNRLTSL 216
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 64/368 (17%), Positives = 120/368 (32%), Gaps = 60/368 (16%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
+ L L + NQL +P P L + N+ +P L + +N
Sbjct: 121 SGLCKLWIFGNQL-TSLP----VLPPGLQELSVSDNQLA-SLPALPSELCKL---WAYNN 171
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNS-TRLNFLAFDGNQFEGE 120
L ++P L L ++ N++ SL + L L N+
Sbjct: 172 QLT-SLPMLPSGLQEL---SVSDNQL-----------ASLPTLPSELYKLWAYNNRLT-S 215
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+P L +L + GNR +P L+ L +S N ++ + L
Sbjct: 216 LPALPSGLK----ELIVSGNRL-TSLPVLPSELKEL---MVSGNRLT-SLPMLPSGLL-- 264
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
SL + NQ++ +P +L +L ++L GN L SE + + S + +
Sbjct: 265 -SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL-SERTLQ--ALREITSAPGYSGPIIR 319
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+ + + ++L E G N+
Sbjct: 320 FDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMF--------GQEDNADAFSLF 371
Query: 301 LEKLLMANN-----KFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLT 355
L++L N F I + LA+L E L ++ ++ S ++
Sbjct: 372 LDRLSETENFIKDAGFKAQISSWLAQLAEDEALRANTFAMATEATSSCEDRVT-----FF 426
Query: 356 FNNLEGVV 363
+ ++ V
Sbjct: 427 LHQMKNVQ 434
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 17/85 (20%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 276 NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKL 335
+++ +GL+ LP+ + L++ +N + ++ A L L++S N+L
Sbjct: 41 GNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNN----LTSLPALPPELRTLEVSGNQL 93
Query: 336 SGSIPSDLQNLRALRSLNLTFNNLE 360
+ S+P L L + +L
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLP 117
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 70/272 (25%), Positives = 101/272 (37%), Gaps = 30/272 (11%)
Query: 440 HSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTW--K 496
SP +F + +G GS+G V+K +E G AVK G
Sbjct: 42 QSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA 101
Query: 497 SFFAECEALRN-TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEH 555
AE + +H V+L + ++ L L E G SL
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQTELCG-PSLQQHC-----EAW 150
Query: 556 GNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615
G L + D AL +LH+ +VH D+KP NI L K+GDFGL L
Sbjct: 151 GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207
Query: 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675
+ + V +G Y+ PE L TA DV+S G+ +LE+ M
Sbjct: 208 -------GTAGAGEVQEGDPRYMAPEL-LQGSYGTAADVFSLGLTILEVACNMELP---H 256
Query: 676 AGEVSLVKWVESNFPKNAQQVLDRELRQLMMS 707
GE + + P L ELR +++
Sbjct: 257 GGE-GWQQLRQGYLPPEFTAGLSSELRSVLVM 287
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-36
Identities = 69/212 (32%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
IG G FG V G R G VAVK + ++ T ++F AE + RH NLV+L+
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
+ L +V E++ GSL D++ R + L L ++D+ A++YL
Sbjct: 255 IV----EEKGGLYIVTEYMAKGSLVDYL---RSRG-RSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
VH DL N+L+ ED AKV DFGL + S+ K + +
Sbjct: 307 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---------SSTQDTGKLPVKWTA 354
Query: 640 PEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
PE +K ST DV+SFG++L EI++ G P
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 65/249 (26%), Positives = 104/249 (41%), Gaps = 27/249 (10%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLIT 518
IG GSF +VYKG + VA L + + F E E L+ +H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAIDIASALD 576
S S K + + LV E + +G+L ++ ++ + I L
Sbjct: 93 SWESTV-KGKKCIVLVTELMTSGTLKTYL-----KRFKV---MKIKVLRSWCRQILKGLQ 143
Query: 577 YLHNDCEVPIVHCDLKPGNILLD-EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
+LH PI+H DLK NI + + K+GD GLA S + G+
Sbjct: 144 FLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT--------LKRASFAKAVIGTP 194
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA-Q 694
++ PE EK + DVY+FG+ +LE+ T P E + + V S +
Sbjct: 195 EFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFD 252
Query: 695 QVLDRELRQ 703
+V E+++
Sbjct: 253 KVAIPEVKE 261
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 73/316 (23%), Positives = 116/316 (36%), Gaps = 47/316 (14%)
Query: 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWK---SFFAECEALRNTRH 510
NF E IG G F VY+ L +G+ VA+K + I K E + L+ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIA 568
N++K S F L +V E G L I K+ ER
Sbjct: 92 PNVIKYYAS-----FIEDNELNIVLELADAGDLSRMI----KHFKKQKRLIPERTVWKYF 142
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+ + SAL+++H ++H D+KP N+ + K+GD GL R ++++ + +
Sbjct: 143 VQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHS 195
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV-KWVES 687
V G+ Y+ PE + D++S G +L E+ SP + SL K +
Sbjct: 196 LV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 253
Query: 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747
++P ELRQL+ C P R D+
Sbjct: 254 DYPPLPSDHYSEELRQLVN----------------------MCINPDPEKRPDVTYVYDV 291
Query: 748 LKNAQKILLKRRQPNE 763
K + +
Sbjct: 292 AKRMHACTASSLEHHH 307
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 40/243 (16%)
Query: 445 ISYDELRRATGNFSHENL------IGSGSFGSVYKGYLR---EGISVAVKVL--DIESTG 493
++ +E+R + L +GSG+FG+V KGY + +VAVK+L +
Sbjct: 1 MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 494 TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN 553
AE ++ + +V++I C + E LV E G L ++ ++N
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYL---QQN 111
Query: 554 EHGNGLNFLERLNIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611
H + + + ++ + YL N VH DL N+LL AK+ DFGL
Sbjct: 112 RH---VKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-G 667
+++L +++ + K + + PE Y K S+ DV+SFGV++ E F+ G
Sbjct: 164 SKALRA---DENYYKAQTHGKWPVKWYAPECINYY---KFSSKSDVWSFGVLMWEAFSYG 217
Query: 668 MSP 670
P
Sbjct: 218 QKP 220
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-35
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
E +G+G FG V+ + VAVK + + + ++F AE ++ +H LVKL
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
+ E + ++ EF+ GSL D++ K++ G+ + ++ + IA + ++
Sbjct: 252 VTK------EPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
+ +H DL+ NIL+ + K+ DFGLAR + + + K I +
Sbjct: 302 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA-----KFPIKWTA 353
Query: 640 PEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
PE + DV+SFG++L+EI T G P
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 460 ENLIGSGSFGSVYKGYLR-----EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLV 514
+G G+FGSV G VAVK L + + F E E L++ +H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
K C S +N+ L+ E+L GSL D++ +H ++ ++ L I
Sbjct: 75 KYKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQ-----KHKERIDHIKLLQYTSQICKG 126
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
++YL +H DL NIL++ + K+GDFGL + L + ++ +
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ---DKEFFKVKEPGESP 180
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
I + PE K S A DV+SFGV+L E+FT
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 460 ENLIGSGSFGSVYKGYLREG----ISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLV 514
+IG G FG VY G L + I AVK L I G F E +++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
L+ C + + +V ++ +G L ++I E N + + + +A
Sbjct: 154 SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAKG 204
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
+ +L VH DL N +LDE T KV DFGLAR + ++ V +
Sbjct: 205 MKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-------EFDSVHNKT 254
Query: 635 IGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+P E K +T DV+SFGV+L E+ T G P
Sbjct: 255 GAKLPVKWMALESLQTQ---KFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 40/227 (17%)
Query: 460 ENLIGSGSFGSVYKGYLREG----ISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLV 514
+ +IG G FG VY G + I A+K L I ++F E +R H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
LI + ++ ++ +G L +I ++N + ++ + +A
Sbjct: 86 ALIGIMLPPEGLPH----VLLPYMCHGDLLQFIRSPQRN-----PTVKDLISFGLQVARG 136
Query: 575 LDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
++YL VH DL N +LDE T KV DFGLAR +L+R V +
Sbjct: 137 MEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDR-------EYYSVQQ 184
Query: 633 GSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+P E + +T DV+SFGV+L E+ T G P
Sbjct: 185 HRHARLPVKWTALESLQTY---RFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 460 ENLIGSGSFGSVYKGYL-----REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLV 514
+G G+FGSV G VAVK L + + F E E L++ +H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
K C S +N+ L+ E+L GSL D++ +H ++ ++ L I
Sbjct: 106 KYKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQ-----KHKERIDHIKLLQYTSQICKG 157
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
++YL +H DL NIL++ + K+GDFGL + L + ++ +
Sbjct: 158 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ---DKEYYKVKEPGESP 211
Query: 635 IGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT 666
I + PE K S A DV+SFGV+L E+FT
Sbjct: 212 IFWYAPESLTES---KFSVASDVWSFGVVLYELFT 243
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
+G+G FG V+ GY VAVK L + + + +F AE ++ +H+ LV+L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
+ E + ++ E++ NGSL D++ + G L + L++A IA + ++
Sbjct: 77 VTQ------EPIYIITEYMENGSLVDFL---KTPS-GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
E +H DL+ NIL+ + ++ K+ DFGLAR + + + K I +
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA-----KFPIKWTA 178
Query: 640 PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
PE YG + DV+SFG++L EI T G P
Sbjct: 179 PEAINYG---TFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 64/225 (28%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 460 ENLIGSGSFGSVYKGYLREG----ISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLV 514
+IG G FG VY G L + I AVK L I G F E +++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
L+ C + + +V ++ +G L ++I E N + + + +A
Sbjct: 90 SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAKG 140
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
+ YL VH DL N +LDE T KV DFGLAR + ++ V +
Sbjct: 141 MKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-------EYYSVHNKT 190
Query: 635 IGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+P E K +T DV+SFGV+L E+ T G P
Sbjct: 191 GAKLPVKWMALESLQTQ---KFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 62/224 (27%), Positives = 87/224 (38%), Gaps = 35/224 (15%)
Query: 460 ENLIGSGSFGSVYKGYLR----EGISVAVKVL---DIESTGTWKSFFAECEALRNTRHRN 512
+G GSFG V +G + +SVAVK L + F E A+ + HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
L++L + + +V E GSL D + +H A+ +A
Sbjct: 83 LIRLYGVVLT------PPMKMVTELAPLGSLLDRLR-----KHQGHFLLGTLSRYAVQVA 131
Query: 573 SALDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
+ YL +H DL N+LL K+GDFGL R+L + N
Sbjct: 132 EGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ---NDDHYVMQEH 183
Query: 631 LKGSIGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
K + PE S A D + FGV L E+FT G P
Sbjct: 184 RKVPFAWCAPESLKTR---TFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-35
Identities = 79/372 (21%), Positives = 133/372 (35%), Gaps = 66/372 (17%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKL------------PNLLGFNFCFNKFTGKIPGSLH 48
+ S A ++ P G++ + +P
Sbjct: 33 VKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPP 91
Query: 49 NLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLN 108
+L + + + N L +P +L L + N ++ L L
Sbjct: 92 HLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKA-----------LSDLPPL--LE 134
Query: 109 FLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISG 168
+L NQ E ++PE + N S L + + N K+P SL + N +
Sbjct: 135 YLGVSNNQLE-KLPE-LQNSSF-LKIIDVDNNSL-KKLPDLPP---SLEFIAAGNNQL-- 185
Query: 169 EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNL 228
E L E+ L L ++ N + +P+ +L+ + N L E N L
Sbjct: 186 EELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNIL--EELPELQNLPFL 239
Query: 229 LSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS 288
+I NN L +P SL +L N+ N+L LPE L + + +GLS
Sbjct: 240 TTIYADNNLLK-TLPDLPPSLEAL----NVRDNYLT-DLPELPQSLTFLDVSENIFSGLS 293
Query: 289 GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRA 348
PN L L ++N+ I ++ LE L++S+NKL +P+
Sbjct: 294 ELPPN-------LYYLNASSNE----IRSLCDLPPSLEELNVSNNKLI-ELPALPPR--- 338
Query: 349 LRSLNLTFNNLE 360
L L +FN+L
Sbjct: 339 LERLIASFNHLA 350
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-35
Identities = 66/359 (18%), Positives = 129/359 (35%), Gaps = 58/359 (16%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L + + +N L ++P D P+L N+ ++P L NL + I +
Sbjct: 152 SSFLKIIDVDNNSL-KKLP----DLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADN 204
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L+ +P +L + G N L + L N L + D N +
Sbjct: 205 NSLK-KLPDLPLSLESI---VAGNNI--------LEELPELQNLPFLTTIYADNNLLK-T 251
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+P+ +L L + N +P L L + ++ +S L
Sbjct: 252 LPDLPPSLEA----LNVRDNYL-TDLPELPQSLTFLDVSENIFSGLSELP-------PNL 299
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
L+ + N+I S+ + +L++LN +S N+L E+P + L S N L
Sbjct: 300 YYLNASSNEIR-SLCDLPPSLEELN---VSNNKL-IELPALPPRLERL---IASFNHLA- 350
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+P+ +L L ++ N L P+ + + L N +P ++
Sbjct: 351 EVPELPQNLKQL----HVEYNPLR-EFPDIPESVED-----LRMNSHLAEVPEL---PQN 397
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359
L++L + N + +E L ++S ++ + L ++
Sbjct: 398 LKQLHVETNPLR----EFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-34
Identities = 69/347 (19%), Positives = 122/347 (35%), Gaps = 69/347 (19%)
Query: 42 KIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSL 101
++P N+ + A + E PPG G + + +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-------------- 70
Query: 102 TNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNL 161
+ + L + +PE + L L N ++P L+SL + N
Sbjct: 71 ---RQAHELELNNLGLS-SLPELPPH----LESLVASCNSL-TELPELPQSLKSLLVDNN 121
Query: 162 SYNSISG---------------EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQ 206
+ ++S E L E+ L+ +D+ N + +P+ +L+ +
Sbjct: 122 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI-- 178
Query: 207 IDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGT 266
N+L E+P N L +I NN L +P LSL S+ N L
Sbjct: 179 -AAGNNQL-EELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESI----VAGNNIL--E 228
Query: 267 LPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLE 326
E+ L + TI N L LP+ + LE L + +N + +P + L L+
Sbjct: 229 ELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLTD-LPELPQSLTFLD 283
Query: 327 VLDLSSNKLSGSIPS----DLQN---------LRALRSLNLTFNNLE 360
V + + LS P+ + + +L LN++ N L
Sbjct: 284 VSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-32
Identities = 79/389 (20%), Positives = 143/389 (36%), Gaps = 80/389 (20%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
L L + L +P + P+L N T ++P +L ++ +
Sbjct: 71 RQAHELELNNLGL-SSLP----ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 124
Query: 62 LLEGTVP---------------PGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTR 106
L P P L N FLK+ ++ N + +
Sbjct: 125 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-------KLPDLPPS--- 174
Query: 107 LNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSI 166
L F+A NQ E E+PE + NL L+ +Y N + SL + N +
Sbjct: 175 LEFIAAGNNQLE-ELPE-LQNLPF-LTAIYADNN----SLKKLPDLPLSLESIVAGNNIL 227
Query: 167 SGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQ 226
L E+ L L ++ N + ++P+ +L+ LN + N L +++P +
Sbjct: 228 E--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYL-TDLPELPQSLT 280
Query: 227 NLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANG 286
L D+S N + + + +L L N S N + +L + ++ +++S N
Sbjct: 281 FL---DVSENIFS-GLSELPPNLYYL----NASSNEIR-SLCDL---PPSLEELNVSNNK 328
Query: 287 LSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSG--SIPSDLQ 344
L LP LE+L+ + N + + + L+ L + N L IP ++
Sbjct: 329 LI-ELPALPPR---LERLIASFNHLA----EVPELPQNLKQLHVEYNPLREFPDIPESVE 380
Query: 345 NLRA-------------LRSLNLTFNNLE 360
+LR L+ L++ N L
Sbjct: 381 DLRMNSHLAEVPELPQNLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-28
Identities = 51/267 (19%), Positives = 95/267 (35%), Gaps = 49/267 (18%)
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQL---- 177
P ++ N L + + ++P ++S T +++ G+
Sbjct: 5 PRNVSNTF--LQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 178 ---------QELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNL 228
++ L+L +S S+P +L+ L S N L +E+P + ++L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSL-TELPELPQSLKSL 116
Query: 229 LSIDLSNNKLNGNIPK---------------EILSLSSLTTIVNLSKNFLDGTLPEEIGM 273
L + + L+ P E+ + S L I ++ N L LP+
Sbjct: 117 LVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKII-DVDNNSLK-KLPDL--- 171
Query: 274 LGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSN 333
++ I N L LP +N L + NN + + LE + +N
Sbjct: 172 PPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNS----LKKLPDLPLSLESIVAGNN 225
Query: 334 KLSGSIPSDLQNLRALRSLNLTFNNLE 360
L +LQNL L ++ N L+
Sbjct: 226 IL--EELPELQNLPFLTTIYADNNLLK 250
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 34/190 (17%), Positives = 65/190 (34%), Gaps = 33/190 (17%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
+L YL +SN++ + D P+L N NK ++P L + + + N
Sbjct: 297 PNLYYLNASSNEI-RSLC----DLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFN 347
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
L VP NL L ++ +N + + + L ++ L E+
Sbjct: 348 HLA-EVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRMNSHLA-----------EV 391
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQ 181
PE NL +L++ N + P S+ L ++ + +L+
Sbjct: 392 PELPQNLK----QLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLE 443
Query: 182 SLDLAGNQIS 191
+
Sbjct: 444 DDVFEHHHHH 453
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 26/220 (11%)
Query: 460 ENLIGSGSFGSVYKGYLR-----EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLV 514
+ +G G+FGSV G VAVK L + F E + L+ +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
K +++ LV E+L +G L D++ H L+ L + I
Sbjct: 88 KYRGVSYGPGRQSL---RLVMEYLPSGCLRDFLQ-----RHRARLDASRLLLYSSQICKG 139
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
++YL VH DL NIL++ + K+ DFGLA+ L ++ +
Sbjct: 140 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL---DKDYYVVREPGQSP 193
Query: 635 IGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
I + PE S DV+SFGV+L E+FT
Sbjct: 194 IFWYAPESLSDN---IFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
+GSG FG V G + VAVK++ E + + FF E + + H LVK
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL- 578
CS + +V E++ NG L +++ HG GL + L + D+ + +L
Sbjct: 72 CS-----KEYPIYIVTEYISNGCLLNYLR-----SHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 579 -HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
H +H DL N L+D D+ KV DFG+ R +L+ S+ K + +
Sbjct: 122 SHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-----DQYVSSVGTKFPVKW 171
Query: 638 IPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
PE Y K S+ DV++FG+++ E+F+ G P
Sbjct: 172 SAPEVFHYF---KYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
IG G FG V G R G VAVK + ++ T ++F AE + RH NLV+L+
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL- 578
+ L +V E++ GSL D++ ++ + L L ++D+ A++YL
Sbjct: 83 IV----EEKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 579 -HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
+N VH DL N+L+ ED AKV DFGL + + K + +
Sbjct: 135 GNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---------TQDTGKLPVKW 180
Query: 638 IPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
PE K ST DV+SFG++L EI++ G P
Sbjct: 181 TAPEALREK---KFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 460 ENLIGSGSFGSVYKGYLREG---ISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVK 515
+ +G G+FGSV +G R I VA+KVL + + E + + + +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575
LI C + E L LV E G G L ++ + + ++ +
Sbjct: 75 LIGVCQA------EALMLVMEMAGGGPLHKFLV-----GKREEIPVSNVAELLHQVSMGM 123
Query: 576 DYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
YL N VH DL N+LL AK+ DFGL+++L + S ++ K
Sbjct: 124 KYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAGKW 175
Query: 634 SIGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ + PE + K S+ DV+S+GV + E + G P
Sbjct: 176 PLKWYAPECINFR---KFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 26/216 (12%)
Query: 460 ENLIGSGSFGSVYKGYL-----REGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNL 513
+G G FG V G VAVK L E E LRN H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
VK C+ + L+ EFL +GSL +++ ++ N +N ++L A+ I
Sbjct: 86 VKYKGICTEDGGNGI---KLIMEFLPSGSLKEYLP-----KNKNKINLKQQLKYAVQICK 137
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
+DYL VH DL N+L++ + K+GDFGL +++ ++ +
Sbjct: 138 GMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET---DKEYYTVKDDRDS 191
Query: 634 SIGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT 666
+ + PE K A DV+SFGV L E+ T
Sbjct: 192 PVFWYAPECLMQS---KFYIASDVWSFGVTLHELLT 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 460 ENLIGSGSFGSVYKGYL-----REGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNL 513
++GSG+FG+VYKG + I VA+K L + S K E + + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
+L+ C + + L+ + + G L D++ EH + + LN + IA
Sbjct: 80 CRLLGICLT------STVQLITQLMPFGCLLDYVR-----EHKDNIGSQYLLNWCVQIAK 128
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
++YL + +VH DL N+L+ K+ DFGLA+ +G + K
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL----LGAEEKEYHAEGGKV 181
Query: 634 SIGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
I ++ E + + DV+S+GV + E+ T G P
Sbjct: 182 PIKWMALESILHR---IYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-34
Identities = 53/220 (24%), Positives = 83/220 (37%), Gaps = 30/220 (13%)
Query: 462 LIGSGSFGSVYKGY-LR-EGISVAVKVLDIESTGTWKS-FFAECEALRNTRHRNLVKLIT 518
I G G +Y G V +K L ++ AE + L H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
D +V E++G SL + L E + ++I AL YL
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--------LPVAEAIAYLLEILPALSYL 198
Query: 579 HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
H + +V+ DLKP NI+L E+ K+ D G I+S L G+ G+
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS----------RINSFGYLYGTPGFQ 244
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
PE P+ A D+Y+ G L + + G
Sbjct: 245 APEIVRTG-PTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
IGSG FG V+ GY VA+K + + + F E E + H LV+L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL- 578
C + LV EF+ +G L D++ L + +D+ + YL
Sbjct: 72 CL-----EQAPICLVTEFMEHGCLSDYLR-----TQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 579 -HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
++H DL N L+ E+ KV DFG+ R +L+ +S+ K + +
Sbjct: 122 EAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-----DQYTSSTGTKFPVKW 171
Query: 638 IPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
PE + + S+ DV+SFGV++ E+F+ G P
Sbjct: 172 ASPEVFSFS---RYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 32/222 (14%)
Query: 460 ENLIGSGSFGSVYKGYLR----EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLV 514
E +IGSG G V G LR + VA+K L T + F +E + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
+L + +V E++ NGSL ++ H ++ + + + +
Sbjct: 114 RLEGVVT-----RGRLAMIVTEYMENGSLDTFLR-----THDGQFTIMQLVGMLRGVGAG 163
Query: 575 LDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
+ YL VH DL N+L+D ++ KV DFGL+R L + + + +T K
Sbjct: 164 MRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED---DPDAAYTTTGGK 215
Query: 633 GSIGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
I + PE + S+A DV+SFGV++ E+ G P
Sbjct: 216 IPIRWTAPEAIAFR---TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 60/234 (25%), Positives = 108/234 (46%), Gaps = 34/234 (14%)
Query: 445 ISYD--ELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAEC 502
+ Y E+ + + +G+G FG V G R VA+K++ E + + F E
Sbjct: 14 LGYGSWEIDPK--DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEA 70
Query: 503 EALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL 562
+ + N H LV+L C+ + ++ E++ NG L +++ E +
Sbjct: 71 KVMMNLSHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLR-----EMRHRFQTQ 120
Query: 563 ERLNIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIG 620
+ L + D+ A++YL +H DL N L+++ KV DFGL+R +L+
Sbjct: 121 QLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--- 172
Query: 621 NQSSISSTHVLKGSIGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+S+ K + + PPE Y K S+ D+++FGV++ EI++ G P
Sbjct: 173 --DEYTSSVGSKFPVRWSPPEVLMYS---KFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-34
Identities = 70/390 (17%), Positives = 142/390 (36%), Gaps = 42/390 (10%)
Query: 26 LPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPG-LGNLPFLKMYNIGF 84
L N F + L + ++++ + +E + ++ +GF
Sbjct: 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 108
Query: 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESI-GNLSNVLSKLYMGGNRFY 143
N I + N L L + N +P I N L+ L M N
Sbjct: 109 NAIR-YLPPHV-----FQNVPLLTVLVLERNDLS-SLPRGIFHNTPK-LTTLSMSNNNL- 159
Query: 144 GKIPTSIGR-LRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLK 202
+I + SL L LS N ++ + ++ + L +++ N +S TL
Sbjct: 160 ERIEDDTFQATTSLQNLQLSSNRLT-HV--DLSLIPSLFHANVSYNLLS-----TLAIPI 211
Query: 203 KLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNF 262
+ ++D S N + + + L + L +N L + +L+ L + +LS N
Sbjct: 212 AVEELDASHNSI-NVVR--GPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEV-DLSYNE 265
Query: 263 LDGTLPEEI-GMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAE 321
L+ + + + + +S N L L + +L+ L +++N + +
Sbjct: 266 LE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQ 322
Query: 322 LKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNP 381
LE L L N + ++ L++L L+ N+ + +FR+ + ++
Sbjct: 323 FDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDC-NSLRALFRNVARPAVDDAD 378
Query: 382 KLCLH-------LGCENSSSHGRRRIIIYI 404
+ C L C+ S R++ YI
Sbjct: 379 QHCKIDYQLEHGLCCKESDKPYLDRLLQYI 408
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-34
Identities = 71/343 (20%), Positives = 135/343 (39%), Gaps = 33/343 (9%)
Query: 49 NLTNIQIIRMAHNLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRL 107
L N +I+ ++ + +P L + +++ N+ +I + + +
Sbjct: 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTY------AFAYAHTI 101
Query: 108 NFLAFDGNQFEGEIPESI-GNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNS 165
L N +P + N+ L+ L + N +P I LT L++S N+
Sbjct: 102 QKLYMGFNAIR-YLPPHVFQNVPL-LTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNN 158
Query: 166 ISGEILTEIGQ-LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGN 224
+ I + Q LQ+L L+ N+++ + L + L ++S N L ++
Sbjct: 159 LE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAI 209
Query: 225 FQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSA 284
+ +D S+N +N + + LT + L N L T + +V +DLS
Sbjct: 210 PIAVEELDASHNSIN-VVRGPV--NVELTIL-KLQHNNL--TDTAWLLNYPGLVEVDLSY 263
Query: 285 NGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQ 344
N L + + F + LE+L ++NN+ + + L+VLDLS N L + +
Sbjct: 264 NELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQP 321
Query: 345 NLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCLHL 387
L +L L N++ + + L N C L
Sbjct: 322 QFDRLENLYLDHNSIVTLKL--STHHTLKNLTLSHNDWDCNSL 362
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 48/291 (16%), Positives = 100/291 (34%), Gaps = 29/291 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++ L + N + +P V +P L N + G HN + + M++
Sbjct: 98 AHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSN 156
Query: 61 NLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG 119
N LE + L+ + N++ + L N
Sbjct: 157 NNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLI---------PSLFHANVSYNLLS- 205
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
++ + +L N + + LT+L L +N+++ +
Sbjct: 206 ----TLAIPIA-VEELDASHNSI-NVVRGPV--NVELTILKLQHNNLTD--TAWLLNYPG 255
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
L +DL+ N++ + + +++L ++ +S N L + L +DLS+N L
Sbjct: 256 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL 314
Query: 240 GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGN 290
++ + L + L N + TL + + + LS N N
Sbjct: 315 -HVERNQPQFDRLENL-YLDHNSI-VTLK--LSTHHTLKNLTLSHNDWDCN 360
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-24
Identities = 38/229 (16%), Positives = 95/229 (41%), Gaps = 17/229 (7%)
Query: 156 LTLLNLSYNSISGEILT--EIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNE 213
++ + + ++ E L + + + + L + +++ ++L+ +
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86
Query: 214 LASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEI- 271
+ +F + + + N + +P + + LT + L +N L +LP I
Sbjct: 87 IEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL-VLERNDLS-SLPRGIF 143
Query: 272 GMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLS 331
+ T+ +S N L ++F+ SL+ L +++N+ + + L+ + L ++S
Sbjct: 144 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVS 200
Query: 332 SNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGN 380
N L S L A+ L+ + N++ V R + +++ L+ N
Sbjct: 201 YNLL-----STLAIPIAVEELDASHNSINVV--RGPVNVELTILKLQHN 242
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 22/140 (15%), Positives = 47/140 (33%), Gaps = 9/140 (6%)
Query: 247 LSLSSLTTIVNLSKNFLDGTLPE--EIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKL 304
+L ++ + + E L N + + + + + +E L
Sbjct: 21 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 80
Query: 305 LMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLTFNNLEGVV 363
+ + + A ++ L + N + +P QN+ L L L N+L +
Sbjct: 81 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSL- 138
Query: 364 PREGIFRHTSM---VHLEGN 380
GIF +T + + N
Sbjct: 139 -PRGIFHNTPKLTTLSMSNN 157
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 63/274 (22%), Positives = 108/274 (39%), Gaps = 36/274 (13%)
Query: 452 RATGNFSHENLIGSGSFGSVYKG-YLREGISVAVKVLDIESTGTWKSFFAECEALRNTRH 510
R +F ++G G+FG V K + A+K + + +E L + H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNH 61
Query: 511 RNLVKLITS--------CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL 562
+ +V+ + K L + E+ NG+L D IH
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-----SENLNQQRD 116
Query: 563 ERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL-----LE 617
E + I AL Y+H+ I+H DLKP NI +DE K+GDFGLA+++ +
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 618 RIGNQSSISSTHVLKGSIG---YIPPEYGLGEKPS--TAGDVYSFGVMLLEIFTGMSPTH 672
++ +Q+ S+ L +IG Y+ E L D+YS G++ E+ S
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEV-LDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
Query: 673 ES-------FAGEVSLVKWVESNFPKNAQQVLDR 699
E + + + N K ++++
Sbjct: 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL 266
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 460 ENLIGSGSFGSVYKGYLR-----EGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNL 513
++GSG FG+V+KG I V +KV+ D ++++ A+ + H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
V+L+ C L LV ++L GSL D + +H L LN + IA
Sbjct: 78 VRLLGLCPG------SSLQLVTQYLPLGSLLDHVR-----QHRGALGPQLLLNWGVQIAK 126
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
+ YL E +VH +L N+LL +V DFG+A + K
Sbjct: 127 GMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL----LPPDDKQLLYSEAKT 179
Query: 634 SIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
I ++ E K + DV+S+GV + E+ T G P
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 58/260 (22%), Positives = 93/260 (35%), Gaps = 21/260 (8%)
Query: 456 NFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLV 514
++ +G G F V L +G A+K + + E + R H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
+L+ C E L+ F G+L + I ER + GN L + L + + I
Sbjct: 90 RLVAYCLRERGAKHEAW-LLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGICRG 146
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK-- 632
L+ +H H DLKP NILL ++ + D G + +
Sbjct: 147 LEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 633 -GSIGYIPPE-------YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684
+I Y PE + E+ DV+S G +L + G P F S+
Sbjct: 204 RCTISYRAPELFSVQSHCVIDER----TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
Query: 685 VESNFPKNAQQVLDRELRQL 704
V++ L QL
Sbjct: 260 VQNQLSIPQSPRHSSALWQL 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 38/239 (15%)
Query: 451 RRATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTR 509
+R +F LIGSG FG V+K +G + +K + + + E +AL
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLD 62
Query: 510 HRNLVKLITS-----------CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNG 558
H N+V + + L + EF G+L WI + G
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI----EKRRGEK 118
Query: 559 LNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618
L+ + L + I +DY+H+ +++ DLKP NI L + K+GDFGL SL
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSL--- 172
Query: 619 IGNQSSISSTHVLKGSIG---YIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHE 673
+ S G Y+ PE + + D+Y+ G++L E+ E
Sbjct: 173 -------KNDGKRTRSKGTLRYMSPEQ-ISSQDYGKEVDLYALGLILAELLHVCDTAFE 223
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 33/224 (14%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIESTG---TWKSFFAECEALRNTRHRNLVKLI 517
+G G +VY I VA+K + I T K F E H+N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM- 76
Query: 518 TSCSSLDF---KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
+D + +L V E++ +L ++I L+ +N I
Sbjct: 77 -----IDVDEEDDCYYL--VMEYIEGPTLSEYIESHGP------LSVDTAINFTNQILDG 123
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
+ + H ++ IVH D+KP NIL+D + T K+ DFG+A++L +++S++ T+ + G+
Sbjct: 124 IKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-----SETSLTQTNHVLGT 175
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
+ Y PE GE D+YS G++L E+ G P F GE
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 31/220 (14%)
Query: 460 ENLIGSGSFGSVYKGYLR----EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLV 514
IG G FG V++G ++VA+K ++ + F E +R H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
KLI + + ++ E G L ++ L+ + A +++A
Sbjct: 80 KLIGVITE------NPVWIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTA 128
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
L YL VH D+ N+L+ + K+GDFGL+R + + S+ K
Sbjct: 129 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-----STYYKASKGKLP 180
Query: 635 IGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
I ++ PE + + ++A DV+ FGV + EI G+ P
Sbjct: 181 IKWMAPESINFR---RFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 45/227 (19%)
Query: 460 ENLIGSGSFGSVYKGYLR----EGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLV 514
++G G FG VY+G E I+VAVK + + F +E ++N H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
KLI E ++ E G LG ++ + N L L + ++ I A
Sbjct: 77 KLIGIIEE------EPTWIIMELYPYGELGHYLE-----RNKNSLKVLTLVLYSLQICKA 125
Query: 575 LDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
+ YL N VH D+ NIL+ K+GDFGL+R + + K
Sbjct: 126 MAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIED----------EDYYK 170
Query: 633 GSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
S+ +P PE + + +TA DV+ F V + EI + G P
Sbjct: 171 ASVTRLPIKWMSPESINFR---RFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 72/329 (21%), Positives = 128/329 (38%), Gaps = 29/329 (8%)
Query: 66 TVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFIT--SLTNSTRLNFLAFDGNQFEGEIPE 123
VP G+ ++ ++G N+I + + L L + N P
Sbjct: 25 AVPEGI--PTETRLLDLGKNRI--------KTLNQDEFASFPHLEELELNENIVSAVEPG 74
Query: 124 SIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNSISGEILTEI-GQLQELQ 181
+ NL N L L + NR IP + L +LT L++S N I +L + L L+
Sbjct: 75 AFNNLFN-LRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLK 131
Query: 182 SLDLAGNQISGSIP-NTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
SL++ N + I L L Q+ L L S + + L+ + L + +N
Sbjct: 132 SLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN- 189
Query: 241 NIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCK 299
I L L + +S T+ N+ ++ ++ L+ + ++
Sbjct: 190 AIRDYSFKRLYRLKVL-EISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLV 248
Query: 300 SLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLTFNN 358
L L ++ N S ++L EL L+ + L +L+ + + L LR LN++ N
Sbjct: 249 YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQ 307
Query: 359 LEGVVPREGIFRHTSM---VHLEGNPKLC 384
L + E +F + L+ NP C
Sbjct: 308 LTTL--EESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 73/363 (20%), Positives = 125/363 (34%), Gaps = 67/363 (18%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
T L L N++ + D P+L N + PG+ +NL N++ + + N
Sbjct: 32 TETRLLDLGKNRI-KTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90
Query: 62 LLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
L+ +P G L L +I NKI L F
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKI-----------------VILLDYMFQD------ 126
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNSISGEILTEI-GQLQ 178
L N L L +G N I L SL L L +++ I TE L
Sbjct: 127 -------LYN-LKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLH 176
Query: 179 ELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKL 238
L L L I+ + L +L +++S + + NL S+ +++ L
Sbjct: 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236
Query: 239 NGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKN 297
+P + L L ++LS N +S +
Sbjct: 237 T-AVPYLAVRHLVYLR-------------------------FLNLSYNPISTIEGSMLHE 270
Query: 298 CKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDL-QNLRALRSLNLTF 356
L+++ + + + P L L VL++S N+L+ ++ + ++ L +L L
Sbjct: 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDS 329
Query: 357 NNL 359
N L
Sbjct: 330 NPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 59/268 (22%), Positives = 109/268 (40%), Gaps = 19/268 (7%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ +L LGL SN+L IP V L NL + NK + +L N++ + +
Sbjct: 79 LFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137
Query: 61 NLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFI--TSLTNSTRLNFLAFDGNQF 117
N L + L L+ + + + I +L++ L L
Sbjct: 138 NDLV-YISHRAFSGLNSLEQLTLEKCNL--------TSIPTEALSHLHGLIVLRLRHLNI 188
Query: 118 EGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTE-IGQ 176
S L L L + + + + +LT L++++ +++ + +
Sbjct: 189 NAIRDYSFKRLYR-LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246
Query: 177 LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236
L L+ L+L+ N IS + L L +L +I L G +LA P +F L +++S N
Sbjct: 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306
Query: 237 KLNGNIPKEIL-SLSSLTTIVNLSKNFL 263
+L + + + S+ +L T+ L N L
Sbjct: 307 QLT-TLEESVFHSVGNLETL-ILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 32/152 (21%), Positives = 66/152 (43%), Gaps = 9/152 (5%)
Query: 229 LSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS 288
++ + +P+ + + T +++L KN + +E ++ ++L+ N +S
Sbjct: 14 RAVLCHRKRFV-AVPE---GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69
Query: 289 GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDL-QNLR 347
P +F N +L L + +N+ + L L LD+S NK+ + + Q+L
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLY 128
Query: 348 ALRSLNLTFNNLEGVVPREGIFRH-TSMVHLE 378
L+SL + N+L + F S+ L
Sbjct: 129 NLKSLEVGDNDLVYI--SHRAFSGLNSLEQLT 158
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 71/263 (26%), Positives = 121/263 (46%), Gaps = 42/263 (15%)
Query: 460 ENLIGSGSFGSVYKGYL----REGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLV 514
+ ++G+G FG V G L ++ ISVA+K L + T + F E + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
+L + + + +V E++ NGSL ++ +H ++ + + IAS
Sbjct: 110 RLEGVVT-----KSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGMLRGIASG 159
Query: 575 LDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
+ YL VH DL NIL++ ++ KV DFGL R L + + + +T K
Sbjct: 160 MKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLED---DPEAAYTTRGGK 211
Query: 633 GSIGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688
I + PE Y K ++A DV+S+G++L E+ + G P E +V +K V+
Sbjct: 212 IPIRWTSPEAIAYR---KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--IKAVDEG 266
Query: 689 F----PKNAQQVLDRELRQLMMS 707
+ P + L QLM+
Sbjct: 267 YRLPPPMDCP----AALYQLMLD 285
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 30/218 (13%)
Query: 460 ENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLIT 518
++ +G G +G VY+G + ++VAVK L E T + F E ++ +H NLV+L+
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYL 578
C+ ++ EF+ G+L D++ + E ++ + L +A I+SA++YL
Sbjct: 77 VCT-----REPPFYIITEFMTYGNLLDYLRECNRQE----VSAVVLLYMATQISSAMEYL 127
Query: 579 --HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
N +H DL N L+ E+ KV DFGL+R + + + K I
Sbjct: 128 EKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA-----KFPIK 177
Query: 637 YIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ PE Y K S DV++FGV+L EI T GMSP
Sbjct: 178 WTAPESLAYN---KFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 460 ENLIGSGSFGSVYKGYLR-----EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNL 513
+ +IG+G FG VYKG L+ + + VA+K L T F E + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
++L S + + ++ E++ NG+L ++ E + L+ + + IA+
Sbjct: 109 IRLEGVISK-----YKPMMIITEYMENGALDKFLR-----EKDGEFSVLQLVGMLRGIAA 158
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
+ YL + VH DL NIL++ ++ KV DFGL+R L + + + +T K
Sbjct: 159 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED---DPEATYTTSGGKI 212
Query: 634 SIGYIPPE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
I + PE Y K ++A DV+SFG+++ E+ T G P
Sbjct: 213 PIRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGERP 250
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 60/242 (24%), Positives = 102/242 (42%), Gaps = 47/242 (19%)
Query: 449 ELRRATGNFSHENLIGSGSFGSVYKGYLR--------EGISVAVKVLDIESTGTWKSFFA 500
++R + +G G+F ++KG R V +KVLD +SFF
Sbjct: 4 KIRNE--DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 501 ECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLN 560
+ H++LV C E + LV EF+ GSL ++ ++ N +N
Sbjct: 62 AASMMSKLSHKHLVLNYGVCV----CGDENI-LVQEFVKFGSLDTYLK-----KNKNCIN 111
Query: 561 FLERLNIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLD--------EDMTAKVGDFG 610
L +L +A +A+A+ +L + ++H ++ NILL K+ D G
Sbjct: 112 ILWKLEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166
Query: 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFT-GM 668
++ ++L +L+ I ++PPE K + A D +SFG L EI + G
Sbjct: 167 ISITVLP----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD 216
Query: 669 SP 670
P
Sbjct: 217 KP 218
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-33
Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 32/237 (13%)
Query: 447 YDELRRATGNFSHENL------IGSGSFGSVYKGYLREG---ISVAVKVLDIEST-GTWK 496
+EL+ +NL +G G+FGSV +G R I VA+KVL + +
Sbjct: 322 PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE 381
Query: 497 SFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHG 556
E + + + +V+LI C + E L LV E G G L ++
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLV-----GKR 430
Query: 557 NGLNFLERLNIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614
+ + ++ + YL N VH +L N+LL AK+ DFGL+++
Sbjct: 431 EEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKA 485
Query: 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
L + S ++ K + + PE K S+ DV+S+GV + E + G P
Sbjct: 486 LGA---DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 23/222 (10%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIESTG---TWKSFFAECEALRNTRHRNLVKLI 517
++G G V+ LR+ VAVKVL + + F E + H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 518 -TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
T + + ++ V E++ +L D +H E + + + D AL+
Sbjct: 79 DTGEAETPAGPLPYI--VMEYVDGVTLRDIVHTEGP------MTPKRAIEVIADACQALN 130
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
+ H + I+H D+KP NI++ KV DFG+AR++ + + +S++ T + G+
Sbjct: 131 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD---SGNSVTQTAAVIGTAQ 184
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
Y+ PE G+ DVYS G +L E+ TG P F G+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 57/240 (23%), Positives = 98/240 (40%), Gaps = 27/240 (11%)
Query: 452 RATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWK-SFFAECEALRNTR 509
R +F +G G FG V++ + + A+K + + + + E +AL
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 510 HRNLVKLITS-------CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL 562
H +V+ + +L + + +L DW+ +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM------NGRCTIEER 115
Query: 563 ER---LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL---L 616
ER L+I + IA A+++LH+ ++H DLKP NI D KVGDFGL ++
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 617 ERIGNQSSISSTHVLKGSIG---YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
E + + + G +G Y+ PE G S D++S G++L E+ S E
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQME 232
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-33
Identities = 38/276 (13%), Positives = 86/276 (31%), Gaps = 46/276 (16%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKS----------------------- 497
++G + + +E G S V V +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 498 -----FFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK 552
F + +++ + + ++++ + + F + G+ +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS-RFFLYPRMQSNLQTFGEVLL-SHS 202
Query: 553 NEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612
+ H + L RL + + + L LH+ +VH L+P +I+LD+ + F
Sbjct: 203 STHKS-LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPST-----AGDVYSFGVMLLEIFTG 667
S++S + A D ++ G+ + I+
Sbjct: 259 VRD-----GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 668 MSP-THESFAGEVSLVKWVESNFPKNAQQVLDRELR 702
P T ++ G + N P+ + +L+ LR
Sbjct: 314 DLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLR 349
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 463 IGSGSFGSVYKGYL-----REGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLVKL 516
+GSG+FG+VYKG + I VA+K L + S K E + + + ++ +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
+ C + + L+ + + G L D++ EH + + LN + IA ++
Sbjct: 83 LGICLT------STVQLITQLMPFGCLLDYVR-----EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
YL + +VH DL N+L+ K+ DFGLA+ +G + K I
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL----LGAEEKEYHAEGGKVPIK 184
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
++ E L + DV+S+GV + E+ T G P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 22/217 (10%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLIT 518
IG+GS+G K +G + K LD + + +E LR +H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY- 71
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALD 576
+ + L +V E+ G L I E L + + AL
Sbjct: 72 --DRIIDRTNTTLYIVMEYCEGGDLASVI----TKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 577 YLH--NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
H +D ++H DLKP N+ LD K+GDFGLAR L + +S + T V G+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----NHDTSFAKTFV--GT 179
Query: 635 IGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSP 670
Y+ PE + + D++S G +L E+ M P
Sbjct: 180 PYYMSPEQ-MNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 61/218 (27%), Positives = 87/218 (39%), Gaps = 38/218 (17%)
Query: 463 IGSGSFGSVYKGYLR-----EGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLVKL 516
+G G FG V G VAVK L + E + LR H +++K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
C ++ LV E++ GSL D++ ++ + + L A I +
Sbjct: 99 KGCCEDAGAASL---QLVMEYVPLGSLRDYL---PRHS----IGLAQLLLFAQQICEGMA 148
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
YLH +H DL N+LLD D K+GDFGLA+++ E + G
Sbjct: 149 YLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE--------GHEYYRVREDG 197
Query: 637 YIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT 666
P PE K A DV+SFGV L E+ T
Sbjct: 198 DSPVFWYAPECLKEY---KFYYASDVWSFGVTLYELLT 232
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 55/261 (21%), Positives = 105/261 (40%), Gaps = 35/261 (13%)
Query: 461 NLIGSGSFGSVYKGYLREGISVAVKVLDIESTG--TWKSFFAECEALRNTRHRNL--VKL 516
IGSG V++ + A+K +++E T S+ E L + + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
+++ +V E GN L W+ + + ++ ER + ++ A+
Sbjct: 75 YDY-----EITDQYIYMVMEC-GNIDLNSWLK-----KKKS-IDPWERKSYWKNMLEAVH 122
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
+H IVH DLKP N L+ + M K+ DFG+A + ++ G++
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQ----MQPDTTSVVKDSQVGTVN 174
Query: 637 YIPPE-----------YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685
Y+PPE K S DV+S G +L + G +P + L +
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234
Query: 686 ESNFPKNAQQVLDRELRQLMM 706
+ N + +++L+ ++
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLK 255
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 66/254 (25%), Positives = 106/254 (41%), Gaps = 33/254 (12%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLIT 518
IG GSFG +G +K ++I S+ + E L N +H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALD 576
S F+ L +V ++ G L I+ +K F E L+ + I AL
Sbjct: 91 S-----FEENGSLYIVMDYCEGGDLFKRIN-AQKGVL-----FQEDQILDWFVQICLALK 139
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
++H + I+H D+K NI L +D T ++GDFG+AR L S++ G+
Sbjct: 140 HVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL------NSTVELARACIGTPY 190
Query: 637 YIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGE--VSLVKWVESNFPKNA 693
Y+ PE KP + D+++ G +L E+ T F +LV + S
Sbjct: 191 YLSPEI-CENKPYNNKSDIWALGCVLYELCTLKHA----FEAGSMKNLVLKIISGSFPPV 245
Query: 694 QQVLDRELRQLMMS 707
+LR L+
Sbjct: 246 SLHYSYDLRSLVSQ 259
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 5e-32
Identities = 55/261 (21%), Positives = 105/261 (40%), Gaps = 35/261 (13%)
Query: 461 NLIGSGSFGSVYKGYLREGISVAVKVLDIESTG--TWKSFFAECEALRNTRHRNL--VKL 516
IGSG V++ + A+K +++E T S+ E L + + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
+++ +V E GN L W+ + + ++ ER + ++ A+
Sbjct: 122 YDY-----EITDQYIYMVMEC-GNIDLNSWLK-----KKKS-IDPWERKSYWKNMLEAVH 169
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
+H IVH DLKP N L+ + M K+ DFG+A + ++ G++
Sbjct: 170 TIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQ----MQPDTTSVVKDSQVGAVN 221
Query: 637 YIPPE-----------YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685
Y+PPE K S DV+S G +L + G +P + L +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
Query: 686 ESNFPKNAQQVLDRELRQLMM 706
+ N + +++L+ ++
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLK 302
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 30/250 (12%), Positives = 60/250 (24%), Gaps = 41/250 (16%)
Query: 449 ELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDI---ESTGTWKSFFAECEA 504
L + + G V+ E A+KV + S + A
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 505 LRNTRHRNLVKLITSC---------------------SSLDFKNMEFLALVYEFLGNGSL 543
+ + D + L+ L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDL 174
Query: 544 GDWIHG-ERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM 602
+ L + + L + +VH P N+ + D
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDG 231
Query: 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP--STAGDVYSFGVM 660
+GD ++G + SS + Y P E+ + A + + G+
Sbjct: 232 RLMLGDVSALW----KVGTRGPASS-----VPVTYAPREFLNASTATFTHALNAWQLGLS 282
Query: 661 LLEIFTGMSP 670
+ ++ P
Sbjct: 283 IYRVWCLFLP 292
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-32
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 23/229 (10%)
Query: 452 RATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGT-WKSFFAECEALRNTR 509
+ G + + +G+G FG V + ++ G VA+K E + + + E + ++
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 510 HRNLVKL---ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLN 566
H N+V L ++ LA+ E+ G L +++ + E+ GL
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAM--EYCEGGDLRKYLN---QFENCCGLKEGPIRT 125
Query: 567 IAIDIASALDYLHNDCEVPIVHCDLKPGNILLD---EDMTAKVGDFGLARSLLERIGNQS 623
+ DI+SAL YLH E I+H DLKP NI+L + + K+ D G A+ L +Q
Sbjct: 126 LLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-----DQG 177
Query: 624 SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTH 672
+ + V G++ Y+ PE +K + D +SFG + E TG P
Sbjct: 178 ELCTEFV--GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 66/303 (21%), Positives = 117/303 (38%), Gaps = 48/303 (15%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITS 519
++G G+ +V++G ++ G A+KV + S E E L+ H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-- 73
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDY 577
+ + L+ EF GSL + E N E L + D+ +++
Sbjct: 74 -AIEEETTTRHKVLIMEFCPCGSLYTVLE-----EPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 578 LHNDCEVPIVHCDLKPGNILL----DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
L + IVH ++KPGNI+ D K+ DFG AR L + L G
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-----EDDEQFVS--LYG 177
Query: 634 SIGYIPPE--------YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685
+ Y+ P+ +K D++S GV TG P +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP-------------FR 224
Query: 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREAL 745
P+ ++V+ + + + S + + I + +SC+ S G ++ + L
Sbjct: 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL-SRGLQVLLTPVL 283
Query: 746 RRL 748
+
Sbjct: 284 ANI 286
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 55/261 (21%), Positives = 105/261 (40%), Gaps = 35/261 (13%)
Query: 461 NLIGSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNL--VKL 516
IGSG V++ + A+K +++E T S+ E L + + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
+++ +V E GN L W+ ++ ++ ER + ++ A+
Sbjct: 94 YDY-----EITDQYIYMVMEC-GNIDLNSWLKKKKS------IDPWERKSYWKNMLEAVH 141
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
+H IVH DLKP N L+ + M K+ DFG+A + ++ G++
Sbjct: 142 TIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQ----MQPDTTSVVKDSQVGTVN 193
Query: 637 YIPPE-----------YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685
Y+PPE K S DV+S G +L + G +P + L +
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 686 ESNFPKNAQQVLDRELRQLMM 706
+ N + +++L+ ++
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLK 274
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 63/239 (26%), Positives = 101/239 (42%), Gaps = 45/239 (18%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLR------EGISVAVKVL-DIESTGTWKSFFAECEA 504
+ E + +G GSFG VY+G + VA+K + + S F E
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 505 LRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNG----LN 560
++ ++V+L+ S + L ++ E + G L ++ R N +
Sbjct: 82 MKEFNCHHVVRLLGVVS----QGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 561 FLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIG 620
+ + +A +IA + YL+ VH DL N ++ ED T K+GDFG+ R + E
Sbjct: 137 LSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--- 190
Query: 621 NQSSISSTHVLKGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
+ + KG G +P PE G +T DV+SFGV+L EI T P
Sbjct: 191 ------TDYYRKGGKGLLPVRWMSPESLKDG---VFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-31
Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFA----ECEALRN-TRH 510
+F ++++G G+ G++ + + VAVK + F+ E + LR H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-------PECFSFADREVQLLRESDEH 77
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
N+++ + K+ +F + E +L +++ + LE + +
Sbjct: 78 PNVIRYFCT-----EKDRQFQYIAIELCA-ATLQEYVE-----QKDFAHLGLEPITLLQQ 126
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDE-----DMTAKVGDFGLARSLLERIGNQSSI 625
S L +LH + IVH DLKP NIL+ + A + DFGL + L + S
Sbjct: 127 TTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV---GRHSF 180
Query: 626 SSTHVLKGSIGYIPPEY---GLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
S + G+ G+I PE E P+ D++S G + + + S
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 48/226 (21%), Positives = 80/226 (35%), Gaps = 33/226 (14%)
Query: 460 ENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTG---TWKSFFAECEALRNTRHRNLVK 515
L+G G G VY+ VA+K++ + E + ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 516 LITSCSSLDF---KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+ DF ++ + + L + G L + I I
Sbjct: 99 I------HDFGEIDGQLYVDM--RLINGVDLAAMLR-----RQG-PLAPPRAVAIVRQIG 144
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
SALD H H D+KP NIL+ D A + DFG+A + ++
Sbjct: 145 SALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT-----TDEKLTQLGNTV 196
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
G++ Y+ PE + D+Y+ +L E TG P + G+
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 463 IGSGSFGSVYKGYLR------EGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLVK 515
+G G+FG VY+G + + VAVK L ++ S F E + H+N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER-KNEHGNGLNFLERLNIAIDIASA 574
I +++ ++ E + G L ++ R + + L L+ L++A DIA
Sbjct: 98 CIGVSL----QSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLD---EDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
YL E +H D+ N LL AK+GDFG+AR + +++
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---------ASYYR 200
Query: 632 KGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
KG +P PE G ++ D +SFGV+L EIF+ G P
Sbjct: 201 KGGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 49/246 (19%), Positives = 97/246 (39%), Gaps = 12/246 (4%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQIS--GSIPNTLGNLKK 203
+PT I S T L L N + +L +L L L+ N +S G +
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 204 LNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNF 262
L +DLS N + + + ++F + L +D ++ L + L +L + ++S
Sbjct: 80 LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL-DISHTH 137
Query: 263 LDGTLPEEI-GMLGNVVTIDLSAN-GLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILA 320
I L ++ + ++ N LP+ F ++L L ++ + P
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196
Query: 321 ELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPR--EGIFRHTSMVHLE 378
L L+VL++S N + L +L+ L+ + N++ + + + ++L
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 256
Query: 379 GNPKLC 384
N C
Sbjct: 257 QNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 54/254 (21%), Positives = 93/254 (36%), Gaps = 25/254 (9%)
Query: 17 EIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLE--GTVPPGLGNL 74
+P + + NK G LT + + ++ N L G
Sbjct: 21 SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 75 PFLKMYNIGFNKIVGSGDEGLSFITS-LTNSTRLNFLAFDGNQFEGEIPESI-GNLSNVL 132
LK ++ FN + ++S +L L F + + S+ +L N L
Sbjct: 78 TSLKYLDLSFNGV--------ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN-L 128
Query: 133 SKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNSISGEILTEI-GQLQELQSLDLAGNQI 190
L + I L SL +L ++ NS L +I +L+ L LDL+ Q+
Sbjct: 129 IYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
Query: 191 SGSIP-NTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS- 248
+ +L L +++S N S + +L +D S N + K+ L
Sbjct: 188 E-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQH 245
Query: 249 -LSSLTTIVNLSKN 261
SSL + NL++N
Sbjct: 246 FPSSLAFL-NLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 48/248 (19%), Positives = 81/248 (32%), Gaps = 46/248 (18%)
Query: 1 MTSLVYLGLASNQL-WGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMA 59
+T L L L+SN L + +L + FN + + L ++ +
Sbjct: 51 LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ 109
Query: 60 HNLLEGTVPPGL-GNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
H+ L+ + +L L +I F+G
Sbjct: 110 HSNLKQMSEFSVFLSLRNLIYLDISHTHT-----------------RVAFNGIFNG---- 148
Query: 119 GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNSISGEILTEIGQ- 176
LS+ L L M GN F I LR+LT L+LS + ++
Sbjct: 149 ---------LSS-LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-----EQLSPT 193
Query: 177 ----LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQ-NLLSI 231
L LQ L+++ N L L +D S N + + +F +L +
Sbjct: 194 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 253
Query: 232 DLSNNKLN 239
+L+ N
Sbjct: 254 NLTQNDFA 261
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-31
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 460 ENLIGSGSFGSVYKGYLR----EGISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLV 514
IG G FG V++G ++VA+K ++ + F E +R H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
KLI + + ++ E G L ++ L+ + A +++A
Sbjct: 455 KLIGVITE------NPVWIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTA 503
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
L YL VH D+ N+L+ + K+GDFGL+R + + S+ K
Sbjct: 504 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-----STYYKASKGKLP 555
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
I ++ PE + ++A DV+ FGV + EI G+ P
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 57/226 (25%), Positives = 90/226 (39%), Gaps = 26/226 (11%)
Query: 449 ELRRATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRN 507
E R +H+ +G GSFG V++ + G AVK + +E E A
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-----EELVACAG 106
Query: 508 TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL-- 565
+V L + + ++ + E L GSLG I + G E
Sbjct: 107 LSSPRIVPLYGA-----VREGPWVNIFMELLEGGSLGQLI-----KQMG---CLPEDRAL 153
Query: 566 NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED-MTAKVGDFGLARSLLERIGNQSS 624
L+YLH I+H D+K N+LL D A + DFG A L+ G S
Sbjct: 154 YYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC-LQPDGLGKS 209
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ + + G+ ++ PE +G+ D++S M+L + G P
Sbjct: 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 66/303 (21%), Positives = 117/303 (38%), Gaps = 48/303 (15%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVLD-IESTGTWKSFFAECEALRNTRHRNLVKLITS 519
++G G+ +V++G ++ G A+KV + I E E L+ H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-- 73
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDY 577
+ + L+ EF GSL + E N E L + D+ +++
Sbjct: 74 -AIEEETTTRHKVLIMEFCPCGSLYTVL-----EEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 578 LHNDCEVPIVHCDLKPGNILL----DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
L + IVH ++KPGNI+ D K+ DFG AR L + L G
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-----EDDEQFVS--LYG 177
Query: 634 SIGYIPPE--------YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685
+ Y+ P+ +K D++S GV TG P +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP-------------FR 224
Query: 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREAL 745
P+ ++V+ + + + S + + I + +SC+ S G ++ + L
Sbjct: 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL-SRGLQVLLTPVL 283
Query: 746 RRL 748
+
Sbjct: 284 ANI 286
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 47/317 (14%), Positives = 99/317 (31%), Gaps = 58/317 (18%)
Query: 425 RKGKAKPIGVSTLFKHSPQMISYD-ELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISV 482
A VST ++ Q + EL ++G + + +E G S
Sbjct: 42 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101
Query: 483 AVKVLDIESTGTWKS----------------------------FFAECEALRNTRHRNLV 514
V V + F + +++ + + ++
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
++ + + F + G+ + + H + L RL + + +
Sbjct: 162 RVRLDERDMWVLS-RFFLYPRMQSNLQTFGEVLL-SHSSTHKS-LVHHARLQLTLQVIRL 218
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
L LH+ +VH L+P +I+LD+ + F + V S
Sbjct: 219 LASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD----------GARVVSSVS 265
Query: 635 IGYIPPEY----------GLGEKPST-AGDVYSFGVMLLEIFTGMSP-THESFAGEVSLV 682
G+ PPE T + D ++ G+++ I+ P T ++ G +
Sbjct: 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI 325
Query: 683 KWVESNFPKNAQQVLDR 699
N P+ + +L+
Sbjct: 326 FRSCKNIPQPVRALLEG 342
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 40/228 (17%)
Query: 463 IGSGSFGSVYKGYLR------EGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRNLVK 515
+G G+FG VY+G + + VAVK L ++ S F E + H+N+V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER-KNEHGNGLNFLERLNIAIDIASA 574
I +++ ++ E + G L ++ R + + L L+ L++A DIA
Sbjct: 139 CIGVSL----QSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLD---EDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
YL E +H D+ N LL AK+GDFG+AR + + +
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---------AGYYR 241
Query: 632 KGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
KG +P PE G ++ D +SFGV+L EIF+ G P
Sbjct: 242 KGGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 68/258 (26%), Positives = 115/258 (44%), Gaps = 53/258 (20%)
Query: 439 KHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREG---ISVAVKVL-DIESTGT 494
K++P Y L + +++IG G+FG V K +++ + A+K + + S
Sbjct: 11 KNNPDPTIYPVLDWN--DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 68
Query: 495 WKSFFAECEALRN-TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN 553
+ F E E L H N++ L+ +C + +L L E+ +G+L D++ R
Sbjct: 69 HRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVL 123
Query: 554 E----------HGNGLNFLERLNIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDED 601
E + L+ + L+ A D+A +DYL +H DL NIL+ E+
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGEN 178
Query: 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP-----PE---YGLGEKPSTAGD 653
AK+ DFGL+R +K ++G +P E Y +T D
Sbjct: 179 YVAKIADFGLSRGQEV------------YVKKTMGRLPVRWMAIESLNYS---VYTTNSD 223
Query: 654 VYSFGVMLLEIFT-GMSP 670
V+S+GV+L EI + G +P
Sbjct: 224 VWSYGVLLWEIVSLGGTP 241
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 50/228 (21%), Positives = 91/228 (39%), Gaps = 25/228 (10%)
Query: 460 ENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRN-TRHRNLVKLI 517
++ G F VY+ + G A+K L ++ E ++ + H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 518 TSCSSL--DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575
++ S + + L+ L G L +++ K E L+ L I A+
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK---KMESRGPLSCDTVLKIFYQTCRAV 149
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK--- 632
++H + PI+H DLK N+LL T K+ DFG A ++ S +++
Sbjct: 150 QHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 633 ---GSIGYIPPE-------YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ Y PE + +GEK D+++ G +L + P
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEK----QDIWALGCILYLLCFRQHP 252
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 58/273 (21%), Positives = 102/273 (37%), Gaps = 25/273 (9%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI-GQLQ 178
+P+ +S + L + N L+ L L L N IS +I + L+
Sbjct: 47 AVPK---EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLR 102
Query: 179 ELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKL 238
+LQ L ++ N + IP L L ++ + N + F +N+ I++ N L
Sbjct: 103 KLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPL 159
Query: 239 -NGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKN 297
N L + +S+ L +P+ + + + L N +
Sbjct: 160 ENSGFEPGAFDGLKLNYL-RISEAKLT-GIPK--DLPETLNELHLDHNKIQAIELEDLLR 215
Query: 298 CKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFN 357
L +L + +N+ L+ L L L L +NKLS +P+ L +L+ L+ + L N
Sbjct: 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274
Query: 358 NLEGVVPREGIFRHTSM---------VHLEGNP 381
N+ V F + L NP
Sbjct: 275 NITKV--GVNDFCPVGFGVKRAYYNGISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 60/282 (21%), Positives = 101/282 (35%), Gaps = 26/282 (9%)
Query: 104 STRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163
S L N + L + L L + N+ + LR L L +S
Sbjct: 53 SPDTTLLDLQNNDISELRKDDFKGLQH-LYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111
Query: 164 NSISGEILTEI--GQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTS 221
N L EI L L + N+I L+ +N I++ GN L
Sbjct: 112 NH-----LVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPL-ENSGFE 165
Query: 222 FGNFQ--NLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEI-GMLGNVV 278
G F L + +S KL IPK++ +L + +L N + + E +
Sbjct: 166 PGAFDGLKLNYLRISEAKLT-GIPKDLPE--TLNEL-HLDHNKIQ-AIELEDLLRYSKLY 220
Query: 279 TIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGS 338
+ L N + S +L +L + NNK S +P L +LK L+V+ L +N ++
Sbjct: 221 RLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-K 278
Query: 339 IPSD-------LQNLRALRSLNLTFNNLEGVVPREGIFRHTS 373
+ + ++L N + + FR +
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 60/315 (19%), Positives = 102/315 (32%), Gaps = 43/315 (13%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
L L +N + E+ D L +L NK + + L +Q + ++ N
Sbjct: 54 PDTTLLDLQNNDI-SELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFIT--SLTNSTRLNFLAFDGNQFEG 119
L +PP L L I N+I + + +N + GN E
Sbjct: 113 HLV-EIPPNL--PSSLVELRIHDNRI--------RKVPKGVFSGLRNMNCIEMGGNPLE- 160
Query: 120 EIPESIGNLSNV-LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI-GQL 177
G + L+ L + + IP + +L L+L +N I I E +
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKL-TGIPKDL--PETLNELHLDHNKIQ-AIELEDLLRY 216
Query: 178 QELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNK 237
+L L L NQI +L L L ++ L N+L S +P + + L + L N
Sbjct: 217 SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNN 275
Query: 238 LNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNL--PNSF 295
+ + + + I L N + P +F
Sbjct: 276 ITKVGVNDFCPVGFGVKRAYYN-------------------GISLFNNPVPYWEVQPATF 316
Query: 296 KNCKSLEKLLMANNK 310
+ + N K
Sbjct: 317 RCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 55/235 (23%), Positives = 89/235 (37%), Gaps = 24/235 (10%)
Query: 155 SLTLLNLSYNSISGEILTEIGQL--QELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212
L ++ S L + + + LDL N IS + L+ L + L N
Sbjct: 34 HLRVVQCSDLG-----LKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN 88
Query: 213 ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIG 272
+++ +F + L + +S N L IP + SSL + + N +
Sbjct: 89 KISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVEL-RIHDNRIRKVPKGVFS 144
Query: 273 MLGNVVTIDLSANGLSGNL--PNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDL 330
L N+ I++ N L + P +F K L L ++ K +G IP L + L L L
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTG-IPKDL--PETLNELHL 200
Query: 331 SSNKLSGSIPS-DLQNLRALRSLNLTFNNLEGVVPREGIFRHTS---MVHLEGNP 381
NK+ +I DL L L L N + + G +HL+ N
Sbjct: 201 DHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIEN--GSLSFLPTLRELHLDNNK 252
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 56/255 (21%), Positives = 87/255 (34%), Gaps = 42/255 (16%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L L ++ N L EIP ++ +L+ N+ G L N+ I M
Sbjct: 101 LRKLQKLYISKNHL-VEIPPNL---PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156
Query: 61 NLL-EGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNS--TRLNFLAFDGNQF 117
N L PG + L I K +T + LN L D N+
Sbjct: 157 NPLENSGFEPGAFDGLKLNYLRISEAK-----------LTGIPKDLPETLNELHLDHNKI 205
Query: 118 EGEIPE-SIGNLSNVLSKLYMGGNRFYGKIPTSIGR-----LRSLTLLNLSYNSISGEIL 171
+ I + S L +L +G N+ I L +L L+L N +S +
Sbjct: 206 Q-AIELEDLLRYSK-LYRLGLGHNQ-----IRMIENGSLSFLPTLRELHLDNNKLS-RVP 257
Query: 172 TEIGQLQELQSLDLAGNQISGSIPNT-------LGNLKKLNQIDLSGNELASEI--PTSF 222
+ L+ LQ + L N I+ + N I L N + P +F
Sbjct: 258 AGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATF 316
Query: 223 GNFQNLLSIDLSNNK 237
+ L+I N K
Sbjct: 317 RCVTDRLAIQFGNYK 331
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 53/272 (19%)
Query: 428 KAKPIGVSTLFKHSPQMISYDELRRATGNFSHENL-----IGSGSFGSVYKGYLR----- 477
+ K G+ +PQ S + ++ +G G+FG V+
Sbjct: 13 EGKGSGLQGHIIENPQYFSDACVHH----IKRRDIVLKWELGEGAFGKVFLAECHNLLPE 68
Query: 478 -EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYE 536
+ + VAVK L S + F E E L +H+++V+ C+ L +V+E
Sbjct: 69 QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----EGRPLLMVFE 123
Query: 537 FLGNGSLGDW---------IHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIV 587
++ +G L + + ++ L + L +A +A+ + YL + V
Sbjct: 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFV 180
Query: 588 HCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP-----PE- 641
H DL N L+ + + K+GDFG++R + + + G +P PE
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYS---------TDYYRVGGRTMLPIRWMPPES 231
Query: 642 --YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
Y K +T DV+SFGV+L EIFT G P
Sbjct: 232 ILYR---KFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 60/247 (24%), Positives = 101/247 (40%), Gaps = 53/247 (21%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLR------EGISVAVKVL-DIESTGTWKSFFAECEA 504
F + L +G G+FG V + +VAVK+L + + ++ +E +
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 83
Query: 505 LRN-TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK----------N 553
L + H N+V L+ +C+ M ++ EF G+L ++ +R +
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLM----VIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 554 EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613
+ + L + + +A +++L +H DL NILL E K+ DFGLAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 614 SLLERIGNQSSISSTHV-LKGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEI 664
I ++ +P PE + DV+SFGV+L EI
Sbjct: 197 ----------DIYKDPDYVRKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVLLWEI 243
Query: 665 FT-GMSP 670
F+ G SP
Sbjct: 244 FSLGASP 250
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 82/395 (20%), Positives = 148/395 (37%), Gaps = 49/395 (12%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L +L + I + L +L+ +N+F G+ + L N++++ +
Sbjct: 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQ 112
Query: 61 NLLEGTVPP-----GLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGN 115
L+G V L +L L + + N I + + + N R + L N
Sbjct: 113 CNLDGAVLSGNFFKPLTSLEMLVLRD---NNI-----KKIQPASFFLNMRRFHVLDLTFN 164
Query: 116 QFEGEIPESIGNLSNV-LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI 174
+ + E + N + L RL S+TL +++ + E
Sbjct: 165 KVKSICEEDLLNFQGKHFTLL----------------RLSSITLQDMNEYWLGWEKCGNP 208
Query: 175 GQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLS 234
+ + +LDL+GN S+ + +I + + +SFG+ D
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNF---KDPD 265
Query: 235 NNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEI-GMLGNVVTIDLSANGLSGNLPN 293
N G L S + T +LSK+ + L + + ++ + L+ N ++ N
Sbjct: 266 NFTFKG------LEASGVKT-CDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEINKIDDN 317
Query: 294 SFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDL-QNLRALRSL 352
+F L KL ++ N + L LEVLDLS N + ++ L L+ L
Sbjct: 318 AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKEL 376
Query: 353 NLTFNNLEGVVPREGIF---RHTSMVHLEGNPKLC 384
L N L+ V +GIF + L NP C
Sbjct: 377 ALDTNQLKSV--PDGIFDRLTSLQKIWLHTNPWDC 409
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-26
Identities = 67/352 (19%), Positives = 122/352 (34%), Gaps = 37/352 (10%)
Query: 36 FNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGL-GNLPFLKMYNIGFNKIVGSGDEG 94
N S L ++Q +++ + L L + + +N+ +
Sbjct: 39 LNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGA 98
Query: 95 LSFITSLTNSTRLNFLAFDGNQF-EGEIPESI-GNLSNVLSKLYMGGNRFYGKIPTSI-G 151
+ + +L L + + L++ L L + N P S
Sbjct: 99 FNGLANLEV------LTLTQCNLDGAVLSGNFFKPLTS-LEMLVLRDNNIKKIQPASFFL 151
Query: 152 RLRSLTLLNLSYN---SISGEILTEIGQLQELQSLDLAGNQISGSIPNTLG--------N 200
+R +L+L++N SI E L L L+ + LG
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKH-FTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 201 LKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSK 260
+ +DLSGN + F + I + N+ ++ N +
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS-FGHTNFKDPDNFTF 269
Query: 261 NFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILA 320
L+ + V T DLS + + L + F + LE+L +A N+ + N
Sbjct: 270 KGLEAS---------GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFW 320
Query: 321 ELKGLEVLDLSSNKLSGSIPSDL-QNLRALRSLNLTFNNLEGVVPREGIFRH 371
L L L+LS N L SI S + +NL L L+L++N++ + + F
Sbjct: 321 GLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRAL--GDQSFLG 369
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 37/214 (17%), Positives = 75/214 (35%), Gaps = 18/214 (8%)
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPT-SFGNFQNLLSIDLSNNKL 238
+ +DL+ N I+ + L+ L + + I +F +L+ + L N+
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 239 NGNIPKEIL-SLSSLTTIVNLSKNFL-DGTLPEEI-GMLGNVVTIDLSANGLSGNLPNS- 294
+ L++L + L++ L L L ++ + L N + P S
Sbjct: 92 -LQLETGAFNGLANLEVL-TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 295 FKNCKSLEKLLMANNKFSGPIPNILAELKG--LEVLDLSSNKL--------SGSIPSDLQ 344
F N + L + NK L +G +L LSS L +
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 345 NLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLE 378
++ +L+L+ N + + F + ++
Sbjct: 210 KNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQ 242
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 45/174 (25%), Positives = 66/174 (37%), Gaps = 12/174 (6%)
Query: 193 SIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL-SLSS 251
+P ++ + DLS N +A TSF Q+L + + I LSS
Sbjct: 24 QVPELPAHVNYV---DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 252 LTTIVNLSKNFLDGTLPEEI-GMLGNVVTIDLSANGL-SGNLP-NSFKNCKSLEKLLMAN 308
L + L N L L N+ + L+ L L N FK SLE L++ +
Sbjct: 81 LIIL-KLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRD 138
Query: 309 NKFSGPIPN-ILAELKGLEVLDLSSNKLSGSIPSDLQNLRA--LRSLNLTFNNL 359
N P ++ VLDL+ NK+ DL N + L L+ L
Sbjct: 139 NNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL 192
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 4e-29
Identities = 56/309 (18%), Positives = 115/309 (37%), Gaps = 40/309 (12%)
Query: 74 LPFLKMYNIG----FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLS 129
LP +++ +N I G+ + + ++ + + N+ + E + ++
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYAD---YFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59
Query: 130 NVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQ 189
S+L + +P ++ +T+L ++ N++ + L+ L D N+
Sbjct: 60 Q-FSELQLNRLNL-SSLPDNLPP--QITVLEITQNALI-SLPELPASLEYL---DACDNR 111
Query: 190 ISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSL 249
+S ++P +LK L+ + N+L + +P + + + NN+L +P+ SL
Sbjct: 112 LS-TLPELPASLKHLD---VDNNQL-TMLPELPALLEYI---NADNNQLT-MLPELPTSL 162
Query: 250 SSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMA-- 307
L ++ N L LPE L +D+S N L +LP E+ +
Sbjct: 163 EVL----SVRNNQL-TFLPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFR 213
Query: 308 --NNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPR 365
N+ + IP + L + L N LS I L A + +
Sbjct: 214 CRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
Query: 366 EGIFRHTSM 374
+
Sbjct: 273 QNTLHRPLA 281
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 60/368 (16%), Positives = 114/368 (30%), Gaps = 52/368 (14%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L L L +P ++ P + N +P +L +
Sbjct: 58 INQFSELQLNRLNL-SSLPDNLP---PQITVLEITQNALI-SLPELPASLEYLD---ACD 109
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNS-TRLNFLAFDGNQFEG 119
N L T+P +L L ++ N++ T L L ++ D NQ
Sbjct: 110 NRLS-TLPELPASLKHL---DVDNNQL-----------TMLPELPALLEYINADNNQLT- 153
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
+PE +L L + N+ +P SL L++S N + + +
Sbjct: 154 MLPELPTSLE----VLSVRNNQL-TFLPELPE---SLEALDVSTNLLE-SLPAVPVRNHH 204
Query: 180 LQS----LDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSN 235
+ N+I+ IP + +L I L N L+S I S
Sbjct: 205 SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPR 263
Query: 236 NKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSF 295
+ + ++ L + + ++ + + + AN S L +
Sbjct: 264 IYFSMSDGQQNTLHRPLA---DAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL-DRL 319
Query: 296 KNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLT 355
+ S + + L +L L S ++ ++ A LT
Sbjct: 320 SDTVSARNTSGFREQ----VAAWLEKLSASAELRQQSFAVAADATESCEDRVA-----LT 370
Query: 356 FNNLEGVV 363
+NNL +
Sbjct: 371 WNNLRKTL 378
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 56/239 (23%), Positives = 101/239 (42%), Gaps = 50/239 (20%)
Query: 460 ENLIGSGSFGSVYKGYLR------EGISVAVKVL-DIESTGTWKSFFAECEALRNTRHRN 512
+G FG VYKG+L + +VA+K L D + F E +H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSL----------GDWIHGERKNEHGNGLNFL 562
+V L+ + + L++++ + +G L D + + L
Sbjct: 74 VVCLLGVVT-----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 563 ERLNIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIG 620
+ +++ IA+ ++YL H+ +VH DL N+L+ + + K+ D GL R +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV----- 178
Query: 621 NQSSISSTHVLKGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
++ + +P PE YG K S D++S+GV+L E+F+ G+ P
Sbjct: 179 ----YAADYYKLLGNSLLPIRWMAPEAIMYG---KFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 67/235 (28%), Positives = 103/235 (43%), Gaps = 49/235 (20%)
Query: 463 IGSGSFGSVYKGYLR------EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKL 516
+G G+FG V+ + + VAVK L + K F E E L N +H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSL----------GDWIHGERKNEHGNGLNFLERLN 566
C + + L +V+E++ +G L + + + L + L+
Sbjct: 83 YGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 567 IAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
IA IAS + YL + VH DL N L+ ++ K+GDFG++R +
Sbjct: 138 IASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDV--------- 183
Query: 625 ISSTHVLKGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIFT-GMSP 670
S+ + G +P PE Y K +T DV+SFGV+L EIFT G P
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 68/254 (26%), Positives = 101/254 (39%), Gaps = 61/254 (24%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLR------EGISVAVKVL-DIESTGTWKSFFAECEA 504
F +NL +G G FG V K +VAVK+L + S + +E
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 505 LRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSL------------------GDW 546
L+ H +++KL +CS ++ L L+ E+ GSL G
Sbjct: 80 LKQVNHPHVIKLYGACS----QDGPLL-LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 547 IHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606
+ L + ++ A I+ + YL E+ +VH DL NIL+ E K+
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKI 191
Query: 607 GDFGLARSLLERIGNQSSISSTHV-LKGSIGYIP-----PE---YGLGEKPSTAGDVYSF 657
DFGL+R + +K S G IP E +T DV+SF
Sbjct: 192 SDFGLSR----------DVYEEDSYVKRSQGRIPVKWMAIESLFDH---IYTTQSDVWSF 238
Query: 658 GVMLLEIFT-GMSP 670
GV+L EI T G +P
Sbjct: 239 GVLLWEIVTLGGNP 252
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 46/241 (19%), Positives = 85/241 (35%), Gaps = 48/241 (19%)
Query: 456 NFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTW--KSFFAECEALRN-TRHR 511
F IGSG FGSV+K +G A+K G+ ++ E A +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAI 569
++V+ ++ + + + + E+ GSL D I + F E ++ +
Sbjct: 72 HVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAI----SENYRIMSYFKEAELKDLLL 122
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDED-------------------MTAKVGDFG 610
+ L Y+H+ +VH D+KP NI + + K+GD G
Sbjct: 123 QVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMS 669
+ SS V +G ++ E D+++ + ++
Sbjct: 180 HVTRI----------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229
Query: 670 P 670
Sbjct: 230 L 230
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 60/249 (24%), Positives = 104/249 (41%), Gaps = 56/249 (22%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLR--------EGISVAVKVL-DIESTGTWKSFFAEC 502
F + L +G G+FG V E ++VAVK+L D + +E
Sbjct: 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 503 EALRN-TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSL----------GDWIHGER 551
E ++ +H+N++ L+ +C+ ++ ++ E+ G+L G +
Sbjct: 92 EMMKMIGKHKNIINLLGACT----QDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 552 KNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611
+ F + ++ +A ++YL +H DL N+L+ E+ K+ DFGL
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGL 203
Query: 612 ARSLLERIGNQSSISSTHV-LKGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLL 662
AR I++ K + G +P PE + DV+SFGV++
Sbjct: 204 AR----------DINNIDYYKKTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVLMW 250
Query: 663 EIFT-GMSP 670
EIFT G SP
Sbjct: 251 EIFTLGGSP 259
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-28
Identities = 53/236 (22%), Positives = 93/236 (39%), Gaps = 36/236 (15%)
Query: 457 FSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALR-NTRHRNLVK 515
E ++G GS G+V +G VAVK + I+ E + L + H N+++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIR 73
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWI-HGERKNEHGNGLNFLERLNIAIDIASA 574
S FL + E +L D + +E+ +++ IAS
Sbjct: 74 YYCS-----ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLD-------------EDMTAKVGDFGLARSLLERIGN 621
+ +LH+ I+H DLKP NIL+ E++ + DFGL + L G
Sbjct: 128 VAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS--GQ 182
Query: 622 QSSISSTHVLKGSIGYIPPE-------YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
S ++ + G+ G+ PE + + + D++S G + I +
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 60/251 (23%), Positives = 103/251 (41%), Gaps = 60/251 (23%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLR--------EGISVAVKVL-DIESTGTWKSFFAEC 502
F + L +G G FG V E ++VAVK+L D + +E
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 503 EALRN-TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSL----------GDWIHGER 551
E ++ +H+N++ L+ +C+ ++ ++ E+ G+L G +
Sbjct: 138 EMMKMIGKHKNIINLLGACT----QDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 552 KNEHGNGLNFLERLNIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609
+ F + ++ +A ++YL +H DL N+L+ E+ K+ DF
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADF 247
Query: 610 GLARSLLERIGNQSSISSTHV-LKGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVM 660
GLAR I++ K + G +P PE + DV+SFGV+
Sbjct: 248 GLAR----------DINNIDYYKKTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVL 294
Query: 661 LLEIFT-GMSP 670
+ EIFT G SP
Sbjct: 295 MWEIFTLGGSP 305
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 26/221 (11%)
Query: 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALRNTRH 510
+ +G G F ++ + A K++ + + E R+ H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK-NEHGNGLNFLERLNIAI 569
+++V F++ +F+ +V E SL + + E E
Sbjct: 75 QHVVGFHGF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEP-------EARYYLR 122
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
I YLH + ++H DLK GN+ L+ED+ K+GDFGLA + +E G +
Sbjct: 123 QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGER-----KK 173
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
VL G+ YI PE + S DV+S G ++ + G P
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-28
Identities = 62/257 (24%), Positives = 96/257 (37%), Gaps = 39/257 (15%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQ-----LQELQSLDLAGNQISGSIPNTLGN 200
+P I + LNL N+I I L L+ L L N I
Sbjct: 69 VPQGI--PSNTRYLNLMENNI-----QMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNG 121
Query: 201 LKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPK---------EILSLSS 251
L LN ++L N L +F L + L NN + +IP L L
Sbjct: 122 LASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGE 180
Query: 252 LTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKF 311
L + +S+ +G L N+ ++L + ++P + LE+L M+ N F
Sbjct: 181 LKKLEYISEGAFEG--------LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHF 230
Query: 312 SGPIPNILAELKGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLTFNNLEGVVPREGIFR 370
P L L+ L + ++++S I + L +L LNL NNL + +F
Sbjct: 231 PEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSL--PHDLFT 287
Query: 371 HTS---MVHLEGNPKLC 384
+HL NP C
Sbjct: 288 PLRYLVELHLHHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-28
Identities = 64/244 (26%), Positives = 100/244 (40%), Gaps = 13/244 (5%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI-GQLQ 178
E+P+ + + L + N + L L +L L NSI +I L
Sbjct: 68 EVPQ---GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLA 123
Query: 179 ELQSLDLAGNQISGSIP-NTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNK 237
L +L+L N ++ IP L KL ++ L N + S +F +L+ +DL K
Sbjct: 124 SLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELK 182
Query: 238 LNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFK 296
I + L +L + NL + + L + +++S N P SF
Sbjct: 183 KLEYISEGAFEGLFNLKYL-NLGMCNI--KDMPNLTPLVGLEELEMSGNHFPEIRPGSFH 239
Query: 297 NCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLT 355
SL+KL + N++ S N L L L+L+ N LS S+P D LR L L+L
Sbjct: 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLH 298
Query: 356 FNNL 359
N
Sbjct: 299 HNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-20
Identities = 50/236 (21%), Positives = 85/236 (36%), Gaps = 11/236 (4%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
++ YL L N + I D L +L N G+ + L ++ + + N
Sbjct: 75 SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133
Query: 62 LLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
L +P G L L+ + N I + + SL L + + E
Sbjct: 134 WLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLM-RLDLG----ELKKLEYI 187
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+ L N L L +G +P + L L L +S N L L
Sbjct: 188 SEGAFEGLFN-LKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236
+ L + +Q+S N L L +++L+ N L+S F + L+ + L +N
Sbjct: 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 40/192 (20%), Positives = 70/192 (36%), Gaps = 41/192 (21%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFN-FCFNKFTGKIPGSLHNLTNIQIIRMA 59
++ L L L +N + IP +++P+L+ + K G+ L N++ + +
Sbjct: 146 LSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 60 HNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG 119
+ + +LT L L GN F
Sbjct: 205 MCN--------------------------------IKDMPNLTPLVGLEELEMSGNHFPE 232
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN---SISGEILTEIGQ 176
P S LS+ L KL++ ++ + L SL LNL++N S+ ++ T
Sbjct: 233 IRPGSFHGLSS-LKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT---P 288
Query: 177 LQELQSLDLAGN 188
L+ L L L N
Sbjct: 289 LRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 24/120 (20%), Positives = 42/120 (35%), Gaps = 15/120 (12%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ +L YL L + ++P L L N F PGS H L++++ + + +
Sbjct: 195 LFNLKYLNLGMCNI-KDMPNLTP--LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 61 NLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITS--LTNSTRLNFLAFDGNQF 117
+ + + L L N+ N LS + T L L N +
Sbjct: 252 SQVS-LIERNAFDGLASLVELNLAHNN--------LSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 60/296 (20%), Positives = 105/296 (35%), Gaps = 77/296 (26%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLR------EGISVAVKVL-DIESTGTWKSFFAECEA 504
F L +G+G+FG V + ++VAVK+L ++ +E +
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 505 LRN-TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSL------------GDWIHGER 551
L H N+V L+ +C+ L ++ E+ G L
Sbjct: 80 LSYLGNHMNIVNLLGACT----IGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 552 KNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611
+ L+ + L+ + +A + +L +H DL NILL K+ DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 612 ARSLLERIGNQSSISSTHV-LKGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLL 662
AR I + + +P PE + DV+S+G+ L
Sbjct: 192 AR----------DIKNDSNYVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLW 238
Query: 663 EIFT-------GMSPTHESFAGEVSLVKWVESNF----PKNAQQVLDRELRQLMMS 707
E+F+ GM + K ++ F P++A E+ +M +
Sbjct: 239 ELFSLGSSPYPGMPVDSK-------FYKMIKEGFRMLSPEHAPA----EMYDIMKT 283
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 23/226 (10%)
Query: 449 ELRRATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLD---IESTGTWKSFFAECEA 504
+ +F NL+G GSF VY+ + G+ VA+K++D + G + E +
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 505 LRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER 564
+H ++++L F++ ++ LV E NG + ++ + E
Sbjct: 65 HCQLKHPSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLK-----NRVKPFSENEA 114
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
+ I + + YLH+ I+H DL N+LL +M K+ DFGLA + L+ +
Sbjct: 115 RHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEK-- 168
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ L G+ YI PE DV+S G M + G P
Sbjct: 169 ---HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 62/255 (24%), Positives = 102/255 (40%), Gaps = 63/255 (24%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLR------EGISVAVKVL-DIESTGTWKSFFAECEA 504
+ N+ IG G+FG V++ VAVK+L + S F E
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 505 LRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSL------------------GDW 546
+ + N+VKL+ C+ + + L++E++ G L
Sbjct: 104 MAEFDNPNIVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 547 IHGERKNEHGNGLNFLERLNIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDEDMTA 604
+ L+ E+L IA +A+ + YL VH DL N L+ E+M
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVV 213
Query: 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP-----PE---YGLGEKPSTAGDVYS 656
K+ DFGL+R++ + + IP PE Y + +T DV++
Sbjct: 214 KIADFGLSRNIYS---------ADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWA 261
Query: 657 FGVMLLEIFT-GMSP 670
+GV+L EIF+ G+ P
Sbjct: 262 YGVVLWEIFSYGLQP 276
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 28/238 (11%)
Query: 439 KHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGT 494
+ ++ R+ + +G G F ++ + A K++ +
Sbjct: 25 PPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ 84
Query: 495 WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNE 554
+ E R+ H+++V F++ +F+ +V E SL + +
Sbjct: 85 REKMSMEISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLELHKRRKA-- 137
Query: 555 HGNGLNFLERL--NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612
E I YLH + ++H DLK GN+ L+ED+ K+GDFGLA
Sbjct: 138 ------LTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA 188
Query: 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ +E G + VL G+ YI PE + S DV+S G ++ + G P
Sbjct: 189 -TKVEYDGER-----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 60/295 (20%), Positives = 112/295 (37%), Gaps = 50/295 (16%)
Query: 100 SLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLL 159
N L+ L N+ P + L L +LY+ N+ ++P + ++L L
Sbjct: 71 DFKNLKNLHTLILINNKISKISPGAFAPLVK-LERLYLSKNQLK-ELPEKM--PKTLQEL 126
Query: 160 NLSYNSISGEILTEI-GQLQELQSLDLAGNQISGSI--PNTLGNLKKLNQIDLSGNELAS 216
+ N I+ ++ + L ++ ++L N + S +KKL+ I ++ + +
Sbjct: 127 RVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-T 184
Query: 217 EIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGMLG 275
IP G +L + L NK+ + L L++L +
Sbjct: 185 TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKL-------------------- 221
Query: 276 NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKL 335
LS N +S S N L +L + NNK +P LA+ K ++V+ L +N +
Sbjct: 222 -----GLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNI 275
Query: 336 SGSIPSD-------LQNLRALRSLNLTFNNLEGVVPREGIFRHTS---MVHLEGN 380
S +I S+ + ++L N ++ + FR V L
Sbjct: 276 S-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 58/242 (23%), Positives = 100/242 (41%), Gaps = 19/242 (7%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN 205
+P + LL+L N I+ + L+ L +L L N+IS P L KL
Sbjct: 46 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFL- 263
++ LS N+L E+P + L + + N++ + K + + L+ + + L N L
Sbjct: 104 RLYLSKNQL-KELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVV-ELGTNPLK 158
Query: 264 DGTLPEEI-GMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAEL 322
+ + + I ++ ++ + L +L + NK + L L
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS---LTELHLDGNKITKVDAASLKGL 215
Query: 323 KGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLTFNNLEGVVPREGIFRHTSM--VHLEG 379
L L LS N +S ++ + L N LR L+L N L VP G+ H + V+L
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVP-GGLADHKYIQVVYLHN 272
Query: 380 NP 381
N
Sbjct: 273 NN 274
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 57/316 (18%), Positives = 109/316 (34%), Gaps = 44/316 (13%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
L L +N++ EI L NL NK + PG+ L ++ + ++ N
Sbjct: 52 PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFIT--SLTNSTRLNFLAFDGNQF-E 118
L+ +P + L+ + N+I + + ++ + N
Sbjct: 111 QLK-ELPEKM--PKTLQELRVHENEI--------TKVRKSVFNGLNQMIVVELGTNPLKS 159
Query: 119 GEIPESI-GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI-GQ 176
I + LS + + IP + SLT L+L N I+ ++
Sbjct: 160 SGIENGAFQGMKK-LSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKIT-KVDAASLKG 214
Query: 177 LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236
L L L L+ N IS +L N L ++ L+ N+L ++P + + + + L NN
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNN 273
Query: 237 KLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNL--PNS 294
++ I T + + L +N + P++
Sbjct: 274 NIS-AIGSNDFCPPGYNT------------------KKASYSGVSLFSNPVQYWEIQPST 314
Query: 295 FKNCKSLEKLLMANNK 310
F+ + + N K
Sbjct: 315 FRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 54/237 (22%), Positives = 101/237 (42%), Gaps = 27/237 (11%)
Query: 155 SLTLLNLSYNSISGEILTEI--GQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212
L ++ S L ++ + LDL N+I+ NLK L+ + L N
Sbjct: 32 HLRVVQCSDLG-----LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 86
Query: 213 ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTIVNLSKNFLDGTLPEEI 271
+++ P +F L + LS N+L +P+++ +L L + +N + + + +
Sbjct: 87 KISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQEL----RVHENEI-TKVRKSV 140
Query: 272 -GMLGNVVTIDLSANGLSGNL--PNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVL 328
L ++ ++L N L + +F+ K L + +A+ + IP L L L
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTEL 197
Query: 329 DLSSNKLSGSIPSD-LQNLRALRSLNLTFNNLEGVVPREGIFRHTS---MVHLEGNP 381
L NK++ + + L+ L L L L+FN++ V G +T +HL N
Sbjct: 198 HLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDN--GSLANTPHLRELHLNNNK 251
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 51/251 (20%), Positives = 91/251 (36%), Gaps = 33/251 (13%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L L L+ NQL E+P + L N+ T + L + ++ +
Sbjct: 99 LVKLERLYLSKNQL-KELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154
Query: 61 NLL-EGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNS--TRLNFLAFDGNQ 116
N L + G + L I IT++ L L DGN+
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTN-----------ITTIPQGLPPSLTELHLDGNK 203
Query: 117 FEGEIPE-SIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIG 175
++ S+ L+N L+KL + N S+ L L+L+ N + ++ +
Sbjct: 204 IT-KVDAASLKGLNN-LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260
Query: 176 QLQELQSLDLAGNQISGSIPNT-------LGNLKKLNQIDLSGNEL-ASEI-PTSFGNFQ 226
+ +Q + L N IS +I + + + L N + EI P++F
Sbjct: 261 DHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
Query: 227 NLLSIDLSNNK 237
++ L N K
Sbjct: 320 VRAAVQLGNYK 330
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-28
Identities = 85/422 (20%), Positives = 144/422 (34%), Gaps = 51/422 (12%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTG-KIPGSLHNLTNIQIIRMA 59
L YL L+ N+L +I NL + FN F I N++ ++ + ++
Sbjct: 68 NQELEYLDLSHNKLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123
Query: 60 HNLLEGTVPPGLGNLPFLKM-YNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
LE + + +L K+ +G EGL + + +
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILD 183
Query: 119 GEIPESIGN-LSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQ- 176
+ LSN+ L ++ I + L+ L L+ + I Q
Sbjct: 184 VSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQL 243
Query: 177 -------------------------------LQELQSLDLAGNQISGSIPNTLGNLKKLN 205
L+ L + + +N
Sbjct: 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMN 303
Query: 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDG 265
+ + + L +D SNN L + + L+ L T+ L N L
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL-ILQMNQLK- 361
Query: 266 TLPEEIGM---LGNVVTIDLSANGLSGNLP-NSFKNCKSLEKLLMANNKFSGPIPNILAE 321
L + M + ++ +D+S N +S + KSL L M++N + I L
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-- 419
Query: 322 LKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLE--G 379
++VLDL SNK+ SIP + L AL+ LN+ N L+ VP R TS+ +
Sbjct: 420 PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHT 477
Query: 380 NP 381
NP
Sbjct: 478 NP 479
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 65/412 (15%), Positives = 136/412 (33%), Gaps = 41/412 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTG------------------- 41
++ L L ++ N++ + V L + NK
Sbjct: 44 LSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAF 102
Query: 42 ---KIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKM-YNIGFNKIVGSGDEGLSF 97
I N++ ++ + ++ LE + + +L K+ +G EGL
Sbjct: 103 DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQD 162
Query: 98 ITSLTNSTRLNFLAFDGNQFEGEIPESIGN-LSNVLSKLYMGGNRFYGKIPTSIGRLRSL 156
+ + + + LSN+ L ++ I + L
Sbjct: 163 FNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKL 222
Query: 157 TLLNLSYNSISGEILTEIGQLQ--------ELQSLDLAGNQISGSIPNTLGNLKKLNQID 208
+ L L+ + I QL + ++ L G + +LK L+
Sbjct: 223 SNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQ 282
Query: 209 LSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLP 268
+ + + F N+ + + + +S + + S N L T+
Sbjct: 283 VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHL-DFSNNLLTDTVF 341
Query: 269 EEIGMLGNVVTIDLSANGLS--GNLPNSFKNCKSLEKLLMANNKF-SGPIPNILAELKGL 325
E G L + T+ L N L + KSL++L ++ N + K L
Sbjct: 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401
Query: 326 EVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHL 377
L++SSN L+ +I L ++ L+L N ++ + + + + ++ L
Sbjct: 402 LSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSI--PKQVVKLEALQEL 449
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 49/370 (13%), Positives = 108/370 (29%), Gaps = 18/370 (4%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
L ++ N + E+ L L N+ ++ + ++HN
Sbjct: 21 QKTTILNISQNYI-SELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
L NL L ++ FN N ++L FL E
Sbjct: 80 KLVKISCHPTVNLKHL---DLSFNAFDALPICKE-----FGNMSQLKFLGLSTTHLEKSS 131
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQ 181
I +L+ L +G + P L+ +L + + I +
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEG---LQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 182 SLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN 241
+L + I + + + L N S + + I + +
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248
Query: 242 IPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSL 301
+ S+S++ L D + L + + ++ ++ ++
Sbjct: 249 V--WYFSISNVKLQGQLDFRDFDYSGTS----LKALSIHQVVSDVFGFPQSYIYEIFSNM 302
Query: 302 EKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEG 361
+ +++ LD S+N L+ ++ + +L L +L L N L+
Sbjct: 303 NIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE 362
Query: 362 VVPREGIFRH 371
+ +
Sbjct: 363 LSKIAEMTTQ 372
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 48/246 (19%), Positives = 94/246 (38%), Gaps = 16/246 (6%)
Query: 127 NLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLA 186
+LS + L + N + I L L +L +S+N I ++ QEL+ LDL+
Sbjct: 18 DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77
Query: 187 GNQISGSIPNTLGNLKKLNQIDLSGNELAS-EIPTSFGNFQNLLSIDLSNNKLNGNIPKE 245
N++ I L +DLS N + I FGN L + LS L +
Sbjct: 78 HNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLP 134
Query: 246 ILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLE--- 302
I L+ ++ L + + E+ L + T L + + +
Sbjct: 135 IAHLNISKVLLVLGETYG---EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 303 ------KLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTF 356
K ++ +NK S + + ++ +L+ N + + S ++ L+ + + +
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 357 NNLEGV 362
++ V
Sbjct: 252 FSISNV 257
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-15
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 14/224 (6%)
Query: 145 KIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKL 204
+P + + T+LN+S N IS ++I L +L+ L ++ N+I + ++L
Sbjct: 14 HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 205 NQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG-NIPKEILSLSSLTTIVNLSKNFL 263
+DLS N+L S NL +DLS N + I KE ++S L + LS L
Sbjct: 72 EYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL-GLSTTHL 127
Query: 264 DGTLPEEIGMLGNV-VTIDLSANGLSGNLPNSFKNC--KSLEKLLMANNKFSGPIPNILA 320
+ + I L V + L P ++ +SL + N +F + +
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVK 187
Query: 321 ELKGLEVLDLSSNKLSGSIPSDLQNLRALRS----LNLTFNNLE 360
+ LE+ ++ L L L++ NLT NN+E
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE 231
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 227 NLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANG 286
+ +D S N L ++PK++ S TTI+N+S+N++ +I L + + +S N
Sbjct: 1 SEFLVDRSKNGLI-HVPKDL---SQKTTILNISQNYISELWTSDILSLSKLRILIISHNR 56
Query: 287 LSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIP--SDLQ 344
+ + FK + LE L +++NK I L+ LDLS N ++P +
Sbjct: 57 IQYLDISVFKFNQELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFD-ALPICKEFG 112
Query: 345 NLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCLH 386
N+ L+ L L+ +LE + S V L
Sbjct: 113 NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEK 154
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-28
Identities = 60/251 (23%), Positives = 98/251 (39%), Gaps = 60/251 (23%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLR--------EGISVAVKVL-DIESTGTWKSFFAEC 502
+ L +G G+FG V VAVK+L + +E
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125
Query: 503 EALRN-TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSL----------GDWIHGER 551
E ++ +H+N++ L+ +C+ ++ ++ E+ G+L G
Sbjct: 126 EMMKMIGKHKNIINLLGACT----QDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 552 KNEHGNGLNFLERLNIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609
+ L+ + ++ A +A ++YL +H DL N+L+ ED K+ DF
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADF 235
Query: 610 GLARSLLERIGNQSSISSTHV-LKGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVM 660
GLAR I K + G +P PE + DV+SFGV+
Sbjct: 236 GLAR----------DIHHIDYYKKTTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVL 282
Query: 661 LLEIFT-GMSP 670
L EIFT G SP
Sbjct: 283 LWEIFTLGGSP 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 25/218 (11%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSC 520
++G G++G VY G L + +A+K + + + E ++ +H+N+V+ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAIDIASALDYL 578
S F + F+ E + GSL + +++ G L E+ I L YL
Sbjct: 89 SENGFIKI-FM----EQVPGGSLSALL----RSKWG-PLKDNEQTIGFYTKQILEGLKYL 138
Query: 579 HNDCEVPIVHCDLKPGNILLDEDM-TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
H++ IVH D+K N+L++ K+ DFG ++ R+ + + T G++ Y
Sbjct: 139 HDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSK----RLAGINPCTET--FTGTLQY 189
Query: 638 IPPE--YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
+ PE A D++S G ++E+ TG P +E
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-28
Identities = 68/245 (27%), Positives = 107/245 (43%), Gaps = 15/245 (6%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI-GQLQ 178
E+P+ +S L + N+ S LR L +L LS N I I L
Sbjct: 57 EVPD---GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLA 112
Query: 179 ELQSLDLAGNQISGSIP-NTLGNLKKLNQIDLSGNELASEIPT-SFGNFQNLLSIDLSNN 236
L +L+L N+++ +IP L KL ++ L N + IP+ +F +L +DL
Sbjct: 113 NLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGEL 170
Query: 237 KLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSF 295
K I + LS+L + NL+ L +P + L + +DLS N LS P SF
Sbjct: 171 KRLSYISEGAFEGLSNLRYL-NLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSF 227
Query: 296 KNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNL 354
+ L+KL M ++ N L+ L ++L+ N L+ +P D L L ++L
Sbjct: 228 QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHL 286
Query: 355 TFNNL 359
N
Sbjct: 287 HHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 61/257 (23%), Positives = 99/257 (38%), Gaps = 39/257 (15%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQ-----LQELQSLDLAGNQISGSIPNTLGN 200
+P I + LLNL N I I L+ L+ L L+ N I
Sbjct: 58 VPDGI--STNTRLLNLHENQI-----QIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNG 110
Query: 201 LKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPK---------EILSLSS 251
L LN ++L N L + +F L + L NN + +IP L L
Sbjct: 111 LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGE 169
Query: 252 LTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKF 311
L + +S+ +G L N+ ++L+ L +P + L++L ++ N
Sbjct: 170 LKRLSYISEGAFEG--------LSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHL 219
Query: 312 SGPIPNILAELKGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLTFNNLEGVVPREGIFR 370
S P L L+ L + +++ I + NL++L +NL NNL + +F
Sbjct: 220 SAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLL--PHDLFT 276
Query: 371 HTS---MVHLEGNPKLC 384
+HL NP C
Sbjct: 277 PLHHLERIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 51/232 (21%), Positives = 100/232 (43%), Gaps = 21/232 (9%)
Query: 36 FNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEG 94
N+ S +L +++I++++ N + T+ G L L + N++
Sbjct: 73 ENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL------- 124
Query: 95 LSFITS--LTNSTRLNFLAFDGNQFEGEIPESI-GNLSNVLSKLYMGGNRFYGKIPTSI- 150
+ I + ++L L N E IP + + L +L +G + I
Sbjct: 125 -TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPS-LRRLDLGELKRLSYISEGAF 181
Query: 151 GRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLS 210
L +L LNL+ ++ + + L +L LDL+GN +S P + L L ++ +
Sbjct: 182 EGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239
Query: 211 GNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTIVNLSKN 261
+++ +F N Q+L+ I+L++N L +P ++ L L I +L N
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERI-HLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 53/240 (22%), Positives = 90/240 (37%), Gaps = 41/240 (17%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L L L+ N + I + L NL N+ T G+ L+ ++ + + +
Sbjct: 87 LRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRN 145
Query: 61 NLLEGTVPPG----LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQ 116
N +E ++P + +L L + + ++ ++ AF+G
Sbjct: 146 NPIE-SIPSYAFNRIPSLRRLDLGE--LKR-----------LSYISEG------AFEG-- 183
Query: 117 FEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQ 176
LSN L L + +IP + L L L+LS N +S
Sbjct: 184 -----------LSN-LRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQG 229
Query: 177 LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236
L LQ L + +QI N NL+ L +I+L+ N L F +L I L +N
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 33/131 (25%), Positives = 55/131 (41%), Gaps = 8/131 (6%)
Query: 250 SSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANN 309
S+ + V + L +P+ I N ++L N + NSFK+ + LE L ++ N
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 310 KFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLTFNNLEGVVPREGI 368
L L L+L N+L+ +IP+ L L+ L L N +E +
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESI--PSYA 155
Query: 369 FRH-TSMVHLE 378
F S+ L+
Sbjct: 156 FNRIPSLRRLD 166
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 70/301 (23%), Positives = 116/301 (38%), Gaps = 82/301 (27%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLR------EGISVAVKVL-DIESTGTWKSFFAECEA 504
F ENL +GSG+FG V I VAVK+L + + ++ +E +
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 505 LRN-TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER------------ 551
+ H N+V L+ +C+ + L++E+ G L +++ +R
Sbjct: 102 MTQLGSHENIVNLLGACT----LSGPIY-LIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 552 -----KNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606
+ E N L F + L A +A +++L VH DL N+L+ K+
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKI 213
Query: 607 GDFGLARSLLERIGNQSSISSTHV-LKGSIGYIP-----PE---YGLGEKPSTAGDVYSF 657
DFGLAR I S + +P PE G + DV+S+
Sbjct: 214 CDFGLAR----------DIMSDSNYVVRGNARLPVKWMAPESLFEG---IYTIKSDVWSY 260
Query: 658 GVMLLEIFT-------GMSPTHESFAGEVSLVKWVESNF----PKNAQQVLDRELRQLMM 706
G++L EIF+ G+ K +++ F P A + E+ +M
Sbjct: 261 GILLWEIFSLGVNPYPGIPVDAN-------FYKLIQNGFKMDQPFYATE----EIYIIMQ 309
Query: 707 S 707
S
Sbjct: 310 S 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 58/359 (16%), Positives = 122/359 (33%), Gaps = 48/359 (13%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+T L L SN + + + NL NK T + + LT + +
Sbjct: 63 LTGLTKLICTSNNI-TTLD---LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDT 115
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L L +L +I ++++T+L L N+ +
Sbjct: 116 NKLTKLDVSQNPLLTYLNCARNTLTEI------------DVSHNTQLTELDCHLNKKITK 163
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+ + + L+ L N+ + + + L LN N+I+ ++ ++ Q +L
Sbjct: 164 LD--VTPQTQ-LTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KL--DLNQNIQL 214
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
LD + N+++ I + L +L D S N L +E+ L ++ L
Sbjct: 215 TFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPL-TELD--VSTLSKLTTLHCIQTDLL- 267
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+ L+ T ++ ++ + +D A G++ L
Sbjct: 268 -----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPK 319
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359
L L + N + + + ++ L+ L + + S + + AL +
Sbjct: 320 LVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-25
Identities = 59/391 (15%), Positives = 127/391 (32%), Gaps = 62/391 (15%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ +L L ++ + ++ + KL L N T + L TN+ +
Sbjct: 41 LATLTSLDCHNSSI-TDMT-GIE-KLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDS 94
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSL------------TNSTRLN 108
N L + + L L N NK+ +T L +++T+L
Sbjct: 95 NKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLTEIDVSHNTQLT 151
Query: 109 FLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISG 168
L N+ ++ + + L+ L N+ + + + L LN N+I+
Sbjct: 152 ELDCHLNKKITKLD--VTPQTQ-LTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT- 204
Query: 169 EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNL 228
++ ++ Q +L LD + N+++ I + L +L D S N L +E+ L
Sbjct: 205 KL--DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPL-TELD--VSTLSKL 256
Query: 229 LSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS 288
++ L + L+ T ++ ++ + +D A G++
Sbjct: 257 TTLHCIQTDLL------EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT 310
Query: 289 ----GNLPN--------------SFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDL 330
P + L+ L N ++ ++ L
Sbjct: 311 ELDLSQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHIQD-FSSV-GKIPALNNNFE 368
Query: 331 SSNKLSGSIPSDLQNLRALRSLNLTFNNLEG 361
+ + L N +++ + G
Sbjct: 369 AEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 62/335 (18%), Positives = 120/335 (35%), Gaps = 44/335 (13%)
Query: 25 KLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGF 84
+L L + + T + G + LT + + N + T+ L L
Sbjct: 40 QLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDS 94
Query: 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYG 144
NK+ +T T+L +L D N+ ++ + L+ L N
Sbjct: 95 NKLTN---------LDVTPLTKLTYLNCDTNKLT-KLD--VSQNPL-LTYLNCARNTLT- 140
Query: 145 KIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKL 204
+I + LT L+ N ++ ++ +L +LD + N+I+ + + K L
Sbjct: 141 EID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT-ELD--VSQNKLL 193
Query: 205 NQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264
N+++ N + +++ L +D S+NKL I + L+ LT + S N L
Sbjct: 194 NRLNCDTNNI-TKLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYF-DCSVNPLT 246
Query: 265 GTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKG 324
L + L + T+ L + + + L + + +
Sbjct: 247 -ELD--VSTLSKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEGCRKIKELD--VTHNTQ 298
Query: 325 LEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359
L +LD + ++ + DL L L L L
Sbjct: 299 LYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 46/255 (18%), Positives = 87/255 (34%), Gaps = 42/255 (16%)
Query: 124 SIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSL 183
S L+ L+ L + T I +L LT L + N+I+ ++ Q L L
Sbjct: 37 SEEQLAT-LTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYL 90
Query: 184 DLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIP 243
N+++ ++ + L KL ++ N+L L ++ + N L
Sbjct: 91 ACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTK---LDVSQNPLLTYLNCARNTL----- 139
Query: 244 KEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS----GNLPN------ 293
+ +S T + L + ++ + T+D S N ++
Sbjct: 140 -TEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNC 198
Query: 294 --------SFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQN 345
L L ++NK + I + L L D S N L+ + +
Sbjct: 199 DTNNITKLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLT-ELD--VST 252
Query: 346 LRALRSLNLTFNNLE 360
L L +L+ +L
Sbjct: 253 LSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 42/208 (20%), Positives = 75/208 (36%), Gaps = 23/208 (11%)
Query: 153 LRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212
S + QL L SLD + I+ + + L L ++ + N
Sbjct: 20 FASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSN 74
Query: 213 ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIG 272
+ + + NL + +NKL N+ + L+ LT + N N L L +
Sbjct: 75 NI-TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL-NCDTNKLT-KLD--VS 124
Query: 273 MLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSS 332
+ ++ + N L+ + + L +L NK + + L LD S
Sbjct: 125 QNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179
Query: 333 NKLSGSIPSDLQNLRALRSLNLTFNNLE 360
NK++ D+ + L LN NN+
Sbjct: 180 NKITE---LDVSQNKLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 42/269 (15%), Positives = 91/269 (33%), Gaps = 33/269 (12%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
T L L + N++ DV + L N N T K+ L+ + + +
Sbjct: 169 QTQLTTLDCSFNKI---TELDVS-QNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSS 221
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSL------------TNSTRLN 108
N L + + L L ++ N + LS +T+L T++T+L
Sbjct: 222 NKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLI 278
Query: 109 FLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISG 168
+ +G + E+ + + + L L ++ + + L L L+ ++
Sbjct: 279 YFQAEGCRKIKELD--VTHNTQ-LYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELT- 331
Query: 169 EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNL 228
E+ ++ +L+SL I + +G + LN + + + + N
Sbjct: 332 EL--DVSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLT 387
Query: 229 LSIDLSNNKLNGNIPKEILSLSSLTTIVN 257
+++ GN +
Sbjct: 388 IAVSPDLLDQFGNPMNIEPGDGGVYDQAT 416
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 31/160 (19%), Positives = 57/160 (35%), Gaps = 18/160 (11%)
Query: 200 NLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLS 259
N + S L S+D N+ + ++ I L+ LT + +
Sbjct: 19 NFASEVAAAFEMQATDT---ISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKL-ICT 72
Query: 260 KNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNIL 319
N + TL + N+ + +N L+ NL L L NK + + +
Sbjct: 73 SNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--V 123
Query: 320 AELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359
++ L L+ + N L+ I D+ + L L+ N
Sbjct: 124 SQNPLLTYLNCARNTLT-EI--DVSHNTQLTELDCHLNKK 160
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 53/237 (22%), Positives = 84/237 (35%), Gaps = 38/237 (16%)
Query: 454 TGNFSHENLIGSG--SFGSVYKGY-LREGISVAVKVLDIESTGT--WKSFFAECEALRNT 508
G + +IG G +V G V V+ +++E+ E +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 509 RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568
H N+V + F L +V F+ GS D I +G+N E IA
Sbjct: 84 NHPNIVPYRAT-----FIADNELWVVTSFMAYGSAKDLI----CTHFMDGMN--ELA-IA 131
Query: 569 I---DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSI 625
+ ALDY+H+ VH +K +IL+ D + S++ Q +
Sbjct: 132 YILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 626 SSTHVLKGSIGYIP---PE------YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
K S+ +P PE G K D+YS G+ E+ G P +
Sbjct: 189 HDFP--KYSVKVLPWLSPEVLQQNLQGYDAK----SDIYSVGITACELANGHVPFKD 239
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 36/234 (15%)
Query: 456 NFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGT-WKSFFAECEALRNTRHRNL 513
++ + +IGSG+ V Y + VA+K +++E T E +A+ H N+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI---D 570
V TS F + L LV + L GS+ D I E IA +
Sbjct: 76 VSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILRE 129
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST-- 628
+ L+YLH + +H D+K GNILL ED + ++ DFG++ L +
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 629 ---------HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
V++ GY K D++SFG+ +E+ TG +P H+
Sbjct: 187 VGTPCWMAPEVMEQVRGY-------DFK----ADIWSFGITAIELATGAAPYHK 229
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 55/246 (22%), Positives = 106/246 (43%), Gaps = 54/246 (21%)
Query: 457 FSHENL-----IGSGSFGSVYKGYLR------EGISVAVKVLDIESTGTWKS-FFAECEA 504
F NL +G+G+FG V + + VAVK+L + K +E +
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 505 LRN-TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNG----- 558
+ + +H N+V L+ +C+ L ++ E+ G L +++ + + +
Sbjct: 103 MSHLGQHENIVNLLGACT----HGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 559 ---LNFLERLNIAIDIASALDYL--HNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613
+ + L+ + +A + +L N +H D+ N+LL AK+GDFGLAR
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 614 SLLERIGNQSSISSTHVLKGSIGYIP-----PE---YGLGEKPSTAGDVYSFGVMLLEIF 665
+ ++ ++ + +P PE + DV+S+G++L EIF
Sbjct: 213 DI---------MNDSNYIVKGNARLPVKWMAPESIFDC---VYTVQSDVWSYGILLWEIF 260
Query: 666 T-GMSP 670
+ G++P
Sbjct: 261 SLGLNP 266
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 53/275 (19%), Positives = 92/275 (33%), Gaps = 60/275 (21%)
Query: 456 NFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTW-KSFFAECEALRNTRHRNL 513
+F +G G FG V++ + + A+K + + + + E +AL H +
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN-------------------- 553
V+ + + + + +
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 554 --------------------------EHGNGLNFLER---LNIAIDIASALDYLHNDCEV 584
L E L+I I IA A+++LH+
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG-- 184
Query: 585 PIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK---GSIG---YI 638
++H DLKP NI D KVGDFGL ++ + Q+ ++ G +G Y+
Sbjct: 185 -LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
PE G S D++S G++L E+ S E
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 46/251 (18%), Positives = 97/251 (38%), Gaps = 43/251 (17%)
Query: 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLD-----------------IESTGTWKS 497
++ + G F + ++ A+K + I +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 498 FFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGN 557
F E + + + ++ + N + + ++YE++ N S+ + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-----ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 558 GLNFLERL--NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615
++ I + ++ Y+HN E I H D+KP NIL+D++ K+ DFG +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGES--- 199
Query: 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAG---DVYSFGVMLLEIFTGMSPTH 672
+G+ ++PPE+ + S G D++S G+ L +F + P
Sbjct: 200 -----EYMVDKKIKGSRGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYNVVP-- 251
Query: 673 ESFAGEVSLVK 683
F+ ++SLV+
Sbjct: 252 --FSLKISLVE 260
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 65/269 (24%), Positives = 106/269 (39%), Gaps = 51/269 (18%)
Query: 425 RKGKAKPIGVSTLFKHSPQMISYDELRRA----------TGNFSHENLIGSGSFGSVYKG 474
+G L+ S + ++++ + A IG GS G V
Sbjct: 6 HHSSGVDLGTENLYFQSGVV-THEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64
Query: 475 Y-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533
G VAVK++D+ + F E +R+ +H N+V++ S + E L +
Sbjct: 65 REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS-----YLVGEELWV 119
Query: 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI---DIASALDYLHNDCEVPIVHCD 590
+ EFL G+L D + R NE IA + AL YLH ++H D
Sbjct: 120 LMEFLQGGALTDIVSQVRLNEE----------QIATVCEAVLQALAYLHAQ---GVIHRD 166
Query: 591 LKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST------HVLKGSIGYIPPEYGL 644
+K +ILL D K+ DFG + + + + S+ T V+ S Y
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRS------LYA- 219
Query: 645 GEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
T D++S G+M++E+ G P
Sbjct: 220 -----TEVDIWSLGIMVIEMVDGEPPYFS 243
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 30/222 (13%)
Query: 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALRNTRH 510
+F +G G FG+VY ++ +A+KVL +E G E E + RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIA 568
N++++ F + + + L+ EF G L + + F E+
Sbjct: 74 PNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGR--------FDEQRSATFM 120
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
++A AL Y H ++H D+KP N+L+ K+ DFG + +
Sbjct: 121 EELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWS--------VHAPSLRR 169
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ G++ Y+PPE G+ D++ GV+ E GM P
Sbjct: 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 48/306 (15%), Positives = 100/306 (32%), Gaps = 35/306 (11%)
Query: 439 KHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIEST 492
P + E + + +L+G G+F VY+ + +KV +
Sbjct: 49 CKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP 108
Query: 493 GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK 552
+ E L+ + +K S+ F+N LV E G+L + I+ K
Sbjct: 109 WEFYIGTQLMERLKPSMQHMFMKF---YSAHLFQN--GSVLVGELYSYGTLLNAIN-LYK 162
Query: 553 NEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL-----------DED 601
N + ++ A+ + ++ +H + I+H D+KP N +L D
Sbjct: 163 NTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219
Query: 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVML 661
+ D G + + + + G+ E + + D + +
Sbjct: 220 AGLALIDLGQSIDMKLFPKGTIFTAKC----ETSGFQCVEMLSNKPWNYQIDYFGVAATV 275
Query: 662 LEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDREL-RQLMMSSESQTIQLHDCLI 720
+ G ++ GE E F + + E ++ + + D L
Sbjct: 276 YCMLFGTYMKVKNEGGECKP----EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331
Query: 721 TIIESV 726
++ V
Sbjct: 332 QKLKKV 337
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 30/222 (13%)
Query: 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALRNTRH 510
+F +G G FG+VY ++ +A+KVL +E G E E + RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIA 568
N+++L F + + L+ E+ G++ + K F E+
Sbjct: 69 PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSK--------FDEQRTATYI 115
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
++A+AL Y H+ ++H D+KP N+LL K+ DFG + + S
Sbjct: 116 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRR 164
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
L G++ Y+PPE G D++S GV+ E G P
Sbjct: 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 40/224 (17%)
Query: 457 FSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVK 515
++ IG G+ G+VY + G VA++ ++++ + E +R ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI---DIA 572
+ S + + L +V E+L GSL D + +E IA +
Sbjct: 82 YLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECL 126
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST---- 628
AL++LH++ ++H D+K NILL D + K+ DFG + +S++ T
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 629 --HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
V+ YG D++S G+M +E+ G P
Sbjct: 184 APEVVTRK------AYG------PKVDIWSLGIMAIEMIEGEPP 215
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 50/245 (20%), Positives = 84/245 (34%), Gaps = 37/245 (15%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN 205
+P I + + L N IS + L L L N ++ L L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 206 QIDLSGNELASEIP-TSFGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFL 263
Q+DLS N + +F L ++ L L + + L++L + L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL-YLQDNAL 141
Query: 264 DGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELK 323
LP ++F++ +L L + N+ S L
Sbjct: 142 Q-ALP-----------------------DDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 324 GLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLTFNNLEGVVPREGIFRHTS---MVHLEG 379
L+ L L N+++ + ++L L +L L NNL +P + L
Sbjct: 178 SLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALP-TEALAPLRALQYLRLND 234
Query: 380 NPKLC 384
NP +C
Sbjct: 235 NPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 47/226 (20%), Positives = 83/226 (36%), Gaps = 23/226 (10%)
Query: 43 IPGSLHNLTNIQIIRMAHNLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITS- 100
+P + Q I + N + VP L + + N + + I +
Sbjct: 26 VPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVL--------ARIDAA 74
Query: 101 -LTNSTRLNFLAFDGNQFEGEIPESI-GNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLT 157
T L L N + + L L L++ ++ + L +L
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGR-LHTLHLDRCGL-QELGPGLFRGLAALQ 132
Query: 158 LLNLSYNSISGEILTEI-GQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELAS 216
L L N++ + + L L L L GN+IS L L+++ L N +A
Sbjct: 133 YLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 217 EIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTIVNLSKN 261
P +F + L+++ L N L+ +P E L L +L + L+ N
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYL-RLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 43/238 (18%), Positives = 79/238 (33%), Gaps = 37/238 (15%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
+ + L N++ +P NL N + L ++ + ++ N
Sbjct: 32 AASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
+V P + RL+ L D + E+
Sbjct: 91 AQLRSVDPA-----------------------------TFHGLGRLHTLHLDRCGLQ-EL 120
Query: 122 PESI-GNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNSISGEILTEI-GQLQ 178
+ L+ L LY+ N +P L +LT L L N IS + L
Sbjct: 121 GPGLFRGLAA-LQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLH 177
Query: 179 ELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236
L L L N+++ P+ +L +L + L N L++ + + L + L++N
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 40/219 (18%), Positives = 65/219 (29%), Gaps = 69/219 (31%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L L L+ N + P + H L + + +
Sbjct: 79 LALLEQLDLSDNAQLRSVD------------------------PATFHGLGRLHTLHLDR 114
Query: 61 NLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG 119
L+ + PG L L+ + N + L F
Sbjct: 115 CGLQ-ELGPGLFRGLAALQYLYLQDNAL-----------------QALPDDTFRD----- 151
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQ--- 176
L N L+ L++ GNR + L SL L L N + +
Sbjct: 152 --------LGN-LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV-----AHVHPHAF 197
Query: 177 --LQELQSLDLAGNQISGSIP-NTLGNLKKLNQIDLSGN 212
L L +L L N +S ++P L L+ L + L+ N
Sbjct: 198 RDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 65/249 (26%), Positives = 100/249 (40%), Gaps = 45/249 (18%)
Query: 440 HSPQMISYDELRRATGN----FSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGT 494
HSP ++ + F+ IG GSFG V+KG R VA+K++D+E
Sbjct: 3 HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED 62
Query: 495 -WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN 553
+ E L + K S + L ++ E+LG GS D + +
Sbjct: 63 EIEDIQQEITVLSQCDSPYVTKYYGS-----YLKDTKLWIIMEYLGGGSALDLLEPGPLD 117
Query: 554 EHGNGLNFLERLNIAI---DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610
E IA +I LDYLH++ +H D+K N+LL E K+ DFG
Sbjct: 118 ET----------QIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG 164
Query: 611 LARSLLERIGNQSSISST------HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEI 664
+A L + +++ T V+K S Y K D++S G+ +E+
Sbjct: 165 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AY-------DSK----ADIWSLGITAIEL 212
Query: 665 FTGMSPTHE 673
G P E
Sbjct: 213 ARGEPPHSE 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 36/244 (14%)
Query: 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECE 503
I LR G F L+G+G++G VYKG ++ G A+KV+D+ + E
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEIN 72
Query: 504 ALRNT-RHRNLVKLITSCSSLDFKNMEF-LALVYEFLGNGSLGDWIHGERKNEHGNGLNF 561
L+ HRN+ + + M+ L LV EF G GS+ D I + N
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT------- 125
Query: 562 LERLNIAI---DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618
L+ IA +I L +LH ++H D+K N+LL E+ K+ DFG++ L
Sbjct: 126 LKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182
Query: 619 IGNQSSISSTHVLKGSIGYIP----PEYGLGEKPSTAG-----DVYSFGVMLLEIFTGMS 669
+G +++ T P PE ++ A D++S G+ +E+ G
Sbjct: 183 VGRRNTFIGT----------PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 670 PTHE 673
P +
Sbjct: 233 PLCD 236
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 56/230 (24%), Positives = 98/230 (42%), Gaps = 39/230 (16%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVK 515
+ +G G+FG VYK +E G A KV++ +S + + E E L H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI---DIA 572
L+ + + + L ++ EF G++ + + L I + +
Sbjct: 81 LLGA-----YYHDGKLWIMIEFCPGGAVDAIMLELDRG--------LTEPQIQVVCRQML 127
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
AL++LH+ I+H DLK GN+L+ + ++ DFG++ L+ + + S T
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT---- 180
Query: 633 GSIGYIP----PEYGLGEKPSTAG-----DVYSFGVMLLEIFTGMSPTHE 673
P PE + E D++S G+ L+E+ P HE
Sbjct: 181 ------PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 56/275 (20%), Positives = 98/275 (35%), Gaps = 31/275 (11%)
Query: 127 NLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNSISGEILTEI-----GQLQEL 180
L+ + L + NR I S R +L L L+ N I I L L
Sbjct: 49 GLTEAVKSLDLSNNRI-TYISNSDLQRCVNLQALVLTSNGI-----NTIEEDSFSSLGSL 102
Query: 181 QSLDLAGNQISGSIPN-TLGNLKKLNQIDLSGNELASEIPTS-FGNFQNLLSIDLSNNKL 238
+ LDL+ N +S ++ + L L ++L GN + TS F + L + + N
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161
Query: 239 NGNIPKEIL-SLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKN 297
I ++ L+ L + + + L P+ + + NV + L L
Sbjct: 162 FTKIQRKDFAGLTFLEEL-EIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDV 220
Query: 298 CKSLEKLLMANNKFSGP----IPNI----LAELKGLEVLDLSSNKLSGSIPSDLQNLRAL 349
S+E L + + + L + + ++ L + L + L
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGL 279
Query: 350 RSLNLTFNNLEGVVPREGIFRHTS---MVHLEGNP 381
L + N L+ V +GIF + + L NP
Sbjct: 280 LELEFSRNQLKSV--PDGIFDRLTSLQKIWLHTNP 312
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 52/273 (19%), Positives = 99/273 (36%), Gaps = 27/273 (9%)
Query: 104 STRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163
+ + L N+ + N L L + N S L SL L+LSY
Sbjct: 51 TEAVKSLDLSNNRITYISNSDLQRCVN-LQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109
Query: 164 N---SISGEILTEIGQLQELQSLDLAGNQISGSIP--NTLGNLKKLNQIDLSGNELASEI 218
N ++S L L L+L GN ++ + +L KL + + + ++I
Sbjct: 110 NYLSNLSSSWFK---PLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKI 165
Query: 219 PT-SFGNFQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTIVNLSKNFLDGTLPEEI-GMLG 275
F L +++ + L + + L S+ +++ + L L E +
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSH-LILHMKQHI-LLLEIFVDVTS 222
Query: 276 NVVTIDLSANGLSGN--------LPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEV 327
+V ++L L NS + + + + + +L ++ GL
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281
Query: 328 LDLSSNKLSGSIPSD-LQNLRALRSLNLTFNNL 359
L+ S N+L S+P L +L+ + L N
Sbjct: 282 LEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 40/249 (16%), Positives = 86/249 (34%), Gaps = 19/249 (7%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+L L L SN + I D L +L + +N + L+++ + +
Sbjct: 75 CVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLG 133
Query: 61 NLLEGTVPPG--LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
N + T+ +L L++ +G T L L D + +
Sbjct: 134 NPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD-----FAGLTFLEELEIDASDLQ 187
Query: 119 GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI---- 174
P+S+ ++ N +S L + + + + S+ L L + +E+
Sbjct: 188 SYEPKSLKSIQN-VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE 246
Query: 175 ----GQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLS 230
+ +++ + + + L + L +++ S N+L S F +L
Sbjct: 247 TNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQK 305
Query: 231 IDLSNNKLN 239
I L N +
Sbjct: 306 IWLHTNPWD 314
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 62/250 (24%), Positives = 104/250 (41%), Gaps = 39/250 (15%)
Query: 441 SPQMISYDELRRATGNFS------HENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTG 493
P + + G + ++G G FG V+K G+ +A K++
Sbjct: 69 PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK 128
Query: 494 TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN 553
+ E + H NL++L + F++ + LV E++ G L D I
Sbjct: 129 DKEEVKNEISVMNQLDHANLIQLYDA-----FESKNDIVLVMEYVDGGELFDRI-----I 178
Query: 554 EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL--DEDMTAKVGDFGL 611
+ L L+ + I + ++H ++ I+H DLKP NIL + K+ DFGL
Sbjct: 179 DESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGL 235
Query: 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGV---MLLEIFTGM 668
AR R + + V G+ ++ PE + S D++S GV MLL +G+
Sbjct: 236 AR----RYKPREKLK---VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL---SGL 285
Query: 669 SPTHESFAGE 678
SP F G+
Sbjct: 286 SP----FLGD 291
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 42/224 (18%)
Query: 452 RATGNFSH----ENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALR 506
T N ++GSG+F V+ R G A+K + S E L+
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 507 NTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL- 565
+H N+V L +++ LV + + G L D I ER + E+
Sbjct: 62 KIKHENIVTLEDI-----YESTTHYYLVMQLVSGGELFDRIL-ERGV-------YTEKDA 108
Query: 566 -NIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLERIGN 621
+ + SA+ YLH E IVH DLKP N+L +E+ + DFGL++
Sbjct: 109 SLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-------- 157
Query: 622 QSSISSTHVLK---GSIGYIPPEYGLGEKP-STAGDVYSFGVML 661
+ ++ G+ GY+ PE L +KP S A D +S GV+
Sbjct: 158 ---MEQNGIMSTACGTPGYVAPEV-LAQKPYSKAVDCWSIGVIT 197
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 38/228 (16%)
Query: 454 TGNFSH-----ENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRN 507
+G F E+++G G+ V AVK+++ + F E E L
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 508 -TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER-- 564
HRN+++LI F+ + LV+E + GS+ IH +R++ F E
Sbjct: 67 CQGHRNVLELIEF-----FEEEDRFYLVFEKMRGGSILSHIH-KRRH-------FNELEA 113
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLERIGN 621
+ D+ASALD+LHN I H DLKP NIL ++ K+ DF L + ++
Sbjct: 114 SVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI--KLNG 168
Query: 622 QSSISSTHVLK---GSIGYIPPE----YGLGEKP-STAGDVYSFGVML 661
S ST L GS Y+ PE + D++S GV+L
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 70/264 (26%), Positives = 107/264 (40%), Gaps = 51/264 (19%)
Query: 431 PIGVSTLFKHSPQMISYDELRRATGNFSH----ENLIGSGSFGSVYKGYLRE-GISVAVK 485
P + +P M ++ +T FS + ++G GSFG V + G AVK
Sbjct: 2 PGSMMDHLHATPGMF----VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVK 57
Query: 486 VLD---IESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGS 542
V+ ++ +S E + L+ H N++KL F++ + LV E G
Sbjct: 58 VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGE 112
Query: 543 LGDWIHGERKNEHGNGLNFLERL--NIAIDIASALDYLHNDCEVPIVHCDLKPGNILL-- 598
L D I F E I + S + Y+H + IVH DLKP N+LL
Sbjct: 113 LFDEI-----ISRKR---FSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLES 161
Query: 599 -DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK---GSIGYIPPEYGLGEKPSTAGDV 654
+D ++ DFGL+ ++ +K G+ YI PE L DV
Sbjct: 162 KSKDANIRIIDFGLST----------HFEASKKMKDKIGTAYYIAPEV-LHGTYDEKCDV 210
Query: 655 YSFGVMLLEIFTGMSPTHESFAGE 678
+S GV+L + +G P F G
Sbjct: 211 WSTGVILYILLSGCPP----FNGA 230
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGT-WKSFFAECEALRNTRHRNLV 514
F + +G+G+ G V+K + G+ +A K++ +E E + L +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI-HGERKNEHGNGLNFLERLNIAIDIAS 573
+ + + E +++ E + GSL + R E G ++I +
Sbjct: 95 GFYGAF----YSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGK-------VSIAVIK 142
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
L YL + I+H D+KP NIL++ K+ DFG++ L++ S++++ V G
Sbjct: 143 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID------SMANSFV--G 192
Query: 634 SIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ Y+ PE G S D++S G+ L+E+ G P
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 60/254 (23%), Positives = 95/254 (37%), Gaps = 41/254 (16%)
Query: 439 KHSPQMISYDELRRATGNFSH----ENLIGSGSFGSVYKGYLRE-GISVAVKVLDIEST- 492
H S E G + +GSG+FG V+ R G+ +K ++ + +
Sbjct: 2 HHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ 61
Query: 493 GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK 552
+ AE E L++ H N++K+ F++ + +V E G L + I +
Sbjct: 62 VPMEQIEAEIEVLKSLDHPNIIKIFEV-----FEDYHNMYIVMETCEGGELLERIV-SAQ 115
Query: 553 NEHGNGLNFLER--LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVG 607
E + + +AL Y H +VH DLKP NIL K+
Sbjct: 116 ARGKA---LSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKII 169
Query: 608 DFGLARSLLERIGNQSSISSTHVLK---GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEI 664
DFGLA S G+ Y+ PE + D++S GV++ +
Sbjct: 170 DFGLAE----------LFKSDEHSTNAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFL 218
Query: 665 FTGMSPTHESFAGE 678
TG P F G
Sbjct: 219 LTGCLP----FTGT 228
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 57/224 (25%), Positives = 91/224 (40%), Gaps = 37/224 (16%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
+GSG+FG V++ + G K ++ + E + H L+ L +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDYLH 579
F++ + L+ EFL G L D I E E +N L ++H
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRIAAE-------DYKMSEAEVINYMRQACEGLKHMH 166
Query: 580 NDCEVPIVHCDLKPGNILL--DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
E IVH D+KP NI+ + + K+ DFGLA ++ + V + +
Sbjct: 167 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT----KLNPDEIVK---VTTATAEF 216
Query: 638 IPPEYGLGEKPSTAGDVYSFGV---MLLEIFTGMSPTHESFAGE 678
PE E D+++ GV +LL +G+SP FAGE
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLL---SGLSP----FAGE 253
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 40/230 (17%)
Query: 454 TGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRN 512
F +G GS+GSVYK G VA+K + +ES + E ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI--- 569
+VK S + L +V E+ G GS+ D I K L IA
Sbjct: 86 VVKYYGS-----YFKNTDLWIVMEYCGAGSVSDIIRLRNKT--------LTEDEIATILQ 132
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST- 628
L+YLH +H D+K GNILL+ + AK+ DFG+A L + + ++++ T
Sbjct: 133 STLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP 189
Query: 629 -----HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673
V++ GY D++S G+ +E+ G P +
Sbjct: 190 FWMAPEVIQEI-GY-------NCV----ADIWSLGITAIEMAEGKPPYAD 227
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 53/271 (19%), Positives = 100/271 (36%), Gaps = 27/271 (9%)
Query: 123 ESIGNLSNV--LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+ I K + + L S+ + + + I + I L +
Sbjct: 12 KQIFPDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK--SVQGIQYLPNV 67
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
L L GN+++ I L NLK L + L N++ ++ +S + + L S+ L +N +
Sbjct: 68 TKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKI-KDL-SSLKDLKKLKSLSLEHNGI-- 121
Query: 241 NIPKEILSLSSLT--TIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNC 298
+I L L + L N + T + L + T+ L N +S ++
Sbjct: 122 ---SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGL 174
Query: 299 KSLEKLLMANNKFSGPIPNI--LAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTF 356
L+ L ++ N I ++ LA LK L+VL+L S + + NL ++ T
Sbjct: 175 TKLQNLYLSKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 230
Query: 357 NNLEGVVPREGIFRHTSMVHLEGNPKLCLHL 387
+L + P+ +
Sbjct: 231 GSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.4 bits (195), Expect = 2e-15
Identities = 45/262 (17%), Positives = 83/262 (31%), Gaps = 40/262 (15%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L + + + +L ++ + + G + L N+ + +
Sbjct: 20 FAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 74
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L L NL L + NKI ++SL + +L L+ + N +
Sbjct: 75 NKLTDI--KPLTNLKNLGWLFLDENKI--------KDLSSLKDLKKLKSLSLEHNGIS-D 123
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN---SISG--------- 168
I + +L L LY+G N+ T + RL L L+L N I
Sbjct: 124 I-NGLVHLPQ-LESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQN 179
Query: 169 --------EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPT 220
L + L+ L L+L + N NL N + + L +
Sbjct: 180 LYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 239
Query: 221 SFGNFQNLLSIDLSNNKLNGNI 242
S ++ + +
Sbjct: 240 SDDGDYEKPNVKWHLPEFTNEV 261
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 3e-11
Identities = 46/226 (20%), Positives = 87/226 (38%), Gaps = 30/226 (13%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ ++ L L N+L +I L NL NK + L +L ++ + + H
Sbjct: 64 LPNVTKLFLNGNKL-TDIKPL--TNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEH 118
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N + + GL +LP L+ +G NKI + IT L+ T+L+ L+ + NQ
Sbjct: 119 NGI--SDINGLVHLPQLESLYLGNNKI--------TDITVLSRLTKLDTLSLEDNQIS-- 166
Query: 121 IPESIGNLSNV--LSKLYMGGNRFYGKIP--TSIGRLRSLTLLNLSYNSISGEILTEIGQ 176
I L+ + L LY+ N I ++ L++L +L L + +
Sbjct: 167 ---DIVPLAGLTKLQNLYLSKN----HISDLRALAGLKNLDVLELFSQECLNKPINHQSN 219
Query: 177 LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSF 222
L ++ + P + + + ++ + SF
Sbjct: 220 LVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSF 263
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 5e-09
Identities = 28/132 (21%), Positives = 55/132 (41%), Gaps = 14/132 (10%)
Query: 233 LSNNKLNGNIPKEILSLSSLTTIV--NLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGN 290
+ K+I + + NL K + + L ++ I + + + +
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-S 57
Query: 291 LPNSFKNCKSLEKLLMANNKFSGPIPNI--LAELKGLEVLDLSSNKLSGSIPSDLQNLRA 348
+ + ++ KL + NK + +I L LK L L L NK+ + S L++L+
Sbjct: 58 VQG-IQYLPNVTKLFLNGNK----LTDIKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKK 110
Query: 349 LRSLNLTFNNLE 360
L+SL+L N +
Sbjct: 111 LKSLSLEHNGIS 122
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 8e-23
Identities = 53/280 (18%), Positives = 81/280 (28%), Gaps = 40/280 (14%)
Query: 95 LSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNV--LSKLYMGGNRFYGKIPTSIGR 152
L T + S L L + I + + L +L + G P +
Sbjct: 58 LGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117
Query: 153 LRSLTLLNLSYNSIS----GEILTEIGQLQE--LQSLDLAGNQISGSIPNTLGNLKKLNQ 206
L L+ ++S L E+ Q + L+ L +A + L+
Sbjct: 118 ATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177
Query: 207 IDLSGNELASEIP----TSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNF 262
+DLS N E F L + L N +
Sbjct: 178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET---------------------- 215
Query: 263 LDGTLPEEIGMLGNVVTIDLSANGLSGNLPN-SFKNCKSLEKLLMANNKFSGPIPNILAE 321
G + +DLS N L S L L ++ + A
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA- 274
Query: 322 LKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEG 361
L VLDLS N+L PS L + +L+L N
Sbjct: 275 --KLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 48/294 (16%), Positives = 89/294 (30%), Gaps = 26/294 (8%)
Query: 35 CFNKFTGKIPGSLHNLTN-IQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDE 93
C ++ G +L ++ + +L + T +L L +
Sbjct: 30 CLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIP------SR 83
Query: 94 GLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNV-LSKLYMGGNRFYGKIPTSIGR 152
L + + L L + + G P + + L+ L + + +
Sbjct: 84 ILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAE 142
Query: 153 L-----RSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSI-------PNTLGN 200
L L +L+++ ++ L +LDL+ N G P
Sbjct: 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT 202
Query: 201 LKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSK 260
L+ L + + L +DLS+N L S +NLS
Sbjct: 203 LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF 262
Query: 261 NFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGP 314
L +P+ + + +DLS N L P S + L + N F
Sbjct: 263 TGLK-QVPKGLPA--KLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 49/279 (17%), Positives = 94/279 (33%), Gaps = 19/279 (6%)
Query: 117 FEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQ 176
+ E+ +L +L ++ + L+ LT+ S +
Sbjct: 34 ADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLG 93
Query: 177 LQELQSLDLAGNQISGSIPNTLGNL--KKLNQIDLSGNELASE--IPTSFGNF--QNLLS 230
+ LQ L L +++G+ P L LN ++L A+ + L
Sbjct: 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV 153
Query: 231 IDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFL--DGTLPEEI--GMLGNVVTIDLSANG 286
+ ++ +++ +L+T+ +LS N + L + + + L G
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTL-DLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 287 ---LSGNLPNSFKNCKSLEKLLMANNKFSG-PIPNILAELKGLEVLDLSSNKLSGSIPSD 342
SG L+ L +++N L L+LS L +P
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271
Query: 343 LQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNP 381
L L L+L++N L+ P + L+GNP
Sbjct: 272 L--PAKLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNP 307
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 27/200 (13%), Positives = 56/200 (28%), Gaps = 15/200 (7%)
Query: 1 MTSLVYLGLASNQLWGEIPYDV---GDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIR 57
L L L + + P L + + + +
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 58 MAHNLLEGTVP----PGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFD 113
++ N G P L++ + + + + L L
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQ---LQGLDLS 236
Query: 114 GNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTE 173
N + + L+ L + ++P + L++L+LSYN +
Sbjct: 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR--NPS 291
Query: 174 IGQLQELQSLDLAGNQISGS 193
+L ++ +L L GN S
Sbjct: 292 PDELPQVGNLSLKGNPFLDS 311
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 1e-22
Identities = 58/287 (20%), Positives = 96/287 (33%), Gaps = 62/287 (21%)
Query: 440 HSPQMISYDELRRATGNFSHE----NLIGSGSFGSVYKGYLRE-GISVAVKVLD-----I 489
HS + + + IG GS+G V + A+K+++
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 490 ESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI-- 547
+ + E ++ H N+ +L +++ +++ LV E G L D +
Sbjct: 67 INPKDVERIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGGHLLDKLNV 121
Query: 548 ------------------------------HGERKNEHGNGLNFLERL--NIAIDIASAL 575
E+L NI I SAL
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 576 DYLHNDCEVPIVHCDLKPGNILL--DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
YLHN I H D+KP N L ++ K+ DFGL++ + + +T G
Sbjct: 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA--G 236
Query: 634 SIGYIPPE--YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
+ ++ PE E D +S GV+L + G P F G
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP----FPGV 279
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 75/423 (17%), Positives = 148/423 (34%), Gaps = 49/423 (11%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTG-KIPGSLHNLTNIQIIRMA 59
L YL ++ N+L I + +L + FN F + NLT + + ++
Sbjct: 99 NQDLEYLDVSHNRLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLS 154
Query: 60 HNLLEGTVPPGLGNLPFLKMY-NIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
+ +L + ++ I G E L + + + Q
Sbjct: 155 AAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVN 214
Query: 119 GEI--PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLN---------------- 160
+ + + L+ + T L ++TL +
Sbjct: 215 MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274
Query: 161 ---LSYNSISGEILTEIG----------QLQELQSLDLAGNQISGSIPNTLGNLKKLNQI 207
+ Y +I +TE L+ L + S ++N
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 208 DLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTL 267
LS ++ + + ++ + N ++ + +L L T + L +N L
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT-LILQRNGLK-NF 392
Query: 268 PEEIGMLGNVVTIDLSANGL----SGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELK 323
+ M N+ +++ L S + +S+ L +++N +G + L
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK- 451
Query: 324 GLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVH--LEGNP 381
++VLDL +N++ SIP D+ +L+AL+ LN+ N L+ VP R TS+ + L NP
Sbjct: 452 -VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
Query: 382 KLC 384
C
Sbjct: 509 WDC 511
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 52/398 (13%), Positives = 118/398 (29%), Gaps = 42/398 (10%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
L L+ N + E+ L L N+ +++ + ++HN
Sbjct: 52 PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110
Query: 62 LLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
L+ + + +L L ++ FN +LT L FL +F
Sbjct: 111 RLQ-NISCCPMASLRHL---DLSFNDFDVLPVCKE--FGNLTK---LTFLGLSAAKFRQL 161
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+ +L L + G S+ + T+L+L ++ S + + L
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNAL 220
Query: 181 QSLDLAGNQISGSIPNTLGNLK-------KLNQIDLSGNELASEIPTSFGNFQN---LLS 230
L L+ +++ L L + L E + F +
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY 280
Query: 231 IDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGN 290
+++ N + I +E + S L +++ + +
Sbjct: 281 LNIYNLTITERIDREEFTYSETA--------------------LKSLMIEHVKNQVFLFS 320
Query: 291 LPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALR 350
+ + +++ + L+ + N + S+ L+ L+
Sbjct: 321 KEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ 380
Query: 351 SLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCLHLG 388
+L L N L+ + ++ S + L+
Sbjct: 381 TLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSH 418
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 69/253 (27%), Positives = 101/253 (39%), Gaps = 44/253 (17%)
Query: 438 FKHSPQMISYDELRRATGNFSH----ENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE-- 490
+ +P M + G+ S +GSG++G V + + A+K++
Sbjct: 20 LQATPGMF----ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV 75
Query: 491 STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGE 550
ST + E L+ H N++KL F++ LV E G L D I
Sbjct: 76 STSSNSKLLEEVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEI--- 127
Query: 551 RKNEHGNGLNFLER--LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAK 605
F E I + S + YLH IVH DLKP N+LL ++D K
Sbjct: 128 --IHRMK---FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIK 179
Query: 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIF 665
+ DFGL+ NQ + G+ YI PE L +K DV+S GV+L +
Sbjct: 180 IVDFGLSA----VFENQKKMKERL---GTAYYIAPEV-LRKKYDEKCDVWSIGVILFILL 231
Query: 666 TGMSPTHESFAGE 678
G P F G+
Sbjct: 232 AGYPP----FGGQ 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 37/224 (16%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
+G+G+FG V++ R G + A K + ++ E + + RH LV L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 222
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDYLH 579
F++ + ++YEF+ G L + + E E + + L ++H
Sbjct: 223 ---FEDDNEMVMIYEFMSGGELFEKVADEHNK-------MSEDEAVEYMRQVCKGLCHMH 272
Query: 580 NDCEVPIVHCDLKPGNILL--DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
E VH DLKP NI+ K+ DFGL + + S+ V G+ +
Sbjct: 273 ---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA----HLDPKQSV---KVTTGTAEF 322
Query: 638 IPPEYGLGEKPSTAGDVYSFGV---MLLEIFTGMSPTHESFAGE 678
PE G+ D++S GV +LL +G+SP F GE
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILL---SGLSP----FGGE 359
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 36/229 (15%)
Query: 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE--------STGTWKSFFAECEAL 505
+S + +GSG+FG V+ +E V VK + E E L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 506 RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGS-LGDWIHGERKNEHGNGLNFLER 564
H N++K++ F+N F LV E G+G L +I + H L+
Sbjct: 84 SRVEHANIIKVLDI-----FENQGFFQLVMEKHGSGLDLFAFI-----DRHPR-LDEPLA 132
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
I + SA+ YL I+H D+K NI++ ED T K+ DFG A +
Sbjct: 133 SYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA-----AYLERGK 184
Query: 625 ISSTHVLKGSIGYIPPEYGLGEK---PSTAGDVYSFGVMLLEIFTGMSP 670
+ T G+I Y PE +G P +++S GV L + +P
Sbjct: 185 LFYTFC--GTIEYCAPEVLMGNPYRGPEL--EMWSLGVTLYTLVFEENP 229
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 68/249 (27%), Positives = 95/249 (38%), Gaps = 46/249 (18%)
Query: 439 KHSPQMISYDELRRATGNFSH----ENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTG 493
H S E G F+ ++G GSFG V K R AVKV++ S
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 494 T--WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER 551
+ E E L+ H N++KL ++ +V E G L D I
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEI---- 112
Query: 552 KNEHGNGLNFLER--LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKV 606
+ F E I + S + Y+H IVH DLKP NILL ++D K+
Sbjct: 113 -IKRKR---FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKI 165
Query: 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPE-----YGLGEKPSTAGDVYSFGVML 661
DFGL+ + + G+ YI PE Y DV+S GV+L
Sbjct: 166 IDFGLST----CFQQNTKMKDRI---GTAYYIAPEVLRGTYD------EKCDVWSAGVIL 212
Query: 662 LEIFTGMSP 670
+ +G P
Sbjct: 213 YILLSGTPP 221
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 66/226 (29%), Positives = 96/226 (42%), Gaps = 37/226 (16%)
Query: 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALRNTRH 510
GN+ IG G+F V G VA+K++D + T K F E ++ H
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIMKILNH 73
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HGERKNEHGNGLNFLERLNIA 568
N+VKL + + +L + E+ G + D++ HG R E E +
Sbjct: 74 PNIVKLFEVIET---EKTLYL--IMEYASGGEVFDYLVAHG-RMKEK-------EARSKF 120
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
I SA+ Y H IVH DLK N+LLD DM K+ DFG + + +
Sbjct: 121 RQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS----------NEFTVG 167
Query: 629 HVLK---GSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLEIFTGMSP 670
L G+ Y PE G+K DV+S GV+L + +G P
Sbjct: 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-22
Identities = 68/280 (24%), Positives = 105/280 (37%), Gaps = 61/280 (21%)
Query: 425 RKGKAKPIGVSTLFKHSPQMISYDELRRATGNFSH----ENLIGSGSFGSVYKGYLRE-G 479
+ +P M +R+ G +GSG++G V +
Sbjct: 6 HHSSGRENLYFQGIAINPGMY----VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 480 ISVAVKVLD-------------IESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526
A+KV+ + + E L++ H N++KL F+
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FE 116
Query: 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDYLHNDCEV 584
+ ++ LV EF G L + I F E NI I S + YLH
Sbjct: 117 DKKYFYLVTEFYEGGELFEQI-----INRHK---FDECDAANIMKQILSGICYLHKHN-- 166
Query: 585 PIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK---GSIGYI 638
IVH D+KP NILL + + K+ DFGL+ S + L+ G+ YI
Sbjct: 167 -IVHRDIKPENILLENKNSLLNIKIVDFGLSS----------FFSKDYKLRDRLGTAYYI 215
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
PE L +K + DV+S GV++ + G P F G+
Sbjct: 216 APEV-LKKKYNEKCDVWSCGVIMYILLCGYPP----FGGQ 250
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 32/228 (14%)
Query: 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFA----ECEALRNTR 509
G + +L+G GS+G V + AVK+L + + A E + LR R
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGS--LGDWIHGERKNEHGNGLNFLERLNI 567
H+N+++L+ L + + + +V E+ G + D + +R +
Sbjct: 65 HKNVIQLVDV---LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVC-------QAHGY 114
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
+ L+YLH+ IVH D+KPGN+LL T K+ G+A +L ++
Sbjct: 115 FCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL-------HPFAA 164
Query: 628 THVLK---GSIGYIPPEYGLGEKP--STAGDVYSFGVMLLEIFTGMSP 670
+ GS + PPE G D++S GV L I TG+ P
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 67/238 (28%), Positives = 91/238 (38%), Gaps = 42/238 (17%)
Query: 439 KHSPQMISYDELRRATGNFSHE----NLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTG 493
H S E G F+ ++G GSFG V K R AVKV++ S
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 494 T--WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER 551
+ E E L+ H N++KL ++ +V E G L D I
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEI---- 112
Query: 552 KNEHGNGLNFLER--LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKV 606
+ F E I + S + Y+H IVH DLKP NILL ++D K+
Sbjct: 113 -IKRKR---FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKI 165
Query: 607 GDFGLARSLLERIGNQSSISSTHVLK---GSIGYIPPEYGLGEKPSTAGDVYSFGVML 661
DFGL+ +K G+ YI PE L DV+S GV+L
Sbjct: 166 IDFGLST----------CFQQNTKMKDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVIL 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDI-----ESTGTWKSFFAECEALRNTRHRNLVKL 516
IG G F V + RE G AVK++D+ + + E +H ++V+L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAIDIASA 574
+ + + + L +V+EF+ L I +R + G + E + + I A
Sbjct: 92 LET-----YSSDGMLYMVFEFMDGADLCFEIV-KRADA---GFVYSEAVASHYMRQILEA 142
Query: 575 LDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
L Y H + I+H D+KP +LL + K+G FG+A L E ++ V
Sbjct: 143 LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE----SGLVAGGRV- 194
Query: 632 KGSIGYIPPEYGLGEKPSTAGDVYSFGVML 661
G+ ++ PE E DV+ GV+L
Sbjct: 195 -GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 52/236 (22%)
Query: 452 RATGNFSHE----NLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKS--------- 497
+T F ++G G V + + AVK++D+ G++ +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 498 FFAECEALRN-TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHG 556
E + LR + H N+++L + ++ F LV++ + G L D++ E
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL-----TEKV 119
Query: 557 NGLNFLER--LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614
E+ I + + LH IVH DLKP NILLD+DM K+ DFG +
Sbjct: 120 T---LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC- 172
Query: 615 LLERIGNQSSISSTHVLK---GSIGYIPPE------YGLGEKPSTAGDVYSFGVML 661
+ L+ G+ Y+ PE D++S GV++
Sbjct: 173 ---------QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 43/264 (16%), Positives = 98/264 (37%), Gaps = 24/264 (9%)
Query: 98 ITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLT 157
I +A + + +L ++ L G + L +L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTD--TVTQADLDG-ITTLSAFGTGV--TTIEGVQYLNNLI 66
Query: 158 LLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASE 217
L L N I+ L + L ++ L+L+GN + ++ + L+ + +DL+ ++ ++
Sbjct: 67 GLELKDNQITD--LAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQI-TD 121
Query: 218 IPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLT--TIVNLSKNFLDGTLPEEIGMLG 275
+ NL + L N++ I L+ LT +++ + + + L
Sbjct: 122 VT-PLAGLSNLQVLYLDLNQI-----TNISPLAGLTNLQYLSIGNAQV--SDLTPLANLS 173
Query: 276 NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKL 335
+ T+ N +S ++ + +L ++ + NN+ S P LA L ++ L++ +
Sbjct: 174 KLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229
Query: 336 SGSIPSDLQNLRALRSLNLTFNNL 359
+ NL +
Sbjct: 230 TNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 45/214 (21%), Positives = 90/214 (42%), Gaps = 21/214 (9%)
Query: 153 LRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212
L + + ++++ L + +L G ++ +I + L L ++L N
Sbjct: 18 LANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 213 ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLT--TIVNLSKNFLDGTLPEE 270
++ +++ N + ++LS N L K + +++ L ++L+ + T
Sbjct: 74 QI-TDLA-PLKNLTKITELELSGNPL-----KNVSAIAGLQSIKTLDLTSTQI--TDVTP 124
Query: 271 IGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDL 330
+ L N+ + L N ++ N+ +L+ L + N + S P LA L L L
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 331 SSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVP 364
NK+S I S L +L L ++L N + V P
Sbjct: 181 DDNKIS-DI-SPLASLPNLIEVHLKNNQISDVSP 212
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 66/346 (19%), Positives = 118/346 (34%), Gaps = 63/346 (18%)
Query: 24 DKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83
L N + + T + +L I + + T G+ L L +
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELK 71
Query: 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFY 143
N+I + + L N T++ L GN + +I L + + L + +
Sbjct: 72 DNQI--------TDLAPLKNLTKITELELSGNPL--KNVSAIAGLQS-IKTLDLTSTQIT 120
Query: 144 GKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKK 203
P + L +L +L L N I+ ++ + L LQ L + Q+S + L NL K
Sbjct: 121 DVTP--LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVS-DLTP-LANLSK 174
Query: 204 LNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFL 263
L + N++ S+I + NL+ + L NN+ I +S L NL
Sbjct: 175 LTTLKADDNKI-SDIS-PLASLPNLIEVHLKNNQ--------ISDVSPLANTSNLF---- 220
Query: 264 DGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELK 323
+ L+ ++ N L+ N GP +A
Sbjct: 221 ---------------IVTLTNQTITNQPVFYNNN-------LVVPNVVKGPSGAPIAPAT 258
Query: 324 GLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIF 369
+ +S L+ ++ S + N ++ TFN F
Sbjct: 259 ISDNGTYASPNLTWNLTSFINN------VSYTFNQSVTFKNTTVPF 298
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 48/262 (18%), Positives = 94/262 (35%), Gaps = 25/262 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ +L+ L L NQ+ ++ L + N + + L +I+ + +
Sbjct: 62 LNNLIGLELKDNQI-TDLAPL--KNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTS 116
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
+ T L L L++ + N+I + I+ L T L +L+ Q +
Sbjct: 117 TQI--TDVTPLAGLSNLQVLYLDLNQI--------TNISPLAGLTNLQYLSIGNAQVS-D 165
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+ + NLS L+ L N+ I + L +L ++L N IS ++ + L
Sbjct: 166 L-TPLANLSK-LTTLKADDNKI-SDIS-PLASLPNLIEVHLKNNQISD--VSPLANTSNL 219
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
+ L I+ NL N + + P + + S +L+ N +
Sbjct: 220 FIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA--PATISDNGTYASPNLTWNLTSF 277
Query: 241 NIPKEILSLSSLTTIVNLSKNF 262
I + + T N + F
Sbjct: 278 -INNVSYTFNQSVTFKNTTVPF 298
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 35/201 (17%), Positives = 78/201 (38%), Gaps = 39/201 (19%)
Query: 164 NSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFG 223
+I+ ++ L + + ++ T +L + + G + +
Sbjct: 7 TAIN--VIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQ 60
Query: 224 NFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLS 283
NL+ ++L +N++ ++ L +LT + ++LS
Sbjct: 61 YLNNLIGLELKDNQI-----TDLAPLKNLT----------------------KITELELS 93
Query: 284 ANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDL 343
N L N+ +S++ L + + + + P LA L L+VL L N+++ +I S L
Sbjct: 94 GNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NI-SPL 147
Query: 344 QNLRALRSLNLTFNNLEGVVP 364
L L+ L++ + + P
Sbjct: 148 AGLTNLQYLSIGNAQVSDLTP 168
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 25/124 (20%), Positives = 51/124 (41%), Gaps = 6/124 (4%)
Query: 244 KEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEK 303
I +L + ++ + T L + T+ G++ + + +L
Sbjct: 10 NVIFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIG 67
Query: 304 LLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVV 363
L + +N+ + P L L + L+LS N L S + L+++++L+LT + V
Sbjct: 68 LELKDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVT 123
Query: 364 PREG 367
P G
Sbjct: 124 PLAG 127
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-22
Identities = 66/277 (23%), Positives = 109/277 (39%), Gaps = 53/277 (19%)
Query: 423 IVRKGKAKP--------IGVSTLFKHSPQMISYDELRRATGNFSHE----NLIGSGSFGS 470
+V KGK +P + +S ++ D+ E +GSG+ G
Sbjct: 91 LVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGE 150
Query: 471 VYKGYLRE-GISVAVKVLD--------IESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
V + R+ VA++++ + E E L+ H ++K+
Sbjct: 151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK---- 206
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAIDIASALDYLH 579
+F + E +V E + G L D + + E + A+ YLH
Sbjct: 207 --NFFDAEDYYIVLELMEGGELFDKV-----VGNKR---LKEATCKLYFYQMLLAVQYLH 256
Query: 580 NDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
E I+H DLKP N+LL +ED K+ DFG ++ L E +S+ T G+
Sbjct: 257 ---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-----TSLMRTLC--GTPT 306
Query: 637 YIPPE--YGLGEKP-STAGDVYSFGVMLLEIFTGMSP 670
Y+ PE +G + A D +S GV+L +G P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 7e-22
Identities = 61/262 (23%), Positives = 106/262 (40%), Gaps = 51/262 (19%)
Query: 425 RKGKAKPIGVSTLFKHSPQMISYDELRRATGNFSHE----NLIGSGSFGSVYKGYLRE-G 479
+ A+P G L+ S A F + ++IG G V + R G
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 480 ISVAVKVLDI--------ESTGTWKSFFAECEALRN-TRHRNLVKLITSCSSLDFKNMEF 530
AVK++++ + ++ E LR H +++ LI S +++ F
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-----YESSSF 174
Query: 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDYLHNDCEVPIVH 588
+ LV++ + G L D++ E E+ +I + A+ +LH + IVH
Sbjct: 175 MFLVFDLMRKGELFDYL-----TEKVA---LSEKETRSIMRSLLEAVSFLHANN---IVH 223
Query: 589 CDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK---GSIGYIPPE---- 641
DLKP NILLD++M ++ DFG + + L+ G+ GY+ PE
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSC----------HLEPGEKLRELCGTPGYLAPEILKC 273
Query: 642 --YGLGEKPSTAGDVYSFGVML 661
D+++ GV+L
Sbjct: 274 SMDETHPGYGKEVDLWACGVIL 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---------IESTGTWKSFFAECEAL 505
+F ++G GSF +V A+K+L+ + E + +
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVM 84
Query: 506 RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE-- 563
H VKL + F++ E L + NG L +I F E
Sbjct: 85 SRLDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYIRKIGS--------FDETC 131
Query: 564 -RLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
R A +I SAL+YLH I+H DLKP NILL+EDM ++ DFG A+ + +
Sbjct: 132 TRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK----VLSPE 183
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
S + + G+ Y+ PE + + D+++ G ++ ++ G+ P
Sbjct: 184 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 56/228 (24%), Positives = 87/228 (38%), Gaps = 50/228 (21%)
Query: 452 RATGNFSH----ENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALR 506
G+ + EN IG GS+G V + I A K + F E E ++
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 507 NTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER-- 564
+ H N+++L + F++ + LV E G L + + F E
Sbjct: 62 SLDHPNIIRLYET-----FEDNTDIYLVMELCTGGELFERV-----VHKRV---FRESDA 108
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLERIGN 621
I D+ SA+ Y H ++ + H DLKP N L D K+ DFGLA
Sbjct: 109 ARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-------- 157
Query: 622 QSSISSTHVLK---GSIGYIPPE-----YGLGEKPSTAGDVYSFGVML 661
+++ G+ Y+ P+ YG D +S GVM+
Sbjct: 158 --RFKPGKMMRTKVGTPYYVSPQVLEGLYG------PECDEWSAGVMM 197
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 51/233 (21%), Positives = 93/233 (39%), Gaps = 35/233 (15%)
Query: 441 SPQMISYDELRRATGNFS-----HENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGT 494
S + + + + ++G G G V + + R G A+K+L
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-----D 64
Query: 495 WKSFFAECEAL-RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN 553
E + + + ++V ++ ++ L ++ E + G L I ER +
Sbjct: 65 SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL-IIMECMEGGELFSRIQ-ERGD 122
Query: 554 EHGNGLNFLER--LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGD 608
+ F ER I DI +A+ +LH+ I H D+KP N+L ++D K+ D
Sbjct: 123 QA-----FTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTD 174
Query: 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVML 661
FG A+ + T + Y+ PE EK + D++S GV++
Sbjct: 175 FGFAK----ETTQNA--LQTPC--YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 57/228 (25%), Positives = 88/228 (38%), Gaps = 40/228 (17%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGT--WKSFFAECEALRNTRHR-NLVKLIT 518
+G G F V + + G A K L G E L + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALD 576
++N + L+ E+ G + E E + + I +
Sbjct: 97 V-----YENTSEIILILEYAAGGEIFSLCL-PELAEM-----VSENDVIRLIKQILEGVY 145
Query: 577 YLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
YLH + IVH DLKP NILL K+ DFG++R +IG+ + + G
Sbjct: 146 YLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR----KIGHACELR---EIMG 195
Query: 634 SIGYIPPEYGLGEKPSTAGDVYSFGV---MLLEIFTGMSPTHESFAGE 678
+ Y+ PE + +TA D+++ G+ MLL T SP F GE
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLL---THTSP----FVGE 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 60/227 (26%), Positives = 90/227 (39%), Gaps = 37/227 (16%)
Query: 457 FSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGT---WKSFFAECEALRNTRHRN 512
FS IG GSFG+VY +R VA+K + + W+ E L+ RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI--- 569
++ + LV E+ GS D + +K L+ + IA
Sbjct: 116 TIQYRGC-----YLREHTAWLVMEYCL-GSASDLLEVHKKP--------LQEVEIAAVTH 161
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
L YLH+ ++H D+K GNILL E K+GDFG A + ++
Sbjct: 162 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--------NSF 210
Query: 630 VLKGSIGYIPPEYGLGEKPSTAG---DVYSFGVMLLEIFTGMSPTHE 673
V G+ ++ PE L DV+S G+ +E+ P
Sbjct: 211 V--GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 58/232 (25%), Positives = 89/232 (38%), Gaps = 46/232 (19%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLD------IESTGTWKSFFAECEALRNTRHRNLVK 515
+GSG F V K + G+ A K + + + E LR H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIAS 573
L ++N + L+ E + G L D++ + E E + I
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFL---AQKES-----LSEEEATSFIKQILD 126
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILL----DEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
++YLH I H DLKP NI+L K+ DFGLA I +
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIEDGVEFK--- 176
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGV---MLLEIFTGMSPTHESFAGE 678
+ G+ ++ PE E D++S GV +LL +G SP F G+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL---SGASP----FLGD 221
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 67/228 (29%), Positives = 99/228 (43%), Gaps = 41/228 (17%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVL---------DIESTGTWKSFFAECEAL 505
F + L+G G+FG V + G A+K+L ++ T E L
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT------LTENRVL 202
Query: 506 RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE-- 563
+N+RH L L S F+ + L V E+ G L + ER F E
Sbjct: 203 QNSRHPFLTALKYS-----FQTHDRLCFVMEYANGGELFFHLSRERV--------FSEDR 249
Query: 564 -RLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
R A +I SALDYLH+ E +V+ DLK N++LD+D K+ DFGL + E I +
Sbjct: 250 ARFYGA-EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDG 303
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
++ G+ Y+ PE A D + GV++ E+ G P
Sbjct: 304 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 48/233 (20%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLD------IESTGTWKSFFAECEALRNTRHRNLVK 515
+GSG F V K + G+ A K + + E LR H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIAS 573
L ++N + L+ E + G L D++ + E E + I
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFL---AQKES-----LSEEEATSFIKQILD 126
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILL----DEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
++YLH I H DLKP NI+L K+ DFGLA I +
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIEDGVEFK--- 176
Query: 630 VLKGSIGYIPPEYGLGEKP-STAGDVYSFGV---MLLEIFTGMSPTHESFAGE 678
+ G+ ++ PE + +P D++S GV +LL +G SP F G+
Sbjct: 177 NIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILL---SGASP----FLGD 221
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCS 521
+G G FG V++ + K + + E L RHRN++ L S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHES-- 69
Query: 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDYLH 579
F++ME L +++EF+ + + I+ ER ++ + AL +LH
Sbjct: 70 ---FESMEELVMIFEFISGLDIFERINTS-------AFELNEREIVSYVHQVCEALQFLH 119
Query: 580 NDCEVPIVHCDLKPGNILL--DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
I H D++P NI+ T K+ +FG AR ++ + +L + Y
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR----QLKPGDNFR---LLFTAPEY 169
Query: 638 IPPEYGLGEKPSTAGDVYSFGV---MLLEIFTGMSPTHESFAGE 678
PE + STA D++S G +LL +G++P F E
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLL---SGINP----FLAE 206
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 43/230 (18%)
Query: 448 DELRRATGNFSHE----NLIGSGSFGSVYKGYLRE-GISVAVKVLDIE--STGTWKSFFA 500
+ + A+ FS +G G+F V + + G+ A K+++ + S ++
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 501 ECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLN 560
E R +H N+V+L S + F LV++ + G L + I
Sbjct: 78 EARICRKLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDI-----VAREF--- 124
Query: 561 FLER--LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSL 615
+ E + I ++ Y H IVH +LKP N+LL + K+ DFGLA
Sbjct: 125 YSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-- 179
Query: 616 LERIGNQSSISSTHVLK---GSIGYIPPEYGLGEKP-STAGDVYSFGVML 661
++ + G+ GY+ PE L + P S D+++ GV+L
Sbjct: 180 --------EVNDSEAWHGFAGTPGYLSPEV-LKKDPYSKPVDIWACGVIL 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 74/228 (32%), Positives = 102/228 (44%), Gaps = 40/228 (17%)
Query: 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLD---IESTGTWKSFFAECEALRNTRH 510
G++ + +G G+FG V G G VAVK+L+ I S E + L+ RH
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HGERKNEHGNGLNFLERLNIA 568
+++KL S+ F+ V E++ G L D+I HG R E E +
Sbjct: 71 PHIIKLYQVIST---PTDFFM--VMEYVSGGELFDYICKHG-RVEEM-------EARRLF 117
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
I SA+DY H +VH DLKP N+LLD M AK+ DFGL S + G
Sbjct: 118 QQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL--SNMMSDG-------- 164
Query: 629 HVLK---GSIGYIPPEYGLGEK---PSTAGDVYSFGVMLLEIFTGMSP 670
L+ GS Y PE G P D++S GV+L + G P
Sbjct: 165 EFLRTSCGSPNYAAPEVISGRLYAGPEV--DIWSCGVILYALLCGTLP 210
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 7e-21
Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 43/224 (19%)
Query: 454 TGNFSHE----NLIGSGSFGSVYKGYLRE-GISVAVKVLDIE--STGTWKSFFAECEALR 506
+ FS +G G+F V + + G+ A K+++ + S ++ E R
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 507 NTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER-- 564
+H N+V+L S + F LV++ + G L + I R+ + E
Sbjct: 61 KLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDIV-AREF-------YSEADA 107
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLERIGN 621
+ I ++ Y H++ IVH +LKP N+LL + K+ DFGLA
Sbjct: 108 SHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI-------- 156
Query: 622 QSSISSTHVLK---GSIGYIPPEYGLGEKP-STAGDVYSFGVML 661
++ + G+ GY+ PE L + P S D+++ GV+L
Sbjct: 157 --EVNDSEAWHGFAGTPGYLSPEV-LKKDPYSKPVDIWACGVIL 197
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 47/219 (21%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLD--------IESTGTWKSFFAECEALRNTRHRNL 513
+GSG+ G V + R+ VA+K++ + E E L+ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAIDI 571
+K+ +F + E +V E + G L D + + E +
Sbjct: 78 IKIK------NFFDAEDYYIVLELMEGGELFDKV-----VGNKR---LKEATCKLYFYQM 123
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLERIGNQSSISST 628
A+ YLH + I+H DLKP N+LL +ED K+ DFG ++ L E T
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE----------T 170
Query: 629 HVLK---GSIGYIPPE--YGLGEKP-STAGDVYSFGVML 661
+++ G+ Y+ PE +G + A D +S GV+L
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 57/250 (22%), Positives = 97/250 (38%), Gaps = 46/250 (18%)
Query: 439 KHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKS 497
H+ ++ E + L+GSG FGSVY G + + + VA+K ++ + W
Sbjct: 27 LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 86
Query: 498 F------FAECEALRNTRHR--NLVKLITSCSSLD-FKNMEFLALVYEF-LGNGSLGDWI 547
E L+ +++L LD F+ + L+ E L D+I
Sbjct: 87 LPNGTRVPMEVVLLKKVSSGFSGVIRL------LDWFERPDSFVLILERPEPVQDLFDFI 140
Query: 548 HGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED-MTAKV 606
E G L + + A+ + HN ++H D+K NIL+D + K+
Sbjct: 141 T-----ERGA-LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191
Query: 607 GDFGLARSLLERIGNQSSISSTHVLK---GSIGYIPPEYGLGEK---PSTAGDVYSFGVM 660
DFG ++ V G+ Y PPE+ + S V+S G++
Sbjct: 192 IDFGS-----------GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA--AVWSLGIL 238
Query: 661 LLEIFTGMSP 670
L ++ G P
Sbjct: 239 LYDMVCGDIP 248
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 8e-21
Identities = 60/233 (25%), Positives = 91/233 (39%), Gaps = 48/233 (20%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDI------ESTGTWKSFFAECEALRNTRHRNLVK 515
+GSG F V K + G A K + + + E LR RH N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIAS 573
L F+N + L+ E + G L D++ + E E I
Sbjct: 73 LHDI-----FENKTDVVLILELVSGGELFDFL---AEKES-----LTEDEATQFLKQILD 119
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILL----DEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+ YLH I H DLKP NI+L + K+ DFG+A +I +
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH----KIEAGNEFK--- 169
Query: 630 VLKGSIGYIPPEYGLGEKP-STAGDVYSFGV---MLLEIFTGMSPTHESFAGE 678
+ G+ ++ PE + +P D++S GV +LL +G SP F GE
Sbjct: 170 NIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILL---SGASP----FLGE 214
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 9e-21
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 26/222 (11%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALRNTRHR 511
F ++G G FG V+ ++ G A K L+ ++ ++ E + L R
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIA 568
+V L F+ L LV + G + I+ ++ G F E A
Sbjct: 246 FIVSL-AYA----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG----FQEPRAIFYTA 296
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
I S L++LH I++ DLKP N+LLD+D ++ D GLA E Q + T
Sbjct: 297 -QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQ---TKT 346
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ G++ PE LGE+ + D ++ GV L E+ P
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 32/189 (16%), Positives = 71/189 (37%), Gaps = 32/189 (16%)
Query: 149 SIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQID 208
+ ++ SLT + L+ +++ LT I ++ L + + P + L L ++
Sbjct: 39 TEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 209 LSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLP 268
+ G ++ S+ + +L +D+S++ + +I +I +L + +I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI------------- 141
Query: 269 EEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVL 328
DLS NG ++ K L+ L + + + + L L
Sbjct: 142 ------------DLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQL 186
Query: 329 DLSSNKLSG 337
S + G
Sbjct: 187 YAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-18
Identities = 33/169 (19%), Positives = 67/169 (39%), Gaps = 14/169 (8%)
Query: 49 NLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLN 108
+ ++ I +A+ + T G+ +K I + I+ L+N L
Sbjct: 42 QMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHA-----TNYNPISGLSN---LE 91
Query: 109 FLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISG 168
L G + ++ L++ L+ L + + I T I L + ++LSYN
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTS-LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 169 EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASE 217
+I + L EL+SL++ + + + + KLNQ+ + +
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 28/172 (16%), Positives = 59/172 (34%), Gaps = 15/172 (8%)
Query: 94 GLSFITSLTNS--TRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIG 151
G S ++T + L ++ ++ I N + L + I
Sbjct: 31 GQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHN-IKDLTINNIHA--TNYNPIS 85
Query: 152 RLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211
L +L L + ++ + + + L L LD++ + SI + L K+N IDLS
Sbjct: 86 GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSY 145
Query: 212 NELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLT--TIVNLSKN 261
N ++I L S+++ + + + + +
Sbjct: 146 NGAITDI-MPLKTLPELKSLNIQFDGV-----HDYRGIEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 28/189 (14%), Positives = 63/189 (33%), Gaps = 33/189 (17%)
Query: 176 QLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSN 235
+ + L + + T + L I L+ + +++ T N+ + ++N
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-TDL-TGIEYAHNIKDLTINN 75
Query: 236 NKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSF 295
+S L+ N+ + + ++ + +
Sbjct: 76 IHA-----TNYNPISGLS----------------------NLERLRIMGKDVTSDKIPNL 108
Query: 296 KNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLT 355
SL L ++++ I + L + +DLS N I L+ L L+SLN+
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQ 167
Query: 356 FNNLEGVVP 364
F+ +
Sbjct: 168 FDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 27/168 (16%), Positives = 56/168 (33%), Gaps = 14/168 (8%)
Query: 25 KLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGF 84
++ +L T + G + NI+ + + + P + L L+ I
Sbjct: 42 QMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMG 97
Query: 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYG 144
+ + + ++ LT+ L L + + I I L ++ + + N
Sbjct: 98 KDV---TSDKIPNLSGLTS---LTLLDISHSAHDDSILTKINTLPK-VNSIDLSYNGAIT 150
Query: 145 KIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISG 192
I + L L LN+ ++ + I +L L I G
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 29/179 (16%), Positives = 62/179 (34%), Gaps = 34/179 (18%)
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
+ L +Q + +IP++ K L + A + +L I L+N
Sbjct: 4 EQTGLKASQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN--- 55
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
+ L+ + N+ + ++ + N +
Sbjct: 56 -----VTDLTGIEYAHNIK-------------------DLTINNIHATN--YNPISGLSN 89
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359
LE+L + + L+ L L +LD+S + SI + + L + S++L++N
Sbjct: 90 LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 21/141 (14%), Positives = 47/141 (33%), Gaps = 13/141 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
++ L + + P L NL T +L LT++ ++ ++H
Sbjct: 65 AHNIKDLTINNIHATNYNPIS---GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
+ + ++ + LP + ++ +N ++ I L L L +
Sbjct: 122 SAHDDSILTKINTLPKVNSIDLSYNG-------AITDIMPLKTLPELKSLNIQFDGVHD- 173
Query: 121 IPESIGNLSNVLSKLYMGGNR 141
I + L++LY
Sbjct: 174 -YRGIEDFPK-LNQLYAFSQT 192
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 34/223 (15%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALR--------NTRHRN 512
+G G F +V+ + VA+K++ + T ++ E + L+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 513 LVKLITSCSSLDFKNMEF--LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
++ + K + +V+E LG +L I +K EH G+ + I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALI---KKYEH-RGIPLIYVKQISKQ 139
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDE------DMTAKVGDFGLARSLLERIGNQSS 624
+ LDY+H C I+H D+KP N+L++ + K+ D G A E +S
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TNS 195
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG 667
I + Y PE LG D++S ++ E+ TG
Sbjct: 196 IQTRE-------YRSPEVLLGAPWGCGADIWSTACLIFELITG 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 23/214 (10%), Positives = 51/214 (23%), Gaps = 55/214 (25%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIESTGT---WKSFFAECEALRNTRHRNLVKLI 517
G ++ VA+ +D + + + L + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV- 96
Query: 518 TSCSSLDFKNMEFLA-LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
LD + +V E++ GSL + + + + +A+A D
Sbjct: 97 -----LDVVHTRAGGLVVAEWIRGGSLQEVADT--------SPSPVGAIRAMQSLAAAAD 143
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG 636
H + P + + D +
Sbjct: 144 AAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-------------------------- 174
Query: 637 YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+P + D+ G L + P
Sbjct: 175 TMPDA-------NPQDDIRGIGASLYALLVNRWP 201
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 40/210 (19%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRN-TRHRNLVKLITSC 520
+G GSF K ++ + AVK++ + E AL+ H N+VKL
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQKEITALKLCEGHPNIVKLHEV- 74
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDYL 578
F + LV E L G L + I ++K+ F E I + SA+ ++
Sbjct: 75 ----FHDQLHTFLVMELLNGGELFERIK-KKKH-------FSETEASYIMRKLVSAVSHM 122
Query: 579 HNDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK--- 632
H+ +VH DLKP N+L ++++ K+ DFG AR LK
Sbjct: 123 HDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP---------DNQPLKTPC 170
Query: 633 GSIGYIPPEYGLGEKP-STAGDVYSFGVML 661
++ Y PE L + + D++S GV+L
Sbjct: 171 FTLHYAAPEL-LNQNGYDESCDLWSLGVIL 199
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-20
Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 32/208 (15%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITS 519
+G G+F V + G A +++ + S + E R +H N+V+L S
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDY 577
L+++ + G L + I + E + I A+ +
Sbjct: 79 -----ISEEGHHYLIFDLVTGGELFEDI-----VAREY---YSEADASHCIQQILEAVLH 125
Query: 578 LHNDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
H ++ +VH +LKP N+LL + K+ DFGLA + + G+
Sbjct: 126 CH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI----EVEGEQQAWFGFA--GT 176
Query: 635 IGYIPPEYGLGEKP-STAGDVYSFGVML 661
GY+ PE L + P D+++ GV+L
Sbjct: 177 PGYLSPEV-LRKDPYGKPVDLWACGVIL 203
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 40/226 (17%)
Query: 449 ELRRATGNFSHE----NLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECE 503
+L R + F+ IG GS+ + + + AVK++D + E E
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIE 67
Query: 504 AL-RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL 562
L R +H N++ L + + +++ +V E + G L D I +K F
Sbjct: 68 ILLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKIL-RQKF-------FS 114
Query: 563 ER--LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTA-KVGDFGLARSLL 616
ER + I ++YLH +VH DLKP NIL + + ++ DFG A+
Sbjct: 115 EREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK--- 168
Query: 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVML 661
++ ++ + T + ++ PE L + A D++S GV+L
Sbjct: 169 -QLRAENGLLMTPC--YTANFVAPEV-LERQGYDAACDIWSLGVLL 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 55/240 (22%), Positives = 93/240 (38%), Gaps = 55/240 (22%)
Query: 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFA------------- 500
++ ++ IG GS+G V Y + A+KVL + F
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 501 -------------ECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI 547
E L+ H N+VKL+ LD N + L +V+E + G + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVP 129
Query: 548 HGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607
+ +E + D+ ++YLH I+H D+KP N+L+ ED K+
Sbjct: 130 TLKPLSED-------QARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIA 179
Query: 608 DFGLARSLLERIGNQSSISSTHVLK---GSIGYIPPEYGLGEKPSTAG---DVYSFGVML 661
DFG++ S +L G+ ++ PE + +G DV++ GV L
Sbjct: 180 DFGVSNEFK---------GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 58/235 (24%), Positives = 90/235 (38%), Gaps = 52/235 (22%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLD------IESTGTWKSFFAECEALRNTRHRNLVK 515
+GSG F V K + G+ A K + + + E L+ +H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIAS 573
L ++N + L+ E + G L D++ E + E I +
Sbjct: 79 LHEV-----YENKTDVILILELVAGGELFDFL-----AEKES---LTEEEATEFLKQILN 125
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILL----DEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+ YLH + I H DLKP NI+L K+ DFGLA I +
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------KIDFGN 172
Query: 630 VLK---GSIGYIPPEYGLGEKPSTAGDVYSFGV---MLLEIFTGMSPTHESFAGE 678
K G+ ++ PE E D++S GV +LL +G SP F G+
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL---SGASP----FLGD 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 4e-20
Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 29/222 (13%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALRNTRHR 511
F ++G G FG V +R G A K L+ I+ E + L R
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIA 568
+V L + ++ + L LV + G L I+ + F E A
Sbjct: 245 FVVSLAYA-----YETKDALCLVLTLMNGGDLKFHIYHMGQAG------FPEARAVFYAA 293
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+I L+ LH + IV+ DLKP NILLD+ ++ D GLA + E +
Sbjct: 294 -EICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-------QTI 342
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G++GY+ PE E+ + + D ++ G +L E+ G SP
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 73/322 (22%), Positives = 131/322 (40%), Gaps = 73/322 (22%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVK--VLDIESTGTWKSFFAECEALRNTRHRNLVKL--- 516
IG G+FG V+K R+ G VA+K +++ E G + E + L+ +H N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHG-NGLNFLERLNIAIDIA--- 572
+ +S + + LV++F EH GL L + + ++
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFC---------------EHDLAGL--LSNVLVKFTLSEIK 127
Query: 573 -------SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSI 625
+ L Y+H + I+H D+K N+L+ D K+ DFGLAR+ +Q +
Sbjct: 128 RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 626 SSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM---------------- 668
+ V+ ++ Y PPE LGE+ D++ G ++ E++T
Sbjct: 185 YTNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 669 ----SPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIE 724
S T E + + + + K ++ + L+ + + + L D L+ +
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA--LDLIDKLLVL-- 298
Query: 725 SVGLSCTTESPGGRIDIREALR 746
P RID +AL
Sbjct: 299 ---------DPAQRIDSDDALN 311
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 51/237 (21%), Positives = 97/237 (40%), Gaps = 29/237 (12%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGT-WKSFFAECE-ALRNTRHRNLVKLITS 519
+G G++G V K G +AVK + K + + ++R V +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAIDIASALDY 577
F+ + + + E + SL + K G E + IA+ I AL++
Sbjct: 75 L----FREGD-VWICMELMD-TSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
LH+ ++ ++H D+KP N+L++ K+ DFG++ L++ + G Y
Sbjct: 125 LHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-------GCKPY 175
Query: 638 IPPEYGLGEKP----STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690
+ PE E S D++S G+ ++E+ P ++S+ +K V
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP-YDSWGTPFQQLKQVVEEPS 231
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 60/256 (23%), Positives = 100/256 (39%), Gaps = 27/256 (10%)
Query: 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRN 512
++ +G G++G V R +VAVK++D++ ++ E + H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HGERKNEHGNGLNFLERLNIAID 570
+VK N+++L L E+ G L D I E +
Sbjct: 67 VVKFYGHRRE---GNIQYLFL--EYCSGGELFDRIEPDI-GMPEP-------DAQRFFHQ 113
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
+ + + YLH I H D+KP N+LLDE K+ DFGL + + R N+ + +
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGL--ATVFRYNNRERLLNKMC 168
Query: 631 LKGSIGYIPPE--YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688
G++ Y+ PE DV+S G++L + G P + W E
Sbjct: 169 --GTLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225
Query: 689 FPKNAQQVLDRELRQL 704
N + +D L
Sbjct: 226 TYLNPWKKIDSAPLAL 241
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-20
Identities = 35/209 (16%), Positives = 76/209 (36%), Gaps = 9/209 (4%)
Query: 153 LRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIP-NTLGNLKKLNQIDLSG 211
S L L + L + + ++ + + ++ NL K+ I++
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 212 NELASEIPTS-FGNFQNLLSIDLSNNKLNGNIPKEI-LSLSSLTTIVNLSKNFLDGTLPE 269
+ I L + + N L P + + + I+ ++ N ++P
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 270 EI--GMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELK-GLE 326
G+ +T+ L NG + +F K L N + + + G
Sbjct: 149 NAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 327 VLDLSSNKLSGSIPSD-LQNLRALRSLNL 354
+LD+S ++ ++PS L++L+ L + N
Sbjct: 209 LLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 38/212 (17%), Positives = 67/212 (31%), Gaps = 36/212 (16%)
Query: 179 ELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKL 238
+ + + I IP+ + + L L L + +F N N+ I +S +
Sbjct: 12 QEEDFRVTCKDIQ-RIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 239 NGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKN 297
+ LS +T I + L+ P++ K
Sbjct: 68 LQQLESHSFYNLSKVTHI-EIRNT-----------------------RNLTYIDPDALKE 103
Query: 298 CKSLEKLLMANNKFSG-PIPNILAELKGLEVLDLSSNKLSGSIPSD-LQNLRA-LRSLNL 354
L+ L + N P + +L+++ N SIP + Q L +L L
Sbjct: 104 LPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163
Query: 355 TFNNLEGVVPREGIFRHTSMV--HLEGNPKLC 384
N V + F T + +L N L
Sbjct: 164 YNNGFTSV--QGYAFNGTKLDAVYLNKNKYLT 193
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 39/239 (16%), Positives = 69/239 (28%), Gaps = 45/239 (18%)
Query: 26 LPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGL-GNLPFLKMYNIGF 84
P+ + NL NI I ++ ++ + NL + I
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYG 144
+ +T + A L L L +
Sbjct: 90 TRN----------LTYIDPD------ALKE-------------LPL-LKFLGIFNTGL-K 118
Query: 145 KIP--TSIGRLRSLTLLNLSYNSISGEILTEI--GQLQELQSLDLAGNQISGSIPNTLGN 200
P T + +L ++ N I G E +L L N + S+ N
Sbjct: 119 MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFN 177
Query: 201 LKKLNQIDLSGNELASEIPTSFGNFQNLLS----IDLSNNKLNGNIPKEIL-SLSSLTT 254
KL+ + L+ N+ + I F + S +D+S + +P + L L L
Sbjct: 178 GTKLDAVYLNKNKYLTVIDK--DAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIA 233
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 41/238 (17%), Positives = 73/238 (30%), Gaps = 35/238 (14%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIP-GSLHNLTNIQIIRMAH 60
S L L L IP LPN+ + ++ S +NL+ + I + +
Sbjct: 31 PSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 61 NLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG 119
+ P L LP LK I + D L+ + S L D
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPD--LTKVYSTDIFFILEIT--DNPYMTS 145
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
+ L N L + N F + L + L+ N +
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKN-------------KY 191
Query: 180 LQSLDLAGNQISGSIPNTLGNLK-KLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236
L +D + G + + +D+S + + +P+ ++L + N
Sbjct: 192 LTVID----------KDAFGGVYSGPSLLDVSQTSV-TALPS--KGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 35/212 (16%), Positives = 66/212 (31%), Gaps = 42/212 (19%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ ++ + ++ + ++ S +NL+ + I + +
Sbjct: 54 LPNISRIYVSIDVTLQQLE------------------------SHSFYNLSKVTHIEIRN 89
Query: 61 NLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG 119
+ P L LP LK I + D L+ + S L D
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPD--LTKVYSTDIFFILEIT--DNPYMTS 145
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI----- 174
+ L N L + N F + L + L+ N LT I
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNK----YLTVIDKDAF 200
Query: 175 -GQLQELQSLDLAGNQISGSIP-NTLGNLKKL 204
G LD++ ++ ++P L +LK+L
Sbjct: 201 GGVYSGPSLLDVSQTSVT-ALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 27/187 (14%), Positives = 57/187 (30%), Gaps = 38/187 (20%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPG--SLHNLTNIQIIRM 58
++ + ++ + + + I D +LP L P +++ I+ +
Sbjct: 79 LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEI 137
Query: 59 AHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
N ++P L N T L N F
Sbjct: 138 TDNPYMTSIPVNA--------------------------FQGLCNETLTLKL--YNNGFT 169
Query: 119 GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSI--GRLRSLTLLNLSYNSIS---GEILTE 173
+ N + L +Y+ N++ I G +LL++S S++ + L
Sbjct: 170 -SVQGYAFNGTK-LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEH 227
Query: 174 IGQLQEL 180
+ +L
Sbjct: 228 LKELIAR 234
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 41/232 (17%)
Query: 451 RRATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLD---IESTGTWKSFFAECEALR 506
+R G + +G GSFG V + VA+K + ++ + E L+
Sbjct: 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK 64
Query: 507 NTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HGERKNEHGNGLNFLER 564
RH +++KL ++ + V E+ G G L D+I R E E
Sbjct: 65 LLRHPHIIKLYDVITT---PTDIVM--VIEYAG-GELFDYIVEKK-RMTED-------EG 110
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
I A++Y H IVH DLKP N+LLD+++ K+ DFGL+ + G
Sbjct: 111 RRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSN--IMTDG---- 161
Query: 625 ISSTHVLK---GSIGYIPPEYGLGEK---PSTAGDVYSFGVMLLEIFTGMSP 670
+ LK GS Y PE G+ P DV+S G++L + G P
Sbjct: 162 ----NFLKTSCGSPNYAAPEVINGKLYAGPEV--DVWSCGIVLYVMLVGRLP 207
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 8e-20
Identities = 72/228 (31%), Positives = 103/228 (45%), Gaps = 40/228 (17%)
Query: 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLD---IESTGTWKSFFAECEALRNTRH 510
G++ + +G G+FG V G G VAVK+L+ I S E + L+ RH
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HGERKNEHGNGLNFLERLNIA 568
+++KL S+ + F+ V E++ G L D+I +G R +E E +
Sbjct: 76 PHIIKLYQVIST---PSDIFM--VMEYVSGGELFDYICKNG-RLDEK-------ESRRLF 122
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
I S +DY H +VH DLKP N+LLD M AK+ DFGL S + G
Sbjct: 123 QQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL--SNMMSDG-------- 169
Query: 629 HVLK---GSIGYIPPEYGLGEK---PSTAGDVYSFGVMLLEIFTGMSP 670
L+ GS Y PE G P D++S GV+L + G P
Sbjct: 170 EFLRTSCGSPNYAAPEVISGRLYAGPEV--DIWSSGVILYALLCGTLP 215
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-20
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 442 PQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVK--VLDIESTGTWKSFF 499
+ I+Y + IG+GSFG V++ L E VA+K + D
Sbjct: 37 QREIAYTNCKV----------IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----- 81
Query: 500 AECEALRNTRHRNLVKLITS-CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNG 558
E + +R +H N+V L S+ D K+ FL LV E++ ++ K +
Sbjct: 82 -ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQT-- 137
Query: 559 LNFLERLNIAI---DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA-KVGDFGLARS 614
+ L I + + +L Y+H+ + I H D+KP N+LLD K+ DFG A+
Sbjct: 138 ---MPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191
Query: 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
L+ N S I S + Y PE G +T D++S G ++ E+ G
Sbjct: 192 LIAGEPNVSYICSRY-------YRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 52/265 (19%), Positives = 101/265 (38%), Gaps = 24/265 (9%)
Query: 98 ITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLT 157
I S + L++ + ++ + K I L ++T
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELNS-IDQIIANNSDI--KSVQGIQYLPNVT 71
Query: 158 LLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASE 217
L L+ N ++ + + L+ L L L N++ + + L +LKKL + L N + S+
Sbjct: 72 KLFLNGNKLTD--IKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGI-SD 126
Query: 218 IPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLT--TIVNLSKNFLDGTLPEEIGMLG 275
I + L S+ L NNK+ +I LS LT ++L N + + + L
Sbjct: 127 I-NGLVHLPQLESLYLGNNKI-----TDITVLSRLTKLDTLSLEDNQI--SDIVPLAGLT 178
Query: 276 NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKL 335
+ + LS N +S +L K+L+ L + + + N + L + + L
Sbjct: 179 KLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
Query: 336 SGSIPSDLQNLRALRSLNLTFNNLE 360
P + + N+ ++ E
Sbjct: 237 VT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 48/282 (17%), Positives = 87/282 (30%), Gaps = 43/282 (15%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L + + + +L ++ + + G + L N+ + +
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L T L NL L + NK+ ++SL + +L L+ + N +
Sbjct: 78 NKL--TDIKPLANLKNLGWLFLDENKV--------KDLSSLKDLKKLKSLSLEHNGIS-D 126
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN---SISG--------- 168
I + +L L LY+G N+ T + RL L L+L N I
Sbjct: 127 I-NGLVHLPQ-LESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQN 182
Query: 169 --------EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPT 220
L + L+ L L+L + N NL N + + L +
Sbjct: 183 LYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 242
Query: 221 SFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNF 262
S ++ + + TI F
Sbjct: 243 SDDGDYEKPNVKWHLPEFTNEV---SFIFYQPVTIGKAKARF 281
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 40/189 (21%), Positives = 75/189 (39%), Gaps = 37/189 (19%)
Query: 176 QLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSN 235
E +L ++ ++ L ++QI + +++ + N+ + L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSV-QGIQYLPNVTKLFLNG 77
Query: 236 NKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSF 295
NKL +I L++L N+ + L N + +L +
Sbjct: 78 NKL-----TDIKPLANLK----------------------NLGWLFLDENKVK-DLSS-L 108
Query: 296 KNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLT 355
K+ K L+ L + +N S I L L LE L L +NK++ + L L L +L+L
Sbjct: 109 KDLKKLKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLE 164
Query: 356 FNNLEGVVP 364
N + +VP
Sbjct: 165 DNQISDIVP 173
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 27/217 (12%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGT-WKSFFAECE-ALRNTRHRNLVKLITS 519
IG G++GSV K + G +AVK + K + + +R++ +V+ +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL--NIAIDIASALDY 577
F+ + + E + S D + + + + E + I + AL++
Sbjct: 90 L----FREGD-CWICMELMS-TSF-DKFYKYVYSVLDDVIP--EEILGKITLATVKALNH 140
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
L + + I+H D+KP NILLD K+ DFG++ L++ I G Y
Sbjct: 141 LKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-------GCRPY 191
Query: 638 IPPE----YGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ PE + DV+S G+ L E+ TG P
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 31/206 (15%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSC 520
+G G+ VY+ + A+KV ++ T K E L H N++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPNIIKLKEI- 116
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDYL 578
F+ ++LV E + G L D I E G + ER + I A+ YL
Sbjct: 117 ----FETPTEISLVLELVTGGELFDRI-----VEKGY---YSERDAADAVKQILEAVAYL 164
Query: 579 HNDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
H E IVH DLKP N+L D K+ DFGL++ + +Q + + + G+
Sbjct: 165 H---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK----IVEHQVLMKT---VCGTP 214
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVML 661
GY PE G D++S G++
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 55/238 (23%), Positives = 93/238 (39%), Gaps = 40/238 (16%)
Query: 439 KHSPQMISYDELRRATGNFSHE-----NLIGSGSFGSVYKGYLRE-GISVAVKVLDIEST 492
+ PQ L+ + ++G G G V + + + A+K+L
Sbjct: 41 QQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---- 96
Query: 493 GTWKSFFAECEAL-RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER 551
E E R ++ ++V+++ +L L +V E L G L I +R
Sbjct: 97 -DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL-IVMECLDGGELFSRIQ-DR 153
Query: 552 KNEHGNGLNFLER--LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKV 606
++ F ER I I A+ YLH + I H D+KP N+L + K+
Sbjct: 154 GDQA-----FTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKL 205
Query: 607 GDFGLARSLLERIGNQSSISSTHVLK---GSIGYIPPEYGLGEKPSTAGDVYSFGVML 661
DFG A+ +S + L + Y+ PE EK + D++S GV++
Sbjct: 206 TDFGFAK----------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 60/256 (23%), Positives = 100/256 (39%), Gaps = 27/256 (10%)
Query: 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRN 512
++ +G G++G V R +VAVK++D++ ++ E + H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HGERKNEHGNGLNFLERLNIAID 570
+VK N+++L L E+ G L D I E +
Sbjct: 67 VVKFYGHRRE---GNIQYLFL--EYCSGGELFDRIEPDI-GMPEP-------DAQRFFHQ 113
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
+ + + YLH I H D+KP N+LLDE K+ DFGL + + R N+ + +
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGL--ATVFRYNNRERLLNKMC 168
Query: 631 LKGSIGYIPPE--YGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688
G++ Y+ PE DV+S G++L + G P + W E
Sbjct: 169 --GTLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225
Query: 689 FPKNAQQVLDRELRQL 704
N + +D L
Sbjct: 226 TYLNPWKKIDSAPLAL 241
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 72/315 (22%), Positives = 119/315 (37%), Gaps = 60/315 (19%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKV--LDIESTGTWKSFFAECEALRNTRHRNL 513
+ +G G++G VYK +G VA+K LD E G + E L+ H N+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 514 VKLITSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
V L +D + L LV+EF+ L + E+ GL + +
Sbjct: 82 VSL------IDVIHSERCLTLVFEFM-EKDLKKVLD-----ENKTGLQDSQIKIYLYQLL 129
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
+ + H I+H DLKP N+L++ D K+ DFGLAR+ G + V+
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA----FGIPVRSYTHEVV- 181
Query: 633 GSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM--------------------SPT 671
++ Y P+ +G K ST+ D++S G + E+ TG +P
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240
Query: 672 HESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCT 731
+ L W + F ++ + + I L ++
Sbjct: 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGF----CQEGIDLLSNMLCF--------- 287
Query: 732 TESPGGRIDIREALR 746
P RI R+A+
Sbjct: 288 --DPNKRISARDAMN 300
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 40/219 (18%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFA----ECEALRNTRHR----- 511
+IG GSFG V K Y + VA+K+ + + K F E L + R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKM--VRNE---KRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 512 -NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
N++ ++ + F+N + + +E L +L + I K G + A
Sbjct: 159 MNVIHML---ENFTFRN--HICMTFELLSM-NLYELI----KKNKFQGFSLPLVRKFAHS 208
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA--KVGDFGLARSLLERIGNQSSISST 628
I LD LH + I+HCDLKP NILL + + KV DFG + +R+ + I S
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--TYIQSR 263
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG 667
Y PE LG + D++S G +L E+ TG
Sbjct: 264 F-------YRAPEVILGARYGMPIDMWSLGCILAELLTG 295
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 64/247 (25%), Positives = 103/247 (41%), Gaps = 33/247 (13%)
Query: 437 LFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISV-AVKVL---DIEST 492
L P ++ E+R +F +IG G+F V +++ V A+K++ D+
Sbjct: 43 LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102
Query: 493 GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HGE 550
G F E + L N R + +L + F++ +L LV E+ G L + GE
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLHFA-----FQDENYLYLVMEYYVGGDLLTLLSKFGE 157
Query: 551 RKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610
R + R +A +I A+D +H + VH D+KP NILLD ++ DFG
Sbjct: 158 RIPAE------MARFYLA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFG 207
Query: 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVY-------SFGVMLLE 663
L+ + + S V G+ Y+ PE Y + GV E
Sbjct: 208 SC---LKLRADGTVRSLVAV--GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
Query: 664 IFTGMSP 670
+F G +P
Sbjct: 263 MFYGQTP 269
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 5e-19
Identities = 63/236 (26%), Positives = 98/236 (41%), Gaps = 45/236 (19%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVL---------DIESTGTWKSFFAECEAL 505
+F+ ++G GSFG V + AVK+L D+E T K A
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA----- 396
Query: 506 RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE-- 563
+ L +L + F+ M+ L V E++ G L I + F E
Sbjct: 397 LPGKPPFLTQLHSC-----FQTMDRLYFVMEYVNGGDLMYHIQQVGR--------FKEPH 443
Query: 564 -RLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
A +IA L +L I++ DLK N++LD + K+ DFG+ + E I +
Sbjct: 444 AVFYAA-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDG 496
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
+T G+ YI PE + + D ++FGV+L E+ G +P F GE
Sbjct: 497 ---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 545
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 57/235 (24%), Positives = 88/235 (37%), Gaps = 46/235 (19%)
Query: 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSF------FAECEALR- 506
+ L+G G FG+V+ G+ L + + VA+KV+ W E L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 507 ---NTRHRNLVKLITSCSSLD-FKNMEFLALVYEFLGNGS-LGDWIHGERKNEHGNGLNF 561
H +++L LD F+ E LV E L D+I E G
Sbjct: 91 VGAGGGHPGVIRL------LDWFETQEGFMLVLERPLPAQDLFDYIT-----EKGP---L 136
Query: 562 LERL--NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-TAKVGDFGLARSLLER 618
E + +A+ + H+ +VH D+K NIL+D AK+ DFG
Sbjct: 137 GEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGS------- 186
Query: 619 IGNQSSISSTHVLKGSIGYIPPEYGLGEK---PSTAGDVYSFGVMLLEIFTGMSP 670
G G+ Y PPE+ + V+S G++L ++ G P
Sbjct: 187 -GALLHDEPYTDFDGTRVYSPPEWISRHQYHALPA--TVWSLGILLYDMVCGDIP 238
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 41/235 (17%)
Query: 155 SLTLLNLSYNSISGEILTEI--GQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212
S +N + LT + ++ L L+ N + TL +L Q++L
Sbjct: 11 SHLEVNCDKRN-----LTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 213 ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIG 272
EL +++ G L ++DLS+N+L ++P +L +LT + ++S N L +LP
Sbjct: 66 EL-TKLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVL-DVSFNRLT-SLP---- 116
Query: 273 MLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSS 332
+ + L++L + N+ P +L LE L L++
Sbjct: 117 -------------------LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157
Query: 333 NKLSGSIPSDL-QNLRALRSLNLTFNNLEGVVPREGIFRHTS--MVHLEGNPKLC 384
N L+ +P+ L L L +L L N+L +P+ G F L GNP LC
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPK-GFFGSHLLPFAFLHGNPWLC 209
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 48/180 (26%), Positives = 74/180 (41%), Gaps = 9/180 (5%)
Query: 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQIS 191
+ L++ N Y ++ LT LNL ++ L G L L +LDL+ NQ+
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLGTLDLSHNQLQ 90
Query: 192 GSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL-SLS 250
S+P L L +D+S N L S + L + L N+L +P +L
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148
Query: 251 SLTTIVNLSKNFLDGTLPEEI-GMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANN 309
L + +L+ N L LP + L N+ T+ L N L +P F L + N
Sbjct: 149 KLEKL-SLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 45/173 (26%), Positives = 69/173 (39%), Gaps = 19/173 (10%)
Query: 98 ITSL-----TNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGR 152
+ + TRL L D + ++ G L L L + N+ +P
Sbjct: 43 LYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPV-LGTLDLSHNQL-QSLPLLGQT 98
Query: 153 LRSLTLLNLSYN---SISGEILTEIGQLQELQSLDLAGNQISGSIP-NTLGNLKKLNQID 208
L +LT+L++S+N S+ L L ELQ L L GN++ ++P L KL ++
Sbjct: 99 LPALTVLDVSFNRLTSLPLGALR---GLGELQELYLKGNELK-TLPPGLLTPTPKLEKLS 154
Query: 209 LSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKN 261
L+ N L +NL ++ L N L IPK L L N
Sbjct: 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA-FLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 41/215 (19%), Positives = 66/215 (30%), Gaps = 68/215 (31%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
T L L L +L ++ V LP L + N+ +P L + ++ ++ N
Sbjct: 55 TRLTQLNLDRAEL-TKLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN 110
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
L ++P G A G
Sbjct: 111 RLT-SLPLG----------------------------------------ALRG------- 122
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYN---SISGEILTEIGQL 177
L L +LY+ GN +P + L L+L+ N + +L L
Sbjct: 123 ------LGE-LQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN---GL 171
Query: 178 QELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212
+ L +L L N + +IP L L GN
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 5/84 (5%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L L L N+L +P + P L + N T G L+ L N+ + +
Sbjct: 123 LGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 61 NLLEGTVPPG---LGNLPFLKMYN 81
N L T+P G LPF ++
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHG 204
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 6e-19
Identities = 58/250 (23%), Positives = 91/250 (36%), Gaps = 41/250 (16%)
Query: 435 STLFKHSPQMISYDELRRAT-GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVL----- 487
S F Q + + T +FS +IG G FG VY + G A+K L
Sbjct: 168 SDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227
Query: 488 ----DIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSL 543
+ + +V + + F + L+ + + + G L
Sbjct: 228 KMKQGETLALNERIML---SLVSTGDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDL 279
Query: 544 GDWIHGERKNEHGNGLNFLERLNI--AIDIASALDYLHNDCEVPIVHCDLKPGNILLDED 601
+ F E A +I L+++HN +V+ DLKP NILLDE
Sbjct: 280 HYHLSQHGV--------FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEH 328
Query: 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVM 660
++ D GLA + H G+ GY+ PE ++ D +S G M
Sbjct: 329 GHVRISDLGLACDFSK--------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 380
Query: 661 LLEIFTGMSP 670
L ++ G SP
Sbjct: 381 LFKLLRGHSP 390
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-19
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 451 RRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVK--VLDIESTGTWKSFFAECEALRN 507
R +++ +IG+GSFG VY+ L + G VA+K + D E + +R
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRK 103
Query: 508 TRHRNLVKLITS-CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLN 566
H N+V+L SS + K+ +L LV +++ ++ + + L +
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQT-----LPVIY 157
Query: 567 IAI---DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA-KVGDFGLARSLLERIGNQ 622
+ + + +L Y+H+ I H D+KP N+LLD D K+ DFG A+ L+ N
Sbjct: 158 VKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
S I S + Y PE G +++ DV+S G +L E+ G
Sbjct: 215 SYICSRY-------YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 42/222 (18%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
L+G G+FG V + G A+K+L ++ T E L+NTRH
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT------VTESRVLQNTRHP 65
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIA 568
L L + F+ + L V E+ G L + ER F E R A
Sbjct: 66 FLTALKYA-----FQTHDRLCFVMEYANGGELFFHLSRERV--------FTEERARFYGA 112
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+I SAL+YLH +V+ D+K N++LD+D K+ DFGL + E I + ++
Sbjct: 113 -EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDG---ATM 162
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ Y+ PE A D + GV++ E+ G P
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 62/244 (25%), Positives = 102/244 (41%), Gaps = 33/244 (13%)
Query: 439 KHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISV-AVKVL---DIESTGT 494
P ++R +F +IG G+FG V L+ V A+K+L ++
Sbjct: 58 WAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE 117
Query: 495 WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNE 554
F E + L N + + L + F++ L LV ++ G GD + K E
Sbjct: 118 TACFREERDVLVNGDSKWITTLHYA-----FQDDNNLYLVMDYY-VG--GDLLTLLSKFE 169
Query: 555 HGNGLNFLE---RLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611
E R +A ++ A+D +H + VH D+KP NIL+D + ++ DFG
Sbjct: 170 D----RLPEEMARFYLA-EMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGS 221
Query: 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAG-----DVYSFGVMLLEIFT 666
L+ + + + SS V G+ YI PE + D +S GV + E+
Sbjct: 222 C---LKLMEDGTVQSSVAV--GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 667 GMSP 670
G +P
Sbjct: 277 GETP 280
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 42/242 (17%), Positives = 79/242 (32%), Gaps = 12/242 (4%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI-GQLQ 178
EIP +L +L + + L + +S N + I ++ L
Sbjct: 23 EIPS---DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79
Query: 179 ELQSLDLA-GNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNK 237
+L + + N + P NL L + +S + + + +D+ +N
Sbjct: 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 139
Query: 238 LNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEI-GMLGNVVTIDLSANGLSGNLPNSF 295
I + LS + I+ L+KN + + N L + F
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVF 198
Query: 296 KNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLT 355
L ++ + L LK L + K +P+ L+ L AL +LT
Sbjct: 199 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLT 254
Query: 356 FN 357
+
Sbjct: 255 YP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 36/237 (15%), Positives = 71/237 (29%), Gaps = 18/237 (7%)
Query: 155 SLTLLNLSYNSISGEILTEI--GQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212
S + + +TEI + L ++ L +I++S N
Sbjct: 10 SNRVFLCQESK-----VTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 64
Query: 213 ELASEIPTS-FGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEE 270
++ I F N L I + I E L +L + +S + LP+
Sbjct: 65 DVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL-LISNTGI-KHLPDV 122
Query: 271 IGM-LGNVVTIDLSANGLSGNLP-NSFKNCKS-LEKLLMANNKFSGPIPNILAELKGLEV 327
+ V +D+ N + NSF L + N + + E+
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDEL 182
Query: 328 LDLSSNKLSGSIPSD-LQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKL 383
+N L +P+D L+++ + + + + L
Sbjct: 183 NLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPS--YGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 44/244 (18%), Positives = 71/244 (29%), Gaps = 48/244 (19%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
L + ++ N + I NL + IR+
Sbjct: 53 FGDLEKIEISQNDVLEVIE------------------------ADVFSNLPKLHEIRIEK 88
Query: 61 -NLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
N L + P NLP L+ I I + I +S + L N
Sbjct: 89 ANNLL-YINPEAFQNLPNLQYLLISNTGI--KHLPDVHKI----HSLQKVLLDIQDNINI 141
Query: 119 GEIPE-SIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYN---SISGEILTE 173
I S LS L++ N +I S + L N + ++
Sbjct: 142 HTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFH- 199
Query: 174 IGQLQELQSLDLAGNQISGSIP-NTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSID 232
LD++ +I S+P L NLKKL ++P + L+
Sbjct: 200 --GASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNL---KKLP-TLEKLVALMEAS 252
Query: 233 LSNN 236
L+
Sbjct: 253 LTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 42/241 (17%), Positives = 68/241 (28%), Gaps = 27/241 (11%)
Query: 35 CFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDE 93
C +IP L N +R L + G L+ I N ++ +
Sbjct: 16 CQESKVTEIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEA 72
Query: 94 GLSFITSLTNSTRLNFLAFDGNQFEGEIPESI-GNLSNVLSKLYMGGNRFYGKIPTSI-G 151
F ++L + N I NL N L L + +P
Sbjct: 73 D-VF-SNLPKLHEIRIE--KANNLL-YINPEAFQNLPN-LQYLLISNTGI-KHLPDVHKI 125
Query: 152 RLRSLTLLNLSYN----SISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQI 207
LL++ N +I G E L L N I + +
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFV--GLSFESVILWLNKNGIQEIHNSAFNGTQLDELN 183
Query: 208 DLSGNELASEIPTSFGNFQNLLSIDLSNNKLN-------GNIPK-EILSLSSLTTIVNLS 259
N L F + +D+S +++ N+ K S +L + L
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTLE 243
Query: 260 K 260
K
Sbjct: 244 K 244
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 23/169 (13%), Positives = 55/169 (32%), Gaps = 18/169 (10%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIP-GSLHNLT-NIQIIRM 58
+ +L YL +++ + +P + + N I S L+ I+ +
Sbjct: 103 LPNLQYLLISNTGI-KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161
Query: 59 AHNLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQF 117
N ++ + ++ N + ++ ++ L +
Sbjct: 162 NKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPND------VFHGASGPVILDISRTRI 214
Query: 118 EGEIPESI-GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNS 165
+P NL L + K+P ++ +L +L +L+Y S
Sbjct: 215 H-SLPSYGLENLKK-LRARSTYNLK---KLP-TLEKLVALMEASLTYPS 257
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 66/222 (29%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
++G GSFG V+ ++ A+K L D+E T K + H
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS-----LAWEHP 78
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIA 568
L + + F+ E L V E+L G L I K F A
Sbjct: 79 FLTHMFCT-----FQTKENLFFVMEYLNGGDLMYHIQSCHK--------FDLSRATFYAA 125
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+I L +LH IV+ DLK NILLD+D K+ DFG+ + E + + T
Sbjct: 126 -EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGD---AKT 175
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ G+ YI PE LG+K + + D +SFGV+L E+ G SP
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 73/337 (21%), Positives = 123/337 (36%), Gaps = 64/337 (18%)
Query: 438 FKHSPQMISYDELR--RATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVK--VLDIEST 492
HS + E ++ + + L+G GS+G V K ++ G VA+K + +
Sbjct: 6 HHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK 65
Query: 493 GTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGER 551
K E + L+ RH NLV L L+ K + LV+EF+ + ++ D +
Sbjct: 66 MVKKIAMREIKLLKQLRHENLVNL------LEVCKKKKRWYLVFEFV-DHTILDDL---- 114
Query: 552 KNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611
NGL++ I + + + H+ I+H D+KP NIL+ + K+ DFG
Sbjct: 115 -ELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF 170
Query: 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM-- 668
AR+L +T Y PE +G+ A DV++ G ++ E+F G
Sbjct: 171 ARTLAAPGEVYDDEVAT------RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL 224
Query: 669 ------------------SPTHESFAGEVSLVKWVESNFPK-NAQQVLDRELRQLMMSSE 709
+ + P+ ++ L+R +L
Sbjct: 225 FPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKL----S 280
Query: 710 SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
I L + I P R E L
Sbjct: 281 EVVIDLAKKCLHI-----------DPDKRPFCAELLH 306
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 67/222 (30%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
+IG GSFG V + + AVKVL + + + ++ + N +H
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK-----NVKHP 99
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIA 568
LV L S F+ + L V +++ G L + ER FLE R A
Sbjct: 100 FLVGLHFS-----FQTADKLYFVLDYINGGELFYHLQRERC--------FLEPRARFYAA 146
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+IASAL YLH + IV+ DLKP NILLD + DFGL + E I + S+T
Sbjct: 147 -EIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHN---STT 196
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ Y+ PE + D + G +L E+ G+ P
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVK-VLDI-ESTGTWKSFFAECEALRNTRHRNL 513
+ + IGSG+ G V Y +VA+K + ++ K + E ++ H+N+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 514 VKL---ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
+ L T SL+ + + +V E + +L I E +E +++ +
Sbjct: 87 IGLLNVFTPQKSLE--EFQDVYIVMELMDA-NLCQVIQMELDHER---MSY-----LLYQ 135
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
+ + +LH+ I+H DLKP NI++ D T K+ DFGLAR + ++ +
Sbjct: 136 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGTSFM 182
Query: 631 LKGSIG---YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG 667
+ + Y PE LG D++S G ++ E+ G
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 62/230 (26%), Positives = 95/230 (41%), Gaps = 45/230 (19%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
++G GSFG V + AVK+L D+E T K A +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-----LPGKPP 81
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIA 568
L +L + F+ M+ L V E++ G L I + F E A
Sbjct: 82 FLTQLHSC-----FQTMDRLYFVMEYVNGGDLMYHIQQVGR--------FKEPHAVFYAA 128
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+IA L +L I++ DLK N++LD + K+ DFG+ + E I + +T
Sbjct: 129 -EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDG---VTT 178
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
G+ YI PE + + D ++FGV+L E+ G +P F GE
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 224
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 74/328 (22%), Positives = 124/328 (37%), Gaps = 70/328 (21%)
Query: 452 RATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALR---- 506
AT + IG G++G+VYK G VA+K + + + G +R
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP-ISTVREVAL 64
Query: 507 -----NTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNF 561
H N+V+L+ C++ + LV+E + + L ++ +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL------DKAPPPGL 117
Query: 562 LERL--NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERI 619
++ LD+LH +C IVH DLKP NIL+ T K+ DFGLAR
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---- 170
Query: 620 GNQSSISSTH-VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGM---------- 668
++ T V+ ++ Y PE L +T D++S G + E+F
Sbjct: 171 --SYQMALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226
Query: 669 ----------SPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDC 718
P + + +VSL + FP + + + ++ E QL
Sbjct: 227 QLGKIFDLIGLPPEDDWPRDVSLPRG---AFPPRGPRPVQSVVPEM----EESGAQLLLE 279
Query: 719 LITIIESVGLSCTTESPGGRIDIREALR 746
++T +P RI AL+
Sbjct: 280 MLTF-----------NPHKRISAFRALQ 296
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 69/260 (26%), Positives = 109/260 (41%), Gaps = 53/260 (20%)
Query: 427 GKAKPIGVSTLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVY----KGYLREGISV 482
G K I ++ K + F ++G GSFG V+
Sbjct: 3 GSIKEIAITHHVKEGHEKADPS-------QFELLKVLGQGSFGKVFLVKKISGSDARQLY 55
Query: 483 AVKVL---------DIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533
A+KVL + + E + L H +VKL + F+ L L
Sbjct: 56 AMKVLKKATLKVRDRVRTK-------MERDILVEVNHPFIVKLHYA-----FQTEGKLYL 103
Query: 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIAIDIASALDYLHNDCEVPIVHCD 590
+ +FL G L + E F E + +A ++A ALD+LH + I++ D
Sbjct: 104 ILDFLRGGDLFTRLSKEVM--------FTEEDVKFYLA-ELALALDHLH---SLGIIYRD 151
Query: 591 LKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPST 650
LKP NILLDE+ K+ DFGL++ E I ++ + G++ Y+ PE +
Sbjct: 152 LKPENILLDEEGHIKLTDFGLSK---ESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQ 205
Query: 651 AGDVYSFGVMLLEIFTGMSP 670
+ D +SFGV++ E+ TG P
Sbjct: 206 SADWWSFGVLMFEMLTGTLP 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 28/216 (12%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGT-WKSFFAECEAL-RNTRHRNLVKLITS 519
+GSG+ G V+K R+ G +AVK + K + + + ++ +V+ +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
N + + + E +G + + K + + + I AL YL
Sbjct: 93 F----ITNTD-VFIAMELMGTCAE------KLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
+ ++H D+KP NILLDE K+ DFG++ L++ S G Y+
Sbjct: 142 E--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA-------GCAAYMA 192
Query: 640 PEYGLGEKPSTAG-----DVYSFGVMLLEIFTGMSP 670
PE P+ DV+S G+ L+E+ TG P
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 61/231 (26%), Positives = 90/231 (38%), Gaps = 46/231 (19%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVL---------DIESTGTWKSFFAECEAL 505
+F IG GSFG V + A+K + ++ + F E + +
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV------FKELQIM 69
Query: 506 RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE-- 563
+ H LV L S F++ E + +V + L G L + F E
Sbjct: 70 QGLEHPFLVNLWYS-----FQDEEDMFMVVDLLLGGDLRYHLQQNVH--------FKEET 116
Query: 564 -RLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
+L I ++ ALDYL I+H D+KP NILLDE + DF +A L
Sbjct: 117 VKLFIC-ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---- 168
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKP---STAGDVYSFGVMLLEIFTGMSP 670
+ + G+ Y+ PE K S A D +S GV E+ G P
Sbjct: 169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 7e-18
Identities = 70/315 (22%), Positives = 126/315 (40%), Gaps = 61/315 (19%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKV--LDIESTGTWKSFFAECEALRNTRHRNL 513
+ IG G++G VYK G + A+K L+ E G + E L+ +H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 514 VKLITSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
VKL D + L LV+E L + L + + GL + + + +
Sbjct: 63 VKL------YDVIHTKKRLVLVFEHL-DQDLKKLL-----DVCEGGLESVTAKSFLLQLL 110
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
+ + Y H+ ++H DLKP N+L++ + K+ DFGLAR+ G + ++
Sbjct: 111 NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA----FGIPVRKYTHEIV- 162
Query: 633 GSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM--------------------SPT 671
++ Y P+ +G K ST D++S G + E+ G +P
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221
Query: 672 HESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCT 731
+++ V+ + + NF + L+ L + I L ++ +
Sbjct: 222 SKNWPN-VTELPKYDPNFTVYEPLPWESFLKGL----DESGIDLLSKMLKL--------- 267
Query: 732 TESPGGRIDIREALR 746
P RI ++AL
Sbjct: 268 --DPNQRITAKQALE 280
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-18
Identities = 67/254 (26%), Positives = 110/254 (43%), Gaps = 45/254 (17%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
+IG GS+ V L++ A++V+ DI+ T K F + + H
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE-----QASNHP 113
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIA 568
LV L + F+ L V E++ G L + +RK E R A
Sbjct: 114 FLVGLHSC-----FQTESRLFFVIEYVNGGDLMFHMQRQRK--------LPEEHARFYSA 160
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+I+ AL+YLH E I++ DLK N+LLD + K+ D+G+ + E + +T
Sbjct: 161 -EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPG---DTT 210
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688
G+ YI PE GE + D ++ GV++ E+ G SP F S ++
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP----FDIVGSSDNPDQNT 266
Query: 689 FPKNAQQVLDRELR 702
Q +L++++R
Sbjct: 267 EDYLFQVILEKQIR 280
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 16/212 (7%)
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
++LDL+ N + + + +L +DLS E+ + ++ + +L ++ L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 240 GNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEI-GMLGNVVTIDLSANGL-SGNLPNSFK 296
++ S LSSL + + L +L G L + ++++ N + S LP F
Sbjct: 90 -SLALGAFSGLSSLQKL-VAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 297 NCKSLEKLLMANNKFSGPIPNILAELKGLEV----LDLSSNKLSGSIPSDLQNLRALRSL 352
N +LE L +++NK L L + + LDLS N ++ I L+ L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205
Query: 353 NLTFNNLEGVVPREGIFRHTS---MVHLEGNP 381
L N L+ VP GIF + + L NP
Sbjct: 206 ALDTNQLK-SVPD-GIFDRLTSLQKIWLHTNP 235
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 49/240 (20%), Positives = 84/240 (35%), Gaps = 39/240 (16%)
Query: 127 NLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIG---QLQELQSL 183
NL L + N S L +L+LS I E G L L +L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT---IEDGAYQSLSHLSTL 81
Query: 184 DLAGNQISGSIP-NTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNI 242
L GN I S+ L L ++ LAS G+ + L +++++N + +
Sbjct: 82 ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SF 139
Query: 243 PKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLE 302
+ L N+ +DLS+N + + +
Sbjct: 140 K---------------LPEYFSN--------LTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 303 ----KLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLTFN 357
L ++ N + P E++ L+ L L +N+L S+P L +L+ + L N
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 44/234 (18%)
Query: 36 FNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGL 95
FN S + +Q++ ++ ++ T+ G +
Sbjct: 37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA------------YQS--------- 74
Query: 96 SFITSLTNSTRLNFLAFDGNQFEGEIPESI-GNLSNVLSKLYMGGNRFYGKIPTSIGRLR 154
L++ L+ L GN + + LS+ L KL IG L+
Sbjct: 75 -----LSH---LSTLILTGNPIQ-SLALGAFSGLSS-LQKLVAVETNLASLENFPIGHLK 124
Query: 155 SLTLLNLSYNSISGEILTEI-GQLQELQSLDLAGNQISGSIPN----TLGNLKKLN-QID 208
+L LN+++N I L E L L+ LDL+ N+I SI L + LN +D
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLD 183
Query: 209 LSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTIVNLSKN 261
LS N + P +F + L + L N+L ++P I L+SL I L N
Sbjct: 184 LSLNPMNFIQPGAFKEIR-LKELALDTNQLK-SVPDGIFDRLTSLQKI-WLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 46/218 (21%), Positives = 72/218 (33%), Gaps = 42/218 (19%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
L L L+ ++ I L +L N G+ L+++Q +
Sbjct: 52 PELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 62 LLEGTVPPGL-GNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
L ++ G+L LK N+ N I S F
Sbjct: 111 NLA-SLENFPIGHLKTLKELNVAHNL-----------IQSFKLPE-----YFS------- 146
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTL----LNLSYNSISGEILTEIG 175
NL+N L L + N+ I + L + L L+LS N ++ I
Sbjct: 147 ------NLTN-LEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 176 QLQELQSLDLAGNQISGSIP-NTLGNLKKLNQIDLSGN 212
+ L+ L L NQ+ S+P L L +I L N
Sbjct: 198 KEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 70/220 (31%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 461 NLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFA----ECEALRNTRHR---- 511
+LIG GSFG V K Y E VA+K+ I++ K+F E L
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKI--IKNK---KAFLNQAQIEVRLLELMNKHDTEM 114
Query: 512 --NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
+V L F+N L LV+E L +L D + +N + G++ A
Sbjct: 115 KYYIVHLK---RHFMFRN--HLCLVFEMLSY-NLYDLL----RNTNFRGVSLNLTRKFAQ 164
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA--KVGDFGLARSLLERIGNQSSISS 627
+ +AL +L E+ I+HCDLKP NILL + K+ DFG + L +RI I S
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQS 221
Query: 628 THVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG 667
Y PE LG A D++S G +L+E+ TG
Sbjct: 222 RF-------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 8e-18
Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVK-VLDI-ESTGTWKSFFAECEALRNTRHRNL 513
+ + IGSG+ G V Y +VA+K + ++ K + E ++ H+N+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 514 VKL---ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
+ L T +L+ + + LV E + +L I E +E +++ +
Sbjct: 124 ISLLNVFTPQKTLE--EFQDVYLVMELMDA-NLCQVIQMELDHER---MSY-----LLYQ 172
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
+ + +LH+ I+H DLKP NI++ D T K+ DFGLAR + ++ +
Sbjct: 173 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGTSFM 219
Query: 631 LKGSIG---YIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG 667
+ + Y PE LG D++S G ++ E+
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 55/240 (22%), Positives = 99/240 (41%), Gaps = 28/240 (11%)
Query: 439 KHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISV-AVKVL---DIESTGT 494
++ + +LR ++ +IG G+FG V + V A+K+L ++
Sbjct: 53 RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 112
Query: 495 WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNE 554
F+ E + + +V+L + F++ +L +V E++ G L + + E
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVNLMSNYDVPE 167
Query: 555 HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614
R A ++ ALD +H + +H D+KP N+LLD+ K+ DFG
Sbjct: 168 K------WARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217
Query: 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPST----AGDVYSFGVMLLEIFTGMSP 670
+ N+ + G+ YI PE + D +S GV L E+ G +P
Sbjct: 218 M-----NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 69/266 (25%), Positives = 116/266 (43%), Gaps = 46/266 (17%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
+IG GS+ V L++ A+KV+ DI+ T K F + + H
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE-----QASNHP 70
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIA 568
LV L + F+ L V E++ G L + +RK E R A
Sbjct: 71 FLVGLHSC-----FQTESRLFFVIEYVNGGDLMFHMQRQRK--------LPEEHARFYSA 117
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+I+ AL+YLH E I++ DLK N+LLD + K+ D+G+ + E + +T
Sbjct: 118 -EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPG---DTT 167
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688
G+ YI PE GE + D ++ GV++ E+ G SP F S ++
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP----FDIVGSSDNPDQNT 223
Query: 689 FPKNAQQVLDRELR-QLMMSSESQTI 713
Q +L++++R +S ++ ++
Sbjct: 224 EDYLFQVILEKQIRIPRSLSVKAASV 249
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-18
Identities = 38/207 (18%), Positives = 75/207 (36%), Gaps = 16/207 (7%)
Query: 153 LRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212
L + NL S++ L +L +Q+ + + I S+ + L ++ LS N
Sbjct: 18 LANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHN 73
Query: 213 ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIG 272
++ S++ + + L + ++ N+L LS L L N L + +
Sbjct: 74 QI-SDL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL----FLDNNEL--RDTDSLI 125
Query: 273 MLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSS 332
L N+ + + N L ++ LE L + N+ + L LK + +DL+
Sbjct: 126 HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTG 181
Query: 333 NKLSGSIPSDLQNLRALRSLNLTFNNL 359
K L ++
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 44/242 (18%), Positives = 81/242 (33%), Gaps = 23/242 (9%)
Query: 123 ESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQS 182
L+N K +G S L + N ++I L + L+
Sbjct: 13 FPDPGLAN-AVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKE 67
Query: 183 LDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNI 242
L L+ NQIS + L +L KL ++ ++ N L + + L + L NN+L
Sbjct: 68 LHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNEL---- 118
Query: 243 PKEILSLSSLT--TIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
++ SL L I+++ N L +G L + +DL N ++ K
Sbjct: 119 -RDTDSLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEITNTGG--LTRLKK 173
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
+ + + K EL + + P + N + + +
Sbjct: 174 VNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
Query: 361 GV 362
Sbjct: 232 YT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 41/193 (21%), Positives = 78/193 (40%), Gaps = 24/193 (12%)
Query: 171 LTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLS 230
+ L +L ++ + + L + + + + S F NL
Sbjct: 12 VFPDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQS--LAGMQFFTNLKE 67
Query: 231 IDLSNNKLNGNIPKEILSLSSLT--TIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS 288
+ LS+N++ ++ L LT +++++N L I + + L N L
Sbjct: 68 LHLSHNQI-----SDLSPLKDLTKLEELSVNRNRL--KNLNGIPSA-CLSRLFLDNNELR 119
Query: 289 GNLPNSFKNCKSLEKLLMANNKFSGPIPNI--LAELKGLEVLDLSSNKLSGSIPSDLQNL 346
+S + K+LE L + NNK + +I L L LEVLDL N+++ + L L
Sbjct: 120 D--TDSLIHLKNLEILSIRNNK----LKSIVMLGFLSKLEVLDLHGNEIT-NT-GGLTRL 171
Query: 347 RALRSLNLTFNNL 359
+ + ++LT
Sbjct: 172 KKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 44/263 (16%), Positives = 99/263 (37%), Gaps = 28/263 (10%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ + V L + + +L + FN + + G + TN++ + ++H
Sbjct: 18 LANAVKQNLGKQSVTDLVSQK---ELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSH 72
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N + + L +L L+ ++ N++ + + ++ L+ L D N+
Sbjct: 73 NQI--SDLSPLKDLTKLEELSVNRNRL--------KNLNGIPSAC-LSRLFLDNNELRD- 120
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
+S+ +L N L L + N+ K +G L L +L+L N I+ + +L+++
Sbjct: 121 -TDSLIHLKN-LEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEITN--TGGLTRLKKV 174
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQI-DLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
+DL G + L N + D G ++ ++ G++ + + L
Sbjct: 175 NWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDG---CVLWE-LP 230
Query: 240 GNIPKEILSLSSLTTIVNLSKNF 262
+ S + F
Sbjct: 231 VYTDEVSYKFSEYINVGETEAIF 253
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 30/180 (16%), Positives = 60/180 (33%), Gaps = 38/180 (21%)
Query: 185 LAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPK 244
I+ P L + +L + + + + + N+ + +
Sbjct: 4 QRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-----Q 54
Query: 245 EILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKL 304
+ + T N+ + LS N +S +L K+ LE+L
Sbjct: 55 SLAGMQFFT----------------------NLKELHLSHNQIS-DLSP-LKDLTKLEEL 90
Query: 305 LMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVP 364
+ N+ + I L L L +N+L L +L+ L L++ N L+ +V
Sbjct: 91 SVNRNRLKN-LNGI--PSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM 145
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 86.3 bits (213), Expect = 1e-17
Identities = 47/217 (21%), Positives = 78/217 (35%), Gaps = 17/217 (7%)
Query: 147 PTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGN---QISGSIPNTLGNLKK 203
L LS + + +E+ +ELQ L+ + L L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 204 LNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFL 263
+ + L + P +L S L N + ++ L +L+ L
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL-------HLAHKDL 453
Query: 264 DGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELK 323
T+ + L V +DLS N L LP + + LE L ++N + +A L
Sbjct: 454 --TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLP 508
Query: 324 GLEVLDLSSNKLSG-SIPSDLQNLRALRSLNLTFNNL 359
L+ L L +N+L + L + L LNL N+L
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.6 bits (198), Expect = 6e-16
Identities = 39/260 (15%), Positives = 89/260 (34%), Gaps = 24/260 (9%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
S L ++ L K T + L + +Q + +
Sbjct: 326 DSQKECVLLKDRPECWCRDS--ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENK 382
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
T+ + L L E L + ++L + D + + +
Sbjct: 383 WCLLTIILLMRALDPLL-----------YEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431
Query: 122 PESIGNLSNVLSK-LYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
S+ + + L++ + + +L +T L+LS+N + + + L+ L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDL-TVLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCL 488
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELAS-EIPTSFGNFQNLLSIDLSNN--- 236
+ L + N + ++ + NL +L ++ L N L + L+ ++L N
Sbjct: 489 EVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
Query: 237 KLNGNIPKEILSLSSLTTIV 256
+ G + L S+++I+
Sbjct: 547 QEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 2e-12
Identities = 40/244 (16%), Positives = 73/244 (29%), Gaps = 62/244 (25%)
Query: 93 EGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNV----LSKLYMGGNRFYGKIPT 148
E + LT + L D +E E + L V + L ++F +
Sbjct: 378 EPENKWCLLTIILLMRAL--DPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSV 435
Query: 149 SIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQID 208
+ +L+L++ ++ +L + QL + LDL+ N++ ++P L L+ L +
Sbjct: 436 LKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQ 492
Query: 209 LSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLP 268
S N L + N L + L NN+L I L
Sbjct: 493 ASDNAL-ENVD-GVANLPRLQELLLCNNRL-----------QQSAAIQPL---------- 529
Query: 269 EEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGP---IPNILAELKGL 325
+C L L + N + L +
Sbjct: 530 ---------------------------VSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562
Query: 326 EVLD 329
+
Sbjct: 563 SSIL 566
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-17
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 46/226 (20%)
Query: 462 LIGSGSFGSVY---KGYLREGISV-AVKVL----------DIESTGTWKSFFAECEALRN 507
++G G +G V+ K + A+KVL D T AE L
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT------KAERNILEE 77
Query: 508 TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---R 564
+H +V LI + F+ L L+ E+L G L + E F+E
Sbjct: 78 VKHPFIVDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGI--------FMEDTAC 124
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
+A +I+ AL +LH + I++ DLKP NI+L+ K+ DFGL + E I +
Sbjct: 125 FYLA-EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDG-- 175
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ TH G+I Y+ PE + + A D +S G ++ ++ TG P
Sbjct: 176 -TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 69/222 (31%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVL---------DIESTGTWKSFFAECEALRNTRHR 511
++G GSFG V ++E G AVKVL D+E T T K + H
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS-----LARNHP 84
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE---RLNIA 568
L +L F+ + L V EF+ G L I R+ F E R A
Sbjct: 85 FLTQLFCC-----FQTPDRLFFVMEFVNGGDLMFHIQKSRR--------FDEARARFYAA 131
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+I SAL +LH + I++ DLK N+LLD + K+ DFG+ + E I N +T
Sbjct: 132 -EIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNG---VTT 181
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
G+ YI PE A D ++ GV+L E+ G +P
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 45/228 (19%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVL---------DIESTGTWKSFFAECEAL 505
F +G+GSFG V +E G A+K+L IE T E L
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT------LNEKRIL 95
Query: 506 RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE-- 563
+ LVKL S FK+ L +V E++ G + + + F E
Sbjct: 96 QAVNFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLRRIGR--------FSEPH 142
Query: 564 -RLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
R A I +YLH + +++ DLKP N+L+D+ +V DFG A+ + R
Sbjct: 143 ARFYAA-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
T L G+ + PE L + + A D ++ GV++ E+ G P
Sbjct: 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 463 IGSGSFGSVYKGYLREGIS---VAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
+G G++G VYK ++G A+K IE TG S E LR +H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI---AIDIASALD 576
S + L++++ + L I R ++ L R + I +
Sbjct: 87 FLS---HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 577 YLHNDCEVPIVHCDLKPGNILLDEDMTA----KVGDFGLARSLLERIGNQSSISSTHVLK 632
YLH + ++H DLKP NIL+ + K+ D G AR + + + V
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 197
Query: 633 GSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
+ Y PE LG + + A D+++ G + E+ T
Sbjct: 198 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 70/315 (22%), Positives = 132/315 (41%), Gaps = 51/315 (16%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNL 513
F +G+G++ +VYKG + G+ VA+K + ++S GT + E ++ +H N+
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
V+L + + L LV+EF+ + L ++ GL +
Sbjct: 66 VRLYDVIHTENK-----LTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
L + H + I+H DLKP N+L+++ K+GDFGLAR+ G + S+ V+
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA----FGIPVNTFSSEVV-- 170
Query: 634 SIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM--------------------SPTH 672
++ Y P+ +G + ST+ D++S G +L E+ TG +P
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230
Query: 673 ESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQT-IQLHDCLITIIESVGLSCT 731
+ V+ + N + + L + L+ + L+ +
Sbjct: 231 SLWPS-VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQL--------- 280
Query: 732 TESPGGRIDIREALR 746
+P R+ ++AL
Sbjct: 281 --NPDMRLSAKQALH 293
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 45/228 (19%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVL---------DIESTGTWKSFFAECEAL 505
+F +G+GSFG V+ R G A+KVL +E T E L
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT------NDERLML 60
Query: 506 RNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE-- 563
H ++++ + F++ + + ++ +++ G L + ++ F
Sbjct: 61 SIVTHPFIIRMWGT-----FQDAQQIFMIMDYIEGGELFSLLRKSQR--------FPNPV 107
Query: 564 -RLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQ 622
+ A ++ AL+YLH I++ DLKP NILLD++ K+ DFG A+ + +
Sbjct: 108 AKFYAA-EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
T+ L G+ YI PE + + + D +SFG+++ E+ G +P
Sbjct: 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKV--LDIESTGTWKSFFAECEALRNTRHRN 512
+ IG G++G+V+K RE VA+K LD + G S E L+ +H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 513 LVKLITSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
+V+L D + + L LV+EF + L + L+ + +
Sbjct: 63 IVRL------HDVLHSDKKLTLVFEFC-DQDLKKYFD-----SCNGDLDPEIVKSFLFQL 110
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
L + H+ ++H DLKP N+L++ + K+ +FGLAR+ G S V+
Sbjct: 111 LKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA----FGIPVRCYSAEVV 163
Query: 632 KGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSP 670
++ Y PP+ G K ST+ D++S G + E+ P
Sbjct: 164 --TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 70/329 (21%), Positives = 117/329 (35%), Gaps = 74/329 (22%)
Query: 452 RATGNFSHENLIGSGSFGSVYKG--YLREGISVAVKV--LDIESTGTWKSFFAECEALR- 506
RA + IG G++G V+K G VA+K + G +R
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIRE 61
Query: 507 --------NTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNG 558
H N+V+L C+ L LV+E + + L ++ G
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL----DKVPEPG 116
Query: 559 LNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618
+ ++ + LD+LH+ +VH DLKP NIL+ K+ DFGLAR
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--- 170
Query: 619 IGNQSSISSTH-VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGM--------- 668
++ T V+ ++ Y PE L +T D++S G + E+F
Sbjct: 171 ---SFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 225
Query: 669 -----------SPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHD 717
P E + +V+L + F + Q +++ + + + L
Sbjct: 226 DQLGKILDVIGLPGEEDWPRDVALPRQ---AFHSKSAQPIEKFVTDI----DELGKDLLL 278
Query: 718 CLITIIESVGLSCTTESPGGRIDIREALR 746
+T +P RI AL
Sbjct: 279 KCLTF-----------NPAKRISAYSALS 296
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 45/236 (19%)
Query: 451 RRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVK-VLDIESTGTWKSF----FAECEA 504
R+ F E + G G+FG+V G + G+SVA+K V+ F +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------PRFRNRELQIMQD 72
Query: 505 LRNTRHRNLVKL---ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNF 561
L H N+V+L + D +++ +L +V E++ + +L +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDI-YLNVVMEYVPD-TLHRCCRNYYRR-------- 122
Query: 562 LERLNIAID--------IASALDYLHNDCEVPIVHCDLKPGNILLD-EDMTAKVGDFGLA 612
++ + ++ LH V + H D+KP N+L++ D T K+ DFG A
Sbjct: 123 --QVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179
Query: 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTG 667
+ L N + I S + Y PE G + +TA D++S G + E+ G
Sbjct: 180 KKLSPSEPNVAYICSRY-------YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 74/315 (23%), Positives = 128/315 (40%), Gaps = 60/315 (19%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNL 513
+ + +G G++ +VYKG + VA+K + +E G + E L++ +H N+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 514 VKLITSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
V L D + L LV+E+L + L ++ + GN +N +
Sbjct: 63 VTL------HDIIHTEKSLTLVFEYL-DKDLKQYLD-----DCGNIINMHNVKLFLFQLL 110
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L Y H ++H DLKP N+L++E K+ DFGLAR+ + V+
Sbjct: 111 RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYDNEVV- 162
Query: 633 GSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM--------------------SPT 671
++ Y PP+ LG ST D++ G + E+ TG +PT
Sbjct: 163 -TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221
Query: 672 HESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCT 731
E++ G +S ++ N+PK + L +L +S L L+
Sbjct: 222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRL----DSDGADLLTKLLQF--------- 268
Query: 732 TESPGGRIDIREALR 746
RI +A++
Sbjct: 269 --EGRNRISAEDAMK 281
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 24/164 (14%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVL-DIESTGTWKSFFAECEAL-RNTRHRNLVKLITS 519
+G G G V + + + A+K+L D E E R ++ ++V+++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------EVELHWRASQCPHIVRIVDV 79
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER--LNIAIDIASALDY 577
+L L +V E L G L I +R ++ F ER I I A+ Y
Sbjct: 80 YENLYAGRKCLL-IVMECLDGGELFSRIQ-DRGDQA-----FTEREASEIMKSIGEAIQY 132
Query: 578 LHNDCEVPIVHCDLKPGNILL---DEDMTAKVGDFGLARSLLER 618
LH + I H D+KP N+L + K+ DFG A+
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 61/330 (18%), Positives = 107/330 (32%), Gaps = 96/330 (29%)
Query: 457 FSHENL-----IGSGSFGSVYKGYL------REGISVAVKVL-DIESTGTWKSFFAECEA 504
F + L +G G+FG V + +VAVK+L + + ++ +E +
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78
Query: 505 LRN--------------TRHRNLVKLITSC------------------------------ 520
L + T+ + +I
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138
Query: 521 ------------SSLDFKNMEFLALVYEFLGNGSLGDWIHGER-KNEHGNGLNFLERLNI 567
LD + F+ SL D E ++ + + L +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
+ +A +++L +H DL NILL E K+ DFGLAR + +
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK---------D 246
Query: 628 THVLKGSIGYIP-----PEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSL 681
++ +P PE + DV+SFGV+L EIF+ G SP + +
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEF 305
Query: 682 VKWVESNF----PKNAQQVLDRELRQLMMS 707
+ ++ P E+ Q M+
Sbjct: 306 CRRLKEGTRMRAPDYTTP----EMYQTMLD 331
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 57/234 (24%), Positives = 103/234 (44%), Gaps = 46/234 (19%)
Query: 456 NFSHENLIGSGSFGSVY---KGYLREGISV-AVKVL----------DIESTGTWKSFFAE 501
NF ++G+G++G V+ K + + A+KVL E T T +
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 502 CEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNF 561
+ LV L + F+ L L+ +++ G L + + F
Sbjct: 115 IR-----QSPFLVTLHYA-----FQTETKLHLILDYINGGELFTHLSQRER--------F 156
Query: 562 LE---RLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618
E ++ + +I AL++LH ++ I++ D+K NILLD + + DFGL++ E
Sbjct: 157 TEHEVQIYVG-EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EF 209
Query: 619 IGNQSSISSTHVLKGSIGYIPPEYGLGEKP--STAGDVYSFGVMLLEIFTGMSP 670
+ +++ + G+I Y+ P+ G A D +S GV++ E+ TG SP
Sbjct: 210 VADETERAYD--FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 62/319 (19%), Positives = 104/319 (32%), Gaps = 80/319 (25%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVK--VLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
IG GS+G V+K R+ G VA+K + + K E L+ +H NLV L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL--- 67
Query: 520 CSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA------ 572
L+ F+ L LV+E+ +H L+ L+R +
Sbjct: 68 ---LEVFRRKRRLHLVFEYC---------------DH-TVLHELDRYQRGVPEHLVKSIT 108
Query: 573 ----SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
A+++ H +H D+KP NIL+ + K+ DFG AR + S
Sbjct: 109 WQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARL----LTGPSDYYDD 161
Query: 629 HVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM------------------- 668
V + Y PE +G+ DV++ G + E+ +G+
Sbjct: 162 EVA--TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219
Query: 669 -SPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVG 727
+ + P L + + L + +
Sbjct: 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDM---EPLELKFPNISYPALGLLKGCLHM----- 271
Query: 728 LSCTTESPGGRIDIREALR 746
P R+ + L
Sbjct: 272 ------DPTERLTCEQLLH 284
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 57/218 (26%), Positives = 83/218 (38%), Gaps = 40/218 (18%)
Query: 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNL 513
+ IGSG+FG + VAVK ++ ++ E R+ RH N+
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNI 78
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWI--HGERKNEHGNGLNFLERLNIAIDI 571
V+ + LA++ E+ G L + I G R +E E +
Sbjct: 79 VRFKEVILT---PTH--LAIIMEYASGGELYERICNAG-RFSED-------EARFFFQQL 125
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA--KVGDFGLARSLLERIGNQSSISSTH 629
S + Y H+ I H DLK N LLD K+ DFG S + +Q
Sbjct: 126 LSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGY--SKSSVLHSQ------- 173
Query: 630 VLK---GSIGYIPPEYGLGEK---PSTAGDVYSFGVML 661
K G+ YI PE L ++ DV+S GV L
Sbjct: 174 -PKSTVGTPAYIAPEVLLRQEYDGKIA--DVWSCGVTL 208
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 59/223 (26%), Positives = 88/223 (39%), Gaps = 40/223 (17%)
Query: 463 IGSGSFGSVYKGYLREGISVAVK-VLDIESTGTWKSFFA----------ECEALRNTRHR 511
I SGS+G+V G EGI VA+K V + S G + + E L + H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK---NEHGNGLNFLERLNIA 568
N++ L + M L LV E + L IH +R +H + +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH---IQY-----FM 140
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
I L LH +VH DL PGNILL ++ + DF LAR ++
Sbjct: 141 YHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAR----------EDTAD 187
Query: 629 HVLKGSIG---YIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
+ Y PE + K + D++S G ++ E+F
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 58/240 (24%), Positives = 93/240 (38%), Gaps = 46/240 (19%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFA----ECEALRNTRHR----- 511
+G G+FG V + AVKV + + K + E + L+ ++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKV--VRNI---KKYTRSAKIEADILKKIQNDDINNN 96
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
N+VK + + + L++E LG SL + I + NG + + I+I
Sbjct: 97 NIVKYH---GKFMYYD--HMCLIFEPLGP-SLYEII----TRNNYNGFHIEDIKLYCIEI 146
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL----LERIGNQSSI-- 625
AL+YL ++ + H DLKP NILLD+ K + + I
Sbjct: 147 LKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 626 ----SSTHVLKGSIGYI------PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMS--PTHE 673
+T I PE L + D++SFG +L E++TG THE
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 52/238 (21%), Positives = 90/238 (37%), Gaps = 46/238 (19%)
Query: 462 LIGSGSFGSVYKGY--LREGISVAVKVLDIESTGTWKSFFA----ECEALRNTRHR---- 511
+G G+FG V + R VA+K+ I + + E L+ + +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKI--IRNV---GKYREAARLEINVLKKIKEKDKEN 80
Query: 512 --NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
V + +F + + +E LG + +++ K + ++A
Sbjct: 81 KFLCVLMS---DWFNFHG--HMCIAFELLGK-NTFEFL----KENNFQPYPLPHVRHMAY 130
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSI---- 625
+ AL +LH E + H DLKP NIL + + +S E+ +SI
Sbjct: 131 QLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNE--HKSCEEKSVKNTSIRVAD 185
Query: 626 --SSTHVLKGSIGYI------PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMS--PTHE 673
S+T + + PPE L + DV+S G +L E + G + THE
Sbjct: 186 FGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 68/336 (20%), Positives = 118/336 (35%), Gaps = 79/336 (23%)
Query: 462 LIGSGSFGSVYKGY--LREGISVAVKVLDIESTGTWKSFFA----ECEALRNTRHR---- 511
+G G+FG V + G VAVK+ +++ + E + L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKI--VKNV---DRYCEAARSEIQVLEHLNTTDPNS 75
Query: 512 --NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
V+++ + + +V+E LG S D+I K +A
Sbjct: 76 TFRCVQML---EWFEHHG--HICIVFELLGL-STYDFI----KENGFLPFRLDHIRKMAY 125
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSI---- 625
I ++++LH + H DLKP NIL + + + + R ER I
Sbjct: 126 QICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD--ERTLINPDIKVVD 180
Query: 626 --SSTHVLKGSIGYI------PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMS--PTHE-- 673
S+T+ + + PE L S DV+S G +L+E + G + PTH+
Sbjct: 181 FGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 674 ---------------SFAGEVSLVK--------WVESNFPKNAQQVLDRELRQLMMSSES 710
+ K W E + + L++ M+S +
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300
Query: 711 QTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
+ +L D + P RI +REAL+
Sbjct: 301 EHERLFDLI--------QKMLEYDPAKRITLREALK 328
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDI-ESTGTWKSFFAECEALRNTRHRNLVKLITSC 520
+G G++G V + G VA+K ++ + E + L++ +H N++ +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGER-KNEHGNGLNFLERLNIAIDIASALDYLH 579
F+N + ++ E + L I + ++H + + A+ LH
Sbjct: 79 RPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDH---IQY-----FIYQTLRAVKVLH 129
Query: 580 --NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL-LERIGNQSSISSTHVLKGSIG 636
N ++H DLKP N+L++ + KV DFGLAR + N + +
Sbjct: 130 GSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 637 ---YIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
Y PE L S A DV+S G +L E+F
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 50/246 (20%), Positives = 98/246 (39%), Gaps = 49/246 (19%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLV 514
+S +G+GSFG V + + E G A+K + + E + ++ H N++
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK----NRELDIMKVLDHVNII 63
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID---- 570
KL+ + + + + G + ++ K+ N LN+ ++
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY-LNVIMEYVPD 122
Query: 571 ---------------------------IASALDYLHNDCEVPIVHCDLKPGNILLD-EDM 602
+ A+ ++H+ + I H D+KP N+L++ +D
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDN 179
Query: 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVML 661
T K+ DFG A+ L+ + + I S Y PE LG + + + D++S G +
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRF-------YRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 662 LEIFTG 667
E+ G
Sbjct: 233 GELILG 238
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 67/325 (20%), Positives = 128/325 (39%), Gaps = 67/325 (20%)
Query: 452 RATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKV--LDIESTGTWKSFFAECEALRNT 508
+ + +G G++G VYK +VA+K L+ E G + E L+
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 509 RHRNLVKLITSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI 567
+HRN+++L + L L++E+ L ++ + ++ +
Sbjct: 91 QHRNIIEL------KSVIHHNHRLHLIFEYA-ENDLKKYM------DKNPDVSMRVIKSF 137
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA-----KVGDFGLARSLLERIGNQ 622
+ + +++ H+ +H DLKP N+LL + K+GDFGLAR+ G
Sbjct: 138 LYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA----FGIP 190
Query: 623 SSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM------------- 668
+ ++ ++ Y PPE LG + ST+ D++S + E+
Sbjct: 191 IRQFTHEII--TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248
Query: 669 -------SPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLIT 721
P ++ G V+ + + +FPK + L R L L+ + + + L ++
Sbjct: 249 KIFEVLGLPDDTTWPG-VTALPDWKQSFPKFRGKTLKRVLGALL---DDEGLDLLTAMLE 304
Query: 722 IIESVGLSCTTESPGGRIDIREALR 746
+ P RI + AL
Sbjct: 305 M-----------DPVKRISAKNALE 318
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 59/285 (20%), Positives = 100/285 (35%), Gaps = 46/285 (16%)
Query: 456 NFSHENLIGSGSFGSVYKGY-LREGISVAVK-VLDI-ESTGTWKSFFAECEALRNTRHRN 512
+ +LIG+GS+G V + Y E VA+K +L + E K E L H +
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK--NEHGNGLNFLERLNIAID 570
+VK++ D + + L +V E + H + +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELH--------IKTLLYN 164
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
+ + Y+H I+H DLKP N L+++D + KV DFGLAR++ S + +
Sbjct: 165 LLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 631 LKGSIG---------------------YIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGM 668
Y PE L ++ + A DV+S G + E+ +
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281
Query: 669 SPTHES-------FAGEVSLVKWVESNFPKNAQQVLDRELRQLMM 706
F G + + + QL +
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNV 326
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 7/181 (3%)
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
+ LDL N++S L KL + L+ N+L + F +NL ++ +++NKL
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ 98
Query: 240 GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEI-GMLGNVVTIDLSANGLSGNLP-NSFKN 297
+P + + L +N L +LP + L + + L N L +LP F
Sbjct: 99 -ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 298 CKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDL-QNLRALRSLNLTF 356
SL++L + NN+ +L L+ L L +N+L +P +L L+ L L
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQE 214
Query: 357 N 357
N
Sbjct: 215 N 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 47/208 (22%), Positives = 81/208 (38%), Gaps = 47/208 (22%)
Query: 37 NKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLS 96
NK + + H LT ++++ + N L+ T+P G+ F +
Sbjct: 47 NKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI------------FKE---------- 83
Query: 97 FITSLTNSTRLNFLAFDGNQFEGEIPESI-GNLSNVLSKLYMGGNRFYGKIPTSI-GRLR 154
L N L L N+ + +P + L N L++L + N+ +P + L
Sbjct: 84 ----LKN---LETLWVTDNKLQ-ALPIGVFDQLVN-LAELRLDRNQL-KSLPPRVFDSLT 133
Query: 155 SLTLLNLSYNSISGEILTEI-----GQLQELQSLDLAGNQISGSIP-NTLGNLKKLNQID 208
LT L+L YN L + +L L+ L L NQ+ +P L +L +
Sbjct: 134 KLTYLSLGYNE-----LQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLK 187
Query: 209 LSGNELASEIPTSFGNFQNLLSIDLSNN 236
L N+L +F + + L + L N
Sbjct: 188 LDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 18/151 (11%)
Query: 227 NLLSIDLSNNKLN---GNIPK--EILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTID 281
N S+D S+ KL NIP + L L S + +L L + +
Sbjct: 17 NKNSVDCSSKKLTAIPSNIPADTKKLDLQS-NKLSSLPSKAFHR--------LTKLRLLY 67
Query: 282 LSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPS 341
L+ N L FK K+LE L + +NK + +L L L L N+L S+P
Sbjct: 68 LNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPP 126
Query: 342 DL-QNLRALRSLNLTFNNLEGVVPREGIFRH 371
+ +L L L+L +N L+ +P +G+F
Sbjct: 127 RVFDSLTKLTYLSLGYNELQ-SLP-KGVFDK 155
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 35/150 (23%), Positives = 61/150 (40%), Gaps = 28/150 (18%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIP-GSLHNLTNIQIIRMA 59
+ +L L + N+L +P V D+L NL N+ +P +LT + + +
Sbjct: 84 LKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLG 141
Query: 60 HNLLEGTVPPG----LGNLPFLKMYNIGFNKIVGSGDEGLSFITSL-----TNSTRLNFL 110
+N L+ ++P G L +L L++YN N+ + + T L L
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYN---NQ-----------LKRVPEGAFDKLTELKTL 186
Query: 111 AFDGNQFEGEIPESIGNLSNVLSKLYMGGN 140
D NQ + +PE + L L + N
Sbjct: 187 KLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 16/113 (14%)
Query: 275 GNVVTIDLSANGLS---GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLS 331
N ++D S+ L+ N+P +KL + +NK S L L +L L+
Sbjct: 16 NNKNSVDCSSKKLTAIPSNIPAD------TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69
Query: 332 SNKLSGSIPSDL-QNLRALRSLNLTFNNLEGVVPREGIFRH---TSMVHLEGN 380
NKL ++P+ + + L+ L +L +T N L+ +P G+F + + L+ N
Sbjct: 70 DNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALP-IGVFDQLVNLAELRLDRN 119
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 62/287 (21%), Positives = 103/287 (35%), Gaps = 45/287 (15%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVK-VLDI-ESTGTWKSFFAECEALRNTRHRNLVKLITS 519
IG GS+G VY Y + +VA+K V + E K E L + +++L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK--NEHGNGLNFLERLNIAIDIASALDY 577
D + L +V E + L EH + I ++ ++
Sbjct: 94 IIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEH---IKT-----ILYNLLLGENF 144
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIG- 636
+H E I+H DLKP N LL++D + KV DFGLAR++ +
Sbjct: 145 IH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 637 ---------------YIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVS 680
Y PE L ++ + + D++S G + E+ +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
Query: 681 LVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVG 727
L FP ++ L + + +S QL+ I +G
Sbjct: 262 L-------FPGSSCFPLSPDRNSKKVHEKSNRDQLN----IIFNIIG 297
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 49/186 (26%), Positives = 77/186 (41%), Gaps = 33/186 (17%)
Query: 179 ELQSLDLAGNQISGSIPNT-LGNLKKLNQIDLSGNELASEIPT-SFGNFQNLLSIDLSNN 236
LDL+ N +S L L+ + LS N L + I + +F NL +DLS+N
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSN 98
Query: 237 KLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSF 295
L+ + + + S L +L + L N + N+F
Sbjct: 99 HLH-TLDEFLFSDLQALEVL-------------------------LLYNNHIVVVDRNAF 132
Query: 296 KNCKSLEKLLMANNKFSGPIPNI---LAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSL 352
++ L+KL ++ N+ S + +L L +LDLSSNKL +DLQ L A
Sbjct: 133 EDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN 192
Query: 353 NLTFNN 358
L +N
Sbjct: 193 GLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 40/179 (22%), Positives = 76/179 (42%), Gaps = 19/179 (10%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIP--TSIGRLRSLTLLNLSYNSISGEILTEI-GQ 176
+P+ +L + + L + N ++ + RL +L L LS+N ++ I +E
Sbjct: 32 NVPQ---SLPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVP 86
Query: 177 LQELQSLDLAGNQISGSIP-NTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSN 235
+ L+ LDL+ N + ++ +L+ L + L N + +F + L + LS
Sbjct: 87 VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ 145
Query: 236 NKLNGNIPKEIL----SLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGN 290
N+++ P E++ L L + +LS N L ++ L V L L N
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLL-DLSSNKLKKLPLTDLQKLPAWVKNGLY---LHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 28/110 (25%), Positives = 45/110 (40%), Gaps = 8/110 (7%)
Query: 276 NVVTIDLSANGLSGNLPN-SFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNK 334
+DLS N LS + +L LL+++N + + L LDLSSN
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
Query: 335 LSGSIPSD-LQNLRALRSLNLTFNNLEGVVPREGIFRHTSM---VHLEGN 380
L ++ +L+AL L L N++ V F + ++L N
Sbjct: 100 LH-TLDEFLFSDLQALEVLLLYNNHIVVV--DRNAFEDMAQLQKLYLSQN 146
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 32/178 (17%), Positives = 58/178 (32%), Gaps = 46/178 (25%)
Query: 45 GSLHNLTNIQIIRMAHNLLEGTVPPG----LGNLPFLKMYNIGFNKIVGSGDEGLSFITS 100
+ LTN+ + ++HN L + + NL +L + + N +
Sbjct: 58 WTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS---NHL------------- 100
Query: 101 LTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLL 159
L+ F L L L + N + + + L L
Sbjct: 101 ----HTLDEFLFSD-------------LQA-LEVLLLYNNHI-VVVDRNAFEDMAQLQKL 141
Query: 160 NLSYN---SISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQ--IDLSGN 212
LS N E++ + +L +L LDL+ N++ L L + + L N
Sbjct: 142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 27/144 (18%), Positives = 53/144 (36%), Gaps = 7/144 (4%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+T+L L L+ N L I + +PNL + N +L ++++ + +
Sbjct: 63 LTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYN 121
Query: 61 NLLEGTVPPG-LGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG 119
N + V ++ L+ + N+I E + L +L L N+ +
Sbjct: 122 NHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKL---PKLMLLDLSSNKLKK 177
Query: 120 EIPESIGNLSN-VLSKLYMGGNRF 142
+ L V + LY+ N
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-15
Identities = 50/328 (15%), Positives = 110/328 (33%), Gaps = 55/328 (16%)
Query: 81 NIGFNKIVGSGDEGLSFITS-LTNSTRLNFLAFDGNQFEGE----IPESIGNLSNVLSKL 135
++ + G ++S L L L N + E + + L KL
Sbjct: 91 SLQNCCL---TGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKL 147
Query: 136 YMGGNRFYGKIPTSIGRL----RSLTLLNLSYNSISGEILTEIGQLQE-----LQSLDLA 186
+ + + L +S N I+ + + Q + L++L L
Sbjct: 148 QLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLE 207
Query: 187 GNQIS----GSIPNTLGNLKKLNQIDLSGNELASE-----IPTSFGNFQNLLSIDLSNNK 237
++ + + + L ++ L N+L P L ++ +
Sbjct: 208 SCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267
Query: 238 LN----GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVV--------TIDLSAN 285
+ G++ + + + SL + +L+ N L E +L + ++ + +
Sbjct: 268 ITAKGCGDLCRVLRAKESLKEL-SLAGNELG---DEGARLLCETLLEPGCQLESLWVKSC 323
Query: 286 GLSG----NLPNSFKNCKSLEKLLMANNKFSGPIPNILAEL-----KGLEVLDLSSNKLS 336
+ + + + L +L ++NN+ L + L VL L+ +S
Sbjct: 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383
Query: 337 ----GSIPSDLQNLRALRSLNLTFNNLE 360
S+ + L +LR L+L+ N L
Sbjct: 384 DSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-10
Identities = 52/321 (16%), Positives = 104/321 (32%), Gaps = 47/321 (14%)
Query: 77 LKMYNIGFNKIVGSGDEGLSFITS-LTNSTRLNFLAFDGNQFEGE----IPESIGNLSNV 131
L+ + + + + S L L N + + + +
Sbjct: 144 LEKLQLEYCSL---SAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQ 200
Query: 132 LSKLYMGGNRF----YGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE-----LQS 182
L L + + + SL L L N + + E+ L++
Sbjct: 201 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT 260
Query: 183 LDLAGNQIS----GSIPNTLGNLKKLNQIDLSGNEL----ASEIPTSFGNFQ-NLLSIDL 233
L + I+ G + L + L ++ L+GNEL A + + L S+ +
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320
Query: 234 SNNKLNGNIPKEILS-LSSLTTI--VNLSKNFLDGTLPEEIG-MLGNV----VTIDLSAN 285
+ S L+ + + +S N L+ E+ LG + L+
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380
Query: 286 GLS----GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAE-LK----GLEVLDLSSNKLS 336
+S +L + SL +L ++NN L E ++ LE L L S
Sbjct: 381 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
Query: 337 ----GSIPSDLQNLRALRSLN 353
+ + ++ +LR ++
Sbjct: 441 EEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 29/152 (19%), Positives = 56/152 (36%), Gaps = 18/152 (11%)
Query: 226 QNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGT----LPEEIGMLGNVVTID 281
++ S+D+ +L+ E+L L +V L L + + + + ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 282 LSANGLSGN----LPNSFKNCK-SLEKLLMANNKFS----GPIPNILAELKGLEVLDLSS 332
L +N L + + ++KL + N + G + + L L L+ L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 333 NKLSGS-----IPSDLQNLRALRSLNLTFNNL 359
N L + L L L L + +L
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL 154
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 6e-05
Identities = 40/232 (17%), Positives = 73/232 (31%), Gaps = 30/232 (12%)
Query: 2 TSLVYLGLASNQLWGE----IPYDVGDKLPNLLGFNFCFNKFTGK----IPGSLHNLTNI 53
SL L L SN+L + + L T K + L ++
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286
Query: 54 QIIRMAHNLLEGTVPPGLGNL-----PFLKMYNIGFNKIVGSGDEGLSFITS-LTNSTRL 107
+ + +A N L L L+ + S +S L + L
Sbjct: 287 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF---TAACCSHFSSVLAQNRFL 343
Query: 108 NFLAFDGNQFEGE----IPESIGNLSNVLSKLYMGGNRF----YGKIPTSIGRLRSLTLL 159
L N+ E + + +G +VL L++ + ++ SL L
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403
Query: 160 NLSYNSISGEILTEIGQLQE-----LQSLDLAGNQISGSIPNTLGNLKKLNQ 206
+LS N + + ++ + L+ L L S + + L L+K
Sbjct: 404 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKP 455
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 31/222 (13%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD-IESTGTWKSFFAECEALRNTRHRNL 513
+++ + IG G++G V Y + VA+K + E + E + L RH N+
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER-KNEHGNGLNFLERLNIAIDIA 572
+ + + + M+ + +V + + L + + N+H + + I
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDH---ICY-----FLYQIL 138
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L Y+H+ ++H DLKP N+LL+ K+ DFGLAR + ++
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT------ 189
Query: 633 GSIGYI------PPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
Y+ PE L K + + D++S G +L E+ +
Sbjct: 190 ---EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 42/225 (18%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVK-VLDI-ESTGTWKSFFAECEALRNTRHRN 512
+ +GSG++GSV + G VA+K + +S K + E L++ +H N
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 513 LVKL---ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
++ L T SSL N LV F+ L + + E + + +
Sbjct: 85 VIGLLDVFTPASSLR--NFYDFYLVMPFMQT-DLQKIMGLKFSEEK---IQY-----LVY 133
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
+ L Y+H+ +VH DLKPGN+ ++ED K+ DFGLAR + T
Sbjct: 134 QMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--------T- 181
Query: 630 VLKGSIGYI------PPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
GY+ PE L + D++S G ++ E+ TG
Sbjct: 182 ------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 51/238 (21%)
Query: 449 ELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFA-----EC 502
+++ + + +G G F +VYK + VA+K + + K E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 503 EALRNTRHRNLVKLITSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGL-N 560
+ L+ H N++ L LD F + ++LV++F+ E L
Sbjct: 64 KLLQELSHPNIIGL------LDAFGHKSNISLVFDFM---------------ETD--LEV 100
Query: 561 FLERLNIAIDIA----------SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610
++ ++ + + L+YLH I+H DLKP N+LLDE+ K+ DFG
Sbjct: 101 IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157
Query: 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
LA+S G+ + + V+ + Y PE G + D+++ G +L E+
Sbjct: 158 LAKS----FGSPNRAYTHQVV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 40/254 (15%), Positives = 84/254 (33%), Gaps = 49/254 (19%)
Query: 154 RSLTLLNLSYNSISGE----ILTEIGQLQELQSLDLAGNQISG----SIPNTLGNLKKLN 205
S+ +L ++I+ E + + + ++ + L+GN I + + + K L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 206 QIDLSGNEL----------ASEIPTSFGNFQNLLSIDLSNNKLNGN----IPKEILSLSS 251
+ S + + L ++ LS+N + + +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 252 LTTIVNLSKNFL-------------DGTLPEEIGMLGNVVTIDLSANGLSGN----LPNS 294
L + L N L + + ++ + +I N L +
Sbjct: 124 LEHL-YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182
Query: 295 FKNCKSLEKLLMANNKF-----SGPIPNILAELKGLEVLDLSSNKLSG----SIPSDLQN 345
F++ + L + M N + LA + L+VLDL N + ++ L++
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 346 LRALRSLNLTFNNL 359
LR L L L
Sbjct: 243 WPNLRELGLNDCLL 256
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 53/332 (15%), Positives = 94/332 (28%), Gaps = 85/332 (25%)
Query: 70 GLGNLPFLKMYNIGFNKIVGSGDEGLSFI----TSLTNSTRLNFLAFDGNQFEGEIPESI 125
L +K + N I G E ++ S + F + + EIPE++
Sbjct: 27 VLLEDDSVKEIVLSGNTI---GTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 126 GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQL----QELQ 181
L L K L + LS N+ + L+
Sbjct: 84 RLLLQALLKC------------------PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 182 SLDLAGNQIS-------------GSIPNTLGNLKKLNQIDLSGNEL----ASEIPTSFGN 224
L L N + ++ N L I N L E +F +
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 225 FQNLLSIDLSNNKLNGNIPKEILS--LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDL 282
+ L ++ + N + + +L L+ + L DL
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVL----------------------DL 223
Query: 283 SANGLSGN----LPNSFKNCKSLEKLLMANNKFSGPIPNILAEL------KGLEVLDLSS 332
N + L + K+ +L +L + + S + + GL+ L L
Sbjct: 224 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 283
Query: 333 NKLSGSIPSDL-----QNLRALRSLNLTFNNL 359
N++ L + + L L L N
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 29/171 (16%), Positives = 53/171 (30%), Gaps = 27/171 (15%)
Query: 70 GLGNLPFLKMYNIGFNKIVGSGDEGLSFI--TSLTNSTRLNFLAFDGNQF--EG--EIPE 123
+ L + N I EG+ + L L L N F G +
Sbjct: 182 TFQSHRLLHTVKMVQNGI---RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238
Query: 124 SIGNLSNVLSKLYMGGNRFYGKIPTSIGRL------RSLTLLNLSYNSISGEILTEIGQ- 176
++ + N L +L + + ++ L L L YN I + + +
Sbjct: 239 ALKSWPN-LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297
Query: 177 ----LQELQSLDLAGNQIS------GSIPNTLGNLKKLNQIDLSGNELASE 217
+ +L L+L GN+ S I + +L E ++
Sbjct: 298 IDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTD 348
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 47/230 (20%), Positives = 88/230 (38%), Gaps = 40/230 (17%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVK 515
+ +G G G V+ + VA+K + + + K E + +R H N+VK
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 516 LI---------TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER-KNEHGNGLNFLERL 565
+ + + + +V E++ L + + EH
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEH---ARL---- 124
Query: 566 NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD-EDMTAKVGDFGLARSLLERIGNQSS 624
+ L Y+H+ ++H DLKP N+ ++ ED+ K+GDFGLAR + ++
Sbjct: 125 -FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 625 ISSTHVLKGSIGYI------PPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
+S + P L + A D+++ G + E+ TG
Sbjct: 181 LS---------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 55/262 (20%), Positives = 90/262 (34%), Gaps = 74/262 (28%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALR-----NTRHRNLVKL 516
+G G F +V+ + ++ VA+KV+ T ++ E L+ + N +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 517 ITSCSSLDFK--NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
+ N + +V+E LG+ L WI + N G L +++ I +
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWI--IKSNYQGLPLPCVKK--IIQQVLQG 158
Query: 575 LDYLHNDCEVPIVHCDLKPGNILL------------------------------------ 598
LDYLH C I+H D+KP NILL
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 599 -------------DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG 645
E + K+ D G A + + I + Y E +G
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQ-------YRSLEVLIG 267
Query: 646 EKPSTAGDVYSFGVMLLEIFTG 667
+T D++S M E+ TG
Sbjct: 268 SGYNTPADIWSTACMAFELATG 289
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 31/129 (24%), Positives = 57/129 (44%), Gaps = 14/129 (10%)
Query: 134 KLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI-----GQLQELQSLDLAGN 188
++ + N P + + L ++LS N ++E+ L+ L SL L GN
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQ-----ISELAPDAFQGLRSLNSLVLYGN 90
Query: 189 QISGSIP-NTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL 247
+I+ +P + L L + L+ N++ +F + NL + L +NKL I K
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF 148
Query: 248 -SLSSLTTI 255
L ++ T+
Sbjct: 149 SPLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 35/154 (22%), Positives = 64/154 (41%), Gaps = 27/154 (17%)
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
+ L N I P KKL +IDLS N+++ P +F ++L S+ L NK+
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 241 NIPKEIL-SLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCK 299
+PK + L SL + L+AN ++ ++F++
Sbjct: 94 ELPKSLFEGLFSLQ-------------------------LLLLNANKINCLRVDAFQDLH 128
Query: 300 SLEKLLMANNKFSGPIPNILAELKGLEVLDLSSN 333
+L L + +NK + L+ ++ + L+ N
Sbjct: 129 NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 39/150 (26%), Positives = 68/150 (45%), Gaps = 18/150 (12%)
Query: 241 NIPK--EILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNC 298
N+P+ + L TI + + IDLS N +S P++F+
Sbjct: 29 NLPETITEIRLEQ-NTIKVIPPGAFSP--------YKKLRRIDLSNNQISELAPDAFQGL 79
Query: 299 KSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDL-QNLRALRSLNLTFN 357
+SL L++ NK + ++ L L++L L++NK++ + D Q+L L L+L N
Sbjct: 80 RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138
Query: 358 NLEGVVPREGIFRHT---SMVHLEGNPKLC 384
L+ + +G F +HL NP +C
Sbjct: 139 KLQTIA--KGTFSPLRAIQTMHLAQNPFIC 166
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 19/102 (18%), Positives = 40/102 (39%), Gaps = 3/102 (2%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
L + L++NQ+ E+ D L +L NK T L ++Q++ + N
Sbjct: 56 KKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNAN 114
Query: 62 LLEGTVPPGL-GNLPFLKMYNIGFNKIVGSGDEGLSFITSLT 102
+ + +L L + ++ NK+ S + ++
Sbjct: 115 KIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ 155
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 35/180 (19%), Positives = 61/180 (33%), Gaps = 61/180 (33%)
Query: 36 FNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGL 95
N PG+ ++ I +++N + + P
Sbjct: 41 QNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPD------------------------- 74
Query: 96 SFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLR 154
AF G L + L+ L + GN+ ++P S+ L
Sbjct: 75 ---------------AFQG-------------LRS-LNSLVLYGNKI-TELPKSLFEGLF 104
Query: 155 SLTLLNLSYNSISGEILTEIGQ-LQELQSLDLAGNQISGSIPN-TLGNLKKLNQIDLSGN 212
SL LL L+ N I+ + + Q L L L L N++ +I T L+ + + L+ N
Sbjct: 105 SLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 17/60 (28%), Positives = 25/60 (41%), Gaps = 1/60 (1%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
SL L L +N++ + D L NL + NK G+ L IQ + +A N
Sbjct: 104 FSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLD--IESTGTWKSFFAECEALRNTRHRNLVKL--- 516
+GSG++GSV + + G+ VAVK L +S K + E L++ +H N++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER-KNEHGNGLNFLERLNIAIDIASAL 575
T SL+ + LV +G L + + ++ ++H + F + I L
Sbjct: 97 FTPARSLE--EFNDVYLVTHLMGA-DLNNIVKCQKLTDDH---VQF-----LIYQILRGL 145
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
Y+H+ I+H DLKP N+ ++ED K+ DFGLAR + + +V +
Sbjct: 146 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-------TADEMTGYV--ATR 193
Query: 636 GYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
Y PE L + D++S G ++ E+ TG
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 56/236 (23%)
Query: 463 IGSGSFGSVYKGY-LREGISVAVK-VLDIESTGTWKSFFAECEALRNTR----------H 510
+G G++G V+K R G VAVK + D F +A R R H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDA--------FQNSTDAQRTFREIMILTELSGH 68
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER-KNEHGNGLNFLERLNIAI 569
N+V L+ + + ++ + LV++++ L I + H + +
Sbjct: 69 ENIVNLLNVLRADNDRD---VYLVFDYMET-DLHAVIRANILEPVH---KQY-----VVY 116
Query: 570 DIASALDYLH--NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
+ + YLH ++H D+KP NILL+ + KV DFGL+RS + ++I
Sbjct: 117 QLIKVIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 628 THVLKGSIG---------------YIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
+ Y PE LG + D++S G +L EI G
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVK-VLDI-ESTGTWKSFFAECEALRNTRHRNLVKL--- 516
+GSG++G+V G VA+K + +S K + E L++ RH N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER-KNEHGNGLNFLERLNIAIDIASAL 575
T +LD + LV F+G LG + E+ + + F + + L
Sbjct: 93 FTPDETLD--DFTDFYLVMPFMGT-DLGKLMKHEKLGEDR---IQF-----LVYQMLKGL 141
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
Y+H I+H DLKPGN+ ++ED K+ DFGLAR S + +V +
Sbjct: 142 RYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ-------ADSEMTGYV--VTR 189
Query: 636 GYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTG 667
Y PE L + D++S G ++ E+ TG
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 30/134 (22%), Positives = 55/134 (41%), Gaps = 12/134 (8%)
Query: 134 KLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNSISGEILTEIG---QLQELQSLDLAGNQ 189
+L + N F T I +L L +N S N I+ E G + + L N+
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD---IEEGAFEGASGVNEILLTSNR 92
Query: 190 ISGSIPN-TLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL- 247
+ ++ + L+ L + L N + SF ++ + L +N++ +
Sbjct: 93 LE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150
Query: 248 SLSSLTTIVNLSKN 261
+L SL+T+ NL N
Sbjct: 151 TLHSLSTL-NLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 12/157 (7%)
Query: 230 SIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEI-GMLGNVVTIDLSANGLS 288
++D SN KLN IP+ I T + L+ N I L + I+ S N ++
Sbjct: 15 TVDCSNQKLN-KIPEHI---PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 289 GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDL-QNLR 347
+F+ + ++L+ +N+ + L+ L+ L L SN+++ + +D L
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLS 129
Query: 348 ALRSLNLTFNNLEGVVPREGIFRH-TSMVH--LEGNP 381
++R L+L N + V P G F S+ L NP
Sbjct: 130 SVRLLSLYDNQITTVAP--GAFDTLHSLSTLNLLANP 164
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 32/149 (21%), Positives = 50/149 (33%), Gaps = 27/149 (18%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
L L +N+ + KLP L NF NK T G+ + + I + N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 62 LLEGTVPPG----LGNLPFLKMYNIGFNKIVGSGDEGLSFITSL-----TNSTRLNFLAF 112
LE V L +L L + + N+ IT + + + L+
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRS---NR-----------ITCVGNDSFIGLSSVRLLSL 136
Query: 113 DGNQFEGEIPESI-GNLSNVLSKLYMGGN 140
NQ + L + LS L + N
Sbjct: 137 YDNQIT-TVAPGAFDTLHS-LSTLNLLAN 163
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 56/332 (16%), Positives = 112/332 (33%), Gaps = 56/332 (16%)
Query: 81 NIGFNKIVGSGDEGLSFITS--LTNSTRLNFLAFDGNQFEGE----IPESIGNLSNVLSK 134
++ N + + + L GN + + + + + ++
Sbjct: 28 DLSLNNL---YSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTS 84
Query: 135 LYMGGNRFYGKIPTSIGRL-----RSLTLLNLSYNSISGEILTEIGQL-----QELQSLD 184
L + GN K + + ++T+L+L +N S + +E Q + SL+
Sbjct: 85 LNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLN 144
Query: 185 LAGNQISGSIPNTLGN-LKKLNQ----IDLSGNEL----ASEIPTSFGNF-QNLLSIDLS 234
L GN + + L L + ++L GN L +E+ + ++ S+DLS
Sbjct: 145 LRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLS 204
Query: 235 NNKLNGNIPKEILSL-----SSLTTIVNLSKNFLDGT----LPEEIGMLGNVVTIDLSAN 285
N L E+ + + + ++ NL N L G L L ++ T+ L +
Sbjct: 205 ANLLGLKSYAELAYIFSSIPNHVVSL-NLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYD 263
Query: 286 GLSG-------NLPNSFKNCKSLEKLLMANNKFSGPIPNILAEL-----KGLEVLDLSSN 333
+ L +F N + + + + ++ L +V L +
Sbjct: 264 IVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323
Query: 334 KLS-----GSIPSDLQNLRALRSLNLTFNNLE 360
L + DL LR T L
Sbjct: 324 CLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 55/321 (17%), Positives = 114/321 (35%), Gaps = 52/321 (16%)
Query: 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE----IPESIGNLSNVLSKLYMGGN 140
+ G + + + L N + ++ N ++ L + GN
Sbjct: 4 KLTLHPGSNPVE--EFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGN 61
Query: 141 RFYGKIPTSIGRL-----RSLTLLNLSYNSISGEILTEIGQL-----QELQSLDLAGNQI 190
K + ++ ++T LNLS N +S + E+ + + LDL N
Sbjct: 62 SLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121
Query: 191 SGSIPNTLGN-LKKLNQ----IDLSGNEL----ASEIPTSFGNFQ-NLLSIDLSNNKLNG 240
S + L ++L GN+L + E+ N+ S++L N L
Sbjct: 122 SSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181
Query: 241 NIPKEILSL-----SSLTTIVNLSKNFLDGTLPEEIGML-----GNVVTIDLSANGLSG- 289
E+ +S+T++ +LS N L E+ + +VV+++L N L G
Sbjct: 182 KNCAELAKFLASIPASVTSL-DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240
Query: 290 ---NLPNSFKNCKSLEKLLMANNKFSGP-------IPNILAELKGLEVLDLSSNKLSGSI 339
NL + K L+ + + + + ++ + ++D + ++
Sbjct: 241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH--- 297
Query: 340 PSDLQNL-RALRSLNLTFNNL 359
PS + +R L+ +
Sbjct: 298 PSHSIPISNLIRELSGKADVP 318
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-12
Identities = 30/107 (28%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 153 LRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212
++ L L N N E LT+ + +EL+ L ++ SI N L L KL +++LS N
Sbjct: 19 VKELVLDNSRSNEGKLEGLTD--EFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDN 74
Query: 213 ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLS 259
++ + NL ++LS NK+ I L L + +L
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLD 119
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-10
Identities = 22/94 (23%), Positives = 42/94 (44%), Gaps = 3/94 (3%)
Query: 144 GKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKK 203
GK+ L L+ ++ + + +L +L+ L+L+ N++SG +
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 204 LNQIDLSGNELAS-EIPTSFGNFQNLLSIDLSNN 236
L ++LSGN++ +NL S+DL N
Sbjct: 90 LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-09
Identities = 26/111 (23%), Positives = 49/111 (44%), Gaps = 3/111 (2%)
Query: 248 SLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMA 307
+ S + +V + +G L + + GL+ ++ N L+KL ++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 308 NNKFSGPIPNILAELKGLEVLDLSSNKLSG-SIPSDLQNLRALRSLNLTFN 357
+N+ SG + + + L L+LS NK+ S L+ L L+SL+L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 28/117 (23%), Positives = 47/117 (40%), Gaps = 5/117 (4%)
Query: 103 NSTRLNFLAFDGNQF-EGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNL 161
+ + L D ++ EG++ L L I ++ +L L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEE-LEFLSTINVGL-TSI-ANLPKLNKLKKLEL 71
Query: 162 SYNSISGEILTEIGQLQELQSLDLAGNQISG-SIPNTLGNLKKLNQIDLSGNELASE 217
S N +SG + + L L+L+GN+I S L L+ L +DL E+ +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNL 128
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-07
Identities = 31/133 (23%), Positives = 58/133 (43%), Gaps = 14/133 (10%)
Query: 276 NVVTIDLSANGLS-GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNK 334
+V + L + + G L + LE L N + I N L +L L+ L+LS N+
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IAN-LPKLNKLKKLELSDNR 75
Query: 335 LSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKL-CLHL-GCENS 392
+SG + + L LNL+ N ++ + +++ L+ L L L CE +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDL---------STIEPLKKLENLKSLDLFNCEVT 126
Query: 393 SSHGRRRIIIYII 405
+ + R + ++
Sbjct: 127 NLNDYRENVFKLL 139
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 49/220 (22%), Positives = 79/220 (35%), Gaps = 45/220 (20%)
Query: 463 IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLI-TS 519
+G G + V++ V VK+L K E + L N R N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS------ 573
+ ALV+E + N + L DI
Sbjct: 101 KDPVSRT----PALVFEHVNNTDFK---------------QLYQTLTDY-DIRFYMYEIL 140
Query: 574 -ALDYLHNDCEVPIVHCDLKPGNILLD-EDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
ALDY H + I+H D+KP N+++D E ++ D+GLA + + V
Sbjct: 141 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF-----YHPGQEYNVRV- 191
Query: 632 KGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSP 670
S + PE + + + D++S G ML + P
Sbjct: 192 -ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 3e-11
Identities = 34/205 (16%), Positives = 58/205 (28%), Gaps = 52/205 (25%)
Query: 453 ATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIEST--------GTWKSFFAECEA 504
T IG G FG V++ VA+K++ IE T++ E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 505 LR---------NTRHRNLVKLITSC-------------------------SSLDFKNMEF 530
+ R + L + DF +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCD 590
L +V EF G + + + + +I + ++L H D
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLA-------TAKSILHQLTASLAVAEASLR--FEHRD 187
Query: 591 LKPGNILLDEDMTAKVGDFGLARSL 615
L GN+LL + K+ +S
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSS 212
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 33/144 (22%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
E +S+ +L+ K+ ++ L++ L LS N+I E ++ + ++
Sbjct: 15 EERKSVVATEAEKVELHGMIPPI-EKMDATLSTLKACKHLALSTNNI--EKISSLSGMEN 71
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
L+ L L N I I N L ++ +S N++ + + + NL + +SNNK+
Sbjct: 72 LRILSLGRNLIK-KIENLDAVADTLEELWISYNQI-ASL-SGIEKLVNLRVLYMSNNKIT 128
Query: 240 GNIPKEILSLSSLT--TIVNLSKN 261
EI L++L + L+ N
Sbjct: 129 N--WGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 33/137 (24%), Positives = 59/137 (43%), Gaps = 16/137 (11%)
Query: 227 NLLSIDLSNNKLNGNIPKEILSLSSLT--TIVNLSKNFLDGTLPEEIGMLGNVVTIDLSA 284
++L I K +LS+L + LS N ++ + + N+ + L
Sbjct: 24 EAEKVELHGM--IPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGR 79
Query: 285 NGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNI--LAELKGLEVLDLSSNKLS--GSIP 340
N + + N +LE+L ++ N+ I ++ + +L L VL +S+NK++ G I
Sbjct: 80 NLIK-KIENLDAVADTLEELWISYNQ----IASLSGIEKLVNLRVLYMSNNKITNWGEI- 133
Query: 341 SDLQNLRALRSLNLTFN 357
L L L L L N
Sbjct: 134 DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 31/191 (16%), Positives = 72/191 (37%), Gaps = 48/191 (25%)
Query: 29 LLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIV 88
+ + K+ +L L + + ++ N +E L + L++ ++G N I
Sbjct: 27 KVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKIS--SLSGMENLRILSLGRNLI- 82
Query: 89 GSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPT 148
++ E++ +++ L +L++ N+ + +
Sbjct: 83 ----------------KKI---------------ENLDAVADTLEELWISYNQI-ASL-S 109
Query: 149 SIGRLRSLTLLNLSYNSISG-EILTEIGQLQELQSLDLAGNQISGSIPNT---------- 197
I +L +L +L +S N I+ + ++ L +L+ L LAGN +
Sbjct: 110 GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169
Query: 198 LGNLKKLNQID 208
+ L L ++D
Sbjct: 170 VKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 3/78 (3%)
Query: 303 KLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGV 362
+L + L+ LK + L LS+N + I S L + LR L+L N ++ +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKI 85
Query: 363 VPREGIFRHTSMVHLEGN 380
+ + + + N
Sbjct: 86 ENLDAVADTLEELWISYN 103
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-11
Identities = 36/130 (27%), Positives = 55/130 (42%), Gaps = 17/130 (13%)
Query: 134 KLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIG---QLQELQSLDLAGNQI 190
LY+ N+ P L +L L L N + +G L +L LDL NQ+
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA---LPVGVFDSLTQLTVLDLGTNQL 100
Query: 191 SGSIPN----TLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEI 246
+ +P+ L +LK+L + N+L +P +L + L N+L +IP
Sbjct: 101 T-VLPSAVFDRLVHLKEL---FMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHGA 154
Query: 247 L-SLSSLTTI 255
LSSLT
Sbjct: 155 FDRLSSLTHA 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 34/130 (26%), Positives = 52/130 (40%), Gaps = 4/130 (3%)
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q L L NQI+ P +L L ++ L N+L + F + L +DL N+L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 241 NIPKEIL-SLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCK 299
+P + L L + + N L LP I L ++ + L N L +F
Sbjct: 102 VLPSAVFDRLVHLKEL-FMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 300 SLEKLLMANN 309
SL + N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 38/133 (28%), Positives = 58/133 (43%), Gaps = 8/133 (6%)
Query: 253 TTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNS-FKNCKSLEKLLMANNKF 311
I+ L N + P L N+ + L +N L LP F + L L + N+
Sbjct: 42 AQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL 100
Query: 312 SGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIF-R 370
+ + L L+ L + NKL+ +P ++ L L L L N L+ +P G F R
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPH-GAFDR 157
Query: 371 HTSMVH--LEGNP 381
+S+ H L GNP
Sbjct: 158 LSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 37/202 (18%), Positives = 58/202 (28%), Gaps = 82/202 (40%)
Query: 36 FNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGL 95
N+ T PG +L N++ + + N L +P G+ F+
Sbjct: 49 DNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGV------------FDS--------- 86
Query: 96 SFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLR 154
LT L L NQ L+ L P+++ RL
Sbjct: 87 -----LTQ---LTVLDLGTNQ---------------LTVL-----------PSAVFDRLV 112
Query: 155 SLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNEL 214
L L + N +L +P + L L + L N+L
Sbjct: 113 HLKELFMCCN-----------KLT--------------ELPRGIERLTHLTHLALDQNQL 147
Query: 215 ASEIPTSFGNFQNLLSIDLSNN 236
S +F +L L N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 21/97 (21%), Positives = 38/97 (39%), Gaps = 3/97 (3%)
Query: 169 EILTEIGQLQELQSLDLAGNQISGSIPN-TLGNLKKLNQIDLSGNELASEIPTSFGNFQN 227
+ L + + L L + Q + L L +L + + + L P +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 228 LLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264
L ++LS N L ++ + + SL + LS N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQEL-VLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 23/99 (23%), Positives = 39/99 (39%), Gaps = 7/99 (7%)
Query: 290 NLPNSFKNCKSLEKLLMANNKFSGPIPN-ILAELKGLEVLDLSSNKLSGSIPSD-LQNLR 347
+ + ++L +L + N + + L L L L + + L + D
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 348 ALRSLNLTFNNLEGVVPREGIFRHTSM--VHLEGNPKLC 384
L LNL+FN LE + + S+ + L GNP C
Sbjct: 81 RLSRLNLSFNALESLSW--KTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 19/111 (17%), Positives = 35/111 (31%), Gaps = 4/111 (3%)
Query: 250 SSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPN-SFKNCKSLEKLLMAN 308
+ + LD + N+ + + +L + L L +
Sbjct: 8 HGSSGLRCTRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 309 NKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359
+ P+ L L+LS N L S+ +L+ L L+ N L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 21/125 (16%), Positives = 39/125 (31%), Gaps = 27/125 (21%)
Query: 212 NELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSKNFLDGTLPEE 270
+ A + +NL + + N + ++ L L L
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELR----------------- 59
Query: 271 IGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDL 330
+ + +GL P++F L +L ++ N + L L+ L L
Sbjct: 60 --------NLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVL 110
Query: 331 SSNKL 335
S N L
Sbjct: 111 SGNPL 115
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 29/219 (13%), Positives = 76/219 (34%), Gaps = 16/219 (7%)
Query: 152 RLRSLTLLNLSYNSISGEILTEIGQ-LQELQSLDLAG-NQIS-GSIPNTLGNLKKLNQID 208
L + L ++ + L I + + + L L+ S + + L ++D
Sbjct: 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELD 162
Query: 209 LSGNELASEIPTSFGNF----QNLLSIDLSN--NKLNGNIPKEILSLSSLTTIVNLSKNF 262
L +++ +F +L+S+++S ++++ + + +++ + L++
Sbjct: 163 LRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAV 222
Query: 263 LDGTLPEEIGMLGNVVTIDLSA------NGLSGNLPNSFKNCKSLEKLLMANNKFSGPIP 316
L + + + + L + CK L L + +P
Sbjct: 223 PLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLP 282
Query: 317 NILAELKGLEVLDLSSNKLSG-SIPSDLQNLRALRSLNL 354
+ + L L+LS + + L L+ L +
Sbjct: 283 AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWV 321
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 38/171 (22%), Positives = 62/171 (36%), Gaps = 32/171 (18%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS- 519
IGSG FG +Y + + A V+ +E F+E + + ++ +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-GPLFSELKFYQRVAKKDCIKKWIER 102
Query: 520 -------------CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER-- 564
+FK + +V E LG L F +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGT--------FKKSTV 153
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV--GDFGLAR 613
L + I + L+Y+H E VH D+K N+LL +V D+GL+
Sbjct: 154 LQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-10
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 3/94 (3%)
Query: 144 GKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKK 203
GKI +L L+L + ++ + +L +L+ L+L+ N+I G + L
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 204 LNQIDLSGNELAS-EIPTSFGNFQNLLSIDLSNN 236
L ++LSGN+L + L S+DL N
Sbjct: 97 LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 27/136 (19%), Positives = 47/136 (34%), Gaps = 29/136 (21%)
Query: 200 NLKKLNQIDLSGNELA-SEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNL 258
+ ++ L + +I F NL + L N L ++ NL
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--------------ISVSNL 67
Query: 259 SKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGP-IPN 317
K L + ++LS N + G L + +L L ++ NK
Sbjct: 68 PK-------------LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLE 114
Query: 318 ILAELKGLEVLDLSSN 333
L +L+ L+ LDL +
Sbjct: 115 PLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 28/114 (24%), Positives = 51/114 (44%), Gaps = 7/114 (6%)
Query: 247 LSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLM 306
+ +++ +V + DG + N+ + L GL ++ N L+KL +
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLEL 78
Query: 307 ANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRA---LRSLNLTFN 357
+ N+ G + + +L L L+LS NKL S L+ L+ L+SL+L
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 30/133 (22%), Positives = 56/133 (42%), Gaps = 14/133 (10%)
Query: 276 NVVTIDLSANGLS-GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNK 334
V + L + G + +LE L + N + N L +L L+ L+LS N+
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKKLELSENR 82
Query: 335 LSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKL-CLHL-GCENS 392
+ G + + L L LNL+ N L+ + +++ L+ L L L CE +
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDI---------STLEPLKKLECLKSLDLFNCEVT 133
Query: 393 SSHGRRRIIIYII 405
+ + R + ++
Sbjct: 134 NLNDYRESVFKLL 146
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 9/100 (9%)
Query: 123 ESIGNLSN--VLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISG-EILTEIGQLQE 179
S+ NL L KL + NR +G + +L +LT LNLS N + L + +L+
Sbjct: 62 ISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLEC 121
Query: 180 LQSLDLAGNQIS------GSIPNTLGNLKKLNQIDLSGNE 213
L+SLDL +++ S+ L L L+ D E
Sbjct: 122 LKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 21/108 (19%), Positives = 42/108 (38%), Gaps = 7/108 (6%)
Query: 153 LRSLTLLNLSYNSISG-EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211
L+L I E L L + ++D + N+I + L++L + ++
Sbjct: 18 AVRDRELDLRGYKIPVIENLGA--TLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNN 73
Query: 212 NELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLS 259
N + +L + L+NN L ++ L+SL ++ L
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTYLC 119
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-09
Identities = 21/115 (18%), Positives = 39/115 (33%), Gaps = 5/115 (4%)
Query: 123 ESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQS 182
N +L + G + I L ++ S N I L L+ L++
Sbjct: 13 AQYTNAVR-DRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKT 68
Query: 183 LDLAGNQISGSIPNTLGNLKKLNQIDLSGNELAS-EIPTSFGNFQNLLSIDLSNN 236
L + N+I L L ++ L+ N L + ++L + + N
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 30/130 (23%), Positives = 45/130 (34%), Gaps = 18/130 (13%)
Query: 237 KLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLG----NVVTIDLSANGLS--GN 290
KL + ++ ++ L L G I LG ID S N +
Sbjct: 3 KLTAELIEQAAQYTNAVRDRELD---LRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG 59
Query: 291 LPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRA-- 348
P + L+ LL+ NN+ + L L L L++N L DL L +
Sbjct: 60 FPL----LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLK 113
Query: 349 -LRSLNLTFN 357
L L + N
Sbjct: 114 SLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 27/126 (21%), Positives = 43/126 (34%), Gaps = 15/126 (11%)
Query: 98 ITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSK---LYMGGNRFYGKIPT--SIGR 152
TN+ R L G + I NL L + + N +I
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDN----EIRKLDGFPL 62
Query: 153 LRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISG-SIPNTLGNLKKLNQIDLSG 211
LR L L ++ N I L +L L L N + + L +LK L + +
Sbjct: 63 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILR 122
Query: 212 NELASE 217
N + ++
Sbjct: 123 NPVTNK 128
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 22/131 (16%), Positives = 48/131 (36%), Gaps = 11/131 (8%)
Query: 255 IVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGP 314
+V L+ + + +DL + + N + + ++N+
Sbjct: 1 MVKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE---- 53
Query: 315 IPNI--LAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE--GVVPREGIFR 370
I + L+ L+ L +++N++ Q L L L LT N+L G + +
Sbjct: 54 IRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK 113
Query: 371 HTSMVHLEGNP 381
+ + + NP
Sbjct: 114 SLTYLCILRNP 124
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 19/111 (17%), Positives = 39/111 (35%), Gaps = 13/111 (11%)
Query: 105 TRLNFLAFDGNQFEGEIPESIGNLSN--VLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLS 162
+ + + F N+ + L L + NR L LT L L+
Sbjct: 42 DQFDAIDFSDNEIR-----KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96
Query: 163 YNSISG-EILTEIGQLQELQSLDLAGNQISGSIPN----TLGNLKKLNQID 208
NS+ L + L+ L L + N ++ + + + + ++ +D
Sbjct: 97 NNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 146
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 28/111 (25%), Positives = 51/111 (45%), Gaps = 9/111 (8%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN 205
IP + T L L N + + E+ + L +DL+ N+IS + N+ +L
Sbjct: 29 IPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTI 255
+ LS N L P +F ++L + L N ++ +P+ LS+L+ +
Sbjct: 82 TLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHL 131
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 33/121 (27%), Positives = 52/121 (42%), Gaps = 15/121 (12%)
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
IP++ T + L N +P+E+ ++ IDLS N +S SF N
Sbjct: 28 GIPRD-------VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQ 79
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPS---DLQNLRALRSLNLTFN 357
L L+++ N+ P LK L +L L N +S +P + +L AL L +
Sbjct: 80 LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFN--DLSALSHLAI-GA 135
Query: 358 N 358
N
Sbjct: 136 N 136
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 11/166 (6%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN 205
IP +L L ++ L +L L+L NQ+ +L +L
Sbjct: 33 IPADTEKLD------LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86
Query: 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTIVNLSKNFLD 264
+ L+ N+LAS F + L + L N+L +P + L+ L + L+ N L
Sbjct: 87 TLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKEL-RLNTNQL- 143
Query: 265 GTLPEEI-GMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANN 309
++P L N+ T+ LS N L +F L+ + + N
Sbjct: 144 QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 46/152 (30%), Positives = 63/152 (41%), Gaps = 36/152 (23%)
Query: 134 KLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISG------EILTEIG-------QLQ-- 178
KL + + L LT LNL YN + + LTE+G QL
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASL 98
Query: 179 ---------ELQSLDLAGNQISGSIPN----TLGNLKKLNQIDLSGNELASEIPTS-FGN 224
+L L L GNQ+ S+P+ L LK+L L+ N+L S IP F
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKEL---RLNTNQLQS-IPAGAFDK 153
Query: 225 FQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTI 255
NL ++ LS N+L ++P L L TI
Sbjct: 154 LTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTI 184
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 41/179 (22%), Positives = 69/179 (38%), Gaps = 28/179 (15%)
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
+ LDL ++ T L KL ++L N+L + F + L ++ L+NN+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS 300
++P + LT + L L N L F
Sbjct: 97 SLPLGVFD--HLTQLDKL----------------------YLGGNQLKSLPSGVFDRLTK 132
Query: 301 LEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIP-SDLQNLRALRSLNLTFNN 358
L++L + N+ +L L+ L LS+N+L S+P L L+++ L F N
Sbjct: 133 LKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITL-FGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 41/206 (19%), Positives = 62/206 (30%), Gaps = 65/206 (31%)
Query: 36 FNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGL 95
+ LT + + + +N L+ T+ G+ F+
Sbjct: 44 STGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGV------------FDD--------- 81
Query: 96 SFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLR 154
LT L L NQ +P + L
Sbjct: 82 -----LTE---LGTLGLANNQLA--------------------------SLPLGVFDHLT 107
Query: 155 SLTLLNLSYN---SISGEILTEIGQLQELQSLDLAGNQISGSIPN-TLGNLKKLNQIDLS 210
L L L N S+ + +L +L+ L L NQ+ SIP L L + LS
Sbjct: 108 QLDKLYLGGNQLKSLPSGVFD---RLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLS 163
Query: 211 GNELASEIPTSFGNFQNLLSIDLSNN 236
N+L S +F L +I L N
Sbjct: 164 TNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 281 DLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIP 340
DL + GL+ +F+ L L + N+ + +L L L L++N+L+ S+P
Sbjct: 41 DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLP 99
Query: 341 SDL-QNLRALRSLNLTFNNLEGVVPREGIFRH 371
+ +L L L L N L+ +P G+F
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLKS-LP-SGVFDR 129
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 34/171 (19%), Positives = 60/171 (35%), Gaps = 29/171 (16%)
Query: 462 LIGSGSFGSVYKGYLREGISVAVK---VLDIESTGTWKSFFAECEALRNTRHRNLVKLIT 518
IG G FG +Y + SV V+ +E + F E + + ++
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWI 100
Query: 519 SCSSL--------------DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER 564
L D + ++ + G+ L + +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIY-----EANAKRFSRKTV 154
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV--GDFGLAR 613
L +++ I L+Y+H E VH D+K N+LL+ +V D+GLA
Sbjct: 155 LQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 37/295 (12%), Positives = 83/295 (28%), Gaps = 35/295 (11%)
Query: 90 SGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGK-IPT 148
E + F + N + + + +PE NL +G + +P
Sbjct: 231 EILELVGFFKAAANLEEFCGGSLNEDI---GMPEKYMNLVFPRKLCRLGLSYMGPNEMPI 287
Query: 149 SIGRLRSLTLLNLSYNSISGEILTE-IGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQI 207
+ L+L Y + E I + L+ L+ + K+L ++
Sbjct: 288 LFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRL 347
Query: 208 DLSGNELASEIPTSFG------------NFQNLLSIDLSNNK--------LNGNIPK-EI 246
+ + G Q L + + + + +
Sbjct: 348 RIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCD 407
Query: 247 LSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNS-----FKNCKSL 301
L L ++ LD + + + G L + + ++
Sbjct: 408 FRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR--QGGLTDLGLSYIGQYSPNV 465
Query: 302 EKLLMANNKFSGP-IPNILAELKGLEVLDLSSNKLS-GSIPSDLQNLRALRSLNL 354
+L+ S + L+ L++ S +I + + L +LR L +
Sbjct: 466 RWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWV 520
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 31/230 (13%), Positives = 76/230 (33%), Gaps = 23/230 (10%)
Query: 152 RLRSLTLLNLSYN---SISGEILTEIGQ-LQELQSLDLAGNQISG----SIPNTLGNLKK 203
R + L + + G+ L E+ Q L+ L+ + + + N +
Sbjct: 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRS 221
Query: 204 LNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFL 263
L + + E+ + F NL + + +P++ ++L + L +++
Sbjct: 222 LVSVKVGDFEILELV-GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM 280
Query: 264 -DGTLPEEIGMLGNVVTIDLS-ANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAE 321
+P + +DL A + + + C +LE L N + +
Sbjct: 281 GPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQY 340
Query: 322 LKGLEVLDLSSNKLSGSIPSDL------------QNLRALRSLNLTFNNL 359
K L+ L + + + Q + L + + +++
Sbjct: 341 CKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDI 390
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 42/299 (14%), Positives = 87/299 (29%), Gaps = 36/299 (12%)
Query: 91 GDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKL------YMGGNRFYG 144
+GL I + + ++ L + + F + + + L+ + L +
Sbjct: 152 TTDGLLSIVT--HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISP 209
Query: 145 KIPTSIG-RLRSLTLLNLSYNSIS--GEILTEIGQLQELQSLDLAGNQISGSIPNTLGNL 201
K +I RSL + + I L+E L + L
Sbjct: 210 KDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFP 269
Query: 202 KKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLSK 260
+KL ++ LS +E+P F + +DL L ++ +L +
Sbjct: 270 RKLCRLGLS-YMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVL-ETRN 327
Query: 261 NFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSF------------KNCKSLEKLLMAN 308
D L + + + + + + C+ LE + +
Sbjct: 328 VIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYV 387
Query: 309 NKFS----GPIPNILAELKGLEVLDLSSNKLSGSIPSD------LQNLRALRSLNLTFN 357
+ + I L L ++ L + +P D L + LR
Sbjct: 388 SDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR 446
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 29/217 (13%), Positives = 71/217 (32%), Gaps = 32/217 (14%)
Query: 153 LRSLTLLNLSYNSISGEILTEIGQLQ--ELQSLDLAG-NQISGSIPNTLG-NLKKLNQID 208
LR L ++ +S L + + + +L++L L + + ++ + +K+ +
Sbjct: 111 LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLL 170
Query: 209 LSGNELASEIPTSFG----NFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264
+ + + + + +L ++ + +S L TI ++
Sbjct: 171 MEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAK------ISPKDLETIARNCRS--- 221
Query: 265 GTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKG 324
+V++ + + L FK +LE+ + +P L
Sbjct: 222 ------------LVSVKVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268
Query: 325 LEVLDLSSNKLSG--SIPSDLQNLRALRSLNLTFNNL 359
L G +P +R L+L + L
Sbjct: 269 PRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALL 305
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 38/131 (29%), Positives = 55/131 (41%), Gaps = 18/131 (13%)
Query: 134 KLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIG---QLQELQSLDLAGNQI 190
L + N L SLT L L N + G +L L L+L+ NQ+
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS---LPNGVFNKLTSLTYLNLSTNQL 88
Query: 191 SGSIPN----TLGNLKKLNQIDLSGNELASEIPT-SFGNFQNLLSIDLSNNKLNGNIPKE 245
S+PN L LK+L L+ N+L S +P F L + L N+L ++P
Sbjct: 89 Q-SLPNGVFDKLTQLKEL---ALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLK-SVPDG 142
Query: 246 IL-SLSSLTTI 255
+ L+SL I
Sbjct: 143 VFDRLTSLQYI 153
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 34/131 (25%), Positives = 56/131 (42%), Gaps = 5/131 (3%)
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
LDL N + L L Q+ L GN+L S F +L ++LS N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 241 NIPKEIL-SLSSLTTIVNLSKNFLDGTLPEEI-GMLGNVVTIDLSANGLSGNLPNSFKNC 298
++P + L+ L + L+ N L +LP+ + L + + L N L F
Sbjct: 90 SLPNGVFDKLTQL-KELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL 147
Query: 299 KSLEKLLMANN 309
SL+ + + +N
Sbjct: 148 TSLQYIWLHDN 158
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 29/122 (23%), Positives = 53/122 (43%), Gaps = 12/122 (9%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISG-EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKL 204
IP L L+ N + G+L L L+L NQ++G PN +
Sbjct: 27 IPLHTTELL------LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 205 NQIDLSGNELASEIPT-SFGNFQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTIVNLSKNF 262
++ L N++ I F L +++L +N+++ + L+SLT++ NL+ N
Sbjct: 81 QELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSL-NLASNP 137
Query: 263 LD 264
+
Sbjct: 138 FN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 28/107 (26%), Positives = 45/107 (42%), Gaps = 8/107 (7%)
Query: 280 IDLSANGLSGNLPN-SFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGS 338
+ L+ N L + F L KL + N+ +G PN ++ L L NK+
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92
Query: 339 IPSDL-QNLRALRSLNLTFNNLEGVVPREGIF---RHTSMVHLEGNP 381
I + + L L++LNL N + V G F + ++L NP
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQISC-VMP-GSFEHLNSLTSLNLASNP 137
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 19/191 (9%)
Query: 126 GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIG---QLQELQS 182
N N + ++ + K I L ++ L L N L +I +L L
Sbjct: 37 QNELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNK-----LHDISALKELTNLTY 89
Query: 183 LDLAGNQISGSIPNTL-GNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN 241
L L GNQ+ S+PN + L L ++ L N+L S F NL ++L++N+L +
Sbjct: 90 LILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-S 147
Query: 242 IPKEIL-SLSSLTTIVNLSKNFLDGTLPEEI-GMLGNVVTIDLSANGLSGNLPN-SFKNC 298
+PK + L++LT + +LS N L +LPE + L + + L N L ++P+ F
Sbjct: 148 LPKGVFDKLTNLTEL-DLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRL 204
Query: 299 KSLEKLLMANN 309
SL+ + + +N
Sbjct: 205 TSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 52/224 (23%), Positives = 78/224 (34%), Gaps = 84/224 (37%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
++ YL L N+L +I +L NL N+ G LTN++ + + N
Sbjct: 63 PNVRYLALGGNKL-HDIS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN 119
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
L+ ++P G+ F+K LTN T LN NQ +
Sbjct: 120 QLQ-SLPDGV------------FDK--------------LTNLTYLN---LAHNQLQ--- 146
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNSISGEILTEIGQLQ-- 178
+P + +L +LT L+LSYN QLQ
Sbjct: 147 -----------------------SLPKGVFDKLTNLTELDLSYN-----------QLQSL 172
Query: 179 ---------ELQSLDLAGNQISGSIPN-TLGNLKKLNQIDLSGN 212
+L+ L L NQ+ S+P+ L L I L N
Sbjct: 173 PEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 37/178 (20%), Positives = 75/178 (42%), Gaps = 18/178 (10%)
Query: 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDG 265
+ +L + + ++ I +N+ + S+ + + N+ L G
Sbjct: 23 KANLKKKSVTDAVT--QNELNSIDQIIANNSDIK--------SVQGIQYLPNVRYLALGG 72
Query: 266 TLPEEIGM---LGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAEL 322
+I L N+ + L+ N L F +L++L++ N+ + +L
Sbjct: 73 NKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKL 132
Query: 323 KGLEVLDLSSNKLSGSIPSDL-QNLRALRSLNLTFNNLEGVVPREGIF-RHTSMVHLE 378
L L+L+ N+L S+P + L L L+L++N L+ +P EG+F + T + L
Sbjct: 133 TNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLP-EGVFDKLTQLKDLR 187
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 39/173 (22%), Positives = 64/173 (36%), Gaps = 37/173 (21%)
Query: 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRH-RN 512
NF IG G+FG + G L VA+K+ ++S E +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER-------L 565
+ ++ + A+V E LG SL D + +R L
Sbjct: 67 IPQVYYFGPCGKYN-----AMVLELLGP-SLEDL------------FDLCDRTFSLKTVL 108
Query: 566 NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG-----DFGLAR 613
IAI + S ++Y+H+ +++ D+KP N L+ DF LA+
Sbjct: 109 MIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 5e-08
Identities = 75/562 (13%), Positives = 166/562 (29%), Gaps = 151/562 (26%)
Query: 290 NLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSI------PSDL 343
++ L L++ + ++ + EVL ++ L I PS +
Sbjct: 56 MSKDAVSGTLRLFWTLLSKQE------EMVQKFVE-EVLRINYKFLMSPIKTEQRQPS-M 107
Query: 344 QNLRALRSLNLTFNNLEGV----VPREGIFR--HTSMVHLEGNPKLCLH--LGC------ 389
+ + +N+ + V R + +++ L + + LG
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 390 -ENSSSHGRRRIIIYIIVAIIAIIAGCFLIFWLIIVRKGKAKPI--GVSTLFKHSPQMIS 446
+ S+ + + F IFWL + + + + L +
Sbjct: 168 LDVCLSYKVQCKM-------------DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT 214
Query: 447 YDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLD-IESTGTWKSFFAECEAL 505
+ ++ K Y + VL +++ W +F C+ L
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYEN-----CLLVLLNVQNAKAWNAFNLSCKIL 269
Query: 506 RNTRHRNLVKLITSCS----SLDFKNMEF-----LALVYEFLGNGSLGD------WIH-- 548
TR + + +++ + SLD +M +L+ ++L D +
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC-RPQDLPREVLTTNPR 328
Query: 549 -----GERKNEHGNGLNF-----LERLNIAIDIASALDYLH--------NDC-----EVP 585
E + + ++L I+ S+L+ L +
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKLTTIIE--SSLNVLEPAEYRKMFDRLSVFPPSAH 386
Query: 586 IVHCDLKPGNIL------LDEDMTAKVGDFGLARSLLERIGNQSSISSTH----VLKGSI 635
I P +L + + V + SL+E+ + S S LK +
Sbjct: 387 I------PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK-QPKESTISIPSIYLELKVKL 439
Query: 636 ------------GY-IPPEYGLGEKPSTAGDVYSF--------GVMLLEIFTGMSPTHES 674
Y IP + + D Y + + E T
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD 499
Query: 675 FAGEVSLVKWVE-----SNFPKNAQQVLDRELRQL------MMSSESQTIQLHDCLITII 723
F +++E + NA + L+QL + ++ + +L + ++ +
Sbjct: 500 F-------RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFL 552
Query: 724 ESVGLSCTTESPGGRIDIREAL 745
+ + S + +R AL
Sbjct: 553 PKIEENL-ICSKYTDL-LRIAL 572
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 5e-04
Identities = 87/611 (14%), Positives = 172/611 (28%), Gaps = 211/611 (34%)
Query: 14 LWGEIPYDVGDKLPNLLGFNFCFNK-FTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLG 72
L I + + ++ + + +N++ +Q L L
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE-----LR 148
Query: 73 NLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNF---LAFDGNQF---------EGE 120
+ + + GSG T + L++ D F
Sbjct: 149 PAKNVLIDGVL-----GSGK------TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPET 197
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSI----GRLRSL--------TLLNLS------ 162
+ E + L + + + I I LR L LL L
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK 257
Query: 163 --------------------YNSISGEILTEIGQ------LQELQSLDLAG---NQISGS 193
+ +S T I L + L +
Sbjct: 258 AWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD 317
Query: 194 IPN--TLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLS------IDLSNNKL------- 238
+P N ++L+ I E + ++ N++++ I+ S N L
Sbjct: 318 LPREVLTTNPRRLSII----AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 239 ----------NGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS 288
+ +IP +LSL + + + M+ VV
Sbjct: 374 MFDRLSVFPPSAHIPTILLSL-------------IWFDVIKSDVMV--VV---------- 408
Query: 289 GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRA 348
N SL + + + IP+I ELK +++ + + L SI +
Sbjct: 409 ----NKLHK-YSL--VEKQPKESTISIPSIYLELK-VKLENEYA--LHRSIVDHYNIPKT 458
Query: 349 LRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCLHL-GCENSSSHGRRRIIIYIIVA 407
S +L L+ + H + H HL E+ R++
Sbjct: 459 FDSDDLIPPYLDQY-----FYSH--IGH---------HLKNIEHPERMTLFRMV------ 496
Query: 408 IIAIIAGCFLIF-WLIIVRKGKAKPIGVSTLFKHSPQMISYDELRRATGNFSHENLIGSG 466
FL F +L + K +H A+G S N +
Sbjct: 497 --------FLDFRFL------EQK-------IRHD------STAWNASG--SILNTLQQL 527
Query: 467 SFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEA-LRNTRHRNLVKLITSCSSLDF 525
F YK Y+ + ++++ F + E L +++ +L+++ +L
Sbjct: 528 KF---YKPYICDNDPKYERLVN-----AILDFLPKIEENLICSKYTDLLRI-----ALMA 574
Query: 526 KNMEFLALVYE 536
++ ++E
Sbjct: 575 EDEA----IFE 581
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 24/215 (11%)
Query: 153 LRSLTLLNLSYNSISGEILTEIGQ-LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211
+ ++LS + I L I +LQ+L L G ++S I NTL L +++LSG
Sbjct: 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 151
Query: 212 NELASE--IPTSFGNFQNLLSIDLSN-NKLNGNIPKEILS--LSSLTTIVNLS---KNFL 263
SE + T + L ++LS + ++ ++T + NLS KN
Sbjct: 152 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQL-NLSGYRKNLQ 210
Query: 264 DGTLPEEIGMLGNVVTIDLS-ANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNI---- 318
L + N+V +DLS + L + F L+ L ++ +I
Sbjct: 211 KSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC------YDIIPET 264
Query: 319 ---LAELKGLEVLDLSSNKLSGSIPSDLQNLRALR 350
L E+ L+ L + G++ + L L+
Sbjct: 265 LLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 299
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 41/221 (18%), Positives = 79/221 (35%), Gaps = 28/221 (12%)
Query: 143 YGKIPTSIGRLRSLTLLNLSYN-SISGEILTEIGQLQELQSLDLAGNQIS-GSIPNTLGN 200
P GRL S ++ S + L E +Q +DL+ + I ++ L
Sbjct: 57 KNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQ 116
Query: 201 LKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSN-NKLNGNIPKEILSLSSLTTIVNLS 259
KL + L G L+ I + NL+ ++LS + + + +LS S +NLS
Sbjct: 117 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS 176
Query: 260 KNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFS---GPIP 316
D + + + +++ +L ++ + + +
Sbjct: 177 W------------------CFDFTEKHVQVAVA---HVSETITQLNLSGYRKNLQKSDLS 215
Query: 317 NILAELKGLEVLDLSS-NKLSGSIPSDLQNLRALRSLNLTF 356
++ L LDLS L + L L+ L+L+
Sbjct: 216 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR 256
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 35/113 (30%), Positives = 51/113 (45%), Gaps = 12/113 (10%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTL-GNLKKL 204
IP+S T L L N + +L +L L L+ NQI S+P+ + L KL
Sbjct: 26 IPSS------ATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78
Query: 205 NQIDLSGNELASEIPTS-FGNFQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTI 255
+ L N+L S +P F L + L N+L ++P I L+SL I
Sbjct: 79 TILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKI 129
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 8/107 (7%)
Query: 134 KLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIG---QLQELQSLDLAGNQI 190
+L + N+ +L LT L+LS N I G +L +L L L N++
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS---LPDGVFDKLTKLTILYLHENKL 88
Query: 191 SGSIPN-TLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236
S+PN L +L ++ L N+L S F +L I L N
Sbjct: 89 Q-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 36/183 (19%), Positives = 58/183 (31%), Gaps = 57/183 (31%)
Query: 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNL 513
++ IG GSFG +++G L VA+K E R + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEP--------------RRSDAPQL 52
Query: 514 VKLITSCSSLD-----------FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL 562
+ L + LV + LG SL D L+
Sbjct: 53 RDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLEDL------------LDLC 99
Query: 563 ER-------LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK-----VGDFG 610
R A + + + +H +V+ D+KP N L+ + V DFG
Sbjct: 100 GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156
Query: 611 LAR 613
+ +
Sbjct: 157 MVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 30/183 (16%), Positives = 59/183 (32%), Gaps = 39/183 (21%)
Query: 455 GNFSHENLIGSGSFGSVYKGY---------LREGISVAVKVLDIESTGTWKSFFAECEAL 505
+ ++ + G +Y+ + ++K +++ F E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK---LDAKDG--RLFNEQNFF 96
Query: 506 RNTRHRNLVKLITSCSSLDFKNM-----------EFLALVYEFLGNGSLGDWIHGERKNE 554
+ V S + ++ LV LG SL + +
Sbjct: 97 QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSAL------D 149
Query: 555 HGNGLNFLER--LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV--GDFG 610
ER L +A + AL++LH E VH ++ NI +D + ++V +G
Sbjct: 150 VSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206
Query: 611 LAR 613
A
Sbjct: 207 FAF 209
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 21/164 (12%)
Query: 455 GNFSHENLIGSGSFGSVYKG-YLREGISVAVKVLDIESTGTWKSFFAECEALRNTRH-RN 512
+ IGSGSFG +Y G + G VA+K+ +++ E + + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+ + + D+ +V E LG SL D N + L +A +
Sbjct: 67 IPTIRWCGAEGDYN-----VMVMELLGP-SLEDLF-----NFCSRKFSLKTVLLLADQMI 115
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK---VGDFGLAR 613
S ++Y+H+ +H D+KP N L+ + DFGLA+
Sbjct: 116 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.1 bits (121), Expect = 8e-07
Identities = 28/177 (15%), Positives = 63/177 (35%), Gaps = 28/177 (15%)
Query: 192 GSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS--L 249
+ L + LN + + G S NL S+++ + L ++ ++IL L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPR---PNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 250 SSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANN 309
+L + + + D N +L+ L + +
Sbjct: 219 PNLEKL--------------VLYVGVEDYGFDGDMNVFRPLFSKD--RFPNLKWLGIVDA 262
Query: 310 KFSGPIPNILAE---LKGLEVLDLSSNKLSGS----IPSDLQNLRALRSLNLTFNNL 359
+ + + E L LE +D+S+ L+ + + ++ L+ +N+ +N L
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 1e-04
Identities = 13/74 (17%), Positives = 31/74 (41%), Gaps = 7/74 (9%)
Query: 151 GRLRSLTLLNLSYNSISGEI---LTEIGQLQELQSLDLAGNQISGS----IPNTLGNLKK 203
R +L L + + E L +L+++D++ ++ + + + +K
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 204 LNQIDLSGNELASE 217
L I++ N L+ E
Sbjct: 309 LKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 2e-04
Identities = 25/193 (12%), Positives = 60/193 (31%), Gaps = 32/193 (16%)
Query: 26 LPNLLGFNFCFNKFTGKIPGSLHNLTNIQII--RMAHNLLEGTVPPGLGNLPFLKMYNIG 83
+P L NL +++II + +++E + L NL L +Y
Sbjct: 171 MPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGV 230
Query: 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFY 143
+ + S L +L + + + E
Sbjct: 231 EDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI------------- 277
Query: 144 GKIPTSIGRLRSLTLLNLSYNSISGE----ILTEIGQLQELQSLDLAGNQISG----SIP 195
L L +++S ++ E +L + +++ L+ +++ N +S +
Sbjct: 278 ---------LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328
Query: 196 NTLGNLKKLNQID 208
+L ++
Sbjct: 329 KSLPMKIDVSDSQ 341
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 21/164 (12%)
Query: 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNL 513
F IGSGSFG +Y G ++ VA+K+ ++++ E + R +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKIYRILQGGTG 64
Query: 514 V-KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+ + D+ LV + LG SL D N L+ L +A +
Sbjct: 65 IPNVRWFGVEGDYN-----VLVMDLLGP-SLEDLF-----NFCSRKLSLKTVLMLADQMI 113
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK---VGDFGLAR 613
+ ++++H+ +H D+KP N L+ A + DFGLA+
Sbjct: 114 NRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 32/232 (13%), Positives = 70/232 (30%), Gaps = 32/232 (13%)
Query: 153 LRSLTLLNLSYNSISGEILTEIGQ-LQE----LQSLDLAGNQISGS----IPNTLGNLKK 203
L L NS+ E ++ L + +L L+ N ++ + + L
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 204 LNQIDLSGNEL----ASEIPTSFGNFQNLLSIDLSNNKLNGN----IPKEILSLSSLTTI 255
+ + L L + + L ++++ N + + SL +
Sbjct: 185 VTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELL 244
Query: 256 VNLSKNFLDGT----LPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKF 311
+L N L L + G + +S L+ S L ++ N +
Sbjct: 245 -HLYFNELSSEGRQVLRDLGGAAEGGARVVVS---LTEGTAVSEYWSVILSEVQRNLNSW 300
Query: 312 SGPIPNILAELKGLEVLDLSSNKLS----GSIPSDLQNLRALRSLNLTFNNL 359
+ L + DL ++ + L+ +R+L +
Sbjct: 301 D---RARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 41/233 (17%), Positives = 77/233 (33%), Gaps = 47/233 (20%)
Query: 153 LRSLTLLNLSYNSISGEILTEIGQL-----QELQSLDLAGNQISGSIPNTLGN-LKKLNQ 206
L SL LNL+ ++ T + + L ++LA Q+ + TL + +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 207 IDLSGNELASEIPTSFG-----NFQNLLSIDLSNNKLNGN----IPKEILSLSSLTTIVN 257
+ L N L E + + ++ LSNN L + + + +S+T + +
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHL-S 189
Query: 258 LSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGP--- 314
L +G D L+ L + L++L +A N
Sbjct: 190 LLHT--------GLG--------DEGLELLAAQL----DRNRQLQELNVAYNGAGDTAAL 229
Query: 315 -IPNILAELKGLEVLDLSSNKLS-------GSIPSDLQNLRALRSLNLTFNNL 359
+ E LE+L L N+LS + + + +
Sbjct: 230 ALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAV 282
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 34/98 (34%), Positives = 46/98 (46%), Gaps = 20/98 (20%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIG---QLQELQSLDLAGNQISGSIPNTLG--- 199
IPT L L+ N I+ E G L LQ L N+++ +IP G
Sbjct: 31 IPTD------KQRLWLNNNQITK---LEPGVFDHLVNLQQLYFNSNKLT-AIPT--GVFD 78
Query: 200 NLKKLNQIDLSGNELASEIPT-SFGNFQNLLSIDLSNN 236
L +L Q+DL+ N L S IP +F N ++L I L NN
Sbjct: 79 KLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 9e-05
Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 22/99 (22%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIG---QLQELQSLDLAGNQISGSIPN----TL 198
IPT+ +L L N I+ E G +L +L LDL NQ++ +P L
Sbjct: 28 IPTT------TQVLYLYDNQITK---LEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKL 77
Query: 199 GNLKKLNQIDLSGNELASEIPT-SFGNFQNLLSIDLSNN 236
L +L L+ N+L S IP +F N ++L I L NN
Sbjct: 78 TQLTQL---SLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 2/76 (2%)
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q L L NQI+ P L +L ++DL N+L F L + L++N+L
Sbjct: 33 QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLK- 91
Query: 241 NIPKEIL-SLSSLTTI 255
+IP+ +L SLT I
Sbjct: 92 SIPRGAFDNLKSLTHI 107
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 767 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.93 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.68 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.63 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.5 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.37 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.34 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.3 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.28 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.04 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.01 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.97 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.96 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.6 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.33 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.31 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.24 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.19 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.94 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.92 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.91 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.89 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.75 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.41 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.39 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.32 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.3 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.28 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.16 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.08 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.02 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.71 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.67 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.53 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.22 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.63 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.89 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.97 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.19 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.06 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 86.83 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.07 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=433.79 Aligned_cols=264 Identities=29% Similarity=0.423 Sum_probs=208.3
Q ss_pred cCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
++|.+.+.||+|+||.||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|. ++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eC
Confidence 46788899999999999999864 37789999997666666788999999999999999999999975 34
Q ss_pred eeeEEEEeecCCCChhhhhcccCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERK-------NEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED 601 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~ 601 (767)
+.+++|||||++|+|.++++..+. ......++|.++..|+.|+++||+|||++ +||||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 567999999999999999976431 12234699999999999999999999999 99999999999999999
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcc
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVS 680 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~ 680 (767)
+.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+| |+.||...... .
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~----~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~ 238 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--E 238 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE----EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--H
T ss_pred CcEEECCcccceecCCCCce----eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999876443211 11234568999999999999999999999999999999999 89999764321 2
Q ss_pred hhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 681 LVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
+...+........+..+++.+ .+++.+||+.||++|||++|+.+.|+++.+.
T Consensus 239 ~~~~i~~~~~~~~p~~~~~~~----------------------~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 239 VIECITQGRVLQRPRTCPQEV----------------------YELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHHHTCCCCCCTTCCHHH----------------------HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccchHHH----------------------HHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 222222211111122222222 2267789999999999999999999987664
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=434.68 Aligned_cols=263 Identities=26% Similarity=0.402 Sum_probs=202.7
Q ss_pred cCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.+|.+.++||+|+||.||+|+++ +++.||||+++.......++|.+|++++++++|||||+++++|. +.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----EG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 45677789999999999999864 37889999997666666788999999999999999999999975 34
Q ss_pred eeeEEEEeecCCCChhhhhcccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKN---------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD 599 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~ 599 (767)
..+++|||||++|+|.++++..... ....+++|.++..|+.|+++||+|||++ +||||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 5679999999999999999865432 1234699999999999999999999999 999999999999999
Q ss_pred CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCC
Q 004218 600 EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGE 678 (767)
Q Consensus 600 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~ 678 (767)
+++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~----~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-- 266 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY----RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-- 266 (329)
T ss_dssp TTTEEEECCCC--------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--
T ss_pred CCCcEEEcccccceeccCCCcc----eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--
Confidence 9999999999999866433211 11234568999999999999999999999999999999999 8999975422
Q ss_pred cchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 679 VSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
......+....+...+..+++.+ .+++.+||+.||++|||++||+++|+.+.+
T Consensus 267 ~~~~~~i~~g~~~~~p~~~~~~~----------------------~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 267 TEAIDCITQGRELERPRACPPEV----------------------YAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHH----------------------HHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCcccccHHH----------------------HHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 12222222222222222222222 226778999999999999999999998865
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=432.28 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=204.1
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
..|++.+.||+|+||.||+|+++ +|+.||||+++.......+.+.+|+++|++++|||||++++++ .+++.+|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence 46999999999999999999976 5999999999877666778899999999999999999999995 45567899
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
|||||+||+|.+++...+ +++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+
T Consensus 149 vmEy~~gg~L~~~l~~~~-------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHTR-------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EECCCTTEEHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence 999999999999997533 99999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc-
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN- 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 692 (767)
.+.... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+....+..
T Consensus 219 ~~~~~~------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~~~ 290 (346)
T 4fih_A 219 QVSKEV------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPRL 290 (346)
T ss_dssp ECCSSS------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCCCC
T ss_pred ecCCCC------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCCCC
Confidence 654321 123456799999999999999999999999999999999999999965321 11222222222111
Q ss_pred -hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 -AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 -~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
....+++. +++++.+||+.||++|||++|++++
T Consensus 291 ~~~~~~s~~----------------------~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 KNLHKVSPS----------------------LKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCGGGSCHH----------------------HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHH----------------------HHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111221 2236678999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=425.92 Aligned_cols=259 Identities=29% Similarity=0.457 Sum_probs=199.0
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.+++++.+.||+|+||+||+|++++ .||||+++... ....+.|.+|++++++++|||||+++++|.. +.+
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~~ 106 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DNL 106 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------CeE
Confidence 3577888999999999999998763 59999986432 3345789999999999999999999998742 246
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++|||||++|+|.+++.... ..+++.++..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred EEEEEcCCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccC
Confidence 89999999999999997543 2499999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC---CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG---EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|+........ .......||+.|||||++.+ .+++.++|||||||++|||+||+.||....... .+...+...
T Consensus 179 a~~~~~~~~~----~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~ 253 (307)
T 3omv_A 179 ATVKSRWSGS----QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRG 253 (307)
T ss_dssp CBC----------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTT
T ss_pred ceecccCCcc----eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcC
Confidence 9865432211 12245679999999999854 468999999999999999999999996532211 112222221
Q ss_pred ccc-c---hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 689 FPK-N---AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 689 ~~~-~---~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
... . ....+++. +.+++.+||+.||++|||++|++++|+.++..+
T Consensus 254 ~~~p~~~~~~~~~~~~----------------------l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 254 YASPDLSKLYKNCPKA----------------------MKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CCCCCSTTSCTTSCHH----------------------HHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCCCcccccccchHH----------------------HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 111 1 11111111 223677899999999999999999999887654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=428.39 Aligned_cols=265 Identities=24% Similarity=0.291 Sum_probs=205.5
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.+.|++.++||+|+||.||+|+++ +|+.||||+++.+. ...+|+.+++.++|||||++++++ .+++.+|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAV-----REGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 356778889999999999999976 49999999997532 234799999999999999999995 4556789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEccccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-TAKVGDFGL 611 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~ 611 (767)
+|||||+||+|.+++...+ .+++.++..++.||+.||+|||++ +||||||||+|||++.+| ++||+|||+
T Consensus 127 ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp EEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred EEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 9999999999999997654 399999999999999999999999 999999999999999887 699999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
|+.+....... ........+||+.|||||++.+..++.++||||+||++|||+||+.||........ .........+.
T Consensus 198 a~~~~~~~~~~-~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~~~ 275 (336)
T 4g3f_A 198 ALCLQPDGLGK-SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEPPPI 275 (336)
T ss_dssp CEEC-------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSCCGG
T ss_pred CeEccCCCccc-ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCCCCc
Confidence 98764432111 11122346799999999999999999999999999999999999999976443322 11221111110
Q ss_pred -chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhhcCCC
Q 004218 692 -NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQP 761 (767)
Q Consensus 692 -~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~~ 761 (767)
..+..+++. +.+++.+||+.||++|||+.|++++|..+.......+.|
T Consensus 276 ~~~~~~~s~~----------------------~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP 324 (336)
T 4g3f_A 276 REIPPSCAPL----------------------TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324 (336)
T ss_dssp GGSCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred hhcCccCCHH----------------------HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence 111112222 223667899999999999999999999888766544433
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=419.65 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=195.0
Q ss_pred CCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 458 SHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 458 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
++.+.||+|+||.||+|.+. +++.||+|++.... ....+.|.+|++++++++|||||++++++... ......+|+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence 56678999999999999976 48899999986442 23456789999999999999999999987532 2335678999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeCC-CCceEEccccc
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVP--IVHCDLKPGNILLDE-DMTAKVGDFGL 611 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~-~~~~kl~Dfg~ 611 (767)
||||+||+|.+++.... .+++..+..|+.||+.||+|||++ + ||||||||+|||++. ++.+||+|||+
T Consensus 108 mEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred EeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 99999999999997654 399999999999999999999998 6 999999999999984 79999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh-hcc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES-NFP 690 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~ 690 (767)
|+.... ......+||+.|||||++.+ .++.++|||||||++|||+||+.||....... .+...+.. ..|
T Consensus 179 a~~~~~--------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~~i~~~~~~ 248 (290)
T 3fpq_A 179 ATLKRA--------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVKP 248 (290)
T ss_dssp GGGCCT--------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCCC
T ss_pred CEeCCC--------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHHHHHcCCCC
Confidence 975322 12245679999999999865 69999999999999999999999996532211 11122211 122
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
........+. +++++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~----------------------~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 ASFDKVAIPE----------------------VKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGGCCCHH----------------------HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCccCCHH----------------------HHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222222222 2236778999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=426.57 Aligned_cols=260 Identities=22% Similarity=0.339 Sum_probs=203.7
Q ss_pred cCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
..+++.+.||+|+||.||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----- 100 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK----- 100 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----
Confidence 34567789999999999999863 36789999996443 3345789999999999999999999999753
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNIL 597 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl 597 (767)
++.+++|||||++|+|.+++...... .....+++.++..|+.|||+||+|||++ +||||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence 34569999999999999999754321 1124599999999999999999999999 9999999999999
Q ss_pred eCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCccc
Q 004218 598 LDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFA 676 (767)
Q Consensus 598 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~ 676 (767)
+++++.+||+|||+|+........ .......||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~----~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYY----KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCB----CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred ECCCCCEEECCcccceeccCCCce----eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999876543221 12234568999999999999999999999999999999998 8999966432
Q ss_pred CCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 677 GEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
..+...+........++.+++. +.+++.+||+.||++|||++||+++|+.
T Consensus 254 --~~~~~~i~~~~~~~~p~~~~~~----------------------~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 254 --QDVVEMIRNRQVLPCPDDCPAW----------------------VYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp --HHHHHHHHTTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred --HHHHHHHHcCCCCCCcccchHH----------------------HHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 2222223222211122222222 1226778999999999999999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=431.89 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=197.2
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++ .+++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCEE
Confidence 58999999999999999999975 59999999997543 23456789999999999999999999995 456678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
|+|||||+||+|.+++...+ ...+++.+++.|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+
T Consensus 99 yiVmEy~~gg~L~~~i~~~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQK----GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence 99999999999999997543 23479999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
|+...... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...... ..+.+.....++.
T Consensus 172 a~~~~~~~------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~~~~ 244 (350)
T 4b9d_A 172 ARVLNSTV------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-NLVLKIISGSFPP 244 (350)
T ss_dssp ESCCCHHH------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCCCC
T ss_pred ceeecCCc------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcCCCCC
Confidence 98654321 1224467999999999999999999999999999999999999999653221 1112222222221
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. ...+++. +++++.+||+.||++|||++|++++
T Consensus 245 ~-~~~~s~~----------------------~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 V-SLHYSYD----------------------LRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp C-CTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C-CccCCHH----------------------HHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1112221 2236778999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=433.85 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=204.2
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
..|++.+.||+|+||.||+|+++ +|+.||||++........+.+.+|+++|+.++|||||++++++. +++.+|+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCEEEE
Confidence 56999999999999999999976 59999999998776667788999999999999999999999954 4567899
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
|||||+||+|.+++...+ +++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+
T Consensus 226 VmEy~~gG~L~~~i~~~~-------l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHTR-------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEECCTTEEHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHhccC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence 999999999999997543 99999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccc-
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN- 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 692 (767)
.+.... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+....+..
T Consensus 296 ~~~~~~------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~~~ 367 (423)
T 4fie_A 296 QVSKEV------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPRL 367 (423)
T ss_dssp ECCSSC------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCCCC
T ss_pred ECCCCC------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCCCC
Confidence 654321 123456799999999999999999999999999999999999999965321 11222222222111
Q ss_pred -hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 -AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 -~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
....+++. +++++.+||+.||++|||++|++++
T Consensus 368 ~~~~~~s~~----------------------~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 KNLHKVSPS----------------------LKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCTTSSCHH----------------------HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCHH----------------------HHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111211 2236678999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=418.75 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=201.4
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++++++++|||||++++++ .+++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 46999999999999999999975 5999999999643 334567899999999999999999999994 45677
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+|||||+||+|.+++...+. +++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~------l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 8999999999999999976543 99999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+|+.+..... .......+||+.|||||++.+..|+.++||||+||++|||++|+.||....... .+.......+
T Consensus 178 la~~~~~~~~----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~- 251 (311)
T 4aw0_A 178 TAKVLSPESK----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKLEY- 251 (311)
T ss_dssp TCEECCTTTT----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC-
T ss_pred CceecCCCCC----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC-
Confidence 9987643211 122345689999999999999999999999999999999999999996532111 1111111111
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
..++.+++. +++++.+||+.||++|||++|++.
T Consensus 252 -~~p~~~s~~----------------------~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 252 -DFPEKFFPK----------------------ARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -CCCTTCCHH----------------------HHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred -CCCcccCHH----------------------HHHHHHHHccCCHhHCcChHHHcC
Confidence 111112211 223777899999999999999754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=465.78 Aligned_cols=391 Identities=35% Similarity=0.560 Sum_probs=340.2
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCcc-CCCCCCCcE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPG-LGNLPFLKM 79 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~-~~~l~~L~~ 79 (767)
+++|++|+|++|+++|.+|..++..+++|++|+|++|.+.+.+|..|+++++|++|+|++|.+++.+|.. +..+++|++
T Consensus 268 l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~ 347 (768)
T 3rgz_A 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKV 347 (768)
T ss_dssp CTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCE
T ss_pred cCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCE
Confidence 4678899999999988888888765688999999999998888888889999999999999888777765 888888888
Q ss_pred EeecCccccCCCCCCc-------------------cccccccC--CCCCCEEECcCCcceeecCchhhhhccccCeEEcc
Q 004218 80 YNIGFNKIVGSGDEGL-------------------SFITSLTN--STRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMG 138 (767)
Q Consensus 80 L~l~~n~l~~~~~~~~-------------------~~~~~l~~--l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~ 138 (767)
|++++|++.+.....+ ..+..+.. +++|++|++++|++++.+|..++++++ |++|+++
T Consensus 348 L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~-L~~L~Ls 426 (768)
T 3rgz_A 348 LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSE-LVSLHLS 426 (768)
T ss_dssp EECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTT-CCEEECC
T ss_pred EeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCC-CCEEECc
Confidence 8888888763221111 11222222 567888888888888888888988888 9999999
Q ss_pred CCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCC
Q 004218 139 GNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEI 218 (767)
Q Consensus 139 ~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 218 (767)
+|++++.+|..+..+++|++|++++|.+.+..|..+..+++|++|++++|++.+.+|..+.++++|++|+|++|++++..
T Consensus 427 ~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 506 (768)
T 3rgz_A 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506 (768)
T ss_dssp SSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred CCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcC
Confidence 99998888999999999999999999999888889999999999999999999888999999999999999999999889
Q ss_pred cccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhh---------------------------
Q 004218 219 PTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEI--------------------------- 271 (767)
Q Consensus 219 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~--------------------------- 271 (767)
|.+|+.+++|+.|+|++|++.+.+|..+..+++| +.+++++|.+++.+|..+
T Consensus 507 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (768)
T 3rgz_A 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL-IWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTC-CEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCT
T ss_pred ChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCC-CEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccc
Confidence 9999999999999999999998999999999988 445899998887666543
Q ss_pred -------------------------------------------cCCCceeEEEccCCCCCCCCCcccccCcccceeeccC
Q 004218 272 -------------------------------------------GMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMAN 308 (767)
Q Consensus 272 -------------------------------------------~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~ 308 (767)
+.+++|+.|||++|++++.+|..++.+++|+.|+|++
T Consensus 586 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~ 665 (768)
T 3rgz_A 586 ECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGH 665 (768)
T ss_dssp TCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcC
Confidence 3457899999999999999999999999999999999
Q ss_pred ccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCccccccccccccCCcCccccC-
Q 004218 309 NKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCLHL- 387 (767)
Q Consensus 309 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c~~~- 387 (767)
|++++.+|..+..+++|+.|||++|+++|.+|..+..+++|+.|++++|+++|.+|..+++.++....+.|||+.|+..
T Consensus 666 N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l 745 (768)
T 3rgz_A 666 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL 745 (768)
T ss_dssp SCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS
T ss_pred CccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999853
Q ss_pred -CCCCCC
Q 004218 388 -GCENSS 393 (767)
Q Consensus 388 -~c~~~~ 393 (767)
.|..+.
T Consensus 746 ~~C~~~~ 752 (768)
T 3rgz_A 746 PRCDPSN 752 (768)
T ss_dssp CCCCSCC
T ss_pred cCCCCCc
Confidence 676443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=405.56 Aligned_cols=246 Identities=28% Similarity=0.389 Sum_probs=185.7
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|++. +|+.||||+++.. .....+.+.+|++++++++|||||++++++ .+.+.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence 68999999999999999999975 5999999999654 233456789999999999999999999995 45667
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+||||+ +|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFG 157 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG 157 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred EEEEEeCC-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecC
Confidence 89999999 679999997643 399999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
+|+...+.. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||..... ..+.+.+....
T Consensus 158 la~~~~~~~-------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~i~~~~ 228 (275)
T 3hyh_A 158 LSNIMTDGN-------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKNISNGV 228 (275)
T ss_dssp CC----------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTC
T ss_pred CCeecCCCC-------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCC
Confidence 998654321 1234679999999999998876 5899999999999999999999965321 11111111111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+ ..+..+++. +++++.+||+.||++|||++|++++
T Consensus 229 ~-~~p~~~s~~----------------------~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 Y-TLPKFLSPG----------------------AAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp C-CCCTTSCHH----------------------HHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred C-CCCCCCCHH----------------------HHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 111112221 2236778999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=424.55 Aligned_cols=273 Identities=25% Similarity=0.369 Sum_probs=213.0
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEEEeCC------CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCC-CCceeEEee
Q 004218 448 DELRRATGNFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIEST-GTWKSFFAECEALRNTRH-RNLVKLITS 519 (767)
Q Consensus 448 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~~~~~ 519 (767)
++.+...++|++.+.||+|+||.||+|.+.. ++.||||.+..... ...+.+.+|+++++++.| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3444556789999999999999999998642 36799999865433 345679999999999965 899999999
Q ss_pred eecCCcccceeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 004218 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHC 589 (767)
Q Consensus 520 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 589 (767)
|.. .+..+++|||||++|+|.++++..+.. .....+++.++..++.|||+||+|||++ +||||
T Consensus 137 ~~~----~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR 209 (353)
T 4ase_A 137 CTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 209 (353)
T ss_dssp ECC----TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEe----cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence 753 345579999999999999999764321 1134589999999999999999999999 99999
Q ss_pred cCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CC
Q 004218 590 DLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GM 668 (767)
Q Consensus 590 Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~ 668 (767)
||||+|||+++++.+||+|||+|+....... ........||+.|||||++.+..++.++|||||||++|||+| |+
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~ 285 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 285 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCC----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence 9999999999999999999999986543221 122345678999999999999999999999999999999998 89
Q ss_pred CCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 669 SPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 669 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
.||....... .+...+........++.+.+.+. +++.+||+.||++|||++|++++|
T Consensus 286 ~Pf~~~~~~~-~~~~~i~~g~~~~~p~~~~~~~~----------------------~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 286 SPYPGVKIDE-EFCRRLKEGTRMRAPDYTTPEMY----------------------QTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp CSSTTCCCSH-HHHHHHHHTCCCCCCTTCCHHHH----------------------HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCHHH-HHHHHHHcCCCCCCCccCCHHHH----------------------HHHHHHcCcChhHCcCHHHHHHHH
Confidence 9997643222 22233332222222232333222 266689999999999999999999
Q ss_pred HHHHHH
Q 004218 749 KNAQKI 754 (767)
Q Consensus 749 ~~~~~~ 754 (767)
+.+.+.
T Consensus 343 ~~llq~ 348 (353)
T 4ase_A 343 GNLLQA 348 (353)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=415.34 Aligned_cols=277 Identities=23% Similarity=0.304 Sum_probs=195.6
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHH--HHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFF--AECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|.+.+.||+|+||.||+|+++ |+.||||+++... .+.+. .|+..+.+++|||||+++++|...+ .....++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEE
Confidence 45778899999999999999985 8999999986432 23333 4555566789999999999986422 1234679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeecCCCCCeeeCCCCceEEc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC-----EVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
+|||||++|+|.++++... +++.++.+++.|+++||+|||+++ .++||||||||+|||++.++.+||+
T Consensus 78 lV~Ey~~~gsL~~~l~~~~-------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred EEecCCCCCcHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 9999999999999997643 899999999999999999999752 3489999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCC------CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcch
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE------KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL 681 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 681 (767)
|||+|+........ .........||+.|||||++.+. .++.++|||||||++|||+||++||..........
T Consensus 151 DFGla~~~~~~~~~--~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 151 DLGLAVRHDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CCTTCEEEETTTTE--ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred eCCCCccccCCCCc--eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 99999865433211 11122345799999999998764 35779999999999999999998875432221111
Q ss_pred hhHhhhhcccchhhhccHHHHHhhhc-----chhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 682 VKWVESNFPKNAQQVLDRELRQLMMS-----SESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
..... . ......+...+.. .........++... +.+++.+||+.||++||||.|+++.|+++.+
T Consensus 229 ~~~~~----~---~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~-l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 229 YDLVP----S---DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV-MAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTTSC----S---SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHH-HHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccc----c---cchHHHHHHHHhcccCCCCCCccccchHHHHH-HHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 10000 0 0000001111000 00000111111222 2337889999999999999999999998865
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=408.91 Aligned_cols=247 Identities=27% Similarity=0.331 Sum_probs=190.3
Q ss_pred cCCCCCCccccccceEEEEEEeC----CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++++++|||||++++++ .++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 57999999999999999999863 37889999986432 23345688999999999999999999995 456
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
+.+|+|||||+||+|.+++...+ .+++.++..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D 169 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD 169 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence 67899999999999999997654 399999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||+|+...... ......+||+.|||||++.+..++.++||||+||++|||+||+.||...... .....+...
T Consensus 170 FGla~~~~~~~------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~ 241 (304)
T 3ubd_A 170 FGLSKESIDHE------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETMTMILKA 241 (304)
T ss_dssp SEEEEC-----------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC
T ss_pred cccceeccCCC------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHHHHHHcC
Confidence 99998653321 1223467999999999999999999999999999999999999999653221 111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCH-----HHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDI-----REALR 746 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~ 746 (767)
.+ ..+..+++. +++++.+||+.||++|||+ +|+++
T Consensus 242 ~~-~~p~~~s~~----------------------~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 KL-GMPQFLSPE----------------------AQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CC-CCCTTSCHH----------------------HHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CC-CCCCcCCHH----------------------HHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11 111222222 2236778999999999985 56665
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=405.83 Aligned_cols=261 Identities=23% Similarity=0.368 Sum_probs=187.2
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-------
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDF------- 525 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------- 525 (767)
++|++.+.||+|+||.||+|+++ +|+.||||+++.... ...+.+.+|++++++++|||||++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45899999999999999999976 589999999975543 345678999999999999999999998754321
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
....++|+|||||++|+|.+++...... ...++..++.|+.|+++||+|||++ +|+||||||+|||++.++.+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 2344689999999999999999865431 2256777899999999999999999 999999999999999999999
Q ss_pred EccccchhhhhhhcCCCc------cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc
Q 004218 606 VGDFGLARSLLERIGNQS------SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV 679 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 679 (767)
|+|||+|+.......... ........+||+.|||||++.+..|+.++||||+||++|||++ ||........
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 999999987754322111 1112234579999999999999999999999999999999996 7743211100
Q ss_pred chhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 680 SLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+.......+|.. ..+..+. ..+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~p~~-------------------~~~~~~~----~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 TLTDVRNLKFPPL-------------------FTQKYPC----EYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHTTCCCHH-------------------HHHHCHH----HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCCCCC-------------------CcccCHH----HHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111111110 0011111 1237779999999999999999873
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=439.91 Aligned_cols=372 Identities=36% Similarity=0.550 Sum_probs=272.9
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCC-CCCCEEEcccccCcccCCccCCCCCCCcE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNL-TNIQIIRMAHNLLEGTVPPGLGNLPFLKM 79 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l-~~L~~L~l~~n~i~~~~~~~~~~l~~L~~ 79 (767)
+++|++|+|++|++++.+|.. .+++|++|++++|.+.+.+|..+..+ ++|++|+|++|.+++.+|..++.+++|++
T Consensus 246 l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 322 (768)
T 3rgz_A 246 CTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322 (768)
T ss_dssp CSSCCEEECCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCE
T ss_pred CCCCCEEECCCCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccE
Confidence 578999999999999888875 58999999999999999999988876 99999999999999999999999999999
Q ss_pred EeecCccccCCCCCCcccccc-ccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCccc---------------
Q 004218 80 YNIGFNKIVGSGDEGLSFITS-LTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFY--------------- 143 (767)
Q Consensus 80 L~l~~n~l~~~~~~~~~~~~~-l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~--------------- 143 (767)
|++++|++.+ .++.. +.++++|++|++++|++++.+|..+..+..+|++|++++|+++
T Consensus 323 L~L~~n~l~~------~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L 396 (768)
T 3rgz_A 323 LALSSNNFSG------ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396 (768)
T ss_dssp EECCSSEEEE------ECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCC
T ss_pred EECCCCcccC------cCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCc
Confidence 9999999863 23333 7778888888888888888888888776522555555555554
Q ss_pred -----------ccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCC
Q 004218 144 -----------GKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212 (767)
Q Consensus 144 -----------~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 212 (767)
+.+|..+.++++|++|+|++|.+++..|..+..+++|++|++++|.+.+.+|..+..+++|++|+|++|
T Consensus 397 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 476 (768)
T 3rgz_A 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476 (768)
T ss_dssp CEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred cEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCC
Confidence 455555566666666666666666666666666666666666666666666666666666666666666
Q ss_pred cCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCC
Q 004218 213 ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLP 292 (767)
Q Consensus 213 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~ 292 (767)
++++..|..+..+++|+.|+|++|++++.+|..+..+++| +.+++++|++++.+|..++.+++|+.|++++|.+++.+|
T Consensus 477 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip 555 (768)
T 3rgz_A 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL-AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555 (768)
T ss_dssp CCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC-CEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCC
T ss_pred cccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCC-CEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCC
Confidence 6666666666666666666666666666666666666666 333667776666666666667777777777766655444
Q ss_pred cc----------------------------------------------------------------------cccCcccc
Q 004218 293 NS----------------------------------------------------------------------FKNCKSLE 302 (767)
Q Consensus 293 ~~----------------------------------------------------------------------~~~l~~L~ 302 (767)
.. +..+++|+
T Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~ 635 (768)
T 3rgz_A 556 AAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMM 635 (768)
T ss_dssp GGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCC
T ss_pred hHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcccccc
Confidence 32 22345667
Q ss_pred eeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCC-ccccccccccccCCc
Q 004218 303 KLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE-GIFRHTSMVHLEGNP 381 (767)
Q Consensus 303 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~~~l~~Np 381 (767)
.|+|++|++++.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|.. ..+..+..+++.+|+
T Consensus 636 ~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~ 715 (768)
T 3rgz_A 636 FLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 715 (768)
T ss_dssp EEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE
T ss_pred EEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc
Confidence 7777777777777777777777777777777777777777777777777777777777776655 445667777777776
Q ss_pred C
Q 004218 382 K 382 (767)
Q Consensus 382 ~ 382 (767)
.
T Consensus 716 l 716 (768)
T 3rgz_A 716 L 716 (768)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=406.01 Aligned_cols=280 Identities=21% Similarity=0.254 Sum_probs=201.7
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCC-ccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~ 530 (767)
++|++.+.||+|+||.||+|+++ +|+.||||+++.... ...+.+.+|+++|+.++|||||++++++.... +.+...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 599999999964422 33567889999999999999999999876432 445678
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+|||||+ |+|.+++...+ .+++.++..+++||+.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence 999999996 68999997644 399999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh--
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES-- 687 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-- 687 (767)
+|+.+...... ........+||+.|+|||++.+. .++.++||||+||++|||++|++||....... .+......
T Consensus 204 la~~~~~~~~~--~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~~g 280 (398)
T 4b99_A 204 MARGLCTSPAE--HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMVLG 280 (398)
T ss_dssp TCBCC---------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHC
T ss_pred eeeecccCccc--cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcC
Confidence 99866433211 11223456799999999998775 46999999999999999999999996542211 11111111
Q ss_pred hcccch-hhhccHHHHHhhhcc----hhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 NFPKNA-QQVLDRELRQLMMSS----ESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~~~~~~-~~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+... ...........+... +.........+...+.+++.+||..||++||||+|++++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111110 000000111111000 000001111111223347779999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=398.34 Aligned_cols=207 Identities=25% Similarity=0.332 Sum_probs=170.3
Q ss_pred HHHHhcCCCCCCccccccceEEEEEEeC----CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCC
Q 004218 450 LRRATGNFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLD 524 (767)
Q Consensus 450 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 524 (767)
+....++|++.+.||+|+||.||+|+.+ +++.||+|.+... ....++.+|+++++.+ +||||+++++++
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~---- 89 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCF---- 89 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEE----
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEE----
Confidence 3445688999999999999999999863 4678999988543 3446788999999998 699999999984
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-Cc
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED-MT 603 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~ 603 (767)
.+.+++|+||||+++|+|.+++.. +++.++..++.|++.||+|||++ ||+||||||+|||++.+ +.
T Consensus 90 -~~~~~~~lvmE~~~g~~L~~~~~~---------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~ 156 (361)
T 4f9c_A 90 -RKNDHVVIAMPYLEHESFLDILNS---------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKK 156 (361)
T ss_dssp -EETTEEEEEEECCCCCCHHHHHTT---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred -EECCEEEEEEeCCCcccHHHHHcC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCe
Confidence 456778999999999999999842 89999999999999999999999 99999999999999876 89
Q ss_pred eEEccccchhhhhhhcCCC----------------------ccccccccccCCCCccCccccCCC-CCCCcccchhhhHH
Q 004218 604 AKVGDFGLARSLLERIGNQ----------------------SSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVM 660 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~----------------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~i 660 (767)
+||+|||+|+...+..... .........+||+.|+|||++.+. .++.++||||+||+
T Consensus 157 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~i 236 (361)
T 4f9c_A 157 YALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVI 236 (361)
T ss_dssp EEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred EEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHH
Confidence 9999999997553321100 001112345799999999998775 48999999999999
Q ss_pred HHHHHhCCCCCCCcc
Q 004218 661 LLEIFTGMSPTHESF 675 (767)
Q Consensus 661 l~el~tg~~p~~~~~ 675 (767)
+|||++|+.||....
T Consensus 237 l~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 237 FLSLLSGRYPFYKAS 251 (361)
T ss_dssp HHHHHHTCSSSSCCS
T ss_pred HHHHHHCCCCCCCCC
Confidence 999999999996543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=405.77 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=194.1
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHH---HHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFA---ECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
++|++.++||+|+||.||+|+.+ +|+.||||++++. .......+.+ ++.+++.++|||||++++++ .+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~~ 263 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT 263 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----EE
Confidence 57999999999999999999976 4999999999643 1222233333 46677788999999999994 56
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
.+.+|+|||||+||+|.+++..... +++..+..++.||+.||+|||++ |||||||||+|||++.+|.+||+
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~------l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~ 334 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGV------FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 334 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEec
Confidence 6788999999999999999976543 99999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc-chhhHh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-SLVKWV 685 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~ 685 (767)
|||+|+..... .....+||+.|||||++.+ ..|+.++||||+||++|||++|++||........ .+...+
T Consensus 335 DFGlA~~~~~~--------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i 406 (689)
T 3v5w_A 335 DLGLACDFSKK--------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406 (689)
T ss_dssp CCTTCEECSSC--------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH
T ss_pred ccceeeecCCC--------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Confidence 99999865322 1245679999999999864 5799999999999999999999999976433221 111111
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC-----HHHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID-----IREALRR 747 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 747 (767)
. ..+...+..+++. +++++.+||+.||++|++ ++|++++
T Consensus 407 ~-~~~~~~p~~~S~~----------------------a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 407 L-TMAVELPDSFSPE----------------------LRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp H-HCCCCCCTTSCHH----------------------HHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred c-CCCCCCCccCCHH----------------------HHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1 1111112222222 223667899999999998 6887764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=405.60 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=202.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|.++ +|+.||+|++........+.+.+|+++|+.++|||||++++++ .+...+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 368999999999999999999976 5999999999766555667889999999999999999999994 4567889
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC--CceEEcccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED--MTAKVGDFG 610 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~--~~~kl~Dfg 610 (767)
+|||||+||+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 231 iv~E~~~gg~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp EEEECCCCCBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred EEEeecCCCcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence 9999999999999986543 2399999999999999999999999 99999999999999854 899999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh--
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN-- 688 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-- 688 (767)
+|+.+... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||....... .+.......
T Consensus 303 ~a~~~~~~-------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~~i~~~~~~ 374 (573)
T 3uto_A 303 LTAHLDPK-------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWN 374 (573)
T ss_dssp SCEECCTT-------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCCC
T ss_pred ceeEccCC-------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHhCCCC
Confidence 99876432 12244679999999999999999999999999999999999999996532211 111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
++......+++. +.+++.+||+.||++|||+.|++++
T Consensus 375 ~~~~~~~~~s~~----------------------~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 375 MDDSAFSGISED----------------------GKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CCSGGGTTSCHH----------------------HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCcccccCCCHH----------------------HHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111122221 2236778999999999999999874
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=416.18 Aligned_cols=373 Identities=23% Similarity=0.246 Sum_probs=250.1
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCcc--CCCCCCCc
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPG--LGNLPFLK 78 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~--~~~l~~L~ 78 (767)
|++|++|||++|...+.++...+..+++|++|+|++|.+.+..|++|+++++|++|+|++|.+++..|.. ++.+++|+
T Consensus 47 l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~ 126 (844)
T 3j0a_A 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126 (844)
T ss_dssp CCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCC
T ss_pred cccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCC
Confidence 3456666666664444554444555666666666666666666666666777777777777666544443 66667777
Q ss_pred EEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhh--ccccCeEEccCCcccccCCccccC----
Q 004218 79 MYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNL--SNVLSKLYMGGNRFYGKIPTSIGR---- 152 (767)
Q Consensus 79 ~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~~L~~L~l~~n~i~~~~~~~l~~---- 152 (767)
+|+|++|.+.+. .....+.++++|++|+|++|.+++..+..+..+ ++ |+.|+++.|.+.+..|..+..
T Consensus 127 ~L~Ls~N~l~~~-----~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~-L~~L~L~~n~l~~~~~~~~~~~~~~ 200 (844)
T 3j0a_A 127 RLDLSKNQIRSL-----YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT-LSFFSLAANSLYSRVSVDWGKCMNP 200 (844)
T ss_dssp EEEEESCCCCCC-----CCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCS-SCCCEECCSBSCCCCCCCCCSSSCT
T ss_pred EEECCCCccccc-----ccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCc-cceEECCCCccccccccchhhcCCc
Confidence 777777766543 223456777777777777777776666666655 33 444444444443322222111
Q ss_pred ----------------------------------------------------------------CCCCCEEECcCCcCcc
Q 004218 153 ----------------------------------------------------------------LRSLTLLNLSYNSISG 168 (767)
Q Consensus 153 ----------------------------------------------------------------l~~L~~L~l~~n~i~~ 168 (767)
.++|+.|++++|.+.+
T Consensus 201 ~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~ 280 (844)
T 3j0a_A 201 FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS 280 (844)
T ss_dssp TTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCE
T ss_pred cccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccc
Confidence 1457777777777776
Q ss_pred cCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcc
Q 004218 169 EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS 248 (767)
Q Consensus 169 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 248 (767)
..+..|..+++|++|+|++|++.+..|..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+.+..+..|..
T Consensus 281 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~ 360 (844)
T 3j0a_A 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360 (844)
T ss_dssp ECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCS
T ss_pred cChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcC
Confidence 66777788888888888888888777778888888888888888888777888888888888888888888766677777
Q ss_pred cccccceeecccccCCCCC----------------------------------------chhhcCCCceeEEEccCCCCC
Q 004218 249 LSSLTTIVNLSKNFLDGTL----------------------------------------PEEIGMLGNVVTIDLSANGLS 288 (767)
Q Consensus 249 l~~l~~~l~l~~n~l~~~~----------------------------------------~~~~~~l~~L~~L~ls~n~l~ 288 (767)
+++|.. +++++|.+++.. +..+..+++|+.|+|++|+++
T Consensus 361 l~~L~~-L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~ 439 (844)
T 3j0a_A 361 LEKLQT-LDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439 (844)
T ss_dssp CCCCCE-EEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCC
T ss_pred CCCCCE-EECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccc
Confidence 777743 477777765421 111335667777777777665
Q ss_pred CCC------------------------------CcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCC
Q 004218 289 GNL------------------------------PNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGS 338 (767)
Q Consensus 289 ~~~------------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 338 (767)
+.. +..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++.
T Consensus 440 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l 519 (844)
T 3j0a_A 440 SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL 519 (844)
T ss_dssp CCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSC
T ss_pred ccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCcc
Confidence 322 23355666777777777777766666677777777777777777765
Q ss_pred CCccccccccCceEeccCCcCcCcCCCCccccccccccccCCcCcc
Q 004218 339 IPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC 384 (767)
Q Consensus 339 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c 384 (767)
.+..+. ++|+.|++++|++++.+|.. +.++..+++.+|||.|
T Consensus 520 ~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C 561 (844)
T 3j0a_A 520 SHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFIC 561 (844)
T ss_dssp CCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCC
T ss_pred Chhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCccc
Confidence 555544 67777777777777766643 5678889999999999
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=401.87 Aligned_cols=356 Identities=25% Similarity=0.356 Sum_probs=312.3
Q ss_pred eeeecCCCccccCCCCCcEEEccCCccccc-----------------CCcccc--CCCCCCEEEcccccCcccCCccCCC
Q 004218 13 QLWGEIPYDVGDKLPNLLGFNFCFNKFTGK-----------------IPGSLH--NLTNIQIIRMAHNLLEGTVPPGLGN 73 (767)
Q Consensus 13 ~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~-----------------~~~~l~--~l~~L~~L~l~~n~i~~~~~~~~~~ 73 (767)
+++| ||..+. .+++|++|+|++|.+.+. +|..++ ++++|++|+|++|.+.+.+|..+++
T Consensus 194 ~l~~-ip~~l~-~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 271 (636)
T 4eco_A 194 NITF-VSKAVM-RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271 (636)
T ss_dssp EEEE-ECGGGG-GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT
T ss_pred CCcc-CCHHHh-cccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhc
Confidence 6665 898876 599999999999999985 999999 9999999999999999999999999
Q ss_pred CCCCcEEeecCcc-ccCCCCCCccccccccCC------CCCCEEECcCCcceeecCc--hhhhhccccCeEEccCCcccc
Q 004218 74 LPFLKMYNIGFNK-IVGSGDEGLSFITSLTNS------TRLNFLAFDGNQFEGEIPE--SIGNLSNVLSKLYMGGNRFYG 144 (767)
Q Consensus 74 l~~L~~L~l~~n~-l~~~~~~~~~~~~~l~~l------~~L~~L~l~~n~l~~~~~~--~~~~l~~~L~~L~l~~n~i~~ 144 (767)
+++|++|++++|+ +++. .++..+.++ ++|++|++++|+++ .+|. .++.+++ |++|++++|++++
T Consensus 272 l~~L~~L~Ls~n~~l~~~-----~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~-L~~L~L~~N~l~g 344 (636)
T 4eco_A 272 LPEMQLINVACNRGISGE-----QLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKK-LGMLECLYNQLEG 344 (636)
T ss_dssp CSSCCEEECTTCTTSCHH-----HHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTT-CCEEECCSCCCEE
T ss_pred CCCCCEEECcCCCCCccc-----cchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCC-CCEEeCcCCcCcc
Confidence 9999999999998 7531 245555554 99999999999999 8998 9999998 9999999999998
Q ss_pred cCCccccCCCCCCEEECcCCcCcccCccccCCCCC-CCEEEccCCccccccCcCcccCC--CCceeeCCCCcCCCCCccc
Q 004218 145 KIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE-LQSLDLAGNQISGSIPNTLGNLK--KLNQIDLSGNELASEIPTS 221 (767)
Q Consensus 145 ~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~-L~~L~L~~n~i~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~ 221 (767)
.+| .|..+++|++|++++|.++ .+|..+..+++ |++|++++|+++ .+|..+..++ +|+.|++++|++++..|..
T Consensus 345 ~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 421 (636)
T 4eco_A 345 KLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421 (636)
T ss_dssp ECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCS
T ss_pred chh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhh
Confidence 889 8999999999999999999 77888999999 999999999999 7888887655 8999999999999999988
Q ss_pred cc-------CccccccccccCcccCCCCChh-hcccccccceeecccccCCCCCchhhcCCC-------ceeEEEccCCC
Q 004218 222 FG-------NFQNLLSIDLSNNKLNGNIPKE-ILSLSSLTTIVNLSKNFLDGTLPEEIGMLG-------NVVTIDLSANG 286 (767)
Q Consensus 222 ~~-------~l~~L~~L~l~~n~l~~~~~~~-~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~-------~L~~L~ls~n~ 286 (767)
|. .+++|+.|+|++|+++ .+|.. +..+++|. .+++++|.++...+..+..+. +|+.|+|++|.
T Consensus 422 l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~-~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~ 499 (636)
T 4eco_A 422 FDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLS-SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499 (636)
T ss_dssp SCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCS-EEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSC
T ss_pred hcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCC-EEECCCCCCCCcCHHHhccccccccccCCccEEECcCCc
Confidence 88 8889999999999999 55554 55688884 559999999944444444333 99999999999
Q ss_pred CCCCCCcccc--cCcccceeeccCccccCCCCchhhccCCceEEEc------CCcccCCCCCccccccccCceEeccCCc
Q 004218 287 LSGNLPNSFK--NCKSLEKLLMANNKFSGPIPNILAELKGLEVLDL------SSNKLSGSIPSDLQNLRALRSLNLTFNN 358 (767)
Q Consensus 287 l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L------s~N~l~~~~~~~~~~l~~L~~L~l~~N~ 358 (767)
++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+..+++|+.|++++|+
T Consensus 500 l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 577 (636)
T 4eco_A 500 LT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577 (636)
T ss_dssp CC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred CC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCc
Confidence 99 6777776 99999999999999997 8999999999999999 5688889999999999999999999999
Q ss_pred CcCcCCCCccccccccccccCCcCcccc
Q 004218 359 LEGVVPREGIFRHTSMVHLEGNPKLCLH 386 (767)
Q Consensus 359 l~~~~~~~~~~~~~~~~~l~~Np~~c~~ 386 (767)
++.++.. ..+++..+++.+||+.|..
T Consensus 578 l~~ip~~--~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 578 IRKVNEK--ITPNISVLDIKDNPNISID 603 (636)
T ss_dssp CCBCCSC--CCTTCCEEECCSCTTCEEE
T ss_pred CCccCHh--HhCcCCEEECcCCCCcccc
Confidence 9655443 3378999999999999864
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=401.31 Aligned_cols=210 Identities=23% Similarity=0.261 Sum_probs=180.0
Q ss_pred cCCCCCCCEEEccCCccccc--cCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCC-hhhcccc
Q 004218 174 IGQLQELQSLDLAGNQISGS--IPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIP-KEILSLS 250 (767)
Q Consensus 174 ~~~l~~L~~L~L~~n~i~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~ 250 (767)
+..+++|++|++++|++++. .|..+..+++|++|++++|.+++ .|..|..+++|+.|++++|++.+..| ..+..++
T Consensus 346 ~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~ 424 (606)
T 3vq2_A 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424 (606)
T ss_dssp CCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCT
T ss_pred hccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccc
Confidence 34456666667777776644 26667778888888888888774 55788889999999999999987777 6788888
Q ss_pred cccceeecccccCCCCCchhhcCCCceeEEEccCCCCCC-CCCcccccCcccceeeccCccccCCCCchhhccCCceEEE
Q 004218 251 SLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSG-NLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLD 329 (767)
Q Consensus 251 ~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 329 (767)
+|. .+++++|.+.+..|..++.+++|+.|++++|.+++ ..|..+..+++|+.|++++|++++..|..+..+++|+.|+
T Consensus 425 ~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 503 (606)
T 3vq2_A 425 KLL-YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503 (606)
T ss_dssp TCC-EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCC-EEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEE
Confidence 884 45999999998899999999999999999999987 4788999999999999999999998899999999999999
Q ss_pred cCCcccCCCCCccccccccCceEeccCCcCcCcCCCCcccc-ccccccccCCcCccc
Q 004218 330 LSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFR-HTSMVHLEGNPKLCL 385 (767)
Q Consensus 330 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-~~~~~~l~~Np~~c~ 385 (767)
|++|++++..|..+..+++|+.|++++|+++.+++....++ ++..+++.+||+.|.
T Consensus 504 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~ 560 (606)
T 3vq2_A 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560 (606)
T ss_dssp CCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred CCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccC
Confidence 99999998889999999999999999999998777655565 588999999999994
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=363.65 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=201.5
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||+++++++. ..+..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECCEEE
Confidence 468999999999999999999964 58999999998766666778999999999999999999999864 445679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++|+|.+++.... +++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 94 lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp EEEECCTTCBHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEECCCCCCHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999999997643 89999999999999999999999 9999999999999999999999999998
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc-
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK- 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~- 691 (767)
........ ......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .........+.
T Consensus 164 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~ 236 (297)
T 3fxz_A 164 AQITPEQS------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPEL 236 (297)
T ss_dssp EECCSTTC------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCCC
T ss_pred eecCCccc------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCC
Confidence 76533211 12345699999999999999999999999999999999999999965322111 11111111111
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.....+++ .+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~----------------------~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 QNPEKLSA----------------------IFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCGGGSCH----------------------HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCH----------------------HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111111 12236778999999999999999874
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=396.75 Aligned_cols=380 Identities=24% Similarity=0.250 Sum_probs=270.1
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
+++|++|+|++|++++..|.. +..+++|++|++++|++.+..|..++++++|++|+|++|.+++..++.+..+++|++|
T Consensus 80 l~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 158 (606)
T 3t6q_A 80 QHRLDTLVLTANPLIFMAETA-LSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVL 158 (606)
T ss_dssp CTTCCEEECTTCCCSEECTTT-TSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEE
T ss_pred ccccCeeeCCCCcccccChhh-hcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEE
Confidence 467888888888887433444 4457788888888888776556667777777777777777775333344446777777
Q ss_pred eecCccccCCCC--------------------------CCccc-------------------------------------
Q 004218 81 NIGFNKIVGSGD--------------------------EGLSF------------------------------------- 97 (767)
Q Consensus 81 ~l~~n~l~~~~~--------------------------~~~~~------------------------------------- 97 (767)
++++|++...+. ..+..
T Consensus 159 ~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~ 238 (606)
T 3t6q_A 159 DFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238 (606)
T ss_dssp ECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTS
T ss_pred EcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccc
Confidence 777766543211 11000
Q ss_pred --------------------------------cccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCccccc
Q 004218 98 --------------------------------ITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGK 145 (767)
Q Consensus 98 --------------------------------~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~ 145 (767)
+..+.++++|++|++++|+++ .+|..+..+++ |++|++++|++.+.
T Consensus 239 ~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~-L~~L~l~~n~l~~~ 316 (606)
T 3t6q_A 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLST-LKKLVLSANKFENL 316 (606)
T ss_dssp CCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTT-CCEEECTTCCCSBG
T ss_pred cccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhccccc-CCEEECccCCcCcC
Confidence 011344556666666666666 55666666655 66666666666655
Q ss_pred CCccccCCCCCCEEECcCCcCcccCc-cccCCCCCCCEEEccCCcccccc--CcCcccCCCCceeeCCCCcCCCCCcccc
Q 004218 146 IPTSIGRLRSLTLLNLSYNSISGEIL-TEIGQLQELQSLDLAGNQISGSI--PNTLGNLKKLNQIDLSGNELASEIPTSF 222 (767)
Q Consensus 146 ~~~~l~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 222 (767)
.|..+..+++|++|++++|.+.+..+ ..+..+++|++|++++|.+.+.. +..+..+++|++|++++|++.+..|..|
T Consensus 317 ~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 396 (606)
T 3t6q_A 317 CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396 (606)
T ss_dssp GGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTT
T ss_pred chhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHh
Confidence 56666666666666666666653333 33667777777777777776554 5667777777777777777777677777
Q ss_pred cCccccccccccCcccCCCCCh-hhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCC---CCcccccC
Q 004218 223 GNFQNLLSIDLSNNKLNGNIPK-EILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGN---LPNSFKNC 298 (767)
Q Consensus 223 ~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~---~~~~~~~l 298 (767)
..+++|+.|++++|++.+..+. .+..+++|. .+++++|.+++..|..++.+++|+.|++++|.+++. .+..+..+
T Consensus 397 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l 475 (606)
T 3t6q_A 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLK-VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475 (606)
T ss_dssp TTCTTCSEEECTTCCEECCTTCCTTTTCTTCC-EEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGC
T ss_pred cCCccCCeEECCCCcCCCcccchhhhCcccCC-EEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccC
Confidence 7788888888888887765554 367777774 448888888877788888888888888888888752 33568888
Q ss_pred cccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCC-ccccccccccc
Q 004218 299 KSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE-GIFRHTSMVHL 377 (767)
Q Consensus 299 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~~~l 377 (767)
++|+.|++++|++++..|..|..+++|+.|+|++|++++..|..+..+++| .|++++|++++.+|.. ..++++..+++
T Consensus 476 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l 554 (606)
T 3t6q_A 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEEC
T ss_pred CCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeC
Confidence 888888888888888888888888889999999998888888888888888 8899999988877764 45678889999
Q ss_pred cCCcCccc
Q 004218 378 EGNPKLCL 385 (767)
Q Consensus 378 ~~Np~~c~ 385 (767)
.+|||.|.
T Consensus 555 ~~N~~~c~ 562 (606)
T 3t6q_A 555 RQNPLDCT 562 (606)
T ss_dssp TTCCEECS
T ss_pred CCCCcccc
Confidence 99999984
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=394.55 Aligned_cols=364 Identities=22% Similarity=0.283 Sum_probs=325.4
Q ss_pred CccEEeCCCCeeeecCCCccccCCCCCcEEEccCCc--------------------------------------------
Q 004218 3 SLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNK-------------------------------------------- 38 (767)
Q Consensus 3 ~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~-------------------------------------------- 38 (767)
.++.|+|++|++.|.+|..++ .|++|++|+|++|.
T Consensus 82 ~V~~L~L~~~~l~g~lp~~l~-~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~ 160 (636)
T 4eco_A 82 RVTGLSLEGFGASGRVPDAIG-QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160 (636)
T ss_dssp CEEEEECTTSCCEEEECGGGG-GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CEEEEEecCcccCCcCChHHh-cCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence 578999999999999998887 59999999999884
Q ss_pred ----------------------------------ccccCCccccCCCCCCEEEcccccCccc-----------------C
Q 004218 39 ----------------------------------FTGKIPGSLHNLTNIQIIRMAHNLLEGT-----------------V 67 (767)
Q Consensus 39 ----------------------------------l~~~~~~~l~~l~~L~~L~l~~n~i~~~-----------------~ 67 (767)
+++ +|..|+++++|++|+|++|.+++. +
T Consensus 161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~i 239 (636)
T 4eco_A 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239 (636)
T ss_dssp HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccC
Confidence 444 788999999999999999999985 9
Q ss_pred CccCC--CCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCc-cee-ecCchhhhh------ccccCeEEc
Q 004218 68 PPGLG--NLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQ-FEG-EIPESIGNL------SNVLSKLYM 137 (767)
Q Consensus 68 ~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~-l~~-~~~~~~~~l------~~~L~~L~l 137 (767)
|..++ ++++|++|+|++|++.+ .++..+.++++|++|++++|+ +++ .+|..++.+ ++ |++|++
T Consensus 240 p~~l~~~~l~~L~~L~L~~n~l~~------~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~-L~~L~L 312 (636)
T 4eco_A 240 TEDLKWDNLKDLTDVEVYNCPNLT------KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK-IQIIYI 312 (636)
T ss_dssp TSCCCGGGCTTCCEEEEECCTTCS------SCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGT-CCEEEC
T ss_pred chhhhhcccCCCCEEEecCCcCCc------cChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCC-CCEEEC
Confidence 99999 99999999999999865 567789999999999999998 998 899999987 76 999999
Q ss_pred cCCcccccCCc--cccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCC-CceeeCCCCcC
Q 004218 138 GGNRFYGKIPT--SIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKK-LNQIDLSGNEL 214 (767)
Q Consensus 138 ~~n~i~~~~~~--~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~-L~~L~L~~N~l 214 (767)
++|+++ .+|. .++++++|++|++++|.+++.+| .+..+++|++|+|++|++. .+|..+..+++ |++|++++|++
T Consensus 313 ~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l 389 (636)
T 4eco_A 313 GYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKL 389 (636)
T ss_dssp CSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCC
T ss_pred CCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcC
Confidence 999999 7888 99999999999999999998888 8999999999999999999 88989999999 99999999999
Q ss_pred CCCCcccccCcc--ccccccccCcccCCCCChhhc-------ccccccceeecccccCCCCCchhhcCCCceeEEEccCC
Q 004218 215 ASEIPTSFGNFQ--NLLSIDLSNNKLNGNIPKEIL-------SLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSAN 285 (767)
Q Consensus 215 ~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~-------~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n 285 (767)
+ .+|..+..++ +|+.|++++|.+.+..|..+. .++++ +.+++++|.++...+..+..+++|+.|+|++|
T Consensus 390 ~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L-~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N 467 (636)
T 4eco_A 390 K-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV-SSINLSNNQISKFPKELFSTGSPLSSINLMGN 467 (636)
T ss_dssp S-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCE-EEEECCSSCCCSCCTHHHHTTCCCSEEECCSS
T ss_pred c-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCC-CEEECcCCccCcCCHHHHccCCCCCEEECCCC
Confidence 8 6788887655 999999999999999998888 77788 44599999999666666778999999999999
Q ss_pred CCCCCCCcccccCc-------ccceeeccCccccCCCCchhh--ccCCceEEEcCCcccCCCCCccccccccCceEec--
Q 004218 286 GLSGNLPNSFKNCK-------SLEKLLMANNKFSGPIPNILA--ELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNL-- 354 (767)
Q Consensus 286 ~l~~~~~~~~~~l~-------~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l-- 354 (767)
.++.+.+..+..+. +|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|++
T Consensus 468 ~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~ 545 (636)
T 4eco_A 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545 (636)
T ss_dssp CCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCS
T ss_pred CCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCC
Confidence 99955544554433 9999999999999 6788876 99999999999999997 8999999999999999
Q ss_pred ----cCCcCcCcCCCC-ccccccccccccCCcC
Q 004218 355 ----TFNNLEGVVPRE-GIFRHTSMVHLEGNPK 382 (767)
Q Consensus 355 ----~~N~l~~~~~~~-~~~~~~~~~~l~~Np~ 382 (767)
++|++.+..|.. ..++++..+++.+|..
T Consensus 546 N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 578 (636)
T 4eco_A 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578 (636)
T ss_dssp CBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred CcccccCcccccChHHHhcCCCCCEEECCCCcC
Confidence 567788777654 5678899999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=368.88 Aligned_cols=285 Identities=34% Similarity=0.562 Sum_probs=218.7
Q ss_pred cCHHHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC
Q 004218 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLD 524 (767)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 524 (767)
+++.++...+++|++.+.||+|+||.||+|.+++++.||||++........+.+.+|+++++.++||||+++++++.
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 105 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD--- 105 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC---
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc---
Confidence 33445556789999999999999999999998889999999987666666788999999999999999999999954
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA 604 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~ 604 (767)
..+..++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 106 --~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~ 178 (321)
T 2qkw_B 106 --ERNEMILIYKYMENGNLKRHLYGSDLP--TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP 178 (321)
T ss_dssp --CTTCCEEEEECCTTCBTGGGSSSSCCC--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCE
T ss_pred --CCCeEEEEEEcCCCCcHHHHHhccCCC--ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCE
Confidence 445679999999999999999764421 33589999999999999999999999 99999999999999999999
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc-chhh
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-SLVK 683 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~ 683 (767)
||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ....
T Consensus 179 kl~Dfg~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~ 254 (321)
T 2qkw_B 179 KITDFGISKKGTELDQT----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254 (321)
T ss_dssp EECCCTTCEECSSSSCC----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH
T ss_pred EEeeccccccccccccc----ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH
Confidence 99999999754322111 112334589999999999888899999999999999999999999976544322 2222
Q ss_pred Hhhhhccc-chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 684 WVESNFPK-NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 684 ~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
+....... .....+++.+.... .. .....+.+++.+||+.||++|||++|++++|+.+.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~------~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 255 WAVESHNNGQLEQIVDPNLADKI------RP----ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HTHHHHTTTCCCSSSSSSCTTCS------CH----HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhhccccccHHHhcChhhcccc------CH----HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 22111110 01111111000000 01 111223337779999999999999999999998875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=365.56 Aligned_cols=270 Identities=24% Similarity=0.346 Sum_probs=209.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++. ++...+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeE
Confidence 367889999999999999999976 48999999986655566788999999999999999999999964 445679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++|+|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp EEEECCTTCBHHHHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccc
Confidence 9999999999999997643 2399999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCc--------cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhH
Q 004218 613 RSLLERIGNQS--------SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 613 ~~~~~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 684 (767)
+.......... .........||+.|+|||++.+..++.++||||||+++|||++|..|+.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 235 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence 86544322111 0011124569999999999999999999999999999999999999986643332211111
Q ss_pred hhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhhc
Q 004218 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKR 758 (767)
Q Consensus 685 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 758 (767)
............+++ .+.+++.+||+.||++|||+.|+++.|+.++......
T Consensus 236 ~~~~~~~~~~~~~~~----------------------~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~ 287 (310)
T 3s95_A 236 VRGFLDRYCPPNCPP----------------------SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287 (310)
T ss_dssp HHHHHHHTCCTTCCT----------------------THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred hhccccccCCCCCCH----------------------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence 110000000000111 1122677899999999999999999999998876543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=392.06 Aligned_cols=382 Identities=25% Similarity=0.271 Sum_probs=222.4
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
|++|++|+|++|+++ .+|...+..+++|++|++++|++.+..|..|+++++|++|+|++|.+++..|..++.+++|++|
T Consensus 72 l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 150 (680)
T 1ziw_A 72 LPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQEL 150 (680)
T ss_dssp CTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEE
T ss_pred ccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEE
Confidence 467888888888887 7887666678888888888888886666778888888888888888887777778888888888
Q ss_pred eecCccccCCCCCCccc--------------------c------------------------------------------
Q 004218 81 NIGFNKIVGSGDEGLSF--------------------I------------------------------------------ 98 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~~~--------------------~------------------------------------------ 98 (767)
++++|++.+.+...+.. +
T Consensus 151 ~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~ 230 (680)
T 1ziw_A 151 LLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLS 230 (680)
T ss_dssp ECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECT
T ss_pred EccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEcc
Confidence 88887765433211000 0
Q ss_pred ---------ccccCC--CCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccC---------------
Q 004218 99 ---------TSLTNS--TRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGR--------------- 152 (767)
Q Consensus 99 ---------~~l~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~--------------- 152 (767)
..+.++ ++|+.|++++|++++..|..+..+++ |++|++++|++.+..|..|.+
T Consensus 231 ~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~ 309 (680)
T 1ziw_A 231 NSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ-LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309 (680)
T ss_dssp TSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTT-CCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCC
T ss_pred CCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCccc-ccEeeCCCCccCccChhhhcCCCCccEEeccchhhh
Confidence 011111 12555555555555444444444444 555555555554433332222
Q ss_pred ------------------CCCCCEEECcCCcCcccCccccCCCCCCCEEEccC---------------------------
Q 004218 153 ------------------LRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAG--------------------------- 187 (767)
Q Consensus 153 ------------------l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~--------------------------- 187 (767)
+++|++|++++|.+++..+..|..+++|++|++++
T Consensus 310 ~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~ 389 (680)
T 1ziw_A 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLT 389 (680)
T ss_dssp C------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECT
T ss_pred cccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECC
Confidence 23333333333333333333333333333333322
Q ss_pred -CccccccCcCcccCCCCceeeCCCCcCCCCCc-ccccCccccccccccCcccCC-------------------------
Q 004218 188 -NQISGSIPNTLGNLKKLNQIDLSGNELASEIP-TSFGNFQNLLSIDLSNNKLNG------------------------- 240 (767)
Q Consensus 188 -n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~n~l~~------------------------- 240 (767)
|++.+..|..|..+++|+.|+|++|++++.+| ..|.++++|++|++++|++.+
T Consensus 390 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~ 469 (680)
T 1ziw_A 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469 (680)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCT
T ss_pred CCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccccc
Confidence 22222223333444444444444444432222 333344444444444443321
Q ss_pred -CCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCC--------cccccCcccceeeccCccc
Q 004218 241 -NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLP--------NSFKNCKSLEKLLMANNKF 311 (767)
Q Consensus 241 -~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~--------~~~~~l~~L~~L~l~~n~l 311 (767)
..|..+..+++| +.+++++|.+++..+..+..+++|+.|++++|.+++..+ ..|..+++|+.|++++|++
T Consensus 470 ~~~p~~~~~l~~L-~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 548 (680)
T 1ziw_A 470 DSSPSPFQPLRNL-TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGF 548 (680)
T ss_dssp TCSSCTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCC
T ss_pred ccCCcccccCCCC-CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCC
Confidence 233344444555 333666666665555556666666666666666654311 2256666777777777777
Q ss_pred cCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCc--cccccccccccCCcCccc
Q 004218 312 SGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREG--IFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 312 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~~~~~~~l~~Np~~c~ 385 (767)
+.+.+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++++.++... .++++..+++.+|||.|.
T Consensus 549 ~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 549 DEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred CCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 75445567778888888888888876666667778888888888888887766532 467888999999999995
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=384.38 Aligned_cols=369 Identities=21% Similarity=0.210 Sum_probs=231.7
Q ss_pred CccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEee
Q 004218 3 SLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNI 82 (767)
Q Consensus 3 ~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 82 (767)
++++|||++|+++ .++...+.++++|++|+|++|++.+..|..|.++++|++|+|++|.+++..|..|+.+++|++|++
T Consensus 34 ~l~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 34 STECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TCCEEECTTCCCS-EECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred cCcEEEccCCccC-cCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 4666777777776 444444445667777777777666666666666777777777777666666666666666666666
Q ss_pred cCccccCCCCCCccccccccCC------------------------CCCCEEECcCCcceeecCchhhhhccccC--eEE
Q 004218 83 GFNKIVGSGDEGLSFITSLTNS------------------------TRLNFLAFDGNQFEGEIPESIGNLSNVLS--KLY 136 (767)
Q Consensus 83 ~~n~l~~~~~~~~~~~~~l~~l------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~~L~--~L~ 136 (767)
++|++...+ +..+.++ ++|++|++++|++++..|..+..+.+ |+ +|+
T Consensus 113 ~~n~i~~l~------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~l~L~ 185 (606)
T 3t6q_A 113 IQTGISSID------FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ-ATNLSLN 185 (606)
T ss_dssp TTSCCSCGG------GSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTT-CCSEEEE
T ss_pred cccCcccCC------cchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcc-cceeEEe
Confidence 666665421 1223444 44444555544444444444444444 44 444
Q ss_pred ccCCcccccCCccccCC---------------------------------------------------CCCCEEECcCCc
Q 004218 137 MGGNRFYGKIPTSIGRL---------------------------------------------------RSLTLLNLSYNS 165 (767)
Q Consensus 137 l~~n~i~~~~~~~l~~l---------------------------------------------------~~L~~L~l~~n~ 165 (767)
+++|++.+..|..+... .+|+.|++++|.
T Consensus 186 l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~ 265 (606)
T 3t6q_A 186 LNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265 (606)
T ss_dssp CTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCC
T ss_pred cCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCc
Confidence 44444443333222110 033344444444
Q ss_pred CcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCCh-
Q 004218 166 ISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPK- 244 (767)
Q Consensus 166 i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~- 244 (767)
+++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+..+++|++|++++|.+.+.++.
T Consensus 266 l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~ 344 (606)
T 3t6q_A 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344 (606)
T ss_dssp CSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSS
T ss_pred cCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchh
Confidence 44444445667777888888888877 6677777778888888888887766677777777777777777777755554
Q ss_pred hhcccccccceeecccccCCCCC--chhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCc-hhhc
Q 004218 245 EILSLSSLTTIVNLSKNFLDGTL--PEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPN-ILAE 321 (767)
Q Consensus 245 ~~~~l~~l~~~l~l~~n~l~~~~--~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~ 321 (767)
.+..+++|. .+++++|.+++.. +..++.+++|+.|++++|.+++..|..|..+++|+.|++++|++++..+. .+..
T Consensus 345 ~~~~l~~L~-~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 423 (606)
T 3t6q_A 345 CLENLENLR-ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423 (606)
T ss_dssp TTTTCTTCC-EEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTT
T ss_pred hhhccCcCC-EEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhC
Confidence 366677763 3477777777554 56677777777777777777766677777777777777777777765443 3667
Q ss_pred cCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcC-CC---CccccccccccccCCc
Q 004218 322 LKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVV-PR---EGIFRHTSMVHLEGNP 381 (767)
Q Consensus 322 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~---~~~~~~~~~~~l~~Np 381 (767)
+++|+.|++++|.+++..|..+..+++|++|++++|++++.. +. ...++++..+++.+|.
T Consensus 424 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~ 487 (606)
T 3t6q_A 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487 (606)
T ss_dssp CTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred cccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence 777777777777777666777777777777777777776521 11 1334556666666664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=390.65 Aligned_cols=363 Identities=23% Similarity=0.339 Sum_probs=260.8
Q ss_pred CccEEeCCCCeeeecCCCccccCCCCCcEEEc-cCCccccc---------------------------------------
Q 004218 3 SLVYLGLASNQLWGEIPYDVGDKLPNLLGFNF-CFNKFTGK--------------------------------------- 42 (767)
Q Consensus 3 ~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l-~~n~l~~~--------------------------------------- 42 (767)
.++.|+|++|++.|.+|..++ .|++|++|+| ++|.+.|.
T Consensus 324 ~V~~L~Ls~~~L~G~ip~~l~-~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 324 RVTGLSLAGFGAKGRVPDAIG-QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp CEEEEECTTTCCEEEECGGGG-GCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CEEEEECccCCCCCcCchHHh-ccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 578899999999999998887 4999999999 77754433
Q ss_pred -------------------------------------CCccccCCCCCCEEEcccccCcc-----------------cCC
Q 004218 43 -------------------------------------IPGSLHNLTNIQIIRMAHNLLEG-----------------TVP 68 (767)
Q Consensus 43 -------------------------------------~~~~l~~l~~L~~L~l~~n~i~~-----------------~~~ 68 (767)
+|..|+++++|++|+|++|.+++ .+|
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP 482 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCC
Confidence 78889999999999999999997 388
Q ss_pred ccCC--CCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCc-cee-ecCchhhhhc-------cccCeEEc
Q 004218 69 PGLG--NLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQ-FEG-EIPESIGNLS-------NVLSKLYM 137 (767)
Q Consensus 69 ~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~-l~~-~~~~~~~~l~-------~~L~~L~l 137 (767)
..++ ++++|++|+|++|++.+ .++..+.++++|+.|+|++|+ +++ .+|..++.+. + |++|+|
T Consensus 483 ~~l~f~~L~~L~~L~Ls~N~l~~------~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~-L~~L~L 555 (876)
T 4ecn_A 483 EELSWSNLKDLTDVELYNCPNMT------QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK-IQIFYM 555 (876)
T ss_dssp SCCCGGGCTTCCEEEEESCTTCC------SCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTT-CCEEEC
T ss_pred hhhhhccCCCCCEEECcCCCCCc------cChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCC-ccEEEe
Confidence 8888 99999999999998764 566788899999999999998 887 7888888877 6 999999
Q ss_pred cCCcccccCCc--cccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCC-CceeeCCCCcC
Q 004218 138 GGNRFYGKIPT--SIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKK-LNQIDLSGNEL 214 (767)
Q Consensus 138 ~~n~i~~~~~~--~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~-L~~L~L~~N~l 214 (767)
++|+++ .+|. .|.++++|++|+|++|.++ .+| .|..+++|++|+|++|++. .+|..+..+++ |+.|+|++|++
T Consensus 556 s~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L 631 (876)
T 4ecn_A 556 GYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKL 631 (876)
T ss_dssp CSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCC
T ss_pred eCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCC
Confidence 999998 7787 8999999999999999998 666 8888999999999999988 78888888888 99999999888
Q ss_pred CCCCcccccCccc--cccccccCcccCCCCC----------------------------hhhc-ccccccceeecccccC
Q 004218 215 ASEIPTSFGNFQN--LLSIDLSNNKLNGNIP----------------------------KEIL-SLSSLTTIVNLSKNFL 263 (767)
Q Consensus 215 ~~~~~~~~~~l~~--L~~L~l~~n~l~~~~~----------------------------~~~~-~l~~l~~~l~l~~n~l 263 (767)
+ .+|..+..++. |+.|+|++|++.+.+| ..+. .+++| +.|+|++|.+
T Consensus 632 ~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L-~~L~Ls~N~L 709 (876)
T 4ecn_A 632 K-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI-STIILSNNLM 709 (876)
T ss_dssp C-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCC-SEEECCSCCC
T ss_pred C-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCC-CEEECCCCcC
Confidence 7 56666655433 6666666666654433 2222 34444 2235555555
Q ss_pred CCCCchh-hcC-------CCceeEEEccCCCCCCCCCcccc--cCcccceeeccCccccCCCCchhhccCCceEEEcCC-
Q 004218 264 DGTLPEE-IGM-------LGNVVTIDLSANGLSGNLPNSFK--NCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSS- 332 (767)
Q Consensus 264 ~~~~~~~-~~~-------l~~L~~L~ls~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~- 332 (767)
+ .+|.. +.. +++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++
T Consensus 710 ~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N 786 (876)
T 4ecn_A 710 T-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ 786 (876)
T ss_dssp S-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCC
T ss_pred C-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCC
Confidence 5 22222 221 125666666666665 4455554 56666666666666664 455566666666666654
Q ss_pred -----cccCCCCCccccccccCceEeccCCcCcCcCCCCccccccccccccCCcCcc
Q 004218 333 -----NKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC 384 (767)
Q Consensus 333 -----N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c 384 (767)
|.+.+.+|..+..+++|+.|+|++|++..+ |.. ..+++..+++.+||+..
T Consensus 787 ~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L~~I-p~~-l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKV-DEK-LTPQLYILDIADNPNIS 841 (876)
T ss_dssp BCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBC-CSC-CCSSSCEEECCSCTTCE
T ss_pred CCcccccccccChHHHhcCCCCCEEECCCCCCCcc-CHh-hcCCCCEEECCCCCCCc
Confidence 555556666666666666666666666333 222 22455666666666543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=366.35 Aligned_cols=289 Identities=36% Similarity=0.570 Sum_probs=221.9
Q ss_pred CCCCccCHHHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEe
Q 004218 440 HSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLIT 518 (767)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~ 518 (767)
.....++++++....++|++.+.||+|+||.||+|...+++.||||++..... .....+.+|+++++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34567889999999999999999999999999999988899999999865432 23447899999999999999999999
Q ss_pred eeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 519 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
++. .....++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+++..+|+||||||+||++
T Consensus 95 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~ 167 (326)
T 3uim_A 95 FCM-----TPTERLLVYPYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167 (326)
T ss_dssp EEC-----CSSCCEEEEECCTTCBHHHHHHCCSTT--CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred EEe-----cCCceEEEEEeccCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence 964 344568999999999999999865432 3459999999999999999999999766699999999999999
Q ss_pred CCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcc---
Q 004218 599 DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF--- 675 (767)
Q Consensus 599 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~--- 675 (767)
+.++.+||+|||.++...... ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||+...
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 168 DEEFEAVVGDFGLAKLMDYKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp CTTCCEEECCCSSCEECCSSS-----SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred CCCCCEEeccCccccccCccc-----ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 999999999999997653221 112234558999999999988889999999999999999999999996321
Q ss_pred cCCcchhhHhhhhcccc-hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 676 AGEVSLVKWVESNFPKN-AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 676 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
........+........ .....+..+.... . .+.... +.+++.+||+.||++|||++|++++|+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---~~~~~~-l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNY------K---DEEVEQ-LIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSC------C---HHHHHH-HHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ccchhHHHHHHHHhhchhhhhhcChhhcccc------C---HHHHHH-HHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 12223333433322221 1111111110000 0 111122 2237779999999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=363.28 Aligned_cols=268 Identities=29% Similarity=0.420 Sum_probs=198.8
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc
Q 004218 448 DELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF 525 (767)
Q Consensus 448 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 525 (767)
+++....++|++.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 104 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT---- 104 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE----
Confidence 334445678999999999999999999885 8899999986543 233467889999999999999999999964
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeCCCCc
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVP--IVHCDLKPGNILLDEDMT 603 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~ 603 (767)
.....++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++.
T Consensus 105 -~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 105 -QPPNLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp -STTCCEEEEECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCC
T ss_pred -ECCceEEEEecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCc
Confidence 44557999999999999999976432 12389999999999999999999998 8 999999999999999999
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhh
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK 683 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 683 (767)
+||+|||+++...... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ...
T Consensus 178 ~kL~Dfg~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~ 249 (309)
T 3p86_A 178 VKVCDFGLSRLKASTF------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVA 249 (309)
T ss_dssp EEECCCC-----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHH
T ss_pred EEECCCCCCccccccc------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence 9999999997543321 11234568999999999999999999999999999999999999996532211 111
Q ss_pred Hhh-hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhh
Q 004218 684 WVE-SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757 (767)
Q Consensus 684 ~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 757 (767)
.+. .......+..+++. +.+++.+||+.||++|||++|+++.|+.+.+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 250 AVGFKCKRLEIPRNLNPQ----------------------VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp HHHHSCCCCCCCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred HHHhcCCCCCCCccCCHH----------------------HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 111 01111111112221 22267789999999999999999999988765443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=359.39 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=207.7
Q ss_pred CCccCHHHHHHHhcC----------CCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCC
Q 004218 442 PQMISYDELRRATGN----------FSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRH 510 (767)
Q Consensus 442 ~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h 510 (767)
...+++++++.+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356788888888765 677789999999999999976 699999999987666667789999999999999
Q ss_pred CCceeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 004218 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCD 590 (767)
Q Consensus 511 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 590 (767)
|||+++++++. .....++||||+++|+|.+++.... +++..+..++.|++.||+|||+. +|+|||
T Consensus 102 ~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~-------l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D 166 (321)
T 2c30_A 102 FNVVEMYKSYL-----VGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLHAQ---GVIHRD 166 (321)
T ss_dssp TTBCCEEEEEE-----ETTEEEEEECCCCSCBHHHHHTTCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CCcceEEEEEE-----ECCEEEEEEecCCCCCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence 99999999964 3456799999999999999986532 99999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCC
Q 004218 591 LKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670 (767)
Q Consensus 591 lkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 670 (767)
|||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||+|+++|+|++|+.|
T Consensus 167 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 240 (321)
T 2c30_A 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVP------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240 (321)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSSSC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCHHHEEECCCCcEEEeeeeeeeecccCcc------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999976533211 12345689999999999999999999999999999999999999
Q ss_pred CCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 671 THESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
|...... .....+....+.... ......+ .+.+++.+||+.||++|||++|++++
T Consensus 241 f~~~~~~--~~~~~~~~~~~~~~~----------------~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 241 YFSDSPV--QAMKRLRDSPPPKLK----------------NSHKVSP----VLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp TTTSCHH--HHHHHHHHSSCCCCT----------------TGGGSCH----HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCHH--HHHHHHhcCCCCCcC----------------ccccCCH----HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9653211 111111111111000 0000111 12236678999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=365.20 Aligned_cols=266 Identities=24% Similarity=0.400 Sum_probs=206.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC--------CCcEEEEEEeeccCC-cchhhHHHHHHHHhcC-CCCCceeEEeeeecC
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR--------EGISVAVKVLDIEST-GTWKSFFAECEALRNT-RHRNLVKLITSCSSL 523 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 523 (767)
.++|++.+.||+|+||.||+|.+. ++..||||+++.... ...+.+.+|+++++.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 467899999999999999999862 356799999965432 3456789999999999 8999999999964
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKP 593 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 593 (767)
..+.+++||||+++|+|.+++...+.. .....+++.+++.++.|++.||+|||++ +|+||||||
T Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 445679999999999999999865421 1123589999999999999999999999 999999999
Q ss_pred CCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 004218 594 GNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTH 672 (767)
Q Consensus 594 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 672 (767)
+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTT----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred hhEEECCCCCEEEccccCCcccCcccce----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999865432211 11233457889999999999999999999999999999999 999986
Q ss_pred CcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 673 ESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
..... .....+........+..+... +.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 308 ~~~~~--~~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 308 GIPVE--ELFKLLKEGHRMDKPANCTNE----------------------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp TCCGG--GHHHHHHTTCCCCCCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHH--HHHHHHhcCCCCCCCCCCCHH----------------------HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 53221 122222221111111111211 222667899999999999999999999987
Q ss_pred HHH
Q 004218 753 KIL 755 (767)
Q Consensus 753 ~~~ 755 (767)
...
T Consensus 364 ~~~ 366 (370)
T 2psq_A 364 TLT 366 (370)
T ss_dssp HHH
T ss_pred HHh
Confidence 644
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=361.82 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=199.2
Q ss_pred HHhcCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
...++|++.+.||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|+++++.++||||+++++++. ..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~ 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TE 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence 3457899999999999999999997 469999999996542 234567889999999999999999999954 45
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++|+|.+++..... +++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~------l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~D 157 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGR------MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIAD 157 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred CEEEEEEECCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEee
Confidence 678999999999999999976543 99999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCC-CcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPS-TAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
||++...... .......||+.|+|||++.+..+. .++||||+||++|+|++|+.||...... .....+..
T Consensus 158 FG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~ 228 (328)
T 3fe3_A 158 FGFSNEFTVG-------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRERVLR 228 (328)
T ss_dssp TTCCGGGSSS-------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred ccCceecCCC-------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHh
Confidence 9999765322 122445799999999999887764 7899999999999999999999653211 11111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
... ..+..+++. +.+++.+||+.||++|||++|++++
T Consensus 229 ~~~-~~p~~~s~~----------------------~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 229 GKY-RIPFYMSTD----------------------CENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCC-CCCTTSCHH----------------------HHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCC-CCCCCCCHH----------------------HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 011111111 2236778999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=361.03 Aligned_cols=264 Identities=25% Similarity=0.380 Sum_probs=203.6
Q ss_pred hcCCCCCCccccccceEEEEEEeC----CCcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|++.+.||+|+||.||+|.+. .+..||||++... .....+.+.+|+++++.++||||+++++++. .+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----RG 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----GG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence 457888999999999999999975 3556999999754 2334567899999999999999999999963 45
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 194 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD 194 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECC
Confidence 56799999999999999996543 2399999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 687 (767)
||+++......... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+..
T Consensus 195 fg~a~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~ 269 (325)
T 3kul_A 195 FGLSRVLEDDPDAA---YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVEE 269 (325)
T ss_dssp CSSCEECC----CC---EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHT
T ss_pred CCcccccccCccce---eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHc
Confidence 99998664432111 11223346778999999988889999999999999999999 99998653221 11111211
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhh
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 757 (767)
.........+.+. +.+++.+||+.||++|||+.|+++.|+.+.+....
T Consensus 270 ~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 270 GYRLPAPMGCPHA----------------------LHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp TCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CCCCCCCCCcCHH----------------------HHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 1111111111211 22267789999999999999999999998775443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=383.53 Aligned_cols=370 Identities=23% Similarity=0.265 Sum_probs=254.0
Q ss_pred CccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEee
Q 004218 3 SLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNI 82 (767)
Q Consensus 3 ~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 82 (767)
++++|||++|+++ .++...+..+++|++|+|++|++.+..|..|.++++|++|+|++|.+++..|..|+.+++|++|++
T Consensus 29 ~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 29 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SCCEEECCSCCCC-EECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred cccEEEccCCccC-ccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 4667777777776 455544555677777777777776655666677777777777777766555566666666666666
Q ss_pred cCccccCCCCCCccccccccCCCCCCEEECcCCccee-ecCchhhhhccccCeEEccCCcccccCCccccCCC-------
Q 004218 83 GFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG-EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLR------- 154 (767)
Q Consensus 83 ~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~------- 154 (767)
++|++...+.. .+.++++|++|++++|.+++ .+|..++++++ |++|++++|++++..+..++.++
T Consensus 108 ~~n~l~~l~~~------~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~ 180 (570)
T 2z63_A 108 VETNLASLENF------PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN-LEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180 (570)
T ss_dssp TTSCCCCSTTC------SCTTCTTCCEEECCSSCCCCCCCCGGGGGCTT-CCEEECTTSCCCEECGGGGHHHHTCTTCCC
T ss_pred cccccccCCCc------cccccccccEEecCCCccceecChhhhcccCC-CCEEeCcCCccceecHHHccchhccchhhh
Confidence 66666543221 24455555555555555553 24555555555 55555555555544444443333
Q ss_pred --------------------------------------------------------------------------------
Q 004218 155 -------------------------------------------------------------------------------- 154 (767)
Q Consensus 155 -------------------------------------------------------------------------------- 154 (767)
T Consensus 181 ~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~ 260 (570)
T 2z63_A 181 SLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260 (570)
T ss_dssp EEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEE
T ss_pred hcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchh
Confidence
Q ss_pred ----------------------CCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcC-c-------------
Q 004218 155 ----------------------SLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNT-L------------- 198 (767)
Q Consensus 155 ----------------------~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~-~------------- 198 (767)
+|++|++++|.++ .+|..+..+ +|++|++++|.+. .+|.. +
T Consensus 261 ~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~~~l~~L~~L~l~~n~~ 337 (570)
T 2z63_A 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKG 337 (570)
T ss_dssp EEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCBCBCSSCCEEEEESCBS
T ss_pred hhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCcccccccCEEeCcCCcc
Confidence 3444444444443 233333333 4444444444433 22211 0
Q ss_pred ------ccCCCCceeeCCCCcCCCCC--cccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCc-h
Q 004218 199 ------GNLKKLNQIDLSGNELASEI--PTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLP-E 269 (767)
Q Consensus 199 ------~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~-~ 269 (767)
..+++|++|++++|++++.. +..+..+++|++|++++|.+.+ ++..+..+++|. .+++++|.+.+..+ .
T Consensus 338 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~l~~L~-~L~l~~n~l~~~~~~~ 415 (570)
T 2z63_A 338 GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLE-HLDFQHSNLKQMSEFS 415 (570)
T ss_dssp CCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE-EEEEEETCTTCC-EEECTTSEEESCTTSC
T ss_pred ccccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc-ccccccccCCCC-EEEccCCccccccchh
Confidence 34566666666666665432 4556677778888888887774 344477888884 44899998887665 5
Q ss_pred hhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCcccc-CCCCchhhccCCceEEEcCCcccCCCCCcccccccc
Q 004218 270 EIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFS-GPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRA 348 (767)
Q Consensus 270 ~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 348 (767)
.+..+++|+.|++++|.+++..|..+..+++|+.|++++|.++ +.+|..+..+++|+.|+|++|++++..|..+..+++
T Consensus 416 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 495 (570)
T 2z63_A 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495 (570)
T ss_dssp TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred hhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccC
Confidence 7889999999999999999889999999999999999999998 578899999999999999999999888999999999
Q ss_pred CceEeccCCcCcCcCCCC-ccccccccccccCCcCccc
Q 004218 349 LRSLNLTFNNLEGVVPRE-GIFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 349 L~~L~l~~N~l~~~~~~~-~~~~~~~~~~l~~Np~~c~ 385 (767)
|+.|++++|++++.++.. ..++++..+++.+||+.|.
T Consensus 496 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 999999999999988764 5678889999999999885
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=349.05 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=205.2
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+++.+|++++++++||||+++++++. +....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceEE
Confidence 35788999999999999999999889999999997443 33467899999999999999999999964 4456799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++
T Consensus 83 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp EEECCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred EEEeCCCCcHHHHHHhcC-----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccc
Confidence 999999999999997643 2489999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
....... .......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||...... .....+.......
T Consensus 155 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~~ 227 (269)
T 4hcu_A 155 FVLDDQY-----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLY 227 (269)
T ss_dssp GBCCHHH-----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCC
T ss_pred ccccccc-----ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCccCC
Confidence 6543211 11123446788999999988899999999999999999999 99998653221 1111122111111
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
.+...++. +.+++.+||+.||++|||++|++++|+++.+
T Consensus 228 ~~~~~~~~----------------------~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KPRLASTH----------------------VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHH----------------------HHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11222221 2226678999999999999999999998865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=359.25 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=198.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++. .+...
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence 468999999999999999999976 58999999986443 233467889999999999999999999954 45667
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence 99999999999999997543 399999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
++....... ........||+.|+|||++.+..+ +.++||||+||++|+|++|+.||............+......
T Consensus 152 a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 227 (323)
T 3tki_A 152 ATVFRYNNR----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227 (323)
T ss_dssp CEECEETTE----ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT
T ss_pred cceeccCCc----ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc
Confidence 976533211 111234569999999999887775 778999999999999999999997654433333333222111
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
......+++. +.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~~----------------------~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 LNPWKKIDSA----------------------PLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp STTGGGSCHH----------------------HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHH----------------------HHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111112211 1226678999999999999999875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=377.60 Aligned_cols=358 Identities=22% Similarity=0.269 Sum_probs=285.1
Q ss_pred cEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecC
Q 004218 5 VYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGF 84 (767)
Q Consensus 5 ~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (767)
++||+++|+++ .+|..++ ++|++|++++|.+.+..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++
T Consensus 3 ~~l~ls~n~l~-~ip~~~~---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 78 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH 78 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC---TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCS
T ss_pred ceEecCCCCcc-ccccccc---ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCC
Confidence 57888888888 7887765 6888888888888876667888888888888888888877788888888888888888
Q ss_pred ccccCCCCCCccccccccCCCCCCEEECcCCccee-ecCchhhhhccccCeEEccCCcccccCCccccCCCCC--CEEEC
Q 004218 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG-EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSL--TLLNL 161 (767)
Q Consensus 85 n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L--~~L~l 161 (767)
|+++. ++.. .+++|++|++++|++++ .+|..++++++ |++|++++|++++ ..+..+++| ++|++
T Consensus 79 N~l~~-------lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~-L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l 145 (520)
T 2z7x_B 79 NKLVK-------ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQ-LKFLGLSTTHLEK---SSVLPIAHLNISKVLL 145 (520)
T ss_dssp SCCCE-------EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTT-CCEEEEEESSCCG---GGGGGGTTSCEEEEEE
T ss_pred Cceee-------cCcc--ccCCccEEeccCCccccccchhhhccCCc-ceEEEecCcccch---hhccccccceeeEEEe
Confidence 88863 3333 67888888888888876 46788888887 8888888888874 345666666 88888
Q ss_pred cCCcC--cccCccccCCCC-------------------------------------------------------------
Q 004218 162 SYNSI--SGEILTEIGQLQ------------------------------------------------------------- 178 (767)
Q Consensus 162 ~~n~i--~~~~~~~~~~l~------------------------------------------------------------- 178 (767)
++|.+ .+..|..+..+.
T Consensus 146 ~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L 225 (520)
T 2z7x_B 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225 (520)
T ss_dssp EECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEE
T ss_pred ecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhc
Confidence 88777 445555444422
Q ss_pred ----------------------CCCEEEccCCccccccCcCc-----ccCCCCceeeCCCCcC-----------------
Q 004218 179 ----------------------ELQSLDLAGNQISGSIPNTL-----GNLKKLNQIDLSGNEL----------------- 214 (767)
Q Consensus 179 ----------------------~L~~L~L~~n~i~~~~~~~~-----~~l~~L~~L~L~~N~l----------------- 214 (767)
+|++|++++|++.+.+|..+ ..+++|+.+++++|.+
T Consensus 226 ~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~ 305 (520)
T 2z7x_B 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIK 305 (520)
T ss_dssp EEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCS
T ss_pred cccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCcee
Confidence 67777777777776777766 5565555555555554
Q ss_pred ---------CCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCC--CCchhhcCCCceeEEEcc
Q 004218 215 ---------ASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDG--TLPEEIGMLGNVVTIDLS 283 (767)
Q Consensus 215 ---------~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~--~~~~~~~~l~~L~~L~ls 283 (767)
.... .+..+++|++|++++|++++..|..+..+++|. .+++++|++++ ..|..++.+++|+.|+++
T Consensus 306 ~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~-~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls 382 (520)
T 2z7x_B 306 NFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELE-TLILQMNQLKELSKIAEMTTQMKSLQQLDIS 382 (520)
T ss_dssp EEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCC-EEECCSSCCCBHHHHHHHHTTCTTCCEEECC
T ss_pred EEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCC-EEEccCCccCccccchHHHhhCCCCCEEECC
Confidence 2211 126789999999999999988999999999995 45999999997 456789999999999999
Q ss_pred CCCCCCCCC-cccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCc
Q 004218 284 ANGLSGNLP-NSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGV 362 (767)
Q Consensus 284 ~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 362 (767)
+|.+++.+| ..+..+++|+.|++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|+++.+
T Consensus 383 ~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l 459 (520)
T 2z7x_B 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSV 459 (520)
T ss_dssp SSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred CCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCcc
Confidence 999998444 4588999999999999999877776554 78999999999999 7888888999999999999999987
Q ss_pred CCC-CccccccccccccCCcCccc
Q 004218 363 VPR-EGIFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 363 ~~~-~~~~~~~~~~~l~~Np~~c~ 385 (767)
++. ...++++..+++.+||+.|.
T Consensus 460 ~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 460 PDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CHHHhccCCcccEEECcCCCCccc
Confidence 765 45678889999999999984
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=362.96 Aligned_cols=285 Identities=23% Similarity=0.289 Sum_probs=204.7
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.++|++.+.||+|+||.||+|++. ++.||||++.... .......+|+.++++++||||+++++++.... .....+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEEE
Confidence 468999999999999999999987 8899999996432 23345567899999999999999999976432 22456799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCeEeecCCCCCeeeCCCCceEE
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC-------EVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
||||+++|+|.+++.... +++..++.++.|++.||+|||+.. ..+|+||||||+||+++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANV-------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 999999999999997543 899999999999999999999741 238999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-----CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcch
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-----KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL 681 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 681 (767)
+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..........
T Consensus 173 ~DFg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 173 ADFGLALKFEAGKSA----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CCCTTCEEECTTSCC----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred ccCCcccccccccCc----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 999999765443211 122345689999999998863 45668899999999999999999997644332211
Q ss_pred hhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 682 VKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
........+. .........................+. ..+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 249 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 249 FEEEIGQHPS-LEDMQEVVVHKKKRPVLRDYWQKHAGM-AMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp THHHHCSSCC-HHHHHHHHTTSCCCCCCCGGGGSSHHH-HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhccCCc-hhhhhhhhhcccCCCCccccccccchH-HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1110000000 000000000000000000000000111 1133377799999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=358.13 Aligned_cols=278 Identities=26% Similarity=0.382 Sum_probs=203.4
Q ss_pred hcCCCCCCccccccceEEEEEEe-----CCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL-----REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. .+.
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---HHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence 46899999999999999999984 2588999999976655666789999999999999999999998753 233
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..+++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence 457999999999999999976542 389999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||+++......... .......++..|+|||++.+..++.++||||+|+++|||++|..|+....... .......
T Consensus 158 fg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~ 231 (295)
T 3ugc_A 158 FGLTKVLPQDKEFF---KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF---MRMIGND 231 (295)
T ss_dssp CCSCC----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH---HHHHCTT
T ss_pred CcccccccCCccee---eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH---HhhhcCc
Confidence 99998764432111 11223447778999999998899999999999999999999999986532110 0000000
Q ss_pred cccchhhhccHHHHHhhhcc-h-hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSS-E-SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~-~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
.........+...+... . .......+ .+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 232 ---KQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp ---CCTHHHHHHHHHHHHTTCCCCCCTTCCH----HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ---cccchhHHHHHHHHhccCcCCCCcCcCH----HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 00000000011110000 0 00001111 1223777999999999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=359.71 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=198.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc------chhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG------TWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++ .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----E 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----E
Confidence 468999999999999999999976 4899999999754322 346788999999999999999999995 3
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM---- 602 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---- 602 (767)
+...+++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ ||+||||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence 4567899999999999999997543 399999999999999999999999 999999999999998776
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchh
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV 682 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 682 (767)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||....... ...
T Consensus 157 ~vkl~DFG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~~ 228 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGV-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA 228 (361)
T ss_dssp CEEECCCSSCEECCTTC-------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH
T ss_pred CEEEEecCCceEcCCCC-------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence 79999999997654321 1234569999999999999999999999999999999999999996532211 011
Q ss_pred hHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 683 KWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
......+.. +.. ....+...+.+++.+||..||++|||+.|++++
T Consensus 229 ~i~~~~~~~------~~~--------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 229 NITAVSYDF------DEE--------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHTTCCCC------CHH--------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhcCCCC------Cch--------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111111100 000 001111223347778999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=367.22 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=203.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++. ..+..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCCc
Confidence 467889999999999999999986 689999999864422 33467889999999999999999999964 34457
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++|+|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 99999999999999997543 2389999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||...... .....+.....
T Consensus 260 s~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~ 333 (377)
T 3cbl_A 260 SREEADGVYA----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKGGR 333 (377)
T ss_dssp CEECTTSEEE----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTTCC
T ss_pred ceecCCCcee----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC
Confidence 9754322111 11112235678999999988889999999999999999998 99998653221 11222222111
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
...+..+++. +.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 334 ~~~~~~~~~~----------------------l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 334 LPCPELCPDA----------------------VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHH----------------------HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1111112221 12266789999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.63 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=198.2
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++++++||||+++++++ ..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence 468999999999999999999975 589999999854432 2346788999999999999999999995 4456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++.... ++++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeC
Confidence 7799999999999999997654 389999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|+++....... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ .........
T Consensus 156 g~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~ 229 (294)
T 4eqm_A 156 GIAKALSETSL-----TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-AIKHIQDSV 229 (294)
T ss_dssp SSSTTC------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-HHHHHSSCC
T ss_pred CCccccccccc-----cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhhccC
Confidence 99986543211 112345689999999999999999999999999999999999999965322111 011111111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-CHHHHHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-DIREALRRLKNAQ 752 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~~ 752 (767)
+..... . ...+...+.+++.+||+.||++|| +++++.+.|+.+.
T Consensus 230 ~~~~~~-~------------------~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 230 PNVTTD-V------------------RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp CCHHHH-S------------------CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred CCcchh-c------------------ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 110000 0 000111222377789999999999 8898988887654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=368.39 Aligned_cols=368 Identities=19% Similarity=0.238 Sum_probs=248.0
Q ss_pred cEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccC-CccCCCCCCCcEEeec
Q 004218 5 VYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTV-PPGLGNLPFLKMYNIG 83 (767)
Q Consensus 5 ~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~-~~~~~~l~~L~~L~l~ 83 (767)
+.++.++++++ .+|. + .++|++|+|++|.+.+..|..|+++++|++|+|++|.+.+.+ +..|..+++|++|+|+
T Consensus 13 ~~~~c~~~~l~-~lp~-l---~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L---PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp TEEECCSSCCS-SCCC-C---CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred cccCcCCCCcc-cCCC-C---CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence 35667777776 7775 2 256777777777777666777777777777777777776443 4567777777777777
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceeecCch--hhhhccccCeEEccCCcccccCCcc-ccCCCCCCEEE
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPES--IGNLSNVLSKLYMGGNRFYGKIPTS-IGRLRSLTLLN 160 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~--~~~l~~~L~~L~l~~n~i~~~~~~~-l~~l~~L~~L~ 160 (767)
+|++.. ..+..+.++++|++|++++|++++..|.. +..+++ |++|++++|++++..|.. +.++++|++|+
T Consensus 88 ~n~l~~------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~ 160 (455)
T 3v47_A 88 YNQFLQ------LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS-LEMLVLRDNNIKKIQPASFFLNMRRFHVLD 160 (455)
T ss_dssp TCTTCE------ECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTT-CCEEECCSSBCCSCCCCGGGGGCTTCCEEE
T ss_pred CCccCc------cChhhccCcccCCEEeCCCCCCCccccCcccccCccc-CCEEECCCCccCccCcccccCCCCcccEEe
Confidence 777653 22445667777777777777777544433 666666 777777777777665655 67777777777
Q ss_pred CcCCcCcccCccccCCC--CCCCEEEccCCccccccCcCc--------ccCCCCceeeCCCCcCCCCCcccccCc---cc
Q 004218 161 LSYNSISGEILTEIGQL--QELQSLDLAGNQISGSIPNTL--------GNLKKLNQIDLSGNELASEIPTSFGNF---QN 227 (767)
Q Consensus 161 l~~n~i~~~~~~~~~~l--~~L~~L~L~~n~i~~~~~~~~--------~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~ 227 (767)
+++|.+++..+..+..+ .+|+.|++++|.+.+..+..+ ..+++|++|++++|++++..|..+... ++
T Consensus 161 L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~ 240 (455)
T 3v47_A 161 LTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK 240 (455)
T ss_dssp CTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCC
T ss_pred CCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccc
Confidence 77777776666666655 567777777777775444332 245677777777777766666555443 66
Q ss_pred cccccccCcccCCC----------CChhhccc--ccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCccc
Q 004218 228 LLSIDLSNNKLNGN----------IPKEILSL--SSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSF 295 (767)
Q Consensus 228 L~~L~l~~n~l~~~----------~~~~~~~l--~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~ 295 (767)
|+.|++++|.+.+. .+..+..+ +++ +.+++++|.+.+..|..++.+++|+.|+|++|.+++..|..|
T Consensus 241 L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 319 (455)
T 3v47_A 241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGV-KTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAF 319 (455)
T ss_dssp EEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCC-CEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTT
T ss_pred eeeEeeccccccccccchhhhccCcccccccccccCc-eEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHh
Confidence 77777776654321 11112211 344 334777777777777777777777777777777776667777
Q ss_pred ccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCC-cccccccc
Q 004218 296 KNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE-GIFRHTSM 374 (767)
Q Consensus 296 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~ 374 (767)
..+++|+.|++++|.+++..+..+..+++|+.|+|++|++++..|..+..+++|++|++++|++++.++.. ..++++..
T Consensus 320 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 399 (455)
T 3v47_A 320 WGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQK 399 (455)
T ss_dssp TTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred cCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccE
Confidence 77777777777777777666677777777777777777777666777777777777777777777766544 34566777
Q ss_pred ccccCCcCccc
Q 004218 375 VHLEGNPKLCL 385 (767)
Q Consensus 375 ~~l~~Np~~c~ 385 (767)
+++.+||+.|.
T Consensus 400 L~l~~N~l~~~ 410 (455)
T 3v47_A 400 IWLHTNPWDCS 410 (455)
T ss_dssp EECCSSCBCCC
T ss_pred EEccCCCcccC
Confidence 77777777664
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.26 Aligned_cols=269 Identities=24% Similarity=0.337 Sum_probs=199.1
Q ss_pred HhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhc--CCCCCceeEEeeeecCCccccee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRN--TRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
..++|++.+.||+|+||.||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ......
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence 357899999999999999999998 4899999998643 34556667777766 7999999999986542 234567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeecCCCCCeeeCCCC
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH--------NDCEVPIVHCDLKPGNILLDEDM 602 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlkp~NIl~~~~~ 602 (767)
.++||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+||+++.++
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred eEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence 89999999999999999643 3999999999999999999999 77 999999999999999999
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC------CCCCcccchhhhHHHHHHHhC---------
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE------KPSTAGDVYSFGVMLLEIFTG--------- 667 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~el~tg--------- 667 (767)
.+||+|||+++......... ........||+.|+|||++.+. .+++++|||||||++|||++|
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~ 228 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQL--DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228 (301)
T ss_dssp CEEECCCTTCEEEETTTTEE--ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CEEEeeCCCeeecccccccc--cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccc
Confidence 99999999997654332111 1112334689999999998876 445789999999999999999
Q ss_pred -CCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 668 -MSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 668 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
+.||............................ ....+.....+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN-------------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG-------------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccccccCCCCcchhhhhHHHhccCCCCCCCh-------------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 77776544433322221111100000000000 0000011122333777999999999999999999
Q ss_pred HHHHH
Q 004218 747 RLKNA 751 (767)
Q Consensus 747 ~L~~~ 751 (767)
.|+++
T Consensus 296 ~L~~i 300 (301)
T 3q4u_A 296 TLTKI 300 (301)
T ss_dssp HHHHH
T ss_pred HHhcc
Confidence 99875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=352.88 Aligned_cols=249 Identities=26% Similarity=0.338 Sum_probs=198.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|+.. +|+.||+|+++.. .....+.+.+|+++++.++||||+++++++. ...
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence 367899999999999999999976 5899999999653 3345567889999999999999999999954 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence 7899999999999999997644 389999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|+++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+....
T Consensus 150 G~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~ 221 (337)
T 1o6l_A 150 GLCKEGISD------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILMEE 221 (337)
T ss_dssp TTCBCSCCT------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC
T ss_pred cchhhcccC------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHHHHHHcCC
Confidence 999753221 11224467999999999999999999999999999999999999999653211 1111111100
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
...+..+++ .+.+++.+||+.||++|| +++|++++
T Consensus 222 -~~~p~~~s~----------------------~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 -IRFPRTLSP----------------------EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCCTTSCH----------------------HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCCCCCH----------------------HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 001111111 122366789999999999 89999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=348.82 Aligned_cols=284 Identities=33% Similarity=0.484 Sum_probs=215.4
Q ss_pred CCCccCHHHHHHHhcCCCCC------CccccccceEEEEEEeCCCcEEEEEEeecc----CCcchhhHHHHHHHHhcCCC
Q 004218 441 SPQMISYDELRRATGNFSHE------NLIGSGSFGSVYKGYLREGISVAVKVLDIE----STGTWKSFFAECEALRNTRH 510 (767)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h 510 (767)
....++++++..++++|... +.||+|+||.||+|... ++.||||++... .....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999887 89999999999999974 889999998643 22345678899999999999
Q ss_pred CCceeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 004218 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCD 590 (767)
Q Consensus 511 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 590 (767)
|||+++++++. .....++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+|||
T Consensus 90 ~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~d 158 (307)
T 2nru_A 90 ENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRD 158 (307)
T ss_dssp TTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCC
Confidence 99999999964 34567999999999999999975432 34599999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCC
Q 004218 591 LKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670 (767)
Q Consensus 591 lkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 670 (767)
|||+||+++.++.+||+|||.++....... ........||+.|+|||.+.+ .++.++||||||+++|+|++|+.|
T Consensus 159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 159 IKSANILLDEAFTAKISDFGLARASEKFAQ----TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSCSS----CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred CCHHHEEEcCCCcEEEeecccccccccccc----cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence 999999999999999999999976433211 111234568999999998765 588999999999999999999999
Q ss_pred CCCcccCCcchhhHhhhh--cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 671 THESFAGEVSLVKWVESN--FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
|........ ...+.... ........++. .+.. ...... ..+.+++.+||+.||++|||++|++++|
T Consensus 234 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~----~~~~---~~~~~~----~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 234 VDEHREPQL-LLDIKEEIEDEEKTIEDYIDK----KMND---ADSTSV----EAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp BCTTBSSSB-TTHHHHHHHTTSCCHHHHSCS----SCSC---CCHHHH----HHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred cccCcchHH-HHHHHHHhhhhhhhhhhhccc----cccc---cchHHH----HHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 976433221 11111110 01111111111 0000 011111 2223377799999999999999999999
Q ss_pred HHHHH
Q 004218 749 KNAQK 753 (767)
Q Consensus 749 ~~~~~ 753 (767)
+++..
T Consensus 302 ~~l~~ 306 (307)
T 2nru_A 302 QEMTA 306 (307)
T ss_dssp HHHC-
T ss_pred HHHhc
Confidence 98754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=361.89 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=193.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC----CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|++.+.||+|+||.||+|++. ++..||||+++... ....+.+.+|++++++++||||+++++++. ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eC
Confidence 358999999999999999999865 47789999996543 234567899999999999999999999964 34
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 190 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CceEEEEeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECc
Confidence 56799999999999999997643 3499999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 687 (767)
||+++......... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+..
T Consensus 191 fg~a~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~i~~ 265 (373)
T 2qol_A 191 FGLGRVLEDDPEAA---YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDE 265 (373)
T ss_dssp C-------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHHHHT
T ss_pred CccccccccCCccc---eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc
Confidence 99998764432111 11122335778999999998899999999999999999998 99998653221 11111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
.........+... +.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 266 ~~~~~~~~~~~~~----------------------l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 266 GYRLPPPMDCPAA----------------------LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp TEECCCCTTCBHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCCCCCccccHH----------------------HHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 1111111111111 222777899999999999999999999987644
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=361.53 Aligned_cols=267 Identities=25% Similarity=0.368 Sum_probs=207.0
Q ss_pred hcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.++++++||||+++++++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 367899999999999999999953 3678999998643 2334557889999999999999999999964
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKN-EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM--- 602 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~--- 602 (767)
.....++||||+++|+|.+++...+.. .....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence 345569999999999999999865432 2234599999999999999999999999 999999999999999555
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcch
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSL 681 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~ 681 (767)
.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++ |..||..... ...
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~ 295 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYR----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEV 295 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCT----TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH
T ss_pred eEEECCCccccccccccccc----cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 59999999998765442221 1234557899999999988899999999999999999998 9999865322 112
Q ss_pred hhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 682 VKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
...+...........+... +.+++.+||+.||++|||++|++++|+.+.+...
T Consensus 296 ~~~i~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 296 LEFVTSGGRMDPPKNCPGP----------------------VYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHHHHTTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHHHcCCCCCCCccCCHH----------------------HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 2222211111111111111 2226778999999999999999999999876554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=367.52 Aligned_cols=357 Identities=19% Similarity=0.197 Sum_probs=311.8
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccC-CccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKI-PGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
++|++|||++|+++ .++...+.++++|++|++++|.+.+.+ +..|.++++|++|+|++|.+++..|..|+.+++|++|
T Consensus 30 ~~l~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 108 (455)
T 3v47_A 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVL 108 (455)
T ss_dssp TTCCEEECCSSCCC-EECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEE
T ss_pred CccCEEEecCCccC-cCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEE
Confidence 57999999999999 554444557999999999999997544 6789999999999999999998889999999999999
Q ss_pred eecCccccCCCCCCccccc--cccCCCCCCEEECcCCcceeecCch-hhhhccccCeEEccCCcccccCCccccCC--CC
Q 004218 81 NIGFNKIVGSGDEGLSFIT--SLTNSTRLNFLAFDGNQFEGEIPES-IGNLSNVLSKLYMGGNRFYGKIPTSIGRL--RS 155 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~~~~~--~l~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~~L~~L~l~~n~i~~~~~~~l~~l--~~ 155 (767)
+|++|++.+ ..+. .+.++++|++|++++|++++..|.. +..+++ |++|++++|++++..+..+..+ .+
T Consensus 109 ~L~~n~l~~------~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~l~~l~~~~ 181 (455)
T 3v47_A 109 TLTQCNLDG------AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRR-FHVLDLTFNKVKSICEEDLLNFQGKH 181 (455)
T ss_dssp ECTTSCCBT------HHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTT-CCEEECTTCCBSCCCTTTSGGGTTCE
T ss_pred eCCCCCCCc------cccCcccccCcccCCEEECCCCccCccCcccccCCCCc-ccEEeCCCCcccccChhhhhcccccc
Confidence 999999864 2233 3888999999999999999887876 788888 9999999999998888888876 79
Q ss_pred CCEEECcCCcCcccCccc--------cCCCCCCCEEEccCCccccccCcCcccC---CCCceeeCCCCcCCCC-------
Q 004218 156 LTLLNLSYNSISGEILTE--------IGQLQELQSLDLAGNQISGSIPNTLGNL---KKLNQIDLSGNELASE------- 217 (767)
Q Consensus 156 L~~L~l~~n~i~~~~~~~--------~~~l~~L~~L~L~~n~i~~~~~~~~~~l---~~L~~L~L~~N~l~~~------- 217 (767)
|+.|++++|.+.+..+.. +..+++|++|++++|++.+..|..+... ++|+.|++++|.+.+.
T Consensus 182 L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~ 261 (455)
T 3v47_A 182 FTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNF 261 (455)
T ss_dssp EEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSS
T ss_pred ccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhh
Confidence 999999999999655443 3467899999999999998888777654 8999999999866532
Q ss_pred ---CcccccC--ccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCC
Q 004218 218 ---IPTSFGN--FQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLP 292 (767)
Q Consensus 218 ---~~~~~~~--l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~ 292 (767)
.+..+.. .++|+.|++++|.+.+..|..+..+++|.. +++++|.+++..|..|+.+++|+.|+|++|.+++..|
T Consensus 262 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 340 (455)
T 3v47_A 262 KDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQ-LTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS 340 (455)
T ss_dssp CCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCE-EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECG
T ss_pred ccCcccccccccccCceEEEecCccccccchhhcccCCCCCE-EECCCCcccccChhHhcCcccCCEEECCCCccCCcCh
Confidence 1222332 368999999999999888999999999954 5999999999899999999999999999999998889
Q ss_pred cccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCc
Q 004218 293 NSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREG 367 (767)
Q Consensus 293 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 367 (767)
..|..+++|+.|++++|++++..|..+..+++|++|+|++|++++..+..+..+++|+.|++++|++++.+|...
T Consensus 341 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 341 RMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp GGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred hHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence 999999999999999999998889999999999999999999998777788999999999999999999888643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=346.56 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=203.1
Q ss_pred HhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
..++|++.+.||+|+||.||+|.+.++..||+|++.... ...+++.+|++++++++||||+++++++. .....+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCeE
Confidence 346888999999999999999999988899999997443 33467899999999999999999999964 455679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 96 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred EEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccc
Confidence 99999999999999976432 399999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+....... .......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||...... .....+......
T Consensus 168 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~ 240 (283)
T 3gen_A 168 RYVLDDEY-----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRL 240 (283)
T ss_dssp GGBCCHHH-----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCC
T ss_pred cccccccc-----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhcccCC
Confidence 86533211 11123346788999999998889999999999999999998 99998653221 111111111111
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
......++. +.+++.+||+.||++|||++|++++|+++.+.
T Consensus 241 ~~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 YRPHLASEK----------------------VYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCTTCCHH----------------------HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHH----------------------HHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 111222211 22267789999999999999999999988754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=383.70 Aligned_cols=370 Identities=21% Similarity=0.189 Sum_probs=235.9
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
++|++|+|++|+++ .++...+.++++|++|++++|.+.+..|.+|.++++|++|+|++|.+++..|..|+.+++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcC-EeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 35667777777776 45554455577777777777777766666677777777777777777655566677777777777
Q ss_pred ecCccccCCCCCCccccccccCCCCCCEEECcCCccee-ecCchhhhhccccCeEEccCCcccccCCccccCCC------
Q 004218 82 IGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG-EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLR------ 154 (767)
Q Consensus 82 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~------ 154 (767)
+++|.+...+. ..+.++++|++|++++|++++ .+|..++++++ |++|++++|++++..+..|..++
T Consensus 111 L~~n~l~~~~~------~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~-L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l 183 (606)
T 3vq2_A 111 AVETKLASLES------FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN-LVHVDLSYNYIQTITVNDLQFLRENPQVN 183 (606)
T ss_dssp CTTSCCCCSSS------SCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTT-CCEEECCSSCCCEECTTTTHHHHHCTTCC
T ss_pred ccCCccccccc------cccCCCCCCCEEeCCCCcccceechHhHhhcCC-CCEEEccCCcceecChhhhhhhhcccccc
Confidence 77776654321 234555555555555555553 34555555555 55555555555544444333322
Q ss_pred ---------------------CCCEEECcCCcCcc---------------------------------------------
Q 004218 155 ---------------------SLTLLNLSYNSISG--------------------------------------------- 168 (767)
Q Consensus 155 ---------------------~L~~L~l~~n~i~~--------------------------------------------- 168 (767)
+|++|++++|.+.+
T Consensus 184 ~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l 263 (606)
T 3vq2_A 184 LSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263 (606)
T ss_dssp CEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEE
T ss_pred ceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccH
Confidence 44444444443320
Q ss_pred -----------------------------------cCccccCCCCCCCEEEccCCccccccCc-----------------
Q 004218 169 -----------------------------------EILTEIGQLQELQSLDLAGNQISGSIPN----------------- 196 (767)
Q Consensus 169 -----------------------------------~~~~~~~~l~~L~~L~L~~n~i~~~~~~----------------- 196 (767)
..+ .+..+++|++|++++|.+. .+|.
T Consensus 264 ~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~-~l~~~~~L~~L~l~~n~l~-~lp~~~l~~L~~L~l~~n~~~ 341 (606)
T 3vq2_A 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLE-DVPKHFKWQSLSIIRCQLK-QFPTLDLPFLKSLTLTMNKGS 341 (606)
T ss_dssp EEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCC-CCCTTCCCSEEEEESCCCS-SCCCCCCSSCCEEEEESCSSC
T ss_pred hheeccccccccccccccccCCCCCEEEecCccchhhh-hccccccCCEEEcccccCc-ccccCCCCccceeeccCCcCc
Confidence 001 2333445555555555552 3332
Q ss_pred ---CcccCCCCceeeCCCCcCCCC--CcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCc-hh
Q 004218 197 ---TLGNLKKLNQIDLSGNELASE--IPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLP-EE 270 (767)
Q Consensus 197 ---~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~-~~ 270 (767)
.+..+++|++|++++|++++. .+..+..+++|++|++++|.+. .+|..+..+++|. .+++++|.+.+..+ ..
T Consensus 342 ~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~ 419 (606)
T 3vq2_A 342 ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQ-HLDFQHSTLKRVTEFSA 419 (606)
T ss_dssp EECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCC-EEECTTSEEESTTTTTT
T ss_pred cchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCC-eeECCCCccCCccChhh
Confidence 223444555555555555433 2455566666666666666666 3556666777773 34777777777666 57
Q ss_pred hcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccC-CCCchhhccCCceEEEcCCcccCCCCCccccccccC
Q 004218 271 IGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSG-PIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRAL 349 (767)
Q Consensus 271 ~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (767)
+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++ ..|..+..+++|+.|+|++|++++..|..+..+++|
T Consensus 420 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 499 (606)
T 3vq2_A 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499 (606)
T ss_dssp TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred hhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccC
Confidence 7788888888888888887777788888888888888888876 367778888888888888888887777778888888
Q ss_pred ceEeccCCcCcCcCCCC-ccccccccccccCCcCc
Q 004218 350 RSLNLTFNNLEGVVPRE-GIFRHTSMVHLEGNPKL 383 (767)
Q Consensus 350 ~~L~l~~N~l~~~~~~~-~~~~~~~~~~l~~Np~~ 383 (767)
+.|++++|++++.+|.. ..++++..+++.+|...
T Consensus 500 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp CEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred CEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence 88888888888775544 44667777888887644
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=388.19 Aligned_cols=365 Identities=21% Similarity=0.250 Sum_probs=312.9
Q ss_pred CCCccEEeCCCCeeee-----------------cCCCccc-cCCCCCcEEEccCCcccccCCccccCCCCCCEEEccccc
Q 004218 1 MTSLVYLGLASNQLWG-----------------EIPYDVG-DKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNL 62 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~-----------------~ip~~~~-~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 62 (767)
|++|++|+|++|++++ .+|..+. ..+++|++|+|++|.+.+.+|..|+++++|++|+|++|+
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 5789999999999996 3999883 459999999999999999999999999999999999998
Q ss_pred -Ccc-cCCccCCCC-------CCCcEEeecCccccCCCCCCccccc--cccCCCCCCEEECcCCcceeecCchhhhhccc
Q 004218 63 -LEG-TVPPGLGNL-------PFLKMYNIGFNKIVGSGDEGLSFIT--SLTNSTRLNFLAFDGNQFEGEIPESIGNLSNV 131 (767)
Q Consensus 63 -i~~-~~~~~~~~l-------~~L~~L~l~~n~l~~~~~~~~~~~~--~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~ 131 (767)
+++ .+|..++.+ ++|++|+|++|++. .++. .+.++++|+.|+|++|+++ .+| .+..+++
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-------~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~- 596 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-------EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVK- 596 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-------BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSE-
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-------ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCc-
Confidence 987 788755554 59999999999997 4555 7899999999999999999 888 8899988
Q ss_pred cCeEEccCCcccccCCccccCCCC-CCEEECcCCcCcccCccccCCCCC--CCEEEccCCccccccCcCc---c--cCCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRS-LTLLNLSYNSISGEILTEIGQLQE--LQSLDLAGNQISGSIPNTL---G--NLKK 203 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~-L~~L~l~~n~i~~~~~~~~~~l~~--L~~L~L~~n~i~~~~~~~~---~--~l~~ 203 (767)
|++|+|++|+++ .+|..+..+++ |++|+|++|.++ .+|..+..++. |+.|+|++|++.+.+|... . .+++
T Consensus 597 L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~ 674 (876)
T 4ecn_A 597 LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674 (876)
T ss_dssp ESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCC
T ss_pred ceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCC
Confidence 999999999999 88999999999 999999999999 77888877755 9999999999997666432 2 3458
Q ss_pred CceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccc--------cccceeecccccCCCCCchhhc--C
Q 004218 204 LNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLS--------SLTTIVNLSKNFLDGTLPEEIG--M 273 (767)
Q Consensus 204 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~--------~l~~~l~l~~n~l~~~~~~~~~--~ 273 (767)
|+.|+|++|+++...+..+..+++|+.|+|++|+++ .+|..+.... +| +.|+|++|+++ .+|..+. .
T Consensus 675 L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L-~~L~Ls~N~L~-~lp~~l~~~~ 751 (876)
T 4ecn_A 675 ASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLL-TTIDLRFNKLT-SLSDDFRATT 751 (876)
T ss_dssp EEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGC-CEEECCSSCCC-CCCGGGSTTT
T ss_pred cCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCc-cEEECCCCCCc-cchHHhhhcc
Confidence 999999999999654445568999999999999999 6776655433 66 45599999999 7788886 9
Q ss_pred CCceeEEEccCCCCCCCCCcccccCcccceeeccC------ccccCCCCchhhccCCceEEEcCCcccCCCCCccccccc
Q 004218 274 LGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMAN------NKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLR 347 (767)
Q Consensus 274 l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~------n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 347 (767)
+++|+.|+|++|.+++ +|..+..+++|+.|+|++ |.+.+.+|..+..+++|+.|+|++|++ +.+|..+. +
T Consensus 752 l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~ 827 (876)
T 4ecn_A 752 LPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--P 827 (876)
T ss_dssp CTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--S
T ss_pred CCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--C
Confidence 9999999999999997 788999999999999976 788889999999999999999999999 58888766 6
Q ss_pred cCceEeccCCcCcCcCCCCc-cccccccccccCCcCcc
Q 004218 348 ALRSLNLTFNNLEGVVPREG-IFRHTSMVHLEGNPKLC 384 (767)
Q Consensus 348 ~L~~L~l~~N~l~~~~~~~~-~~~~~~~~~l~~Np~~c 384 (767)
+|+.|+|++|++..+.+... .........+..|++.|
T Consensus 828 ~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~ 865 (876)
T 4ecn_A 828 QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865 (876)
T ss_dssp SSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSE
T ss_pred CCCEEECCCCCCCccChHHccccccchheeecCCCccc
Confidence 99999999999988765431 12234456677777655
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=345.35 Aligned_cols=257 Identities=27% Similarity=0.405 Sum_probs=203.7
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.++|++.+.||+|+||.||+|.++++..||+|++.... ...+++.+|++++++++||||+++++++. .....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceEE
Confidence 46899999999999999999999988899999996443 34467899999999999999999999963 4556799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp EEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred EEEccCCCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccce
Confidence 999999999999997643 2389999999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
....... .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||....... ............
T Consensus 153 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~ 225 (268)
T 3sxs_A 153 YVLDDQY-----VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VVLKVSQGHRLY 225 (268)
T ss_dssp ECCTTCE-----EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTCCCC
T ss_pred ecchhhh-----hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HHHHHHcCCCCC
Confidence 6533211 11123346778999999988889999999999999999999 999986532211 111111111111
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
.+...++. +.+++.+||+.||++|||++|++++|+.+++
T Consensus 226 ~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 226 RPHLASDT----------------------IYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCTTSCHH----------------------HHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCcChHH----------------------HHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 11111211 2226678999999999999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=349.49 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=197.9
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
++|++.+.||+|+||.||+|.+. ++.||+|++.. ....+.+.+|++++++++||||+++++++.. ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcEEE
Confidence 57889999999999999999986 78999999853 3455788999999999999999999998642 25899
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc-eEEccccchh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT-AKVGDFGLAR 613 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~a~ 613 (767)
|||+++|+|.+++..... ...+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||.+.
T Consensus 78 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 999999999999976542 123789999999999999999999932239999999999999998886 7999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccch
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 155 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (307)
T 2eva_A 155 DIQTH---------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225 (307)
T ss_dssp -------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC
T ss_pred ccccc---------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc
Confidence 55322 123358999999999999999999999999999999999999997543222111111111111111
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhh
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 757 (767)
...+++. +.+++.+||+.||++|||++|+++.|+.+.+.+..
T Consensus 226 ~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 226 IKNLPKP----------------------IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp BTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ccccCHH----------------------HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 1111111 22367789999999999999999999998766543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=350.52 Aligned_cols=282 Identities=22% Similarity=0.275 Sum_probs=206.8
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceE
Confidence 3679999999999999999999765 8999999996433 3445678899999999999999999998753 234467
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL----DEDMTAKVG 607 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~ 607 (767)
++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred EEEEeCCCCCCHHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEc
Confidence 999999999999999986543 23489999999999999999999999 99999999999999 788889999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccC--------CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL--------GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV 679 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 679 (767)
|||+++...... ......||..|+|||++. +..++.++||||+||++|||++|+.||........
T Consensus 159 Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 231 (319)
T 4euu_A 159 DFGAARELEDDE-------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (319)
T ss_dssp CCTTCEECCTTC-------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred cCCCceecCCCC-------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence 999997654321 112346899999999875 56789999999999999999999999964322211
Q ss_pred --chhhHhhhhcccchhhhccHHHHHhhh--cchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 680 --SLVKWVESNFPKNAQQVLDRELRQLMM--SSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 680 --~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
.....+....|......+.......+. ........+.+.+...+.+++.+||+.||++|||++|++++..+.
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111111111111100000000000000 000000112233344455577899999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=351.17 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=197.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc------chhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG------TWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----- 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 357999999999999999999976 4899999998654321 3567889999999999999999999954
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM---- 602 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---- 602 (767)
.....++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence 4566799999999999999997543 399999999999999999999999 999999999999999887
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchh
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV 682 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 682 (767)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....... ...
T Consensus 156 ~~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~ 227 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA 227 (326)
T ss_dssp CEEECCCTTCEECCTTS-------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH
T ss_pred CEEEEECCCCeECCCCC-------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHH
Confidence 89999999997653221 1233568999999999999999999999999999999999999996532211 000
Q ss_pred hHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 683 KWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
......+... . .........+.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~------~--------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 228 NVSAVNYEFE------D--------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHTCCCCC------H--------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhcCCCcC------c--------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1101000000 0 0000011122337778999999999999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=355.57 Aligned_cols=249 Identities=25% Similarity=0.323 Sum_probs=195.8
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.... ++.||+|++... .....+.+.+|+++++.++||||+++++++. +..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 3679999999999999999999764 889999998643 2344577889999999999999999999954 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence 7899999999999999997643 399999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCC---CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc-chhhHh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG---EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-SLVKWV 685 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~ 685 (767)
|+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ......
T Consensus 160 G~a~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~ 232 (384)
T 4fr4_A 160 NIAAMLPRE-------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232 (384)
T ss_dssp TTCEECCTT-------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH
T ss_pred ceeeeccCC-------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence 999765322 12244679999999999864 4589999999999999999999999965332221 111111
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC-HHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID-IREALR 746 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~evl~ 746 (767)
..... ..+..+++ .+.+++.+||+.||++||+ ++++.+
T Consensus 233 ~~~~~-~~p~~~s~----------------------~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 233 ETTVV-TYPSAWSQ----------------------EMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHCCC-CCCTTSCH----------------------HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hhccc-CCCCcCCH----------------------HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11111 11111111 1223677899999999998 666654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=350.79 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=198.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|.+... ......+.+|+++++.++||||+++++++. +...++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence 468999999999999999999976 4889999998643 334566889999999999999999999964 455789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--CCceEEcccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE--DMTAKVGDFG 610 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg 610 (767)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 78 lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEEeCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 9999999999999997543 2489999999999999999999999 9999999999999987 7899999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+++..... .......||+.|+|||++.+..++.++||||+|+++|+|++|..||....... .........+.
T Consensus 150 ~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~ 221 (321)
T 1tki_A 150 QARQLKPG-------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYT 221 (321)
T ss_dssp TCEECCTT-------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC
T ss_pred CCeECCCC-------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCCC
Confidence 99765322 11234568999999999998889999999999999999999999996532211 11111111111
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
... .. ...+...+.+++.+||..||++|||+.|++++-
T Consensus 222 ~~~----------------~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 222 FDE----------------EA----FKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CCH----------------HH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCh----------------hh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 000 00 000111223377799999999999999999853
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=353.00 Aligned_cols=274 Identities=23% Similarity=0.359 Sum_probs=194.8
Q ss_pred HHhcCCCCCCccccccceEEEEEEeCC-C---cEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLRE-G---ISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF 525 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 525 (767)
...++|++.+.||+|+||.||+|.+.. + ..||||++... .....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999999764 3 37999998654 34456789999999999999999999999764322
Q ss_pred c-cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 004218 526 K-NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA 604 (767)
Q Consensus 526 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~ 604 (767)
. .....++||||+++|+|.+++...........+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 1 1123489999999999999997655433334599999999999999999999999 99999999999999999999
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhh
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVK 683 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~ 683 (767)
||+|||.++......... ......+++.|+|||.+.+..++.++||||+||++|+|++ |+.||...... ....
T Consensus 177 kl~Dfg~a~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~ 250 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYR----QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYN 250 (323)
T ss_dssp EECCCCC---------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHH
T ss_pred EEeecccccccccccccc----ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHH
Confidence 999999998664432111 1123446788999999998899999999999999999999 89998654322 1111
Q ss_pred HhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 684 WVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 684 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
.+...........+.+. +.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 251 ~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 251 YLIGGNRLKQPPECMEE----------------------VYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HHHTTCCCCCCTTCCHH----------------------HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHhcCCCCCCCCccCHH----------------------HHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 11111111111111111 2237778999999999999999999999876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=361.95 Aligned_cols=277 Identities=24% Similarity=0.355 Sum_probs=212.6
Q ss_pred cCHHHHHHHhcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCC-cchhhHHHHHHHHhcC-CCCCceeE
Q 004218 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIEST-GTWKSFFAECEALRNT-RHRNLVKL 516 (767)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~ 516 (767)
+...+.....++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344555667789999999999999999999842 367899999965432 3346789999999999 79999999
Q ss_pred EeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCC------------------------------------------
Q 004218 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNE------------------------------------------ 554 (767)
Q Consensus 517 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------ 554 (767)
++++.. .+...++||||+++|+|.+++.......
T Consensus 92 ~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 92 LGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 999753 3345799999999999999998654210
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhh
Q 004218 555 ------------------HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLL 616 (767)
Q Consensus 555 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 616 (767)
....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 012289999999999999999999999 99999999999999999999999999998653
Q ss_pred hhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchhh
Q 004218 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQ 695 (767)
Q Consensus 617 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (767)
.... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||........ ....+........+.
T Consensus 245 ~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 319 (359)
T 3vhe_A 245 KDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRMRAPD 319 (359)
T ss_dssp SCTT----CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCCCCCCT
T ss_pred cccc----chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCCCCCCC
Confidence 3211 112234568899999999998899999999999999999998 9999965432221 112222211111222
Q ss_pred hccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 696 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
.+.+.+ .+++.+||+.||++|||++|++++|+.+....
T Consensus 320 ~~~~~l----------------------~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 320 YTTPEM----------------------YQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp TCCHHH----------------------HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHH----------------------HHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 222221 22667899999999999999999999987653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=357.68 Aligned_cols=200 Identities=28% Similarity=0.382 Sum_probs=172.5
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|++.+.||+|+||.||+|+.+. ++.||+|+++.. .....+.+.+|..+++++ +||||+++++++ ...
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EEC
Confidence 4679999999999999999999764 889999999754 233445688999999876 899999999985 455
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..+++||||+++|+|.+++...+. +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRK------LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence 678999999999999999976543 99999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
||+++..... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 197 FGla~~~~~~------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 197 YGMCKEGLRP------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CTTCBCCCCT------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred cceeeecccC------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 9999753211 1123456799999999999999999999999999999999999999964
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=349.66 Aligned_cols=274 Identities=24% Similarity=0.327 Sum_probs=197.9
Q ss_pred HhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
..++|++.+.||+|+||.||+|.+.+++.||+|++.... ....+.+.+|++++++++||||+++++++. ....
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 93 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERC 93 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSC
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCE
Confidence 357899999999999999999999889999999986442 233467889999999999999999999954 4567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++ +|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEcCCCC-CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence 7999999985 8888886543 3489999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh---
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE--- 686 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--- 686 (767)
+++...... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ ......
T Consensus 165 ~a~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~ 237 (311)
T 3niz_A 165 LARAFGIPV------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILG 237 (311)
T ss_dssp TCEETTSCC------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHC
T ss_pred CceecCCCc------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHC
Confidence 997653221 11233468999999999876 5689999999999999999999999976443322 111111
Q ss_pred hhcccchhhhccH-HHHHhh-hc-chhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SNFPKNAQQVLDR-ELRQLM-MS-SESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~~~~~~~~~~~~-~l~~~~-~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+.......+. ...... .. .........+.+...+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111111111000 000000 00 0000000001111122337779999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=358.73 Aligned_cols=256 Identities=24% Similarity=0.305 Sum_probs=197.5
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc-----CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE-----STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
.++|++.+.||+|+||.||+|.++ +++.||||++... .....+.+.+|+++++.++||||+++++++. .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----S 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 457999999999999999999975 5899999998542 1224577899999999999999999999954 4
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---e
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT---A 604 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~ 604 (767)
.+.+++||||+++|+|.+++...... +..+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence 56789999999999999888654321 23489999999999999999999999 9999999999999986554 9
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhH
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 684 (767)
||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ......
T Consensus 173 kl~Dfg~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i 244 (351)
T 3c0i_A 173 KLGGFGVAIQLGESG------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGI 244 (351)
T ss_dssp EECCCTTCEECCTTS------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHH
T ss_pred EEecCcceeEecCCC------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHH
Confidence 999999997654321 112345699999999999999999999999999999999999999965321 011111
Q ss_pred hhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 685 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
....+.... ..... +...+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~----------------~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 245 IKGKYKMNP----------------RQWSH----ISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHTCCCCCH----------------HHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HcCCCCCCc----------------ccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111111100 00001 11122337778999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=364.81 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=197.9
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
...++|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++ .+.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EEC
Confidence 34678999999999999999999975 589999999865432 2356788999999999999999999995 455
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceE
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD---EDMTAK 605 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~k 605 (767)
+..++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++ .++.+|
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vk 153 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVK 153 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEE
T ss_pred CEEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEE
Confidence 67799999999999999987643 399999999999999999999999 999999999999998 467899
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 685 (767)
|+|||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||...... .....+
T Consensus 154 L~DFG~a~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--~~~~~i 225 (444)
T 3soa_A 154 LADFGLAIEVEGEQ------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLYQQI 225 (444)
T ss_dssp ECCCSSCBCCCTTC------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH
T ss_pred EccCceeEEecCCC------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--HHHHHH
Confidence 99999997654321 1123456999999999999999999999999999999999999999653211 111111
Q ss_pred -hhh--cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 -ESN--FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 -~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
... ++......+++. +.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~s~~----------------------~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 226 KAGAYDFPSPEWDTVTPE----------------------AKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHTCCCCCTTTTTTSCHH----------------------HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhCCCCCCccccccCCHH----------------------HHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111 111111112221 2236678999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=364.50 Aligned_cols=254 Identities=30% Similarity=0.415 Sum_probs=203.5
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++.. .....++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~i 264 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI 264 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCceEE
Confidence 467888999999999999999987 7899999996433 55789999999999999999999999753 3346799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 265 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp EEECCTTCBHHHHHHHHC----TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 999999999999998653 23379999999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
..... .....++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....+.......
T Consensus 338 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~~~ 406 (450)
T 1k9a_A 338 EASST---------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKMD 406 (450)
T ss_dssp ECC---------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTCCCC
T ss_pred ccccc---------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCC
Confidence 43221 112246889999999999999999999999999999998 999997643222 222222222222
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
.+..+++.+ .+++.+||+.||++|||+.|+++.|+.+...
T Consensus 407 ~p~~~~~~l----------------------~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 407 APDGCPPAV----------------------YDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCTTCCHHH----------------------HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcCCHHH----------------------HHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 222222222 2266689999999999999999999988754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=356.33 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=198.5
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
...++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++. +.
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~ 100 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EE 100 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence 34568999999999999999999976 489999999965432 34567889999999999999999999954 45
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC---CceE
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED---MTAK 605 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~k 605 (767)
...++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.+ +.+|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~k 171 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVK 171 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEE
T ss_pred CEEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence 66799999999999999987543 389999999999999999999999 99999999999999865 4599
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 685 (767)
|+|||++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .....+
T Consensus 172 l~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~~i 242 (362)
T 2bdw_A 172 LADFGLAIEVNDSE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQI 242 (362)
T ss_dssp ECCCTTCBCCTTCC-------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred EeecCcceEecCCc-------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH
Confidence 99999997654321 123456999999999999999999999999999999999999999653211 111111
Q ss_pred h-hh--cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 E-SN--FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 ~-~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. .. ++......+++. +.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~----------------------~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 243 KAGAYDYPSPEWDTVTPE----------------------AKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHTCCCCCTTGGGGSCHH----------------------HHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HhCCCCCCcccccCCCHH----------------------HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 11 111111111111 2236778999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=345.98 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=190.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--------------------------cchhhHHHHHHHHh
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--------------------------GTWKSFFAECEALR 506 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 506 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999975 588999999864321 12356889999999
Q ss_pred cCCCCCceeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 004218 507 NTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPI 586 (767)
Q Consensus 507 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 586 (767)
+++||||+++++++.. ......++||||+++++|.+++... .+++.++..++.|++.||+|||++ +|
T Consensus 92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i 158 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPTLK-------PLSEDQARFYFQDLIKGIEYLHYQ---KI 158 (298)
T ss_dssp TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSCSS-------CCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 9999999999999753 2356789999999999998876432 399999999999999999999999 99
Q ss_pred EeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC---CCCcccchhhhHHHHH
Q 004218 587 VHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK---PSTAGDVYSFGVMLLE 663 (767)
Q Consensus 587 vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~e 663 (767)
+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++||||+||++|+
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSS------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred eccCCCHHHEEECCCCCEEEecCCCcccccccc------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence 999999999999999999999999997653321 1123456899999999987765 3778999999999999
Q ss_pred HHhCCCCCCCcccCCcchhhHhhhh-cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHH
Q 004218 664 IFTGMSPTHESFAGEVSLVKWVESN-FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIR 742 (767)
Q Consensus 664 l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ 742 (767)
|++|+.||...... .....+... .+......+++ . +.+++.+||+.||++|||++
T Consensus 233 l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~------------------~----l~~li~~~l~~dp~~R~s~~ 288 (298)
T 2zv2_A 233 FVFGQCPFMDERIM--CLHSKIKSQALEFPDQPDIAE------------------D----LKDLITRMLDKNPESRIVVP 288 (298)
T ss_dssp HHHSSCSSCCSSHH--HHHHHHHHCCCCCCSSSCCCH------------------H----HHHHHHHHTCSCTTTSCCHH
T ss_pred HHHCCCCCCCccHH--HHHHHHhcccCCCCCccccCH------------------H----HHHHHHHHhhcChhhCCCHH
Confidence 99999999653211 111111110 00000001111 1 22367789999999999999
Q ss_pred HHHHH
Q 004218 743 EALRR 747 (767)
Q Consensus 743 evl~~ 747 (767)
|++++
T Consensus 289 e~l~h 293 (298)
T 2zv2_A 289 EIKLH 293 (298)
T ss_dssp HHTTC
T ss_pred HHhcC
Confidence 99864
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=370.55 Aligned_cols=359 Identities=19% Similarity=0.253 Sum_probs=294.1
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
.+++|+++|+++ .+|..++ ++|++|++++|.+.+..|..|.++++|++|+|++|.+++..|..|+.+++|++|+|+
T Consensus 33 ~~~l~ls~~~L~-~ip~~~~---~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 108 (562)
T 3a79_B 33 ESMVDYSNRNLT-HVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108 (562)
T ss_dssp CCEEECTTSCCC-SCCTTSC---TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred CcEEEcCCCCCc-cCCCCCC---CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence 368999999998 7998775 689999999999997777899999999999999999998888899999999999999
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceee-cCchhhhhccccCeEEccCCcccccCCccccCCCCC--CEEE
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE-IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSL--TLLN 160 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L--~~L~ 160 (767)
+|++... +.. .+++|++|++++|++++. .|..++++++ |++|++++|+++.. .+..+++| ++|+
T Consensus 109 ~N~l~~l-------p~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~-L~~L~L~~n~l~~~---~~~~l~~L~L~~L~ 175 (562)
T 3a79_B 109 HNRLQNI-------SCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTK-LTFLGLSAAKFRQL---DLLPVAHLHLSCIL 175 (562)
T ss_dssp TSCCCEE-------CSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTT-CCEEEEECSBCCTT---TTGGGTTSCEEEEE
T ss_pred CCcCCcc-------Ccc--ccccCCEEECCCCCccccCchHhhcccCc-ccEEecCCCccccC---chhhhhhceeeEEE
Confidence 9998743 333 789999999999999863 4688999988 99999999999853 34555555 9999
Q ss_pred CcCCcC--cccCccccCCCC------------------------------------------------------------
Q 004218 161 LSYNSI--SGEILTEIGQLQ------------------------------------------------------------ 178 (767)
Q Consensus 161 l~~n~i--~~~~~~~~~~l~------------------------------------------------------------ 178 (767)
+++|.+ ++..+..+..+.
T Consensus 176 L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~ 255 (562)
T 3a79_B 176 LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255 (562)
T ss_dssp EEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEE
T ss_pred eecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEE
Confidence 999988 655555554433
Q ss_pred ---------------------CCCEEEccCCccccccCcCc-----ccC--------------------------CCCce
Q 004218 179 ---------------------ELQSLDLAGNQISGSIPNTL-----GNL--------------------------KKLNQ 206 (767)
Q Consensus 179 ---------------------~L~~L~L~~n~i~~~~~~~~-----~~l--------------------------~~L~~ 206 (767)
+|++|++++|.+.+.+|..+ ..+ .+|++
T Consensus 256 L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~ 335 (562)
T 3a79_B 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335 (562)
T ss_dssp EEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSE
T ss_pred ecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceE
Confidence 56677777777776666554 222 23666
Q ss_pred eeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCC--chhhcCCCceeEEEccC
Q 004218 207 IDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTL--PEEIGMLGNVVTIDLSA 284 (767)
Q Consensus 207 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~--~~~~~~l~~L~~L~ls~ 284 (767)
|++++|.+.... .+..+++|++|++++|++++..|..+..+++|. .+++++|++++.. |..++.+++|+.|++++
T Consensus 336 L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~ 412 (562)
T 3a79_B 336 LSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ-TLILQRNGLKNFFKVALMTKNMSSLETLDVSL 412 (562)
T ss_dssp EEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCC-EEECCSSCCCBTTHHHHTTTTCTTCCEEECTT
T ss_pred EEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCC-EEECCCCCcCCcccchhhhcCCCCCCEEECCC
Confidence 666666664221 126889999999999999988999999999995 4599999999743 56789999999999999
Q ss_pred CCCCC-CCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcC
Q 004218 285 NGLSG-NLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVV 363 (767)
Q Consensus 285 n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 363 (767)
|.+++ ..+..+..+++|+.|++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|++++++
T Consensus 413 N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~ 489 (562)
T 3a79_B 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVP 489 (562)
T ss_dssp SCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCC
T ss_pred CcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCC
Confidence 99998 4455689999999999999999876665544 68999999999999 77877779999999999999999877
Q ss_pred CC-CccccccccccccCCcCccc
Q 004218 364 PR-EGIFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 364 ~~-~~~~~~~~~~~l~~Np~~c~ 385 (767)
+. ...++++..+++.+|||.|.
T Consensus 490 ~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 490 DGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp TTSTTTCTTCCCEECCSCCBCCC
T ss_pred HHHHhcCCCCCEEEecCCCcCCC
Confidence 76 46678889999999999994
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=350.95 Aligned_cols=247 Identities=28% Similarity=0.371 Sum_probs=196.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|.+.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+++++.++||||+++++++. ...
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 468999999999999999999974 5899999998643 2233467889999999999999999999964 445
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+ +|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred EEEEEEECC-CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence 679999999 679999887644 399999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|++....... ......||+.|+|||++.+..+ ++++||||+||++|+|++|+.||........ ...+...
T Consensus 153 G~s~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~~i~~~ 223 (336)
T 3h4j_B 153 GLSNIMTDGN-------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--FKKVNSC 223 (336)
T ss_dssp SCTBTTTTSB-------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--BCCCCSS
T ss_pred ccceeccCCc-------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--HHHHHcC
Confidence 9997654321 1234569999999999988776 7899999999999999999999976432211 0000000
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
....+..+++. +.+++.+||+.||.+|||++|++++
T Consensus 224 -~~~~p~~~s~~----------------------~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 -VYVMPDFLSPG----------------------AQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCCCTTSCHH----------------------HHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -CCCCcccCCHH----------------------HHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00111112221 2237778999999999999999875
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=375.42 Aligned_cols=368 Identities=21% Similarity=0.223 Sum_probs=239.8
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
++|++|||++|+++ .++...+..+++|++|++++|++.+..|+.|.++++|++|+|++|.+++..|..|+.+++|++|+
T Consensus 26 ~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 104 (549)
T 2z81_A 26 AAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104 (549)
T ss_dssp TTCCEEECCSSCCC-EECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEE
T ss_pred CCccEEECcCCccC-ccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEE
Confidence 47899999999998 55444455799999999999999988888999999999999999999976666799999999999
Q ss_pred ecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecC-chhhhhccccCeEEccCCcccccCCccccCCCCCCEEE
Q 004218 82 IGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIP-ESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLN 160 (767)
Q Consensus 82 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~ 160 (767)
+++|.+... ..+..+.++++|++|++++|++.+.+| ..+..+++ |++|++++|++++..|..+..+++|++|+
T Consensus 105 Ls~n~l~~~-----~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 178 (549)
T 2z81_A 105 LMGNPYQTL-----GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS-LNELEIKALSLRNYQSQSLKSIRDIHHLT 178 (549)
T ss_dssp CTTCCCSSS-----CSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCE-EEEEEEEETTCCEECTTTTTTCSEEEEEE
T ss_pred CCCCccccc-----chhhhhhccCCccEEECCCCccccccCHhhhhcccc-cCeeeccCCcccccChhhhhccccCceEe
Confidence 999998754 334567888999999999998443454 67888887 99999999999888888877665555555
Q ss_pred CcCCcCcccCccccCCCCCCCEEEccCCcccccc--CcC-----------------------------------------
Q 004218 161 LSYNSISGEILTEIGQLQELQSLDLAGNQISGSI--PNT----------------------------------------- 197 (767)
Q Consensus 161 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~--~~~----------------------------------------- 197 (767)
++.|.+.......+..+++|++|++++|++.+.. |..
T Consensus 179 l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l 258 (549)
T 2z81_A 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEF 258 (549)
T ss_dssp EECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEE
T ss_pred cccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccc
Confidence 5555444221111223444444444444443210 000
Q ss_pred -----------------------------------------------cccCCCCceeeCCCCcCCCCCcccc-cCccccc
Q 004218 198 -----------------------------------------------LGNLKKLNQIDLSGNELASEIPTSF-GNFQNLL 229 (767)
Q Consensus 198 -----------------------------------------------~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~ 229 (767)
+...++|+.|++++|.++. +|..+ ..+++|+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~-ip~~~~~~l~~L~ 337 (549)
T 2z81_A 259 DDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLE 337 (549)
T ss_dssp ESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCC-CCHHHHHHCTTCC
T ss_pred ccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCcccc-CCHHHHhcCcccc
Confidence 0001233333334444332 22222 3344555
Q ss_pred cccccCcccCCCCCh---hhcccccccceeecccccCCCCCc--hhhcCCCceeEEEccCCCCCCCCCcccccCc-----
Q 004218 230 SIDLSNNKLNGNIPK---EILSLSSLTTIVNLSKNFLDGTLP--EEIGMLGNVVTIDLSANGLSGNLPNSFKNCK----- 299 (767)
Q Consensus 230 ~L~l~~n~l~~~~~~---~~~~l~~l~~~l~l~~n~l~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~----- 299 (767)
.|++++|++.+.+|. .+..+++| +.+++++|.+++..+ ..+..+++|+.|++++|+++ .+|..+..++
T Consensus 338 ~L~Ls~N~l~~~~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L 415 (549)
T 2z81_A 338 FLDLSENLMVEEYLKNSACKGAWPSL-QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415 (549)
T ss_dssp EEECCSSCCCHHHHHHHTCTTSSTTC-CEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEE
T ss_pred EEEccCCccccccccchhhhhccccC-cEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEE
Confidence 555555554433321 13334444 222455554443221 23444445555555555444 3344444444
Q ss_pred ----------------ccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcC
Q 004218 300 ----------------SLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVV 363 (767)
Q Consensus 300 ----------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 363 (767)
+|+.|++++|++++. +..+++|++|+|++|+++ .+|. ...+++|+.|++++|++++.+
T Consensus 416 ~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~----~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~ 489 (549)
T 2z81_A 416 NLSSTGIRVVKTCIPQTLEVLDVSNNNLDSF----SLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVP 489 (549)
T ss_dssp ECTTSCCSCCCTTSCTTCSEEECCSSCCSCC----CCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCC
T ss_pred ECCCCCcccccchhcCCceEEECCCCChhhh----cccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcC
Confidence 455555555555432 136889999999999998 6665 567899999999999999988
Q ss_pred CCC-ccccccccccccCCcCccc
Q 004218 364 PRE-GIFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 364 ~~~-~~~~~~~~~~l~~Np~~c~ 385 (767)
|.. ..++++..+++.+|||.|.
T Consensus 490 ~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 490 DGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp TTGGGGCTTCCEEECCSSCBCCC
T ss_pred HHHHhcCcccCEEEecCCCccCC
Confidence 874 5678889999999999884
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=348.98 Aligned_cols=274 Identities=23% Similarity=0.371 Sum_probs=199.9
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC----CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCC
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLD 524 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 524 (767)
....++|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 334578889999999999999999854 24589999986543 234567889999999999999999999987544
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA 604 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~ 604 (767)
.......++||||+++|+|.+++...........+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence 333446799999999999999996544333345699999999999999999999999 99999999999999999999
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhh
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVK 683 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~ 683 (767)
||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 187 kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~ 260 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYD 260 (313)
T ss_dssp EECSCSCC--------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHH
T ss_pred EEeecCcceeccccccc----CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHH
Confidence 99999999866433211 11233457889999999999999999999999999999999 88898653322 1111
Q ss_pred HhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 684 WVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 684 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
.............+.+. +.+++.+||+.||++|||+.|++++|+++.+..
T Consensus 261 ~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 261 YLLHGHRLKQPEDCLDE----------------------LYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHTTCCCCCBTTCCHH----------------------HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHcCCCCCCCccccHH----------------------HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11111111111111111 222667899999999999999999999987754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=358.73 Aligned_cols=267 Identities=24% Similarity=0.383 Sum_probs=207.5
Q ss_pred hcCCCCCCccccccceEEEEEEeC--------CCcEEEEEEeeccCC-cchhhHHHHHHHHhcC-CCCCceeEEeeeecC
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR--------EGISVAVKVLDIEST-GTWKSFFAECEALRNT-RHRNLVKLITSCSSL 523 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 523 (767)
.++|.+.+.||+|+||.||+|.+. .+..||||++..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence 468999999999999999999863 246799999965432 3456788999999999 8999999999964
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKP 593 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 593 (767)
.++..++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||+. +|+||||||
T Consensus 146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 219 (382)
T 3tt0_A 146 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219 (382)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred ---cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence 445579999999999999999865421 1124599999999999999999999999 999999999
Q ss_pred CCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 004218 594 GNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTH 672 (767)
Q Consensus 594 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 672 (767)
+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTT----CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ceEEEcCCCcEEEcccCccccccccccc----ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999865432111 11233457889999999999999999999999999999999 999986
Q ss_pred CcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 673 ESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
..... .....+...........+.+. +.+++.+||+.||++|||++|++++|+.+.
T Consensus 296 ~~~~~--~~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 296 GVPVE--ELFKLLKEGHRMDKPSNCTNE----------------------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp TCCHH--HHHHHHHTTCCCCCCSSCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHH--HHHHHHHcCCCCCCCccCCHH----------------------HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 53211 122222221111111111111 222667899999999999999999999998
Q ss_pred HHHh
Q 004218 753 KILL 756 (767)
Q Consensus 753 ~~~~ 756 (767)
....
T Consensus 352 ~~~~ 355 (382)
T 3tt0_A 352 ALTS 355 (382)
T ss_dssp HHSC
T ss_pred HHHh
Confidence 7554
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=341.75 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=197.2
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcc-------hhhHHHHHHHHhcCCCCCceeEEeeeecCCc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGT-------WKSFFAECEALRNTRHRNLVKLITSCSSLDF 525 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 525 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... .+.+.+|++++++++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 468999999999999999999975 58999999986443221 267889999999999999999999964322
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeCCCCc
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVP--IVHCDLKPGNILLDEDMT 603 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~ 603 (767)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ + |+||||||+||+++.++.
T Consensus 97 ------~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 97 ------RMVMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp ------EEEEECCTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCT
T ss_pred ------eEEEEecCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCC
Confidence 79999999999999886543 3499999999999999999999998 8 999999999999988776
Q ss_pred -----eEEccccchhhhhhhcCCCccccccccccCCCCccCccccC--CCCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 604 -----AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL--GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 604 -----~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
+||+|||.++.... ......||+.|+|||++. ...++.++||||+|+++|+|++|+.||.....
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSVH---------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp TCSCCEEECCCTTCBCCSS---------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCceeEEeCCCCccccccc---------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 99999999974322 123456899999999984 45578899999999999999999999976443
Q ss_pred CCcchhhHh-hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 677 GEVSLVKWV-ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 677 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
......... ....+......+++. +.+++.+||+.||++|||++|+++.|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 234 GKIKFINMIREEGLRPTIPEDCPPR----------------------LRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CHHHHHHHHHHSCCCCCCCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cHHHHHHHHhccCCCCCCCcccCHH----------------------HHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 332222221 111222222222222 2226678999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=343.04 Aligned_cols=254 Identities=28% Similarity=0.413 Sum_probs=189.1
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCC----cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIEST----GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+++++.++||||+++++++. .++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KEP 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC-
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCC
Confidence 468899999999999999999986 88999999864422 23567889999999999999999999964 445
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--------C
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE--------D 601 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~--------~ 601 (767)
..++||||+++++|.+++... .+++..++.++.|++.||+|||++...+|+||||||+||+++. +
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred ceEEEEEcCCCCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 679999999999999999643 3899999999999999999999981112999999999999986 7
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcch
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL 681 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 681 (767)
+.+||+|||.++...... .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||........ .
T Consensus 153 ~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~ 223 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT--------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-A 223 (271)
T ss_dssp CCEEECCCCC---------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-H
T ss_pred cceEEccCCccccccccc--------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence 789999999997654321 1234589999999999888899999999999999999999999965322111 1
Q ss_pred hhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 682 VKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
...............+++. +.+++.+||+.||++|||+.|++++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~----------------------~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 224 YGVAMNKLALPIPSTCPEP----------------------FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHTSCCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HhhhcCCCCCCCCcccCHH----------------------HHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111111111111112211 22266789999999999999999999753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=356.93 Aligned_cols=250 Identities=27% Similarity=0.351 Sum_probs=193.5
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 527 (767)
..++|++.+.||+|+||.||+|+++ +++.||||++... .....+.+.+|.++++.+ +||||+++++++ ..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence 4578999999999999999999976 4899999999653 233456688999999988 799999999995 45
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
...+|+||||+++|+|.+++...+. +++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSRR------FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEc
Confidence 5678999999999999999976543 99999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
|||+++..... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+..
T Consensus 167 DFG~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~ 238 (353)
T 3txo_A 167 DFGMCKEGICN------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILN 238 (353)
T ss_dssp CCTTCBCSCC---------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred cccceeecccC------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHHHHHHc
Confidence 99999743211 11234567999999999998888999999999999999999999999653221 11111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCH------HHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDI------REALRR 747 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~evl~~ 747 (767)
... ..+..+++. +.+++.+||+.||++||++ +|++++
T Consensus 239 ~~~-~~p~~~~~~----------------------~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 239 DEV-VYPTWLHED----------------------ATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CCC-CCCTTSCHH----------------------HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCC-CCCCCCCHH----------------------HHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 000 011111111 2236678999999999998 777763
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=350.38 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=198.4
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-Cc----EEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GI----SVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
.++|++.+.||+|+||.||+|.+.. ++ +||+|.+... .....+.+.+|+.++++++||||++++++|...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence 3579999999999999999999653 44 4688887533 334567899999999999999999999997532
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 90 --~~~~v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~ 159 (327)
T 3poz_A 90 --TVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp --SEEEEEECCTTCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred --CeEEEEEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEc
Confidence 2579999999999999997643 2399999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 686 (767)
|||+++......... ......||..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.
T Consensus 160 Dfg~a~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~ 233 (327)
T 3poz_A 160 DFGLAKLLGAEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE 233 (327)
T ss_dssp CTTHHHHHTTTCC-----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH
T ss_pred cCcceeEccCCcccc----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHH
Confidence 999998765432211 1233456889999999999999999999999999999999 99999654322 2222222
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
.............. +.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 234 ~~~~~~~~~~~~~~----------------------~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 234 KGERLPQPPICTID----------------------VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TTCCCCCCTTBCHH----------------------HHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred cCCCCCCCccCCHH----------------------HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 22111111112211 11267789999999999999999999988654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.98 Aligned_cols=257 Identities=27% Similarity=0.430 Sum_probs=204.1
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++. .....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeEE
Confidence 357889999999999999999998889999999975432 3467899999999999999999999964 3455799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+.
T Consensus 81 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp EECCCTTCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhhCc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccc
Confidence 999999999999997643 2389999999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
....... .......++..|+|||++.+..++.++||||+|+++|+|++ |+.||...... .....+.......
T Consensus 153 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~~~~ 225 (267)
T 3t9t_A 153 FVLDDQY-----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLY 225 (267)
T ss_dssp GBCCHHH-----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCC
T ss_pred ccccccc-----cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCCcCC
Confidence 6533211 11123446788999999988889999999999999999999 89998653211 1111111111111
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
.+...++. +.+++.+||+.||++|||++|++++|+++.+
T Consensus 226 ~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTH----------------------VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHH----------------------HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111111 2236778999999999999999999998865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=350.58 Aligned_cols=259 Identities=25% Similarity=0.320 Sum_probs=200.0
Q ss_pred cCCCCCCccccccceEEEEEEeCC-Cc----EEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GI----SVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
++|++.+.||+|+||.||+|.+.. ++ +||+|.+... .....+.+.+|+.++++++||||+++++++. +
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence 578899999999999999999653 44 3788877433 2344567889999999999999999999863 2
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++|+|.+++...+ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 158 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVAD 158 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECS
T ss_pred CccEEEEEeCCCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECC
Confidence 34689999999999999997653 2388999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 687 (767)
||+++........ .......||..|+|||++.+..++.++||||+|+++|+|++ |+.||...... .....+..
T Consensus 159 fg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~ 232 (325)
T 3kex_A 159 FGVADLLPPDDKQ----LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEK 232 (325)
T ss_dssp CSGGGGSCCCTTC----CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHT
T ss_pred CCcccccCccccc----ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHc
Confidence 9999876443221 11234567889999999998899999999999999999999 99999764322 12222221
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
............. +.+++.+||+.||++|||++|++++|+.+....
T Consensus 233 ~~~~~~~~~~~~~----------------------~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 233 GERLAQPQICTID----------------------VYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp TCBCCCCTTBCTT----------------------TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred CCCCCCCCcCcHH----------------------HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1111111111111 112677899999999999999999999886543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=365.48 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=201.6
Q ss_pred CHHHHHHHhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeee
Q 004218 446 SYDELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCS 521 (767)
Q Consensus 446 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 521 (767)
.+.+++...++|++.++||+|+||.||+|+++. ++.||+|++... .....+.+.+|..+++.++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345566667899999999999999999999775 789999999642 2233455889999999999999999999954
Q ss_pred cCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 004218 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED 601 (767)
Q Consensus 522 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~ 601 (767)
+...+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 145 -----~~~~~~lV~Ey~~gg~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~ 211 (437)
T 4aw2_A 145 -----DDNNLYLVMDYYVGGDLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMN 211 (437)
T ss_dssp -----CSSEEEEEECCCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred -----eCCEEEEEEecCCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCC
Confidence 4567899999999999999997632 2399999999999999999999999 99999999999999999
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
+.+||+|||+++....... ......+||+.|+|||++. ...++.++||||+||++|||++|+.||.....
T Consensus 212 g~vkL~DFGla~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 212 GHIRLADFGSCLKLMEDGT-----VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp SCEEECCCTTCEECCTTSC-----EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CCEEEcchhhhhhcccCCC-----cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999976533211 1123457999999999986 56789999999999999999999999965322
Q ss_pred CCcchhhHhhh----hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCC--CCCHHHHHHH
Q 004218 677 GEVSLVKWVES----NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGG--RIDIREALRR 747 (767)
Q Consensus 677 ~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~ 747 (767)
... ....... .+|... ..+++. +.+++.+||..+|++ ||+++|++++
T Consensus 287 ~~~-~~~i~~~~~~~~~p~~~-~~~s~~----------------------~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 287 VET-YGKIMNHKERFQFPTQV-TDVSEN----------------------AKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHH-HHHHHTHHHHCCCCSSC-CCSCHH----------------------HHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hHH-HHhhhhccccccCCccc-ccCCHH----------------------HHHHHHHHhcccccccCCCCHHHHhCC
Confidence 111 1111110 111110 011111 223666888888888 9999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=354.53 Aligned_cols=269 Identities=25% Similarity=0.374 Sum_probs=206.2
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecC
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSL 523 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 523 (767)
....++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-- 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc--
Confidence 345678999999999999999999975 348899999975432 34567899999999999999999999964
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKNE------------------HGNGLNFLERLNIAIDIASALDYLHNDCEVP 585 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 585 (767)
.+...++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||++ +
T Consensus 121 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ 194 (343)
T 1luf_A 121 ---VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 194 (343)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ---cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3456799999999999999997643210 124599999999999999999999999 9
Q ss_pred eEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHH
Q 004218 586 IVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIF 665 (767)
Q Consensus 586 ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 665 (767)
|+||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||+
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 270 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccc----cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence 999999999999999999999999999876543211 1123345789999999998888999999999999999999
Q ss_pred h-CCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 004218 666 T-GMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREA 744 (767)
Q Consensus 666 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ev 744 (767)
+ |+.||...... .....+...........+++. +.+++.+||+.||++|||+.|+
T Consensus 271 t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~~~ 326 (343)
T 1luf_A 271 SYGLQPYYGMAHE--EVIYYVRDGNILACPENCPLE----------------------LYNLMRLCWSKLPADRPSFCSI 326 (343)
T ss_dssp TTTCCTTTTSCHH--HHHHHHHTTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCcCCCCChH--HHHHHHhCCCcCCCCCCCCHH----------------------HHHHHHHHcccCcccCCCHHHH
Confidence 9 99998653221 111111111111111111111 2226778999999999999999
Q ss_pred HHHHHHHHHHH
Q 004218 745 LRRLKNAQKIL 755 (767)
Q Consensus 745 l~~L~~~~~~~ 755 (767)
++.|+++....
T Consensus 327 ~~~L~~~~~~~ 337 (343)
T 1luf_A 327 HRILQRMCERA 337 (343)
T ss_dssp HHHHHHTTC--
T ss_pred HHHHHHHHhhh
Confidence 99998876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.95 Aligned_cols=251 Identities=23% Similarity=0.305 Sum_probs=199.2
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|++..........+.+|+++++.++||||+++++++. +....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence 468999999999999999999976 58999999997655555667899999999999999999999954 456789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--CCceEEcccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE--DMTAKVGDFG 610 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg 610 (767)
+||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++. .+.+||+|||
T Consensus 125 lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp EEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence 9999999999999997543 2389999999999999999999999 9999999999999974 5789999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc-
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF- 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~- 689 (767)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........+
T Consensus 197 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~ 268 (387)
T 1kob_A 197 LATKLNPDE-------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE 268 (387)
T ss_dssp TCEECCTTS-------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC
T ss_pred cceecCCCc-------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC
Confidence 997653321 1233468999999999999999999999999999999999999996532110 1111111111
Q ss_pred -ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 -PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 -~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+......+++ .+.+++.+||+.||++|||+.|++++
T Consensus 269 ~~~~~~~~~s~----------------------~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 FDEDAFSSVSP----------------------EAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCSSTTTTSCH----------------------HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCccccccCCH----------------------HHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111111111 12237779999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=351.13 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=183.8
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
..++|++.+.||+|+||.||+|.+.. ++.||||++.... ..+.+.+|++++++++||||+++++++. .....
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeE
Confidence 45789999999999999999999864 8899999987432 3466789999999999999999999964 44567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEcc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE---DMTAKVGD 608 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~D 608 (767)
++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~D 194 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD 194 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEcc
Confidence 99999999999999997643 389999999999999999999999 9999999999999975 88999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 195 fg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~ 267 (349)
T 2w4o_A 195 FGLSKIVEHQV-------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE 267 (349)
T ss_dssp CC-----------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC
T ss_pred CccccccCccc-------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC
Confidence 99998653321 12345689999999999999999999999999999999999999965432211111111111
Q ss_pred ccc--chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPK--NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+.. .....++. .+.+++.+||+.||++|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~----------------------~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 268 YYFISPWWDEVSL----------------------NAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CCCCTTTTTTSCH----------------------HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CccCCchhhhCCH----------------------HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 00111111 12237779999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.37 Aligned_cols=270 Identities=24% Similarity=0.381 Sum_probs=204.1
Q ss_pred HhcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeecc-CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCC
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIE-STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLD 524 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 524 (767)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+++++++ +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--- 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence 4578999999999999999999962 3668999999644 334557889999999999 8999999999964
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKN-----------------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIV 587 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 587 (767)
..+..++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||++ +|+
T Consensus 120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 194 (344)
T 1rjb_A 120 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 194 (344)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred --eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 345679999999999999999865421 0113489999999999999999999999 999
Q ss_pred eecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-
Q 004218 588 HCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT- 666 (767)
Q Consensus 588 H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t- 666 (767)
||||||+||+++.++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|+|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccc----eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 9999999999999999999999999866443211 12234457889999999988889999999999999999998
Q ss_pred CCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 667 GMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 667 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
|..||...... ...................++. +.+++.+||+.||++|||+.|+++
T Consensus 271 g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 271 GVNPYPGIPVD-ANFYKLIQNGFKMDQPFYATEE----------------------IYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp SCCSSTTCCCS-HHHHHHHHTTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccCCcH-HHHHHHHhcCCCCCCCCCCCHH----------------------HHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999664322 1122222222221111112221 122667899999999999999999
Q ss_pred HHHHHHHHHhh
Q 004218 747 RLKNAQKILLK 757 (767)
Q Consensus 747 ~L~~~~~~~~~ 757 (767)
+|+.+......
T Consensus 328 ~l~~~~~~~~~ 338 (344)
T 1rjb_A 328 FLGCQLADAEE 338 (344)
T ss_dssp HHHHHC-----
T ss_pred HHHHHHHHHHH
Confidence 99988765443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.09 Aligned_cols=264 Identities=26% Similarity=0.378 Sum_probs=205.2
Q ss_pred hcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS----- 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe-----
Confidence 568999999999999999999862 35789999996443 334567889999999999999999999964
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNE------------------HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVH 588 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 588 (767)
.....++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||++ +|+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence 4456799999999999999998654210 123489999999999999999999999 9999
Q ss_pred ecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-C
Q 004218 589 CDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-G 667 (767)
Q Consensus 589 ~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g 667 (767)
|||||+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||+|+++|||++ |
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDS----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSC----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred cccchheEEEcCCCCEEEcccccccccccccc----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999976543211 111233457888999999988889999999999999999999 9
Q ss_pred CCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 668 MSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 668 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+.||...... .....+...........+++. +.+++.+||+.||++|||+.|++++
T Consensus 250 ~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~----------------------~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 250 GNPYPGIPPE--RLFNLLKTGHRMERPDNCSEE----------------------MYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCSSTTCCGG--GHHHHHHTTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHH--HHHHHhhcCCcCCCCccCCHH----------------------HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999654322 122222221111111111211 2226678999999999999999999
Q ss_pred HHHHHH
Q 004218 748 LKNAQK 753 (767)
Q Consensus 748 L~~~~~ 753 (767)
|+++..
T Consensus 306 l~~~~~ 311 (314)
T 2ivs_A 306 LEKMMV 311 (314)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 998765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=348.79 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=196.0
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-----
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF----- 525 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 525 (767)
..++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467999999999999999999986 69999999997543 3355778999999999999999999998754321
Q ss_pred -----------------------------------------------ccceeeEEEEeecCCCChhhhhcccCCCCCCCC
Q 004218 526 -----------------------------------------------KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNG 558 (767)
Q Consensus 526 -----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~ 558 (767)
....+.++||||+++|+|.+++...... ..
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~ 160 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---ED 160 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GG
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cc
Confidence 1223589999999999999999875432 33
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCcc------cccccccc
Q 004218 559 LNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS------ISSTHVLK 632 (767)
Q Consensus 559 l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~------~~~~~~~~ 632 (767)
.++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........... ........
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 67778999999999999999999 9999999999999999999999999999876443211110 11223456
Q ss_pred CCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh-hhhcccchhhhccHHHHHhhhcchhh
Q 004218 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV-ESNFPKNAQQVLDRELRQLMMSSESQ 711 (767)
Q Consensus 633 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~ 711 (767)
||+.|+|||++.+..++.++||||+|+++|||++|..|+.... ...... ...++ ..
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----~~~~~~~~~~~~-------------------~~ 294 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----RIITDVRNLKFP-------------------LL 294 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----HHHHHHHTTCCC-------------------HH
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----HHHHHhhccCCC-------------------cc
Confidence 9999999999999999999999999999999999877642110 000000 00000 00
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 712 TIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 712 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.....+ .+.+++.+||+.||++|||++|++++
T Consensus 295 ~~~~~~----~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 295 FTQKYP----QEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCH----HHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccCCh----hHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 001111 11237779999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=345.73 Aligned_cols=206 Identities=28% Similarity=0.476 Sum_probs=160.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|++++++++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeE
Confidence 468999999999999999999975 58999999996543 334567889999999999999999999954 45678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||++ |+|.+++...........+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999998 59999987654333344599999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 155 ~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 155 ARAFGIPVN------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp CEETTSCCC------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ceecCCCcc------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 976532211 1233468999999999876 46899999999999999999999999654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=349.76 Aligned_cols=207 Identities=29% Similarity=0.408 Sum_probs=172.8
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-----cchhhHHHHHHHHhcC---CCCCceeEEeeeecC
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-----GTWKSFFAECEALRNT---RHRNLVKLITSCSSL 523 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~ 523 (767)
..++|++.+.||+|+||.||+|++. +++.||||++..... .....+.+|+++++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4679999999999999999999964 589999999864321 2234677888887776 499999999998765
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT 603 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~ 603 (767)
........++||||++ |+|.+++.... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 4444557899999997 59999997654 23489999999999999999999999 9999999999999999999
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+||+|||.++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 159 ~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 159 VKLADFGLARIYSYQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp EEECSCSCTTTSTTCC-------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred EEEeeCccccccCCCc-------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999997653221 123456899999999999999999999999999999999999999654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=387.74 Aligned_cols=373 Identities=21% Similarity=0.236 Sum_probs=287.5
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccC-CccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKI-PGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
++|++|||++|.++ .++...+..+++|++|+|++|...+.+ |..|+++++|++|+|++|.+++..|..|+.+++|++|
T Consensus 24 ~~l~~LdLs~N~i~-~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 24 NTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp TTCCEEEEESCCCC-EECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCcCEEECCCCcCC-ccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 67999999999999 555555567999999999999665555 8899999999999999999998889999999999999
Q ss_pred eecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecC-chhhhhccccCeEEccCCcccccCCccccCC--CCCC
Q 004218 81 NIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIP-ESIGNLSNVLSKLYMGGNRFYGKIPTSIGRL--RSLT 157 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l--~~L~ 157 (767)
+|++|.+.+... ....+.++++|++|+|++|.+++..+ ..++++++ |++|++++|.+++..+..+..+ ++|+
T Consensus 103 ~Ls~n~l~~~~~----~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~-L~~L~Ls~N~i~~~~~~~l~~l~~~~L~ 177 (844)
T 3j0a_A 103 RLYFCGLSDAVL----KDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNS-LKSIDFSSNQIFLVCEHELEPLQGKTLS 177 (844)
T ss_dssp ECTTCCCSSCCS----TTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSS-CCEEEEESSCCCCCCSGGGHHHHHCSSC
T ss_pred eCcCCCCCcccc----cCccccccCCCCEEECCCCcccccccchhHhhCCC-CCEEECCCCcCCeeCHHHcccccCCccc
Confidence 999999875211 11237899999999999999987655 57899998 9999999999998888888766 6666
Q ss_pred EEECcCCcCcccCccccCCC------------------------------------------------------------
Q 004218 158 LLNLSYNSISGEILTEIGQL------------------------------------------------------------ 177 (767)
Q Consensus 158 ~L~l~~n~i~~~~~~~~~~l------------------------------------------------------------ 177 (767)
.|++++|.+.+..+..+..+
T Consensus 178 ~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~ 257 (844)
T 3j0a_A 178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQ 257 (844)
T ss_dssp CCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGG
T ss_pred eEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCCh
Confidence 66666665554333322221
Q ss_pred --------CCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhccc
Q 004218 178 --------QELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSL 249 (767)
Q Consensus 178 --------~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 249 (767)
++|++|+|++|.+.+..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..+..+
T Consensus 258 ~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 337 (844)
T 3j0a_A 258 NTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL 337 (844)
T ss_dssp TTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSC
T ss_pred hhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCC
Confidence 457777777777776667777788888888888888887777788888888888888888887777788888
Q ss_pred ccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCC-------------------------------------
Q 004218 250 SSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLP------------------------------------- 292 (767)
Q Consensus 250 ~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~------------------------------------- 292 (767)
++| +.+++++|.+.+..+..|..+++|+.|+|++|.+++...
T Consensus 338 ~~L-~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l 416 (844)
T 3j0a_A 338 PKV-AYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENL 416 (844)
T ss_dssp TTC-CEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSS
T ss_pred CCC-CEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccC
Confidence 887 444888888887777778888888888888887764211
Q ss_pred ---cccccCcccceeeccCccccCC------------------------------CCchhhccCCceEEEcCCcccCCCC
Q 004218 293 ---NSFKNCKSLEKLLMANNKFSGP------------------------------IPNILAELKGLEVLDLSSNKLSGSI 339 (767)
Q Consensus 293 ---~~~~~l~~L~~L~l~~n~l~~~------------------------------~~~~~~~l~~L~~L~Ls~N~l~~~~ 339 (767)
..+..+++|+.|++++|++++. .+..|..+++|+.|+|++|.+++..
T Consensus 417 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 496 (844)
T 3j0a_A 417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLP 496 (844)
T ss_dssp TTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCC
T ss_pred chhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccC
Confidence 0122556666666666666532 1234667788888888888888888
Q ss_pred CccccccccCceEeccCCcCcCcCCCCccccccccccccCCcC
Q 004218 340 PSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPK 382 (767)
Q Consensus 340 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~ 382 (767)
|..+..+++|+.|+|++|++++.++.... +++..+++.+|..
T Consensus 497 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l 538 (844)
T 3j0a_A 497 PGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQL 538 (844)
T ss_dssp TTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECC
T ss_pred hhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcC
Confidence 88888899999999999999887766543 6777788887754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=348.82 Aligned_cols=199 Identities=28% Similarity=0.371 Sum_probs=172.9
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccce
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 529 (767)
++|++.+.||+|+||.||+|+++ +++.||+|++..... ...+.+.+|..+++++ +||||+++++++. ...
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~~ 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TES 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eCC
Confidence 57899999999999999999976 488999999975422 2345678999999988 8999999999953 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF 154 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY 154 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCG
T ss_pred EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEec
Confidence 7899999999999999997643 299999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
|+++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 155 G~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 155 GMCKEGLRP------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp GGCBCSCCT------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCC------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 999753221 1122446799999999999999999999999999999999999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=341.59 Aligned_cols=200 Identities=27% Similarity=0.427 Sum_probs=168.7
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||+|+||.||+|.+.+++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeEE
Confidence 5789999999999999999999889999999986443 223467889999999999999999999964 445679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++ +|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 77 lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA 147 (288)
T ss_dssp EEEECCSE-EHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred EEEEecCC-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccc
Confidence 99999986 9999987643 2389999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+....... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus 148 ~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 148 RAFGIPVR------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp HHHCC---------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCcccc------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 86543211 11234589999999998764 5899999999999999999999999654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.23 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=197.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++. +..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence 367899999999999999999976 5899999999653 2234567889999999999999999999954 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.+|.+||+||
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence 7899999999999999997643 389999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..........
T Consensus 151 g~a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~ 220 (318)
T 1fot_A 151 GFAKYVPDV---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAEL 220 (318)
T ss_dssp SSCEECSSC---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCCC
T ss_pred CcceecCCc---------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCC
Confidence 999754321 234569999999999999999999999999999999999999996532110 0111111110
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
..+..+++ .+.+++.+||+.||++|| +++|++++
T Consensus 221 --~~p~~~~~----------------------~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 --RFPPFFNE----------------------DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CCCTTSCH----------------------HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCH----------------------HHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 01111111 122366789999999999 88998864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=352.06 Aligned_cols=280 Identities=16% Similarity=0.198 Sum_probs=204.8
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC------CcEEEEEEeeccCCcc-----------hhhHHHHHHHHhcCCCCCcee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIESTGT-----------WKSFFAECEALRNTRHRNLVK 515 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~ 515 (767)
..++|++.+.||+|+||.||+|.+.. ++.||||++....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999999764 4789999986543211 122345566677788999999
Q ss_pred EEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 004218 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGN 595 (767)
Q Consensus 516 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 595 (767)
+++++... .....+.++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+|
T Consensus 113 ~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N 182 (364)
T 3op5_A 113 YWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN 182 (364)
T ss_dssp EEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred EEeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence 99997642 22346789999999 999999997642 3499999999999999999999999 99999999999
Q ss_pred eeeC--CCCceEEccccchhhhhhhcCCCc-cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCC
Q 004218 596 ILLD--EDMTAKVGDFGLARSLLERIGNQS-SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTH 672 (767)
Q Consensus 596 Il~~--~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 672 (767)
|+++ .++.+||+|||+++.+........ .........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999 889999999999987654332211 1112234569999999999999999999999999999999999999997
Q ss_pred CcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 673 ESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
...... .........+........ ...+.. ... ...+.+++..||+.||++||+++++++.|+++.
T Consensus 263 ~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~-----~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 263 DNLKDP-KYVRDSKIRYRENIASLM----DKCFPA-----ANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp GGTTCH-HHHHHHHHHHHHCHHHHH----HHHSCT-----TCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccccCH-HHHHHHHHHhhhhHHHHH----HHhccc-----ccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 532221 111111111111111111 111100 000 112233777899999999999999999999988
Q ss_pred HHHh
Q 004218 753 KILL 756 (767)
Q Consensus 753 ~~~~ 756 (767)
....
T Consensus 329 ~~~~ 332 (364)
T 3op5_A 329 KAIG 332 (364)
T ss_dssp HHTT
T ss_pred HHcC
Confidence 7654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=373.33 Aligned_cols=123 Identities=24% Similarity=0.336 Sum_probs=66.4
Q ss_pred ccccCCCCCchhhcCCCceeEEEccCCCCCCCCC-cccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccC-
Q 004218 259 SKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLP-NSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLS- 336 (767)
Q Consensus 259 ~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~- 336 (767)
++|++++..|..+..+++|+.|++++|.+++.+| ..|.++++|+.|++++|++.+..+..|..+++|+.|++++|.+.
T Consensus 389 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~ 468 (680)
T 1ziw_A 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468 (680)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBC
T ss_pred CCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccc
Confidence 3344444444445555555555555555543322 44555555555555555555555555555555555555555554
Q ss_pred -CCCCccccccccCceEeccCCcCcCcCCCC-ccccccccccccCCc
Q 004218 337 -GSIPSDLQNLRALRSLNLTFNNLEGVVPRE-GIFRHTSMVHLEGNP 381 (767)
Q Consensus 337 -~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~~~l~~Np 381 (767)
+..|..+..+++|+.|++++|++++.++.. ..++++..+++.+|.
T Consensus 469 ~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 515 (680)
T 1ziw_A 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515 (680)
T ss_dssp TTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCC
Confidence 345556666666666666666666655543 334556666666664
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.29 Aligned_cols=276 Identities=25% Similarity=0.337 Sum_probs=205.2
Q ss_pred cCC-CCCCccccccceEEEEEEeC-----CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 455 GNF-SHENLIGSGSFGSVYKGYLR-----EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 455 ~~~-~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
++| ++.+.||+|+||.||++.+. +++.||||++..... ...+.+.+|++++++++||||+++++++.. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~ 106 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AG 106 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CC
Confidence 344 89999999999999998753 588999999975432 345678999999999999999999999753 23
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
...+++||||+++|+|.+++.... +++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~ 176 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIG 176 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred CceEEEEEecccCCcHHHHHhhCC-------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEEC
Confidence 457799999999999999997643 89999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
|||.+........ .........||..|+|||++.+..++.++||||+|+++|+|++|+.||............
T Consensus 177 Dfg~a~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~---- 249 (318)
T 3lxp_A 177 DFGLAKAVPEGHE---YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG---- 249 (318)
T ss_dssp CGGGCEECCTTCS---EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC----
T ss_pred Ccccccccccccc---ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhc----
Confidence 9999986643211 111123345788899999999888999999999999999999999998543211100000
Q ss_pred hcccchhhhccHHHHHhhhcch--hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhh
Q 004218 688 NFPKNAQQVLDRELRQLMMSSE--SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 757 (767)
... .......+...+.... ....... ..+.+++.+||+.||++|||++|+++.|+.+.+.+..
T Consensus 250 -~~~--~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 250 -IAQ--GQMTVLRLTELLERGERLPRPDKCP----AEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp -SCC--HHHHHHHHHHHHHTTCCCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred -ccc--cchhHHHHHHHHhcccCCCCCcccc----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 000 0000000111110000 0000111 1222377799999999999999999999999887764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=350.74 Aligned_cols=264 Identities=24% Similarity=0.390 Sum_probs=192.3
Q ss_pred hcCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... .....+.+|++++++++||||+++++++.... ..+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 46899999999999999999997 4589999999975432 23457889999999999999999999875422 2234
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred ccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence 5699999999999999997643 389999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|+++........ ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||......... ........
T Consensus 161 g~a~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~ 236 (311)
T 3ork_A 161 GIARAIADSGNS---VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-YQHVREDP 236 (311)
T ss_dssp SCC---------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHCCC
T ss_pred cCcccccccccc---cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhcCCC
Confidence 999866443211 11223456899999999999999999999999999999999999999653221110 01111100
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH-HHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR-RLKNA 751 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~-~L~~~ 751 (767)
.. .. .....+...+.+++.+||+.||++||++.++++ .+...
T Consensus 237 ~~-~~-------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 237 IP-PS-------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CC-HH-------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CC-cc-------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00 00 000001111223677899999999997766554 44443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=340.55 Aligned_cols=268 Identities=17% Similarity=0.163 Sum_probs=205.9
Q ss_pred hcCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+ .+++.||||++... ...+.+.+|+++++.+ +|++++++++++ ......
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCcee
Confidence 46799999999999999999996 45899999998643 3345688999999999 799999999985 345667
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc-----eEE
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT-----AKV 606 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~-----~kl 606 (767)
++||||+ +++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++. +||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred EEEEEec-CCCHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 9999999 899999997643 2399999999999999999999999 9999999999999987765 999
Q ss_pred ccccchhhhhhhcCCCcc-ccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcc-hhh-
Q 004218 607 GDFGLARSLLERIGNQSS-ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS-LVK- 683 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~- 683 (767)
+|||.++........... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......... ...
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence 999999876543221111 11234566999999999999999999999999999999999999999764322110 000
Q ss_pred HhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 684 WVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 684 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
......+.... .....+...+.+++.+||+.||++|||++++++.|+++.+...
T Consensus 233 ~~~~~~~~~~~-------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 233 IGEKKQSTPLR-------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHHHHHHSCHH-------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhhccCccHH-------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 00000000000 0000111122337778999999999999999999999887654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.16 Aligned_cols=267 Identities=22% Similarity=0.367 Sum_probs=206.9
Q ss_pred HhcCCCCCCccccccceEEEEEEe------CCCcEEEEEEeeccCC-cchhhHHHHHHHHhcC-CCCCceeEEeeeecCC
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYL------REGISVAVKVLDIEST-GTWKSFFAECEALRNT-RHRNLVKLITSCSSLD 524 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 524 (767)
..++|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--- 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--- 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe---
Confidence 346899999999999999999985 2467899999975433 3456788999999999 9999999999964
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKN------------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLK 592 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 592 (767)
.++..++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||++ +|+|||||
T Consensus 98 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 172 (313)
T 1t46_A 98 --IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172 (313)
T ss_dssp --SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred --cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence 345569999999999999999865421 1123589999999999999999999999 99999999
Q ss_pred CCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCC
Q 004218 593 PGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPT 671 (767)
Q Consensus 593 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~ 671 (767)
|+||+++.++.+||+|||.++........ .......||+.|+|||++.+..++.++||||+|+++|+|++ |+.||
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 248 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTS----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cceEEEcCCCCEEEccccccccccccccc----eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999866443211 11233457889999999988899999999999999999999 99998
Q ss_pred CCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 672 HESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
....... ..................++. +.+++.+||+.||++|||+.|++++|+++
T Consensus 249 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 249 PGMPVDS-KFYKMIKEGFRMLSPEHAPAE----------------------MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp TTCCSSH-HHHHHHHHTCCCCCCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccccchh-HHHHHhccCCCCCCcccCCHH----------------------HHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 6543221 112222221111111111111 22367789999999999999999999988
Q ss_pred HHH
Q 004218 752 QKI 754 (767)
Q Consensus 752 ~~~ 754 (767)
...
T Consensus 306 ~~~ 308 (313)
T 1t46_A 306 ISE 308 (313)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=354.04 Aligned_cols=296 Identities=22% Similarity=0.298 Sum_probs=201.3
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHH--hcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEAL--RNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l--~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|+.. ++.||||++.... ...+..|.++. ..++||||+++++++..........+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 468999999999999999999874 8999999986432 33444555554 45799999999987655445566778
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeecCCCCCeeeCCCCceE
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC------EVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
++||||+++|+|.+++.... .++..++.++.|++.||+|||+.. .++|+||||||+||+++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 99999999999999997544 689999999999999999999752 23899999999999999999999
Q ss_pred EccccchhhhhhhcCCC--ccccccccccCCCCccCccccCC-------CCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 606 VGDFGLARSLLERIGNQ--SSISSTHVLKGSIGYIPPEYGLG-------EKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
|+|||+++......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998654322111 11112234569999999999887 3556789999999999999999877644322
Q ss_pred CCcchhhHhhhhcccchhhhccHHHHHhh--hcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 677 GEVSLVKWVESNFPKNAQQVLDRELRQLM--MSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
.......+..................... ...+..... .......+.+++.+||+.||++|||++|+++.|+++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE-NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC-CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc-ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 11111000000000000000000000000 000000000 000111233377799999999999999999999999887
Q ss_pred HhhcCCC
Q 004218 755 LLKRRQP 761 (767)
Q Consensus 755 ~~~~~~~ 761 (767)
+.+....
T Consensus 320 ~~~~~~~ 326 (336)
T 3g2f_A 320 WERNKSV 326 (336)
T ss_dssp CCC----
T ss_pred HHhcccC
Confidence 7755443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=340.09 Aligned_cols=269 Identities=25% Similarity=0.368 Sum_probs=209.8
Q ss_pred cCCCCCC-ccccccceEEEEEEeC---CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 455 GNFSHEN-LIGSGSFGSVYKGYLR---EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
++|.+.+ .||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++. .+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CC
Confidence 4566666 8999999999999864 47889999997543 234577889999999999999999999963 23
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df 154 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 154 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred CcEEEEEeCCCCCHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence 4799999999999999996543 3499999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|.+......... ........||+.|+|||++.+..++.++||||+|+++|+|++ |+.||...... .....+...
T Consensus 155 g~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~~ 229 (287)
T 1u59_A 155 GLSKALGADDSY---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQG 229 (287)
T ss_dssp TTCEECTTCSCE---ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTT
T ss_pred cceeeeccCcce---eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhcC
Confidence 999865432111 111223346889999999988889999999999999999998 99999653221 122222211
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhhcCCCCcc
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQPNEK 764 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~~~~~ 764 (767)
.....+..+++. +.+++.+||+.||++|||+.|++++|+.+..+.......+++
T Consensus 230 ~~~~~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~ 283 (287)
T 1u59_A 230 KRMECPPECPPE----------------------LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 283 (287)
T ss_dssp CCCCCCTTCCHH----------------------HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred CcCCCCCCcCHH----------------------HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCcc
Confidence 111111111221 222667899999999999999999999999988877666554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=353.24 Aligned_cols=280 Identities=24% Similarity=0.250 Sum_probs=205.2
Q ss_pred hcCCCCCCccccccceEEEEEEe-----CCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL-----REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++.. .+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence 36899999999999999999984 3588999999976665666779999999999999999999998753 345
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcc
Confidence 678999999999999999976432 389999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||.++....... .........||..|+|||++.+..++.++||||+|+++|+|++|+.||........... ...
T Consensus 171 fg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~---~~~ 244 (327)
T 3lxl_A 171 FGLAKLLPLDKD---YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM---GCE 244 (327)
T ss_dssp GGGCEECCTTCS---EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC---C--
T ss_pred cccceecccCCc---cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc---ccc
Confidence 999986543221 11122334578889999999888899999999999999999999999854321100000 000
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
............+...... ....... ..+.+++.+||+.||++|||++|++++|+.+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~--~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 245 RDVPALSRLLELLEEGQRL--PAPPACP----AEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp --CCHHHHHHHHHHTTCCC--CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred cccccHHHHHHHhhcccCC--CCCCccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 0000000000000000000 0000111 122237778999999999999999999998765443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=351.11 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=196.9
Q ss_pred HHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCC
Q 004218 450 LRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLD 524 (767)
Q Consensus 450 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 524 (767)
.....++|++.+.||+|+||.||+|+++ +|+.||+|+++.. .....+.+..|.++++.+ +||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~--- 88 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--- 88 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE---
Confidence 3455689999999999999999999976 4899999999653 234456778899999876 9999999999954
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA 604 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~ 604 (767)
+...+++||||+++|+|.+++..... +++.++..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 89 --~~~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~v 157 (345)
T 1xjd_A 89 --TKENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHI 157 (345)
T ss_dssp --CSSEEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred --eCCEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCE
Confidence 45678999999999999999976432 89999999999999999999999 99999999999999999999
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhH
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 684 (767)
||+|||+++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....
T Consensus 158 kL~DFG~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~ 229 (345)
T 1xjd_A 158 KIADFGMCKENMLG------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHS 229 (345)
T ss_dssp EECCCTTCBCCCCT------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH
T ss_pred EEeEChhhhhcccC------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHH
Confidence 99999999753221 11234567999999999999999999999999999999999999999653221 11111
Q ss_pred hhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHH-HHHH
Q 004218 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIR-EALR 746 (767)
Q Consensus 685 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~ 746 (767)
+....+ ..+..+++ .+.+++.+||+.||++||++. |+++
T Consensus 230 i~~~~~-~~p~~~s~----------------------~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 230 IRMDNP-FYPRWLEK----------------------EAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHCCC-CCCTTSCH----------------------HHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHhCCC-CCCcccCH----------------------HHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 111111 01111111 122366789999999999997 6653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.05 Aligned_cols=260 Identities=23% Similarity=0.330 Sum_probs=193.6
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC----CcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
..++|++.+.||+|+||.||+|.+.. +..||+|+..... ....+.+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------
Confidence 35689999999999999999999753 4579999986433 234567889999999999999999999863
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
++..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG 158 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred cCccEEEEecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEEC
Confidence 234689999999999999997543 2389999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 686 (767)
|||+++........ ......+|+.|+|||++.+..++.++||||+|+++|||++ |..||...... .....+.
T Consensus 159 Dfg~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~ 231 (281)
T 1mp8_A 159 DFGLSRYMEDSTYY-----KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIE 231 (281)
T ss_dssp C------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH
T ss_pred ccccccccCccccc-----ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHH
Confidence 99999876432211 1123346788999999988889999999999999999997 99999654322 1111221
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
..........+++. +.+++.+||+.||++|||+.|+++.|+++....
T Consensus 232 ~~~~~~~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 232 NGERLPMPPNCPPT----------------------LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp TTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHH----------------------HHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111111111111 222667899999999999999999999987643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=346.71 Aligned_cols=266 Identities=19% Similarity=0.220 Sum_probs=204.4
Q ss_pred hcCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++.+ +||||+++++++. .+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCcc
Confidence 46799999999999999999996 458999999986443 345688999999999 9999999999854 45567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc-----eEE
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT-----AKV 606 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~-----~kl 606 (767)
++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++. +||
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl 151 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHI 151 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred EEEEEeC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEE
Confidence 9999999 899999997642 2499999999999999999999999 9999999999999998887 999
Q ss_pred ccccchhhhhhhcCCCc-cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcc-hhhH
Q 004218 607 GDFGLARSLLERIGNQS-SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS-LVKW 684 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~~ 684 (767)
+|||+++.......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....
T Consensus 152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~ 231 (330)
T 2izr_A 152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK 231 (330)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence 99999986544322111 111224567999999999999999999999999999999999999999764322110 0000
Q ss_pred h-hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 685 V-ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 685 ~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
+ ....+... ....+... .+.+++..||+.||.+||+++++.+.|+++.+..
T Consensus 232 i~~~~~~~~~-------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 232 IGDTKRATPI-------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHSCH-------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHhhhccCCH-------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0 00000000 00000011 1223777899999999999999999999887654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=366.37 Aligned_cols=259 Identities=24% Similarity=0.382 Sum_probs=204.5
Q ss_pred HHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
...++|++.+.||+|+||.||+|.++++..||||+++... ...+.+.+|++++++++||||+++++++. ....
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~ 257 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPI 257 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCcc
Confidence 3456788999999999999999999888999999997543 45678999999999999999999999864 2346
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred EEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999975431 2388999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
++....... .......++..|+|||++....++.++||||||+++|||++ |+.||...... .....+...+.
T Consensus 331 a~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~ 403 (454)
T 1qcf_A 331 ARVIEDNEY-----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYR 403 (454)
T ss_dssp GGGBCCHHH-----HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTCC
T ss_pred ceEcCCCce-----eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC
Confidence 986533211 11122346788999999988899999999999999999999 99999653221 11122222111
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
...+..+.+. +.+++.+||+.||++|||++++++.|+.+..
T Consensus 404 ~~~~~~~~~~----------------------l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 MPRPENCPEE----------------------LYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCHH----------------------HHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1111111111 2226778999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=341.44 Aligned_cols=199 Identities=26% Similarity=0.411 Sum_probs=167.8
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++. ++...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 57899999999999999999976 489999999965432 33467889999999999999999999954 45678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++ ++.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCC-CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999999976 6666655432 2399999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCC-CCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
++...... .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||..
T Consensus 148 ~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 148 ARAFGIPV------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CEECCSCC------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ceecCCcc------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 97653221 1123456899999999987766 79999999999999999999888643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=353.90 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=191.3
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCC--CCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIEST--GTWKSFFAECEALRNTRH--RNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.+.+++.||||++..... ...+.+.+|++++++++| |||+++++++. .+.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~ 82 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 82 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eCC
Confidence 467999999999999999999998899999999875432 234678899999999976 99999999954 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||| +.+|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++ ++.+||+||
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DF 151 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF 151 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCC
T ss_pred EEEEEEe-CCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeec
Confidence 7899999 55789999997643 389999999999999999999999 999999999999997 578999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCC-----------CCCCCcccchhhhHHHHHHHhCCCCCCCcccCC
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-----------EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 678 (767)
|+++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......
T Consensus 152 G~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 227 (343)
T 3dbq_A 152 GIANQMQPDTTS----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227 (343)
T ss_dssp SSSCCC----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred ccccccCccccc----ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH
Confidence 999865432211 11234569999999999754 678899999999999999999999996532221
Q ss_pred cchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 679 VSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
...........+...+...++. +.+++.+||+.||++|||+.|++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 228 SKLHAIIDPNHEIEFPDIPEKD----------------------LQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHH----------------------HHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHhcCCcccCCcccCCHH----------------------HHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1122222111111111111111 12367789999999999999998763
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=362.66 Aligned_cols=274 Identities=22% Similarity=0.237 Sum_probs=197.1
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-cccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+++.+|+.+++.++||||+++++++.... .....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999976 4899999999644 3334567889999999999999999999976543 23446
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence 78999999976 57766642 289999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .+...+....
T Consensus 209 G~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg 280 (464)
T 3ttj_A 209 GLARTAGTS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLG 280 (464)
T ss_dssp CCC-----C-------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred EeeeecCCC-------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence 999865432 11234578999999999999999999999999999999999999996532211 1111111100
Q ss_pred --ccchhhhccHHHHHhhhcchh----------------hHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 --PKNAQQVLDRELRQLMMSSES----------------QTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 --~~~~~~~~~~~l~~~~~~~~~----------------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
............+..+...+. ............+.+++.+||+.||++|||++|++++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000111111112111111000 0001111112334447889999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.47 Aligned_cols=271 Identities=21% Similarity=0.229 Sum_probs=204.0
Q ss_pred hcCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+++++.++||||+++++++... .......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence 46899999999999999999997 45899999998766556677899999999999999999999987532 12456789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++|+|.+++...... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEeCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 999999999999999764221 34599999999999999999999999 9999999999999999999999999988
Q ss_pred hhhhhhcCCCc---cccccccccCCCCccCccccCCCC---CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 613 RSLLERIGNQS---SISSTHVLKGSIGYIPPEYGLGEK---PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 613 ~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
........... .........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...............
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 65432111000 001112345799999999987654 689999999999999999999998543222222221111
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
..........+++ .+.+++.+||+.||++|||++|++++|+.+.
T Consensus 262 ~~~~~~~~~~~~~----------------------~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 262 NQLSIPQSPRHSS----------------------ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp CC--CCCCTTSCH----------------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ccCCCCccccCCH----------------------HHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 1111111111111 1223677899999999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.21 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=199.9
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|+++ ++.||||++.... ....+.+.+|++++++++||||+++++++... .....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 84 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPHP 84 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSSC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCCe
Confidence 367999999999999999999986 8899999997543 23456789999999999999999999997532 23567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeCCCCceEEccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVP--IVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||++ + |+||||||+||+++.++.++|+||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGT----NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCS----SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred EeeecccCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEec
Confidence 99999999999999998644 23589999999999999999999998 7 999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCC---cccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPST---AGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
|++..... ....||+.|+|||++.+..++. ++||||+|+++|||++|+.||........ ......
T Consensus 158 ~~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~ 225 (271)
T 3kmu_A 158 DVKFSFQS-----------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVAL 225 (271)
T ss_dssp GSCCTTSC-----------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHH
T ss_pred cceeeecc-----------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHh
Confidence 88754211 2245789999999988766554 79999999999999999999965322111 111111
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
.......+..+++. +.+++.+||+.||++|||++|+++.|+.+.
T Consensus 226 ~~~~~~~~~~~~~~----------------------~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 226 EGLRPTIPPGISPH----------------------VSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCCCCCCCCCCHH----------------------HHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11111112222222 222666899999999999999999998874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=341.89 Aligned_cols=261 Identities=30% Similarity=0.473 Sum_probs=190.8
Q ss_pred HHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
...++|++.+.||+|+||.||+|++.. .||+|++..... ...+.+.+|++++++++||||+++++++. ..
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~ 92 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------AP 92 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CC
Confidence 345789999999999999999998753 599999865432 34567899999999999999999999743 23
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df 164 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDF 164 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred ccEEEEEecCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccc
Confidence 4689999999999999996543 3499999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccC---CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh-
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL---GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV- 685 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~- 685 (767)
|.++........ .......||+.|+|||++. +..++.++||||+|+++|+|++|+.||........ ....+
T Consensus 165 g~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~ 239 (289)
T 3og7_A 165 GLATEKSRWSGS----HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEMVG 239 (289)
T ss_dssp C----------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHHHHH
T ss_pred eecccccccccc----ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHHHhc
Confidence 999765432111 1123456899999999986 56788899999999999999999999965432211 11111
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
....+....... ....+ .+.+++.+||+.||++|||++|+++.|+++.
T Consensus 240 ~~~~~~~~~~~~---------------~~~~~----~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 240 RGSLSPDLSKVR---------------SNCPK----RMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HTSCCCCTTSSC---------------TTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccCcchhhcc---------------ccCCH----HHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111111111000 00011 1222677899999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=355.90 Aligned_cols=209 Identities=22% Similarity=0.266 Sum_probs=175.8
Q ss_pred hcCCCCCCccccc--cceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSG--SFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|++.+.||+| +||.||+|++. +++.||||++.... ....+.+.+|+++++.++||||+++++++. .+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----AD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----EC
Confidence 4689999999999 99999999976 59999999997543 234567888999999999999999999964 45
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
+.+++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHF----MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred CEEEEEEEccCCCCHHHHHhhhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence 57899999999999999997653 23499999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCC-CccccccccccCCCCccCccccCC--CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 609 FGLARSLLERIGN-QSSISSTHVLKGSIGYIPPEYGLG--EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 609 fg~a~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
||.+......... ...........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 9998654332111 111111233468999999999987 57899999999999999999999999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=358.36 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=200.5
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecC
Q 004218 448 DELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSL 523 (767)
Q Consensus 448 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 523 (767)
.+++...++|++.+.||+|+||.||+|+++. ++.||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-- 139 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-- 139 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--
Confidence 4455567899999999999999999999764 889999998642 2334456889999999999999999999954
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT 603 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~ 603 (767)
+...+++||||++||+|.+++.... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 140 ---~~~~~~lV~E~~~gg~L~~~l~~~~-------~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 140 ---DDRYLYMVMEYMPGGDLVNLMSNYD-------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp ---CSSEEEEEECCCTTEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred ---ECCEEEEEEeCCCCCcHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCC
Confidence 5567899999999999999997543 89999999999999999999999 9999999999999999999
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC----CCCcccchhhhHHHHHHHhCCCCCCCcccCCc
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK----PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV 679 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 679 (767)
+||+|||+++...... .......+||+.|+|||++.+.. ++.++||||+||++|||++|+.||.......
T Consensus 207 ikL~DFG~a~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~- 280 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG- 280 (410)
T ss_dssp EEECCCTTCEECCTTS-----EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-
T ss_pred EEEeccceeEeeccCC-----cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-
Confidence 9999999997653221 11223567999999999987655 7899999999999999999999996532211
Q ss_pred chhhHhhhh--cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCC--CCCHHHHHHH
Q 004218 680 SLVKWVESN--FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGG--RIDIREALRR 747 (767)
Q Consensus 680 ~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~ 747 (767)
......... +.......+++ .+++++.+||..+|.+ ||+++|++++
T Consensus 281 ~~~~i~~~~~~~~~p~~~~~s~----------------------~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 281 TYSKIMNHKNSLTFPDDNDISK----------------------EAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHHHTHHHHCCCCTTCCCCH----------------------HHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHHHHHhccccccCCCcccccH----------------------HHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111111110 00000011111 1223666899999988 9999999876
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=337.27 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=199.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++. .+...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 467999999999999999999976 58999999986543 344577889999999999999999999854 45567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCC
Confidence 99999999999999987543 389999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+........ ........||..|+|||++.+..+ +.++||||+|+++|+|++|+.||............+......
T Consensus 152 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (276)
T 2yex_A 152 ATVFRYNNR----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227 (276)
T ss_dssp CEECEETTE----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT
T ss_pred ccccCCCcc----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc
Confidence 976533211 111234568999999999987765 778999999999999999999997654333222222221111
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
......+++ .+.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~----------------------~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 LNPWKKIDS----------------------APLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp STTGGGSCH----------------------HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCchhhcCH----------------------HHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 111111111 12236778999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=353.24 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=193.6
Q ss_pred CCCCCCccccccceEEEEEEeC--C--CcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR--E--GISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.|++.+.||+|+||.||+|.+. + +..||+|.+... .....+.+.+|+.++++++||||++++++|.. .++.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCCC
Confidence 4667789999999999999864 2 246899988643 33456789999999999999999999998743 3356
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++|+|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG 237 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG 237 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEECCCCCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecc
Confidence 689999999999999997643 3388999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
+++........ .........+|+.|+|||++.+..++.++||||||+++|||++ |.+||....... ....+....
T Consensus 238 ~a~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~~~ 313 (373)
T 3c1x_A 238 LARDMYDKEFD--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGR 313 (373)
T ss_dssp ----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHTTC
T ss_pred ccccccccccc--cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHcCC
Confidence 99865432211 1111233457889999999998899999999999999999999 667775533222 222221111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhh
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 757 (767)
....+..++.. +.+++.+||+.||++|||++|+++.|+.+...+..
T Consensus 314 ~~~~p~~~~~~----------------------l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 314 RLLQPEYCPDP----------------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCCCCCCHH----------------------HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 11111112221 12266789999999999999999999998876553
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=339.55 Aligned_cols=265 Identities=26% Similarity=0.378 Sum_probs=205.1
Q ss_pred HhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
..++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.. +..+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CCcE
Confidence 346899999999999999999999888899999986433 345788999999999999999999998642 3468
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++++|.+++.... ...+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||.+
T Consensus 84 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp EEEECCTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 9999999999999997543 12389999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
....... ........++..|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+......
T Consensus 157 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~ 229 (279)
T 1qpc_A 157 RLIEDNE-----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRM 229 (279)
T ss_dssp EECSSSC-----EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCC
T ss_pred ccccCcc-----cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccCC
Confidence 7654321 111123446788999999988889999999999999999999 89998653221 111111111111
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhhcCC
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQ 760 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~ 760 (767)
.....+++ .+.+++.+||+.||++|||++++++.|+++........+
T Consensus 230 ~~~~~~~~----------------------~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 276 (279)
T 1qpc_A 230 VRPDNCPE----------------------ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276 (279)
T ss_dssp CCCTTCCH----------------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-----
T ss_pred CCcccccH----------------------HHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCC
Confidence 11111111 122367789999999999999999999998876554333
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=346.23 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=197.1
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-C-------cEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-G-------ISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF 525 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 525 (767)
.++|++.+.||+|+||.||+|.+.. + ..||+|++........+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV---- 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC----
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE----
Confidence 4678999999999999999998653 3 579999997666666788999999999999999999999964
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT-- 603 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~-- 603 (767)
.+...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 83 -~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 83 -CGDENILVQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp -CTTCCEEEEECCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGG
T ss_pred -eCCCCEEEEECCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccc
Confidence 3445699999999999999997643 2389999999999999999999999 9999999999999998876
Q ss_pred ------eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 604 ------AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 604 ------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
+||+|||.+...... ....||+.|+|||++.+ ..++.++||||+|+++|||++|..|+.....
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLPK----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSCH----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccccceeeeccCcccccccCc----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 999999999654221 23457889999999887 6789999999999999999996655433211
Q ss_pred CCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 677 GEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
... ......... .......+ .+.+++.+||+.||++|||++|++++|+++.....
T Consensus 224 ~~~-~~~~~~~~~--~~~~~~~~----------------------~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 224 SQR-KLQFYEDRH--QLPAPKAA----------------------ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHH-HHHHHHTTC--CCCCCSSC----------------------TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred hHH-HHHHhhccC--CCCCCCCH----------------------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 111 111111000 00000010 01226778999999999999999999998766544
Q ss_pred hcC
Q 004218 757 KRR 759 (767)
Q Consensus 757 ~~~ 759 (767)
..+
T Consensus 279 ~~~ 281 (289)
T 4fvq_A 279 VPR 281 (289)
T ss_dssp ---
T ss_pred CCC
Confidence 433
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=338.60 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=195.5
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
..|++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++... ......+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceE
Confidence 34778889999999999999975 48899999986442 33456788999999999999999999987542 2345778
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeC-CCCceEEcc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVP--IVHCDLKPGNILLD-EDMTAKVGD 608 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~-~~~~~kl~D 608 (767)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. + |+||||||+||+++ .++.+||+|
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EEEEEecCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEee
Confidence 99999999999999997643 289999999999999999999998 7 99999999999998 789999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||++...... ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.................
T Consensus 176 fg~~~~~~~~--------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (290)
T 1t4h_A 176 LGLATLKRAS--------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 246 (290)
T ss_dssp TTGGGGCCTT--------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC
T ss_pred CCCccccccc--------ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC
Confidence 9999654221 1233568999999998764 589999999999999999999999965322211111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+........+. +.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 247 KPASFDKVAIPE----------------------VKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCGGGGGCCCHH----------------------HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccccCCCCCHH----------------------HHHHHHHHccCChhhCCCHHHHhhC
Confidence 111111111111 2236778999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=365.88 Aligned_cols=265 Identities=28% Similarity=0.407 Sum_probs=202.6
Q ss_pred HhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++.. +..+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~ 254 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 254 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence 346788999999999999999999888889999997543 345789999999999999999999998642 3469
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++|+|.+++.... +..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 255 iv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp EEECCCTTCBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEehhhcCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccc
Confidence 9999999999999997532 23489999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+......
T Consensus 328 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~ 400 (452)
T 1fmk_A 328 RLIEDNEYT-----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYRM 400 (452)
T ss_dssp C-------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCC
T ss_pred eecCCCcee-----cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC
Confidence 865432111 1123346788999999988899999999999999999999 99998653221 111222221111
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhhcCC
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQ 760 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~ 760 (767)
..+..+++. +.+++.+||+.||++|||++++++.|+.+.......-+
T Consensus 401 ~~~~~~~~~----------------------l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~ 447 (452)
T 1fmk_A 401 PCPPECPES----------------------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 447 (452)
T ss_dssp CCCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred CCCCCCCHH----------------------HHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccc
Confidence 111111111 22267789999999999999999999887654443333
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=348.19 Aligned_cols=202 Identities=26% Similarity=0.361 Sum_probs=174.9
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 527 (767)
..++|++.+.||+|+||.||+|+.+. ++.||+|++... .....+.+.+|.++++.+ +||+|+++++++ ..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 45789999999999999999999875 889999999654 234456788999999988 899999999985 45
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
....|+||||++||+|.+++..... +++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEE
Confidence 5678999999999999999976442 99999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|||+++..... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 164 DFG~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 164 DFGMCKENIWD------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CCTTCBCCCCT------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eCCcccccccC------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 99999753211 11234567999999999999999999999999999999999999999653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=345.18 Aligned_cols=249 Identities=25% Similarity=0.326 Sum_probs=187.6
Q ss_pred hcCCCCCCccccccceEEEEEEe----CCCcEEEEEEeeccC----CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL----REGISVAVKVLDIES----TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF 525 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 525 (767)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 91 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ---- 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE----
Confidence 46899999999999999999997 368999999986432 234456789999999999999999999954
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
..+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 92 -~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k 161 (327)
T 3a62_A 92 -TGGKLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK 161 (327)
T ss_dssp -CSSCEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred -cCCEEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence 4567799999999999999997643 289999999999999999999999 999999999999999999999
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 685 (767)
|+|||+++...... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ......
T Consensus 162 l~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~ 234 (327)
T 3a62_A 162 LTDFGLCKESIHDG------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKIL 234 (327)
T ss_dssp ECCCSCC----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH
T ss_pred EEeCCcccccccCC------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHH
Confidence 99999997543221 11234568999999999999899999999999999999999999996532211 011111
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
.... ..+..+++ .+.+++.+||+.||++|| ++.|++++
T Consensus 235 ~~~~--~~p~~~~~----------------------~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 235 KCKL--NLPPYLTQ----------------------EARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HTCC--CCCTTSCH----------------------HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred hCCC--CCCCCCCH----------------------HHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1100 01111111 122366789999999999 77888764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=347.67 Aligned_cols=246 Identities=23% Similarity=0.300 Sum_probs=197.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|++. +|+.||+|++... .....+.+.+|+++++.++||||+++++++. +..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCC
Confidence 367999999999999999999976 5899999998643 2344567889999999999999999999854 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++||||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEcCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccc
Confidence 78999999999999999976432 89999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+....
T Consensus 186 g~a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~ 254 (350)
T 1rdq_E 186 GFAKRVKGR---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEKIVSGK 254 (350)
T ss_dssp TTCEECSSC---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC
T ss_pred ccceeccCC---------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--HHHHHHHcCC
Confidence 999765321 23456899999999999999999999999999999999999999653211 1111111100
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC-----HHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID-----IREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 747 (767)
. ..+..+++. +.+++.+||+.||++||+ ++|++++
T Consensus 255 ~-~~p~~~~~~----------------------~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 V-RFPSHFSSD----------------------LKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C-CCCTTCCHH----------------------HHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C-CCCCCCCHH----------------------HHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 0 011111111 223677899999999998 8888764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=338.45 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=197.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence 578999999999999999999976 48999999986543 234567889999999999999999999964 4556
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT---AKVG 607 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~kl~ 607 (767)
.++||||+++++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 799999999999999887654 389999999999999999999999 9999999999999986655 9999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh-
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE- 686 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~- 686 (767)
|||.+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||...... .....+.
T Consensus 151 Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~ 221 (284)
T 3kk8_A 151 DFGLAIEVNDSE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKA 221 (284)
T ss_dssp CCTTCEECCSSC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred eceeeEEcccCc-------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHh
Confidence 999997543221 123356899999999999999999999999999999999999999653221 1111111
Q ss_pred hhc--ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 687 SNF--PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 687 ~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
... +......+++. +.+++.+||+.||++|||++|++++-
T Consensus 222 ~~~~~~~~~~~~~~~~----------------------~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 222 GAYDYPSPEWDTVTPE----------------------AKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp TCCCCCTTTTTTSCHH----------------------HHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred ccccCCchhhcccCHH----------------------HHHHHHHHcccChhhCCCHHHHhcCc
Confidence 111 11111111111 22366789999999999999999853
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=340.93 Aligned_cols=265 Identities=25% Similarity=0.388 Sum_probs=201.1
Q ss_pred hcCCCCCCccccccceEEEEEEeCC----CcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
..+|++.+.||+|+||.||+|.+.+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++.. .+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CC
Confidence 4578889999999999999999643 3368999886432 2345678899999999999999999998643 34
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECS
T ss_pred CceEEEEeCCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECc
Confidence 56789999999999999997543 3489999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhC-CCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG-MSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg-~~p~~~~~~~~~~~~~~~~~ 687 (767)
||.++........ .........||+.|+|||.+.+..++.++||||+|+++|+|++| .+||....... .......
T Consensus 172 fg~a~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~~~ 247 (298)
T 3f66_A 172 FGLARDMYDKEYY--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQ 247 (298)
T ss_dssp CGGGCCCSCGGGC--BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHHHT
T ss_pred ccccccccccchh--ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhc
Confidence 9999865433211 11122344578899999999988999999999999999999994 55554432221 1111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
......+..+++. +.+++.+||+.||++|||++|+++.|+++.+.+.
T Consensus 248 ~~~~~~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 248 GRRLLQPEYCPDP----------------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp TCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCCCCCCccCCHH----------------------HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111111112211 2226678999999999999999999999877543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=355.33 Aligned_cols=345 Identities=17% Similarity=0.162 Sum_probs=270.8
Q ss_pred cEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecC
Q 004218 5 VYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGF 84 (767)
Q Consensus 5 ~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (767)
+.++.++++++ .+|..+. +++++|+|++|++.+..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 57888899998 8998764 4789999999999988788899999999999999999987888899999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCC
Q 004218 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN 164 (767)
Q Consensus 85 n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n 164 (767)
|++...+. ..+.++++|++|+|++|++++..|..+..+++ |++|++++|++.+..+..|.++++|++|+|++|
T Consensus 90 n~l~~~~~------~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 162 (477)
T 2id5_A 90 NRLKLIPL------GVFTGLSNLTKLDISENKIVILLDYMFQDLYN-LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC 162 (477)
T ss_dssp SCCCSCCT------TSSTTCTTCCEEECTTSCCCEECTTTTTTCTT-CCEEEECCTTCCEECTTSSTTCTTCCEEEEESC
T ss_pred CcCCccCc------ccccCCCCCCEEECCCCccccCChhHcccccc-CCEEECCCCccceeChhhccCCCCCCEEECCCC
Confidence 98875432 24567788888888888888777777777777 888888888887777777888888888888888
Q ss_pred cCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCCh
Q 004218 165 SISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPK 244 (767)
Q Consensus 165 ~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 244 (767)
.+++..+..+..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+..+..+....+|+.|++++|+++
T Consensus 163 ~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~----- 237 (477)
T 2id5_A 163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT----- 237 (477)
T ss_dssp CCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC-----
T ss_pred cCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccc-----
Confidence 887666666777788888888888777666667777777777777777665555554444445666666555554
Q ss_pred hhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCC
Q 004218 245 EILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKG 324 (767)
Q Consensus 245 ~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 324 (767)
+..+..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..+++
T Consensus 238 --------------------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 297 (477)
T 2id5_A 238 --------------------AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNY 297 (477)
T ss_dssp --------------------SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTT
T ss_pred --------------------ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCccc
Confidence 333456677788888888888888887888888889999999999988888888888999
Q ss_pred ceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCccccccccccccCCcCccc
Q 004218 325 LEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 325 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c~ 385 (767)
|+.|+|++|.+++..+..|..+++|+.|++++|++++..+..+.+.......+.++.+.|.
T Consensus 298 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~ 358 (477)
T 2id5_A 298 LRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCA 358 (477)
T ss_dssp CCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEE
T ss_pred CCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeC
Confidence 9999999999987777778888999999999999887665444444444456677777775
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=339.18 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=208.3
Q ss_pred HHhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
...++|++.+.||+|+||.||+|.+.. +..||+|++... ....+.+.+|++++++++||||+++++++. ....
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 83 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPP 83 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCC
Confidence 346789999999999999999999775 889999998643 345678899999999999999999999954 4456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCC----TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEEEEEcCCCCcHHHHHHhcc----cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCc
Confidence 799999999999999997643 24489999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
.+....... ........+|+.|+|||++.+..++.++||||+|+++|+|++ |..||...... ..........
T Consensus 157 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~ 229 (288)
T 3kfa_A 157 LSRLMTGDT-----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDY 229 (288)
T ss_dssp GGGTSCSSS-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTC
T ss_pred cceeccCCc-----cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccC
Confidence 998654321 112233456888999999988899999999999999999999 99998653222 2222222222
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
.......+++. +.+++.+||+.||++|||++|+++.|+.+....
T Consensus 230 ~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 230 RMERPEGCPEK----------------------VYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHH----------------------HHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 22112222221 222667899999999999999999999876543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=349.35 Aligned_cols=249 Identities=24% Similarity=0.283 Sum_probs=187.1
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++. .....+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence 468999999999999999999976 58999999996433 33467889999999999999999999964 455679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--eEEcccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT--AKVGDFG 610 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg 610 (767)
+||||+++|+|.+++..... +++.++..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 93 lv~e~~~~~~L~~~l~~~~~------~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGR------FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred EEEEeCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 99999999999999976442 99999999999999999999999 9999999999999987665 9999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCc-ccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh--
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTA-GDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES-- 687 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-- 687 (767)
+++..... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........ .......
T Consensus 164 ~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~ 235 (361)
T 3uc3_A 164 YSKSSVLH-------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRIL 235 (361)
T ss_dssp CC----------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHH
T ss_pred cccccccc-------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHh
Confidence 99743221 11233468999999999988777655 8999999999999999999976433221 1111111
Q ss_pred --hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 --NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 --~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+.......+++ .+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~s~----------------------~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 236 SVKYSIPDDIRISP----------------------ECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TTCCCCCTTSCCCH----------------------HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCCCCcCCCCH----------------------HHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000000001111 12236778999999999999999886
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=343.55 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=198.0
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc------chhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG------TWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|++.+.||+|+||.||+|.+. +|+.||+|++...... ..+.+.+|++++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 467999999999999999999976 4899999998654322 3567899999999999999999999954
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM---- 602 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---- 602 (767)
.....++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence 4566799999999999999997643 389999999999999999999999 999999999999999887
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchh
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV 682 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 682 (767)
.+||+|||.+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ...
T Consensus 157 ~~kl~Dfg~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~ 228 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGV-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA 228 (321)
T ss_dssp CEEECCCTTCEECCTTC-------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH
T ss_pred CEEEccCccceecCccc-------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-HHH
Confidence 79999999997654321 1133468999999999999999999999999999999999999996532111 011
Q ss_pred hHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 683 KWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
......+.. +... .......+.+++.+||+.||++|||+.|++++
T Consensus 229 ~i~~~~~~~------~~~~--------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 229 NITSVSYDF------DEEF--------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHTTCCCC------CHHH--------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHhccccc------Chhh--------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111100000 0000 00111123347779999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=343.87 Aligned_cols=274 Identities=24% Similarity=0.303 Sum_probs=193.9
Q ss_pred hcCCCCC-CccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHE-NLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.+.|++. +.||+|+||.||+|.+. +++.||||++........+.+.+|+++++++ +||||+++++++. ..+.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCE
Confidence 3578874 78999999999999965 5899999999766666677899999999985 7999999999954 4567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT---AKVG 607 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~kl~ 607 (767)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++. +||+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred EEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEE
Confidence 899999999999999997653 389999999999999999999999 9999999999999998765 9999
Q ss_pred cccchhhhhhhcCCC-ccccccccccCCCCccCccccCC-----CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcch
Q 004218 608 DFGLARSLLERIGNQ-SSISSTHVLKGSIGYIPPEYGLG-----EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL 681 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 681 (767)
|||++.......... ..........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..........
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 236 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236 (316)
T ss_dssp CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence 999997654321111 11111233458999999999865 457899999999999999999999997654322110
Q ss_pred hhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 682 VKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. ...........+...+.......+. .....+...+.+++.+||+.||++|||++|++++
T Consensus 237 ~---~~~~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 237 D---RGEACPACQNMLFESIQEGKYEFPD---KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp -------CCHHHHHHHHHHHHHCCCCCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred c---ccccchhHHHHHHHHHhccCcccCc---hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 0000000000000000000000000 0001112223347779999999999999999884
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.23 Aligned_cols=271 Identities=21% Similarity=0.270 Sum_probs=202.8
Q ss_pred HHhcCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
...++|++.+.||+|+||.||+|.+ .+++.||||++.... ..+.+.+|+++++.++|++++..+.++. .....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeec----CCCCc
Confidence 3457899999999999999999997 458999999875432 3356889999999999988888877763 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVG 607 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~ 607 (767)
.++||||+ +++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||++ +.++.+||+
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~ 150 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEe
Confidence 79999999 889999997533 2399999999999999999999999 99999999999999 788999999
Q ss_pred cccchhhhhhhcCCCc-cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc-c-hhhH
Q 004218 608 DFGLARSLLERIGNQS-SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-S-LVKW 684 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~-~~~~ 684 (767)
|||.++.......... .........||+.|+|||++.+..++.++||||+||++|+|++|+.||........ . ....
T Consensus 151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 4hgt_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence 9999987654322111 11122345689999999999999999999999999999999999999976433221 1 1111
Q ss_pred hhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 685 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
.....+..... ....+...+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 231 ~~~~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 231 SEKKMSTPIEV-------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHHHSCHHH-------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hcccccchhhh-------------------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 11111100000 000001122237778999999999999999999999887665
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.70 Aligned_cols=269 Identities=25% Similarity=0.344 Sum_probs=205.3
Q ss_pred HHhcCCCCCC-ccccccceEEEEEEeC---CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc
Q 004218 452 RATGNFSHEN-LIGSGSFGSVYKGYLR---EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF 525 (767)
Q Consensus 452 ~~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 525 (767)
...++|++.+ .||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 88 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---- 88 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE----
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC----
Confidence 3456788888 9999999999999643 36889999986543 223567899999999999999999999862
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
.+..++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 89 --~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~k 157 (291)
T 1xbb_A 89 --AESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAK 157 (291)
T ss_dssp --SSSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred --CCCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEE
Confidence 345689999999999999997643 389999999999999999999999 999999999999999999999
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhH
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~ 684 (767)
|+|||++......... ........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... .....
T Consensus 158 l~Dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~ 232 (291)
T 1xbb_A 158 ISDFGLSKALRADENY---YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAM 232 (291)
T ss_dssp ECCCTTCEECCTTCSE---EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH
T ss_pred EccCCcceeeccCCCc---ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH
Confidence 9999999765432211 111122346788999999988888999999999999999999 99998653221 11112
Q ss_pred hhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhhcCCCC
Q 004218 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQPN 762 (767)
Q Consensus 685 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~~~ 762 (767)
+...........+++. +.+++.+||+.||++|||+.|+++.|+++........++.
T Consensus 233 ~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~ 288 (291)
T 1xbb_A 233 LEKGERMGCPAGCPRE----------------------MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHH 288 (291)
T ss_dssp HHTTCCCCCCTTCCHH----------------------HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHHC-
T ss_pred HHcCCCCCCCCCCCHH----------------------HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhccccc
Confidence 2111111111111211 2236778999999999999999999999988777655543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=338.62 Aligned_cols=254 Identities=30% Similarity=0.413 Sum_probs=196.1
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.++|++.+.||+|+||.||+|.+. |+.||||++... ...+.+.+|++++++++||||+++++++.. .....++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCceEE
Confidence 468999999999999999999986 889999998643 345778999999999999999999998642 3346799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+.
T Consensus 93 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 165 (278)
T ss_dssp EECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred EEecCCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccc
Confidence 9999999999999975431 2378999999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 692 (767)
...... ....++..|+|||++.+..++.++||||+|+++|+|++ |+.||...... .....+.......
T Consensus 166 ~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~ 234 (278)
T 1byg_A 166 EASSTQ---------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMD 234 (278)
T ss_dssp -------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCCCC
T ss_pred cccccc---------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCCCC
Confidence 543321 22347889999999988889999999999999999998 99998654221 1112221111111
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
....+++. +.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 235 ~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 235 APDGCPPA----------------------VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccCCHH----------------------HHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11111221 22266689999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=341.13 Aligned_cols=268 Identities=25% Similarity=0.357 Sum_probs=196.5
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++. ..+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCC
Confidence 467999999999999999999964 58999999986432 234567889999999999999999999964 345
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Df 180 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 180 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred cEEEEEecCCCCCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEec
Confidence 679999999999999999753211 23489999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh-h
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES-N 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~ 688 (767)
|++........ ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.............+.. .
T Consensus 181 g~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 254 (310)
T 2wqm_A 181 GLGRFFSSKTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 254 (310)
T ss_dssp ------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC
T ss_pred cceeeecCCCc------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc
Confidence 99976543211 1123468999999999999999999999999999999999999986533222122111111 1
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRR 759 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~ 759 (767)
++......+++. +.+++.+||+.||++|||++|+++.|+++......+-
T Consensus 255 ~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 255 YPPLPSDHYSEE----------------------LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp SCCCCTTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred CCCCcccccCHH----------------------HHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 111111111111 2226678999999999999999999999988766543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=355.98 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=190.4
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCC--cchhhHHHHHHHHhcCC--CCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIEST--GTWKSFFAECEALRNTR--HRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~~ 530 (767)
.+|++.+.||+|+||.||+|...+++.||||++..... ...+.+.+|++++++++ ||||+++++++. ....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~~ 130 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQY 130 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCCE
Confidence 45999999999999999999988899999999865432 34567899999999996 599999999864 3456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+++||| +.+++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG 199 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG 199 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCS
T ss_pred EEEEEe-cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecC
Confidence 899999 56789999997644 389999999999999999999999 999999999999995 5899999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCC-----------CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-----------EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV 679 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 679 (767)
+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 200 ~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 275 (390)
T 2zmd_A 200 IANQMQPDTTS----VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275 (390)
T ss_dssp SSCCC-------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred ccccccCCCcc----ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH
Confidence 99865432111 11234569999999999864 3688899999999999999999999965322111
Q ss_pred chhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 680 SLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+............+...+. .+.+++.+||+.||++|||+.|++++
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~----------------------~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 276 KLHAIIDPNHEIEFPDIPEK----------------------DLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHHCTTSCCCCCCCSCH----------------------HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCccccCCCCccchH----------------------HHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111111111111111111 12237778999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=343.38 Aligned_cols=275 Identities=26% Similarity=0.369 Sum_probs=200.7
Q ss_pred hcCCCCCCccccccceEEEEEEe-----CCCcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL-----REGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
.++|++.+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|+++++.++||||+++++++.. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CC
Confidence 35688999999999999999984 35889999998644 33445788999999999999999999999763 23
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
...+++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred CceEEEEEEeCCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEEC
Confidence 356799999999999999996543 2399999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
|||.+........ .........||..|+|||++.+..++.++||||+|+++|+|++|+.|+...... ....
T Consensus 169 Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~ 239 (302)
T 4e5w_A 169 DFGLTKAIETDKE---YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL------FLKM 239 (302)
T ss_dssp CCTTCEECCTTCC---EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH------HHHH
T ss_pred cccccccccCCCc---ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH------Hhhc
Confidence 9999986543321 111223455788899999998888999999999999999999999986432110 0000
Q ss_pred hcccchhhhccHHHHHhhhcch-hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSE-SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
..+................... .......+ .+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 240 IGPTHGQMTVTRLVNTLKEGKRLPCPPNCPD----EVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HCSCCGGGHHHHHHHHHHTTCCCCCCTTCCH----HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCcccccCHHHHHHHHhccCCCCCCCCCCH----HHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0010000000000010000000 00001111 2223777999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.42 Aligned_cols=246 Identities=26% Similarity=0.287 Sum_probs=186.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||+||+|.+. +++.||||++..... .....+..|+..+.++ +||||+++++++. .++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~ 130 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGG 130 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCC
Confidence 367999999999999999999986 699999999854322 2334455666655554 8999999999964 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DF 201 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDF 201 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCC
T ss_pred EEEEEEecc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccc
Confidence 789999999 669999887653 3499999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ..........
T Consensus 202 G~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~~~~ 269 (311)
T 3p1a_A 202 GLLVELGTAG-------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQLRQGYL 269 (311)
T ss_dssp TTCEECC-------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHHHTTTCC
T ss_pred eeeeecccCC-------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHhccCC
Confidence 9987653321 1233458999999999876 78999999999999999999977653311 1111111111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+...... +...+.+++.+||+.||++|||++|++++
T Consensus 270 ~~~~~~~----------------------~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 270 PPEFTAG----------------------LSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CHHHHTT----------------------SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccccC----------------------CCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1111111 11122337778999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.96 Aligned_cols=249 Identities=23% Similarity=0.258 Sum_probs=171.8
Q ss_pred CCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccceeeEEEEee
Q 004218 460 ENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEFLALVYEF 537 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~ 537 (767)
.+.||+|+||.||+|.+. +++.||||++... ....+.+|+.+++.+. ||||+++++++. +....++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEEEc
Confidence 378999999999999976 5899999998643 3466789999999997 999999999954 45677999999
Q ss_pred cCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEEccccchhh
Q 004218 538 LGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM---TAKVGDFGLARS 614 (767)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~Dfg~a~~ 614 (767)
+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++.
T Consensus 88 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 88 LNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp CCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999999997643 399999999999999999999999 999999999999998665 899999999975
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc--chhhHhhhhcccc
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV--SLVKWVESNFPKN 692 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~ 692 (767)
..... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ .............
T Consensus 159 ~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~ 232 (325)
T 3kn6_A 159 KPPDN------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232 (325)
T ss_dssp CCC----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC
T ss_pred cCCCC------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC
Confidence 43221 112345689999999999999999999999999999999999999976432210 1111110000000
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
... .......+...+.+++.+||+.||++|||++|++++
T Consensus 233 ------------~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 233 ------------FSF----EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ------------CCC----CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ------------CCC----CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 000 000001111223337778999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=345.98 Aligned_cols=267 Identities=24% Similarity=0.401 Sum_probs=204.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC--------CCcEEEEEEeeccCC-cchhhHHHHHHHHhcC-CCCCceeEEeeeecC
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR--------EGISVAVKVLDIEST-GTWKSFFAECEALRNT-RHRNLVKLITSCSSL 523 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 523 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence 478999999999999999999863 467899999965432 3456788999999999 8999999999964
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKNE----------HGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKP 593 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 593 (767)
..+..++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||+. +|+||||||
T Consensus 112 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 185 (334)
T 2pvf_A 112 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185 (334)
T ss_dssp ---SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred ---cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence 3456799999999999999998654211 123489999999999999999999999 999999999
Q ss_pred CCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 004218 594 GNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTH 672 (767)
Q Consensus 594 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 672 (767)
+||+++.++.+||+|||.++....... ........+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||.
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSS----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ceEEEcCCCCEEEcccccccccccccc----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 999999999999999999976543211 111223456788999999988889999999999999999999 999986
Q ss_pred CcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 673 ESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
..... .....+...........+... +.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 262 ~~~~~--~~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 262 GIPVE--ELFKLLKEGHRMDKPANCTNE----------------------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp TCCHH--HHHHHHHHTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHH--HHHHHHhcCCCCCCCccCCHH----------------------HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 53211 111111111111111111111 222667899999999999999999999987
Q ss_pred HHHh
Q 004218 753 KILL 756 (767)
Q Consensus 753 ~~~~ 756 (767)
....
T Consensus 318 ~~~~ 321 (334)
T 2pvf_A 318 TLTT 321 (334)
T ss_dssp HHHC
T ss_pred hccc
Confidence 6544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=349.36 Aligned_cols=274 Identities=18% Similarity=0.194 Sum_probs=198.1
Q ss_pred hcCCCCCCccccccceEEEEEEeC----CCcEEEEEEeeccCCc-----------chhhHHHHHHHHhcCCCCCceeEEe
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIESTG-----------TWKSFFAECEALRNTRHRNLVKLIT 518 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~ 518 (767)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999975 4788999998654321 1234667888999999999999999
Q ss_pred eeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 519 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
++... +.+....++||||+ +++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||++
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 184 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL 184 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence 97542 23467889999999 999999997654 399999999999999999999999 99999999999999
Q ss_pred CCCC--ceEEccccchhhhhhhcCCC-ccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcc
Q 004218 599 DEDM--TAKVGDFGLARSLLERIGNQ-SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675 (767)
Q Consensus 599 ~~~~--~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 675 (767)
+.++ .+||+|||+++.+....... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8877 99999999998765432211 11122244579999999999999899999999999999999999999996432
Q ss_pred cCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 676 AGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
.......... .... ......+...... ....+ .+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 265 ~~~~~~~~~~-~~~~----~~~~~~~~~~~~~-----~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 265 KDPVAVQTAK-TNLL----DELPQSVLKWAPS-----GSSCC----EIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TCHHHHHHHH-HHHH----HTTTHHHHHHSCT-----TSCCH----HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccHHHHHHH-Hhhc----ccccHHHHhhccc-----cccHH----HHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 2221111111 0000 0011111111100 00111 2223777899999999999999999997653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=337.07 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=200.9
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC----CcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+++++.++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 34689999999999999999998643 3469999986542 2345778999999999999999999998642
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEEC
T ss_pred -CCCEEEEecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeC
Confidence 23489999999999999997643 3389999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 686 (767)
|||.+......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+.
T Consensus 156 Dfg~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~ 228 (281)
T 3cc6_A 156 DFGLSRYIEDEDYY-----KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLE 228 (281)
T ss_dssp CCCGGGCC--------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHH
T ss_pred ccCCCccccccccc-----ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHh
Confidence 99999865432111 1123456888999999988889999999999999999998 999996532221 111111
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
..........+++. +.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus 229 ~~~~~~~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 229 KGDRLPKPDLCPPV----------------------LYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp HTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHH----------------------HHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 11111111111211 223677899999999999999999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=350.62 Aligned_cols=245 Identities=25% Similarity=0.339 Sum_probs=189.2
Q ss_pred CCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEeec
Q 004218 460 ENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++. ..+..++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEeCC
Confidence 567999999999999975 58999999997665556678999999999999999999999964 445679999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee--CCCCceEEccccchhhhh
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL--DEDMTAKVGDFGLARSLL 616 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg~a~~~~ 616 (767)
++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 169 ~~~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 169 DGGELFDRIIDES-----YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp TTCEEHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred CCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 9999999886543 2389999999999999999999999 99999999999999 577899999999998654
Q ss_pred hhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc--chh
Q 004218 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK--NAQ 694 (767)
Q Consensus 617 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 694 (767)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.......+.. ...
T Consensus 241 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 312 (373)
T 2x4f_A 241 PRE-------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWDLEDEEF 312 (373)
T ss_dssp TTC-------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCSCSGGG
T ss_pred Ccc-------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCChhhh
Confidence 321 122346899999999999888999999999999999999999999653221 1111111111110 000
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..++ + .+.+++.+||+.||++|||+.|++++
T Consensus 313 ~~~~------------------~----~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 313 QDIS------------------E----EAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TTSC------------------H----HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCC------------------H----HHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111 1 12237779999999999999999983
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=365.82 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=203.6
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
..+|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|++++++++||||++++++|. ....++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~~ 292 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY 292 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCcEE
Confidence 4568889999999999999999875 8899999996443 34678999999999999999999999964 344579
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 293 lv~E~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp EEEECCTTCBHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred EEEEccCCCCHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence 9999999999999997643 23489999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+...+..
T Consensus 366 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~ 438 (495)
T 1opk_A 366 RLMTGDT-----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRM 438 (495)
T ss_dssp ECCTTCC-----EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCC
T ss_pred eeccCCc-----eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC
Confidence 8653321 111123346788999999988889999999999999999999 99998654321 222222222222
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
..+..+.+. +.+++.+||+.||++|||+.|+++.|+.+
T Consensus 439 ~~~~~~~~~----------------------l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 439 ERPEGCPEK----------------------VYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCHH----------------------HHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 112222221 12266789999999999999999999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=342.73 Aligned_cols=261 Identities=20% Similarity=0.233 Sum_probs=193.4
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++++++||||+++++++. .+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----ID 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ET
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----eC
Confidence 3578999999999999999999976 588999999865422 22467889999999999999999999964 35
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
+..++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~D 177 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVD 177 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred CeEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEec
Confidence 56799999999999999997643 389999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||++........ .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .........
T Consensus 178 fg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~ 250 (309)
T 2h34_A 178 FGIASATTDEKL-----TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQA 250 (309)
T ss_dssp CCC---------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSC
T ss_pred CccCcccccccc-----ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccC
Confidence 999976543211 1123446899999999999999999999999999999999999999653221 111111111
Q ss_pred ccc--chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-CHHHHHHHHHHHHHHHh
Q 004218 689 FPK--NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-DIREALRRLKNAQKILL 756 (767)
Q Consensus 689 ~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~~~~~~ 756 (767)
.+. .....+++ .+.+++.+||+.||++|| |++++++.|+.+.....
T Consensus 251 ~~~~~~~~~~~~~----------------------~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 251 IPRPSTVRPGIPV----------------------AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp CCCGGGTSTTCCT----------------------HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CCCccccCCCCCH----------------------HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 111 00111111 122366789999999999 99999999987754443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=344.00 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=197.0
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcE----EEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GIS----VAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
.++|++.+.||+|+||.||+|.+.. ++. ||+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence 4689999999999999999999653 443 577776433 344567899999999999999999999997532
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 90 --~~~~v~~~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~ 159 (327)
T 3lzb_A 90 --TVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp --SEEEEECCCSSCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred --CceEEEEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEc
Confidence 2589999999999999997643 2389999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 686 (767)
|||+++......... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+.
T Consensus 160 DfG~a~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~ 233 (327)
T 3lzb_A 160 DFGLAKLLGAEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE 233 (327)
T ss_dssp CTTC--------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH
T ss_pred cCcceeEccCccccc----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH
Confidence 999998764432211 1123446788999999999999999999999999999999 99999664322 2222222
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
.............. +.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 234 ~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 234 KGERLPQPPICTID----------------------VYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp TTCCCCCCTTBCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred cCCCCCCCccCCHH----------------------HHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 22111112222221 122667899999999999999999999987443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.28 Aligned_cols=211 Identities=26% Similarity=0.333 Sum_probs=178.9
Q ss_pred CHHHHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeee
Q 004218 446 SYDELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCS 521 (767)
Q Consensus 446 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 521 (767)
.+++.+...++|++.+.||+|+||.||+|+.+ +|+.||+|++... .....+.+.+|..++..++||||+++++++
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~- 130 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF- 130 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-
Confidence 44555666789999999999999999999976 5999999999643 223445688999999999999999999985
Q ss_pred cCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 004218 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED 601 (767)
Q Consensus 522 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~ 601 (767)
.+...+|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 131 ----~~~~~~~lVmE~~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~ 198 (412)
T 2vd5_A 131 ----QDENYLYLVMEYYVGGDLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRC 198 (412)
T ss_dssp ----ECSSEEEEEECCCCSCBHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred ----eeCCEEEEEEcCCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCC
Confidence 45567899999999999999997643 2399999999999999999999999 99999999999999999
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccC-------CCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL-------GEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+.+||+|||+++....... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||...
T Consensus 199 g~vkL~DFGla~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 199 GHIRLADFGSCLKLRADGT-----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp SCEEECCCTTCEECCTTSC-----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCEEEeechhheeccCCCc-----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 9999999999976533211 1123457999999999986 456899999999999999999999999653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.35 Aligned_cols=252 Identities=27% Similarity=0.328 Sum_probs=198.6
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
..++|++.+.||+|+||.||+|.+.. +..||+|++........+.+.+|++++++++||||+++++++. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeE
Confidence 35679999999999999999999765 7799999998766666788999999999999999999999964 45667
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEcc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGD 608 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~D 608 (767)
++||||+++++|.+++..... +++.+++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~D 152 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLID 152 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEeccCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEe
Confidence 999999999999999876442 89999999999999999999999 99999999999999 7889999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||.+....... ......||+.|+|||++.+. ++.++||||+|+++|+|++|+.||....... .........
T Consensus 153 fg~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~ 223 (277)
T 3f3z_A 153 FGLAARFKPGK-------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGT 223 (277)
T ss_dssp CTTCEECCTTS-------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC
T ss_pred cccceeccCcc-------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCC
Confidence 99997653321 12334689999999998654 8999999999999999999999996532211 111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...... ...... ..+.+++.+||+.||++|||+.|++++
T Consensus 224 ~~~~~~----------------~~~~~~----~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 224 FTFPEK----------------DWLNVS----PQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCCCHH----------------HHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCch----------------hhhcCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110000 000011 122236778999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=335.16 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=195.4
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
+.++|++.+.||+|+||.||+|.+.. ++.||+|++... .....+.+.+|++++++++||||+++++++. +.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cC
Confidence 35689999999999999999999764 779999998543 2233567889999999999999999999964 44
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~------~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEe
Confidence 567999999999999999976543 89999999999999999999998 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||++...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ....+..
T Consensus 153 fg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~- 221 (279)
T 3fdn_A 153 FGWSVHAPSS--------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRISR- 221 (279)
T ss_dssp CCEESCC----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHH-
T ss_pred ccccccCCcc--------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--HHHHHHh-
Confidence 9998644322 1133468999999999999999999999999999999999999996532111 1111110
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
.....+..+.+. +.+++.+||+.||++|||++|++++-
T Consensus 222 ~~~~~~~~~~~~----------------------~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 222 VEFTFPDFVTEG----------------------ARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp TCCCCCTTSCHH----------------------HHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CCCCCCCcCCHH----------------------HHHHHHHHhccChhhCCCHHHHhhCc
Confidence 000111111111 22367789999999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=348.98 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=188.8
Q ss_pred hcCCCCC-CccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHh-cCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHE-NLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALR-NTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|.+. +.||+|+||.||+|.+. +++.||||++.. ...+.+|++++. ..+||||+++++++... ..+...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence 3567666 68999999999999976 589999999852 245678888874 45899999999986431 234567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE---DMTAKVG 607 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~ 607 (767)
+++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEeCCCCcHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence 899999999999999997643 23499999999999999999999999 9999999999999997 7899999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc--chhhHh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV--SLVKWV 685 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~ 685 (767)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+
T Consensus 207 DFG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i 279 (400)
T 1nxk_A 207 DFGFAKETTSH-------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279 (400)
T ss_dssp CCTTCEECC------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH
T ss_pred ecccccccCCC-------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH
Confidence 99999754321 112345689999999999999999999999999999999999999976433221 111111
Q ss_pred -hhhc--ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 -ESNF--PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 -~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+ +......+.+ .+.+++.+||+.||++|||+.|++++
T Consensus 280 ~~~~~~~~~~~~~~~s~----------------------~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 280 RMGQYEFPNPEWSEVSE----------------------EVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHTCCCCCTTTTTTSCH----------------------HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HcCcccCCCcccccCCH----------------------HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111 1100111111 12237779999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=345.30 Aligned_cols=276 Identities=24% Similarity=0.360 Sum_probs=211.5
Q ss_pred CHHHHHHHhcCCCCCCccccccceEEEEEEe------CCCcEEEEEEeeccCC-cchhhHHHHHHHHhcC-CCCCceeEE
Q 004218 446 SYDELRRATGNFSHENLIGSGSFGSVYKGYL------REGISVAVKVLDIEST-GTWKSFFAECEALRNT-RHRNLVKLI 517 (767)
Q Consensus 446 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~ 517 (767)
...+.....++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+++++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 4445555678999999999999999999984 2468899999965433 2346788999999999 799999999
Q ss_pred eeeecCCcccceeeEEEEeecCCCChhhhhcccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 004218 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNE----------HGNGLNFLERLNIAIDIASALDYLHNDCEVPIV 587 (767)
Q Consensus 518 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 587 (767)
+++.. .+..+++||||+++|+|.+++....... ....+++..++.++.|++.||+|||++ +|+
T Consensus 98 ~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~ 170 (316)
T 2xir_A 98 GACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 170 (316)
T ss_dssp EEECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred EEEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 99743 3345799999999999999998654210 012388999999999999999999999 999
Q ss_pred eecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-
Q 004218 588 HCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT- 666 (767)
Q Consensus 588 H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t- 666 (767)
||||||+||+++.++.+||+|||.++....... ........||+.|+|||++.+..++.++||||+|+++|+|++
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cccCccceEEECCCCCEEECCCccccccccCcc----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence 999999999999999999999999976543211 112234457889999999988899999999999999999998
Q ss_pred CCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 667 GMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 667 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
|+.||........ ....+............++. +.+++.+||+.||++|||+.|+++
T Consensus 247 g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~ell~ 303 (316)
T 2xir_A 247 GASPYPGVKIDEE-FCRRLKEGTRMRAPDYTTPE----------------------MYQTMLDCWHGEPSQRPTFSELVE 303 (316)
T ss_dssp SCCSSTTCCCSHH-HHHHHHHTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcccchhHH-HHHHhccCccCCCCCCCCHH----------------------HHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999865432211 11111111111111112221 122666899999999999999999
Q ss_pred HHHHHHHHH
Q 004218 747 RLKNAQKIL 755 (767)
Q Consensus 747 ~L~~~~~~~ 755 (767)
+|+.+....
T Consensus 304 ~L~~~~~~~ 312 (316)
T 2xir_A 304 HLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHhhh
Confidence 999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.23 Aligned_cols=263 Identities=26% Similarity=0.410 Sum_probs=196.9
Q ss_pred cCCCCCCccccccceEEEEEEeCC-----CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-----GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.+|++.+.||+|+||.||+|.+.. +..||||++..... .....+.+|++++++++||||+++++++. ..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----cC
Confidence 567778999999999999998653 24699999865432 34457889999999999999999999964 45
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECC
Confidence 56799999999999999997542 3489999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 687 (767)
||.++......... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+..
T Consensus 191 fg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~ 265 (333)
T 1mqb_A 191 FGLSRVLEDDPEAT---YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAIND 265 (333)
T ss_dssp CCC--------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT
T ss_pred CCcchhhccccccc---cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHC
Confidence 99998764432111 11122346788999999998899999999999999999999 99998653221 11111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhh
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 757 (767)
.........+.+. +.+++.+||+.||++|||+.|+++.|+++.+....
T Consensus 266 ~~~~~~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 266 GFRLPTPMDCPSA----------------------IYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp TCCCCCCTTCBHH----------------------HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred CCcCCCcccCCHH----------------------HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 1111111111111 22267789999999999999999999998765443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=360.01 Aligned_cols=204 Identities=27% Similarity=0.351 Sum_probs=159.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+++.+|+++++.++||||+++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999976 58999999986432 234567889999999999999999999987655566678
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+||||++ |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEeccc-cchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence 899999985 69999997643 399999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCcc---------------------ccccccccCCCCccCcccc-CCCCCCCcccchhhhHHHHHHHhC
Q 004218 611 LARSLLERIGNQSS---------------------ISSTHVLKGSIGYIPPEYG-LGEKPSTAGDVYSFGVMLLEIFTG 667 (767)
Q Consensus 611 ~a~~~~~~~~~~~~---------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~tg 667 (767)
+++........... .......+||+.|+|||++ .+..++.++||||+||++|||++|
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 99876432211000 0122445789999999975 566799999999999999999994
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=346.67 Aligned_cols=278 Identities=26% Similarity=0.382 Sum_probs=205.8
Q ss_pred hcCCCCCCccccccceEEEEEEe-----CCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL-----REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++.. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCC
Confidence 46789999999999999999984 3588999999976666667789999999999999999999998753 233
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred CceEEEEECCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEec
Confidence 46799999999999999997653 2389999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||.+......... ........++..|+|||.+.+..++.++||||+|+++|+|++|..||...... ........
T Consensus 189 fg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~ 262 (326)
T 2w1i_A 189 FGLTKVLPQDKEY---YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGND 262 (326)
T ss_dssp CTTCEECCSSCSE---EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTT
T ss_pred Ccchhhccccccc---cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccc
Confidence 9999865432111 01112344677899999998888999999999999999999999997542110 00000000
Q ss_pred cccchhhhccHHHHHhhhcch--hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSE--SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
. ........+...+.... ....... ..+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 263 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 263 K---QGQMIVFHLIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp C---CTHHHHHHHHHHHHTTCCCCCCTTCC----HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred c---chhhhHHHHHHHhhcCCCCCCCCccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 00000001111110000 0000111 12223777999999999999999999999998765
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=353.36 Aligned_cols=209 Identities=27% Similarity=0.395 Sum_probs=164.8
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCccc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 527 (767)
...++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+++.+. ||||+++++++.. .+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~ 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DN 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TT
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CC
Confidence 45679999999999999999999975 5899999998543 2334567889999999997 9999999999753 23
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
...+|+||||++ |+|.+++.... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~~~-------~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRANI-------LEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHTC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred CCEEEEEecccC-cCHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence 456899999997 59999997543 89999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCC---------------ccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCC
Q 004218 608 DFGLARSLLERIGNQ---------------SSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPT 671 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~---------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~ 671 (767)
|||+|+......... ..........||+.|+|||++.+ ..++.++||||+||++|||++|++||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 999997653211000 01112234579999999999876 67899999999999999999999999
Q ss_pred CCc
Q 004218 672 HES 674 (767)
Q Consensus 672 ~~~ 674 (767)
...
T Consensus 232 ~~~ 234 (388)
T 3oz6_A 232 PGS 234 (388)
T ss_dssp CCS
T ss_pred CCC
Confidence 654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=336.13 Aligned_cols=269 Identities=21% Similarity=0.266 Sum_probs=205.2
Q ss_pred hcCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|.+ .+++.||||++.... ..+.+.+|+++++.++|++++..+.++. ..+...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCcccccc----CCCCceE
Confidence 57899999999999999999997 469999999986433 3356889999999999988887777653 3456779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD---EDMTAKVGDF 609 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~Df 609 (767)
+||||+ +++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++ .++.+||+||
T Consensus 82 lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEEec-CCCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 999999 889999997433 2399999999999999999999999 999999999999994 8889999999
Q ss_pred cchhhhhhhcCCCc-cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc-c-hhhHhh
Q 004218 610 GLARSLLERIGNQS-SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-S-LVKWVE 686 (767)
Q Consensus 610 g~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~-~~~~~~ 686 (767)
|.++.......... .........||+.|+|||++.+..++.++||||||+++|+|++|+.||........ . ......
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 99986644322111 01112445699999999999999999999999999999999999999976432211 1 111111
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
...+..... ....+...+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 233 ~~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 233 KKMSTPIEV-------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHSCHHH-------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cccCCchHH-------------------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 111100000 000011112237778999999999999999999999877654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=346.42 Aligned_cols=275 Identities=21% Similarity=0.369 Sum_probs=210.4
Q ss_pred HHHHhcCCCCCCccccccceEEEEEEeCC------CcEEEEEEeeccCC-cchhhHHHHHHHHhcC-CCCCceeEEeeee
Q 004218 450 LRRATGNFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIEST-GTWKSFFAECEALRNT-RHRNLVKLITSCS 521 (767)
Q Consensus 450 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 521 (767)
.....++|++.+.||+|+||.||+|.+.. ...||+|.+..... ...+.+.+|+++++.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456789999999999999999999753 24799999865432 3456788999999999 8999999999964
Q ss_pred cCCcccceeeEEEEeecCCCChhhhhcccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 004218 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKN--------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKP 593 (767)
Q Consensus 522 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 593 (767)
..+..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||++ +|+||||||
T Consensus 121 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 192 (333)
T 2i1m_A 121 -----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA 192 (333)
T ss_dssp -----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred -----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCccc
Confidence 345679999999999999999754310 0123489999999999999999999999 999999999
Q ss_pred CCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 004218 594 GNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTH 672 (767)
Q Consensus 594 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 672 (767)
+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 268 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNY----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTS----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ceEEECCCCeEEECccccccccccccce----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999999999865443211 11233457889999999988889999999999999999998 999986
Q ss_pred CcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 673 ESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
...... ..................++. +.+++.+||+.||++|||+.|+++.|+++.
T Consensus 269 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 269 GILVNS-KFYKLVKDGYQMAQPAFAPKN----------------------IYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp TCCSSH-HHHHHHHHTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhH-HHHHHHhcCCCCCCCCCCCHH----------------------HHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 543221 112222222211111111211 122667899999999999999999999988
Q ss_pred HHHhhcC
Q 004218 753 KILLKRR 759 (767)
Q Consensus 753 ~~~~~~~ 759 (767)
....+.+
T Consensus 326 ~~~~~~r 332 (333)
T 2i1m_A 326 QEDRRER 332 (333)
T ss_dssp HHHHHHC
T ss_pred HhhhccC
Confidence 7765543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=337.20 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=202.0
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc------
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF------ 525 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 525 (767)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|++++++++||||+++++++....+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999986 69999999986432 467799999999999999999998753211
Q ss_pred -----ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC
Q 004218 526 -----KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE 600 (767)
Q Consensus 526 -----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~ 600 (767)
......++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR----GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 23556899999999999999997543 23489999999999999999999999 9999999999999999
Q ss_pred CCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcc
Q 004218 601 DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS 680 (767)
Q Consensus 601 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 680 (767)
++.+||+|||.+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|..|+.... .
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~ 226 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG-------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----K 226 (284)
T ss_dssp TTEEEECCCTTCEESSCCS-------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----H
T ss_pred CCCEEECcchhheeccccc-------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----H
Confidence 9999999999997654321 1123458999999999999899999999999999999999998863210 0
Q ss_pred hhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhh
Q 004218 681 LVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757 (767)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 757 (767)
...... .......+++ .+.+++.+||+.||++|||+.|++++|+.+.+....
T Consensus 227 ~~~~~~---~~~~~~~~~~----------------------~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 227 FFTDLR---DGIISDIFDK----------------------KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp HHHHHH---TTCCCTTSCH----------------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred HHHHhh---cccccccCCH----------------------HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 000000 0001111111 122367789999999999999999999988765543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=357.17 Aligned_cols=248 Identities=29% Similarity=0.402 Sum_probs=197.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+++++.++||||+++++++. ...
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence 368999999999999999999976 6999999999643 2234567889999999999999999999964 445
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence 6799999999999999997543 399999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|++...... .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...... .....+...
T Consensus 161 G~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~ 231 (476)
T 2y94_A 161 GLSNMMSDG-------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFKKICDG 231 (476)
T ss_dssp SSCEECCTT-------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHHHHHTT
T ss_pred cchhhcccc-------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhcC
Confidence 999765332 11234569999999999988776 68999999999999999999999653221 111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. ..+..+++. +.+++.+||+.||++|||++|++++
T Consensus 232 ~~-~~p~~~s~~----------------------~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 232 IF-YTPQYLNPS----------------------VISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CC-CCCTTCCHH----------------------HHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred Cc-CCCccCCHH----------------------HHHHHHHHcCCCchhCcCHHHHHhC
Confidence 00 001111111 2236778999999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.62 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=200.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+++++.++||||+++++++. +..
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eCC
Confidence 467999999999999999999976 5999999999643 2334567889999999999999999999854 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++||||++||+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.+|.+||+||
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~----~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMG----QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence 7899999999999999997643 23489999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc--chhhHhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV--SLVKWVES 687 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~ 687 (767)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .+...+.
T Consensus 331 Gla~~~~~~~-------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~- 402 (576)
T 2acx_A 331 GLAVHVPEGQ-------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK- 402 (576)
T ss_dssp TTCEECCTTC-------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-
T ss_pred ccceecccCc-------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-
Confidence 9997653321 12335799999999999998999999999999999999999999976432211 1111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
..+......+++ .+.+++.+||+.||++|| +++|++++
T Consensus 403 ~~~~~~p~~~s~----------------------~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 403 EVPEEYSERFSP----------------------QARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HCCCCCCTTSCH----------------------HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cccccCCccCCH----------------------HHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111111111222 122367789999999999 78998865
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=348.82 Aligned_cols=250 Identities=27% Similarity=0.357 Sum_probs=186.6
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC---CcchhhHHHHHHH-HhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES---TGTWKSFFAECEA-LRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|++.+.||+|+||.||+|+.+. ++.||+|++.... ....+.+.+|..+ ++.++||||+++++++. ..
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----CS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----eC
Confidence 3679999999999999999999764 8899999996543 2234556677776 46789999999999854 45
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..+|+||||+++|+|.+++...+. +++..+..++.||+.||+|||++ +|+||||||+||+++.+|.+||+|
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D 182 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERC------FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD 182 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence 678999999999999999976443 89999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+...
T Consensus 183 FG~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~ 254 (373)
T 2r5t_A 183 FGLCKENIEHN------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILNK 254 (373)
T ss_dssp CCBCGGGBCCC------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HHHHHHHHS
T ss_pred CccccccccCC------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHhc
Confidence 99997542211 1234567999999999999999999999999999999999999999653211 111111100
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
+......++. .+.+++.+||+.||++||++.+.++.+
T Consensus 255 -~~~~~~~~~~----------------------~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 255 -PLQLKPNITN----------------------SARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp -CCCCCSSSCH----------------------HHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred -ccCCCCCCCH----------------------HHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 0000111111 122366789999999999986444333
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=337.19 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=191.6
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++. +....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeE
Confidence 357999999999999999999975 48899999986543 334678899999999999999999999964 45567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEcc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGD 608 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~D 608 (767)
++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeCCCCcHHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 9999999999999998654211 23499999999999999999999999 99999999999999 4568899999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||.+....... ......||+.|+|||++. ..++.++||||+|+++|+|++|+.||....... ........
T Consensus 171 fg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~~~ 240 (285)
T 3is5_A 171 FGLAELFKSDE-------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKATYK 240 (285)
T ss_dssp CCCCCC-----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC
T ss_pred eecceecCCcc-------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhccC
Confidence 99997654321 123456899999999876 468899999999999999999999996532211 11111110
Q ss_pred cccch--hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNA--QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+... ...++ +. +.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~------------------~~----~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 241 EPNYAVECRPLT------------------PQ----AVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCCC--CCCC------------------HH----HHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CcccccccCcCC------------------HH----HHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00011 11 1226778999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=357.08 Aligned_cols=210 Identities=25% Similarity=0.330 Sum_probs=170.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+++.+|+++++.++||||+++++++..........
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999976 4889999999643 2234567899999999999999999999986655445567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+||||++ |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCC-cCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence 899999996 59999997643 399999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCc----------------cccccccccCCCCccCcccc-CCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 611 LARSLLERIGNQS----------------SISSTHVLKGSIGYIPPEYG-LGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 611 ~a~~~~~~~~~~~----------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
+++.......... .........||+.|+|||++ .+..++.++||||+||++|||++|..||..
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 9987644321100 00122456799999999985 566799999999999999999997666543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=346.49 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=196.7
Q ss_pred HHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc-----CCcchhhHHHHHHHHhcCCCCCceeEEeeeecC
Q 004218 450 LRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE-----STGTWKSFFAECEALRNTRHRNLVKLITSCSSL 523 (767)
Q Consensus 450 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 523 (767)
+....++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-- 98 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-- 98 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc--
Confidence 3456788999999999999999999975 4889999998643 3445678999999999999999999999964
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCCC----------------------------------CCCCCCHHHHHHHHH
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKNE----------------------------------HGNGLNFLERLNIAI 569 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------~~~~l~~~~~~~i~~ 569 (767)
+....++||||+++|+|.+++....... ....+++..++.++.
T Consensus 99 ---~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 99 ---DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp ---CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred ---cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 4567899999999999999996321110 011246778899999
Q ss_pred HHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC--ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC--
Q 004218 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDM--TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-- 645 (767)
Q Consensus 570 ~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 645 (767)
|++.||+|||+. +|+||||||+||+++.++ .+||+|||.++.+....... ........||+.|+|||++.+
T Consensus 176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE--YYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC----------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccc--cccccccCCCccccCchhhccCC
Confidence 999999999999 999999999999998776 89999999998654322111 112234568999999999875
Q ss_pred CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc--cchhhhccHHHHHhhhcchhhHHHHHHHHHHHH
Q 004218 646 EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP--KNAQQVLDRELRQLMMSSESQTIQLHDCLITII 723 (767)
Q Consensus 646 ~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l 723 (767)
..++.++||||||+++|||++|+.||....... ........... ......+++ .+
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~----------------------~~ 307 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKLCFENPNYNVLSP----------------------LA 307 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCTTSGGGGGSCH----------------------HH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcccccCCcccccCCH----------------------HH
Confidence 678999999999999999999999996532211 11111111111 001111111 12
Q ss_pred HHHhccccCCCCCCCCCHHHHHHH
Q 004218 724 ESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 724 ~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+++.+||+.||++|||+.|++++
T Consensus 308 ~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 308 RDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHcCCChhHCCCHHHHhcC
Confidence 236678999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=350.84 Aligned_cols=254 Identities=25% Similarity=0.320 Sum_probs=188.3
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--------CcchhhHHHHHHHHhcCCCCCceeEEeeeec
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--------TGTWKSFFAECEALRNTRHRNLVKLITSCSS 522 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 522 (767)
...++|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 44679999999999999999999976 48999999986431 122346889999999999999999999853
Q ss_pred CCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-
Q 004218 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED- 601 (767)
Q Consensus 523 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~- 601 (767)
....++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 211 -----~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 211 -----AEDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp -----SSEEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred -----cCceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence 233689999999999999987543 399999999999999999999999 99999999999999754
Q ss_pred --CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC---CCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 602 --MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG---EKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 602 --~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
+.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.....
T Consensus 277 ~~~~~kl~DFG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGET-------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp SSCCEEECCSSTTTSCC------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred CcceEEEeecccceecCCC-------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 45999999999865432 11234568999999999853 5678899999999999999999999975433
Q ss_pred CCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 677 GEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
... ....+........... ...+...+.+++.+||+.||++|||++|++++
T Consensus 350 ~~~-~~~~i~~~~~~~~~~~-------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 350 QVS-LKDQITSGKYNFIPEV-------------------WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp SCC-HHHHHHTTCCCCCHHH-------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHH-HHHHHhcCCCCCCchh-------------------hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 222 2222211111100000 00011112237778999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.79 Aligned_cols=265 Identities=25% Similarity=0.372 Sum_probs=202.6
Q ss_pred CCCCCCccccccceEEEEEEeCC----CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 456 NFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.|+..+.||+|+||.||+|.+.+ +..||+|.+..... ...+.+.+|+++++.++||||+++++++.. .+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCC
Confidence 46667899999999999998542 33799999864332 345778899999999999999999999743 2334
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+.+|+|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg 169 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFG 169 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred cEEEEecccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCC
Confidence 589999999999999997643 3489999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
.++........ .........+|..|+|||.+.+..++.++||||+|+++|+|++|..|+...... ............
T Consensus 170 ~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~ 246 (298)
T 3pls_A 170 LARDILDREYY--SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQGRR 246 (298)
T ss_dssp SSCTTTTGGGG--CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTTCC
T ss_pred CcccccCCccc--ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcCCC
Confidence 99865443211 111223456789999999999999999999999999999999966664332221 122222222211
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhh
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 757 (767)
......+++. +.+++.+||+.||.+|||++|+++.|+++...+..
T Consensus 247 ~~~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 247 LPQPEYCPDS----------------------LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp CCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred CCCCccchHH----------------------HHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 1111112221 22266789999999999999999999999887653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=344.00 Aligned_cols=243 Identities=26% Similarity=0.345 Sum_probs=196.2
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--------cchhhHHHHHHHHhcCCCCCceeEEeeeecC
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--------GTWKSFFAECEALRNTRHRNLVKLITSCSSL 523 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 523 (767)
..++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-- 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 4578999999999999999999965 588999999965421 13456788999999999999999999954
Q ss_pred CcccceeeEEEEeecCCC-ChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 004218 524 DFKNMEFLALVYEFLGNG-SLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM 602 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~ 602 (767)
..+..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 100 ---~~~~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 100 ---NQGFFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDF 167 (335)
T ss_dssp ---CSSEEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTS
T ss_pred ---eCCEEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCC
Confidence 556779999999777 9999997654 399999999999999999999999 999999999999999999
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCcccCCcch
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL 681 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 681 (767)
.+||+|||+++...... ......||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||......
T Consensus 168 ~~kL~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---- 236 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGK-------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---- 236 (335)
T ss_dssp CEEECCCTTCEECCTTC-------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----
T ss_pred cEEEeecccceECCCCC-------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----
Confidence 99999999997653321 1234568999999999988877 78999999999999999999999652211
Q ss_pred hhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 682 VKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...... .+..+++. +.+++.+||+.||++|||++|++++
T Consensus 237 ---~~~~~~--~~~~~~~~----------------------l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ---VEAAIH--PPYLVSKE----------------------LMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TTTCCC--CSSCCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HhhccC--CCcccCHH----------------------HHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 11112221 2226678999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=348.79 Aligned_cols=285 Identities=25% Similarity=0.261 Sum_probs=202.6
Q ss_pred CHHHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCc-----------chhhHHHHHHHHhcCCCCCce
Q 004218 446 SYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTG-----------TWKSFFAECEALRNTRHRNLV 514 (767)
Q Consensus 446 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv 514 (767)
.++++....++|++.+.||+|+||.||+|.+.+|+.||||++...... ..+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356788899999999999999999999999888999999998543221 126789999999999999999
Q ss_pred eEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 004218 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPG 594 (767)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~ 594 (767)
++++++...+.......++||||++ |+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 163 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG 163 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence 9999986654455668899999998 58888887543 3499999999999999999999999 9999999999
Q ss_pred CeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 595 NILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 595 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
||+++.++.+||+|||.++...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADA-------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp GEEECTTCCEEECCTTC----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred HEEEcCCCCEEEEecCccccccccc-------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999997543321 1233468999999998876 6789999999999999999999999965
Q ss_pred cccCCcchhhHhhhhcccc---hhhhccHHHHHhhhcc----hh-hHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 004218 674 SFAGEVSLVKWVESNFPKN---AQQVLDRELRQLMMSS----ES-QTIQLHDCLITIIESVGLSCTTESPGGRIDIREAL 745 (767)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~~~~~~----~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl 745 (767)
..... ............. ................ +. ............+.+++.+||+.||++|||+.|++
T Consensus 237 ~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 237 STFYN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp SSHHH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCHHH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 42211 1111111100000 0011111111111000 00 00001111112233477799999999999999998
Q ss_pred HH
Q 004218 746 RR 747 (767)
Q Consensus 746 ~~ 747 (767)
++
T Consensus 316 ~h 317 (362)
T 3pg1_A 316 RH 317 (362)
T ss_dssp TS
T ss_pred cC
Confidence 75
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=340.10 Aligned_cols=284 Identities=25% Similarity=0.347 Sum_probs=202.3
Q ss_pred cCHHHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcC--CCCCceeEEeeeec
Q 004218 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNT--RHRNLVKLITSCSS 522 (767)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~ 522 (767)
.+........++|++.+.||+|+||.||+|++. ++.||||++... ....+.+|.+++... +||||+++++++..
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 344444556689999999999999999999987 899999998533 234455666666665 89999999998754
Q ss_pred CCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeecCCCCCee
Q 004218 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC-----EVPIVHCDLKPGNIL 597 (767)
Q Consensus 523 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlkp~NIl 597 (767)
.. ......++||||+++|+|.+++.... +++..++.++.|++.||+|||+.. .++|+||||||+||+
T Consensus 103 ~~-~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nil 174 (337)
T 3mdy_A 103 GT-GSWTQLYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174 (337)
T ss_dssp SC-GGGCEEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEE
T ss_pred CC-CCCCceEEEEeccCCCcHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEE
Confidence 32 22367899999999999999996543 899999999999999999999751 238999999999999
Q ss_pred eCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCc------ccchhhhHHHHHHHhC----
Q 004218 598 LDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTA------GDVYSFGVMLLEIFTG---- 667 (767)
Q Consensus 598 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slG~il~el~tg---- 667 (767)
++.++.+||+|||+++.......... .......||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 175 VKKNGTCCIADLGLAVKFISDTNEVD--IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp ECTTSCEEECCCTTCEECC-----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred ECCCCCEEEEeCCCceeecccccccc--CCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 99999999999999976543321111 11124568999999999988776665 9999999999999999
Q ss_pred ------CCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCH
Q 004218 668 ------MSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDI 741 (767)
Q Consensus 668 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~ 741 (767)
+.||.......................... ........ ....+.+++.+||+.||++|||+
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~ 319 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF------------PNRWSSDE-CLRQMGKLMTECWAHNPASRLTA 319 (337)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC------------CGGGGGSH-HHHHHHHHHHHHSCSSGGGSCCH
T ss_pred cccccccccHhhhcCCCCchhhhHHHHhhhccCccc------------cccchhhH-HHHHHHHHHHHhhhhChhhCCCH
Confidence 555544332222111111100000000000 00000001 11222337779999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 004218 742 REALRRLKNAQKIL 755 (767)
Q Consensus 742 ~evl~~L~~~~~~~ 755 (767)
.|++++|+.+.+..
T Consensus 320 ~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 320 LRVKKTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhhc
Confidence 99999999987643
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=359.77 Aligned_cols=344 Identities=18% Similarity=0.268 Sum_probs=287.0
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
++|++|+|++|+++ .+|...+.++++|++|+|++|++.+..|..|+++++|++|+|++|+++ .+|.. .+++|++|+
T Consensus 21 ~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 96 (520)
T 2z7x_B 21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLD 96 (520)
T ss_dssp TTCSEEECCSSCCC-CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred ccccEEECCCCccc-ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEe
Confidence 47899999999998 677666667999999999999999888999999999999999999999 56665 799999999
Q ss_pred ecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhcccc--CeEEccCCcc--cccCCccccCCC---
Q 004218 82 IGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVL--SKLYMGGNRF--YGKIPTSIGRLR--- 154 (767)
Q Consensus 82 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L--~~L~l~~n~i--~~~~~~~l~~l~--- 154 (767)
+++|++.+. ..+..+.++++|++|++++|++++ ..+..+++ | ++|++++|++ .+..|..+..+.
T Consensus 97 L~~N~l~~~-----~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~-L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~ 167 (520)
T 2z7x_B 97 LSFNAFDAL-----PICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAH-LNISKVLLVLGETYGEKEDPEGLQDFNTES 167 (520)
T ss_dssp CCSSCCSSC-----CCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTT-SCEEEEEEEECTTTTSSCCTTTTTTCCEEE
T ss_pred ccCCccccc-----cchhhhccCCcceEEEecCcccch---hhcccccc-ceeeEEEeecccccccccccccccccccce
Confidence 999998754 456788899999999999999875 35566665 6 8888888888 555565555533
Q ss_pred --------------------------------------------------------------------------------
Q 004218 155 -------------------------------------------------------------------------------- 154 (767)
Q Consensus 155 -------------------------------------------------------------------------------- 154 (767)
T Consensus 168 l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~ 247 (520)
T 2z7x_B 168 LHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247 (520)
T ss_dssp EEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTS
T ss_pred EEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhC
Confidence
Q ss_pred CCCEEECcCCcCcccCcccc-----CCCCCCCEEEccCCccccccC-c-------------------------CcccCCC
Q 004218 155 SLTLLNLSYNSISGEILTEI-----GQLQELQSLDLAGNQISGSIP-N-------------------------TLGNLKK 203 (767)
Q Consensus 155 ~L~~L~l~~n~i~~~~~~~~-----~~l~~L~~L~L~~n~i~~~~~-~-------------------------~~~~l~~ 203 (767)
+|++|++++|.+++..|..+ ..+++|+.+++++|.+ .+| . .+..+++
T Consensus 248 ~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~ 325 (520)
T 2z7x_B 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325 (520)
T ss_dssp SCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCC
T ss_pred cccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCc
Confidence 68888888888887777777 6666666666666655 122 1 1267899
Q ss_pred CceeeCCCCcCCCCCcccccCccccccccccCcccCC--CCChhhcccccccceeecccccCCCCCch-hhcCCCceeEE
Q 004218 204 LNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG--NIPKEILSLSSLTTIVNLSKNFLDGTLPE-EIGMLGNVVTI 280 (767)
Q Consensus 204 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~l~~~l~l~~n~l~~~~~~-~~~~l~~L~~L 280 (767)
|++|++++|++++..|..++.+++|+.|++++|++++ .+|..+..+++|. .+++++|.+++.+|. .+..+++|+.|
T Consensus 326 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~-~L~Ls~N~l~~~l~~~~~~~l~~L~~L 404 (520)
T 2z7x_B 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQ-QLDISQNSVSYDEKKGDCSWTKSLLSL 404 (520)
T ss_dssp CCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCC-EEECCSSCCBCCGGGCSCCCCTTCCEE
T ss_pred ccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCC-EEECCCCcCCcccccchhccCccCCEE
Confidence 9999999999998889999999999999999999996 5567889999994 459999999985555 58899999999
Q ss_pred EccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCcc-ccccccCceEeccCCcC
Q 004218 281 DLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLTFNNL 359 (767)
Q Consensus 281 ~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~l~~N~l 359 (767)
++++|.+++..|..+. ++|+.|++++|+++ .+|..+..+++|+.|+|++|++++ +|.. +..+++|+.|++++|++
T Consensus 405 ~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~ 480 (520)
T 2z7x_B 405 NMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 480 (520)
T ss_dssp ECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCB
T ss_pred ECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCC
Confidence 9999999887776665 79999999999999 788888899999999999999995 5554 89999999999999999
Q ss_pred cCcCCC
Q 004218 360 EGVVPR 365 (767)
Q Consensus 360 ~~~~~~ 365 (767)
++..+.
T Consensus 481 ~c~c~~ 486 (520)
T 2z7x_B 481 DCSCPR 486 (520)
T ss_dssp CCCHHH
T ss_pred cccCCc
Confidence 986553
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.78 Aligned_cols=267 Identities=25% Similarity=0.375 Sum_probs=201.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++... ......++.+|+.++++++||||+++++++.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 103 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 103 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-----
Confidence 478999999999999999999842 4778999998643 2334567889999999999999999999964
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CC
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKN-EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE---DM 602 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~ 602 (767)
.....++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||+. +|+||||||+||+++. +.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence 345569999999999999999865432 1224589999999999999999999999 9999999999999984 45
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcch
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSL 681 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~ 681 (767)
.+||+|||.++......... ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ..
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~ 254 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYR----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EV 254 (327)
T ss_dssp CEEECCCHHHHHHHC----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred eEEECccccccccccccccc----cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HH
Confidence 69999999998664432111 1233457899999999988889999999999999999998 99998653211 11
Q ss_pred hhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 682 VKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
...+...........+++. +.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 255 LEFVTSGGRMDPPKNCPGP----------------------VYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHHhcCCCCCCCCCCCHH----------------------HHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 1222111111111111111 2226778999999999999999999998876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=347.14 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=192.5
Q ss_pred cCCCCCCccccccceEEEEEEe-CCCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYL-REGISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
..|+..+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++. ....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCe
Confidence 4588999999999999999996 4689999999965432 23467889999999999999999999964 3456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||++ |++.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEecCC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence 799999997 58888886433 2489999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccC---CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL---GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
+++..... ....||+.|+|||++. +..++.++|||||||++|||++|+.||....... ........
T Consensus 200 ~a~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~ 268 (348)
T 1u5q_A 200 SASIMAPA----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN 268 (348)
T ss_dssp TCBSSSSB----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHS
T ss_pred CceecCCC----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhc
Confidence 99754321 2346899999999874 5678999999999999999999999986532111 11111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+.......++. +.+++.+||+.||++|||++|++++
T Consensus 269 ~~~~~~~~~~~~~----------------------l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 269 ESPALQSGHWSEY----------------------FRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCCCCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCCCCHH----------------------HHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111111111111 2236678999999999999999865
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=364.02 Aligned_cols=365 Identities=19% Similarity=0.234 Sum_probs=274.4
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
...++.++.+++ ++|..+. +++++|++++|.+.+..+.+|.++++|++|+|++|.+++..+..|+.+++|++|+|+
T Consensus 9 ~~~~~c~~~~l~-~ip~~l~---~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 84 (570)
T 2z63_A 9 NITYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84 (570)
T ss_dssp TTEEECCSSCCS-SCCSSSC---SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CcEEEeCCCCcc-ccCCCcc---ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCc
Confidence 457888999998 9998764 479999999999998888899999999999999999998778899999999999999
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccc-cCCccccCCCCCCEEECc
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYG-KIPTSIGRLRSLTLLNLS 162 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~-~~~~~l~~l~~L~~L~l~ 162 (767)
+|++...+ +..+.++++|++|++++|++++..+..++++++ |++|++++|.+++ .+|..|+++++|++|+++
T Consensus 85 ~n~l~~~~------~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~-L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~ 157 (570)
T 2z63_A 85 GNPIQSLA------LGAFSGLSSLQKLVAVETNLASLENFPIGHLKT-LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157 (570)
T ss_dssp TCCCCEEC------TTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTT-CCEEECCSSCCCCCCCCGGGGGCTTCCEEECT
T ss_pred CCcCCccC------HhhhcCccccccccccccccccCCCcccccccc-ccEEecCCCccceecChhhhcccCCCCEEeCc
Confidence 99987532 356889999999999999999665557889988 9999999999986 469999999999999999
Q ss_pred CCcCcccCccccCCCCCC----CEEEccCCccccccC-------------------------------------------
Q 004218 163 YNSISGEILTEIGQLQEL----QSLDLAGNQISGSIP------------------------------------------- 195 (767)
Q Consensus 163 ~n~i~~~~~~~~~~l~~L----~~L~L~~n~i~~~~~------------------------------------------- 195 (767)
+|++++..+..+..+++| ++|++++|.+.+..|
T Consensus 158 ~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~ 237 (570)
T 2z63_A 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237 (570)
T ss_dssp TSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEEC
T ss_pred CCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccc
Confidence 999987666666655555 556666655543322
Q ss_pred --------------------------------------cCcccCCCCceeeCCCCcCCCCCcccc---------------
Q 004218 196 --------------------------------------NTLGNLKKLNQIDLSGNELASEIPTSF--------------- 222 (767)
Q Consensus 196 --------------------------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~--------------- 222 (767)
..+..+++|++|++++|.++. +|..+
T Consensus 238 ~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~~L~~L~l~~n~~ 316 (570)
T 2z63_A 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKF 316 (570)
T ss_dssp CCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCCCCSEEEEESCBC
T ss_pred cCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccCCccEEeeccCcc
Confidence 223334555555555555542 33333
Q ss_pred ---------------------------cCccccccccccCcccCCCC--ChhhcccccccceeecccccCCCCCchhhcC
Q 004218 223 ---------------------------GNFQNLLSIDLSNNKLNGNI--PKEILSLSSLTTIVNLSKNFLDGTLPEEIGM 273 (767)
Q Consensus 223 ---------------------------~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~ 273 (767)
..+++|+.|++++|++++.. +..+..+++|. .+++++|.+.+..+. +..
T Consensus 317 ~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~-~L~l~~n~l~~~~~~-~~~ 394 (570)
T 2z63_A 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK-YLDLSFNGVITMSSN-FLG 394 (570)
T ss_dssp SSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCC-EEECCSCSEEEEEEE-EET
T ss_pred cccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccccccCccC-EEECCCCcccccccc-ccc
Confidence 23455555555555555332 45555666663 336777766644333 777
Q ss_pred CCceeEEEccCCCCCCCCC-cccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccC-CCCCccccccccCce
Q 004218 274 LGNVVTIDLSANGLSGNLP-NSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLS-GSIPSDLQNLRALRS 351 (767)
Q Consensus 274 l~~L~~L~ls~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~ 351 (767)
+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.+..|..+..+++|+.|+|++|.++ +.+|..+..+++|+.
T Consensus 395 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~ 474 (570)
T 2z63_A 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474 (570)
T ss_dssp CTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred cCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCE
Confidence 7777777777777776554 46777888888888888888777778888888888888888886 567778888888888
Q ss_pred EeccCCcCcCcCCCC-ccccccccccccCCcC
Q 004218 352 LNLTFNNLEGVVPRE-GIFRHTSMVHLEGNPK 382 (767)
Q Consensus 352 L~l~~N~l~~~~~~~-~~~~~~~~~~l~~Np~ 382 (767)
|++++|++++..|.. ..++++..+++.+|..
T Consensus 475 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 506 (570)
T 2z63_A 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506 (570)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCccccCChhhhhcccCCCEEeCCCCcC
Confidence 888888888775544 4567777788887754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=346.36 Aligned_cols=268 Identities=24% Similarity=0.338 Sum_probs=205.0
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeee
Q 004218 448 DELRRATGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSC 520 (767)
Q Consensus 448 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~ 520 (767)
++.....++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+++++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344556789999999999999999999865 367899999864332 3345688999999999999999999996
Q ss_pred ecCCcccceeeEEEEeecCCCChhhhhcccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 004218 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN----EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNI 596 (767)
Q Consensus 521 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 596 (767)
. .....++||||+++|+|.+++...+.. .....+++..++.++.|++.||+|||++ +|+||||||+||
T Consensus 98 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI 169 (322)
T 1p4o_A 98 S-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 169 (322)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred c-----cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence 4 445679999999999999999764311 1113479999999999999999999999 999999999999
Q ss_pred eeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcc
Q 004218 597 LLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESF 675 (767)
Q Consensus 597 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~ 675 (767)
+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||+|+++|+|++ |+.||....
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCE----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred EEcCCCeEEECcCcccccccccccc----ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 9999999999999999866443211 11223456889999999988889999999999999999999 889986532
Q ss_pred cCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 676 AGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
.. .....+...........++. .+.+++.+||+.||++|||+.|++++|++.
T Consensus 246 ~~--~~~~~~~~~~~~~~~~~~~~----------------------~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 246 NE--QVLRFVMEGGLLDKPDNCPD----------------------MLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HH--HHHHHHHTTCCCCCCTTCCH----------------------HHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HH--HHHHHHHcCCcCCCCCCCCH----------------------HHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 11 11111111110011111111 122367789999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.51 Aligned_cols=284 Identities=22% Similarity=0.275 Sum_probs=207.4
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCee
Confidence 4679999999999999999999765 8999999996432 3345678899999999999999999998753 234467
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL----DEDMTAKVG 607 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~ 607 (767)
++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred EEEEecCCCCCHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEe
Confidence 999999999999999976543 23489999999999999999999999 99999999999999 778889999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCC--------CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG--------EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV 679 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 679 (767)
|||.++...... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 159 DFG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~ 231 (396)
T 4eut_A 159 DFGAARELEDDE-------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (396)
T ss_dssp CGGGCEECCCGG-------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred cCCCceEccCCC-------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence 999997653321 1233568999999998764 4567899999999999999999999965332221
Q ss_pred c--hhhHhhhhcccchhhhccHHHHHhh--hcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 680 S--LVKWVESNFPKNAQQVLDRELRQLM--MSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 680 ~--~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
. ....+....|......+.......+ .........+.+.+...+.+++.+||+.||++|||++|+++.++++..
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1 1111111111110000000000000 000000011223344445557789999999999999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=358.63 Aligned_cols=250 Identities=26% Similarity=0.340 Sum_probs=188.5
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
..++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+++++.++||||+++++++. ..
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~ 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----TH 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ET
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eC
Confidence 3467999999999999999999975 5899999999653 3344567788999999999999999999964 44
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
+.+++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~ 291 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKIT 291 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEEC
T ss_pred CEEEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEc
Confidence 56799999999999999997644 38999999999999999999998 8 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+..
T Consensus 292 DFG~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~ 363 (446)
T 4ejn_A 292 DFGLCKEGIKDG------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILM 363 (446)
T ss_dssp CCCCCCTTCC-----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred cCCCceeccCCC------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHHh
Confidence 999997532211 1123467999999999999999999999999999999999999999653221 11111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
... ..+..+++ .+.+++.+||+.||++|| |++|++++
T Consensus 364 ~~~-~~p~~~~~----------------------~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 364 EEI-RFPRTLGP----------------------EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CCC-CCCTTSCH----------------------HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCC-CCCccCCH----------------------HHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 000 01111111 122367789999999999 99999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=336.31 Aligned_cols=257 Identities=24% Similarity=0.303 Sum_probs=198.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 468999999999999999999976 58999999997543 2345678899999999999999999998642 34557
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEeecCCCCCeeeCCCCceE
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVP-----IVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~NIl~~~~~~~k 605 (767)
.++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+|
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~k 156 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVK 156 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEE
T ss_pred EEEEEeCCCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEE
Confidence 89999999999999999764321 34489999999999999999999998 7 99999999999999999999
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 685 (767)
|+|||.++...... .......||..|+|||++.+..++.++||||+|+++|+|++|+.||...... .....+
T Consensus 157 l~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i 228 (279)
T 2w5a_A 157 LGDFGLARILNHDT------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKI 228 (279)
T ss_dssp ECCCCHHHHC---C------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred EecCchheeecccc------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHH
Confidence 99999998654321 1112346899999999999888999999999999999999999998654211 111111
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
...........+++ .+.+++.+||+.||++|||+.|+++++
T Consensus 229 ~~~~~~~~~~~~~~----------------------~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 229 REGKFRRIPYRYSD----------------------ELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHTCCCCCCTTSCH----------------------HHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred hhcccccCCcccCH----------------------HHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 11111111111111 122366789999999999999999865
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=341.57 Aligned_cols=281 Identities=22% Similarity=0.311 Sum_probs=207.5
Q ss_pred ccCHHHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhc--CCCCCceeEEeeee
Q 004218 444 MISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRN--TRHRNLVKLITSCS 521 (767)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~ 521 (767)
..++.......++|++.+.||+|+||.||+|++. ++.||||++... ..+.+.+|+++++. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 4455555667789999999999999999999985 899999998632 34667889998887 78999999999975
Q ss_pred cCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeecCCC
Q 004218 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH--------NDCEVPIVHCDLKP 593 (767)
Q Consensus 522 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlkp 593 (767)
... ......++||||+++|+|.+++.... +++.+++.++.|++.||+||| +. +|+||||||
T Consensus 107 ~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp 175 (342)
T 1b6c_B 107 KDN-GTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKS 175 (342)
T ss_dssp CCC-SSCCCEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSG
T ss_pred ccC-CccceeEEEEeecCCCcHHHHHhccC-------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCH
Confidence 432 12236799999999999999997543 899999999999999999999 77 999999999
Q ss_pred CCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC------CCCcccchhhhHHHHHHHhC
Q 004218 594 GNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK------PSTAGDVYSFGVMLLEIFTG 667 (767)
Q Consensus 594 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~el~tg 667 (767)
+||+++.++.+||+|||++......... .........||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 176 KNILVKKNGTCCIADLGLAVRHDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTE--EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHEEECCCCCEEEEECCCceeccccccc--cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 9999999999999999999765433211 001123456899999999987653 33689999999999999999
Q ss_pred ----------CCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCC
Q 004218 668 ----------MSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGG 737 (767)
Q Consensus 668 ----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 737 (767)
+.||............+.............. .+....+ ....+.+++.+||+.||++
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~-~~~~l~~li~~cl~~dp~~ 320 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP------------NRWQSCE-ALRVMAKIMRECWYANGAA 320 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC------------GGGGTSH-HHHHHHHHHHHHCCSSGGG
T ss_pred cCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCc------------ccccchh-HHHHHHHHHHHHhccChhh
Confidence 6777654333322222211110000000000 0000001 1122333777999999999
Q ss_pred CCCHHHHHHHHHHHHHH
Q 004218 738 RIDIREALRRLKNAQKI 754 (767)
Q Consensus 738 Rpt~~evl~~L~~~~~~ 754 (767)
|||+.|++++|+.+.+.
T Consensus 321 Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 321 RLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp SCCHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHHHHHHHHH
Confidence 99999999999998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=347.68 Aligned_cols=271 Identities=15% Similarity=0.179 Sum_probs=201.9
Q ss_pred cCCCCCCccccccceEEEEEEeCC---------CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeE---------
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE---------GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKL--------- 516 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~--------- 516 (767)
++|++.+.||+|+||.||+|.+.. ++.||+|++... +.+.+|++++++++||||+++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 689999999999999999999764 789999998643 568899999999999999984
Q ss_pred ------EeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 004218 517 ------ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCD 590 (767)
Q Consensus 517 ------~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 590 (767)
++++. ..+...++||||+ +++|.+++.... ...+++.+++.++.|++.||+|||++ +|+|||
T Consensus 117 ~~i~~~~~~~~----~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D 184 (352)
T 2jii_A 117 LAIPTCMGFGV----HQDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHEN---EYVHGN 184 (352)
T ss_dssp CSCCCCCEEEE----ETTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSC
T ss_pred cCccchhhccc----cCCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCC
Confidence 44432 2356789999999 999999998652 13499999999999999999999999 999999
Q ss_pred CCCCCeeeCCCC--ceEEccccchhhhhhhcCCCc-cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhC
Q 004218 591 LKPGNILLDEDM--TAKVGDFGLARSLLERIGNQS-SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG 667 (767)
Q Consensus 591 lkp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg 667 (767)
|||+||+++.++ .+||+|||+++.......... .........||+.|+|||++.+..++.++||||||+++|||++|
T Consensus 185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999998 999999999987654322111 11122345799999999999999999999999999999999999
Q ss_pred CCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 668 MSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 668 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+.||.........+...... +.......... ......+.+. +.+++.+||+.||++|||++|+++.
T Consensus 265 ~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~~~----l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 265 FLPWTNCLPNTEDIMKQKQK-FVDKPGPFVGP---------CGHWIRPSET----LQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp CCTTGGGTTCHHHHHHHHHH-HHHSCCCEECT---------TSCEECCCHH----HHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CCCcccCCcCHHHHHHHHHh-ccCChhhhhhh---------ccccCCCcHH----HHHHHHHHHhCChhhCCCHHHHHHH
Confidence 99997643222212111110 00000000000 0000000111 2226678999999999999999999
Q ss_pred HHHHHHHHh
Q 004218 748 LKNAQKILL 756 (767)
Q Consensus 748 L~~~~~~~~ 756 (767)
|+++.....
T Consensus 331 L~~~~~~~~ 339 (352)
T 2jii_A 331 LEALLQDLR 339 (352)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHhcC
Confidence 999887665
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.93 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=194.6
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
..++|++.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|+++++.++||||+++++++. ..+..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCeE
Confidence 34689999999999999999999864 8999999997666667788999999999999999999999964 34567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 163 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELD-----RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGV 163 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred EEEEEeCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCC
Confidence 99999999999999987533 2399999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCcccc-----CCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYG-----LGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
+......... .....||..|+|||++ .+..++.++||||+|+++|+|++|+.||....... .......
T Consensus 164 ~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~ 236 (302)
T 2j7t_A 164 SAKNLKTLQK------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAK 236 (302)
T ss_dssp HHHHHHHHHC-----------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred Cccccccccc------cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhc
Confidence 8654332111 1234589999999987 46678999999999999999999999986532211 1111111
Q ss_pred hhcccc-hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SNFPKN-AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+.. ....++. .+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~----------------------~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 237 SDPPTLLTPSKWSV----------------------EFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp SCCCCCSSGGGSCH----------------------HHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cCCcccCCccccCH----------------------HHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111110 1111111 12236778999999999999999863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=332.11 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=194.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC------cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST------GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----- 78 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE----- 78 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----
Confidence 357899999999999999999976 589999999865422 13567899999999999999999999964
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM---- 602 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---- 602 (767)
.....++||||+++++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSC
T ss_pred CCCeEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCC
Confidence 4456799999999999999997543 389999999999999999999999 999999999999998877
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchh
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV 682 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 682 (767)
.+||+|||.+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ...
T Consensus 150 ~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~ 221 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLT 221 (283)
T ss_dssp CEEECCCTTCEECC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHH
T ss_pred ceEEEecccceeccCCC-------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHH
Confidence 89999999997653321 1133458999999999999999999999999999999999999996532211 000
Q ss_pred hHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 683 KWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
......... ... ........+.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~~~~------~~~--------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 222 NISAVNYDF------DEE--------------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHTTCCCC------CHH--------------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HhHhcccCC------cch--------------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 000000000 000 000011122337779999999999999999984
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.37 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=177.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++. ...
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence 467999999999999999999974 68999999986432 233567889999999999999999999954 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df 156 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADF 156 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEee
Confidence 7799999999999999997643 3489999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|.+........ ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ ........+
T Consensus 157 g~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~ 229 (278)
T 3cok_A 157 GLATQLKMPHE------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVLADY 229 (278)
T ss_dssp TTCEECC----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSSCC
T ss_pred cceeeccCCCC------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHhhccc
Confidence 99976532211 11234689999999999988899999999999999999999999965432211 000000000
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+..++.. +.+++.+||+.||++|||++|++++
T Consensus 230 --~~~~~~~~~----------------------~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 --EMPSFLSIE----------------------AKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --CCCTTSCHH----------------------HHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --CCccccCHH----------------------HHHHHHHHcccCHhhCCCHHHHhcC
Confidence 011111111 1236778999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.89 Aligned_cols=270 Identities=19% Similarity=0.215 Sum_probs=191.1
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCC---ccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLITSCSSLD---FKN 527 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~---~~~ 527 (767)
...+|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++++. ||||+++++++.... ...
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3468999999999999999999975 58999999987665566678899999999996 999999999974322 245
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeCCCCceE
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVP--IVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~~k 605 (767)
...+++||||++ |+|.+++..... ...+++.+++.++.|++.||+|||+. + |+||||||+||+++.++.+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHT---TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred CceEEEEEEecC-CCHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 567899999996 699998875332 23499999999999999999999998 8 99999999999999999999
Q ss_pred EccccchhhhhhhcCCCcc------ccccccccCCCCccCcccc---CCCCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 606 VGDFGLARSLLERIGNQSS------ISSTHVLKGSIGYIPPEYG---LGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
|+|||+++........... ........||+.|+|||++ .+..++.++||||||+++|+|++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999865432211100 0111234589999999998 566788999999999999999999999965322
Q ss_pred CCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 677 GEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
.. ................. +.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 259 ~~-----~~~~~~~~~~~~~~~~~----------------------~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 259 LR-----IVNGKYSIPPHDTQYTV----------------------FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------------CCCCTTCCSSGG----------------------GHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HH-----hhcCcccCCcccccchH----------------------HHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 11 11111111111111110 1226778999999999999999999999877544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=347.22 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=192.8
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCccccee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 530 (767)
..++|++.+.||+|+||.||+|.++ +++.||||++.... ....+|++++.++ +||||+++++++ .++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVY-----DDGKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCE
Confidence 3567999999999999999999976 48899999996543 2345788888887 799999999995 45567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC----CceEE
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED----MTAKV 606 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~----~~~kl 606 (767)
+++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ ||+||||||+||++.+. +.+||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI 161 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred EEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence 899999999999999997643 399999999999999999999999 99999999999998533 35999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc-chhhHh
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-SLVKWV 685 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~ 685 (767)
+|||+++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .+...+
T Consensus 162 ~Dfg~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i 235 (342)
T 2qr7_A 162 CDFGFAKQLRAENG------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235 (342)
T ss_dssp CCCTTCEECBCTTC------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH
T ss_pred EECCCcccCcCCCC------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH
Confidence 99999976533211 12345689999999999887889999999999999999999999975322111 111111
Q ss_pred h-hhcc--cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 E-SNFP--KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 ~-~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. ..++ ......+++ .+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~s~----------------------~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 236 GSGKFSLSGGYWNSVSD----------------------TAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHCCCCCCSTTTTTSCH----------------------HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCCcccCccccccCCH----------------------HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 1111 001111111 12236778999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.83 Aligned_cols=279 Identities=20% Similarity=0.252 Sum_probs=202.5
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999976 58899999986433 2334678899999999999999999999876555556678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++ +|.+++.... +++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 106 ~iv~e~~~~-~L~~~l~~~~-------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQH-------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEECCSE-EHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEcccCc-CHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence 999999974 9999987543 99999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh--
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN-- 688 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-- 688 (767)
++......... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ +.......
T Consensus 175 a~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~ 250 (364)
T 3qyz_A 175 ARVADPDHDHT---GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGS 250 (364)
T ss_dssp CEECCGGGCBC---CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHHHCS
T ss_pred eEecCCCCCcc---ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHHhCC
Confidence 98654432211 11234568999999998654 4589999999999999999999999966432221 11111100
Q ss_pred ccc-chhhhccHHHHHhhhcch----hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPK-NAQQVLDRELRQLMMSSE----SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~-~~~~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+. .................+ .........+...+.+++.+||+.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 011111111111100000 00000000111223347779999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=334.55 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=191.8
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
+|.....||+|+||.||+|.+. +++.||+|.+........+.+.+|+.+++.++||||+++++++. ..+..++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEEE
Confidence 4555568999999999999975 58899999997666666778999999999999999999999964 44567999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEccccchh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE-DMTAKVGDFGLAR 613 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~a~ 613 (767)
|||+++++|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||.+.
T Consensus 98 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp EECCSEEEHHHHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred EEeCCCCCHHHHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 999999999999976432 23477899999999999999999999 9999999999999987 8999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCC--CCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK--PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
...... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....................
T Consensus 172 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 2clq_A 172 RLAGIN------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 245 (295)
T ss_dssp ESCC-----------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC
T ss_pred ccCCCC------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc
Confidence 653221 1123446899999999987643 78899999999999999999999854322111111110101111
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.....+++. +.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~----------------------~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 246 EIPESMSAE----------------------AKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCTTSCHH----------------------HHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccCCHH----------------------HHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111111 2236678999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=334.55 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=199.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
...|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++. .....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeE
Confidence 457999999999999999999965 58999999997543 345678899999999999999999999864 34567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 96 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp EEEEECCTTEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeeccc
Confidence 9999999999999999653 389999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+....+.
T Consensus 166 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~ 237 (303)
T 3a7i_A 166 AGQLTDTQI------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPP 237 (303)
T ss_dssp CEECBTTBC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCC
T ss_pred ceecCcccc------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCC
Confidence 976543211 123456899999999999999999999999999999999999998653211 111111111111
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
.....++.. +.+++.+||+.||++|||+.|++++.
T Consensus 238 ~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 238 TLEGNYSKP----------------------LKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCCSSCCHH----------------------HHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCccccCHH----------------------HHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 111111111 22367789999999999999998864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.69 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=194.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++........+.+.+|+++++.++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence 467999999999999999999976 58999999997655445567889999999999999999999954 456779
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGDF 609 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~Df 609 (767)
+||||+++++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 83 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp EEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred EEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccC
Confidence 9999999999999987543 289999999999999999999999 99999999999999 78899999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh-
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN- 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~- 688 (767)
|.+...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||...... .....+...
T Consensus 154 g~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~ 223 (304)
T 2jam_A 154 GLSKMEQNG--------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIKEGY 223 (304)
T ss_dssp STTCCCCCB--------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHCC
T ss_pred CcceecCCC--------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCC
Confidence 998643211 123346899999999999999999999999999999999999999653221 111111111
Q ss_pred c--ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 F--PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+ +......+++ .+.+++.+||+.||++|||++|++++
T Consensus 224 ~~~~~~~~~~~~~----------------------~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 224 YEFESPFWDDISE----------------------SAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCCCTTTTTTSCH----------------------HHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCccccccCCH----------------------HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 0001111111 12236778999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=349.05 Aligned_cols=209 Identities=28% Similarity=0.333 Sum_probs=177.4
Q ss_pred CccCHHHHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-----CCCceeE
Q 004218 443 QMISYDELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTR-----HRNLVKL 516 (767)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~ 516 (767)
..+++.+.....++|++.+.||+|+||.||+|++. +++.||||++.. .....+.+..|+++++.+. ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34555555666789999999999999999999975 588999999863 2233456778999999986 9999999
Q ss_pred EeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 004218 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNI 596 (767)
Q Consensus 517 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 596 (767)
++++. ..+..++||||+ +++|.+++.... ...+++.++..++.|++.||+|||++ +|+||||||+||
T Consensus 102 ~~~~~-----~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 168 (360)
T 3llt_A 102 HGKFM-----YYDHMCLIFEPL-GPSLYEIITRNN----YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENI 168 (360)
T ss_dssp EEEEE-----ETTEEEEEECCC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cceee-----ECCeeEEEEcCC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccE
Confidence 99964 345679999999 889999997654 23489999999999999999999999 999999999999
Q ss_pred eeCC-------------------------CCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCc
Q 004218 597 LLDE-------------------------DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTA 651 (767)
Q Consensus 597 l~~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 651 (767)
+++. ++.+||+|||+++..... .....||+.|+|||++.+..++.+
T Consensus 169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~ 239 (360)
T 3llt_A 169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---------HGSIINTRQYRAPEVILNLGWDVS 239 (360)
T ss_dssp EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---------CCSCCSCGGGCCHHHHTTCCCCTT
T ss_pred EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC---------CcCccCcccccCcHHHcCCCCCCc
Confidence 9975 789999999999754321 123568999999999999999999
Q ss_pred ccchhhhHHHHHHHhCCCCCCCc
Q 004218 652 GDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 652 ~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+||||+||++|+|++|+.||...
T Consensus 240 ~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 240 SDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cchHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=344.06 Aligned_cols=272 Identities=24% Similarity=0.314 Sum_probs=190.5
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+++++.++||||+++++++. .....+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 57899999999999999999976 589999999864432 22335668999999999999999999964 455679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||++ |+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 77 lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp EEEECCS-EEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred EEecccc-cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence 9999997 49999887643 3489999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh---hh
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE---SN 688 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---~~ 688 (767)
+...... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ ...... ..
T Consensus 148 ~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~ 220 (324)
T 3mtl_A 148 RAKSIPT------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-LHFIFRILGTP 220 (324)
T ss_dssp ECC------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred ccccCCc------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCC
Confidence 7543221 11233468999999999876 5689999999999999999999999976432211 111111 00
Q ss_pred cccchhhhcc-HHHHHhhhc--chhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLD-RELRQLMMS--SESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~-~~l~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+........ ......... ...........+...+.+++.+||+.||++|||++|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 221 TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1111111111 111100000 0000000001111223347779999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=365.00 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=197.1
Q ss_pred ccccccceEEEEEEeC---CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEEee
Q 004218 462 LIGSGSFGSVYKGYLR---EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEF 537 (767)
Q Consensus 462 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 537 (767)
.||+|+||.||+|.++ ++..||||+++... ....+.+.+|++++++++||||++++++|.. +..++||||
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~ 416 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEM 416 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEEC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEe
Confidence 7999999999999864 46679999997543 3456789999999999999999999999753 347999999
Q ss_pred cCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhh
Q 004218 538 LGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLE 617 (767)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 617 (767)
+++|+|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 417 ~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 417 AGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp CTTCBHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999997543 3499999999999999999999999 999999999999999999999999999987543
Q ss_pred hcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchhhh
Q 004218 618 RIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQQV 696 (767)
Q Consensus 618 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (767)
..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+........+..
T Consensus 489 ~~~~~---~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~~~~p~~ 563 (613)
T 2ozo_A 489 DDSYY---TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKRMECPPE 563 (613)
T ss_dssp ----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTTCCCCCCTT
T ss_pred CCcee---eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCCCCCCCc
Confidence 22111 11122335688999999998899999999999999999998 99999664321 22222222221111122
Q ss_pred ccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhh
Q 004218 697 LDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757 (767)
Q Consensus 697 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 757 (767)
+.+.+ .+++.+||+.||++|||+.++++.|+.+......
T Consensus 564 ~~~~l----------------------~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 564 CPPEL----------------------YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CCHHH----------------------HHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCHHH----------------------HHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 22222 2266789999999999999999999998776643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=354.84 Aligned_cols=205 Identities=27% Similarity=0.414 Sum_probs=176.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|.+.+.||+|+||.||+|+++ +|+.||+|++... .....+.+.+|++++++++||||+++++++. ...
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eCC
Confidence 367889999999999999999986 5999999999643 2334567889999999999999999999853 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+|+||||++||+|.+++...... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.+|.+||+||
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEeccCCCHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeec
Confidence 789999999999999998764321 23599999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 334 Gla~~~~~~~------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 334 GLAVELKAGQ------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTCEECCTTC------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred ceeeeccCCC------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 9998653321 1123457999999999999999999999999999999999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.35 Aligned_cols=204 Identities=25% Similarity=0.405 Sum_probs=163.2
Q ss_pred HHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 450 LRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 450 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.....++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 103 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH----- 103 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----
Confidence 3455679999999999999999999965 589999999964432 23456789999999999999999999954
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee-----CCC
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL-----DED 601 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~-----~~~ 601 (767)
.....++||||+++ +|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||++ +..
T Consensus 104 ~~~~~~lv~e~~~~-~L~~~~~~~~~------~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 173 (329)
T 3gbz_A 104 HNHRLHLIFEYAEN-DLKKYMDKNPD------VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASET 173 (329)
T ss_dssp ETTEEEEEEECCSE-EHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----C
T ss_pred cCCEEEEEEecCCC-CHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCcc
Confidence 45678999999985 99999976543 89999999999999999999999 99999999999999 455
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+.+||+|||.++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 174 PVLKIGDFGLARAFGIPIR------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp CEEEECCTTHHHHHC-----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceEEECcCCCccccCCccc------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 6699999999987643211 12334579999999998874 4899999999999999999999999654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.72 Aligned_cols=199 Identities=24% Similarity=0.413 Sum_probs=173.1
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++. .++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCEE
Confidence 357999999999999999999976 58999999997553 334567889999999999999999999864 44567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
++||||+++|+|.+++..... +++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 177 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG 177 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred EEEEECCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECC
Confidence 999999999999999976542 8999999999999999999998 5 89999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
++....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 178 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 178 VSGQLIDSM--------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CCHHHHHHC------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred CCccccccc--------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 997664431 12346899999999999999999999999999999999999999654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.98 Aligned_cols=210 Identities=26% Similarity=0.393 Sum_probs=172.2
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc---cc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF---KN 527 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 527 (767)
.++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+++++.++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999974 58999999985443 2334578899999999999999999999865321 12
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
.+.+++||||+++ +|.+.+.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence 4578999999975 8887776543 2399999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|||+++........ .........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 167 Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 167 DFGLARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp CCTTCEECCCCSSS--SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cchhcccccccccc--cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999865432211 1122234568999999998876 45799999999999999999999999764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=362.43 Aligned_cols=375 Identities=19% Similarity=0.233 Sum_probs=293.8
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
+++++|||++|+|+ .+|...|.++++|++|+|++|+|.++.|++|.++++|++|+|++|+|++..+..|..+++|++|+
T Consensus 52 ~~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 52 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred cCCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 36899999999998 88888888899999999999999988888999999999999999999966667899999999999
Q ss_pred ecCccccCCCCCCccccccccCCCCCCEEECcCCccee-ecCchhhhhccccCeEEccCCcccccCCccccCCCCC----
Q 004218 82 IGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG-EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSL---- 156 (767)
Q Consensus 82 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L---- 156 (767)
|++|++++.+. ..+.++++|++|++++|++++ ..|..++.+++ |++|++++|++++..+..|..+.++
T Consensus 131 Ls~N~l~~l~~------~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~l~~L~~l~~~~ 203 (635)
T 4g8a_A 131 AVETNLASLEN------FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN-LEHLDLSSNKIQSIYCTDLRVLHQMPLLN 203 (635)
T ss_dssp CTTSCCCCSTT------CCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTT-CCEEECCSSCCCEECGGGGHHHHTCTTCC
T ss_pred CCCCcCCCCCh------hhhhcCcccCeeccccCccccCCCchhhccchh-hhhhcccCccccccccccccchhhhhhhh
Confidence 99999986533 247889999999999999975 35788888888 9999999999987766665443322
Q ss_pred CEEECcCCcCcccCc-----------------------------------------------------------------
Q 004218 157 TLLNLSYNSISGEIL----------------------------------------------------------------- 171 (767)
Q Consensus 157 ~~L~l~~n~i~~~~~----------------------------------------------------------------- 171 (767)
..++++.|.+..+.+
T Consensus 204 ~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~ 283 (635)
T 4g8a_A 204 LSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 283 (635)
T ss_dssp CEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEE
T ss_pred hhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhh
Confidence 234444443321110
Q ss_pred --------------------------------------cccCCCCCCCEEEccCCccccccCc-----------------
Q 004218 172 --------------------------------------TEIGQLQELQSLDLAGNQISGSIPN----------------- 196 (767)
Q Consensus 172 --------------------------------------~~~~~l~~L~~L~L~~n~i~~~~~~----------------- 196 (767)
..+....+|+.|++.+|.+....+.
T Consensus 284 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~ 363 (635)
T 4g8a_A 284 EEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 363 (635)
T ss_dssp EEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCC
T ss_pred hhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCC
Confidence 0112223455555555554422111
Q ss_pred --CcccCCCCceeeCCCCcCCCC-------------------------CcccccCccccccccccCcccCCCCC-hhhcc
Q 004218 197 --TLGNLKKLNQIDLSGNELASE-------------------------IPTSFGNFQNLLSIDLSNNKLNGNIP-KEILS 248 (767)
Q Consensus 197 --~~~~l~~L~~L~L~~N~l~~~-------------------------~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~ 248 (767)
....+++|+.|++++|.+... .+..+..+++|+.+++++|......+ ..+..
T Consensus 364 ~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~ 443 (635)
T 4g8a_A 364 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 443 (635)
T ss_dssp BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTT
T ss_pred Ccccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccc
Confidence 122456777777777766421 22345566777777777766654443 45667
Q ss_pred cccccceeecccccCCCCCchhhcCCCceeEEEccCCCC-CCCCCcccccCcccceeeccCccccCCCCchhhccCCceE
Q 004218 249 LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGL-SGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEV 327 (767)
Q Consensus 249 l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l-~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 327 (767)
+.++ ..++++.|.+.+..+..+..+++|+.|+|++|.+ .+..|..|..+++|+.|+|++|+|++..|..|.++++|+.
T Consensus 444 l~~l-~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~ 522 (635)
T 4g8a_A 444 LRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 522 (635)
T ss_dssp CTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cccc-ccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCE
Confidence 7777 4559999999989999999999999999999974 4567889999999999999999999999999999999999
Q ss_pred EEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCc-cc-cccccccccCCcCccc
Q 004218 328 LDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREG-IF-RHTSMVHLEGNPKLCL 385 (767)
Q Consensus 328 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~-~~~~~~~l~~Np~~c~ 385 (767)
|+|++|+|++..|..|..+++|+.|++++|++++.+|... .+ .++..+++.+|||.|.
T Consensus 523 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 523 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp EECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred EECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 9999999999889999999999999999999999988753 33 5788999999999995
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=336.86 Aligned_cols=200 Identities=27% Similarity=0.365 Sum_probs=166.7
Q ss_pred cCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCc--chhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTG--TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|+||.||+|.+.. |+.||+|++...... ..+.+.+|++++++++||||+++++++. .....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence 689999999999999999999764 899999998544322 2466789999999999999999999964 45567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 148 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF 148 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence 99999999999999887543 389999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+........ ......||..|+|||++.+ ..++.++||||+|+++|+|++|+.||...
T Consensus 149 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 149 ARLLTGPSD------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp CEECC------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred chhccCccc------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 976542211 1133468999999999876 56799999999999999999999999664
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=338.82 Aligned_cols=261 Identities=27% Similarity=0.425 Sum_probs=198.5
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcE--EEEEEeecc-CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccce
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGIS--VAVKVLDIE-STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 529 (767)
++|++.+.||+|+||.||+|.+. ++.. ||+|.+... .....+.+.+|+++++++ +||||+++++++. ..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eCC
Confidence 68999999999999999999965 4654 499988643 334557789999999999 8999999999964 445
Q ss_pred eeEEEEeecCCCChhhhhcccCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 004218 530 FLALVYEFLGNGSLGDWIHGERK----------NEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD 599 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~ 599 (767)
..++||||+++|+|.+++...+. ......+++.+++.++.|++.||+|||++ +|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 67999999999999999976531 01124599999999999999999999999 999999999999999
Q ss_pred CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCC
Q 004218 600 EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGE 678 (767)
Q Consensus 600 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~ 678 (767)
.++.+||+|||+++..... .......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~- 248 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA- 248 (327)
T ss_dssp GGGCEEECCTTCEESSCEE-------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred CCCeEEEcccCcCcccccc-------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-
Confidence 9999999999999743221 11123346889999999988888999999999999999998 99999653221
Q ss_pred cchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 679 VSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
.....+...........+++. +.+++.+||+.||++|||++|++++|+.+...
T Consensus 249 -~~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 249 -ELYEKLPQGYRLEKPLNCDDE----------------------VYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp -HHHHHGGGTCCCCCCTTBCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -HHHHHhhcCCCCCCCCCCCHH----------------------HHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111111111111111111111 22267789999999999999999999988764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=367.04 Aligned_cols=260 Identities=28% Similarity=0.417 Sum_probs=204.2
Q ss_pred HhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|++++++++||||+++++++.. ...+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence 456788999999999999999999888889999997543 345789999999999999999999998642 3469
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++|+|.+++.... +..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 338 lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred EeeehhcCCcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 9999999999999997532 23489999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+...+..
T Consensus 411 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~ 483 (535)
T 2h8h_A 411 RLIEDNEY-----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYRM 483 (535)
T ss_dssp TTCCCHHH-----HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHHHTTCCC
T ss_pred eecCCCce-----ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC
Confidence 86543211 11122346788999999988899999999999999999999 99998653221 111222221111
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
.....+.+. +.+++.+||+.||++|||++++++.|+.+....
T Consensus 484 ~~~~~~~~~----------------------l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 484 PCPPECPES----------------------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCCCCHH----------------------HHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 111111111 222677899999999999999999998765433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.17 Aligned_cols=262 Identities=20% Similarity=0.279 Sum_probs=200.1
Q ss_pred ccCHHHHHHHhcCCCCC-CccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcC-CCCCceeEEe
Q 004218 444 MISYDELRRATGNFSHE-NLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNT-RHRNLVKLIT 518 (767)
Q Consensus 444 ~~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~ 518 (767)
.+.+.......++|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.+ .||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34444555667788887 88999999999999976 48999999986542 23456788999999999 5699999999
Q ss_pred eeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 519 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
++. .....++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||++ +|+||||||+||++
T Consensus 97 ~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~ 164 (327)
T 3lm5_A 97 VYE-----NTSEIILILEYAAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILL 164 (327)
T ss_dssp EEE-----CSSEEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred EEE-----eCCeEEEEEEecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEE
Confidence 954 4566799999999999999986532 24499999999999999999999999 99999999999999
Q ss_pred CC---CCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcc
Q 004218 599 DE---DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675 (767)
Q Consensus 599 ~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 675 (767)
+. ++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....
T Consensus 165 ~~~~~~~~~kL~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 165 SSIYPLGDIKIVDFGMSRKIGHAC-------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp SCBTTBCCEEECCGGGCEEC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCCCCcEEEeeCccccccCCcc-------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 97 7899999999998654321 1133568999999999999999999999999999999999999996532
Q ss_pred cCCcchhhHhh--hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 676 AGEVSLVKWVE--SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 676 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... ...... ..++......+++ .+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~-~~~i~~~~~~~~~~~~~~~~~----------------------~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 238 NQET-YLNISQVNVDYSEETFSSVSQ----------------------LATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHH-HHHHHHTCCCCCTTTTTTSCH----------------------HHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred chHH-HHHHHhcccccCchhhcccCH----------------------HHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 2111 001110 0111111111111 12236778999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.28 Aligned_cols=273 Identities=23% Similarity=0.302 Sum_probs=193.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-cccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+++.+|+++++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999975 59999999985432 223567889999999999999999999976432 22335
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++||||+ +++|.+++.... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~-------l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEK-------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecC-CCCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence 679999999 789999997532 89999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh-
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES- 687 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~- 687 (767)
|+++..... .....||..|+|||++.+ ..++.++||||+||++|||++|+.||....... .+......
T Consensus 173 g~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~ 242 (367)
T 1cm8_A 173 GLARQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVT 242 (367)
T ss_dssp TTCEECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH
T ss_pred ecccccccc---------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhc
Confidence 999764321 233568999999998876 678999999999999999999999996532211 11111111
Q ss_pred -hcccc-hhhhccHHHHHhhhcch----hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 -NFPKN-AQQVLDRELRQLMMSSE----SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 -~~~~~-~~~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+.. .........+..+...+ .............+.+++.+||..||++|||++|++++
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 11111 11111111111111000 00000000111223347779999999999999999884
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=343.11 Aligned_cols=275 Identities=21% Similarity=0.234 Sum_probs=193.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-cccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999975 58899999986532 234567889999999999999999999976432 23345
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEcCCC-CHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence 78999999975 88888852 289999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....... ..........
T Consensus 172 g~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~ 243 (371)
T 2xrw_A 172 GLARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLG 243 (371)
T ss_dssp CC-----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CC
T ss_pred eccccccccc-------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 9998654321 1233568999999999999999999999999999999999999996542211 1111111000
Q ss_pred --ccchhhhccHHHHHhhhcchh----------------hHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 690 --PKNAQQVLDRELRQLMMSSES----------------QTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 690 --~~~~~~~~~~~l~~~~~~~~~----------------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
.........+.+.......+. ............+.+++.+||+.||++|||++|++++=
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000111111111111111000 00011112233344578899999999999999999863
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=364.85 Aligned_cols=253 Identities=26% Similarity=0.362 Sum_probs=195.0
Q ss_pred CccccccceEEEEEEeC---CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLR---EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|++++++++||||+++++++.. +..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 47999999999999753 36789999996543 2345789999999999999999999999742 2368999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++.++..|+.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 449 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred EccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 9999999999997543 389999999999999999999999 9999999999999999999999999999876
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchh
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+........+
T Consensus 520 ~~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~~~~p 594 (635)
T 4fl3_A 520 RADENYY---KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERMGCP 594 (635)
T ss_dssp TC----------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCCCCC
T ss_pred ccCcccc---ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCC
Confidence 4432111 11123346788999999998899999999999999999998 99999654221 122222222111112
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
..+++. +.+++.+||+.||++|||++++++.|+++....
T Consensus 595 ~~~~~~----------------------l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 595 AGCPRE----------------------MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TTCCHH----------------------HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCHH----------------------HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 222222 122667899999999999999999999887654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.06 Aligned_cols=273 Identities=22% Similarity=0.277 Sum_probs=183.6
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-cccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.... .....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999965 58999999986432 234567889999999999999999999975431 23345
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCEEEEECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred eEEEEeccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence 679999999 67999988653 299999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|+++..... .....||..|+|||++.+ ..++.++||||+||++|||++|+.||....... .+.......
T Consensus 177 G~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~ 246 (367)
T 2fst_X 177 GLARHTADE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLV 246 (367)
T ss_dssp -----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ccccccccc---------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 999765322 233568999999999877 678999999999999999999999996532211 111111110
Q ss_pred --cccc-hhhhccHHHHHhhhcc---h-hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 --FPKN-AQQVLDRELRQLMMSS---E-SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 --~~~~-~~~~~~~~l~~~~~~~---~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+.. .........+..+... + .............+.+++.+||+.||++|||+.|++++
T Consensus 247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 1111111111111110 0 00001111112223347779999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=334.67 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=192.6
Q ss_pred HHhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
...++|++.+.||+|+||.||+|.+.. |+.||+|++... ...+.+.+|+++++.++||||+++++++. ....
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 98 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTD 98 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCE
Confidence 346789999999999999999999764 899999998743 34577899999999999999999999964 3456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 170 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG 170 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEeecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecc
Confidence 799999999999999986432 3489999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
.+........ ......||..|+|||++.+..++.++||||+|+++|+|++|+.||....... .........+
T Consensus 171 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~ 242 (314)
T 3com_A 171 VAGQLTDTMA------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPP 242 (314)
T ss_dssp TCEECBTTBS------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCC
T ss_pred cchhhhhhcc------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCC
Confidence 9976543211 1233468999999999999899999999999999999999999996532111 0011111111
Q ss_pred cc--hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KN--AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. ....++. .+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~----------------------~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 243 PTFRKPELWSD----------------------NFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CCCSSGGGSCH----------------------HHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccCCcccCCH----------------------HHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 0111111 12236778999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=329.06 Aligned_cols=247 Identities=22% Similarity=0.353 Sum_probs=196.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++. ...
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCC
Confidence 367999999999999999999976 4789999998643 2234567889999999999999999999964 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence 7799999999999999997653 289999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|.+...... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ .........
T Consensus 159 g~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~ 229 (284)
T 2vgo_A 159 GWSVHAPSL--------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-HRRIVNVDL 229 (284)
T ss_dssp TTCEECSSS--------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTCC
T ss_pred cccccCccc--------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-HHHHhcccc
Confidence 998654221 11335689999999999999999999999999999999999999965321110 000000000
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+..++. .+.+++.+||+.||.+|||++|++++
T Consensus 230 --~~~~~~~~----------------------~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 --KFPPFLSD----------------------GSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --CCCTTSCH----------------------HHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --CCCCcCCH----------------------HHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 01111111 12236778999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=331.16 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=197.9
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|.+.+.||+|+||.||+|.+.+ ++.||+|++.... ....+.+.+|+.+++.++||||+++++++. ..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence 4689999999999999999999764 8899999986542 234567889999999999999999999964 455
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence 6799999999999999987643 389999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|.+....... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ .........
T Consensus 160 g~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~ 232 (294)
T 2rku_A 160 GLATKVEYDG------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNEY 232 (294)
T ss_dssp TTCEECCSTT------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTCC
T ss_pred cCceecccCc------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhhccC
Confidence 9997653221 112335689999999999998899999999999999999999999965322110 001101000
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+..+++ .+.+++.+||+.||++|||++|++++
T Consensus 233 --~~~~~~~~----------------------~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 --SIPKHINP----------------------VAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCCTTSCH----------------------HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCccccCH----------------------HHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01111111 12236778999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=336.41 Aligned_cols=196 Identities=24% Similarity=0.311 Sum_probs=168.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++.. ...+.+.+|++++++++ ||||+++++++.. ......
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCce
Confidence 367999999999999999999964 589999999863 33577889999999997 9999999999753 235567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEcccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-TAKVGDFG 610 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg 610 (767)
++||||+++++|.+++.. +++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 109 ~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg 176 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT---------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWG 176 (330)
T ss_dssp EEEEECCCCCCHHHHGGG---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeccCchhHHHHHHh---------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence 999999999999999853 88999999999999999999999 999999999999999776 89999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+++...... ......||..|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 177 ~a~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 177 LAEFYHPGQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp TCEECCTTC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CceEcCCCC-------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 997653321 1233468999999999877 66899999999999999999999999553
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=337.76 Aligned_cols=278 Identities=21% Similarity=0.285 Sum_probs=195.8
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC--------
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-------- 524 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 524 (767)
.++|++.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999875 8999999997666666778999999999999999999999874321
Q ss_pred -cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCC
Q 004218 525 -FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD-EDM 602 (767)
Q Consensus 525 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~ 602 (767)
.......++||||++ |+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++ +++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 234567899999998 5999999643 289999999999999999999999 999999999999997 567
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcch
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL 681 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 681 (767)
.+||+|||.++........ ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~ 233 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSH---KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQ 233 (320)
T ss_dssp EEEECCCTTCBCC-----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH
T ss_pred eEEEccCccccccCCCccc---ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HH
Confidence 9999999999865432111 111233457899999998765 67899999999999999999999999754321 11
Q ss_pred hhHhhhhcccchhh-------hccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 682 VKWVESNFPKNAQQ-------VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 682 ~~~~~~~~~~~~~~-------~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+....+..... .....+.................+...+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 11111111111100 1111111111110000011111122233447779999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.55 Aligned_cols=258 Identities=24% Similarity=0.411 Sum_probs=199.2
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc--------chhhHHHHHHHHhcC-CCCCceeE
Q 004218 447 YDELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG--------TWKSFFAECEALRNT-RHRNLVKL 516 (767)
Q Consensus 447 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~~ 516 (767)
+.......++|++.+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3445566778999999999999999999986 6999999998654321 135678999999998 79999999
Q ss_pred EeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 004218 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNI 596 (767)
Q Consensus 517 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 596 (767)
++++. .....++||||+++++|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||
T Consensus 166 ~~~~~-----~~~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NI 231 (365)
T 2y7j_A 166 IDSYE-----SSSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENI 231 (365)
T ss_dssp EEEEE-----BSSEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred EEEEe-----eCCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 99854 4566799999999999999997543 399999999999999999999999 999999999999
Q ss_pred eeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccC------CCCCCCcccchhhhHHHHHHHhCCCC
Q 004218 597 LLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL------GEKPSTAGDVYSFGVMLLEIFTGMSP 670 (767)
Q Consensus 597 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~el~tg~~p 670 (767)
+++.++.+||+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|+.|
T Consensus 232 l~~~~~~ikl~DfG~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~p 304 (365)
T 2y7j_A 232 LLDDNMQIRLSDFGFSCHLEPGE-------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304 (365)
T ss_dssp EECTTCCEEECCCTTCEECCTTC-------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred EECCCCCEEEEecCcccccCCCc-------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCC
Confidence 99999999999999997654321 123456899999999875 33578999999999999999999999
Q ss_pred CCCcccCCcchhhHh-hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 671 THESFAGEVSLVKWV-ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 671 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
|...... .....+ ...+...... .......+.+++.+||+.||++|||+.|++++
T Consensus 305 f~~~~~~--~~~~~i~~~~~~~~~~~--------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 305 FWHRRQI--LMLRMIMEGQYQFSSPE--------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SCCSSHH--HHHHHHHHTCCCCCHHH--------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCHH--HHHHHHHhCCCCCCCcc--------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 9653211 111111 1111100000 00001112337778999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=355.09 Aligned_cols=248 Identities=26% Similarity=0.349 Sum_probs=191.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++.++||||+++++++. ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 457999999999999999999976 58899999986542 334577899999999999999999999964 4566
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE---DMTAKVG 607 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~ 607 (767)
+++||||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEecCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence 7999999999999998876432 89999999999999999999999 9999999999999976 4559999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh-h
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV-E 686 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~ 686 (767)
|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... .....+ .
T Consensus 182 DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~ 251 (494)
T 3lij_A 182 DFGLSAVFENQK-------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEK 251 (494)
T ss_dssp CCTTCEECBTTB-------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred ECCCCeECCCCc-------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh
Confidence 999997654321 123456999999999876 46899999999999999999999999653221 111111 1
Q ss_pred hhcc--cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SNFP--KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+. ......+++ .+.+++.+||+.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~s~----------------------~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 252 GKYTFDSPEWKNVSE----------------------GAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp TCCCCCSGGGTTSCH----------------------HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCCCchhcccCCH----------------------HHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1111 111111111 12236778999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=339.29 Aligned_cols=204 Identities=25% Similarity=0.379 Sum_probs=164.7
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-----cchhhHHHHHHHHhcCCCCCceeEEeeeecCC
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-----GTWKSFFAECEALRNTRHRNLVKLITSCSSLD 524 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 524 (767)
....++|++.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+++++.++||||+++++++.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 82 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--- 82 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe---
Confidence 344678999999999999999999976 489999999864322 12356889999999999999999999964
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA 604 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~ 604 (767)
.....++||||+++ +|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 83 --~~~~~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 151 (346)
T 1ua2_A 83 --HKSNISLVFDFMET-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVL 151 (346)
T ss_dssp --CTTCCEEEEECCSE-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred --eCCceEEEEEcCCC-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCE
Confidence 44567999999986 8998887543 3488899999999999999999999 99999999999999999999
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
||+|||+++....... ......||+.|+|||++.+. .++.++||||+||++|+|++|.+||...
T Consensus 152 kl~Dfg~a~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 152 KLADFGLAKSFGSPNR------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp EECCCGGGSTTTSCCC------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEecccceeccCCcc------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 9999999986543211 12335689999999998764 5789999999999999999999998654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=341.42 Aligned_cols=258 Identities=14% Similarity=0.108 Sum_probs=198.2
Q ss_pred HHhcCCCCCCccccccceEEEEEE------eCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCC---CCCceeEEeeeec
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGY------LREGISVAVKVLDIESTGTWKSFFAECEALRNTR---HRNLVKLITSCSS 522 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~ 522 (767)
...++|++.+.||+|+||.||+|. ..+++.||||++... ...++.+|+++++.++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~- 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL- 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE-
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee-
Confidence 345789999999999999999994 345889999998643 3456778888888886 999999999964
Q ss_pred CCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--
Q 004218 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE-- 600 (767)
Q Consensus 523 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-- 600 (767)
..+..++||||+++|+|.+++...+.. ....+++..++.|+.|++.||+|||++ +|+||||||+||+++.
T Consensus 138 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 138 ----FQNGSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp ----CSSCEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGG
T ss_pred ----cCCCcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccc
Confidence 345569999999999999999753221 134599999999999999999999998 9999999999999998
Q ss_pred ---------CCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCC
Q 004218 601 ---------DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPT 671 (767)
Q Consensus 601 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 671 (767)
++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPK----GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCT----TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cCccccccccCCEEEeeCchhhhhhccCC----CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 89999999999975532211 12234456999999999999999999999999999999999999998
Q ss_pred CCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCC-CCHHHHHHHHHH
Q 004218 672 HESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGR-IDIREALRRLKN 750 (767)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-pt~~evl~~L~~ 750 (767)
............ .++.. .. .+. +.+++..|++.+|.+| |+++++.+.|++
T Consensus 286 ~~~~~~~~~~~~----~~~~~---~~------------------~~~----~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 286 VKNEGGECKPEG----LFRRL---PH------------------LDM----WNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp EEEETTEEEECS----CCTTC---SS------------------HHH----HHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ccCCCCceeech----hcccc---Cc------------------HHH----HHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 543322111100 00000 00 111 1125567999999998 578888888887
Q ss_pred HHHH
Q 004218 751 AQKI 754 (767)
Q Consensus 751 ~~~~ 754 (767)
....
T Consensus 337 ~l~~ 340 (365)
T 3e7e_A 337 VFQQ 340 (365)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=353.82 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=196.0
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
..++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|++++++++||||+++++++. ...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCC
Confidence 3467999999999999999999976 5899999998643 2345678899999999999999999999954 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEE
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD---EDMTAKV 606 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl 606 (767)
.+++||||+++|+|.+++..... +++.++..++.|++.||+|||++ +|+||||||+||+++ .++.+||
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 165 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI 165 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence 78999999999999998876442 99999999999999999999999 999999999999995 4567999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||....... .......
T Consensus 166 ~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~ 236 (486)
T 3mwu_A 166 IDFGLSTCFQQNT-------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVET 236 (486)
T ss_dssp CSCSCTTTBCCC-----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred EECCcCeECCCCC-------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh
Confidence 9999997653321 1234568999999999876 58999999999999999999999996532211 1111111
Q ss_pred hhcccc--hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SNFPKN--AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..++.. ....+++ . +.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~s~------------------~----~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 GKYAFDLPQWRTISD------------------D----AKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp TCCCSCSGGGGGSCH------------------H----HHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCCCcccCCCCH------------------H----HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111 1111111 1 2236778999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=337.46 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=198.0
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|.+.+.||+|+||.||+|.+.+ ++.||+|++.... ....+.+.+|+.+++.++||||+++++++. +.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence 4689999999999999999999764 8899999986542 234567889999999999999999999964 455
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence 7799999999999999987643 389999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|.++...... .......||..|+|||++.+..++.++||||||+++|+|++|+.||........ ........+
T Consensus 186 g~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~ 258 (335)
T 2owb_A 186 GLATKVEYDG------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNEY 258 (335)
T ss_dssp TTCEECCSTT------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCC
T ss_pred cCceecccCc------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHhcCCC
Confidence 9997653221 112345689999999999998899999999999999999999999965321110 000101000
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.....+++ .+.+++.+||+.||++|||++|++++
T Consensus 259 --~~~~~~~~----------------------~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 --SIPKHINP----------------------VAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CCCTTSCH----------------------HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCCccCCH----------------------HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111111 12236778999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=341.29 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=194.7
Q ss_pred hcCCCCCCccccccceEEEEEEe----CCCcEEEEEEeeccC----CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCC
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL----REGISVAVKVLDIES----TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLD 524 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 524 (767)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++.+ +||||+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 129 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--- 129 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe---
Confidence 36899999999999999999997 358999999985432 23446677899999999 6999999999854
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA 604 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~ 604 (767)
.....++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 130 --~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 198 (355)
T 1vzo_A 130 --TETKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV 198 (355)
T ss_dssp --ETTEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred --eCceEEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcE
Confidence 4456799999999999999997643 389999999999999999999999 99999999999999999999
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCC--CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc--c
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG--EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV--S 680 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~ 680 (767)
||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .
T Consensus 199 kl~DfG~a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 273 (355)
T 1vzo_A 199 VLTDFGLSKEFVADET-----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273 (355)
T ss_dssp EESCSSEEEECCGGGG-----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred EEeeCCCCeecccCCC-----CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH
Confidence 9999999976533211 11234569999999999885 3478999999999999999999999965332211 1
Q ss_pred hhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHHH
Q 004218 681 LVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRRL 748 (767)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L 748 (767)
+........+. ....+. ..+.+++.+||+.||++|| |++|++++.
T Consensus 274 ~~~~~~~~~~~-~~~~~~----------------------~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 274 ISRRILKSEPP-YPQEMS----------------------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHHHHCCCC-CCTTSC----------------------HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHHHhccCCC-CCcccC----------------------HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11111111010 111111 1122377789999999999 999998865
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=330.35 Aligned_cols=248 Identities=21% Similarity=0.307 Sum_probs=192.6
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 528 (767)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+..+..+ +||||+++++++. ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~ 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----ED 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ET
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cC
Confidence 4578999999999999999999976 6999999998754 233456788999999999 9999999999964 44
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-------
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED------- 601 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~------- 601 (767)
+..++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred CeEEEEEEecCCCcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence 5779999999999999999764321 23489999999999999999999999 99999999999999844
Q ss_pred ------------CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCC
Q 004218 602 ------------MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGM 668 (767)
Q Consensus 602 ------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~ 668 (767)
..+||+|||.+...... ....||+.|+|||++.+. .+++++||||+|+++|+|++|.
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~ 228 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSP----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCS----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC
T ss_pred cccccccccCCceEEEEcccccccccCCc----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC
Confidence 47999999999765322 223489999999998766 5668999999999999999998
Q ss_pred CCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 669 SPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 669 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+|+... ...........+ ..+..+++. +.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~----~~~~~~~~~~~~-~~~~~~~~~----------------------~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 229 PLPRNG----DQWHEIRQGRLP-RIPQVLSQE----------------------FTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp CCCSSS----HHHHHHHTTCCC-CCSSCCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCcch----hHHHHHHcCCCC-CCCcccCHH----------------------HHHHHHHHhCCCcccCCCHHHHhhC
Confidence 876332 111111111111 111112221 2226678999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=355.29 Aligned_cols=248 Identities=27% Similarity=0.389 Sum_probs=197.6
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++. ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 467999999999999999999976 58999999986542 345677899999999999999999999954 456
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEE
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKV 606 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl 606 (767)
..++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||++ +.++.+||
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence 7899999999999999987644 399999999999999999999999 99999999999999 46789999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh-
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV- 685 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~- 685 (767)
+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .....+
T Consensus 171 ~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~ 240 (484)
T 3nyv_A 171 IDFGLSTHFEASK-------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVE 240 (484)
T ss_dssp CCTTHHHHBCCCC-------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred EeeeeeEEccccc-------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH
Confidence 9999998653321 1234568999999999876 6899999999999999999999999653221 111111
Q ss_pred hhhccc--chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 ESNFPK--NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 ~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+.. .....+++ .+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~s~----------------------~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 241 KGKYTFELPQWKKVSE----------------------SAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HCCCCCCSGGGGGSCH----------------------HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCCCCCCcccccCCH----------------------HHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 111111 11111111 12236778999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=339.55 Aligned_cols=265 Identities=26% Similarity=0.387 Sum_probs=196.3
Q ss_pred CHHHHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecC
Q 004218 446 SYDELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSL 523 (767)
Q Consensus 446 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 523 (767)
++.++....++|++.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++...
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 33444556789999999999999999999975 58999999986443 3457788999999998 899999999997643
Q ss_pred Cc-ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 004218 524 DF-KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM 602 (767)
Q Consensus 524 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~ 602 (767)
.. ......++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCC
Confidence 21 12467899999999999999997643 23489999999999999999999999 999999999999999999
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhCCCCCCCcccC
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAG 677 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 677 (767)
.+||+|||++........ ......||+.|+|||++. +..++.++||||||+++|+|++|+.||......
T Consensus 167 ~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp CEEECCCTTTC-------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred CEEEeeCcCceecCcCcc------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 999999999976543211 123346899999999987 566899999999999999999999998653211
Q ss_pred CcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 678 EVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. ..........+......+++ .+.+++.+||+.||++|||++|++++
T Consensus 241 ~-~~~~~~~~~~~~~~~~~~~~----------------------~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 R-ALFLIPRNPAPRLKSKKWSK----------------------KFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp H-HHHHHHHSCCCCCSCSCSCH----------------------HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred H-HHHHhhcCccccCCccccCH----------------------HHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1 01111111111111111111 12236678999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.30 Aligned_cols=248 Identities=29% Similarity=0.416 Sum_probs=189.6
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+++++.++||||+++++++. ...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 468999999999999999999976 6999999998643 2334567889999999999999999999954 445
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence 6799999999999999997643 289999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|.+....... ......||+.|+|||.+.+..+ +.++||||+|+++|+|++|+.||...... .....+...
T Consensus 156 g~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~ 226 (276)
T 2h6d_A 156 GLSNMMSDGE-------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGG 226 (276)
T ss_dssp CGGGCCCC--------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC
T ss_pred ccccccCCCc-------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcC
Confidence 9997653321 1123458999999999987765 68999999999999999999999653211 111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. ..+..++. .+.+++.+||+.||++|||++|++++
T Consensus 227 ~~-~~~~~~~~----------------------~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 VF-YIPEYLNR----------------------SVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CC-CCCTTSCH----------------------HHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cc-cCchhcCH----------------------HHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 00111111 12236778999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.75 Aligned_cols=252 Identities=25% Similarity=0.313 Sum_probs=190.4
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--------CcchhhHHHHHHHHhcCCCCCceeEEeeeecC
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--------TGTWKSFFAECEALRNTRHRNLVKLITSCSSL 523 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 523 (767)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 3468999999999999999999976 48899999985432 1223468899999999999999999998643
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT 603 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~ 603 (767)
...++||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 87 -----~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 87 -----EDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp -----SSEEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSS
T ss_pred -----CceEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCC
Confidence 22699999999999999987543 389999999999999999999999 9999999999999987654
Q ss_pred ---eEEccccchhhhhhhcCCCccccccccccCCCCccCcccc---CCCCCCCcccchhhhHHHHHHHhCCCCCCCcccC
Q 004218 604 ---AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYG---LGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAG 677 (767)
Q Consensus 604 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 677 (767)
+||+|||.++..... .......||+.|+|||++ ....++.++||||+||++|+|++|+.||......
T Consensus 153 ~~~~kl~Dfg~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGET-------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp SCCEEECCCTTCEECCCC-------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred CCeEEEccCccceecccc-------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 999999999764321 112345689999999986 3567899999999999999999999999754332
Q ss_pred CcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 678 EVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
.. ....+.......... . ...+...+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~-~~~~~~~~~~~~~~~-----~--------------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 226 VS-LKDQITSGKYNFIPE-----V--------------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SC-HHHHHHHTCCCCCHH-----H--------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH-HHHHHHhCccccCch-----h--------------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 21 211111111000000 0 0001111223777899999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=343.25 Aligned_cols=207 Identities=23% Similarity=0.337 Sum_probs=166.7
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc----
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF---- 525 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 525 (767)
....++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999974 58999999986432 223479999999999999999999754321
Q ss_pred -----------------------------ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 004218 526 -----------------------------KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576 (767)
Q Consensus 526 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~ 576 (767)
....+.++||||+++ +|.+.+...... ...+++..+..++.|+++||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRS--GRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHH
Confidence 344568999999984 888877642211 244999999999999999999
Q ss_pred HHHhCCCCCeEeecCCCCCeeeC-CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccc
Q 004218 577 YLHNDCEVPIVHCDLKPGNILLD-EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDV 654 (767)
Q Consensus 577 ~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv 654 (767)
|||+. ||+||||||+||+++ .++.+||+|||.++...... ......||..|+|||++.+. .++.++||
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-------PSVAYICSRFYRAPELMLGATEYTPSIDL 225 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-------CCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-------CCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence 99999 999999999999997 68899999999998653321 11334689999999988765 48999999
Q ss_pred hhhhHHHHHHHhCCCCCCCc
Q 004218 655 YSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 655 ~slG~il~el~tg~~p~~~~ 674 (767)
||+||++|||++|+.||...
T Consensus 226 wslG~il~ell~g~~pf~~~ 245 (383)
T 3eb0_A 226 WSIGCVFGELILGKPLFSGE 245 (383)
T ss_dssp HHHHHHHHHHHHSSCSSCCS
T ss_pred hhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=342.73 Aligned_cols=282 Identities=23% Similarity=0.272 Sum_probs=200.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|++++++++||||+++++++....+......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999976 58999999986432 2334678899999999999999999999876555566788
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||++ |+|.+++.... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 90 ~lv~e~~~-~~L~~~~~~~~-------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQM-------LSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEECCCS-EEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccC-ccHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 99999997 59999987532 89999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCcc----ccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 612 ARSLLERIGNQSS----ISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 612 a~~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
++........... ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ ......
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~ 237 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFG 237 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHH
Confidence 9865433211110 011233568999999998654 6789999999999999999999999965432111 000000
Q ss_pred h-hccc---chhhhccHHHHHhhhcc----hhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 S-NFPK---NAQQVLDRELRQLMMSS----ESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~-~~~~---~~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. ..+. ................. ..........+...+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0000 00111111111111000 000000001112223347779999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=345.13 Aligned_cols=267 Identities=22% Similarity=0.274 Sum_probs=200.5
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+|+++++.++|++.+..+.++. ......+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEE
Confidence 468999999999999999999974 58999999886433 3356889999999998755544444432 3455679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL---DEDMTAKVGDF 609 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~Df 609 (767)
+||||+ +++|.+++.... ..+++.+++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+||
T Consensus 80 lvme~~-g~sL~~ll~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp EEEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEECC-CCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeC
Confidence 999999 889999997543 2399999999999999999999999 99999999999999 58899999999
Q ss_pred cchhhhhhhcCCCc-cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcc--hhhHhh
Q 004218 610 GLARSLLERIGNQS-SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS--LVKWVE 686 (767)
Q Consensus 610 g~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~ 686 (767)
|+++.+........ .........||..|+|||++.+..++.++|||||||++|||++|+.||......... +.....
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence 99987654322111 111223567999999999999999999999999999999999999999764332210 011100
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
....... ..+...+...+.+++..||+.||++||+++++++.|+.+...
T Consensus 231 ~~~~~~~-------------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 231 KKVATSI-------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHSCH-------------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccccH-------------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000 000001111223377799999999999999999999988653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=337.23 Aligned_cols=201 Identities=29% Similarity=0.425 Sum_probs=167.5
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCc--chhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTG--TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|.+.. ++.||+|++...... ..+.+.+|++++++++||||+++++++. ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCE
Confidence 4689999999999999999999764 899999998644332 2456789999999999999999999964 4566
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++++|.++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence 799999999999998876433 399999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
.++....... ......||..|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus 170 ~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 170 FARTLAAPGE------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp TC------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CceeecCCcc------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9976543211 12334589999999998775 6899999999999999999999999664
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=340.19 Aligned_cols=265 Identities=18% Similarity=0.308 Sum_probs=197.1
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcc-----------------hhhHHHHHHHHhcCCCCCceeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGT-----------------WKSFFAECEALRNTRHRNLVKL 516 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~ 516 (767)
.++|++.+.||+|+||.||+|.+ +++.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 79999999986432111 1788999999999999999999
Q ss_pred EeeeecCCcccceeeEEEEeecCCCChhhh------hcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEee
Q 004218 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDW------IHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHC 589 (767)
Q Consensus 517 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~ 589 (767)
++++. ..+..++||||+++|+|.++ +.... ...+++..++.++.|++.||+|||+ . +|+||
T Consensus 109 ~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~ 176 (348)
T 2pml_X 109 EGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHR 176 (348)
T ss_dssp SEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECC
T ss_pred EEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeec
Confidence 99964 34577999999999999999 44321 3459999999999999999999998 8 99999
Q ss_pred cCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCC-cccchhhhHHHHHHHhC
Q 004218 590 DLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPST-AGDVYSFGVMLLEIFTG 667 (767)
Q Consensus 590 Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slG~il~el~tg 667 (767)
||||+||+++.++.+||+|||.+...... ......||..|+|||++.+. .++. ++||||+|+++|+|++|
T Consensus 177 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 177 DVKPSNILMDKNGRVKLSDFGESEYMVDK--------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECBTT--------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred CCChHhEEEcCCCcEEEeccccccccccc--------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999765332 12345689999999999877 5665 99999999999999999
Q ss_pred CCCCCCcccCCcchhhHhhhh---cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 004218 668 MSPTHESFAGEVSLVKWVESN---FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREA 744 (767)
Q Consensus 668 ~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ev 744 (767)
+.||....... .....+... ++......... ... .........+...+.+++.+||+.||++|||+.|+
T Consensus 249 ~~pf~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~----~~~---~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~ 320 (348)
T 2pml_X 249 VVPFSLKISLV-ELFNNIRTKNIEYPLDRNHFLYP----LTN---KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320 (348)
T ss_dssp SCSSCCSSCSH-HHHHHHTSCCCCCCCSSSSSTTT----TCC-----------CCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCCCCcHH-HHHHHHhccCcCCccchhhhhcc----ccc---cccccchhhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 99997643321 111111111 11100000000 000 00000001111122337779999999999999999
Q ss_pred HHH
Q 004218 745 LRR 747 (767)
Q Consensus 745 l~~ 747 (767)
+++
T Consensus 321 l~h 323 (348)
T 2pml_X 321 LKH 323 (348)
T ss_dssp HTS
T ss_pred hcC
Confidence 874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=352.56 Aligned_cols=251 Identities=26% Similarity=0.343 Sum_probs=193.7
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCC-------------cchhhHHHHHHHHhcCCCCCceeEEe
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIEST-------------GTWKSFFAECEALRNTRHRNLVKLIT 518 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~ 518 (767)
..++|++.+.||+|+||.||+|.+.. ++.||+|++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999764 88999999864321 23467889999999999999999999
Q ss_pred eeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 519 SCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 519 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
++. +...+++||||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 114 ~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~ 179 (504)
T 3q5i_A 114 VFE-----DKKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL 179 (504)
T ss_dssp EEE-----CSSEEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred EEE-----cCCEEEEEEecCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEE
Confidence 964 55678999999999999999876442 99999999999999999999999 99999999999999
Q ss_pred CCCC---ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcc
Q 004218 599 DEDM---TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675 (767)
Q Consensus 599 ~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 675 (767)
+.++ .+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||....
T Consensus 180 ~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 180 ENKNSLLNIKIVDFGLSSFFSKDY-------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp SSTTCCSSEEECCCTTCEECCTTS-------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCCCccEEEEECCCCEEcCCCC-------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8775 69999999997654321 123456999999999987 468999999999999999999999996532
Q ss_pred cCCcchhhHhh-hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 676 AGEVSLVKWVE-SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 676 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. .....+. ..+..... . ...+...+.+++.+||+.||++|||++|++++
T Consensus 252 ~~--~~~~~i~~~~~~~~~~----------------~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 252 DQ--DIIKKVEKGKYYFDFN----------------D----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HH--HHHHHHHHCCCCCCHH----------------H----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH--HHHHHHHcCCCCCCcc----------------c----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 21 1111111 11110000 0 00011122337778999999999999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=354.50 Aligned_cols=345 Identities=18% Similarity=0.250 Sum_probs=287.3
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
++|++|+|++|+++ .+|...+..+++|++|+|++|++.+..|+.|.++++|++|+|++|.++ .+|.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCC-CCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCcCEEECCCCCcc-ccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 57999999999998 788767778999999999999999888999999999999999999999 67766 899999999
Q ss_pred ecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhcccc--CeEEccCCcc--cccCCccccCCC---
Q 004218 82 IGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVL--SKLYMGGNRF--YGKIPTSIGRLR--- 154 (767)
Q Consensus 82 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L--~~L~l~~n~i--~~~~~~~l~~l~--- 154 (767)
+++|++... ..+..+.++++|++|++++|++++. .+..+.. | ++|++++|++ ++..|..+..+.
T Consensus 128 Ls~N~l~~l-----~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~-L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~ 198 (562)
T 3a79_B 128 LSFNDFDVL-----PVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAH-LHLSCILLDLVSYHIKGGETESLQIPNTTV 198 (562)
T ss_dssp CCSSCCSBC-----CCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTT-SCEEEEEEEESSCCCCSSSCCEEEECCEEE
T ss_pred CCCCCcccc-----CchHhhcccCcccEEecCCCccccC---chhhhhh-ceeeEEEeecccccccccCcccccccCcce
Confidence 999999754 3456789999999999999999853 4445544 5 9999999988 666666655543
Q ss_pred ------------------------------------------------------------------------------CC
Q 004218 155 ------------------------------------------------------------------------------SL 156 (767)
Q Consensus 155 ------------------------------------------------------------------------------~L 156 (767)
+|
T Consensus 199 l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L 278 (562)
T 3a79_B 199 LHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278 (562)
T ss_dssp EEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSE
T ss_pred EEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccc
Confidence 67
Q ss_pred CEEECcCCcCcccCcccc-----CCC--------------------------CCCCEEEccCCccccccCcCcccCCCCc
Q 004218 157 TLLNLSYNSISGEILTEI-----GQL--------------------------QELQSLDLAGNQISGSIPNTLGNLKKLN 205 (767)
Q Consensus 157 ~~L~l~~n~i~~~~~~~~-----~~l--------------------------~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 205 (767)
++|++++|.+++.+|..+ ..+ .+|++|++++|.+.... ....+++|+
T Consensus 279 ~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~ 356 (562)
T 3a79_B 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFT 356 (562)
T ss_dssp EEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCC
T ss_pred cEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCce
Confidence 788888888887677655 333 34777777777765221 126889999
Q ss_pred eeeCCCCcCCCCCcccccCccccccccccCcccCCC--CChhhcccccccceeecccccCCCCCc-hhhcCCCceeEEEc
Q 004218 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN--IPKEILSLSSLTTIVNLSKNFLDGTLP-EEIGMLGNVVTIDL 282 (767)
Q Consensus 206 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~~~l~~l~~~l~l~~n~l~~~~~-~~~~~l~~L~~L~l 282 (767)
+|++++|++++..|..+..+++|+.|++++|++++. +|..+..+++|. .+++++|.+++.+| ..+..+++|+.|++
T Consensus 357 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~~l~~L~~L~l 435 (562)
T 3a79_B 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLE-TLDVSLNSLNSHAYDRTCAWAESILVLNL 435 (562)
T ss_dssp EEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCC-EEECTTSCCBSCCSSCCCCCCTTCCEEEC
T ss_pred EEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCC-EEECCCCcCCCccChhhhcCcccCCEEEC
Confidence 999999999988999999999999999999999953 346788999994 45999999998444 56889999999999
Q ss_pred cCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCcc-ccccccCceEeccCCcCcC
Q 004218 283 SANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD-LQNLRALRSLNLTFNNLEG 361 (767)
Q Consensus 283 s~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~~ 361 (767)
++|.+++..|..+. ++|+.|++++|+++ .+|..+..+++|+.|+|++|++++ +|.. +..+++|+.|++++|++++
T Consensus 436 ~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c 511 (562)
T 3a79_B 436 SSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDC 511 (562)
T ss_dssp CSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCC
T ss_pred CCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCC
Confidence 99999877766554 79999999999999 677767799999999999999994 5555 8999999999999999998
Q ss_pred cCCCC
Q 004218 362 VVPRE 366 (767)
Q Consensus 362 ~~~~~ 366 (767)
..+..
T Consensus 512 ~c~~~ 516 (562)
T 3a79_B 512 TCPGI 516 (562)
T ss_dssp CHHHH
T ss_pred CcchH
Confidence 76543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.06 Aligned_cols=261 Identities=26% Similarity=0.341 Sum_probs=190.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC--CCc--EEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR--EGI--SVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|++.+.||+|+||.||+|.+. +++ .||+|++... .....+.+.+|++++++++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 467999999999999999999853 233 6899988644 233457789999999999999999999996532
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
..++||||+++++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 94 ---~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl 162 (291)
T 1u46_A 94 ---PMKMVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI 162 (291)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred ---CceeeEecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEE
Confidence 2689999999999999997643 2389999999999999999999999 9999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHh
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~ 685 (767)
+|||.+........ .........+|..|+|||++.+..++.++||||+|+++|+|++ |+.||...... .....+
T Consensus 163 ~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~ 237 (291)
T 1u46_A 163 GDFGLMRALPQNDD---HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKI 237 (291)
T ss_dssp CCCTTCEECCC-CC---EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHH
T ss_pred cccccccccccccc---chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHH
Confidence 99999976543211 1111233457888999999988888999999999999999999 99999653221 111111
Q ss_pred h-hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 686 E-SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 686 ~-~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
. ..........+++. +.+++.+||+.||++|||+.|+++.|+++....
T Consensus 238 ~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 238 DKEGERLPRPEDCPQD----------------------IYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp HTSCCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HccCCCCCCCcCcCHH----------------------HHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 1 11111111111111 222677899999999999999999999876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=331.21 Aligned_cols=255 Identities=20% Similarity=0.253 Sum_probs=182.1
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc-c-hhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG-T-WKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... . .+.+.++...++.++||||+++++++. ..+.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccCC
Confidence 468999999999999999999974 5899999998654222 2 233444555678889999999999964 4456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++ +|.+++...... ...+++..++.++.|++.||+|||++ .+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred EEEEEehhcc-chHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecC
Confidence 7999999975 888887643211 23499999999999999999999984 289999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCcccc----CCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYG----LGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
.++....... .....||+.|+|||++ .+..++.++||||+|+++|+|++|+.||...............
T Consensus 156 ~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 228 (290)
T 3fme_A 156 ISGYLVDDVA-------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228 (290)
T ss_dssp ---------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH
T ss_pred Cccccccccc-------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc
Confidence 9986543311 1234589999999995 5667899999999999999999999999653322222222222
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+......+++. +.+++.+||+.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~----------------------~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 229 EPSPQLPADKFSAE----------------------FVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp SCCCCCCTTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCcccccCCHH----------------------HHHHHHHHhhcChhhCcCHHHHHhC
Confidence 22222111112221 2226678999999999999999884
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=362.45 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=197.9
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcc
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 526 (767)
...++|++.+.||+|+||.||+|++. +++.||||++... .....+.+..|.+++..+ +||+|++++++ +.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~ 412 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQ 412 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CB
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EE
Confidence 34578999999999999999999976 4889999999643 334556788999999988 79999999998 45
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl 606 (767)
+.+.+|+||||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL 483 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI 483 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEE
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEE
Confidence 56678999999999999999986543 99999999999999999999999 9999999999999999999999
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+.
T Consensus 484 ~DFGla~~~~~~------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~~~~i~ 555 (674)
T 3pfq_A 484 ADFGMCKENIWD------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIM 555 (674)
T ss_dssp CCCTTCEECCCT------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred eecceeeccccC------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HHHHHHH
Confidence 999999753221 11234567999999999999999999999999999999999999999653221 1111111
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCH-----HHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDI-----REALRR 747 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~ 747 (767)
.... ..+..+++. +.+++.+||+.||++||++ +|++++
T Consensus 556 ~~~~-~~p~~~s~~----------------------~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 556 EHNV-AYPKSMSKE----------------------AVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp SSCC-CCCTTSCHH----------------------HHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred hCCC-CCCccCCHH----------------------HHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1000 011111111 2236678999999999998 666653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=355.20 Aligned_cols=346 Identities=21% Similarity=0.218 Sum_probs=238.7
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcc-cCCccCCCCCCCcE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEG-TVPPGLGNLPFLKM 79 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~ 79 (767)
|++|++|+|++|+++ .++...+..+++|++|++++|.+.+..|..|+++++|++|+|++|.+++ ..|..++.+++|++
T Consensus 49 l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 127 (549)
T 2z81_A 49 CANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127 (549)
T ss_dssp CTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCE
T ss_pred CCcccEEECCCCCcC-ccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccE
Confidence 578999999999999 5665556679999999999999997777789999999999999999986 35678999999999
Q ss_pred EeecCccccCCCCCCccc-cccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCE
Q 004218 80 YNIGFNKIVGSGDEGLSF-ITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTL 158 (767)
Q Consensus 80 L~l~~n~l~~~~~~~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~ 158 (767)
|++++|++.+ .+ ...+.++++|++|++++|++++..|..+..+++ |++|+++.|.+.......+..+++|++
T Consensus 128 L~L~~n~~~~------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~-L~~L~l~~n~~~~~~~~~~~~l~~L~~ 200 (549)
T 2z81_A 128 LRIGNVETFS------EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD-IHHLTLHLSESAFLLEIFADILSSVRY 200 (549)
T ss_dssp EEEEESSSCC------EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSE-EEEEEEECSBSTTHHHHHHHSTTTBSE
T ss_pred EECCCCcccc------ccCHhhhhcccccCeeeccCCcccccChhhhhcccc-CceEecccCcccccchhhHhhcccccE
Confidence 9999998432 22 246788999999999999999888887766544 444444444333111111122333333
Q ss_pred EECcCCcCcc----------------------------------------------------------------------
Q 004218 159 LNLSYNSISG---------------------------------------------------------------------- 168 (767)
Q Consensus 159 L~l~~n~i~~---------------------------------------------------------------------- 168 (767)
|++++|.+++
T Consensus 201 L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l 280 (549)
T 2z81_A 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSEL 280 (549)
T ss_dssp EEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCC
T ss_pred EEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhh
Confidence 3333333322
Q ss_pred -------------------------------------------cCcccc-CCCCCCCEEEccCCccccccC---cCcccC
Q 004218 169 -------------------------------------------EILTEI-GQLQELQSLDLAGNQISGSIP---NTLGNL 201 (767)
Q Consensus 169 -------------------------------------------~~~~~~-~~l~~L~~L~L~~n~i~~~~~---~~~~~l 201 (767)
.+|..+ ..+++|++|++++|++.+..| ..+..+
T Consensus 281 ~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l 360 (549)
T 2z81_A 281 GKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360 (549)
T ss_dssp TTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSS
T ss_pred cccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhcc
Confidence 122222 245556666666666554332 224555
Q ss_pred CCCceeeCCCCcCCCCCc--ccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeE
Q 004218 202 KKLNQIDLSGNELASEIP--TSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVT 279 (767)
Q Consensus 202 ~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~ 279 (767)
++|++|+|++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++| +.+++++|.++.. |..+ .++|+.
T Consensus 361 ~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L-~~L~Ls~N~l~~l-~~~~--~~~L~~ 435 (549)
T 2z81_A 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM-RFLNLSSTGIRVV-KTCI--PQTLEV 435 (549)
T ss_dssp TTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTC-CEEECTTSCCSCC-CTTS--CTTCSE
T ss_pred ccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccc-cEEECCCCCcccc-cchh--cCCceE
Confidence 666666666666654321 33555666666666666665 455555555555 3336666666532 2222 245666
Q ss_pred EEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcC
Q 004218 280 IDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359 (767)
Q Consensus 280 L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 359 (767)
|++++|++++. +..+++|+.|++++|+++ .+|. ...+++|+.|+|++|++++..|..+..+++|+.|++++|++
T Consensus 436 L~Ls~N~l~~~----~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 509 (549)
T 2z81_A 436 LDVSNNNLDSF----SLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509 (549)
T ss_dssp EECCSSCCSCC----CCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCB
T ss_pred EECCCCChhhh----cccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCc
Confidence 66666666643 257899999999999999 5665 56899999999999999998888899999999999999999
Q ss_pred cCcCCC
Q 004218 360 EGVVPR 365 (767)
Q Consensus 360 ~~~~~~ 365 (767)
++..|.
T Consensus 510 ~~~~~~ 515 (549)
T 2z81_A 510 DCSCPR 515 (549)
T ss_dssp CCCHHH
T ss_pred cCCCcc
Confidence 987764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=337.01 Aligned_cols=208 Identities=28% Similarity=0.415 Sum_probs=174.9
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC--CCcEEEEEEeeccC--CcchhhHHHHHHHHhcC---CCCCceeEEeeeecCC
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR--EGISVAVKVLDIES--TGTWKSFFAECEALRNT---RHRNLVKLITSCSSLD 524 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~ 524 (767)
.+.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 35688999999999999999999973 58899999986442 22345677888877766 8999999999976433
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA 604 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~ 604 (767)
.......++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCE
Confidence 345678899999998 59999997654 23489999999999999999999999 99999999999999999999
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
||+|||.++...... ......||..|+|||++.+..++.++||||+|+++|+|++|+.||...
T Consensus 160 kl~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 160 KLADFGLARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp EECSCCSCCCCCGGG-------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEecCcccccccCCC-------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999997653221 123456899999999999999999999999999999999999999754
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=339.39 Aligned_cols=345 Identities=28% Similarity=0.377 Sum_probs=297.6
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
++|+.|++++|.+. .+|. +..+++|++|++++|.+.+. +. +.++++|++|++++|.+++..+ ++.+++|++|+
T Consensus 46 ~~l~~L~l~~~~i~-~l~~--~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 46 DQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HTCCEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred ccccEEecCCCCCc-cCcc--hhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 57899999999998 7885 34699999999999999954 44 9999999999999999985444 99999999999
Q ss_pred ecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEEC
Q 004218 82 IGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNL 161 (767)
Q Consensus 82 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l 161 (767)
+++|++... ..+.++++|++|++++|.+++ ++ .+..+++ |++|+++ |.+.+. ..+.++++|++|++
T Consensus 119 L~~n~l~~~--------~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~-L~~L~l~-~~~~~~--~~~~~l~~L~~L~l 184 (466)
T 1o6v_A 119 LFNNQITDI--------DPLKNLTNLNRLELSSNTISD-IS-ALSGLTS-LQQLSFG-NQVTDL--KPLANLTTLERLDI 184 (466)
T ss_dssp CCSSCCCCC--------GGGTTCTTCSEEEEEEEEECC-CG-GGTTCTT-CSEEEEE-ESCCCC--GGGTTCTTCCEEEC
T ss_pred CCCCCCCCC--------hHHcCCCCCCEEECCCCccCC-Ch-hhccCCc-ccEeecC-CcccCc--hhhccCCCCCEEEC
Confidence 999998743 238899999999999999984 44 5888888 9999997 555533 23899999999999
Q ss_pred cCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCC
Q 004218 162 SYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN 241 (767)
Q Consensus 162 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 241 (767)
++|.+++. ..+..+++|++|++++|.+.+..| ++.+++|++|++++|++++. ..+..+++|+.|++++|.+.+.
T Consensus 185 ~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~ 258 (466)
T 1o6v_A 185 SSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNL 258 (466)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred cCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccc
Confidence 99999863 458899999999999999996655 78899999999999999854 4688999999999999999965
Q ss_pred CChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhc
Q 004218 242 IPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAE 321 (767)
Q Consensus 242 ~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 321 (767)
.+ +..+++|. .+++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..| +..
T Consensus 259 ~~--~~~l~~L~-~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~ 329 (466)
T 1o6v_A 259 AP--LSGLTKLT-ELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS 329 (466)
T ss_dssp GG--GTTCTTCS-EEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGG
T ss_pred hh--hhcCCCCC-EEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hcc
Confidence 54 88888884 45999999997655 8899999999999999997654 8899999999999999997765 789
Q ss_pred cCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCccccccccccccCCcCccc
Q 004218 322 LKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 322 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c~ 385 (767)
+++|+.|++++|++++. ..+..+++|+.|++++|++++.+| ...++.+..+.+.+|++.+.
T Consensus 330 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 330 LTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEECC
T ss_pred CccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccCC
Confidence 99999999999999865 578899999999999999999887 56678889999999988764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=347.11 Aligned_cols=258 Identities=15% Similarity=0.153 Sum_probs=187.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHH---HHhcCCCCCceeEE-------ee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECE---ALRNTRHRNLVKLI-------TS 519 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~niv~~~-------~~ 519 (767)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|++ ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467888999999999999999964 5999999999643 3345677889994 55556899999998 44
Q ss_pred eecCCc-------ccce-----eeEEEEeecCCCChhhhhcccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 004218 520 CSSLDF-------KNME-----FLALVYEFLGNGSLGDWIHGERKN-EHGNGLNFLERLNIAIDIASALDYLHNDCEVPI 586 (767)
Q Consensus 520 ~~~~~~-------~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 586 (767)
+...+. .+++ ..++||||+ +|+|.+++...... .....+++..++.|+.|++.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 322110 0111 378999999 57999999864321 1112345688889999999999999999 99
Q ss_pred EeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-----------CCCCcccch
Q 004218 587 VHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-----------KPSTAGDVY 655 (767)
Q Consensus 587 vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~ 655 (767)
+||||||+||+++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---------cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 9999999999999999999999999975322 1234457 999999999877 789999999
Q ss_pred hhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCC
Q 004218 656 SFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESP 735 (767)
Q Consensus 656 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 735 (767)
||||++|||++|+.||........ ........ ..+++. +.+++.+||+.||
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~--~~~~~~~~-----~~~~~~----------------------~~~li~~~L~~dp 348 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGG--SEWIFRSC-----KNIPQP----------------------VRALLEGFLRYPK 348 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CC--SGGGGSSC-----CCCCHH----------------------HHHHHHHHTCSSG
T ss_pred HHHHHHHHHHHCCCCCcccccccc--hhhhhhhc-----cCCCHH----------------------HHHHHHHHcCCCc
Confidence 999999999999999965432211 01110000 011111 2226678999999
Q ss_pred CCCCCHHHHHH--HHHHHHHH
Q 004218 736 GGRIDIREALR--RLKNAQKI 754 (767)
Q Consensus 736 ~~Rpt~~evl~--~L~~~~~~ 754 (767)
++|||+.|+++ .++.+...
T Consensus 349 ~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 349 EDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp GGCCCHHHHHTSHHHHHHHHH
T ss_pred hhCCCHHHHhhChHHHHHHHH
Confidence 99999999997 44554443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.13 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=192.5
Q ss_pred HHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCC--cchhhHHHHHHHHhcCC--CCCceeEEeeeecCC
Q 004218 449 ELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIEST--GTWKSFFAECEALRNTR--HRNLVKLITSCSSLD 524 (767)
Q Consensus 449 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 524 (767)
.+....++|++.+.||+|+||.||+|.+.+++.||||++..... ...+.+.+|++++++++ ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--- 98 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--- 98 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE---
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee---
Confidence 33445678999999999999999999998899999999965432 34567889999999996 599999999964
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA 604 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~ 604 (767)
.....++||| +.+++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||++++ +.+
T Consensus 99 --~~~~~~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~ 165 (313)
T 3cek_A 99 --TDQYIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GML 165 (313)
T ss_dssp --CSSEEEEEEC-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEE
T ss_pred --cCCEEEEEEe-cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeE
Confidence 4456799999 56789999997643 389999999999999999999999 9999999999999964 899
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCC-----------CCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-----------EKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
||+|||.++........ .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..
T Consensus 166 kL~Dfg~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 166 KLIDFGIANQMQPDTTS----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp EECCCSSSCC------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEeeccccccccCcccc----ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 99999999865432211 11233468999999999875 4678899999999999999999999965
Q ss_pred cccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 674 SFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
........................++. +.+++.+||+.||++|||++|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 242 IINQISKLHAIIDPNHEIEFPDIPEKD----------------------LQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CCSHHHHHHHHHCTTSCCCCCCCSCHH----------------------HHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHHHHHHHhcccccCCcccchHH----------------------HHHHHHHHccCCcccCcCHHHHhcCc
Confidence 332211111111111111111111111 22266789999999999999999763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=326.63 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=193.4
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC----CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES----TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EE 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C-
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CC
Confidence 3578999999999999999999975 58899999986432 3445778999999999999999999998642 34
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
....++||||++++ +.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVP----EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHST----TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred CCeEEEEehhccCC-HHHHHHhCc----ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEee
Confidence 45779999999876 777776543 23499999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCC--CCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP--STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV 685 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 685 (767)
|||.+......... .......||..|+|||++.+... +.++||||+|+++|+|++|+.||...... .....+
T Consensus 152 dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i 225 (305)
T 2wtk_C 152 ALGVAEALHPFAAD----DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFENI 225 (305)
T ss_dssp CCTTCEECCTTCSS----CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH
T ss_pred ccccccccCccccc----cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHH
Confidence 99999765332111 11234568999999999876543 77999999999999999999999653211 111111
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..... .....+.+ .+.+++.+||+.||++|||++|++++
T Consensus 226 ~~~~~-~~~~~~~~----------------------~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 226 GKGSY-AIPGDCGP----------------------PLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHCCC-CCCSSSCH----------------------HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hcCCC-CCCCccCH----------------------HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11000 00111111 12236778999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=336.81 Aligned_cols=270 Identities=24% Similarity=0.336 Sum_probs=194.5
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
....++|++.+.||+|+||.||+|.+.+ .||+|++... .....+.+.+|+.++++++||||+++++++. ..
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 101 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-----SP 101 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-----CS
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cC
Confidence 3445789999999999999999999864 4999998644 2334567889999999999999999999965 34
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++ ++.+||+|
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~D 172 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITD 172 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECC
T ss_pred CceEEEeecccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEee
Confidence 55799999999999999997643 3489999999999999999999999 999999999999998 67999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCC---------CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG---------EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV 679 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 679 (767)
||+++........ ..........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 173 fg~~~~~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~- 250 (319)
T 2y4i_B 173 FGLFSISGVLQAG-RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA- 250 (319)
T ss_dssp CSCCC-----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-
T ss_pred cCCcccccccccc-ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 9998765322111 11112234458999999998864 357889999999999999999999996532211
Q ss_pred chhhHhhhh-cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhhc
Q 004218 680 SLVKWVESN-FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKR 758 (767)
Q Consensus 680 ~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 758 (767)
....+... .+......++.. +.+++.+||+.||++|||+.|+++.|+.+.+.....
T Consensus 251 -~~~~~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 251 -IIWQMGTGMKPNLSQIGMGKE----------------------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp -HHHHHHTTCCCCCCCSSCCTT----------------------HHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred -HHHHhccCCCCCCCcCCCCHH----------------------HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 11111111 111000011111 122677899999999999999999999988766554
Q ss_pred CCC
Q 004218 759 RQP 761 (767)
Q Consensus 759 ~~~ 761 (767)
..|
T Consensus 308 ~~~ 310 (319)
T 2y4i_B 308 SHP 310 (319)
T ss_dssp ---
T ss_pred CCC
Confidence 443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=341.74 Aligned_cols=252 Identities=12% Similarity=0.057 Sum_probs=176.1
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHH---HHHhcCCCCCceeEEe-------e
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAEC---EALRNTRHRNLVKLIT-------S 519 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~~~~-------~ 519 (767)
...|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+ +.++. +||||++++. +
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 345889999999999999999976 589999999976533 2345667774 45555 7999888553 2
Q ss_pred eecCCc------------ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhC
Q 004218 520 CSSLDF------------KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER------LNIAIDIASALDYLHND 581 (767)
Q Consensus 520 ~~~~~~------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~ 581 (767)
+..... .....+++||||++ |+|.+++..... .+++..+ ..++.|++.||+|||++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 221110 01145899999998 799999986532 1444555 67889999999999999
Q ss_pred CCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC--CCCCCcccchhhhH
Q 004218 582 CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG--EKPSTAGDVYSFGV 659 (767)
Q Consensus 582 ~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~ 659 (767)
+|+||||||+||+++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||+||
T Consensus 214 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~ 281 (371)
T 3q60_A 214 ---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---------GPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281 (371)
T ss_dssp ---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE---------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred ---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC---------ccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence 9999999999999999999999999999865321 113446799999999987 67899999999999
Q ss_pred HHHHHHhCCCCCCCcccCCcchhhHh------hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCC
Q 004218 660 MLLEIFTGMSPTHESFAGEVSLVKWV------ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTE 733 (767)
Q Consensus 660 il~el~tg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 733 (767)
++|||++|+.||.............. ...+.......+++. +.+++.+||+.
T Consensus 282 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~li~~~L~~ 339 (371)
T 3q60_A 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF----------------------VKTLIGRFLNF 339 (371)
T ss_dssp HHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHH----------------------HHHHHHHHTCS
T ss_pred HHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHH----------------------HHHHHHHHcCC
Confidence 99999999999977643321111000 000000000111211 22266789999
Q ss_pred CCCCCCCHHHHHH
Q 004218 734 SPGGRIDIREALR 746 (767)
Q Consensus 734 dP~~Rpt~~evl~ 746 (767)
||++|||+.|+++
T Consensus 340 dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 340 DRRRRLLPLEAME 352 (371)
T ss_dssp STTTCCCHHHHTT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=344.69 Aligned_cols=198 Identities=29% Similarity=0.401 Sum_probs=168.1
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcC------CCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNT------RHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~ 526 (767)
..+|++.+.||+|+||.||+|.+.. ++.||||++... ....+.+.+|+++++.+ .|+||+++++++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~----- 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT----- 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-----
Confidence 4679999999999999999999764 899999998642 22345677888888776 5789999999854
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--e
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT--A 604 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~--~ 604 (767)
....+++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNK----FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred cCCeEEEEEeccC-CCHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence 4467799999996 59999987654 23489999999999999999999999 9999999999999999887 9
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 242 kL~DFG~a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR---------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EECCCTTCEETTCC---------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeecccceecCCc---------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999654221 12346899999999999999999999999999999999999999664
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=339.77 Aligned_cols=204 Identities=27% Similarity=0.317 Sum_probs=165.2
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-ccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF-KNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 532 (767)
..+|++.+.||+|+||.||+|++..+..||+|++.... ....+|+++++.++||||+++++++..... .+..+++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 45799999999999999999998877779999885332 223379999999999999999999755432 4455688
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEccccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD-EDMTAKVGDFGL 611 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~ 611 (767)
+||||++++ +.+.+..... ....+++..+..++.|+++||+|||++ +|+||||||+||+++ .++.+||+|||+
T Consensus 115 lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeeccCcc-HHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 999999874 4443332111 123499999999999999999999999 999999999999999 799999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 189 a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 189 AKILIAGEP-------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp CEECCTTCC-------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccCCCC-------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 976533211 1234689999999998765 5899999999999999999999999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=342.91 Aligned_cols=208 Identities=25% Similarity=0.345 Sum_probs=156.7
Q ss_pred cCCCC-CCccccccceEEEEEEeC---CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSH-ENLIGSGSFGSVYKGYLR---EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
+.|++ .++||+|+||.||+|+++ +++.||||++... .....+.+|++++++++||||+++++++.. ..+..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence 44665 558999999999999965 4789999998643 334578899999999999999999999753 34567
Q ss_pred eEEEEeecCCCChhhhhcccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKN---EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL----DEDMT 603 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~ 603 (767)
+++||||+++ +|.+++...+.. .....+++..++.++.||+.||+|||++ +|+||||||+||++ +.++.
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 8999999975 888887643211 1123499999999999999999999999 99999999999999 67789
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+||+|||+++........ ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EEECCTTCCC-------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEEECCCceecCCCCcc---cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999999876432111 1122345789999999998874 5899999999999999999999999654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=325.76 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=195.1
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC---------cchhhHHHHHHHHhcCC-CCCceeEEeee
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---------GTWKSFFAECEALRNTR-HRNLVKLITSC 520 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~ 520 (767)
...++|++.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 44678999999999999999999976 589999999965431 12356789999999995 99999999995
Q ss_pred ecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC
Q 004218 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE 600 (767)
Q Consensus 521 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~ 600 (767)
. .....++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 94 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~ 159 (298)
T 1phk_A 94 E-----TNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDD 159 (298)
T ss_dssp E-----CSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred c-----cCCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcC
Confidence 3 4567899999999999999997643 389999999999999999999999 9999999999999999
Q ss_pred CCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccC------CCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 601 DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL------GEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 601 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
++.+||+|||.+....... ......|++.|+|||++. ...++.++||||+|+++|+|++|+.||...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 160 DMNIKLTDFGFSCQLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp TCCEEECCCTTCEECCTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcEEEecccchhhcCCCc-------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 9999999999997653321 123346899999999874 456889999999999999999999998653
Q ss_pred ccCCcchhhHh-hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 675 FAGEVSLVKWV-ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 675 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
... .....+ ...+..... ......+ .+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~--~~~~~~~~~~~~~~~~----------------~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 233 KQM--LMLRMIMSGNYQFGSP----------------EWDDYSD----TVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SHH--HHHHHHHHTCCCCCTT----------------TGGGSCH----HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cHH--HHHHHHhcCCcccCcc----------------cccccCH----HHHHHHHHHccCCcccCCCHHHHHh
Confidence 211 111111 111110000 0001111 1223677899999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=336.17 Aligned_cols=272 Identities=22% Similarity=0.282 Sum_probs=193.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-ccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDF-KNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 529 (767)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++..... ....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999976 589999999965432 235678899999999999999999999754331 1222
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++||||++ ++|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred eEEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence 4599999997 589888732 289999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|.++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ +.......
T Consensus 189 g~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~ 258 (371)
T 4exu_A 189 GLARHADAE---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVT 258 (371)
T ss_dssp TCC-----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred CcccccccC---------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHh
Confidence 999765332 133468999999999887 6789999999999999999999999965322111 11111100
Q ss_pred -cc-cch-hhhccHHHHHhh----hcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 -FP-KNA-QQVLDRELRQLM----MSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 -~~-~~~-~~~~~~~l~~~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+ ... ....+....... ........+........+.+++.+||+.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 01 000 011111111110 000000011111112233447779999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.67 Aligned_cols=272 Identities=24% Similarity=0.362 Sum_probs=180.8
Q ss_pred HHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
...++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++. ..+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 86 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKD 86 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SSS
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecC
Confidence 44678999999999999999999964 58899999986442 334567889999999999999999999964 344
Q ss_pred eeEEEEeecCCCChhhhhcccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKN--EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
..++||||+++++|.+++...... .....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence 579999999999999998742111 1134489999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
|||.+......... ..........||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||........ ......
T Consensus 164 dfg~~~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~ 241 (303)
T 2vwi_A 164 DFGVSAFLATGGDI-TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLTLQ 241 (303)
T ss_dssp CCHHHHHCC----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHT
T ss_pred eccchheeccCCCc-cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHHHhc
Confidence 99999865432111 11111234568999999998865 5689999999999999999999999976432211 111111
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. +......... ...... ..+ .+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~-~~~~~~~~~~--~~~~~~-------~~~----~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 ND-PPSLETGVQD--KEMLKK-------YGK----SFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SS-CCCTTC-------CCCCC-------CCH----HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cC-CCcccccccc--chhhhh-------hhH----HHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11 1100000000 000000 011 12237778999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=340.61 Aligned_cols=204 Identities=27% Similarity=0.353 Sum_probs=165.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-ccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF-KNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~ 531 (767)
..+|++.+.||+|+||.||+|++. +|+.||||++.... ....+|+++++.++||||+++++++..... .+..++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346899999999999999999986 48999999986432 234479999999999999999998754322 334567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEcccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED-MTAKVGDFG 610 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg 610 (767)
++||||+++ ++.+.+..... ....+++..+..++.|+++||+|||++ +|+||||||+||+++.+ +.+||+|||
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred Eeehhcccc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 899999976 77766653211 123499999999999999999999999 99999999999999955 678999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+++...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 203 ~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 203 SAKQLVRGE-------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp TCEECCTTC-------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhhcccCC-------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 998653321 11234689999999998765 6899999999999999999999999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=326.38 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=189.2
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-------
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLD------- 524 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 524 (767)
..++|++.+.||+|+||.||+|.+. +++.||||++... ....+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3567999999999999999999975 6899999998642 334567889999999999999999999875421
Q ss_pred -cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 004218 525 -FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT 603 (767)
Q Consensus 525 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~ 603 (767)
.......++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 134578899999999999999997543 2378899999999999999999999 9999999999999999999
Q ss_pred eEEccccchhhhhhhcCC--------CccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 604 AKVGDFGLARSLLERIGN--------QSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+||+|||.++........ ...........||..|+|||++.+. .++.++||||+|+++|+|++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 999999999765432110 0001122345689999999998764 68999999999999999998 55321
Q ss_pred ccCCcchhhHhhh---hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 675 FAGEVSLVKWVES---NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 675 ~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... .....+.. .++........ ..+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 MERV-NILKKLRSVSIEFPPDFDDNKM----------------------KVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHH-HHHHHHHSTTCCCCTTCCTTTS----------------------HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhHH-HHHHhccccccccCccccccch----------------------HHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1110 11111110 11111111111 112237778999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.66 Aligned_cols=213 Identities=25% Similarity=0.341 Sum_probs=162.2
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-
Q 004218 448 DELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF- 525 (767)
Q Consensus 448 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~- 525 (767)
.+.....++|++.+.||+|+||.||+|.+. +++.||||++... ......+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677899999999999999999999975 5899999988543 3334567788888899999999999999854322
Q ss_pred -ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeecCCCCCeeeCC-C
Q 004218 526 -KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH--NDCEVPIVHCDLKPGNILLDE-D 601 (767)
Q Consensus 526 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~Dlkp~NIl~~~-~ 601 (767)
....+.++||||+++ +|.+.+..... ....+++..+..++.|++.||.||| +. +|+||||||+||+++. +
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 334468899999986 55554432111 1234899999999999999999999 77 9999999999999996 8
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCC-CCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+.+||+|||+++...... ......||+.|+|||++.+.. ++.++||||+||++|+|++|+.||...
T Consensus 169 ~~~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSE-------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp TEEEECCCTTCBCCCTTS-------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcEEEeeCCCceecCCCC-------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 999999999998654321 113346899999999986654 899999999999999999999999764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=356.65 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=199.2
Q ss_pred HhcCCCCCCccccccceEEEEEEeCC----CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
..++|++.+.||+|+||.||+|.+.. +..||+|.+..... ...+.+.+|+.++++++||||+++++++..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 44678888999999999999999743 56799999864332 334678999999999999999999998632
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEE
Confidence 34689999999999999997543 2389999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 686 (767)
|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .....+.
T Consensus 534 DFG~a~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~ 606 (656)
T 2j0j_A 534 DFGLSRYMEDSTY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIE 606 (656)
T ss_dssp CCCCCCSCCC---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH
T ss_pred ecCCCeecCCCcc-----eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHH
Confidence 9999986533211 11123446789999999988899999999999999999997 99998653221 1111111
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
.......+..+++. +.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 607 ~~~~~~~~~~~~~~----------------------l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 607 NGERLPMPPNCPPT----------------------LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCccccHH----------------------HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11111111111111 22367789999999999999999999998754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.06 Aligned_cols=253 Identities=27% Similarity=0.346 Sum_probs=196.1
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
....++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++. .
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 92 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----D 92 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----C
Confidence 445678999999999999999999976 5899999998654 2345678899999999999999999999964 4
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC---Cce
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED---MTA 604 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~ 604 (767)
....++||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.+ +.+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~ 163 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDI 163 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCeEEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccE
Confidence 556799999999999999887543 289999999999999999999999 99999999999999754 479
Q ss_pred EEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhH
Q 004218 605 KVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 605 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 684 (767)
||+|||.+....... ......||+.|+|||.+.+ .++.++||||+|+++|+|++|+.||...... .....
T Consensus 164 kL~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~ 233 (287)
T 2wei_A 164 KIIDFGLSTCFQQNT-------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKR 233 (287)
T ss_dssp EECSTTGGGTBCCCS-------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH
T ss_pred EEeccCcceeecCCC-------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 999999997653321 1123357899999999876 4899999999999999999999999653221 11111
Q ss_pred h-hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 685 V-ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 685 ~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+ ...++..... ...+.+. +.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~----------------~~~~~~~----~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 234 VETGKYAFDLPQ----------------WRTISDD----AKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHCCCCCCSGG----------------GTTSCHH----HHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHcCCCCCCchh----------------hhhcCHH----HHHHHHHHcccChhhCcCHHHHhcC
Confidence 1 1111111000 0001111 2236778999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.37 Aligned_cols=254 Identities=21% Similarity=0.313 Sum_probs=170.6
Q ss_pred HhcCCCCCC-ccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 453 ATGNFSHEN-LIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 453 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
..++|.+.+ .||+|+||.||+|.+. +++.||||++... .....+....++.++||||+++++++... ......
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENM-HHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCce
Confidence 357888855 6999999999999977 5899999998632 12222233345667999999999987542 123566
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE---DMTAKVG 607 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~ 607 (767)
.++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG----DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-----CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence 899999999999999998653 23599999999999999999999999 9999999999999986 4569999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcch--hhHh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL--VKWV 685 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~~ 685 (767)
|||+++..... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......... ....
T Consensus 174 Dfg~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (336)
T 3fhr_A 174 DFGFAKETTQN--------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245 (336)
T ss_dssp CCTTCEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred ccccceecccc--------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh
Confidence 99999754322 1233458999999999988889999999999999999999999996543321100 0000
Q ss_pred ---hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 686 ---ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 686 ---~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
...++......+++ .+.+++.+||+.||++|||++|++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~----------------------~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 246 RLGQYGFPNPEWSEVSE----------------------DAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp -----CCCTTTSTTCCH----------------------HHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hccccccCchhhccCCH----------------------HHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00011100111111 122366789999999999999999853
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=332.88 Aligned_cols=326 Identities=28% Similarity=0.413 Sum_probs=283.6
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
+++|++|||++|.++ .+|. +..+++|++|++++|.+.+..+ +.++++|++|++++|.+++. +. +..+++|++|
T Consensus 67 l~~L~~L~Ls~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L 139 (466)
T 1o6v_A 67 LNNLTQINFSNNQLT-DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRL 139 (466)
T ss_dssp CTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEE
T ss_pred hcCCCEEECCCCccC-Cchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEE
Confidence 578999999999998 6765 5579999999999999995444 99999999999999999854 33 8999999999
Q ss_pred eecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEE
Q 004218 81 NIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLN 160 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~ 160 (767)
++++|.+... ..+..+++|+.|+++ |.+.+. ..+.++++ |++|++++|+++.. ..+..+++|++|+
T Consensus 140 ~l~~n~l~~~--------~~~~~l~~L~~L~l~-~~~~~~--~~~~~l~~-L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 205 (466)
T 1o6v_A 140 ELSSNTISDI--------SALSGLTSLQQLSFG-NQVTDL--KPLANLTT-LERLDISSNKVSDI--SVLAKLTNLESLI 205 (466)
T ss_dssp EEEEEEECCC--------GGGTTCTTCSEEEEE-ESCCCC--GGGTTCTT-CCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred ECCCCccCCC--------hhhccCCcccEeecC-CcccCc--hhhccCCC-CCEEECcCCcCCCC--hhhccCCCCCEEE
Confidence 9999998643 358889999999997 555533 23888888 99999999999853 4589999999999
Q ss_pred CcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCC
Q 004218 161 LSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 161 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
+++|.+.+..+ +..+++|++|++++|++.+. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++
T Consensus 206 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 279 (466)
T 1o6v_A 206 ATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 279 (466)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC
T ss_pred ecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc
Confidence 99999997544 78899999999999999854 468899999999999999987654 8899999999999999996
Q ss_pred CCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhh
Q 004218 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILA 320 (767)
Q Consensus 241 ~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 320 (767)
..+ +..+++| +.+++++|++++..+ ++.+++|+.|++++|.+++..| +..+++|+.|++++|++++. ..+.
T Consensus 280 ~~~--~~~l~~L-~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~ 350 (466)
T 1o6v_A 280 ISP--LAGLTAL-TNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLA 350 (466)
T ss_dssp CGG--GTTCTTC-SEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGT
T ss_pred ccc--ccCCCcc-CeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhc
Confidence 444 8888888 455999999997655 8899999999999999997766 88999999999999999965 5789
Q ss_pred ccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCC
Q 004218 321 ELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVP 364 (767)
Q Consensus 321 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 364 (767)
.+++|+.|++++|++++..| +..+++|+.|++++|++++.+.
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p~ 392 (466)
T 1o6v_A 351 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPV 392 (466)
T ss_dssp TCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCCB
T ss_pred cCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCCch
Confidence 99999999999999998776 8999999999999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=337.18 Aligned_cols=203 Identities=32% Similarity=0.414 Sum_probs=167.9
Q ss_pred HHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CC-----CceeEEeeeecC
Q 004218 451 RRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTR-HR-----NLVKLITSCSSL 523 (767)
Q Consensus 451 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~ 523 (767)
....++|++.+.||+|+||.||+|.+. +++.||||++... ......+.+|+++++.++ |+ +|+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~-- 126 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM-- 126 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE--
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec--
Confidence 344679999999999999999999976 5889999998632 233456778888888874 44 4999999854
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CC
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD--ED 601 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~ 601 (767)
.....++||||+++ +|.+++..... ..+++..+..++.|++.||+|||++ ..+|+||||||+||+++ .+
T Consensus 127 ---~~~~~~lv~e~~~~-~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 127 ---FRNHLCLVFEMLSY-NLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp ---ETTEEEEEEECCCC-BHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTS
T ss_pred ---cCCceEEEEecCCC-CHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCC
Confidence 44677999999964 99999976542 3489999999999999999999952 23999999999999995 47
Q ss_pred CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 602 MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 602 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 198 ~~~kL~DFG~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR---------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCEEECCCTTCEETTCC---------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcEEEEeccCceecccc---------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 88999999999765322 12356899999999999999999999999999999999999999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.04 Aligned_cols=205 Identities=26% Similarity=0.344 Sum_probs=169.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCC--------CCCceeEEeeeecCC
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTR--------HRNLVKLITSCSSLD 524 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~~~ 524 (767)
.++|++.+.||+|+||.||+|++. +++.||||++... ....+.+.+|+++++.++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999965 4889999998632 234567889999999885 788999999865321
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC--
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-- 602 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-- 602 (767)
......++||||+ ++++.+++.... ...+++..++.++.||+.||+|||+++ ||+||||||+||+++.++
T Consensus 115 -~~~~~~~lv~e~~-~~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 115 -VNGTHICMVFEVL-GHHLLKWIIKSN----YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp -TTEEEEEEEECCC-CCBHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred -CCCceEEEEEecc-CccHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 2456789999999 557766665432 234999999999999999999999852 899999999999999775
Q ss_pred -----------------------------------------------ceEEccccchhhhhhhcCCCccccccccccCCC
Q 004218 603 -----------------------------------------------TAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635 (767)
Q Consensus 603 -----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~ 635 (767)
.+||+|||.++..... .....||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---------~~~~~gt~ 257 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---------FTEDIQTR 257 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---------SCSCCSCG
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---------CccCCCCC
Confidence 7999999999765322 12346899
Q ss_pred CccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 636 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 99999999999999999999999999999999999976443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.81 Aligned_cols=198 Identities=26% Similarity=0.356 Sum_probs=168.0
Q ss_pred hcCCCCCCccccccceEEEEEEe-C-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCC------CceeEEeeeecCCc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYL-R-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHR------NLVKLITSCSSLDF 525 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~ 525 (767)
.++|++.+.||+|+||.||+|.+ . +++.||||++... ....+.+.+|+++++.++|+ +++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~---- 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE---- 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc----
Confidence 46899999999999999999997 3 5889999998632 23456788899999888654 5999999854
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-----
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE----- 600 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~----- 600 (767)
..+..++||||+ +++|.+++.... ...+++.++..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 88 -~~~~~~lv~e~~-~~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 88 -HHGHICIVFELL-GLSTYDFIKENG----FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred -cCCcEEEEEcCC-CCCHHHHHHhcC----CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence 455789999999 889999997654 23489999999999999999999999 9999999999999987
Q ss_pred --------------CCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh
Q 004218 601 --------------DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666 (767)
Q Consensus 601 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 666 (767)
++.+||+|||.++..... .....||+.|+|||++.+..++.++||||+||++|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH---------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC---------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc---------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 668999999999754321 123468999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 004218 667 GMSPTHES 674 (767)
Q Consensus 667 g~~p~~~~ 674 (767)
|+.||...
T Consensus 230 g~~pf~~~ 237 (339)
T 1z57_A 230 GFTVFPTH 237 (339)
T ss_dssp SSCSCCCS
T ss_pred CCCCCCCC
Confidence 99999654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.94 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=180.5
Q ss_pred HhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceee
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
...+|++.+.||+|+||+||.....+++.||||++... ....+.+|+++++.+ +||||+++++++ .+....
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~ 93 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQ 93 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEE
Confidence 34568888999999999976655667999999998643 234567899999999 799999999985 345667
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-----CCceEE
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE-----DMTAKV 606 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-----~~~~kl 606 (767)
++||||++ |+|.+++..... ..++.++..++.|++.||+|||++ +|+||||||+||+++. ...+||
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSC-----CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred EEEEECCC-CCHHHHHHhcCC-----CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEE
Confidence 99999996 599999976542 244556788999999999999999 9999999999999953 336889
Q ss_pred ccccchhhhhhhcCCCccccccccccCCCCccCccccC---CCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchh
Q 004218 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL---GEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLV 682 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~ 682 (767)
+|||+++........ ........||+.|+|||++. ...++.++||||+||++|||++ |..||....... .
T Consensus 165 ~DFG~a~~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---~ 238 (432)
T 3p23_A 165 SDFGLCKKLAVGRHS---FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---A 238 (432)
T ss_dssp CCTTEEECC---------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---H
T ss_pred ecccceeeccCCCcc---eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---H
Confidence 999999866432111 11223456999999999987 4567889999999999999999 889985432111 1
Q ss_pred hHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 683 KWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
............ .. .. .....+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~---~~------------~~----~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 239 NILLGACSLDCL---HP------------EK----HEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHTTCCCCTTS---CT------------TC----HHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhccCCcccc---Cc------------cc----cccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111110000000 00 00 01111233777999999999999999995
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=326.61 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=192.6
Q ss_pred HHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc------chhhHHHHHHHHhcCC--CCCceeEEee
Q 004218 449 ELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG------TWKSFFAECEALRNTR--HRNLVKLITS 519 (767)
Q Consensus 449 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~ 519 (767)
+.....++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445678999999999999999999965 5899999999654322 2356778999999996 5999999999
Q ss_pred eecCCcccceeeEEEEeecCC-CChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 004218 520 CSSLDFKNMEFLALVYEFLGN-GSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL 598 (767)
Q Consensus 520 ~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~ 598 (767)
+. ..+..++|||++.+ ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 117 ~~-----~~~~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 182 (320)
T 3a99_A 117 FE-----RPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILI 182 (320)
T ss_dssp EE-----CSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred Ee-----cCCcEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEE
Confidence 64 45567999999976 89999997643 389999999999999999999999 99999999999999
Q ss_pred C-CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCccc
Q 004218 599 D-EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFA 676 (767)
Q Consensus 599 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~ 676 (767)
+ +++.+||+|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 183 ~~~~~~~kL~Dfg~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 254 (320)
T 3a99_A 183 DLNRGELKLIDFGSGALLKDT--------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254 (320)
T ss_dssp ETTTTEEEECCCTTCEECCSS--------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred eCCCCCEEEeeCccccccccc--------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh
Confidence 9 7899999999999765322 1123458999999999877665 6789999999999999999999864210
Q ss_pred CCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 677 GEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...... .....+++. +.+++.+||+.||++|||++|++++
T Consensus 255 -------~~~~~~--~~~~~~~~~----------------------~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 -------IIRGQV--FFRQRVSSE----------------------CQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -------HHHCCC--CCSSCCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------hhcccc--cccccCCHH----------------------HHHHHHHHccCChhhCcCHHHHhcC
Confidence 111000 001111111 2236778999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.05 Aligned_cols=272 Identities=23% Similarity=0.282 Sum_probs=192.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-ccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDF-KNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 529 (767)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999975 589999999865322 234678899999999999999999999754321 1223
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..++||||++ ++|.+++.. .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred eEEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence 4699999997 588888742 289999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh-
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES- 687 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~- 687 (767)
|.++..... .....||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||....... .+......
T Consensus 171 g~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~ 240 (353)
T 3coi_A 171 GLARHADAE---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVT 240 (353)
T ss_dssp TCTTC-----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHH
T ss_pred ccccCCCCC---------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 999764322 123468999999999877 678999999999999999999999996532211 11111110
Q ss_pred hcc-cc-hhhhccHHHHHhhhcch---h-hHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 NFP-KN-AQQVLDRELRQLMMSSE---S-QTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~~~-~~-~~~~~~~~l~~~~~~~~---~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+ .. .....+......+...+ . ............+.+++.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00 01111111111110000 0 0000000111223347779999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=322.98 Aligned_cols=246 Identities=23% Similarity=0.326 Sum_probs=185.7
Q ss_pred HHHHHhcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC------cchhhHHHHHHHHhcC----CCCCceeEE
Q 004218 449 ELRRATGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST------GTWKSFFAECEALRNT----RHRNLVKLI 517 (767)
Q Consensus 449 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~~~ 517 (767)
+.....++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34556789999999999999999999964 588999999964432 2334566899999888 899999999
Q ss_pred eeeecCCcccceeeEEEEee-cCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 004218 518 TSCSSLDFKNMEFLALVYEF-LGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNI 596 (767)
Q Consensus 518 ~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 596 (767)
+++. ..+..++|||| +++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 105 ~~~~-----~~~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 170 (312)
T 2iwi_A 105 DWFE-----TQEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENI 170 (312)
T ss_dssp EEC----------CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGE
T ss_pred EEEe-----cCCeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhE
Confidence 9853 44567999999 78999999997643 389999999999999999999999 999999999999
Q ss_pred eeC-CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 597 LLD-EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 597 l~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+++ .++.+||+|||.++..... ......||..|+|||++.+..+ +.++||||+|+++|+|++|+.||...
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHDE--------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCSS--------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EEeCCCCeEEEEEcchhhhcccC--------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 999 8899999999999765332 1233458999999999877666 45899999999999999999998642
Q ss_pred ccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 675 FAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. ....... .....++.. +.+++.+||+.||++|||++|++++
T Consensus 243 ~-------~~~~~~~--~~~~~~~~~----------------------~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 243 Q-------EILEAEL--HFPAHVSPD----------------------CCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp H-------HHHHTCC--CCCTTSCHH----------------------HHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred H-------HHhhhcc--CCcccCCHH----------------------HHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1111000 001111111 2236778999999999999999974
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=334.40 Aligned_cols=302 Identities=19% Similarity=0.179 Sum_probs=248.4
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
+++++|||++|+++ .++...+..+++|++|+|++|.+.+..|..|.++++|++|+|++|.+++..+..|..+++|++|+
T Consensus 32 ~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 110 (477)
T 2id5_A 32 TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLD 110 (477)
T ss_dssp TTCSEEECCSSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEE
T ss_pred CCCcEEECCCCccc-eECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEE
Confidence 47899999999999 67666667899999999999999988899999999999999999999966666789999999999
Q ss_pred ecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEEC
Q 004218 82 IGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNL 161 (767)
Q Consensus 82 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l 161 (767)
|++|++... .+..+.++++|++|++++|.+++..+..+..+++ |++|++++|++++..+..|.++++|+.|+|
T Consensus 111 Ls~n~i~~~------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l 183 (477)
T 2id5_A 111 ISENKIVIL------LDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS-LEQLTLEKCNLTSIPTEALSHLHGLIVLRL 183 (477)
T ss_dssp CTTSCCCEE------CTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTT-CCEEEEESCCCSSCCHHHHTTCTTCCEEEE
T ss_pred CCCCccccC------ChhHccccccCCEEECCCCccceeChhhccCCCC-CCEEECCCCcCcccChhHhcccCCCcEEeC
Confidence 999998753 3456788999999999999999888999999998 999999999999877778999999999999
Q ss_pred cCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCC
Q 004218 162 SYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN 241 (767)
Q Consensus 162 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 241 (767)
++|.+.+..+..|..+++|++|++++|.+.+.+|.......+|++|+|++|+++...+..|..+++|+.|+|++|.+++.
T Consensus 184 ~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 263 (477)
T 2id5_A 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI 263 (477)
T ss_dssp ESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCcc
Confidence 99999988888999999999999999988878887777777999999999999976667899999999999999998854
Q ss_pred CChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhc
Q 004218 242 IPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAE 321 (767)
Q Consensus 242 ~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 321 (767)
.+..+.. +++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++..+..|..
T Consensus 264 ~~~~~~~-------------------------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 318 (477)
T 2id5_A 264 EGSMLHE-------------------------LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHS 318 (477)
T ss_dssp CTTSCTT-------------------------CTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSC
T ss_pred Chhhccc-------------------------cccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCC
Confidence 4444444 445555555555555555555555555555555555555544445555
Q ss_pred cCCceEEEcCCcccC
Q 004218 322 LKGLEVLDLSSNKLS 336 (767)
Q Consensus 322 l~~L~~L~Ls~N~l~ 336 (767)
+++|+.|+|++|++.
T Consensus 319 l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 319 VGNLETLILDSNPLA 333 (477)
T ss_dssp GGGCCEEECCSSCEE
T ss_pred CcccCEEEccCCCcc
Confidence 555666666666555
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=322.73 Aligned_cols=333 Identities=19% Similarity=0.202 Sum_probs=256.1
Q ss_pred CCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCC
Q 004218 26 LPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNST 105 (767)
Q Consensus 26 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~ 105 (767)
+++++.|++++|.+....+..|..+++|++|+|++|.+++..+..|+.+++|++|+|++|.+...+ +..+.+++
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~------~~~~~~l~ 117 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLP------PHVFQNVP 117 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCC------TTTTTTCT
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCC------HHHhcCCC
Confidence 677888888888887544455778888888888888887666667888888888888888876432 33467778
Q ss_pred CCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEc
Q 004218 106 RLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDL 185 (767)
Q Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 185 (767)
+|++|++++|+++...+..+..+++ |++|++++|++++..+..|..+++|++|++++|.+++. .+..+++|++|++
T Consensus 118 ~L~~L~L~~n~l~~l~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l 193 (390)
T 3o6n_A 118 LLTVLVLERNDLSSLPRGIFHNTPK-LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANV 193 (390)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTT-CCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEEC
T ss_pred CCCEEECCCCccCcCCHHHhcCCCC-CcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeec
Confidence 8888888888887333333567776 88888888888877777788888888888888888754 3556788888888
Q ss_pred cCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCC
Q 004218 186 AGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDG 265 (767)
Q Consensus 186 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~ 265 (767)
++|.+.+ +...++|++|++++|.++.. |.. ..++|+.|++++|.+++. ..+..+++|.. +++++|.+++
T Consensus 194 ~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~-L~Ls~n~l~~ 262 (390)
T 3o6n_A 194 SYNLLST-----LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVE-VDLSYNELEK 262 (390)
T ss_dssp CSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSE-EECCSSCCCE
T ss_pred ccccccc-----cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccE-EECCCCcCCC
Confidence 8888773 23346788888888888754 332 347888888888888753 56777777744 4888888888
Q ss_pred CCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccc
Q 004218 266 TLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQN 345 (767)
Q Consensus 266 ~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 345 (767)
..|..+..+++|+.|+|++|++++ +|..+..+++|+.|++++|+++ .+|..+..+++|+.|+|++|+++.. + +..
T Consensus 263 ~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~ 337 (390)
T 3o6n_A 263 IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LST 337 (390)
T ss_dssp EESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCT
T ss_pred cChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chh
Confidence 888889999999999999999985 5666788999999999999998 5677788999999999999999854 3 678
Q ss_pred cccCceEeccCCcCcCcCCCCccccccccccccCCcCccc
Q 004218 346 LRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 346 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c~ 385 (767)
+++|+.|++++|++++... ...+..+....+.+++..|.
T Consensus 338 ~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~c~ 376 (390)
T 3o6n_A 338 HHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCK 376 (390)
T ss_dssp TCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCSCCC
T ss_pred hccCCEEEcCCCCccchhH-HHHHHHHHhhcccccCceec
Confidence 8999999999999987532 23345566666778888885
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.27 Aligned_cols=257 Identities=24% Similarity=0.325 Sum_probs=179.6
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++ ......++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEE
Confidence 345556889999999998777677999999998643 235678999999876 899999999985 45567899
Q ss_pred EEeecCCCChhhhhcccCCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-----------
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHG-NGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED----------- 601 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~----------- 601 (767)
||||++ |+|.+++......... ...++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence 999996 5999999865432111 1123445678999999999999999 99999999999999754
Q ss_pred --CceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCC-------CCCCCcccchhhhHHHHHHHh-CCCCC
Q 004218 602 --MTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-------EKPSTAGDVYSFGVMLLEIFT-GMSPT 671 (767)
Q Consensus 602 --~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~t-g~~p~ 671 (767)
+.+||+|||+++......... ........||+.|+|||++.+ ..++.++||||+||++|||++ |+.||
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSF--RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CSCEEEECCCTTCEECCC----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CceEEEEcccccceecCCCCccc--eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 489999999998654322111 111234569999999999865 568999999999999999999 99999
Q ss_pred CCcccCCcchhhHhhhhcccc-hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 672 HESFAGEVSLVKWVESNFPKN-AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
....... .......+... ....... . +...+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~---~~i~~~~~~~~~~~~~~~~--------------~----~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 241 GDKYSRE---SNIIRGIFSLDEMKCLHDR--------------S----LIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CSTTTHH---HHHHHTCCCCCCCTTCCCH--------------H----HHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCchhhH---HHHhcCCCCcccccccccc--------------c----chHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 6543221 11111111110 0000000 1 1112233777999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.88 Aligned_cols=256 Identities=22% Similarity=0.292 Sum_probs=172.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-cchhhHHHHHH-HHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-GTWKSFFAECE-ALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|.+. +|+.||||++..... ....++..|+. +++.++||||+++++++. ..+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCCc
Confidence 368999999999999999999975 589999999975432 23345566666 677789999999999964 3456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++ +|.+++..... .....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 7999999985 88888763211 0123489999999999999999999984 289999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCcccc----CCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYG----LGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
+++....... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||...............
T Consensus 172 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (327)
T 3aln_A 172 ISGQLVDSIA-------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244 (327)
T ss_dssp SSCC-------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC
T ss_pred Cceecccccc-------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc
Confidence 9976543211 1223589999999998 4567899999999999999999999999653222111111111
Q ss_pred hhccc---chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 687 SNFPK---NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 687 ~~~~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+. .....+++. +.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPS----------------------FINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp SCCCCCCCCSSCCCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCcccccCCHH----------------------HHHHHHHHhhCChhhCcCHHHHHhC
Confidence 11111 000111111 2226678999999999999999874
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=339.89 Aligned_cols=358 Identities=23% Similarity=0.237 Sum_probs=285.8
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
|++|++|||++|+|+ .||...|..+++|++|+|++|++++..+++|.++++|++|+|++|.+++..+..|+.+++|++|
T Consensus 75 l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L 153 (635)
T 4g8a_A 75 FPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 153 (635)
T ss_dssp CTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEE
T ss_pred CCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCee
Confidence 578999999999998 8998888889999999999999997777889999999999999999997666789999999999
Q ss_pred eecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhcc---ccCeEEccCCcccccCC----------
Q 004218 81 NIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSN---VLSKLYMGGNRFYGKIP---------- 147 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~---~L~~L~l~~n~i~~~~~---------- 147 (767)
+|++|.+... ..+..+.++++|++|++++|++++..+..+..+.+ .+..++++.|.+....+
T Consensus 154 ~Ls~N~l~~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~ 228 (635)
T 4g8a_A 154 NVAHNLIQSF-----KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHK 228 (635)
T ss_dssp ECCSSCCCCC-----CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEE
T ss_pred ccccCccccC-----CCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhh
Confidence 9999999765 55677889999999999999999877777665543 01233333333221100
Q ss_pred --------------------------------------------------------------------------------
Q 004218 148 -------------------------------------------------------------------------------- 147 (767)
Q Consensus 148 -------------------------------------------------------------------------------- 147 (767)
T Consensus 229 l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l 308 (635)
T 4g8a_A 229 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNV 308 (635)
T ss_dssp EEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTC
T ss_pred hhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccc
Confidence
Q ss_pred -------------ccccCCCCCCEEECcCCcCcccCcc-------------------ccCCCCCCCEEEccCCcccc---
Q 004218 148 -------------TSIGRLRSLTLLNLSYNSISGEILT-------------------EIGQLQELQSLDLAGNQISG--- 192 (767)
Q Consensus 148 -------------~~l~~l~~L~~L~l~~n~i~~~~~~-------------------~~~~l~~L~~L~L~~n~i~~--- 192 (767)
..+....+|+.|++.+|.+...... ....+++|+.|++++|.+..
T Consensus 309 ~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~ 388 (635)
T 4g8a_A 309 SSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 388 (635)
T ss_dssp SEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEE
T ss_pred ccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccc
Confidence 0122233455666666554432211 12245667777777766642
Q ss_pred ----------------------ccCcCcccCCCCceeeCCCCcCCCCC-cccccCccccccccccCcccCCCCChhhccc
Q 004218 193 ----------------------SIPNTLGNLKKLNQIDLSGNELASEI-PTSFGNFQNLLSIDLSNNKLNGNIPKEILSL 249 (767)
Q Consensus 193 ----------------------~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 249 (767)
..+..+..+++|+.++++.|...... +..|..+++++.++++.|.+.+..+..+..+
T Consensus 389 ~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~ 468 (635)
T 4g8a_A 389 CSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 468 (635)
T ss_dssp CCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTC
T ss_pred cccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccc
Confidence 22344566778888888877765443 4568899999999999999998888888888
Q ss_pred ccccceeecccccCC-CCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEE
Q 004218 250 SSLTTIVNLSKNFLD-GTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVL 328 (767)
Q Consensus 250 ~~l~~~l~l~~n~l~-~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 328 (767)
+.+ +.+++++|.+. +..|..|..+++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|
T Consensus 469 ~~L-~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L 547 (635)
T 4g8a_A 469 SSL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 547 (635)
T ss_dssp TTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred hhh-hhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence 888 45599999754 4578889999999999999999999999999999999999999999999999999999999999
Q ss_pred EcCCcccCCCCCcccccc-ccCceEeccCCcCcCcCCC
Q 004218 329 DLSSNKLSGSIPSDLQNL-RALRSLNLTFNNLEGVVPR 365 (767)
Q Consensus 329 ~Ls~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~ 365 (767)
+|++|+|++..|..+..+ ++|+.|+|++|++++...-
T Consensus 548 ~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 548 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp ECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred ECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 999999999999999988 6899999999999986653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=331.10 Aligned_cols=203 Identities=23% Similarity=0.325 Sum_probs=167.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-----------CCCceeEEeeee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTR-----------HRNLVKLITSCS 521 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~ 521 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++... ....+.+.+|+++++++. ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 368999999999999999999974 5899999998632 223466788999988875 899999999875
Q ss_pred cCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--
Q 004218 522 SLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD-- 599 (767)
Q Consensus 522 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-- 599 (767)
... .....+++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+++ +|+||||||+||+++
T Consensus 97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVL-GENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEE-TTEEEEEEEECCC-CEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred ccC-CCCceEEEEEecC-CCCHHHHHHHhh----ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence 422 2345789999999 889999997643 234899999999999999999999842 899999999999994
Q ss_pred ----CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 600 ----EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 600 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CCCcCcceEEEcccccccccCCC---------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 4458999999999765332 12346899999999999999999999999999999999999999754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=341.35 Aligned_cols=207 Identities=28% Similarity=0.414 Sum_probs=173.2
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-ccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|++++++++||||+++++++.... ...+..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999975 5899999998654 2334567889999999999999999999875422 233667
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT---AKVG 607 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~kl~ 607 (767)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++. +||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred EEEEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 7999999999999999986542 23488999999999999999999999 9999999999999997664 9999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
|||.+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||..
T Consensus 167 DFG~a~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 167 DLGYAKELDQGE-------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp SCCCCCBTTSCC-------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccccc-------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 999998654321 12335689999999999999999999999999999999999999965
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.99 Aligned_cols=198 Identities=23% Similarity=0.354 Sum_probs=165.3
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-C-cEEEEEEeeccCCcchhhHHHHHHHHhcCCCCC------ceeEEeeeecCCc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-G-ISVAVKVLDIESTGTWKSFFAECEALRNTRHRN------LVKLITSCSSLDF 525 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~ 525 (767)
.++|++.+.||+|+||.||+|.+.. + +.||+|+++.. ....+.+.+|+++++.++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~---- 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN---- 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee----
Confidence 4689999999999999999999753 4 68999998632 234567788999999887655 888888743
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee-------
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILL------- 598 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~------- 598 (767)
.....++||||+ ++++.+++.... ...+++.++..++.|++.||+|||++ +|+||||||+||++
T Consensus 93 -~~~~~~lv~e~~-~~~l~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 93 -FHGHMCIAFELL-GKNTFEFLKENN----FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEE
T ss_pred -eCCeEEEEEecc-CCChHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccc
Confidence 455779999999 567777776543 23489999999999999999999999 99999999999999
Q ss_pred ------------CCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh
Q 004218 599 ------------DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666 (767)
Q Consensus 599 ------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 666 (767)
+.++.+||+|||.++..... .....||+.|+|||++.+..++.++||||+||++|||++
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC---------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccCCCcEEEeecCcccccccc---------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 56789999999999753221 123468999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 004218 667 GMSPTHES 674 (767)
Q Consensus 667 g~~p~~~~ 674 (767)
|+.||...
T Consensus 235 g~~pf~~~ 242 (355)
T 2eu9_A 235 GFTLFQTH 242 (355)
T ss_dssp SSCSCCCS
T ss_pred CCCCCCCC
Confidence 99999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=319.41 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=173.0
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc-ch-hhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG-TW-KSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|.+. +|+.||||++...... .. +.+.++..+++.++||||+++++++. ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCCc
Confidence 467899999999999999999986 5899999999754322 22 33444555778889999999999964 4456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.++||||+ ++.+..+..... ..+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+||
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecc-CCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence 79999999 445655554322 238999999999999999999998 6 8999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhH
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 684 (767)
|.+....... ......||+.|+|||++. ...++.++||||+|+++|+|++|+.||.............
T Consensus 170 g~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (318)
T 2dyl_A 170 GISGRLVDDK-------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242 (318)
T ss_dssp TTC---------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred CCchhccCCc-------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 9997654321 112345899999999984 4567899999999999999999999996532211111111
Q ss_pred hhhhcccch-hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 685 VESNFPKNA-QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 685 ~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.....+... ...+++. +.+++.+||+.||.+|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~----------------------l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 243 LQEEPPLLPGHMGFSGD----------------------FQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHSCCCCCCSSSCCCHH----------------------HHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred hccCCCCCCccCCCCHH----------------------HHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111100 0011111 2226678999999999999999874
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=336.08 Aligned_cols=334 Identities=19% Similarity=0.199 Sum_probs=264.3
Q ss_pred CCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCC
Q 004218 26 LPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNST 105 (767)
Q Consensus 26 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~ 105 (767)
+.+++.|++++|.+....+..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+.+.+ +..+.+++
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~------~~~~~~l~ 123 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLP------PHVFQNVP 123 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCC------TTTTTTCT
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCC------HHHHcCCC
Confidence 567888888888888655666788888888888888888777778888888888888888877532 33467788
Q ss_pred CCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEc
Q 004218 106 RLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDL 185 (767)
Q Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 185 (767)
+|++|+|++|.+++..+..+..+++ |++|+|++|.+++..|..|.++++|++|+|++|.+++. .+..+++|+.|++
T Consensus 124 ~L~~L~L~~n~l~~l~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l 199 (597)
T 3oja_B 124 LLTVLVLERNDLSSLPRGIFHNTPK-LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANV 199 (597)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTT-CCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEEC
T ss_pred CCCEEEeeCCCCCCCCHHHhccCCC-CCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---Chhhhhhhhhhhc
Confidence 8888888888888444444577777 88888888888877787888888888888888888854 3556788888888
Q ss_pred cCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCC
Q 004218 186 AGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDG 265 (767)
Q Consensus 186 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~ 265 (767)
++|.+.+ +...++|+.|++++|.++...+. + .++|+.|+|++|.+++ +..+..+++|.. |++++|.+++
T Consensus 200 ~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~-L~Ls~N~l~~ 268 (597)
T 3oja_B 200 SYNLLST-----LAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVE-VDLSYNELEK 268 (597)
T ss_dssp CSSCCSE-----EECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSE-EECCSSCCCE
T ss_pred ccCcccc-----ccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCE-EECCCCccCC
Confidence 8888774 33446788888888888744332 2 3678888888888885 467778888844 4888898888
Q ss_pred CCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccc
Q 004218 266 TLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQN 345 (767)
Q Consensus 266 ~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 345 (767)
..|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++. | +..
T Consensus 269 ~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~ 343 (597)
T 3oja_B 269 IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LST 343 (597)
T ss_dssp EESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCT
T ss_pred CCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhh
Confidence 888999999999999999999996 5677788999999999999999 6777889999999999999999854 3 677
Q ss_pred cccCceEeccCCcCcCcCCCCccccccccccccCCcCcccc
Q 004218 346 LRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCLH 386 (767)
Q Consensus 346 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c~~ 386 (767)
+++|+.|++++|++++... ...+..+....+.+++..|..
T Consensus 344 ~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 344 HHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp TCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCCCCCT
T ss_pred cCCCCEEEeeCCCCCChhH-HHHHHHHhhhccccccccCCc
Confidence 8999999999999987642 233555666667888888874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=309.03 Aligned_cols=231 Identities=13% Similarity=0.103 Sum_probs=178.5
Q ss_pred hcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCc---chhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTG---TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|.+.. ++.||||++...... ..+.+.+|+.++++++||||+++++++. ..+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TRA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----ECC
Confidence 3689999999999999999999865 899999999754332 3467899999999999999999999954 445
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
..|+||||++|++|.+++... ....++.+|+.|++.||+|||++ ||+||||||+||+++.++.+||+++
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC
T ss_pred cEEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec
Confidence 679999999999999998532 45567899999999999999999 9999999999999999999999754
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcc--hhhHhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS--LVKWVES 687 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~ 687 (767)
| |++ .++.++|||||||++|||++|+.||......... .......
T Consensus 174 ~--------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~ 220 (286)
T 3uqc_A 174 A--------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAG 220 (286)
T ss_dssp C--------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTS
T ss_pred c--------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhcc
Confidence 3 333 3688999999999999999999999765432211 0011111
Q ss_pred hccc--chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHh
Q 004218 688 NFPK--NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILL 756 (767)
Q Consensus 688 ~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 756 (767)
..+. .....+++ .+.+++.+||+.||++| |+.|+++.|+.+.....
T Consensus 221 ~~~~~~~~~~~~~~----------------------~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 221 QPIEPADIDRDIPF----------------------QISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CBCCHHHHCTTSCH----------------------HHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CCCChhhcccCCCH----------------------HHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 1110 00011111 12236778999999999 99999999999875443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=344.63 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=191.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC--CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR--EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+......
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999975 58999999986432 234467889999999999999999999986544333344
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.|+||||+++++|.+++.. .+++.+++.|+.||+.||+|||++ +|+||||||+||+++.+ .+||+|||
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eEEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 7999999999999987754 399999999999999999999999 99999999999999985 89999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||........ +
T Consensus 227 ~a~~~~~~----------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~ 285 (681)
T 2pzi_A 227 AVSRINSF----------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P 285 (681)
T ss_dssp TCEETTCC----------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C
T ss_pred cchhcccC----------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------c
Confidence 99765321 335689999999998765 48899999999999999999988765322111 0
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC-HHHHHHHHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID-IREALRRLKNAQKI 754 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~evl~~L~~~~~~ 754 (767)
.. ... .... ..+.+++.+||+.||++||+ ++++.+.+..+.+.
T Consensus 286 ~~-----~~~------------~~~~----~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 286 ED-----DPV------------LKTY----DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp TT-----CHH------------HHHC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred cc-----ccc------------cccC----HHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 00 000 0001 11223777999999999995 66677777766543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=304.87 Aligned_cols=305 Identities=25% Similarity=0.382 Sum_probs=222.5
Q ss_pred CCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCC
Q 004218 25 KLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNS 104 (767)
Q Consensus 25 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l 104 (767)
.+++|++|++++|.+. .++. +..+++|++|++++|.+++ ++. +..+++|++|++++|.+... ..+.++
T Consensus 42 ~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~~--------~~~~~l 109 (347)
T 4fmz_A 42 ELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITDI--------SALQNL 109 (347)
T ss_dssp HHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC--------GGGTTC
T ss_pred hcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccCc--------hHHcCC
Confidence 4667777777777777 3443 7777777778887777773 333 77777777887777776532 346777
Q ss_pred CCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEE
Q 004218 105 TRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLD 184 (767)
Q Consensus 105 ~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 184 (767)
++|++|++++|++++ ++. +..+++ |++|++++|..... +..+..+++|++|++++|.+.+..+ +..+++|++|+
T Consensus 110 ~~L~~L~l~~n~i~~-~~~-~~~l~~-L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~ 183 (347)
T 4fmz_A 110 TNLRELYLNEDNISD-ISP-LANLTK-MYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183 (347)
T ss_dssp TTCSEEECTTSCCCC-CGG-GTTCTT-CCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEE
T ss_pred CcCCEEECcCCcccC-chh-hccCCc-eeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEE
Confidence 777788887777773 333 666666 78888887755433 3347777788888888887775333 67777888888
Q ss_pred ccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCC
Q 004218 185 LAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264 (767)
Q Consensus 185 L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~ 264 (767)
+++|.+.+..+ +..+++|+.|++++|.++...+ +..+++|++|++++|++++..+ +..++++.. +++++|.++
T Consensus 184 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~-L~l~~n~l~ 256 (347)
T 4fmz_A 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTW-LEIGTNQIS 256 (347)
T ss_dssp CTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCE-EECCSSCCC
T ss_pred ccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCE-EECCCCccC
Confidence 88887774333 7777788888888887775433 6777788888888887774333 666777733 477777777
Q ss_pred CCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCcccc
Q 004218 265 GTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQ 344 (767)
Q Consensus 265 ~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 344 (767)
+. ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++..+..+..+++|+.|+|++|++++..| +.
T Consensus 257 ~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~ 330 (347)
T 4fmz_A 257 DI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA 330 (347)
T ss_dssp CC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GG
T ss_pred CC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hh
Confidence 53 4577888899999999988864 458888999999999999988888888889999999999999886655 78
Q ss_pred ccccCceEeccCCcCc
Q 004218 345 NLRALRSLNLTFNNLE 360 (767)
Q Consensus 345 ~l~~L~~L~l~~N~l~ 360 (767)
.+++|+.|++++|+++
T Consensus 331 ~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 331 SLSKMDSADFANQVIK 346 (347)
T ss_dssp GCTTCSEESSSCC---
T ss_pred hhhccceeehhhhccc
Confidence 8899999999999876
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=314.83 Aligned_cols=298 Identities=20% Similarity=0.216 Sum_probs=224.6
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
|++|++|+|++|+++ .+| .+ ..+++|++|++++|.+.+ +| ++.+++|++|++++|.+++. + ++.+++|++|
T Consensus 41 l~~L~~L~Ls~n~l~-~~~-~l-~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L 111 (457)
T 3bz5_A 41 LATLTSLDCHNSSIT-DMT-GI-EKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYL 111 (457)
T ss_dssp HTTCCEEECCSSCCC-CCT-TG-GGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEE
T ss_pred cCCCCEEEccCCCcc-cCh-hh-cccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEE
Confidence 467899999999998 677 44 468999999999999995 44 88999999999999999853 3 8889999999
Q ss_pred eecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEE
Q 004218 81 NIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLN 160 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~ 160 (767)
++++|++.+. .+.++++|++|++++|++++ ++ ++.+++ |++|++++|+..+.+ .+..+++|++|+
T Consensus 112 ~L~~N~l~~l---------~~~~l~~L~~L~l~~N~l~~-l~--l~~l~~-L~~L~l~~n~~~~~~--~~~~l~~L~~L~ 176 (457)
T 3bz5_A 112 NCDTNKLTKL---------DVSQNPLLTYLNCARNTLTE-ID--VSHNTQ-LTELDCHLNKKITKL--DVTPQTQLTTLD 176 (457)
T ss_dssp ECCSSCCSCC---------CCTTCTTCCEEECTTSCCSC-CC--CTTCTT-CCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred ECCCCcCCee---------cCCCCCcCCEEECCCCccce-ec--cccCCc-CCEEECCCCCccccc--ccccCCcCCEEE
Confidence 9999988743 27788999999999999986 33 777777 999999999654444 478889999999
Q ss_pred CcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCC
Q 004218 161 LSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 161 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
+++|++++. + +..+++|++|++++|++++. .+..+++|+.|++++|++++ +| ++.+++|+.|++++|++++
T Consensus 177 ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 177 CSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp CCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred CCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCC
Confidence 999999863 3 88889999999999999854 38888999999999999987 44 7888999999999999987
Q ss_pred CCChhhcccc-------cccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCc--------ccccCcccceee
Q 004218 241 NIPKEILSLS-------SLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPN--------SFKNCKSLEKLL 305 (767)
Q Consensus 241 ~~~~~~~~l~-------~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~--------~~~~l~~L~~L~ 305 (767)
..+..+.++. ++ +.+++++|.+.+.+| ++.+++|+.|++++|...+.+|. .+..+++|+.|+
T Consensus 248 ~~~~~l~~L~~L~l~~n~L-~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~ 324 (457)
T 3bz5_A 248 LDVSTLSKLTTLHCIQTDL-LEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLY 324 (457)
T ss_dssp CCCTTCTTCCEEECTTCCC-SCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred cCHHHCCCCCEEeccCCCC-CEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEE
Confidence 6555544444 22 233666666555554 45667777777777765544442 234445566666
Q ss_pred ccCccccCCCCchhhccCCceEEEcCCcccCC
Q 004218 306 MANNKFSGPIPNILAELKGLEVLDLSSNKLSG 337 (767)
Q Consensus 306 l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 337 (767)
+++|++++. + +..+++|+.|++++|++++
T Consensus 325 L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 325 LNNTELTEL-D--VSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp CTTCCCSCC-C--CTTCTTCSEEECCSSCCCB
T ss_pred CCCCccccc-c--cccCCcCcEEECCCCCCCC
Confidence 666666653 2 5556666666666666653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.74 Aligned_cols=304 Identities=22% Similarity=0.340 Sum_probs=263.2
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
+++|++|++++|.+. .+|. +..+++|++|++++|.+.+ ++. +..+++|++|++++|.+++ + +.+..+++|++|
T Consensus 43 l~~L~~L~l~~~~i~-~~~~--~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~~L 115 (347)
T 4fmz_A 43 LESITKLVVAGEKVA-SIQG--IEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNLREL 115 (347)
T ss_dssp HTTCSEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCSEE
T ss_pred cccccEEEEeCCccc-cchh--hhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcCCEE
Confidence 368999999999998 7875 4469999999999999995 554 9999999999999999984 3 469999999999
Q ss_pred eecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEE
Q 004218 81 NIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLN 160 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~ 160 (767)
++++|.+... + .+..+++|++|++++|..... +..+..+++ |++|++++|++....+ +..+++|++|+
T Consensus 116 ~l~~n~i~~~-------~-~~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~-L~~L~l~~~~~~~~~~--~~~l~~L~~L~ 183 (347)
T 4fmz_A 116 YLNEDNISDI-------S-PLANLTKMYSLNLGANHNLSD-LSPLSNMTG-LNYLTVTESKVKDVTP--IANLTDLYSLS 183 (347)
T ss_dssp ECTTSCCCCC-------G-GGTTCTTCCEEECTTCTTCCC-CGGGTTCTT-CCEEECCSSCCCCCGG--GGGCTTCSEEE
T ss_pred ECcCCcccCc-------h-hhccCCceeEEECCCCCCccc-ccchhhCCC-CcEEEecCCCcCCchh--hccCCCCCEEE
Confidence 9999998743 2 278899999999999976644 445888888 9999999999985433 88999999999
Q ss_pred CcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCC
Q 004218 161 LSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 161 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
+++|.+.+..+ +..+++|+.|++++|.+.+..+ +..+++|++|++++|+++...+ +..+++|++|++++|.+++
T Consensus 184 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 257 (347)
T 4fmz_A 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257 (347)
T ss_dssp CTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred ccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC
Confidence 99999996433 8899999999999999996544 8899999999999999986544 8899999999999999985
Q ss_pred CCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhh
Q 004218 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILA 320 (767)
Q Consensus 241 ~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 320 (767)
+ ..+..+++|. .+++++|.+++. ..+..+++|+.|++++|.+++..+..+..+++|+.|++++|++++..| +.
T Consensus 258 -~-~~~~~l~~L~-~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~ 330 (347)
T 4fmz_A 258 -I-NAVKDLTKLK-MLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA 330 (347)
T ss_dssp -C-GGGTTCTTCC-EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GG
T ss_pred -C-hhHhcCCCcC-EEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hh
Confidence 3 4688888884 459999999965 468899999999999999998889999999999999999999997666 88
Q ss_pred ccCCceEEEcCCcccC
Q 004218 321 ELKGLEVLDLSSNKLS 336 (767)
Q Consensus 321 ~l~~L~~L~Ls~N~l~ 336 (767)
.+++|+.|++++|+|+
T Consensus 331 ~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 331 SLSKMDSADFANQVIK 346 (347)
T ss_dssp GCTTCSEESSSCC---
T ss_pred hhhccceeehhhhccc
Confidence 9999999999999986
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.38 Aligned_cols=313 Identities=21% Similarity=0.210 Sum_probs=271.6
Q ss_pred cCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhh
Q 004218 48 HNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGN 127 (767)
Q Consensus 48 ~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 127 (767)
-.+++|++|++++|.++...+..+..+++|++|++++|.+... .+..+..+++|++|++++|++++..|..+.+
T Consensus 42 ~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 115 (390)
T 3o6n_A 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI------DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN 115 (390)
T ss_dssp GGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEE------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred cccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccccc------ChhhccCCCCcCEEECCCCCCCcCCHHHhcC
Confidence 3578999999999999954445578899999999999998743 2336788999999999999999888888999
Q ss_pred hccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCcee
Q 004218 128 LSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQI 207 (767)
Q Consensus 128 l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 207 (767)
+++ |++|++++|+++...+..|.++++|++|++++|.+++..+..+..+++|++|++++|++++. .+..+++|+.|
T Consensus 116 l~~-L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L 191 (390)
T 3o6n_A 116 VPL-LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHA 191 (390)
T ss_dssp CTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEE
T ss_pred CCC-CCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---cccccccccee
Confidence 998 99999999999966556679999999999999999988888899999999999999999854 36778999999
Q ss_pred eCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCC
Q 004218 208 DLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGL 287 (767)
Q Consensus 208 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l 287 (767)
++++|.+++ +...++|+.|++++|.+... |... .+++ +.+++++|.+++. ..+..+++|+.|++++|.+
T Consensus 192 ~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~~--~~~L-~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l 260 (390)
T 3o6n_A 192 NVSYNLLST-----LAIPIAVEELDASHNSINVV-RGPV--NVEL-TILKLQHNNLTDT--AWLLNYPGLVEVDLSYNEL 260 (390)
T ss_dssp ECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECCC--CSSC-CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred ecccccccc-----cCCCCcceEEECCCCeeeec-cccc--cccc-cEEECCCCCCccc--HHHcCCCCccEEECCCCcC
Confidence 999999874 34557899999999999843 4322 3455 4559999999864 5789999999999999999
Q ss_pred CCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCc
Q 004218 288 SGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREG 367 (767)
Q Consensus 288 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 367 (767)
++..|..|..+++|+.|++++|++++ ++..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++..+ ..
T Consensus 261 ~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~ 336 (390)
T 3o6n_A 261 EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LS 336 (390)
T ss_dssp CEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CC
T ss_pred CCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC--ch
Confidence 99889999999999999999999985 5666788999999999999998 67778899999999999999999875 44
Q ss_pred cccccccccccCCcCccc
Q 004218 368 IFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 368 ~~~~~~~~~l~~Np~~c~ 385 (767)
.++++..+++.+||+.|.
T Consensus 337 ~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 337 THHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp TTCCCSEEECCSSCEEHH
T ss_pred hhccCCEEEcCCCCccch
Confidence 578899999999999884
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=303.19 Aligned_cols=231 Identities=23% Similarity=0.368 Sum_probs=175.0
Q ss_pred hcCCCCC-CccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHH-hcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHE-NLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEAL-RNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|.+. +.||+|+||.||+|.+. +++.||+|++.. ...+.+|+.++ +..+||||+++++++... ......
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence 4567777 78999999999999975 589999999853 25677899888 566999999999986532 234667
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE---DMTAKVG 607 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~ 607 (767)
.++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEEEeecCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence 899999999999999998643 23599999999999999999999999 9999999999999997 7899999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcc--hhhHh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS--LVKWV 685 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~ 685 (767)
|||++... .+..++.++||||+||++|||++|+.||......... .....
T Consensus 163 Dfg~a~~~----------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 214 (299)
T 3m2w_A 163 DFGFAKET----------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 214 (299)
T ss_dssp CCTTCEEC----------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS
T ss_pred cccccccc----------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH
Confidence 99998532 1234678899999999999999999999654322110 00000
Q ss_pred -hhhc--ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 -ESNF--PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 -~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.... +......++ ..+.+++.+||+.||++|||++|++++
T Consensus 215 ~~~~~~~~~~~~~~~~----------------------~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 215 RMGQYEFPNPEWSEVS----------------------EEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CTTCCSSCHHHHTTSC----------------------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccCCchhcccCC----------------------HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 000001111 112236778999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.21 Aligned_cols=251 Identities=17% Similarity=0.152 Sum_probs=178.2
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCC-CCceeE---------Eee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEALRNTRH-RNLVKL---------ITS 519 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~~---------~~~ 519 (767)
..+|...+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.++| ++.... .+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345778889999999999999965 599999999863322 336788999999999977 321111 111
Q ss_pred eec------------CCcccceeeEEEEeecCCCChhhhhcccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 004218 520 CSS------------LDFKNMEFLALVYEFLGNGSLGDWIHGERK-NEHGNGLNFLERLNIAIDIASALDYLHNDCEVPI 586 (767)
Q Consensus 520 ~~~------------~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 586 (767)
+.. .........+++|+++ +++|.+++..... ......+++..++.++.|+++||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 100 0000122356777765 6799999852211 01123488889999999999999999999 99
Q ss_pred EeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCcccc----------CCCCCCCcccchh
Q 004218 587 VHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYG----------LGEKPSTAGDVYS 656 (767)
Q Consensus 587 vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s 656 (767)
+||||||+||+++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 99999999999999999999999998764332 233457 999999998 5666888999999
Q ss_pred hhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCC
Q 004218 657 FGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPG 736 (767)
Q Consensus 657 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 736 (767)
|||++|||++|+.||......... .. .+... ..++ + .+.+++.+||+.||+
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~~--~~---~~~~~--~~~~------------------~----~~~~li~~~l~~dP~ 353 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGGS--EW---IFRSC--KNIP------------------Q----PVRALLEGFLRYPKE 353 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSCS--GG---GGSSC--CCCC------------------H----HHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHCCCCCCCcchhhhH--HH---HHhhc--ccCC------------------H----HHHHHHHHHccCChh
Confidence 999999999999999664322110 00 01100 0011 1 122367789999999
Q ss_pred CCCCHHHHHHH
Q 004218 737 GRIDIREALRR 747 (767)
Q Consensus 737 ~Rpt~~evl~~ 747 (767)
+|||+.|++++
T Consensus 354 ~Rpt~~~~l~~ 364 (413)
T 3dzo_A 354 DRLLPLQAMET 364 (413)
T ss_dssp GSCCHHHHTTS
T ss_pred hCcCHHHHHhC
Confidence 99999888654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=310.83 Aligned_cols=316 Identities=20% Similarity=0.210 Sum_probs=269.4
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
+++|++|+|++|+++ .+| +..+++|++|++++|.+.+ ++ ++++++|++|++++|.+++ ++ ++.+++|++|
T Consensus 63 l~~L~~L~Ls~n~l~-~~~---~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L 132 (457)
T 3bz5_A 63 LTGLTKLICTSNNIT-TLD---LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYL 132 (457)
T ss_dssp CTTCSEEECCSSCCS-CCC---CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEE
T ss_pred cCCCCEEEccCCcCC-eEc---cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEE
Confidence 578999999999998 676 4469999999999999996 44 8999999999999999995 44 8999999999
Q ss_pred eecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEE
Q 004218 81 NIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLN 160 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~ 160 (767)
++++|++++. .+.++++|++|++++|+..+.+ .+..+++ |++|++++|++++ +| +..+++|+.|+
T Consensus 133 ~l~~N~l~~l---------~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~-L~~L~ls~n~l~~-l~--l~~l~~L~~L~ 197 (457)
T 3bz5_A 133 NCARNTLTEI---------DVSHNTQLTELDCHLNKKITKL--DVTPQTQ-LTTLDCSFNKITE-LD--VSQNKLLNRLN 197 (457)
T ss_dssp ECTTSCCSCC---------CCTTCTTCCEEECTTCSCCCCC--CCTTCTT-CCEEECCSSCCCC-CC--CTTCTTCCEEE
T ss_pred ECCCCcccee---------ccccCCcCCEEECCCCCccccc--ccccCCc-CCEEECCCCccce-ec--cccCCCCCEEE
Confidence 9999998753 2778999999999999665555 4777887 9999999999996 45 88999999999
Q ss_pred CcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCcc-------ccccccc
Q 004218 161 LSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQ-------NLLSIDL 233 (767)
Q Consensus 161 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-------~L~~L~l 233 (767)
+++|.+++. .+..+++|++|++++|++++ +| +..+++|+.|++++|++++..+..+..++ +|+.|++
T Consensus 198 l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l 271 (457)
T 3bz5_A 198 CDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDL 271 (457)
T ss_dssp CCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCC
T ss_pred CcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEEC
Confidence 999999965 48899999999999999996 56 88999999999999999987766666665 6678888
Q ss_pred cCcccCCCCChhhcccccccceeecccccCCCCCch--------hhcCCCceeEEEccCCCCCCCCCcccccCcccceee
Q 004218 234 SNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPE--------EIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLL 305 (767)
Q Consensus 234 ~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~--------~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~ 305 (767)
++|.+.+.+| +..+++|.. +++++|...+.+|. .++.+++|+.|++++|++++. .+..+++|+.|+
T Consensus 272 ~~n~~~~~~~--~~~l~~L~~-L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l---~l~~l~~L~~L~ 345 (457)
T 3bz5_A 272 THNTQLIYFQ--AEGCRKIKE-LDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLS 345 (457)
T ss_dssp TTCTTCCEEE--CTTCTTCCC-CCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC---CCTTCTTCSEEE
T ss_pred CCCccCCccc--ccccccCCE-EECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc---ccccCCcCcEEE
Confidence 8888777766 467788844 49999987766554 366778999999999999975 389999999999
Q ss_pred ccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCC
Q 004218 306 MANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE 366 (767)
Q Consensus 306 l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 366 (767)
+++|++++ ++.|..|++++|.+.|. ..+..|+.+++++|+++|.+|..
T Consensus 346 l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 346 CVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp CCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred CCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence 99999985 35677888999999875 46678899999999999988764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=318.08 Aligned_cols=196 Identities=19% Similarity=0.223 Sum_probs=161.0
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCC--------cchhhHHHHHHHHhcCC---------CCCceeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIEST--------GTWKSFFAECEALRNTR---------HRNLVKL 516 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~niv~~ 516 (767)
.++|++.+.||+|+||.||+|++ +|+.||||++..... ...+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999998 589999999975432 23467889999998885 7777777
Q ss_pred EeeeecC-------------------------CcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHH
Q 004218 517 ITSCSSL-------------------------DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571 (767)
Q Consensus 517 ~~~~~~~-------------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i 571 (767)
.+++... ++.....+++||||+++|++.+.+... .+++.++..++.|+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-------~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-------LSSLATAKSILHQL 170 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-------CCCHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-------CCCHHHHHHHHHHH
Confidence 7654211 011356789999999999877766432 28999999999999
Q ss_pred HHHHHHHH-hCCCCCeEeecCCCCCeeeCCCC--------------------ceEEccccchhhhhhhcCCCcccccccc
Q 004218 572 ASALDYLH-NDCEVPIVHCDLKPGNILLDEDM--------------------TAKVGDFGLARSLLERIGNQSSISSTHV 630 (767)
Q Consensus 572 ~~~l~~LH-~~~~~~ivH~Dlkp~NIl~~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 630 (767)
+.||+||| +. +|+||||||+|||++.++ .+||+|||+|+.... ..
T Consensus 171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----------~~ 236 (336)
T 2vuw_A 171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----------GI 236 (336)
T ss_dssp HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----------TE
T ss_pred HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----------Cc
Confidence 99999999 88 999999999999999887 899999999986532 13
Q ss_pred ccCCCCccCccccCCCCCCCcccchhhhHH-HHHHHhCCCCCC
Q 004218 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVM-LLEIFTGMSPTH 672 (767)
Q Consensus 631 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~i-l~el~tg~~p~~ 672 (767)
..||+.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 237 ~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 237 VVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp EECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred EEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 46899999999998766 889999998777 778888999873
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=323.60 Aligned_cols=312 Identities=21% Similarity=0.210 Sum_probs=273.4
Q ss_pred CCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhh
Q 004218 49 NLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNL 128 (767)
Q Consensus 49 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l 128 (767)
.+.+++.|++++|.++...+..+..+++|++|+|++|.+.+. .+..+..+++|++|+|++|.+++..|..++++
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 122 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI------DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEE------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCC------ChHHhcCCCCCCEEECCCCcCCCCCHHHHcCC
Confidence 468999999999999965556688899999999999998753 23478899999999999999998888888999
Q ss_pred ccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceee
Q 004218 129 SNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQID 208 (767)
Q Consensus 129 ~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 208 (767)
++ |++|+|++|+++...+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|.+.+. + +..+++|+.|+
T Consensus 123 ~~-L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~--~~~l~~L~~L~ 198 (597)
T 3oja_B 123 PL-LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIPSLFHAN 198 (597)
T ss_dssp TT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-C--GGGCTTCSEEE
T ss_pred CC-CCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-C--hhhhhhhhhhh
Confidence 98 99999999999977667789999999999999999998888999999999999999999954 3 67789999999
Q ss_pred CCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCC
Q 004218 209 LSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS 288 (767)
Q Consensus 209 L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~ 288 (767)
+++|.+++ +...++|+.|++++|.+... +..+. ++| +.+++++|.+++ +..++.+++|+.|+|++|.++
T Consensus 199 l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~-~~~~~--~~L-~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~ 267 (597)
T 3oja_B 199 VSYNLLST-----LAIPIAVEELDASHNSINVV-RGPVN--VEL-TILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE 267 (597)
T ss_dssp CCSSCCSE-----EECCTTCSEEECCSSCCCEE-ECSCC--SCC-CEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred cccCcccc-----ccCCchhheeeccCCccccc-ccccC--CCC-CEEECCCCCCCC--ChhhccCCCCCEEECCCCccC
Confidence 99999874 44567899999999999843 33222 345 555999999986 478999999999999999999
Q ss_pred CCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCcc
Q 004218 289 GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGI 368 (767)
Q Consensus 289 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 368 (767)
+..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|++++.+ ...
T Consensus 268 ~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~ 343 (597)
T 3oja_B 268 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LST 343 (597)
T ss_dssp EEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCT
T ss_pred CCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhh
Confidence 9999999999999999999999995 5667788999999999999999 67888999999999999999999875 345
Q ss_pred ccccccccccCCcCccc
Q 004218 369 FRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 369 ~~~~~~~~l~~Np~~c~ 385 (767)
++.+..+++.+|||.|.
T Consensus 344 ~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 344 HHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp TCCCSEEECCSSCEEHH
T ss_pred cCCCCEEEeeCCCCCCh
Confidence 78899999999999985
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=293.03 Aligned_cols=295 Identities=19% Similarity=0.241 Sum_probs=141.2
Q ss_pred CccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEee
Q 004218 3 SLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNI 82 (767)
Q Consensus 3 ~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 82 (767)
++++++++++.++ .+|..+. ++|++|++++|++.+..+..|.++++|++|+|++|.+++..|..|+.+++|++|++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 3555566666555 5555443 35555666666655444445556666666666666655444555555555555555
Q ss_pred cCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECc
Q 004218 83 GFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLS 162 (767)
Q Consensus 83 ~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~ 162 (767)
++|+++. +|..+. ++ |++|++++|++++..+..|.++++|++|+++
T Consensus 108 s~n~l~~-------------------------------l~~~~~--~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 153 (330)
T 1xku_A 108 SKNQLKE-------------------------------LPEKMP--KT-LQELRVHENEITKVRKSVFNGLNQMIVVELG 153 (330)
T ss_dssp CSSCCSB-------------------------------CCSSCC--TT-CCEEECCSSCCCBBCHHHHTTCTTCCEEECC
T ss_pred CCCcCCc-------------------------------cChhhc--cc-ccEEECCCCcccccCHhHhcCCccccEEECC
Confidence 5555543 332222 12 4455555555544444444555555555555
Q ss_pred CCcCcc--cCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCC
Q 004218 163 YNSISG--EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 163 ~n~i~~--~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
+|.+.. ..+..+..+++|++|++++|.+. .+|..+. ++|++|++++|++++..+..|..+++|+.|++++|.+++
T Consensus 154 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 230 (330)
T 1xku_A 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230 (330)
T ss_dssp SSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred CCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce
Confidence 555432 33444555555555555555555 2333322 455555555555555445555555555555555555543
Q ss_pred CCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhh
Q 004218 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILA 320 (767)
Q Consensus 241 ~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 320 (767)
..+..+..+++|. .+++++|.++ .+|..+..+++|+.|++++|.+++..+..|..... ..
T Consensus 231 ~~~~~~~~l~~L~-~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~------------------~~ 290 (330)
T 1xku_A 231 VDNGSLANTPHLR-ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY------------------NT 290 (330)
T ss_dssp ECTTTGGGSTTCC-EEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSC------------------CT
T ss_pred eChhhccCCCCCC-EEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCccc------------------cc
Confidence 2222222222221 1122222222 22333344444555555555554444333322100 01
Q ss_pred ccCCceEEEcCCcccCC--CCCccccccccCceEeccCCc
Q 004218 321 ELKGLEVLDLSSNKLSG--SIPSDLQNLRALRSLNLTFNN 358 (767)
Q Consensus 321 ~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~l~~N~ 358 (767)
..+.|+.|++++|++.. ..|..|..+.+++.+++++|+
T Consensus 291 ~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 291 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp TSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 12456666666666642 445566666667777766663
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=294.88 Aligned_cols=304 Identities=17% Similarity=0.219 Sum_probs=216.5
Q ss_pred CCeeeecCCCccccCCC-----CCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCc
Q 004218 11 SNQLWGEIPYDVGDKLP-----NLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFN 85 (767)
Q Consensus 11 ~n~l~~~ip~~~~~~l~-----~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n 85 (767)
.+.+. ++|..+....+ +++.++++++.+. .+|..+. ++|++|+|++|.+++..|..|+.+++|++|++++|
T Consensus 13 ~~~l~-~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 88 (332)
T 2ft3_A 13 IPDLD-SLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN 88 (332)
T ss_dssp -------------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCccc-cCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCC
Confidence 34444 66665543322 6888888888888 6776553 68888888888888766778888888888888888
Q ss_pred cccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCc
Q 004218 86 KIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNS 165 (767)
Q Consensus 86 ~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~ 165 (767)
++.. ..+..+.++++|++|++++|+++ .+|..+. ++ |++|++++|+++...+..|.++++|++|++++|.
T Consensus 89 ~l~~------~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~-L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 158 (332)
T 2ft3_A 89 KISK------IHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SS-LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNP 158 (332)
T ss_dssp CCCE------ECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TT-CCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCC
T ss_pred ccCc------cCHhHhhCcCCCCEEECCCCcCC-ccCcccc--cc-CCEEECCCCccCccCHhHhCCCccCCEEECCCCc
Confidence 8763 23556788888888888888888 6666555 44 9999999999987777779999999999999999
Q ss_pred Ccc--cCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCC
Q 004218 166 ISG--EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIP 243 (767)
Q Consensus 166 i~~--~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 243 (767)
++. ..+..+..+ +|++|++++|++++ +|..+. ++|++|++++|.+++..+..|..+++|+.|++++|++++..+
T Consensus 159 l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 234 (332)
T 2ft3_A 159 LENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIEN 234 (332)
T ss_dssp CBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCT
T ss_pred cccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCCh
Confidence 963 667778888 99999999999984 565554 789999999999998888899999999999999998885444
Q ss_pred hhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhc--
Q 004218 244 KEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAE-- 321 (767)
Q Consensus 244 ~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-- 321 (767)
..+.. +++|+.|++++|+++ .+|..+..+++|+.|++++|++++..+..|..
T Consensus 235 ~~~~~-------------------------l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~ 288 (332)
T 2ft3_A 235 GSLSF-------------------------LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVG 288 (332)
T ss_dssp TGGGG-------------------------CTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSS
T ss_pred hHhhC-------------------------CCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccc
Confidence 44444 445555555555555 44445555556666666666555544444433
Q ss_pred ----cCCceEEEcCCcccC--CCCCccccccccCceEeccCCc
Q 004218 322 ----LKGLEVLDLSSNKLS--GSIPSDLQNLRALRSLNLTFNN 358 (767)
Q Consensus 322 ----l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~l~~N~ 358 (767)
.++|+.|++++|++. +..|..+..+++|+.+++++|+
T Consensus 289 ~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 289 FGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 356777888888776 5666777778888888887764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-33 Score=290.47 Aligned_cols=218 Identities=22% Similarity=0.275 Sum_probs=101.1
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
++++++++++++ .+|..++ ++|++|++++|.+.+..|..|.++++|++|+|++|.+++..|..|+.+++|++|+++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred CCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 444555555554 4444432 244555555555544444445555555555555555544444445555555555555
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCccc--ccCCccccCCCCCCEEEC
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFY--GKIPTSIGRLRSLTLLNL 161 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~--~~~~~~l~~l~~L~~L~l 161 (767)
+|++...+.. +. ++|++|++++|++++..+..+..+++ |++|++++|.++ +..+..+..+ +|++|++
T Consensus 111 ~n~l~~l~~~-------~~--~~L~~L~l~~n~i~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l 179 (332)
T 2ft3_A 111 KNHLVEIPPN-------LP--SSLVELRIHDNRIRKVPKGVFSGLRN-MNCIEMGGNPLENSGFEPGAFDGL-KLNYLRI 179 (332)
T ss_dssp SSCCCSCCSS-------CC--TTCCEEECCSSCCCCCCSGGGSSCSS-CCEEECCSCCCBGGGSCTTSSCSC-CCSCCBC
T ss_pred CCcCCccCcc-------cc--ccCCEEECCCCccCccCHhHhCCCcc-CCEEECCCCccccCCCCcccccCC-ccCEEEC
Confidence 5544432211 11 34455555555554333333444444 555555555443 1334444444 4555555
Q ss_pred cCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccC
Q 004218 162 SYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 162 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
++|.+++ +|..+. ++|++|++++|.+.+..+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|+++
T Consensus 180 ~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 254 (332)
T 2ft3_A 180 SEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254 (332)
T ss_dssp CSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred cCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence 5555442 222222 34555555555554444444445555555555555554444444444455555544444443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.35 Aligned_cols=253 Identities=34% Similarity=0.577 Sum_probs=171.2
Q ss_pred CCCCEEECcCCccee--ecCchhhhhccccCeEEccC-CcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCC
Q 004218 105 TRLNFLAFDGNQFEG--EIPESIGNLSNVLSKLYMGG-NRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQ 181 (767)
Q Consensus 105 ~~L~~L~l~~n~l~~--~~~~~~~~l~~~L~~L~l~~-n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~ 181 (767)
.+++.|+|++|++++ .+|..+.+++. |++|++++ |++.+.+|..|.++++|++|+|++|.+++..|..|.++++|+
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~-L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 128 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPY-LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTT-CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCC-CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence 356666666666665 56666666655 66666663 556555566666666666666666666555555566666666
Q ss_pred EEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCcc-ccccccccCcccCCCCChhhcccccccceeeccc
Q 004218 182 SLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQ-NLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSK 260 (767)
Q Consensus 182 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~ 260 (767)
+|+|++|.+.+.+|..|..+++|++|+|++|++++..|..+..++ +|+.|++++|+++
T Consensus 129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~--------------------- 187 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT--------------------- 187 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE---------------------
T ss_pred EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeee---------------------
Confidence 666666666555555566666666666666666555555555555 5555555555555
Q ss_pred ccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCC
Q 004218 261 NFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIP 340 (767)
Q Consensus 261 n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 340 (767)
+..|..++.++ |+.|++++|.+++..|..|..+++|+.|++++|.+++..+. +..+++|++|+|++|++++.+|
T Consensus 188 ----~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p 261 (313)
T 1ogq_A 188 ----GKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLP 261 (313)
T ss_dssp ----EECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCC
T ss_pred ----ccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCC
Confidence 44455555554 77777777777777777777777777777777777755554 6777888888888888887888
Q ss_pred ccccccccCceEeccCCcCcCcCCCCccccccccccccCCcCccc
Q 004218 341 SDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 341 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c~ 385 (767)
..+..+++|+.|++++|++++.+|....++++..+++.+||+.|+
T Consensus 262 ~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 262 QGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp GGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred hHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccC
Confidence 888888888888888888887777777778888888888888887
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=303.54 Aligned_cols=330 Identities=23% Similarity=0.293 Sum_probs=179.9
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCC-------------CEEEcccccCcccCC
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNI-------------QIIRMAHNLLEGTVP 68 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L-------------~~L~l~~n~i~~~~~ 68 (767)
++|++|++++|++ |++|.+++ .+++|++|++++|++.+.+|..++++++| ++|++++|.+++ +|
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~-~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp 87 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAE-NVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LP 87 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CC
T ss_pred ccchhhhcccCch-hhCChhHh-cccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CC
Confidence 5799999999999 59999886 59999999999999999999999988864 889999998884 44
Q ss_pred ccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCc
Q 004218 69 PGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPT 148 (767)
Q Consensus 69 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~ 148 (767)
.. .++|++|++++|.+.+.+.. .++|++|++++|++++ +|... ++ |++|++++|++++ +|
T Consensus 88 ~~---~~~L~~L~l~~n~l~~lp~~----------~~~L~~L~l~~n~l~~-l~~~~---~~-L~~L~L~~n~l~~-lp- 147 (454)
T 1jl5_A 88 EL---PPHLESLVASCNSLTELPEL----------PQSLKSLLVDNNNLKA-LSDLP---PL-LEYLGVSNNQLEK-LP- 147 (454)
T ss_dssp SC---CTTCSEEECCSSCCSSCCCC----------CTTCCEEECCSSCCSC-CCSCC---TT-CCEEECCSSCCSS-CC-
T ss_pred CC---cCCCCEEEccCCcCCccccc----------cCCCcEEECCCCccCc-ccCCC---CC-CCEEECcCCCCCC-Cc-
Confidence 42 36788888888887754321 2456666666666552 22211 22 5666666666653 44
Q ss_pred cccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCcccc
Q 004218 149 SIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNL 228 (767)
Q Consensus 149 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 228 (767)
.|+++++|++|++++|++++ +|.. .++|++|++++|++.+ +| .+.++++|++|++++|++++ .|... ++|
T Consensus 148 ~~~~l~~L~~L~l~~N~l~~-lp~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L 217 (454)
T 1jl5_A 148 ELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSL 217 (454)
T ss_dssp CCTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTC
T ss_pred ccCCCCCCCEEECCCCcCcc-cCCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---Ccc
Confidence 35556666666666665553 2322 2355555555555553 33 35555555555555555543 22211 345
Q ss_pred ccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCccc-------------
Q 004218 229 LSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSF------------- 295 (767)
Q Consensus 229 ~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~------------- 295 (767)
+.|++++|.+. .+| .+..++++. .+++++|++++ +|. .+++|+.|++++|.+++ +|..+
T Consensus 218 ~~L~l~~n~l~-~lp-~~~~l~~L~-~L~l~~N~l~~-l~~---~~~~L~~L~l~~N~l~~-l~~~~~~L~~L~ls~N~l 289 (454)
T 1jl5_A 218 ESIVAGNNILE-ELP-ELQNLPFLT-TIYADNNLLKT-LPD---LPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIF 289 (454)
T ss_dssp CEEECCSSCCS-SCC-CCTTCTTCC-EEECCSSCCSS-CCS---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCC
T ss_pred cEEECcCCcCC-ccc-ccCCCCCCC-EEECCCCcCCc-ccc---cccccCEEECCCCcccc-cCcccCcCCEEECcCCcc
Confidence 55555555554 344 244444442 22555555543 221 12344444444444443 22211
Q ss_pred ----ccCcccceeeccCccccCCCCchhhcc-CCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCcccc
Q 004218 296 ----KNCKSLEKLLMANNKFSGPIPNILAEL-KGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFR 370 (767)
Q Consensus 296 ----~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~ 370 (767)
.-.++|+.|++++|.+++. ..+ ++|+.|++++|++++ +|.. +++|+.|++++|.+++++. .+.
T Consensus 290 ~~l~~~~~~L~~L~l~~N~l~~i-----~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~lp~---~l~ 357 (454)
T 1jl5_A 290 SGLSELPPNLYYLNASSNEIRSL-----CDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEVPE---LPQ 357 (454)
T ss_dssp SEESCCCTTCCEEECCSSCCSEE-----CCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC---CCT
T ss_pred CcccCcCCcCCEEECcCCcCCcc-----cCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccccccc---hhh
Confidence 0013455555555555431 122 478888888888885 5543 5788889999998887554 467
Q ss_pred ccccccccCCcCcc
Q 004218 371 HTSMVHLEGNPKLC 384 (767)
Q Consensus 371 ~~~~~~l~~Np~~c 384 (767)
++..+++.+|+..+
T Consensus 358 ~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 358 NLKQLHVEYNPLRE 371 (454)
T ss_dssp TCCEEECCSSCCSS
T ss_pred hccEEECCCCCCCc
Confidence 78888888887655
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.26 Aligned_cols=255 Identities=32% Similarity=0.504 Sum_probs=226.1
Q ss_pred CCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcC-CcceeecCchhhhhccccCeEEccCCcccccCCccccCC
Q 004218 75 PFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDG-NQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRL 153 (767)
Q Consensus 75 ~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l 153 (767)
.+++.|+|++|.+.+. ..++..+.++++|++|++++ |++.+.+|..+.++++ |++|++++|++++.+|..|.++
T Consensus 50 ~~l~~L~L~~~~l~~~----~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~-L~~L~Ls~n~l~~~~p~~~~~l 124 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKP----YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ-LHYLYITHTNVSGAIPDFLSQI 124 (313)
T ss_dssp CCEEEEEEECCCCSSC----EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTT-CSEEEEEEECCEEECCGGGGGC
T ss_pred ceEEEEECCCCCccCC----cccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCC-CCEEECcCCeeCCcCCHHHhCC
Confidence 5799999999998631 13567889999999999995 9999999999999998 9999999999999999999999
Q ss_pred CCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCC-CCceeeCCCCcCCCCCcccccCcccccccc
Q 004218 154 RSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLK-KLNQIDLSGNELASEIPTSFGNFQNLLSID 232 (767)
Q Consensus 154 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 232 (767)
++|++|+|++|.+++..|..+..+++|++|++++|++++.+|..+..++ +|++|+|++|++++..|..|..++ |+.|+
T Consensus 125 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~ 203 (313)
T 1ogq_A 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVD 203 (313)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEE
T ss_pred CCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEE
Confidence 9999999999999999999999999999999999999999999999998 999999999999988999998887 88888
Q ss_pred ccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCcccc
Q 004218 233 LSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFS 312 (767)
Q Consensus 233 l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 312 (767)
+++|.+++. .|..+..+++|+.|+|++|.+++..|. +..+++|++|++++|.++
T Consensus 204 Ls~N~l~~~-------------------------~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~ 257 (313)
T 1ogq_A 204 LSRNMLEGD-------------------------ASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIY 257 (313)
T ss_dssp CCSSEEEEC-------------------------CGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCE
T ss_pred CcCCcccCc-------------------------CCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCccc
Confidence 888877643 344566677888888888888866554 788899999999999999
Q ss_pred CCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCc-CcCc
Q 004218 313 GPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNN-LEGV 362 (767)
Q Consensus 313 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~ 362 (767)
+.+|..+..+++|+.|+|++|++++.+|.. ..+++|+.+++++|+ +.+.
T Consensus 258 ~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp ECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEEST
T ss_pred CcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCC
Confidence 889999999999999999999999888876 889999999999998 5553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-31 Score=293.25 Aligned_cols=322 Identities=25% Similarity=0.343 Sum_probs=195.9
Q ss_pred CccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEee
Q 004218 3 SLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNI 82 (767)
Q Consensus 3 ~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 82 (767)
++++|++++|+++ .+|.. .++|++|++++|.+.+ +|.. .++|++|++++|.+++ ++.. .++|++|++
T Consensus 72 ~l~~L~l~~~~l~-~lp~~----~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L 138 (454)
T 1jl5_A 72 QAHELELNNLGLS-SLPEL----PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGV 138 (454)
T ss_dssp TCSEEECTTSCCS-CCCSC----CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEEC
T ss_pred CCCEEEecCCccc-cCCCC----cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEEC
Confidence 3567777777776 56642 3567777777777774 5543 3677777777777763 3321 157777777
Q ss_pred cCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECc
Q 004218 83 GFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLS 162 (767)
Q Consensus 83 ~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~ 162 (767)
++|++.+. + .+.++++|++|++++|++++ +|..+ .+ |++|++++|++++ +| .+.++++|++|+++
T Consensus 139 ~~n~l~~l-------p-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~-L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 139 SNNQLEKL-------P-ELQNSSFLKIIDVDNNSLKK-LPDLP---PS-LEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp CSSCCSSC-------C-CCTTCTTCCEEECCSSCCSC-CCCCC---TT-CCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred cCCCCCCC-------c-ccCCCCCCCEEECCCCcCcc-cCCCc---cc-ccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 77777532 2 46777778888888887773 55433 23 7778888887775 45 47777788888888
Q ss_pred CCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCC
Q 004218 163 YNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNI 242 (767)
Q Consensus 163 ~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 242 (767)
+|.+++ +|.. .++|++|++++|.+. .+| .+..+++|++|++++|++++ +|.. +++|+.|++++|++++ +
T Consensus 204 ~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l 272 (454)
T 1jl5_A 204 NNSLKK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-L 272 (454)
T ss_dssp SSCCSS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-C
T ss_pred CCcCCc-CCCC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-c
Confidence 887774 3322 247777788877777 555 37777778888888887764 3332 3677777777777774 4
Q ss_pred ChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccC-cccceeeccCccccCCCCchhhc
Q 004218 243 PKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNC-KSLEKLLMANNKFSGPIPNILAE 321 (767)
Q Consensus 243 ~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~ 321 (767)
|..+ +++ +.+++++|.+++.. . ..++|+.|++++|.+++. + .+ ++|+.|++++|++++ +|..
T Consensus 273 ~~~~---~~L-~~L~ls~N~l~~l~-~---~~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~--- 335 (454)
T 1jl5_A 273 PELP---QSL-TFLDVSENIFSGLS-E---LPPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL--- 335 (454)
T ss_dssp CCCC---TTC-CEEECCSSCCSEES-C---CCTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---
T ss_pred Cccc---CcC-CEEECcCCccCccc-C---cCCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---
Confidence 4432 334 34477777776521 1 124667777777766642 1 22 477777777777775 4433
Q ss_pred cCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCc--CCCC-ccc-------------cccccccccCCcCcc
Q 004218 322 LKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGV--VPRE-GIF-------------RHTSMVHLEGNPKLC 384 (767)
Q Consensus 322 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~-~~~-------------~~~~~~~l~~Np~~c 384 (767)
+++|+.|++++|+++ .+|. .+++|++|++++|++++. .|.. ..+ +++..+++.+|+...
T Consensus 336 ~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 336 PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE 410 (454)
T ss_dssp CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------
T ss_pred CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCc
Confidence 466777777777777 3554 357777777777777773 2322 222 455666677776543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-32 Score=285.00 Aligned_cols=287 Identities=22% Similarity=0.311 Sum_probs=223.5
Q ss_pred CCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccc
Q 004218 52 NIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNV 131 (767)
Q Consensus 52 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~ 131 (767)
+|+.++++++.++ .+|..+. ++|++|++++|++++.+ ...+.++++|++|++++|++++..|..+..+++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~- 101 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIK------DGDFKNLKNLHTLILINNKISKISPGAFAPLVK- 101 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBC------TTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTT-
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeC------hhhhccCCCCCEEECCCCcCCeeCHHHhcCCCC-
Confidence 5677777777776 5555443 56777777777776432 224677788888888888888777889999988
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCcccc--ccCcCcccCCCCceeeC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISG--SIPNTLGNLKKLNQIDL 209 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L 209 (767)
|++|++++|+++ .+|..+. ++|++|++++|.+++..+..|..+++|++|++++|.+.. ..+..|..+++|++|++
T Consensus 102 L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l 178 (330)
T 1xku_A 102 LERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178 (330)
T ss_dssp CCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred CCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEEC
Confidence 999999999998 5566554 799999999999998888889999999999999999963 67788999999999999
Q ss_pred CCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCC
Q 004218 210 SGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSG 289 (767)
Q Consensus 210 ~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~ 289 (767)
++|.++. +|..+. ++|++|++++|++++ ..+..+..+++|+.|++++|.+++
T Consensus 179 ~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~-------------------------~~~~~~~~l~~L~~L~Ls~n~l~~ 230 (330)
T 1xku_A 179 ADTNITT-IPQGLP--PSLTELHLDGNKITK-------------------------VDAASLKGLNNLAKLGLSFNSISA 230 (330)
T ss_dssp CSSCCCS-CCSSCC--TTCSEEECTTSCCCE-------------------------ECTGGGTTCTTCCEEECCSSCCCE
T ss_pred CCCcccc-CCcccc--ccCCEEECCCCcCCc-------------------------cCHHHhcCCCCCCEEECCCCcCce
Confidence 9999985 454443 778888888877763 334456667788888888888887
Q ss_pred CCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccc------cccCceEeccCCcCcCcC
Q 004218 290 NLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQN------LRALRSLNLTFNNLEGVV 363 (767)
Q Consensus 290 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~l~~N~l~~~~ 363 (767)
..+..+..+++|+.|++++|+++ .+|..+..+++|+.|+|++|++++..+..|.. .+.|+.|++++|++....
T Consensus 231 ~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~ 309 (330)
T 1xku_A 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309 (330)
T ss_dssp ECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGG
T ss_pred eChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccc
Confidence 77778888888888888888888 67777888889999999999998766666643 378999999999997532
Q ss_pred --CCC-ccccccccccccCC
Q 004218 364 --PRE-GIFRHTSMVHLEGN 380 (767)
Q Consensus 364 --~~~-~~~~~~~~~~l~~N 380 (767)
|.. .....+..+++.+|
T Consensus 310 i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 310 IQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp SCGGGGTTCCCGGGEEC---
T ss_pred cCccccccccceeEEEeccc
Confidence 222 33456677777776
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-36 Score=331.13 Aligned_cols=358 Identities=15% Similarity=0.120 Sum_probs=286.6
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccc----cCCccccCCCCCCEEEcccccCcccCCccCC-CCC
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTG----KIPGSLHNLTNIQIIRMAHNLLEGTVPPGLG-NLP 75 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~----~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~-~l~ 75 (767)
+++|++|||++|++++.....++..+++|++|++++|++.+ .++..+..+++|++|+|++|.+++..+..+. .++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 35789999999999844334446679999999999999985 4577889999999999999999865443332 244
Q ss_pred ----CCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhh-----ccccCeEEccCCccccc-
Q 004218 76 ----FLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNL-----SNVLSKLYMGGNRFYGK- 145 (767)
Q Consensus 76 ----~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l-----~~~L~~L~l~~n~i~~~- 145 (767)
+|++|+|++|++...+. ..++..+.++++|++|++++|.+++..+..+... .+ |++|++++|+++..
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~--~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~-L~~L~L~~n~l~~~~ 158 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGC--GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR-LEKLQLEYCSLSAAS 158 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGH--HHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCC-CCEEECTTSCCBGGG
T ss_pred hCCCceeEEEccCCCCCHHHH--HHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCc-ceEEECCCCCCCHHH
Confidence 79999999999864211 1457788999999999999999987666666542 34 99999999999864
Q ss_pred ---CCccccCCCCCCEEECcCCcCcccCccccC-----CCCCCCEEEccCCccccc----cCcCcccCCCCceeeCCCCc
Q 004218 146 ---IPTSIGRLRSLTLLNLSYNSISGEILTEIG-----QLQELQSLDLAGNQISGS----IPNTLGNLKKLNQIDLSGNE 213 (767)
Q Consensus 146 ---~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~-----~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~ 213 (767)
++..+..+++|++|++++|.++...+..+. ..++|++|++++|.++.. ++..+..+++|++|+|++|+
T Consensus 159 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 238 (461)
T 1z7x_W 159 CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238 (461)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSB
T ss_pred HHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCc
Confidence 366677889999999999999865555544 367999999999999853 56778889999999999999
Q ss_pred CCCCC-----cccccCccccccccccCcccCCC----CChhhcccccccceeecccccCCCCCchhhcC-----CCceeE
Q 004218 214 LASEI-----PTSFGNFQNLLSIDLSNNKLNGN----IPKEILSLSSLTTIVNLSKNFLDGTLPEEIGM-----LGNVVT 279 (767)
Q Consensus 214 l~~~~-----~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~-----l~~L~~ 279 (767)
++... +..+..+++|++|++++|.++.. ++..+..+++|. .+++++|.+++..+..+.. .++|+.
T Consensus 239 l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~-~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~ 317 (461)
T 1z7x_W 239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLK-ELSLAGNELGDEGARLLCETLLEPGCQLES 317 (461)
T ss_dssp CHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCC-EEECTTCCCHHHHHHHHHHHHTSTTCCCCE
T ss_pred CChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcc-eEECCCCCCchHHHHHHHHHhccCCcccee
Confidence 87532 22334689999999999999854 567777788885 4599999997654444433 369999
Q ss_pred EEccCCCCCCC----CCcccccCcccceeeccCccccCCCCchhhc-----cCCceEEEcCCcccCC----CCCcccccc
Q 004218 280 IDLSANGLSGN----LPNSFKNCKSLEKLLMANNKFSGPIPNILAE-----LKGLEVLDLSSNKLSG----SIPSDLQNL 346 (767)
Q Consensus 280 L~ls~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l 346 (767)
|++++|.+++. ++..+..+++|+.|++++|.+++..+..+.. .++|+.|+|++|.+++ .+|..+..+
T Consensus 318 L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~ 397 (461)
T 1z7x_W 318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 397 (461)
T ss_dssp EECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC
T ss_pred eEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhC
Confidence 99999999865 4566778899999999999998765555554 6799999999999986 778888899
Q ss_pred ccCceEeccCCcCcCc
Q 004218 347 RALRSLNLTFNNLEGV 362 (767)
Q Consensus 347 ~~L~~L~l~~N~l~~~ 362 (767)
++|+.|++++|++++.
T Consensus 398 ~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 398 HSLRELDLSNNCLGDA 413 (461)
T ss_dssp CCCCEEECCSSSCCHH
T ss_pred CCccEEECCCCCCCHH
Confidence 9999999999999864
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-33 Score=310.41 Aligned_cols=356 Identities=16% Similarity=0.160 Sum_probs=274.1
Q ss_pred CCCccEEeCCCCeeee----cCCCccccCCCCCcEEEccCCcccccCCccc-cCCC----CCCEEEcccccCcc----cC
Q 004218 1 MTSLVYLGLASNQLWG----EIPYDVGDKLPNLLGFNFCFNKFTGKIPGSL-HNLT----NIQIIRMAHNLLEG----TV 67 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~----~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l-~~l~----~L~~L~l~~n~i~~----~~ 67 (767)
+++|++|+|++|++++ .+|..+ ..+++|++|+|++|.+.+..+..+ ..++ +|++|+|++|.+++ .+
T Consensus 27 ~~~L~~L~L~~~~l~~~~~~~l~~~l-~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l 105 (461)
T 1z7x_W 27 LQQCQVVRLDDCGLTEARCKDISSAL-RVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL 105 (461)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHH-HTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred cCCccEEEccCCCCCHHHHHHHHHHH-HhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHH
Confidence 4689999999999984 244444 358999999999999986544333 3455 79999999999985 45
Q ss_pred CccCCCCCCCcEEeecCccccCCCCCCcccccc-ccCCCCCCEEECcCCcceeec----CchhhhhccccCeEEccCCcc
Q 004218 68 PPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITS-LTNSTRLNFLAFDGNQFEGEI----PESIGNLSNVLSKLYMGGNRF 142 (767)
Q Consensus 68 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~-l~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~~L~~L~l~~n~i 142 (767)
+..+..+++|++|++++|.+...+.. .+... ....++|++|++++|++++.. +..+..+++ |++|++++|.+
T Consensus 106 ~~~l~~~~~L~~L~Ls~n~i~~~~~~--~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~-L~~L~L~~n~i 182 (461)
T 1z7x_W 106 SSTLRTLPTLQELHLSDNLLGDAGLQ--LLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD-FKELTVSNNDI 182 (461)
T ss_dssp HHHTTSCTTCCEEECCSSBCHHHHHH--HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTT-CCEEECCSSBC
T ss_pred HHHHccCCceeEEECCCCcCchHHHH--HHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCC-CCEEECcCCCc
Confidence 88899999999999999998632111 12222 223578999999999998644 555666677 99999999999
Q ss_pred cccCCcccc-----CCCCCCEEECcCCcCccc----CccccCCCCCCCEEEccCCcccccc-----CcCcccCCCCceee
Q 004218 143 YGKIPTSIG-----RLRSLTLLNLSYNSISGE----ILTEIGQLQELQSLDLAGNQISGSI-----PNTLGNLKKLNQID 208 (767)
Q Consensus 143 ~~~~~~~l~-----~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~-----~~~~~~l~~L~~L~ 208 (767)
+...+..+. .+++|++|++++|.++.. ++..+..+++|++|++++|.+.+.. +..+..+++|++|+
T Consensus 183 ~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~ 262 (461)
T 1z7x_W 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262 (461)
T ss_dssp HHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred chHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEE
Confidence 865555554 367999999999999964 4667788999999999999998543 22334689999999
Q ss_pred CCCCcCCCC----CcccccCccccccccccCcccCCCCChhhccc-----ccccceeecccccCCCC----CchhhcCCC
Q 004218 209 LSGNELASE----IPTSFGNFQNLLSIDLSNNKLNGNIPKEILSL-----SSLTTIVNLSKNFLDGT----LPEEIGMLG 275 (767)
Q Consensus 209 L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-----~~l~~~l~l~~n~l~~~----~~~~~~~l~ 275 (767)
+++|.++.. ++..+..+++|++|++++|.+++..+..+... +++ +.+++++|.+++. ++..+..++
T Consensus 263 L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L-~~L~L~~n~l~~~~~~~l~~~l~~~~ 341 (461)
T 1z7x_W 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL-ESLWVKSCSFTAACCSHFSSVLAQNR 341 (461)
T ss_dssp CTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCC-CEEECTTSCCBGGGHHHHHHHHHHCS
T ss_pred CcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccc-eeeEcCCCCCchHHHHHHHHHHhhCC
Confidence 999999854 46677789999999999999975555444433 466 5559999999865 466777889
Q ss_pred ceeEEEccCCCCCCCCCccccc-----CcccceeeccCccccC----CCCchhhccCCceEEEcCCcccCCCCCcccc--
Q 004218 276 NVVTIDLSANGLSGNLPNSFKN-----CKSLEKLLMANNKFSG----PIPNILAELKGLEVLDLSSNKLSGSIPSDLQ-- 344 (767)
Q Consensus 276 ~L~~L~ls~n~l~~~~~~~~~~-----l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-- 344 (767)
+|+.|++++|.+++..+..+.. .++|+.|++++|.+++ .++..+..+++|++|+|++|++++.....+.
T Consensus 342 ~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~ 421 (461)
T 1z7x_W 342 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 421 (461)
T ss_dssp SCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHH
T ss_pred CccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHH
Confidence 9999999999998665555543 6799999999999986 6788889999999999999999854222222
Q ss_pred ---ccccCceEeccCCcCcC
Q 004218 345 ---NLRALRSLNLTFNNLEG 361 (767)
Q Consensus 345 ---~l~~L~~L~l~~N~l~~ 361 (767)
...+|+.|++.++.+..
T Consensus 422 l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 422 VRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp HTSTTCCCCEEECTTCCCCH
T ss_pred hccCCcchhheeecccccCH
Confidence 13467888887776654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=265.42 Aligned_cols=254 Identities=24% Similarity=0.296 Sum_probs=159.6
Q ss_pred CCCCEEECcCCcceeecCchhhhhccccCeEEccCCccccc--CCccccCCCCCCEEECcCCcCcccCccccCCCCCCCE
Q 004218 105 TRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGK--IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQS 182 (767)
Q Consensus 105 ~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~--~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~ 182 (767)
++|++|++++|+++...+..+.++++ |++|++++|+++.. .+..+..+++|++|+|++|.+. ..+..+..+++|++
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~ 105 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQ-LTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH 105 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTT-CSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCE
T ss_pred CCCCEEECCCCccCccCHhHhhcccc-CCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCE
Confidence 35555555555555222223445554 55555555555421 1344445555555555555555 23444555555555
Q ss_pred EEccCCccccccC-cCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccc
Q 004218 183 LDLAGNQISGSIP-NTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKN 261 (767)
Q Consensus 183 L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n 261 (767)
|++++|++.+..+ ..+..+++|++|++++|.+++..+..|..+++|++|++++|.+.
T Consensus 106 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~---------------------- 163 (306)
T 2z66_A 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ---------------------- 163 (306)
T ss_dssp EECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG----------------------
T ss_pred EECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc----------------------
Confidence 5555555553332 34555555555555555555444555555555555555555544
Q ss_pred cCCC-CCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCC
Q 004218 262 FLDG-TLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIP 340 (767)
Q Consensus 262 ~l~~-~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 340 (767)
+ ..|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..+..+..+++|+.|+|++|++++..|
T Consensus 164 ---~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (306)
T 2z66_A 164 ---ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240 (306)
T ss_dssp ---GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSS
T ss_pred ---cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCH
Confidence 3 345667778888888888888887778888888888888888888887777778888889999999999888888
Q ss_pred ccccccc-cCceEeccCCcCcCcCCCCc---cccccccccccCCcCccc
Q 004218 341 SDLQNLR-ALRSLNLTFNNLEGVVPREG---IFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 341 ~~~~~l~-~L~~L~l~~N~l~~~~~~~~---~~~~~~~~~l~~Np~~c~ 385 (767)
..+..++ +|+.|++++|++++..+... .+...+.+....+...|.
T Consensus 241 ~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~ 289 (306)
T 2z66_A 241 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 289 (306)
T ss_dssp SSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEE
T ss_pred HHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccC
Confidence 8888885 88999999998887654321 123333444555655664
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=272.51 Aligned_cols=278 Identities=14% Similarity=0.130 Sum_probs=177.3
Q ss_pred cEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCE
Q 004218 30 LGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNF 109 (767)
Q Consensus 30 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~ 109 (767)
...++++|+++ .+|..+. ++|++|++++|.+++..+..++.+++|++|++++|++.+. .+..+.++++|++
T Consensus 34 ~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~------~~~~~~~l~~L~~ 104 (353)
T 2z80_A 34 GICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI------EEDSFSSLGSLEH 104 (353)
T ss_dssp SEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEE------CTTTTTTCTTCCE
T ss_pred eEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCcc------CHhhcCCCCCCCE
Confidence 34555555555 4444333 3555555555555544444555555555555555555421 1223555566666
Q ss_pred EECcCCcceeecCchhhhhccccCeEEccCCcccccCC-ccccCCCCCCEEECcCC-cCcccCccccCCCCCCCEEEccC
Q 004218 110 LAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIP-TSIGRLRSLTLLNLSYN-SISGEILTEIGQLQELQSLDLAG 187 (767)
Q Consensus 110 L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~L~l~~n-~i~~~~~~~~~~l~~L~~L~L~~ 187 (767)
|++++|++++..+..+..+++ |++|++++|+++...+ ..+.++++|++|++++| .+....+..|..+++|++|++++
T Consensus 105 L~Ls~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~ 183 (353)
T 2z80_A 105 LDLSYNYLSNLSSSWFKPLSS-LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183 (353)
T ss_dssp EECCSSCCSSCCHHHHTTCTT-CSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred EECCCCcCCcCCHhHhCCCcc-CCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCC
Confidence 666666666333333666666 7777777777774333 36777888888888887 46666667788888888888888
Q ss_pred CccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCC
Q 004218 188 NQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTL 267 (767)
Q Consensus 188 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~ 267 (767)
|++.+..|..|..+++|++|++++|+++...+..+..+++|+.|++++|.+++..+..+..
T Consensus 184 n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~------------------- 244 (353)
T 2z80_A 184 SDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST------------------- 244 (353)
T ss_dssp TTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-----------------------
T ss_pred CCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc-------------------
Confidence 8888777788888888888888888886544444456788888888888887543322211
Q ss_pred chhhcCCCceeEEEccCCCCCC----CCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCC
Q 004218 268 PEEIGMLGNVVTIDLSANGLSG----NLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSI 339 (767)
Q Consensus 268 ~~~~~~l~~L~~L~ls~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 339 (767)
....+.++.++++++.+++ .+|..+..+++|+.|++++|+++...+..|..+++|+.|+|++|++.+..
T Consensus 245 ---~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 245 ---GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp -----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ---ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 1123345566666666654 34566777888888888888888444444678888888888888887543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=263.78 Aligned_cols=282 Identities=18% Similarity=0.219 Sum_probs=175.4
Q ss_pred cEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCccc--CCccCCCCCCCcEEee
Q 004218 5 VYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGT--VPPGLGNLPFLKMYNI 82 (767)
Q Consensus 5 ~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~--~~~~~~~l~~L~~L~l 82 (767)
+.+++++++++ .+|..+. ++|++|+|++|++....+..|.++++|++|+|++|.++.. .+..+..+++|++|++
T Consensus 10 ~~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 46777777777 7777654 4677888888887744444567777888888887777632 2445555677777777
Q ss_pred cCccccCCCCCCccccccccCCCCCCEEECcCCcceeecC-chhhhhccccCeEEccCCcccccCCccccCCCCCCEEEC
Q 004218 83 GFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIP-ESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNL 161 (767)
Q Consensus 83 ~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l 161 (767)
++|.+. .++..+..+++|++|++++|++++..+ ..+..+++ |++|++++|++.+..+..+..+++|++|++
T Consensus 86 s~n~i~-------~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 157 (306)
T 2z66_A 86 SFNGVI-------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN-LIYLDISHTHTRVAFNGIFNGLSSLEVLKM 157 (306)
T ss_dssp CSCSEE-------EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTT-CCEEECTTSCCEECSTTTTTTCTTCCEEEC
T ss_pred CCCccc-------cChhhcCCCCCCCEEECCCCcccccccchhhhhccC-CCEEECCCCcCCccchhhcccCcCCCEEEC
Confidence 777665 344455666666666666666664333 34555555 666666666666555666666666666666
Q ss_pred cCCcCcc-cCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCC
Q 004218 162 SYNSISG-EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 162 ~~n~i~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
++|.+++ ..|..+..+++|++|++++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|++++|++.+
T Consensus 158 ~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 237 (306)
T 2z66_A 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 237 (306)
T ss_dssp TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCB
T ss_pred CCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcc
Confidence 6666654 345556666666666666666665555566666666666666666655545455555666666666655553
Q ss_pred CCChhhcccccccceeecccccCCCCCchhhcCC-CceeEEEccCCCCCCCCC--cccccCcccceeeccCccccCCCCc
Q 004218 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGML-GNVVTIDLSANGLSGNLP--NSFKNCKSLEKLLMANNKFSGPIPN 317 (767)
Q Consensus 241 ~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l-~~L~~L~ls~n~l~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~~ 317 (767)
..|..+..+ ++|+.|+|++|.++.... .....+...+.+....+.+....|.
T Consensus 238 -------------------------~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 238 -------------------------SKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp -------------------------CSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred -------------------------cCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence 444445555 377888888888764321 1233445556666667777766776
Q ss_pred hhhccC
Q 004218 318 ILAELK 323 (767)
Q Consensus 318 ~~~~l~ 323 (767)
.+.+.+
T Consensus 293 ~~~g~~ 298 (306)
T 2z66_A 293 DKQGMP 298 (306)
T ss_dssp GGTTCB
T ss_pred hhCCce
Confidence 665543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=269.14 Aligned_cols=256 Identities=21% Similarity=0.265 Sum_probs=144.9
Q ss_pred CCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEcc
Q 004218 107 LNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLA 186 (767)
Q Consensus 107 L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 186 (767)
|++|++++|++++..+..+.++++ |++|++++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+++
T Consensus 54 L~~L~l~~n~i~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 54 VKSLDLSNNRITYISNSDLQRCVN-LQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL 132 (353)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTT-CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred CcEEECCCCcCcccCHHHhccCCC-CCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence 334444444444333333444444 4444444444444444444444444444444444443333334444444444444
Q ss_pred CCccccccC-cCcccCCCCceeeCCCC-cCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCC
Q 004218 187 GNQISGSIP-NTLGNLKKLNQIDLSGN-ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264 (767)
Q Consensus 187 ~n~i~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~ 264 (767)
+|++....+ ..|..+++|++|++++| .++...+..|..+++|++|++++|++.+..|..+..+++|.. +++++|.+.
T Consensus 133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~-L~l~~n~l~ 211 (353)
T 2z80_A 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSH-LILHMKQHI 211 (353)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEE-EEEECSCST
T ss_pred CCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCe-ecCCCCccc
Confidence 444442222 24444445555555444 233333444444555555555555554444444444444422 255555554
Q ss_pred CCCchhhcCCCceeEEEccCCCCCCCCCcccc---cCcccceeeccCccccC----CCCchhhccCCceEEEcCCcccCC
Q 004218 265 GTLPEEIGMLGNVVTIDLSANGLSGNLPNSFK---NCKSLEKLLMANNKFSG----PIPNILAELKGLEVLDLSSNKLSG 337 (767)
Q Consensus 265 ~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~---~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~ 337 (767)
...+..+..+++|+.|++++|.+++..+..+. ....++.++++++.+.+ .+|..+..+++|+.|+|++|+++
T Consensus 212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~- 290 (353)
T 2z80_A 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK- 290 (353)
T ss_dssp THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-
T ss_pred cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-
Confidence 33333445578889999999988876554443 35667778888877765 36777889999999999999999
Q ss_pred CCCcc-ccccccCceEeccCCcCcCcCCC
Q 004218 338 SIPSD-LQNLRALRSLNLTFNNLEGVVPR 365 (767)
Q Consensus 338 ~~~~~-~~~l~~L~~L~l~~N~l~~~~~~ 365 (767)
.+|.. +..+++|+.|++++|++++.+|.
T Consensus 291 ~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 291 SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 45554 68999999999999999987653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-29 Score=258.34 Aligned_cols=231 Identities=20% Similarity=0.226 Sum_probs=147.4
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
+.+++|+|++|+++ .+|..++. +++|++|+|++|.+. .+|..++++++|++|+|++|.++ .+|..++.+++|++|+
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~-l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFR-LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGG-GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred cceeEEEccCCCch-hcChhhhh-CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 45677777777776 77777664 777777777777777 67777777777777777777777 6676777777777777
Q ss_pred ecCccccCCCCCCc---cccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCE
Q 004218 82 IGFNKIVGSGDEGL---SFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTL 158 (767)
Q Consensus 82 l~~n~l~~~~~~~~---~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~ 158 (767)
+++|++.+.-+..+ .....+.++++|++|++++|+++ .+|..+..+++ |++|++++|++++ +|..+..+++|++
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~-L~~L~L~~N~l~~-l~~~l~~l~~L~~ 233 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQN-LKSLKIRNSPLSA-LGPAIHHLPKLEE 233 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTT-CCEEEEESSCCCC-CCGGGGGCTTCCE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCC-CCEEEccCCCCCc-CchhhccCCCCCE
Confidence 77765443211100 00111233666666666666666 56666666665 6666666666663 4445666666666
Q ss_pred EECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCccc
Q 004218 159 LNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKL 238 (767)
Q Consensus 159 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l 238 (767)
|+|++|.+.+..|..+..+++|++|+|++|.+.+.+|..+..+++|++|+|++|++.+.+|..++++++|+.+++..+.+
T Consensus 234 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp EECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred EECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666665554
Q ss_pred C
Q 004218 239 N 239 (767)
Q Consensus 239 ~ 239 (767)
.
T Consensus 314 ~ 314 (328)
T 4fcg_A 314 A 314 (328)
T ss_dssp C
T ss_pred H
Confidence 4
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=269.59 Aligned_cols=228 Identities=25% Similarity=0.256 Sum_probs=112.8
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
|++|+|++|++++..+..|.++++|++|+|++|.|+++.+..|.++++|++|+|++|+++...+..|..+++|++|+|++
T Consensus 77 l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 156 (452)
T 3zyi_A 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRN 156 (452)
T ss_dssp CSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCS
T ss_pred ccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCC
Confidence 55555555555544455555555555555555555544445555555555555555555544444455555555555555
Q ss_pred CcCCCCCcccccCccccccccccCcccCCCCC-hhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCC
Q 004218 212 NELASEIPTSFGNFQNLLSIDLSNNKLNGNIP-KEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGN 290 (767)
Q Consensus 212 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~ 290 (767)
|+++...+..|..+++|+.|++++|...+.++ ..|.++++| +.|++++|.+++. | .+..+++|+.|+|++|.+++.
T Consensus 157 N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L-~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 157 NPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNL-KYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp CCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTC-CEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEE
T ss_pred CCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCC-CEEECCCCccccc-c-cccccccccEEECcCCcCccc
Confidence 55554444445555555555555422211111 122222222 1112333322211 1 234445555555555555555
Q ss_pred CCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCc
Q 004218 291 LPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGV 362 (767)
Q Consensus 291 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 362 (767)
.|..|..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++.+.
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 555555555555555555555555555555555555555555555544444555555555555555555443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=268.11 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=137.2
Q ss_pred CCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEcc
Q 004218 107 LNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLA 186 (767)
Q Consensus 107 L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 186 (767)
...++++++.++ .+|..+. ..++.|+|++|+++...+..|.++++|++|+|++|.|+++.+..|.++++|++|+|+
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 345566666665 4555443 226666666666666666666666677777777776666666666666677777777
Q ss_pred CCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCC
Q 004218 187 GNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGT 266 (767)
Q Consensus 187 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~ 266 (767)
+|+++...+..|..+++|++|+|++|+++...+..|..+++|+.|++++|...+.++
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~----------------------- 177 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS----------------------- 177 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC-----------------------
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeC-----------------------
Confidence 776665555566666667777777776665555566666666666666643221111
Q ss_pred CchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCcccccc
Q 004218 267 LPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNL 346 (767)
Q Consensus 267 ~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 346 (767)
+..|..+++|+.|+|++|.++. +| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+
T Consensus 178 -~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 254 (440)
T 3zyj_A 178 -EGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254 (440)
T ss_dssp -TTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTC
T ss_pred -cchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCC
Confidence 1223344444444444444442 22 24444455555555555544444445555555555555555554444445555
Q ss_pred ccCceEeccCCcCcCcCCCC-ccccccccccccCCcCcc
Q 004218 347 RALRSLNLTFNNLEGVVPRE-GIFRHTSMVHLEGNPKLC 384 (767)
Q Consensus 347 ~~L~~L~l~~N~l~~~~~~~-~~~~~~~~~~l~~Np~~c 384 (767)
++|+.|+|++|++++.++.. ..++++..+++.+|||.|
T Consensus 255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp TTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 55555555555555444332 223444455555555555
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=253.45 Aligned_cols=226 Identities=19% Similarity=0.213 Sum_probs=200.8
Q ss_pred cEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecC
Q 004218 5 VYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGF 84 (767)
Q Consensus 5 ~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (767)
++++.++++++ .+|..+ .++|++|++++|.+.+..+..|..+++|++|+|++|.+++..|..++.+++|++|++++
T Consensus 14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 67999999998 899765 45899999999999987778899999999999999999988788999999999999999
Q ss_pred cc-ccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcC
Q 004218 85 NK-IVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163 (767)
Q Consensus 85 n~-l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~ 163 (767)
|. +... .+..+..+++|++|++++|++++..|..+..+++ |++|++++|++++..+..|..+++|++|+|++
T Consensus 90 n~~l~~~------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 162 (285)
T 1ozn_A 90 NAQLRSV------DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA-LQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162 (285)
T ss_dssp CTTCCCC------CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCcccc------CHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcC-CCEEECCCCcccccCHhHhccCCCccEEECCC
Confidence 97 6543 2456788899999999999999777888888888 99999999999977777799999999999999
Q ss_pred CcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCC
Q 004218 164 NSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN 241 (767)
Q Consensus 164 n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 241 (767)
|++++..+..|..+++|++|++++|.+.+..|..|..+++|+.|+|++|++++..+..|..+++|+.|++++|.+...
T Consensus 163 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 240 (285)
T 1ozn_A 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (285)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred CcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCC
Confidence 999977777799999999999999999988889999999999999999999987777889999999999999998743
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=288.12 Aligned_cols=214 Identities=21% Similarity=0.192 Sum_probs=143.9
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
|++|+|++|++++..|..|..+++|++|+|++|.+++..+ +..+++|++|+|++|.|++.. ..++|++|++++
T Consensus 36 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~~ 108 (487)
T 3oja_A 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAAN 108 (487)
T ss_dssp CCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCS
T ss_pred ccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECcC
Confidence 7777777777776666677777777777777777765443 667777777777777776432 226677777777
Q ss_pred CcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhc-CCCceeEEEccCCCCCCC
Q 004218 212 NELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIG-MLGNVVTIDLSANGLSGN 290 (767)
Q Consensus 212 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~-~l~~L~~L~ls~n~l~~~ 290 (767)
|.+++..+. .+++|+.|+|++|.+++..|..+..+++|. .|++++|.+++..|..+. .+++|+.|+|++|.+++.
T Consensus 109 N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 109 NNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQ-YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEE-EEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCC-EEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 777655443 346677777777777765566666666663 336666666665666554 577777777777777755
Q ss_pred CCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCc
Q 004218 291 LPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360 (767)
Q Consensus 291 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 360 (767)
.+ +..+++|+.|+|++|.+++. |..+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++.
T Consensus 185 ~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 185 KG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp EC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred cc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 22 33477777777777777753 3347777777777777777773 5666777777777777777776
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=256.04 Aligned_cols=236 Identities=19% Similarity=0.272 Sum_probs=154.0
Q ss_pred CCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEE
Q 004218 105 TRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLD 184 (767)
Q Consensus 105 ~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 184 (767)
++++.|+|++|+++ .+|..++.+++ |++|+|++|+++ .+|..++++++|++|+|++|.++ .+|..+..+++|++|+
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~-L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSH-LQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTT-CSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCC-CCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 44555555555555 45555555554 555555555555 45555555555555555555555 4455555555555555
Q ss_pred ccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCC
Q 004218 185 LAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264 (767)
Q Consensus 185 L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~ 264 (767)
|++|++.+.+|..+... ..+..|.++++|++|+|++|+++ .+|..+..+++|. .+++++|.++
T Consensus 157 L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~-~L~L~~N~l~ 219 (328)
T 4fcg_A 157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK-SLKIRNSPLS 219 (328)
T ss_dssp EEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCC-EEEEESSCCC
T ss_pred CCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCC-EEEccCCCCC
Confidence 55555444445443320 00011223555555566555555 5555555555553 3356666665
Q ss_pred CCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCcccc
Q 004218 265 GTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQ 344 (767)
Q Consensus 265 ~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 344 (767)
+ +|..++.+++|+.|+|++|.+.+.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++.+.+|..+.
T Consensus 220 ~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~ 298 (328)
T 4fcg_A 220 A-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298 (328)
T ss_dssp C-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGG
T ss_pred c-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHh
Confidence 3 444577788888899999888888888888899999999999888888888889999999999999998889999999
Q ss_pred ccccCceEeccCCcCcCc
Q 004218 345 NLRALRSLNLTFNNLEGV 362 (767)
Q Consensus 345 ~l~~L~~L~l~~N~l~~~ 362 (767)
.+++|+.+++..|.+...
T Consensus 299 ~L~~L~~l~l~~~~~~~l 316 (328)
T 4fcg_A 299 QLPANCIILVPPHLQAQL 316 (328)
T ss_dssp GSCTTCEEECCGGGSCC-
T ss_pred hccCceEEeCCHHHHHHH
Confidence 999999998887776654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-28 Score=269.72 Aligned_cols=268 Identities=22% Similarity=0.267 Sum_probs=152.2
Q ss_pred CccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEee
Q 004218 3 SLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNI 82 (767)
Q Consensus 3 ~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 82 (767)
.+++|++++|+++ .+|..++ ++|++|+|++|.++ .+|. .+++|++|+|++|.++ .+|. .+++|++|++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~---~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC---TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCcEEEecCCCcC-ccChhhC---CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 3667777777777 7777664 57777777777777 4554 4677777777777776 4554 4567777777
Q ss_pred cCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECc
Q 004218 83 GFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLS 162 (767)
Q Consensus 83 ~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~ 162 (767)
++|+++..+ . .+++|+.|++++|+++ .+|..+ ++ |++|++++|++++ +|. .+.+|+.|+++
T Consensus 109 s~N~l~~l~-------~---~l~~L~~L~L~~N~l~-~lp~~l---~~-L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~ 169 (622)
T 3g06_A 109 FSNPLTHLP-------A---LPSGLCKLWIFGNQLT-SLPVLP---PG-LQELSVSDNQLAS-LPA---LPSELCKLWAY 169 (622)
T ss_dssp CSCCCCCCC-------C---CCTTCCEEECCSSCCS-CCCCCC---TT-CCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred cCCcCCCCC-------C---CCCCcCEEECCCCCCC-cCCCCC---CC-CCEEECcCCcCCC-cCC---ccCCCCEEECC
Confidence 777765432 1 3456666666666666 344322 33 6666666666553 232 23455556666
Q ss_pred CCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCC
Q 004218 163 YNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNI 242 (767)
Q Consensus 163 ~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 242 (767)
+|.+++ +| ..+++|+.|++++|++++ +|.. +++|+.|++++|.++. +|.. +++|+.|+|++|+++
T Consensus 170 ~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~--- 234 (622)
T 3g06_A 170 NNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT--- 234 (622)
T ss_dssp SSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS---
T ss_pred CCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccC---
Confidence 665553 22 334555555555555552 2321 2455555555555542 2221 244444444444444
Q ss_pred ChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhcc
Q 004218 243 PKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAEL 322 (767)
Q Consensus 243 ~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 322 (767)
+ +| ..+++|+.|+|++|.|++ +|. .+++|+.|+|++|+|+ .+|..+..+
T Consensus 235 ----------------------~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l 283 (622)
T 3g06_A 235 ----------------------S-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHL 283 (622)
T ss_dssp ----------------------C-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGS
T ss_pred ----------------------c-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhc
Confidence 1 11 223556666666666663 333 4456666666666666 455666666
Q ss_pred CCceEEEcCCcccCCCCCccccccc
Q 004218 323 KGLEVLDLSSNKLSGSIPSDLQNLR 347 (767)
Q Consensus 323 ~~L~~L~Ls~N~l~~~~~~~~~~l~ 347 (767)
++|+.|+|++|++++..|..+..++
T Consensus 284 ~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 284 SSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred cccCEEEecCCCCCCcCHHHHHhcc
Confidence 6666666666666665555554443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=267.97 Aligned_cols=248 Identities=24% Similarity=0.256 Sum_probs=223.7
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
...+++++++++ .+|..+. ++|++|+|++|.|+++.+..|.++++|++|+|++|+|.+..+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 567888888888 5676654 6999999999999998899999999999999999999988889999999999999999
Q ss_pred CcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeeccc-ccCCCCCchhhcCCCceeEEEccCCCCCCC
Q 004218 212 NELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSK-NFLDGTLPEEIGMLGNVVTIDLSANGLSGN 290 (767)
Q Consensus 212 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~-n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~ 290 (767)
|+++...+..|..+++|++|+|++|++....+..|..+++|.. +++++ |.+....+..|..+++|+.|+|++|++++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMR-LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCE-EECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccE-EeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 9999888888999999999999999999777778999999955 49998 555555556799999999999999999954
Q ss_pred CCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCC-ccc
Q 004218 291 LPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE-GIF 369 (767)
Q Consensus 291 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~ 369 (767)
| .+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++.++.. ..+
T Consensus 212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 4 5889999999999999999999999999999999999999999999999999999999999999999887765 457
Q ss_pred cccccccccCCcCccc
Q 004218 370 RHTSMVHLEGNPKLCL 385 (767)
Q Consensus 370 ~~~~~~~l~~Np~~c~ 385 (767)
+++..+++.+|||.|.
T Consensus 290 ~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 290 RYLVELHLHHNPWNCD 305 (452)
T ss_dssp TTCCEEECCSSCEECS
T ss_pred cCCCEEEccCCCcCCC
Confidence 8889999999999995
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=252.41 Aligned_cols=248 Identities=24% Similarity=0.286 Sum_probs=159.8
Q ss_pred CEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccC
Q 004218 108 NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAG 187 (767)
Q Consensus 108 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 187 (767)
+.++++++.++ .+|..+. ++ |++|++++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|++++
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~-l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGIP--AA-SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTCC--TT-CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCCC--CC-ceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 57788888887 5565432 23 88888888888877667788888888888888888877777788888888888888
Q ss_pred Cc-cccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCC
Q 004218 188 NQ-ISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGT 266 (767)
Q Consensus 188 n~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~ 266 (767)
|. +....|..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~--------------------- 148 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT--------------------- 148 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT---------------------
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhH---------------------
Confidence 86 77565777788888888888888887777777777888888888777776433333
Q ss_pred CchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCcccccc
Q 004218 267 LPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNL 346 (767)
Q Consensus 267 ~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 346 (767)
++.+++|+.|+|++|.+++..+..|..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..+..+..+
T Consensus 149 ----~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 224 (285)
T 1ozn_A 149 ----FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224 (285)
T ss_dssp ----TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTC
T ss_pred ----hccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccC
Confidence 4444555555555555554444445555555555555555555555555555555556666555554444445555
Q ss_pred ccCceEeccCCcCcCcCCCCccccccccccccCCcCcc
Q 004218 347 RALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC 384 (767)
Q Consensus 347 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c 384 (767)
++|+.|++++|++.+..+.......+.......|...|
T Consensus 225 ~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c 262 (285)
T 1ozn_A 225 RALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262 (285)
T ss_dssp TTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBE
T ss_pred cccCEEeccCCCccCCCCcHHHHHHHHhcccccCcccc
Confidence 55666666666555544333222223333334444444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-28 Score=266.43 Aligned_cols=223 Identities=24% Similarity=0.278 Sum_probs=187.4
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
...+++++++++ .+|..+. ++++.|+|++|+|+.+.+..|.++++|++|+|++|+|.+..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 667888888887 5676665 6889999999999887788888899999999999998877778888889999999999
Q ss_pred CcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCC-CCCCC
Q 004218 212 NELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSAN-GLSGN 290 (767)
Q Consensus 212 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n-~l~~~ 290 (767)
|+++...+..|..+++|++|+|++|++.. ..+..|..+++|+.|+|++| .+...
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~-------------------------~~~~~~~~l~~L~~L~l~~~~~l~~i 176 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIES-------------------------IPSYAFNRIPSLRRLDLGELKRLSYI 176 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCE-------------------------ECTTTTTTCTTCCEEECCCCTTCCEE
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccc-------------------------cCHHHhhhCcccCEeCCCCCCCccee
Confidence 98887777778888888888888887762 23345667888999999994 56656
Q ss_pred CCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCC-ccc
Q 004218 291 LPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE-GIF 369 (767)
Q Consensus 291 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~ 369 (767)
.+..|.++++|+.|++++|+++. +| .+..+++|+.|+|++|++++..|..|..+++|+.|++++|++++..+.. ..+
T Consensus 177 ~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 254 (440)
T 3zyj_A 177 SEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254 (440)
T ss_dssp CTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTC
T ss_pred CcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCC
Confidence 66689999999999999999994 45 4889999999999999999988999999999999999999999987765 456
Q ss_pred cccccccccCCcCcc
Q 004218 370 RHTSMVHLEGNPKLC 384 (767)
Q Consensus 370 ~~~~~~~l~~Np~~c 384 (767)
+++..+++.+|....
T Consensus 255 ~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 255 QSLVEINLAHNNLTL 269 (440)
T ss_dssp TTCCEEECTTSCCCC
T ss_pred CCCCEEECCCCCCCc
Confidence 888899999997543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-30 Score=265.74 Aligned_cols=257 Identities=19% Similarity=0.198 Sum_probs=128.8
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
++.++++.+.+. .++..++..+++|++|+|++|.+.+..|..|.++++|++|+|++|.+++..+ +..+++|++|+++
T Consensus 12 l~i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 12 YKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred eeEeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 455666666665 5555555556667777777777775555666777777777777777664333 6666666666666
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcC
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~ 163 (767)
+|++.+. ...++|++|++++|++++..+. . +++|++|++++
T Consensus 89 ~n~l~~l-----------~~~~~L~~L~l~~n~l~~~~~~-------------------------~---~~~L~~L~l~~ 129 (317)
T 3o53_A 89 NNYVQEL-----------LVGPSIETLHAANNNISRVSCS-------------------------R---GQGKKNIYLAN 129 (317)
T ss_dssp SSEEEEE-----------EECTTCCEEECCSSCCSEEEEC-------------------------C---CSSCEEEECCS
T ss_pred CCccccc-----------cCCCCcCEEECCCCccCCcCcc-------------------------c---cCCCCEEECCC
Confidence 6665421 1224455555555555433222 1 34455555555
Q ss_pred CcCcccCccccCCCCCCCEEEccCCccccccCcCc-ccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCC
Q 004218 164 NSISGEILTEIGQLQELQSLDLAGNQISGSIPNTL-GNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNI 242 (767)
Q Consensus 164 n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 242 (767)
|++++..+..+..+++|++|+|++|.+.+..+..+ ..+++|++|+|++|.+++. + ....+++|+.|+|++|++++ +
T Consensus 130 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l 206 (317)
T 3o53_A 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-M 206 (317)
T ss_dssp SCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-E
T ss_pred CCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-c
Confidence 55554444445555555555555555554444433 2445555555555555432 1 12234555555555555541 1
Q ss_pred ChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCC-CCCCcccccCcccceeecc
Q 004218 243 PKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS-GNLPNSFKNCKSLEKLLMA 307 (767)
Q Consensus 243 ~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~-~~~~~~~~~l~~L~~L~l~ 307 (767)
|..+..+++|. .+++++|.++ .+|..+..+++|+.|++++|.+. +..|..+..+++|+.|+++
T Consensus 207 ~~~~~~l~~L~-~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 207 GPEFQSAAGVT-WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp CGGGGGGTTCS-EEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred hhhhcccCccc-EEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 21222222221 1122222222 12223344445555555555554 3444445555555555554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-29 Score=260.13 Aligned_cols=248 Identities=20% Similarity=0.227 Sum_probs=171.3
Q ss_pred CCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCccc-ccCCcccc-------CCCCCCEEECcCCcCcccCcccc
Q 004218 103 NSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFY-GKIPTSIG-------RLRSLTLLNLSYNSISGEILTEI 174 (767)
Q Consensus 103 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~-~~~~~~l~-------~l~~L~~L~l~~n~i~~~~~~~~ 174 (767)
..++|+.|++++|.+ .+|..+... |+.|++++|++. ..+|..+. ++++|++|+|++|.+++..|..+
T Consensus 41 ~~~~L~~l~l~~n~l--~~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 41 GGRSLEYLLKRVDTE--ADLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEECTTHHHHCCTT--CCCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred cCCCceeEeeccccc--ccHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 345566666666666 556555543 556666666663 33444443 56677777777777766666654
Q ss_pred --CCCCCCCEEEccCCccccccCcCcccC-----CCCceeeCCCCcCCCCCcccccCccccccccccCcccCCC--CChh
Q 004218 175 --GQLQELQSLDLAGNQISGSIPNTLGNL-----KKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN--IPKE 245 (767)
Q Consensus 175 --~~l~~L~~L~L~~n~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~ 245 (767)
..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..+..|+.+++|++|++++|++.+. .+..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 6677777777777777654 6666655 6777777777777666666677777777777777766543 2223
Q ss_pred h--cccccccceeecccccCCCC---CchhhcCCCceeEEEccCCCCCCCCC-cccccCcccceeeccCccccCCCCchh
Q 004218 246 I--LSLSSLTTIVNLSKNFLDGT---LPEEIGMLGNVVTIDLSANGLSGNLP-NSFKNCKSLEKLLMANNKFSGPIPNIL 319 (767)
Q Consensus 246 ~--~~l~~l~~~l~l~~n~l~~~---~~~~~~~l~~L~~L~ls~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~ 319 (767)
+ ..+++|. .+++++|.+++. ....+..+++|+.|++++|.+++..| ..+..+++|+.|++++|.|+ .+|..+
T Consensus 195 ~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 195 LCPLKFPTLQ-VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp SCTTSCTTCC-EEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHhccCCCCC-EEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 3 5566663 336777776632 22345678899999999999987664 56677899999999999998 666666
Q ss_pred hccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCc
Q 004218 320 AELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGV 362 (767)
Q Consensus 320 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 362 (767)
. ++|+.|+|++|+|++. |. +..+++|++|++++|++++.
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 5 7899999999999865 65 88899999999999998863
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-26 Score=261.28 Aligned_cols=262 Identities=26% Similarity=0.341 Sum_probs=183.9
Q ss_pred CCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCC
Q 004218 28 NLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRL 107 (767)
Q Consensus 28 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L 107 (767)
++++|++++|.++ .+|..+. ++|++|+|++|.++ .+|. .+++|++|+|++|++++.+ . .+++|
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp-------~---~l~~L 103 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLP-------V---LPPGL 103 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCC-------C---CCTTC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCC-------C---CCCCC
Confidence 5778888888888 6776555 78888888888887 5554 4577888888888776432 1 45677
Q ss_pred CEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccC
Q 004218 108 NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAG 187 (767)
Q Consensus 108 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 187 (767)
++|++++|+++ .+|. .+.+ |+.|++++|+++. +|.. +++|++|+|++|.+++ +|. .+++|+.|++++
T Consensus 104 ~~L~Ls~N~l~-~l~~---~l~~-L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~ 170 (622)
T 3g06_A 104 LELSIFSNPLT-HLPA---LPSG-LCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYN 170 (622)
T ss_dssp CEEEECSCCCC-CCCC---CCTT-CCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred CEEECcCCcCC-CCCC---CCCC-cCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCC
Confidence 77777777777 3444 2333 7777777777763 4432 3667777777776663 222 245666667777
Q ss_pred CccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCC
Q 004218 188 NQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTL 267 (767)
Q Consensus 188 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~ 267 (767)
|.+++ +| ..+++|+.|+|++|.+++ +|.. +++|+.|++++|.++ .+
T Consensus 171 N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~--------------------------~l 216 (622)
T 3g06_A 171 NQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT--------------------------SL 216 (622)
T ss_dssp SCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--------------------------SC
T ss_pred CCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc--------------------------cc
Confidence 66663 34 334666666666666654 2322 355666666666555 12
Q ss_pred chhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccc
Q 004218 268 PEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLR 347 (767)
Q Consensus 268 ~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 347 (767)
|. .+++|+.|+|++|.+++ +| ..+++|+.|++++|.|++ +|. .+++|+.|+|++|+|+ .+|..+..++
T Consensus 217 ~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~ 284 (622)
T 3g06_A 217 PA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLS 284 (622)
T ss_dssp CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSC
T ss_pred CC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhcc
Confidence 21 23689999999999996 44 556899999999999994 554 6788999999999999 7799999999
Q ss_pred cCceEeccCCcCcCcCCC
Q 004218 348 ALRSLNLTFNNLEGVVPR 365 (767)
Q Consensus 348 ~L~~L~l~~N~l~~~~~~ 365 (767)
+|+.|+|++|++++..+.
T Consensus 285 ~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 285 SETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp TTCEEECCSCCCCHHHHH
T ss_pred ccCEEEecCCCCCCcCHH
Confidence 999999999999987654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=281.69 Aligned_cols=184 Identities=18% Similarity=0.063 Sum_probs=126.8
Q ss_pred cccccceEEEEEE-eCCCcEEEEEEeeccC----------CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCccccee
Q 004218 463 IGSGSFGSVYKGY-LREGISVAVKVLDIES----------TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 463 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.+.|++|.+..++ .-.|+.||+|++.... ....+++.+|+++|+++ .|+||++++++ ++++..
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQS 316 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSSE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECCE
Confidence 4455666555544 2238889999996542 12345689999999999 79999999999 556778
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.||||||++|++|.+++..... ++.. +|+.||+.||+|+|++ |||||||||+|||++++|.+||+|||
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~~~------l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFG 384 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAGEE------IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFG 384 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTTCC------CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHHhCCC------CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecc
Confidence 8999999999999999976542 5554 5899999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCC
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 670 (767)
+|+...... ......+||+.|+|||++.+ .+..++|+||+|++.+++.++..|
T Consensus 385 lAr~~~~~~------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 385 SIVTTPQDC------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp TEESCC---------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cCeeCCCCC------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 998654321 12245679999999999876 467789999999998877665444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=255.36 Aligned_cols=205 Identities=18% Similarity=0.172 Sum_probs=148.4
Q ss_pred ccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCc-ccCCccCC-------CCCCCcEEeecCccccCCCCCC
Q 004218 23 GDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLE-GTVPPGLG-------NLPFLKMYNIGFNKIVGSGDEG 94 (767)
Q Consensus 23 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~-~~~~~~~~-------~l~~L~~L~l~~n~l~~~~~~~ 94 (767)
+...++|++|++++|.+ .+|..+... |+.|+|++|.+. ..+|..+. .+++|++|+|++|++.+.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~---- 110 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGT---- 110 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSC----
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccch----
Confidence 34566788888888888 577666554 888888988884 34555554 678899999999888742
Q ss_pred ccccccc--cCCCCCCEEECcCCcceeecCchhhhh-----ccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCc
Q 004218 95 LSFITSL--TNSTRLNFLAFDGNQFEGEIPESIGNL-----SNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSIS 167 (767)
Q Consensus 95 ~~~~~~l--~~l~~L~~L~l~~n~l~~~~~~~~~~l-----~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~ 167 (767)
.+..+ ..+++|++|+|++|++++. |..+..+ ++ |++|++++|++.+..+..|+++++|++|+|++|++.
T Consensus 111 --~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 186 (312)
T 1wwl_A 111 --APPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPG-LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186 (312)
T ss_dssp --CCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTT-CCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTC
T ss_pred --hHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCC-CcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcC
Confidence 23333 7788899999999998866 8888887 55 888888888888777788888888888888888876
Q ss_pred cc--Ccccc--CCCCCCCEEEccCCcccc---ccCcCcccCCCCceeeCCCCcCCCCCc-ccccCccccccccccCcccC
Q 004218 168 GE--ILTEI--GQLQELQSLDLAGNQISG---SIPNTLGNLKKLNQIDLSGNELASEIP-TSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 168 ~~--~~~~~--~~l~~L~~L~L~~n~i~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~n~l~ 239 (767)
+. .+..+ ..+++|++|+|++|++++ .....+..+++|++|+|++|++++..| ..+..+++|++|+|++|+++
T Consensus 187 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp HHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred cchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 53 23333 777888888888888772 112334566777777777777776553 34455666666666666665
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-29 Score=259.40 Aligned_cols=268 Identities=19% Similarity=0.193 Sum_probs=199.3
Q ss_pred CcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCC
Q 004218 29 LLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLN 108 (767)
Q Consensus 29 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~ 108 (767)
++.++++.+.+...+...+..+++|++|+|++|.+++..|..|+.+++|++|+|++|++.
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-------------------- 71 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-------------------- 71 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCE--------------------
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCC--------------------
Confidence 344556666666444455556667777777777776555556666666666666666553
Q ss_pred EEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCC
Q 004218 109 FLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGN 188 (767)
Q Consensus 109 ~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 188 (767)
+..+ +..+++ |++|++++|++++.. ..++|++|++++|.+++..+. .+++|++|++++|
T Consensus 72 ----------~~~~--~~~l~~-L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N 130 (317)
T 3o53_A 72 ----------ETLD--LESLST-LRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANN 130 (317)
T ss_dssp ----------EEEE--ETTCTT-CCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSS
T ss_pred ----------cchh--hhhcCC-CCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCC
Confidence 2222 444444 666666666655322 227888999999988865443 3688999999999
Q ss_pred ccccccCcCcccCCCCceeeCCCCcCCCCCcccc-cCccccccccccCcccCCCCChhhcccccccceeecccccCCCCC
Q 004218 189 QISGSIPNTLGNLKKLNQIDLSGNELASEIPTSF-GNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTL 267 (767)
Q Consensus 189 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~ 267 (767)
++++..+..+..+++|++|+|++|.+++..+..+ ..+++|++|+|++|.+++. +
T Consensus 131 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~------------------------ 185 (317)
T 3o53_A 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K------------------------ 185 (317)
T ss_dssp CCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E------------------------
T ss_pred CCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c------------------------
Confidence 9998888899999999999999999998777776 4789999999999998721 1
Q ss_pred chhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccC-CCCCcccccc
Q 004218 268 PEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLS-GSIPSDLQNL 346 (767)
Q Consensus 268 ~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l 346 (767)
....+++|+.|+|++|.+++. |..+..+++|+.|++++|+++ .+|..+..+++|+.|+|++|++. +.+|..+..+
T Consensus 186 --~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~ 261 (317)
T 3o53_A 186 --GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261 (317)
T ss_dssp --CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTC
T ss_pred --cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhcc
Confidence 111367899999999999854 445889999999999999998 56778889999999999999998 7788888999
Q ss_pred ccCceEecc-CCcCcCcCCCC
Q 004218 347 RALRSLNLT-FNNLEGVVPRE 366 (767)
Q Consensus 347 ~~L~~L~l~-~N~l~~~~~~~ 366 (767)
++|+.|+++ .+.+++..+..
T Consensus 262 ~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 262 QRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp HHHHHHHHHHHHHHHSSSSCC
T ss_pred ccceEEECCCchhccCCchhc
Confidence 999999998 44566655443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=263.05 Aligned_cols=236 Identities=21% Similarity=0.260 Sum_probs=177.9
Q ss_pred CCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEE
Q 004218 104 STRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSL 183 (767)
Q Consensus 104 l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 183 (767)
+++|++|+|++|.+++..|..+..+++ |++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|++|
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTK-LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTT-CCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCC-CCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 346777777777777666667777776 7777777777765544 7777777777777777774322 2677777
Q ss_pred EccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhc-ccccccceeeccccc
Q 004218 184 DLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTIVNLSKNF 262 (767)
Q Consensus 184 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~l~~~l~l~~n~ 262 (767)
++++|.+.+..+. .+++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++..|..+. .+++| +.|+|++|.
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L-~~L~Ls~N~ 180 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL-EHLNLQYNF 180 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTC-CEEECTTSC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcc-cEEecCCCc
Confidence 7777777755443 346677777777777776677777777777777777777766666665 56666 344777777
Q ss_pred CCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccC-CCCCc
Q 004218 263 LDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLS-GSIPS 341 (767)
Q Consensus 263 l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~ 341 (767)
+++.. ....+++|+.|+|++|.+++.+| .+..+++|+.|++++|.+++ +|..+..+++|+.|++++|++. +.+|.
T Consensus 181 l~~~~--~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~ 256 (487)
T 3oja_A 181 IYDVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (487)
T ss_dssp CCEEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred ccccc--ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHH
Confidence 77552 23458999999999999997555 59999999999999999995 6777999999999999999998 67777
Q ss_pred cccccccCceEecc
Q 004218 342 DLQNLRALRSLNLT 355 (767)
Q Consensus 342 ~~~~l~~L~~L~l~ 355 (767)
.+..++.|+.++++
T Consensus 257 ~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 257 FFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHTTCHHHHHHHHH
T ss_pred HHHhCCCCcEEecc
Confidence 88888888888775
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.9e-26 Score=230.24 Aligned_cols=228 Identities=21% Similarity=0.223 Sum_probs=155.2
Q ss_pred EECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCc
Q 004218 110 LAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQ 189 (767)
Q Consensus 110 L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 189 (767)
.+..+.++. .+|..+. .+|++|++++|++++..+..|.++++|++|++++|.+++..+..|..+++|++|+|++|.
T Consensus 12 ~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 445555555 4454332 237777777777776666667777777777777777776666667777777777777777
Q ss_pred cccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCch
Q 004218 190 ISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPE 269 (767)
Q Consensus 190 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~ 269 (767)
+.+..+..|..+++|++|++++|.+++..+..++.+++|++|++++|.+++. .+|.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------------------------~l~~ 143 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF------------------------KLPE 143 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC------------------------CCCG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee------------------------cCch
Confidence 7766666677777777777777777766555667777777777777766521 1344
Q ss_pred hhcCCCceeEEEccCCCCCCCCCcccccCcccc----eeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccc
Q 004218 270 EIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLE----KLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQN 345 (767)
Q Consensus 270 ~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~----~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 345 (767)
.++.+++|+.|++++|++++..+..+..+++|+ .|++++|.+++..+..+. ..+|+.|+|++|++++..+..+..
T Consensus 144 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~ 222 (276)
T 2z62_A 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDR 222 (276)
T ss_dssp GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTT
T ss_pred hhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcc
Confidence 556666777777777777766666666666666 677777777755444443 347888888888888666666778
Q ss_pred cccCceEeccCCcCcCcCCCC
Q 004218 346 LRALRSLNLTFNNLEGVVPRE 366 (767)
Q Consensus 346 l~~L~~L~l~~N~l~~~~~~~ 366 (767)
+++|+.|++++|++++..+..
T Consensus 223 l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 223 LTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CCSCCEEECCSSCBCCCTTTT
T ss_pred cccccEEEccCCcccccCCch
Confidence 888888888888888766543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-25 Score=225.95 Aligned_cols=226 Identities=19% Similarity=0.236 Sum_probs=188.6
Q ss_pred cEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecC
Q 004218 5 VYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGF 84 (767)
Q Consensus 5 ~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (767)
..++.++.+++ .+|..+. ++|++|++++|++.+..+..|.++++|++|+|++|.+++..+..+..+++|++|++++
T Consensus 10 ~~~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 85 (276)
T 2z62_A 10 ITYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (276)
T ss_dssp TEEECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ceEEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCC
Confidence 35677888887 8998764 4799999999999977777899999999999999999977777899999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCccccc-CCccccCCCCCCEEECcC
Q 004218 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGK-IPTSIGRLRSLTLLNLSY 163 (767)
Q Consensus 85 n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~-~~~~l~~l~~L~~L~l~~ 163 (767)
|.+... .+..+.++++|++|++++|++.+..+..+..+++ |++|++++|++++. +|..+.++++|++|++++
T Consensus 86 n~l~~~------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~ 158 (276)
T 2z62_A 86 NPIQSL------ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT-LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158 (276)
T ss_dssp CCCCEE------CTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTT-CCEEECCSSCCCCCCCCGGGGGCTTCCEEECCS
T ss_pred CccCcc------ChhhhcCCccccEEECCCCCccccCchhcccCCC-CCEEECcCCccceecCchhhccCCCCCEEECCC
Confidence 998743 2346788899999999999998766667888887 99999999999863 588899999999999999
Q ss_pred CcCcccCccccCCCCCCC----EEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccC
Q 004218 164 NSISGEILTEIGQLQELQ----SLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 164 n~i~~~~~~~~~~l~~L~----~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
|++++..+..+..+++|+ +|++++|.+.+..+..+.. .+|++|+|++|++++..+..|..+++|+.|++++|++.
T Consensus 159 N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp SCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred CCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 999987777777777766 8999999998665555544 48999999999998877777888999999999999988
Q ss_pred CCC
Q 004218 240 GNI 242 (767)
Q Consensus 240 ~~~ 242 (767)
+..
T Consensus 238 c~c 240 (276)
T 2z62_A 238 CSC 240 (276)
T ss_dssp CCT
T ss_pred ccC
Confidence 644
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-29 Score=282.91 Aligned_cols=350 Identities=11% Similarity=0.075 Sum_probs=153.1
Q ss_pred CCCCCcEEEccCCcccccCCccccCC--CCCCEEEccccc-Ccc-cCCccCCCCCCCcEEeecCccccCCCCCCcccccc
Q 004218 25 KLPNLLGFNFCFNKFTGKIPGSLHNL--TNIQIIRMAHNL-LEG-TVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITS 100 (767)
Q Consensus 25 ~l~~L~~L~l~~n~l~~~~~~~l~~l--~~L~~L~l~~n~-i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~ 100 (767)
.+++|++|+|++|.+.+..+..+... .+|++|+|++|. ++. .++.....+++|++|+|++|.+.+.+.. .+...
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~--~l~~~ 187 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGK--WLHEL 187 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSH--HHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchh--HHHHH
Confidence 35566666666665554444444432 235566665554 111 1111222445555555555554322100 02222
Q ss_pred ccCCCCCCEEECcCCcce----eecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECc--------------
Q 004218 101 LTNSTRLNFLAFDGNQFE----GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLS-------------- 162 (767)
Q Consensus 101 l~~l~~L~~L~l~~n~l~----~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~-------------- 162 (767)
+.++++|++|++++|.++ +.++..+..+++ |++|++++|.+.+ ++..+..+++|++|+++
T Consensus 188 ~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~-L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~ 265 (592)
T 3ogk_B 188 AQHNTSLEVLNFYMTEFAKISPKDLETIARNCRS-LVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMN 265 (592)
T ss_dssp HHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTT-CCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSC
T ss_pred HhcCCCccEEEeeccCCCccCHHHHHHHHhhCCC-CcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHH
Confidence 334455555555555554 122233334444 5555555555542 33444444444444444
Q ss_pred -------------CCcCcccCccccCCCCCCCEEEccCCccccccC-cCcccCCCCceeeCCCCcCCC-CCcccccCccc
Q 004218 163 -------------YNSISGEILTEIGQLQELQSLDLAGNQISGSIP-NTLGNLKKLNQIDLSGNELAS-EIPTSFGNFQN 227 (767)
Q Consensus 163 -------------~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~ 227 (767)
++... ..+..+..+++|++|+|++|.+.+... ..+..+++|++|+++ |.+.. ..+..+..+++
T Consensus 266 l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~ 343 (592)
T 3ogk_B 266 LVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQ 343 (592)
T ss_dssp CCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTT
T ss_pred hhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCC
Confidence 32111 223333344444444444444332111 122344444444444 22211 11112233445
Q ss_pred cccccccC-----------cccCCCC-ChhhcccccccceeecccccCCCCCchhhcC-CCceeEEEcc----CCCCCCC
Q 004218 228 LLSIDLSN-----------NKLNGNI-PKEILSLSSLTTIVNLSKNFLDGTLPEEIGM-LGNVVTIDLS----ANGLSGN 290 (767)
Q Consensus 228 L~~L~l~~-----------n~l~~~~-~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~-l~~L~~L~ls----~n~l~~~ 290 (767)
|++|++++ |.+++.. +..+..+++|.. ++++.|.+++..+..+.. +++|+.|+++ .|.+++.
T Consensus 344 L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~-L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~ 422 (592)
T 3ogk_B 344 LKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEY-MAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDL 422 (592)
T ss_dssp CCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSE-EEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSC
T ss_pred CCEEEeecCccccccccccCccCHHHHHHHHhhCccCeE-EEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCc
Confidence 55555552 3333211 111223444422 255555555444444433 5556666664 4444432
Q ss_pred -----CCcccccCcccceeeccCcc--ccCCCCchhhc-cCCceEEEcCCcccCC-CCCccccccccCceEeccCCcCcC
Q 004218 291 -----LPNSFKNCKSLEKLLMANNK--FSGPIPNILAE-LKGLEVLDLSSNKLSG-SIPSDLQNLRALRSLNLTFNNLEG 361 (767)
Q Consensus 291 -----~~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~~-l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~ 361 (767)
++..+.++++|+.|++++|. +++..+..+.. +++|+.|+|++|++++ .++..+..+++|+.|++++|++++
T Consensus 423 p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~ 502 (592)
T 3ogk_B 423 PLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE 502 (592)
T ss_dssp CCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred hHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence 12224445566666665332 33333333322 5566666666666653 223334555666666666666543
Q ss_pred cCCC--CccccccccccccCCc
Q 004218 362 VVPR--EGIFRHTSMVHLEGNP 381 (767)
Q Consensus 362 ~~~~--~~~~~~~~~~~l~~Np 381 (767)
.... ...++++..+.+.+|.
T Consensus 503 ~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 503 RAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHHHHHHhcCccCeeECcCCc
Confidence 2111 1234555566666654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-28 Score=277.38 Aligned_cols=356 Identities=12% Similarity=0.063 Sum_probs=257.4
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCC-CcEEEccCCc-ccc-cCCccccCCCCCCEEEcccccCccc----CCccCCC
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPN-LLGFNFCFNK-FTG-KIPGSLHNLTNIQIIRMAHNLLEGT----VPPGLGN 73 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~-L~~L~l~~n~-l~~-~~~~~l~~l~~L~~L~l~~n~i~~~----~~~~~~~ 73 (767)
+++|++|+|++|.+++..+..+...++. |++|+|++|. +.. .++....++++|++|+|++|.+++. ++..+..
T Consensus 111 ~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~ 190 (592)
T 3ogk_B 111 LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQH 190 (592)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHH
T ss_pred CCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhc
Confidence 4678999999998876555554432344 8999998886 221 2233345788999999999988754 2234456
Q ss_pred CCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcc-----------
Q 004218 74 LPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRF----------- 142 (767)
Q Consensus 74 l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i----------- 142 (767)
+++|++|++++|.+.....+ .+...+.++++|+.|++++|.+.+ +|..+..+++ |++|+++.+..
T Consensus 191 ~~~L~~L~L~~n~~~~~~~~--~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~-L~~L~l~~~~~~~~~~~~~~~l 266 (592)
T 3ogk_B 191 NTSLEVLNFYMTEFAKISPK--DLETIARNCRSLVSVKVGDFEILE-LVGFFKAAAN-LEEFCGGSLNEDIGMPEKYMNL 266 (592)
T ss_dssp CCCCCEEECTTCCCSSCCHH--HHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTT-CCEEEECBCCCCTTCTTSSSCC
T ss_pred CCCccEEEeeccCCCccCHH--HHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhH-HHhhcccccccccchHHHHHHh
Confidence 78899999998887633222 344455678889999999988874 6677777776 77777763211
Q ss_pred ---------------cccCCccccCCCCCCEEECcCCcCcccCc-cccCCCCCCCEEEccCCccc-cccCcCcccCCCCc
Q 004218 143 ---------------YGKIPTSIGRLRSLTLLNLSYNSISGEIL-TEIGQLQELQSLDLAGNQIS-GSIPNTLGNLKKLN 205 (767)
Q Consensus 143 ---------------~~~~~~~l~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~ 205 (767)
...+|..+..+++|++|+|++|.+++... ..+..+++|++|+++ +.+. ..++..+..+++|+
T Consensus 267 ~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~ 345 (592)
T 3ogk_B 267 VFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLK 345 (592)
T ss_dssp CCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCC
T ss_pred hccccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCC
Confidence 12356667778899999999999875443 346889999999999 4444 33444456789999
Q ss_pred eeeCCC-----------CcCCCCC-cccccCccccccccccCcccCCCCChhhcc-cccccceeecc----cccCCCC--
Q 004218 206 QIDLSG-----------NELASEI-PTSFGNFQNLLSIDLSNNKLNGNIPKEILS-LSSLTTIVNLS----KNFLDGT-- 266 (767)
Q Consensus 206 ~L~L~~-----------N~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~l~~~l~l~----~n~l~~~-- 266 (767)
+|+|++ |.++... +..+..+++|++|+++.|.+++..+..+.. +++|.. ++++ .|.+++.
T Consensus 346 ~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~-L~l~~~~~~n~l~~~p~ 424 (592)
T 3ogk_B 346 RLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCD-FRLVLLDREERITDLPL 424 (592)
T ss_dssp EEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCE-EEEEECSCCSCCSSCCC
T ss_pred EEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcE-EEEeecCCCccccCchH
Confidence 999993 5665322 222456899999999999998777767665 777744 4885 6788764
Q ss_pred ---CchhhcCCCceeEEEccCCC--CCCCCCcccc-cCcccceeeccCccccCC-CCchhhccCCceEEEcCCcccCCC-
Q 004218 267 ---LPEEIGMLGNVVTIDLSANG--LSGNLPNSFK-NCKSLEKLLMANNKFSGP-IPNILAELKGLEVLDLSSNKLSGS- 338 (767)
Q Consensus 267 ---~~~~~~~l~~L~~L~ls~n~--l~~~~~~~~~-~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~- 338 (767)
++..+..+++|+.|++++|. +++..+..+. .+++|+.|++++|++++. .+..+..+++|+.|+|++|.+++.
T Consensus 425 ~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 504 (592)
T 3ogk_B 425 DNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERA 504 (592)
T ss_dssp HHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHH
T ss_pred HHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHH
Confidence 34457789999999998644 6654444444 488999999999999863 445567889999999999998744
Q ss_pred CCccccccccCceEeccCCcCcCc
Q 004218 339 IPSDLQNLRALRSLNLTFNNLEGV 362 (767)
Q Consensus 339 ~~~~~~~l~~L~~L~l~~N~l~~~ 362 (767)
++..+..+++|+.|++++|+++..
T Consensus 505 ~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 505 IAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHHhcCccCeeECcCCcCCHH
Confidence 344456789999999999998865
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.5e-25 Score=224.08 Aligned_cols=205 Identities=24% Similarity=0.276 Sum_probs=102.0
Q ss_pred ccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccc
Q 004218 150 IGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLL 229 (767)
Q Consensus 150 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 229 (767)
++++++++++++++|.++ .+|..+. +++++|+|++|.+.+..+..|..+++|++|+|++|.+++..+ .+.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence 344455555555555555 2333222 455555555555554445555555555555555555553222 14555555
Q ss_pred cccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCc
Q 004218 230 SIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANN 309 (767)
Q Consensus 230 ~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n 309 (767)
+|++++|+++ .+|.. +..+++|+.|++++|++++..+..|..+++|+.|+|++|
T Consensus 81 ~L~Ls~N~l~-~l~~~-------------------------~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N 134 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLL-------------------------GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134 (290)
T ss_dssp EEECCSSCCS-SCCCC-------------------------TTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred EEECCCCcCC-cCchh-------------------------hccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence 5555555554 22222 233344444444444444444444444555555555555
Q ss_pred cccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCccccccccccccCCcCccc
Q 004218 310 KFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 310 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c~ 385 (767)
++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|+++.+++.......+..+.+.+|||.|.
T Consensus 135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence 5544444444455555555555555554333344445555555555555554444433444455556666666663
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-24 Score=217.80 Aligned_cols=205 Identities=22% Similarity=0.279 Sum_probs=146.9
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
.+.+++++++++ .+|..+. ++|++|+|++|.+++..+..|..+++|++|+|++|+++...+..|..+++|++|+|++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 677888888887 4565543 5778888888888766666777788888888888887755556667777888888888
Q ss_pred CcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCC
Q 004218 212 NELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNL 291 (767)
Q Consensus 212 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~ 291 (767)
|+++...+..|..+++|++|++++|++++ ..+..|+.+++|+.|+|++|.+++..
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-------------------------~~~~~~~~l~~L~~L~Ls~n~l~~~~ 149 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKS-------------------------LPPRVFDSLTKLTYLSLGYNELQSLP 149 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCC-------------------------CCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCe-------------------------eCHHHhCcCcCCCEEECCCCcCCccC
Confidence 87776666667777777777777776663 23344556667777777777777666
Q ss_pred CcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCC
Q 004218 292 PNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVP 364 (767)
Q Consensus 292 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 364 (767)
+..|..+++|+.|++++|.+++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++.+..+
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 6667777777777777777776666667777777777777777776555567777777777777777665443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-24 Score=215.98 Aligned_cols=201 Identities=21% Similarity=0.283 Sum_probs=112.6
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
.+.+++++++++ .+|..+. ++|++|+|++|++.+..+..|.++++|++|+|++|.++...+..|..+++|++|+++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP---ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCEEEccCCCCC-ccCCCCC---CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 455666666665 5655443 355666666666654444455666666666666666553333334555555555555
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcC
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~ 163 (767)
+|++. +..+..+..+++ |++|++++|++++..+..|..+++|++|+|++
T Consensus 94 ~n~l~------------------------------~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 142 (270)
T 2o6q_A 94 DNKLQ------------------------------ALPIGVFDQLVN-LAELRLDRNQLKSLPPRVFDSLTKLTYLSLGY 142 (270)
T ss_dssp SSCCC------------------------------CCCTTTTTTCSS-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCcCC------------------------------cCCHhHcccccC-CCEEECCCCccCeeCHHHhCcCcCCCEEECCC
Confidence 55544 333333444444 55555555555554455555566666666666
Q ss_pred CcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccC
Q 004218 164 NSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 164 n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 143 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 143 NELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 6665544444556666666666666666544455566666666666666666555555556666666666666655
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-24 Score=218.88 Aligned_cols=202 Identities=22% Similarity=0.179 Sum_probs=143.8
Q ss_pred CCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCC
Q 004218 25 KLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNS 104 (767)
Q Consensus 25 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l 104 (767)
.+++++++++++|+++ .+|..+. ++|++|+|++|.+++..+..|..+++|++|+|++|.++.. + ....+
T Consensus 8 ~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-------~-~~~~l 76 (290)
T 1p9a_G 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-------Q-VDGTL 76 (290)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-------E-CCSCC
T ss_pred ccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-------c-CCCCC
Confidence 4566666666666666 4454443 5666666666666655556666666666666666666432 1 12456
Q ss_pred CCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEE
Q 004218 105 TRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLD 184 (767)
Q Consensus 105 ~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 184 (767)
++|++|++++|+++ .+|..+..+++ |++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~~l~~-L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQTLPA-LTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTT-CCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CcCCEEECCCCcCC-cCchhhccCCC-CCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEE
Confidence 67777777777776 56666777776 88888888888766667788888888888888888877667778888888888
Q ss_pred ccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCC
Q 004218 185 LAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 185 L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
|++|+++...+..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+..
T Consensus 155 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 8888888666666778888888888888887 456666677788888888888763
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-26 Score=252.16 Aligned_cols=192 Identities=16% Similarity=0.130 Sum_probs=141.3
Q ss_pred CCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCc--------chhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTG--------TWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
.+...+.||+|+||.||+|... ++.+|+|........ ..+++.+|++++++++||||+++..++. .
T Consensus 337 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----~ 410 (540)
T 3en9_A 337 RKIPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-----D 410 (540)
T ss_dssp -----------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-----E
T ss_pred cCCCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-----e
Confidence 3345678999999999999554 788999986432211 1345789999999999999994444432 2
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
....++||||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+||+++. .+||+
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~ 471 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYII 471 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEEC
T ss_pred CCccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEE
Confidence 2334999999999999999864 457999999999999999 9999999999999999 99999
Q ss_pred cccchhhhhhhcCCCcc-ccccccccCCCCccCccccCC--CCCCCcccchhhhHHHHHHHhCCCCCC
Q 004218 608 DFGLARSLLERIGNQSS-ISSTHVLKGSIGYIPPEYGLG--EKPSTAGDVYSFGVMLLEIFTGMSPTH 672 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~ 672 (767)
|||+++........... ........||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 472 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 472 DFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 99999876432110000 001235679999999999876 567888999999999999888887763
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=219.16 Aligned_cols=204 Identities=23% Similarity=0.308 Sum_probs=124.8
Q ss_pred hhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCc
Q 004218 126 GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN 205 (767)
Q Consensus 126 ~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 205 (767)
..+.+ |++|++++|.++. ...+..+++|++|++++|.+++ ...+..+++|++|++++|.+++..+..|..+++|+
T Consensus 38 ~~l~~-L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 38 NELNS-IDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHD--ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHTT-CCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCC--CGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred ccccc-eeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCC--chhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 34444 5555555555542 1235555555555555555553 13455555555555555555544444455555555
Q ss_pred eeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCC
Q 004218 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSAN 285 (767)
Q Consensus 206 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n 285 (767)
+|+|++|++++..+..|..+++|++|++++|+++ +..+..++.+++|+.|++++|
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-------------------------~~~~~~~~~l~~L~~L~l~~n 167 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-------------------------SLPKGVFDKLTNLTELDLSYN 167 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------CCCTTTTTTCTTCCEEECCSS
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccC-------------------------ccCHHHhccCccCCEEECCCC
Confidence 5555555555544444555555555555555544 333444556667777777777
Q ss_pred CCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCC
Q 004218 286 GLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPR 365 (767)
Q Consensus 286 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 365 (767)
++++..+..+..+++|+.|++++|++++..+..+..+++|+.|+|++|++.+. +++|+.|+++.|.++|.+|.
T Consensus 168 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 168 QLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred CcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence 77766666677777777777777777776666677777788888887777643 34677777788888777665
Q ss_pred C
Q 004218 366 E 366 (767)
Q Consensus 366 ~ 366 (767)
.
T Consensus 241 ~ 241 (272)
T 3rfs_A 241 S 241 (272)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=221.81 Aligned_cols=199 Identities=25% Similarity=0.334 Sum_probs=108.3
Q ss_pred CCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCC
Q 004218 28 NLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRL 107 (767)
Q Consensus 28 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L 107 (767)
++..+++..+.+.+.. .+..+++|+.|++++|.++ .+ ..++.+++|++|++++|++.+ +..+.++++|
T Consensus 20 ~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~~-~~l~~l~~L~~L~l~~n~l~~--------~~~l~~l~~L 87 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SV-QGIQYLPNVRYLALGGNKLHD--------ISALKELTNL 87 (272)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECTTSCCCC--------CGGGTTCTTC
T ss_pred HHHHHHhcCccccccc--ccccccceeeeeeCCCCcc-cc-cccccCCCCcEEECCCCCCCC--------chhhcCCCCC
Confidence 3444555555554322 2445555666666666554 22 235555556666666555532 1244555555
Q ss_pred CEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccC
Q 004218 108 NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAG 187 (767)
Q Consensus 108 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 187 (767)
++|++++|++++..+..+..+++ |++|++++|++++..+..|..+++|++|++++|.+++..+..+..+++|++|++++
T Consensus 88 ~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 166 (272)
T 3rfs_A 88 TYLILTGNQLQSLPNGVFDKLTN-LKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSY 166 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTT-CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEECCCCccCccChhHhcCCcC-CCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCC
Confidence 55555555555444444555555 66666666665555455555555666666666655554444455555666666666
Q ss_pred CccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccC
Q 004218 188 NQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 188 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+.
T Consensus 167 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (272)
T 3rfs_A 167 NQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 218 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc
Confidence 6655544445555556666666666665555555555555666655555554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.5e-27 Score=267.08 Aligned_cols=351 Identities=12% Similarity=0.061 Sum_probs=192.1
Q ss_pred CCCCCcEEEccCCcccccCCcccc-CCCCCCEEEcccc-cCccc-CCccCCCCCCCcEEeecCccccCCCCCCccccccc
Q 004218 25 KLPNLLGFNFCFNKFTGKIPGSLH-NLTNIQIIRMAHN-LLEGT-VPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSL 101 (767)
Q Consensus 25 ~l~~L~~L~l~~n~l~~~~~~~l~-~l~~L~~L~l~~n-~i~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l 101 (767)
.+++|++|+|++|.+.+..+..+. .+++|++|+|++| .+++. ++..+..+++|++|+|++|.+...... .+....
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~--~l~~~~ 180 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGH--WLSHFP 180 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGG--GGGGSC
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchH--HHHHHh
Confidence 345555566655555544444443 4555555555555 33321 222223455555555555554432111 111222
Q ss_pred cCCCCCCEEECcCCc--ceee-cCchhhhhccccCeEEccCC-cccccCCccccCCCCCCEEECcCCc------------
Q 004218 102 TNSTRLNFLAFDGNQ--FEGE-IPESIGNLSNVLSKLYMGGN-RFYGKIPTSIGRLRSLTLLNLSYNS------------ 165 (767)
Q Consensus 102 ~~l~~L~~L~l~~n~--l~~~-~~~~~~~l~~~L~~L~l~~n-~i~~~~~~~l~~l~~L~~L~l~~n~------------ 165 (767)
..+++|+.|++++|. ++.. ++..+..+++ |++|++++| .+. .++..+..+++|++|+++.+.
T Consensus 181 ~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~-L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~ 258 (594)
T 2p1m_B 181 DTYTSLVSLNISCLASEVSFSALERLVTRCPN-LKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLS 258 (594)
T ss_dssp TTCCCCCEEECTTCCSCCCHHHHHHHHHHCTT-CCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHH
T ss_pred hcCCcCcEEEecccCCcCCHHHHHHHHHhCCC-CcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHH
Confidence 244555555555554 1100 1111122233 555555555 222 234444444444444433321
Q ss_pred --------------Cc----ccCccccCCCCCCCEEEccCCcccccc-CcCcccCCCCceeeCCCCcCCCC-CcccccCc
Q 004218 166 --------------IS----GEILTEIGQLQELQSLDLAGNQISGSI-PNTLGNLKKLNQIDLSGNELASE-IPTSFGNF 225 (767)
Q Consensus 166 --------------i~----~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l 225 (767)
+. ..++..+..+++|++|+|++|.+.+.. +..+..+++|++|++++| +... .+.....+
T Consensus 259 ~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~ 337 (594)
T 2p1m_B 259 VALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTC 337 (594)
T ss_dssp HHHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHC
T ss_pred HHHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhC
Confidence 11 122333335688888888888876432 223457788888888887 4321 12222357
Q ss_pred ccccccccc---------CcccCCCCChhhc-ccccccceeecccccCCCCCchhhc-CCCceeEEEcc--C----CCCC
Q 004218 226 QNLLSIDLS---------NNKLNGNIPKEIL-SLSSLTTIVNLSKNFLDGTLPEEIG-MLGNVVTIDLS--A----NGLS 288 (767)
Q Consensus 226 ~~L~~L~l~---------~n~l~~~~~~~~~-~l~~l~~~l~l~~n~l~~~~~~~~~-~l~~L~~L~ls--~----n~l~ 288 (767)
++|++|+++ .+.+++.....+. .+++|..+ .+..|.+++..+..+. .+++|+.|+++ + |.++
T Consensus 338 ~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L-~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~ 416 (594)
T 2p1m_B 338 KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESV-LYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT 416 (594)
T ss_dssp TTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEE-EEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT
T ss_pred CCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHH-HHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc
Confidence 888888873 3444433223333 36777555 7777887765555554 57888888888 3 4555
Q ss_pred CCCC-----cccccCcccceeeccCccccCCCCchhhc-cCCceEEEcCCcccCCCCCccc-cccccCceEeccCCcCcC
Q 004218 289 GNLP-----NSFKNCKSLEKLLMANNKFSGPIPNILAE-LKGLEVLDLSSNKLSGSIPSDL-QNLRALRSLNLTFNNLEG 361 (767)
Q Consensus 289 ~~~~-----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~ 361 (767)
+... ..+..+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|++++
T Consensus 417 ~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 417 LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred CCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 2211 2256778888888877 565544455554 7888888888888865444444 567888888888888854
Q ss_pred cCCC--CccccccccccccCCcC
Q 004218 362 VVPR--EGIFRHTSMVHLEGNPK 382 (767)
Q Consensus 362 ~~~~--~~~~~~~~~~~l~~Np~ 382 (767)
.... ...++++..+.+.+|+.
T Consensus 496 ~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 496 KALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHHHHHhCCCCCEEeeeCCCC
Confidence 3221 13356777778877753
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-25 Score=236.35 Aligned_cols=269 Identities=12% Similarity=0.147 Sum_probs=194.9
Q ss_pred EEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCC----ccccCCC-CCCEEEcccccCcccCCccCCCC-----C
Q 004218 6 YLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIP----GSLHNLT-NIQIIRMAHNLLEGTVPPGLGNL-----P 75 (767)
Q Consensus 6 ~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~----~~l~~l~-~L~~L~l~~n~i~~~~~~~~~~l-----~ 75 (767)
.++|++|+++|.+|.... ..++|++|+|++|.+.+..+ ..|.+++ +|++|+|++|.+++..+..+..+ +
T Consensus 2 ~~~ls~n~~~~~~~~~~~-~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTS-IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHHHHHT-SCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHHHHHh-CCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 468899999977775543 35669999999999997666 7788888 89999999999987766666664 8
Q ss_pred CCcEEeecCccccCCCCCCccccccccCC-CCCCEEECcCCcceeecCchhhhh----ccccCeEEccCCcccccC----
Q 004218 76 FLKMYNIGFNKIVGSGDEGLSFITSLTNS-TRLNFLAFDGNQFEGEIPESIGNL----SNVLSKLYMGGNRFYGKI---- 146 (767)
Q Consensus 76 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~l-~~L~~L~l~~n~l~~~~~~~~~~l----~~~L~~L~l~~n~i~~~~---- 146 (767)
+|++|+|++|.+...+.. .+...+..+ ++|++|+|++|++++..+..+... ..+|++|+|++|+++...
T Consensus 81 ~L~~L~Ls~n~l~~~~~~--~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 158 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSD--ELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158 (362)
T ss_dssp TCCEEECCSSCGGGSCHH--HHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred CccEEECcCCcCChHHHH--HHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence 899999999998753222 233345555 789999999999987666666553 224999999999988533
Q ss_pred CccccCCC-CCCEEECcCCcCcccCcccc----CCC-CCCCEEEccCCccccc----cCcCccc-CCCCceeeCCCCcCC
Q 004218 147 PTSIGRLR-SLTLLNLSYNSISGEILTEI----GQL-QELQSLDLAGNQISGS----IPNTLGN-LKKLNQIDLSGNELA 215 (767)
Q Consensus 147 ~~~l~~l~-~L~~L~l~~n~i~~~~~~~~----~~l-~~L~~L~L~~n~i~~~----~~~~~~~-l~~L~~L~L~~N~l~ 215 (767)
+..+..++ +|++|+|++|++++..+..+ ..+ ++|++|+|++|.|.+. ++..+.. .++|++|+|++|+++
T Consensus 159 ~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence 34445555 89999999999987666444 344 5899999999998852 3445555 358999999999988
Q ss_pred CCCc----ccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCC
Q 004218 216 SEIP----TSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNL 291 (767)
Q Consensus 216 ~~~~----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~ 291 (767)
...+ ..+..+++|+.|+|++|.+.+..+..+.. ++..+..+++|+.||+++|.+....
T Consensus 239 ~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~------------------l~~~~~~l~~L~~LdL~~N~l~~~~ 300 (362)
T 3goz_A 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKA------------------LGAAFPNIQKIILVDKNGKEIHPSH 300 (362)
T ss_dssp CCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHH------------------HHTTSTTCCEEEEECTTSCBCCGGG
T ss_pred cHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHH------------------HHHHhccCCceEEEecCCCcCCCcc
Confidence 6544 33466788888888888876433332221 2334567788999999999887654
Q ss_pred Cccc
Q 004218 292 PNSF 295 (767)
Q Consensus 292 ~~~~ 295 (767)
+..+
T Consensus 301 ~~~~ 304 (362)
T 3goz_A 301 SIPI 304 (362)
T ss_dssp CHHH
T ss_pred hHHH
Confidence 4333
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.2e-25 Score=233.44 Aligned_cols=262 Identities=16% Similarity=0.204 Sum_probs=147.1
Q ss_pred EEEccCCcccccCCccccCCCCCCEEEcccccCcccCC----ccCCCCC-CCcEEeecCccccCCCCCCccccccccCC-
Q 004218 31 GFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVP----PGLGNLP-FLKMYNIGFNKIVGSGDEGLSFITSLTNS- 104 (767)
Q Consensus 31 ~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~----~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~l~~l- 104 (767)
.+++++|++.+.+|..+...++|++|+|++|.+++..+ ..+..++ +|++|+|++|++...+.. .+...+...
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~--~l~~~l~~~~ 79 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSD--ELVQILAAIP 79 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHH--HHHHHHHTSC
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHH--HHHHHHhccC
Confidence 35677888887777777777778888888888875554 5566666 677777777776542211 122222222
Q ss_pred CCCCEEECcCCcceeecCchhhhh-----ccccCeEEccCCcccccCCccc----cC-CCCCCEEECcCCcCcccCcc--
Q 004218 105 TRLNFLAFDGNQFEGEIPESIGNL-----SNVLSKLYMGGNRFYGKIPTSI----GR-LRSLTLLNLSYNSISGEILT-- 172 (767)
Q Consensus 105 ~~L~~L~l~~n~l~~~~~~~~~~l-----~~~L~~L~l~~n~i~~~~~~~l----~~-l~~L~~L~l~~n~i~~~~~~-- 172 (767)
++|++|+|++|++++..+..++.. ++ |++|++++|+++...+..+ .. .++|++|+|++|.+++....
T Consensus 80 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~-L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 158 (362)
T 3goz_A 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFT-ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158 (362)
T ss_dssp TTCCEEECCSSCGGGSCHHHHHHHHHTSCTT-CCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred CCccEEECcCCcCChHHHHHHHHHHHhCCCC-ccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence 667777777777765555544443 34 6667777666665444333 22 24666666666666643322
Q ss_pred --ccCCCC-CCCEEEccCCccccccCcCcc----cC-CCCceeeCCCCcCCCC----CcccccC-ccccccccccCcccC
Q 004218 173 --EIGQLQ-ELQSLDLAGNQISGSIPNTLG----NL-KKLNQIDLSGNELASE----IPTSFGN-FQNLLSIDLSNNKLN 239 (767)
Q Consensus 173 --~~~~l~-~L~~L~L~~n~i~~~~~~~~~----~l-~~L~~L~L~~N~l~~~----~~~~~~~-l~~L~~L~l~~n~l~ 239 (767)
.+..++ +|++|+|++|++++..+..+. .+ ++|++|+|++|.++.. ++..+.. .++|++|+|++|.++
T Consensus 159 ~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence 223343 666666666666544443332 23 3666666666666532 1222322 235555555555555
Q ss_pred CCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCC-------CcccccCcccceeeccCcccc
Q 004218 240 GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNL-------PNSFKNCKSLEKLLMANNKFS 312 (767)
Q Consensus 240 ~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~-------~~~~~~l~~L~~L~l~~n~l~ 312 (767)
+..+..+ ...+..+++|+.|+|++|.+.+.. +..+..+++|+.|++++|.+.
T Consensus 239 ~~~~~~l---------------------~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~ 297 (362)
T 3goz_A 239 GPSLENL---------------------KLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297 (362)
T ss_dssp CCCHHHH---------------------HHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCC
T ss_pred cHHHHHH---------------------HHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCC
Confidence 3222111 122345566777777777744332 234556666777777777766
Q ss_pred CCCC
Q 004218 313 GPIP 316 (767)
Q Consensus 313 ~~~~ 316 (767)
...+
T Consensus 298 ~~~~ 301 (362)
T 3goz_A 298 PSHS 301 (362)
T ss_dssp GGGC
T ss_pred Ccch
Confidence 5433
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-26 Score=260.69 Aligned_cols=351 Identities=16% Similarity=0.147 Sum_probs=221.7
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCC-ccccc-CCccccCCCCCCEEEcccccCcccCCccC----CCCC
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFN-KFTGK-IPGSLHNLTNIQIIRMAHNLLEGTVPPGL----GNLP 75 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n-~l~~~-~~~~l~~l~~L~~L~l~~n~i~~~~~~~~----~~l~ 75 (767)
++|++|+|++|.+++..+..+...+++|++|+|++| .+... ++..+.++++|++|+|++|.+++..+..+ ..++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 568888888888776555555545788888888888 45432 44445578888888888888765443333 3566
Q ss_pred CCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCC-cceeecCchhhhhccccCeEEccCCc-------------
Q 004218 76 FLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGN-QFEGEIPESIGNLSNVLSKLYMGGNR------------- 141 (767)
Q Consensus 76 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~~L~~L~l~~n~------------- 141 (767)
+|++|++++|. ...... .+.....++++|++|++++| .+. .++..+..+++ |++|+++.+.
T Consensus 185 ~L~~L~l~~~~-~~~~~~--~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~-L~~L~l~~~~~~~~~~~~~~l~~ 259 (594)
T 2p1m_B 185 SLVSLNISCLA-SEVSFS--ALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQ-LEELGTGGYTAEVRPDVYSGLSV 259 (594)
T ss_dssp CCCEEECTTCC-SCCCHH--HHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTT-CSEEECSBCCCCCCHHHHHHHHH
T ss_pred cCcEEEecccC-CcCCHH--HHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCc-ceEcccccccCccchhhHHHHHH
Confidence 88888888876 111111 12222345688888888888 444 46677777776 8888765442
Q ss_pred -------------ccc----cCCccccCCCCCCEEECcCCcCcccCcc-ccCCCCCCCEEEccCCccccc-cCcCcccCC
Q 004218 142 -------------FYG----KIPTSIGRLRSLTLLNLSYNSISGEILT-EIGQLQELQSLDLAGNQISGS-IPNTLGNLK 202 (767)
Q Consensus 142 -------------i~~----~~~~~l~~l~~L~~L~l~~n~i~~~~~~-~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~ 202 (767)
+.. .++..+..+++|++|+|++|.+++.... .+..+++|++|++++| +... ++.....++
T Consensus 260 ~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~ 338 (594)
T 2p1m_B 260 ALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCK 338 (594)
T ss_dssp HHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCT
T ss_pred HHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCC
Confidence 111 1222233567888888888887643222 3567888888888887 4322 222233578
Q ss_pred CCceeeCC---------CCcCCCCCccccc-CccccccccccCcccCCCCChhhc-ccccccceeecc--c----ccCCC
Q 004218 203 KLNQIDLS---------GNELASEIPTSFG-NFQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTIVNLS--K----NFLDG 265 (767)
Q Consensus 203 ~L~~L~L~---------~N~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~-~l~~l~~~l~l~--~----n~l~~ 265 (767)
+|++|+|+ .+.++......+. .+++|+.|.++.|.+++..+..+. .+++|.. ++++ + +.++.
T Consensus 339 ~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~-L~L~~~~~~~~~~l~~ 417 (594)
T 2p1m_B 339 DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTR-FRLCIIEPKAPDYLTL 417 (594)
T ss_dssp TCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCE-EEEEESSTTCCCTTTC
T ss_pred CCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcce-eEeecccCCCcccccC
Confidence 88888873 3444432222222 477888888888887755555554 4666643 4777 3 45552
Q ss_pred CC-----chhhcCCCceeEEEccCCCCCCCCCccccc-CcccceeeccCccccCCCCchh-hccCCceEEEcCCcccCCC
Q 004218 266 TL-----PEEIGMLGNVVTIDLSANGLSGNLPNSFKN-CKSLEKLLMANNKFSGPIPNIL-AELKGLEVLDLSSNKLSGS 338 (767)
Q Consensus 266 ~~-----~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~ 338 (767)
.. +..+..+++|+.|+|++ .+++..+..+.. +++|+.|++++|.+++..+..+ ..+++|+.|+|++|.+++.
T Consensus 418 ~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 418 EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred CchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHH
Confidence 21 12356677888888876 565544445544 7788888888888765444444 5678888888888888543
Q ss_pred CCc-cccccccCceEeccCCcCc
Q 004218 339 IPS-DLQNLRALRSLNLTFNNLE 360 (767)
Q Consensus 339 ~~~-~~~~l~~L~~L~l~~N~l~ 360 (767)
... .+..+++|+.|++++|+++
T Consensus 497 ~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 497 ALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp HHHHTGGGGGGSSEEEEESSCCB
T ss_pred HHHHHHHhCCCCCEEeeeCCCCC
Confidence 333 3445788888888888774
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=216.35 Aligned_cols=229 Identities=21% Similarity=0.220 Sum_probs=163.4
Q ss_pred CCCCEEECcCCcceeecCc---hhhhhccccCeEEccCCcccccCCccc--cCCCCCCEEECcCCcCcccCc----cccC
Q 004218 105 TRLNFLAFDGNQFEGEIPE---SIGNLSNVLSKLYMGGNRFYGKIPTSI--GRLRSLTLLNLSYNSISGEIL----TEIG 175 (767)
Q Consensus 105 ~~L~~L~l~~n~l~~~~~~---~~~~l~~~L~~L~l~~n~i~~~~~~~l--~~l~~L~~L~l~~n~i~~~~~----~~~~ 175 (767)
..++.|.+.++.++...-. .+..+++ |++|++++|++.+..|..+ ..+++|++|+|++|.+++..+ ..+.
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~-L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~ 142 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSR-LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW 142 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSC-CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCc-eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence 4567777777766532111 1223445 8889999998888888877 888889999999988886443 3455
Q ss_pred CCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCC---C-cccccCccccccccccCcccCCCCChhhccccc
Q 004218 176 QLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASE---I-PTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSS 251 (767)
Q Consensus 176 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 251 (767)
.+++|++|+|++|++.+..+..|..+++|++|+|++|++.+. . +..+..+++|++|+|++|+++ .++...
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~----- 216 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVC----- 216 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHH-----
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHH-----
Confidence 788899999999988877778888888899999999887642 1 223467888888888888876 222110
Q ss_pred ccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccC---cccceeeccCccccCCCCchhhccCCceEE
Q 004218 252 LTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNC---KSLEKLLMANNKFSGPIPNILAELKGLEVL 328 (767)
Q Consensus 252 l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 328 (767)
...++.+++|++|+|++|.+++..|..+..+ ++|++|++++|+|+ .+|..+. ++|+.|
T Consensus 217 ----------------~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L 277 (310)
T 4glp_A 217 ----------------AALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVL 277 (310)
T ss_dssp ----------------HHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCE
T ss_pred ----------------HHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEE
Confidence 0123556777888888888877666666665 58888888888888 4555553 688888
Q ss_pred EcCCcccCCCCCccccccccCceEeccCCcCcC
Q 004218 329 DLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEG 361 (767)
Q Consensus 329 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 361 (767)
+|++|+|++. |. +..+++|+.|++++|+++.
T Consensus 278 ~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 278 DLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp ECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred ECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 8888888854 33 5677888888888888864
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-25 Score=241.10 Aligned_cols=259 Identities=15% Similarity=0.165 Sum_probs=147.8
Q ss_pred ccCCcccccCCccccCCCCCCEEEcccccCcccC----CccCCCCCCCcEEeecCccccCCCC----CCccccccccCCC
Q 004218 34 FCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTV----PPGLGNLPFLKMYNIGFNKIVGSGD----EGLSFITSLTNST 105 (767)
Q Consensus 34 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~~~~l~~l~ 105 (767)
+....+. .++..+..+++|++|+|++|.+++.. +..+..+++|++|+|++|.+..... +...+...+.+++
T Consensus 16 l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~ 94 (386)
T 2ca6_A 16 ITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCP 94 (386)
T ss_dssp CCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCT
T ss_pred CCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCC
Confidence 3333444 45556666666666666666666542 2335566666666666654432110 0001122235566
Q ss_pred CCCEEECcCCccee----ecCchhhhhccccCeEEccCCcccccCCccc----cCC---------CCCCEEECcCCcCcc
Q 004218 106 RLNFLAFDGNQFEG----EIPESIGNLSNVLSKLYMGGNRFYGKIPTSI----GRL---------RSLTLLNLSYNSISG 168 (767)
Q Consensus 106 ~L~~L~l~~n~l~~----~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l----~~l---------~~L~~L~l~~n~i~~ 168 (767)
+|++|+|++|+++. .+|..+..+++ |++|+|++|+++...+..+ ..+ ++|++|+|++|+++.
T Consensus 95 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~-L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTP-LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TCCEEECCSCCCCTTTHHHHHHHHHHCTT-CCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred cccEEECCCCcCCHHHHHHHHHHHHhCCC-CCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 66666666666664 34555566665 6666666666653333222 222 677777777777762
Q ss_pred -cCc---cccCCCCCCCEEEccCCcccc-----ccCcCcccCCCCceeeCCCCcCC----CCCcccccCccccccccccC
Q 004218 169 -EIL---TEIGQLQELQSLDLAGNQISG-----SIPNTLGNLKKLNQIDLSGNELA----SEIPTSFGNFQNLLSIDLSN 235 (767)
Q Consensus 169 -~~~---~~~~~l~~L~~L~L~~n~i~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~l~~ 235 (767)
..+ ..+..+++|++|+|++|++.. ..+..+..+++|+.|+|++|.++ ..+|..+..+++|+.|+|++
T Consensus 174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~ 253 (386)
T 2ca6_A 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253 (386)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCC
Confidence 222 345566677777777777662 23336666777777777777764 34555666667777777777
Q ss_pred cccCCCCChhhcccccccceeecccccCCCCCchhh--cCCCceeEEEccCCCCCC----CCCccc-ccCcccceeeccC
Q 004218 236 NKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEI--GMLGNVVTIDLSANGLSG----NLPNSF-KNCKSLEKLLMAN 308 (767)
Q Consensus 236 n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~--~~l~~L~~L~ls~n~l~~----~~~~~~-~~l~~L~~L~l~~ 308 (767)
|.+++.... .++..+ +.+++|+.|+|++|.+++ .+|..+ .++++|+.|++++
T Consensus 254 n~i~~~~~~---------------------~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~ 312 (386)
T 2ca6_A 254 CLLSARGAA---------------------AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 312 (386)
T ss_dssp CCCCHHHHH---------------------HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTT
T ss_pred CCCchhhHH---------------------HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccC
Confidence 766532111 122333 235667777777777765 255555 4567777777777
Q ss_pred ccccCCC
Q 004218 309 NKFSGPI 315 (767)
Q Consensus 309 n~l~~~~ 315 (767)
|.+++..
T Consensus 313 N~l~~~~ 319 (386)
T 2ca6_A 313 NRFSEED 319 (386)
T ss_dssp SBSCTTS
T ss_pred CcCCcch
Confidence 7777554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-23 Score=206.81 Aligned_cols=196 Identities=15% Similarity=0.245 Sum_probs=103.3
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCc-CcccCccccCCCCCCCEEEccC-CccccccCcCcccCCCCceeeC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNS-ISGEILTEIGQLQELQSLDLAG-NQISGSIPNTLGNLKKLNQIDL 209 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~-i~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L 209 (767)
|++|++++|++++..+..|.++++|++|++++|+ ++.+.+..|.++++|++|++++ |+++...+..|.++++|++|++
T Consensus 33 l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l 112 (239)
T 2xwt_C 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112 (239)
T ss_dssp CCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEE
T ss_pred ccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeC
Confidence 5555555555554444455555555555555554 5544444555555555555555 5555444445555555555555
Q ss_pred CCCcCCCCCcccccCccccc---cccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCcee-EEEccCC
Q 004218 210 SGNELASEIPTSFGNFQNLL---SIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVV-TIDLSAN 285 (767)
Q Consensus 210 ~~N~l~~~~~~~~~~l~~L~---~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~-~L~ls~n 285 (767)
++|++++ +|. |..+++|+ .|++++|. .+++..+..|..+++|+ .|++++|
T Consensus 113 ~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~------------------------~l~~i~~~~~~~l~~L~~~L~l~~n 166 (239)
T 2xwt_C 113 FNTGLKM-FPD-LTKVYSTDIFFILEITDNP------------------------YMTSIPVNAFQGLCNETLTLKLYNN 166 (239)
T ss_dssp EEECCCS-CCC-CTTCCBCCSEEEEEEESCT------------------------TCCEECTTTTTTTBSSEEEEECCSC
T ss_pred CCCCCcc-ccc-cccccccccccEEECCCCc------------------------chhhcCcccccchhcceeEEEcCCC
Confidence 5555543 332 44444444 44444440 33333334455566666 6666666
Q ss_pred CCCCCCCcccccCcccceeeccCcc-ccCCCCchhhcc-CCceEEEcCCcccCCCCCccccccccCceEeccCC
Q 004218 286 GLSGNLPNSFKNCKSLEKLLMANNK-FSGPIPNILAEL-KGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFN 357 (767)
Q Consensus 286 ~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 357 (767)
+++.+.+..|.. ++|+.|++++|+ +++..+..|..+ ++|+.|++++|++++ +|.. .+++|+.|+++++
T Consensus 167 ~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 167 GFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred CCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 666433333443 566666666663 665555556666 666666666666663 3322 4455666666544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-23 Score=214.25 Aligned_cols=222 Identities=18% Similarity=0.125 Sum_probs=170.2
Q ss_pred ccEEeCCCCeeee----cCCCccccCCCCCcEEEccCCcccccCCccc--cCCCCCCEEEcccccCcccCC----ccCCC
Q 004218 4 LVYLGLASNQLWG----EIPYDVGDKLPNLLGFNFCFNKFTGKIPGSL--HNLTNIQIIRMAHNLLEGTVP----PGLGN 73 (767)
Q Consensus 4 L~~L~l~~n~l~~----~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l--~~l~~L~~L~l~~n~i~~~~~----~~~~~ 73 (767)
++.|.++++.+.. .++... .+++|++|++++|.+.+..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 66 l~~l~l~~~~~~~~~~~~~~~~~--~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 66 VRRLTVGAAQVPAQLLVGALRVL--AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCEEEECSCCCBHHHHHHHHHHH--HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred eeEEEEeCCcCCHHHHHHHHHhc--ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 5677777777652 122222 25679999999999988888877 889999999999999886544 34557
Q ss_pred CCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceee--c--CchhhhhccccCeEEccCCcccccCCc-
Q 004218 74 LPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE--I--PESIGNLSNVLSKLYMGGNRFYGKIPT- 148 (767)
Q Consensus 74 l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~--~--~~~~~~l~~~L~~L~l~~n~i~~~~~~- 148 (767)
+++|++|+|++|++... .+..+.++++|++|+|++|++.+. + +..+..+++ |++|++++|+++. ++.
T Consensus 144 ~~~L~~L~Ls~n~l~~~------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~-L~~L~Ls~N~l~~-l~~~ 215 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAF------SCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPA-IQNLALRNTGMET-PTGV 215 (310)
T ss_dssp CSCCCEEEEECCSSCCC------CTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCC-CCSCBCCSSCCCC-HHHH
T ss_pred ccCCCEEEeeCCCcchh------hHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCC-CCEEECCCCCCCc-hHHH
Confidence 88999999999988653 334677888999999999987642 2 222356776 9999999999873 232
Q ss_pred ---cccCCCCCCEEECcCCcCcccCccccCCC---CCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccc
Q 004218 149 ---SIGRLRSLTLLNLSYNSISGEILTEIGQL---QELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSF 222 (767)
Q Consensus 149 ---~l~~l~~L~~L~l~~n~i~~~~~~~~~~l---~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 222 (767)
.+..+++|++|+|++|.+++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|+|++|++++. |. +
T Consensus 216 ~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~ 290 (310)
T 4glp_A 216 CAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-P 290 (310)
T ss_dssp HHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-T
T ss_pred HHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-h
Confidence 35778999999999999998777777766 69999999999999 6676664 7999999999999864 33 6
Q ss_pred cCccccccccccCcccCC
Q 004218 223 GNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 223 ~~l~~L~~L~l~~n~l~~ 240 (767)
..+++|+.|+|++|+++.
T Consensus 291 ~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 291 DELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp TSCCCCSCEECSSTTTSC
T ss_pred hhCCCccEEECcCCCCCC
Confidence 788999999999999873
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-25 Score=237.56 Aligned_cols=247 Identities=18% Similarity=0.242 Sum_probs=143.0
Q ss_pred cccccccCCCCCCEEECcCCcceeecCch----hhhhccccCeEEccCCc---ccccCCccc-------cCCCCCCEEEC
Q 004218 96 SFITSLTNSTRLNFLAFDGNQFEGEIPES----IGNLSNVLSKLYMGGNR---FYGKIPTSI-------GRLRSLTLLNL 161 (767)
Q Consensus 96 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~----~~~l~~~L~~L~l~~n~---i~~~~~~~l-------~~l~~L~~L~l 161 (767)
.++..+..+++|+.|+|++|+++...+.. +..+++ |++|+|++|. +.+.+|..+ ..+++|++|+|
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~-L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~L 101 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD-LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRL 101 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTT-CCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEEC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCC-ccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEEC
Confidence 34445555566666666666665443333 334444 6666665542 222333333 45555555555
Q ss_pred cCCcCcc----cCccccCCCCCCCEEEccCCccccccCcCcc----cC---------CCCceeeCCCCcCCC-CCc---c
Q 004218 162 SYNSISG----EILTEIGQLQELQSLDLAGNQISGSIPNTLG----NL---------KKLNQIDLSGNELAS-EIP---T 220 (767)
Q Consensus 162 ~~n~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~----~l---------~~L~~L~L~~N~l~~-~~~---~ 220 (767)
++|.++. .++..+..+++|++|+|++|.+....+..+. .+ ++|++|+|++|+++. ..+ .
T Consensus 102 s~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 181 (386)
T 2ca6_A 102 SDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181 (386)
T ss_dssp CSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHH
T ss_pred CCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHH
Confidence 5555554 2344455555555555555555432222222 22 555555555555541 122 2
Q ss_pred cccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCC----CCCCcccc
Q 004218 221 SFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS----GNLPNSFK 296 (767)
Q Consensus 221 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~----~~~~~~~~ 296 (767)
.+..+++|++|+|++|+++.. .+. ...+..+..+++|+.|+|++|.++ ..+|..+.
T Consensus 182 ~l~~~~~L~~L~L~~n~l~~~---g~~-----------------~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~ 241 (386)
T 2ca6_A 182 TFQSHRLLHTVKMVQNGIRPE---GIE-----------------HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 241 (386)
T ss_dssp HHHHCTTCCEEECCSSCCCHH---HHH-----------------HHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG
T ss_pred HHHhCCCcCEEECcCCCCCHh---HHH-----------------HHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHc
Confidence 333445555555555544310 000 022335667788888888888885 45667778
Q ss_pred cCcccceeeccCccccCC----CCchhhc--cCCceEEEcCCcccCC----CCCccc-cccccCceEeccCCcCcCcC
Q 004218 297 NCKSLEKLLMANNKFSGP----IPNILAE--LKGLEVLDLSSNKLSG----SIPSDL-QNLRALRSLNLTFNNLEGVV 363 (767)
Q Consensus 297 ~l~~L~~L~l~~n~l~~~----~~~~~~~--l~~L~~L~Ls~N~l~~----~~~~~~-~~l~~L~~L~l~~N~l~~~~ 363 (767)
.+++|+.|+|++|.+++. ++..+.. +++|+.|+|++|.+++ .+|..+ ..+++|+.|++++|++++..
T Consensus 242 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp GCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred cCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 888888888888888754 4455533 7888888888888886 366666 55788888888888888653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.8e-24 Score=223.06 Aligned_cols=250 Identities=21% Similarity=0.249 Sum_probs=158.8
Q ss_pred CCEEECcCCcceeecCchhhhh--ccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCccc-CccccCCCCCCCEE
Q 004218 107 LNFLAFDGNQFEGEIPESIGNL--SNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGE-ILTEIGQLQELQSL 183 (767)
Q Consensus 107 L~~L~l~~n~l~~~~~~~~~~l--~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~-~~~~~~~l~~L~~L 183 (767)
++.+++++|.+. +..+..+ .. ++.|++++|.+.+..+. +..+++|++|++++|.+++. .+..+..+++|++|
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~-l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQG-VIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTT-CSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred heeeccccccCC---HHHHHhhhhcc-ceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 455555555554 2344444 33 66666666666544333 34556666666666665543 44555666666666
Q ss_pred EccCCccccccCcCcccCCCCceeeCCCC-cCCCC-CcccccCccccccccccCc-ccCCC-CChhhcccc-cccceeec
Q 004218 184 DLAGNQISGSIPNTLGNLKKLNQIDLSGN-ELASE-IPTSFGNFQNLLSIDLSNN-KLNGN-IPKEILSLS-SLTTIVNL 258 (767)
Q Consensus 184 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~l~~n-~l~~~-~~~~~~~l~-~l~~~l~l 258 (767)
+|++|.+.+..+..++.+++|++|+|++| .+++. .+..+..+++|++|++++| .+++. ++..+..++ +| +.+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L-~~L~l 202 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI-TQLNL 202 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC-CEEEC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCC-CEEEe
Confidence 66666665555555566666666666666 44431 3444555666666666666 55532 344555555 55 33366
Q ss_pred ccc--cCC-CCCchhhcCCCceeEEEccCCC-CCCCCCcccccCcccceeeccCcc-ccCCCCchhhccCCceEEEcCCc
Q 004218 259 SKN--FLD-GTLPEEIGMLGNVVTIDLSANG-LSGNLPNSFKNCKSLEKLLMANNK-FSGPIPNILAELKGLEVLDLSSN 333 (767)
Q Consensus 259 ~~n--~l~-~~~~~~~~~l~~L~~L~ls~n~-l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~Ls~N 333 (767)
++| .++ +.++..+..+++|+.|++++|. +++..+..+..+++|+.|++++|. +.......+..+++|+.|++++|
T Consensus 203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 666 333 3456667788899999999998 776777788999999999999995 33222236788999999999999
Q ss_pred ccCCCCCcccccc-ccCceEeccCCcCcCcCCCC
Q 004218 334 KLSGSIPSDLQNL-RALRSLNLTFNNLEGVVPRE 366 (767)
Q Consensus 334 ~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~ 366 (767)
+. ...+..+ .+++.|++++|++++..|..
T Consensus 283 -i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 283 -VP---DGTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp -SC---TTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred -cC---HHHHHHHHhhCcceEEecccCccccCCc
Confidence 43 2344555 34888889999999887754
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=209.38 Aligned_cols=207 Identities=20% Similarity=0.328 Sum_probs=157.0
Q ss_pred eCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccc
Q 004218 8 GLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKI 87 (767)
Q Consensus 8 ~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l 87 (767)
.+..+.+++.++.. .+++|++|++++|.+. .+| .+..+++|++|+|++|.+++. +. +..+++|++|++++|++
T Consensus 25 ~l~~~~~~~~~~~~---~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l 97 (308)
T 1h6u_A 25 AAGKSNVTDTVTQA---DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPL 97 (308)
T ss_dssp HTTCSSTTSEECHH---HHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCC
T ss_pred HhCCCCcCceecHH---HcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcC
Confidence 44555555323222 3678888888888888 455 478888888888888888843 33 88888888888888887
Q ss_pred cCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCc
Q 004218 88 VGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSIS 167 (767)
Q Consensus 88 ~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~ 167 (767)
... ..+.++++|++|++++|++++ ++ .+..+++ |++|++++|++++..+ +..+++|++|++++|.++
T Consensus 98 ~~~--------~~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~-L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 164 (308)
T 1h6u_A 98 KNV--------SAIAGLQSIKTLDLTSTQITD-VT-PLAGLSN-LQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164 (308)
T ss_dssp SCC--------GGGTTCTTCCEEECTTSCCCC-CG-GGTTCTT-CCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred CCc--------hhhcCCCCCCEEECCCCCCCC-ch-hhcCCCC-CCEEECCCCccCcCcc--ccCCCCccEEEccCCcCC
Confidence 632 357788888888888888874 33 3777777 8888888888875433 788888888888888888
Q ss_pred ccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCC
Q 004218 168 GEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 168 ~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
+..+ +..+++|++|++++|++++..+ +..+++|++|+|++|++++.. .+..+++|+.|++++|++++
T Consensus 165 ~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 165 DLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred CChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 5433 8888888888888888885433 788888888888888887544 37888888888888888873
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=201.76 Aligned_cols=211 Identities=15% Similarity=0.162 Sum_probs=177.1
Q ss_pred CCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccccc-CcccCCccCCCCCCCcEEeecC-cc
Q 004218 9 LASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNL-LEGTVPPGLGNLPFLKMYNIGF-NK 86 (767)
Q Consensus 9 l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~-i~~~~~~~~~~l~~L~~L~l~~-n~ 86 (767)
++.++++ ++|. +. ++|++|++++|++++..+..|.++++|++|++++|. ++...+..|..+++|++|++++ |+
T Consensus 18 v~c~~l~-~ip~-~~---~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~ 92 (239)
T 2xwt_C 18 VTCKDIQ-RIPS-LP---PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92 (239)
T ss_dssp EEECSCS-SCCC-CC---TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETT
T ss_pred eEccCcc-ccCC-CC---CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCC
Confidence 3344466 8987 43 489999999999997777789999999999999997 8866667899999999999998 88
Q ss_pred ccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccC---eEEccCC-cccccCCccccCCCCCC-EEEC
Q 004218 87 IVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLS---KLYMGGN-RFYGKIPTSIGRLRSLT-LLNL 161 (767)
Q Consensus 87 l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~---~L~l~~n-~i~~~~~~~l~~l~~L~-~L~l 161 (767)
++..+ +..+.++++|++|++++|++++ +|. +..+.+ |+ +|++++| +++...+..|.++++|+ +|++
T Consensus 93 l~~i~------~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~-L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l 163 (239)
T 2xwt_C 93 LTYID------PDALKELPLLKFLGIFNTGLKM-FPD-LTKVYS-TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163 (239)
T ss_dssp CCEEC------TTSEECCTTCCEEEEEEECCCS-CCC-CTTCCB-CCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEEC
T ss_pred eeEcC------HHHhCCCCCCCEEeCCCCCCcc-ccc-cccccc-cccccEEECCCCcchhhcCcccccchhcceeEEEc
Confidence 87432 2357788999999999999995 776 778877 88 9999999 99988788899999999 9999
Q ss_pred cCCcCcccCccccCCCCCCCEEEccCCc-cccccCcCcccC-CCCceeeCCCCcCCCCCcccccCccccccccccCcc
Q 004218 162 SYNSISGEILTEIGQLQELQSLDLAGNQ-ISGSIPNTLGNL-KKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNK 237 (767)
Q Consensus 162 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~ 237 (767)
++|+++.+.+..|.. ++|++|++++|+ ++...+..|..+ ++|+.|++++|++++..+. .+++|+.|+++++.
T Consensus 164 ~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 164 YNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW 237 (239)
T ss_dssp CSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred CCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence 999999555555555 899999999995 997777889999 9999999999999865444 57888999888763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-23 Score=210.65 Aligned_cols=152 Identities=19% Similarity=0.093 Sum_probs=119.9
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCC------------------cchhhHHHHHHHHhcCC
Q 004218 448 DELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIEST------------------GTWKSFFAECEALRNTR 509 (767)
Q Consensus 448 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~ 509 (767)
..+......|.+.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455566778899999999999999997799999999864321 12356889999999998
Q ss_pred CCCceeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 004218 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHC 589 (767)
Q Consensus 510 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 589 (767)
| +++.+++. .+..++||||++||+|.+ +.. .+...++.|++.||+|||+. ||+||
T Consensus 163 ~---~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~~---giiHr 217 (282)
T 1zar_A 163 G---LAVPKVYA------WEGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYHR---GIVHG 217 (282)
T ss_dssp T---SSSCCEEE------EETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred C---CCcCeEEe------ccceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHHC---CCEeC
Confidence 4 55555432 134599999999999998 421 12456999999999999999 99999
Q ss_pred cCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccC
Q 004218 590 DLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL 644 (767)
Q Consensus 590 Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 644 (767)
||||+||+++ ++.+||+|||+|+. +..+.|||++.
T Consensus 218 Dlkp~NILl~-~~~vkl~DFG~a~~-------------------~~~~~a~e~l~ 252 (282)
T 1zar_A 218 DLSQYNVLVS-EEGIWIIDFPQSVE-------------------VGEEGWREILE 252 (282)
T ss_dssp CCSTTSEEEE-TTEEEECCCTTCEE-------------------TTSTTHHHHHH
T ss_pred CCCHHHEEEE-CCcEEEEECCCCeE-------------------CCCCCHHHHHH
Confidence 9999999999 99999999999963 34578899764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=2.8e-22 Score=207.46 Aligned_cols=194 Identities=24% Similarity=0.347 Sum_probs=100.1
Q ss_pred hhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCc
Q 004218 126 GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN 205 (767)
Q Consensus 126 ~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 205 (767)
.++.+ |++|++++|++.. ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++|++++. + .+..+++|+
T Consensus 38 ~~l~~-L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~ 110 (308)
T 1h6u_A 38 ADLDG-ITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIK 110 (308)
T ss_dssp HHHHT-CCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCC
T ss_pred HHcCC-cCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCC
Confidence 34444 6666666666552 23 35556666666666666654322 56666666666666666532 2 455666666
Q ss_pred eeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCC
Q 004218 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSAN 285 (767)
Q Consensus 206 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n 285 (767)
+|+|++|++++. + .+..+++|++|++++|.+++..+ ++.+++|+.|++++|
T Consensus 111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~---------------------------l~~l~~L~~L~l~~n 161 (308)
T 1h6u_A 111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP---------------------------LAGLTNLQYLSIGNA 161 (308)
T ss_dssp EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG---------------------------GGGCTTCCEEECCSS
T ss_pred EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc---------------------------ccCCCCccEEEccCC
Confidence 666666666542 2 25566666666666665552211 333444444455544
Q ss_pred CCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcC
Q 004218 286 GLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEG 361 (767)
Q Consensus 286 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 361 (767)
.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|+|++|++++.. .+..+++|+.|++++|++++
T Consensus 162 ~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 162 QVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred cCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 4443222 4444555555555555443222 444555555555555554332 14455555555555555544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-23 Score=219.57 Aligned_cols=253 Identities=16% Similarity=0.220 Sum_probs=194.6
Q ss_pred ccEEeCCCCeeeecCCCccccCC--CCCcEEEccCCcccccCCccccCCCCCCEEEcccccCccc-CCccCCCCCCCcEE
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKL--PNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGT-VPPGLGNLPFLKMY 80 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l--~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~-~~~~~~~l~~L~~L 80 (767)
++.||+++|++.. . .+..+ ++++.|++++|.+.+..+. +.++++|++|+|++|.+++. ++..+..+++|++|
T Consensus 49 ~~~l~l~~~~~~~---~-~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 49 WQTLDLTGKNLHP---D-VTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp SSEEECTTCBCCH---H-HHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred heeeccccccCCH---H-HHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 6789999988762 2 22345 7899999999999876665 66789999999999998765 77778889999999
Q ss_pred eecCccccCCCCCCccccccccCCCCCCEEECcCC-cceee-cCchhhhhccccCeEEccCC-ccccc-CCccccCCC-C
Q 004218 81 NIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGN-QFEGE-IPESIGNLSNVLSKLYMGGN-RFYGK-IPTSIGRLR-S 155 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n-~l~~~-~~~~~~~l~~~L~~L~l~~n-~i~~~-~~~~l~~l~-~ 155 (767)
++++|.+.. ..+..+..+++|++|++++| .+++. ++..+..+++ |++|++++| ++++. ++..+..++ +
T Consensus 124 ~L~~~~l~~------~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~-L~~L~l~~~~~l~~~~~~~~~~~l~~~ 196 (336)
T 2ast_B 124 SLEGLRLSD------PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR-LDELNLSWCFDFTEKHVQVAVAHVSET 196 (336)
T ss_dssp ECTTCBCCH------HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT-CCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred eCcCcccCH------HHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCC-CCEEcCCCCCCcChHHHHHHHHhcccC
Confidence 999998753 45667788899999999999 67753 6666778887 999999999 88754 567788888 9
Q ss_pred CCEEECcCC--cCc-ccCccccCCCCCCCEEEccCCc-cccccCcCcccCCCCceeeCCCCc-CCCCCcccccCcccccc
Q 004218 156 LTLLNLSYN--SIS-GEILTEIGQLQELQSLDLAGNQ-ISGSIPNTLGNLKKLNQIDLSGNE-LASEIPTSFGNFQNLLS 230 (767)
Q Consensus 156 L~~L~l~~n--~i~-~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~ 230 (767)
|++|++++| .++ +..+..+..+++|++|++++|. +++..+..+..+++|++|+|++|. +.......+..+++|+.
T Consensus 197 L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~ 276 (336)
T 2ast_B 197 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 276 (336)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred CCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCE
Confidence 999999999 454 3456667788999999999998 776777788889999999999995 32222225778899999
Q ss_pred ccccCcccCCCCChhhc-ccccccceeecccccCCCCCchhhcC
Q 004218 231 IDLSNNKLNGNIPKEIL-SLSSLTTIVNLSKNFLDGTLPEEIGM 273 (767)
Q Consensus 231 L~l~~n~l~~~~~~~~~-~l~~l~~~l~l~~n~l~~~~~~~~~~ 273 (767)
|++++| ++......+. .++.+ ++++|.+++..|..++.
T Consensus 277 L~l~~~-i~~~~~~~l~~~l~~L----~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 277 LQVFGI-VPDGTLQLLKEALPHL----QINCSHFTTIARPTIGN 315 (336)
T ss_dssp EECTTS-SCTTCHHHHHHHSTTS----EESCCCSCCTTCSSCSS
T ss_pred EeccCc-cCHHHHHHHHhhCcce----EEecccCccccCCcccc
Confidence 999998 5533333332 24433 78999999888877664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8.7e-22 Score=197.65 Aligned_cols=181 Identities=20% Similarity=0.263 Sum_probs=128.4
Q ss_pred CCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCcccccccccc
Q 004218 155 SLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLS 234 (767)
Q Consensus 155 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 234 (767)
+.++++++++.++ .+|..+. ++|++|+|++|.+.+..+..|.++++|++|+|++|.+++..+..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4567778877777 4454443 577778888887777666677777778888887777777667777777777777777
Q ss_pred CcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCC
Q 004218 235 NNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGP 314 (767)
Q Consensus 235 ~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 314 (767)
+|++++. .+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++.
T Consensus 92 ~n~l~~~-------------------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 146 (251)
T 3m19_A 92 NNQLASL-------------------------PLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI 146 (251)
T ss_dssp TSCCCCC-------------------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCccccc-------------------------ChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence 7776633 334455566677777777777766666667777777777777777766
Q ss_pred CCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcC
Q 004218 315 IPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVV 363 (767)
Q Consensus 315 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 363 (767)
.+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++++..
T Consensus 147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 6666777777777777777777666666777777777777777777653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-21 Score=195.53 Aligned_cols=179 Identities=21% Similarity=0.274 Sum_probs=119.4
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
.+++++++++++ .+|..+. +++++|+|++|++.+..+..|.++++|++|+|++|.+++..+..|..+++|++|+|+
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CeEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 456677777776 6666554 366677777777766556666666677777777666665555555556666666655
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcC
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~ 163 (767)
+|++. +..+..+..+++ |++|+|++|++++..+..|..+++|++|+|++
T Consensus 92 ~n~l~------------------------------~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 140 (251)
T 3m19_A 92 NNQLA------------------------------SLPLGVFDHLTQ-LDKLYLGGNQLKSLPSGVFDRLTKLKELRLNT 140 (251)
T ss_dssp TSCCC------------------------------CCCTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCccc------------------------------ccChhHhcccCC-CCEEEcCCCcCCCcChhHhccCCcccEEECcC
Confidence 55554 333344455555 66666666666655555667777777777777
Q ss_pred CcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCC
Q 004218 164 NSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASE 217 (767)
Q Consensus 164 n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 217 (767)
|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++...
T Consensus 141 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 141 NQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 777766666677777777777777777766666777777888888888877653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-21 Score=205.42 Aligned_cols=241 Identities=17% Similarity=0.202 Sum_probs=125.8
Q ss_pred EEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccC-ccccCCCCCCCE-EEcc
Q 004218 109 FLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEI-LTEIGQLQELQS-LDLA 186 (767)
Q Consensus 109 ~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~-~~~~~~l~~L~~-L~L~ 186 (767)
+++.++++++ .+|..+ +.++++|+|++|+|+.+.+++|.++++|++|+|++|++.+.+ +.+|.++++|++ +.++
T Consensus 13 ~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred EEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 4455555555 445433 122666666666666444455666666666666666654322 334555655543 4444
Q ss_pred CCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccC-cccCCCCChhhcccccccceeecccccCCC
Q 004218 187 GNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSN-NKLNGNIPKEILSLSSLTTIVNLSKNFLDG 265 (767)
Q Consensus 187 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~ 265 (767)
.|++....|..|..+++|++|++++|+++...+..+....++..|++.+ +++. .
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-------------------------~ 143 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-------------------------T 143 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-------------------------E
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-------------------------c
Confidence 5666655555666666666666666666554444444445555555543 2333 2
Q ss_pred CCchhhcCCC-ceeEEEccCCCCCCCCCcccccCcccceeeccC-ccccCCCCchhhccCCceEEEcCCcccCCCCCccc
Q 004218 266 TLPEEIGMLG-NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMAN-NKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDL 343 (767)
Q Consensus 266 ~~~~~~~~l~-~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 343 (767)
..+..|..+. .++.|++++|+|+.+.+..| ...+|+.|++++ |.++.+.++.|..+++|+.|||++|+|+...+..+
T Consensus 144 l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~ 222 (350)
T 4ay9_X 144 IERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL 222 (350)
T ss_dssp ECTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC
T ss_pred ccccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh
Confidence 2222333332 45666666666664433333 345666666653 45554444556667777777777777764333333
Q ss_pred cccccCceEeccCC-cCcCcCCCCccccccccccccCCcCcc
Q 004218 344 QNLRALRSLNLTFN-NLEGVVPREGIFRHTSMVHLEGNPKLC 384 (767)
Q Consensus 344 ~~l~~L~~L~l~~N-~l~~~~~~~~~~~~~~~~~l~~Np~~c 384 (767)
..+ +.|.+.++ .++.. |....++++..+.+ .||+.|
T Consensus 223 ~~L---~~L~~l~~~~l~~l-P~l~~l~~L~~l~l-~~~~~c 259 (350)
T 4ay9_X 223 ENL---KKLRARSTYNLKKL-PTLEKLVALMEASL-TYPSHC 259 (350)
T ss_dssp TTC---CEEECTTCTTCCCC-CCTTTCCSCCEEEC-SCHHHH
T ss_pred ccc---hHhhhccCCCcCcC-CCchhCcChhhCcC-CCCccc
Confidence 333 33333322 33333 33444555555555 356666
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-21 Score=204.86 Aligned_cols=218 Identities=16% Similarity=0.152 Sum_probs=168.5
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccC-cCcccCCCCce-eeC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIP-NTLGNLKKLNQ-IDL 209 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~-L~L 209 (767)
-+++++++++++ .+|..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| .+|.++++|.+ +.+
T Consensus 11 ~~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 11 NRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TTEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CCEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 367889999998 677766 3689999999999997777789999999999999999865554 57888888776 567
Q ss_pred CCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccC-CCCC
Q 004218 210 SGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSA-NGLS 288 (767)
Q Consensus 210 ~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~-n~l~ 288 (767)
+.|+++.+.|+.|..+++|++|++++|++....+. .+....++..|++++ |.+.
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~-------------------------~~~~~~~l~~l~l~~~~~i~ 142 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV-------------------------HKIHSLQKVLLDIQDNINIH 142 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCC-------------------------TTCCBSSCEEEEEESCTTCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCch-------------------------hhcccchhhhhhhccccccc
Confidence 78999888888999999999999999988732221 222344677888865 5777
Q ss_pred CCCCcccccCc-ccceeeccCccccCCCCchhhccCCceEEEcCC-cccCCCCCccccccccCceEeccCCcCcCcCCCC
Q 004218 289 GNLPNSFKNCK-SLEKLLMANNKFSGPIPNILAELKGLEVLDLSS-NKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE 366 (767)
Q Consensus 289 ~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 366 (767)
.+.+..|..+. .++.|++++|+|+.+.+..| ...+|+.|++++ |.++...+..|..+++|+.|++++|+++.+++..
T Consensus 143 ~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~ 221 (350)
T 4ay9_X 143 TIERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 221 (350)
T ss_dssp EECTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS
T ss_pred cccccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh
Confidence 67777787775 68999999999995544444 556799999985 6677555567899999999999999999887643
Q ss_pred ccccccccccccCC
Q 004218 367 GIFRHTSMVHLEGN 380 (767)
Q Consensus 367 ~~~~~~~~~~l~~N 380 (767)
+.++..+...++
T Consensus 222 --~~~L~~L~~l~~ 233 (350)
T 4ay9_X 222 --LENLKKLRARST 233 (350)
T ss_dssp --CTTCCEEECTTC
T ss_pred --hccchHhhhccC
Confidence 555555554443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-20 Score=208.81 Aligned_cols=190 Identities=19% Similarity=0.286 Sum_probs=133.4
Q ss_pred CCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCC
Q 004218 28 NLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRL 107 (767)
Q Consensus 28 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L 107 (767)
+|+.|+|++|++.+ +|..+ .++|++|+|++|.|+ .+| ..+++|++|+|++|++++.+ . +.+ +|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~ip-------~-l~~--~L 122 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLSTLP-------E-LPA--SL 122 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCC-------C-CCT--TC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCCcc-------h-hhc--CC
Confidence 67777777777764 55544 266777777777776 555 34567777777777766432 1 222 67
Q ss_pred CEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccC
Q 004218 108 NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAG 187 (767)
Q Consensus 108 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 187 (767)
++|+|++|++++ +|. .+++ |++|+|++|++++ +|. .+++|++|+|++|+|++ +|. |. ++|++|+|++
T Consensus 123 ~~L~Ls~N~l~~-lp~---~l~~-L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~ 189 (571)
T 3cvr_A 123 KHLDVDNNQLTM-LPE---LPAL-LEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVST 189 (571)
T ss_dssp CEEECCSSCCSC-CCC---CCTT-CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCS
T ss_pred CEEECCCCcCCC-CCC---cCcc-ccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcC
Confidence 777777777774 555 3455 8888888888875 454 46788888888888885 455 55 7888888888
Q ss_pred CccccccCcCcccCCCC-------ceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccc
Q 004218 188 NQISGSIPNTLGNLKKL-------NQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSL 252 (767)
Q Consensus 188 n~i~~~~~~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l 252 (767)
|+|+ .+|. |.. +| +.|+|++|+|+. +|..+..+++|+.|+|++|++++.+|..+..+...
T Consensus 190 N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~ 256 (571)
T 3cvr_A 190 NLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256 (571)
T ss_dssp SCCS-SCCC-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHHS
T ss_pred CCCC-chhh-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhcC
Confidence 8888 5565 543 66 889999999984 67777778999999999999988888887776553
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=3e-20 Score=180.74 Aligned_cols=181 Identities=16% Similarity=0.130 Sum_probs=109.0
Q ss_pred cEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecC
Q 004218 5 VYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGF 84 (767)
Q Consensus 5 ~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (767)
+.+++++++++ .+|..+. ++|++|++++|++.+..+..|..+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 10 ~~v~c~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGIP---AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCcc-CCCCCCC---CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 45666777776 6665543 3667777777777755555566777777777777776644444455666666666666
Q ss_pred ccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCC
Q 004218 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN 164 (767)
Q Consensus 85 n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n 164 (767)
|++.. ..+..+..+++ |++|++++|++++..+..|..+++|++|++++|
T Consensus 86 n~l~~------------------------------~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 134 (208)
T 2o6s_A 86 NQLQS------------------------------LPNGVFDKLTQ-LKELALNTNQLQSLPDGVFDKLTQLKDLRLYQN 134 (208)
T ss_dssp SCCCC------------------------------CCTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CcCCc------------------------------cCHhHhcCccC-CCEEEcCCCcCcccCHhHhccCCcCCEEECCCC
Confidence 65543 22333444444 555555555555444445566666666666666
Q ss_pred cCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccc
Q 004218 165 SISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQN 227 (767)
Q Consensus 165 ~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 227 (767)
.+++..+..+..+++|++|++++|.+.+ .+++|+.|+++.|++++.+|..++.++.
T Consensus 135 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 135 QLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 6665555556666666666666665542 3346666677777776666666665544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.2e-20 Score=179.63 Aligned_cols=180 Identities=22% Similarity=0.258 Sum_probs=96.4
Q ss_pred CeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCC
Q 004218 133 SKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212 (767)
Q Consensus 133 ~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 212 (767)
+.+++++++++ .+|..+ .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 34555555554 233322 245666666666666544445556666666666666666444445556666666666666
Q ss_pred cCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCC
Q 004218 213 ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLP 292 (767)
Q Consensus 213 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~ 292 (767)
++++..+..|..+++|++|++++|++++..+ ..+..+++|+.|+|++|.+++..+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-------------------------~~~~~l~~L~~L~l~~N~l~~~~~ 141 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPD-------------------------GVFDKLTQLKDLRLYQNQLKSVPD 141 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCT-------------------------TTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCH-------------------------hHhccCCcCCEEECCCCccceeCH
Confidence 6665555555566666666666655553222 223344455555555555554444
Q ss_pred cccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccc
Q 004218 293 NSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLR 347 (767)
Q Consensus 293 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 347 (767)
..+..+++|+.|++++|.+.+ .+++|+.|+++.|.++|.+|..++.++
T Consensus 142 ~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 142 GVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp TTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred HHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 445555555555555555442 233455555666666666665555444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.9e-20 Score=203.73 Aligned_cols=189 Identities=22% Similarity=0.341 Sum_probs=155.2
Q ss_pred CCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccc
Q 004218 52 NIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNV 131 (767)
Q Consensus 52 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~ 131 (767)
+|+.|+|++|.+++ +|..+. ++|++|+|++|+++..| ..+++|++|+|++|++++ +|. +.. +
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~ip----------~~l~~L~~L~Ls~N~l~~-ip~-l~~--~- 121 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISLP----------ELPASLEYLDACDNRLST-LPE-LPA--S- 121 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCCC----------CCCTTCCEEECCSSCCSC-CCC-CCT--T-
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcccc----------cccCCCCEEEccCCCCCC-cch-hhc--C-
Confidence 89999999999985 777663 78999999999987543 346899999999999995 777 555 4
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
|++|+|++|++++ +|. .+++|+.|+|++|.|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++
T Consensus 122 L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~ 189 (571)
T 3cvr_A 122 LKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVST 189 (571)
T ss_dssp CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCS
T ss_pred CCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcC
Confidence 9999999999986 565 67899999999999996 444 57899999999999995 666 66 8999999999
Q ss_pred CcCCCCCcccccCcccc-------ccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCc
Q 004218 212 NELASEIPTSFGNFQNL-------LSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGN 276 (767)
Q Consensus 212 N~l~~~~~~~~~~l~~L-------~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~ 276 (767)
|+|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|. .+++++|.+++..|..++.++.
T Consensus 190 N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 190 NLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTC-TIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp SCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTE-EEECCSSSCCHHHHHHHHHHHH
T ss_pred CCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCC-EEEeeCCcCCCcCHHHHHHhhc
Confidence 9998 4555 554 77 99999999999 6888888899884 5599999999888888876543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.7e-20 Score=189.73 Aligned_cols=188 Identities=26% Similarity=0.346 Sum_probs=112.7
Q ss_pred cEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCE
Q 004218 30 LGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNF 109 (767)
Q Consensus 30 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~ 109 (767)
..+.+..+.+.+..+ +..+++|++|++++|.+.. ++ .+..+++|++|++++|++.+. +. +.++++|++
T Consensus 27 ~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~-------~~-l~~l~~L~~ 94 (291)
T 1h6t_A 27 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-------KP-LANLKNLGW 94 (291)
T ss_dssp HHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-------GG-GTTCTTCCE
T ss_pred HHHHhcCCCcccccc--hhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCC-------cc-cccCCCCCE
Confidence 334455555543222 3455666666666666652 22 355566666666666665432 11 555666666
Q ss_pred EECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCc
Q 004218 110 LAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQ 189 (767)
Q Consensus 110 L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 189 (767)
|++++|++++ ++ .+..+++ |++|++++|++++. ..+..+++|++|++++|++++. ..+..+++|++|++++|+
T Consensus 95 L~l~~n~l~~-~~-~l~~l~~-L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~ 167 (291)
T 1h6t_A 95 LFLDENKVKD-LS-SLKDLKK-LKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQ 167 (291)
T ss_dssp EECCSSCCCC-GG-GGTTCTT-CCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred EECCCCcCCC-Ch-hhccCCC-CCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCc
Confidence 6666666653 22 3555555 66666666666632 3466667777777777777643 456667777777777777
Q ss_pred cccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCC
Q 004218 190 ISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 190 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
+++..+ +..+++|+.|+|++|.++.. + .+..+++|+.|++++|++..
T Consensus 168 l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 168 ISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred cccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 764433 66677777777777777642 3 36677777777777777663
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=4.2e-20 Score=207.42 Aligned_cols=169 Identities=28% Similarity=0.371 Sum_probs=77.3
Q ss_pred CCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCC
Q 004218 26 LPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNST 105 (767)
Q Consensus 26 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~ 105 (767)
|++|+.|++++|.+. .+| .+..+++|+.|+|++|.+++..+ +..+++|+.|+|++|.+... ..+..++
T Consensus 42 L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--------~~l~~l~ 109 (605)
T 1m9s_A 42 LNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--------SSLKDLK 109 (605)
T ss_dssp HTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--------TTSTTCT
T ss_pred CCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--------hhhccCC
Confidence 445555555555554 233 24555555555555555553222 44555555555555554321 1344445
Q ss_pred CCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEc
Q 004218 106 RLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDL 185 (767)
Q Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 185 (767)
+|+.|+|++|++++ + +.+..+++ |+.|+|++|++++. ..+..+++|+.|+|++|.|.+..+ +..+++|++|+|
T Consensus 110 ~L~~L~Ls~N~l~~-l-~~l~~l~~-L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 182 (605)
T 1m9s_A 110 KLKSLSLEHNGISD-I-NGLVHLPQ-LESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 182 (605)
T ss_dssp TCCEEECTTSCCCC-C-GGGGGCTT-CSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCEEEecCCCCCC-C-ccccCCCc-cCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEEC
Confidence 55555555555442 1 23444444 44444444444432 334444444444444444443322 444444444444
Q ss_pred cCCccccccCcCcccCCCCceeeCCCCcCC
Q 004218 186 AGNQISGSIPNTLGNLKKLNQIDLSGNELA 215 (767)
Q Consensus 186 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 215 (767)
++|+|++. ..+..+++|+.|+|++|++.
T Consensus 183 s~N~i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 183 SKNHISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp CSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred cCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence 44444422 12444444444444444444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.3e-20 Score=209.47 Aligned_cols=198 Identities=25% Similarity=0.324 Sum_probs=165.8
Q ss_pred CCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCC
Q 004218 27 PNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTR 106 (767)
Q Consensus 27 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~ 106 (767)
.++..++++.+.+.+.++ +..+++|+.|++++|.+. .++ .++.+++|+.|+|++|.+... +. +..+++
T Consensus 21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~-------~~-l~~l~~ 88 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDI-------KP-LTNLKN 88 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCC-------GG-GGGCTT
T ss_pred HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCC-------hh-hccCCC
Confidence 356777888888886544 678999999999999998 444 689999999999999998743 22 888999
Q ss_pred CCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEcc
Q 004218 107 LNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLA 186 (767)
Q Consensus 107 L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 186 (767)
|+.|+|++|++++ +| .+..+++ |++|+|++|++... ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|+
T Consensus 89 L~~L~Ls~N~l~~-l~-~l~~l~~-L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls 161 (605)
T 1m9s_A 89 LGWLFLDENKIKD-LS-SLKDLKK-LKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLE 161 (605)
T ss_dssp CCEEECCSSCCCC-CT-TSTTCTT-CCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECC
T ss_pred CCEEECcCCCCCC-Ch-hhccCCC-CCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECc
Confidence 9999999999984 44 6888888 99999999999853 4688999999999999999964 678999999999999
Q ss_pred CCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhc
Q 004218 187 GNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEIL 247 (767)
Q Consensus 187 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 247 (767)
+|.|.+..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+.....+.
T Consensus 162 ~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~ 218 (605)
T 1m9s_A 162 DNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS 218 (605)
T ss_dssp SSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCS
T ss_pred CCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccc
Confidence 999997656 89999999999999999864 4688999999999999999854333333
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-19 Score=185.25 Aligned_cols=188 Identities=26% Similarity=0.356 Sum_probs=154.2
Q ss_pred EeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCcc
Q 004218 7 LGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNK 86 (767)
Q Consensus 7 L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 86 (767)
+.+..+.+++.++. ..+++|++|++++|.+.. ++. +..+++|++|+|++|.+++..+ ++.+++|++|++++|+
T Consensus 29 ~~l~~~~~~~~~~~---~~l~~L~~L~l~~~~i~~-~~~-~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~ 101 (291)
T 1h6t_A 29 DNLKKKSVTDAVTQ---NELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK 101 (291)
T ss_dssp HHTTCSCTTSEECH---HHHHTCCEEECTTSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHhcCCCcccccch---hhcCcccEEEccCCCccc-Chh-HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCc
Confidence 45566666532222 247789999999999984 554 8899999999999999985443 8899999999999999
Q ss_pred ccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcC
Q 004218 87 IVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSI 166 (767)
Q Consensus 87 l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i 166 (767)
+.. +..+.++++|++|++++|++++. ..+..+++ |++|++++|++++. ..+..+++|++|++++|.+
T Consensus 102 l~~--------~~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~-L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l 168 (291)
T 1h6t_A 102 VKD--------LSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQ-LESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 168 (291)
T ss_dssp CCC--------GGGGTTCTTCCEEECTTSCCCCC--GGGGGCTT-CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred CCC--------ChhhccCCCCCEEECCCCcCCCC--hhhcCCCC-CCEEEccCCcCCcc--hhhccCCCCCEEEccCCcc
Confidence 863 34588899999999999999853 56888888 99999999999854 6789999999999999999
Q ss_pred cccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCC
Q 004218 167 SGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEI 218 (767)
Q Consensus 167 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 218 (767)
++..+ +..+++|++|++++|.+++ ++ .+..+++|+.|++++|+++...
T Consensus 169 ~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 169 SDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECCC
T ss_pred ccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCCc
Confidence 96544 8999999999999999985 44 4889999999999999997543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3e-19 Score=174.79 Aligned_cols=152 Identities=22% Similarity=0.329 Sum_probs=87.5
Q ss_pred CEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCc
Q 004218 157 TLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236 (767)
Q Consensus 157 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 236 (767)
+.++++++.++ .+|..+. ++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45666666665 3343332 45666666666666555555666666666666666665555555555555555555555
Q ss_pred ccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCC
Q 004218 237 KLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIP 316 (767)
Q Consensus 237 ~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 316 (767)
+++. ..+..|..+++|+.|+|++|.+++..|..|..+++|+.|+|++|+|++..+
T Consensus 91 ~l~~-------------------------l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 145 (220)
T 2v9t_B 91 KITE-------------------------LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145 (220)
T ss_dssp CCCC-------------------------CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCCc-------------------------cCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECH
Confidence 5441 222334455666666666666666666666666666666666666665555
Q ss_pred chhhccCCceEEEcCCcccC
Q 004218 317 NILAELKGLEVLDLSSNKLS 336 (767)
Q Consensus 317 ~~~~~l~~L~~L~Ls~N~l~ 336 (767)
..|..+++|+.|+|++|++.
T Consensus 146 ~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 146 GTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp TTTTTCTTCCEEECCSSCEE
T ss_pred HHHhCCCCCCEEEeCCCCcC
Confidence 55555666666666666554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.6e-19 Score=187.89 Aligned_cols=177 Identities=20% Similarity=0.189 Sum_probs=118.4
Q ss_pred cEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCC-CCCCCcEEeecCccccCCCCCCccccccccCCCCCC
Q 004218 30 LGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLG-NLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLN 108 (767)
Q Consensus 30 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~ 108 (767)
+.++++++++. .+|..+. +.+++|+|++|.|++..+..+. .+++|++|+|++|++...+ +..+.++++|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~------~~~~~~l~~L~ 91 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFIS------SEAFVPVPNLR 91 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEEC------TTTTTTCTTCC
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccC------hhhccCCCCCC
Confidence 34555555555 3444332 2355555555555544444444 5556666666666554321 12355566666
Q ss_pred EEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCcccc---CCCCCCCEEEc
Q 004218 109 FLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI---GQLQELQSLDL 185 (767)
Q Consensus 109 ~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~---~~l~~L~~L~L 185 (767)
+|+|++|+++...+..+..+.+ |++|+|++|+|+...+..|.++++|++|+|++|.|+...+..| ..+++|++|+|
T Consensus 92 ~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L 170 (361)
T 2xot_A 92 YLDLSSNHLHTLDEFLFSDLQA-LEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDL 170 (361)
T ss_dssp EEECCSSCCCEECTTTTTTCTT-CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEEC
T ss_pred EEECCCCcCCcCCHHHhCCCcC-CCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEEC
Confidence 6666666666555566777776 8888888888887778888888888888888888886555555 56889999999
Q ss_pred cCCccccccCcCcccCCC--CceeeCCCCcCCC
Q 004218 186 AGNQISGSIPNTLGNLKK--LNQIDLSGNELAS 216 (767)
Q Consensus 186 ~~n~i~~~~~~~~~~l~~--L~~L~L~~N~l~~ 216 (767)
++|+|+...+..|..++. |+.|+|++|++..
T Consensus 171 ~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 171 SSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred CCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 999998655567777776 4889999999864
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.7e-19 Score=187.15 Aligned_cols=179 Identities=22% Similarity=0.264 Sum_probs=128.5
Q ss_pred CEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCcccc-CCCCCCEEECcCCcCcccCccccCCCCCCCEEEcc
Q 004218 108 NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIG-RLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLA 186 (767)
Q Consensus 108 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~-~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 186 (767)
+.+++++++++ .+|..+.. .++.|+|++|+|++..+..|. ++++|++|+|++|+|+++.+..|..+++|++|+|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~~---~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLPS---YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCS-SCCSSCCT---TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcC-ccCccCCC---CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 57888888887 56665432 377888888888877777776 78888888888888887777778888888888888
Q ss_pred CCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCC
Q 004218 187 GNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGT 266 (767)
Q Consensus 187 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~ 266 (767)
+|+|+...+..|..+++|+.|+|++|+|+...+..|..+++|+.|+|++|++++ +|..+..
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~------------------ 157 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIK------------------ 157 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC------------------
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhc------------------
Confidence 888886666677888888888888888877777778888888888888887773 2221100
Q ss_pred CchhhcCCCceeEEEccCCCCCCCCCcccccCcc--cceeeccCcccc
Q 004218 267 LPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS--LEKLLMANNKFS 312 (767)
Q Consensus 267 ~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~--L~~L~l~~n~l~ 312 (767)
.+..+++|+.|+|++|+|++..+..+..++. |+.|+|++|++.
T Consensus 158 ---~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 158 ---DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp -------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred ---CcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 0134667777777777777665566666665 366777777765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.9e-18 Score=169.01 Aligned_cols=134 Identities=22% Similarity=0.270 Sum_probs=84.9
Q ss_pred CCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEE
Q 004218 105 TRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLD 184 (767)
Q Consensus 105 ~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 184 (767)
++|+.|++++|++++..+..+..+++ |++|+|++|++++..|..|.++++|++|+|++|.|+.+.+..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~-L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~ 110 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKK-LRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLL 110 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTT-CCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCC-CCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEE
Confidence 34555555555555444445555555 66666666666655566666666666666666666655555566666666666
Q ss_pred ccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccC
Q 004218 185 LAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 185 L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
|++|+|.+..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 111 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 111 LNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 6666666665666666666666666666666655556666666666666666665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.1e-19 Score=180.45 Aligned_cols=136 Identities=24% Similarity=0.254 Sum_probs=105.2
Q ss_pred CCCCCccccccceEEEEEEe-CCCcE--EEEEEeeccCCcc------------------------hhhHHHHHHHHhcCC
Q 004218 457 FSHENLIGSGSFGSVYKGYL-REGIS--VAVKVLDIESTGT------------------------WKSFFAECEALRNTR 509 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~------------------------~~~~~~e~~~l~~l~ 509 (767)
|++.+.||+|+||.||+|.+ .+|+. ||||+++...... ...+.+|+++++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999998 67888 9999875331110 125788999999998
Q ss_pred CCCc--eeEEeeeecCCcccceeeEEEEeecCC-C----ChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hC
Q 004218 510 HRNL--VKLITSCSSLDFKNMEFLALVYEFLGN-G----SLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH-ND 581 (767)
Q Consensus 510 h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~ 581 (767)
|+++ ..++++ ...++||||+++ | +|.++... .++.++..++.|++.|+.||| +.
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHC
Confidence 7754 334432 234899999942 4 67666432 223457889999999999999 88
Q ss_pred CCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 582 CEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 582 ~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+||||||+|||++. .++|+|||+|...
T Consensus 191 ---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 ---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999999998 9999999999643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.1e-18 Score=168.78 Aligned_cols=153 Identities=20% Similarity=0.211 Sum_probs=98.1
Q ss_pred cEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCC-ccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 5 VYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIP-GSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 5 ~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
+++++++|+++ .+|..+.. .+++|+|++|++.+..| ..|..+++|++|+|++|.|++..+..|..+++|++|+|+
T Consensus 14 ~~l~~s~n~l~-~iP~~~~~---~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIPQ---YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TEEECCSSCCS-SCCSCCCT---TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEeEeCCCCcc-cCccCCCC---CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 45667777766 66665532 45666777776665433 346666666666666666665444455555555555555
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcC
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~ 163 (767)
+|++ ++..+..+..+++ |++|+|++|++++..|..|..+++|++|+|++
T Consensus 90 ~N~l------------------------------~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 138 (220)
T 2v70_A 90 SNRL------------------------------ENVQHKMFKGLES-LKTLMLRSNRITCVGNDSFIGLSSVRLLSLYD 138 (220)
T ss_dssp SSCC------------------------------CCCCGGGGTTCSS-CCEEECTTSCCCCBCTTSSTTCTTCSEEECTT
T ss_pred CCcc------------------------------CccCHhHhcCCcC-CCEEECCCCcCCeECHhHcCCCccCCEEECCC
Confidence 5554 4344444555555 66677777777666667777777777777777
Q ss_pred CcCcccCccccCCCCCCCEEEccCCcccc
Q 004218 164 NSISGEILTEIGQLQELQSLDLAGNQISG 192 (767)
Q Consensus 164 n~i~~~~~~~~~~l~~L~~L~L~~n~i~~ 192 (767)
|+|++..|..|..+++|++|+|++|.+..
T Consensus 139 N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 139 NQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp SCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 77776667777777777777777777763
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.7e-18 Score=167.96 Aligned_cols=134 Identities=19% Similarity=0.250 Sum_probs=97.8
Q ss_pred CCEEECcCCcceeecC-chhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEc
Q 004218 107 LNFLAFDGNQFEGEIP-ESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDL 185 (767)
Q Consensus 107 L~~L~l~~n~l~~~~~-~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 185 (767)
+++|+|++|++++..+ ..+..+++ |++|+|++|+|++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~-L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 112 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQ-LRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTT-CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred CCEEEcCCCcCCccCchhhhccCCC-CCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence 4566666666664433 33566666 777777777777666667777777777777777777766667777777888888
Q ss_pred cCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCC
Q 004218 186 AGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN 241 (767)
Q Consensus 186 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 241 (767)
++|+|++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|.+.+.
T Consensus 113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 88877777677777777888888888888777777777778888888888777643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.6e-21 Score=214.84 Aligned_cols=190 Identities=17% Similarity=0.222 Sum_probs=98.5
Q ss_pred cccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcc-------------cccCCccccCCCCCCEEE-CcCCc
Q 004218 100 SLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRF-------------YGKIPTSIGRLRSLTLLN-LSYNS 165 (767)
Q Consensus 100 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i-------------~~~~~~~l~~l~~L~~L~-l~~n~ 165 (767)
.+..++.|+.|+|++|+++ .+|..++++++ |++|++++|.. .+..|..++++++|+.|+ ++.|.
T Consensus 344 d~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~-L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~ 421 (567)
T 1dce_A 344 DSATDEQLFRCELSVEKST-VLQSELESCKE-LQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY 421 (567)
T ss_dssp CCSTTTTSSSCCCCHHHHH-HHHHHHHHHHH-HHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHH
T ss_pred ccccCccceeccCChhhHH-hhHHHHHHHHH-HHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcc
Confidence 3466788888888888887 78888888888 88888877652 223333333334444443 33322
Q ss_pred CcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChh
Q 004218 166 ISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKE 245 (767)
Q Consensus 166 i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 245 (767)
+. +|+.+.+++|.+....+ ..|+.|+|++|.+++ +|. |+.+++|+.|+|++|+++ .
T Consensus 422 ~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~---- 477 (567)
T 1dce_A 422 LD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-A---- 477 (567)
T ss_dssp HH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-C----
T ss_pred cc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-c----
Confidence 21 12222333333331111 124555555555543 233 445555555555555444 2
Q ss_pred hcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCC-CchhhccCC
Q 004218 246 ILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPI-PNILAELKG 324 (767)
Q Consensus 246 ~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~ 324 (767)
+|..++.+++|+.|+|++|.|++ +| .++.+++|+.|+|++|+|++.. |..+..+++
T Consensus 478 ---------------------lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~ 534 (567)
T 1dce_A 478 ---------------------LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534 (567)
T ss_dssp ---------------------CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTT
T ss_pred ---------------------cchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCC
Confidence 23334444455555555555553 33 4555555555555555555443 555555555
Q ss_pred ceEEEcCCcccCCC
Q 004218 325 LEVLDLSSNKLSGS 338 (767)
Q Consensus 325 L~~L~Ls~N~l~~~ 338 (767)
|+.|+|++|++++.
T Consensus 535 L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 535 LVLLNLQGNSLCQE 548 (567)
T ss_dssp CCEEECTTSGGGGS
T ss_pred CCEEEecCCcCCCC
Confidence 55555555555543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.2e-18 Score=167.80 Aligned_cols=105 Identities=23% Similarity=0.268 Sum_probs=52.6
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
.+.+++++++++ .+|..+. ++|++|+|++|.|++..+..|..+++|++|+|++|+|....+..|..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 344555555554 3343332 4555555555555554455555555555555555555543334445555555555555
Q ss_pred CcCCCCCcccccCccccccccccCcccC
Q 004218 212 NELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 212 N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
|++++..+..|..+++|+.|+|++|+++
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~ 125 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT 125 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc
Confidence 5555444444444444444444444443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.1e-19 Score=178.97 Aligned_cols=168 Identities=26% Similarity=0.401 Sum_probs=94.7
Q ss_pred CCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCC
Q 004218 28 NLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRL 107 (767)
Q Consensus 28 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L 107 (767)
+++.+++++|.+.+ ++ .+..+++|++|++++|.++ .++ .++.+++|++|+|++|++.+. +. +.++++|
T Consensus 20 ~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-------~~-l~~l~~L 87 (263)
T 1xeu_A 20 NAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-------SP-LKDLTKL 87 (263)
T ss_dssp HHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-------GG-GTTCSSC
T ss_pred HHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-------hh-hccCCCC
Confidence 44555555555553 22 3555555566666665555 333 455555566666665555422 11 5555556
Q ss_pred CEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccC
Q 004218 108 NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAG 187 (767)
Q Consensus 108 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 187 (767)
++|++++|++++ +|.... .+ |++|++++|++++. ..+..+++|++|++++|++++. ..+..+++|++|++++
T Consensus 88 ~~L~L~~N~l~~-l~~~~~--~~-L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~ 159 (263)
T 1xeu_A 88 EELSVNRNRLKN-LNGIPS--AC-LSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHG 159 (263)
T ss_dssp CEEECCSSCCSC-CTTCCC--SS-CCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECTT
T ss_pred CEEECCCCccCC-cCcccc--Cc-ccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECCC
Confidence 666666666553 232221 33 66666666666532 2466666666666666666643 2566666666666666
Q ss_pred CccccccCcCcccCCCCceeeCCCCcCCCC
Q 004218 188 NQISGSIPNTLGNLKKLNQIDLSGNELASE 217 (767)
Q Consensus 188 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 217 (767)
|++++. ..+..+++|+.|++++|++...
T Consensus 160 N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 160 NEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp SCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred CcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 666644 4566666666666666666543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=166.85 Aligned_cols=154 Identities=19% Similarity=0.283 Sum_probs=84.8
Q ss_pred cccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchh
Q 004218 46 SLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESI 125 (767)
Q Consensus 46 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~ 125 (767)
....+++|++|++++|.++ .+| .+..+++|++|++++|.+. .+..+..+++|++|++++|++++..+..+
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--------~~~~l~~l~~L~~L~l~~n~l~~~~~~~l 108 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--------NYNPISGLSNLERLRIMGKDVTSDKIPNL 108 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--------CCGGGTTCTTCCEEEEECTTCBGGGSCCC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--------cchhhhcCCCCCEEEeECCccCcccChhh
Confidence 3467788888888888887 555 5777788888888877553 22345555556666666665554445555
Q ss_pred hhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCc-CcccCccccCCCCCCCEEEccCCccccccCcCcccCCCC
Q 004218 126 GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNS-ISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKL 204 (767)
Q Consensus 126 ~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~-i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 204 (767)
..+++ |++|++++|++++..+..+..+++|++|++++|. ++. .+ .+..+++|++|++++|++++ ++ .+..+++|
T Consensus 109 ~~l~~-L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L 183 (197)
T 4ezg_A 109 SGLTS-LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKL 183 (197)
T ss_dssp TTCTT-CCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSC
T ss_pred cCCCC-CCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCC
Confidence 55544 5555555555554444445555555555555554 332 22 34444455555555554442 22 34444444
Q ss_pred ceeeCCCCcC
Q 004218 205 NQIDLSGNEL 214 (767)
Q Consensus 205 ~~L~L~~N~l 214 (767)
++|++++|++
T Consensus 184 ~~L~l~~N~i 193 (197)
T 4ezg_A 184 NQLYAFSQTI 193 (197)
T ss_dssp CEEEECBC--
T ss_pred CEEEeeCccc
Confidence 4444444444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-19 Score=182.06 Aligned_cols=178 Identities=22% Similarity=0.287 Sum_probs=144.5
Q ss_pred cccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCccee
Q 004218 40 TGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEG 119 (767)
Q Consensus 40 ~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~ 119 (767)
....|+ ..+.++..+++++|.+++. + .+..+++|++|++++|++... ..+..+++|++|++++|++++
T Consensus 10 ~~~~pd--~~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~l--------~~l~~l~~L~~L~L~~N~i~~ 77 (263)
T 1xeu_A 10 NQVFPD--PGLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQSL--------AGMQFFTNLKELHLSHNQISD 77 (263)
T ss_dssp HHHCCS--HHHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCCC--------TTGGGCTTCCEEECCSSCCCC
T ss_pred HHhCCC--HHHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcccc--------hHHhhCCCCCEEECCCCccCC
Confidence 334454 2567778888999999843 3 577889999999999988743 257888999999999999985
Q ss_pred ecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcc
Q 004218 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLG 199 (767)
Q Consensus 120 ~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 199 (767)
. +. +..+++ |++|++++|++++ ++. +.. ++|++|+|++|++++. ..+..+++|++|+|++|++++. + .+.
T Consensus 78 ~-~~-l~~l~~-L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~ 147 (263)
T 1xeu_A 78 L-SP-LKDLTK-LEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLG 147 (263)
T ss_dssp C-GG-GTTCSS-CCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGG
T ss_pred C-hh-hccCCC-CCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHc
Confidence 4 44 888887 9999999999985 343 333 8999999999999863 4688999999999999999854 3 688
Q ss_pred cCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCC
Q 004218 200 NLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN 241 (767)
Q Consensus 200 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 241 (767)
.+++|+.|+|++|++++. ..+..+++|+.|++++|.+.+.
T Consensus 148 ~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 148 FLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp GCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred cCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 899999999999999865 6788999999999999998854
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.6e-20 Score=209.61 Aligned_cols=204 Identities=18% Similarity=0.174 Sum_probs=138.8
Q ss_pred CCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCc-------------ceeecCchhhhhccccCeEE-c
Q 004218 72 GNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQ-------------FEGEIPESIGNLSNVLSKLY-M 137 (767)
Q Consensus 72 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~-------------l~~~~~~~~~~l~~~L~~L~-l 137 (767)
..+++|+.|+|+.|++. .+|..+.++++|+.|++++|. +.+..|..+..+.+ |+.|+ +
T Consensus 346 ~~~~~L~~L~Ls~n~L~-------~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~-L~~L~~l 417 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-------VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST-LKAVDPM 417 (567)
T ss_dssp STTTTSSSCCCCHHHHH-------HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHH-HHHHCGG
T ss_pred ccCccceeccCChhhHH-------hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHh-cccCcch
Confidence 34455555555555554 344455555555555554443 45577888888888 99998 6
Q ss_pred cCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCC
Q 004218 138 GGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASE 217 (767)
Q Consensus 138 ~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 217 (767)
+.|.+. +|+.+.+++|.++...+ ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .
T Consensus 418 ~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~ 477 (567)
T 1dce_A 418 RAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-A 477 (567)
T ss_dssp GHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-C
T ss_pred hhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-c
Confidence 776653 45556677777774322 248888899888884 565 888889999999999888 5
Q ss_pred CcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCC-Ccccc
Q 004218 218 IPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNL-PNSFK 296 (767)
Q Consensus 218 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~-~~~~~ 296 (767)
+|..|+.+++|+.|+|++|++++ +| .++.+++|+.|+|++|.|++.. |..++
T Consensus 478 lp~~~~~l~~L~~L~Ls~N~l~~-lp--------------------------~l~~l~~L~~L~Ls~N~l~~~~~p~~l~ 530 (567)
T 1dce_A 478 LPPALAALRCLEVLQASDNALEN-VD--------------------------GVANLPRLQELLLCNNRLQQSAAIQPLV 530 (567)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCC-CG--------------------------GGTTCSSCCEEECCSSCCCSSSTTGGGG
T ss_pred cchhhhcCCCCCEEECCCCCCCC-Cc--------------------------ccCCCCCCcEEECCCCCCCCCCCcHHHh
Confidence 67788888888888888888773 22 3445566777777777777665 77777
Q ss_pred cCcccceeeccCccccCCCCc---hhhccCCceEEEc
Q 004218 297 NCKSLEKLLMANNKFSGPIPN---ILAELKGLEVLDL 330 (767)
Q Consensus 297 ~l~~L~~L~l~~n~l~~~~~~---~~~~l~~L~~L~L 330 (767)
.+++|+.|+|++|++++..+. .+..+++|+.|++
T Consensus 531 ~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 531 SCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp GCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred cCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 777777777777777755442 2344677777754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=8.5e-18 Score=165.62 Aligned_cols=154 Identities=21% Similarity=0.273 Sum_probs=113.8
Q ss_pred CcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCC
Q 004218 77 LKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSL 156 (767)
Q Consensus 77 L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L 156 (767)
-+.++.+.+.+...|. .+. ++|++|+|++|++++..|..+..+++ |++|+|++|+++...+..|..+++|
T Consensus 21 ~~~v~c~~~~l~~ip~-------~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~-L~~L~L~~N~l~~i~~~~~~~l~~L 90 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPA-------GIP--TNAQILYLHDNQITKLEPGVFDSLIN-LKELYLGSNQLGALPVGVFDSLTQL 90 (229)
T ss_dssp TTEEECTTSCCSSCCS-------CCC--TTCSEEECCSSCCCCCCTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCEeEccCCCcCccCC-------CCC--CCCCEEEcCCCccCccCHHHhhCccC-CcEEECCCCCCCCcChhhcccCCCc
Confidence 4456666666554332 121 56777777777777666777777776 8888888888876656667788888
Q ss_pred CEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCc
Q 004218 157 TLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNN 236 (767)
Q Consensus 157 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 236 (767)
++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus 91 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 169 (229)
T 3e6j_A 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169 (229)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCC
Confidence 88888888888666666778888888888888888 66777788888888888888888766677788888888888888
Q ss_pred ccCCC
Q 004218 237 KLNGN 241 (767)
Q Consensus 237 ~l~~~ 241 (767)
.+.+.
T Consensus 170 ~~~c~ 174 (229)
T 3e6j_A 170 PWDCE 174 (229)
T ss_dssp CBCTT
T ss_pred CccCC
Confidence 87743
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.7e-19 Score=204.22 Aligned_cols=197 Identities=23% Similarity=0.237 Sum_probs=105.5
Q ss_pred CCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhcc
Q 004218 51 TNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSN 130 (767)
Q Consensus 51 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 130 (767)
+.++.|+|++|.+.. .+. ..|+.++|+.|.+. .++++.|.+. ..++.+..+..
T Consensus 173 ~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i~--------------------~~~~~~n~~~-~~~~~~~~l~~ 225 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSID--------------------EDDDIENRMV-MPKDSKYDDQL 225 (727)
T ss_dssp ----------------------------------------------------------------------------CCCC
T ss_pred CccceEEeeCCCCCc-chh-----hHhhcCccCccccc--------------------Ccccccccee-cChhhhccCCC
Confidence 456667777776663 222 23455566665543 2445556665 56666777776
Q ss_pred ccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCC
Q 004218 131 VLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLS 210 (767)
Q Consensus 131 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 210 (767)
|+.|+|++|++. .+|..+.++++|++|+|++|.|+ .+|..|..+++|++|+|++|.|+ .+|..|+.+++|++|+|+
T Consensus 226 -L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~ 301 (727)
T 4b8c_D 226 -WHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF 301 (727)
T ss_dssp -CCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred -CcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence 888888888877 56666667888888888888888 66777888888888888888888 667788888888888888
Q ss_pred CCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCC
Q 004218 211 GNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSAN 285 (767)
Q Consensus 211 ~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n 285 (767)
+|.|+ .+|..|+.+++|+.|+|++|.+++.+|..+..+......+++++|.+++.+|. .|..|++++|
T Consensus 302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n 369 (727)
T 4b8c_D 302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTD 369 (727)
T ss_dssp SSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---------
T ss_pred CCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecc
Confidence 88886 45667888888888888888888777777766544433456777777766654 3455666666
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.9e-18 Score=162.22 Aligned_cols=153 Identities=21% Similarity=0.286 Sum_probs=121.7
Q ss_pred CCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCcccc
Q 004218 72 GNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIG 151 (767)
Q Consensus 72 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~ 151 (767)
+.+++|++|++++|.+... + .+..+++|++|++++|.++ .+..+..+++ |++|++++|++++..+..++
T Consensus 41 ~~l~~L~~L~l~~n~i~~l-------~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~-L~~L~l~~n~l~~~~~~~l~ 109 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDL-------T-GIEYAHNIKDLTINNIHAT--NYNPISGLSN-LERLRIMGKDVTSDKIPNLS 109 (197)
T ss_dssp HHHHTCCEEEEESSCCSCC-------T-TGGGCTTCSEEEEESCCCS--CCGGGTTCTT-CCEEEEECTTCBGGGSCCCT
T ss_pred hhcCCccEEeccCCCccCh-------H-HHhcCCCCCEEEccCCCCC--cchhhhcCCC-CCEEEeECCccCcccChhhc
Confidence 5567889999999888633 2 4777888999999988775 3347777877 89999999988877788888
Q ss_pred CCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCc-cccccCcCcccCCCCceeeCCCCcCCCCCcccccCcccccc
Q 004218 152 RLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQ-ISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLS 230 (767)
Q Consensus 152 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 230 (767)
.+++|++|++++|.+++..+..+..+++|++|++++|. +. .+| .+..+++|+.|++++|+++.. + .+..+++|+.
T Consensus 110 ~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~ 185 (197)
T 4ezg_A 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQ 185 (197)
T ss_dssp TCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCE
T ss_pred CCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCE
Confidence 88899999999998887778888888899999999887 66 444 688888899999999888753 3 6788888888
Q ss_pred ccccCcccC
Q 004218 231 IDLSNNKLN 239 (767)
Q Consensus 231 L~l~~n~l~ 239 (767)
|++++|++.
T Consensus 186 L~l~~N~i~ 194 (197)
T 4ezg_A 186 LYAFSQTIG 194 (197)
T ss_dssp EEECBC---
T ss_pred EEeeCcccC
Confidence 888888876
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-18 Score=199.84 Aligned_cols=182 Identities=25% Similarity=0.304 Sum_probs=83.4
Q ss_pred cCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcc
Q 004218 169 EILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILS 248 (767)
Q Consensus 169 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 248 (767)
..+..+..+++|++|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|+ .+|..+..
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 291 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS 291 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence 33445555555555555555555 44444445555555555555555 44555555555555555555555 44555555
Q ss_pred cccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcc-cceeeccCccccCCCCchhhccCCceE
Q 004218 249 LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKS-LEKLLMANNKFSGPIPNILAELKGLEV 327 (767)
Q Consensus 249 l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~ 327 (767)
+++| +.|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.. |+.
T Consensus 292 l~~L-~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~ 363 (727)
T 4b8c_D 292 CFQL-KYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRF 363 (727)
T ss_dssp GTTC-SEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------
T ss_pred CCCC-CEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cce
Confidence 5555 22355555554 44555777777788888888887777766655422 234678888887776653 556
Q ss_pred EEcCCc--------ccCCCCCccccccccCceEeccCCcCcC
Q 004218 328 LDLSSN--------KLSGSIPSDLQNLRALRSLNLTFNNLEG 361 (767)
Q Consensus 328 L~Ls~N--------~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 361 (767)
|+++.| .+.+..+..+..+..+....+++|-+.+
T Consensus 364 l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 364 IEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp --------------------------------------CCCG
T ss_pred eEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence 667666 2333333334445555555666665543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.5e-17 Score=171.15 Aligned_cols=243 Identities=12% Similarity=0.068 Sum_probs=128.8
Q ss_pred CCCccEEeCCCCeeee-------------------cCCCccccC--------CCCCcEEEccCCcccccCCccccCCCCC
Q 004218 1 MTSLVYLGLASNQLWG-------------------EIPYDVGDK--------LPNLLGFNFCFNKFTGKIPGSLHNLTNI 53 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~-------------------~ip~~~~~~--------l~~L~~L~l~~n~l~~~~~~~l~~l~~L 53 (767)
+++|++|||++|++.. .||...|.+ +++|++|+|.+ .++.+-+.+|.++++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 5789999999999971 356666666 67777777776 6665555667777777
Q ss_pred CEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCC-EEECcCCcceeecCchhhh----h
Q 004218 54 QIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLN-FLAFDGNQFEGEIPESIGN----L 128 (767)
Q Consensus 54 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~-~L~l~~n~l~~~~~~~~~~----l 128 (767)
+.|++++|.+....+..|..+.++..+.+..+........ -....+.++..|+ .+.+.... .++..+.. .
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~--i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~ 201 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNR--WEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQP 201 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTT--TTTSCEEESCCCEEEEEECTTC---CHHHHHHHTTCCG
T ss_pred ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccc--ccccccccccccceeEEecCCC---cHHHHHhhcccCc
Confidence 7777777766655556666666555555544211000000 0001122233333 22222111 11121111 1
Q ss_pred ccccCeEEccCCcccccCCccc-cCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCc-e
Q 004218 129 SNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN-Q 206 (767)
Q Consensus 129 ~~~L~~L~l~~n~i~~~~~~~l-~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~-~ 206 (767)
.+ +..+.+.++-.. .....+ ..+++|+.|+|++|.++.+...+|.++++|++|+|.+| +..+.+.+|.++++|+ .
T Consensus 202 ~~-~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~ 278 (329)
T 3sb4_A 202 RD-INFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGT 278 (329)
T ss_dssp GG-CSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEE
T ss_pred cc-cceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEE
Confidence 12 444444433211 111111 12556666666666666555556666666666666665 5545555666666666 6
Q ss_pred eeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhccccccc
Q 004218 207 IDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLT 253 (767)
Q Consensus 207 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~ 253 (767)
|++.+ .++.+.+.+|.++++|+.|++++|+++...+..|.++++|.
T Consensus 279 l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~ 324 (329)
T 3sb4_A 279 LELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSK 324 (329)
T ss_dssp EEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCC
T ss_pred EEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchh
Confidence 66665 45545556666666666666666666644455566665553
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=174.03 Aligned_cols=282 Identities=12% Similarity=0.083 Sum_probs=123.9
Q ss_pred CCCCCEEEcccccCcccCCccCCC-CCCCcEEeecCcccc--CCCCCCccccccccCCCCCCEEECcCCcceeecCchhh
Q 004218 50 LTNIQIIRMAHNLLEGTVPPGLGN-LPFLKMYNIGFNKIV--GSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIG 126 (767)
Q Consensus 50 l~~L~~L~l~~n~i~~~~~~~~~~-l~~L~~L~l~~n~l~--~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~ 126 (767)
+.+|+.|.++++--. .....+.. +++|+.|+|++|++. .+..+ ..+.+..+.+..|.+ .+..|.
T Consensus 24 ~~~l~~L~l~g~i~~-~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---------~~~~~~~~~~~~~~I---~~~aF~ 90 (329)
T 3sb4_A 24 ANSITHLTLTGKLNA-EDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---------TYPNGKFYIYMANFV---PAYAFS 90 (329)
T ss_dssp HHHCSEEEEEEEECH-HHHHHHHHSCTTCCEEEEEEEEECCEEESSS---------SSGGGCCEEECTTEE---CTTTTE
T ss_pred hCceeEEEEeccccH-HHHHHHHHhhccCeEEecCcceeEEecCccc---------ccccccccccccccc---CHHHhc
Confidence 556777777765221 11112222 566777777777765 22111 011122333333321 122233
Q ss_pred h--------hccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCcc----cccc
Q 004218 127 N--------LSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQI----SGSI 194 (767)
Q Consensus 127 ~--------l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i----~~~~ 194 (767)
+ +.+ |++|+|.+ +++.+.+.+|.++++|+.|++++|.+..+.+.+|..+.++..+.+..+.. ....
T Consensus 91 ~~~~~~~~g~~~-L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~ 168 (329)
T 3sb4_A 91 NVVNGVTKGKQT-LEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWE 168 (329)
T ss_dssp EEETTEEEECTT-CCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTT
T ss_pred ccccccccccCC-CcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccc
Confidence 3 444 55555555 45444445555555555555555555544455555544444444443211 1122
Q ss_pred CcCcccCCCCc-eeeCCCCcCCCCCcccc----cCccccccccccCcccCCCCChhhc-ccccccceeecccccCCCCCc
Q 004218 195 PNTLGNLKKLN-QIDLSGNELASEIPTSF----GNFQNLLSIDLSNNKLNGNIPKEIL-SLSSLTTIVNLSKNFLDGTLP 268 (767)
Q Consensus 195 ~~~~~~l~~L~-~L~L~~N~l~~~~~~~~----~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~l~~~l~l~~n~l~~~~~ 268 (767)
...|.++..|+ .+.+.... .++..+ ....+++.+.+.++-.. .....+. .+++| +.+++++|.++.+.+
T Consensus 169 ~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L-~~l~L~~n~i~~I~~ 243 (329)
T 3sb4_A 169 HFAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNL-VSLDISKTNATTIPD 243 (329)
T ss_dssp TSCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTC-CEEECTTBCCCEECT
T ss_pred ccccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCC-eEEECCCCCcceecH
Confidence 23344444444 23222211 011100 01223333333322110 0001111 13333 222555555554444
Q ss_pred hhhcCCCceeEEEccCCCCCCCCCcccccCcccc-eeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccc
Q 004218 269 EEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLE-KLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLR 347 (767)
Q Consensus 269 ~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 347 (767)
..|.++++|+.|+|++| ++.+.+..|.++++|+ .+++.+ .++.+.+..|.++++|+.|++++|.+....+..|..++
T Consensus 244 ~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~ 321 (329)
T 3sb4_A 244 FTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGV 321 (329)
T ss_dssp TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTC
T ss_pred hhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCc
Confidence 45555555555555555 4445555555555555 555555 44444455555555555555555555544444555555
Q ss_pred cCceEe
Q 004218 348 ALRSLN 353 (767)
Q Consensus 348 ~L~~L~ 353 (767)
+|+.++
T Consensus 322 ~L~~ly 327 (329)
T 3sb4_A 322 PSKLIY 327 (329)
T ss_dssp CCCEEE
T ss_pred chhhhc
Confidence 555544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=5.1e-17 Score=155.26 Aligned_cols=129 Identities=23% Similarity=0.330 Sum_probs=71.1
Q ss_pred ceeeCCCCcCCCCCcccccCccccccccccCcccCCCCCh-hhcccccccceeecccccCCCCCchhhcCCCceeEEEcc
Q 004218 205 NQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPK-EILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLS 283 (767)
Q Consensus 205 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls 283 (767)
+.+++++|.++ .+|..+. .+|++|++++|++++..+. .+..+++|. .|++++|.+++..|..|..+++|+.|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLV-KLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCC-EEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCC-EEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 67888888886 4555443 3777888888877744332 244555542 22555555555445555555555555555
Q ss_pred CCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCC
Q 004218 284 ANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSG 337 (767)
Q Consensus 284 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 337 (767)
+|++++..+..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|++.+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 555554444445555555555555555554445555555555555555555543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=5e-16 Score=148.30 Aligned_cols=91 Identities=27% Similarity=0.392 Sum_probs=47.3
Q ss_pred hhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCC
Q 004218 125 IGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKL 204 (767)
Q Consensus 125 ~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 204 (767)
+..+++ |++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|..+++|
T Consensus 50 ~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 128 (192)
T 1w8a_A 50 FGRLPH-LVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128 (192)
T ss_dssp GGGCTT-CCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTC
T ss_pred cccCCC-CCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCC
Confidence 344444 5555555555554445555555555555555555554444445555555555555555554445555555555
Q ss_pred ceeeCCCCcCCC
Q 004218 205 NQIDLSGNELAS 216 (767)
Q Consensus 205 ~~L~L~~N~l~~ 216 (767)
++|+|++|++.+
T Consensus 129 ~~L~L~~N~l~c 140 (192)
T 1w8a_A 129 TSLNLASNPFNC 140 (192)
T ss_dssp CEEECTTCCBCC
T ss_pred CEEEeCCCCccC
Confidence 555555555543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=7.7e-17 Score=167.17 Aligned_cols=136 Identities=15% Similarity=0.146 Sum_probs=99.1
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCc--------------chhh--------HHHHHHHHhcCCCCC
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTG--------------TWKS--------FFAECEALRNTRHRN 512 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~e~~~l~~l~h~n 512 (767)
.=|++.+.||.|++|.||+|...+|+.||||+++..... .... ..+|...+.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348899999999999999999989999999987532100 0011 124555555554333
Q ss_pred c--eeEEeeeecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 004218 513 L--VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCD 590 (767)
Q Consensus 513 i--v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 590 (767)
+ ...++. ...++||||++|++|.++... .....++.|++.+|.|||+. ||||||
T Consensus 175 v~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~~---gIVHrD 230 (397)
T 4gyi_A 175 FPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAKH---GLIHGD 230 (397)
T ss_dssp CSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCCCeeeec---------cCceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHHC---CCcCCC
Confidence 2 222222 123799999999888765421 12456889999999999999 999999
Q ss_pred CCCCCeeeCCCC----------ceEEccccchhh
Q 004218 591 LKPGNILLDEDM----------TAKVGDFGLARS 614 (767)
Q Consensus 591 lkp~NIl~~~~~----------~~kl~Dfg~a~~ 614 (767)
|||.|||+++++ .+.|+||+.+..
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999999998776 389999998854
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.8e-16 Score=146.80 Aligned_cols=133 Identities=23% Similarity=0.266 Sum_probs=96.2
Q ss_pred CCCCCEEECcCCcce-eecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCE
Q 004218 104 STRLNFLAFDGNQFE-GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQS 182 (767)
Q Consensus 104 l~~L~~L~l~~n~l~-~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~ 182 (767)
.++|+.|++++|+++ +.+|..+..+++ |++|++++|++++. ..+..+++|++|++++|.+++..|..+..+++|++
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~-L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVN-LEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGG-CCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCC-CCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 356777777777776 566666677776 78888888877754 66777778888888888877656666666778888
Q ss_pred EEccCCccccccC-cCcccCCCCceeeCCCCcCCCCCc---ccccCccccccccccCcccC
Q 004218 183 LDLAGNQISGSIP-NTLGNLKKLNQIDLSGNELASEIP---TSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 183 L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~~n~l~ 239 (767)
|++++|++++..+ ..+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+.
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 8888887774322 567777788888888887775544 36777778888888777776
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=7.9e-16 Score=143.69 Aligned_cols=132 Identities=16% Similarity=0.183 Sum_probs=77.8
Q ss_pred CCCCEEEcccccCc-ccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhc
Q 004218 51 TNIQIIRMAHNLLE-GTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLS 129 (767)
Q Consensus 51 ~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 129 (767)
++|++|++++|.++ +.+|..+..+++|++|++++|.+... ..+..+++|++|++++|++++.+|..+..++
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 95 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--------SNLPKLPKLKKLELSENRIFGGLDMLAEKLP 95 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--------SSCCCCSSCCEEEEESCCCCSCCCHHHHHCT
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--------hhhccCCCCCEEECcCCcCchHHHHHHhhCC
Confidence 55566666666655 44555555556666666666655421 3445556666666666666644555555566
Q ss_pred cccCeEEccCCcccccC-CccccCCCCCCEEECcCCcCcccCc---cccCCCCCCCEEEccCCccc
Q 004218 130 NVLSKLYMGGNRFYGKI-PTSIGRLRSLTLLNLSYNSISGEIL---TEIGQLQELQSLDLAGNQIS 191 (767)
Q Consensus 130 ~~L~~L~l~~n~i~~~~-~~~l~~l~~L~~L~l~~n~i~~~~~---~~~~~l~~L~~L~L~~n~i~ 191 (767)
+ |++|++++|++++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 96 ~-L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 96 N-LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp T-CCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred C-CCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 6 777777777766421 1556666666666666666664333 35666666666666666655
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-15 Score=145.83 Aligned_cols=127 Identities=25% Similarity=0.449 Sum_probs=89.1
Q ss_pred CEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccC
Q 004218 108 NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAG 187 (767)
Q Consensus 108 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 187 (767)
+.+++++|+++ .+|..+. .+ |++|++++|+++ .+|..|.++++|++|+|++|.|+++.+..|..+++|++|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~-l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RD-VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TT-CCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCCC-cCCCCCC--CC-CCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 35666666666 4554432 23 777777777776 5566777777777777777777766666777777777777777
Q ss_pred CccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccC
Q 004218 188 NQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 188 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
|+|++..+..|..+++|+.|+|++|+++...+..|..+++|+.|+|++|.+.
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 7777666667777777777777777777666666777777777777777765
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.5e-14 Score=154.16 Aligned_cols=267 Identities=9% Similarity=0.086 Sum_probs=189.6
Q ss_pred CCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCC
Q 004218 25 KLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNS 104 (767)
Q Consensus 25 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l 104 (767)
....++.+.+-+ .++.+-..+|.+. +|+.+.+..+ ++.....+|.++ +|+.+.+.. .+...+. .++.++
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~------~aF~~c 179 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKE------DIFYYC 179 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECS------STTTTC
T ss_pred ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehH------HHhhCc
Confidence 346677777765 4554666778775 7999998877 554556677774 688888875 4543322 356788
Q ss_pred CCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEE
Q 004218 105 TRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLD 184 (767)
Q Consensus 105 ~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 184 (767)
++|+.++++.|+++. ++...+.... |+.+.|..+ +..+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.
T Consensus 180 ~~L~~l~l~~n~l~~-I~~~aF~~~~-L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~ 254 (401)
T 4fdw_A 180 YNLKKADLSKTKITK-LPASTFVYAG-IEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVK 254 (401)
T ss_dssp TTCCEEECTTSCCSE-ECTTTTTTCC-CSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEE
T ss_pred ccCCeeecCCCcceE-echhhEeecc-cCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEE
Confidence 889999999998884 4444444565 999999854 77678889999999999999875 66677788888 7899999
Q ss_pred ccCCccccccCcCcccCCCCceeeCCCCcCC-----CCCcccccCccccccccccCcccCCCCChhhcccccccceeecc
Q 004218 185 LAGNQISGSIPNTLGNLKKLNQIDLSGNELA-----SEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLS 259 (767)
Q Consensus 185 L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~ 259 (767)
+. +.+..+...+|.++++|+.+.+.+|.+. .+.+.+|.++++|+.+.|.+ .+.....
T Consensus 255 lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~---------------- 316 (401)
T 4fdw_A 255 LP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQ---------------- 316 (401)
T ss_dssp EE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECT----------------
T ss_pred eC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhh----------------
Confidence 94 5566577788999999999999888775 45677899999999998874 3542222
Q ss_pred cccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccC-CceEEEcCCcccC
Q 004218 260 KNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELK-GLEVLDLSSNKLS 336 (767)
Q Consensus 260 ~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~ 336 (767)
..|.++++|+.+.|..| ++.+....|.++ +|+.+++.+|.+.......|..++ +++.|++..+.+.
T Consensus 317 ---------~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 317 ---------GLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp ---------TTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred ---------hhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 34455556666666443 554556666666 677777777766655556666663 5667777666543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-14 Score=154.85 Aligned_cols=240 Identities=7% Similarity=0.068 Sum_probs=140.6
Q ss_pred CCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEc
Q 004218 106 RLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDL 185 (767)
Q Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 185 (767)
+|+.+.+..+ ++.....+|.+. + |+.+.+.+ .++.+...+|.++.+|+.+++++|.++.+...+|. ..+|+.+.|
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~~-~-L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~l 210 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFNS-T-VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLL 210 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTC-C-CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEEC
T ss_pred CccEEEeCCC-ccEECHHhcCCC-C-ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEe
Confidence 4666666554 553444555553 3 77777765 55555666677777777777777777655555555 466777777
Q ss_pred cCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCC-
Q 004218 186 AGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD- 264 (767)
Q Consensus 186 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~- 264 (767)
..+ +..+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+. +.++......|.++++|..+ .+.+|.+.
T Consensus 211 p~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l-~l~~~~~~~ 285 (401)
T 4fdw_A 211 PVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEV-TTYGSTFND 285 (401)
T ss_dssp CTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEE-EEESSCCCC
T ss_pred CCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEE-EeCCccccC
Confidence 643 55455666777777777777654 44455556655 566666663 33443334444444444322 44443332
Q ss_pred ----CCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCC
Q 004218 265 ----GTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIP 340 (767)
Q Consensus 265 ----~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 340 (767)
.+.+..|.++++|+.++|. +.++.+....|.++++|+.++|..| ++.+....|.++ +|+.+++++|.+....+
T Consensus 286 ~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~ 362 (401)
T 4fdw_A 286 DPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFE 362 (401)
T ss_dssp CTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCC
T ss_pred CcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCccccc
Confidence 2344556666677777776 3455556666667777777777444 554555666666 67777777766665555
Q ss_pred ccccccc-cCceEeccCCc
Q 004218 341 SDLQNLR-ALRSLNLTFNN 358 (767)
Q Consensus 341 ~~~~~l~-~L~~L~l~~N~ 358 (767)
..|..++ +++.|++..+.
T Consensus 363 ~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 363 KVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp SSCCCSCTTCCEEEECGGG
T ss_pred ccccCCCCCccEEEeCHHH
Confidence 5555553 45556555444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=145.88 Aligned_cols=93 Identities=29% Similarity=0.343 Sum_probs=53.3
Q ss_pred hhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccC
Q 004218 270 EIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRAL 349 (767)
Q Consensus 270 ~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (767)
.|..+++|+.|+|++|.|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.|+...+..|..+++|
T Consensus 49 ~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 128 (193)
T 2wfh_A 49 ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSAL 128 (193)
T ss_dssp GGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTC
T ss_pred HhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccc
Confidence 34444455555555555555555555555555555555555555555555666666666666666664444455666666
Q ss_pred ceEeccCCcCcCc
Q 004218 350 RSLNLTFNNLEGV 362 (767)
Q Consensus 350 ~~L~l~~N~l~~~ 362 (767)
+.|++++|++.+.
T Consensus 129 ~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 129 SHLAIGANPLYCD 141 (193)
T ss_dssp CEEECCSSCEECS
T ss_pred cEEEeCCCCeecC
Confidence 6666666666553
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.6e-15 Score=140.50 Aligned_cols=131 Identities=22% Similarity=0.262 Sum_probs=94.8
Q ss_pred CEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccC
Q 004218 108 NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAG 187 (767)
Q Consensus 108 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 187 (767)
+.+++++|+++ .+|..+. .. |++|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|++++
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~-l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SS-ATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TT-CSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCc-cCCCCCC--CC-CcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 45666666666 4454332 23 77777777777766666677778888888888888766666677788888888888
Q ss_pred CccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCC
Q 004218 188 NQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNI 242 (767)
Q Consensus 188 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 242 (767)
|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|.+.+..
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 8887666666777888888888888887666666777888888888888777543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=5.5e-16 Score=141.54 Aligned_cols=127 Identities=22% Similarity=0.273 Sum_probs=63.3
Q ss_pred CCCCEEECcCCcce-eecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEE
Q 004218 105 TRLNFLAFDGNQFE-GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSL 183 (767)
Q Consensus 105 ~~L~~L~l~~n~l~-~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 183 (767)
++|+.|++++|.++ +.+|..+..+++ |++|++++|++++. ..+..+++|++|++++|.+++..|..+..+++|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~-L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEE-LEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTT-CCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCC-CcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 34444555555544 344444444444 55555555555433 445555555555555555554444444445555555
Q ss_pred EccCCccccc-cCcCcccCCCCceeeCCCCcCCCCCc---ccccCcccccccccc
Q 004218 184 DLAGNQISGS-IPNTLGNLKKLNQIDLSGNELASEIP---TSFGNFQNLLSIDLS 234 (767)
Q Consensus 184 ~L~~n~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~ 234 (767)
++++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 5555555532 12445555555555555555554333 244555555555544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-15 Score=138.91 Aligned_cols=127 Identities=16% Similarity=0.183 Sum_probs=64.7
Q ss_pred CCCCEEEcccccCc-ccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhc
Q 004218 51 TNIQIIRMAHNLLE-GTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLS 129 (767)
Q Consensus 51 ~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 129 (767)
++|++|++++|.++ +.+|..+..+++|++|++++|++... ..+.++++|++|++++|++++.+|..+..++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--------~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 88 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--------ANLPKLNKLKKLELSDNRVSGGLEVLAEKCP 88 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--------TTCCCCTTCCEEECCSSCCCSCTHHHHHHCT
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--------hhhhcCCCCCEEECCCCcccchHHHHhhhCC
Confidence 44555555555554 34444455555555555555554321 3344455555555555555544555555555
Q ss_pred cccCeEEccCCccccc-CCccccCCCCCCEEECcCCcCcccCc---cccCCCCCCCEEEcc
Q 004218 130 NVLSKLYMGGNRFYGK-IPTSIGRLRSLTLLNLSYNSISGEIL---TEIGQLQELQSLDLA 186 (767)
Q Consensus 130 ~~L~~L~l~~n~i~~~-~~~~l~~l~~L~~L~l~~n~i~~~~~---~~~~~l~~L~~L~L~ 186 (767)
+ |++|++++|++++. .+..+..+++|++|++++|.+++..+ ..+..+++|++|+++
T Consensus 89 ~-L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 89 N-LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp T-CCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred C-CCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 5 66666666665532 22445555555555555555554332 244455555555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=1e-14 Score=137.31 Aligned_cols=133 Identities=22% Similarity=0.289 Sum_probs=93.9
Q ss_pred CceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEcc
Q 004218 204 LNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLS 283 (767)
Q Consensus 204 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls 283 (767)
.+.+++++|.++. +|..+ .++|+.|++++|+++ +..+..++.+++|+.|+++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~-------------------------~~~~~~~~~l~~L~~L~l~ 60 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQ-------------------------SLPHGVFDKLTQLTKLSLS 60 (177)
T ss_dssp TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCC-------------------------CCCTTTTTTCTTCSEEECC
T ss_pred CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCccc-------------------------EeCHHHhcCcccccEEECC
Confidence 3566666666653 33222 245555555555554 3444455667778888888
Q ss_pred CCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcC
Q 004218 284 ANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVV 363 (767)
Q Consensus 284 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 363 (767)
+|.+++..+..|..+++|+.|++++|.+++..+..+..+++|+.|+|++|.+++..+..+..+++|+.|++++|++++.+
T Consensus 61 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 61 QNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 88888766677788888888888888888766667788888888888888888666656677888888888888888765
Q ss_pred C
Q 004218 364 P 364 (767)
Q Consensus 364 ~ 364 (767)
+
T Consensus 141 ~ 141 (177)
T 2o6r_A 141 P 141 (177)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.56 E-value=9e-14 Score=149.06 Aligned_cols=319 Identities=12% Similarity=0.042 Sum_probs=227.5
Q ss_pred eeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCC
Q 004218 13 QLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGD 92 (767)
Q Consensus 13 ~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 92 (767)
.++ +|....|.+..+|+++.|.. .++.+-..+|.++++|+.++|..+ ++......|..+.+|+.+.+..+ +...+.
T Consensus 58 ~Vt-sIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~ 133 (394)
T 4fs7_A 58 DVV-SIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGV 133 (394)
T ss_dssp EEE-EECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECT
T ss_pred eEe-EhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecc
Confidence 455 79999999899999999975 477666788999999999999876 55455678999999998887654 333222
Q ss_pred CCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCcc
Q 004218 93 EGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILT 172 (767)
Q Consensus 93 ~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~ 172 (767)
. ++.++..+....... .......+|.++.+ |+.+.+.++.. .+...+|.++.+|+.+.+..| ++.+...
T Consensus 134 ~------aF~~~~~~~~~~~~~--~~~i~~~aF~~c~~-L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~ 202 (394)
T 4fs7_A 134 E------AFKGCDFKEITIPEG--VTVIGDEAFATCES-LEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDY 202 (394)
T ss_dssp T------TTTTCCCSEEECCTT--CCEECTTTTTTCTT-CCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTT
T ss_pred e------eeecccccccccCcc--ccccchhhhcccCC-CcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCch
Confidence 2 233443333332222 22244567777777 99999876643 366778888999999998876 5556677
Q ss_pred ccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccc
Q 004218 173 EIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSL 252 (767)
Q Consensus 173 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l 252 (767)
+|.++..|+.+.+..+... . ...+....+|+.+.+..+ ++.+...+|.++..|+.+.+..+... .....|..+..+
T Consensus 203 ~F~~~~~L~~i~~~~~~~~-i-~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l 278 (394)
T 4fs7_A 203 CFAECILLENMEFPNSLYY-L-GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGL 278 (394)
T ss_dssp TTTTCTTCCBCCCCTTCCE-E-CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTC
T ss_pred hhccccccceeecCCCceE-e-ehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eecccccccccc
Confidence 8888888988888776544 2 333444577888887654 33355667888888888888777544 555666666666
Q ss_pred cceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCC
Q 004218 253 TTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSS 332 (767)
Q Consensus 253 ~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 332 (767)
... ....+.+ ....|....+|+.+.+.++ ++.+....|.++.+|+.+++.++ ++.+...+|.++.+|+.+++..
T Consensus 279 ~~~-~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~ 352 (394)
T 4fs7_A 279 KKV-IYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPL 352 (394)
T ss_dssp CEE-EECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCT
T ss_pred cee-ccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECc
Confidence 443 4443332 2346777888898888765 66567778888999999998754 6656678888999999999987
Q ss_pred cccCCCCCccccccccCceEeccCC
Q 004218 333 NKLSGSIPSDLQNLRALRSLNLTFN 357 (767)
Q Consensus 333 N~l~~~~~~~~~~l~~L~~L~l~~N 357 (767)
| ++.+....|..+.+|+.+++..+
T Consensus 353 ~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 353 S-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp T-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred c-ccEehHHHhhCCCCCCEEEECCC
Confidence 7 66566778888899999988654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-13 Score=147.45 Aligned_cols=318 Identities=10% Similarity=0.045 Sum_probs=220.0
Q ss_pred cccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcc
Q 004218 38 KFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQF 117 (767)
Q Consensus 38 ~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l 117 (767)
.++.+-..+|.++++|+.+.|..+ ++.....+|.++++|+.+++..+ ++..+. .++.++++|+.+.+..+ +
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~------~aF~~c~~L~~i~~p~~-l 128 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGR------CTFSGCYALKSILLPLM-L 128 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECT------TTTTTCTTCCCCCCCTT-C
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccc------hhhcccccchhhcccCc-e
Confidence 456566678999999999999754 66456678999999999999754 443332 24567777877777654 4
Q ss_pred eeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcC
Q 004218 118 EGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNT 197 (767)
Q Consensus 118 ~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 197 (767)
......+|.+.. +....+..+ +......+|.++.+|+.+.+.++. ..+...+|.++.+|+.+.+..| +......+
T Consensus 129 ~~i~~~aF~~~~--~~~~~~~~~-~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~ 203 (394)
T 4fs7_A 129 KSIGVEAFKGCD--FKEITIPEG-VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYC 203 (394)
T ss_dssp CEECTTTTTTCC--CSEEECCTT-CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTT
T ss_pred eeecceeeeccc--ccccccCcc-ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchh
Confidence 435555666554 333333322 233556789999999999998664 3367788999999999999877 55466778
Q ss_pred cccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCce
Q 004218 198 LGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNV 277 (767)
Q Consensus 198 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L 277 (767)
|.++..|+.+.+..+... +.+.+....+|+.+.+..+- .......+..+..+..+ .+..+... .....|.....+
T Consensus 204 F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~-~~~~~~~~-i~~~~F~~~~~l 278 (394)
T 4fs7_A 204 FAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESI-SIQNNKLR-IGGSLFYNCSGL 278 (394)
T ss_dssp TTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEE-EECCTTCE-ECSCTTTTCTTC
T ss_pred hccccccceeecCCCceE--eehhhcccCCCceEEECCCc-eecccccccccccceeE-EcCCCcce-eecccccccccc
Confidence 889999999988876543 23334455788888876543 32445566677777444 66665443 566678888888
Q ss_pred eEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCC
Q 004218 278 VTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFN 357 (767)
Q Consensus 278 ~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 357 (767)
+.+.+..+.+. ...|..+.+|+.+.+.++ ++.+....|..+.+|+.++|.++ ++.+....|..+.+|+.+++..|
T Consensus 279 ~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 279 KKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred ceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 88888776543 356888899999998765 66566778999999999999754 66566778889999999999766
Q ss_pred cCcCcCCCCc-cccccccccccCC
Q 004218 358 NLEGVVPREG-IFRHTSMVHLEGN 380 (767)
Q Consensus 358 ~l~~~~~~~~-~~~~~~~~~l~~N 380 (767)
++.+..... ...++..+.+..+
T Consensus 354 -l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 354 -LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp -CCEECTTTBTTCTTCCEEEEEGG
T ss_pred -ccEehHHHhhCCCCCCEEEECCC
Confidence 665543331 1244555655443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=7.4e-15 Score=138.13 Aligned_cols=133 Identities=20% Similarity=0.216 Sum_probs=93.9
Q ss_pred ccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCC
Q 004218 101 LTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180 (767)
Q Consensus 101 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L 180 (767)
+.++++|+.|++++|+++ .+|. +..+..+|++|++++|++++. ..|..+++|++|++++|.|++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 445666777777777776 3443 444442278888888887754 567778888888888888876544555778888
Q ss_pred CEEEccCCccccccCc--CcccCCCCceeeCCCCcCCCCCcc----cccCccccccccccCcccC
Q 004218 181 QSLDLAGNQISGSIPN--TLGNLKKLNQIDLSGNELASEIPT----SFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 181 ~~L~L~~n~i~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~l~~n~l~ 239 (767)
++|+|++|+|. .+|. .+..+++|+.|++++|+++. .|. .+..+++|+.|++++|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 88888888886 4454 67778888888888888864 444 3777888888888887765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=2.8e-14 Score=134.12 Aligned_cols=132 Identities=17% Similarity=0.197 Sum_probs=65.3
Q ss_pred ccCCCCCCEEEcccccCcccCCccCCCCC-CCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchh
Q 004218 47 LHNLTNIQIIRMAHNLLEGTVPPGLGNLP-FLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESI 125 (767)
Q Consensus 47 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~ 125 (767)
+.++.+|++|++++|.++ .++. +..+. +|++|++++|.+.+ + ..+..+++|++|++++|++++..+..+
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-------~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 84 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-------L-DGFPLLRRLKTLLVNNNRICRIGEGLD 84 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-------E-CCCCCCSSCCEEECCSSCCCEECSCHH
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-------c-cccccCCCCCEEECCCCcccccCcchh
Confidence 445555555555555555 2332 22222 55555555555432 1 334455555555555555553333333
Q ss_pred hhhccccCeEEccCCcccccCCc--cccCCCCCCEEECcCCcCcccCcc----ccCCCCCCCEEEccCCccc
Q 004218 126 GNLSNVLSKLYMGGNRFYGKIPT--SIGRLRSLTLLNLSYNSISGEILT----EIGQLQELQSLDLAGNQIS 191 (767)
Q Consensus 126 ~~l~~~L~~L~l~~n~i~~~~~~--~l~~l~~L~~L~l~~n~i~~~~~~----~~~~l~~L~~L~L~~n~i~ 191 (767)
..+++ |++|++++|+++ .+|. .+..+++|++|++++|.++. .+. .+..+++|+.|++++|.+.
T Consensus 85 ~~l~~-L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 85 QALPD-LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp HHCTT-CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred hcCCC-CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 55555 666666666554 2333 45555555555555555552 232 2444555555555555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.50 E-value=2.7e-16 Score=151.21 Aligned_cols=109 Identities=24% Similarity=0.358 Sum_probs=61.1
Q ss_pred ccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCc-cccCCCCC
Q 004218 101 LTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEIL-TEIGQLQE 179 (767)
Q Consensus 101 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~ 179 (767)
+.++++|++|++++|+++ .+|..+..+++ |++|++++|++++ +| .+..+++|++|++++|.+++..+ ..+..+++
T Consensus 66 ~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~-L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~ 141 (198)
T 1ds9_A 66 LSGMENLRILSLGRNLIK-KIENLDAVADT-LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDK 141 (198)
T ss_dssp HHHHTTCCEEEEEEEEEC-SCSSHHHHHHH-CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTT
T ss_pred cccCCCCCEEECCCCCcc-cccchhhcCCc-CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCC
Confidence 334444444555555544 44555555555 6666666666663 23 45566666666666666664222 35666666
Q ss_pred CCEEEccCCccccccCc----------CcccCCCCceeeCCCCcCC
Q 004218 180 LQSLDLAGNQISGSIPN----------TLGNLKKLNQIDLSGNELA 215 (767)
Q Consensus 180 L~~L~L~~n~i~~~~~~----------~~~~l~~L~~L~L~~N~l~ 215 (767)
|++|++++|.+.+..|. .+..+++|+.|+ +|.++
T Consensus 142 L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 142 LEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp CSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 77777776666644443 255566666665 44443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.50 E-value=4e-16 Score=150.01 Aligned_cols=152 Identities=22% Similarity=0.280 Sum_probs=117.4
Q ss_pred CCCCcEEEccCCcccccCCc------cccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccc
Q 004218 26 LPNLLGFNFCFNKFTGKIPG------SLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFIT 99 (767)
Q Consensus 26 l~~L~~L~l~~n~l~~~~~~------~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 99 (767)
...++.++++.+.+.+.+|. .+..+++|++|+|++|.+++ +| .+..+++|++|++++|.+.. ++.
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-------l~~ 87 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-------IEN 87 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-------CSS
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-------ccc
Confidence 55667777777777766665 78888888888888888884 56 77888888888888888863 334
Q ss_pred cccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCC-ccccCCCCCCEEECcCCcCcccCcc------
Q 004218 100 SLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIP-TSIGRLRSLTLLNLSYNSISGEILT------ 172 (767)
Q Consensus 100 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~L~l~~n~i~~~~~~------ 172 (767)
.+..+++|++|++++|++++ +| .+..+++ |++|++++|+++...+ ..+..+++|++|++++|.+.+..|.
T Consensus 88 ~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~-L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~ 164 (198)
T 1ds9_A 88 LDAVADTLEELWISYNQIAS-LS-GIEKLVN-LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164 (198)
T ss_dssp HHHHHHHCSEEEEEEEECCC-HH-HHHHHHH-SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHH
T ss_pred hhhcCCcCCEEECcCCcCCc-CC-ccccCCC-CCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHH
Confidence 45566788899999998884 45 6888887 9999999999985332 4788899999999999999765443
Q ss_pred ----ccCCCCCCCEEEccCCccc
Q 004218 173 ----EIGQLQELQSLDLAGNQIS 191 (767)
Q Consensus 173 ----~~~~l~~L~~L~L~~n~i~ 191 (767)
.+..+++|++|| +|.++
T Consensus 165 ~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 165 YRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHHHHHCSSCSEEC--CGGGT
T ss_pred HHHHHHHhCCCcEEEC--CcccC
Confidence 277899999987 66665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=3.3e-13 Score=125.72 Aligned_cols=105 Identities=28% Similarity=0.333 Sum_probs=57.9
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
.+.+++++|+++ .+|..+. ++|++|+|++|.|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 344555555554 2343332 4555555555555555555555555555555555555544444555555666666666
Q ss_pred CcCCCCCcccccCccccccccccCcccC
Q 004218 212 NELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 212 N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
|+|++..+..|..+++|+.|+|++|.+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 6655544555555566666666666555
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=5.3e-13 Score=124.75 Aligned_cols=104 Identities=21% Similarity=0.331 Sum_probs=49.3
Q ss_pred CEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccC
Q 004218 108 NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAG 187 (767)
Q Consensus 108 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 187 (767)
+.+++++|+++ .+|..+. .. |++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TD-KQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TT-CSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCCcC--CC-CcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 44555555554 4444332 22 55555555555544444455555555555555555543333344445555555555
Q ss_pred CccccccCcCcccCCCCceeeCCCCcCC
Q 004218 188 NQISGSIPNTLGNLKKLNQIDLSGNELA 215 (767)
Q Consensus 188 n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 215 (767)
|+|++..+..|..+++|+.|+|++|++.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc
Confidence 5544333333444444444444444444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=4.7e-13 Score=124.65 Aligned_cols=107 Identities=25% Similarity=0.312 Sum_probs=92.3
Q ss_pred CCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEcc
Q 004218 107 LNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLA 186 (767)
Q Consensus 107 L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 186 (767)
.+.+++++|+++ .+|..+. .. |++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|+
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~-l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TT-TQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TT-CSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCccCC--CC-CcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 467888888887 5676553 34 9999999999998888899999999999999999998777788999999999999
Q ss_pred CCccccccCcCcccCCCCceeeCCCCcCCCC
Q 004218 187 GNQISGSIPNTLGNLKKLNQIDLSGNELASE 217 (767)
Q Consensus 187 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 217 (767)
+|+|++..+..|..+++|++|+|++|++...
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 9999977777899999999999999999754
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=8e-13 Score=123.50 Aligned_cols=106 Identities=25% Similarity=0.290 Sum_probs=93.5
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
-+.+++++|+++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 468999999997 6677664 8999999999999988888999999999999999999977667788999999999999
Q ss_pred CcCCCCCcccccCccccccccccCcccCC
Q 004218 212 NELASEIPTSFGNFQNLLSIDLSNNKLNG 240 (767)
Q Consensus 212 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 240 (767)
|+|++..+..|..+++|+.|+|++|.+..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccc
Confidence 99998777779999999999999999983
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.37 E-value=4e-11 Score=128.36 Aligned_cols=318 Identities=11% Similarity=0.103 Sum_probs=150.3
Q ss_pred cCCCccccCCC-CCcEEEccCCcccccCCccccCCCCCCEEEccccc---CcccCCccCCCCCCCcEEeecCccccCCCC
Q 004218 17 EIPYDVGDKLP-NLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNL---LEGTVPPGLGNLPFLKMYNIGFNKIVGSGD 92 (767)
Q Consensus 17 ~ip~~~~~~l~-~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~---i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 92 (767)
+|+...|.... .|+++.+-.+ ++.+-..+|.++++|+.+.++.|. ++.....+|..+.+|+.+.+..+ ++..+
T Consensus 53 ~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~- 129 (394)
T 4gt6_A 53 KIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEID- 129 (394)
T ss_dssp EECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEEC-
T ss_pred EcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceeh-
Confidence 45555555443 4677766543 554555667777777777776653 44334456666666666665433 22211
Q ss_pred CCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCcc
Q 004218 93 EGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILT 172 (767)
Q Consensus 93 ~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~ 172 (767)
...+..+.+|+.+.+..+ +.......+..+.. |+.+.+..+ ++.+...+|.. .+|+.+.+..+-.. +...
T Consensus 130 -----~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~-L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~ 199 (394)
T 4gt6_A 130 -----SEAFHHCEELDTVTIPEG-VTSVADGMFSYCYS-LHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTN 199 (394)
T ss_dssp -----TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT-CCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTT
T ss_pred -----hhhhhhhcccccccccce-eeeecccceecccc-cccccccce-eeEeccccccc-cceeEEEECCcccc-cccc
Confidence 123455666666666543 22244445555555 666666554 33344444543 45666666554333 4455
Q ss_pred ccCCCCCCCEEEccCCccccccCcCcc--------------cCCCCceeeCCCCcCCCCCcccccCccccccccccCccc
Q 004218 173 EIGQLQELQSLDLAGNQISGSIPNTLG--------------NLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKL 238 (767)
Q Consensus 173 ~~~~l~~L~~L~L~~n~i~~~~~~~~~--------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l 238 (767)
+|..+.+++......+... .....+. ....+..+.+.. .++.+...+|.++.+|+.+.+.++..
T Consensus 200 af~~c~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~ 277 (394)
T 4gt6_A 200 AFSECFALSTITSDSESYP-AIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVV 277 (394)
T ss_dssp TTTTCTTCCEEEECCSSSC-BSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCC
T ss_pred hhhhccccceecccccccc-cccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccc
Confidence 6666666666655544433 1111111 111222222221 12222334555556666665554332
Q ss_pred CCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCch
Q 004218 239 NGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNI 318 (767)
Q Consensus 239 ~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 318 (767)
. .....|.++..|..+ .+. +.++.+....|.++.+|+.++|..+ ++.+....|.++.+|+.+.+..+ ++.+...+
T Consensus 278 ~-I~~~aF~~c~~L~~i-~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~a 352 (394)
T 4gt6_A 278 S-IGTGAFMNCPALQDI-EFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESA 352 (394)
T ss_dssp E-ECTTTTTTCTTCCEE-ECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGG
T ss_pred e-ecCcccccccccccc-cCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhH
Confidence 2 333444444444332 332 2333333444555555555555433 33344455555555555555432 44344445
Q ss_pred hhccCCceEEEcCCcccCCCCCccccccccCceEeccCC
Q 004218 319 LAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFN 357 (767)
Q Consensus 319 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 357 (767)
|.++.+|+.+++.+|.... ..+..+.+|+.+.+..|
T Consensus 353 F~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~ 388 (394)
T 4gt6_A 353 FSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPG 388 (394)
T ss_dssp GTTCTTCCEEEESSCHHHH---HTCBCCCCC--------
T ss_pred hhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCC
Confidence 5555555555555544321 23334444554444433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.8e-14 Score=152.14 Aligned_cols=109 Identities=20% Similarity=0.249 Sum_probs=45.1
Q ss_pred CCCEEECcCCcceeecCchhhhh-----ccccCeEEccCCcccc----cCCccccCCCCCCEEECcCCcCcccC----cc
Q 004218 106 RLNFLAFDGNQFEGEIPESIGNL-----SNVLSKLYMGGNRFYG----KIPTSIGRLRSLTLLNLSYNSISGEI----LT 172 (767)
Q Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l-----~~~L~~L~l~~n~i~~----~~~~~l~~l~~L~~L~l~~n~i~~~~----~~ 172 (767)
+|+.|+|++|+++......++.. .. |++|+|++|+|+. .++..+..+++|++|+|++|.|+... ..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~-L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQ-ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCC-CCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCc-cceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 44555555555543333333221 22 4555555554432 12222344444555555555444221 22
Q ss_pred ccCCCCCCCEEEccCCccccc----cCcCcccCCCCceeeCCCCcCC
Q 004218 173 EIGQLQELQSLDLAGNQISGS----IPNTLGNLKKLNQIDLSGNELA 215 (767)
Q Consensus 173 ~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~ 215 (767)
.+...++|++|+|++|.|++. ++..+...++|++|+|++|.|+
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence 333444455555555544421 1122223344444444444443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=9e-14 Score=146.73 Aligned_cols=164 Identities=13% Similarity=0.126 Sum_probs=111.1
Q ss_pred CCCcEEeecCccccCCCCCCccccccccC-CCCCCEEECcCCcceeecCchhhh-hccccCeEEccCCcccccCCccc--
Q 004218 75 PFLKMYNIGFNKIVGSGDEGLSFITSLTN-STRLNFLAFDGNQFEGEIPESIGN-LSNVLSKLYMGGNRFYGKIPTSI-- 150 (767)
Q Consensus 75 ~~L~~L~l~~n~l~~~~~~~~~~~~~l~~-l~~L~~L~l~~n~l~~~~~~~~~~-l~~~L~~L~l~~n~i~~~~~~~l-- 150 (767)
+.|++|+|++|.++..... .+...+.. .++|+.|+|++|.++......+.. +.+ |++|+|++|+++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~--~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~-L~~L~Ls~n~l~~~~~~~L~~ 148 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCT--VVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLR-ARKLGLQLNSLGPEACKDLRD 148 (372)
T ss_dssp TTCCEEECTTSCCCHHHHH--HHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHT-EEEEECCSSCCCHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHH--HHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHh-ccHhhcCCCCCCHHHHHHHHH
Confidence 5677777777776532111 22223332 368888888888887554445544 344 8899999998875444444
Q ss_pred ---cCCCCCCEEECcCCcCccc----CccccCCCCCCCEEEccCCcccccc----CcCcccCCCCceeeCCCCcCCCCC-
Q 004218 151 ---GRLRSLTLLNLSYNSISGE----ILTEIGQLQELQSLDLAGNQISGSI----PNTLGNLKKLNQIDLSGNELASEI- 218 (767)
Q Consensus 151 ---~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~N~l~~~~- 218 (767)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|.+.. +..+...++|++|+|++|.|+...
T Consensus 149 ~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~ 228 (372)
T 3un9_A 149 LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAA 228 (372)
T ss_dssp HHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHH
T ss_pred HHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHH
Confidence 3467899999999988753 3334467888999999999887432 455667788999999999887432
Q ss_pred ---cccccCccccccccccCcccCCC
Q 004218 219 ---PTSFGNFQNLLSIDLSNNKLNGN 241 (767)
Q Consensus 219 ---~~~~~~l~~L~~L~l~~n~l~~~ 241 (767)
+..+...++|++|+|++|.|+..
T Consensus 229 ~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 229 LALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 23344567888888888887743
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=6.7e-12 Score=126.44 Aligned_cols=147 Identities=16% Similarity=0.070 Sum_probs=113.1
Q ss_pred HHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccc
Q 004218 450 LRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 450 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~ 528 (767)
+......|++....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++. ..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~ 82 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HD 82 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ET
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cC
Confidence 4455678988888999999999999865 6889999986432233456889999999884 677888888754 34
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC-------------------------- 582 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------- 582 (767)
+..|+||||++|.++.+.+.. ..+...++.+++++++.||+..
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred CceEEEEEecCCeehhhccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence 556999999999999876421 1123468899999999999810
Q ss_pred ------------------------------CCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 583 ------------------------------EVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 583 ------------------------------~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
+..++|||++|.||+++++..+.|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1359999999999999876666799998874
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.3e-10 Score=124.34 Aligned_cols=311 Identities=11% Similarity=0.093 Sum_probs=217.1
Q ss_pred CccEEeCCCCeeeecCCCccccCCCCCcEEEccCCc---ccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcE
Q 004218 3 SLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNK---FTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKM 79 (767)
Q Consensus 3 ~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~---l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~ 79 (767)
.|+.+.+..+ ++ +|....|.+..+|+.+.+..|. ++.+-..+|..+.+|+.+.+..+ ++......|..+.+|+.
T Consensus 65 ~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~ 141 (394)
T 4gt6_A 65 VLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDT 141 (394)
T ss_dssp CCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCE
T ss_pred cCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccc
Confidence 4777888654 66 8899999999999999998874 66555678999999999888766 44356678899999999
Q ss_pred EeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEE
Q 004218 80 YNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLL 159 (767)
Q Consensus 80 L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L 159 (767)
+.+..+- ...+ ...+..+.+|+.+.+..+ ++.....+|. ... |+.+.+..+-.. ....+|.++.+|+..
T Consensus 142 i~lp~~~-~~I~------~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~-l~~i~ip~~~~~-i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 142 VTIPEGV-TSVA------DGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTA-LTQIHIPAKVTR-IGTNAFSECFALSTI 210 (394)
T ss_dssp EECCTTC-CEEC------TTTTTTCTTCCEEECCTT-CCEECTTTTT-TCC-CSEEEECTTCCE-ECTTTTTTCTTCCEE
T ss_pred cccccee-eeec------ccceecccccccccccce-eeEecccccc-ccc-eeEEEECCcccc-cccchhhhcccccee
Confidence 9997543 3222 235677889999999865 4434444454 445 999999876554 677889999999998
Q ss_pred ECcCCcCcccCccc-------------cCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCcc
Q 004218 160 NLSYNSISGEILTE-------------IGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQ 226 (767)
Q Consensus 160 ~l~~n~i~~~~~~~-------------~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 226 (767)
....+......-.. +.....+..+.+.. .+......+|.++..|+.+.+.++... +...+|.+++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~ 288 (394)
T 4gt6_A 211 TSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCP 288 (394)
T ss_dssp EECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCT
T ss_pred cccccccccccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccce-ecCccccccc
Confidence 87766544211111 11223444555443 333355677888899999998766543 6677888889
Q ss_pred ccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeec
Q 004218 227 NLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLM 306 (767)
Q Consensus 227 ~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l 306 (767)
+|+.+.+. +.++......|.++.+|..+ .+..+ ++.+....|.++.+|+.+.|..+ ++.+....|.++++|+.+++
T Consensus 289 ~L~~i~l~-~~i~~I~~~aF~~c~~L~~i-~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~ 364 (394)
T 4gt6_A 289 ALQDIEFS-SRITELPESVFAGCISLKSI-DIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEY 364 (394)
T ss_dssp TCCEEECC-TTCCEECTTTTTTCTTCCEE-ECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEE
T ss_pred ccccccCC-CcccccCceeecCCCCcCEE-EeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEE
Confidence 99999886 44554556778888888555 77654 55566778999999999999765 77677889999999999999
Q ss_pred cCccccCCCCchhhccCCceEEEcCCcccC
Q 004218 307 ANNKFSGPIPNILAELKGLEVLDLSSNKLS 336 (767)
Q Consensus 307 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 336 (767)
.++.... ..+..+.+|+.+.+..|.+.
T Consensus 365 ~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 365 SGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp SSCHHHH---HTCBCCCCC-----------
T ss_pred CCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 9987542 45677788999988877653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=9.9e-12 Score=130.78 Aligned_cols=105 Identities=20% Similarity=0.187 Sum_probs=79.7
Q ss_pred ecccc-cCCCCCchhhcCCCceeEEEccC-CCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcc
Q 004218 257 NLSKN-FLDGTLPEEIGMLGNVVTIDLSA-NGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNK 334 (767)
Q Consensus 257 ~l~~n-~l~~~~~~~~~~l~~L~~L~ls~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 334 (767)
+.+++ .++ .+|. +..+++|+.|+|++ |.|+++.+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+
T Consensus 14 ~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 91 (347)
T 2ifg_A 14 RCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (347)
T ss_dssp ECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence 56665 666 3555 77777888888885 88887777788888888888888888887777788888888888888888
Q ss_pred cCCCCCccccccccCceEeccCCcCcCcCC
Q 004218 335 LSGSIPSDLQNLRALRSLNLTFNNLEGVVP 364 (767)
Q Consensus 335 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 364 (767)
|++..+..+..++ |+.|+|.+|++.+...
T Consensus 92 l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 92 LESLSWKTVQGLS-LQELVLSGNPLHCSCA 120 (347)
T ss_dssp CSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred cceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence 8865555555555 8888888888876543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=2.7e-11 Score=127.40 Aligned_cols=103 Identities=20% Similarity=0.225 Sum_probs=65.3
Q ss_pred eEEccCC-cccccCCccccCCCCCCEEECcC-CcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 134 KLYMGGN-RFYGKIPTSIGRLRSLTLLNLSY-NSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 134 ~L~l~~n-~i~~~~~~~l~~l~~L~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
.++++++ +++ .+|. |..+++|++|+|++ |.|+++.+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3455555 555 3555 66666666666664 666665556666666666666666666666666666666666666666
Q ss_pred CcCCCCCcccccCccccccccccCcccC
Q 004218 212 NELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 212 N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
|+|++..+..|..++ |+.|+|.+|.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 666655555555544 666666666665
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=9.1e-11 Score=118.05 Aligned_cols=138 Identities=14% Similarity=0.012 Sum_probs=98.8
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCC--ceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRN--LVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~ 531 (767)
...|.+....+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.+ +.+++++.. .++..
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~ 90 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRD 90 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCC
Confidence 3445544333456669999998777888999997533 3356788999998885444 455777643 23456
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC----------------------------- 582 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------- 582 (767)
++||||++|.++. ... .+ ...++.++++.++.||+..
T Consensus 91 ~~v~e~i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD 156 (264)
T ss_dssp EEEEECCSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred EEEEEecCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence 9999999998884 211 11 2356788888888888752
Q ss_pred --------------------------CCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 583 --------------------------EVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 583 --------------------------~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
+..++|||++|.||++++++.+.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999874
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.7e-08 Score=107.39 Aligned_cols=301 Identities=11% Similarity=0.082 Sum_probs=208.3
Q ss_pred CCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCC
Q 004218 25 KLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNS 104 (767)
Q Consensus 25 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l 104 (767)
.-.+|+++.+.. .++.+-..+|.++.+|+.++|..+ ++.....+|.++ +|+.+.+..+ +...+.. ++..
T Consensus 44 ~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~------aF~~- 112 (379)
T 4h09_A 44 DRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDY------VFQG- 112 (379)
T ss_dssp GGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTT------TTTT-
T ss_pred cccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccc------eecc-
Confidence 345788888864 577566778999999999999765 554556678776 6888777643 4433332 2222
Q ss_pred CCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcc------------cCcc
Q 004218 105 TRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISG------------EILT 172 (767)
Q Consensus 105 ~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~------------~~~~ 172 (767)
.+|+.+.+..+- .......+.+. . |+.+.+..+ ++.....+|..+.+++.+.+..+.... ....
T Consensus 113 ~~L~~i~lp~~~-~~i~~~~F~~~-~-l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (379)
T 4h09_A 113 TDLDDFEFPGAT-TEIGNYIFYNS-S-VKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILE 188 (379)
T ss_dssp CCCSEEECCTTC-CEECTTTTTTC-C-CCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEE
T ss_pred CCcccccCCCcc-ccccccccccc-e-eeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceec
Confidence 478889887653 32444444443 3 777776654 444667788888899888877654331 1223
Q ss_pred ccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccc
Q 004218 173 EIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSL 252 (767)
Q Consensus 173 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l 252 (767)
.+.....+..+.+..+.-. .....+....+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++......|.++.++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l 265 (379)
T 4h09_A 189 SYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTAL 265 (379)
T ss_dssp ECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTC
T ss_pred cccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehh
Confidence 4555666777766654433 55667777888888888765 44456677888888998888765 554555677777777
Q ss_pred cceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCC
Q 004218 253 TTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSS 332 (767)
Q Consensus 253 ~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 332 (767)
..+ .+.. .+.......|.++++|+.+.+.++.++.+....|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..
T Consensus 266 ~~i-~l~~-~i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 266 KTL-NFYA-KVKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CEE-EECC-CCSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred ccc-cccc-cceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 544 5543 355455667889999999999999898788889999999999999755 6666778899999999999876
Q ss_pred cccCCCCCccccccc
Q 004218 333 NKLSGSIPSDLQNLR 347 (767)
Q Consensus 333 N~l~~~~~~~~~~l~ 347 (767)
+ ++.+....|..+.
T Consensus 343 ~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 343 S-ITLIESGAFEGSS 356 (379)
T ss_dssp T-CCEECTTTTTTSS
T ss_pred c-cCEEchhHhhCCC
Confidence 5 5545555666554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.01 E-value=2.1e-08 Score=106.54 Aligned_cols=296 Identities=11% Similarity=0.101 Sum_probs=208.9
Q ss_pred ccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCch
Q 004218 45 GSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPES 124 (767)
Q Consensus 45 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 124 (767)
.++....+|+.+.+... ++.....+|.++.+|+.+.|..+ ++..+... +.++ +|+.+.+..+ ++.....+
T Consensus 40 ~~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~a------F~~c-~l~~i~~~~~-l~~I~~~a 109 (379)
T 4h09_A 40 PWYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGA------FADT-KLQSYTGMER-VKKFGDYV 109 (379)
T ss_dssp TTGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTT------TTTC-CCCEEEECTT-CCEECTTT
T ss_pred cccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhh------hcCC-CCceEECCce-eeEeccce
Confidence 35677788999998754 55456678999999999999754 55544442 3444 5777777643 55333444
Q ss_pred hhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccc-----------
Q 004218 125 IGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGS----------- 193 (767)
Q Consensus 125 ~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~----------- 193 (767)
|.. .+ |+.+.+..+-. .....+|.+. +|+.+.+..+ ++.+...+|..+.+++...+..+.....
T Consensus 110 F~~-~~-L~~i~lp~~~~-~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (379)
T 4h09_A 110 FQG-TD-LDDFEFPGATT-EIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNK 184 (379)
T ss_dssp TTT-CC-CSEEECCTTCC-EECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTS
T ss_pred ecc-CC-cccccCCCccc-cccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceeccccc
Confidence 444 45 99999987643 3555666654 6888777654 4546677888999999988876554311
Q ss_pred -cCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhc
Q 004218 194 -IPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIG 272 (767)
Q Consensus 194 -~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~ 272 (767)
....+.....+..+.+..+.- ......+....+|+.+.+..+ +.......+.++..|..+ .+..+ ++.+....|.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i-~lp~~-v~~I~~~aF~ 260 (379)
T 4h09_A 185 TILESYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEI-AIPKN-VTSIGSFLLQ 260 (379)
T ss_dssp SEEEECCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEE-EECTT-CCEECTTTTT
T ss_pred ceecccccccccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEE-EcCCC-ccEeCccccc
Confidence 112234445566666554433 245567778889999888765 343556677778877554 66654 5556667888
Q ss_pred CCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceE
Q 004218 273 MLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSL 352 (767)
Q Consensus 273 ~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 352 (767)
+..+|+.+.+..+ +..+....|.++++|+.+.+.++.++.+....|.++.+|+.+.|..+ ++.+....|..+.+|+.+
T Consensus 261 ~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i 338 (379)
T 4h09_A 261 NCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTI 338 (379)
T ss_dssp TCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCC
T ss_pred eeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEE
Confidence 8999999999765 66567788999999999999999998778889999999999999765 665666789999999999
Q ss_pred eccCCcCcCc
Q 004218 353 NLTFNNLEGV 362 (767)
Q Consensus 353 ~l~~N~l~~~ 362 (767)
.+..+ ++.+
T Consensus 339 ~ip~~-v~~I 347 (379)
T 4h09_A 339 SYPKS-ITLI 347 (379)
T ss_dssp CCCTT-CCEE
T ss_pred EECCc-cCEE
Confidence 98654 5443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.97 E-value=2e-10 Score=119.95 Aligned_cols=177 Identities=15% Similarity=0.162 Sum_probs=114.8
Q ss_pred CCCCCcEEEccCCccc---------ccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCc
Q 004218 25 KLPNLLGFNFCFNKFT---------GKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGL 95 (767)
Q Consensus 25 ~l~~L~~L~l~~n~l~---------~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 95 (767)
++++|+.|.+..+... +.++..+..+++|+.|+|++|.-. .++. +. +++|++|+|..|.+..
T Consensus 137 ~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~------ 207 (362)
T 2ra8_A 137 KFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPD------ 207 (362)
T ss_dssp HHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCH------
T ss_pred hcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCCh------
Confidence 5778888888665331 124456678889999999887311 2333 43 7889999998887642
Q ss_pred ccccccc--CCCCCCEEECcC--Ccceee-----cCchh--hhhccccCeEEccCCcccccCCcccc---CCCCCCEEEC
Q 004218 96 SFITSLT--NSTRLNFLAFDG--NQFEGE-----IPESI--GNLSNVLSKLYMGGNRFYGKIPTSIG---RLRSLTLLNL 161 (767)
Q Consensus 96 ~~~~~l~--~l~~L~~L~l~~--n~l~~~-----~~~~~--~~l~~~L~~L~l~~n~i~~~~~~~l~---~l~~L~~L~l 161 (767)
.....+. .+++|+.|+|+. |...+. +...+ ..+++ |++|+|.+|.+....+..+. .+++|++|+|
T Consensus 208 ~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~-Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdL 286 (362)
T 2ra8_A 208 SVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPN-LKWLGIVDAEEQNVVVEMFLESDILPQLETMDI 286 (362)
T ss_dssp HHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTT-CCEEEEESCTTHHHHHHHHHHCSSGGGCSEEEC
T ss_pred HHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCC-cCEEeCCCCCCchHHHHHHHhCccCCCCCEEEC
Confidence 2233333 678888888753 221111 11112 13455 99999999988754333333 4789999999
Q ss_pred cCCcCcccCc----cccCCCCCCCEEEccCCccccccCcCccc-CCCCceeeCCCCc
Q 004218 162 SYNSISGEIL----TEIGQLQELQSLDLAGNQISGSIPNTLGN-LKKLNQIDLSGNE 213 (767)
Q Consensus 162 ~~n~i~~~~~----~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-l~~L~~L~L~~N~ 213 (767)
+.|.+++... ..+..+++|+.|+|++|.|+......+.. + ...++++.++
T Consensus 287 s~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 287 SAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp CSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred CCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 9999886433 23345789999999999888544444443 2 4668888887
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.1e-10 Score=121.75 Aligned_cols=63 Identities=19% Similarity=0.291 Sum_probs=31.4
Q ss_pred CCCCCEEEccCCccccccCcCcc---cCCCCceeeCCCCcCCCC----CcccccCccccccccccCcccC
Q 004218 177 LQELQSLDLAGNQISGSIPNTLG---NLKKLNQIDLSGNELASE----IPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 177 l~~L~~L~L~~n~i~~~~~~~~~---~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
+++|++|+|++|.+.+..+..+. .+++|++|+|+.|.++.. ++..+..+++|+.|+|++|.++
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 45566666655555432222222 345566666666655432 1222234556666666666555
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=2.2e-09 Score=113.19 Aligned_cols=145 Identities=16% Similarity=0.167 Sum_probs=106.1
Q ss_pred CCCccccccceEEEEEEeCCCcEEEEEEee--ccC-CcchhhHHHHHHHHhcCC--CCCceeEEeeeecCCcccceeeEE
Q 004218 459 HENLIGSGSFGSVYKGYLREGISVAVKVLD--IES-TGTWKSFFAECEALRNTR--HRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 459 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
..+.++.|.++.||++... +..+++|+.. ... ......+.+|+++++.+. +..+.+++.++.... ..+..++
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEE
Confidence 3567899999999999876 4678888775 322 123457788999999886 455788888865432 1234689
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC------------------------------- 582 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------- 582 (767)
||||++|.++.+... ..++..++..++.++++.|+.||+..
T Consensus 119 vme~v~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSL--------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE 190 (359)
T ss_dssp EEECCCCBCCCCTTC--------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred EEEecCCeecCCCcc--------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence 999999987754211 12778888999999999999999731
Q ss_pred ------------------------CCCeEeecCCCCCeeeCCCCc--eEEccccchhh
Q 004218 583 ------------------------EVPIVHCDLKPGNILLDEDMT--AKVGDFGLARS 614 (767)
Q Consensus 583 ------------------------~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~ 614 (767)
+..++|||++|.||+++.++. +.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=5.4e-10 Score=114.95 Aligned_cols=194 Identities=14% Similarity=0.090 Sum_probs=121.4
Q ss_pred CCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCC--ceeEEeeeecCCcccceeeEEEEe
Q 004218 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTR-HRN--LVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
.+.++.|....||++. ..+++|+.... .....+.+|+++++.+. +.. +.+++...... ......|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEEc
Confidence 4568999999999863 46899986422 33467889999998873 322 34444443211 11123488999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC---------------------------------- 582 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------- 582 (767)
+++|.++.+.... .++..++..++.++++.++.||+..
T Consensus 97 ~i~G~~l~~~~~~--------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 97 KIKGVPLTPLLLN--------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CCCCEECCHHHHH--------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred ccCCeECCccccc--------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 9999888754321 1777888889999999999999621
Q ss_pred ---------------------CCCeEeecCCCCCeeeCC--CCceEEccccchhhhhhhcC--CCcc------ccccccc
Q 004218 583 ---------------------EVPIVHCDLKPGNILLDE--DMTAKVGDFGLARSLLERIG--NQSS------ISSTHVL 631 (767)
Q Consensus 583 ---------------------~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg~a~~~~~~~~--~~~~------~~~~~~~ 631 (767)
+..++|+|++|.||++++ ...+.++||+.+........ .... .......
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHH
Confidence 135899999999999998 55688999999864321100 0000 0000000
Q ss_pred cCCCCccC-ccccCCCCCCCcccchhhhHHHHHHHhCCCCC
Q 004218 632 KGSIGYIP-PEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPT 671 (767)
Q Consensus 632 ~gt~~y~a-PE~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 671 (767)
....+... |+.... .....+.|++|.++|.+.+|..+|
T Consensus 249 l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00001111 111110 011258999999999999998875
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.60 E-value=3.9e-09 Score=99.35 Aligned_cols=60 Identities=15% Similarity=0.167 Sum_probs=33.8
Q ss_pred cCeEEccCCccccc----CCccccCCCCCCEEEC--cCCcCcccC----ccccCCCCCCCEEEccCCccc
Q 004218 132 LSKLYMGGNRFYGK----IPTSIGRLRSLTLLNL--SYNSISGEI----LTEIGQLQELQSLDLAGNQIS 191 (767)
Q Consensus 132 L~~L~l~~n~i~~~----~~~~l~~l~~L~~L~l--~~n~i~~~~----~~~~~~l~~L~~L~L~~n~i~ 191 (767)
|++|+|++|+|+.. +...+...++|++|+| ++|.|.... ...+...++|++|+|++|.+.
T Consensus 95 L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 95 LKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred cCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 55555555554421 2344555566777777 667666432 233444566777777777765
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.56 E-value=7.1e-09 Score=97.58 Aligned_cols=66 Identities=20% Similarity=0.245 Sum_probs=40.5
Q ss_pred ccCCCCCCEEECcCCcCccc----CccccCCCCCCCEEEc--cCCccccc----cCcCcccCCCCceeeCCCCcCC
Q 004218 150 IGRLRSLTLLNLSYNSISGE----ILTEIGQLQELQSLDL--AGNQISGS----IPNTLGNLKKLNQIDLSGNELA 215 (767)
Q Consensus 150 l~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L--~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~ 215 (767)
+...++|++|+|++|.|... +...+...++|++|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 89 L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 89 LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 44456677777777777643 2344556667777777 66777633 2233444567777777777664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.6e-06 Score=88.67 Aligned_cols=136 Identities=16% Similarity=0.082 Sum_probs=95.2
Q ss_pred CCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCC---CceeEEeeeecCCcccceeeEEEEe
Q 004218 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHR---NLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
.+.++.|....||+. |..+++|+.. .......+.+|+++++.+.+. .+.+++.++. ...+..++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEe
Confidence 356888888999998 5678899853 223456788999999998642 3556666543 12344589999
Q ss_pred ecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 004218 537 FLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHND----------------------------------- 581 (767)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------- 581 (767)
|++|.++.+.... .++..+...++.++++.|+.||+.
T Consensus 94 ~i~G~~l~~~~~~--------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~ 165 (306)
T 3tdw_A 94 KVQGQILGEDGMA--------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD 165 (306)
T ss_dssp CCCSEECHHHHHT--------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred ccCCeECchhhhh--------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence 9999888763211 145556666666677666666653
Q ss_pred ----------------------CCCCeEeecCCCCCeeeCC---CCc-eEEccccchh
Q 004218 582 ----------------------CEVPIVHCDLKPGNILLDE---DMT-AKVGDFGLAR 613 (767)
Q Consensus 582 ----------------------~~~~ivH~Dlkp~NIl~~~---~~~-~kl~Dfg~a~ 613 (767)
.+..++|+|++|.||+++. ++. +.|+||+.+.
T Consensus 166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1235699999999999987 455 4899999875
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.33 E-value=1.3e-07 Score=93.36 Aligned_cols=80 Identities=21% Similarity=0.287 Sum_probs=53.9
Q ss_pred cCCCceeEEEccCCCCCCC--CCcccccCcccceeeccCccccCCCCchhhccC--CceEEEcCCcccCCCCCc------
Q 004218 272 GMLGNVVTIDLSANGLSGN--LPNSFKNCKSLEKLLMANNKFSGPIPNILAELK--GLEVLDLSSNKLSGSIPS------ 341 (767)
Q Consensus 272 ~~l~~L~~L~ls~n~l~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~------ 341 (767)
.++++|+.|+|++|+|++. +|..+..+++|+.|+|++|.|++. ..+..+. +|++|+|++|++.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 4567788888888888763 345666777888888888877754 2334444 778888888887765552
Q ss_pred -cccccccCceEe
Q 004218 342 -DLQNLRALRSLN 353 (767)
Q Consensus 342 -~~~~l~~L~~L~ 353 (767)
.+..+|+|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 355667777665
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.31 E-value=3.4e-08 Score=97.42 Aligned_cols=41 Identities=20% Similarity=0.310 Sum_probs=23.5
Q ss_pred cCCCCCCEEEcccccCcc--cCCccCCCCCCCcEEeecCcccc
Q 004218 48 HNLTNIQIIRMAHNLLEG--TVPPGLGNLPFLKMYNIGFNKIV 88 (767)
Q Consensus 48 ~~l~~L~~L~l~~n~i~~--~~~~~~~~l~~L~~L~l~~n~l~ 88 (767)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|++.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~ 209 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 209 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence 445666666666666664 23344445566666666666654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=2.5e-06 Score=85.79 Aligned_cols=134 Identities=16% Similarity=0.067 Sum_probs=95.5
Q ss_pred ccccccce-EEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccceeeEEEEeec
Q 004218 462 LIGSGSFG-SVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 462 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
.+..|..+ .||+.... ++..+++|+-.. .....+.+|..+++.+. +--+.++++++.. .+..++|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEee
Confidence 45556655 68988865 467899998653 23456778999888774 3336677777543 34569999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC------------------------------------ 582 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 582 (767)
+|.++.+...... .....++.+++..++.||+..
T Consensus 103 ~G~~~~~~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 103 PGKTAFQVLEEYP----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp CSEEHHHHHHHCG----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred CCccccccccCCH----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 9988887654321 233456777888888888531
Q ss_pred -------------------CCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 583 -------------------EVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 583 -------------------~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
+..++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0138999999999999988777899998874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=4.8e-06 Score=87.45 Aligned_cols=84 Identities=10% Similarity=-0.024 Sum_probs=56.1
Q ss_pred CCcc-ccccceEEEEEEeC-------CCcEEEEEEeeccC---CcchhhHHHHHHHHhcCC-C--CCceeEEeeeecCCc
Q 004218 460 ENLI-GSGSFGSVYKGYLR-------EGISVAVKVLDIES---TGTWKSFFAECEALRNTR-H--RNLVKLITSCSSLDF 525 (767)
Q Consensus 460 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~ 525 (767)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998754 26689999865322 112356778998888773 2 356777777543211
Q ss_pred ccceeeEEEEeecCCCChhh
Q 004218 526 KNMEFLALVYEFLGNGSLGD 545 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~ 545 (767)
.+..++||||++|.++.+
T Consensus 105 --~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 --LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp --TSSCEEEEECCCCBCCCB
T ss_pred --cCCceEEEEecCCCChhh
Confidence 134579999999977654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.02 E-value=9.5e-07 Score=80.56 Aligned_cols=81 Identities=12% Similarity=0.132 Sum_probs=37.6
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCCc-CcccCccccCCC----CCCCEEEccCCc-cccccCcCcccCCCCc
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNS-ISGEILTEIGQL----QELQSLDLAGNQ-ISGSIPNTLGNLKKLN 205 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~-i~~~~~~~~~~l----~~L~~L~L~~n~-i~~~~~~~~~~l~~L~ 205 (767)
|++|++++|.|+...-..+.++++|++|+|++|. |++.....++.+ ++|++|+|++|. |++..-..+.++++|+
T Consensus 63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~ 142 (176)
T 3e4g_A 63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLK 142 (176)
T ss_dssp EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCC
T ss_pred EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCC
Confidence 5555555555544444444555555555555552 443333333332 245555555542 4432223344445555
Q ss_pred eeeCCCC
Q 004218 206 QIDLSGN 212 (767)
Q Consensus 206 ~L~L~~N 212 (767)
+|+|+++
T Consensus 143 ~L~L~~c 149 (176)
T 3e4g_A 143 YLFLSDL 149 (176)
T ss_dssp EEEEESC
T ss_pred EEECCCC
Confidence 5555544
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=5e-05 Score=80.88 Aligned_cols=75 Identities=20% Similarity=0.114 Sum_probs=48.4
Q ss_pred CCccccccceEEEEEEeC-CCcEEEEEEeeccCC-------cchhhHHHHHHHHhcCCC--C-CceeEEeeeecCCcccc
Q 004218 460 ENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-------GTWKSFFAECEALRNTRH--R-NLVKLITSCSSLDFKNM 528 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~~ 528 (767)
.+.+|.|..+.||++... +++.|+||....... ....++..|.++++.+.. + .+.+++.+..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~------- 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------- 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcC-------
Confidence 467999999999999754 468899998643211 233556789998887632 3 3445554421
Q ss_pred eeeEEEEeecCCC
Q 004218 529 EFLALVYEFLGNG 541 (767)
Q Consensus 529 ~~~~lv~e~~~~g 541 (767)
...++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 1237999999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.94 E-value=2.4e-06 Score=77.89 Aligned_cols=34 Identities=18% Similarity=0.080 Sum_probs=21.8
Q ss_pred cCeEEccCCc-ccccCCccccCCCCCCEEECcCCc
Q 004218 132 LSKLYMGGNR-FYGKIPTSIGRLRSLTLLNLSYNS 165 (767)
Q Consensus 132 L~~L~l~~n~-i~~~~~~~l~~l~~L~~L~l~~n~ 165 (767)
|++|+|++|. |+...-..+.++++|++|+|+++.
T Consensus 116 L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 116 MLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred CCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 6677776663 665444456667777777777764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.92 E-value=1.2e-06 Score=81.44 Aligned_cols=122 Identities=12% Similarity=0.163 Sum_probs=71.1
Q ss_pred CccccCCCCCCEEEcccc-cCccc----CCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcce
Q 004218 44 PGSLHNLTNIQIIRMAHN-LLEGT----VPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118 (767)
Q Consensus 44 ~~~l~~l~~L~~L~l~~n-~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~ 118 (767)
...+.+.+.|++|+|++| .|.+. +...+..-+.|+.|+|++|.+.. .+...+...|...++|+.|+|++|+|.
T Consensus 34 ~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd--~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 34 NRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISD--SEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBH--HHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCCh--HHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 334455666777777664 66532 33445555667777777776643 223355556666677777777777776
Q ss_pred eecCchhhhh---ccccCeEEccCC---cccc----cCCccccCCCCCCEEECcCCcCc
Q 004218 119 GEIPESIGNL---SNVLSKLYMGGN---RFYG----KIPTSIGRLRSLTLLNLSYNSIS 167 (767)
Q Consensus 119 ~~~~~~~~~l---~~~L~~L~l~~n---~i~~----~~~~~l~~l~~L~~L~l~~n~i~ 167 (767)
......++.. ..+|++|+|++| .+.. .+...+...++|+.|+++.|.+.
T Consensus 112 ~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 112 PELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 5444443332 112777777654 2332 23445566678888888777654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.91 E-value=5e-05 Score=76.81 Aligned_cols=79 Identities=16% Similarity=0.097 Sum_probs=57.6
Q ss_pred CCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCC---CCceeEEeeeecCCcccceeeE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRH---RNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~ 532 (767)
+..-++.+|.|..+.||+....+|+.|++|+...........+..|++.|+.+.. --+.+++++.. -+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~---------~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD---------RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET---------TE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC---------ce
Confidence 3445677999999999999999999999998764444444567889998887732 23555555421 27
Q ss_pred EEEeecCCCCh
Q 004218 533 LVYEFLGNGSL 543 (767)
Q Consensus 533 lv~e~~~~gsL 543 (767)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.89 E-value=1.6e-06 Score=80.56 Aligned_cols=120 Identities=13% Similarity=0.103 Sum_probs=76.1
Q ss_pred ccCCCCCCCcEEeecCc-cccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhh----hccccCeEEccCCccc
Q 004218 69 PGLGNLPFLKMYNIGFN-KIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGN----LSNVLSKLYMGGNRFY 143 (767)
Q Consensus 69 ~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~----l~~~L~~L~l~~n~i~ 143 (767)
..+.+-+.|++|+|++| +|.. .+...+...|...+.|+.|+|++|++.......+.. -.. |++|+|++|+|+
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd--~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~t-L~~L~L~~N~Ig 111 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSK--ERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPS-LRVLNVESNFLT 111 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCH--HHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSS-CCEEECCSSBCC
T ss_pred HHHhcCCCccEEECCCCCCCCH--HHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCc-cCeEecCCCcCC
Confidence 34455577888888775 5532 223356667777788888888888887554444443 233 888888888887
Q ss_pred c----cCCccccCCCCCCEEECcCC---cCccc----CccccCCCCCCCEEEccCCccc
Q 004218 144 G----KIPTSIGRLRSLTLLNLSYN---SISGE----ILTEIGQLQELQSLDLAGNQIS 191 (767)
Q Consensus 144 ~----~~~~~l~~l~~L~~L~l~~n---~i~~~----~~~~~~~l~~L~~L~L~~n~i~ 191 (767)
. .+.+++...+.|++|+|++| .+... +...+..-+.|+.|+++.|.+.
T Consensus 112 ~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 112 PELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 4 23445666677888888765 33321 2334555677888888777654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.75 E-value=7.7e-05 Score=77.64 Aligned_cols=148 Identities=19% Similarity=0.148 Sum_probs=79.3
Q ss_pred CccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCC--CCCceeEEeeeecCC-cccceeeEEEEee
Q 004218 461 NLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTR--HRNLVKLITSCSSLD-FKNMEFLALVYEF 537 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~-~~~~~~~~lv~e~ 537 (767)
+.++.|..+.||++...+| .+++|+.... ...+..|.++++.+. .-.+.+++....... ....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677899999987655 5899988641 233445555555542 112333333110000 1123456899999
Q ss_pred cCCCChh--------------hhhcccCC-C--CCC-----CCCCHHHH-------------------------------
Q 004218 538 LGNGSLG--------------DWIHGERK-N--EHG-----NGLNFLER------------------------------- 564 (767)
Q Consensus 538 ~~~gsL~--------------~~l~~~~~-~--~~~-----~~l~~~~~------------------------------- 564 (767)
++|.++. ..++.... . ... ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 01111100 0 000 01122211
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 565 LNIAIDIASALDYLHN----------DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 565 ~~i~~~i~~~l~~LH~----------~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
..+..++..++++|++ ..+..++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112234445666653 023589999999999999888899999998774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00044 Score=70.33 Aligned_cols=74 Identities=9% Similarity=0.146 Sum_probs=45.3
Q ss_pred CCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCc-eeEEeeeecCCcccceeeEEEE
Q 004218 457 FSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNL-VKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 457 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.-.+.|+.|....+|++ ..+++|+...... ......+|+.+++.+....+ .++++++.. .-++|+
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~-------~~~~v~ 86 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDPA-------TGVMVT 86 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT-------TCCEEE
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEECC-------CCEEEE
Confidence 333678999999999999 4689998754321 12233568877776632222 456655321 126899
Q ss_pred eec-CCCCh
Q 004218 536 EFL-GNGSL 543 (767)
Q Consensus 536 e~~-~~gsL 543 (767)
||+ +|.++
T Consensus 87 e~i~~g~~l 95 (301)
T 3dxq_A 87 RYIAGAQTM 95 (301)
T ss_dssp ECCTTCEEC
T ss_pred eecCCCccC
Confidence 999 66444
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00067 Score=68.83 Aligned_cols=141 Identities=18% Similarity=0.104 Sum_probs=89.0
Q ss_pred CCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCC---CCCceeEEeeeecCCcccceeeEEEEe
Q 004218 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTR---HRNLVKLITSCSSLDFKNMEFLALVYE 536 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e 536 (767)
.+.++.|....+|+.... +..+++|+.... ....+..|++.|+.+. ...+.++++++.. .+..++|||
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEE
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEE
Confidence 467899999999999864 678899987532 3456788988888773 3567788877542 245699999
Q ss_pred ecCCCChhh-----------hhcccCC-CC---------------CCCCCCHHHHH---HHHH----------------H
Q 004218 537 FLGNGSLGD-----------WIHGERK-NE---------------HGNGLNFLERL---NIAI----------------D 570 (767)
Q Consensus 537 ~~~~gsL~~-----------~l~~~~~-~~---------------~~~~l~~~~~~---~i~~----------------~ 570 (767)
|+++.++.. .++.... .. ....-+|.+.. ++.. +
T Consensus 112 ~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~ 191 (312)
T 3jr1_A 112 ALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDL 191 (312)
T ss_dssp CCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHH
T ss_pred eccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 999876421 1222111 00 01112454332 1111 1
Q ss_pred HHHH-HHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 571 IASA-LDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 571 i~~~-l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
++.. ...|.. ..++.++|+|+.+.|++++.++ +.|+|++
T Consensus 192 l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 192 IVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1111 223421 2245899999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0006 Score=72.97 Aligned_cols=77 Identities=12% Similarity=0.119 Sum_probs=47.3
Q ss_pred CCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccC--CCCccCccccCCC---CCCCcccchhhh
Q 004218 584 VPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG--SIGYIPPEYGLGE---KPSTAGDVYSFG 658 (767)
Q Consensus 584 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~Dv~slG 658 (767)
..++|||++|.||+++.++ ++++||+.+..-.....- ....+ ...|++|+..... ......++.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-------a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-------GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTI 303 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-------HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-------HHHHHHHHHHHHhcccccccccchHHHHHHHHHHH
Confidence 4899999999999998876 999999988643221100 00000 1235666654311 112234556778
Q ss_pred HHHHHHHhCC
Q 004218 659 VMLLEIFTGM 668 (767)
Q Consensus 659 ~il~el~tg~ 668 (767)
..+|+.+++.
T Consensus 304 ~~~~~~y~~~ 313 (420)
T 2pyw_A 304 EQTWNLFNKR 313 (420)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 8888887754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0014 Score=67.75 Aligned_cols=144 Identities=13% Similarity=0.048 Sum_probs=73.5
Q ss_pred CccccccceE-EEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCC--CCceeEEeeeecCCcccceeeEEEEee
Q 004218 461 NLIGSGSFGS-VYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRH--RNLVKLITSCSSLDFKNMEFLALVYEF 537 (767)
Q Consensus 461 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~ 537 (767)
+.++.|.... +|+....+++.+++|...... ...+..|+++++.+.. -.+.+++.+.. ..+ +++||+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~-----~~g--~ll~e~ 93 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH-----ARG--LLLIED 93 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET-----TTT--EEEECC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC-----CCC--EEEEee
Confidence 4566665554 667765446778888654321 1344567777766632 23556666522 112 689999
Q ss_pred cCCCChhhhhcccCCC--------------------CCCCCCCHHHHH-------H-------------HHHHHHHHHHH
Q 004218 538 LGNGSLGDWIHGERKN--------------------EHGNGLNFLERL-------N-------------IAIDIASALDY 577 (767)
Q Consensus 538 ~~~gsL~~~l~~~~~~--------------------~~~~~l~~~~~~-------~-------------i~~~i~~~l~~ 577 (767)
+++.++.+++...... ..-..++..... . ....+...++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9877776554321100 000112211100 0 00111122222
Q ss_pred HH---hCCCCCeEeecCCCCCeeeCCC----CceEEccccchhh
Q 004218 578 LH---NDCEVPIVHCDLKPGNILLDED----MTAKVGDFGLARS 614 (767)
Q Consensus 578 LH---~~~~~~ivH~Dlkp~NIl~~~~----~~~kl~Dfg~a~~ 614 (767)
+. ...+..++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 21 1124489999999999999874 6899999998853
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0018 Score=66.60 Aligned_cols=167 Identities=18% Similarity=0.129 Sum_probs=90.9
Q ss_pred CCccCHHHHHHHhcCCCC-----CCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCC--Cce
Q 004218 442 PQMISYDELRRATGNFSH-----ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHR--NLV 514 (767)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv 514 (767)
...++.+.+......|.+ ...++ |....||++...+|+.+++|...... .....+..|..+++.+... .+.
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence 344566666655555533 23466 78889999887778789999985321 2345666788887776322 234
Q ss_pred eEEeeeecCC-cccceeeEEEEeecCCCChhh-----h---------hcccC---CCCCCCCCCHHHH------------
Q 004218 515 KLITSCSSLD-FKNMEFLALVYEFLGNGSLGD-----W---------IHGER---KNEHGNGLNFLER------------ 564 (767)
Q Consensus 515 ~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~-----~---------l~~~~---~~~~~~~l~~~~~------------ 564 (767)
+++.. .... ....+..+++|||++|.++.. + ++... ........++...
T Consensus 86 ~~~~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 86 APVAF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCCB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred ceeec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence 44432 1100 112345678999998854321 0 11100 0000111222111
Q ss_pred ----------HHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 565 ----------LNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 565 ----------~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
...+.+++..+...-. ..+..++|||+++.||+++ + .+.++||+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 1111222222222211 1234789999999999999 4 89999998875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0024 Score=65.43 Aligned_cols=167 Identities=17% Similarity=0.112 Sum_probs=90.0
Q ss_pred ccCHHHHHHHhcCCCCC-----CccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCC--ceeE
Q 004218 444 MISYDELRRATGNFSHE-----NLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRN--LVKL 516 (767)
Q Consensus 444 ~~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~ 516 (767)
.++.+++.....+|.+. +.++.|....+|+....+| .+++|+.... .....+..|+.+++.+.... +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 45667777777777652 3466788899999987655 6889988642 12345567777777663212 2333
Q ss_pred EeeeecCC-cccceeeEEEEeecCCCChhh--------------hhcccCCC-CCC--CCC---CHHHHHH---------
Q 004218 517 ITSCSSLD-FKNMEFLALVYEFLGNGSLGD--------------WIHGERKN-EHG--NGL---NFLERLN--------- 566 (767)
Q Consensus 517 ~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-~~~--~~l---~~~~~~~--------- 566 (767)
+....... ....+..+++|+|++|..+.. .++..... ... ... .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 32210000 011244689999999865421 01111000 000 001 1222100
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 567 ---IAIDIASALDYLHND----CEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 567 ---i~~~i~~~l~~LH~~----~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
+...+...++++++. .+.+++|+|+++.||++++++.+.++||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234445555531 23479999999999999987666899998874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0015 Score=70.02 Aligned_cols=74 Identities=12% Similarity=0.026 Sum_probs=47.7
Q ss_pred CCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCc-eeEEeeeecCCcccceeeEEEEee
Q 004218 460 ENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNL-VKLITSCSSLDFKNMEFLALVYEF 537 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 537 (767)
.+.|+.|-...+|++...+ +..+++|+..... .....-.+|..+++.+...++ .++++.+ . + ..||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~-~---G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFF-----T-N---GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----T-T---EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----C-C---eEEEEe
Confidence 3568888899999999875 5789999874322 111222578888888864444 5666653 1 1 359999
Q ss_pred cCCCCh
Q 004218 538 LGNGSL 543 (767)
Q Consensus 538 ~~~gsL 543 (767)
++|.++
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 988554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00098 Score=71.23 Aligned_cols=73 Identities=21% Similarity=0.113 Sum_probs=49.1
Q ss_pred CCccccccceEEEEEEeCC--------CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCC-ceeEEeeeecCCccccee
Q 004218 460 ENLIGSGSFGSVYKGYLRE--------GISVAVKVLDIESTGTWKSFFAECEALRNTRHRN-LVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~ 530 (767)
.+.|+.|....+|++...+ ++.|++|+.... .....+.+|..+++.+...+ ..++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS-----G--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C---
Confidence 3568888899999998653 578999988421 11245668998888774333 356666532 1
Q ss_pred eEEEEeecCCCCh
Q 004218 531 LALVYEFLGNGSL 543 (767)
Q Consensus 531 ~~lv~e~~~~gsL 543 (767)
.+|+||++|.++
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 489999987444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0017 Score=67.81 Aligned_cols=142 Identities=16% Similarity=0.164 Sum_probs=83.1
Q ss_pred CccccccceEEEEEEeC--------CCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccceee
Q 004218 461 NLIGSGSFGSVYKGYLR--------EGISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 531 (767)
+.+..|-...+|++... +++.|++|+... .........+|.++++.+. +.-..++++++. +
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-----~---- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP-----E---- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-----T----
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-----C----
Confidence 56777888899999864 257899998632 2233456668999888773 222356666532 2
Q ss_pred EEEEeecCCCChhhh-h----------------cccCCCCCCCCCC--HHHHHHHHHHHHH-------------------
Q 004218 532 ALVYEFLGNGSLGDW-I----------------HGERKNEHGNGLN--FLERLNIAIDIAS------------------- 573 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~-l----------------~~~~~~~~~~~l~--~~~~~~i~~~i~~------------------- 573 (767)
.+||||++|.++..- + +.... ..+.... +.++.++..++..
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~-~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEM-PFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC-SSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCC-CCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 389999998655421 1 11100 1111222 4555555544422
Q ss_pred HHHHHH----hC-CCCCeEeecCCCCCeeeCCC----CceEEccccchh
Q 004218 574 ALDYLH----ND-CEVPIVHCDLKPGNILLDED----MTAKVGDFGLAR 613 (767)
Q Consensus 574 ~l~~LH----~~-~~~~ivH~Dlkp~NIl~~~~----~~~kl~Dfg~a~ 613 (767)
.+..|. .. .+..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 223332 21 23478999999999999876 789999998885
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0014 Score=68.82 Aligned_cols=73 Identities=16% Similarity=0.184 Sum_probs=43.8
Q ss_pred CccccccceEEEEEEeCC---------CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCC-ceeEEeeeecCCccccee
Q 004218 461 NLIGSGSFGSVYKGYLRE---------GISVAVKVLDIESTGTWKSFFAECEALRNTRHRN-LVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~ 530 (767)
+.++.|....+|++...+ ++.+++|+..... ........|.++++.+...+ +.++++.. . +
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~-~-- 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF-----N-G-- 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T-T--
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec-----C-C--
Confidence 467788888999998754 2689999875322 22223457888887774333 44666542 1 1
Q ss_pred eEEEEeecCCCCh
Q 004218 531 LALVYEFLGNGSL 543 (767)
Q Consensus 531 ~~lv~e~~~~gsL 543 (767)
++||||++|.++
T Consensus 110 -~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 -GRIEEWLYGDPL 121 (369)
T ss_dssp -EEEEECCCSEEC
T ss_pred -cEEEEEecCCcC
Confidence 689999988543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0061 Score=62.87 Aligned_cols=31 Identities=19% Similarity=0.374 Sum_probs=27.6
Q ss_pred CCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 584 VPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 584 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0023 Score=55.43 Aligned_cols=55 Identities=16% Similarity=0.200 Sum_probs=32.6
Q ss_pred EEeCCCCeee-ecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccC
Q 004218 6 YLGLASNQLW-GEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLL 63 (767)
Q Consensus 6 ~L~l~~n~l~-~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i 63 (767)
+++.++++++ ..+|..+. ++|++|+|++|+|+...++.|..+++|++|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp---~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP---VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC---TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC---cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 5566666663 25665443 2566666666666644445566666666666666654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.53 E-value=0.01 Score=55.26 Aligned_cols=102 Identities=11% Similarity=0.052 Sum_probs=66.7
Q ss_pred ChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCC
Q 004218 542 SLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGN 621 (767)
Q Consensus 542 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 621 (767)
||.+++.... .+++++++|.++.|.+.+|.-.-.+. .-..+=+.|..|++..+|.+...+ +.+.
T Consensus 34 SL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 34 SLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc--------
Confidence 7999998764 56999999999999999988772210 111223456888999999888764 2111
Q ss_pred CccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCC
Q 004218 622 QSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670 (767)
Q Consensus 622 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 670 (767)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123467888753 3456778899999999999865554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0036 Score=54.13 Aligned_cols=35 Identities=29% Similarity=0.389 Sum_probs=16.7
Q ss_pred CCEEEccCCccccccCcCcccCCCCceeeCCCCcC
Q 004218 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNEL 214 (767)
Q Consensus 180 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l 214 (767)
|++|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44444444444433334444445555555555544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.63 E-value=0.031 Score=59.06 Aligned_cols=144 Identities=14% Similarity=0.153 Sum_probs=84.6
Q ss_pred CCccccccceEEEEEEeCC--------CcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCccccee
Q 004218 460 ENLIGSGSFGSVYKGYLRE--------GISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 530 (767)
.+.+..|-...+|+....+ ++.|++|+..... .....-.+|.++++.+. +.-..++++.+. +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~------~-- 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP------E-- 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET------T--
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC------C--
Confidence 3567778888999998763 5789999874322 22223457888887774 222455555421 1
Q ss_pred eEEEEeecCCCChhh-hh----------------cccCC-----CC--CCCCCCHHHHHHHHHHHH--------------
Q 004218 531 LALVYEFLGNGSLGD-WI----------------HGERK-----NE--HGNGLNFLERLNIAIDIA-------------- 572 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~-~l----------------~~~~~-----~~--~~~~l~~~~~~~i~~~i~-------------- 572 (767)
+.||||++|.++.. -+ +.... .. ...+.-+.++.++..++-
T Consensus 146 -~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~ 224 (424)
T 3mes_A 146 -GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKEL 224 (424)
T ss_dssp -EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHH
T ss_pred -CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhcccc
Confidence 78999999865421 00 00000 00 111122444444443322
Q ss_pred -----HHHHHHHh---------------------CCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 573 -----SALDYLHN---------------------DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 573 -----~~l~~LH~---------------------~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
..+..|.+ ..+..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 225 ~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 225 YSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22233321 11346899999999999 7788999999998853
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.89 E-value=0.13 Score=54.24 Aligned_cols=29 Identities=34% Similarity=0.463 Sum_probs=24.8
Q ss_pred CeEeecCCCCCeee------CCCCceEEccccchh
Q 004218 585 PIVHCDLKPGNILL------DEDMTAKVGDFGLAR 613 (767)
Q Consensus 585 ~ivH~Dlkp~NIl~------~~~~~~kl~Dfg~a~ 613 (767)
.++|+|+.+.||++ +++..++++||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36799999999999 456789999999885
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.97 E-value=0.18 Score=33.29 Aligned_cols=17 Identities=18% Similarity=-0.013 Sum_probs=8.0
Q ss_pred HHHHHHHHHHHhHcCCC
Q 004218 413 AGCFLIFWLIIVRKGKA 429 (767)
Q Consensus 413 ~~~~~~~~~~~~r~~~~ 429 (767)
+++++.+|++++|++++
T Consensus 25 ~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 25 LVVALGIGLFMRRRHIV 41 (44)
T ss_dssp HHHHHHHHHHHHTTTCC
T ss_pred HHHHHHHHHHhhhhHhh
Confidence 33444445555555443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.19 E-value=0.55 Score=30.82 Aligned_cols=8 Identities=25% Similarity=0.430 Sum_probs=3.3
Q ss_pred HHHHhHcC
Q 004218 420 WLIIVRKG 427 (767)
Q Consensus 420 ~~~~~r~~ 427 (767)
..+++|++
T Consensus 32 ~~~~RRR~ 39 (44)
T 2jwa_A 32 GILIKRRQ 39 (44)
T ss_dssp HHHHHHHC
T ss_pred Hhheehhh
Confidence 33444443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.06 E-value=0.72 Score=42.92 Aligned_cols=87 Identities=15% Similarity=0.183 Sum_probs=64.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCcc
Q 004218 559 LNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638 (767)
Q Consensus 559 l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~ 638 (767)
.+..++++++.+|+....+++.+ +|--++|+|++++.++.+++.-.|+...+
T Consensus 78 ~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~~~p~i~~RGik~~l----------------------- 129 (215)
T 4ann_A 78 FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRDGLPIAKTRGLQNVV----------------------- 129 (215)
T ss_dssp SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTTSCEEESCCEETTTB-----------------------
T ss_pred cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCCCCEEEEEccCccCC-----------------------
Confidence 78899999999999998777643 78889999999999999999887765321
Q ss_pred CccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCC
Q 004218 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678 (767)
Q Consensus 639 aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 678 (767)
+|. ..++..=.-.+=|++..+++++..|+....+.
T Consensus 130 ~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~ 164 (215)
T 4ann_A 130 DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGN 164 (215)
T ss_dssp SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSC
T ss_pred CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcCh
Confidence 222 11222223457788999999999986654443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.83 E-value=0.92 Score=29.82 Aligned_cols=16 Identities=25% Similarity=0.108 Sum_probs=7.3
Q ss_pred HHHHHHHHHHhHcCCC
Q 004218 414 GCFLIFWLIIVRKGKA 429 (767)
Q Consensus 414 ~~~~~~~~~~~r~~~~ 429 (767)
++++.+|++++|+++.
T Consensus 25 ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 25 IVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHTTCSS
T ss_pred HHHHHHHHHhhhhhhh
Confidence 3334445555554443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.07 E-value=3.5 Score=38.45 Aligned_cols=82 Identities=17% Similarity=0.229 Sum_probs=60.2
Q ss_pred CCHHHHHHHHHHHHHHHH-HHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCc
Q 004218 559 LNFLERLNIAIDIASALD-YLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637 (767)
Q Consensus 559 l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y 637 (767)
.+..++++++.+|+.... +++ .-+|--++|+|++++.++.+++.-.|.-..
T Consensus 82 ~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~----------------------- 133 (219)
T 4ano_A 82 TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPFFLHVGVKES----------------------- 133 (219)
T ss_dssp SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEEESCCEETTT-----------------------
T ss_pred cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEEEEEcCCccc-----------------------
Confidence 788899999999998877 666 447888999999999999999988876532
Q ss_pred cCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 638 IPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 638 ~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
++|.- .++..=.-.+=|++..++.++..|+.
T Consensus 134 lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 134 LPPDE-----WDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 23322 11111233577888888888888744
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 767 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.002 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-13 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-11 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-09 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-07 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 4e-58
Identities = 81/309 (26%), Positives = 125/309 (40%), Gaps = 50/309 (16%)
Query: 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRN 512
G + IGSGSFG+VYKG VAVK+L++ + ++F E LR TRH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
++ + + LA+V ++ SL +H ++ ++IA A
Sbjct: 66 ILLFM------GYSTAPQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTA 114
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
+DYLH I+H DLK NI L ED+T K+GDFGLA S L
Sbjct: 115 QGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK----SRWSGSHQFEQLS 167
Query: 633 GSIGYIPPEYGLGEKP---STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689
GSI ++ PE + S DVY+FG++L E+ TG P + +
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227
Query: 690 PKNAQQV---LDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
+ +V + +++LM C + R + L
Sbjct: 228 SPDLSKVRSNCPKAMKRLMA----------------------ECLKKKRDERPLFPQILA 265
Query: 747 RLKNAQKIL 755
++ + L
Sbjct: 266 SIELLARSL 274
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-54
Identities = 76/319 (23%), Positives = 124/319 (38%), Gaps = 42/319 (13%)
Query: 445 ISYDELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEA 504
++ D + E +G G FG V+ G VA+K L T + ++F E +
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQV 65
Query: 505 LRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER 564
++ RH LV+L S E + +V E++ GSL D++ GE +
Sbjct: 66 MKKLRHEKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGKYL----RLPQL 115
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
+++A IAS + Y+ VH DL+ NIL+ E++ KV DFGLAR + +
Sbjct: 116 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI-----EDNE 167
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684
++ K I + PE L + + DV+SFG++L E+ T + ++
Sbjct: 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQ 226
Query: 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREA 744
VE + L LM C + P R
Sbjct: 227 VERGYRMPCPPECPESLHDLMC----------------------QCWRKEPEERPTFEYL 264
Query: 745 LRRLKNAQKILLKRRQPNE 763
L++ + QP E
Sbjct: 265 QAFLEDYFTSTEPQYQPGE 283
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 6e-54
Identities = 69/295 (23%), Positives = 117/295 (39%), Gaps = 42/295 (14%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVK 515
+G+G FG V+ GY VAVK L S +F AE ++ +H+ LV+
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR 72
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575
L + E + ++ E++ NGSL D++ + L + L++A IA +
Sbjct: 73 LYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGM 122
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
++ +H DL+ NIL+ + ++ K+ DFGLAR + + ++ K I
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI-----EDNEYTAREGAKFPI 174
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQ 695
+ PE + DV+SFG++L EI T + +++ +E +
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGYRMVRPD 233
Query: 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750
EL QLM C E P R L++
Sbjct: 234 NCPEELYQLM----------------------RLCWKERPEDRPTFDYLRSVLED 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (472), Expect = 7e-54
Identities = 75/335 (22%), Positives = 134/335 (40%), Gaps = 58/335 (17%)
Query: 446 SYDELRRATGNFSHE---------NLIGSGSFGSVYKGYLR----EGISVAVKVLDIEST 492
++++ A F+ E +IG+G FG V G+L+ I VA+K L T
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 493 -GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGER 551
+ F +E + H N++ L + + ++ EF+ NGSL ++
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122
Query: 552 KNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611
++ + + IA+ + YL + VH DL NIL++ ++ KV DFGL
Sbjct: 123 GQF-----TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPT 671
+R LE + + +S K I + PE K ++A DV+S+G+++ E+ +
Sbjct: 175 SR-FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233
Query: 672 HESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCT 731
+ + ++ +E ++ L QLM L C
Sbjct: 234 YWDMTNQ-DVINAIEQDYRLPPPMDCPSALHQLM----------------------LDCW 270
Query: 732 TESPGGRIDIREALRRLKNAQKILLKRRQPNE-KA 765
+ R + + L K++ R PN KA
Sbjct: 271 QKDRNHRPKFGQIVNTL---DKMI---RNPNSLKA 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 1e-51
Identities = 68/304 (22%), Positives = 121/304 (39%), Gaps = 30/304 (9%)
Query: 460 ENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEA--LRNTRHRNLVKLI 517
+ IG G FG V++G R G VAVK+ +S+F E E RH N++ I
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 63
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
+ + D L LV ++ +GSL D+++ + +A+ AS L +
Sbjct: 64 AADNK-DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAH 115
Query: 578 LHNDC-----EVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
LH + + I H DLK NIL+ ++ T + D GLA + + I+ H +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-RHDSATDTIDIAPNHRV- 173
Query: 633 GSIGYIPPEYGLGE------KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686
G+ Y+ PE + D+Y+ G++ EI S ++ V
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
S+ + +++ Q + + Q + L + + + C + R+ +
Sbjct: 234 SD--PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK-IMRECWYANGAARLTALRIKK 290
Query: 747 RLKN 750
L
Sbjct: 291 TLSQ 294
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-51
Identities = 53/230 (23%), Positives = 98/230 (42%), Gaps = 23/230 (10%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNL 513
+F + +G+G+ G V+K + G+ +A K++ +E E + L +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
V + S +++ E + GSL + + + ++I +
Sbjct: 67 VGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIK 115
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
L YL I+H D+KP NIL++ K+ DFG++ L S++++ V G
Sbjct: 116 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFV--G 165
Query: 634 SIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK 683
+ Y+ PE G S D++S G+ L+E+ G P A E+ L+
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-51
Identities = 68/296 (22%), Positives = 104/296 (35%), Gaps = 40/296 (13%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTW--KSFFAECEALRNTRHRN 512
++ IG+GS+G K + G + K LD S + +E LR +H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+V+ + L +V E+ G L I K L+ L + +
Sbjct: 65 IVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQY--LDEEFVLRVMTQLT 119
Query: 573 SALDYLH--NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
AL H +D ++H DLKP N+ LD K+GDFGLAR L S
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL------NHDTSFAKA 173
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690
G+ Y+ PE + D++S G +L E+ M P E+ K E F
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFR 232
Query: 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
+ + EL +++ R + E L
Sbjct: 233 RIPYRY-SDELNEIIT----------------------RMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-51
Identities = 69/291 (23%), Positives = 114/291 (39%), Gaps = 43/291 (14%)
Query: 460 ENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKL 516
+ IG GSF +VYKG E + VA L + + F E E L+ +H N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 517 ITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALD 576
S S K + + LV E + +G+L ++ + + + I L
Sbjct: 74 YDSWES-TVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQ 126
Query: 577 YLHNDCEVPIVHCDLKPGNILL-DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
+LH PI+H DLK NI + + K+GD GLA S + G+
Sbjct: 127 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT--------LKRASFAKAVIGTP 177
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQ 695
++ PE EK + DVY+FG+ +LE+ T P E + P + +
Sbjct: 178 EFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236
Query: 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
V E+++++ C ++ R I++ L
Sbjct: 237 VAIPEVKEIIE----------------------GCIRQNKDERYSIKDLLN 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-51
Identities = 74/298 (24%), Positives = 122/298 (40%), Gaps = 46/298 (15%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVK 515
IG G FG V G R G VAVK + ++T ++F AE + RH NLV+
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575
L+ + L +V E++ GSL D++ ++ L L ++D+ A+
Sbjct: 65 LLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAM 116
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
+YL + VH DL N+L+ ED AKV DFGL + S+ K +
Sbjct: 117 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---------SSTQDTGKLPV 164
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQ 695
+ PE +K ST DV+SFG++L EI++ + + +V VE + +A
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMDAPD 223
Query: 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753
+ ++M +C R + +L++ +
Sbjct: 224 GCPPAVYEVMK----------------------NCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-50
Identities = 69/294 (23%), Positives = 115/294 (39%), Gaps = 42/294 (14%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVK 515
+ IGSG FG V+ GY VA+K + + + F E E + H LV+
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQ 64
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575
L C + LV+EF+ +G L D++ L + +D+ +
Sbjct: 65 LYGVCL-----EQAPICLVFEFMEHGCLSDYLR-----TQRGLFAAETLLGMCLDVCEGM 114
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
YL C ++H DL N L+ E+ KV DFG+ R + +S+ K +
Sbjct: 115 AYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-----LDDQYTSSTGTKFPV 166
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQ 695
+ PE + S+ DV+SFGV++ E+F+ +E+ +V+ + + F +
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGFRLYKPR 225
Query: 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749
+ + Q+M C E P R LR+L
Sbjct: 226 LASTHVYQIM----------------------NHCWKERPEDRPAFSRLLRQLA 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-50
Identities = 69/319 (21%), Positives = 121/319 (37%), Gaps = 45/319 (14%)
Query: 449 ELRRATGNFSHENL-IGSGSFGSVYKGYLR---EGISVAVKVLDIEST-GTWKSFFAECE 503
+L N ++ +G G+FGSV +G R + I VA+KVL + + E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 504 ALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLE 563
+ + +V+LI C + L LV E G G L ++ G+R+ +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREE-----IPVSN 110
Query: 564 RLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQS 623
+ ++ + YL VH DL N+LL AK+ DFGL+++L + S
Sbjct: 111 VAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDS 164
Query: 624 SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK 683
++ K + + PE K S+ DV+S+GV + E + ++ G ++
Sbjct: 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMA 223
Query: 684 WVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIRE 743
++E EL LM C R D
Sbjct: 224 FIEQGKRMECPPECPPELYALMS----------------------DCWIYKWEDRPDFLT 261
Query: 744 ALRRLKNAQKILLKRRQPN 762
+R++ L + + +
Sbjct: 262 VEQRMRACYYSLASKVEGH 280
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 5e-49
Identities = 62/295 (21%), Positives = 116/295 (39%), Gaps = 42/295 (14%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVK 515
+ + +G+G FG V G R VA+K++ S F E + + N H LV+
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQ 63
Query: 516 LITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASAL 575
L C+ + ++ E++ NG L +++ R + L + D+ A+
Sbjct: 64 LYGVCTK-----QRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAM 113
Query: 576 DYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSI 635
+YL + +H DL N L+++ KV DFGL+R + +S+ K +
Sbjct: 114 EYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV-----LDDEYTSSVGSKFPV 165
Query: 636 GYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQ 695
+ PPE + K S+ D+++FGV++ EI++ +E F + +
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRLYRPH 224
Query: 696 VLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750
+ ++ +M SC E R + L + +
Sbjct: 225 LASEKVYTIM----------------------YSCWHEKADERPTFKILLSNILD 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-48
Identities = 74/343 (21%), Positives = 127/343 (37%), Gaps = 44/343 (12%)
Query: 432 IGVSTLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLRE----GISVAVKVL 487
I +S L Q + + + ++ +IG G FG VY G L + I AVK L
Sbjct: 4 IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63
Query: 488 D-IESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDW 546
+ I G F E +++ H N++ L+ C + + +V ++ +G L ++
Sbjct: 64 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL----VVLPYMKHGDLRNF 119
Query: 547 IHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKV 606
I E N + + + +A + VH DL N +LDE T KV
Sbjct: 120 IRNETHN-----PTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKV 171
Query: 607 GDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT 666
DFGLAR + + S+ + K + ++ E +K +T DV+SFGV+L E+ T
Sbjct: 172 ADFGLARDMYD--KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229
Query: 667 GMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESV 726
+P + + ++ + L ++M
Sbjct: 230 RGAPPYPDV-NTFDITVYLLQGRRLLQPEYCPDPLYEVM--------------------- 267
Query: 727 GLSCTTESPGGRIDIREALRRLKNAQKILLKRR--QPNEKAMN 767
L C R E + R+ + N +N
Sbjct: 268 -LKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVN 309
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-48
Identities = 69/293 (23%), Positives = 112/293 (38%), Gaps = 49/293 (16%)
Query: 461 NLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITS 519
+G G+FG VYK +E + A KV+D +S + + E + L + H N+VKL+ +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLH 579
L ++ EF G++ + E L + + AL+YLH
Sbjct: 78 F-----YYENNLWILIEFCAGGAVDAVML-----ELERPLTESQIQVVCKQTLDALNYLH 127
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIP 639
+ I+H DLK GNIL D K+ DFG++ +I G+ ++
Sbjct: 128 ---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN------TRTIQRRDSFIGTPYWMA 178
Query: 640 PEYGLGEKP-----STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQ 694
PE + E DV+S G+ L+E+ P HE V L+K +S P AQ
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPPTLAQ 237
Query: 695 -QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
+ + C ++ R + L+
Sbjct: 238 PSRWSSNFKDFLK----------------------KCLEKNVDARWTTSQLLQ 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-48
Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 46/296 (15%)
Query: 460 ENLIGSGSFGSVYKGYLRE---GISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLV 514
+ +GSG+FG+V KGY + +VAVK+L E+ AE ++ + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
++I C E LV E G L ++ R + + + ++
Sbjct: 72 RMIGIC------EAESWMLVMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVSMG 119
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
+ YL VH DL N+LL AK+ DFGL+++L +++ + K
Sbjct: 120 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR---ADENYYKAQTHGKWP 173
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQ 694
+ + PE K S+ DV+SFGV++ E F+ + G + +E
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKGERMGCP 232
Query: 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750
RE+ LM C T R RL+N
Sbjct: 233 AGCPREMYDLMN----------------------LCWTYDVENRPGFAAVELRLRN 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-48
Identities = 65/296 (21%), Positives = 107/296 (36%), Gaps = 53/296 (17%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALRNTRHR 511
+F +G G FG+VY ++ +A+KVL +E G E E + RH
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
N+++L + + L+ E+ G++ + K + ++
Sbjct: 67 NILRLYGYFH-----DATRVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITEL 115
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
A+AL Y H ++H D+KP N+LL K+ DFG + S L
Sbjct: 116 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--------SRRTTL 164
Query: 632 KGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP-THESFAGEVSLVKWVESNFP 690
G++ Y+PPE G D++S GV+ E G P ++ + VE FP
Sbjct: 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 224
Query: 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
+ R L+ +P R +RE L
Sbjct: 225 DF----VTEGARDLIS----------------------RLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (430), Expect = 7e-48
Identities = 64/297 (21%), Positives = 95/297 (31%), Gaps = 54/297 (18%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALRNTRHRN 512
FS IG GSFG+VY VA+K + +S W+ E L+ RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
++ LV E+ + H L +E +
Sbjct: 77 TIQYRGCYL-----REHTAWLVMEYCLGSASDLLEV------HKKPLQEVEIAAVTHGAL 125
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L YLH ++H D+K GNILL E K+GDFG A ++ +
Sbjct: 126 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS----------IMAPANSFV 172
Query: 633 GSIGYIPPEYGLGEKP---STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689
G+ ++ PE L DV+S G+ +E+ P A L ++
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNES 231
Query: 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
P R + SC + P R L+
Sbjct: 232 PALQSGHWSEYFRNFVD----------------------SCLQKIPQDRPTSEVLLK 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (426), Expect = 1e-47
Identities = 72/314 (22%), Positives = 133/314 (42%), Gaps = 42/314 (13%)
Query: 441 SPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFF 499
P +YD+ + + ++ +G G +G VY+G ++ ++VAVK L E T + F
Sbjct: 3 DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFL 61
Query: 500 AECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGL 559
E ++ +H NLV+L+ C+ ++ EF+ G+L D++ + E +
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNRQE----V 112
Query: 560 NFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERI 619
+ + L +A I+SA++YL +H DL N L+ E+ KV DFGL+R +
Sbjct: 113 SAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM---- 165
Query: 620 GNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV 679
+ ++ K I + PE K S DV++FGV+L EI T +
Sbjct: 166 -TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS- 223
Query: 680 SLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI 739
+ + +E ++ + ++ +LM +C +P R
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELM----------------------RACWQWNPSDRP 261
Query: 740 DIREALRRLKNAQK 753
E + + +
Sbjct: 262 SFAEIHQAFETMFQ 275
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-47
Identities = 64/319 (20%), Positives = 118/319 (36%), Gaps = 59/319 (18%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIEST-GTWKSFFAECEALRN- 507
N ++GSG+FG V I VAVK+L ++ ++ +E + +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 508 TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN-------------- 553
H N+V L+ +C+ + L++E+ G L +++ +R+
Sbjct: 98 GSHENIVNLLGACTLSGP-----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 554 ---EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610
E N L F + L A +A +++L VH DL N+L+ K+ DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
LAR ++ S+ + + ++ PE + DV+S+G++L EIF+
Sbjct: 210 LARDIMS----DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 671 THESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSC 730
+ + + K +++ F + E+ +M SC
Sbjct: 266 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIM----------------------QSC 303
Query: 731 TTESPGGRIDIREALRRLK 749
R L
Sbjct: 304 WAFDSRKRPSFPNLTSFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-47
Identities = 69/304 (22%), Positives = 122/304 (40%), Gaps = 45/304 (14%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREG-----ISVAVKVLDIEST-GTWKSFFAECEALRNTR 509
+ + +IG+G FG VYKG L+ + VA+K L T F E +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
H N+++L + + ++ E++ NG+L ++ E + L+ + +
Sbjct: 68 HHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLR-----EKDGEFSVLQLVGMLR 117
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
IA+ + YL N VH DL NIL++ ++ KV DFGL+R L + + + +T
Sbjct: 118 GIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED---DPEATYTTS 171
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689
K I + PE K ++A DV+SFG+++ E+ T + + ++K + F
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGF 230
Query: 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLK 749
+ QLMM C + R + + L
Sbjct: 231 RLPTPMDCPSAIYQLMM----------------------QCWQQERARRPKFADIVSILD 268
Query: 750 NAQK 753
+
Sbjct: 269 KLIR 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 56/294 (19%), Positives = 103/294 (35%), Gaps = 44/294 (14%)
Query: 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRN 512
++ IG G+ G+VY G VA++ ++++ + E +R ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+V + S + L +V E+L GSL D + +E + + +
Sbjct: 79 IVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECL 126
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
AL++LH ++H D+K NILL D + K+ DFG + S +
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI------TPEQSKRSTMV 177
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692
G+ ++ PE + D++S G+M +E+ G P +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
+ L R + C R +E L+
Sbjct: 238 NPEKLSAIFRDFLN----------------------RCLDMDVEKRGSAKELLQ 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 3e-47
Identities = 72/322 (22%), Positives = 127/322 (39%), Gaps = 57/322 (17%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREG---ISVAVKVLD-IESTGTWKSFFAECEALRN-TRH 510
+ +++IG G+FG V K +++ + A+K + S + F E E L H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK----------NEHGNGLN 560
N++ L+ +C ++ +L L E+ +G+L D++ R N + L+
Sbjct: 71 PNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 561 FLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIG 620
+ L+ A D+A +DYL + +H DL NIL+ E+ AK+ DFGL+R
Sbjct: 126 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG------ 176
Query: 621 NQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS 680
Q + + + ++ E +T DV+S+GV+L EI + +
Sbjct: 177 -QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAE 234
Query: 681 LVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID 740
L + + + D E+ LM C E P R
Sbjct: 235 LYEKLPQGYRLEKPLNCDDEVYDLM----------------------RQCWREKPYERPS 272
Query: 741 IREALRRLKNAQKILLKRRQPN 762
+ L L +L+ R+
Sbjct: 273 FAQILVSLNR----MLEERKTY 290
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-47
Identities = 64/295 (21%), Positives = 108/295 (36%), Gaps = 43/295 (14%)
Query: 455 GNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE-STGTWKSFFAECEALRNTRHRN 512
++ +G G++G V R +VAVK++D++ + ++ E + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+VK + L E+ G L D I + G+ + +
Sbjct: 65 VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLM 113
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
+ + YLH I H D+KP N+LLDE K+ DFGLA R N+ + +
Sbjct: 114 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMC-- 166
Query: 633 GSIGYIPPEYGLGEKPST-AGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691
G++ Y+ PE + DV+S G++L + G P + W E
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226
Query: 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
N + +D L+ E+P RI I + +
Sbjct: 227 NPWKKIDSAPLALLH----------------------KILVENPSARITIPDIKK 259
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 8e-47
Identities = 74/330 (22%), Positives = 122/330 (36%), Gaps = 60/330 (18%)
Query: 446 SYDELRRATGNFSHENLIGSGSFGSVYKGYLREGIS------VAVKVLDIE-STGTWKSF 498
L N + IG G+FG V++ + VAVK+L E S F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 499 FAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN----- 553
E + + N+VKL+ C + + L++E++ G L +++ +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 554 -------------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE 600
L+ E+L IA +A+ + YL E VH DL N L+ E
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGE 175
Query: 601 DMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVM 660
+M K+ DFGL+R++ + I ++PPE + +T DV+++GV+
Sbjct: 176 NMVVKIADFGLSRNIYS----ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 231
Query: 661 LLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLI 720
L EIF+ + A E + + N + EL LM
Sbjct: 232 LWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENC-PLELYNLM--------------- 275
Query: 721 TIIESVGLSCTTESPGGRIDIREALRRLKN 750
C ++ P R R L+
Sbjct: 276 -------RLCWSKLPADRPSFCSIHRILQR 298
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-46
Identities = 59/314 (18%), Positives = 121/314 (38%), Gaps = 54/314 (17%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIEST-GTWKSFFAECEALRN- 507
S +G+G+FG V + ++VAVK+L + ++ +E + L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 508 TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN------------EH 555
H N+V L+ +C+ ++ E+ G L +++ +R + +
Sbjct: 84 GNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 556 GNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615
L+ + L+ + +A + +L + +H DL NILL K+ DFGLAR +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675
N S+ + + ++ PE + DV+S+G+ L E+F+ S +
Sbjct: 196 ----KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 676 AGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESP 735
+ K ++ F + + E+ +M +C P
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIM----------------------KTCWDADP 289
Query: 736 GGRIDIREALRRLK 749
R ++ ++ ++
Sbjct: 290 LKRPTFKQIVQLIE 303
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-46
Identities = 69/304 (22%), Positives = 104/304 (34%), Gaps = 46/304 (15%)
Query: 456 NFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLD---IESTGTWKSFFAECEALRNT 508
+ +G GSFG V +G + +SVAVK L + F E A+ +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 509 RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568
HRNL++L + + +V E GSL D + + + A
Sbjct: 69 DHRNLIRLYGVVLT------PPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRYA 117
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+ +A + YL + +H DL N+LL K+GDFGL R+L + N
Sbjct: 118 VQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ---NDDHYVMQ 171
Query: 629 HVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688
K + PE S A D + FGV L E+FT G L K +
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231
Query: 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748
+ +++ +M + C P R L
Sbjct: 232 ERLPRPEDCPQDIYNVM----------------------VQCWAHKPEDRPTFVALRDFL 269
Query: 749 KNAQ 752
AQ
Sbjct: 270 LEAQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 163 bits (414), Expect = 3e-45
Identities = 63/295 (21%), Positives = 113/295 (38%), Gaps = 46/295 (15%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLV 514
++ +G+G+FG V++ R G + A K + ++ E + + RH LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
L + F++ + ++YEF+ G L + + E N ++ E + +
Sbjct: 87 NLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKG 136
Query: 575 LDYLHNDCEVPIVHCDLKPGNILL--DEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L ++H + VH DLKP NI+ K+ DFGL L S V
Sbjct: 137 LCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-------DPKQSVKVTT 186
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP-THESFAGEVSLVKWVESNFPK 691
G+ + PE G+ D++S GV+ + +G+SP E+ + VK + N
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 246
Query: 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
+A + + + + P R+ I +AL
Sbjct: 247 SAFSGISEDGKDFIR----------------------KLLLADPNTRMTIHQALE 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 64/313 (20%), Positives = 115/313 (36%), Gaps = 47/313 (15%)
Query: 457 FSHENLIGSGSFGSVYKGYLRE-----GISVAVKVL-DIESTGTWKSFFAECEALRNTRH 510
F ++GSG+FG+VYKG I VA+K L + S K E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
++ +L+ C + + L+ + + G L D++ EH + + LN +
Sbjct: 71 PHVCRLLGICLT------STVQLITQLMPFGCLLDYVR-----EHKDNIGSQYLLNWCVQ 119
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
IA ++YL + +VH DL N+L+ K+ DFGLA+ L G +
Sbjct: 120 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEG 172
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690
K I ++ E L + DV+S+GV + E+ T S ++ + +E
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGER 231
Query: 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750
+ ++ +M+ C R RE +
Sbjct: 232 LPQPPICTIDVYMIMV----------------------KCWMIDADSRPKFRELIIEFSK 269
Query: 751 AQKILLKRRQPNE 763
+ +
Sbjct: 270 MARDPQRYLVIQG 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-44
Identities = 60/262 (22%), Positives = 107/262 (40%), Gaps = 27/262 (10%)
Query: 451 RRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALR 506
++ +F ++G GSF +V A+K+L+ I E + +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 507 NTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLN 566
H VKL + F++ E L + NG L +I +
Sbjct: 64 RLDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYIR------KIGSFDETCTRF 112
Query: 567 IAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSIS 626
+I SAL+YLH I+H DLKP NILL+EDM ++ DFG A+ + +S +
Sbjct: 113 YTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK----VLSPESKQA 165
Query: 627 STHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP-THESFAGEVSLVKWV 685
+ G+ Y+ PE + + D+++ G ++ ++ G+ P + + +
Sbjct: 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 225
Query: 686 ESNFPKNAQQVLDRELRQLMMS 707
E +FP+ + R L+
Sbjct: 226 EYDFPEK----FFPKARDLVEK 243
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-43
Identities = 63/312 (20%), Positives = 109/312 (34%), Gaps = 49/312 (15%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIEST-GTWKSFFAECEALRNT 508
+G G+FG V + +VAVK+L +T ++ +E + L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 509 RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK----------NEHGNG 558
H V + K L ++ EF G+L ++ +R + + +
Sbjct: 74 GHHLNVVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 559 LNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLER 618
L + + +A +++L +H DL NILL E K+ DFGLAR +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI--- 184
Query: 619 IGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE 678
+ + ++ PE + DV+SFGV+L EIF+ + + +
Sbjct: 185 -YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 679 VSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGR 738
+ ++ A E+ Q M L C P R
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQTM----------------------LDCWHGEPSQR 281
Query: 739 IDIREALRRLKN 750
E + L N
Sbjct: 282 PTFSELVEHLGN 293
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 67/306 (21%), Positives = 112/306 (36%), Gaps = 46/306 (15%)
Query: 456 NFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLD-IESTGTWKSFFAECEALRNT 508
+ +G GSFG VY+G + VA+K ++ S F E ++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 509 RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNG----LNFLER 564
++V+L+ S + ++ E + G L ++ R N + +
Sbjct: 81 NCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
+ +A +IA + YL+ + VH DL N ++ ED T K+GDFG+ R I
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDY 188
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW 684
+ ++ PE +T DV+SFGV+L EI T ++ + E L
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 685 VESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREA 744
+E D L +LM C +P R E
Sbjct: 249 MEGGLLDKPDNCPD-MLFELM----------------------RMCWQYNPKMRPSFLEI 285
Query: 745 LRRLKN 750
+ +K
Sbjct: 286 ISSIKE 291
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 155 bits (392), Expect = 3e-42
Identities = 61/289 (21%), Positives = 109/289 (37%), Gaps = 46/289 (15%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSC 520
+GSG+FG V++ + G K ++ + E + H L+ L +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 94
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN 580
F++ + L+ EFL G L D I ++ E +N L ++H
Sbjct: 95 ----FEDKYEMVLILEFLSGGELFDRIA-----AEDYKMSEAEVINYMRQACEGLKHMH- 144
Query: 581 DCEVPIVHCDLKPGNILLD--EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
E IVH D+KP NI+ + + + K+ DFGLA L + V + +
Sbjct: 145 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-------NPDEIVKVTTATAEFA 195
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP-THESFAGEVSLVKWVESNFPKNAQQVL 697
PE E D+++ GV+ + +G+SP E + VK + F ++A +
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 698 DRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
E + + + + P R+ + +AL
Sbjct: 256 SPEAKDFIK----------------------NLLQKEPRKRLTVHDALE 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (383), Expect = 7e-42
Identities = 67/305 (21%), Positives = 123/305 (40%), Gaps = 42/305 (13%)
Query: 454 TGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLD---IESTGTWKSFFAECEALRNTR 509
+ + ++G G V+ LR VAVKVL + F E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 510 HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAI 569
H +V + + + + +V E++ +L D +H E + + +
Sbjct: 66 HPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGP------MTPKRAIEVIA 118
Query: 570 DIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTH 629
D AL++ + I+H D+KP NI++ KV DFG+AR++ + + +S++ T
Sbjct: 119 DACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD---SGNSVTQTA 172
Query: 630 VLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689
+ G+ Y+ PE G+ DVYS G +L E+ TG P F G+
Sbjct: 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD----------- 217
Query: 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI----DIREAL 745
+ V + +R+ + ++ L L ++ ++P R ++R L
Sbjct: 218 --SPVSVAYQHVREDPIPPSARHEGLSADLDAVVL----KALAKNPENRYQTAAEMRADL 271
Query: 746 RRLKN 750
R+ N
Sbjct: 272 VRVHN 276
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-42
Identities = 62/296 (20%), Positives = 104/296 (35%), Gaps = 47/296 (15%)
Query: 460 ENLIGSGSFGSVYKGYLR----EGISVAVKVLD-IESTGTWKSFFAECEALRNTRHRNLV 514
IG G FG V++G ++VA+K S + F E +R H ++V
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
KLI + + ++ E G L ++ L+ + A +++A
Sbjct: 72 KLIGVITE------NPVWIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTA 120
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
L YL + VH D+ N+L+ + K+GDFGL+R + S+ K
Sbjct: 121 LAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLP 172
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQ 694
I ++ PE + ++A DV+ FGV + EI + ++ +E+
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERLPMP 231
Query: 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750
L LM C P R E +L
Sbjct: 232 PNCPPTLYSLMT----------------------KCWAYDPSRRPRFTELKAQLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 9e-41
Identities = 66/315 (20%), Positives = 116/315 (36%), Gaps = 55/315 (17%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE--------GISVAVKVLDIEST-GTWKSFFAECEALR 506
+G G+FG V VAVK+L ++T +E E ++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 507 N-TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERK----------NEH 555
+H+N++ L+ +C+ L ++ E+ G+L +++ R +
Sbjct: 74 MIGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 556 GNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615
L+ + ++ A +A ++YL +H DL N+L+ ED K+ DFGLAR
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR-- 183
Query: 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESF 675
I + T + + ++ PE + DV+SFGV+L EIFT +
Sbjct: 184 --DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 676 AGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESP 735
E L K ++ + EL +M C P
Sbjct: 242 PVE-ELFKLLKEGHRMDKPSNCTNELYMMM----------------------RDCWHAVP 278
Query: 736 GGRIDIREALRRLKN 750
R ++ + L
Sbjct: 279 SQRPTFKQLVEDLDR 293
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-40
Identities = 63/289 (21%), Positives = 112/289 (38%), Gaps = 47/289 (16%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSC 520
+G G FG V++ + K + ++ T E L RHRN++ L S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHES- 69
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN 580
F++ME L +++EF+ + + I+ LN E ++ + AL +LH
Sbjct: 70 ----FESMEELVMIFEFISGLDIFERIN-----TSAFELNEREIVSYVHQVCEALQFLH- 119
Query: 581 DCEVPIVHCDLKPGNILLD--EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYI 638
I H D++P NI+ T K+ +FG AR L + +L + Y
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-------KPGDNFRLLFTAPEYY 170
Query: 639 PPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP-THESFAGEVSLVKWVESNFPKNAQQVL 697
PE + STA D++S G ++ + +G++P E+ + + E F + A + +
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230
Query: 698 DRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
E + + R+ EAL+
Sbjct: 231 SIEAMDFVD----------------------RLLVKERKSRMTASEALQ 257
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-39
Identities = 70/309 (22%), Positives = 126/309 (40%), Gaps = 25/309 (8%)
Query: 452 RATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES--TGTWKSFFAECEALRNT 508
+ IG G+FG V+K R+ G VA+K + +E+ G + E + L+
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 509 RHRNLVKLITSCSSLDFKNMEF---LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERL 565
+H N+V LI C + + LV++F + G + K E
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIK 120
Query: 566 NIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSI 625
+ + L+ L+ I+H D+K N+L+ D K+ DFGLAR+ + S
Sbjct: 121 RVMQML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF--SLAKNSQP 175
Query: 626 SSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTH-ESFAGEVSLVK 683
+ ++ Y PPE LGE+ D++ G ++ E++T + +++L+
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235
Query: 684 WVESNF-PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGL-----SCTTESPGG 737
+ + P+ V + EL + + + Q ++ D L + P
Sbjct: 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 295
Query: 738 RIDIREALR 746
RID +AL
Sbjct: 296 RIDSDDALN 304
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (366), Expect = 2e-39
Identities = 63/309 (20%), Positives = 110/309 (35%), Gaps = 61/309 (19%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTW---------KSFFAECEAL 505
N+ + ++G G V + + AVK++D+ G++ ++ E + L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 506 RNTR-HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER 564
R H N+++L ++ F LV++ + G L D++ + L+ E
Sbjct: 64 RKVSGHPNIIQLKD-----TYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKET 112
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
I + + LH ++ IVH DLKP NILLD+DM K+ DFG + L
Sbjct: 113 RKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-------DP 162
Query: 625 ISSTHVLKGSIGYIPPEYGLGE------KPSTAGDVYSFGVMLLEIFTGMSP-THESFAG 677
+ G+ Y+ PE D++S GV++ + G P H
Sbjct: 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222
Query: 678 EVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGG 737
+ ++ F ++ L+ P
Sbjct: 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVS----------------------RFLVVQPQK 260
Query: 738 RIDIREALR 746
R EAL
Sbjct: 261 RYTAEEALA 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-39
Identities = 62/302 (20%), Positives = 117/302 (38%), Gaps = 23/302 (7%)
Query: 454 TGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD-IESTGTWKSFFAECEALRNTRHR 511
+++ + IG G++G V Y + VA+K + E + E + L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
N++ + + + M+ + LV +G L + + + I
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQHLSND-------HICYFLYQI 118
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
L Y+H ++H DLKP N+LL+ K+ DFGLAR +
Sbjct: 119 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP---DHDHTGFLTEY 172
Query: 632 KGSIGYIPPEYGLGEKPST-AGDVYSFGVMLLEIFTGMSPTHESFAGEV--SLVKWVESN 688
+ Y PE L K T + D++S G +L E+ + + ++ + S
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232
Query: 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGL----SCTTESPGGRIDIREA 744
++ +++ + R ++S + + L +S L T +P RI++ +A
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
Query: 745 LR 746
L
Sbjct: 293 LA 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (367), Expect = 8e-39
Identities = 58/260 (22%), Positives = 95/260 (36%), Gaps = 30/260 (11%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGT------WKSFFAECEALRNT 508
+FS +IG G FG VY + G A+K LD + + +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 509 RHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568
+V + + F + L+ + + + G L + + A
Sbjct: 65 DCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSE------ADMRFYA 113
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISST 628
+I L+++HN +V+ DLKP NILLDE ++ D GLA S
Sbjct: 114 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF--------SKKKP 162
Query: 629 HVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687
H G+ GY+ PE ++ D +S G ML ++ G SP + + + +
Sbjct: 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 222
Query: 688 NFPKNAQQVLDRELRQLMMS 707
ELR L+
Sbjct: 223 TMAVELPDSFSPELRSLLEG 242
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 1e-38
Identities = 56/290 (19%), Positives = 102/290 (35%), Gaps = 43/290 (14%)
Query: 460 ENLIGSGSFGSVYKGYLRE-GISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLI 517
+++G+G+F V + VA+K + ++ G S E L +H N+V L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
+++ L L+ + + G L D I + + + + A+ Y
Sbjct: 74 DI-----YESGGHLYLIMQLVSGGELFDRIVEKGF------YTERDASRLIFQVLDAVKY 122
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
LH+ V LDED + DFGL++ + S+ ST G+ GY
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-----DPGSVLSTAC--GTPGY 175
Query: 638 IPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-SLVKWVESNFPKNAQQV 696
+ PE + S A D +S GV+ + G P ++ ++ + E F
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 697 LDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
+ + + + P R +AL+
Sbjct: 236 ISDSAKDFIR----------------------HLMEKDPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 4e-38
Identities = 68/259 (26%), Positives = 108/259 (41%), Gaps = 32/259 (12%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGT---WKSFFAECEALRNT-RH 510
+F ++G GSFG V+ ++ A+K L + + E L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
L + + + E L V E+L G L I K + A +
Sbjct: 63 PFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAE 111
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHV 630
I L +L IV+ DLK NILLD+D K+ DFG+ + N + T+
Sbjct: 112 IILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE------NMLGDAKTNT 162
Query: 631 LKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGE--VSLVKWVESN 688
G+ YI PE LG+K + + D +SFGV+L E+ G SP F G+ L + +
Sbjct: 163 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRMD 218
Query: 689 FPKNAQQVLDRELRQLMMS 707
P + + ++E + L++
Sbjct: 219 NPFYPRWL-EKEAKDLLVK 236
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 6e-38
Identities = 73/304 (24%), Positives = 117/304 (38%), Gaps = 24/304 (7%)
Query: 452 RATGNFSHENLIGSGSFGSVYKGYLRE--GISVAVKVLDIEST--GTWKSFFAECEALR- 506
RA + IG G++G V+K + G VA+K + +++ G S E LR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 507 --NTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLER 564
H N+V+L C+ L LV+E + G+
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTETI 118
Query: 565 LNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSS 624
++ + LD+LH+ +VH DLKP NIL+ K+ DFGLAR S
Sbjct: 119 KDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY-------SF 168
Query: 625 ISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP-THESFAGEVSLVK 683
+ + ++ Y PE L +T D++S G + E+F S ++ +
Sbjct: 169 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228
Query: 684 WVESNFPKNAQQVLDRELRQLMMSSESQTI-QLHDCLITIIESVGLSCTTESPGGRIDIR 742
V + RQ S +Q I + + + + + L C T +P RI
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
Query: 743 EALR 746
AL
Sbjct: 289 SALS 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 70/308 (22%), Positives = 119/308 (38%), Gaps = 33/308 (10%)
Query: 451 RRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTR 509
R +++ +IG+GSFG VY+ L + G VA+K + + + E + +R
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLD 71
Query: 510 HRNLVKLITSC-SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568
H N+V+L SS + K+ +L LV +++ H R + L +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---LPVIYVKLYM 128
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLDED-MTAKVGDFGLARSLLERIGNQSSISS 627
+ +L Y+H I H D+KP N+LLD D K+ DFG A+ L+ N S I S
Sbjct: 129 YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 628 THVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEV------S 680
+ Y PE G +++ DV+S G +L E+ G +
Sbjct: 186 RY-------YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 681 LVKWVESNFPKNAQQVLDRELRQLMMSSESQTI--QLHDCLITIIESVGLSCTTESPGGR 738
L + + + Q+ ++ + I + +P R
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS----RLLEYTPTAR 294
Query: 739 IDIREALR 746
+ EA
Sbjct: 295 LTPLEACA 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (353), Expect = 2e-37
Identities = 58/257 (22%), Positives = 106/257 (41%), Gaps = 32/257 (12%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWK---SFFAECEALRNTRHR 511
+F +G+GSFG V+ R G A+KVL E K E L H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
++++ + + + + ++ +++ G L + A ++
Sbjct: 65 FIIRMWGTFQ-----DAQQIFMIMDYIEGGELFSLLR------KSQRFPNPVAKFYAAEV 113
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
AL+YLH I++ DLKP NILLD++ K+ DFG A+ + + + L
Sbjct: 114 CLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---------YTL 161
Query: 632 KGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP-THESFAGEVSLVKWVESNFP 690
G+ YI PE + + + D +SFG+++ E+ G +P + + E FP
Sbjct: 162 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP 221
Query: 691 KNAQQVLDRELRQLMMS 707
+ +++ L+
Sbjct: 222 PF----FNEDVKDLLSR 234
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 8e-37
Identities = 60/297 (20%), Positives = 107/297 (36%), Gaps = 52/297 (17%)
Query: 460 ENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEAL-RNTRHRNLVKLI 517
++G G G V + + + A+K+L E E R ++ ++V+++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71
Query: 518 TSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
+L + L +V E L G L I ++ E I I A+ Y
Sbjct: 72 DVYENLYAGR-KCLLIVMECLDGGELFSRI----QDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 578 LHNDCEVPIVHCDLKPGNILLD---EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
LH + I H D+KP N+L + K+ DFG A+ +S +S +
Sbjct: 127 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-------TSHNSLTTPCYT 176
Query: 635 IGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP-----THESFAGEVSLVKWVESNF 689
Y+ PE EK + D++S GV++ + G P G + ++ + F
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236
Query: 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746
P + E++ L+ + P R+ I E +
Sbjct: 237 PNPEWSEVSEEVKMLIR----------------------NLLKTEPTQRMTITEFMN 271
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (343), Expect = 2e-36
Identities = 64/298 (21%), Positives = 113/298 (37%), Gaps = 27/298 (9%)
Query: 456 NFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNL 513
+ IG G++G VYK G + A+K + +E G + E L+ +H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
VKL + L LV+E L E GL + + + + +
Sbjct: 63 VKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLN 111
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKG 633
+ Y H + ++H DLKP N+L++ + K+ DFGLAR+ +
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF------GIPVRKYTHEIV 162
Query: 634 SIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSP-THESFAGEVSLVKWVESNFPK 691
++ Y P+ +G K ST D++S G + E+ G S A ++ + +
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222
Query: 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVG---LSCTTESPGGRIDIREALR 746
+ + + + + L + ES P RI ++AL
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 9e-36
Identities = 67/330 (20%), Positives = 114/330 (34%), Gaps = 68/330 (20%)
Query: 457 FSHENL---------IGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTW------KSFFA 500
F EN+ +GSG F V K + G+ A K + T + +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 501 ECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLN 560
E L+ +H N++ L ++N + L+ E + G L D++ L
Sbjct: 63 EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLA------EKESLT 111
Query: 561 FLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTA----KVGDFGLARSLL 616
E I + + YLH+ I H DLKP NI+L + K+ DFGLA +
Sbjct: 112 EEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI- 167
Query: 617 ERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFA 676
+ + G+ ++ PE E D++S GV+ + +G SP
Sbjct: 168 ------DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
Query: 677 GEV-SLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESP 735
E + V V F + + + P
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIR----------------------RLLVKDP 259
Query: 736 GGRIDIREALR----RLKNAQKILLKRRQP 761
R+ I+++L+ + K+ Q+ L
Sbjct: 260 KKRMTIQDSLQHPWIKPKDTQQALSSAWSH 289
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 61/296 (20%), Positives = 107/296 (36%), Gaps = 30/296 (10%)
Query: 461 NLIGSGSFGSVYKGYLRE-GISVAVKVLDIEST-----GTWKSFFAECEALRNTRHRNLV 514
+ +G G F +VYK + VA+K + + G ++ E + L+ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 515 KLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASA 574
L+ + + ++LV++F+ + L +
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVIIKD------NSLVLTPSHIKAYMLMTLQG 112
Query: 575 LDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGS 634
L+YLH I+H DLKP N+LLDE+ K+ DFGLA+S S + +
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF------GSPNRAYTHQVVT 163
Query: 635 IGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA 693
Y PE G + D+++ G +L E+ + + + P
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
Query: 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVG---LSCTTESPGGRIDIREALR 746
Q L + I LH + + +P RI +AL+
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (334), Expect = 4e-35
Identities = 55/266 (20%), Positives = 92/266 (34%), Gaps = 25/266 (9%)
Query: 452 RATGNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRH 510
R + IGSGSFG +Y G + G VA+K+ +++ E + + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQG 61
Query: 511 RNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAID 570
+ I C ++ +V E LG + RK + L +A
Sbjct: 62 GVGIPTIRWC----GAEGDYNVMVMELLGPSLEDLFNFCSRK------FSLKTVLLLADQ 111
Query: 571 IASALDYLHNDCEVPIVHCDLKPGNIL---LDEDMTAKVGDFGLARSLLE-RIGNQSSIS 626
+ S ++Y+H +H D+KP N L + + DFGLA+ + R
Sbjct: 112 MISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168
Query: 627 STHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS--LVKW 684
L G+ Y LG + S D+ S G +L+ G P A +
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228
Query: 685 VESNFPKNAQQV---LDRELRQLMMS 707
E + + E +
Sbjct: 229 SEKKMSTPIEVLCKGYPSEFATYLNF 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 67/298 (22%), Positives = 107/298 (35%), Gaps = 25/298 (8%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVL--DIESTGTWKSFFAECEALRNTRHRN 512
NF IG G++G VYK + G VA+K + D E+ G + E L+ H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+VKL+ L LV+EFL G+ + +
Sbjct: 63 IVKLLDVI-----HTENKLYLVFEFLHQDLKKFM-----DASALTGIPLPLIKSYLFQLL 112
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L + H+ ++H DLKP N+L++ + K+ DFGLAR+ + TH +
Sbjct: 113 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV 164
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKN 692
P + STA D++S G + E+ T + + + P
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224
Query: 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLS----CTTESPGGRIDIREALR 746
+ S Q ++ ++ G S P RI + AL
Sbjct: 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 131 bits (329), Expect = 2e-34
Identities = 45/265 (16%), Positives = 85/265 (32%), Gaps = 27/265 (10%)
Query: 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNL 513
++ IG GSFG +++G L VA+K S E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 514 VKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIAS 573
+ + + LV + LG + + G + A + +
Sbjct: 63 IPNVYYF----GQEGLHNVLVIDLLG------PSLEDLLDLCGRKFSVKTVAMAAKQMLA 112
Query: 574 ALDYLHNDCEVPIVHCDLKPGNILLDEDMT-----AKVGDFGLARSLLERIGNQSSIS-S 627
+ +H E +V+ D+KP N L+ + V DFG+ + + + Q
Sbjct: 113 RVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 628 THVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTG-MSPTHESFAGEVSLVKWV- 685
L G+ Y+ LG + S D+ + G + + G + A + +
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
Query: 686 ---ESNFPKNAQQVLDRELRQLMMS 707
+S + E + M
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHY 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 60/257 (23%), Positives = 97/257 (37%), Gaps = 29/257 (11%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IESTGTWKSFFAECEALRNTRHR 511
+F + L+G G+FG V + G A+K+L I + E L+NTRH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 512 NLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDI 571
L L + + + L V E+ G L + +I
Sbjct: 66 FLTALKYAF-----QTHDRLCFVMEYANGGELFFHLS------RERVFTEERARFYGAEI 114
Query: 572 ASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVL 631
SAL +V+ D+K N++LD+D K+ DFGL + S ++
Sbjct: 115 VSAL---EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG------ISDGATMKTF 165
Query: 632 KGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP-THESFAGEVSLVKWVESNFP 690
G+ Y+ PE A D + GV++ E+ G P ++ L+ E FP
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 225
Query: 691 KNAQQVLDRELRQLMMS 707
+ L E + L+
Sbjct: 226 RT----LSPEAKSLLAG 238
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (318), Expect = 2e-32
Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 38/277 (13%)
Query: 435 STLFKHSPQMISYDELRRATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLD---IE 490
T +++ Q+ +D ++ +G+GSFG V +E G A+K+LD +
Sbjct: 31 ETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 491 STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGE 550
+ E L+ LVKL S K+ L +V E++ G + +
Sbjct: 81 KLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 551 RKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610
+ + A I +YLH + +++ DLKP N+L+D+ +V DFG
Sbjct: 136 GR------FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
A+ T L G+ + PE L + + A D ++ GV++ E+ G P
Sbjct: 187 FAK---------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 671 -THESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMM 706
+ + + FP + L LR L+
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 6e-32
Identities = 49/255 (19%), Positives = 94/255 (36%), Gaps = 39/255 (15%)
Query: 462 LIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTW------KSFFAECEALR--NTRHRN 512
L+GSG FGSVY G + + + VA+K ++ + W E L+ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+++L+ + + L+ E ER L + +
Sbjct: 71 VIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVL 120
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDED-MTAKVGDFGLARSLLERIGNQSSISSTHVL 631
A+ + ++H D+K NIL+D + K+ DFG L + +
Sbjct: 121 EAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--------TVYTDF 169
Query: 632 KGSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKW---VES 687
G+ Y PPE+ + + V+S G++L ++ G P F + +++
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQ 225
Query: 688 NFPKNAQQVLDRELR 702
Q ++ L
Sbjct: 226 RVSSECQHLIRWCLA 240
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 6e-31
Identities = 54/299 (18%), Positives = 107/299 (35%), Gaps = 27/299 (9%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE--STGTWKSFFAECEALRNTRHRN 512
+ IG G++G+V+K RE VA+K + ++ G S E L+ +H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+V+L S + V+EF + + + +
Sbjct: 63 IVRLHDVLHSDKKLTL-----VFEFCDQDLKKYFDSCNGDLDP------EIVKSFLFQLL 111
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L + H+ ++H DLKP N+L++ + K+ +FGLAR+ + +
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVV 163
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP--THESFAGEVSLVKWVESNFP 690
P + ST+ D++S G + E+ P ++ + +
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223
Query: 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVG---LSCTTESPGGRIDIREALR 746
+ + + T L + + + + + +P RI EAL+
Sbjct: 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-30
Identities = 69/305 (22%), Positives = 115/305 (37%), Gaps = 39/305 (12%)
Query: 457 FSHENLIGSGSFGSVYKGY-LREGISVAVKVL--DIESTGTWKSFFAECEALRNTRHRNL 513
+ +GSG++G+V R G VA+K L +S K + E L++ RH N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 514 VKLITSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
+ L+ + + + LV F+G G + E+ E + +
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDL-GKLMKHEKLGED-------RIQFLVYQML 131
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L Y+H I+H DLKPGN+ ++ED K+ DFGLAR S + +V
Sbjct: 132 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-------DSEMTGYV-- 179
Query: 633 GSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSP-THESFAGEVSLVKWVESNFP 690
+ Y PE L + D++S G ++ E+ TG + ++ + V P
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 691 KNAQQVLDRELRQLMMSS---------ESQTIQLHDCLITIIESVGLSCTTESPGGRIDI 741
Q L + + M S + ++E R+
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE----KMLVLDAEQRVTA 295
Query: 742 REALR 746
EAL
Sbjct: 296 GEALA 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-29
Identities = 57/300 (19%), Positives = 113/300 (37%), Gaps = 27/300 (9%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE-GISVAVKVL--DIESTGTWKSFFAECEALRNTRHRN 512
+ + + +GSG++GSV + + G+ VAVK L +S K + E L++ +H N
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 513 LVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIA 572
++ L+ + + L L + + ++ + + I
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-------HVQFLIYQIL 131
Query: 573 SALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLK 632
L Y+H+ I+H DLKP N+ ++ED K+ DFGLA + T +
Sbjct: 132 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA--------RHTDDEMTGYVA 180
Query: 633 GSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP-THESFAGEVSLVKWVESNFPK 691
P + D++S G ++ E+ TG + ++ L+ +
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240
Query: 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGL-----SCTTESPGGRIDIREALR 746
+ + E + + S +Q +++ + I + RI +AL
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 2e-28
Identities = 64/310 (20%), Positives = 112/310 (36%), Gaps = 48/310 (15%)
Query: 462 LIGSGSFGSVYKGYLRE-GISVAVKVL--DIESTGTWKSFFAECEALRNTRHRNLVKLIT 518
IGSG+ G V Y +VA+K L ++ K + E ++ H+N++ L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 519 SCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDY 577
+ + + + LV E + I E +E + + + +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLC-QVIQMELDHE--------RMSYLLYQMLCGIKH 134
Query: 578 LHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGY 637
LH+ I+H DLKP NI++ D T K+ DFGLAR+ + + Y
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMMTPYVVTRYY 184
Query: 638 IPPEYGLGEKPSTAGDVYSFGVMLLEIFTG--------------------MSPTHESFAG 677
PE LG D++S G ++ E+ +P E
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 678 EVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDC-LITIIESVGLSCTTESPG 736
V+ N PK A + + ++S+ +L ++ P
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS----KMLVIDPA 300
Query: 737 GRIDIREALR 746
RI + +AL+
Sbjct: 301 KRISVDDALQ 310
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 4e-28
Identities = 52/263 (19%), Positives = 102/263 (38%), Gaps = 29/263 (11%)
Query: 456 NFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLD----IESTGTWKSFFAECEALRN 507
NF ++G+G++G V+ G A+KVL ++ T + E + L +
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 508 TRHRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI 567
R + + F+ L L+ +++ G L + + +
Sbjct: 85 IRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRER---------FTEHEV 131
Query: 568 AIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISS 627
I + + L + ++ I++ D+K NILLD + + DFGL++ + +
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER----- 186
Query: 628 THVLKGSIGYIPPEYGLG--EKPSTAGDVYSFGVMLLEIFTGMSP-THESFAGEVSLVKW 684
+ G+I Y+ P+ G A D +S GV++ E+ TG SP T + + +
Sbjct: 187 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246
Query: 685 VESNFPKNAQQVLDRELRQLMMS 707
Q + + L+
Sbjct: 247 RILKSEPPYPQEMSALAKDLIQR 269
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (283), Expect = 6e-28
Identities = 51/239 (21%), Positives = 84/239 (35%), Gaps = 32/239 (13%)
Query: 439 KHSPQMISYDELRRATGN---FSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGT 494
+ Y+ GN + +G G + V++ V VK+L
Sbjct: 16 HRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-- 73
Query: 495 WKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKN 553
K E + L N R N++ L + ALV+E + N
Sbjct: 74 -KKIKREIKILENLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQ----- 124
Query: 554 EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD-EDMTAKVGDFGLA 612
L + +I ALDY H+ I+H D+KP N+++D E ++ D+GLA
Sbjct: 125 ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 177
Query: 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSP 670
+V S + PE + + + D++S G ML + P
Sbjct: 178 EFY-------HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 1e-26
Identities = 42/223 (18%), Positives = 83/223 (37%), Gaps = 14/223 (6%)
Query: 455 GNFSHENLIGSGSFGSVYKGY-LREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNL 513
+ +G G F +V+ + VA+K++ + T ++ E + L+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADN 71
Query: 514 VKLITSCSSLDFKNMEFLA-----LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIA 568
K + ++ K ++ V+ + LG+ + K G+ + I+
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 569 IDIASALDYLHNDCEVPIVHCDLKPGNILLD-EDMTAKVGDFGLARSLLERIGNQSSISS 627
+ LDY+H C I+H D+KP N+L++ D + +A
Sbjct: 132 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEH 185
Query: 628 THVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSP 670
+ Y PE LG D++S ++ E+ TG
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 103 bits (257), Expect = 2e-24
Identities = 78/340 (22%), Positives = 127/340 (37%), Gaps = 25/340 (7%)
Query: 24 DKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83
+ L NL NF N+ T P L NLT + I M +N + P
Sbjct: 63 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 120
Query: 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGN------LSNVLSKLYM 137
+ + +S ++ ++ + L+N+ + +
Sbjct: 121 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERL 180
Query: 138 GGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNT 197
+ + + +L +L L + N IS +T +G L L L L GNQ+ T
Sbjct: 181 DISSNKVSDISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--IGT 236
Query: 198 LGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVN 257
L +L L +DL+ N++++ P L + L N+++ P L+ LT + N
Sbjct: 237 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTN 289
Query: 258 LSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPN 317
L N I L N+ + L N +S P + L++L ANNK S
Sbjct: 290 LELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSS- 346
Query: 318 ILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFN 357
LA L + L N++S P L NL + L L
Sbjct: 347 -LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.1 bits (217), Expect = 4e-19
Identities = 52/207 (25%), Positives = 81/207 (39%), Gaps = 24/207 (11%)
Query: 6 YLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEG 65
L +NQ+ P + L L + N+ G+L +LTN+ + +A+N +
Sbjct: 201 SLIATNNQISDITPLGILTNLDEL---SLNGNQLKD--IGTLASLTNLTDLDLANNQISN 255
Query: 66 TVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESI 125
P L L L +G N+I I+ L T L L + NQ E P S
Sbjct: 256 LAP--LSGLTKLTELKLGANQISN--------ISPLAGLTALTNLELNENQLEDISPISN 305
Query: 126 GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDL 185
L+ L + N P + L L L + N +S ++ + L + L
Sbjct: 306 ---LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 186 AGNQISGSIPNTLGNLKKLNQIDLSGN 212
NQIS P L NL ++ Q+ L+
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.6 bits (156), Expect = 1e-11
Identities = 56/286 (19%), Positives = 103/286 (36%), Gaps = 49/286 (17%)
Query: 127 NLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLA 186
L+ + K +G + + L +T L I + + L L ++ +
Sbjct: 20 ALAEKM-KTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 74
Query: 187 GNQISGSIPNTLGNLKKLNQIDLSGNELASEIPT-------------------------- 220
NQ++ P L NL KL I ++ N++A P
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 221 ----------SFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEE 270
+ + L + GN ++ L++LTT+ L + +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 271 IGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDL 330
+ L N+ ++ + N +S P +L++L + N+ LA L L LDL
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKDIGT--LASLTNLTDLDL 248
Query: 331 SSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVH 376
++N++S P L L L L L N + + P G+ T++
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 6e-04
Identities = 11/69 (15%), Positives = 23/69 (33%), Gaps = 4/69 (5%)
Query: 296 KNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLT 355
K ++ + + +L + L + SI ++ L L +N +
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFS 74
Query: 356 FNNLEGVVP 364
N L + P
Sbjct: 75 NNQLTDITP 83
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 90.2 bits (223), Expect = 3e-21
Identities = 24/156 (15%), Positives = 54/156 (34%), Gaps = 10/156 (6%)
Query: 461 NLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSC 520
L+G G +V+ Y + VK + + F + + R+ + L
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVG-----HTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 521 SSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFL-ERLNIAIDIASALDYLH 579
+ +F+ ++ L + G+ + E + + + I + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 580 NDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615
+ IVH DL N+L+ + + DF + +
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 152
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.8 bits (229), Expect = 3e-21
Identities = 58/273 (21%), Positives = 102/273 (37%), Gaps = 13/273 (4%)
Query: 104 STRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163
L N+ NL N L L + N+ P + L L L LS
Sbjct: 30 PPDTALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSK 88
Query: 164 NSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFG 223
N + LQEL+ + ++ S+ N L + + + + +F
Sbjct: 89 NQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP-LKSSGIENGAFQ 147
Query: 224 NFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLS 283
+ L I +++ + IP+ + SLT + +L N + + L N+ + LS
Sbjct: 148 GMKKLSYIRIADTNIT-TIPQGLPP--SLTEL-HLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 284 ANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSG------ 337
N +S S N L +L + NNK +P LA+ K ++V+ L +N +S
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 262
Query: 338 SIPSDLQNLRALRSLNLTFNNLEGVVPREGIFR 370
P + ++L N ++ + FR
Sbjct: 263 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.4 bits (215), Expect = 2e-19
Identities = 52/262 (19%), Positives = 102/262 (38%), Gaps = 13/262 (4%)
Query: 127 NLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLA 186
+L + L + N+ L++L L L N IS L +L+ L L+
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 187 GNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEI 246
NQ+ L++L + ++ + + N ++ + + K +G
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVF-NGLNQMIVVELGTNPLKSSGIENGAF 146
Query: 247 LSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLM 306
+ L + + ++ + T+P+ G+ ++ + L N ++ S K +L KL +
Sbjct: 147 QGMKKL-SYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202
Query: 307 ANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPRE 366
+ N S LA L L L++NKL +P L + + ++ + L NN+ + +
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 261
Query: 367 GIFRHT-------SMVHLEGNP 381
S V L NP
Sbjct: 262 FCPPGYNTKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.5 bits (210), Expect = 9e-19
Identities = 53/237 (22%), Positives = 89/237 (37%), Gaps = 7/237 (2%)
Query: 145 KIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKL 204
K+P + LL+L N I+ + L+ L +L L N+IS P L KL
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 205 NQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264
++ LS N+L Q L + K+ ++ + + + + +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV--ELGTNPLKSS 139
Query: 265 GTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKG 324
G + + I ++ ++ +P SL +L + NK + L L
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 325 LEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNP 381
L L LS N +S L N LR L+L N L V ++ +V+L N
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 253
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.4 bits (202), Expect = 9e-18
Identities = 54/331 (16%), Positives = 105/331 (31%), Gaps = 59/331 (17%)
Query: 27 PNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNK 86
P+ + NK T G NL N+ + + +N + P L L+ + N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 87 IVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSN-VLSKLYMGGNRFYGK 145
+ ++ + L N+ L+ ++ +L + G
Sbjct: 91 LKELPEKMPKTLQELRVH---------ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN 205
+ ++ L+ + ++ +I+ G L L L GN+I+ +L L L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDG 265
++ LS N +++ S N +L + L+NNKL
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV------------------------ 234
Query: 266 TLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGL 325
P + + + L N +S N F P +
Sbjct: 235 --PGGLADHKYIQVVYLHNNNISAIGSNDFCP------------------PGYNTKKASY 274
Query: 326 EVLDLSSNKLSGS--IPSDLQNLRALRSLNL 354
+ L SN + PS + + ++ L
Sbjct: 275 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.5 bits (153), Expect = 2e-11
Identities = 49/245 (20%), Positives = 94/245 (38%), Gaps = 19/245 (7%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ +L L L +N++ P L L N+ +P + +Q +R+
Sbjct: 54 LKNLHTLILINNKISKISP-GAFAPLVKLERLYLSKNQLKE-LPEKMPK--TLQELRVHE 109
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N + L + + +G N + SG E +F +L+++
Sbjct: 110 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF----QGMKKLSYIRIADTNIT-T 164
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
IP+ L L++L++ GN+ S+ L +L L LS+NSIS + L
Sbjct: 165 IPQG---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSF------GNFQNLLSIDLS 234
+ L L N++ +P L + K + + L N +++ F + + L
Sbjct: 222 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 280
Query: 235 NNKLN 239
+N +
Sbjct: 281 SNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 38.5 bits (88), Expect = 0.002
Identities = 29/138 (21%), Positives = 52/138 (37%), Gaps = 3/138 (2%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
SL L L N++ + L NL FN + GSL N +++ + + +
Sbjct: 170 PPSLTELHLDGNKITKVDAASL-KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE-G 119
N L VP GL + ++++ + N I G T + ++ N +
Sbjct: 229 NKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287
Query: 120 EIPESIGNLSNVLSKLYM 137
EI S V + + +
Sbjct: 288 EIQPSTFRCVYVRAAVQL 305
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (226), Expect = 5e-21
Identities = 50/260 (19%), Positives = 85/260 (32%), Gaps = 8/260 (3%)
Query: 102 TNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNL 161
S R+ GN+ S N+ G L
Sbjct: 32 AASQRIFL---HGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 162 SYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTS 221
+ L L +L L + P L L + L N L + +
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 222 FGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTID 281
F + NL + L N+++ + L SL + L +N + P LG ++T+
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLD-RLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 282 LSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPS 341
L AN LS + ++L+ L + +N + L+ SS+++ S+P
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQ 266
Query: 342 DLQNLRALRSLNLTFNNLEG 361
L L N+L+G
Sbjct: 267 RLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (181), Expect = 4e-15
Identities = 45/273 (16%), Positives = 84/273 (30%), Gaps = 14/273 (5%)
Query: 17 EIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPF 76
+P + + N+ + S N+ I+ + N
Sbjct: 25 AVPVGIPAASQRI---FLHGNRISHVPAASFRACRNLTILWLHSN--VLARIDAAAFTGL 79
Query: 77 LKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLY 136
+ + + + L L+ E+ + L LY
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL----DRCGLQELGPGLFRGLAALQYLY 135
Query: 137 MGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPN 196
+ N + L +LT L L N IS L L L L N+++ P+
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 197 TLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIV 256
+L +L + L N L++ + + L + L++N + L +
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKF 253
Query: 257 NLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSG 289
S + + +LP+ L L+AN L G
Sbjct: 254 RGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (171), Expect = 6e-14
Identities = 49/217 (22%), Positives = 82/217 (37%), Gaps = 3/217 (1%)
Query: 171 LTEI--GQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNL 228
L + G Q + L GN+IS + + L + L N LA +F L
Sbjct: 23 LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 229 LSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLS 288
+DLS+N ++ ++L + L P L + + L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 289 GNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRA 348
++F++ +L L + N+ S L L+ L L N+++ P ++L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 349 LRSLNLTFNNLEGV-VPREGIFRHTSMVHLEGNPKLC 384
L +L L NNL + R + L NP +C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (154), Expect = 1e-11
Identities = 57/240 (23%), Positives = 89/240 (37%), Gaps = 4/240 (1%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN 205
+P I + + L N IS + L L L N ++ L L
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 206 QIDLSGNELASEI-PTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264
Q+DLS N + P +F L ++ L L P L++L + L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL-YLQDNALQ 142
Query: 265 GTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKG 324
+ LGN+ + L N +S +F+ SL++LL+ N+ + P+ +L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 325 LEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC 384
L L L +N LS L LRAL+ L L N ++ + C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 2e-08
Identities = 35/213 (16%), Positives = 61/213 (28%), Gaps = 35/213 (16%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L L L E+ + L L N + +L N+ + +
Sbjct: 104 LGRLHTLHL-DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N + L L + N+
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQ------------------------------NRVAHV 192
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180
P + +L + LY+ N ++ LR+L L L+ N + L
Sbjct: 193 HPHAFRDLGRL-MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWL 250
Query: 181 QSLDLAGNQISGSIPNTLGN--LKKLNQIDLSG 211
Q + +++ S+P L LK+L DL G
Sbjct: 251 QKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.7 bits (226), Expect = 1e-20
Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 10/297 (3%)
Query: 95 LSFITSLTNSTRLNFLAFDGN----QFEGEIPESIGNLSNVLSKLYMGGNRFYGK--IPT 148
L L N T L+ + + G + ++ V + L + G IP+
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNN-LDLSGLNLPKPYPIPS 70
Query: 149 SIGRLRSLTLLNLSYN-SISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQI 207
S+ L L L + ++ G I I +L +L L + +SG+IP+ L +K L +
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 208 DLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTL 267
D S N L+ +P S + NL+ I N+++G IP S S L T + +S+N L G +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 268 PEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEV 327
P + + + + + + + K L
Sbjct: 191 PPTFAN--LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNG 248
Query: 328 LDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC 384
LDL +N++ G++P L L+ L SLN++FNNL G +P+ G + + N LC
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 80.6 bits (197), Expect = 4e-17
Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 25/263 (9%)
Query: 102 TNSTRLNFLAFDGNQFEG--EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLL 159
T + R+N L G IP S+ NL + G N G IP +I +L L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 160 NLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIP 219
+++ ++SG I + Q++ L +LD + N +SG++P ++ +L L I GN ++ IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 220 TSFGNFQNLLS-IDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLG--- 275
S+G+F L + + +S N+L G IP +L+ ++ + D ++
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 276 ------------------NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPN 317
N+ +DL N + G LP K L L ++ N G IP
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 318 ILAELKGLEVLDLSSNKLSGSIP 340
L+ +V ++NK P
Sbjct: 287 -GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.5 bits (163), Expect = 1e-12
Identities = 66/265 (24%), Positives = 106/265 (40%), Gaps = 33/265 (12%)
Query: 4 LVYLGLASNQLWG--EIPYDVGDKLPNLLGFNFCFN-KFTGKIPGSLHNLTNIQIIRMAH 60
+ L L+ L IP + LP L G IP ++ LT + + + H
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
+ G +P L + L + +N + G+ S+++ L + FDGN+ G
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGT------LPPSISSLPNLVGITFDGNRISGA 164
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLS------------------ 162
IP+S G+ S + + + + NR GKIP + L +
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 163 ----YNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEI 218
+ L ++G + L LDL N+I G++P L LK L+ +++S N L EI
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 219 PTSFGNFQNLLSIDLSNNKLNGNIP 243
P GN Q +NNK P
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.6 bits (166), Expect = 2e-13
Identities = 47/211 (22%), Positives = 81/211 (38%), Gaps = 8/211 (3%)
Query: 149 SIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQID 208
+ ++ S +N +++ + ++ + + L L+ N + TL +L Q++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 209 LSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLP 268
L E G L ++DLS+N+L T++++S N L
Sbjct: 62 LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQ--TLPALTVLDVSFNRLTSLPL 117
Query: 269 EEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVL 328
+ LG + + L N L P LEKL +ANN + +L L+ L+ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 329 DLSSNKLSGSIPSDLQNLRALRSLNLTFNNL 359
L N L +IP L L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 1e-11
Identities = 40/213 (18%), Positives = 75/213 (35%), Gaps = 9/213 (4%)
Query: 173 EIGQLQELQSLDLAGNQISGSIPNTLG-NLKKLNQIDLSGNELASEIPTSFGNFQNLLSI 231
E+ ++ ++ ++ ++P L + L LS N L + + + L +
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTIL---HLSENLLYTFSLATLMPYTRLTQL 60
Query: 232 DLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNL 291
+L +L L + + + L + V+ N L+
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSF----NRLTSLP 116
Query: 292 PNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRS 351
+ + L++L + N+ P +L LE L L++N L+ L L L +
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 352 LNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC 384
L L N+L + L GNP LC
Sbjct: 177 LLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 3e-07
Identities = 37/211 (17%), Positives = 68/211 (32%), Gaps = 15/211 (7%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
S + + L +P D+ + + N +L T + + +
Sbjct: 10 ASHLEVNCDKRNL-TALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
E T G LP L ++ N++ + L + + +
Sbjct: 66 --ELTKLQVDGTLPVLGTLDLSHNQLQ--------SLPLLGQTLPALTVLDVSFNRLTSL 115
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQ 181
P L +LY+ GN P + L L+L+ N+++ + L+ L
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 182 SLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212
+L L N + +IP L L GN
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 4e-07
Identities = 35/192 (18%), Positives = 62/192 (32%), Gaps = 8/192 (4%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQE 179
+P + + L++ N Y ++ LT LNL + L G L
Sbjct: 24 ALPPDLPKD---TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPV 78
Query: 180 LQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
L +LDL+ NQ+ + + G + N
Sbjct: 79 LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK- 137
Query: 240 GNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCK 299
+P +L+ + ++L+ N L + L N+ T+ L N L +P F
Sbjct: 138 -TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH 195
Query: 300 SLEKLLMANNKF 311
L + N +
Sbjct: 196 LLPFAFLHGNPW 207
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 62.0 bits (149), Expect = 3e-11
Identities = 37/218 (16%), Positives = 70/218 (32%), Gaps = 25/218 (11%)
Query: 153 LRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212
L + + ++++ + L + +L G ++ +I + L L ++L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 213 ELASEIPTS---------------FGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVN 257
++ P + L ++ L+ L+ +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 258 LSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPN 317
L + + + G LS + N L L +NK S P
Sbjct: 134 LYLDL--NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 318 ILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLT 355
LA L L + L +N++S P L N L + LT
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 2e-07
Identities = 35/219 (15%), Positives = 70/219 (31%), Gaps = 15/219 (6%)
Query: 24 DKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83
L N + + T + + +L I + + G+ L L +
Sbjct: 16 PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFY 143
N+I + + I + + + G
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 144 GKIPTSIGRLRSLTLL-------NLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPN 196
+ + ++ +++ L LS + LT + L +L +L N+IS P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 197 TLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSN 235
L +L L ++ L N+++ P N NL + L+N
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 37/217 (17%), Positives = 70/217 (32%), Gaps = 16/217 (7%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ + + + + + + L + + T I G + L N+ + +
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N + P + K V + S T ST++ + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 121 I-------PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTE 173
+ +I L+ + + Y+ T + L LT L N IS ++
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISP 190
Query: 174 IGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLS 210
+ L L + L NQIS P L N L + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 14/58 (24%), Positives = 24/58 (41%), Gaps = 5/58 (8%)
Query: 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQ 189
L+ L N+ P + L +L ++L N IS ++ + L + L NQ
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLT-NQ 227
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 3e-10
Identities = 32/227 (14%), Positives = 78/227 (34%), Gaps = 6/227 (2%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQII--RM 58
+ ++ L+++ + + + + L + + + I +L +N+ +
Sbjct: 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104
Query: 59 AHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118
E + L + L N+ + ++ T+LN + N +
Sbjct: 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK 164
Query: 119 GEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY-NSISGEILTEIGQL 177
++ + N++ +L L L+LS I E L E+G++
Sbjct: 165 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224
Query: 178 QELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGN 224
L++L + G G++ L L ++ + + + GN
Sbjct: 225 PTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 3e-10
Identities = 41/243 (16%), Positives = 78/243 (32%), Gaps = 14/243 (5%)
Query: 134 KLYMGGNRFYGKIPTSIGRLRSLTLLNLS-YNSISGEILTEIGQLQELQSLDLAGNQISG 192
L + G + P GRL S ++ S + L E +Q +DL+ + I
Sbjct: 4 TLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 193 -SIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNL--LSIDLSNNKLNGNIPKEILSL 249
++ L KL + L G L+ I + NL L++ + + + S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 250 SSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLM--- 306
S L + + + L+ +G NL S + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 307 ---ANNKFSGPIPNILAELKGLEVLDLSS-NKLSGSIPSDLQNLRALRSLNLTFNNLEGV 362
+ +L L+ L LS + +L + L++L + +G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 363 VPR 365
+
Sbjct: 241 LQL 243
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 8e-08
Identities = 47/248 (18%), Positives = 85/248 (34%), Gaps = 10/248 (4%)
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEI-GQLQEL 180
P+ G L + + F + + ++LS + I L I Q +L
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLS--GNELASEIPTSFGNFQNLLSIDLSNNKL 238
Q+L L G ++S I NTL L +++LS + T + L ++LS
Sbjct: 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133
Query: 239 NGNIPKEILSLSSL-----TTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSAN-GLSGNLP 292
++ + KN L + N+V +DLS + L +
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193
Query: 293 NSFKNCKSLEKLLMAN-NKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRS 351
F L+ L ++ L E+ L+ L + G++ + L L+
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 253
Query: 352 LNLTFNNL 359
F +
Sbjct: 254 NCSHFTTI 261
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 8e-06
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 2/101 (1%)
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
Q+LDL G + + L + + + + + F F+ + +DLSN+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 241 NIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTID 281
+ ILS S ++L L + + N+V ++
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 9e-06
Identities = 30/265 (11%), Positives = 73/265 (27%), Gaps = 13/265 (4%)
Query: 100 SLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGK-IPTSIGRLRSLTL 158
+AF + + P + + + + + + + + L
Sbjct: 16 VTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN 75
Query: 159 LNLSYNSISGEILTEIGQLQELQSLDL--------AGNQISGSIPNTLGNLKKLNQIDLS 210
L+L +S I+ + + L L+L Q S + L L D +
Sbjct: 76 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT 135
Query: 211 GNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEE 270
+ + L N ++ + +L + L +E
Sbjct: 136 EKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQE 195
Query: 271 IGMLGNVVTIDLS-ANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLD 329
L + + LS + +L+ L + G + + + L L
Sbjct: 196 FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQ 252
Query: 330 LSSNKLSGSIPSDLQNLRALRSLNL 354
++ + + + N + +
Sbjct: 253 INCSHFTTIARPTIGNKKNQEIWGI 277
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 59.8 bits (143), Expect = 5e-10
Identities = 23/93 (24%), Positives = 39/93 (41%), Gaps = 9/93 (9%)
Query: 160 NLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIP 219
N+ S EI + L+ L+++ N++ +P L++L S N L +E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHL-AEVP 320
Query: 220 TSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSL 252
QNL + + N L P S+ L
Sbjct: 321 EL---PQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 59.1 bits (141), Expect = 8e-10
Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 9/89 (10%)
Query: 140 NRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLG 199
N +I + SL LN+S N + E+ +L+ L + N ++ +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELPQ 324
Query: 200 NLKKLNQIDLSGNELASEIPTSFGNFQNL 228
NLK+L + N L E P + ++L
Sbjct: 325 NLKQL---HVEYNPL-REFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 9e-08
Identities = 18/93 (19%), Positives = 36/93 (38%), Gaps = 10/93 (10%)
Query: 257 NLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIP 316
N + + ++ +++S N L LP LE+L+ + N +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA---- 317
Query: 317 NILAELKGLEVLDLSSNKLSG--SIPSDLQNLR 347
+ + L+ L + N L IP +++LR
Sbjct: 318 EVPELPQNLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 2e-07
Identities = 23/81 (28%), Positives = 35/81 (43%), Gaps = 8/81 (9%)
Query: 282 LSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPS 341
N S + + SLE+L ++NNK + A LE L S N L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI----ELPALPPRLERLIASFNHLA-EVPE 321
Query: 342 DLQNLRALRSLNLTFNNLEGV 362
QN L+ L++ +N L
Sbjct: 322 LPQN---LKQLHVEYNPLREF 339
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 4e-05
Identities = 15/77 (19%), Positives = 28/77 (36%), Gaps = 10/77 (12%)
Query: 105 TRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN 164
L L N+ E+P L +L N ++P L+ L ++ YN
Sbjct: 284 PSLEELNVSNNKLI-ELPALPPRLE----RLIASFNHL-AEVPELPQNLKQL---HVEYN 334
Query: 165 SISGEILTEIGQLQELQ 181
+ E +++L+
Sbjct: 335 PLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.002
Identities = 16/75 (21%), Positives = 31/75 (41%), Gaps = 6/75 (8%)
Query: 323 KGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGV--VPREGIFRHTSMVHLEGN 380
+ L+L++ LS S+P + L SL + N+L + +P+ +L+
Sbjct: 38 RQAHELELNNLGLS-SLPELPPH---LESLVASCNSLTELPELPQSLKSLLVDNNNLKAL 93
Query: 381 PKLCLHLGCENSSSH 395
L L S++
Sbjct: 94 SDLPPLLEYLGVSNN 108
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.002
Identities = 13/61 (21%), Positives = 24/61 (39%), Gaps = 5/61 (8%)
Query: 154 RSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNE 213
R L L+ +S + L+ SL + N ++ +P +LK L + +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 214 L 214
L
Sbjct: 93 L 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.004
Identities = 17/98 (17%), Positives = 31/98 (31%), Gaps = 5/98 (5%)
Query: 298 CKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFN 357
+ +L + N S +P LE L S N L+ +P Q+L++L N
Sbjct: 37 DRQAHELELNNLGLSS-LP---ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91
Query: 358 NLEGVVPREGIFRHTSMVHLEGNPKLCLHLGCENSSSH 395
L + P ++ + +
Sbjct: 92 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDN 129
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.1 bits (138), Expect = 2e-09
Identities = 16/92 (17%), Positives = 31/92 (33%), Gaps = 10/92 (10%)
Query: 155 SLTLLNLSYNSISGEILTEI-GQLQELQSLDLAGNQISG----SIPNTLGNLKKLNQIDL 209
+ L++ +S E+ LQ+ Q + L ++ I + L L +++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 210 SGNELASEIPTSFG-----NFQNLLSIDLSNN 236
NEL + + L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 2e-08
Identities = 18/88 (20%), Positives = 36/88 (40%), Gaps = 7/88 (7%)
Query: 179 ELQSLDLAGNQISGS-IPNTLGNLKKLNQIDLSGNEL----ASEIPTSFGNFQNLLSIDL 233
++QSLD+ ++S + L L++ + L L +I ++ L ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 234 SNNKLNGNIPKEILSL--SSLTTIVNLS 259
+N+L +L + I LS
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 2e-08
Identities = 13/91 (14%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 276 NVVTIDLSANGLSGN-LPNSFKNCKSLEKLLMANNKFSG----PIPNILAELKGLEVLDL 330
++ ++D+ LS + + + + + + I + L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 331 SSNKLSGSIPSDLQNLRALRSLNLTFNNLEG 361
SN+L + S + +L+
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 4e-08
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 9/95 (9%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGK----IPTSIGRLRSLTLLNLSYNSISGEILTEIG 175
E+ + +G +VL L++ + ++ SL L+LS N + + ++
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 176 QLQE-----LQSLDLAGNQISGSIPNTLGNLKKLN 205
+ L+ L L S + + L L+K
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 3e-07
Identities = 16/93 (17%), Positives = 31/93 (33%), Gaps = 15/93 (16%)
Query: 155 SLTLLNLSYNSISGEILTEIGQ----LQELQSLDLAGNQISGSIPNTLG-----NLKKLN 205
L +L L+ +S + + L+ LDL+ N + + L L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 206 QIDLSGNELASEIPTSFGNFQNLLSIDLSNNKL 238
Q+ L + E+ L +++ L
Sbjct: 430 QLVLYDIYWSEEME------DRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 2e-06
Identities = 18/91 (19%), Positives = 26/91 (28%), Gaps = 9/91 (9%)
Query: 285 NGLSGNLPNSFKNCKSLEKLLMANNKFSG----PIPNILAELKGLEVLDLSSNKLSGSIP 340
G+ + L L +A+ S + L L LDLS+N L +
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414
Query: 341 SDL-----QNLRALRSLNLTFNNLEGVVPRE 366
L Q L L L +
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 13/83 (15%), Positives = 29/83 (34%), Gaps = 8/83 (9%)
Query: 200 NLKKLNQIDLSGNEL----ASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSL----SS 251
L + L+ ++ S + + +L +DLSNN L +++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 252 LTTIVNLSKNFLDGTLPEEIGML 274
L + L + + + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 14/116 (12%), Positives = 40/116 (34%), Gaps = 33/116 (28%)
Query: 227 NLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANG 286
++ S+D+ +L+ D E + +L + L G
Sbjct: 3 DIQSLDIQCEELS------------------------DARWAELLPLLQQCQVVRLDDCG 38
Query: 287 LSG----NLPNSFKNCKSLEKLLMANNKFSGPIPNILAEL-----KGLEVLDLSSN 333
L+ ++ ++ + +L +L + +N+ + + + ++ L L +
Sbjct: 39 LTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 14/96 (14%), Positives = 29/96 (30%), Gaps = 11/96 (11%)
Query: 104 STRLNFLAFDGNQF-EGEIPESIGNLSNVLSKLYMGGNRFYGK----IPTSIGRLRSLTL 158
S + L + + E + L + + I +++ +L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQ-CQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 159 LNLSYNSISGEILTEIGQL-----QELQSLDLAGNQ 189
LNL N + + + Q ++Q L L
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 17/106 (16%), Positives = 38/106 (35%), Gaps = 24/106 (22%)
Query: 222 FGNFQNLLSIDLSNNKLNGN----IPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNV 277
L + L++ ++ + + +L+ SL + +LS N L
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL-DLSNNCLG------------- 410
Query: 278 VTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELK 323
D L ++ LE+L++ + +S + + L L+
Sbjct: 411 ---DAGILQLVESVRQ---PGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 55.4 bits (132), Expect = 3e-09
Identities = 40/215 (18%), Positives = 79/215 (36%), Gaps = 23/215 (10%)
Query: 146 IPTSIGR------LRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLG 199
+PT I + NL S++ + +L + + + I +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQ 65
Query: 200 NLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLS 259
L + ++ L+GN+L P N +NL + L NK+ + L ++ +
Sbjct: 66 YLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNG 123
Query: 260 KNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNIL 319
+ ++G + + ++ + L + +N+ S +P L
Sbjct: 124 ISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS-------LEDNQISDIVP--L 174
Query: 320 AELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNL 354
A L L+ L LS N +S + + L L+ L L L
Sbjct: 175 AGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 38/197 (19%), Positives = 67/197 (34%), Gaps = 17/197 (8%)
Query: 24 DKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83
D + N T + + + L +I I ++ ++ G+ LP + +
Sbjct: 21 DAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLN 76
Query: 84 FNKIVGSGDEG---------LSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSK 134
NK+ L S+ + E I L ++
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 135 LYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSI 194
+ T + RL L L+L N IS + + L +LQ+L L+ N IS +
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHIS-DL 193
Query: 195 PNTLGNLKKLNQIDLSG 211
L LK L+ ++L
Sbjct: 194 RA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 26/196 (13%), Positives = 52/196 (26%), Gaps = 18/196 (9%)
Query: 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAH 60
+ L + + + +L ++ + + L N+ + +
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 61 NLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGE 120
N L L NL L + NK+ + +G +
Sbjct: 78 NKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135
Query: 121 IPESIGNLSNVLSKLYMGGNRFYGKI---------PTSIGRLRSLTLLNLSYNSISGEIL 171
+ + + + + + L L L LS N IS L
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--L 193
Query: 172 TEIGQLQELQSLDLAG 187
+ L+ L L+L
Sbjct: 194 RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 10/81 (12%), Positives = 25/81 (30%), Gaps = 4/81 (4%)
Query: 296 KNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLT 355
K + + + EL ++ + +++ + +Q L + L L
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 356 FNNLEGVVPREGIFRHTSMVH 376
N L + P + +
Sbjct: 77 GNKLTDIKPLANLKNLGWLFL 97
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 5e-08
Identities = 24/124 (19%), Positives = 48/124 (38%), Gaps = 29/124 (23%)
Query: 159 LNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN------------- 205
L+L++ ++ +L + QL + LDL+ N++ P L L+ L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 206 ---------QIDLSGNELAS-EIPTSFGNFQNLLSIDLSNNKLNG--NIPKEILS-LSSL 252
++ L N L + L+ ++L N L I + + L S+
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
Query: 253 TTIV 256
++I+
Sbjct: 120 SSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 28/109 (25%), Positives = 45/109 (41%), Gaps = 6/109 (5%)
Query: 255 IVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGP 314
+++L+ L T+ + L V +DLS N L P + + LE L ++N
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 315 IPNILAELKGLEVLDLSSNKL-SGSIPSDLQNLRALRSLNLTFNNLEGV 362
L L+ L L +N+L + L + L LNL N+L
Sbjct: 59 DGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 24/129 (18%), Positives = 44/129 (34%), Gaps = 10/129 (7%)
Query: 181 QSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNG 240
+ L LA + ++ L L + +DLS N L + P + + L + S+N L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 241 NIPKEILSLSSLTTIVNLSKNFL-DGTLPEEIGMLGNVVTIDLSAN---GLSGNLPNSFK 296
+ L N L + + +V ++L N G +
Sbjct: 58 VDGVAN---LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 297 NCKSLEKLL 305
S+ +L
Sbjct: 115 MLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 26/124 (20%), Positives = 48/124 (38%), Gaps = 7/124 (5%)
Query: 231 IDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGN 290
+ L++ L + + L +T + +LS N L P + L + + S N +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHL-DLSHNRLRAL-PPALAALRCLEVLQASDN--ALE 56
Query: 291 LPNSFKNCKSLEKLLMANNKF-SGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRAL 349
+ N L++LL+ NN+ L L +L+L N L + L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 350 RSLN 353
S++
Sbjct: 117 PSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 3e-04
Identities = 23/117 (19%), Positives = 39/117 (33%), Gaps = 13/117 (11%)
Query: 54 QIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFD 113
+++ +AH L TV L L + ++ N++ + +L L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNA 54
Query: 114 GNQFEGEIPESIGNLSNVLSKLYMGGNRF-YGKIPTSIGRLRSLTLLNLSYNSISGE 169
+G L +L + NR + L LLNL NS+ E
Sbjct: 55 LENVDGVANL------PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.7 bits (117), Expect = 3e-07
Identities = 39/200 (19%), Positives = 67/200 (33%), Gaps = 17/200 (8%)
Query: 153 LRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGN 212
L L +++ + L ++ +L I SI + L L QI+ S N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 72
Query: 213 ELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIG 272
L + N + + + +
Sbjct: 73 ---------QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 273 MLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSS 332
+ L + + + ++ SL++L ++N+ + P LA L LE LD+SS
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 333 NKLSGSIPSDLQNLRALRSL 352
NK+S S L L L SL
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.0 bits (84), Expect = 0.004
Identities = 25/189 (13%), Positives = 51/189 (26%), Gaps = 12/189 (6%)
Query: 24 DKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83
L + T + S +L + ++ + G+ L L N
Sbjct: 15 TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFS 70
Query: 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNR-- 141
N++ + + + +
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 142 -----FYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISG-SIP 195
I +L L+++S L + L L+ LD++ N++S S+
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVL 190
Query: 196 NTLGNLKKL 204
L NL+ L
Sbjct: 191 AKLTNLESL 199
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.1 bits (115), Expect = 5e-07
Identities = 34/218 (15%), Positives = 72/218 (33%), Gaps = 7/218 (3%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLN 205
IP+ + R+ L + +L+ ++++ N + I + +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 206 QIDLS---GNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNF 262
N L + + + +I SL + + + N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 263 LDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAEL 322
+G+ V + L+ NG+ +F + E L NN ++
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 323 KGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLE 360
G +LD+S ++ L+NL+ LR+ + NL+
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 8/49 (16%), Positives = 15/49 (30%), Gaps = 3/49 (6%)
Query: 293 NSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPS 341
+ F L ++ + L LK L + K +P+
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 30/221 (13%), Positives = 61/221 (27%), Gaps = 6/221 (2%)
Query: 17 EIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPF 76
EIP D+ N + F K G+ +++ I ++ N + + ++
Sbjct: 22 EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA---DVFS 75
Query: 77 LKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLY 136
+ ++ L + I +L VL +
Sbjct: 76 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 135
Query: 137 MGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPN 196
N + + +G +L L+ N I Q + N + +
Sbjct: 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPND 195
Query: 197 TLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNK 237
+D+S + S N + L + N K
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 2e-04
Identities = 25/219 (11%), Positives = 49/219 (22%), Gaps = 7/219 (3%)
Query: 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHN 61
+ + L +L I +L N I + +
Sbjct: 29 RNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87
Query: 62 LLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121
+ + + + I SL + + E
Sbjct: 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 147
Query: 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQ 181
+ S +L G + N + + ++
Sbjct: 148 FVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVF---HGASGPV 204
Query: 182 SLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPT 220
LD++ +I L NLKKL ++PT
Sbjct: 205 ILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.3 bits (108), Expect = 3e-06
Identities = 38/176 (21%), Positives = 70/176 (39%), Gaps = 9/176 (5%)
Query: 120 EIPESIGNLSNVLSKLYMGGNRFYGKIPTSI-GRLRSLTLLNLSYNSISGEILTEIGQLQ 178
EIP ++ ++L + N + GRL L L L N ++G
Sbjct: 22 EIPR---DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78
Query: 179 ELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKL 238
+Q L L N+I L +L ++L N+++ +P SF + +L S++L++N
Sbjct: 79 HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138
Query: 239 NGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNS 294
N N + + +L+ P + + +V DL + + NS
Sbjct: 139 NCNCH--LAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENS 189
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.4 bits (90), Expect = 7e-04
Identities = 35/198 (17%), Positives = 70/198 (35%), Gaps = 32/198 (16%)
Query: 146 IPTSIGRLRSLTLLNLSYNSISGEILTEI-GQLQELQSLDLAGNQISGSIPNTLGNLKKL 204
IP I T L L+ N + + G+L L L+L NQ++G PN +
Sbjct: 23 IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 205 NQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264
++ L N++ F L +++L +N+++ +P L+SLT++ S F
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN- 139
Query: 265 GTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKG 324
+ L+ P ++++
Sbjct: 140 -CNCHLAWFAEWLRKKSLNGGAARCGAP---------------------------SKVRD 171
Query: 325 LEVLDLSSNKLSGSIPSD 342
+++ DL ++ S +
Sbjct: 172 VQIKDLPHSEFKCSSENS 189
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.8 bits (109), Expect = 6e-06
Identities = 15/90 (16%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 154 RSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISG----SIPNTLGNLKKLNQIDL 209
+SL L ++ + + + ++ + L+GN I + + + K L +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 210 SGNELASEIPTSFGNFQNLLSIDLSNNKLN 239
S + LL L KL+
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 5e-05
Identities = 17/82 (20%), Positives = 28/82 (34%), Gaps = 12/82 (14%)
Query: 160 NLSYNSISGEILTEIGQ------LQELQSLDLAGNQISGSIPNTL-----GNLKKLNQID 208
L+ +S + LQ+L L N+I TL + L ++
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 209 LSGNELASEIPTSFGNFQNLLS 230
L+GN SE + + S
Sbjct: 309 LNGNRF-SEEDDVVDEIREVFS 329
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 5e-04
Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 7/61 (11%)
Query: 153 LRSLTLLNLSYNSISGEILTEI-----GQLQELQSLDLAGNQIS--GSIPNTLGNLKKLN 205
L L L YN I + + + ++ +L L+L GN+ S + + + +
Sbjct: 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTR 331
Query: 206 Q 206
Sbjct: 332 G 332
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 6e-04
Identities = 46/313 (14%), Positives = 84/313 (26%), Gaps = 27/313 (8%)
Query: 67 VPPGLGNLPFLKMYNIGFNKIVGSGDEGLS-FITSLTNSTRLNFLAFDGNQFEGEIPESI 125
V L +K + N I LS I S + F + + EIPE++
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 126 GNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDL 185
L L K L + + L G +
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL-GPQAGAKI 141
Query: 186 AGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKE 245
A ++ N L I N L + + + + + I E
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 246 ILS------------LSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPN 293
+ L L N + L + N+ + L+ LS
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 294 SFKNC------KSLEKLLMANNKFSGPIPNILAE-----LKGLEVLDLSSNKLS--GSIP 340
+ + L+ L + N+ L + L L+L+ N+ S +
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVV 321
Query: 341 SDLQNLRALRSLN 353
+++ + + R
Sbjct: 322 DEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.002
Identities = 35/297 (11%), Positives = 80/297 (26%), Gaps = 11/297 (3%)
Query: 281 DLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGP----IPNILAELKGLEVLDLSSN--- 333
++ ++ S+++++++ N + +A K LE+ + S
Sbjct: 14 AITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG 72
Query: 334 KLSGSIPSDLQNLRALRSLN--LTFNNLEGVVPREGIFRHTSMVHLEGNPKLCLHLGCEN 391
++ IP L+ L L L + P L+L
Sbjct: 73 RVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG 132
Query: 392 SSSHGRRRIIIYIIVAIIAIIAGCFLIFWLIIVRKGKAKPIGVSTLFKHSPQMISYDELR 451
+I + + A II + + + + K ++
Sbjct: 133 LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVK 192
Query: 452 RATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHR 511
E + G Y L+ + S+ + + +
Sbjct: 193 MVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252
Query: 512 NLVKLITSCSSLD-FKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNI 567
L+ + + +D F +E + L L + K + L L +
Sbjct: 253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (104), Expect = 7e-06
Identities = 24/145 (16%), Positives = 55/145 (37%), Gaps = 9/145 (6%)
Query: 166 ISGEILTEIGQ---LQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSF 222
++ E++ + Q + LDL G +I I N L + + ID S NE+ F
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGF 59
Query: 223 GNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDL 282
+ L ++ ++NN++ +L LT ++ + + ++ + + L ++ + +
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119
Query: 283 S---ANGLSGNLPNSFKNCKSLEKL 304
+ L
Sbjct: 120 LRNPVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 19/100 (19%), Positives = 34/100 (34%), Gaps = 6/100 (6%)
Query: 287 LSGNLPN---SFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDL 343
L+ L + N +L + K I N+ A L + +D S N++
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGF 59
Query: 344 QNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKL 383
LR L++L + N + + + N L
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 99
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (104), Expect = 9e-06
Identities = 26/155 (16%), Positives = 57/155 (36%), Gaps = 12/155 (7%)
Query: 232 DLSNNKLNGNIPKEILSLSSLTT-IVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGN 290
+L ++ + + + ++L D ++ V ++ ++ ++
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSD----PDLVAQNIDVVLNRRSS-MAAT 56
Query: 291 LPNSFKNCKSLEKLLMANNKFSG--PIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRA 348
L +N L L ++NN+ + +I+ + L++L+LS N+L D
Sbjct: 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116
Query: 349 LRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKL 383
L L L N+L + + PKL
Sbjct: 117 LEELWLDGNSLSDTFRDQSTYISAIRERF---PKL 148
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 1e-04
Identities = 26/134 (19%), Positives = 53/134 (39%), Gaps = 3/134 (2%)
Query: 232 DLSNNKLNGNIPKEILSLSSLTTIVNLSK-NFLDGTLPEEIGMLGNVVTIDLSANGLSG- 289
D S L+ + L + V L++ + + TL + +++++LS N L
Sbjct: 21 DGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRL 80
Query: 290 -NLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRA 348
++ + + +L+ L ++ N+ + LE L L N LS + + A
Sbjct: 81 DDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140
Query: 349 LRSLNLTFNNLEGV 362
+R L+G
Sbjct: 141 IRERFPKLLRLDGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 2/105 (1%)
Query: 139 GNRFYGKIPTSIGRLRSLTLLNLSYNSISG--EILTEIGQLQELQSLDLAGNQISGSIPN 196
+ + + L LNLS N + ++ + + + L+ L+L+GN++
Sbjct: 50 RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSEREL 109
Query: 197 TLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN 241
KL ++ L GN L+ + +L+G+
Sbjct: 110 DKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (97), Expect = 5e-05
Identities = 18/143 (12%), Positives = 44/143 (30%), Gaps = 1/143 (0%)
Query: 204 LNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFL 263
+ + + + + +NL + + N + ++ L + + K+ L
Sbjct: 10 SSGLRCTRDGA-LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 264 DGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELK 323
P+ + ++LS N L + + E +L N L +
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128
Query: 324 GLEVLDLSSNKLSGSIPSDLQNL 346
+ + KL L ++
Sbjct: 129 EEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 4e-04
Identities = 22/109 (20%), Positives = 34/109 (31%)
Query: 276 NVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKL 335
+ + +G +L + E + L L L L + + L
Sbjct: 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 336 SGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLC 384
P L LNL+FN LE + + + L GNP C
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.004
Identities = 16/90 (17%), Positives = 31/90 (34%), Gaps = 2/90 (2%)
Query: 155 SLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIP-NTLGNLKKLNQIDLSGNE 213
+ L + + + L + + L L + Q + L L +L + + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 214 LASEIPTSFGNFQNLLSIDLSNNKLNGNIP 243
L P +F L ++LS N L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSW 97
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 767 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.69 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.6 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.53 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.37 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.35 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.3 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.3 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.55 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.47 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.36 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.95 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.91 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.89 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.6 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.4 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.37 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.15 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.82 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.64 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=413.55 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=198.8
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|++++++++||||+++++++. +++.+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCceeE
Confidence 57999999999999999999976 58999999996543 234567899999999999999999999954 456789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||+++|+|.+++.... .+++.++..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|
T Consensus 80 ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA 150 (271)
T ss_dssp EEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhh
Confidence 9999999999999997543 399999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhccc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPK 691 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 691 (767)
+....... .......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....................
T Consensus 151 ~~~~~~~~----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~ 226 (271)
T d1nvra_ 151 TVFRYNNR----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226 (271)
T ss_dssp EECEETTE----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS
T ss_pred eeeccCCc----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 86543211 112244679999999999988776 5789999999999999999999976443332222222211111
Q ss_pred chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 692 NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 692 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.....+++. +.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~~s~~----------------------~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 NPWKKIDSA----------------------PLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTGGGSCHH----------------------HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHH----------------------HHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111112221 1226668999999999999999763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=413.66 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=202.2
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
++|++.+.||+|+||.||+|.+. +|+.||||++........+.+.+|++++++++||||+++++++. .++.+|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEEEE
Confidence 47999999999999999999965 59999999998766666778999999999999999999999954 4567899
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++|+|.+++.... +++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+
T Consensus 95 vmEy~~gg~L~~~~~~~~-------l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEECCTTCBHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecCCCcHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 999999999999886533 99999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc-cc
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP-KN 692 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~ 692 (767)
.+.... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .+........+ ..
T Consensus 165 ~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~~~ 237 (293)
T d1yhwa1 165 QITPEQ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQ 237 (293)
T ss_dssp ECCSTT------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCCCS
T ss_pred eecccc------ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCCCC
Confidence 653321 12244579999999999999999999999999999999999999996532211 11111111111 11
Q ss_pred hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 693 AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 693 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+..+++. +++++.+||+.||++|||++|++++
T Consensus 238 ~~~~~s~~----------------------~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 NPEKLSAI----------------------FRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SGGGSCHH----------------------HHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CcccCCHH----------------------HHHHHHHHccCChhHCcCHHHHhcC
Confidence 11222222 2236678999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-51 Score=410.39 Aligned_cols=258 Identities=30% Similarity=0.469 Sum_probs=199.4
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|+++. .||||+++.. .....+.|.+|++++++++||||+++++++.. +.+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~~ 78 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQL 78 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cEE
Confidence 4689999999999999999998753 5999998644 34456789999999999999999999998642 346
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++||||+++|+|.+++...+ ..+++.++..++.|+++||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred EEEEecCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccc
Confidence 89999999999999997543 2499999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC---CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG---EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|+........ .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+...+...
T Consensus 151 a~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~ 225 (276)
T d1uwha_ 151 ATVKSRWSGS----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRG 225 (276)
T ss_dssp SCC----------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHT
T ss_pred eeeccccCCc----ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcC
Confidence 9765432211 12244679999999999864 357899999999999999999999996542221 111222221
Q ss_pred cc-cch---hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 689 FP-KNA---QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 689 ~~-~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
.. ... ...+++. +.+++.+||+.||++||||+|++++|+.+.+.
T Consensus 226 ~~~p~~~~~~~~~~~~----------------------l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 226 YLSPDLSKVRSNCPKA----------------------MKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp SCCCCGGGSCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcchhccccchHH----------------------HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 11 111 1111111 22367789999999999999999999988764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=405.26 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=196.5
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
++|++.+.||+|+||.||+|.+.+++.||||+++.. ....+++.+|++++++++||||++++|+|.. ++..++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEEE
Confidence 478889999999999999999988889999998753 3345789999999999999999999999753 3456999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++.
T Consensus 79 ~E~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp EECCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred EEecCCCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhee
Confidence 99999999999987643 3489999999999999999999999 999999999999999999999999999987
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchh
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
....... ......||+.|+|||++.+..++.++|||||||++|||+|+..|+..... ...+...+....+...+
T Consensus 151 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~~~~~~~p 224 (263)
T d1sm2a_ 151 VLDDQYT-----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKP 224 (263)
T ss_dssp -------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-HHHHHHHHHHTCCCCCC
T ss_pred ccCCCce-----eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-HHHHHHHHHhcCCCCCc
Confidence 6443211 12335689999999999999999999999999999999996554433211 11222222222222222
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
...++. +.+++.+||+.||++||||+|++++|+++.++
T Consensus 225 ~~~~~~----------------------l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 RLASTH----------------------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCHH----------------------HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 222222 12277789999999999999999999988653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=401.02 Aligned_cols=250 Identities=27% Similarity=0.401 Sum_probs=195.4
Q ss_pred CC-CCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 456 NF-SHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 456 ~~-~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
+| +..+.||+|+||+||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++... ......+
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~ 87 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI 87 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEE
Confidence 44 56678999999999999976 48899999986542 23456789999999999999999999987542 2345678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeC-CCCceEEcc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVP--IVHCDLKPGNILLD-EDMTAKVGD 608 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~-~~~~~kl~D 608 (767)
++||||+++|+|.+++..... +++.++..++.||++||+|||++ + |+||||||+|||++ +++.+||+|
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~------~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~D 158 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD 158 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EEEEeCCCCCcHHHHHhcccc------ccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEee
Confidence 999999999999999976543 99999999999999999999998 6 99999999999997 578999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh-
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES- 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~- 687 (767)
||+|+..... ......||+.|+|||++.+ +++.++||||+||++|||++|+.||....... .+.+.+..
T Consensus 159 FGla~~~~~~--------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~~~i~~~ 228 (270)
T d1t4ha_ 159 LGLATLKRAS--------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSG 228 (270)
T ss_dssp TTGGGGCCTT--------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTT
T ss_pred cCcceeccCC--------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHHHHHHcC
Confidence 9999753221 1234679999999999865 59999999999999999999999996532221 11111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+........+. +++++.+||++||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~----------------------~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 229 VKPASFDKVAIPE----------------------VKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCCGGGGGCCCHH----------------------HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCcccCccCCHH----------------------HHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1122222222222 2236778999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=407.63 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=201.3
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
+.|++.+.||+|+||.||+|++. +++.||||+++.......+.+.+|++++++++|||||++++++. +++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence 46899999999999999999976 58999999998777777889999999999999999999999954 4567899
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++|+|.+++.... .++++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 87 vmEy~~~g~L~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEECCTTEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence 999999999999986543 2399999999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccC-----CCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGL-----GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
...... .......||+.|+|||++. +..++.++||||+||++|||+||+.||....... .+.......
T Consensus 159 ~~~~~~------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~ 231 (288)
T d2jfla1 159 KNTRTI------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSE 231 (288)
T ss_dssp ECHHHH------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSC
T ss_pred ccCCCc------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCC
Confidence 654321 1123456999999999874 4567899999999999999999999996643221 111222221
Q ss_pred cccc-hhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKN-AQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+.. .+..+++. +.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~s~~----------------------~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 PPTLAQPSRWSSN----------------------FKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CCCCSSGGGSCHH----------------------HHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCCccccCCHH----------------------HHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 11112221 2236678999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=400.05 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=199.3
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|+++ +++.||+|++... .....+.+.+|++++++++||||+++++++. +++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence 46899999999999999999986 5899999998643 3344567889999999999999999999954 5567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+++||||+++|+|.+++..... +++.++..++.||++||+|||++ +||||||||+||+++.++.+||+|||
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~------l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence 8999999999999999976543 99999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+|+..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+... +
T Consensus 152 ~a~~~~~~--------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~-~ 220 (263)
T d2j4za1 152 WSVHAPSS--------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISRV-E 220 (263)
T ss_dssp SCSCCCCC--------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTT-C
T ss_pred eeeecCCC--------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--HHHHHHHcC-C
Confidence 99754321 123456999999999999999999999999999999999999999653211 111111111 0
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...++.+++. +++++.+||+.||++|||++|++++
T Consensus 221 ~~~p~~~s~~----------------------~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 FTFPDFVTEG----------------------ARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCCCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCccCCHH----------------------HHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0111112221 2236678999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=405.91 Aligned_cols=257 Identities=25% Similarity=0.325 Sum_probs=190.0
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+ ..+..+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEE
Confidence 56999999999999999999975 58999999986543 2335678899999999999999999998753 334567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC--EVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
|+||||+++|+|.+++...... ...+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEecCCCCcHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 9999999999999998754321 345999999999999999999999861 014999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHh-hhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWV-ESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~ 688 (767)
|+|+....... ......||+.|+|||++.+..++.++||||+||++|||+||+.||...... .+...+ ...
T Consensus 159 G~a~~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~i~~~~ 230 (269)
T d2java1 159 GLARILNHDTS------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGK 230 (269)
T ss_dssp HHHHHC-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHTC
T ss_pred cceeecccCCC------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHHHHHcCC
Confidence 99987643211 123467999999999999999999999999999999999999999653221 111111 111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
++ ..+..+++. +.+++.+||+.||++|||++|++++
T Consensus 231 ~~-~~~~~~s~~----------------------l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 FR-RIPYRYSDE----------------------LNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CC-CCCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC-CCCcccCHH----------------------HHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11 111112221 2236678999999999999999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-50 Score=408.31 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=206.3
Q ss_pred HHhcCCCCCCccccccceEEEEEEeCC-CcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 452 RATGNFSHENLIGSGSFGSVYKGYLRE-GISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 452 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
...++|++.+.||+|+||.||+|.++. ++.||||+++.. ....+++.+|++++++++|||||+++++|. +++.
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 87 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPP 87 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCe
Confidence 345678899999999999999999764 889999998644 344678999999999999999999999964 4456
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+++|+|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred eEEEeecccCcchHHHhhhcc----ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccc
Confidence 799999999999999997543 24599999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+|+...... ........|++.|+|||++.+..++.++|||||||++|||++|+.||..... ...+.+.+...++
T Consensus 161 ~a~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~~ 234 (287)
T d1opja_ 161 LSRLMTGDT-----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYR 234 (287)
T ss_dssp CTTTCCSSS-----SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCC
T ss_pred ceeecCCCC-----ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCCC
Confidence 998654321 1122334588999999999999999999999999999999998777643222 1122233333332
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
...+..+++.+ .+++.+||+.||++||||+|+++.|+.+
T Consensus 235 ~~~~~~~~~~l----------------------~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 235 MERPEGCPEKV----------------------YELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCCTTCCHHH----------------------HHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCccchHHH----------------------HHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22222222222 2267789999999999999999998765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-49 Score=406.26 Aligned_cols=262 Identities=24% Similarity=0.407 Sum_probs=193.6
Q ss_pred cCCCCCCccccccceEEEEEEeCC-C---cEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-G---ISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
++|++.+.||+|+||.||+|.++. + ..||||.+... .....+.|.+|++++++++|||||+++++|. .++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eCC
Confidence 456677899999999999999753 3 35899988644 3334567999999999999999999999964 345
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++|||||++|+|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 172 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDF 172 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEEecCCCcceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCc
Confidence 6799999999999999887643 2399999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|+|+.......... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||..... ..+...+...
T Consensus 173 Gla~~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i~~~ 249 (299)
T d1jpaa_ 173 GLSRFLEDDTSDPT-YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQD 249 (299)
T ss_dssp ------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTT
T ss_pred ccceEccCCCCcce-eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC
Confidence 99987654322211 112223457899999999999999999999999999999998 8999865422 1222223222
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
.....+..+++. +.+++.+||+.||++||||+|+++.|+++.+.
T Consensus 250 ~~~~~~~~~~~~----------------------l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 YRLPPPMDCPSA----------------------LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCCCCCTTCCHH----------------------HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCccchHH----------------------HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 222111112221 22367789999999999999999999987653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=401.47 Aligned_cols=265 Identities=25% Similarity=0.383 Sum_probs=207.4
Q ss_pred cCCCCCCc-cccccceEEEEEEeC---CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 455 GNFSHENL-IGSGSFGSVYKGYLR---EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
++|.+.+. ||+|+||.||+|.++ ++..||||+++... ....++|.+|++++++++|||||+++++|.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence 45666664 999999999999865 35579999996543 3345789999999999999999999998743 2
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+++||||+++|+|.+++...+ ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred eEEEEEEeCCCCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence 3689999999999999986543 2499999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhh
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 688 (767)
|+|+....... .........||+.|+|||++.++.++.++|||||||++|||+| |+.||..... ..+...+...
T Consensus 154 Gla~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~~ 228 (285)
T d1u59a_ 154 GLSKALGADDS---YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQG 228 (285)
T ss_dssp TTCEECTTCSC---EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTT
T ss_pred hhhhccccccc---ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC
Confidence 99987644321 1122234568999999999998899999999999999999998 8999976432 2222333222
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhhcCC
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQ 760 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~ 760 (767)
.+...+..+++.+ .+++.+||+.||++|||+.++.+.|+.+........+
T Consensus 229 ~~~~~p~~~~~~l----------------------~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~ 278 (285)
T d1u59a_ 229 KRMECPPECPPEL----------------------YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278 (285)
T ss_dssp CCCCCCTTCCHHH----------------------HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred CCCCCCCcCCHHH----------------------HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence 2222222222222 2267789999999999999999999988776654443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=400.17 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=203.9
Q ss_pred hcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
.++|++.+.||+|+||.||+|.+++++.||||+++... ...+.+.+|++++++++|||||++++++.. +..++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeEE
Confidence 45788999999999999999999888999999996433 345789999999999999999999998642 23589
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
||||+++|+|.+++.... ...+++.++..|+.||++||+|||++ +|+||||||+||++++++.+||+|||+|+
T Consensus 85 v~Ey~~~g~L~~~~~~~~----~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp EEECCTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceE
Confidence 999999999999886543 23489999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccch
Q 004218 614 SLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
...... ........||+.|+|||++.++.++.++|||||||++|||+||..|+...... ......+....+...
T Consensus 158 ~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i~~~~~~~~ 231 (272)
T d1qpca_ 158 LIEDNE-----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERGYRMVR 231 (272)
T ss_dssp ECSSSC-----EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCCCC
T ss_pred EccCCc-----cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCCCC
Confidence 654321 11223456899999999999889999999999999999999976665332221 112222222222212
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
+..+.+. +.+++.+||+.||++||||+|+++.|+....
T Consensus 232 p~~~~~~----------------------l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 232 PDNCPEE----------------------LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccChHH----------------------HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 2222221 2236778999999999999999999987654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=393.27 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=205.6
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
++|++.+.||+|+||+||+|++++++.||||+++... ...+++.+|++++++++||||++++|+|. +++.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEEE
Confidence 5799999999999999999999888899999997543 34578999999999999999999999964 34567999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++|+|.+++..... .+++..+.+++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 78 ~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp EECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred EEccCCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhee
Confidence 999999999999766543 389999999999999999999999 999999999999999999999999999976
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccch
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+........
T Consensus 150 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~~~~~~ 222 (258)
T d1k2pa_ 150 VLDDEYT-----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYR 222 (258)
T ss_dssp CSSSSCC-----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCCCCC
T ss_pred ccCCCce-----eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhCCCCCC
Confidence 5432211 1233568999999999999999999999999999999998 89999764322 12222222222222
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKN 750 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 750 (767)
+....+. +.+++.+||+.||++|||++|++++|.+
T Consensus 223 p~~~~~~----------------------l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASEK----------------------VYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCHH----------------------HHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccccHH----------------------HHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2222222 2236778999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=408.81 Aligned_cols=199 Identities=24% Similarity=0.413 Sum_probs=175.2
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|++++++++|||||++++++. +...+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 568999999999999999999975 58999999997553 334567899999999999999999999964 45678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
++||||+++|+|.+++..... +++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~------l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred EEEEEcCCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence 999999999999999976543 9999999999999999999996 6 89999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+|+...+.. ....+||+.|+|||++.+..+++++||||+||++|||++|+.||...
T Consensus 151 la~~~~~~~--------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 151 VSGQLIDSM--------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CCHHHHHHT--------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred CccccCCCc--------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 998765432 13457999999999999999999999999999999999999999654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=395.27 Aligned_cols=251 Identities=27% Similarity=0.366 Sum_probs=195.0
Q ss_pred CccccccceEEEEEEeCC---CcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEEE
Q 004218 461 NLIGSGSFGSVYKGYLRE---GISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALVY 535 (767)
Q Consensus 461 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 535 (767)
+.||+|+||.||+|.+++ ++.||||+++.. .....+++.+|++++++++|||||+++++|.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 469999999999998643 568999998643 22345679999999999999999999999742 2358999
Q ss_pred eecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhhh
Q 004218 536 EFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARSL 615 (767)
Q Consensus 536 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 615 (767)
||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 87 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence 9999999999997644 399999999999999999999999 9999999999999999999999999999865
Q ss_pred hhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccchh
Q 004218 616 LERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 616 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
..... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ..+...+....+...+
T Consensus 158 ~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~~~~~~~p 232 (277)
T d1xbba_ 158 RADEN---YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCP 232 (277)
T ss_dssp CTTCS---EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCC
T ss_pred ccccc---ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHcCCCCCCC
Confidence 43221 1112234568999999999999999999999999999999998 8999975322 1222222222222222
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
..+++.+ .+++.+||+.||++|||++|+++.|+....
T Consensus 233 ~~~~~~~----------------------~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 233 AGCPREM----------------------YDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TTCCHHH----------------------HHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cccCHHH----------------------HHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 2222222 226778999999999999999999887643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-49 Score=400.80 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=184.8
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
.+.|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|++++++++||||+++++++ .+++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 467999999999999999999976 58999999996543 23345678999999999999999999995 456678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEcc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD---EDMTAKVGD 608 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~D 608 (767)
|+|||||+||+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||++. +++.+||+|
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence 99999999999999997643 399999999999999999999999 999999999999995 578999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||+|+...... ......||+.|+|||++.+..+++++||||+||++|||++|+.||....... .........
T Consensus 154 FG~a~~~~~~~-------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~ 225 (307)
T d1a06a_ 154 FGLSKMEDPGS-------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKAE 225 (307)
T ss_dssp C-------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHTTC
T ss_pred cceeEEccCCC-------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhccC
Confidence 99998654321 1234569999999999999999999999999999999999999996532211 111111111
Q ss_pred cc--cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FP--KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+ ......+++. +.+++.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~s~~----------------------~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 YEFDSPYWDDISDS----------------------AKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCCTTTTTTSCHH----------------------HHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCccccCCCHH----------------------HHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11 1111112221 2236778999999999999999884
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=398.39 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=197.6
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++++++++||||+++++++ .+++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 46999999999999999999975 5899999998643 234557789999999999999999999995 45567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+||||+++|+|.+++...+. +++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~------l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEccCCCCHHHhhhccCC------CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence 8999999999999999876543 99999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+|+.+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........+
T Consensus 154 ~a~~~~~~~~~----~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~- 227 (288)
T d1uu3a_ 154 TAKVLSPESKQ----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEY- 227 (288)
T ss_dssp TCEECC--------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTCC-
T ss_pred cceecccCCcc----cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHHcCCC-
Confidence 99865432211 12234579999999999999999999999999999999999999996532111 1111111111
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
..+..+++. +++++.+||+.||++|||++|++++
T Consensus 228 -~~p~~~s~~----------------------~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 -DFPEKFFPK----------------------ARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -CCCTTCCHH----------------------HHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -CCCccCCHH----------------------HHHHHHHHccCCHhHCcCHHHHcCC
Confidence 111111211 2237779999999999999997654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=394.81 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=196.6
Q ss_pred cCCCCCCccccccceEEEEEEeCCC-----cEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREG-----ISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
..|+..++||+|+||.||+|.++.. ..||||++..... ....+|.+|++++++++|||||+++|++. ..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----cC
Confidence 4678889999999999999997642 4799999865433 33457899999999999999999999964 34
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
...++||||+.+|++.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~D 153 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 153 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CceEEEEEecccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcc
Confidence 55799999999999999886543 3499999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN 688 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 688 (767)
||+|+......... .......||+.|+|||++.++.++.++|||||||++|||++|..|+...... ..+...+...
T Consensus 154 FGla~~~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~ 229 (283)
T d1mqba_ 154 FGLSRVLEDDPEAT---YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDG 229 (283)
T ss_dssp CCC--------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTT
T ss_pred cchhhcccCCCccc---eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhcc
Confidence 99998765432111 1123345899999999999999999999999999999999977665432221 1222222222
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
.....+..+... +.+++.+||+.||++||||+|+++.|+++.+.
T Consensus 230 ~~~~~~~~~~~~----------------------l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 FRLPTPMDCPSA----------------------IYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCCCTTCBHH----------------------HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCchhhHHH----------------------HHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 222212222221 22377789999999999999999999988764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=402.77 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=201.5
Q ss_pred cCCCCCCccccccceEEEEEEeCC------CcEEEEEEeecc-CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE------GISVAVKVLDIE-STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 526 (767)
++|++.+.||+|+||.||+|++.. ...||+|.+... .......+.+|+.+++++ +|||||++++++.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~----- 111 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT----- 111 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe-----
Confidence 578899999999999999999653 236999988543 334456789999999998 8999999999964
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKN-----------------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHC 589 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 589 (767)
+.+.+++|||||++|+|.++++..+.. .....+++.+++.++.|+++||+|||++ +||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 445679999999999999999765421 1123589999999999999999999999 99999
Q ss_pred cCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CC
Q 004218 590 DLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GM 668 (767)
Q Consensus 590 Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~ 668 (767)
||||+||+++.++.+||+|||+|+........ .......||+.|+|||++.++.++.++|||||||++|||+| |+
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cCchhccccccCCeEEEeeccccccccCCCce----eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 99999999999999999999999865443211 12234568999999999999999999999999999999998 89
Q ss_pred CCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 004218 669 SPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRL 748 (767)
Q Consensus 669 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 748 (767)
.||...... ..+.+.+...++...+..+++.+ .+++.+||+.||++|||++|++++|
T Consensus 265 ~Pf~~~~~~-~~~~~~~~~~~~~~~p~~~~~~l----------------------~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 265 NPYPGIPVD-ANFYKLIQNGFKMDQPFYATEEI----------------------YIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp CSSTTCCCS-HHHHHHHHTTCCCCCCTTCCHHH----------------------HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCHH-HHHHHHHhcCCCCCCCCcCCHHH----------------------HHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999654322 22333333333322222233222 2367789999999999999999998
Q ss_pred H
Q 004218 749 K 749 (767)
Q Consensus 749 ~ 749 (767)
.
T Consensus 322 ~ 322 (325)
T d1rjba_ 322 G 322 (325)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-49 Score=401.48 Aligned_cols=245 Identities=25% Similarity=0.315 Sum_probs=194.4
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
..|+..+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|++++++++|||||++++++. +++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCE
Confidence 35899999999999999999975 588999999875432 23457889999999999999999999964 4566
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+|||||++|++..++.... ++++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEEecCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence 899999999999987765433 399999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCC---CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhh
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG---EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 687 (767)
+|+.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+......
T Consensus 161 ~a~~~~~----------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~~~ 229 (309)
T d1u5ra_ 161 SASIMAP----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN 229 (309)
T ss_dssp TCBSSSS----------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHS
T ss_pred cccccCC----------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhC
Confidence 9975422 133569999999999864 45899999999999999999999999653221 111111222
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALR 746 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 746 (767)
..+......+++. +.+++.+||+.||++||||+|+++
T Consensus 230 ~~~~~~~~~~s~~----------------------~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 230 ESPALQSGHWSEY----------------------FRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCCCSCTTSCHH----------------------HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCHH----------------------HHHHHHHHCcCChhHCcCHHHHHh
Confidence 2222111112221 223667899999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-48 Score=403.90 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=201.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||.||+|+++ +|+.||||++........+.+.+|++++++++|||||++++++ .+++.++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 468999999999999999999975 5999999999766555667889999999999999999999995 4556789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CCCceEEcccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD--EDMTAKVGDFG 610 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~~~kl~Dfg 610 (767)
+|||||+||+|.+++.... ..+++.++..|+.||+.||+|||++ +||||||||+||+++ .++.+||+|||
T Consensus 100 ivmE~~~gg~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEECCCCSCBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence 9999999999999986543 2399999999999999999999999 999999999999996 46889999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc-
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF- 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~- 689 (767)
+|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .+.......+
T Consensus 172 ~a~~~~~~-------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~ 243 (350)
T d1koaa2 172 LTAHLDPK-------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWN 243 (350)
T ss_dssp TCEECCTT-------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC
T ss_pred hheecccc-------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC
Confidence 99865432 12234679999999999999999999999999999999999999996532211 1111111111
Q ss_pred -ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 -PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 -~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+......+++. +++++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~s~~----------------------~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 MDDSAFSGISED----------------------GKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SCCGGGGGCCHH----------------------HHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCcccccCCCHH----------------------HHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111111211 2236678999999999999999885
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=393.81 Aligned_cols=267 Identities=28% Similarity=0.404 Sum_probs=204.6
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++++|.. +..++|
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~lv 89 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIV 89 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeEEE
Confidence 5799999999999999999999888899999996443 345789999999999999999999998642 235899
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++|+|.+++.... ...+++.++..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+|+.
T Consensus 90 ~Ey~~~g~l~~~~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp ECCCTTCBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEecCCCchhhhhhhcc----cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhh
Confidence 99999999999987643 23499999999999999999999999 999999999999999999999999999986
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchh
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
...... .......||+.|+|||++..+.++.++|||||||++|||++|..|+...... ......+.........
T Consensus 163 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~~~~~ 236 (285)
T d1fmka3 163 IEDNEY-----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP 236 (285)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCCCCC
T ss_pred ccCCCc-----eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCCCCC
Confidence 543221 1223456899999999999999999999999999999999977665443222 1222222222222222
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhhcCCCCc
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLKRRQPNE 763 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~~~~ 763 (767)
..+++.+ .+++.+||+.||++|||+++|++.|+..........+|++
T Consensus 237 ~~~~~~l----------------------~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~ 283 (285)
T d1fmka3 237 PECPESL----------------------HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283 (285)
T ss_dssp TTSCHHH----------------------HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred cccCHHH----------------------HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCC
Confidence 2222222 2367789999999999999999999876655444444443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=387.37 Aligned_cols=253 Identities=30% Similarity=0.413 Sum_probs=197.3
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
++|++.+.||+|+||.||+|.++ |+.||||+++. ....+.+.+|++++++++||||++++|+|.+ ..+.+++|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv 79 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIV 79 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEEEE
Confidence 46788899999999999999996 88999999964 3455789999999999999999999998742 33457999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
|||+++|+|.+++..... ..+++..+++|+.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~ey~~~g~L~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp ECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccccccee
Confidence 999999999999975431 2389999999999999999999999 999999999999999999999999999986
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhhhcccch
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVESNFPKNA 693 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 693 (767)
.... .....+|..|+|||++.+..+++++|||||||++|||+| |++||..... ..+...+........
T Consensus 153 ~~~~---------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~~~~~~~ 221 (262)
T d1byga_ 153 ASST---------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKMDA 221 (262)
T ss_dssp ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTCCCCC
T ss_pred cCCC---------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCCC
Confidence 5332 123457899999999998999999999999999999998 6777755322 233333333222222
Q ss_pred hhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 694 QQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 694 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
+...++.++ +++.+||+.||++||||.|++++|+.++..
T Consensus 222 ~~~~~~~~~----------------------~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 222 PDGCPPAVY----------------------EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CTTCCHHHH----------------------HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccCCHHHH----------------------HHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 222332222 266789999999999999999999988653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.3e-48 Score=401.99 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=202.2
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.+.|++.+.||+|+||.||+|.+. +|+.||||+++.......+.+.+|++++++++||||+++++++ .++..+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 357999999999999999999975 5999999999766555567788999999999999999999995 4567789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CCCceEEcccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD--EDMTAKVGDFG 610 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~~~kl~Dfg 610 (767)
+|||||+||+|.+++.... .++++.+++.|+.||+.||+|||++ ||+||||||+|||++ .++.+||+|||
T Consensus 103 ivmE~~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp EEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEcCCCChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence 9999999999999876543 3499999999999999999999999 999999999999998 67899999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh--
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN-- 688 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-- 688 (767)
+|+..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||....... .+.......
T Consensus 175 la~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~ 246 (352)
T d1koba_ 175 LATKLNPD-------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE 246 (352)
T ss_dssp TCEECCTT-------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC
T ss_pred cceecCCC-------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC
Confidence 99875432 12234568999999999999999999999999999999999999996532211 111111111
Q ss_pred cccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 FPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
++......+++. +.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~s~~----------------------~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 FDEDAFSSVSPE----------------------AKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCSSTTTTSCHH----------------------HHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCcccccCCCHH----------------------HHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111222222 2236778999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=391.08 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=198.6
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC------cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST------GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|++.+.||+|+||.||+|+++ +|+.||||+++.... ...+.+.+|++++++++|||||++++++ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 368999999999999999999975 589999999864321 2356789999999999999999999995 4
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM---- 602 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---- 602 (767)
+...+|+|||||++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSC
T ss_pred ECCEEEEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCccc
Confidence 5667899999999999999997654 399999999999999999999999 999999999999998776
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchh
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLV 682 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 682 (767)
.+||+|||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...
T Consensus 155 ~vkl~DfG~a~~~~~~~-------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~ 226 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA 226 (293)
T ss_dssp CEEECCCTTCEECTTSC-------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH
T ss_pred ceEecchhhhhhcCCCc-------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHH
Confidence 59999999997654321 1234568999999999999999999999999999999999999996532211 011
Q ss_pred hHhhhhc--ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 683 KWVESNF--PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 683 ~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
....... +......+ ...+.+++.+||+.||++|||++|++++
T Consensus 227 ~i~~~~~~~~~~~~~~~----------------------s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 227 NVSAVNYEFEDEYFSNT----------------------SALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHTTCCCCCHHHHTTS----------------------CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHhcCCCCCchhcCCC----------------------CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111 10011111 1122337779999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=393.25 Aligned_cols=268 Identities=24% Similarity=0.354 Sum_probs=197.5
Q ss_pred HhcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcC-CCCCceeEEeeeecCC
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIES-TGTWKSFFAECEALRNT-RHRNLVKLITSCSSLD 524 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 524 (767)
..++|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++..
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-- 88 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 88 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc--
Confidence 3467999999999999999999964 24689999986443 23456678888888776 68999999998743
Q ss_pred cccceeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 004218 525 FKNMEFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPG 594 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~ 594 (767)
.+..+++|||||++|+|.+++...+.. .....+++.++..++.||++||+|||++ +||||||||+
T Consensus 89 --~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~ 163 (299)
T d1ywna1 89 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 163 (299)
T ss_dssp --TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred --CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence 345679999999999999999764321 1124589999999999999999999999 9999999999
Q ss_pred CeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCC-CCCCC
Q 004218 595 NILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGM-SPTHE 673 (767)
Q Consensus 595 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~-~p~~~ 673 (767)
|||+++++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+||. +||..
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTS----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ceeECCCCcEEEccCcchhhccccccc----cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999865432211 1224457999999999999999999999999999999999975 56654
Q ss_pred cccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 674 SFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
... ...+...+........++.+.+.+ .+++.+||+.||++||||+|++++|+++.+
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l----------------------~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 240 VKI-DEEFCRRLKEGTRMRAPDYTTPEM----------------------YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCC-SHHHHHHHHHTCCCCCCTTCCHHH----------------------HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCH-HHHHHHHHhcCCCCCCCccCCHHH----------------------HHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 322 222223333222222222222222 226778999999999999999999998865
Q ss_pred H
Q 004218 754 I 754 (767)
Q Consensus 754 ~ 754 (767)
+
T Consensus 297 ~ 297 (299)
T d1ywna1 297 A 297 (299)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-47 Score=387.08 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=198.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC---cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST---GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++++.++||||+++++++...+ ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 467999999999999999999975 599999999965432 23457899999999999999999999875422 2345
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+|+||||++||+|.+++...+. +++.++..++.||+.||+|||++ +|+||||||+||+++.++..+++||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~------l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGP------MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred eEEEEEECCCCCEehhhhcccCC------CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence 68999999999999999876543 99999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|.+........ .........||+.|+|||++.+..+++++||||+||++|||+||+.||........ .........
T Consensus 156 ~~~~~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~~ 231 (277)
T d1o6ya_ 156 GIARAIADSGN---SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDP 231 (277)
T ss_dssp TTCEECC-------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCC
T ss_pred hhhhhhccccc---cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHhcCC
Confidence 99875433221 11223456799999999999999999999999999999999999999965322111 111111111
Q ss_pred cc--chhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-CHHHHHHHHHHHH
Q 004218 690 PK--NAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-DIREALRRLKNAQ 752 (767)
Q Consensus 690 ~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~~ 752 (767)
.. .....+++ .+.+++.+||++||++|| ||+|+++.|.+++
T Consensus 232 ~~~~~~~~~~s~----------------------~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 IPPSARHEGLSA----------------------DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCGGGTSSSCCH----------------------HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCchhccCCCH----------------------HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 10 01111111 122366789999999999 8999999988765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=390.68 Aligned_cols=249 Identities=26% Similarity=0.343 Sum_probs=201.1
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
.++|++.+.||+|+||.||+|+.+ +|+.||||+++.. .....+.+.+|++++++++||||+++++++ .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 357999999999999999999975 5999999999643 334567789999999999999999999994 4567
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+|+||||++||+|.+++...+. +++..++.++.|++.||+|||++ +|+||||||+||+++.+|.+||+||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~------~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERV------FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ccccceeccCCCchhhhhhcccC------CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence 78999999999999999987553 89999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|+|+...... ......+||+.|+|||++.+..++.++||||+||++|||++|++||...... .+.+......
T Consensus 150 G~a~~~~~~~------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~~i~~~~ 221 (337)
T d1o6la_ 150 GLCKEGISDG------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILMEE 221 (337)
T ss_dssp TTCBCSCCTT------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC
T ss_pred ccccccccCC------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--HHHHHHhcCC
Confidence 9998643221 1224467999999999999999999999999999999999999999664321 1111111111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC-----HHHHHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID-----IREALRR 747 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 747 (767)
+ ..+..+++. +++++.+||++||++||+ ++|++++
T Consensus 222 ~-~~p~~~s~~----------------------~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 I-RFPRTLSPE----------------------AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C-CCCTTSCHH----------------------HHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C-CCCccCCHH----------------------HHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1 111112221 223677899999999995 8888874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=390.24 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=199.9
Q ss_pred cCCCCCCccccccceEEEEEEeCC-Cc----EEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GI----SVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
..|++.+.||+|+||.||+|.+.. |+ +||+|.++.. .....+++.+|++++++++|||||+++++|...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 468999999999999999999753 43 6899988543 344567899999999999999999999997542
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
..++++||+.+|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D 154 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 154 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred -CeeEEEEeccCCcccccccccc-----cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeec
Confidence 3478999999999999887653 3499999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 687 (767)
||+|+........ .......||+.|+|||++.++.++.++|||||||++|||+| |++||...... .+...+..
T Consensus 155 FGla~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~~ 228 (317)
T d1xkka_ 155 FGLAKLLGAEEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK 228 (317)
T ss_dssp CSHHHHTTTTCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHHH
T ss_pred cccceeccccccc----ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc
Confidence 9999876543221 11233468999999999999999999999999999999998 78888654322 22233322
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
......+..+++.+ .+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 229 ~~~~~~p~~~~~~~----------------------~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 229 GERLPQPPICTIDV----------------------YMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp TCCCCCCTTBCHHH----------------------HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCcccCHHH----------------------HHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 22222222222222 2267789999999999999999999887654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=384.71 Aligned_cols=258 Identities=23% Similarity=0.341 Sum_probs=194.2
Q ss_pred hcCCCCCCccccccceEEEEEEeCC----CcEEEEEEeeccCC-cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIEST-GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 528 (767)
.++|++.+.||+|+||.||+|.+.. +..||||.++.... ...+.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 3578999999999999999998753 45688998864433 335679999999999999999999998632
Q ss_pred eeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 004218 529 EFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGD 608 (767)
Q Consensus 529 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D 608 (767)
+.+++||||+++|++.+++.... ..+++.++..++.||++||+|||++ +|+||||||+||++++++.+||+|
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CeEEEEEEeccCCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEcc
Confidence 35699999999999999876543 3489999999999999999999999 999999999999999999999999
Q ss_pred ccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHhhh
Q 004218 609 FGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWVES 687 (767)
Q Consensus 609 fg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 687 (767)
||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...... .+...+..
T Consensus 152 fG~a~~~~~~~~-----~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~ 224 (273)
T d1mp8a_ 152 FGLSRYMEDSTY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIEN 224 (273)
T ss_dssp ------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred chhheeccCCcc-----eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHc
Confidence 999987543221 11234568999999999999999999999999999999998 88898664332 22222222
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
......+..+++. +.+++.+||+.||++|||++|++++|+.+.+.
T Consensus 225 ~~~~~~~~~~~~~----------------------~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 GERLPMPPNCPPT----------------------LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHH----------------------HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 2211222222222 22367789999999999999999999988654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-47 Score=389.89 Aligned_cols=267 Identities=25% Similarity=0.367 Sum_probs=205.0
Q ss_pred HHHHhcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCCc-chhhHHHHHHHHhcCCCCCceeEEeeeec
Q 004218 450 LRRATGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIESTG-TWKSFFAECEALRNTRHRNLVKLITSCSS 522 (767)
Q Consensus 450 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 522 (767)
++...++|++.+.||+|+||.||+|+++ +++.||||+++..... ..+++.+|++++++++||||++++++|..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3345678999999999999999999964 3578999998654333 35679999999999999999999999753
Q ss_pred CCcccceeeEEEEeecCCCChhhhhcccCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 004218 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKN------------------EHGNGLNFLERLNIAIDIASALDYLHNDCEV 584 (767)
Q Consensus 523 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 584 (767)
....++||||+++|+|.+++...... .....+++.++..|+.|++.||+|||++
T Consensus 88 -----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--- 159 (301)
T d1lufa_ 88 -----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--- 159 (301)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred -----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---
Confidence 45569999999999999999753321 1234589999999999999999999999
Q ss_pred CeEeecCCCCCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHH
Q 004218 585 PIVHCDLKPGNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEI 664 (767)
Q Consensus 585 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el 664 (767)
+||||||||+||+++.++.+||+|||+|+...+..... ......||+.|+|||.+.+..++.++|||||||++|||
T Consensus 160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~el 235 (301)
T d1lufa_ 160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235 (301)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC--------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CeEeeEEcccceEECCCCcEEEccchhheeccCCcccc----ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHH
Confidence 99999999999999999999999999998765432221 22345688999999999999999999999999999999
Q ss_pred HhCC-CCCCCcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHH
Q 004218 665 FTGM-SPTHESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIRE 743 (767)
Q Consensus 665 ~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~e 743 (767)
++|. +||...... .....+........+..+.+. +.+|+.+||+.||++||||.|
T Consensus 236 l~~~~~p~~~~~~~--e~~~~v~~~~~~~~p~~~~~~----------------------~~~li~~cl~~~P~~RPt~~e 291 (301)
T d1lufa_ 236 FSYGLQPYYGMAHE--EVIYYVRDGNILACPENCPLE----------------------LYNLMRLCWSKLPADRPSFCS 291 (301)
T ss_dssp HTTTCCTTTTSCHH--HHHHHHHTTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHH
T ss_pred HccCCCCCCCCCHH--HHHHHHHcCCCCCCCccchHH----------------------HHHHHHHHcCCChhHCcCHHH
Confidence 9996 566543221 122222221111112122221 122777899999999999999
Q ss_pred HHHHHHHHH
Q 004218 744 ALRRLKNAQ 752 (767)
Q Consensus 744 vl~~L~~~~ 752 (767)
|++.|+++.
T Consensus 292 v~~~L~~i~ 300 (301)
T d1lufa_ 292 IHRILQRMC 300 (301)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHhc
Confidence 999998763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-46 Score=393.94 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=193.4
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC---CcchhhHH---HHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES---TGTWKSFF---AECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
++|++.+.||+|+||.||+|++. +|+.||||++.... ......+. +|+++++.++||||+++++++ ..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----EE
Confidence 57999999999999999999976 59999999986431 12223333 447777888999999999995 45
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
.+.+|+||||+++|+|.+++..... +++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~~~------~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQHGV------FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEEC
T ss_pred CCEEEEEEEecCCCcHHHHHHhccc------ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEe
Confidence 5678999999999999999976543 89999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE 686 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 686 (767)
|||+|+..... ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||...............
T Consensus 150 DFGla~~~~~~--------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 221 (364)
T d1omwa3 150 DLGLACDFSKK--------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 221 (364)
T ss_dssp CCTTCEECSSS--------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS
T ss_pred eeceeeecCCC--------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 99999865332 1234569999999999864 56899999999999999999999999764333221111111
Q ss_pred hhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCC-----HHHHHHH
Q 004218 687 SNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRID-----IREALRR 747 (767)
Q Consensus 687 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 747 (767)
...+...+..+++.+ .+++.+||+.||++||| |+|++++
T Consensus 222 ~~~~~~~~~~~s~~~----------------------~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 222 LTMAVELPDSFSPEL----------------------RSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SSCCCCCCSSSCHHH----------------------HHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ccCCCCCCCCCCHHH----------------------HHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 111111122222222 23667899999999999 6888764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=384.15 Aligned_cols=261 Identities=25% Similarity=0.394 Sum_probs=202.3
Q ss_pred CCccccccceEEEEEEeCC----CcEEEEEEeecc-CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEEE
Q 004218 460 ENLIGSGSFGSVYKGYLRE----GISVAVKVLDIE-STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLALV 534 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 534 (767)
.++||+|+||+||+|.+.+ ...||||+++.. .....++|.+|++++++++||||++++|+|.. .+...++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence 4679999999999999754 236899998643 34456789999999999999999999999753 33467999
Q ss_pred EeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccchhh
Q 004218 535 YEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLARS 614 (767)
Q Consensus 535 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 614 (767)
||||++|+|.+++.... ...++..+.+++.|++.||.|+|+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 108 ~E~~~~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EECCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred EEEeecCchhhhhcccc-----ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhh
Confidence 99999999999987654 3378899999999999999999999 999999999999999999999999999987
Q ss_pred hhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcccchh
Q 004218 615 LLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFPKNAQ 694 (767)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 694 (767)
........ ........||+.|+|||.+.+..++.++||||||+++|||+||+.||....... .....+........+
T Consensus 180 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~~~~p 256 (311)
T d1r0pa_ 180 MYDKEFDS--VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRRLLQP 256 (311)
T ss_dssp TTTTTCCC--TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCCCCC
T ss_pred cccccccc--ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCCCCCc
Confidence 65432221 112234568999999999999999999999999999999999888876543222 222222222211112
Q ss_pred hhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHHhh
Q 004218 695 QVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKILLK 757 (767)
Q Consensus 695 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 757 (767)
..+.+.+ .+++.+||+.||++||||.||+++|+++...+..
T Consensus 257 ~~~~~~l----------------------~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 257 EYCPDPL----------------------YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp TTCCHHH----------------------HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ccCcHHH----------------------HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 2222221 2267789999999999999999999999876544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-46 Score=384.09 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=198.7
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++.+.||+|+||+||+|+++ +|+.||||+++.. .....+.+.+|+.++++++||||+++++++ .+.+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 56899999999999999999975 5999999999643 334567889999999999999999999995 45667
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+||||++||+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~------~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQR------FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSS------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eeeEeeecCCcccccccccccc------ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence 8999999999999999876543 88999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+|+..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..........
T Consensus 150 ~a~~~~~~---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~- 218 (316)
T d1fota_ 150 FAKYVPDV---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAEL- 218 (316)
T ss_dssp SCEECSSC---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCCC-
T ss_pred cceEeccc---------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-HHHHHHcCCC-
Confidence 99865322 234579999999999999999999999999999999999999996532211 0111111111
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
..+..+++. +.+++.+||+.||.+|| |++|++++
T Consensus 219 -~~p~~~s~~----------------------~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 -RFPPFFNED----------------------VKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCCTTSCHH----------------------HHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCHH----------------------HHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111112221 22366689999999996 89999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=382.61 Aligned_cols=256 Identities=26% Similarity=0.348 Sum_probs=191.6
Q ss_pred cCCCCCCccccccceEEEEEEeCC----CcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE----GISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKN 527 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 527 (767)
++|++.+.||+|+||.||+|++.. ...||||++... .....++|.+|++++++++||||++++|+|.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 568899999999999999998542 247899988643 33345789999999999999999999999743
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
...++||||+++|++.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~ 153 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG 153 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred -cchheeeeeecCcchhhhhhcccC-----CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence 235899999999999998876542 399999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCCCcccCCcchhhHh-
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTHESFAGEVSLVKWV- 685 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~- 685 (767)
|||+++........ ........|+..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+
T Consensus 154 DfGl~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~ 228 (273)
T d1u46a_ 154 DFGLMRALPQNDDH---YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKID 228 (273)
T ss_dssp CCTTCEECCC-CCE---EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH
T ss_pred cchhhhhcccCCCc---ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHH
Confidence 99999876443211 112234557889999999999999999999999999999998 89998653221 111221
Q ss_pred hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHH
Q 004218 686 ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNA 751 (767)
Q Consensus 686 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 751 (767)
...........+++. +.+++.+||+.||++||||+|+.+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~----------------------l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 229 KEGERLPRPEDCPQD----------------------IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TSCCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCCCCcccccHH----------------------HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111111222222 22267789999999999999999999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=383.97 Aligned_cols=278 Identities=24% Similarity=0.305 Sum_probs=197.3
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHH--HHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECE--ALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~--~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
..|...+.||+|+||.||+|+++ |+.||||+++.. ..+.+.+|.+ .+.+++||||++++++|...+ .....++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEE
Confidence 45777889999999999999975 889999998643 2234444444 455779999999999986532 2334689
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeecCCCCCeeeCCCCceEEc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC-----EVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
+||||+++|+|.+++++.. +++..+..++.|++.||+|+|+.. .++||||||||+||+++.++.+||+
T Consensus 78 lv~Ey~~~g~L~~~l~~~~-------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEecccCCCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 9999999999999997643 899999999999999999999631 2499999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCC------CCCcccchhhhHHHHHHHhCCCCCCCcccCCcch
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK------PSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL 681 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 681 (767)
|||+++........ .........||+.|+|||++.+.. ++.++|||||||++|||+||..||..........
T Consensus 151 DFGl~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 151 DLGLAVRHDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CCTTCEEEETTTTE--ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred ecCccccccCCCcc--eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 99999876443211 111234567999999999987643 5678999999999999999998875433222111
Q ss_pred hhHhhhhcccchhhhccHHHHHhhhc-----chhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHH
Q 004218 682 VKWVESNFPKNAQQVLDRELRQLMMS-----SESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKI 754 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 754 (767)
...... ......+...... .........+.... +.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 229 ~~~~~~-------~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~-l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 229 YDLVPS-------DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV-MAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTSCS-------SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHH-HHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcccc-------cchHHHHHHHHhccccCCCCCcccCChHHHHH-HHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 110000 0000111111100 00011111112222 23378899999999999999999999988764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-46 Score=375.65 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=196.8
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCc---------chhhHHHHHHHHhcCC-CCCceeEEeeeecC
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTG---------TWKSFFAECEALRNTR-HRNLVKLITSCSSL 523 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 523 (767)
++|++.+.||+|+||+||+|++. +|+.||||+++..... ..+.+.+|+.++++++ ||||+++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 68999999999999999999975 5899999998654322 1245889999999996 99999999995
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMT 603 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~ 603 (767)
.+++.+|+||||+++|+|.+++.... ++++.+++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred --ccCcceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence 45678899999999999999997644 399999999999999999999999 9999999999999999999
Q ss_pred eEEccccchhhhhhhcCCCccccccccccCCCCccCccccC------CCCCCCcccchhhhHHHHHHHhCCCCCCCcccC
Q 004218 604 AKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGL------GEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAG 677 (767)
Q Consensus 604 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 677 (767)
+||+|||+++...... ......||+.|+|||++. ...++.++||||+||++|||++|+.||......
T Consensus 149 ~kl~DFG~a~~~~~~~-------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221 (277)
T ss_dssp EEECCCTTCEECCTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eEEccchheeEccCCC-------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence 9999999998764321 123456999999999875 345788999999999999999999999764321
Q ss_pred CcchhhHhhhhc--ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 678 EVSLVKWVESNF--PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 678 ~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
. .........+ +......+++. +.+++.+||++||++|||++|++++
T Consensus 222 ~-~~~~i~~~~~~~~~~~~~~~s~~----------------------~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 222 L-MLRMIMSGNYQFGSPEWDDYSDT----------------------VKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp H-HHHHHHHTCCCCCTTTGGGSCHH----------------------HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred H-HHHHHHhCCCCCCCcccccCCHH----------------------HHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 1111111111 11111112221 2236668999999999999999764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=383.68 Aligned_cols=267 Identities=21% Similarity=0.349 Sum_probs=208.5
Q ss_pred hcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccCC-cchhhHHHHHHHHhcC-CCCCceeEEeeeecCCc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIEST-GTWKSFFAECEALRNT-RHRNLVKLITSCSSLDF 525 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 525 (767)
.++|++.+.||+|+||.||+|++. +++.||||+++.... .....+.+|+.+++++ +|||||+++++|..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence 468889999999999999999852 367899999975433 3455788999999998 69999999999753
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKN------------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKP 593 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 593 (767)
....++||||+++|+|.++++..... .....+++.++..++.||++|++|||++ +||||||||
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 34569999999999999999765421 1234599999999999999999999999 999999999
Q ss_pred CCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 594 GNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 594 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
+||+++.++.+|++|||.++........ .......||+.|+|||++.+..++.++|||||||++|||+|++.|+..
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTS----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccCcccccccchheeccCCCcc----eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 9999999999999999999876443221 222446789999999999999999999999999999999995555443
Q ss_pred cccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 674 SFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
.......+.+.+....+...+...++.+ .+++.+||+.||++||||+|++++|+++..
T Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l----------------------~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEM----------------------YDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp TCCSSHHHHHHHHHTCCCCCCTTSCHHH----------------------HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCcccccHHH----------------------HHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 3333333334444433333222223222 236778999999999999999999987654
Q ss_pred H
Q 004218 754 I 754 (767)
Q Consensus 754 ~ 754 (767)
+
T Consensus 308 ~ 308 (311)
T d1t46a_ 308 E 308 (311)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-46 Score=386.58 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=198.6
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
++|++++.||+|+||.||+|+++ +|+.||||++... .....+.+.+|+++++.++||||+++++++ .....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence 57999999999999999999975 5999999998643 334456789999999999999999999995 45567
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.++||||+.+|+|.+++..... +++.++..++.||+.||.|||++ +||||||||+|||++.+|.+||+|||
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~------l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccccccccccchhhhHhhcCC------CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence 8999999999999999976543 99999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
+|+..... .....||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+....+
T Consensus 187 ~a~~~~~~---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~~~~ 255 (350)
T d1rdqe_ 187 FAKRVKGR---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSGKV 255 (350)
T ss_dssp TCEECSSC---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC
T ss_pred eeeecccc---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHHHHhcCCC
Confidence 99865321 2345699999999999999999999999999999999999999965321 111111111111
Q ss_pred cchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 691 KNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 691 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
. .+..+++. +.+++.+||+.||++|+ |++|++++
T Consensus 256 ~-~p~~~s~~----------------------~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 R-FPSHFSSD----------------------LKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C-CCTTCCHH----------------------HHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C-CCccCCHH----------------------HHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1 11112221 22366689999999994 89999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=381.85 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=198.0
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
.++|++.+.||+|+||+||+|.+. +++.||||+++... .....+.+|+++++.++||||+++++++ .+++.+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESF-----ESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 468999999999999999999976 58899999997543 2345688999999999999999999994 4566789
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC--CceEEcccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDED--MTAKVGDFG 610 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~--~~~kl~Dfg 610 (767)
+|||||+||+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.+ ..+||+|||
T Consensus 78 lvmE~~~gg~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence 9999999999999997643 2399999999999999999999999 99999999999999854 589999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc-
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF- 689 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~- 689 (767)
+++..... .......||+.|+|||...+..++.++||||+||++|+|++|+.||....... .........+
T Consensus 150 ~~~~~~~~-------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~~~~ 221 (321)
T d1tkia_ 150 QARQLKPG-------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYT 221 (321)
T ss_dssp TCEECCTT-------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC
T ss_pred hhhccccC-------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC
Confidence 99764321 12234568999999999999999999999999999999999999996532211 0111111111
Q ss_pred -ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 690 -PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 690 -~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
+......++ ..+.+++.+||..||++|||++|++++
T Consensus 222 ~~~~~~~~~s----------------------~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 FDEEAFKEIS----------------------IEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCHHHHTTSC----------------------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CChhhccCCC----------------------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 100001111 112337779999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=379.57 Aligned_cols=264 Identities=25% Similarity=0.387 Sum_probs=202.1
Q ss_pred hcCCCCCCccccccceEEEEEEeCC--------CcEEEEEEeeccCC-cchhhHHHHHHHHhcC-CCCCceeEEeeeecC
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLRE--------GISVAVKVLDIEST-GTWKSFFAECEALRNT-RHRNLVKLITSCSSL 523 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 523 (767)
.++|++.+.||+|+||.||+|+... +..||||+++.... .....+.+|...+.++ +|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-- 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence 3578899999999999999998532 34799999975543 3456788899988888 8999999999975
Q ss_pred CcccceeeEEEEeecCCCChhhhhcccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 004218 524 DFKNMEFLALVYEFLGNGSLGDWIHGERKN----------EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKP 593 (767)
Q Consensus 524 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 593 (767)
+++.+++||||+++|+|.+++...+.. .....+++.+++.++.|++.||+|||++ +||||||||
T Consensus 90 ---~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 90 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp ---SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ---cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 345679999999999999999765421 1234589999999999999999999999 999999999
Q ss_pred CCeeeCCCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 004218 594 GNILLDEDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFT-GMSPTH 672 (767)
Q Consensus 594 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 672 (767)
+|||++.++.+||+|||.++........ .......||+.|+|||.+.++.+++++|||||||++|||++ |++||.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTT----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cceeecCCCCeEeccchhhccccccccc----cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 9999999999999999999876543222 12244568999999999999999999999999999999998 688876
Q ss_pred CcccCCcchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 673 ESFAGEVSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
..... .....+........+..+.+. +.+++.+||+.||++||||+||++.|+++.
T Consensus 240 ~~~~~--~~~~~i~~~~~~~~p~~~~~~----------------------l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 240 GVPVE--ELFKLLKEGHRMDKPSNCTNE----------------------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp TCCHH--HHHHHHHTTCCCCCCSSCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHH--HHHHHHHcCCCCCCCccchHH----------------------HHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 53321 222233222222222222222 223777899999999999999999999885
Q ss_pred H
Q 004218 753 K 753 (767)
Q Consensus 753 ~ 753 (767)
+
T Consensus 296 a 296 (299)
T d1fgka_ 296 A 296 (299)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=384.49 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=194.1
Q ss_pred hcCCCCCC-ccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhc-CCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHEN-LIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRN-TRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|.+.. .||+|+||.||+|++. +++.||||+++. .+.+.+|++++.+ .+||||+++++++.+. ...+..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 36788875 6999999999999974 589999999853 3567789998755 5899999999986432 234577
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE---DMTAKVG 607 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~ 607 (767)
+|+|||||+||+|.+++.... ...+++.+++.|+.|++.||+|||++ +|+||||||+||+++. .+.+||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEECCCCCcHHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 899999999999999997643 24599999999999999999999999 9999999999999985 5679999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCc--chhhHh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV--SLVKWV 685 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~ 685 (767)
|||+|+...... ......||+.|+|||++.+..++.++||||+||++|+|+||+.||........ .+...+
T Consensus 157 DFG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i 229 (335)
T d2ozaa1 157 DFGFAKETTSHN-------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229 (335)
T ss_dssp CCTTCEECCCCC-------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred ccceeeeccCCC-------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH
Confidence 999997653321 12345699999999999999999999999999999999999999965432211 000000
Q ss_pred ---hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 ---ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 ---~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...+|......++ ..+.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~s----------------------~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 230 RMGQYEFPNPEWSEVS----------------------EEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CSCSSSCCTTHHHHSC----------------------HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCCCCCcccccCC----------------------HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0011111111111 122336778999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=380.06 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=198.9
Q ss_pred cCCCCCCccccccceEEEEEEeCC-Cc--EEEEEEeecc-CCcchhhHHHHHHHHhcC-CCCCceeEEeeeecCCcccce
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLRE-GI--SVAVKVLDIE-STGTWKSFFAECEALRNT-RHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 529 (767)
++|++.++||+|+||.||+|.+++ |. .||||.++.. .....+.+.+|+++++++ +||||++++++|. ..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----cCC
Confidence 578889999999999999999764 44 5788887543 344567899999999998 7999999999965 345
Q ss_pred eeEEEEeecCCCChhhhhcccCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 004218 530 FLALVYEFLGNGSLGDWIHGERK----------NEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD 599 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~ 599 (767)
.+++||||+++|+|.++++.... ......+++..+..++.||+.||.|+|++ +|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 67999999999999999976421 12235699999999999999999999999 999999999999999
Q ss_pred CCCceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCC-CCCCcccCC
Q 004218 600 EDMTAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMS-PTHESFAGE 678 (767)
Q Consensus 600 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~-p~~~~~~~~ 678 (767)
.++.+||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.... .
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~ 232 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--C 232 (309)
T ss_dssp GGGCEEECCTTCEESSCEEC-------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--H
T ss_pred CCCceEEccccccccccccc-------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--H
Confidence 99999999999997543321 1234468999999999999999999999999999999999765 564322 1
Q ss_pred cchhhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 679 VSLVKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
..+...+........+..+++. +.+++.+||+.||++||||+|++++|+++.+
T Consensus 233 ~~~~~~i~~~~~~~~~~~~~~~----------------------~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 233 AELYEKLPQGYRLEKPLNCDDE----------------------VYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHHHHHGGGTCCCCCCTTBCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCccCCHH----------------------HHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1222222222222222222222 2236678999999999999999999998865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=382.27 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=196.2
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc---CCcchhhHHHHHHHHh-cCCCCCceeEEeeeecCCcccce
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE---STGTWKSFFAECEALR-NTRHRNLVKLITSCSSLDFKNME 529 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 529 (767)
++|++.+.||+|+||+||+|++. +|+.||||+++.. .....+.+..|..++. .++||||+++++++ .+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 47899999999999999999976 5999999999643 2344556777777765 68999999999995 4566
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+|+||||+++|+|.+++..... +++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~------~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEEeecCCCcHHHHhhccCC------CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence 78999999999999999986543 89999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhc
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNF 689 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 689 (767)
|+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+...+....
T Consensus 148 G~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~~ 219 (320)
T d1xjda_ 148 GMCKENMLGD------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDN 219 (320)
T ss_dssp TTCBCCCCTT------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC
T ss_pred chhhhccccc------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC
Confidence 9997643321 1223457999999999999999999999999999999999999999653221 1111111111
Q ss_pred ccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHH-HHHH
Q 004218 690 PKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIR-EALR 746 (767)
Q Consensus 690 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~ 746 (767)
+ ..+..+++. +.+++.+||+.||++|||+. |+++
T Consensus 220 ~-~~p~~~s~~----------------------~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 P-FYPRWLEKE----------------------AKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C-CCCTTSCHH----------------------HHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C-CCCccCCHH----------------------HHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 111112222 22377789999999999995 6754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=384.83 Aligned_cols=207 Identities=28% Similarity=0.374 Sum_probs=173.4
Q ss_pred HhcCCCCCCccccccceEEEEEEeC-C-CcEEEEEEeeccC--CcchhhHHHHHHHHhcC---CCCCceeEEeeeecCCc
Q 004218 453 ATGNFSHENLIGSGSFGSVYKGYLR-E-GISVAVKVLDIES--TGTWKSFFAECEALRNT---RHRNLVKLITSCSSLDF 525 (767)
Q Consensus 453 ~~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~ 525 (767)
..++|++.+.||+|+||+||+|++. + ++.||||+++... ......+.+|+.+++.+ +||||+++++++.....
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3578999999999999999999974 4 6779999986542 23345677888877765 79999999999866555
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
.....++++|||++++++....... ...+++..+..++.|++.||+|||++ +||||||||+|||+++++.+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSC-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred ccCceEEEEEEeccCCchhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCee
Confidence 6677899999999987766544433 23489999999999999999999999 999999999999999999999
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|+|||.++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 157 l~dfg~~~~~~~~-------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 157 LADFGLARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp ECSCCSCCCCCGG-------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ecchhhhhhhccc-------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 9999998754322 2234567999999999999999999999999999999999999999654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=375.86 Aligned_cols=196 Identities=25% Similarity=0.351 Sum_probs=162.6
Q ss_pred CCCccccccceEEEEEEeC-CCcEEEEEEeeccCC-----cchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 459 HENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST-----GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 459 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
..++||+|+||+||+|+++ +|+.||||+++.... ...+.+.+|++++++++|||||++++++. .++.++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCcee
Confidence 3578999999999999975 589999999864322 22457889999999999999999999954 456689
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
+||||++++++..+..... .+++.++..+++||+.||+|||++ +|+||||||+||+++.++.+||+|||.|
T Consensus 77 ivmE~~~~~~~~~~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp EEEECCSEEHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ehhhhhcchHHhhhhhccc------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccc
Confidence 9999999987777665432 388999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+....... ......||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 148 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 148 KSFGSPNR------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp STTTSCCC------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCCcc------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 86543321 12335689999999988654 5799999999999999999999999653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=376.29 Aligned_cols=201 Identities=29% Similarity=0.447 Sum_probs=167.3
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|+||.||+|++. +|+.||||+++... ....+++.+|++++++++||||+++++++ .++..+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence 57999999999999999999975 59999999996543 23467889999999999999999999995 455678
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
|+||||+.+ ++.+++.... ...+++.++..++.|++.||+|||++ +||||||||+||+++.++.+||+|||.
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred eEEEeecCC-chhhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence 999999976 4555443322 23499999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCC-CCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|+...... .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||...
T Consensus 149 a~~~~~~~------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 149 ARAFGVPV------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp HHHHCCCS------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ceeccCCc------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 98764321 1223456999999999877665 488999999999999999999999654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=378.38 Aligned_cols=263 Identities=23% Similarity=0.319 Sum_probs=202.5
Q ss_pred hcCCCCCCccccccceEEEEEEeC------CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR------EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFK 526 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 526 (767)
.++|++.+.||+|+||.||+|.++ +++.||||+++... ......+.+|++++++++||||++++++|.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~----- 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----- 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe-----
Confidence 367889999999999999999864 25789999996442 233456899999999999999999999964
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKN----EHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM 602 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~ 602 (767)
..+..++||||+++|+|.+++...+.. .....+++..+.+++.|+++||+|||++ +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 344569999999999999998754311 1223479999999999999999999999 999999999999999999
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCC-CCCCCcccCCcch
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGM-SPTHESFAGEVSL 681 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~-~p~~~~~~~~~~~ 681 (767)
.+||+|||+|+........ .......||+.|+|||.+.+..++.++||||||+++|||+||. +||..... ...
T Consensus 171 ~~Kl~DFGla~~~~~~~~~----~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--~~~ 244 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQV 244 (308)
T ss_dssp CEEECCTTCCCGGGGGGCE----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHH
T ss_pred eEEEeecccceeccCCcce----eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 9999999999876544221 1223446899999999999999999999999999999999985 56643211 111
Q ss_pred hhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHH
Q 004218 682 VKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQ 752 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 752 (767)
...+........+..+++. +.+++.+||+.||++|||++|++++|++..
T Consensus 245 ~~~i~~~~~~~~p~~~~~~----------------------l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 245 LRFVMEGGLLDKPDNCPDM----------------------LFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHHHTTCCCCCCTTCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHhCCCCCCcccchHH----------------------HHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1111111111111112221 223777899999999999999999997653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.6e-45 Score=373.27 Aligned_cols=200 Identities=27% Similarity=0.401 Sum_probs=168.9
Q ss_pred cCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||+|+||+||+|++++|+.||||+++... ....+++.+|+.++++++||||+++++++. .++..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 76 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRLV 76 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCcee
Confidence 5899999999999999999999999999999996542 334578999999999999999999999954 556679
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccch
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGLA 612 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 612 (767)
++|||+.++.+..+..... .+++.++..++.||+.||+|||+. +||||||||+||+++.++.+|++|||.|
T Consensus 77 i~~e~~~~~~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp EEEECCSEEHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred EEEEeehhhhHHHHHhhcC------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccc
Confidence 9999998877766665433 399999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
........ ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 148 ~~~~~~~~------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 148 RAFGIPVR------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp HHHCC---------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eecccCcc------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 87643221 12344589999999998764 4689999999999999999999999654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=368.70 Aligned_cols=241 Identities=22% Similarity=0.306 Sum_probs=190.1
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC------cchhhHHHHHHHHhcCC--CCCceeEEeeeecCC
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST------GTWKSFFAECEALRNTR--HRNLVKLITSCSSLD 524 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 524 (767)
.++|++.+.||+|+||.||+|++. +|+.||||++..... ....++.+|+.++++++ ||||+++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~---- 78 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---- 78 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence 368999999999999999999975 589999999865421 12345779999999986 89999999995
Q ss_pred cccceeeEEEEeecCC-CChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CC
Q 004218 525 FKNMEFLALVYEFLGN-GSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE-DM 602 (767)
Q Consensus 525 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~ 602 (767)
.+.+..++||||+.+ +++.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++. ++
T Consensus 79 -~~~~~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 79 -ERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG 148 (273)
T ss_dssp -ECSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred -eeCCeEEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCC
Confidence 455678999999976 67888886543 399999999999999999999999 9999999999999985 57
Q ss_pred ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCC-CCcccchhhhHHHHHHHhCCCCCCCcccCCcch
Q 004218 603 TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKP-STAGDVYSFGVMLLEIFTGMSPTHESFAGEVSL 681 (767)
Q Consensus 603 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 681 (767)
.+||+|||+|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 149 ~vkl~DFG~a~~~~~~--------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------ 214 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDT--------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 214 (273)
T ss_dssp EEEECCCTTCEECCSS--------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred eEEECccccceecccc--------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------
Confidence 9999999999754321 1234569999999999887665 577999999999999999999996521
Q ss_pred hhHhhhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 682 VKWVESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
....... .....+++. +++++.+||+.||++|||++|++++
T Consensus 215 -~i~~~~~--~~~~~~s~~----------------------~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 -EIIRGQV--FFRQRVSSE----------------------CQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -HHHHCCC--CCSSCCCHH----------------------HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHhhccc--CCCCCCCHH----------------------HHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111100 011111211 2236678999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-44 Score=373.70 Aligned_cols=280 Identities=21% Similarity=0.235 Sum_probs=197.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC-CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES-TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
..+|++++.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|++++||||+++++++....+.....+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999964 69999999996543 2345678999999999999999999999876555555555
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++++ |+.+|+|.+++...+ +++..+..++.|++.||+|||++ |||||||||+|||+++++.+||+|||+
T Consensus 87 ~l~~-~~~~g~L~~~l~~~~-------l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 87 YLVT-HLMGADLYKLLKTQH-------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp EEEE-ECCCEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEE-eecCCchhhhhhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence 5554 566899999997543 99999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhhcc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESNFP 690 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 690 (767)
|+......... .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||..................+
T Consensus 156 a~~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 156 ARVADPDHDHT---GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp CEECCGGGCBC---CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred eeeccCCCccc---eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 98654432221 12244669999999999854 456889999999999999999999996643221111000000011
Q ss_pred cc--hhhhccHHHHHhhhcch----hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 691 KN--AQQVLDRELRQLMMSSE----SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 691 ~~--~~~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.. ................+ .........+...+.+++.+||+.||++||||+|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00111111111110000 00000111111123347779999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=368.45 Aligned_cols=283 Identities=24% Similarity=0.302 Sum_probs=194.9
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeecc--CCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC---ccc
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIE--STGTWKSFFAECEALRNTRHRNLVKLITSCSSLD---FKN 527 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~ 527 (767)
.++|++.+.||+|+||+||+|++. +|+.||||++... .....+++.+|++++++++||||+++++++.... ...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999975 6999999998544 3344577899999999999999999999975532 123
Q ss_pred ceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 004218 528 MEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVG 607 (767)
Q Consensus 528 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~ 607 (767)
...+++||||++++.+..+.... ..+++..++.+++|++.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~------~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccCCCccchhhhcc------cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence 45789999999887666554433 3389999999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCc-chhhHh
Q 004218 608 DFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEV-SLVKWV 685 (767)
Q Consensus 608 Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~ 685 (767)
|||+++........ .........||+.|+|||++.+. .+++++||||+||++|||++|+.||........ ......
T Consensus 160 dfg~~~~~~~~~~~--~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 160 DFGLARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp CCTTCEECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ecceeeeccccccc--ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 99999765433211 11222345699999999998765 689999999999999999999999965322111 001111
Q ss_pred hhhcccc-hhhhccHHHHHhhhcchhhHHHHHHH-----HHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 686 ESNFPKN-AQQVLDRELRQLMMSSESQTIQLHDC-----LITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 686 ~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~-----~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
...++.. ........................+. ....+.+++.+||+.||++||||+|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1111111 11111111111110000000000000 01122347789999999999999999865
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=369.04 Aligned_cols=277 Identities=23% Similarity=0.290 Sum_probs=194.4
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-cccce
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKNME 529 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 529 (767)
.++|++++.||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+++|++++|||||++++++...+ .....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 59999999996432 233567889999999999999999999986543 23445
Q ss_pred eeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 004218 530 FLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDF 609 (767)
Q Consensus 530 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Df 609 (767)
.+|+||||+ +++|..+....+ +++..++.++.|++.||+|||++ ||+||||||+|||++.++.+|++||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~-------l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEK-------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecc-cccHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence 679999999 568888776433 99999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhh--
Q 004218 610 GLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVE-- 686 (767)
Q Consensus 610 g~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-- 686 (767)
|.|+..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|++||....... .+.....
T Consensus 166 g~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~ 235 (346)
T d1cm8a_ 166 GLARQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVT 235 (346)
T ss_dssp TTCEECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH
T ss_pred cceeccCCc---------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhcc
Confidence 999764322 234568999999998876 456899999999999999999999996542211 1111111
Q ss_pred hhcccchhhhccH-H---HHHhhhcc-hhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH--HHHH
Q 004218 687 SNFPKNAQQVLDR-E---LRQLMMSS-ESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR--LKNA 751 (767)
Q Consensus 687 ~~~~~~~~~~~~~-~---l~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~ 751 (767)
...+......... . ........ ..............+.+++.+||..||++||||+|++++ ++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1111111110000 0 00000000 000000000111122347779999999999999999986 5544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-42 Score=356.47 Aligned_cols=265 Identities=22% Similarity=0.285 Sum_probs=195.8
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceeeEE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFLAL 533 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 533 (767)
++|++.+.||+|+||.||+|++. +|+.||||++.... ..+++..|+++++.++|++++..+..+. ..++..++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEE
Confidence 57999999999999999999975 58999999986543 3356889999999998887766666553 34566799
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEcccc
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD---EDMTAKVGDFG 610 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg 610 (767)
||||++ +++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++ .+..+||+|||
T Consensus 81 vme~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEECCC-CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEcC-Cchhhhhhhcc-----CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence 999994 57777665433 3499999999999999999999999 999999999999986 35579999999
Q ss_pred chhhhhhhcCCCc-cccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcc--hhhHhhh
Q 004218 611 LARSLLERIGNQS-SISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS--LVKWVES 687 (767)
Q Consensus 611 ~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~ 687 (767)
+|+.+........ .........||+.|+|||++.+..++.++|||||||++|||+||+.||......... .......
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence 9987654332211 112234567999999999999999999999999999999999999999764332211 1111111
Q ss_pred hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHH
Q 004218 688 NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQK 753 (767)
Q Consensus 688 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 753 (767)
..+..... .. ....+. +.+++..||+.||++||+++++.+.|+.+..
T Consensus 232 ~~~~~~~~--------~~-------~~~p~~----~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 232 KMSTPIEV--------LC-------KGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHSCHHH--------HT-------TTSCHH----HHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred cCCCChhH--------hc-------cCCCHH----HHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00000000 00 001111 2226668999999999999999998887654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=364.76 Aligned_cols=202 Identities=29% Similarity=0.364 Sum_probs=164.6
Q ss_pred CCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCCceeEEeeeecCC-cccceeeEE
Q 004218 456 NFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRHRNLVKLITSCSSLD-FKNMEFLAL 533 (767)
Q Consensus 456 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l 533 (767)
+|+..++||+|+||+||+|++. +|+.||||++.... ....+|++++++++||||+++++++.... ..+..++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888899999999999999976 59999999996443 23347999999999999999999986543 244567899
Q ss_pred EEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEccccch
Q 004218 534 VYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-TAKVGDFGLA 612 (767)
Q Consensus 534 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a 612 (767)
||||++++.+..+...... ...+++.++..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 97 v~Ey~~~~~~~~l~~~~~~---~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEECCSEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEeccCCccHHHHHhhhhc---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 9999987544443322111 34599999999999999999999999 999999999999999765 8999999999
Q ss_pred hhhhhhcCCCccccccccccCCCCccCccccCC-CCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 613 RSLLERIGNQSSISSTHVLKGSIGYIPPEYGLG-EKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+...... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 171 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 171 KQLVRGE-------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp EECCTTS-------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred hhccCCc-------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 7653321 1233568999999998765 46899999999999999999999999654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.4e-42 Score=347.90 Aligned_cols=267 Identities=18% Similarity=0.188 Sum_probs=201.7
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCCC-CCceeEEeeeecCCcccceee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTRH-RNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 531 (767)
.++|++.+.||+|+||.||+|++. +|+.||||+++... ..+.+.+|+++++.+.| +|++.+++++ ..+...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCcc
Confidence 368999999999999999999976 58999999986432 33567889999999965 8999999884 345667
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-----CCceEE
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDE-----DMTAKV 606 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-----~~~~kl 606 (767)
++||||+ +++|.+++.... ..+++.++..++.|++.||+|||++ ||+||||||+||+++. ++.+||
T Consensus 77 ~~vme~~-~~~l~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl 147 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 147 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred EEEEEec-CCCHHHHHHhhc-----cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEE
Confidence 9999999 679999987643 3499999999999999999999999 9999999999999974 578999
Q ss_pred ccccchhhhhhhcCCC-ccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCcccCCcc-hhhH
Q 004218 607 GDFGLARSLLERIGNQ-SSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVS-LVKW 684 (767)
Q Consensus 607 ~Dfg~a~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~~ 684 (767)
+|||+|+......... ..........||+.|+|||++.+..+++++||||+||++|||+||+.||......... ....
T Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 227 (293)
T d1csna_ 148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227 (293)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence 9999998765433221 1112234567999999999999999999999999999999999999999754332211 1111
Q ss_pred h-hhhcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004218 685 V-ESNFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRRLKNAQKIL 755 (767)
Q Consensus 685 ~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 755 (767)
+ ........ .+.... ..+. +.+++..|+..+|++||+++.+.+.|+++.+..
T Consensus 228 i~~~~~~~~~--------~~l~~~-------~p~~----l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 228 IGEKKQSTPL--------RELCAG-------FPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHHHHHSCH--------HHHTTT-------SCHH----HHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHhccCCCCh--------HHhcCC-------CCHH----HHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 1 00000000 000000 1111 222666899999999999999999888876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.2e-42 Score=356.58 Aligned_cols=195 Identities=24% Similarity=0.305 Sum_probs=166.8
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcccceeeE
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEFLA 532 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 532 (767)
++|++.+.||+|+||+||+|++. +|+.||||+++. ...+++.+|+++|+++. ||||+++++++.. .....++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence 57999999999999999999975 589999999863 33567889999999995 9999999998753 3445689
Q ss_pred EEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEccccc
Q 004218 533 LVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDM-TAKVGDFGL 611 (767)
Q Consensus 533 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~ 611 (767)
+||||+++++|.++.+ .+++.++..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus 109 ~v~e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp EEEECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred EEEeecCCCcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence 9999999999987642 289999999999999999999999 999999999999998655 699999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
|+...... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 177 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 177 AEFYHPGQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CEECCTTC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ceeccCCC-------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 98654321 12345689999999997765 4799999999999999999999998654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=355.95 Aligned_cols=251 Identities=24% Similarity=0.297 Sum_probs=194.3
Q ss_pred cCCCCCCccccccceEEEEEEeC----CCcEEEEEEeecc----CCcchhhHHHHHHHHhcCCC-CCceeEEeeeecCCc
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR----EGISVAVKVLDIE----STGTWKSFFAECEALRNTRH-RNLVKLITSCSSLDF 525 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 525 (767)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|++++++++| |||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~----- 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----- 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence 56999999999999999999852 3789999998543 22345678899999999976 8999999984
Q ss_pred ccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 004218 526 KNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAK 605 (767)
Q Consensus 526 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k 605 (767)
.+...+++||||+.+|+|.+++..... +++..+..++.|++.||+|+|+. +||||||||+||+++.++.+|
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~------~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred ccCCceeeeeecccccHHHHHHHhccc------ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEE
Confidence 455678999999999999999987653 78999999999999999999999 999999999999999999999
Q ss_pred EccccchhhhhhhcCCCccccccccccCCCCccCccccCCC--CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhh
Q 004218 606 VGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE--KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVK 683 (767)
Q Consensus 606 l~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 683 (767)
|+|||+++....... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......... ..
T Consensus 170 L~DFG~a~~~~~~~~-----~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-~~ 243 (322)
T d1vzoa_ 170 LTDFGLSKEFVADET-----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AE 243 (322)
T ss_dssp ESCSSEEEECCGGGG-----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HH
T ss_pred Eeeccchhhhccccc-----ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HH
Confidence 999999976543221 122345689999999998764 4688999999999999999999999765433221 11
Q ss_pred Hhhh--hcccchhhhccHHHHHhhhcchhhHHHHHHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 004218 684 WVES--NFPKNAQQVLDRELRQLMMSSESQTIQLHDCLITIIESVGLSCTTESPGGRI-----DIREALRR 747 (767)
Q Consensus 684 ~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 747 (767)
.... ..+...+...++. +.+++.+||++||++|| ||+|++++
T Consensus 244 i~~~~~~~~~~~~~~~s~~----------------------~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 244 ISRRILKSEPPYPQEMSAL----------------------AKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHHHHCCCCCCTTSCHH----------------------HHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHhcccCCCCCcccCCHH----------------------HHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 1111 1111111112222 12266689999999999 58899874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-42 Score=359.32 Aligned_cols=201 Identities=24% Similarity=0.293 Sum_probs=162.1
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCc-cccee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDF-KNMEF 530 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 530 (767)
++|++.++||+|+||+||+|++. +|+.||||++.... ....+++.+|+.++++++||||+++++++...+. +....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999976 59999999997543 2334578899999999999999999999865432 35678
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
+|+||||+.++.+ +.+.. .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+|++|||
T Consensus 97 ~~iv~Ey~~~~l~-~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEECCSEEHH-HHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEeccchHHH-Hhhhc--------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence 9999999976544 44422 289999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
.++...... ......||+.|+|||++.+..+++++||||+||++|+|++|+.||...
T Consensus 165 ~~~~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 165 LARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp C----------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhcccccc-------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 987654321 223456899999999999999999999999999999999999999653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=350.52 Aligned_cols=199 Identities=26% Similarity=0.380 Sum_probs=170.8
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccC--CcchhhHHHHHHHHhcCCCCCceeEEeeeecCCcccceee
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIES--TGTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEFL 531 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 531 (767)
++|++.+.||+|+||+||+|++. +++.||||+++... ....+++.+|+.+++.++||||+++++++. +....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence 57999999999999999999975 58999999986543 334678899999999999999999999954 45567
Q ss_pred EEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 004218 532 ALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFGL 611 (767)
Q Consensus 532 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 611 (767)
++|+|++.++++..++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEeeecccccccccccccc------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence 99999999999988886544 389999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhhcCCCccccccccccCCCCccCccccCCCC-CCCcccchhhhHHHHHHHhCCCCCCC
Q 004218 612 ARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEK-PSTAGDVYSFGVMLLEIFTGMSPTHE 673 (767)
Q Consensus 612 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~ 673 (767)
|+....... ......++..|+|||.+.+.. ++.++||||+||++|||++|+.||..
T Consensus 148 a~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 148 ARAFGIPVR------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CEECCSCCS------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred hhcccCCCc------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 986543221 123345778899999887665 68999999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=363.27 Aligned_cols=274 Identities=21% Similarity=0.240 Sum_probs=194.3
Q ss_pred hcCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCC--cchhhHHHHHHHHhcCCCCCceeEEeeeecCCccccee
Q 004218 454 TGNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIEST--GTWKSFFAECEALRNTRHRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 454 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 530 (767)
.++|++.+.||+|+||+||+|++. +|+.||||+++.... ...+++.+|++++++++|||++++++++.......+..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999975 599999999965432 34467889999999999999999999876544333444
Q ss_pred eEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 004218 531 LALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLDEDMTAKVGDFG 610 (767)
Q Consensus 531 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 610 (767)
.+++|+|+.+|+|.+++...+ +++.++..++.||+.||+|||++ ||+||||||+||+++.++.+|++|||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~-------l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEEeecCCchhhhccccc-------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence 566677788999999996533 99999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcCCCccccccccccCCCCccCccccCCC-CCCCcccchhhhHHHHHHHhCCCCCCCcccCCcchhhHhhhh-
Q 004218 611 LARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGE-KPSTAGDVYSFGVMLLEIFTGMSPTHESFAGEVSLVKWVESN- 688 (767)
Q Consensus 611 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~- 688 (767)
.+...... .....||..|+|||...+. .++.++||||+||++|+|++|+.||........ ........
T Consensus 167 ~a~~~~~~---------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~ 236 (348)
T d2gfsa1 167 LARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVG 236 (348)
T ss_dssp ---CCTGG---------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHC
T ss_pred hhcccCcc---------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence 99754332 2335688999999987665 468999999999999999999999965322111 11111110
Q ss_pred -cccch-hhhccHHHHHhhhc---ch-hhHHHHHHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 004218 689 -FPKNA-QQVLDRELRQLMMS---SE-SQTIQLHDCLITIIESVGLSCTTESPGGRIDIREALRR 747 (767)
Q Consensus 689 -~~~~~-~~~~~~~l~~~~~~---~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 747 (767)
.+... .............. .. .........+...+.+++.+||+.||++||||+|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000 00011111111100 00 00000001112223347779999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-37 Score=325.58 Aligned_cols=201 Identities=21% Similarity=0.248 Sum_probs=157.4
Q ss_pred cCCCCCCccccccceEEEEEEeC-CCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-----------CCCceeEEeeeec
Q 004218 455 GNFSHENLIGSGSFGSVYKGYLR-EGISVAVKVLDIESTGTWKSFFAECEALRNTR-----------HRNLVKLITSCSS 522 (767)
Q Consensus 455 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 522 (767)
++|++.++||+|+||+||+|++. +|+.||||+++.+. ...+.+.+|+++++.+. |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999975 59999999996432 23456788999888774 5789999988642
Q ss_pred CCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCC
Q 004218 523 LDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDED 601 (767)
Q Consensus 523 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~ 601 (767)
......+++|+++..+........... ...+++..+..++.|++.||+|||+ . ||+||||||+|||++.+
T Consensus 92 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 92 ---KGPNGVHVVMVFEVLGENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIV 162 (362)
T ss_dssp ---EETTEEEEEEEECCCCEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEE
T ss_pred ---ccccceeeeeeeccccccccccccccc---ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeecc
Confidence 333455667776655443332222221 3448999999999999999999998 6 99999999999999865
Q ss_pred C------ceEEccccchhhhhhhcCCCccccccccccCCCCccCccccCCCCCCCcccchhhhHHHHHHHhCCCCCCCc
Q 004218 602 M------TAKVGDFGLARSLLERIGNQSSISSTHVLKGSIGYIPPEYGLGEKPSTAGDVYSFGVMLLEIFTGMSPTHES 674 (767)
Q Consensus 602 ~------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 674 (767)
+ .++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||...
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CcccccceeeEeecccccccccc---------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 4 4999999999754321 13456899999999999999999999999999999999999999654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1e-30 Score=270.01 Aligned_cols=253 Identities=34% Similarity=0.551 Sum_probs=141.0
Q ss_pred CCCEEECcCCccee--ecCchhhhhccccCeEEccC-CcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCE
Q 004218 106 RLNFLAFDGNQFEG--EIPESIGNLSNVLSKLYMGG-NRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQS 182 (767)
Q Consensus 106 ~L~~L~l~~n~l~~--~~~~~~~~l~~~L~~L~l~~-n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~ 182 (767)
+++.|+|++|.+.+ .+|..+++++. |++|+|++ |++.+.+|..|+++++|++|+|++|++.+..+..+..+.+|+.
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~-L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPY-LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTT-CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCcc-ccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 35555555555544 24455555554 55555543 4444444555555555555555555555444444444455555
Q ss_pred EEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeeccccc
Q 004218 183 LDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNF 262 (767)
Q Consensus 183 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~ 262 (767)
+++++|.+.+.+|..+..++.|+.+++++ |.+.+.+|..+..+..+...+.+++|+
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~------------------------n~l~~~ip~~~~~l~~l~~~l~~~~n~ 185 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDG------------------------NRISGAIPDSYGSFSKLFTSMTISRNR 185 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCS------------------------SCCEEECCGGGGCCCTTCCEEECCSSE
T ss_pred cccccccccccCchhhccCcccceeeccc------------------------ccccccccccccccccccccccccccc
Confidence 55555544444444444444444444444 444444444444444444444555555
Q ss_pred CCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCcc
Q 004218 263 LDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD 342 (767)
Q Consensus 263 l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 342 (767)
+++..|..+..+..+ .+++++|...+.+|..+..+++|+.|++++|.+.+.++ .+..+++|+.|+|++|+++|.+|..
T Consensus 186 l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~ 263 (313)
T d1ogqa_ 186 LTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQG 263 (313)
T ss_dssp EEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGG
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChH
Confidence 555555555554333 46666666666666666666666666666666664433 4555666666666666666666666
Q ss_pred ccccccCceEeccCCcCcCcCCCCccccccccccccCCcCccc
Q 004218 343 LQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGNPKLCL 385 (767)
Q Consensus 343 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~Np~~c~ 385 (767)
++.+++|++|+|++|+++|.+|....+.++..+.+.+|+..|+
T Consensus 264 l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 264 LTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp GGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred HhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccC
Confidence 6666666666666666666666555556666666777776665
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=4.3e-30 Score=265.29 Aligned_cols=255 Identities=33% Similarity=0.497 Sum_probs=216.7
Q ss_pred CCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcC-CcceeecCchhhhhccccCeEEccCCcccccCCccccCC
Q 004218 75 PFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDG-NQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRL 153 (767)
Q Consensus 75 ~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l 153 (767)
..++.|+|++|.+.+. ..++..+.++++|++|+|++ |+++|.+|..++++++ |++|+|++|++.+..+..+..+
T Consensus 50 ~~v~~L~L~~~~l~g~----~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~-L~~L~Ls~N~l~~~~~~~~~~~ 124 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKP----YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ-LHYLYITHTNVSGAIPDFLSQI 124 (313)
T ss_dssp CCEEEEEEECCCCSSC----EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTT-CSEEEEEEECCEEECCGGGGGC
T ss_pred EEEEEEECCCCCCCCC----CCCChHHhcCccccccccccccccccccccccccccc-cchhhhccccccccccccccch
Confidence 4689999999988642 25778999999999999997 8999999999999998 9999999999999999999999
Q ss_pred CCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCC-ceeeCCCCcCCCCCcccccCcccccccc
Q 004218 154 RSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKL-NQIDLSGNELASEIPTSFGNFQNLLSID 232 (767)
Q Consensus 154 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 232 (767)
.+|+.+++++|.+.+..|..+.++++|+++++++|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .++
T Consensus 125 ~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~ 203 (313)
T d1ogqa_ 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVD 203 (313)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEE
T ss_pred hhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccc
Confidence 999999999999999999999999999999999999999999988888776 778889888887777666554333 355
Q ss_pred ccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCcccc
Q 004218 233 LSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFS 312 (767)
Q Consensus 233 l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 312 (767)
++++... +.+|..+..+++|+.|++++|.+.+.+ ..+..+++|+.|+|++|+++
T Consensus 204 l~~~~~~-------------------------~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~ 257 (313)
T d1ogqa_ 204 LSRNMLE-------------------------GDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIY 257 (313)
T ss_dssp CCSSEEE-------------------------ECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCE
T ss_pred ccccccc-------------------------ccccccccccccccccccccccccccc-cccccccccccccCccCeec
Confidence 5554444 455566667778888888888887654 46788889999999999999
Q ss_pred CCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCc-CcCc
Q 004218 313 GPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNN-LEGV 362 (767)
Q Consensus 313 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~ 362 (767)
+.+|..+..+++|++|+|++|+|+|.+|. ++.+.+|+.+++++|+ ++|.
T Consensus 258 g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp ECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred ccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 88999999999999999999999988884 6788999999999998 5554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=3.1e-28 Score=259.51 Aligned_cols=321 Identities=29% Similarity=0.381 Sum_probs=158.5
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
.+|++|++++|+|+ .++ .+ +.+++|++|+|++|+|++ +|. ++++++|++|++++|.+.+. + .++.+++|+.|+
T Consensus 44 ~~l~~L~l~~~~I~-~l~-gl-~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~ 116 (384)
T d2omza2 44 DQVTTLQADRLGIK-SID-GV-EYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 116 (384)
T ss_dssp TTCCEEECCSSCCC-CCT-TG-GGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred CCCCEEECCCCCCC-Ccc-cc-ccCCCCCEEeCcCCcCCC-Ccc-ccCCcccccccccccccccc-c-cccccccccccc
Confidence 34556666666655 442 22 245566666666666553 332 55666666666666665532 2 255556666666
Q ss_pred ecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecC-------------------chhhhhccccCeEEccCCcc
Q 004218 82 IGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIP-------------------ESIGNLSNVLSKLYMGGNRF 142 (767)
Q Consensus 82 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~-------------------~~~~~l~~~L~~L~l~~n~i 142 (767)
++.|.+.... .......+..+....|.+....+ ..+..... ........|..
T Consensus 117 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 187 (384)
T d2omza2 117 LFNNQITDID--------PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTT-LERLDISSNKV 187 (384)
T ss_dssp CCSSCCCCCG--------GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTT-CCEEECCSSCC
T ss_pred cccccccccc--------cccccccccccccccccccccccccccccccccccccccchhhhhccccc-ccccccccccc
Confidence 6555544221 11222333333333333321111 01111111 22222222222
Q ss_pred cccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccc
Q 004218 143 YGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSF 222 (767)
Q Consensus 143 ~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 222 (767)
. ....+..+++++.|++++|.+++..+ +...++|++|++++|+++. + ..+..+++|+.|++++|++++.. .+
T Consensus 188 ~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~ 259 (384)
T d2omza2 188 S--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PL 259 (384)
T ss_dssp C--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GG
T ss_pred c--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cc
Confidence 1 23344555666666666666654322 3445566666666666653 2 24555666666666666665432 25
Q ss_pred cCccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccc
Q 004218 223 GNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLE 302 (767)
Q Consensus 223 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~ 302 (767)
..+++|+.|++++|++++.. .+..++.+ ..+.+..|.+++. ..+..+++++.|++++|++++.. .+..+++|+
T Consensus 260 ~~~~~L~~L~l~~~~l~~~~--~~~~~~~l-~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~ 332 (384)
T d2omza2 260 SGLTKLTELKLGANQISNIS--PLAGLTAL-TNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQ 332 (384)
T ss_dssp TTCTTCSEEECCSSCCCCCG--GGTTCTTC-SEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCC
T ss_pred cccccCCEeeccCcccCCCC--cccccccc-ccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCC
Confidence 55566666666666665321 23444444 2335555555532 23455556666666666665432 255556666
Q ss_pred eeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCC
Q 004218 303 KLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFN 357 (767)
Q Consensus 303 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 357 (767)
+|++++|+|++ ++ .+..+++|++|++++|++++..| +..+++|++|+|++|
T Consensus 333 ~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 333 RLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp EEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred EEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 66666666553 22 35556666666666666654433 555566666666555
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=1.1e-26 Score=247.37 Aligned_cols=337 Identities=26% Similarity=0.333 Sum_probs=264.9
Q ss_pred eCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccc
Q 004218 8 GLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKI 87 (767)
Q Consensus 8 ~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l 87 (767)
.++.+.+++.++.. .+.+|++|++++|+|+. +. .+..+++|++|+|++|+|++ ++ .++++++|++|++++|++
T Consensus 28 ~l~~~~~~~~~~~~---~l~~l~~L~l~~~~I~~-l~-gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 28 VLGKTNVTDTVSQT---DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HTTCSSTTSEECHH---HHTTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCC
T ss_pred HhCCCCCCCccCHH---HhCCCCEEECCCCCCCC-cc-ccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccc
Confidence 45666666555543 36789999999999984 54 58899999999999999985 44 399999999999999998
Q ss_pred cCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCccccc-------------------CCc
Q 004218 88 VGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGK-------------------IPT 148 (767)
Q Consensus 88 ~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~-------------------~~~ 148 (767)
... ..+.++++|+.|++++|.+++..+ ...... +..+....|.+... ...
T Consensus 101 ~~i--------~~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (384)
T d2omza2 101 ADI--------TPLANLTNLTGLTLFNNQITDIDP--LKNLTN-LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK 169 (384)
T ss_dssp CCC--------GGGTTCTTCCEEECCSSCCCCCGG--GTTCTT-CSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG
T ss_pred ccc--------cccccccccccccccccccccccc--cccccc-ccccccccccccccccccccccccccccccccchhh
Confidence 642 247889999999999999985433 223333 66666666555422 122
Q ss_pred cccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCcccc
Q 004218 149 SIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNL 228 (767)
Q Consensus 149 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 228 (767)
.+.............|... ....+..+++++.|++++|.+++..| +...++|++|++++|+++. ...+..+++|
T Consensus 170 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~~L 243 (384)
T d2omza2 170 PLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNL 243 (384)
T ss_dssp GGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTC
T ss_pred hhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--cchhhccccc
Confidence 2344455556666665554 24567788999999999999996544 5677899999999999985 3468899999
Q ss_pred ccccccCcccCCCCChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccC
Q 004218 229 LSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMAN 308 (767)
Q Consensus 229 ~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~ 308 (767)
+.|++++|.+++.. .+..++++ +.+++++|.+++.. .+..++.++.++++.|.+++. ..+..+++++.|++++
T Consensus 244 ~~L~l~~n~l~~~~--~~~~~~~L-~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~ 316 (384)
T d2omza2 244 TDLDLANNQISNLA--PLSGLTKL-TELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYF 316 (384)
T ss_dssp SEEECCSSCCCCCG--GGTTCTTC-SEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCS
T ss_pred chhccccCccCCCC--cccccccC-CEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCC
Confidence 99999999998543 37788888 44599999998654 477889999999999999853 4588999999999999
Q ss_pred ccccCCCCchhhccCCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCCCCccccccccccccCC
Q 004218 309 NKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVPREGIFRHTSMVHLEGN 380 (767)
Q Consensus 309 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N 380 (767)
|++++.. .+..+++|+.|++++|+|++ ++ .+..+++|++|++++|++++.+| ...+++++.+++.+|
T Consensus 317 n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 317 NNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 9999654 38899999999999999984 33 68999999999999999999876 455778888999887
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=3e-26 Score=235.36 Aligned_cols=219 Identities=21% Similarity=0.271 Sum_probs=152.4
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeec
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (767)
++++|-++++++ ++|..++ +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|..+++|++|+++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 567888888998 8998775 479999999999985555679999999999999999997677889999999999999
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCccc--ccCCccccCCCCCCEEEC
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFY--GKIPTSIGRLRSLTLLNL 161 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~--~~~~~~l~~l~~L~~L~l 161 (767)
+|+++..+.. ....|..|++.+|.+....+..+..... +..+++..|... ...+..+..+++|+.+++
T Consensus 88 ~n~l~~l~~~---------~~~~l~~L~~~~n~l~~l~~~~~~~~~~-~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l 157 (305)
T d1xkua_ 88 KNQLKELPEK---------MPKTLQELRVHENEITKVRKSVFNGLNQ-MIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 157 (305)
T ss_dssp SSCCSBCCSS---------CCTTCCEEECCSSCCCBBCHHHHTTCTT-CCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred CCccCcCccc---------hhhhhhhhhccccchhhhhhhhhhcccc-ccccccccccccccCCCccccccccccCcccc
Confidence 9988754322 2346777778888777443333444444 666777666433 234455666677777777
Q ss_pred cCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccC
Q 004218 162 SYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 162 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
++|.+.. .+.. .+++|++|++++|.+....+..|.+++.++.|++++|.+++..+..|.++++|++|+|++|+|+
T Consensus 158 ~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~ 232 (305)
T d1xkua_ 158 ADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232 (305)
T ss_dssp CSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred ccCCccc-cCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc
Confidence 7776663 2322 2456666777766666666666666666666666666666655666666666666666666555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=9.6e-25 Score=223.95 Aligned_cols=124 Identities=19% Similarity=0.228 Sum_probs=68.7
Q ss_pred CCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCC
Q 004218 28 NLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRL 107 (767)
Q Consensus 28 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L 107 (767)
.++.++.++++++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|++++|.+...+ +..+.++++|
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~------~~~f~~l~~L 81 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS------PGAFAPLVKL 81 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBC------TTTTTTCTTC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccc------hhhhhCCCcc
Confidence 3566777777777 5666553 56777777777777333346777777777777777665321 2234555566
Q ss_pred CEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCC
Q 004218 108 NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN 164 (767)
Q Consensus 108 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n 164 (767)
++|++++|+++ .+|..+. .. +..|++..|.+....+..+.....+..++...|
T Consensus 82 ~~L~l~~n~l~-~l~~~~~--~~-l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n 134 (305)
T d1xkua_ 82 ERLYLSKNQLK-ELPEKMP--KT-LQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134 (305)
T ss_dssp CEEECCSSCCS-BCCSSCC--TT-CCEEECCSSCCCBBCHHHHTTCTTCCEEECCSS
T ss_pred CEecccCCccC-cCccchh--hh-hhhhhccccchhhhhhhhhhccccccccccccc
Confidence 66666666555 3333221 12 445555555554443334444444444444444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.4e-25 Score=225.76 Aligned_cols=226 Identities=19% Similarity=0.211 Sum_probs=196.8
Q ss_pred cEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecC
Q 004218 5 VYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGF 84 (767)
Q Consensus 5 ~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (767)
.+++.++++++ ++|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....+..+..+..++.+....
T Consensus 14 ~~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~ 89 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccc
Confidence 45788999998 9998775 4789999999999976677899999999999999999988888888899999988764
Q ss_pred -ccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcC
Q 004218 85 -NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSY 163 (767)
Q Consensus 85 -n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~ 163 (767)
|.+... .+..+.++++|++|++++|.+....+..+....+ |+.+++++|+++++.+..|..+++|++|++++
T Consensus 90 ~~~~~~l------~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~-L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~ 162 (284)
T d1ozna_ 90 NAQLRSV------DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA-LQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162 (284)
T ss_dssp CTTCCCC------CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ccccccc------cchhhcccccCCEEecCCcccccccccccchhcc-cchhhhccccccccChhHhccccchhhccccc
Confidence 445433 2446788899999999999998666666666776 99999999999977788899999999999999
Q ss_pred CcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCC
Q 004218 164 NSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN 241 (767)
Q Consensus 164 n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 241 (767)
|.++.+.+.+|.++++|+.|++++|++.+..|..|..+++|++|++++|++.+..+..|+.+++|+.|+|++|.+...
T Consensus 163 N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred CcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 999988888999999999999999999988899999999999999999999988888999999999999999998753
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.5e-25 Score=225.64 Aligned_cols=225 Identities=26% Similarity=0.309 Sum_probs=138.6
Q ss_pred EEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEcc-C
Q 004218 109 FLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLA-G 187 (767)
Q Consensus 109 ~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~-~ 187 (767)
.+++++++++ .+|..+. .++++|+|++|+|+...+.+|.++++|++|++++|++..+.+..+..+..++.++.. .
T Consensus 15 ~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp EEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 4566666666 5565432 337777777777776666677777777777777777776666667777777777654 4
Q ss_pred CccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCCC
Q 004218 188 NQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTL 267 (767)
Q Consensus 188 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~ 267 (767)
|.+....+..|.++++|++|++++|.+....+..+...++|+.+++++|++++..+..|
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f--------------------- 149 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF--------------------- 149 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT---------------------
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHh---------------------
Confidence 55665556667777777777777777766666666667777777777777664334444
Q ss_pred chhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCccccccc
Q 004218 268 PEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSDLQNLR 347 (767)
Q Consensus 268 ~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 347 (767)
+.+++|+.|++++|++++..+..|.++++|+.+++++|++++..|..|..+++|++|++++|.+.+..+..|..++
T Consensus 150 ----~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~ 225 (284)
T d1ozna_ 150 ----RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (284)
T ss_dssp ----TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred ----ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccccc
Confidence 4444555555555555544455555555555555555555555555555555555555555555544444555555
Q ss_pred cCceEeccCCcCcCc
Q 004218 348 ALRSLNLTFNNLEGV 362 (767)
Q Consensus 348 ~L~~L~l~~N~l~~~ 362 (767)
+|+.|++++|++.+.
T Consensus 226 ~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 226 ALQYLRLNDNPWVCD 240 (284)
T ss_dssp TCCEEECCSSCEECS
T ss_pred ccCEEEecCCCCCCC
Confidence 555555555555543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.5e-23 Score=209.86 Aligned_cols=199 Identities=19% Similarity=0.160 Sum_probs=108.9
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
+++.++|.++++++ .||..+. +++++|+|++|.|++..+.+|.++++|++|+|++|+|+ .++ .++.+++|++|+
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~ 83 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLD 83 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEE
T ss_pred CCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccc
Confidence 34555677777776 6776553 35677777777776544556677777777777777766 333 245566666666
Q ss_pred ecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEEC
Q 004218 82 IGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNL 161 (767)
Q Consensus 82 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l 161 (767)
|++|++.. .+..+..+++|+.|++++|.+. ...+..+..+.++++|++
T Consensus 84 Ls~N~l~~-------~~~~~~~l~~L~~L~l~~~~~~-------------------------~~~~~~~~~l~~l~~L~l 131 (266)
T d1p9ag_ 84 LSHNQLQS-------LPLLGQTLPALTVLDVSFNRLT-------------------------SLPLGALRGLGELQELYL 131 (266)
T ss_dssp CCSSCCSS-------CCCCTTTCTTCCEEECCSSCCC-------------------------CCCSSTTTTCTTCCEEEC
T ss_pred cccccccc-------cccccccccccccccccccccc-------------------------eeeccccccccccccccc
Confidence 66666542 2233444455555555555544 444444444455555555
Q ss_pred cCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccC
Q 004218 162 SYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 162 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
++|.++...+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 132 ~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 555555444444445555555555555555444444555555555555555554 33444444555555555555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=7.5e-23 Score=204.69 Aligned_cols=200 Identities=26% Similarity=0.309 Sum_probs=158.2
Q ss_pred CCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCC
Q 004218 26 LPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNST 105 (767)
Q Consensus 26 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~ 105 (767)
...+.+.+.++++++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+++.
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~---------------- 69 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK---------------- 69 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE----------------
T ss_pred cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc----------------
Confidence 445566677777777 4565443 466777777777764444556666666666666665532
Q ss_pred CCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEc
Q 004218 106 RLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDL 185 (767)
Q Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 185 (767)
+| .++.+++ |++|+|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.++++|++
T Consensus 70 ---------------l~-~~~~l~~-L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l 131 (266)
T d1p9ag_ 70 ---------------LQ-VDGTLPV-LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (266)
T ss_dssp ---------------EE-CCSCCTT-CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred ---------------cc-ccccccc-cccccccccccc-ccccccccccccccccccccccceeeccccccccccccccc
Confidence 11 1233444 777777777776 45667888999999999999999888888999999999999
Q ss_pred cCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCC
Q 004218 186 AGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264 (767)
Q Consensus 186 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~ 264 (767)
++|.+....+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++| +.++|++|.+.
T Consensus 132 ~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L-~~L~L~~Np~~ 208 (266)
T d1p9ag_ 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL-PFAFLHGNPWL 208 (266)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCC-SEEECCSCCBC
T ss_pred cccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCC-CEEEecCCCCC
Confidence 999999888888899999999999999999988899999999999999999999 899999999998 45599999886
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.6e-23 Score=197.98 Aligned_cols=132 Identities=20% Similarity=0.193 Sum_probs=104.8
Q ss_pred CCCCccccccceEEEEEEeCCCcEEEEEEeeccCCc------------------chhhHHHHHHHHhcCCCCCceeEEee
Q 004218 458 SHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTG------------------TWKSFFAECEALRNTRHRNLVKLITS 519 (767)
Q Consensus 458 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~~~~~ 519 (767)
.+.++||+|+||.||+|.+.+|+.||||+++..... ......+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999988999999987532110 01234568889999999999998876
Q ss_pred eecCCcccceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 004218 520 CSSLDFKNMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDCEVPIVHCDLKPGNILLD 599 (767)
Q Consensus 520 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~ 599 (767)
.. .+++|||++++.+.+ ++...+..++.|++.+++|||++ ||+||||||+||+++
T Consensus 83 ~~---------~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~ 137 (191)
T d1zara2 83 EG---------NAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS 137 (191)
T ss_dssp ET---------TEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred cC---------CEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeee
Confidence 21 179999998865433 33344678999999999999999 999999999999999
Q ss_pred CCCceEEccccchhhh
Q 004218 600 EDMTAKVGDFGLARSL 615 (767)
Q Consensus 600 ~~~~~kl~Dfg~a~~~ 615 (767)
+++ ++|+|||.|...
T Consensus 138 ~~~-~~liDFG~a~~~ 152 (191)
T d1zara2 138 EEG-IWIIDFPQSVEV 152 (191)
T ss_dssp TTE-EEECCCTTCEET
T ss_pred CCC-EEEEECCCcccC
Confidence 654 899999999654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.87 E-value=2.4e-20 Score=195.21 Aligned_cols=303 Identities=24% Similarity=0.309 Sum_probs=211.6
Q ss_pred CccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEee
Q 004218 3 SLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNI 82 (767)
Q Consensus 3 ~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 82 (767)
++++|||++|+++ ++|.. .++|++|+|++|+|+ .+|+.+ .+|+.|++++|.++ .++. + -+.|++|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~----~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC----CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEEC
T ss_pred CCCEEEeCCCCCC-CCCCC----CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--ccccccccc
Confidence 6889999999998 89953 578999999999999 778654 68999999999998 4443 2 146999999
Q ss_pred cCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECc
Q 004218 83 GFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLS 162 (767)
Q Consensus 83 ~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~ 162 (767)
++|.+...+ ...++++|+.|++++|.+. ..+... .. +..+.+..+... ....+..++.++.|+++
T Consensus 106 ~~n~l~~lp--------~~~~l~~L~~L~l~~~~~~-~~~~~~---~~-l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~ 170 (353)
T d1jl5a_ 106 SNNQLEKLP--------ELQNSSFLKIIDVDNNSLK-KLPDLP---PS-LEFIAAGNNQLE--ELPELQNLPFLTAIYAD 170 (353)
T ss_dssp CSSCCSSCC--------CCTTCTTCCEEECCSSCCS-CCCCCC---TT-CCEEECCSSCCS--SCCCCTTCTTCCEEECC
T ss_pred ccccccccc--------chhhhccceeecccccccc-cccccc---cc-ccchhhcccccc--ccccccccccceecccc
Confidence 999987432 3567899999999999987 334332 23 777888777764 35567888999999999
Q ss_pred CCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCC
Q 004218 163 YNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNI 242 (767)
Q Consensus 163 ~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 242 (767)
+|.+... +. .....+.+....+.+. .++ .+..++.|+.+++++|.... .+. ...++..+.+.++.+.. .
T Consensus 171 ~n~~~~~-~~---~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~-~ 239 (353)
T d1jl5a_ 171 NNSLKKL-PD---LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTD-L 239 (353)
T ss_dssp SSCCSSC-CC---CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSC-C
T ss_pred ccccccc-cc---cccccccccccccccc-ccc-cccccccccccccccccccc-ccc---ccccccccccccccccc-c
Confidence 9988732 22 2334567777777666 444 36778899999999998763 333 34567777788887763 3
Q ss_pred ChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhcc
Q 004218 243 PKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAEL 322 (767)
Q Consensus 243 ~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 322 (767)
+.....+ ....+..+.+.+.. .-.......++..+.+.+. ...+++|++|++++|+|+ .+|. .+
T Consensus 240 ~~~~~~l----~~~~~~~~~~~~l~----~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~---~~ 303 (353)
T d1jl5a_ 240 PELPQSL----TFLDVSENIFSGLS----ELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPA---LP 303 (353)
T ss_dssp CCCCTTC----CEEECCSSCCSEES----CCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCC---CC
T ss_pred ccccccc----cccccccccccccc----cccchhcccccccCccccc----cccCCCCCEEECCCCccC-cccc---cc
Confidence 3222222 22244444443211 0113445667777776632 234578888999998888 4554 35
Q ss_pred CCceEEEcCCcccCCCCCccccccccCceEeccCCcCcCcCC
Q 004218 323 KGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLTFNNLEGVVP 364 (767)
Q Consensus 323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 364 (767)
++|+.|+|++|+|+ .+|.. +++|+.|++++|+++.++.
T Consensus 304 ~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~lp~ 341 (353)
T d1jl5a_ 304 PRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREFPD 341 (353)
T ss_dssp TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSCCC
T ss_pred CCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCCCCc
Confidence 67888999999887 55643 4678889999999887653
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=1e-18 Score=182.55 Aligned_cols=295 Identities=23% Similarity=0.318 Sum_probs=212.0
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
++|++|+|++|+|+ ++|.. +.+|++|++++|+++ .++.. .+.|++|++++|.+. .+|. ++.+++|++|+
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhhhccceeec
Confidence 67999999999999 99965 458999999999998 45532 146999999999998 5664 68899999999
Q ss_pred ecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEEC
Q 004218 82 IGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNL 161 (767)
Q Consensus 82 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l 161 (767)
+++|.+...+ .....+..+.+..+... .+..+..+.. ++.|+++.|.+.. .+. .....+.+..
T Consensus 127 l~~~~~~~~~----------~~~~~l~~l~~~~~~~~--~~~~l~~l~~-l~~L~l~~n~~~~-~~~---~~~~~~~l~~ 189 (353)
T d1jl5a_ 127 VDNNSLKKLP----------DLPPSLEFIAAGNNQLE--ELPELQNLPF-LTAIYADNNSLKK-LPD---LPLSLESIVA 189 (353)
T ss_dssp CCSSCCSCCC----------CCCTTCCEEECCSSCCS--SCCCCTTCTT-CCEEECCSSCCSS-CCC---CCTTCCEEEC
T ss_pred cccccccccc----------cccccccchhhcccccc--cccccccccc-ceecccccccccc-ccc---cccccccccc
Confidence 9999886432 12456778888777665 2345666776 9999999998873 332 2245677788
Q ss_pred cCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCC
Q 004218 162 SYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGN 241 (767)
Q Consensus 162 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 241 (767)
.++.+.. ...+..++.|+.+++++|... ..+. ...++..+.+.+|.+.. .+.. ...+..+++..+.+.+
T Consensus 190 ~~~~~~~--~~~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~~~~~- 258 (353)
T d1jl5a_ 190 GNNILEE--LPELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG- 258 (353)
T ss_dssp CSSCCSS--CCCCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-
T ss_pred ccccccc--ccccccccccccccccccccc-cccc---ccccccccccccccccc-cccc---cccccccccccccccc-
Confidence 7777663 334678999999999999887 3443 34678889999998864 3332 3455666666655541
Q ss_pred CChhhcccccccceeecccccCCCCCchhhcCCCceeEEEccCCCCCCCCCcccccCcccceeeccCccccCCCCchhhc
Q 004218 242 IPKEILSLSSLTTIVNLSKNFLDGTLPEEIGMLGNVVTIDLSANGLSGNLPNSFKNCKSLEKLLMANNKFSGPIPNILAE 321 (767)
Q Consensus 242 ~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 321 (767)
+..++......++..+.+.+ ....+++|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..
T Consensus 259 ----l~~l~~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~--- 322 (353)
T d1jl5a_ 259 ----LSELPPNLYYLNASSNEIRS----LCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL--- 322 (353)
T ss_dssp ----ESCCCTTCCEEECCSSCCSE----ECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC---
T ss_pred ----cccccchhcccccccCcccc----ccccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc---
Confidence 22233332334566666552 2345789999999999998 4554 3678999999999998 45543
Q ss_pred cCCceEEEcCCcccCCCCCccccccccCceEecc
Q 004218 322 LKGLEVLDLSSNKLSGSIPSDLQNLRALRSLNLT 355 (767)
Q Consensus 322 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 355 (767)
+++|+.|+|++|+|+ .+|... ..|+.|.+.
T Consensus 323 ~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~~ 352 (353)
T d1jl5a_ 323 PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRMN 352 (353)
T ss_dssp CTTCCEEECCSSCCS-SCCCCC---TTCCEEECC
T ss_pred cCCCCEEECcCCcCC-CCCccc---cccCeeECc
Confidence 468999999999998 667543 346666553
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=3.3e-19 Score=175.50 Aligned_cols=219 Identities=17% Similarity=0.186 Sum_probs=122.4
Q ss_pred CEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCccc-CccccCCCCCCCEEEcc
Q 004218 108 NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGE-ILTEIGQLQELQSLDLA 186 (767)
Q Consensus 108 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~-~~~~~~~l~~L~~L~L~ 186 (767)
+.++++++.++ .+|..+. .+ +++|++++|+|+...+.+|.++++|++|++++|.+... .+..|..++++++|.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~-l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RN-AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SC-CSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC--CC-CCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 34555555555 4444332 12 55566666655544444555555555555555555432 23345555555555544
Q ss_pred C-CccccccCcCcccCCCCceeeCCCCcCCCCCcc-cccCccccccccccCcccCCCCChhhcccccccceeecccccCC
Q 004218 187 G-NQISGSIPNTLGNLKKLNQIDLSGNELASEIPT-SFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264 (767)
Q Consensus 187 ~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~ 264 (767)
. |.+....+..|..+++|++|++++|.+....+. .+..++.+..+..++ +.+.
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n-------------------------~~l~ 141 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN-------------------------INIH 141 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESC-------------------------TTCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccc-------------------------cccc
Confidence 2 444444455555555555555555555422111 112223333333333 3333
Q ss_pred CCCchhhcCCC-ceeEEEccCCCCCCCCCcccccCcccc-eeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCcc
Q 004218 265 GTLPEEIGMLG-NVVTIDLSANGLSGNLPNSFKNCKSLE-KLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD 342 (767)
Q Consensus 265 ~~~~~~~~~l~-~L~~L~ls~n~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 342 (767)
...+..+..++ .++.|++++|+++.+.+..+.. ++++ .+++++|+++...+..|.++++|+.|+|++|+|+...+..
T Consensus 142 ~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~-~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~ 220 (242)
T d1xwdc1 142 TIERNSFVGLSFESVILWLNKNGIQEIHNCAFNG-TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 220 (242)
T ss_dssp EECTTSSTTSBSSCEEEECCSSCCCEECTTTTTT-CCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSS
T ss_pred cccccccccccccceeeecccccccccccccccc-hhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHH
Confidence 33334444433 6778888888888555544443 4444 4456777888666667888888999999888888655666
Q ss_pred ccccccCceEeccC
Q 004218 343 LQNLRALRSLNLTF 356 (767)
Q Consensus 343 ~~~l~~L~~L~l~~ 356 (767)
|.++++|+.+++.+
T Consensus 221 ~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 221 LENLKKLRARSTYN 234 (242)
T ss_dssp CTTCCEEESSSEES
T ss_pred HcCCcccccCcCCC
Confidence 77788887776643
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=4.1e-19 Score=174.80 Aligned_cols=220 Identities=16% Similarity=0.117 Sum_probs=165.8
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccC-CccCCCCCCCcEEee
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTV-PPGLGNLPFLKMYNI 82 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~-~~~~~~l~~L~~L~l 82 (767)
.++++.++++++ ++|..++ +++++|++++|.|....+.+|.++++|++|+|++|.+...+ +..|..++++++|.+
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CCEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 357888888998 9998775 47899999999999656668999999999999999987654 456888999999987
Q ss_pred cC-ccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhh-hhccccCeEEccCCcccccCCccccCCC-CCCEE
Q 004218 83 GF-NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIG-NLSNVLSKLYMGGNRFYGKIPTSIGRLR-SLTLL 159 (767)
Q Consensus 83 ~~-n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~~L~~L~l~~n~i~~~~~~~l~~l~-~L~~L 159 (767)
.. |++.. ..+..+..+++|+.|++++|++....+.... .+.. +..+...++++....+..|..++ .++.|
T Consensus 86 ~~~n~l~~------~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~-l~~~~~~n~~l~~i~~~~~~~~~~~l~~L 158 (242)
T d1xwdc1 86 EKANNLLY------INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK-VLLDIQDNINIHTIERNSFVGLSFESVIL 158 (242)
T ss_dssp ECCTTCCE------ECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSC-EEEEEESCTTCCEECTTSSTTSBSSCEEE
T ss_pred cccccccc------cccccccccccccccccchhhhcccccccccccccc-cccccccccccccccccccccccccceee
Confidence 65 45543 2334578889999999999988744333222 2333 66667777788766677777765 78889
Q ss_pred ECcCCcCcccCccccCCCCCCCEE-EccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccC
Q 004218 160 NLSYNSISGEILTEIGQLQELQSL-DLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSN 235 (767)
Q Consensus 160 ~l~~n~i~~~~~~~~~~l~~L~~L-~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 235 (767)
++++|+++.+....+ ...+++++ ++++|+++...+..|.++++|++|+|++|+++...+..|.++++|+.+++.+
T Consensus 159 ~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 159 WLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp ECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 999999986555444 44555444 5677888855566788899999999999999877677788888888887754
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=2.7e-19 Score=174.04 Aligned_cols=204 Identities=20% Similarity=0.300 Sum_probs=148.6
Q ss_pred EEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCc
Q 004218 6 YLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFN 85 (767)
Q Consensus 6 ~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n 85 (767)
.++++.+++++.++. ..+.+|++|++.+|+|+. ++ .+.++++|++|++++|.+++.. .+..+++|+++++++|
T Consensus 23 ~~~l~~~~~~d~~~~---~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 23 KIAAGKSNVTDTVTQ---ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGN 95 (227)
T ss_dssp HHHTTCSSTTSEECH---HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSC
T ss_pred HHHhCCCCcCCcCCH---HHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeeccc--cccccccccccccccc
Confidence 345666666643322 236688888888888884 54 4788888888888888887433 3788888888888888
Q ss_pred cccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCc
Q 004218 86 KIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNS 165 (767)
Q Consensus 86 ~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~ 165 (767)
.++. ...+..+++|+++++++|...+. ..+..... +..+.++.+.+.. ...+..+++|++|++++|.
T Consensus 96 ~~~~--------i~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~-~~~l~~~~~~~~~--~~~~~~~~~L~~L~l~~n~ 162 (227)
T d1h6ua2 96 PLKN--------VSAIAGLQSIKTLDLTSTQITDV--TPLAGLSN-LQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQ 162 (227)
T ss_dssp CCSC--------CGGGTTCTTCCEEECTTSCCCCC--GGGTTCTT-CCEEECCSSCCCC--CGGGGGCTTCCEEECCSSC
T ss_pred cccc--------ccccccccccccccccccccccc--chhccccc-hhhhhchhhhhch--hhhhccccccccccccccc
Confidence 7753 23567788888888888877633 33455555 8888888888763 3346778888888888888
Q ss_pred CcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccC
Q 004218 166 ISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSN 235 (767)
Q Consensus 166 i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 235 (767)
+... ..+.++++|++|+|++|++++. + .++++++|++|+|++|++++.. .++++++|+.|++++
T Consensus 163 ~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 163 VSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp CCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred cccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 8742 3477888888888888888743 3 3788888888888888887543 377888888888763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=5.6e-22 Score=215.78 Aligned_cols=357 Identities=15% Similarity=0.113 Sum_probs=206.4
Q ss_pred CCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccc----cCCccccCCCCCCEEEcccccCccc----CCccCCC
Q 004218 2 TSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTG----KIPGSLHNLTNIQIIRMAHNLLEGT----VPPGLGN 73 (767)
Q Consensus 2 ~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~----~~~~~l~~l~~L~~L~l~~n~i~~~----~~~~~~~ 73 (767)
.+|++|||++|++++.-=..++..+++++.|+|++|+++. .++..+..+++|++|||++|.|++. +...+..
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 3689999999999842213444568999999999999873 4566788999999999999999742 2333332
Q ss_pred -CCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhh----ccccCeEEccCCcccc----
Q 004218 74 -LPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNL----SNVLSKLYMGGNRFYG---- 144 (767)
Q Consensus 74 -l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l----~~~L~~L~l~~n~i~~---- 144 (767)
..+|++|+|++|+++.. +...++..+..+++|++|++++|.++......+... ......+......+..
T Consensus 82 ~~~~L~~L~L~~n~it~~--~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 159 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGA--GCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 159 (460)
T ss_dssp TTCCCCEEECTTSCCBGG--GHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred CCCCCCEEECCCCCcccc--ccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhc
Confidence 35899999999998642 112345678889999999999999875433333221 1112333333333321
Q ss_pred cCCccccCCCCCCEEECcCCcCcccCcc----cc-CCCCCCCEEEccCCccccc----cCcCcccCCCCceeeCCCCcCC
Q 004218 145 KIPTSIGRLRSLTLLNLSYNSISGEILT----EI-GQLQELQSLDLAGNQISGS----IPNTLGNLKKLNQIDLSGNELA 215 (767)
Q Consensus 145 ~~~~~l~~l~~L~~L~l~~n~i~~~~~~----~~-~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~ 215 (767)
.....+.....++.++++++.+...... .+ ........|++..+.+... ....+...+.++.+++++|.+.
T Consensus 160 ~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~ 239 (460)
T d1z7xw1 160 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 239 (460)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccc
Confidence 1112234456677777777665521111 11 1123455666666655421 1122344566667777766653
Q ss_pred CC-----CcccccCccccccccccCcccCCCCC----hhhcccccccceeecccccCCCCCchhh-----cCCCceeEEE
Q 004218 216 SE-----IPTSFGNFQNLLSIDLSNNKLNGNIP----KEILSLSSLTTIVNLSKNFLDGTLPEEI-----GMLGNVVTID 281 (767)
Q Consensus 216 ~~-----~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~~l~~~l~l~~n~l~~~~~~~~-----~~l~~L~~L~ 281 (767)
.. ....+.....|+.+++++|.+..... ..+...+.+ ..+++++|.++......+ .....|+.++
T Consensus 240 ~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l-~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~ 318 (460)
T d1z7xw1 240 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL-KELSLAGNELGDEGARLLCETLLEPGCQLESLW 318 (460)
T ss_dssp HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTC-CEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred ccccchhhcccccccccccccccccccccccccccccccccccccc-cccccccccccccccchhhcccccccccccccc
Confidence 11 12223345566677777766652211 122334444 334666666643211111 2234677777
Q ss_pred ccCCCCCCCCCc----ccccCcccceeeccCccccCCC----Cchhh-ccCCceEEEcCCcccCCC----CCcccccccc
Q 004218 282 LSANGLSGNLPN----SFKNCKSLEKLLMANNKFSGPI----PNILA-ELKGLEVLDLSSNKLSGS----IPSDLQNLRA 348 (767)
Q Consensus 282 ls~n~l~~~~~~----~~~~l~~L~~L~l~~n~l~~~~----~~~~~-~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~ 348 (767)
+++|.++..... .+...++|++|+|++|++++.. +..+. ..+.|+.|+|++|.|++. ++..+..+++
T Consensus 319 l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~ 398 (460)
T d1z7xw1 319 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 398 (460)
T ss_dssp CTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCC
T ss_pred ccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCC
Confidence 777776643322 2234456777777777765422 22222 245577777777777632 3334555677
Q ss_pred CceEeccCCcCcC
Q 004218 349 LRSLNLTFNNLEG 361 (767)
Q Consensus 349 L~~L~l~~N~l~~ 361 (767)
|++|++++|+++.
T Consensus 399 L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 399 LRELDLSNNCLGD 411 (460)
T ss_dssp CCEEECCSSSCCH
T ss_pred CCEEECCCCcCCH
Confidence 7777777777754
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=2.2e-18 Score=167.51 Aligned_cols=187 Identities=27% Similarity=0.363 Sum_probs=156.9
Q ss_pred CCCccEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEE
Q 004218 1 MTSLVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMY 80 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 80 (767)
|++|++|++++|+|+ .++ . ++++++|++|++++|.+.+..| +..+++|++|++++|.++ .+ ..++.+++|+.+
T Consensus 40 l~~L~~L~l~~~~i~-~l~-~-l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i-~~l~~l~~L~~l 112 (227)
T d1h6ua2 40 LDGITTLSAFGTGVT-TIE-G-VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NV-SAIAGLQSIKTL 112 (227)
T ss_dssp HHTCCEEECTTSCCC-CCT-T-GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CC-GGGTTCTTCCEE
T ss_pred cCCcCEEECCCCCCC-cch-h-HhcCCCCcEeecCCceeecccc--cccccccccccccccccc-cc-cccccccccccc
Confidence 357999999999998 785 3 4579999999999999995433 899999999999999997 33 358899999999
Q ss_pred eecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEE
Q 004218 81 NIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLN 160 (767)
Q Consensus 81 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~ 160 (767)
+++.|.... ...+...+.+..+.++.+.+... ..+....+ |++|++++|.+... ..++++++|++|+
T Consensus 113 ~l~~~~~~~--------~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~-L~~L~l~~n~~~~~--~~l~~l~~L~~L~ 179 (227)
T d1h6ua2 113 DLTSTQITD--------VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTN-LQYLSIGNAQVSDL--TPLANLSKLTTLK 179 (227)
T ss_dssp ECTTSCCCC--------CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTT-CCEEECCSSCCCCC--GGGTTCTTCCEEE
T ss_pred ccccccccc--------cchhccccchhhhhchhhhhchh--hhhccccc-cccccccccccccc--hhhcccccceecc
Confidence 999998653 34467788999999999998743 34677777 99999999999743 3489999999999
Q ss_pred CcCCcCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 161 LSYNSISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 161 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
|++|++++. ..++.+++|++|+|++|++++.. .+.++++|+.|++++
T Consensus 180 Ls~n~l~~l--~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 180 ADDNKISDI--SPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp CCSSCCCCC--GGGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred cCCCccCCC--hhhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 999999863 34889999999999999999543 389999999999974
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=7.6e-18 Score=161.05 Aligned_cols=183 Identities=26% Similarity=0.367 Sum_probs=131.6
Q ss_pred cEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCE
Q 004218 30 LGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNF 109 (767)
Q Consensus 30 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~ 109 (767)
...++..+.+.+.++. ..+.+|++|++++|.++. ++ .+..+++|++|++++|++++. ..+.++++|++
T Consensus 27 i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l--------~~~~~l~~L~~ 94 (210)
T d1h6ta2 27 IKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI--------KPLANLKNLGW 94 (210)
T ss_dssp HHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC--------GGGTTCTTCCE
T ss_pred HHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc--------cccccCccccc
Confidence 3446666666655442 346677888888888763 32 467778888888888877532 23567778888
Q ss_pred EECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCc
Q 004218 110 LAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQ 189 (767)
Q Consensus 110 L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 189 (767)
|++++|+++ .+| .+.++++ |+.|++++|.+.. ...+..+++|+.+++++|.+++ +..+..+++|+++++++|+
T Consensus 95 L~l~~n~i~-~l~-~l~~l~~-L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~ 167 (210)
T d1h6ta2 95 LFLDENKVK-DLS-SLKDLKK-LKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ 167 (210)
T ss_dssp EECCSSCCC-CGG-GGTTCTT-CCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSC
T ss_pred ccccccccc-ccc-ccccccc-ccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccc
Confidence 888888887 344 4777777 8888888888762 3457778888888888888874 3456778888888888888
Q ss_pred cccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccC
Q 004218 190 ISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSN 235 (767)
Q Consensus 190 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 235 (767)
+++. + .+.++++|++|+|++|+++. ++ .|.++++|++|+|++
T Consensus 168 l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 168 ISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 8743 2 37788888888888888874 33 578888888888764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.6e-17 Score=158.85 Aligned_cols=181 Identities=25% Similarity=0.362 Sum_probs=147.8
Q ss_pred EeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCcc
Q 004218 7 LGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNK 86 (767)
Q Consensus 7 L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 86 (767)
..++.+.+++.++.. .+.+|++|++++|.+.+ +++ +..+++|++|+|++|++++ ++ .++.+++|++|++++|+
T Consensus 29 ~~l~~~~~~~~~~~~---~L~~L~~L~l~~~~i~~-l~~-l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENK 101 (210)
T ss_dssp HHTTCSCTTSEECHH---HHHTCCEEECTTSCCCC-CTT-GGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred HHhCcCccCCccCHH---HhcCccEEECcCCCCCC-chh-HhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccc
Confidence 356667766555543 25689999999999984 443 8899999999999999985 33 46889999999999999
Q ss_pred ccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcC
Q 004218 87 IVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSI 166 (767)
Q Consensus 87 l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i 166 (767)
++. ...+.++++|+.|++++|.+. . ...+..++. ++.+++++|+++. +..+..+++|+++++++|++
T Consensus 102 i~~--------l~~l~~l~~L~~L~l~~~~~~-~-~~~l~~l~~-l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l 168 (210)
T d1h6ta2 102 VKD--------LSSLKDLKKLKSLSLEHNGIS-D-INGLVHLPQ-LESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 168 (210)
T ss_dssp CCC--------GGGGTTCTTCCEEECTTSCCC-C-CGGGGGCTT-CCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCC
T ss_pred ccc--------ccccccccccccccccccccc-c-ccccccccc-ccccccccccccc--cccccccccccccccccccc
Confidence 863 235788999999999999987 3 346778887 9999999999973 44678899999999999999
Q ss_pred cccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCC
Q 004218 167 SGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSG 211 (767)
Q Consensus 167 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 211 (767)
++. ..+.++++|++|+|++|+|++ ++ .|.++++|++|+|++
T Consensus 169 ~~i--~~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 169 SDI--VPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCC--GGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred ccc--ccccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 853 348899999999999999984 44 589999999999874
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=2.1e-17 Score=156.57 Aligned_cols=179 Identities=25% Similarity=0.378 Sum_probs=106.4
Q ss_pred cEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCE
Q 004218 30 LGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNF 109 (767)
Q Consensus 30 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~ 109 (767)
..+.++.+.+.+.++ ...+.+|++|++++|.++. + ..++.+++|++|++++|++++. ..+.++++|++
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~--------~~l~~l~~L~~ 88 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI--------TPLKNLTKLVD 88 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC--------GGGTTCTTCCE
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc--------ccccCCccccc
Confidence 334455555554332 2345566666666666652 2 2355566666666666665421 12555666666
Q ss_pred EECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCCc
Q 004218 110 LAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGNQ 189 (767)
Q Consensus 110 L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 189 (767)
|++++|.+. .++ .+.++.. |++|++++|.+.. ...+..+++|+.|++++|++.. .+.+..+++|+.|++++|+
T Consensus 89 L~l~~n~~~-~~~-~l~~l~~-L~~L~l~~~~~~~--~~~~~~l~~L~~L~l~~n~l~~--~~~l~~~~~L~~L~l~~n~ 161 (199)
T d2omxa2 89 ILMNNNQIA-DIT-PLANLTN-LTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLNFSSNQ 161 (199)
T ss_dssp EECCSSCCC-CCG-GGTTCTT-CSEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEECCSSC
T ss_pred ccccccccc-ccc-ccccccc-ccccccccccccc--ccccchhhhhHHhhhhhhhhcc--ccccccccccccccccccc
Confidence 666666665 222 3555655 7777777666653 2346667777777777777763 2356677777777777777
Q ss_pred cccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccc
Q 004218 190 ISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSI 231 (767)
Q Consensus 190 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 231 (767)
+++. + .++++++|++|++++|+++.. + .++.+++|++|
T Consensus 162 l~~l-~-~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 162 VTDL-K-PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp CCCC-G-GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred ccCC-c-cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 7643 2 367777777777777777642 2 46666666654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=1.2e-17 Score=157.26 Aligned_cols=152 Identities=21% Similarity=0.250 Sum_probs=73.2
Q ss_pred CCEEECcCCcceeec-CchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEc
Q 004218 107 LNFLAFDGNQFEGEI-PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDL 185 (767)
Q Consensus 107 L~~L~l~~n~l~~~~-~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 185 (767)
+++|+|++|+|++.+ +..|.++++ |++|+|++|++....+..|..+++|++|+|++|+|+.+.+.+|.++++|++|+|
T Consensus 31 l~~L~Ls~N~i~~~~~~~~f~~l~~-L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 31 TTELLLNDNELGRISSDGLFGRLPH-LVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp CSEEECCSCCCCSBCCSCSGGGCTT-CCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCEEEeCCCCCcccccccccCCCce-EeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 334444444443222 233344444 555555555555555555555555555555555555555555555555555555
Q ss_pred cCCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCC
Q 004218 186 AGNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLD 264 (767)
Q Consensus 186 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~ 264 (767)
++|+|+...+.+|..+++|++|+|++|.+..... ...-...++.+.+..+.+....|..+.++ .+++++.|.+.
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~~l~~~----~l~~L~~n~l~ 183 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKVRDV----QIKDLPHSEFK 183 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSSTTTTTS----BGGGSCTTTCC
T ss_pred CCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCChhhcCC----EeeecCHhhCc
Confidence 5555555555555555555555555555543211 11112234455555555554444443332 22345555443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=3e-17 Score=154.45 Aligned_cols=172 Identities=23% Similarity=0.310 Sum_probs=113.6
Q ss_pred CEEECcCCcceeecCchhhhhccccCeEEccCCcccc-cCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEcc
Q 004218 108 NFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYG-KIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLA 186 (767)
Q Consensus 108 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~-~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 186 (767)
+++++++++++ .+|..+. .++++|+|++|+|+. ..+..|.++++|++|+|++|.+....+..|..+++|++|+|+
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 45677777776 5665442 237777888887764 345566777778888887777777777777777778888888
Q ss_pred CCccccccCcCcccCCCCceeeCCCCcCCCCCcccccCccccccccccCcccCCCCChhhcccccccceeecccccCCCC
Q 004218 187 GNQISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGT 266 (767)
Q Consensus 187 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~ 266 (767)
+|+|....+.+|.++++|++|+|++|+|+++.+++|..+++|++|+|++|.+.......+. ...+ ....+..+.+...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~-~~~l-~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF-AEWL-RKKSLNGGAARCG 164 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH-HHHH-HHHCCSGGGCBBC
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHH-hhhh-hhhcccCCCeEeC
Confidence 8877766677777777788888888877777777777777788888877777643322111 1112 2235555666544
Q ss_pred CchhhcCCCceeEEEccCCCCC
Q 004218 267 LPEEIGMLGNVVTIDLSANGLS 288 (767)
Q Consensus 267 ~~~~~~~l~~L~~L~ls~n~l~ 288 (767)
.|..+ ..++.++|+.|.+.
T Consensus 165 ~p~~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 165 APSKV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp SSTTT---TTSBGGGSCTTTCC
T ss_pred CChhh---cCCEeeecCHhhCc
Confidence 55433 34455666666664
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=4.8e-17 Score=154.02 Aligned_cols=178 Identities=26% Similarity=0.340 Sum_probs=146.5
Q ss_pred EEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCc
Q 004218 6 YLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFN 85 (767)
Q Consensus 6 ~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n 85 (767)
.+.++.+.+++.++.. .++++++|++++|++. .++ .++.+++|++|++++|++++. + .++.+++|++|++++|
T Consensus 22 ~~~l~~~~~~~~~~~~---~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~-~-~l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 22 KTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHTTCSSTTSEECHH---HHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSS
T ss_pred HHHhCCCCCCCccCHH---HhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCc-c-cccCCccccccccccc
Confidence 3467777777544332 3679999999999999 454 489999999999999999854 3 3899999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCc
Q 004218 86 KIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNS 165 (767)
Q Consensus 86 ~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~ 165 (767)
.+.. ...+.++++|+.|++++|.+... +.+..+++ |+.|++++|++.. + ..+..+++|+.|++.+|+
T Consensus 95 ~~~~--------~~~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~-L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~ 161 (199)
T d2omxa2 95 QIAD--------ITPLANLTNLTGLTLFNNQITDI--DPLKNLTN-LNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQ 161 (199)
T ss_dssp CCCC--------CGGGTTCTTCSEEECCSSCCCCC--GGGTTCTT-CSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSC
T ss_pred cccc--------ccccccccccccccccccccccc--cccchhhh-hHHhhhhhhhhcc-c-cccccccccccccccccc
Confidence 8753 23578899999999999998743 45778888 9999999999973 3 468999999999999999
Q ss_pred CcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCcee
Q 004218 166 ISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQI 207 (767)
Q Consensus 166 i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 207 (767)
+++. ..+.++++|++|++++|++++ ++ .++.+++|++|
T Consensus 162 l~~l--~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 162 VTDL--KPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ccCC--ccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 9863 358999999999999999985 33 58889999876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=1.1e-19 Score=197.35 Aligned_cols=357 Identities=17% Similarity=0.155 Sum_probs=211.4
Q ss_pred CCCccEEeCCCCeeee----cCCCccccCCCCCcEEEccCCccccc----CCcccc-CCCCCCEEEcccccCccc----C
Q 004218 1 MTSLVYLGLASNQLWG----EIPYDVGDKLPNLLGFNFCFNKFTGK----IPGSLH-NLTNIQIIRMAHNLLEGT----V 67 (767)
Q Consensus 1 l~~L~~L~l~~n~l~~----~ip~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~-~l~~L~~L~l~~n~i~~~----~ 67 (767)
|+++++|+|++|+++. .|+..+ ...++|++|+|++|+|+.. +...+. ...+|++|+|++|.+++. +
T Consensus 26 l~~l~~L~L~~~~i~~~~~~~l~~~L-~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l 104 (460)
T d1z7xw1 26 LQQCQVVRLDDCGLTEARCKDISSAL-RVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL 104 (460)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHH-HTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCEEEeCCCCCCHHHHHHHHHHH-hcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccc
Confidence 4689999999999873 233333 3588999999999998732 233333 345899999999999853 4
Q ss_pred CccCCCCCCCcEEeecCccccCCCCCCcccccccc-CCCCCCEEECcCCcceeecC----chhhhhccccCeEEccCCcc
Q 004218 68 PPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLT-NSTRLNFLAFDGNQFEGEIP----ESIGNLSNVLSKLYMGGNRF 142 (767)
Q Consensus 68 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~-~l~~L~~L~l~~n~l~~~~~----~~~~~l~~~L~~L~l~~n~i 142 (767)
+..+..+++|++|++++|.+...+.. .....+. ..............+..... ..+..... ++.++++.+.+
T Consensus 105 ~~~l~~~~~L~~L~L~~N~i~~~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~~ls~~~~ 181 (460)
T d1z7xw1 105 SSTLRTLPTLQELHLSDNLLGDAGLQ--LLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD-FKELTVSNNDI 181 (460)
T ss_dssp HHHTTSCTTCCEEECCSSBCHHHHHH--HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTT-CCEEECCSSBC
T ss_pred cchhhccccccccccccccchhhhhh--hhhhcccccccccccccccccccchhhhcccccccccccc-ccccccccccc
Confidence 56788899999999999987532110 1111121 12233444444444331111 11122233 66677776655
Q ss_pred cccC----Cccc-cCCCCCCEEECcCCcCcccC----ccccCCCCCCCEEEccCCcccc-----ccCcCcccCCCCceee
Q 004218 143 YGKI----PTSI-GRLRSLTLLNLSYNSISGEI----LTEIGQLQELQSLDLAGNQISG-----SIPNTLGNLKKLNQID 208 (767)
Q Consensus 143 ~~~~----~~~l-~~l~~L~~L~l~~n~i~~~~----~~~~~~l~~L~~L~L~~n~i~~-----~~~~~~~~l~~L~~L~ 208 (767)
.... ...+ ........+++..+.+.... ...+...+.++.+++++|.+.. ..+........++.|+
T Consensus 182 ~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~ 261 (460)
T d1z7xw1 182 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 261 (460)
T ss_dssp HHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred ccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccccccc
Confidence 4211 1111 12235566676666555221 1223445667777777776542 1122233455677777
Q ss_pred CCCCcCCCCC----cccccCccccccccccCcccCCCCChhh----c-ccccccceeecccccCCCCCch----hhcCCC
Q 004218 209 LSGNELASEI----PTSFGNFQNLLSIDLSNNKLNGNIPKEI----L-SLSSLTTIVNLSKNFLDGTLPE----EIGMLG 275 (767)
Q Consensus 209 L~~N~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~~----~-~l~~l~~~l~l~~n~l~~~~~~----~~~~l~ 275 (767)
+++|.+.... ...+...+.++.+++++|.++......+ . ....+ +.+++++|.++..... .+...+
T Consensus 262 l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L-~~l~l~~~~l~~~~~~~l~~~~~~~~ 340 (460)
T d1z7xw1 262 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL-ESLWVKSCSFTAACCSHFSSVLAQNR 340 (460)
T ss_dssp CTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCC-CEEECTTSCCBGGGHHHHHHHHHHCS
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhcccccccccc-ccccccccchhhhhhhhccccccccc
Confidence 7777665321 1223455667777777776653222211 1 12233 4447777776644332 334556
Q ss_pred ceeEEEccCCCCCCC----CCcccc-cCcccceeeccCccccCC----CCchhhccCCceEEEcCCcccCCCCCccc---
Q 004218 276 NVVTIDLSANGLSGN----LPNSFK-NCKSLEKLLMANNKFSGP----IPNILAELKGLEVLDLSSNKLSGSIPSDL--- 343 (767)
Q Consensus 276 ~L~~L~ls~n~l~~~----~~~~~~-~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~--- 343 (767)
+|++|+|++|.+++. ++..+. ..+.|++|+|++|.|+.. +.+.+..+++|++|+|++|+|+......+
T Consensus 341 ~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 420 (460)
T d1z7xw1 341 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420 (460)
T ss_dssp SCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHH
T ss_pred chhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHH
Confidence 899999999988642 222232 456799999999998753 34556677999999999999874333322
Q ss_pred -c-ccccCceEeccCCcCcCc
Q 004218 344 -Q-NLRALRSLNLTFNNLEGV 362 (767)
Q Consensus 344 -~-~l~~L~~L~l~~N~l~~~ 362 (767)
. ....|+.|++.+|.+...
T Consensus 421 l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 421 VRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp HTSTTCCCCEEECTTCCCCHH
T ss_pred HHhCCCccCEEECCCCCCCHH
Confidence 1 223699999999988753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=2.6e-16 Score=157.87 Aligned_cols=222 Identities=16% Similarity=0.217 Sum_probs=140.4
Q ss_pred cEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCccc-CCccCCCCCCCcEEeec
Q 004218 5 VYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGT-VPPGLGNLPFLKMYNIG 83 (767)
Q Consensus 5 ~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~-~~~~~~~l~~L~~L~l~ 83 (767)
+.|||+++.+...+...+.. ..+..+.++.+.+...+ .......+|++|||++|.+++. +...+..+++|++|+|+
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred CEEECCCCCCCchHHHHHHh--ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence 47888888876444444443 23556666666665332 2344556888888888887643 34456777888888888
Q ss_pred CccccCCCCCCccccccccCCCCCCEEECcCC-cceeecCch-hhhhccccCeEEccCC-ccccc-CCccccC-CCCCCE
Q 004218 84 FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGN-QFEGEIPES-IGNLSNVLSKLYMGGN-RFYGK-IPTSIGR-LRSLTL 158 (767)
Q Consensus 84 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n-~l~~~~~~~-~~~l~~~L~~L~l~~n-~i~~~-~~~~l~~-l~~L~~ 158 (767)
+|++.. ..+..+..+++|++|++++| .++...-.. ...+++ |++|++++| +++.. +...+.. .++|+.
T Consensus 80 ~~~l~~------~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~-L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~ 152 (284)
T d2astb2 80 GLRLSD------PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR-LDELNLSWCFDFTEKHVQVAVAHVSETITQ 152 (284)
T ss_dssp TCBCCH------HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT-CCEEECCCCTTCCHHHHHHHHHHSCTTCCE
T ss_pred ccCCCc------HHHHHHhcCCCCcCccccccccccccccchhhHHHHh-ccccccccccccccccchhhhcccccccch
Confidence 887643 45566777788888888885 455322122 234555 888888875 34321 1222333 467888
Q ss_pred EECcCC--cCcccCc-cccCCCCCCCEEEccCC-ccccccCcCcccCCCCceeeCCCC-cCCCCCcccccCccccccccc
Q 004218 159 LNLSYN--SISGEIL-TEIGQLQELQSLDLAGN-QISGSIPNTLGNLKKLNQIDLSGN-ELASEIPTSFGNFQNLLSIDL 233 (767)
Q Consensus 159 L~l~~n--~i~~~~~-~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l 233 (767)
|+++++ .++.... ..+..+++|++|++++| .+++.....+..+++|++|+|++| .++......++++++|+.|++
T Consensus 153 L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l 232 (284)
T d2astb2 153 LNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQV 232 (284)
T ss_dssp EECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEEC
T ss_pred hhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEee
Confidence 888764 3442222 22345778888888775 466566666777888888888874 565444556677778888887
Q ss_pred cCc
Q 004218 234 SNN 236 (767)
Q Consensus 234 ~~n 236 (767)
+++
T Consensus 233 ~~~ 235 (284)
T d2astb2 233 FGI 235 (284)
T ss_dssp TTS
T ss_pred eCC
Confidence 776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=7.4e-16 Score=154.46 Aligned_cols=234 Identities=15% Similarity=0.177 Sum_probs=167.2
Q ss_pred ccEEeCCCCeeeecCCCccccCCCCCcEEEccCCccccc-CCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEee
Q 004218 4 LVYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGK-IPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNI 82 (767)
Q Consensus 4 L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~-~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 82 (767)
+..+.++...+. ......+ ...+|++|++++|.+... ++..+.++++|++|+|++|.+++..+..++.+++|++|++
T Consensus 25 ~~~lrl~~~~~~-~~~~~~~-~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L 102 (284)
T d2astb2 25 VIAFRCPRSFMD-QPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 102 (284)
T ss_dssp CSEEECTTCEEC-SCCCSCC-CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred ceEeeccccccc-cchhhhc-cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccc
Confidence 456677777765 3333333 467899999999998743 4566889999999999999999888888999999999999
Q ss_pred cCcc-ccCCCCCCccccccccCCCCCCEEECcCC-cceee-cCchhhhhccccCeEEccCC--ccccc-CCccccCCCCC
Q 004218 83 GFNK-IVGSGDEGLSFITSLTNSTRLNFLAFDGN-QFEGE-IPESIGNLSNVLSKLYMGGN--RFYGK-IPTSIGRLRSL 156 (767)
Q Consensus 83 ~~n~-l~~~~~~~~~~~~~l~~l~~L~~L~l~~n-~l~~~-~~~~~~~l~~~L~~L~l~~n--~i~~~-~~~~l~~l~~L 156 (767)
++|. ++.. .+..-..++++|++|++++| .++.. +...+......|+.|+++++ .++.. +...+.++++|
T Consensus 103 s~c~~itd~-----~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L 177 (284)
T d2astb2 103 SGCSGFSEF-----ALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177 (284)
T ss_dssp TTCBSCCHH-----HHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTC
T ss_pred ccccccccc-----ccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccc
Confidence 9964 4321 12222456899999999997 45422 23344454444999999976 34422 23334678999
Q ss_pred CEEECcCC-cCcccCccccCCCCCCCEEEccCC-ccccccCcCcccCCCCceeeCCCCcCCCCCcccccCc-cccccccc
Q 004218 157 TLLNLSYN-SISGEILTEIGQLQELQSLDLAGN-QISGSIPNTLGNLKKLNQIDLSGNELASEIPTSFGNF-QNLLSIDL 233 (767)
Q Consensus 157 ~~L~l~~n-~i~~~~~~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l 233 (767)
++|++++| .+++.....+.++++|++|+|++| .+++.....++.+++|+.|+++++ ++. ..+..+ ..+..|.+
T Consensus 178 ~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d---~~l~~l~~~lp~L~i 253 (284)
T d2astb2 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQI 253 (284)
T ss_dssp SEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEE
T ss_pred cccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCH---HHHHHHHHhCccccc
Confidence 99999986 577777788999999999999995 677666667889999999999988 332 222222 34555566
Q ss_pred cCcccCCCCChhhcc
Q 004218 234 SNNKLNGNIPKEILS 248 (767)
Q Consensus 234 ~~n~l~~~~~~~~~~ 248 (767)
..+.++...+..++.
T Consensus 254 ~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 254 NCSHFTTIARPTIGN 268 (284)
T ss_dssp SCCCSCCTTCSSCSS
T ss_pred cCccCCCCCCCccCc
Confidence 777777555544443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=4.4e-15 Score=134.36 Aligned_cols=128 Identities=20% Similarity=0.154 Sum_probs=71.5
Q ss_pred ccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCC
Q 004218 101 LTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQEL 180 (767)
Q Consensus 101 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L 180 (767)
+.+..+|++|+|++|+|+ .++..+..+.+ |+.|+|++|+|+.. +.|..+++|++|++++|+++...+..+..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~-L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQ-FDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTC-CSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred ccCcCcCcEEECCCCCCC-ccCcccccccc-CCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 344555666666666665 34444444554 66666666666532 235666666666666666665444445556666
Q ss_pred CEEEccCCccccccC-cCcccCCCCceeeCCCCcCCCCC---cccccCcccccccc
Q 004218 181 QSLDLAGNQISGSIP-NTLGNLKKLNQIDLSGNELASEI---PTSFGNFQNLLSID 232 (767)
Q Consensus 181 ~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~ 232 (767)
++|++++|+|..... ..+..+++|++|++++|+++... +..+..+++|+.||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 666666666653211 34556666666666666664321 11345556666555
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.53 E-value=3.6e-16 Score=162.09 Aligned_cols=248 Identities=15% Similarity=0.168 Sum_probs=132.3
Q ss_pred CCccccCCCCCCEEEcccccCccc----CCccCCCCCCCcEEeecCccccCCCCC----CccccccccCCCCCCEEECcC
Q 004218 43 IPGSLHNLTNIQIIRMAHNLLEGT----VPPGLGNLPFLKMYNIGFNKIVGSGDE----GLSFITSLTNSTRLNFLAFDG 114 (767)
Q Consensus 43 ~~~~l~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~----~~~~~~~l~~l~~L~~L~l~~ 114 (767)
+...+....+|+.|+|++|.++.. +...+...++|+.|+++.+........ ...+...+..+++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 344455566666666666655432 223445556666666665543221111 112233444556666666666
Q ss_pred Ccceeec----CchhhhhccccCeEEccCCcccccCCc-------------cccCCCCCCEEECcCCcCcccC----ccc
Q 004218 115 NQFEGEI----PESIGNLSNVLSKLYMGGNRFYGKIPT-------------SIGRLRSLTLLNLSYNSISGEI----LTE 173 (767)
Q Consensus 115 n~l~~~~----~~~~~~l~~~L~~L~l~~n~i~~~~~~-------------~l~~l~~L~~L~l~~n~i~~~~----~~~ 173 (767)
|.++... ...+...+. |++|++++|.+...... .....+.|+.|++++|.+.... ...
T Consensus 103 n~i~~~~~~~l~~~l~~~~~-L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~ 181 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTP-LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTT-CCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred cccccccccchhhhhccccc-chheecccccccccccccccccccccccccccccCcccceeecccccccccccccccch
Confidence 6655332 222223343 66666666655421111 1134567777777777776322 223
Q ss_pred cCCCCCCCEEEccCCccccc-----cCcCcccCCCCceeeCCCCcCCCC----CcccccCccccccccccCcccCCCCCh
Q 004218 174 IGQLQELQSLDLAGNQISGS-----IPNTLGNLKKLNQIDLSGNELASE----IPTSFGNFQNLLSIDLSNNKLNGNIPK 244 (767)
Q Consensus 174 ~~~l~~L~~L~L~~n~i~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~ 244 (767)
+...+.|++|+|++|+|... +...+..+++|+.|+|++|.++.. +...+...++|++|+|++|.+++....
T Consensus 182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~ 261 (344)
T d2ca6a1 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261 (344)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhH
Confidence 44567777888877777631 234566677788888887776532 233455677777777777776632222
Q ss_pred hhcccccccceeecccccCCCCCchhhc--CCCceeEEEccCCCCCCCC----Cccc-ccCcccceeeccCcccc
Q 004218 245 EILSLSSLTTIVNLSKNFLDGTLPEEIG--MLGNVVTIDLSANGLSGNL----PNSF-KNCKSLEKLLMANNKFS 312 (767)
Q Consensus 245 ~~~~l~~l~~~l~l~~n~l~~~~~~~~~--~l~~L~~L~ls~n~l~~~~----~~~~-~~l~~L~~L~l~~n~l~ 312 (767)
.+.. .+. ..+.|+.|+|++|.++... ...+ .++++|+.|+|++|.+.
T Consensus 262 ~l~~---------------------~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 262 AVVD---------------------AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHH---------------------HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHHH---------------------HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 2211 111 1235677777777665321 1222 24566777777777775
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=2.4e-14 Score=122.93 Aligned_cols=103 Identities=26% Similarity=0.401 Sum_probs=82.1
Q ss_pred cEEeCCCCeeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecC
Q 004218 5 VYLGLASNQLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGF 84 (767)
Q Consensus 5 ~~L~l~~n~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (767)
++|||++|+++ .+|. + ..+++|++|++++|+|+ .+|..++.+++|++|++++|.|+ .+| .++.+++|++|++++
T Consensus 1 R~L~Ls~n~l~-~l~~-l-~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-L-EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCS-SCCC-G-GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCS
T ss_pred CEEEcCCCCCC-CCcc-c-ccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCC
Confidence 57899999998 7774 3 46889999999999998 67778889999999999999998 344 588888899999998
Q ss_pred ccccCCCCCCccccccccCCCCCCEEECcCCcce
Q 004218 85 NKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118 (767)
Q Consensus 85 n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~ 118 (767)
|++... ..+..+..+++|++|++++|+++
T Consensus 75 N~i~~~-----~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 75 NRLQQS-----AAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp SCCCSS-----STTGGGGGCTTCCEEECTTSGGG
T ss_pred CccCCC-----CCchhhcCCCCCCEEECCCCcCC
Confidence 888754 22345677778888888888776
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.5e-14 Score=130.76 Aligned_cols=111 Identities=16% Similarity=0.114 Sum_probs=54.5
Q ss_pred ccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhh
Q 004218 47 LHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIG 126 (767)
Q Consensus 47 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~ 126 (767)
+.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|++... ..+..+++|++|++++|+++...+..+.
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--------~~~~~l~~L~~L~ls~N~i~~l~~~~~~ 84 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--------DGFPLLRRLKTLLVNNNRICRIGEGLDQ 84 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--------CCCCCCSSCCEEECCSSCCCEECSCHHH
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--------CCcccCcchhhhhcccccccCCCccccc
Confidence 344445555555555554 3344344455555555555554321 2244455555555555555533333334
Q ss_pred hhccccCeEEccCCcccccC-CccccCCCCCCEEECcCCcCc
Q 004218 127 NLSNVLSKLYMGGNRFYGKI-PTSIGRLRSLTLLNLSYNSIS 167 (767)
Q Consensus 127 ~l~~~L~~L~l~~n~i~~~~-~~~l~~l~~L~~L~l~~n~i~ 167 (767)
.++. |++|++++|++.... ...+..+++|++|++++|.++
T Consensus 85 ~l~~-L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 85 ALPD-LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp HCTT-CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccc-cccceeccccccccccccccccccccchhhcCCCccc
Confidence 4444 666666666655221 123455555555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.50 E-value=7.5e-16 Score=159.69 Aligned_cols=241 Identities=17% Similarity=0.215 Sum_probs=168.6
Q ss_pred CCCCCcEEEccCCcccc----cCCccccCCCCCCEEEcccccCcc----------cCCccCCCCCCCcEEeecCccccCC
Q 004218 25 KLPNLLGFNFCFNKFTG----KIPGSLHNLTNIQIIRMAHNLLEG----------TVPPGLGNLPFLKMYNIGFNKIVGS 90 (767)
Q Consensus 25 ~l~~L~~L~l~~n~l~~----~~~~~l~~l~~L~~L~l~~n~i~~----------~~~~~~~~l~~L~~L~l~~n~l~~~ 90 (767)
....|++|+|++|.+.. .+...+..+++|+.|+++++.... .+...+..+++|++|+|++|.+...
T Consensus 29 ~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 108 (344)
T d2ca6a1 29 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 108 (344)
T ss_dssp HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTT
T ss_pred hCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccc
Confidence 46789999999998864 344567888999999999876542 1233456778999999999987642
Q ss_pred CCCCccccccccCCCCCCEEECcCCcceeecCchhh-------------hhccccCeEEccCCccccc----CCccccCC
Q 004218 91 GDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIG-------------NLSNVLSKLYMGGNRFYGK----IPTSIGRL 153 (767)
Q Consensus 91 ~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~-------------~l~~~L~~L~l~~n~i~~~----~~~~l~~l 153 (767)
+...+...+..+++|+.|++++|.+.......++ .... |+.|++++|+++.. +...+..+
T Consensus 109 --~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~-L~~l~l~~n~i~~~~~~~l~~~l~~~ 185 (344)
T d2ca6a1 109 --AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPP-LRSIICGRNRLENGSMKEWAKTFQSH 185 (344)
T ss_dssp --THHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCC-CCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred --cccchhhhhcccccchheecccccccccccccccccccccccccccccCcc-cceeecccccccccccccccchhhhh
Confidence 2224555667789999999999988633222221 1223 88999999988632 33445678
Q ss_pred CCCCEEECcCCcCccc-----CccccCCCCCCCEEEccCCccccc----cCcCcccCCCCceeeCCCCcCCCCCcccc--
Q 004218 154 RSLTLLNLSYNSISGE-----ILTEIGQLQELQSLDLAGNQISGS----IPNTLGNLKKLNQIDLSGNELASEIPTSF-- 222 (767)
Q Consensus 154 ~~L~~L~l~~n~i~~~-----~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-- 222 (767)
++|++|+|++|.|+.. +...+..+++|++|+|++|.+... +...+..+++|++|+|++|.|+......+
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 8999999999998742 234567789999999999998732 34566788999999999999975422222
Q ss_pred --c--CccccccccccCcccCCCCChhhcccccccceeecccccCCCCCchhh-cCCCceeEEEccCCCCCC
Q 004218 223 --G--NFQNLLSIDLSNNKLNGNIPKEILSLSSLTTIVNLSKNFLDGTLPEEI-GMLGNVVTIDLSANGLSG 289 (767)
Q Consensus 223 --~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~l~~~l~l~~n~l~~~~~~~~-~~l~~L~~L~ls~n~l~~ 289 (767)
. ..+.|++|++++|+++......+ ...+ .++++|+.|+|++|.+..
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l---------------------~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTL---------------------KTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHH---------------------HHHHHHHCTTCCEEECTTSBSCT
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHH---------------------HHHHHccCCCCCEEECCCCcCCC
Confidence 2 23678888888888763211111 1122 245678888898888864
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=3.7e-14 Score=121.66 Aligned_cols=101 Identities=25% Similarity=0.383 Sum_probs=47.5
Q ss_pred EEECcCCcceeecCchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccCC
Q 004218 109 FLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAGN 188 (767)
Q Consensus 109 ~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 188 (767)
+|+|++|+++ .++ .+..+.. |++|++++|+|+ .+|..++.+++|++|++++|.|+.. +.+..+++|++|++++|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~-L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLL-VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTT-CCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCc-ccccCCC-CCEEECCCCccC-cchhhhhhhhccccccccccccccc--CccccccccCeEECCCC
Confidence 3444444444 222 2444444 555555555554 3344455555555555555555432 23455555555555555
Q ss_pred ccccccC-cCcccCCCCceeeCCCCcCC
Q 004218 189 QISGSIP-NTLGNLKKLNQIDLSGNELA 215 (767)
Q Consensus 189 ~i~~~~~-~~~~~l~~L~~L~L~~N~l~ 215 (767)
+|..... ..+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 5542211 23444555555555555543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.37 E-value=1.5e-14 Score=135.75 Aligned_cols=115 Identities=24% Similarity=0.365 Sum_probs=59.8
Q ss_pred cCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEeecCccccCCCCCCccccccccCCCCCCEEECcCCcceeec
Q 004218 42 KIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYNIGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEI 121 (767)
Q Consensus 42 ~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 121 (767)
.++.+++.+++|++|+|++|.|+ .++ .+..+++|++|+|++|.+ + .+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i------------------------------~-~i 85 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLI------------------------------K-KI 85 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEE------------------------------C-SC
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhccccc------------------------------c-cc
Confidence 34445555566666666665555 222 244444455555544444 3 33
Q ss_pred CchhhhhccccCeEEccCCcccccCCccccCCCCCCEEECcCCcCcccCc-cccCCCCCCCEEEccCCcccc
Q 004218 122 PESIGNLSNVLSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYNSISGEIL-TEIGQLQELQSLDLAGNQISG 192 (767)
Q Consensus 122 ~~~~~~l~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~i~~ 192 (767)
|.....+.. |++|++++|+++.. ..+..+++|++|++++|+|+.... ..+..+++|++|+|++|.+..
T Consensus 86 ~~~~~~~~~-L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 86 ENLDAVADT-LEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SSHHHHHHH-CCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccc-cccccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 333333333 66666666666532 235555666666666666653221 345666666666666666653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.35 E-value=1.3e-14 Score=136.18 Aligned_cols=127 Identities=22% Similarity=0.270 Sum_probs=85.5
Q ss_pred ccEEeCCCC--eeeecCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcccccCcccCCccCCCCCCCcEEe
Q 004218 4 LVYLGLASN--QLWGEIPYDVGDKLPNLLGFNFCFNKFTGKIPGSLHNLTNIQIIRMAHNLLEGTVPPGLGNLPFLKMYN 81 (767)
Q Consensus 4 L~~L~l~~n--~l~~~ip~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 81 (767)
++.++++++ .+. .+|..+. .+++|++|+|++|+|. .++ .+..+++|++|+|++|.|+ .+|..+..+++|++|+
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~-~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLS-TLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHH-HTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred cceeeeecccCchh-hhhhHHh-cccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccc
Confidence 445566554 344 5555555 5999999999999999 455 4899999999999999998 4554443344566666
Q ss_pred ecCccccCCCCCCccccccccCCCCCCEEECcCCcceeecCchhhhhccccCeEEccCCcccccCC-ccccCCCCCCEEE
Q 004218 82 IGFNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFEGEIPESIGNLSNVLSKLYMGGNRFYGKIP-TSIGRLRSLTLLN 160 (767)
Q Consensus 82 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~L~ 160 (767)
+++|+++ . + +.+..+++ |++|++++|+|+.... ..+..+++|+.|+
T Consensus 100 l~~N~i~------------------------------~-l-~~~~~l~~-L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~ 146 (198)
T d1m9la_ 100 ISYNQIA------------------------------S-L-SGIEKLVN-LRVLYMSNNKITNWGEIDKLAALDKLEDLL 146 (198)
T ss_dssp CSEEECC------------------------------C-H-HHHHHHHH-SSEEEESEEECCCHHHHHHHTTTTTCSEEE
T ss_pred ccccccc------------------------------c-c-cccccccc-ccccccccchhccccccccccCCCccceee
Confidence 6665553 1 1 23555655 7777777777653211 3567777777777
Q ss_pred CcCCcCcc
Q 004218 161 LSYNSISG 168 (767)
Q Consensus 161 l~~n~i~~ 168 (767)
|++|++..
T Consensus 147 L~~N~l~~ 154 (198)
T d1m9la_ 147 LAGNPLYN 154 (198)
T ss_dssp ECSSHHHH
T ss_pred cCCCcccc
Confidence 77777664
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=3.9e-12 Score=113.79 Aligned_cols=104 Identities=18% Similarity=0.145 Sum_probs=50.7
Q ss_pred EEECcCCcceeecCchhhhhccccCeEEccCC-cccccCCccccCCCCCCEEECcCCcCcccCccccCCCCCCCEEEccC
Q 004218 109 FLAFDGNQFEGEIPESIGNLSNVLSKLYMGGN-RFYGKIPTSIGRLRSLTLLNLSYNSISGEILTEIGQLQELQSLDLAG 187 (767)
Q Consensus 109 ~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n-~i~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 187 (767)
.++++++.+. ..|..+..+++ |++|++++| .++.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~-l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAEN-LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSC-CSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred eEEecCCCCc-cCcccccCccc-cCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 3444444444 33444444444 555555433 24444444555555555555555555554455555555555555555
Q ss_pred CccccccCcCcccCCCCceeeCCCCcCC
Q 004218 188 NQISGSIPNTLGNLKKLNQIDLSGNELA 215 (767)
Q Consensus 188 n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 215 (767)
|+|+...+..|.. .+|+.|+|++|++.
T Consensus 90 N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CCCcccChhhhcc-ccccccccCCCccc
Confidence 5555333333332 24555555555553
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=6e-12 Score=112.57 Aligned_cols=106 Identities=21% Similarity=0.198 Sum_probs=94.0
Q ss_pred cCeEEccCCcccccCCccccCCCCCCEEECcCC-cCcccCccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCC
Q 004218 132 LSKLYMGGNRFYGKIPTSIGRLRSLTLLNLSYN-SISGEILTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLS 210 (767)
Q Consensus 132 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n-~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 210 (767)
.+.++++++++. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 567899999987 56888999999999999876 5998888899999999999999999998888999999999999999
Q ss_pred CCcCCCCCcccccCccccccccccCcccC
Q 004218 211 GNELASEIPTSFGNFQNLLSIDLSNNKLN 239 (767)
Q Consensus 211 ~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 239 (767)
+|+|+...+..|..+ +|+.|+|++|.+.
T Consensus 89 ~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCCcccChhhhccc-cccccccCCCccc
Confidence 999997666667554 7999999999986
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.55 E-value=1.1e-07 Score=93.01 Aligned_cols=149 Identities=17% Similarity=0.099 Sum_probs=104.7
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCcc
Q 004218 448 DELRRATGNFSHENLIGSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFK 526 (767)
Q Consensus 448 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 526 (767)
.++.....+|+..+..+.++.+.||+.... ++.+++|+...........+.+|...++.+. +--+.+++.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~----- 80 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----- 80 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe-----
Confidence 466777778887776555556789998754 6678889886555555566788988887663 333566666532
Q ss_pred cceeeEEEEeecCCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------
Q 004218 527 NMEFLALVYEFLGNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC------------------------ 582 (767)
Q Consensus 527 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------ 582 (767)
.++..++||++++|.++.+...... ....++.++++.++.||+..
T Consensus 81 ~~~~~~lv~~~l~G~~~~~~~~~~~-----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (263)
T d1j7la_ 81 HDGWSNLLMSEADGVLCSEEYEDEQ-----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND 149 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHTTTCS-----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred cCCceEEEEEecccccccccccccc-----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHH
Confidence 3355689999999988876543211 23345677777777787531
Q ss_pred --------------------------------CCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 583 --------------------------------EVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 583 --------------------------------~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
+..++|+|+.|.||++++++.+-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0137999999999999987767799998875
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.47 E-value=4.3e-09 Score=94.32 Aligned_cols=64 Identities=27% Similarity=0.274 Sum_probs=26.6
Q ss_pred CCCCCCEEECcCCcCcccC--ccccCCCCCCCEEEccCCccccccCcCcccCCCCceeeCCCCcCC
Q 004218 152 RLRSLTLLNLSYNSISGEI--LTEIGQLQELQSLDLAGNQISGSIPNTLGNLKKLNQIDLSGNELA 215 (767)
Q Consensus 152 ~l~~L~~L~l~~n~i~~~~--~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 215 (767)
.+++|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+-.+....+|+.|++++|++.
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 3444455555555444321 122334444445555555444222211222234444555555444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=4.2e-08 Score=87.69 Aligned_cols=82 Identities=20% Similarity=0.173 Sum_probs=47.9
Q ss_pred cCCCceeEEEccCCCCCCCC--CcccccCcccceeeccCccccCCCCchhhccCCceEEEcCCcccCCCCCcc-------
Q 004218 272 GMLGNVVTIDLSANGLSGNL--PNSFKNCKSLEKLLMANNKFSGPIPNILAELKGLEVLDLSSNKLSGSIPSD------- 342 (767)
Q Consensus 272 ~~l~~L~~L~ls~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------- 342 (767)
..+++|+.|+|++|+|+... +..+..+++|+.|++++|.|+...+-.+....+|+.|++++|++.......
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 34556666666666666432 234556667777777777766443333334455777777777776443322
Q ss_pred ccccccCceEe
Q 004218 343 LQNLRALRSLN 353 (767)
Q Consensus 343 ~~~l~~L~~L~ 353 (767)
+..+|+|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 44567777664
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.95 E-value=6.7e-07 Score=80.01 Aligned_cols=91 Identities=12% Similarity=0.099 Sum_probs=48.5
Q ss_pred CCCCcEEEccCC-cccc----cCCccccCCCCCCEEEcccccCcccCC----ccCCCCCCCcEEeecCccccCCCCCCcc
Q 004218 26 LPNLLGFNFCFN-KFTG----KIPGSLHNLTNIQIIRMAHNLLEGTVP----PGLGNLPFLKMYNIGFNKIVGSGDEGLS 96 (767)
Q Consensus 26 l~~L~~L~l~~n-~l~~----~~~~~l~~l~~L~~L~l~~n~i~~~~~----~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 96 (767)
.+.|++|+|+++ .+.. .+...+...++|++|+|++|.+++... ..+...+.|++|+|++|.+.. .+...
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~--~g~~~ 91 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP--ELLAR 91 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH--HHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch--HHHHH
Confidence 456777777653 3442 133445666667777777776664222 223334556666666665542 22223
Q ss_pred ccccccCCCCCCEEECcCCcce
Q 004218 97 FITSLTNSTRLNFLAFDGNQFE 118 (767)
Q Consensus 97 ~~~~l~~l~~L~~L~l~~n~l~ 118 (767)
+...+...++|++|++++|.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 4445555556666666555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.91 E-value=1.5e-06 Score=77.66 Aligned_cols=19 Identities=11% Similarity=0.233 Sum_probs=9.3
Q ss_pred cccCCCCCCEEECcCCcce
Q 004218 100 SLTNSTRLNFLAFDGNQFE 118 (767)
Q Consensus 100 ~l~~l~~L~~L~l~~n~l~ 118 (767)
.+...++|++|+|++|.+.
T Consensus 39 ~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 39 AACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp HHTTCSCCCEEECTTSCCB
T ss_pred HHhhCCccceeeccccccc
Confidence 3444445555555555444
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.89 E-value=2.4e-05 Score=75.19 Aligned_cols=130 Identities=15% Similarity=0.013 Sum_probs=84.9
Q ss_pred ccccccc-eEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCC--CCCceeEEeeeecCCcccceeeEEEEeec
Q 004218 462 LIGSGSF-GSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTR--HRNLVKLITSCSSLDFKNMEFLALVYEFL 538 (767)
Q Consensus 462 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 538 (767)
.+..|.. +.||+....++..+++|..... ....+..|+..++.+. .-.+.+++.++. +++..++||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEee
Confidence 4455554 6789999887888999986533 2345667888777663 233566676643 334568999999
Q ss_pred CCCChhhhhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 004218 539 GNGSLGDWIHGERKNEHGNGLNFLERLNIAIDIASALDYLHNDC------------------------------------ 582 (767)
Q Consensus 539 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 582 (767)
+|.++.+.. .+. ...+.++.+.++-||+..
T Consensus 89 ~G~~~~~~~-----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (255)
T d1nd4a_ 89 PGQDLLSSH-----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 154 (255)
T ss_dssp SSEETTTSC-----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred ecccccccc-----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhh
Confidence 986654321 111 122344555555555321
Q ss_pred -------------------CCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 583 -------------------EVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 583 -------------------~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
+..++|+|+.|.||+++++..+-|+||+.+.
T Consensus 155 ~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 155 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1248999999999999987777899998774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.60 E-value=9.8e-05 Score=75.55 Aligned_cols=76 Identities=21% Similarity=0.124 Sum_probs=48.6
Q ss_pred CCccccccceEEEEEEeCC-CcEEEEEEeecc-------CCcchhhHHHHHHHHhcCC-C--CCceeEEeeeecCCcccc
Q 004218 460 ENLIGSGSFGSVYKGYLRE-GISVAVKVLDIE-------STGTWKSFFAECEALRNTR-H--RNLVKLITSCSSLDFKNM 528 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~~ 528 (767)
.+.||.|....||++...+ ++.|+||.-... -+....+...|.+.++.+. + ..+.+++.+...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~------ 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE------ 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT------
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC------
Confidence 3568999999999998654 678999975321 1112345667888887662 2 346666665322
Q ss_pred eeeEEEEeecCCCC
Q 004218 529 EFLALVYEFLGNGS 542 (767)
Q Consensus 529 ~~~~lv~e~~~~gs 542 (767)
..++|||++++..
T Consensus 105 -~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 -MAVTVMEDLSHLK 117 (392)
T ss_dssp -TTEEEECCCTTSE
T ss_pred -CCEEEEeccCCcc
Confidence 2378999997754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.40 E-value=9e-06 Score=72.42 Aligned_cols=62 Identities=19% Similarity=0.086 Sum_probs=27.5
Q ss_pred CCCCcEEEccC-Ccccc----cCCccccCCCCCCEEEcccccCcccC----CccCCCCCCCcEEeecCccc
Q 004218 26 LPNLLGFNFCF-NKFTG----KIPGSLHNLTNIQIIRMAHNLLEGTV----PPGLGNLPFLKMYNIGFNKI 87 (767)
Q Consensus 26 l~~L~~L~l~~-n~l~~----~~~~~l~~l~~L~~L~l~~n~i~~~~----~~~~~~l~~L~~L~l~~n~l 87 (767)
.+.|++|+|++ +.++. .+...+..+++|++|+|++|.++... ...+...+.++.+++++|.+
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~ 86 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 86 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccc
Confidence 34555555554 23432 12233445555555555555554321 12223334444555444443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.37 E-value=6.6e-06 Score=73.33 Aligned_cols=115 Identities=11% Similarity=0.070 Sum_probs=79.5
Q ss_pred CCccEEeCCC-CeeeecCCCcc---ccCCCCCcEEEccCCccccc----CCccccCCCCCCEEEcccccCccc----CCc
Q 004218 2 TSLVYLGLAS-NQLWGEIPYDV---GDKLPNLLGFNFCFNKFTGK----IPGSLHNLTNIQIIRMAHNLLEGT----VPP 69 (767)
Q Consensus 2 ~~L~~L~l~~-n~l~~~ip~~~---~~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~l~~n~i~~~----~~~ 69 (767)
+.|++|+|++ +.++...-..+ +...++|++|+|++|.+... +...+...++|+.|++++|.++.. +..
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 6799999998 45653221112 23578899999999998743 445678889999999999999753 335
Q ss_pred cCCCCCCCcEEeec--CccccCCCCCCccccccccCCCCCCEEECcCCcce
Q 004218 70 GLGNLPFLKMYNIG--FNKIVGSGDEGLSFITSLTNSTRLNFLAFDGNQFE 118 (767)
Q Consensus 70 ~~~~l~~L~~L~l~--~n~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~ 118 (767)
.+...++|+.++|+ .|++. ..+...+...+...++|+.|+++.+...
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~--~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLG--NNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCC--HHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCccccEEeeccCCCcCc--HHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 66777888876664 44443 2222345566677788888888776543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.15 E-value=0.00054 Score=67.94 Aligned_cols=142 Identities=17% Similarity=0.118 Sum_probs=78.8
Q ss_pred ceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCC--ceeEEeeeecCCcccceeeEEEEeecCCCChh-
Q 004218 468 FGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRN--LVKLITSCSSLDFKNMEFLALVYEFLGNGSLG- 544 (767)
Q Consensus 468 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~- 544 (767)
--.||++...+|+.|++|+.+.. ....+++..|.+.+..+.... ++..+...........+..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35899999999999999998643 223466778888887764222 22222221111233455678899999874321
Q ss_pred -----------------hhhcccCCCCCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhCCCC
Q 004218 545 -----------------DWIHGERKNEHGNGLNFL----------------------ERLNIAIDIASALDYL-HNDCEV 584 (767)
Q Consensus 545 -----------------~~l~~~~~~~~~~~l~~~----------------------~~~~i~~~i~~~l~~L-H~~~~~ 584 (767)
....... .......+.. .....+.++...+.-. .+..+.
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~-~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQL-FIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSC-CSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCHHHHHHHHHHHHHHHhhcccCC-ccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1111110 0111111111 1122223333333222 122245
Q ss_pred CeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 585 PIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 585 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
++||+|+.+.||+++++ ..++||+.+.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC--ceEEechhcc
Confidence 79999999999999753 4589999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.82 E-value=0.0011 Score=67.59 Aligned_cols=73 Identities=19% Similarity=0.096 Sum_probs=49.5
Q ss_pred CCccccccceEEEEEEeCC--------CcEEEEEEeeccCCcchhhHHHHHHHHhcCC-CCCceeEEeeeecCCccccee
Q 004218 460 ENLIGSGSFGSVYKGYLRE--------GISVAVKVLDIESTGTWKSFFAECEALRNTR-HRNLVKLITSCSSLDFKNMEF 530 (767)
Q Consensus 460 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 530 (767)
++.|+.|-.-.+|++...+ .+.|.+++.. . ........+|..+++.+. +.-..++++++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-------- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG-------- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--------
Confidence 3568888999999998653 3567777764 2 223345568888888874 4334577776431
Q ss_pred eEEEEeecCCCCh
Q 004218 531 LALVYEFLGNGSL 543 (767)
Q Consensus 531 ~~lv~e~~~~gsL 543 (767)
++||||++|.++
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 689999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.64 E-value=0.0048 Score=60.53 Aligned_cols=166 Identities=14% Similarity=0.011 Sum_probs=84.3
Q ss_pred cCHHHHHHHhcCCCCCCcc-----ccccceEEEEEEeCCCcEEEEEEeeccCCcchhhHHHHHHHHhcCCCCC--ceeEE
Q 004218 445 ISYDELRRATGNFSHENLI-----GSGSFGSVYKGYLREGISVAVKVLDIESTGTWKSFFAECEALRNTRHRN--LVKLI 517 (767)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~ 517 (767)
++-+++.....+|.+.+.. ..|---+.|+.+..+| .+++|++... ...+.+..|++++..+...+ +...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 5678888888999886553 3566678899987766 4899998532 12344555666666653221 11111
Q ss_pred eeeecC-CcccceeeEEEEeecCCCChhhh--------------hc----ccCCCCCCCCC-----------------CH
Q 004218 518 TSCSSL-DFKNMEFLALVYEFLGNGSLGDW--------------IH----GERKNEHGNGL-----------------NF 561 (767)
Q Consensus 518 ~~~~~~-~~~~~~~~~lv~e~~~~gsL~~~--------------l~----~~~~~~~~~~l-----------------~~ 561 (767)
...... -..-....+.++.++.+...... ++ ........... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110000 01112344566666665332110 00 00000000000 00
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccccchh
Q 004218 562 LERLNIAIDIASALDYLHN-DCEVPIVHCDLKPGNILLDEDMTAKVGDFGLAR 613 (767)
Q Consensus 562 ~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 613 (767)
......+......+...+. ..+.|+||+|+.++||+++.+...-++||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111122222222222222 224689999999999999988877899999885
|